Citrus Sinensis ID: 007073
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 619 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGT1 | 613 | Probable LRR receptor-lik | yes | no | 0.956 | 0.965 | 0.809 | 0.0 | |
| C0LGX1 | 607 | Probable LRR receptor-lik | no | no | 0.956 | 0.975 | 0.787 | 0.0 | |
| Q8W4S5 | 614 | Probable LRR receptor-lik | no | no | 0.896 | 0.903 | 0.578 | 0.0 | |
| Q94AG2 | 625 | Somatic embryogenesis rec | no | no | 0.951 | 0.942 | 0.556 | 1e-179 | |
| Q94F62 | 615 | BRASSINOSTEROID INSENSITI | no | no | 0.883 | 0.889 | 0.567 | 1e-169 | |
| Q9SKG5 | 620 | Somatic embryogenesis rec | no | no | 0.882 | 0.880 | 0.555 | 1e-158 | |
| Q8LPS5 | 601 | Somatic embryogenesis rec | no | no | 0.877 | 0.903 | 0.539 | 1e-156 | |
| Q8RY65 | 635 | Protein NSP-INTERACTING K | no | no | 0.924 | 0.900 | 0.498 | 1e-156 | |
| Q9LFS4 | 638 | Protein NSP-INTERACTING K | no | no | 0.941 | 0.913 | 0.488 | 1e-152 | |
| Q93ZS4 | 632 | Protein NSP-INTERACTING K | no | no | 0.925 | 0.906 | 0.485 | 1e-147 |
| >sp|C0LGT1|Y5129_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g10290 OS=Arabidopsis thaliana GN=At5g10290 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 960 bits (2481), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 483/597 (80%), Positives = 528/597 (88%), Gaps = 5/597 (0%)
Query: 28 WLTFLCSL-----SGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVT 82
+ LCS GDALFALR SLR NQL DWNQNQVNPCTWS VICD+ N V S+T
Sbjct: 17 FFACLCSFVSPDAQGDALFALRISLRALPNQLSDWNQNQVNPCTWSQVICDDKNFVTSLT 76
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 142
LS MNFSGTLS R+G+L L TLTLKGNGITGEIPE+ GNL+SLTSLDL++N+L G+IP
Sbjct: 77 LSDMNFSGTLSSRVGILENLKTLTLKGNGITGEIPEDFGNLTSLTSLDLEDNQLTGRIPS 136
Query: 143 SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTG 202
++GNLKKLQFLTLS+N +GTIP+SLT L +L+++ LDSN+LSGQIP LF+IPKYNFT
Sbjct: 137 TIGNLKKLQFLTLSRNKLNGTIPESLTGLPNLLNLLLDSNSLSGQIPQSLFEIPKYNFTS 196
Query: 203 NNLNCGKTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGLLFFLCKGRHKGYKR 262
NNLNCG PH C S+ SG S KPK GII G+V G+ V++ G LLF CK RHKGY+R
Sbjct: 197 NNLNCGGRQPHPCVSAVAHSGDSSKPKTGIIAGVVAGVTVVLFGILLFLFCKDRHKGYRR 256
Query: 263 EVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVA 322
+VFVDVAGEVDRRIAFGQLKR++WRELQLATDNFSEKNVLGQGGFGKVY+GVL D TKVA
Sbjct: 257 DVFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVA 316
Query: 323 VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRL 382
VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT TERLLVYPFMQNLS+A+RL
Sbjct: 317 VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRL 376
Query: 383 REIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 442
REIK G+PVLDW TRKR+ALGAARG EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF
Sbjct: 377 REIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 436
Query: 443 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 502
GLAKLVDVR+TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS
Sbjct: 437 GLAKLVDVRRTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 496
Query: 503 RLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA 562
RLEEEDDVLLLDHVKKLEREKRL AIVD+NL+ Y +EVE MIQVALLCTQ SPEDRP
Sbjct: 497 RLEEEDDVLLLDHVKKLEREKRLGAIVDKNLDGEYIKEEVEMMIQVALLCTQGSPEDRPV 556
Query: 563 MSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR 619
MSEVVRMLEGEGLAERWEEWQ+VEVTRR E+ERLQRRFDWGEDS++NQ+AIELSGGR
Sbjct: 557 MSEVVRMLEGEGLAERWEEWQNVEVTRRHEFERLQRRFDWGEDSMHNQDAIELSGGR 613
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGX1|Y5524_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g65240 OS=Arabidopsis thaliana GN=At5g65240 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 931 bits (2405), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 467/593 (78%), Positives = 521/593 (87%), Gaps = 1/593 (0%)
Query: 28 WLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMN 87
W + GDALFALR+SLR QL DWNQNQV+PCTWS VICD+ +V SVTLS MN
Sbjct: 15 WSSVSPDAQGDALFALRSSLRASPEQLSDWNQNQVDPCTWSQVICDDKKHVTSVTLSYMN 74
Query: 88 FS-GTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGN 146
FS GTLS IG+L TL TLTLKGNGI G IPE +GNLSSLTSLDL++N L +IP +LGN
Sbjct: 75 FSSGTLSSGIGILTTLKTLTLKGNGIMGGIPESIGNLSSLTSLDLEDNHLTDRIPSTLGN 134
Query: 147 LKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLN 206
LK LQFLTLS+NN +G+IPDSLT LS LI+I LDSNNLSG+IP LF+IPKYNFT NNL+
Sbjct: 135 LKNLQFLTLSRNNLNGSIPDSLTGLSKLINILLDSNNLSGEIPQSLFKIPKYNFTANNLS 194
Query: 207 CGKTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGLLFFLCKGRHKGYKREVFV 266
CG T P C + S+ SG S K GII G+V G+ V++ G FF CK +HKGYKR+VFV
Sbjct: 195 CGGTFPQPCVTESSPSGDSSSRKTGIIAGVVSGIAVILLGFFFFFFCKDKHKGYKRDVFV 254
Query: 267 DVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL 326
DVAGEVDRRIAFGQL+R++WRELQLATD FSEKNVLGQGGFGKVY+G+L+DGTKVAVKRL
Sbjct: 255 DVAGEVDRRIAFGQLRRFAWRELQLATDEFSEKNVLGQGGFGKVYKGLLSDGTKVAVKRL 314
Query: 327 TDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIK 386
TDFE PGGD AFQREVEMISVAVHRNLLRLIGFCTT TERLLVYPFMQNLSVAY LREIK
Sbjct: 315 TDFERPGGDEAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSVAYCLREIK 374
Query: 387 PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446
PG+PVLDW RK++ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK
Sbjct: 375 PGDPVLDWFRRKQIALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 434
Query: 447 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE 506
LVDVR+TNVTTQVRGTMGHIAPE +STGKSSE+TDVFGYGIMLLELVTGQRAIDFSRLEE
Sbjct: 435 LVDVRRTNVTTQVRGTMGHIAPECISTGKSSEKTDVFGYGIMLLELVTGQRAIDFSRLEE 494
Query: 507 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 566
EDDVLLLDHVKKLEREKRL+ IVD+ L+++Y +EVE MIQVALLCTQA+PE+RPAMSEV
Sbjct: 495 EDDVLLLDHVKKLEREKRLEDIVDKKLDEDYIKEEVEMMIQVALLCTQAAPEERPAMSEV 554
Query: 567 VRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR 619
VRMLEGEGLAERWEEWQ++EVTR++E++RLQRRFDWGEDS+ NQ+AIELSGGR
Sbjct: 555 VRMLEGEGLAERWEEWQNLEVTRQEEFQRLQRRFDWGEDSINNQDAIELSGGR 607
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8W4S5|Y5371_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g63710 OS=Arabidopsis thaliana GN=At5g63710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 635 bits (1639), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 343/593 (57%), Positives = 429/593 (72%), Gaps = 38/593 (6%)
Query: 35 LSGDALFALRTSLRVPNNQLRDWNQNQVNPC-TWSNVICDNSNNVASVTLSSMNFSGTLS 93
+ G AL LR SL +N+L+ W ++ V+PC +WS V C +V ++ L+S F+GTLS
Sbjct: 52 IEGGALLQLRDSLNDSSNRLK-WTRDFVSPCYSWSYVTC-RGQSVVALNLASSGFTGTLS 109
Query: 94 PRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFL 153
P I L+ L TL +L NN L G +P SLGN+ LQ L
Sbjct: 110 PAITKLKFLVTL------------------------ELQNNSLSGALPDSLGNMVNLQTL 145
Query: 154 TLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPH 213
LS N+FSG+IP S + LS+L + L SNNL+G IP F IP ++F+G L CGK+L
Sbjct: 146 NLSVNSFSGSIPASWSQLSNLKHLDLSSNNLTGSIPTQFFSIPTFDFSGTQLICGKSLNQ 205
Query: 214 SCESSSNDSGSSKKPK---IGIIVGIVGGLIVLISGGLLFFLCKGRHKGYKREVFVDVAG 270
C SSS +S K K I + V +I+ + +++ + R Y ++F DVAG
Sbjct: 206 PCSSSSRLPVTSSKKKLRDITLTASCVASIILFLGAMVMYHHHRVRRTKY--DIFFDVAG 263
Query: 271 EVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE 330
E DR+I+FGQLKR+S RE+QLATD+F+E N++GQGGFGKVYRG+L D TKVAVKRL D+
Sbjct: 264 EDDRKISFGQLKRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLPDKTKVAVKRLADYF 323
Query: 331 SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEP 390
SPGG+AAFQRE+++ISVAVH+NLLRLIGFCTT +ER+LVYP+M+NLSVAYRLR++K GE
Sbjct: 324 SPGGEAAFQREIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENLSVAYRLRDLKAGEE 383
Query: 391 VLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450
LDW TRKRVA G+A GLEYLHEHCNPKIIHRD+KAAN+LLD +FE V+GDFGLAKLVD
Sbjct: 384 GLDWPTRKRVAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNNFEPVLGDFGLAKLVDT 443
Query: 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV 510
T+VTTQVRGTMGHIAPEYL TGKSSE+TDVFGYGI LLELVTGQRAIDFSRLEEE+++
Sbjct: 444 SLTHVTTQVRGTMGHIAPEYLCTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEENI 503
Query: 511 LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 570
LLLDH+KKL RE+RL IVD NL Y+ +EVET++QVALLCTQ SPEDRPAMSEVV+ML
Sbjct: 504 LLLDHIKKLLREQRLRDIVDSNLT-TYDSKEVETIVQVALLCTQGSPEDRPAMSEVVKML 562
Query: 571 EGE-GLAERWEEWQHVEVTRRQE---YERLQRRFDWGEDSVYNQEAIELSGGR 619
+G GLAE+W EW+ +E R +E L +D E++ +QE+I LS R
Sbjct: 563 QGTGGLAEKWTEWEQLEEVRNKEALLLPTLPATWD-EEETTVDQESIRLSTAR 614
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 628 bits (1620), Expect = e-179, Method: Compositional matrix adjust.
Identities = 341/613 (55%), Positives = 415/613 (67%), Gaps = 24/613 (3%)
Query: 25 HNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLS 84
H+ WL +L GDAL LR +L PNN L+ W+ VNPCTW +V C+N N+V V L
Sbjct: 19 HSLWLAS-ANLEGDALHTLRVTLVDPNNVLQSWDPTLVNPCTWFHVTCNNENSVIRVDLG 77
Query: 85 SMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSL 144
+ SG L P +GVL+ L L L N ITG IP LGNL++L SLDL N G IP SL
Sbjct: 78 NAELSGHLVPELGVLKNLQYLELYSNNITGPIPSNLGNLTNLVSLDLYLNSFSGPIPESL 137
Query: 145 GNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP----VHLFQIPKYNF 200
G L KL+FL L+ N+ +G+IP SLT +++L + L +N LSG +P LF +
Sbjct: 138 GKLSKLRFLRLNNNSLTGSIPMSLTNITTLQVLDLSNNRLSGSVPDNGSFSLFTPISF-- 195
Query: 201 TGNNLN-CGKTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGLLF--------- 250
NNL+ CG H C S S + + G I G +
Sbjct: 196 -ANNLDLCGPVTSHPCPGSPPFSPPPPFIQPPPVSTPSGYGITGAIAGGVAAGAALLFAA 254
Query: 251 ----FLCKGRHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGG 306
F R K ++F DV E D + GQLKR+S RELQ+A+D FS KN+LG+GG
Sbjct: 255 PAIAFAWWRRRKPL--DIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGG 312
Query: 307 FGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 366
FGKVY+G LADGT VAVKRL + +PGG+ FQ EVEMIS+AVHRNLLRL GFC TPTER
Sbjct: 313 FGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 372
Query: 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKA 426
LLVYP+M N SVA LRE P +P LDW TRKR+ALG+ARGL YLH+HC+PKIIHRDVKA
Sbjct: 373 LLVYPYMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKA 432
Query: 427 ANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYG 486
AN+LLDE+FEAVVGDFGLAKL+D + T+VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYG
Sbjct: 433 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG 492
Query: 487 IMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMI 546
IMLLEL+TGQRA D +RL +DDV+LLD VK L +EK+L+ +VD +L NY +E+E +I
Sbjct: 493 IMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVI 552
Query: 547 QVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDS 606
QVALLCTQ SP +RP MSEVVRMLEG+GLAE+W+EWQ VE+ R + DW DS
Sbjct: 553 QVALLCTQGSPMERPKMSEVVRMLEGDGLAEKWDEWQKVEILREEIDLSPNPNSDWILDS 612
Query: 607 VYNQEAIELSGGR 619
YN A+ELSG R
Sbjct: 613 TYNLHAVELSGPR 625
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 597 bits (1538), Expect = e-169, Method: Compositional matrix adjust.
Identities = 319/562 (56%), Positives = 394/562 (70%), Gaps = 15/562 (2%)
Query: 37 GDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRI 96
GDAL AL+ SL PN L+ W+ V PCTW +V C++ N+V V L + N SG L ++
Sbjct: 29 GDALSALKNSLADPNKVLQSWDATLVTPCTWFHVTCNSDNSVTRVDLGNANLSGQLVMQL 88
Query: 97 GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 156
G L L L L N ITG IPE+LGNL+ L SLDL N L G IP +LG LKKL+FL L+
Sbjct: 89 GQLPNLQYLELYSNNITGTIPEQLGNLTELVSLDLYLNNLSGPIPSTLGRLKKLRFLRLN 148
Query: 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH----LFQIPKYNFTGNNLNCGKTLP 212
N+ SG IP SLT + +L + L +N L+G IPV+ LF + T P
Sbjct: 149 NNSLSGEIPRSLTAVLTLQVLDLSNNPLTGDIPVNGSFSLFTPISFANTKLTPLPASPPP 208
Query: 213 HSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGLLFFLCKGRHKGYKR----EVFVDV 268
+ + +GS++ + V LLF + ++R + F DV
Sbjct: 209 PISPTPPSPAGSNR-------ITGAIAGGVAAGAALLFAVPAIALAWWRRKKPQDHFFDV 261
Query: 269 AGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTD 328
E D + GQLKR+S RELQ+A+DNFS KN+LG+GGFGKVY+G LADGT VAVKRL +
Sbjct: 262 PAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKE 321
Query: 329 FESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG 388
+ GG+ FQ EVEMIS+AVHRNLLRL GFC TPTERLLVYP+M N SVA LRE
Sbjct: 322 ERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPES 381
Query: 389 EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448
+P LDW R+R+ALG+ARGL YLH+HC+PKIIHRDVKAAN+LLDE+FEAVVGDFGLAKL+
Sbjct: 382 QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 441
Query: 449 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED 508
D + T+VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYG+MLLEL+TGQRA D +RL +D
Sbjct: 442 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 501
Query: 509 DVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568
DV+LLD VK L +EK+L+A+VD +L NY +EVE +IQVALLCTQ+SP +RP MSEVVR
Sbjct: 502 DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 561
Query: 569 MLEGEGLAERWEEWQHVEVTRR 590
MLEG+GLAERWEEWQ E+ R+
Sbjct: 562 MLEGDGLAERWEEWQKEEMFRQ 583
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 560 bits (1444), Expect = e-158, Method: Compositional matrix adjust.
Identities = 310/558 (55%), Positives = 383/558 (68%), Gaps = 12/558 (2%)
Query: 37 GDALFALRTSLRV---PNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLS 93
GDAL L+ SL NN L+ W+ V PCTW +V C+ N V V L + SG L
Sbjct: 33 GDALTQLKNSLSSGDPANNVLQSWDATLVTPCTWFHVTCNPENKVTRVDLGNAKLSGKLV 92
Query: 94 PRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFL 153
P +G L L L L N ITGEIPEELG+L L SLDL N + G IP SLG L KL+FL
Sbjct: 93 PELGQLLNLQYLELYSNNITGEIPEELGDLVELVSLDLYANSISGPIPSSLGKLGKLRFL 152
Query: 154 TLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH----LFQIPKYNFTGNNLNCGK 209
L+ N+ SG IP +LT++ L + + +N LSG IPV+ LF +F N+L
Sbjct: 153 RLNNNSLSGEIPMTLTSVQ-LQVLDISNNRLSGDIPVNGSFSLFT--PISFANNSLTDLP 209
Query: 210 TLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGLLFFLCKGRHKGYKREVFVDVA 269
P + S + S + I G+ G +L + + F R K ++ F DV
Sbjct: 210 EPPPTSTSPTPPPPSGGQMTAAIAGGVAAGAALLFAVPAIAFAWWLRRK--PQDHFFDVP 267
Query: 270 GEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDF 329
E D + GQLKR++ REL +ATDNFS KNVLG+GGFGKVY+G LADG VAVKRL +
Sbjct: 268 AEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVKRLKEE 327
Query: 330 ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGE 389
+ GG+ FQ EVEMIS+AVHRNLLRL GFC TPTERLLVYP+M N SVA LRE G
Sbjct: 328 RTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGN 387
Query: 390 PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449
P LDW RK +ALG+ARGL YLH+HC+ KIIHRDVKAAN+LLDE+FEAVVGDFGLAKL++
Sbjct: 388 PALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGLAKLMN 447
Query: 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD 509
++VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYG+MLLEL+TGQ+A D +RL +DD
Sbjct: 448 YNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDD 507
Query: 510 VLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569
++LLD VK++ +EK+L+++VD L Y EVE +IQ+ALLCTQ+S +RP MSEVVRM
Sbjct: 508 IMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRM 567
Query: 570 LEGEGLAERWEEWQHVEV 587
LEG+GLAERWEEWQ E+
Sbjct: 568 LEGDGLAERWEEWQKEEM 585
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LPS5|SERK5_ARATH Somatic embryogenesis receptor kinase 5 OS=Arabidopsis thaliana GN=SERK5 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 553 bits (1426), Expect = e-156, Method: Compositional matrix adjust.
Identities = 307/569 (53%), Positives = 387/569 (68%), Gaps = 26/569 (4%)
Query: 28 WLTFLCSLSG----DALFALRTSLRV---PNNQLRDWNQNQVNPCTWSNVICDNSNNVAS 80
+L F+ ++G DAL ALR+SL NN L+ WN V PC+W +V C+ N+V
Sbjct: 15 FLDFVSRVTGKTQVDALIALRSSLSSGDHTNNILQSWNATHVTPCSWFHVTCNTENSVTR 74
Query: 81 VTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKI 140
+ L S N SG L P++ L L L L N ITGEIPEELG+L L SLDL N + G I
Sbjct: 75 LDLGSANLSGELVPQLAQLPNLQYLELFNNNITGEIPEELGDLMELVSLDLFANNISGPI 134
Query: 141 PPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH--LFQIPKY 198
P SLG L KL+FL L N+ SG IP SLT L L + + +N LSG IPV+ Q
Sbjct: 135 PSSLGKLGKLRFLRLYNNSLSGEIPRSLTALP-LDVLDISNNRLSGDIPVNGSFSQFTSM 193
Query: 199 NFTGNNLNCGKTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGLLFFLCKGRHK 258
+F N L ++ S S I+VG+ G +L + L + + + +
Sbjct: 194 SFANNKLRP---------RPASPSPSPSGTSAAIVVGVAAGAALLFA---LAWWLRRKLQ 241
Query: 259 GYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADG 318
G+ F+DV E D + GQ KR+S REL +AT+ FS++NVLG+G FG +Y+G LAD
Sbjct: 242 GH----FLDVPAEEDPEVYLGQFKRFSLRELLVATEKFSKRNVLGKGRFGILYKGRLADD 297
Query: 319 TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV 378
T VAVKRL + + GG+ FQ EVEMIS+AVHRNLLRL GFC TPTERLLVYP+M N SV
Sbjct: 298 TLVAVKRLNEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 357
Query: 379 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV 438
A LRE G P LDW RK +ALG+ARGL YLH+HC+ KIIH DVKAAN+LLDE+FEAV
Sbjct: 358 ASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHLDVKAANILLDEEFEAV 417
Query: 439 VGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRA 498
VGDFGLAKL++ ++VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYG+MLLEL+TGQ+A
Sbjct: 418 VGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKA 477
Query: 499 IDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPE 558
D +RL +DD++LLD VK++ +EK+L+++VD L Y EVE +IQ+ALLCTQ+S
Sbjct: 478 FDLARLANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAM 537
Query: 559 DRPAMSEVVRMLEGEGLAERWEEWQHVEV 587
+RP MSEVVRMLEG+GLAERWEEWQ E+
Sbjct: 538 ERPKMSEVVRMLEGDGLAERWEEWQKEEM 566
|
Serine/threonine-kinase of unknown function. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 552 bits (1422), Expect = e-156, Method: Compositional matrix adjust.
Identities = 299/600 (49%), Positives = 394/600 (65%), Gaps = 28/600 (4%)
Query: 39 ALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGV 98
AL +++SL P+ L +W+ V+PC+W+ + C + V + S N SGTLS IG
Sbjct: 45 ALIGIKSSLTDPHGVLMNWDDTAVDPCSWNMITCSDGF-VIRLEAPSQNLSGTLSSSIGN 103
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
L L T+ L+ N ITG IP E+G L L +LDL N G+IP +L K LQ+L ++ N
Sbjct: 104 LTNLQTVLLQNNYITGNIPHEIGKLMKLKTLDLSTNNFTGQIPFTLSYSKNLQYLRVNNN 163
Query: 159 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHSCE-- 216
+ +GTIP SL ++ L + L NNLSG +P L + +N GN+ C C
Sbjct: 164 SLTGTIPSSLANMTQLTFLDLSYNNLSGPVPRSLAKT--FNVMGNSQICPTGTEKDCNGT 221
Query: 217 ----------SSSNDS--GSSKKPKIGIIVGIVGGLIVLISGGLLFFLCKGRHKGYKREV 264
SS N S G +K KI ++ G+ + L+ G F L R + K+ +
Sbjct: 222 QPKPMSITLNSSQNKSSDGGTKNRKIAVVFGVSLTCVCLLIIGFGFLLW-WRRRHNKQVL 280
Query: 265 FVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVK 324
F D+ + + G L+R++++ELQ AT NFS KN++G+GGFG VY+G L DG+ +AVK
Sbjct: 281 FFDINEQNKEEMCLGNLRRFNFKELQSATSNFSSKNLVGKGGFGNVYKGCLHDGSIIAVK 340
Query: 325 RLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE 384
RL D + GG+ FQ E+EMIS+AVHRNLLRL GFCTT +ERLLVYP+M N SVA RL+
Sbjct: 341 RLKDINNGGGEVQFQTELEMISLAVHRNLLRLYGFCTTSSERLLVYPYMSNGSVASRLK- 399
Query: 385 IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444
+PVLDW TRKR+ALGA RGL YLHE C+PKIIHRDVKAAN+LLD+ FEAVVGDFGL
Sbjct: 400 ---AKPVLDWGTRKRIALGAGRGLLYLHEQCDPKIIHRDVKAANILLDDYFEAVVGDFGL 456
Query: 445 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRL 504
AKL+D +++VTT VRGT+GHIAPEYLSTG+SSE+TDVFG+GI+LLEL+TG RA++F +
Sbjct: 457 AKLLDHEESHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGKA 516
Query: 505 EEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 564
+ +LD VKKL++EK+L+ IVD++L NY+ EVE M+QVALLCTQ P RP MS
Sbjct: 517 ANQRGA-ILDWVKKLQQEKKLEQIVDKDLKSNYDRIEVEEMVQVALLCTQYLPIHRPKMS 575
Query: 565 EVVRMLEGEGLAERWE-EWQHVEVTRR----QEYERLQRRFDWGEDSVYNQEAIELSGGR 619
EVVRMLEG+GL E+WE Q E R E+ +R D +DS +A+ELSG R
Sbjct: 576 EVVRMLEGDGLVEKWEASSQRAETNRSYSKPNEFSSSERYSDLTDDSSVLVQAMELSGPR 635
|
Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 538 bits (1385), Expect = e-152, Method: Compositional matrix adjust.
Identities = 307/629 (48%), Positives = 404/629 (64%), Gaps = 46/629 (7%)
Query: 27 GWLTFLCS------------LSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDN 74
G+L LCS AL ++ SL P+ L +W+++ V+PC+W+ V C +
Sbjct: 20 GFLCLLCSSVHGLLSPKGVNFEVQALMDIKASLHDPHGVLDNWDRDAVDPCSWTMVTCSS 79
Query: 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNN 134
N V + S N SGTLSP I L L + L+ N I G+IP E+G L+ L +LDL +N
Sbjct: 80 ENFVIGLGTPSQNLSGTLSPSITNLTNLRIVLLQNNNIKGKIPAEIGRLTRLETLDLSDN 139
Query: 135 RLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
G+IP S+G L+ LQ+L L+ N+ SG P SL+ ++ L + L NNLSG PV F
Sbjct: 140 FFHGEIPFSVGYLQSLQYLRLNNNSLSGVFPLSLSNMTQLAFLDLSYNNLSG--PVPRFA 197
Query: 195 IPKYNFTGNNLNC---------GKTL-PHSCESSSND----SGSSKKPKIGIIVGIVGGL 240
++ GN L C G TL P S + +G S+ K+ I VG G
Sbjct: 198 AKTFSIVGNPLICPTGTEPDCNGTTLIPMSMNLNQTGVPLYAGGSRNHKMAIAVGSSVGT 257
Query: 241 IVLISGGL-LFFLCKGRHKGYKREVFVDVA-GEVDRRIAFGQLKRYSWRELQLATDNFSE 298
+ LI + LF + RH + F DV G ++ G L+R+ +RELQ+AT+NFS
Sbjct: 258 VSLIFIAVGLFLWWRQRHN---QNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSS 314
Query: 299 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 358
KN+LG+GG+G VY+G+L D T VAVKRL D + GG+ FQ EVEMIS+AVHRNLLRL G
Sbjct: 315 KNLLGKGGYGNVYKGILGDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYG 374
Query: 359 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 418
FC T TE+LLVYP+M N SVA R++ +PVLDW RKR+A+GAARGL YLHE C+PK
Sbjct: 375 FCITQTEKLLVYPYMSNGSVASRMK----AKPVLDWSIRKRIAIGAARGLVYLHEQCDPK 430
Query: 419 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 478
IIHRDVKAAN+LLD+ EAVVGDFGLAKL+D + ++VTT VRGT+GHIAPEYLSTG+SSE
Sbjct: 431 IIHRDVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSE 490
Query: 479 RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL--NKN 536
+TDVFG+GI+LLELVTGQRA +F + + V +LD VKK+ +EK+L+ +VD+ L K+
Sbjct: 491 KTDVFGFGILLLELVTGQRAFEFGKAANQKGV-MLDWVKKIHQEKKLELLVDKELLKKKS 549
Query: 537 YNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVT-----RRQ 591
Y+ E++ M++VALLCTQ P RP MSEVVRMLEG+GLAE+WE Q + R
Sbjct: 550 YDEIELDEMVRVALLCTQYLPGHRPKMSEVVRMLEGDGLAEKWEASQRSDSVSKCSNRIN 609
Query: 592 EYERLQRRF-DWGEDSVYNQEAIELSGGR 619
E R+ D +DS +A+ELSG R
Sbjct: 610 ELMSSSDRYSDLTDDSSLLVQAMELSGPR 638
|
Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 523 bits (1347), Expect = e-147, Method: Compositional matrix adjust.
Identities = 293/603 (48%), Positives = 389/603 (64%), Gaps = 30/603 (4%)
Query: 39 ALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGV 98
AL A++ L P L +W+ N V+PC+W V C + V+S+ L S + SGTLSPRIG
Sbjct: 38 ALVAVKNELNDPYKVLENWDVNSVDPCSWRMVSCTDGY-VSSLDLPSQSLSGTLSPRIGN 96
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
L L ++ L+ N ITG IPE +G L L SLDL NN G+IP SLG LK L +L L+ N
Sbjct: 97 LTYLQSVVLQNNAITGPIPETIGRLEKLQSLDLSNNSFTGEIPASLGELKNLNYLRLNNN 156
Query: 159 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGK--------- 209
+ GT P+SL+ + L + + NNLSG +P + GN L CG
Sbjct: 157 SLIGTCPESLSKIEGLTLVDISYNNLSGSLPK--VSARTFKVIGNALICGPKAVSNCSAV 214
Query: 210 ----TLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGLLFFLCKGRHKGYKREVF 265
TLP S + + V + G+ + R+K ++F
Sbjct: 215 PEPLTLPQDGPDESGTRTNGHHVALAFAASFSAAFFVFFTSGMFLWWRYRRNK----QIF 270
Query: 266 VDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKR 325
DV + D ++ G LKRY+++EL+ AT++F+ KN+LG+GG+G VY+G L DGT VAVKR
Sbjct: 271 FDVNEQYDPEVSLGHLKRYTFKELRSATNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKR 330
Query: 326 LTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREI 385
L D GG+ FQ EVE IS+A+HRNLLRL GFC++ ER+LVYP+M N SVA RL++
Sbjct: 331 LKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVASRLKDN 390
Query: 386 KPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 445
GEP LDW RK++A+G ARGL YLHE C+PKIIHRDVKAAN+LLDEDFEAVVGDFGLA
Sbjct: 391 IRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA 450
Query: 446 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLE 505
KL+D R ++VTT VRGT+GHIAPEYLSTG+SSE+TDVFG+GI+LLEL+TGQ+A+DF R
Sbjct: 451 KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALDFGRSA 510
Query: 506 EEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSE 565
+ V +LD VKKL +E +L ++D++LN ++ E+E ++QVALLCTQ +P RP MSE
Sbjct: 511 HQKGV-MLDWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHRPKMSE 569
Query: 566 VVRMLEGEGLAERWEEWQHVEVTRR---------QEYERLQRRFDWGEDSVYNQEAIELS 616
V++MLEG+GLAERWE Q+ + R++ D+ ++S EAIELS
Sbjct: 570 VMKMLEGDGLAERWEATQNGTGEHQPPPLPPGMVSSSPRVRYYSDYIQESSLVVEAIELS 629
Query: 617 GGR 619
G R
Sbjct: 630 GPR 632
|
Involved in defense response to geminivirus infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 619 | ||||||
| 224093748 | 611 | predicted protein [Populus trichocarpa] | 0.949 | 0.962 | 0.857 | 0.0 | |
| 118486735 | 611 | unknown [Populus trichocarpa] | 0.949 | 0.962 | 0.855 | 0.0 | |
| 356525465 | 610 | PREDICTED: probable LRR receptor-like se | 0.954 | 0.968 | 0.832 | 0.0 | |
| 356512695 | 610 | PREDICTED: probable LRR receptor-like se | 0.954 | 0.968 | 0.832 | 0.0 | |
| 224081132 | 606 | predicted protein [Populus trichocarpa] | 0.954 | 0.975 | 0.852 | 0.0 | |
| 449458289 | 612 | PREDICTED: probable LRR receptor-like se | 0.970 | 0.982 | 0.789 | 0.0 | |
| 297811131 | 613 | leucine-rich repeat family protein [Arab | 0.949 | 0.959 | 0.814 | 0.0 | |
| 22326703 | 613 | putative LRR receptor-like serine/threon | 0.956 | 0.965 | 0.809 | 0.0 | |
| 8953410 | 605 | protein serine/threonine kinase-like pro | 0.956 | 0.978 | 0.809 | 0.0 | |
| 20260260 | 613 | protein serine/threonine kinase-like pro | 0.956 | 0.965 | 0.807 | 0.0 |
| >gi|224093748|ref|XP_002309974.1| predicted protein [Populus trichocarpa] gi|222852877|gb|EEE90424.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1025 bits (2650), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 505/589 (85%), Positives = 540/589 (91%), Gaps = 1/589 (0%)
Query: 32 LCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGT 91
L +L GDAL AL+ S+ VP+NQL+DWN NQV PCTW+NVICD++ +V SVTLS +N SGT
Sbjct: 23 LSNLQGDALSALKLSMNVPDNQLKDWNPNQVTPCTWTNVICDSNEHVISVTLSGINCSGT 82
Query: 92 LSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQ 151
LSP+IGVL+TL+TLTLKGNGITG IP+E GNL+SLTSLDL+NNRL G+IP SLGNLK+LQ
Sbjct: 83 LSPKIGVLKTLNTLTLKGNGITGGIPKEFGNLTSLTSLDLENNRLSGEIPSSLGNLKRLQ 142
Query: 152 FLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTL 211
FLTL QNN SG IP+SL L +LI+I LDSNNLSGQIP HLFQ+PKYNFTGN+LNC
Sbjct: 143 FLTLGQNNLSGAIPESLAGLQNLINILLDSNNLSGQIPDHLFQVPKYNFTGNHLNCSGPN 202
Query: 212 PHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGLLFF-LCKGRHKGYKREVFVDVAG 270
HSCES ++DSG S K K GII+G+VGG VL G L F +CKGRHKGYKREVFVDVAG
Sbjct: 203 LHSCESHNSDSGGSHKSKTGIIIGVVGGFTVLFLFGGLLFFVCKGRHKGYKREVFVDVAG 262
Query: 271 EVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE 330
EVD+RIAFGQLKR+SWRELQLATDNFSEKN+LGQGGFGKVY+GVLAD TK+AVKRLTDFE
Sbjct: 263 EVDQRIAFGQLKRFSWRELQLATDNFSEKNILGQGGFGKVYKGVLADNTKIAVKRLTDFE 322
Query: 331 SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEP 390
SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT TERLLVYPFMQNLSVAY LRE KP EP
Sbjct: 323 SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTTTERLLVYPFMQNLSVAYCLRERKPEEP 382
Query: 391 VLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450
VLDW TRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV
Sbjct: 383 VLDWTTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 442
Query: 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV 510
RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV
Sbjct: 443 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV 502
Query: 511 LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 570
LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVE MIQVALLCTQASPE+RPAMSEVVRML
Sbjct: 503 LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVEMMIQVALLCTQASPENRPAMSEVVRML 562
Query: 571 EGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR 619
EGEGLAERWEEWQHVEVTR QEYERLQRRFDWGEDSVYNQ+AIELSGGR
Sbjct: 563 EGEGLAERWEEWQHVEVTRMQEYERLQRRFDWGEDSVYNQDAIELSGGR 611
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|118486735|gb|ABK95203.1| unknown [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1023 bits (2644), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 504/589 (85%), Positives = 539/589 (91%), Gaps = 1/589 (0%)
Query: 32 LCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGT 91
L +L GDAL AL+ S+ VP+NQL+DWN NQV PCTW+NVICD++ +V SVTLS +N SGT
Sbjct: 23 LSNLQGDALSALKLSMNVPDNQLKDWNPNQVTPCTWTNVICDSNEHVISVTLSGINCSGT 82
Query: 92 LSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQ 151
LSP+IGVL+TL+TLTLKGNGITG IP+E GNL+SLTSLDL+NNRL G+IP SLGNLK+LQ
Sbjct: 83 LSPKIGVLKTLNTLTLKGNGITGGIPKEFGNLTSLTSLDLENNRLSGEIPSSLGNLKRLQ 142
Query: 152 FLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTL 211
FLTL QNN SG IP+SL L +LI+I LDSNNLSGQIP HLFQ+PKYNFTGN+LNC
Sbjct: 143 FLTLGQNNLSGAIPESLAGLQNLINILLDSNNLSGQIPDHLFQVPKYNFTGNHLNCSGPN 202
Query: 212 PHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGLLFF-LCKGRHKGYKREVFVDVAG 270
HSCES ++DSG S K K GII+G+VGG VL G L F +CKGRHKGYKREVFVDVAG
Sbjct: 203 LHSCESHNSDSGGSHKSKTGIIIGVVGGFTVLFLFGGLLFFVCKGRHKGYKREVFVDVAG 262
Query: 271 EVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE 330
EVD+RIAFGQLKR+SWRELQLATDNFSEKN+LGQGGFGKVY+GVLAD TK+AVKRLTD E
Sbjct: 263 EVDQRIAFGQLKRFSWRELQLATDNFSEKNILGQGGFGKVYKGVLADNTKIAVKRLTDVE 322
Query: 331 SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEP 390
SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT TERLLVYPFMQNLSVAY LRE KP EP
Sbjct: 323 SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTTTERLLVYPFMQNLSVAYCLRERKPEEP 382
Query: 391 VLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450
VLDW TRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV
Sbjct: 383 VLDWTTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 442
Query: 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV 510
RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV
Sbjct: 443 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV 502
Query: 511 LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 570
LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVE MIQVALLCTQASPE+RPAMSEVVRML
Sbjct: 503 LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVEMMIQVALLCTQASPENRPAMSEVVRML 562
Query: 571 EGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR 619
EGEGLAERWEEWQHVEVTR QEYERLQRRFDWGEDSVYNQ+AIELSGGR
Sbjct: 563 EGEGLAERWEEWQHVEVTRMQEYERLQRRFDWGEDSVYNQDAIELSGGR 611
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356525465|ref|XP_003531345.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g10290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1022 bits (2642), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/597 (83%), Positives = 539/597 (90%), Gaps = 6/597 (1%)
Query: 29 LTFLCSL-----SGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTL 83
L LCS GDALFAL+ SL +QL DWNQNQVNPCTWS V CD++NNV V+L
Sbjct: 14 LGCLCSFVLPDTQGDALFALKISLNASAHQLTDWNQNQVNPCTWSRVYCDSNNNVMQVSL 73
Query: 84 SSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPS 143
+ M F+G L+PRIGVL+ L+ L+L+GNGITG IP+ELGNL+SL+ LDL+ N+L G+IP S
Sbjct: 74 AYMGFTGYLNPRIGVLKYLTALSLQGNGITGNIPKELGNLTSLSRLDLEGNKLTGEIPSS 133
Query: 144 LGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGN 203
LGNLKKLQFLTLSQNN SGTIP+SL +L LI++ LDSNNLSGQIP LF++PKYNFTGN
Sbjct: 134 LGNLKKLQFLTLSQNNLSGTIPESLASLPILINVLLDSNNLSGQIPEQLFKVPKYNFTGN 193
Query: 204 NLNCGKTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIV-LISGGLLFFLCKGRHKGYKR 262
NL+CG + CE+ + D GSS KPK G+IVGIV GL+V L GGL+FF CKGRHKGY+R
Sbjct: 194 NLSCGASYHQPCETDNADQGSSHKPKTGLIVGIVIGLVVILFLGGLMFFGCKGRHKGYRR 253
Query: 263 EVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVA 322
EVFVDVAGEVDRRIAFGQL+R++WRELQ+ATDNFSEKNVLGQGGFGKVY+GVLAD TKVA
Sbjct: 254 EVFVDVAGEVDRRIAFGQLRRFAWRELQIATDNFSEKNVLGQGGFGKVYKGVLADNTKVA 313
Query: 323 VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRL 382
VKRLTD+ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRL
Sbjct: 314 VKRLTDYESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRL 373
Query: 383 REIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 442
REIKPGEPVLDW TRK+VALG ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF
Sbjct: 374 REIKPGEPVLDWPTRKQVALGTARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 433
Query: 443 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 502
GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS
Sbjct: 434 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 493
Query: 503 RLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA 562
RLEEEDDVLLLDHVKKLEREKRLDAIVD NLNKNYNIQEVE MI+VALLCTQA+PEDRP
Sbjct: 494 RLEEEDDVLLLDHVKKLEREKRLDAIVDHNLNKNYNIQEVEMMIKVALLCTQATPEDRPP 553
Query: 563 MSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR 619
MSEVVRMLEGEGLAERWEEWQHVEV RRQEYERLQRRFDWGEDSVYNQ+AIELSGGR
Sbjct: 554 MSEVVRMLEGEGLAERWEEWQHVEVNRRQEYERLQRRFDWGEDSVYNQDAIELSGGR 610
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356512695|ref|XP_003525052.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g10290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1022 bits (2642), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/597 (83%), Positives = 539/597 (90%), Gaps = 6/597 (1%)
Query: 29 LTFLCSL-----SGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTL 83
L LCS GDALFAL+ SL +QL DWNQNQVNPCTWS V CD++NNV V+L
Sbjct: 14 LGCLCSFVLPDTQGDALFALKISLNASAHQLTDWNQNQVNPCTWSRVYCDSNNNVMQVSL 73
Query: 84 SSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPS 143
+ M F+G L+P IGVL+ L+ L+L+GNGITG IP+ELGNL+SL+ LDL++N+L G+IP S
Sbjct: 74 AYMGFTGYLTPIIGVLKYLTALSLQGNGITGNIPKELGNLTSLSRLDLESNKLTGEIPSS 133
Query: 144 LGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGN 203
LGNLK+LQFLTLSQNN SGTIP+SL +L LI++ LDSNNLSGQIP LF++PKYNFTGN
Sbjct: 134 LGNLKRLQFLTLSQNNLSGTIPESLASLPILINVLLDSNNLSGQIPEQLFKVPKYNFTGN 193
Query: 204 NLNCGKTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIV-LISGGLLFFLCKGRHKGYKR 262
NLNCG + CE+ + D GSS KPK G+IVGIV GL+V L GGLLFF CKGRHK Y+R
Sbjct: 194 NLNCGASYHQPCETDNADQGSSHKPKTGLIVGIVIGLVVILFLGGLLFFWCKGRHKSYRR 253
Query: 263 EVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVA 322
EVFVDVAGEVDRRIAFGQL+R++WRELQ+ATDNFSEKNVLGQGGFGKVY+GVLAD TKVA
Sbjct: 254 EVFVDVAGEVDRRIAFGQLRRFAWRELQIATDNFSEKNVLGQGGFGKVYKGVLADNTKVA 313
Query: 323 VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRL 382
VKRLTD+ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRL
Sbjct: 314 VKRLTDYESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRL 373
Query: 383 REIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 442
RE+KPGEPVLDW TRKRVALG ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF
Sbjct: 374 RELKPGEPVLDWPTRKRVALGTARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 433
Query: 443 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 502
GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS
Sbjct: 434 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 493
Query: 503 RLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA 562
RLEEEDDVLLLDHVKKLEREKRL+AIVDRNLNKNYNIQEVE MIQVALLCTQA+PEDRP
Sbjct: 494 RLEEEDDVLLLDHVKKLEREKRLEAIVDRNLNKNYNIQEVEMMIQVALLCTQATPEDRPP 553
Query: 563 MSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR 619
MSEVVRMLEGEGLAERWEEWQHVEV RRQEYERLQRRFDWGEDSVYNQ+AIELSGGR
Sbjct: 554 MSEVVRMLEGEGLAERWEEWQHVEVNRRQEYERLQRRFDWGEDSVYNQDAIELSGGR 610
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224081132|ref|XP_002306304.1| predicted protein [Populus trichocarpa] gi|222855753|gb|EEE93300.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 983 bits (2542), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 509/597 (85%), Positives = 542/597 (90%), Gaps = 6/597 (1%)
Query: 29 LTFLCSL-----SGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTL 83
L FL S GDAL+AL+ S+ +PNNQL DWNQNQVNPCTW+NVICD SNNV SVTL
Sbjct: 10 LAFLQSFVLSDPQGDALYALKLSMNIPNNQLTDWNQNQVNPCTWTNVICDKSNNVVSVTL 69
Query: 84 SSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPS 143
S +N SG LSP IG LRTL+TLTLKGNGITG IP+E GNLSSLTSLDL+NNRL G+IP S
Sbjct: 70 SDINCSGILSPMIGALRTLTTLTLKGNGITGGIPKEFGNLSSLTSLDLENNRLSGEIPSS 129
Query: 144 LGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGN 203
LG+LKKLQFLTLSQNN SG IP+SL +L SLI+I LDSNNLSGQ+P HLFQIPKYNFTGN
Sbjct: 130 LGDLKKLQFLTLSQNNLSGAIPESLASLESLINILLDSNNLSGQVPNHLFQIPKYNFTGN 189
Query: 204 NLNCGKTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGLLFF-LCKGRHKGYKR 262
+LNCG H CES S DSG S K KIGIIVG+VGG ++L G L F +CKGR KGY+R
Sbjct: 190 HLNCGGLNLHLCESYSGDSGGSHKSKIGIIVGVVGGFVILFLLGGLLFFVCKGRRKGYRR 249
Query: 263 EVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVA 322
E+FVDVAGEVDRRIAFGQLKR++WRELQLATDNFSE+N+LGQGGFGKVY+GVLAD TKVA
Sbjct: 250 EIFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEENILGQGGFGKVYKGVLADNTKVA 309
Query: 323 VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRL 382
VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT TERLLVYPFMQNLSVAYRL
Sbjct: 310 VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTTTERLLVYPFMQNLSVAYRL 369
Query: 383 REIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 442
RE KP EPVLDW TRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF
Sbjct: 370 RERKPEEPVLDWTTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 429
Query: 443 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 502
GLAKL+DVRKTNVTTQVRGTMGHIAPEYLSTGKSS RTDVFGYGIMLLELVTGQRAIDFS
Sbjct: 430 GLAKLMDVRKTNVTTQVRGTMGHIAPEYLSTGKSSGRTDVFGYGIMLLELVTGQRAIDFS 489
Query: 503 RLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA 562
RLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVE MI+VALLCTQASPEDRPA
Sbjct: 490 RLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVEMMIKVALLCTQASPEDRPA 549
Query: 563 MSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR 619
MSEVVRMLEGEGLAERWEEWQHVEVTRR+EY RLQRRFD+GEDS+YNQ+AIELSGGR
Sbjct: 550 MSEVVRMLEGEGLAERWEEWQHVEVTRREEYSRLQRRFDFGEDSLYNQDAIELSGGR 606
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449458289|ref|XP_004146880.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g10290-like [Cucumis sativus] gi|449519138|ref|XP_004166592.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g10290-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 978 bits (2527), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 487/617 (78%), Positives = 538/617 (87%), Gaps = 16/617 (2%)
Query: 4 IDLLLYCLKCFRFFDNFDPDLHNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVN 63
+ LL+ L C+ + L GDAL+ALRT+L NQL DWN NQVN
Sbjct: 11 VYLLILVLACYNYLA-------------LSDFQGDALYALRTTLNATANQLTDWNPNQVN 57
Query: 64 PCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNL 123
PCTWSNVIC N+V SV+LS+M F+GTLSPRIG +++LSTL L+GN I+GEIP++ GNL
Sbjct: 58 PCTWSNVIC-RGNSVISVSLSTMGFTGTLSPRIGSIKSLSTLILQGNYISGEIPKDFGNL 116
Query: 124 SSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNN 183
++L SLDL NN L G+IP SLGNLKKLQFLTLSQN +GTIPDSL+TL SLI++ LDSN+
Sbjct: 117 TNLVSLDLGNNSLTGQIPSSLGNLKKLQFLTLSQNRLTGTIPDSLSTLPSLINLLLDSND 176
Query: 184 LSGQIPVHLFQIPKYNFTGNNLNCGKTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIV- 242
LSG IP LFQ+PK+NF+ N LNCG H+C S S +SGSS KPK+G+IVGI+ G V
Sbjct: 177 LSGPIPQQLFQVPKFNFSANKLNCGGKSLHACASDSTNSGSSNKPKVGLIVGIIAGFTVA 236
Query: 243 LISGGLLFFLCKGRHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVL 302
L+ G+LFFL KGR+K YKREVFVDVAGEVDRRIAFGQLKR++WRELQLAT+NFSEKNVL
Sbjct: 237 LLLVGVLFFLSKGRYKSYKREVFVDVAGEVDRRIAFGQLKRFAWRELQLATENFSEKNVL 296
Query: 303 GQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT 362
GQGGFGKVY+GVLADGTKVAVKRLTD+ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT
Sbjct: 297 GQGGFGKVYKGVLADGTKVAVKRLTDYESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT 356
Query: 363 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHR 422
TERLLVYPFMQNLSVAYRLRE+KPGE VLDW TRKRVALG ARGLEYLHEHCNPKIIHR
Sbjct: 357 QTERLLVYPFMQNLSVAYRLRELKPGEAVLDWPTRKRVALGTARGLEYLHEHCNPKIIHR 416
Query: 423 DVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDV 482
DVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ+RGTMGHIAPEYLSTGKSSERTDV
Sbjct: 417 DVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQIRGTMGHIAPEYLSTGKSSERTDV 476
Query: 483 FGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEV 542
FGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN NYNIQEV
Sbjct: 477 FGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN-NYNIQEV 535
Query: 543 ETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDW 602
E MIQVALLCTQ +DRPAMS+VVRMLEGEGLAERWEEWQH+EVTRRQEYERLQRRF+W
Sbjct: 536 EMMIQVALLCTQPCSDDRPAMSQVVRMLEGEGLAERWEEWQHLEVTRRQEYERLQRRFEW 595
Query: 603 GEDSVYNQEAIELSGGR 619
GEDS++ Q+AI+LSGGR
Sbjct: 596 GEDSIHRQDAIQLSGGR 612
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297811131|ref|XP_002873449.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] gi|297319286|gb|EFH49708.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 974 bits (2517), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 483/593 (81%), Positives = 525/593 (88%), Gaps = 5/593 (0%)
Query: 32 LCSL-----SGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSM 86
LCS GDALFALR SLR NQL DWNQNQVNPCTWS VICD+ N V S+TLS M
Sbjct: 21 LCSFVSPDAQGDALFALRISLRALPNQLSDWNQNQVNPCTWSQVICDDKNFVTSLTLSDM 80
Query: 87 NFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGN 146
NFSGTLS RIG+L L TLTLKGNGITGEIPE+ GNL+SLTSLDL++N+L G+IP ++GN
Sbjct: 81 NFSGTLSSRIGILENLKTLTLKGNGITGEIPEDFGNLTSLTSLDLEDNQLTGRIPSTIGN 140
Query: 147 LKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLN 206
LKKLQFLTLS+N +GTIP SLT L +L+++ LDSN+LSGQIP LF+IPKYNFT NNL
Sbjct: 141 LKKLQFLTLSRNKLNGTIPQSLTGLPNLLNLLLDSNSLSGQIPQSLFEIPKYNFTANNLT 200
Query: 207 CGKTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGLLFFLCKGRHKGYKREVFV 266
CG PH C S+ SG S KPK GII G+V G+ V++ G LLF CK RHKGY+R+VFV
Sbjct: 201 CGGGQPHPCVSAVAHSGDSSKPKTGIIAGVVAGVTVILFGILLFLFCKDRHKGYRRDVFV 260
Query: 267 DVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL 326
DVAGEVDRRIAFGQLKR++WRELQLATDNFSEKNVLGQGGFGKVY+GVL D TKVAVKRL
Sbjct: 261 DVAGEVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVAVKRL 320
Query: 327 TDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIK 386
TDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT TERLLVYPFMQNLS+A+RLREIK
Sbjct: 321 TDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRLREIK 380
Query: 387 PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446
G+PVLDW TRKR+ALGAARG EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK
Sbjct: 381 AGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 440
Query: 447 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE 506
LVDVR+TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE
Sbjct: 441 LVDVRRTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE 500
Query: 507 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 566
EDDVLLLDHVKKLEREKRL AIVD+NL+ Y +EVE MIQVALLCTQ SPEDRP MSEV
Sbjct: 501 EDDVLLLDHVKKLEREKRLGAIVDKNLDGEYIKEEVEMMIQVALLCTQGSPEDRPVMSEV 560
Query: 567 VRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR 619
VRMLEGEGLAERWEEWQ+VEVTRR E+ERLQRRFDWGEDS++NQ+AIELSGGR
Sbjct: 561 VRMLEGEGLAERWEEWQNVEVTRRHEFERLQRRFDWGEDSMHNQDAIELSGGR 613
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|22326703|ref|NP_196591.2| putative LRR receptor-like serine/threonine-protein kinase [Arabidopsis thaliana] gi|264664527|sp|C0LGT1.1|Y5129_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At5g10290; Flags: Precursor gi|224589669|gb|ACN59366.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332004134|gb|AED91517.1| putative LRR receptor-like serine/threonine-protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 960 bits (2481), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 483/597 (80%), Positives = 528/597 (88%), Gaps = 5/597 (0%)
Query: 28 WLTFLCSL-----SGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVT 82
+ LCS GDALFALR SLR NQL DWNQNQVNPCTWS VICD+ N V S+T
Sbjct: 17 FFACLCSFVSPDAQGDALFALRISLRALPNQLSDWNQNQVNPCTWSQVICDDKNFVTSLT 76
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 142
LS MNFSGTLS R+G+L L TLTLKGNGITGEIPE+ GNL+SLTSLDL++N+L G+IP
Sbjct: 77 LSDMNFSGTLSSRVGILENLKTLTLKGNGITGEIPEDFGNLTSLTSLDLEDNQLTGRIPS 136
Query: 143 SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTG 202
++GNLKKLQFLTLS+N +GTIP+SLT L +L+++ LDSN+LSGQIP LF+IPKYNFT
Sbjct: 137 TIGNLKKLQFLTLSRNKLNGTIPESLTGLPNLLNLLLDSNSLSGQIPQSLFEIPKYNFTS 196
Query: 203 NNLNCGKTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGLLFFLCKGRHKGYKR 262
NNLNCG PH C S+ SG S KPK GII G+V G+ V++ G LLF CK RHKGY+R
Sbjct: 197 NNLNCGGRQPHPCVSAVAHSGDSSKPKTGIIAGVVAGVTVVLFGILLFLFCKDRHKGYRR 256
Query: 263 EVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVA 322
+VFVDVAGEVDRRIAFGQLKR++WRELQLATDNFSEKNVLGQGGFGKVY+GVL D TKVA
Sbjct: 257 DVFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVA 316
Query: 323 VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRL 382
VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT TERLLVYPFMQNLS+A+RL
Sbjct: 317 VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRL 376
Query: 383 REIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 442
REIK G+PVLDW TRKR+ALGAARG EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF
Sbjct: 377 REIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 436
Query: 443 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 502
GLAKLVDVR+TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS
Sbjct: 437 GLAKLVDVRRTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 496
Query: 503 RLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA 562
RLEEEDDVLLLDHVKKLEREKRL AIVD+NL+ Y +EVE MIQVALLCTQ SPEDRP
Sbjct: 497 RLEEEDDVLLLDHVKKLEREKRLGAIVDKNLDGEYIKEEVEMMIQVALLCTQGSPEDRPV 556
Query: 563 MSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR 619
MSEVVRMLEGEGLAERWEEWQ+VEVTRR E+ERLQRRFDWGEDS++NQ+AIELSGGR
Sbjct: 557 MSEVVRMLEGEGLAERWEEWQNVEVTRRHEFERLQRRFDWGEDSMHNQDAIELSGGR 613
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|8953410|emb|CAB96685.1| protein serine/threonine kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 960 bits (2481), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 483/597 (80%), Positives = 528/597 (88%), Gaps = 5/597 (0%)
Query: 28 WLTFLCSL-----SGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVT 82
+ LCS GDALFALR SLR NQL DWNQNQVNPCTWS VICD+ N V S+T
Sbjct: 9 FFACLCSFVSPDAQGDALFALRISLRALPNQLSDWNQNQVNPCTWSQVICDDKNFVTSLT 68
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 142
LS MNFSGTLS R+G+L L TLTLKGNGITGEIPE+ GNL+SLTSLDL++N+L G+IP
Sbjct: 69 LSDMNFSGTLSSRVGILENLKTLTLKGNGITGEIPEDFGNLTSLTSLDLEDNQLTGRIPS 128
Query: 143 SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTG 202
++GNLKKLQFLTLS+N +GTIP+SLT L +L+++ LDSN+LSGQIP LF+IPKYNFT
Sbjct: 129 TIGNLKKLQFLTLSRNKLNGTIPESLTGLPNLLNLLLDSNSLSGQIPQSLFEIPKYNFTS 188
Query: 203 NNLNCGKTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGLLFFLCKGRHKGYKR 262
NNLNCG PH C S+ SG S KPK GII G+V G+ V++ G LLF CK RHKGY+R
Sbjct: 189 NNLNCGGRQPHPCVSAVAHSGDSSKPKTGIIAGVVAGVTVVLFGILLFLFCKDRHKGYRR 248
Query: 263 EVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVA 322
+VFVDVAGEVDRRIAFGQLKR++WRELQLATDNFSEKNVLGQGGFGKVY+GVL D TKVA
Sbjct: 249 DVFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVA 308
Query: 323 VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRL 382
VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT TERLLVYPFMQNLS+A+RL
Sbjct: 309 VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRL 368
Query: 383 REIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 442
REIK G+PVLDW TRKR+ALGAARG EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF
Sbjct: 369 REIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 428
Query: 443 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 502
GLAKLVDVR+TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS
Sbjct: 429 GLAKLVDVRRTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 488
Query: 503 RLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA 562
RLEEEDDVLLLDHVKKLEREKRL AIVD+NL+ Y +EVE MIQVALLCTQ SPEDRP
Sbjct: 489 RLEEEDDVLLLDHVKKLEREKRLGAIVDKNLDGEYIKEEVEMMIQVALLCTQGSPEDRPV 548
Query: 563 MSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR 619
MSEVVRMLEGEGLAERWEEWQ+VEVTRR E+ERLQRRFDWGEDS++NQ+AIELSGGR
Sbjct: 549 MSEVVRMLEGEGLAERWEEWQNVEVTRRHEFERLQRRFDWGEDSMHNQDAIELSGGR 605
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|20260260|gb|AAM13028.1| protein serine/threonine kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 957 bits (2474), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 482/597 (80%), Positives = 527/597 (88%), Gaps = 5/597 (0%)
Query: 28 WLTFLCSL-----SGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVT 82
+ LCS GDALFALR SLR NQL DWNQNQVNPCTWS VICD+ N V S+T
Sbjct: 17 FFACLCSFVSPDAQGDALFALRISLRALPNQLSDWNQNQVNPCTWSQVICDDKNFVTSLT 76
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 142
LS MNFSGTLS R+G+L L TLTLKGNGITGEIPE+ GNL+SLTSLDL++N+L G+IP
Sbjct: 77 LSDMNFSGTLSSRVGILENLKTLTLKGNGITGEIPEDFGNLTSLTSLDLEDNQLTGRIPS 136
Query: 143 SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTG 202
++GNLKKLQFLTLS+N +GTIP+SLT L +L+++ LDSN+LSGQIP LF+IPKYNFT
Sbjct: 137 TIGNLKKLQFLTLSRNKLNGTIPESLTGLPNLLNLLLDSNSLSGQIPQSLFEIPKYNFTS 196
Query: 203 NNLNCGKTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGLLFFLCKGRHKGYKR 262
NNLNCG PH C S+ SG S KPK GII G+V G+ V++ G LLF CK RHKGY+R
Sbjct: 197 NNLNCGGRQPHPCVSAVAHSGDSSKPKTGIIAGVVAGVTVVLFGILLFLFCKDRHKGYRR 256
Query: 263 EVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVA 322
+VFVDVAGEVDRRIAFGQLKR++WRELQLATDNFSEKNVLGQGGFGKVY+GVL D TKVA
Sbjct: 257 DVFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVA 316
Query: 323 VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRL 382
VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT TERLLVYPFMQNLS+A+RL
Sbjct: 317 VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRL 376
Query: 383 REIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 442
REIK G+PVLDW TRKR+ALGAARG EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF
Sbjct: 377 REIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 436
Query: 443 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 502
GLAKLVDVR+TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS
Sbjct: 437 GLAKLVDVRRTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 496
Query: 503 RLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA 562
RLEEEDDVLLLDHVKKLEREKRL AIVD+NL+ Y +EV MIQVALLCTQ SPEDRP
Sbjct: 497 RLEEEDDVLLLDHVKKLEREKRLGAIVDKNLDGEYIKEEVGMMIQVALLCTQGSPEDRPV 556
Query: 563 MSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR 619
MSEVVRMLEGEGLAERWEEWQ+VEVTRR E+ERLQRRFDWGEDS++NQ+AIELSGGR
Sbjct: 557 MSEVVRMLEGEGLAERWEEWQNVEVTRRHEFERLQRRFDWGEDSMHNQDAIELSGGR 613
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 619 | ||||||
| TAIR|locus:2145407 | 613 | AT5G10290 [Arabidopsis thalian | 0.941 | 0.951 | 0.723 | 4.7e-222 | |
| TAIR|locus:2013021 | 625 | SERK1 "somatic embryogenesis r | 0.576 | 0.571 | 0.652 | 1.1e-150 | |
| TAIR|locus:2026097 | 628 | SERK2 "somatic embryogenesis r | 0.576 | 0.568 | 0.649 | 2.6e-145 | |
| TAIR|locus:2160644 | 614 | AT5G63710 [Arabidopsis thalian | 0.838 | 0.845 | 0.538 | 1.9e-138 | |
| TAIR|locus:2040461 | 620 | SERK4 "somatic embryogenesis r | 0.521 | 0.520 | 0.653 | 7.6e-133 | |
| TAIR|locus:2040471 | 601 | SERK5 "somatic embryogenesis r | 0.521 | 0.537 | 0.631 | 1.1e-129 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.579 | 0.568 | 0.552 | 2.4e-125 | |
| TAIR|locus:2146102 | 638 | NIK1 "NSP-interacting kinase 1 | 0.573 | 0.556 | 0.563 | 3.5e-122 | |
| TAIR|locus:2061466 | 634 | AT2G23950 [Arabidopsis thalian | 0.483 | 0.471 | 0.605 | 2.3e-116 | |
| TAIR|locus:2118811 | 648 | SARK "SENESCENCE-ASSOCIATED RE | 0.864 | 0.825 | 0.436 | 2.2e-112 |
| TAIR|locus:2145407 AT5G10290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2144 (759.8 bits), Expect = 4.7e-222, P = 4.7e-222
Identities = 422/583 (72%), Positives = 451/583 (77%)
Query: 37 GDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRI 96
GDALFALR SLR NQL DWNQNQVNPCTWS VICD+ N V S+TLS MNFSGTLS R+
Sbjct: 31 GDALFALRISLRALPNQLSDWNQNQVNPCTWSQVICDDKNFVTSLTLSDMNFSGTLSSRV 90
Query: 97 GVLRTLSTLTLKGNGITGEIPEEXXXXXXXXXXXXXXXXXVGKIPPSLGNLKKLQFLTLS 156
G+L L TLTLKGNGITGEIPE+ G+IP ++GNLKKLQFLTLS
Sbjct: 91 GILENLKTLTLKGNGITGEIPEDFGNLTSLTSLDLEDNQLTGRIPSTIGNLKKLQFLTLS 150
Query: 157 QNNFSGTIPXXXXXXXXXXXXXXXXXXXXGQIPVHLFQIPKYNFTGNNLNCGKTLPHXXX 216
+N +GTIP GQIP LF+IPKYNFT NNLNCG PH
Sbjct: 151 RNKLNGTIPESLTGLPNLLNLLLDSNSLSGQIPQSLFEIPKYNFTSNNLNCGGRQPHPCV 210
Query: 217 XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXFFLCKGRHKGYKREVFVDVAGEVDRRI 276
F CK RHKGY+R+VFVDVAGEVDRRI
Sbjct: 211 SAVAHSGDSSKPKTGIIAGVVAGVTVVLFGILLFLFCKDRHKGYRRDVFVDVAGEVDRRI 270
Query: 277 AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDA 336
AFGQLKR++WRELQLATDNFSEKNVLGQGGFGKVY+GVL D TKVAVKRLTDFESPGGDA
Sbjct: 271 AFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVAVKRLTDFESPGGDA 330
Query: 337 AFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT 396
AFQREVEMISVAVHRNLLRLIGFCTT TERLLVYPFMQNLS+A+RLREIK G+PVLDW T
Sbjct: 331 AFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRLREIKAGDPVLDWET 390
Query: 397 RKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 456
RKR+ALGAARG EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR+TNVT
Sbjct: 391 RKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVT 450
Query: 457 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXX 516
TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSR
Sbjct: 451 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV 510
Query: 517 XXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLA 576
REKRL AIVD+NL+ Y +EVE MIQVALLCTQ SPEDRP MSEVVRMLEGEGLA
Sbjct: 511 KKLEREKRLGAIVDKNLDGEYIKEEVEMMIQVALLCTQGSPEDRPVMSEVVRMLEGEGLA 570
Query: 577 ERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR 619
ERWEEWQ+VEVTRR E+ERLQRRFDWGEDS++NQ+AIELSGGR
Sbjct: 571 ERWEEWQNVEVTRRHEFERLQRRFDWGEDSMHNQDAIELSGGR 613
|
|
| TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1193 (425.0 bits), Expect = 1.1e-150, Sum P(2) = 1.1e-150
Identities = 233/357 (65%), Positives = 276/357 (77%)
Query: 263 EVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVA 322
++F DV E D + GQLKR+S RELQ+A+D FS KN+LG+GGFGKVY+G LADGT VA
Sbjct: 269 DIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKVYKGRLADGTLVA 328
Query: 323 VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRL 382
VKRL + +PGG+ FQ EVEMIS+AVHRNLLRL GFC TPTERLLVYP+M N SVA L
Sbjct: 329 VKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL 388
Query: 383 REIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 442
RE P +P LDW TRKR+ALG+ARGL YLH+HC+PKIIHRDVKAAN+LLDE+FEAVVGDF
Sbjct: 389 RERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 448
Query: 443 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 502
GLAKL+D + T+VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYGIMLLEL+TGQRA D +
Sbjct: 449 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLA 508
Query: 503 RXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA 562
R +EK+L+ +VD +L NY +E+E +IQVALLCTQ SP +RP
Sbjct: 509 RLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLCTQGSPMERPK 568
Query: 563 MSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR 619
MSEVVRMLEG+GLAE+W+EWQ VE+ R + DW DS YN A+ELSG R
Sbjct: 569 MSEVVRMLEGDGLAEKWDEWQKVEILREEIDLSPNPNSDWILDSTYNLHAVELSGPR 625
|
|
| TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1160 (413.4 bits), Expect = 2.6e-145, Sum P(2) = 2.6e-145
Identities = 233/359 (64%), Positives = 275/359 (76%)
Query: 262 REVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKV 321
+E F DV E D + GQLKR+S RELQ+ATD+FS KN+LG+GGFGKVY+G LADGT V
Sbjct: 271 QEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGTLV 330
Query: 322 AVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYR 381
AVKRL + +PGG+ FQ EVEMIS+AVHRNLLRL GFC TPTERLLVYP+M N SVA
Sbjct: 331 AVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASC 390
Query: 382 LREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD 441
LRE P + L W R+++ALG+ARGL YLH+HC+PKIIHRDVKAAN+LLDE+FEAVVGD
Sbjct: 391 LRERPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 450
Query: 442 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDF 501
FGLA+L+D + T+VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYGIMLLEL+TGQRA D
Sbjct: 451 FGLARLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 510
Query: 502 SRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP 561
+R +EK+L+ +VD +L NY EVE +IQVALLCTQ+SP +RP
Sbjct: 511 ARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQSNYTEAEVEQLIQVALLCTQSSPMERP 570
Query: 562 AMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQR-RFDWGEDSVYNQEAIELSGGR 619
MSEVVRMLEG+GLAE+W+EWQ VEV R QE E DW DS N A+ELSG R
Sbjct: 571 KMSEVVRMLEGDGLAEKWDEWQKVEVLR-QEVELSSHPTSDWILDSTDNLHAMELSGPR 628
|
|
| TAIR|locus:2160644 AT5G63710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1355 (482.0 bits), Expect = 1.9e-138, P = 1.9e-138
Identities = 282/524 (53%), Positives = 342/524 (65%)
Query: 100 RTLSTLTLKGNGITGEIPEEXXXXXXXXXXXXXXXXXVGKIPPSLGNLKKLQFLTLSQNN 159
+++ L L +G TG + G +P SLGN+ LQ L LS N+
Sbjct: 92 QSVVALNLASSGFTGTLSPAITKLKFLVTLELQNNSLSGALPDSLGNMVNLQTLNLSVNS 151
Query: 160 FSGTIPXXXXXXXXXXXXXXXXXXXXGQIPVHLFQIPKYNFTGNNLNCGKTLPHXXXXXX 219
FSG+IP G IP F IP ++F+G L CGK+L
Sbjct: 152 FSGSIPASWSQLSNLKHLDLSSNNLTGSIPTQFFSIPTFDFSGTQLICGKSLNQPCSSSS 211
Query: 220 XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXFFLCKG-RHKGYKREVFVDVAGEVDRRIAF 278
+ R + K ++F DVAGE DR+I+F
Sbjct: 212 RLPVTSSKKKLRDITLTASCVASIILFLGAMVMYHHHRVRRTKYDIFFDVAGEDDRKISF 271
Query: 279 GQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAF 338
GQLKR+S RE+QLATD+F+E N++GQGGFGKVYRG+L D TKVAVKRL D+ SPGG+AAF
Sbjct: 272 GQLKRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLPDKTKVAVKRLADYFSPGGEAAF 331
Query: 339 QREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK 398
QRE+++ISVAVH+NLLRLIGFCTT +ER+LVYP+M+NLSVAYRLR++K GE LDW TRK
Sbjct: 332 QREIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENLSVAYRLRDLKAGEEGLDWPTRK 391
Query: 399 RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 458
RVA G+A GLEYLHEHCNPKIIHRD+KAAN+LLD +FE V+GDFGLAKLVD T+VTTQ
Sbjct: 392 RVAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNNFEPVLGDFGLAKLVDTSLTHVTTQ 451
Query: 459 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXX 518
VRGTMGHIAPEYL TGKSSE+TDVFGYGI LLELVTGQRAIDFSR
Sbjct: 452 VRGTMGHIAPEYLCTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEENILLLDHIKK 511
Query: 519 XXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG-LAE 577
RE+RL IVD NL Y+ +EVET++QVALLCTQ SPEDRPAMSEVV+ML+G G LAE
Sbjct: 512 LLREQRLRDIVDSNLT-TYDSKEVETIVQVALLCTQGSPEDRPAMSEVVKMLQGTGGLAE 570
Query: 578 RWEEWQHVEVTRRQEYERLQRR-FDWGED-SVYNQEAIELSGGR 619
+W EW+ +E R +E L W E+ + +QE+I LS R
Sbjct: 571 KWTEWEQLEEVRNKEALLLPTLPATWDEEETTVDQESIRLSTAR 614
|
|
| TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1072 (382.4 bits), Expect = 7.6e-133, Sum P(2) = 7.6e-133
Identities = 211/323 (65%), Positives = 249/323 (77%)
Query: 265 FVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVK 324
F DV E D + GQLKR++ REL +ATDNFS KNVLG+GGFGKVY+G LADG VAVK
Sbjct: 263 FFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVK 322
Query: 325 RLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE 384
RL + + GG+ FQ EVEMIS+AVHRNLLRL GFC TPTERLLVYP+M N SVA LRE
Sbjct: 323 RLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 382
Query: 385 IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444
G P LDW RK +ALG+ARGL YLH+HC+ KIIHRDVKAAN+LLDE+FEAVVGDFGL
Sbjct: 383 RPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGL 442
Query: 445 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRX 504
AKL++ ++VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYG+MLLEL+TGQ+A D +R
Sbjct: 443 AKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARL 502
Query: 505 XXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 564
+EK+L+++VD L Y EVE +IQ+ALLCTQ+S +RP MS
Sbjct: 503 ANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMS 562
Query: 565 EVVRMLEGEGLAERWEEWQHVEV 587
EVVRMLEG+GLAERWEEWQ E+
Sbjct: 563 EVVRMLEGDGLAERWEEWQKEEM 585
|
|
| TAIR|locus:2040471 SERK5 "somatic embryogenesis receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1034 (369.0 bits), Expect = 1.1e-129, Sum P(2) = 1.1e-129
Identities = 204/323 (63%), Positives = 246/323 (76%)
Query: 265 FVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVK 324
F+DV E D + GQ KR+S REL +AT+ FS++NVLG+G FG +Y+G LAD T VAVK
Sbjct: 244 FLDVPAEEDPEVYLGQFKRFSLRELLVATEKFSKRNVLGKGRFGILYKGRLADDTLVAVK 303
Query: 325 RLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE 384
RL + + GG+ FQ EVEMIS+AVHRNLLRL GFC TPTERLLVYP+M N SVA LRE
Sbjct: 304 RLNEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 363
Query: 385 IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444
G P LDW RK +ALG+ARGL YLH+HC+ KIIH DVKAAN+LLDE+FEAVVGDFGL
Sbjct: 364 RPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHLDVKAANILLDEEFEAVVGDFGL 423
Query: 445 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRX 504
AKL++ ++VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYG+MLLEL+TGQ+A D +R
Sbjct: 424 AKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARL 483
Query: 505 XXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 564
+EK+L+++VD L Y EVE +IQ+ALLCTQ+S +RP MS
Sbjct: 484 ANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMS 543
Query: 565 EVVRMLEGEGLAERWEEWQHVEV 587
EVVRMLEG+GLAERWEEWQ E+
Sbjct: 544 EVVRMLEGDGLAERWEEWQKEEM 566
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1005 (358.8 bits), Expect = 2.4e-125, Sum P(2) = 2.4e-125
Identities = 205/371 (55%), Positives = 269/371 (72%)
Query: 260 YKR--EVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLAD 317
Y+R ++F DV + D ++ G LKRY+++EL+ AT++F+ KN+LG+GG+G VY+G L D
Sbjct: 263 YRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNSKNILGRGGYGIVYKGHLND 322
Query: 318 GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS 377
GT VAVKRL D GG+ FQ EVE IS+A+HRNLLRL GFC++ ER+LVYP+M N S
Sbjct: 323 GTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMPNGS 382
Query: 378 VAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA 437
VA RL++ GEP LDW RK++A+G ARGL YLHE C+PKIIHRDVKAAN+LLDEDFEA
Sbjct: 383 VASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEA 442
Query: 438 VVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 497
VVGDFGLAKL+D R ++VTT VRGT+GHIAPEYLSTG+SSE+TDVFG+GI+LLEL+TGQ+
Sbjct: 443 VVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQK 502
Query: 498 AIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASP 557
A+DF R +E +L ++D++LN ++ E+E ++QVALLCTQ +P
Sbjct: 503 ALDFGRSAHQKGVMLDWVKKLH-QEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQFNP 561
Query: 558 EDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRR---------QEYERLQRRFDWGEDSVY 608
RP MSEV++MLEG+GLAERWE Q+ + R++ D+ ++S
Sbjct: 562 SHRPKMSEVMKMLEGDGLAERWEATQNGTGEHQPPPLPPGMVSSSPRVRYYSDYIQESSL 621
Query: 609 NQEAIELSGGR 619
EAIELSG R
Sbjct: 622 VVEAIELSGPR 632
|
|
| TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 989 (353.2 bits), Expect = 3.5e-122, Sum P(2) = 3.5e-122
Identities = 208/369 (56%), Positives = 264/369 (71%)
Query: 260 YKREVFVDVA-GEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADG 318
+ + F DV G ++ G L+R+ +RELQ+AT+NFS KN+LG+GG+G VY+G+L D
Sbjct: 275 HNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKGILGDS 334
Query: 319 TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV 378
T VAVKRL D + GG+ FQ EVEMIS+AVHRNLLRL GFC T TE+LLVYP+M N SV
Sbjct: 335 TVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYMSNGSV 394
Query: 379 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV 438
A R++ +PVLDW RKR+A+GAARGL YLHE C+PKIIHRDVKAAN+LLD+ EAV
Sbjct: 395 ASRMK----AKPVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDDYCEAV 450
Query: 439 VGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRA 498
VGDFGLAKL+D + ++VTT VRGT+GHIAPEYLSTG+SSE+TDVFG+GI+LLELVTGQRA
Sbjct: 451 VGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVTGQRA 510
Query: 499 IDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNL--NKNYNIQEVETMIQVALLCTQAS 556
+F + +EK+L+ +VD+ L K+Y+ E++ M++VALLCTQ
Sbjct: 511 FEFGKAANQKGVMLDWVKKIH-QEKKLELLVDKELLKKKSYDEIELDEMVRVALLCTQYL 569
Query: 557 PEDRPAMSEVVRMLEGEGLAERWEEWQHVEVT-----RRQEYERLQRRF-DWGEDSVYNQ 610
P RP MSEVVRMLEG+GLAE+WE Q + R E R+ D +DS
Sbjct: 570 PGHRPKMSEVVRMLEGDGLAEKWEASQRSDSVSKCSNRINELMSSSDRYSDLTDDSSLLV 629
Query: 611 EAIELSGGR 619
+A+ELSG R
Sbjct: 630 QAMELSGPR 638
|
|
| TAIR|locus:2061466 AT2G23950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 936 (334.5 bits), Expect = 2.3e-116, Sum P(2) = 2.3e-116
Identities = 184/304 (60%), Positives = 230/304 (75%)
Query: 276 IAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGD 335
+ G L+ +++REL +ATD FS K++LG GGFG VYRG DGT VAVKRL D G+
Sbjct: 279 LGLGNLRSFTFRELHVATDGFSSKSILGAGGFGNVYRGKFGDGTVVAVKRLKDVNGTSGN 338
Query: 336 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 395
+ F+ E+EMIS+AVHRNLLRLIG+C + +ERLLVYP+M N SVA RL+ +P LDW
Sbjct: 339 SQFRTELEMISLAVHRNLLRLIGYCASSSERLLVYPYMSNGSVASRLK----AKPALDWN 394
Query: 396 TRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455
TRK++A+GAARGL YLHE C+PKIIHRDVKAAN+LLDE FEAVVGDFGLAKL++ ++V
Sbjct: 395 TRKKIAIGAARGLFYLHEQCDPKIIHRDVKAANILLDEYFEAVVGDFGLAKLLNHEDSHV 454
Query: 456 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXX 515
TT VRGT+GHIAPEYLSTG+SSE+TDVFG+GI+LLEL+TG RA++F +
Sbjct: 455 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSVSQKGAMLEWV 514
Query: 516 XXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGL 575
+E +++ +VDR L Y+ EV M+QVALLCTQ P RP MSEVV+MLEG+GL
Sbjct: 515 RKLH-KEMKVEELVDRELGTTYDRIEVGEMLQVALLCTQFLPAHRPKMSEVVQMLEGDGL 573
Query: 576 AERW 579
AERW
Sbjct: 574 AERW 577
|
|
| TAIR|locus:2118811 SARK "SENESCENCE-ASSOCIATED RECEPTOR-LIKE KINASE" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1109 (395.4 bits), Expect = 2.2e-112, P = 2.2e-112
Identities = 240/550 (43%), Positives = 316/550 (57%)
Query: 38 DALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIG 97
+AL ++R +L P+ L +W++ V+PC+W+ + C N V + S + SG LS IG
Sbjct: 39 EALISIRNNLHDPHGALNNWDEFSVDPCSWAMITCSPDNLVIGLGAPSQSLSGGLSESIG 98
Query: 98 VLRTLSTLTLKGNGITGEIPEEXXXXXXXXXXXXXXXXXVGKIPPSLGNLKKLQFLTLSQ 157
L L ++L+ N I+G+IP E G IP S+ L LQ+L L+
Sbjct: 99 NLTNLRQVSLQNNNISGKIPPELGFLPKLQTLDLSNNRFSGDIPVSIDQLSSLQYLRLNN 158
Query: 158 NNFSGTIPXXXXXXXXXXXXXXXXXXXXGQIPVHLFQIPKYNFTGNNLNCGKTLPHXXXX 217
N+ SG P G +P F +N GN L C P
Sbjct: 159 NSLSGPFPASLSQIPHLSFLDLSYNNLSGPVPK--FPARTFNVAGNPLICRSNPPEICSG 216
Query: 218 XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX---FFLCKGRHKGYKRE----VFVDVAG 270
L G Y+++ + +++
Sbjct: 217 SINASPLSVSLSSSSGRRSNRLAIALSVSLGSVVILVLALGSFCWYRKKQRRLLILNLND 276
Query: 271 EVDRRI-AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDF 329
+ + + G L+ +++REL + TD FS KN+LG GGFG VYRG L DGT VAVKRL D
Sbjct: 277 KQEEGLQGLGNLRSFTFRELHVYTDGFSSKNILGAGGFGNVYRGKLGDGTMVAVKRLKDI 336
Query: 330 ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGE 389
GD+ F+ E+EMIS+AVH+NLLRLIG+C T ERLLVYP+M N SVA +L+ +
Sbjct: 337 NGTSGDSQFRMELEMISLAVHKNLLRLIGYCATSGERLLVYPYMPNGSVASKLKS----K 392
Query: 390 PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449
P LDW RKR+A+GAARGL YLHE C+PKIIHRDVKAAN+LLDE FEAVVGDFGLAKL++
Sbjct: 393 PALDWNMRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANILLDECFEAVVGDFGLAKLLN 452
Query: 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXX 509
++VTT VRGT+GHIAPEYLSTG+SSE+TDVFG+GI+LLEL+TG RA++F +
Sbjct: 453 HADSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGKTVSQKG 512
Query: 510 XXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569
E +++ ++DR L NY+ EV M+QVALLCTQ P RP MSEVV M
Sbjct: 513 AMLEWVRKLH-EEMKVEELLDRELGTNYDKIEVGEMLQVALLCTQYLPAHRPKMSEVVLM 571
Query: 570 LEGEGLAERW 579
LEG+GLAERW
Sbjct: 572 LEGDGLAERW 581
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGX1 | Y5524_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7875 | 0.9563 | 0.9752 | no | no |
| C0LGT1 | Y5129_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8090 | 0.9563 | 0.9657 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_fgenesh4_pg.C_LG_VII0470 | SubName- Full=Putative uncharacterized protein; (611 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 619 | |||
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-45 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-44 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-43 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-42 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-42 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-42 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-28 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-27 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-21 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-21 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-17 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-16 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-15 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-13 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-13 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-12 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-12 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-11 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-09 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-07 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 2e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-07 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.001 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 0.002 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.002 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.003 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.003 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 4e-45
Identities = 82/288 (28%), Positives = 127/288 (44%), Gaps = 42/288 (14%)
Query: 300 NVLGQGGFGKVYRGVLADG----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 355
LG+G FG+VY+G L T+VAVK L + S F +E ++ H N++R
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 356 LIGFCTTPTERLLVYPFMQN---LSV--AYRLREIKPGEPVLDWVTRKRVALGAARGLEY 410
L+G CT LV +M+ L R P + L A+ A+G+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 411 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---A 467
L K +HRD+ A N L+ ED + DFGL++ V G I A
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK--TGGKLPIRWMA 175
Query: 468 PEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKK---LEREK 523
PE L G + ++DV+ +G++L E+ T G + + +L++++K L + +
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGA-----TPYPGLSNEEVLEYLRKGYRLPKPE 230
Query: 524 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ + ++ L C Q PEDRP SE+V LE
Sbjct: 231 YCP----------------DELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 4e-44
Identities = 78/276 (28%), Positives = 126/276 (45%), Gaps = 29/276 (10%)
Query: 301 VLGQGGFGKVYRGVLADG-----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 355
LG+G FG+VY+G L +VAVK L + S F RE ++ H N+++
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 356 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 415
L+G CT ++V +M + LR K L AL ARG+EYL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYLESK- 122
Query: 416 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK 475
IHRD+ A N L+ E+ + DFGL++ + + + +APE L GK
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 476 SSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN 534
+ ++DV+ +G++L E+ T G+ + + + +L+++KK R +
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEE--PYPGMSNAE---VLEYLKKGYRLPKPPNCPPE--- 232
Query: 535 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 570
+ ++ L C PEDRP SE+V +L
Sbjct: 233 ----------LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 2e-43
Identities = 80/282 (28%), Positives = 126/282 (44%), Gaps = 38/282 (13%)
Query: 299 KNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 353
LG+G FG+VY+G L +VAVK L + S F RE ++ H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 354 LRLIGFCTTPTERLLVYPFMQNLSVAYRLRE-IKPGEPVLDWVTRKRVALGAARGLEYLH 412
++L+G CT +V +M+ L ++ P L AL ARG+EYL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGD----LLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 413 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APE 469
IHRD+ A N L+ E+ + DFGL++ + RG I APE
Sbjct: 120 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYR---KRGGKLPIRWMAPE 173
Query: 470 YLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528
L GK + ++DV+ +G++L E+ T G++ + + E+ +L+++K R +
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTLGEQ--PYPGMSNEE---VLEYLKNGYRLPQPPNC 228
Query: 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 570
+ + L C PEDRP SE+V +L
Sbjct: 229 PPE-------------LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 2e-43
Identities = 138/531 (25%), Positives = 237/531 (44%), Gaps = 89/531 (16%)
Query: 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNN 134
S + ++ LS FSG + ++G L L L L N ++GEIP+EL + L SLDL +N
Sbjct: 474 SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHN 533
Query: 135 RLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV--HL 192
+L G+IP S + L L LSQN SG IP +L + SL+ + + N+L G +P
Sbjct: 534 QLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAF 593
Query: 193 FQIPKYNFTGNNLNCGKTLPHSCESSSNDSGSSKKP---------KIGIIVGIVGGLIVL 243
I GN CG D+ S P I +G +VL
Sbjct: 594 LAINASAVAGNIDLCG-----------GDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVL 642
Query: 244 ISGGLLFFLCKGRHKGYKREVFVDVAGEVDRRIAFGQLKRY-----SWRELQLATDNFS- 297
F +GR+ +LKR +W ELQ S
Sbjct: 643 ALVAFGFVFIRGRNNL--------------------ELKRVENEDGTW-ELQFFDSKVSK 681
Query: 298 ------------EKNVLGQGGFGKVYRG-VLADGTKVAVKRLTDFES-PGGDAAFQREVE 343
E+NV+ +G G Y+G + +G + VK + D S P + A +++
Sbjct: 682 SITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQ 741
Query: 344 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 403
H N+++LIG C + L++ +++ +++ LR L W R+++A+G
Sbjct: 742 ------HPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIG 788
Query: 404 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 463
A+ L +LH C+P ++ ++ +++D E + L L+ +
Sbjct: 789 IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKCFISS----- 842
Query: 464 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 523
++APE T +E++D++G+G++L+EL+TG+ D E +++ + +
Sbjct: 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD---AEFGVHGSIVEWARYCYSDC 899
Query: 524 RLDAIVDRNLNKNYNIQE---VETMIQVALLCTQASPEDRPAMSEVVRMLE 571
LD +D ++ + ++ + VE M +AL CT P RP ++V++ LE
Sbjct: 900 HLDMWIDPSIRGDVSVNQNEIVEVM-NLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 1e-42
Identities = 71/199 (35%), Positives = 100/199 (50%), Gaps = 11/199 (5%)
Query: 301 VLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNLLRLIG 358
LG G FG VY+ G VAVK L E D +RE+ ++ H N++RLI
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 359 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 418
LV + + + L L K++AL RGLEYLH +
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSR----GGPLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 419 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK-SS 477
IIHRD+K N+LLDE+ + DFGLAK + +++TT V GT ++APE L G
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177
Query: 478 ERTDVFGYGIMLLELVTGQ 496
+ DV+ G++L EL+TG+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 2e-42
Identities = 89/284 (31%), Positives = 132/284 (46%), Gaps = 45/284 (15%)
Query: 301 VLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 355
LG+G FG+VY+G L TKVAVK L + S F E ++ H N++R
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 356 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 415
L+G CT +V +M + LR K GE L ++AL A+G+EYL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLR--KHGEK-LTLKDLLQMALQIAKGMEYLESK- 121
Query: 416 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYLS 472
+HRD+ A N L+ E+ + DFGL++ D+ + + + G I APE L
Sbjct: 122 --NFVHRDLAARNCLVTENLVVKISDFGLSR--DIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 473 TGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531
GK + ++DV+ +G++L E+ T G+ + + E +VL + LE RL
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGE--QPYPGMSNE-EVL-----ELLEDGYRLPR---- 225
Query: 532 NLNKN-----YNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 570
+N Y + M L C PEDRP SE+V L
Sbjct: 226 --PENCPDELYEL-----M----LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 3e-42
Identities = 66/194 (34%), Positives = 100/194 (51%), Gaps = 10/194 (5%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 360
LG+GGFG VY G KVA+K + +S RE+E++ H N+++L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 361 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 420
LV + + S+ L+E + L R+ L GLEYLH + II
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK---LSEDEILRILLQILEGLEYLHSN---GII 114
Query: 421 HRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL-STGKSSE 478
HRD+K N+LLD D + + DFGL+KL+ ++ + GT ++APE L G SE
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 479 RTDVFGYGIMLLEL 492
++D++ G++L EL
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 10/202 (4%)
Query: 296 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 354
+ LG+G FGKVY G VA+K + + RE++++ H N++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 355 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 414
RL + LV + + + L++ L + LEYLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR----LSEDEARFYLRQILSALEYLHSK 116
Query: 415 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG 474
I+HRD+K N+LLDED + DFGLA+ +D +TT V GT ++APE L
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFV-GTPEYMAPEVLLGK 171
Query: 475 KSSERTDVFGYGIMLLELVTGQ 496
+ D++ G++L EL+TG+
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 16/219 (7%)
Query: 300 NVLGQGGFGKVYRGVLAD-GTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNLLRLI 357
+LG+G FG VY + D G +AVK + +S A +RE+ ++S H N++R
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 358 GFCTTPTER-LLVY-PFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLHEH 414
G + L ++ ++ S++ L++ EPV+ ++ GL YLH +
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI-----RKYTRQILEGLAYLHSN 120
Query: 415 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-DVRKTNVTTQVRGTMGHIAPEYLST 473
I+HRD+K AN+L+D D + DFG AK + D+ T VRGT +APE +
Sbjct: 121 ---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 474 GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL 512
+ D++ G ++E+ TG+ +S L L
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPP--WSELGNPMAALY 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 6e-28
Identities = 62/203 (30%), Positives = 95/203 (46%), Gaps = 12/203 (5%)
Query: 296 FSEKNVLGQGGFGKVYRG-VLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 354
F +G+GGFG+VY+ G +VA+K + ES E++++ H N++
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVI-KLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 355 RLIGFCTTPTERLLVYPFMQNLSVAYRLREI-KPGEPVLDWVTRKRVALGAARGLEYLHE 413
+ G E +V F S L+++ K L V +GLEYLH
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGS----LKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116
Query: 414 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 473
+ IIHRD+KAAN+LL D E + DFGL+ + K T GT +APE ++
Sbjct: 117 N---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVING 171
Query: 474 GKSSERTDVFGYGIMLLELVTGQ 496
+ D++ GI +EL G+
Sbjct: 172 KPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 9e-28
Identities = 82/277 (29%), Positives = 123/277 (44%), Gaps = 37/277 (13%)
Query: 299 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 358
+G+G FG V G G KVAVK L D +S A F E +++ H NL++L+G
Sbjct: 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKD-DSTAAQA-FLAEASVMTTLRHPNLVQLLG 67
Query: 359 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 418
+V +M S+ LR G V+ + AL G+EYL E
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYLRS--RGRAVITLAQQLGFALDVCEGMEYLEEK---N 122
Query: 419 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 478
+HRD+ A NVL+ ED A V DFGLAK + + V+ T APE L K S
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFST 178
Query: 479 RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 538
++DV+ +GI+L E+ + R + R+ +D ++ HV+ K Y
Sbjct: 179 KSDVWSFGILLWEIYSFGRV-PYPRIPLKD---VVPHVE-----------------KGYR 217
Query: 539 IQEVET----MIQVALLCTQASPEDRPAMSEVVRMLE 571
++ E + +V C + P RP ++ L
Sbjct: 218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-27
Identities = 73/218 (33%), Positives = 100/218 (45%), Gaps = 55/218 (25%)
Query: 40 LFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASV------------------ 81
L + ++S+ P L +WN + + C W + C+NS+ V S+
Sbjct: 34 LLSFKSSINDPLKYLSNWNSS-ADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRL 92
Query: 82 -------------------------------TLSSMNFSGTLSPRIGVLRTLSTLTLKGN 110
LS+ NF+G++ PR G + L TL L N
Sbjct: 93 PYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSI-PR-GSIPNLETLDLSNN 150
Query: 111 GITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTT 170
++GEIP ++G+ SSL LDL N LVGKIP SL NL L+FLTL+ N G IP L
Sbjct: 151 MLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQ 210
Query: 171 LSSLISIQLDSNNLSGQIPVHLFQIPKYN---FTGNNL 205
+ SL I L NNLSG+IP + + N NNL
Sbjct: 211 MKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNL 248
|
Length = 968 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 89/284 (31%), Positives = 135/284 (47%), Gaps = 39/284 (13%)
Query: 300 NVLGQGGFGKVYRGVLADG----TKVAVK---RLTDFESPGGDAAFQREVEMISVAVHRN 352
V+G+G FG VY G L D AVK R+TD E F +E ++ H N
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEV---EQFLKEGIIMKDFSHPN 57
Query: 353 LLRLIGFCTTPTE--RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 410
+L L+G C P+E L+V P+M++ + +R V D + L A+G+EY
Sbjct: 58 VLSLLGICL-PSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG---FGLQVAKGMEY 113
Query: 411 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV---DVRKTNVTTQVRGTMGHIA 467
L + K +HRD+ A N +LDE F V DFGLA+ + + + T + + +A
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
Query: 468 PEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527
E L T K + ++DV+ +G++L EL+T + A + DV D L + +RL
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYP------DVDSFDITVYLLQGRRL-- 221
Query: 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
L Y + + +V L C PE RP SE+V +E
Sbjct: 222 -----LQPEYC---PDPLYEVMLSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-26
Identities = 60/133 (45%), Positives = 79/133 (59%), Gaps = 14/133 (10%)
Query: 81 VTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKI 140
+TL+S G + +G +++L + L N ++GEIP E+G L+SL LDL N L G I
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252
Query: 141 PPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP----------- 189
P SLGNLK LQ+L L QN SG IP S+ +L LIS+ L N+LSG+IP
Sbjct: 253 PSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEI 312
Query: 190 VHLFQIPKYNFTG 202
+HLF NFTG
Sbjct: 313 LHLFS---NNFTG 322
|
Length = 968 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 4e-25
Identities = 73/285 (25%), Positives = 119/285 (41%), Gaps = 24/285 (8%)
Query: 295 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAA-FQREVE-MISVAVHR 351
++ LG+G FG+VY D VA+K L ES + F RE++ + S+
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 352 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 411
N+++L F LV ++ S+ L++I P+ + + LEYL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALF-ILAQILSALEYL 117
Query: 412 HEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVR-----GTMGH 465
H IIHRD+K N+LLD D + DFGLAKL+ + + GT G+
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 466 IAPEYL---STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 522
+APE L S +S +D++ GI L EL+TG + + L + +L
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS-QTLKIILELPTP 233
Query: 523 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV 567
L+ + + + P++R + S +
Sbjct: 234 SLA-----SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 79/283 (27%), Positives = 130/283 (45%), Gaps = 40/283 (14%)
Query: 300 NVLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 355
V+G G FG+V RG L K VA+K L S F E ++ H N++R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 356 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 415
L G T +++ +M+N S+ LRE + + G A G++YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 416 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-----VRGTMGHIAPEY 470
+HRD+ A N+L++ + V DFGL++ ++ + TT+ +R T APE
Sbjct: 127 ---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEA 179
Query: 471 LSTGKSSERTDVFGYGIMLLELVT-GQRAI-DFSRLEEEDDVLLLDHVKKLEREKRLDAI 528
++ K + +DV+ +GI++ E+++ G+R D S DV+ K +E RL
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS----NQDVI-----KAVEDGYRLPPP 230
Query: 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+D + Q+ L C Q +RP S++V L+
Sbjct: 231 MDCP----------SALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 68/240 (28%), Positives = 110/240 (45%), Gaps = 43/240 (17%)
Query: 301 VLGQGGFGKVYRGV---LADGTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 355
VLG G FG VY+GV + K VA+K L + SP + E +++ H +++R
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 356 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA----------A 405
L+G C + L+ M P +LD+V + +G+ A
Sbjct: 74 LLGICLSSQ-VQLITQLM-------------PLGCLLDYVRNHKDNIGSQYLLNWCVQIA 119
Query: 406 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 465
+G+ YL E +++HRD+ A NVL+ + DFGLAKL+DV + G
Sbjct: 120 KGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVP 174
Query: 466 I---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLER 521
I A E + + ++DV+ YG+ + EL+T G + + E + D ++K ER
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-----IPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 75/291 (25%), Positives = 137/291 (47%), Gaps = 38/291 (13%)
Query: 300 NVLGQGGFGKVYRG---VLADGT--KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 354
LG+G FGKV L D T +VAVK L + F+RE+E++ H N++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 355 RLIGFCTTPTER--LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 412
+ G C P R L+ ++ + S+ L+ + ++ + +G++YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ---INLKRLLLFSSQICKGMDYLG 126
Query: 413 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT--MGHIAPEY 470
+ IHRD+ A N+L++ + + DFGLAK++ K + G + APE
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183
Query: 471 LSTGKSSERTDVFGYGIMLLELVTGQRAI-----DFSRL--EEEDDVLLLDHVKKLEREK 523
L T K S +DV+ +G+ L EL T +F R+ + +++ ++ L+ +
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243
Query: 524 RL---DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
RL + D EV +++ LC +A P+DRP+ ++++ +++
Sbjct: 244 RLPRPPSCPD----------EVYDLMK---LCWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-24
Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 302 LGQGGFGKVYRGVLADGTKVAVK--RLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 359
+G+G FG VY+GVL T+VAVK R T P F +E E++ H N+++LIG
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 360 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 419
C +V + S+ LR+ K V + +++L AA G+EYL
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLL---QMSLDAAAGMEYLESKN---C 114
Query: 420 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI-----APEYLSTG 474
IHRD+ A N L+ E+ + DFG+++ + V + I APE L+ G
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 475 KSSERTDVFGYGIMLLELVTG 495
+ + +DV+ YGI+L E +
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 76/285 (26%), Positives = 125/285 (43%), Gaps = 51/285 (17%)
Query: 302 LGQGGFGKVYRGV--LADGT--KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLI 357
LG G FG V +GV + G +VAVK L G F RE +++ H ++RLI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 358 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR---------VALGAARGL 408
G C P M + E+ P P+L ++ ++R +A A G+
Sbjct: 63 GVCKGE-------PLML-------VMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGM 108
Query: 409 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT--NVTTQVRGTMGHI 466
YL +HRD+ A NVLL +A + DFG+++ + TT R +
Sbjct: 109 AYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY 165
Query: 467 APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525
APE ++ GK S ++DV+ YG+ L E + G + + ++ + + +L+ ++L R +
Sbjct: 166 APECINYGKFSSKSDVWSYGVTLWEAFSYGAKP--YGEMKGAEVIAMLESGERLPRPEEC 223
Query: 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 570
+ + + L C + PEDRP SE+
Sbjct: 224 P----------------QEIYSIMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 75/286 (26%), Positives = 130/286 (45%), Gaps = 39/286 (13%)
Query: 302 LGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 355
LGQG FG VY G+ T+VA+K + + S F E ++ +++R
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 356 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGE---PVLDWVTRKRV---ALGAARGLE 409
L+G +T L+V M + LR +P P L T ++ A A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 410 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI--- 466
YL K +HRD+ A N ++ ED +GDFG+ + D+ +T+ + + +
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWM 188
Query: 467 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526
APE L G + ++DV+ +G++L E+ T L E+ + L E+ L
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMAT---------LAEQP-------YQGLSNEEVLK 232
Query: 527 AIVDRN-LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
++D L+ N + ++++ +C Q +P+ RP E+V L+
Sbjct: 233 FVIDGGHLDLPENCPDK--LLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 79/271 (29%), Positives = 125/271 (46%), Gaps = 34/271 (12%)
Query: 296 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNLL 354
F+ + LG G FG+V+ G+ + +VA+K L +D D FQ+EV+ + H++L+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD--FQKEVQALKRLRHKHLI 65
Query: 355 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 414
L C+ ++ M+ S+ LR P VL + +A A G+ YL E
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 415 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTT-QVRGTMGHIAPEYL 471
IHRD+ A N+L+ ED V DFGLA+L+ DV ++ + T APE
Sbjct: 124 ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT----APEAA 176
Query: 472 STGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530
S G S ++DV+ +GI+L E+ T GQ + + + + + ++ + +
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQ--VPYPGMNNHEVYDQITAGYRMPCPAKCPQEI- 233
Query: 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRP 561
Y I L C A PEDRP
Sbjct: 234 ------YKIM---------LECWAAEPEDRP 249
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 64/210 (30%), Positives = 109/210 (51%), Gaps = 22/210 (10%)
Query: 295 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGD-AAFQREVEMISVAVHRN 352
N+ +++G+G FG VY+G+ L G VA+K+++ + + +E++++ H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEP-----VLDWVTRKRVALGAARG 407
+++ IG T ++ + +N S+ + IK P V +V + +G
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLR---QIIKKFGPFPESLVAVYVYQ------VLQG 111
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQVRGTMGHI 466
L YLHE +IHRD+KAAN+L +D + DFG+A KL DV K V GT +
Sbjct: 112 LAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWM 166
Query: 467 APEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
APE + +S +D++ G ++EL+TG
Sbjct: 167 APEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 71/217 (32%), Positives = 106/217 (48%), Gaps = 19/217 (8%)
Query: 300 NVLGQGGFGKVYRGV-LADGTKVAVK--RLTDFESPGGDAAFQREVEMISVAVHRNLLRL 356
N +G G FGKVY V L G +AVK R+ D P E++++ + H NL++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD-NDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 357 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 416
G R VY FM+ S L E+ +LD + L GL YLH H
Sbjct: 65 YG---VEVHREKVYIFMEYCSGG-TLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH-- 118
Query: 417 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG---HIAPEYLST 473
I+HRD+K AN+ LD + +GDFG A + T + +V+ G ++APE ++
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 474 GKSSER---TDVFGYGIMLLELVTGQRAIDFSRLEEE 507
GK D++ G ++LE+ TG+R +S L+ E
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRP--WSELDNE 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-22
Identities = 87/295 (29%), Positives = 136/295 (46%), Gaps = 52/295 (17%)
Query: 285 SWRELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKR--LTDFESPGGDAAFQ-- 339
WR+ +L LG G FG VY G+ L DG AVK L D G +A Q
Sbjct: 1 RWRKGEL----------LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLE 50
Query: 340 REVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL---SVAYRLREIKP-GEPVLDWV 395
+E+ ++S H N+++ +G T E +Y F++ + S+A L++ EPV+
Sbjct: 51 QEIALLSKLQHPNIVQYLG---TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLY 107
Query: 396 TRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455
TR+ + GLEYLH + +HRD+K AN+L+D + + DFG+AK V
Sbjct: 108 TRQILL-----GLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFS 156
Query: 456 TTQ-VRGTMGHIAPEYL-STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL 513
+ +G+ +APE + G D++ G +LE+ TG+ +S+LE V
Sbjct: 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK--PPWSQLEGVAAVF-- 212
Query: 514 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568
K+ R K L I D ++ + L C Q P RP +E++
Sbjct: 213 ----KIGRSKELPPIPDHLSDEAKDF---------ILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 9e-22
Identities = 82/281 (29%), Positives = 129/281 (45%), Gaps = 39/281 (13%)
Query: 299 KNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLI 357
K+ LG G +G+VY GV VAVK L + + F +E ++ H NL++L+
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 68
Query: 358 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 417
G CT ++ FM ++ LRE ++ V +A + +EYL +
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK--- 123
Query: 418 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYLSTG 474
IHRD+ A N L+ E+ V DFGL++L+ + T G I APE L+
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYN 180
Query: 475 KSSERTDVFGYGIMLLELVT-GQR---AIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530
K S ++DV+ +G++L E+ T G ID S++ E LL+ ++ER + V
Sbjct: 181 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-----LLEKGYRMERPEGCPPKV- 234
Query: 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
E M C Q +P DRP+ +E+ + E
Sbjct: 235 -----------YELMRA----CWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 1e-21
Identities = 62/165 (37%), Positives = 83/165 (50%), Gaps = 20/165 (12%)
Query: 35 LSG---DALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVIC----DNSNNVASVTLSSMN 87
LSG D +F +SLR N N N ++ D SNN+
Sbjct: 105 LSGPIPDDIFTTSSSLRYLNLS----NNNFTGSIPRGSIPNLETLDLSNNM--------- 151
Query: 88 FSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNL 147
SG + IG +L L L GN + G+IP L NL+SL L L +N+LVG+IP LG +
Sbjct: 152 LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQM 211
Query: 148 KKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL 192
K L+++ L NN SG IP + L+SL + L NNL+G IP L
Sbjct: 212 KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSL 256
|
Length = 968 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 1e-21
Identities = 72/228 (31%), Positives = 102/228 (44%), Gaps = 42/228 (18%)
Query: 39 ALFALRTSLRVPNNQLR-DWNQNQVNPCT-----WSNVICDNSNNVASVTLSSMNFSGTL 92
AL L++SL +P LR WN + PC WS C F T
Sbjct: 376 ALQTLKSSLGLP---LRFGWNGD---PCVPQQHPWSGADC--------------QFDSTK 415
Query: 93 SPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQF 152
+ L L G+ G IP ++ L L S++L N + G IPPSLG++ L+
Sbjct: 416 GKWF-----IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEV 470
Query: 153 LTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIP----KYNFTGNNLNCG 208
L LS N+F+G+IP+SL L+SL + L+ N+LSG++P L +NFT N CG
Sbjct: 471 LDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG 530
Query: 209 KTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGLLFFLCKGR 256
+C S KIGI G+ + L+ + K R
Sbjct: 531 IPGLRACGPH-----LSVGAKIGIAFGVSVAFLFLVICAM--CWWKRR 571
|
Length = 623 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 65/221 (29%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISV 347
D K LG+G FGKV+ G D VAVK L + S F+RE E+++
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTN 64
Query: 348 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE--------IKPGEPV--LDWVTR 397
H N+++ G CT ++V+ +M++ + LR P P+ L
Sbjct: 65 FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 398 KRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT 457
++A+ A G+ YL +HRD+ N L+ D +GDFG+++ DV T+
Sbjct: 125 LQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSR--DVYTTDY-Y 178
Query: 458 QVRG-TMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT 494
+V G TM I PE + K + +DV+ +G++L E+ T
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 5e-21
Identities = 62/200 (31%), Positives = 97/200 (48%), Gaps = 21/200 (10%)
Query: 302 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 359
LG G FG+V+ G TKVAVK L PG AF +E +++ H L++L
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 360 CTTPTERLLVYPFMQNLSVAYRLRE---IKPGEPVLDWVTRKRVALGA--ARGLEYLHEH 414
C+ +V +M S+ L+ K P L V + A A G+ YL
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL-------VDMAAQIAEGMAYLESR 122
Query: 415 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG 474
IHRD+ A N+L+ E+ + DFGLA+L++ + + + APE + G
Sbjct: 123 ---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYG 179
Query: 475 KSSERTDVFGYGIMLLELVT 494
+ + ++DV+ +GI+L E+VT
Sbjct: 180 RFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 6e-21
Identities = 56/198 (28%), Positives = 97/198 (48%), Gaps = 10/198 (5%)
Query: 301 VLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 359
VLGQG G VY+ G A+K++ RE++ + +++ G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 360 CTTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLHEHCNPK 418
E +V +M S+A L+++ EPVL ++ R+ +GL+YLH
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQ-----ILKGLDYLHT--KRH 120
Query: 419 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 478
IIHRD+K +N+L++ E + DFG++K+++ T V GT+ +++PE + S
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSY 179
Query: 479 RTDVFGYGIMLLELVTGQ 496
D++ G+ LLE G+
Sbjct: 180 AADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 6e-21
Identities = 66/292 (22%), Positives = 128/292 (43%), Gaps = 54/292 (18%)
Query: 295 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKR--LTDFESPGGDAAFQREVEMISVAVHR 351
+ +G+G FGKVY +DG +K L++ + A EV+++ H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDA-LNEVKILKKLNHP 59
Query: 352 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE-IKPGEP-----VLDWVTRKRVALGAA 405
N+++ + +V + ++ ++++ K G+P +LDW + + L
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ--LCLA-- 115
Query: 406 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 465
L+YLH KI+HRD+K N+ L + +GDFG++K++ ++ V GT +
Sbjct: 116 --LKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKTVVGTPYY 169
Query: 466 IAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE-- 522
++PE L K + ++D++ G +L EL T + + L E L + K +
Sbjct: 170 LSPE-LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-----LALKILKGQYPPI 223
Query: 523 -----KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569
L +V L K+ PE+RP+++++++
Sbjct: 224 PSQYSSELRNLVSSLLQKD--------------------PEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 4e-20
Identities = 59/195 (30%), Positives = 89/195 (45%), Gaps = 11/195 (5%)
Query: 302 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 359
LG G FG+V+ G+ + T VAVK L PG F E +++ H L++L
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTL----KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 360 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 419
CT +V M+ S+ L+ L +A A G+ YL
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGGAGR--ALKLPQLIDMAAQVASGMAYLEAQ---NY 124
Query: 420 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSER 479
IHRD+ A NVL+ E+ V DFGLA+++ + + APE + S +
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 480 TDVFGYGIMLLELVT 494
+DV+ +GI+L E+VT
Sbjct: 185 SDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 5e-20
Identities = 80/293 (27%), Positives = 131/293 (44%), Gaps = 69/293 (23%)
Query: 301 VLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 360
+LG+G FG+V++G L D T VAVK + F E ++ H N+++LIG C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 361 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK----------RVALGAARGLEY 410
T+R +Y M E+ PG L ++ +K + AL AA G+ Y
Sbjct: 62 ---TQRQPIYIVM----------ELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAY 108
Query: 411 LH-EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD--VRKTNVTTQVRGTMGHIA 467
L ++C IHRD+ A N L+ E+ + DFG+++ D + ++ Q+ + A
Sbjct: 109 LESKNC----IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTA 162
Query: 468 PEYLSTGKSSERTDVFGYGIMLLEL----------VTGQRAIDFSRLEEEDDVLLLDHVK 517
PE L+ G+ S +DV+ YGI+L E +T Q+A
Sbjct: 163 PEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA------------------- 203
Query: 518 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 570
RE+ V++ + + + + +V C PE+RP SE+ + L
Sbjct: 204 ---REQ-----VEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 81/284 (28%), Positives = 121/284 (42%), Gaps = 42/284 (14%)
Query: 300 NVLGQGGFGKVYRGV-LADGTKVAVKRL------TDFESPGGDAAFQREVEMISVAVHRN 352
V+G G VY + L + KVA+KR+ T + ++EV+ +S H N
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDE------LRKEVQAMSQCNHPN 60
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 412
+++ E LV P++ S+ ++ P LD V +GLEYLH
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLH 119
Query: 413 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFG----LAKLVDVRKTNVTTQVRGTMGHIAP 468
+ IHRD+KA N+LL ED + DFG LA D + T V GT +AP
Sbjct: 120 SN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV-GTPCWMAP 175
Query: 469 EYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL---DHVKKLEREKR 524
E + + D++ +GI +EL TG A +S+ VL+L + LE
Sbjct: 176 EVMEQVHGYDFKADIWSFGITAIELATG--AAPYSKYPPM-KVLMLTLQNDPPSLETGAD 232
Query: 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568
K Y+ + MI LC Q P RP E+++
Sbjct: 233 ---------YKKYS-KSFRKMIS---LCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 6e-20
Identities = 51/111 (45%), Positives = 69/111 (62%)
Query: 87 NFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGN 146
N SG + IG L +L+ L L N +TG IP LGNL +L L L N+L G IPPS+ +
Sbjct: 223 NLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS 282
Query: 147 LKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK 197
L+KL L LS N+ SG IP+ + L +L + L SNN +G+IPV L +P+
Sbjct: 283 LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPR 333
|
Length = 968 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 8e-20
Identities = 82/294 (27%), Positives = 129/294 (43%), Gaps = 48/294 (16%)
Query: 302 LGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMI-SVAVHRNLL 354
LG+G FG+V + + VAVK L D + + E+EM+ + H+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 355 RLIGFCTT--PTERLLVYPFMQNLSVAYRLREIKPGE---PVLDWVTRKRV--------A 401
L+G CT P ++ Y NL R R PGE P + + A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARR-PPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 402 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV---TTQ 458
ARG+E+L K IHRD+ A NVL+ ED + DFGLA+ D+ + TT
Sbjct: 139 YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR--DIHHIDYYRKTTN 193
Query: 459 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVK 517
R + +APE L + ++DV+ +G++L E+ T G +EE L +K
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-----LFKLLK 248
Query: 518 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ R +++ N QE+ ++ C P RP ++V L+
Sbjct: 249 EGYR-------MEKPQNCT---QELYHLM---RDCWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 9e-20
Identities = 65/197 (32%), Positives = 100/197 (50%), Gaps = 18/197 (9%)
Query: 302 LGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 360
+G+G FG+V+ G L AD T VAVK + P A F +E ++ H N++RLIG C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 361 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH-EHCNPKI 419
T++ +Y M+ + L ++ P L ++ AA G+EYL +HC
Sbjct: 63 ---TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC---- 115
Query: 420 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI-----APEYLSTG 474
IHRD+ A N L+ E + DFG+++ + + G M I APE L+ G
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 475 KSSERTDVFGYGIMLLE 491
+ S +DV+ +GI+L E
Sbjct: 172 RYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 33/273 (12%)
Query: 302 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 361
+G G FG V+ G + KVA+K T E + F E +++ H L++L G CT
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIK--TIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 362 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 421
+ LV+ FM++ ++ LR + T + L G+ YL +IH
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 422 RDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTD 481
RD+ A N L+ E+ V DFG+ + V + +T + + +PE S K S ++D
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 482 VFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQE 541
V+ +G+++ E+ FS K E R ++ V +N + + +
Sbjct: 184 VWSFGVLMWEV--------FSE-------------GKTPYENRSNSEVVETINAGFRLYK 222
Query: 542 ----VETMIQVALLCTQASPEDRPAMSEVVRML 570
+++ ++ C + PEDRP+ S ++ L
Sbjct: 223 PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 359
+G+G +G+VY+ G VA+K++ + E G RE++++ H N++RL
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 360 CTTPTER--LLVYPFMQN-LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 416
T+ + +V+ +M + L+ E+K E + K GL+YLH +
Sbjct: 67 VTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQI-----KCYMKQLLEGLQYLHSN-- 119
Query: 417 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL--STG 474
I+HRD+K +N+L++ D + DFGLA+ R + T T+ + PE L +T
Sbjct: 120 -GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT- 177
Query: 475 KSSERTDVFGYGIMLLELVTG 495
+ D++ G +L EL G
Sbjct: 178 RYGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-19
Identities = 71/278 (25%), Positives = 122/278 (43%), Gaps = 40/278 (14%)
Query: 302 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDA--AFQREVEMISVAVHRNLLRLIGF 359
LG G FG+V+ G + TKVAVK L PG + AF E ++ H L+RL
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTL----KPGTMSVQAFLEEANLMKTLQHDKLVRLYAV 69
Query: 360 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--ARGLEYLHEHCNP 417
T ++ +M S+ L+ + G+ +L K + A A G+ Y+
Sbjct: 70 VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP----KLIDFSAQIAEGMAYIERK--- 122
Query: 418 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 477
IHRD++AANVL+ E + DFGLA++++ + + + APE ++ G +
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 478 ERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNY 537
++DV+ +GI+L E+VT K+ ++ V L + Y
Sbjct: 183 IKSDVWSFGILLYEIVT---------------------YGKIPYPGMSNSDVMSALQRGY 221
Query: 538 NIQEVET----MIQVALLCTQASPEDRPAMSEVVRMLE 571
+ +E + + C + E+RP + +L+
Sbjct: 222 RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 4e-19
Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 300 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAA------FQREVEMISVAVHRNL 353
VLG+G +G VY G+ G +AVK++ + ++ AA Q EV+++ H N+
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQV-ELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 354 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLH 412
++ +G C + F+ S++ L P EPV T++ + G+ YLH
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL-----DGVAYLH 119
Query: 413 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-----DVRKTNVTTQVRGTMGHIA 467
+C ++HRD+K NV+L + + DFG A+ + +N+ + GT +A
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 468 PEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
PE ++ ++D++ G + E+ TG+
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 7e-19
Identities = 69/275 (25%), Positives = 115/275 (41%), Gaps = 37/275 (13%)
Query: 302 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 361
LG G FG V+ G VA+K + E + F E +++ H NL++L G CT
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR--EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 362 TPTERLLVYPFMQNLSVAYRLREIK---PGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 418
+V +M N + LRE K E +LD + +EYL +
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLD------MCSDVCEAMEYLESNG--- 120
Query: 419 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 478
IHRD+ A N L+ ED V DFGLA+ V + + + + PE + S
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 479 RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK---KLEREKRLDAIVDRNLNK 535
++DV+ +G+++ E+ + + + + R + +++ V +L R K
Sbjct: 181 KSDVWSFGVLMWEVFSEGK-MPYERFSNSE---VVESVSAGYRLYRPK------------ 224
Query: 536 NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 570
+ + C PEDRPA +++ L
Sbjct: 225 ----LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-18
Identities = 45/106 (42%), Positives = 64/106 (60%)
Query: 87 NFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGN 146
N +G + +G L+ L L L N ++G IP + +L L SLDL +N L G+IP +
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306
Query: 147 LKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL 192
L+ L+ L L NNF+G IP +LT+L L +QL SN SG+IP +L
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNL 352
|
Length = 968 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 81/298 (27%), Positives = 128/298 (42%), Gaps = 39/298 (13%)
Query: 290 QLATDNFSEKNVLGQGGFGKVY----RGVLADGTK--VAVKRLTDFESPGGDAAFQREVE 343
++ D+ + LG G FG+VY RG D + VAVK L + S ++ F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 344 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP--GEP-VLDWVTRKRV 400
++S H+N++RLIG R ++ M + LRE +P P L
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 401 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGDFGLAKLVDVRKTNVTT 457
A A+G +YL E+ IHRD+ A N LL A + DFG+A+ D+ + +
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--DIYRASYYR 176
Query: 458 QVRGTMGHIA---PEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 514
+ M I PE G + +TDV+ +G++L E+ + R +E V+
Sbjct: 177 KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VMEF- 233
Query: 515 HVKKLEREKRLDAIVDRNL-NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ RLD + Y I M C Q +PEDRP + ++ ++
Sbjct: 234 ----VTGGGRLDP--PKGCPGPVYRI-----MTD----CWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 71/277 (25%), Positives = 124/277 (44%), Gaps = 39/277 (14%)
Query: 302 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 361
LG G FG+V+ G TKVA+K L + AF E ++ H L+RL T
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK--QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 362 T-PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--ARGLEYLHEHCNPK 418
P ++ +M+N S+ L+ + K + + A A G+ ++
Sbjct: 72 QEPI--YIITEYMENGSLVDFLKT----PEGIKLTINKLIDMAAQIAEGMAFIERK---N 122
Query: 419 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 478
IHRD++AAN+L+ E + DFGLA+L++ + + + APE ++ G +
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 479 RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 538
++DV+ +GI+L E+VT R I + + + V +NL + Y
Sbjct: 183 KSDVWSFGILLTEIVTYGR-IPYPGMTNPE--------------------VIQNLERGYR 221
Query: 539 IQEVET----MIQVALLCTQASPEDRPAMSEVVRMLE 571
+ + + ++ LC + PE+RP + +LE
Sbjct: 222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 302 LGQGGFGKVYRGVLADGTKV-AVKRLTD--FESPGGDAAFQREVEMISVAVHRNLLRLIG 358
LG+GGFG+V + K+ A K+L + G+ E +++ R ++ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 359 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLEYLHEHC 415
T + LV M + Y + + GEP R AA+ GLE+LH+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFP---EARAIFYAAQIICGLEHLHQR- 114
Query: 416 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK 475
+I++RD+K NVLLD+ + D GLA V+++ GT G++APE L
Sbjct: 115 --RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEV 170
Query: 476 SSERTDVFGYGIMLLELVTGQ 496
D F G L E++ G+
Sbjct: 171 YDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 66/240 (27%), Positives = 99/240 (41%), Gaps = 52/240 (21%)
Query: 295 NFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVAVHRNL 353
+F V+G+G FGKV D K+ A+K + Q+ VE SV RN+
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNK----------QKCVEKGSV---RNV 47
Query: 354 LRLIGFCTTPTERLLV----YPFMQNLSVAYRLRE--------IKPGEPVLDWVTRKRVA 401
L ER ++ +PF+ NL +++ E + G+ L + ++V
Sbjct: 48 LN---------ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGD--LRYHLSQKVK 96
Query: 402 LGAAR----------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451
+ LEYLH IIHRD+K N+LLDE + DF +A V
Sbjct: 97 FSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIA--TKVT 151
Query: 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL 511
+TT GT G++APE L S D + G+ E + G+R D +
Sbjct: 152 PDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR 211
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 66/199 (33%), Positives = 104/199 (52%), Gaps = 16/199 (8%)
Query: 301 VLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 359
++G+G FG V +G G KVAVK + D + AF E +++ H+NL+RL+G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA----QAFLEETAVMTKLHHKNLVRLLG- 66
Query: 360 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 419
+V M ++ LR G ++ + + +L A G+EYL + K+
Sbjct: 67 VILHNGLYIVMELMSKGNLVNFLR--TRGRALVSVIQLLQFSLDVAEGMEYLE---SKKL 121
Query: 420 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSER 479
+HRD+ A N+L+ ED A V DFGLA++ + N V+ T APE L K S +
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSK 177
Query: 480 TDVFGYGIMLLELVTGQRA 498
+DV+ YG++L E+ + RA
Sbjct: 178 SDVWSYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 20/206 (9%)
Query: 296 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAF-QREVEMISVAVHRNL 353
F+ +G+G FG+VY+ + VA+K + D E + Q+E++ +S +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQEIQFLSQCRSPYI 61
Query: 354 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 413
+ G ++ ++ + S L+ K E + ++ R+ + GLEYLHE
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVL-----LGLEYLHE 116
Query: 414 HCNPKIIHRDVKAANVLLDEDFEAVVGDFG----LAKLVDVRKTNVTTQVRGTMGHIAPE 469
IHRD+KAAN+LL E+ + + DFG L + R T V GT +APE
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-----GTPFWMAPE 168
Query: 470 YLSTGKSSERTDVFGYGIMLLELVTG 495
+ E+ D++ GI +EL G
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 84/296 (28%), Positives = 136/296 (45%), Gaps = 56/296 (18%)
Query: 301 VLGQGGFGKVYRGVLA--DGT--KVAVKRLTDFESPGGDAAFQREVE-MISVAV------ 349
+LG+G FG V G L+ DG+ KVAVK + D E+E +S A
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMK------LDIHTYSEIEEFLSEAACMKDFD 59
Query: 350 HRNLLRLIGFCTTPTER------LLVYPFMQNLSV-AYRLREIKPGEPV-LDWVTRKRVA 401
H N+++LIG C + +++ PFM++ + ++ L G P L T +
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 402 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV----DVRKTNVTT 457
+ A G+EYL N IHRD+ A N +L ED V DFGL+K + R+ +
Sbjct: 120 VDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA- 175
Query: 458 QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHV 516
+ + IA E L+ + ++DV+ +G+ + E+ T GQ + +E + L H
Sbjct: 176 --KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP--YPGVENHEIYDYLRHG 231
Query: 517 KKLER-EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+L++ E LD + D M C +A P+DRP +++ +LE
Sbjct: 232 NRLKQPEDCLDELYD-------------LMYS----CWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-18
Identities = 78/284 (27%), Positives = 136/284 (47%), Gaps = 35/284 (12%)
Query: 297 SEKNVLGQGGFGKVYRGVL-ADGTK---VAVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
+++ V+G G FG+V+RG+L G K VA+K L + F E ++ H N
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGE-PVLDWVTRKRVALGAARGLEYL 411
++RL G T +++ +M+N ++ LR+ GE V R G A G++YL
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRD-HDGEFSSYQLVGMLR---GIAAGMKYL 123
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPE 469
+ +HRD+ A N+L++ + E V DFGL++++ D T T+ + + APE
Sbjct: 124 SDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE 180
Query: 470 YLSTGKSSERTDVFGYGIMLLELVT-GQRAI-DFSRLEEEDDVLLLDHVKKLEREKRLDA 527
++ K + +DV+ +GI++ E+++ G+R D S E +K + RL A
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV---------MKAINDGFRLPA 231
Query: 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+D + Q+ L C Q RP ++V +L+
Sbjct: 232 PMDCP----------SAVYQLMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 77/291 (26%), Positives = 133/291 (45%), Gaps = 49/291 (16%)
Query: 302 LGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 355
LGQG FG VY G D T+VAVK + + S F E ++ +++R
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 356 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKP------GEPVLDWVTRKRVALGAARGLE 409
L+G + L+V M + + LR ++P G P ++A A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 410 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-------VRGT 462
YL+ K +HRD+ A N ++ DF +GDFG+ + D+ +T+ + VR
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW- 187
Query: 463 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 522
+APE L G + +D++ +G++L E+ + L E+ + L E
Sbjct: 188 ---MAPESLKDGVFTTSSDMWSFGVVLWEI---------TSLAEQP-------YQGLSNE 228
Query: 523 KRLDAIVDRN-LNKNYNIQE-VETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ L ++D L++ N E V +++ +C Q +P+ RP E+V +L+
Sbjct: 229 QVLKFVMDGGYLDQPDNCPERVTDLMR---MCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 78/276 (28%), Positives = 118/276 (42%), Gaps = 30/276 (10%)
Query: 302 LGQGGFGKVYRG----VLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLI 357
LG G FG V RG VAVK L + F +E ++ H NL+RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 358 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 417
G T ++V S+ RLR K T A+ A G+ YL
Sbjct: 63 GVVLTHP-LMMVTELAPLGSLLDRLR--KDALGHFLISTLCDYAVQIANGMRYLESK--- 116
Query: 418 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ--VRGTMGHIAPEYLSTGK 475
+ IHRD+ A N+LL D + +GDFGL + + + + + ++ APE L T
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 476 SSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN 534
S +DV+ +G+ L E+ T G+ ++ L + +D K+ ER +R +A
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEEP--WAGLSGSQILKKID--KEGERLERPEACPQD--- 229
Query: 535 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 570
YN+ M+Q C +P DRP + + L
Sbjct: 230 -IYNV-----MLQ----CWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 351
+ + +G+G G+VY+ A G +VA+K++ + E+ ++ H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIIN-EILIMKDCKHP 75
Query: 352 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLR--EIKPGEPVLDWVTRKRVALGAARGLE 409
N++ E +V +M S+ + ++ EP + +V R+ + +GLE
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVL-----QGLE 130
Query: 410 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 469
YLH +IHRD+K+ N+LL +D + DFG A + K+ + V GT +APE
Sbjct: 131 YLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPE 186
Query: 470 YLSTGKSSERTDVFGYGIMLLELVTGQ 496
+ + D++ GIM +E+ G+
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 73/231 (31%), Positives = 110/231 (47%), Gaps = 27/231 (11%)
Query: 301 VLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDA---AFQREVEMISVAVHRNLLRLI 357
+G+G FG V G G KVAVK + + DA AF E +++ H NL++L+
Sbjct: 13 TIGKGEFGDVMLGDY-RGNKVAVKCIKN------DATAQAFLAEASVMTQLRHSNLVQLL 65
Query: 358 GFCTTPTERL-LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 416
G L +V +M S+ LR G VL + +L +EYL +
Sbjct: 66 GVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEAN-- 121
Query: 417 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKS 476
+HRD+ A NVL+ ED A V DFGL K + V+ T APE L K
Sbjct: 122 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKF 176
Query: 477 SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527
S ++DV+ +GI+L E+ + R + + R+ L D V ++E+ ++DA
Sbjct: 177 STKSDVWSFGILLWEIYSFGR-VPYPRIP------LKDVVPRVEKGYKMDA 220
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 65/221 (29%), Positives = 114/221 (51%), Gaps = 20/221 (9%)
Query: 301 VLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 355
VLG G FG VY+G+ + +G V A+K L + P + F E +++ H +L+R
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 356 LIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 413
L+G C +PT +L+ + P L + ++ + +L+W + A+G+ YL E
Sbjct: 74 LLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 414 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYL 471
+++HRD+ A NVL+ + DFGLA+L+ D ++ N + + +A E +
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG-KMPIKWMALECI 183
Query: 472 STGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVL 511
K + ++DV+ YG+ + EL+T G + D E D+L
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 59/221 (26%), Positives = 109/221 (49%), Gaps = 28/221 (12%)
Query: 301 VLGQGGFGKVYRGVLAD-GTKVAVKR--LTDFESPGGD-------AAFQREVEMISVAVH 350
++G+G +G+VY + G +AVK+ L + D A + E+E + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 351 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG---EPVLDWVTRKRVALGAARG 407
N+++ +GF TT + ++ S+ LR G E ++ + T + + G
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR--TYGRFEEQLVRFFTEQVL-----EG 120
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-DVRKTNVTTQVRGTMGHI 466
L YLH + I+HRD+KA N+L+D D + DFG++K D+ + ++G++ +
Sbjct: 121 LAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177
Query: 467 APEYLSTGKS--SERTDVFGYGIMLLELVTGQRAIDFSRLE 505
APE + + S + D++ G ++LE+ G+R +S E
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP--WSDEE 216
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-17
Identities = 48/126 (38%), Positives = 66/126 (52%), Gaps = 3/126 (2%)
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 142
L S NF+G + + L L L L N +GEIP+ LG ++LT LDL N L G+IP
Sbjct: 315 LFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE 374
Query: 143 SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNF-- 200
L + L L L N+ G IP SL SL ++L N+ SG++P ++P F
Sbjct: 375 GLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLD 434
Query: 201 -TGNNL 205
+ NNL
Sbjct: 435 ISNNNL 440
|
Length = 968 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 32/228 (14%)
Query: 288 ELQLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQRE 341
E+ L+ F E+ LG+G FGKVY+G L T VA+K L + P F++E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 342 VEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPV---------- 391
E++S H N++ L+G CT +++ ++ + + L P V
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 392 --LDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV- 448
LD +A+ A G+EYL H +HRD+ A N L+ E + DFGL++ +
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 449 --DVRK--TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLEL 492
D + + VR + PE + GK + +D++ +G++L E+
Sbjct: 176 SADYYRVQSKSLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 18/209 (8%)
Query: 295 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRL-TDFESPGGD---AAFQREVEMISVAV 349
N+ +LGQG FG+VY D G ++AVK++ D +SP A + E++++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 350 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK--RVALGAARG 407
H R++ + + + FM+ + ++K + + VTRK R L G
Sbjct: 63 HE---RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL---EG 116
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT--TQVRGTMGH 465
+EYLH + I+HRD+K AN+L D +GDFG +K + ++ T V GT
Sbjct: 117 VEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173
Query: 466 IAPEYLSTGKSSERTDVFGYGIMLLELVT 494
++PE +S + DV+ G ++E++T
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 15/203 (7%)
Query: 296 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 354
F LG+G +G VY+ + G VA+K + +E+ ++ ++
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQEIIKEISILKQCDSPYIV 61
Query: 355 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 414
+ G T+ +V M+ +K L + +GLEYLH +
Sbjct: 62 KYYGSYFKNTDLWIV---MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 415 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVD-VRKTNVTTQVRGTMGHIAPEYLS 472
K IHRD+KA N+LL+E+ +A + DFG++ +L D + K N V GT +APE +
Sbjct: 119 ---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN---TVIGTPFWMAPEVIQ 172
Query: 473 TGKSSERTDVFGYGIMLLELVTG 495
+ + D++ GI +E+ G
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-17
Identities = 72/297 (24%), Positives = 124/297 (41%), Gaps = 49/297 (16%)
Query: 302 LGQGGFGKVYR----GVLA--DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 355
+GQG FG+V++ G+L T VAVK L + S A FQRE +++ H N+++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 356 LIGFCTTPTERLLVYPFM----------------QNLSVAYRLREIKPGEPVLDWVTRKR 399
L+G C L++ +M Q K G L ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 400 VALGA--ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK---LVDVRKTN 454
+ + A G+ YL E K +HRD+ N L+ E+ + DFGL++ D K +
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 455 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 514
+ + + PE + + + +DV+ YG++L E+ + + EE
Sbjct: 190 ENDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE------- 240
Query: 515 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
V R+ + + D + YN+ LC P DRP+ + + R+L+
Sbjct: 241 -VIYYVRDGNVLSCPDNCPLELYNLMR---------LCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 66/274 (24%), Positives = 123/274 (44%), Gaps = 33/274 (12%)
Query: 302 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDA--AFQREVEMISVAVHRNLLRLIGF 359
LG G FG+V+ TKVAVK + PG + AF E ++ H L++L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTM----KPGSMSVEAFLAEANVMKTLQHDKLVKLHA- 68
Query: 360 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--ARGLEYLHEHCNP 417
T ++ FM S+ L+ + + L K + A A G+ ++ +
Sbjct: 69 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP----KLIDFSAQIAEGMAFIEQR--- 121
Query: 418 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 477
IHRD++AAN+L+ + DFGLA++++ + + + APE ++ G +
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 181
Query: 478 ERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNY 537
++DV+ +GI+L+E+VT R I + + + + L+ ++ R +
Sbjct: 182 IKSDVWSFGILLMEIVTYGR-IPYPGMSNPEVIRALERGYRMPRPENCP----------- 229
Query: 538 NIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
E + + + C + PE+RP + +L+
Sbjct: 230 -----EELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 58/214 (27%), Positives = 106/214 (49%), Gaps = 31/214 (14%)
Query: 301 VLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDA-----------AFQREVEMISVA 348
++G G FG VY G+ A G +AVK++ E P A A RE+ ++
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQV---ELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 349 VHRNLLRLIGFCTTPTERLLVY-PFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAAR 406
H N+++ +G + + L ++ ++ SVA L E ++ R+ + +
Sbjct: 64 QHENIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL-----K 117
Query: 407 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-----VRG 461
GL YLH N IIHRD+K AN+L+D + DFG++K ++ + T ++G
Sbjct: 118 GLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQG 174
Query: 462 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 495
++ +APE + + + D++ G +++E++TG
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 7e-17
Identities = 67/275 (24%), Positives = 130/275 (47%), Gaps = 33/275 (12%)
Query: 301 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAA-FQREVEMISVAVH---RNLLR 355
++G+G +G VYRG + G VA+K + + ++P D + QREV ++S N+ +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKII-NLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 356 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 415
G ++ + + SV ++ E + + R+ + L+Y+H+
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLV-----ALKYIHKV- 120
Query: 416 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK 475
+IHRD+KAAN+L+ + DFG+A L++ + +T V GT +APE ++ GK
Sbjct: 121 --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGK 177
Query: 476 SSE-RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN 534
+ + D++ GI + E+ TG +S ++ ++L+ K RL+ D +
Sbjct: 178 YYDTKADIWSLGITIYEMATGNPP--YSDVDAFRAMMLIPKSKP----PRLE---DNGYS 228
Query: 535 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569
K + + C P++R + E+++
Sbjct: 229 K--------LLREFVAACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 9e-17
Identities = 78/283 (27%), Positives = 129/283 (45%), Gaps = 39/283 (13%)
Query: 301 VLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 356
V+G G FG+V RG L K VA+K L + F E ++ H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 357 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 416
G T +++ FM+N ++ LR+ V+ V R G A G++YL E
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSEM-- 125
Query: 417 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT-TQVRGTMGHI-----APEY 470
+HRD+ A N+L++ + V DFGL++ ++ ++ T T G G I APE
Sbjct: 126 -NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG--GKIPIRWTAPEA 182
Query: 471 LSTGKSSERTDVFGYGIMLLELVT-GQRAI-DFSRLEEEDDVLLLDHVKKLEREKRLDAI 528
++ K + +DV+ YGI++ E+++ G+R D S D + +E++ RL
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---------QDVINAIEQDYRLPPP 233
Query: 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+D + Q+ L C Q RP ++V L+
Sbjct: 234 MDCP----------TALHQLMLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 31/273 (11%)
Query: 302 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 359
LG G FG+V+ G TKVAVK L PG +F E +++ H L++L
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTL----KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV 69
Query: 360 CTTPTERLLVYPFMQNLSVAYRLREIKPGE-PVLDWVTRKRVALGAARGLEYLHEHCNPK 418
+ +Y + +S L +K GE L +A A G+ Y+ E N
Sbjct: 70 VS----EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI-ERMN-- 122
Query: 419 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 478
IHRD+++AN+L+ + + DFGLA+L++ + + + APE G+ +
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 479 RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 538
++DV+ +GI+L ELVT R + + + +VL +++ER R+ D ++ +
Sbjct: 183 KSDVWSFGILLTELVTKGR-VPYPGMNNR-EVL-----EQVERGYRMPCPQDCPISLH-- 233
Query: 539 IQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
E M+Q C + PE+RP + LE
Sbjct: 234 ----ELMLQ----CWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 76/294 (25%), Positives = 125/294 (42%), Gaps = 42/294 (14%)
Query: 295 NFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA 348
N E LG+G FG+V+ T V VK L + + F+RE++M
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 349 VHRNLLRLIGFC--TTPTERLLVYPFMQNLS---VAYRLREIKPGEPVLDWVTRKRVALG 403
H+N++RL+G C P +L Y + +L A + ++ K P L + +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 404 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 463
A G+++L N + +HRD+ A N L+ E V L+K V + +
Sbjct: 126 IALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 464 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE- 522
+APE + S ++DV+ +G+++ E+ T Q + F L +E +VL KLE
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-QGELPFYGLSDE-EVLNRLQAGKLELPV 240
Query: 523 -----KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
RL ++ R C +P+DRP+ SE+V L
Sbjct: 241 PEGCPSRLYKLMTR--------------------CWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 71/219 (32%), Positives = 104/219 (47%), Gaps = 33/219 (15%)
Query: 302 LGQGGFGKVYRGVLADG-----------TKVAVKRLTDFESPGGDAAFQREVEMIS-VAV 349
LG+G FG+V V+A+ VAVK L D + + E+EM+ +
Sbjct: 20 LGEGCFGQV---VMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76
Query: 350 HRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLREIKPG-----------EPVLDWVT 396
H+N++ L+G CT P L+ Y NL R R PG E L +
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARR-PPGMDYSFDTCKLPEEQLTFKD 135
Query: 397 RKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-DVRKTNV 455
A ARG+EYL + K IHRD+ A NVL+ ED + DFGLA+ V ++
Sbjct: 136 LVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192
Query: 456 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 494
TT R + +APE L + ++DV+ +G++L E+ T
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 25/214 (11%)
Query: 300 NVLGQGGFGKVYRG----VLADGT---KVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
N LG G FG+VY G +L G+ +VAVK L + F +E ++S H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 353 LLRLIGFCTTPTERLLVYPFMQN---LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 409
+++L+G C + ++ M+ LS R + G P+L + L A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 410 YLHEHCNPKIIHRDVKAANVLLDE---DFEAVV--GDFGLAKLVDVRKTNVTTQVRGT-- 462
YL + IHRD+ A N L+ E D + VV GDFGLA+ D+ K++ + G
Sbjct: 121 YLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--DIYKSDYY-RKEGEGL 174
Query: 463 --MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 494
+ +APE L GK + ++DV+ +G+++ E++T
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 79/315 (25%), Positives = 144/315 (45%), Gaps = 67/315 (21%)
Query: 286 WRELQLATDNFSEKNVLGQGGFGKVYRG-VLADGTKV--AVKRLTDFESPGGDAAFQREV 342
W +++ ++V+G+G FG+V + + DG ++ A+KR+ ++ S F E+
Sbjct: 6 WNDIKF-------QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGEL 58
Query: 343 EMI-SVAVHRNLLRLIGFCTTPTERLLVYPFMQ--NLSVAYRLREIKPGEPVLDWVTRKR 399
E++ + H N++ L+G C L + NL R + +P
Sbjct: 59 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 118
Query: 400 VALGA----------ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449
L + ARG++YL + + IHRD+ A N+L+ E++ A + DFGL++ +
Sbjct: 119 STLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE 175
Query: 450 VRKTNVTTQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELV----TGQRAID 500
V V+ TMG + A E L+ + +DV+ YG++L E+V T +
Sbjct: 176 V-------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228
Query: 501 FSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDR 560
+ L E KL + RL ++ LN + EV +++ C + P +R
Sbjct: 229 CAELYE-----------KLPQGYRL----EKPLNCD---DEVYDLMR---QCWREKPYER 267
Query: 561 PAMSEVV----RMLE 571
P+ ++++ RMLE
Sbjct: 268 PSFAQILVSLNRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 74/285 (25%), Positives = 136/285 (47%), Gaps = 45/285 (15%)
Query: 302 LGQGGFGKVYRGVLADG-------TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 354
LGQG FG VY G+ A G T+VA+K + + S F E ++ +++
Sbjct: 14 LGQGSFGMVYEGI-AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 355 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP---GEPVLDWVTRKRVALGA---ARGL 408
RL+G + L++ M + LR ++P PV + K++ A A G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 409 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG---- 464
YL+ + K +HRD+ A N ++ EDF +GDFG+ + D+ +T+ +G G
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR--KGGKGLLPV 185
Query: 465 -HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 523
++PE L G + +DV+ +G++L E+ T L E+ + + E+
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQP-------YQGMSNEQ 229
Query: 524 RLDAIVDRN-LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV 567
L +++ L+K N ++ + ++ +C Q +P+ RP+ E++
Sbjct: 230 VLRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 78/275 (28%), Positives = 125/275 (45%), Gaps = 35/275 (12%)
Query: 302 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 359
LGQG FG+V+ G T+VA+K L PG AF +E +++ H L++L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 67
Query: 360 CTTPTERL-LVYPFMQNLSVAYRLREIKPGE--PVLDWVTRKRVALGAARGLEYLHEHCN 416
E + +V +M S L + GE L +A A G+ Y+ E N
Sbjct: 68 AVVSEEPIYIVTEYMSKGS----LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMN 122
Query: 417 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKS 476
+HRD++AAN+L+ E+ V DFGLA+L++ + + + APE G+
Sbjct: 123 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 477 SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKN 536
+ ++DV+ +GI+L EL T R + E +LD V ER R+ +
Sbjct: 181 TIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV---ERGYRMPCPPECP---- 229
Query: 537 YNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
E++ + C + PE+RP + LE
Sbjct: 230 ------ESLHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 61/232 (26%), Positives = 112/232 (48%), Gaps = 42/232 (18%)
Query: 301 VLGQGGFGKVYRGV-LADGTK----VAVKRLTDFESPGGDAAFQREVE-MISVAV--HRN 352
+LG G FG V++G+ + +G VA+K + D G FQ + M+++ H
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS---GRQTFQEITDHMLAMGSLDHAY 70
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA-------- 404
++RL+G C + +L+ ++ P +LD V + R +L
Sbjct: 71 IVRLLGICPGASLQLVT--------------QLSPLGSLLDHVRQHRDSLDPQRLLNWCV 116
Query: 405 --ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVR 460
A+G+ YL EH ++HR++ A N+LL D + DFG+A L+ D +K ++ +
Sbjct: 117 QIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY-FYSEHK 172
Query: 461 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVL 511
+ +A E + G+ + ++DV+ YG+ + E+++ G R E D+L
Sbjct: 173 TPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 77/284 (27%), Positives = 125/284 (44%), Gaps = 52/284 (18%)
Query: 301 VLGQGGFGKVYRGVLA-DGTK----VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 355
VLG G FG VY+G+ DG VA+K L + SP + E +++ + R
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 356 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA----------A 405
L+G C T T +L+ ++ P +LD+V + +G+ A
Sbjct: 74 LLGICLTSTVQLVT--------------QLMPYGCLLDYVRENKDRIGSQDLLNWCVQIA 119
Query: 406 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGTMG 464
+G+ YL E +++HRD+ A NVL+ + DFGLA+L+D+ +T + +
Sbjct: 120 KGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 176
Query: 465 HIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREK 523
+A E + + + ++DV+ YG+ + EL+T G + D E D+L +K ER
Sbjct: 177 WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL-----EKGER-- 229
Query: 524 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV 567
L + MI V C E RP E+V
Sbjct: 230 ---------LPQPPICTIDVYMIMVK--CWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 32/216 (14%)
Query: 302 LGQGGFGKVYRGVLA------DGTKVAVKRLTDF-ESPGGDAAFQREVEMISVAVHRNLL 354
LG+G FGKV+ D VAVK L + ES D FQRE E+++V H++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD--FQREAELLTVLQHQHIV 70
Query: 355 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA---------- 404
R G CT L+V+ +M++ + LR P +L + VA G
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILA--GGEDVAPGQLTLGQMLAIA 128
Query: 405 ---ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 461
A G+ YL + +HRD+ N L+ + +GDFG+++ D+ T+
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYRVGGR 183
Query: 462 TMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT 494
TM I PE + K + +D++ +G++L E+ T
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK--RLTDFESPGGDAAF-QREVEMISVAV 349
+++ +G G +G VY+ +A G VA+K +L PG D Q+E+ M+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE----PGDDFEIIQQEISMLKECR 58
Query: 350 HRNLLRLIGFCTTPTERLLVYPFM--QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARG 407
H N++ G + +V + +L Y++ E + +V R+ +G
Sbjct: 59 HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRE-----TLKG 113
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV----RKTNVTTQVRGTM 463
L YLHE IHRD+K AN+LL ED + + DFG++ + RK+ + GT
Sbjct: 114 LAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-----GTP 165
Query: 464 GHIAPEYL---STGKSSERTDVFGYGIMLLELVTGQ 496
+APE G + D++ GI +EL Q
Sbjct: 166 YWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (193), Expect = 5e-16
Identities = 61/204 (29%), Positives = 89/204 (43%), Gaps = 23/204 (11%)
Query: 302 LGQGGFGKVYRGV--LADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLI 357
LG+G FGKV V G A+K L + E ++S H +++L
Sbjct: 1 LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 358 -GFCTTPTERL-LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLEYLH 412
F T E+L LV + + L + E +R AA LEYLH
Sbjct: 60 YAFQTE--EKLYLVLEYAPGGELFSHLSK----EGRFS---EERARFYAAEIVLALEYLH 110
Query: 413 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS 472
II+RD+K N+LLD D + DFGLAK + + T GT ++APE L
Sbjct: 111 SL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLL 166
Query: 473 TGKSSERTDVFGYGIMLLELVTGQ 496
+ D + G++L E++TG+
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 40/111 (36%), Positives = 66/111 (59%), Gaps = 14/111 (12%)
Query: 388 GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-K 446
E +L ++A+ +GL YLHE KIIHRDVK +N+L++ + + DFG++ +
Sbjct: 98 PERIL-----GKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ 150
Query: 447 LVD-VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
LV+ + KT V GT ++APE + S ++D++ G+ L+EL TG+
Sbjct: 151 LVNSLAKTFV-----GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 61/212 (28%), Positives = 105/212 (49%), Gaps = 17/212 (8%)
Query: 291 LATDNFSEKNVLGQGGFGKVYRGV-LADGTK----VAVKRLTDFESPGGDAAFQREVEMI 345
L F + VLG G FG VY+G+ + +G K VA+K L + SP + E ++
Sbjct: 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 63
Query: 346 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 403
+ + ++ RL+G C T T +L+ + PF L ++ + +L+W +
Sbjct: 64 ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 117
Query: 404 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGT 462
A+G+ YL E +++HRD+ A NVL+ + DFGLAKL+ K +
Sbjct: 118 IAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174
Query: 463 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 494
+ +A E + + ++DV+ YG+ + EL+T
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 64/209 (30%), Positives = 93/209 (44%), Gaps = 29/209 (13%)
Query: 301 VLGQGGFGKV--YRGVLA-DGTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 355
VLG+G FGKV Y A DGT VAVK L + +++E+ ++ H N+++
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 356 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--------ARG 407
G C+ + L + E P + D++ + ++ L G
Sbjct: 71 YKGCCSEQGGKGLQL-----------IMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEG 119
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT--NVTTQVRGTMGH 465
+ YLH IHRD+ A NVLLD D +GDFGLAK V V +
Sbjct: 120 MAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176
Query: 466 IAPEYLSTGKSSERTDVFGYGIMLLELVT 494
A E L K S +DV+ +G+ L EL+T
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 74/292 (25%), Positives = 129/292 (44%), Gaps = 51/292 (17%)
Query: 302 LGQGGFGKVYRGVLADGT---KVAVKRL-------TDFESPGGDAAFQREVEMISVAVHR 351
LG+G FG V G L KVAVK + ++ E +A +E + H
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD------HP 60
Query: 352 NLLRLIGFCTTPTER------LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA- 404
N++RLIG C E +++ PFM++ + L + G+ T+ V
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 405 -ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV---DVRKTNVTTQVR 460
A G+EYL + IHRD+ A N +L+E+ V DFGL+K + D + ++
Sbjct: 121 IASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM- 176
Query: 461 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKL 519
+ IA E L+ + ++DV+ +G+ + E+ T GQ + +E + + D++++
Sbjct: 177 -PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP--YPGVENSE---IYDYLRQG 230
Query: 520 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
R K+ +D + + C +P+DRP+ + LE
Sbjct: 231 NRLKQPPDCLD-------------GLYSLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 75/298 (25%), Positives = 126/298 (42%), Gaps = 47/298 (15%)
Query: 301 VLGQGGFGKVYRGV------LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 354
LG+G FGKV + A T VAVK L + S E ++ H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 355 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIK--------------------PGEPVLDW 394
+L G C+ LL+ + + S+ LRE + P E L
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 395 VTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 454
A +RG++YL E K++HRD+ A NVL+ E + + DFGL++ V +
Sbjct: 127 GDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 455 VT-TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL 513
V ++ R + +A E L + ++DV+ +G++L E+VT + + E LL
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT-LGGNPYPGIAPERLFNLL 242
Query: 514 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
++ER + E M + L C + P+ RP +++ + LE
Sbjct: 243 KTGYRMERPENCS----------------EEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-15
Identities = 44/116 (37%), Positives = 63/116 (54%)
Query: 77 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRL 136
+ S+ LS + SG + + L+ L L L N TG+IP L +L L L L +N+
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF 344
Query: 137 VGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL 192
G+IP +LG L L LS NN +G IP+ L + +L + L SN+L G+IP L
Sbjct: 345 SGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSL 400
|
Length = 968 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 73/233 (31%), Positives = 108/233 (46%), Gaps = 37/233 (15%)
Query: 290 QLATDNFSEKNVLGQGGFGKVYRGVLADG-----------TKVAVKRLTDFESPGGDAAF 338
++ D LG+G FG+V V+A+ TKVAVK L + +
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDL 70
Query: 339 QREVEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLREIKPG------- 388
E+EM+ + H+N++ L+G CT P ++ Y NL R R PG
Sbjct: 71 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR-PPGMEYCYNP 129
Query: 389 --EPVLDWVTRKRV--ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444
P + V A ARG+EYL + K IHRD+ A NVL+ ED + DFGL
Sbjct: 130 TQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGL 186
Query: 445 AK---LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 494
A+ +D K TT R + +APE L + ++DV+ +G++L E+ T
Sbjct: 187 ARDIHHIDYYKK--TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 64/230 (27%), Positives = 109/230 (47%), Gaps = 57/230 (24%)
Query: 299 KNVLGQGGFGKVYRGVL-ADGTKV--AVKRLTDFESPGGDAAFQREVEMI-SVAVHRNLL 354
++V+G+G FG+V R ++ DG K+ A+K L +F S F E+E++ + H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 355 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV-------------- 400
L+G C +N Y E P +LD++ + RV
Sbjct: 67 NLLGAC-------------ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTA 113
Query: 401 -----------ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449
A A G++YL E + IHRD+ A NVL+ E+ + + DFGL++ +
Sbjct: 114 STLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEE 170
Query: 450 VRKTNVTTQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT 494
V V+ TMG + A E L+ + ++DV+ +G++L E+V+
Sbjct: 171 V-------YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 65/209 (31%), Positives = 107/209 (51%), Gaps = 16/209 (7%)
Query: 295 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLT-DFESPGGD---AAFQREVEMISVAV 349
N+ +LGQG FG+VY AD G ++AVK++ D ESP A + E++++ +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 350 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK--RVALGAARG 407
H +++ G P ER L FM+++ ++K + + VTRK R L G
Sbjct: 63 HERIVQYYGCLRDPMERTLSI-FMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL---EG 118
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT--TQVRGTMGH 465
+ YLH + I+HRD+K AN+L D +GDFG +K + + T V GT
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 466 IAPEYLSTGKSSERTDVFGYGIMLLELVT 494
++PE +S + D++ G ++E++T
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 25/215 (11%)
Query: 302 LGQGGFGKVYR----GVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISV-AVHRN 352
LG+G FG+V R G+ VAVK L D + A E+E++ + H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRK-----------RV 400
++ L+G CT ++ + ++ LR +P P + +T+
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 401 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-DVRKTNVTTQV 459
A ARG+EYL + IHRD+ A NVL+ ED + DFGLA+ V D+ T+
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 460 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 494
R + +APE L + ++DV+ +GI++ E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 359
+G+G +G VY+ G VA+K++ FES G RE++++ H N+++L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 360 CTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 418
+ LV+ FM +L + IK + L K +GL + H H
Sbjct: 67 FRHKGDLYLVFEFMDTDL-----YKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---G 118
Query: 419 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKS-S 477
I+HRD+K N+L++ + + DFGLA+ T V T + APE L K S
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAPELLLGDKGYS 177
Query: 478 ERTDVFGYGIMLLELVTGQ 496
D++ G + EL++ +
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 3e-15
Identities = 77/273 (28%), Positives = 125/273 (45%), Gaps = 31/273 (11%)
Query: 302 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 359
LGQG FG+V+ G TKVA+K L PG AF +E +++ H L+ L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTL----KPGTMMPEAFLQEAQIMKKLRHDKLVPL--Y 67
Query: 360 CTTPTERL-LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 418
E + +V FM S+ L+E L + +A A G+ Y+ E N
Sbjct: 68 AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVD--MAAQIADGMAYI-ERMN-- 122
Query: 419 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 478
IHRD++AAN+L+ ++ + DFGLA+L++ + + + APE G+ +
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 479 RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 538
++DV+ +GI+L ELVT R + E LE+ V+R
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMVNRE----------VLEQ-------VERGYRMPCP 225
Query: 539 IQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
E++ ++ LC + P++RP + LE
Sbjct: 226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 18/213 (8%)
Query: 295 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQ----REVEMISVAVH 350
+F N +G+G FG V++ V +V + D + + E +++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLS--KMNRREREEAIDEARVLAKLDS 58
Query: 351 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD---WVTRKRVALGAARG 407
++R + +V + +N + L+ + G P+ + W R + G
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKM-QRGRPLPEDQVW----RFFIQILLG 113
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 467
L +LH KI+HRD+K+ N+ LD +GD G+AKL+ TN + GT +++
Sbjct: 114 LAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD-NTNFANTIVGTPYYLS 169
Query: 468 PEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 500
PE +E++DV+ G++L E TG+ D
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 5e-15
Identities = 74/284 (26%), Positives = 114/284 (40%), Gaps = 34/284 (11%)
Query: 302 LGQGGFGKVYRGVLADGTKVA---VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 358
+G G FGKV G G A VK L +P F +EV+ H N+L+ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 359 FCTTPTERLLVYPF--MQNLSVAYR-LREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 415
C LLV F + +L R R + +R+A A GL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMA--QKDVLQRMACEVASGLLWLHQA- 119
Query: 416 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT--QVRGTMGHIAPEY--- 470
IH D+ N L D +GD+GLA L + T + +APE
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 471 ----LSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526
L +++++++ G+ + EL T + L +E +L V + E++ +L
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAA-DQPYPDLSDEQ---VLKQVVR-EQDIKLP 231
Query: 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 570
L+ Y+ + E M L PE RP EV +L
Sbjct: 232 ---KPQLDLKYSDRWYEVMQFCWL-----DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 5e-15
Identities = 74/278 (26%), Positives = 128/278 (46%), Gaps = 31/278 (11%)
Query: 301 VLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 356
V+G G FG+V G L K VA+K L + F E ++ H N++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 357 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 416
G T ++V +M+N S+ LR+ V+ V R G A G++YL +
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---GIASGMKYLSDM-- 125
Query: 417 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYLSTG 474
+HRD+ A N+L++ + V DFGL++++ D T + + APE ++
Sbjct: 126 -GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 475 KSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 533
K + +DV+ YGI++ E+++ G+R + + + D +K +E RL A +D
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERP--YWEMSNQ------DVIKAIEEGYRLPAPMDCPA 236
Query: 534 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ Q+ L C Q +RP ++V +L+
Sbjct: 237 ----------ALHQLMLDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 5e-15
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 296 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAA-FQREVEMISVAVHRNLL 354
F++ +G+G FG+V++G+ KV ++ D E + Q+E+ ++S +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 355 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 414
+ G T+ ++ M+ L L ++PG LD + +GL+YLH
Sbjct: 66 KYYGSYLKDTKLWII---MEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSE 120
Query: 415 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQVR-----GTMGHIAP 468
K IHRD+KAANVLL E E + DFG+A +L D TQ++ GT +AP
Sbjct: 121 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD-------TQIKRNTFVGTPFWMAP 170
Query: 469 EYLSTGKSSERTDVFGYGIMLLELVTGQ 496
E + + D++ GI +EL G+
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 7e-15
Identities = 43/114 (37%), Positives = 63/114 (55%)
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 142
L S FSG + +G L+ L L N +TGEIPE L + +L L L +N L G+IP
Sbjct: 339 LWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPK 398
Query: 143 SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIP 196
SLG + L+ + L N+FSG +P T L + + + +NNL G+I + +P
Sbjct: 399 SLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMP 452
|
Length = 968 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 9e-15
Identities = 68/275 (24%), Positives = 114/275 (41%), Gaps = 35/275 (12%)
Query: 302 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 361
LG G FG V G VA+K + E + F E +++ H L++L G CT
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 362 TPTERLLVYPFMQNLSVAYRLREIKPG-EPVLDWVTRKRVALGAARGLEYLHEHCNPKII 420
+V +M N + LRE +P K V G+ YL + I
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVC----EGMAYLESK---QFI 122
Query: 421 HRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQ--VRGTMGHIAPEYLSTGKS 476
HRD+ A N L+D+ V DFGL++ V D ++V ++ VR + PE L K
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLLYSKF 178
Query: 477 SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKN 536
S ++DV+ +G+++ E+ + + + + R + V + +L R
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGK-MPYERFNNSETVEKVSQGLRLYRPH------------- 224
Query: 537 YNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
E + + C E+RP +++ +E
Sbjct: 225 ---LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 9e-15
Identities = 61/229 (26%), Positives = 109/229 (47%), Gaps = 57/229 (24%)
Query: 300 NVLGQGGFGKVYRGVL-ADGTKV--AVKRLTDFESPGGDAAFQREVEMI-SVAVHRNLLR 355
+V+G+G FG+V + + DG ++ A+KR+ ++ S F E+E++ + H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 356 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV--------------- 400
L+G C ++ Y E P +LD++ + RV
Sbjct: 61 LLGAC-------------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 107
Query: 401 ----------ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450
A ARG++YL + + IHRD+ A N+L+ E++ A + DFGL++ +V
Sbjct: 108 TLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEV 164
Query: 451 RKTNVTTQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT 494
V+ TMG + A E L+ + +DV+ YG++L E+V+
Sbjct: 165 -------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 77/297 (25%), Positives = 128/297 (43%), Gaps = 54/297 (18%)
Query: 302 LGQGGFGKV----YRGVLADGTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 355
LG+G FG V Y L D T VAVK+L + F+RE+E++ H N+++
Sbjct: 12 LGKGNFGSVELCRY-DPLQDNTGEVVAVKKLQH-STAEHLRDFEREIEILKSLQHDNIVK 69
Query: 356 LIGFCTTPTERLLVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAAR-------- 406
G C + R L RL E P + D++ + R L +
Sbjct: 70 YKGVCYSAGRRNL------------RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI 117
Query: 407 --GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT-- 462
G+EYL + +HRD+ N+L++ + +GDFGL K++ K + G
Sbjct: 118 CKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESP 174
Query: 463 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-----GQRAIDFSRL--EEEDDVLLLDH 515
+ APE L+ K S +DV+ +G++L EL T +F R+ ++ +++ H
Sbjct: 175 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH 234
Query: 516 -VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
++ L+ RL A E+ ++ C P RP+ SE+ +E
Sbjct: 235 LIELLKNNGRLPAPPGCP-------AEIYAIM---KECWNNDPSQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 296 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAA-FQREVEMISVAVHRNLL 354
F++ +G+G FG+VY+G+ +V ++ D E + Q+E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 355 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG---EPVLDWVTRKRVALGAARGLEYL 411
R G T+ ++ M+ L L +KPG E + + R+ + +GL+YL
Sbjct: 66 RYYGSYLKGTKLWII---MEYLGGGSALDLLKPGPLEETYIATILREIL-----KGLDYL 117
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVR-KTNVTTQVRGTMGHIAPE 469
H + IHRD+KAANVLL E + + DFG+A +L D + K N GT +APE
Sbjct: 118 HSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV---GTPFWMAPE 171
Query: 470 YLSTGKSSERTDVFGYGIMLLELVTGQ 496
+ + D++ GI +EL G+
Sbjct: 172 VIKQSAYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 24/226 (10%)
Query: 288 ELQLATDNFSEKNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREV 342
EL L+ F E+ LG+ FGK+Y+G L VA+K L D +P FQ+E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 343 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPV----------- 391
+++ H N++ L+G T +++ ++ + L P V
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 392 --LDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LV 448
LD +A+ A G+EYL H +H+D+ A N+L+ E + D GL++ +
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 449 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 494
V + + + PE + GK S +D++ +G++L E+ +
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-14
Identities = 45/129 (34%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 81 VTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKI 140
V L +FSG L L + L + N + G I ++ SL L L N+ G +
Sbjct: 409 VRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGL 468
Query: 141 PPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK--- 197
P S G+ K+L+ L LS+N FSG +P L +LS L+ ++L N LSG+IP L K
Sbjct: 469 PDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVS 527
Query: 198 YNFTGNNLN 206
+ + N L+
Sbjct: 528 LDLSHNQLS 536
|
Length = 968 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 68/224 (30%), Positives = 110/224 (49%), Gaps = 34/224 (15%)
Query: 296 FSEKNVLGQGGFGKVYRGVLA--DGT--KVAVKRL-------TDFESPGGDAAFQREVEM 344
F+ +LG+G FG V L DG+ KVAVK L +D E +AA +E +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD- 59
Query: 345 ISVAVHRNLLRLIGFC--TTPTERL----LVYPFMQNLSVAYRLREIKPGE-PV-LDWVT 396
H N+++LIG + RL ++ PFM++ + L + GE P L T
Sbjct: 60 -----HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQT 114
Query: 397 RKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV---DVRKT 453
R + A G+EYL + IHRD+ A N +L+E+ V DFGL+K + D +
Sbjct: 115 LVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQ 171
Query: 454 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQ 496
+++ + +A E L+ + +DV+ +G+ + E++T GQ
Sbjct: 172 GCASKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
+ E + LG+G G V + L + + A+K +T +P RE+E+
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 353 LLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKP-----GEPVLDWVTRKRVALGAA 405
+++ G + + + + S+ +++K GE VL ++A
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESVL 115
Query: 406 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQVRGTMG 464
+GL YLH KIIHRD+K +N+LL + + DFG++ +LV+ T GT
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSF 168
Query: 465 HIAPEYLSTGKSSERTDVFGYGIMLLELVTG 495
++APE + S +DV+ G+ LLE+
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQN 199
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 33/225 (14%)
Query: 292 ATDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMI-SVAV 349
T F V+G+G +GKVY+ G VA+K + D + + E ++ +
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDII-EDEEEEIKEEYNILRKYSN 61
Query: 350 HRNLLRLIG--FCTTPT----ERLLVYPFMQNLSV-----AYRLREIKPGEPVLDWVTRK 398
H N+ G P + LV SV R + + E + ++ R
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR- 120
Query: 399 RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD--VRKTNVT 456
RGL YLHE+ K+IHRD+K N+LL ++ E + DFG++ +D + + N
Sbjct: 121 ----ETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF 173
Query: 457 TQVRGTMGHIAPEYLSTGKSSE-----RTDVFGYGIMLLELVTGQ 496
GT +APE ++ + + R+DV+ GI +EL G+
Sbjct: 174 I---GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-14
Identities = 69/230 (30%), Positives = 108/230 (46%), Gaps = 31/230 (13%)
Query: 290 QLATDNFSEKNVLGQGGFGKVYR----GVLADGTK----VAVKRLTDFESPGGDAAFQRE 341
+ + D + LG+G FG+V G+ D K VAVK L D + + E
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70
Query: 342 VEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLREIK-----------P 387
+EM+ + H+N++ L+G CT P ++ Y NL R R P
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 388 GEPVL--DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 445
E + D V+ ARG+EYL + K IHRD+ A NVL+ E+ + DFGLA
Sbjct: 131 DEQMTFKDLVS---CTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA 184
Query: 446 KLV-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 494
+ V ++ TT R + +APE L + ++DV+ +G+++ E+ T
Sbjct: 185 RDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 69/283 (24%), Positives = 120/283 (42%), Gaps = 48/283 (16%)
Query: 301 VLGQGGFGK--VYRGVLADGTKVAVKR--LTDFESPGGDAAFQREVEMISVAVHRNLLRL 356
VLG+G FG+ +YR D + V K LT A E+ ++S+ H N++
Sbjct: 7 VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDA-LNEIVILSLLQHPNIIAY 64
Query: 357 IG-FCTTPTERLLV---YPFMQNLS--VAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 410
F T LL+ Y L + + ++ E VL ++ + A+ Y
Sbjct: 65 YNHFMDDNT--LLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVS------Y 116
Query: 411 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 470
+H+ I+HRD+K N+ L + +GDFG++K++ + T V GT +++PE
Sbjct: 117 IHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPEL 172
Query: 471 LSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530
K + ++D++ G +L EL+T +R D + +V
Sbjct: 173 CQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN---------------------LVV 211
Query: 531 RNLNKNYN-IQEVET--MIQVALLCTQASPEDRPAMSEVVRML 570
+ + NY + V + +I + Q PE RP EV+
Sbjct: 212 KIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 64/207 (30%), Positives = 93/207 (44%), Gaps = 26/207 (12%)
Query: 296 FSEKNVLGQGGFGKVY--RGVLADGTKVAVKRLTDFESPGGDAAFQ---REVEMISVAVH 350
F++ +G G FG VY R V + VA+K+++ + + +Q +EV + H
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEV-VAIKKMS-YSGKQSNEKWQDIIKEVRFLQQLRH 74
Query: 351 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREI--KPGEPVLDWVTRKRVALGAARGL 408
N + G LV + L A + E+ KP L V + GA +GL
Sbjct: 75 PNTIEYKGCYLREHTAWLVMEYC--LGSASDILEVHKKP----LQEVEIAAICHGALQGL 128
Query: 409 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 468
YLH H IHRD+KA N+LL E + DFG A LV + V GT +AP
Sbjct: 129 AYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAP 180
Query: 469 EY---LSTGKSSERTDVFGYGIMLLEL 492
E + G+ + DV+ GI +EL
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 26/203 (12%)
Query: 302 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 361
LG G FGKVY+ + A ++ ES F E++++S H N++ L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 362 TPTERLLVYPFMQNLSVAYRLREIKPG--EPVLDWVTRKRVALGAARGLEYLHEHCNPKI 419
+ ++ F ++ + E++ G EP + +V R+ + L +LH H K+
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQML-----EALNFLHSH---KV 124
Query: 420 IHRDVKAANVLLDEDFEAVVGDFGL-AKLVDVRKTNVTTQVR----GTMGHIAPEYLSTG 474
IHRD+KA N+LL D + + DFG+ AK T Q R GT +APE ++
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKS------TLQKRDTFIGTPYWMAPEVVACE 178
Query: 475 KSSE-----RTDVFGYGIMLLEL 492
+ + D++ GI L+EL
Sbjct: 179 TFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 68/273 (24%), Positives = 116/273 (42%), Gaps = 33/273 (12%)
Query: 302 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 361
LG G FG V+ G KVA+K + E + F E +++ H L++L G CT
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN--EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 362 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR----GLEYLHEHCNP 417
+V FM+N + LR+ + G K + L + G+EYL +
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQ-RQG------KLSKDMLLSMCQDVCEGMEYLERN--- 119
Query: 418 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 477
IHRD+ A N L+ V DFG+ + V + ++ + + PE + K S
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179
Query: 478 ERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNY 537
++DV+ +G+++ E+ T + + F + + V ++ +L R K V
Sbjct: 180 SKSDVWSFGVLMWEVFTEGK-MPFEKKSNYEVVEMISRGFRLYRPKLASMTV-------- 230
Query: 538 NIQEVETMIQVALLCTQASPEDRPAMSEVVRML 570
+V C PE RP +E++R +
Sbjct: 231 --------YEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 56/220 (25%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLADGT-----KVAVKRLTDFESPGGDAAFQREVEMISVA 348
D + ++L +G FG+++ G+L D +V VK + D S +E ++
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 349 VHRNLLRLIGFCTTPTERLLV-YPFMQ--NLSVAYRLREIKPGEPVLDWVTRKRVALGA- 404
H+N+L ++ C E V YP+M NL + + + T++ V +
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 405 -ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK---------LVDVRKTN 454
A G+ YLH+ +IH+D+ A N ++DE+ + + D L++ L D N
Sbjct: 126 IACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD----N 178
Query: 455 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 494
V+ +A E L + S +DV+ +G++L EL+T
Sbjct: 179 ENRPVK----WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 57/189 (30%), Positives = 98/189 (51%), Gaps = 24/189 (12%)
Query: 296 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGG-DAAFQREVEM---ISVAVH 350
+ E +G+G +G VY+ L G VA+K++ S G + RE+ + + H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 351 RNLLRLIGFCTTP-TER----LLVYPFM-QNLSVAYRLREIKPG--EPVLDWVTRKRVAL 402
N++RL+ C P T+R LV+ + Q+L+ Y + KPG + + R+ +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLAT-YLSKCPKPGLPPETIKDLMRQLL-- 117
Query: 403 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT 462
RG+++LH H I+HRD+K N+L+ D + + DFGLA++ + +T+ V T
Sbjct: 118 ---RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYS-FEMALTSVVV-T 169
Query: 463 MGHIAPEYL 471
+ + APE L
Sbjct: 170 LWYRAPEVL 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 34/225 (15%)
Query: 288 ELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAF----QREV 342
E + D E+ VLG+G +G VY L+ ++A+K E P D+ + E+
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIK-----EIPERDSRYVQPLHEEI 56
Query: 343 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL---SVAYRLRE----IKPGEPVLDWV 395
+ S HRN+++ +G + E FM+ + S++ LR +K E + +
Sbjct: 57 ALHSYLKHRNIVQYLGSDS---ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFY 113
Query: 396 TRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV--GDFGLAKLVDVRKT 453
T++ + GL+YLH++ +I+HRD+K NVL++ + VV DFG +K +
Sbjct: 114 TKQIL-----EGLKYLHDN---QIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRL-AGIN 163
Query: 454 NVTTQVRGTMGHIAPEYLSTGKS--SERTDVFGYGIMLLELVTGQ 496
T GT+ ++APE + G D++ G ++E+ TG+
Sbjct: 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 63/217 (29%), Positives = 107/217 (49%), Gaps = 27/217 (12%)
Query: 295 NFSEKNVLGQGGFGKVY--RGVLADGTKVAVKRLTDFESPGGDA-----AFQREVEMISV 347
+ + LG G F Y R V GT +AVK++T + + A ++E+ +++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKT-GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMAR 59
Query: 348 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAAR 406
H +++R++G + L +M SV++ L + E V+ T + R
Sbjct: 60 LNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQ-----LLR 114
Query: 407 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNV---TTQVRGT 462
GL YLHE+ +IIHRDVK AN+L+D + + + DFG A + + T Q+ GT
Sbjct: 115 GLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGT 171
Query: 463 MGHIAPEYL---STGKSSERTDVFGYGIMLLELVTGQ 496
+ +APE L G+S DV+ G +++E+ T +
Sbjct: 172 IAFMAPEVLRGEQYGRSC---DVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 2e-13
Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 48/222 (21%)
Query: 299 KNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDA--AFQREVEMISVAVHRNLLR 355
+G G +G V V G KVA+K++++ DA RE++++ H N++
Sbjct: 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHLRHENIIG 63
Query: 356 LIGFCTTPTERL------LVYPFMQ-NLSVAYRLREIKPGEPVLDWVTRKRV------AL 402
L+ P +V M+ +L +++ IK +P+ T + L
Sbjct: 64 LLDI-LRPPSPEDFNDVYIVTELMETDL---HKV--IKSPQPL----TDDHIQYFLYQIL 113
Query: 403 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV---RKTNVTTQV 459
RGL+YLH N +IHRD+K +N+L++ + + + DFGLA+ VD K +T V
Sbjct: 114 ---RGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167
Query: 460 -----RGTMGHIAPE-YLSTGKSSERTDVFGYGIMLLELVTG 495
R APE LS+ + ++ D++ G + EL+T
Sbjct: 168 VTRWYR------APELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 295 NFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA 348
N K LG+G FGKV+ D VAVK L D S F RE E+++
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-ASDNARKDFHREAELLTNL 64
Query: 349 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-------GEPVLDWVTRK--R 399
H ++++ G C ++V+ +M++ + LR P G + +
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 400 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 459
+A A G+ YL + +HRD+ N L+ E+ +GDFG+++ DV T+
Sbjct: 125 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR--DVYSTDYYRVG 179
Query: 460 RGTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT 494
TM I PE + K + +DV+ G++L E+ T
Sbjct: 180 GHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 302 LGQGGFGKVY--RGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMI---SVAVHRNLLR 355
+G+G +GKV+ R + G VA+KR+ G + REV ++ H N++R
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 356 LIGFCTTP-----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 410
L CT T+ LV+ + Y + +PG P T K + RGL++
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT---ETIKDMMFQLLRGLDF 125
Query: 411 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 470
LH H +++HRD+K N+L+ + + DFGLA++ + T V T+ + APE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEV 180
Query: 471 LSTGKSSERTDVFGYGIMLLEL 492
L + D++ G + E+
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (173), Expect = 3e-13
Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 296 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNL 353
+ + LG+G +G VY+ G VA+K++ D E G + RE+ ++ H N+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 354 LRLIGFCTTPTERLLVYPFMQNLSVAYRLRE-IKPGEPVLDWVTRKRVALGAARGLEYLH 412
++L+ T + LV+ + L++ + L K + RGL Y H
Sbjct: 61 VKLLDVIHTERKLYLVFEYCD-----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 413 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL- 471
H +I+HRD+K N+L++ D + DFGLA+ + T +V T+ + APE L
Sbjct: 116 SH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILL 171
Query: 472 -----STGKSSERTDVFGYGIMLLELVTGQ 496
ST D++ G + E++TG+
Sbjct: 172 GSKHYSTA-----VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 16/209 (7%)
Query: 295 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLT-DFESPGGD---AAFQREVEMISVAV 349
N+ +LGQG FG+VY D G ++A K++ D ESP +A + E++++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 350 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK--RVALGAARG 407
H +++ G E+ L FM+ + ++K + + VTRK R L G
Sbjct: 63 HERIVQYYGCLRDRAEKTLTI-FMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL---EG 118
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT--TQVRGTMGH 465
+ YLH + I+HRD+K AN+L D +GDFG +K + + T V GT
Sbjct: 119 MSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 466 IAPEYLSTGKSSERTDVFGYGIMLLELVT 494
++PE +S + DV+ G ++E++T
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 55/177 (31%), Positives = 81/177 (45%), Gaps = 17/177 (9%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGD-----AAFQREVEMISVAVHRNLLR 355
LG+G + VY+ G VA+K++ E A RE++++ H N++
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL-REIKLLQELKHPNIIG 66
Query: 356 LIGFCTTPTERLLVYPFMQ-NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 414
L+ + LV+ FM+ +L IK VL K L RGLEYLH +
Sbjct: 67 LLDVFGHKSNINLVFEFMETDLEKV-----IKDKSIVLTPADIKSYMLMTLRGLEYLHSN 121
Query: 415 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 471
I+HRD+K N+L+ D + DFGLA+ +T QV T + APE L
Sbjct: 122 ---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELL 174
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 55/179 (30%), Positives = 86/179 (48%), Gaps = 17/179 (9%)
Query: 316 ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLI-GFCTTPTERLLVYPFMQ 374
KV VK +T ++PG RE++++ HR ++ LI + T +++ +
Sbjct: 117 EQRKKVIVKAVTGGKTPG------REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC 170
Query: 375 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED 434
+L + + P+ +T +R L A L YLH IIHRDVK N+ LDE
Sbjct: 171 DL---FTYVDRSGPLPLEQAITIQRRLLEA---LAYLHGR---GIIHRDVKTENIFLDEP 221
Query: 435 FEAVVGDFGLA-KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLEL 492
AV+GDFG A KL T GT+ +PE L+ +TD++ G++L E+
Sbjct: 222 ENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 5e-13
Identities = 39/124 (31%), Positives = 65/124 (52%), Gaps = 1/124 (0%)
Query: 74 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 133
+S N+ + L S + G + +G R+L + L+ N +GE+P E L + LD+ N
Sbjct: 378 SSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISN 437
Query: 134 NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF 193
N L G+I ++ LQ L+L++N F G +PDS + L ++ L N SG +P L
Sbjct: 438 NNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLG 496
Query: 194 QIPK 197
+ +
Sbjct: 497 SLSE 500
|
Length = 968 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 61/278 (21%), Positives = 121/278 (43%), Gaps = 22/278 (7%)
Query: 295 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQ--REVEMISVAVHR 351
NF + +G+G F +VYR L DG VA+K++ F+ A +E++++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 352 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 411
N+++ E +V ++ ++ K + ++ T + + LE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 471
H +++HRD+K ANV + +GD GL + KT + GT +++PE +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI 178
Query: 472 STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531
+ ++D++ G +L E+ Q D + L KK+E+
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPF------YGDKMNLYSLCKKIEQCDY------P 226
Query: 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569
L ++ +E+ ++ +C PE RP ++ V +
Sbjct: 227 PLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 51/178 (28%), Positives = 76/178 (42%), Gaps = 35/178 (19%)
Query: 295 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDF-ESPGGDAAFQREVEMISVAVHRN 352
K LG+G FG+VY+ + G VA+K++ E G RE++++ H N
Sbjct: 11 EILGK--LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPN 68
Query: 353 LLRLI--------GFCTTPTERLLVYPFM--------QNLSVAYRLREIKPGEPVLDWVT 396
++ LI +V P+M +N SV +IK
Sbjct: 69 VVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK---------- 118
Query: 397 RKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 454
L G+ YLHE+ I+HRD+KAAN+L+D + DFGLA+ D N
Sbjct: 119 --CYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 8e-13
Identities = 64/203 (31%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 302 LGQGGFGKVY------RGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH-RNLL 354
LG+GGFG+V G L K+ KRL + G +R I VH R ++
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKR----ILAKVHSRFIV 56
Query: 355 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLEYL 411
L T T+ LV M + Y + + P R A+ GLE+L
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFP---EPRACFYTAQIISGLEHL 113
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQVRGTMGHIAPEY 470
H+ +II+RD+K NVLLD D + D GLA +L D + T GT G +APE
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKD--GQSKTKGYAGTPGFMAPEL 168
Query: 471 LSTGKSSERTDVFGYGIMLLELV 493
L + D F G+ L E++
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 8e-13
Identities = 64/226 (28%), Positives = 98/226 (43%), Gaps = 47/226 (20%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLADG-------TKVAVKRLTDFESPGGDAAFQREVEMIS 346
+N S LG G FGKV A G KVAVK L A E++++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEAT-AYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS 93
Query: 347 -VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL- 402
+ H N++ L+G CT P + Y +L L+++ RKR +
Sbjct: 94 HLGNHENIVNLLGACTIGGPILVITEYCCYGDL---------------LNFLRRKRESFL 138
Query: 403 ----------GAARGLEYL-HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451
A+G+ +L ++C IHRD+ A NVLL + DFGLA+ D+
Sbjct: 139 TLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLAR--DIM 192
Query: 452 KTN---VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 494
+ V R + +APE + + +DV+ YGI+L E+ +
Sbjct: 193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 8e-13
Identities = 54/204 (26%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 295 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 353
NF + LG+G + VY+G G VA+K + G + RE+ ++ H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 354 LRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 412
+RL T + +LV+ +M ++L + + LD T K +G+ + H
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKDLK---KYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 413 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS 472
E+ +++HRD+K N+L+++ E + DFGLA+ + + +V T+ + AP+ L
Sbjct: 118 EN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLL 173
Query: 473 TGKS-SERTDVFGYGIMLLELVTG 495
++ S D++ G ++ E++TG
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 9e-13
Identities = 70/290 (24%), Positives = 124/290 (42%), Gaps = 37/290 (12%)
Query: 301 VLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQ---REVEMISVAVHRNLLRL 356
++G+G +G V + + G VA+K+ ES + RE+ M+ H NL+ L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF--LESEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 357 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 416
I LV+ F+ + L +++ LD ++ RG+E+ H H
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTV----LDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH-- 119
Query: 417 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL-STGK 475
IIHRD+K N+L+ + + DFG A+ + T V T + APE L K
Sbjct: 120 -NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWYRAPELLVGDTK 177
Query: 476 SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL--EREKRLDAIVDRN- 532
D++ G ++ E++TG+ + D+ L H+ K R I +N
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGE-----PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232
Query: 533 ---LNKNYNIQEVETM-----------IQVALLCTQASPEDRPAMSEVVR 568
+ ++E+E + + +A C + P+DRP+ S+++
Sbjct: 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 77/299 (25%), Positives = 128/299 (42%), Gaps = 44/299 (14%)
Query: 299 KNVLGQGGFGKVYRG------VLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
K LG+G FGKV+ D VAVK L D + FQRE E+++ H +
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAARKDFQREAELLTNLQHEH 68
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-------GEPV-----LDWVTRKRV 400
+++ G C ++V+ +M++ + LR P G+P L +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 401 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 460
A A G+ YL + +HRD+ N L+ + +GDFG+++ DV T+
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTDYYRVGG 183
Query: 461 GTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 517
TM I PE + K + +DV+ +G++L E+ T + F +L + + + +
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF-QLSNTEVIECITQGR 242
Query: 518 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLA 576
LER + V Y+I L C Q P+ R + E+ ++L G A
Sbjct: 243 VLERPRVCPKEV-------YDIM---------LGCWQREPQQRLNIKEIYKILHALGKA 285
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 61/203 (30%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 302 LGQGGFGKVYRGVLADG---TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 358
+G G FGKV G + G +V VK L S F E + H NLL+ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 359 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVL-DWVTRKRVALGAARGLEYLHEHCNP 417
CT T LLV F + LR + E + D T +R+A A GL +LH++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 418 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT-QVRGTMGHIAPEYLSTGKS 476
IH D+ N LL D +GD+GL+ VT Q+ + IAPE +
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 477 -------SERTDVFGYGIMLLEL 492
++ ++V+ G+ + EL
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 44/148 (29%), Positives = 66/148 (44%), Gaps = 31/148 (20%)
Query: 407 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV-------TTQV 459
LEYLH + IIHRD+K N+L+D + + DFGL+K+ VR+ ++
Sbjct: 105 ALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161
Query: 460 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG-----------------QRAIDFS 502
GT +IAPE + S+ D + G +L E + G I++
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWP 221
Query: 503 RLEEEDDVLLLDHVKKL---EREKRLDA 527
E D +D + KL + EKRL A
Sbjct: 222 EDVEVSDE-AIDLISKLLVPDPEKRLGA 248
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 50/220 (22%), Positives = 91/220 (41%), Gaps = 33/220 (15%)
Query: 296 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV----- 349
+ +G+G FG V + +DG + K + D+ + ++E + + V
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEI-DYGNMT-----EKEKQQLVSEVNILRE 55
Query: 350 --HRNLLRLIGFCTTPTERLLVYPFM---------QNLSVAYRLREIKPGEPVLDWVTRK 398
H N++R + + L Y M Q + + R+ E +
Sbjct: 56 LKHPNIVRYYDRIIDRSNQTL-YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW------ 108
Query: 399 RVALGAARGLEYLH--EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 456
R+ L H ++HRD+K AN+ LD + +GDFGLAK++ +
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK 168
Query: 457 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
T V GT +++PE L+ E++D++ G ++ EL
Sbjct: 169 TYV-GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 64/236 (27%), Positives = 106/236 (44%), Gaps = 26/236 (11%)
Query: 296 FSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTD--FESPGGDAAFQREVEMISVAVHRN 352
F + VLG+GGFG+V V A G A KRL + G++ E +++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLE 409
++ L T LV M + + + + G P + +R AA GLE
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFE---EERALFYAAEILCGLE 116
Query: 410 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 469
LH ++RD+K N+LLD+ + D GLA V + + GT+G++APE
Sbjct: 117 DLHRE---NTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPE 171
Query: 470 YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525
L+ + + D +G G ++ E++ GQ R +E VK+ E ++R+
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQSPF---RGRKE-------KVKREEVDRRV 217
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 301 VLGQGGFGKVYRG-VLADGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIG 358
V+G+G +G V + A G VA+K+ + E REV+++ H N++ L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 359 FCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 417
LV+ ++ + L L E PG L + + + Y H H
Sbjct: 68 AFRRKGRLYLVFEYVERTL---LELLEASPGG--LPPDAVRSYIWQLLQAIAYCHSH--- 119
Query: 418 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL----ST 473
IIHRD+K N+L+ E + DFG A+ + R + T T + APE L +
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179
Query: 474 GKSSERTDVFGYGIMLLELVTGQ 496
GK DV+ G ++ EL+ G+
Sbjct: 180 GKP---VDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 52/207 (25%), Positives = 97/207 (46%), Gaps = 15/207 (7%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDAAFQREVEMISVAVH 350
T+ + + +G G FG V G VA+K++ F +P RE++++ H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 351 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 410
N++ L +P E + + + RL +P E + RGL+Y
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGTDLH-RLLTSRPLEKQF----IQYFLYQILRGLKY 123
Query: 411 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 470
+H + ++HRD+K +N+L++E+ + + DFGLA++ D + T + T + APE
Sbjct: 124 VH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS----TRYYRAPEI 176
Query: 471 LST-GKSSERTDVFGYGIMLLELVTGQ 496
+ T K D++ G + E++ G+
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 57/191 (29%), Positives = 88/191 (46%), Gaps = 36/191 (18%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKR-LTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 359
+GQG FG+V++ VA+K+ L + E G RE++++ + H N++ LI
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 360 CTTPTER--------LLVYPF--------MQNLSVAYRLREIKPGEPVLDWVTRKRVALG 403
C T LV+ F + N +V + L EIK +V
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIK------------KVMKM 127
Query: 404 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT---NVTTQVR 460
GL Y+H + KI+HRD+KAAN+L+ +D + DFGLA+ + K N T
Sbjct: 128 LLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV 184
Query: 461 GTMGHIAPEYL 471
T+ + PE L
Sbjct: 185 VTLWYRPPELL 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 89/342 (26%), Positives = 140/342 (40%), Gaps = 97/342 (28%)
Query: 301 VLGQGGFGKVYRGVLADGTK------VAVKRLTDFESPGGDAAFQREVE-MISVAVHRNL 353
LG+G FGKV + K VAVK L + + A E++ +I + H N+
Sbjct: 14 PLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNV 73
Query: 354 LRLIGFCTTPTERLLV---YPFMQNLSVAY----------------RLREIKPGEPV--- 391
+ L+G CT P L+V Y NLS Y R RE+K E
Sbjct: 74 VNLLGACTKPGGPLMVIVEYCKFGNLS-NYLRSKRECFSPYRNKSTRKREMKQKEGKKQR 132
Query: 392 LD------------WVTRKRV-------------------------ALGAARGLEYLHEH 414
LD ++ K + + ARG+E+L
Sbjct: 133 LDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL--- 189
Query: 415 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-----DVRKTNVTTQVRGTMGHIAPE 469
+ K IHRD+ A N+LL E+ + DFGLA+ + VRK + R + +APE
Sbjct: 190 ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD----ARLPLKWMAPE 245
Query: 470 YLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528
+ + ++DV+ +G++L E+ + G +++EE ++L+ R+ A
Sbjct: 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-------FCRRLKEGTRMRA- 297
Query: 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 570
Y E + + L C +PEDRP SE+V +L
Sbjct: 298 ------PEYATPE---IYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 50/226 (22%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTD-FESPGGDAAFQREVEMISVAVHR 351
D + + +G G +G+V G KVA+K+L+ F+S RE+ ++ H
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 352 NLLRLIGFCTTPTERL-------LVYPFM----------QNLS---VAYRLREIKPGEPV 391
N++ L+ TP L LV M Q LS + + + +I
Sbjct: 75 NVIGLLD-VFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQI------ 127
Query: 392 LDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451
RGL+Y+H + IIHRD+K +N+ ++ED E + DFGLA+ D
Sbjct: 128 -------------LRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD-- 169
Query: 452 KTNVTTQVRGTMGHIAPE-YLSTGKSSERTDVFGYGIMLLELVTGQ 496
+T V T + APE L+ ++ D++ G ++ EL+TG+
Sbjct: 170 -DEMTGYV-ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 296 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAA-FQREVEMISVAVHRNLL 354
F++ +G+G FG+V++G+ +V ++ D E + Q+E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 355 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 414
+ G T+ ++ ++ S LR P + K + +GL+YLH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEI----LKGLDYLHSE 120
Query: 415 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDV---RKTNVTTQVRGTMGHIAPEY 470
K IHRD+KAANVLL E + + DFG+A +L D R T V GT +APE
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-----GTPFWMAPEV 172
Query: 471 LSTGKSSERTDVFGYGIMLLELVTGQ 496
+ + D++ GI +EL G+
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 60/210 (28%), Positives = 106/210 (50%), Gaps = 15/210 (7%)
Query: 295 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRN 352
NF + +G+G +G VY+ G VA+K++ D E+ G + RE+ ++ H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 353 LLRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPV-LDWVTRKRVALGAARGLEY 410
+++L+ T + LV+ F+ Q+L + + P + L + K +GL +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLK---KFMDASPLSGIPLPLI--KSYLFQLLQGLAF 115
Query: 411 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 470
H H +++HRD+K N+L++ + + DFGLA+ V T +V T+ + APE
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEI 171
Query: 471 LSTGK-SSERTDVFGYGIMLLELVTGQRAI 499
L K S D++ G + E+VT +RA+
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 3e-12
Identities = 59/289 (20%), Positives = 109/289 (37%), Gaps = 81/289 (28%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAF----------QREV 342
D+F ++G+G F V + A+K L D + E
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL--------DKRQLIKEKKVKYVKIEK 52
Query: 343 EMIS-VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV-TRKRV 400
E+++ + H +++L + T F Q+ Y + E P +L ++ +
Sbjct: 53 EVLTRLNGHPGIIKL--YYT----------F-QDEENLYFVLEYAPNGELLQYIRKYGSL 99
Query: 401 ALGAAR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452
R LEYLH IIHRD+K N+LLD+D + DFG AK++D
Sbjct: 100 DEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156
Query: 453 TNVTTQVR-------------------GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 493
+ + + GT +++PE L+ + + +D++ G ++ +++
Sbjct: 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQML 216
Query: 494 TG-----------------QRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525
TG + F D L++ + L+ + RL
Sbjct: 217 TGKPPFRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRL 265
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 296 FSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTD--FESPGGDAAFQREVEMISVAVHRN 352
F + VLG+GGFG+V V A G A K+L + G++ E +++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLE 409
++ L T LV M + + + + GE + R AA GLE
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFE---EGRAVFYAAEICCGLE 116
Query: 410 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 469
LH+ +I++RD+K N+LLD+ + D GLA V V + GT+G++APE
Sbjct: 117 DLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPE 171
Query: 470 YLSTGKSSERTDVFGYGIMLLELVTGQ 496
+ + + D + G +L E++ GQ
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 42/215 (19%)
Query: 301 VLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMI-----SVAVHRNLL 354
VLG+G FGKV L + A+K A +++V + V R +L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIK------------ALKKDVVLEDDDVECTMVERRVL 49
Query: 355 RLIG--------FCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 404
L FCT T+ L V ++ + + ++ + R A
Sbjct: 50 ALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFD-------EARARFYA 102
Query: 405 AR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 461
A GL++LH+ II+RD+K NVLLD+D + DFG+ K + +T G
Sbjct: 103 AEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-G 158
Query: 462 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
T +IAPE L K +E D + +G++L E++ GQ
Sbjct: 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 24/202 (11%)
Query: 302 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 361
LG G FGKVY+ + +A ++ D +S + E+++++ H N+++L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 362 TPTERLLVYPFMQNLSVAYRLREIKPG--EPVLDWVTRKRVALGAARGLEYLHEHCNPKI 419
++ F +V + E++ EP + V ++ + L YLHE+ KI
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTL-----EALNYLHEN---KI 124
Query: 420 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR----GTMGHIAPEYLSTGK 475
IHRD+KA N+L D + + DFG++ K T Q R GT +APE +
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSA-----KNTRTIQRRDSFIGTPYWMAPEVVMCET 179
Query: 476 SSER-----TDVFGYGIMLLEL 492
S +R DV+ GI L+E+
Sbjct: 180 SKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 19/212 (8%)
Query: 296 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMIS-VAVHRNLL 354
F V+G G +G+VY+G ++A ++ D + + + E+ M+ + HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TEDEEEEIKLEINMLKKYSHHRNIA 76
Query: 355 RLIGFCTTPT------ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 408
G + + LV F SV ++ K DW+ + RGL
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGL 134
Query: 409 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 468
+LH H K+IHRD+K NVLL E+ E + DFG++ +D R GT +AP
Sbjct: 135 AHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-RTVGRRNTFIGTPYWMAP 190
Query: 469 EYLSTGKSSE-----RTDVFGYGIMLLELVTG 495
E ++ ++ + R+D++ GI +E+ G
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 302 LGQGGFGKVY------RGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 355
LG+G FGKV G G +VAVK L A ++E+E++ H N+++
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 356 LIGFCTTPTER--LLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLH 412
G CT L+ F+ + S L+E P + ++ + + A+ +G++YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGS----LKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126
Query: 413 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ--VRGTMGHIAPEY 470
+ +HRD+ A NVL++ + + +GDFGL K ++ K T + + + APE
Sbjct: 127 SR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 471 LSTGKSSERTDVFGYGIMLLELVT 494
L K +DV+ +G+ L EL+T
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 16/209 (7%)
Query: 295 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLT----DFESPGGDAAFQREVEMISVAV 349
N+ +LG+G FG+VY AD G ++AVK++ E+ A + E++++
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 350 HRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARG 407
H +++ G P E+ L +M S+ +L K + + VTR R +G
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTR-RYTRQILQG 118
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT--TQVRGTMGH 465
+ YLH + I+HRD+K AN+L D +GDFG +K + + T V GT
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 466 IAPEYLSTGKSSERTDVFGYGIMLLELVT 494
++PE +S + DV+ ++E++T
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 36/208 (17%)
Query: 302 LGQGGFGKVYR------GVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 355
LG G FGKVY+ G LA + K + E + E+E+++ H +++
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED------YMVEIEILATCNHPYIVK 73
Query: 356 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG--EPVLDWVTRKRVALGAARGLEYLHE 413
L+G + ++ F +V + E+ G EP + + R+ + L+YLH
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML-----EALQYLH- 127
Query: 414 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR----GTMGHIAPE 469
+ KIIHRD+KA NVLL D + + DFG++ K T Q R GT +APE
Sbjct: 128 --SMKIIHRDLKAGNVLLTLDGDIKLADFGVSA-----KNVKTLQRRDSFIGTPYWMAPE 180
Query: 470 YL--STGKSSE---RTDVFGYGIMLLEL 492
+ T K + + D++ GI L+E+
Sbjct: 181 VVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 9e-12
Identities = 65/226 (28%), Positives = 101/226 (44%), Gaps = 20/226 (8%)
Query: 302 LGQGGFGKVYR-GVLADGTKVAVKRLTD--FESPGGDAAFQREVEMISVAVHRNLLRLIG 358
LG+GGFG+V V G A K+L + G+ E E++ ++ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 359 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLEYLHEHC 415
+ T LV M + Y + + GE L+ +RV +A+ G+ +LH
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEM---ERVIHYSAQITCGILHLHSM- 114
Query: 416 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK 475
I++RD+K NVLLD+ + D GLA V+++ TQ GT G++APE L
Sbjct: 115 --DIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEP 170
Query: 476 SSERTDVFGYGIMLLELVTGQRAI-DFSRLEEEDDVL---LLDHVK 517
S D F G + E+V G+ D ++++ L D VK
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 296 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMIS-VAVHRNLL 354
F ++G G +G+VY+G ++A ++ D + + ++E+ M+ + HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIA 66
Query: 355 RLIGFCTTPT------ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 408
G + LV F SV ++ K +W+ + RGL
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGL 124
Query: 409 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 468
+LH+H K+IHRD+K NVLL E+ E + DFG++ +D R GT +AP
Sbjct: 125 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-RTVGRRNTFIGTPYWMAP 180
Query: 469 EYLSTGKSSE-----RTDVFGYGIMLLELVTG 495
E ++ ++ + ++D++ GI +E+ G
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 68/287 (23%), Positives = 119/287 (41%), Gaps = 52/287 (18%)
Query: 295 NFSEKNVLGQGGFGKVYR-GVLADGTKVAVKR-----LTDFESPGGDAAFQREVEMISVA 348
+F LG+G +G VY+ L+D A+K ++ E DA E+ +++
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERE--DAV--NEIRILASV 56
Query: 349 VHRNLLR-----LIG--FCTTPTERLLVYPFMQNLSVAYRLREI--KPGEPVLDWVTRKR 399
H N++ L G C ++ Y +LS A R+ K W R
Sbjct: 57 NHPNIISYKEAFLDGNKLCI-----VMEYAPFGDLSKAISKRKKKRKLIPEQEIW----R 107
Query: 400 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 459
+ + RGL+ LHE KI+HRD+K+AN+LL + +GD G++K++ K N+
Sbjct: 108 IFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQ 161
Query: 460 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL 519
GT ++APE S ++D++ G +L E+ T + +++
Sbjct: 162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD------------- 208
Query: 520 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 566
R K + Y+ + + Q P+ RP ++
Sbjct: 209 LRYKVQRGKYPP-IPPIYS----QDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 72/238 (30%), Positives = 113/238 (47%), Gaps = 45/238 (18%)
Query: 301 VLGQGGFGKVYRGVLADGTKV----AVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 356
VLG+G FGKV +LA+ K A+K L GD + EVE S+ + +
Sbjct: 6 VLGRGHFGKV---LLAEYKKTGELYAIKALKK-----GDIIARDEVE--SLMCEKRI--- 52
Query: 357 IGFCTTPTERLLVYPFMQNL-------SVAYRLREIKPGEPVL-----DWVTRKRVALGA 404
F T +ER +PF+ NL + E G ++ D + R A
Sbjct: 53 --FETANSER---HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYA 107
Query: 405 AR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 461
A GL+YLHE+ KI++RD+K N+LLD + + DFGL K + + T+ G
Sbjct: 108 ACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCG 163
Query: 462 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED--DVLLLDHVK 517
T +APE L+ + D +G G+++ E++ G+ F +EE+ D ++ D V+
Sbjct: 164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP--FPGDDEEEVFDSIVNDEVR 219
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 53/218 (24%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 295 NFSEKNVLGQGGFGKVY--RGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 351
+ + V+G+G FG V+ R AD V +K++ + + A Q E +++ + H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 352 NLLRLIGFCTTPTERLLVYPFMQNLSVA----YRLREIKPGEPVLDWVTRKRVALGAARG 407
N++ ++V + ++A R + + +L + + +AL
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL----- 114
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMGHI 466
++H I+HRD+K N+LLD+ V +GDFG++K++ + T V GT +I
Sbjct: 115 -HHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYI 168
Query: 467 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRL 504
+PE ++++D++ G +L EL + +RA + + L
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 57/223 (25%), Positives = 87/223 (39%), Gaps = 41/223 (18%)
Query: 295 NFSEKNVLGQGGFGKVY----RGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH 350
NF VLG G +GKV+ G G A+K L Q+
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKA------TIVQKAKTAEHTRTE 54
Query: 351 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYR--------LREIKPGEPVLDWVTRKRVAL 402
R +L + C PF+ L A++ L + GE R+
Sbjct: 55 RQVLEAVRRC----------PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE 104
Query: 403 GAAR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 454
R L++LH+ II+RD+K N+LLD + V+ DFGL+K +
Sbjct: 105 SEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161
Query: 455 VTTQVRGTMGHIAPEYLSTGKS--SERTDVFGYGIMLLELVTG 495
GT+ ++APE + G + D + G++ EL+TG
Sbjct: 162 RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 45/278 (16%)
Query: 302 LGQGGFGKVYRGVLA--DGTK-VAVKRL-TDFESPGGDAAFQREVEMISVAVHRNLLRLI 357
LG G FG V +G+ K VAVK L D P RE ++ + ++R+I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 358 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD---WVTRKRV---ALGAARGLEYL 411
G C ++ + L E+ P L VT K + + G++YL
Sbjct: 63 GICEA-----------ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYL 111
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT--MGHIAPE 469
E +HRD+ A NVLL A + DFGL+K + + + G + APE
Sbjct: 112 EET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE 168
Query: 470 YLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528
++ K S ++DV+ +G+++ E + GQ+ + ++ + +++ +++E +R
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWEAFSYGQKP--YKGMKGNEVTQMIESGERMECPQRCPPE 226
Query: 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 566
+ Y++ + LC ++RP + V
Sbjct: 227 M-------YDLMK---------LCWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 301 VLGQGGFGKVYRGVLADGTKVAVKRLTD---FESPGGDAAFQREVEMISVAVHRNLLRLI 357
++G+GGFG+VY AD K+ + D + G+ E M+S+ + ++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 358 GFCT---TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 414
TP + + M + Y L + V + A GLE++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMH-- 114
Query: 415 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG 474
N +++RD+K AN+LLDE + D GLA +K + + GT G++APE L G
Sbjct: 115 -NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKG 170
Query: 475 KSSERT-DVFGYGIMLLELVTGQ 496
+ + + D F G ML +L+ G
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 76/253 (30%), Positives = 118/253 (46%), Gaps = 51/253 (20%)
Query: 295 NFSEKNVLGQGGFGKVYRGVLAD--GTK--VAVKRLTDFESPGGDAAFQRE-VEMISVAV 349
+F+ VLG+G FGKV +LA+ GT A+K L D Q + VE V
Sbjct: 1 DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKK------DVIIQDDDVE--CTMV 49
Query: 350 HRNLLRLIG---------FCTTPTERL-LVYPFMQNLSVAYRLREI-KPGEPVLDWVTRK 398
+ +L L G C +RL V ++ + Y ++++ K EP +
Sbjct: 50 EKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY--- 106
Query: 399 RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 458
A A GL +LH + II+RD+K NV+LD + + DFG+ K ++ T
Sbjct: 107 --AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK-ENIFGGKTTRT 160
Query: 459 VRGTMGHIAPE---YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL--LL 513
GT +IAPE Y GKS D + +G++L E++ GQ D E+ED++ ++
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAGQPPFDG---EDEDELFQSIM 214
Query: 514 DHV----KKLERE 522
+H K L +E
Sbjct: 215 EHNVSYPKSLSKE 227
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 39/220 (17%)
Query: 295 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRN 352
F + N +G+G +G VYR G VA+K++ D E G + RE+ ++ H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 353 LLRL---------------IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR 397
++ L + +C LL N+ + ++K
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLL-----DNMPTPFSESQVKC---------- 112
Query: 398 KRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT 457
+ L RGL+YLHE+ IIHRD+K +N+LL + + DFGLA+ + +T
Sbjct: 113 --LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTP 167
Query: 458 QVRGTMGHIAPEYL-STGKSSERTDVFGYGIMLLELVTGQ 496
+V T+ + APE L + D++ G +L EL+ +
Sbjct: 168 KVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 64/280 (22%), Positives = 121/280 (43%), Gaps = 28/280 (10%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQR-----EVEMIS 346
NF + +G+G F VY+ + L DG VA+K++ FE A R E++++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM---DAKARQDCLKEIDLLK 57
Query: 347 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR 406
H N+++ + E +V ++ ++ K + ++ T + +
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 407 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 466
LE++H +I+HRD+K ANV + +GD GL + + T + V GT ++
Sbjct: 118 ALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYM 173
Query: 467 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526
+PE + + ++D++ G +L E+ Q D + L KK+E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPF------YGDKMNLYSLCKKIEKCDY-- 225
Query: 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 566
L ++ +E+ ++ C PE RP +S V
Sbjct: 226 ----PPLPADHYSEELRDLVSR---CINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 12/199 (6%)
Query: 302 LGQGGFGKVYR-GVLADGTKVAVKRLTDFESPGGDA-AFQREVEMISVAVHRNLLRLIGF 359
+G+G G V++ G VA+K++ GG RE++ + H +++L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 360 CTTPTERLLVYPFMQ-NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 418
+ +LV +M +LS R E E + K +G+ Y+H +
Sbjct: 68 FPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQV-----KSYMRMLLKGVAYMHAN---G 119
Query: 419 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL-STGKSS 477
I+HRD+K AN+L+ D + DFGLA+L + + + T + APE L K
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179
Query: 478 ERTDVFGYGIMLLELVTGQ 496
D++ G + EL+ G
Sbjct: 180 PGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 64/230 (27%), Positives = 100/230 (43%), Gaps = 47/230 (20%)
Query: 301 VLGQGGFGKVYRGVLAD--GTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 356
VLG+G FGKV LA+ GT AVK L D Q + ++ + +L L
Sbjct: 2 VLGKGSFGKVL---LAELKGTDELYAVKVLKK------DVILQDD-DVECTMTEKRVLAL 51
Query: 357 IGFCTTPTERLLVYPFMQNLSVAYRLRE--------IKPGEPVLDWVTRKRVALGAAR-- 406
G +PF+ L ++ ++ + G+ + R AR
Sbjct: 52 AG----------KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY 101
Query: 407 ------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 460
GL++LHE II+RD+K NVLLD + + DFG+ K + T+
Sbjct: 102 AAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFC 157
Query: 461 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV 510
GT +IAPE LS D + G++L E++ GQ + ++ED++
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE---GDDEDEL 204
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-11
Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 21/202 (10%)
Query: 318 GTKVAVKRLTDFESPGGD---AAFQREVEMISVAVHRNLLRLIGFCTTPTERLL-VYPFM 373
G +VA+K L ++P + A F+RE + + H N++ L+ P L V+ ++
Sbjct: 3 GHEVAIKLLRT-DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 374 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL-- 431
+ LRE+ + L R+ L L H N I+HRD+K N+++
Sbjct: 62 PGRT----LREVLAADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQ 114
Query: 432 -DEDFEAVVGDFGLAKL------VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFG 484
A V DFG+ L DV TT+V GT + APE L + +D++
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 485 YGIMLLELVTGQRAIDFSRLEE 506
+G++ LE +TGQR + + + E
Sbjct: 175 WGLIFLECLTGQRVVQGASVAE 196
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 74/276 (26%), Positives = 117/276 (42%), Gaps = 41/276 (14%)
Query: 302 LGQGGFGKVYRGVLADGTK-VAVKRLTDFESPGGDAAFQ---REVEMISVAVHRNLLRLI 357
+G G FG VY + + VAVK+++ + + +Q +EV+ + H N +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMS-YSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 358 GFCTTPTERLLVYPFMQNLSVAYRLREI--KPGEPVLDWVTRKRVALGAARGLEYLHEHC 415
G LV + L A L E+ KP L V + GA +GL YLH H
Sbjct: 88 GCYLKEHTAWLVMEYC--LGSASDLLEVHKKP----LQEVEIAAITHGALQGLAYLHSHN 141
Query: 416 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY---LS 472
+IHRD+KA N+LL E + + DFG A + V GT +APE +
Sbjct: 142 ---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMD 193
Query: 473 TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532
G+ + DV+ GI +EL + L + + L H+ + +
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERKPP-----LFNMNAMSALYHIAQNDSP---------T 239
Query: 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568
L N + ++ C Q P++RPA +E++R
Sbjct: 240 LQSN---EWTDSFRGFVDYCLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 67/207 (32%), Positives = 94/207 (45%), Gaps = 26/207 (12%)
Query: 296 FSEKNVLGQGGFGKVY--RGVLADGTKVAVKRLTDFESPGGDAAFQ---REVEMISVAVH 350
FS+ +G G FG VY R V VA+K+++ + + +Q +EV + H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEV-VAIKKMS-YSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 351 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREI--KPGEPVLDWVTRKRVALGAARGL 408
N ++ G LV + L A L E+ KP L V V GA +GL
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYC--LGSASDLLEVHKKP----LQEVEIAAVTHGALQGL 128
Query: 409 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 468
YLH H +IHRDVKA N+LL E +GDFG A ++ V GT +AP
Sbjct: 129 AYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAP 180
Query: 469 EY---LSTGKSSERTDVFGYGIMLLEL 492
E + G+ + DV+ GI +EL
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 3e-11
Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 38/217 (17%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
D+F LG G FG+V K A+K L ++VE V +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKIL-----SKAKIVKLKQVE--HVLNEKR 53
Query: 353 LLRLIG--FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-RVALGAAR--- 406
+L+ I F L F + ++ Y + E PG + + + R AR
Sbjct: 54 ILQSIRHPFLVN-----LYGSFQDDSNL-YLVMEYVPGGELFSHLRKSGRFPEPVARFYA 107
Query: 407 -----GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 461
LEYLH + I++RD+K N+LLD D + DFG AK V R T + G
Sbjct: 108 AQVVLALEYLH-SLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCG 160
Query: 462 TMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTG 495
T ++APE + + GK+ D + GI++ E++ G
Sbjct: 161 TPEYLAPEIILSKGYGKAV---DWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 52/196 (26%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 360
+GQG G VY + +A G +VA+K++ + P + E+ ++ H N++ +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKHPNIVNYLDSY 85
Query: 361 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 420
E +V ++ S+ + E E + V R+ + LE+LH + ++I
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE-----CLQALEFLHSN---QVI 137
Query: 421 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERT 480
HRD+K+ N+LL D + DFG + ++ +T V GT +APE ++ +
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 481 DVFGYGIMLLELVTGQ 496
D++ GIM +E+V G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 48/177 (27%), Positives = 88/177 (49%), Gaps = 23/177 (12%)
Query: 399 RVALGAARGLEYLH-EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVD-VRKTNV 455
++A+ GL YL+ H +I+HRD+K +N+L++ + + DFG++ +L++ + T V
Sbjct: 107 KIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV 163
Query: 456 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH 515
GT +++PE + GK + ++DV+ GI ++EL G+ FS DD D
Sbjct: 164 -----GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS---NIDDDGQDDP 215
Query: 516 VKKLEREKRLDAIVDR---NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569
+ L+ L IV L + +++ + LL P +RP ++ M
Sbjct: 216 MGILD---LLQQIVQEPPPRLPSSDFPEDLRDFVDACLL---KDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 351
D + + +G G +G V + G KVA+K+L F+S RE+ ++ H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 352 NLLRLIGFCTTPTERL-------LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 404
N++ L+ TP L LV PFM + ++ K E + ++ + +
Sbjct: 75 NVIGLLD-VFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQML---- 128
Query: 405 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 464
+GL+Y+H IIHRD+K N+ ++ED E + DFGLA+ D T T
Sbjct: 129 -KGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV----TRW 180
Query: 465 HIAPEY-LSTGKSSERTDVFGYGIMLLELVTGQ 496
+ APE L+ ++ D++ G ++ E++TG+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 33/212 (15%)
Query: 302 LGQGGFGKVYRGVLADGTK---VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 358
LG G FG V +GV K VA+K L + RE E++ + ++R+IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 359 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR----------GL 408
C E L++ + E+ G P+ +++ K+ + + G+
Sbjct: 63 VCEA--EALML------------VMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGM 108
Query: 409 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT--MGHI 466
+YL +HRD+ A NVLL A + DFGL+K + + + G +
Sbjct: 109 KYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWY 165
Query: 467 APEYLSTGKSSERTDVFGYGIMLLELVT-GQR 497
APE ++ K S R+DV+ YGI + E + GQ+
Sbjct: 166 APECINFRKFSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 301 VLGQGGFGKVYRGVLADGTKVAVKRLTD---FESPGGDAAFQREVEMISVAVHRNLLRLI 357
++G+GGFG+VY AD K+ + D + G+ E M+S+ + ++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 358 GFC---TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 414
TP + + M + Y L + V + A GLE++H
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMH-- 114
Query: 415 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG 474
N +++RD+K AN+LLDE + D GLA D K V GT G++APE L G
Sbjct: 115 -NRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV-GTHGYMAPEVLQKG 170
Query: 475 KSSERT-DVFGYGIMLLELVTGQ 496
+ + + D F G ML +L+ G
Sbjct: 171 VAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 36/118 (30%), Positives = 64/118 (54%), Gaps = 15/118 (12%)
Query: 383 REIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 442
+ + E +L ++A+ + LEYLH +IHRDVK +NVL++ + + + DF
Sbjct: 96 KGLTIPEDIL-----GKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDF 148
Query: 443 GLA-KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE----RTDVFGYGIMLLELVTG 495
G++ LVD + T G ++APE ++ + + ++DV+ GI ++EL TG
Sbjct: 149 GISGYLVD---SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 5e-11
Identities = 59/205 (28%), Positives = 88/205 (42%), Gaps = 22/205 (10%)
Query: 296 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQ---REVEMISVAVHRN 352
F++ +G G FG VY +V + + + +Q +EV+ + H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREI--KPGEPVLDWVTRKRVALGAARGLEY 410
+ G LV + L A L E+ KP L V + GA +GL Y
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC--LGSASDLLEVHKKP----LQEVEIAAITHGALQGLAY 140
Query: 411 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 470
LH H +IHRD+KA N+LL E + + DFG A + + V GT +APE
Sbjct: 141 LHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEV 192
Query: 471 ---LSTGKSSERTDVFGYGIMLLEL 492
+ G+ + DV+ GI +EL
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 46/217 (21%)
Query: 301 VLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 359
VLG+G FGKV L G AVK A +++V +I V
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVK------------ALKKDVVLIDDDVE--------- 40
Query: 360 CTTPTERLLVY----PFMQNLSVAYRLRE--------IKPGEPVLDWVTRKRVALGAAR- 406
CT +R+L PF+ +L ++ +E + G+ + + R L A
Sbjct: 41 CTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF 100
Query: 407 -------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 459
GL++LH II+RD+K NV+LD D + DFG+ K +V N +
Sbjct: 101 YAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCK-ENVFGDNRASTF 156
Query: 460 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
GT +IAPE L K + D + +G++L E++ GQ
Sbjct: 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 5/88 (5%)
Query: 406 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 465
GL YLH +IIHRDVK N+ +++ + +GD G A+ V + + GT+
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--LAGTVET 222
Query: 466 IAPEYLSTGKSSERTDVFGYGIMLLELV 493
APE L+ K + + D++ GI+L E++
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 12/161 (7%)
Query: 341 EVEMISVAVHRNLLRLIGFCTTPTERLLVYP-FMQNLSVAYRLREIKPGEPVLDWVTRKR 399
E ++ H ++++L G T L+ P + +L Y K + D + +R
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDL---YCYLAAKRNIAICDILAIER 189
Query: 400 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL-VDVRKTNVTTQ 458
L R ++YLHE+ +IIHRD+KA N+ ++ + +GDFG A VD+ N
Sbjct: 190 SVL---RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NKYYG 242
Query: 459 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 499
GT+ APE L+ D++ GI+L E+ T ++
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 69/285 (24%), Positives = 130/285 (45%), Gaps = 55/285 (19%)
Query: 301 VLGQGGFGKV----YRGVLADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLR 355
V+G+G +G+V +R DG + +K+L S A ++E +++S H N++
Sbjct: 7 VVGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63
Query: 356 LIGFCTTPTERL-LVYPFMQNLSVAYRLREIK----PGEPVLDWVTRKRVALGAARGLEY 410
L +V F + + ++L+E K P V++W + A L+Y
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ------IAMALQY 117
Query: 411 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 470
LHE I+HRD+K NV L VGD G+A++++ + +T + GT +++PE
Sbjct: 118 LHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPEL 173
Query: 471 LSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530
S + ++DV+ G + E+ T + A + K ++++V
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATLKHAFN---------------------AKDMNSLVY 212
Query: 531 R-------NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568
R + K+Y+ + E +I +L + PE RP++ ++R
Sbjct: 213 RIIEGKLPPMPKDYSPELGE-LIA-TMLSKR--PEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 9e-11
Identities = 70/285 (24%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 302 LGQGGFGKVYRGVLADGTKVA---VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 358
+G G FGKV + T VA VK L S F ++ + + H N+L+ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 359 FCTTPTERLLVYPF--MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 416
C LLV+ + + +L + + +R+A A G+ ++H+H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNS--QLLLLQRMACEIAAGVTHMHKH-- 118
Query: 417 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ--VRGTMGHIAPEY---- 470
+H D+ N L D VGD+G+ ++ + T+ + +APE
Sbjct: 119 -NFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPELVGEF 176
Query: 471 ---LSTGKSSERTDVFGYGIMLLELV--TGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525
L T + ++ ++V+ G+ L EL Q S E +L+HV K +++ +L
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VLNHVIK-DQQVKL 229
Query: 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 570
L Y+ E +V C SPE R EV R+L
Sbjct: 230 ---FKPQLELPYS----ERWYEVLQFC-WLSPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 37/103 (35%), Positives = 55/103 (53%), Gaps = 10/103 (9%)
Query: 399 RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTT 457
++ + + L YL E +IHRDVK +N+LLD + DFG++ +LVD + T
Sbjct: 118 KMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK---AKT 172
Query: 458 QVRGTMGHIAPEYL----STGKSSERTDVFGYGIMLLELVTGQ 496
+ G ++APE + K R DV+ GI L+EL TGQ
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 16/207 (7%)
Query: 296 FSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTD--FESPGGDAAFQREVEMISVAVHRN 352
F VLG+GGFG+V V A G A K+L + G+A E +++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLE 409
++ L T LV M + + + + G P D +R AA GLE
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNM--GNPGFD---EERAVFYAAEITCGLE 116
Query: 410 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 469
LH +I++RD+K N+LLD+ + D GLA V++ + GT+G++APE
Sbjct: 117 DLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAPE 171
Query: 470 YLSTGKSSERTDVFGYGIMLLELVTGQ 496
+ + + D +G G ++ E++ G+
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 66/236 (27%), Positives = 106/236 (44%), Gaps = 26/236 (11%)
Query: 296 FSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTD--FESPGGDAAFQREVEMISVAVHRN 352
F VLG+GGFG+V V A G A K+L + G+A E ++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLE 409
++ L T LV M + + + + G P D +R AA GLE
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFD---EQRAIFYAAELCCGLE 116
Query: 410 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 469
L +I++RD+K N+LLD+ + D GLA V + + GT+G++APE
Sbjct: 117 DLQRE---RIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAPE 171
Query: 470 YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525
++ K + D +G G ++ E++ GQ F + +E VK+ E ++R+
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMIQGQSP--FRKRKER--------VKREEVDRRV 217
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 50/196 (25%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 360
+GQG G VY + +A G +VA+K++ + P + E+ ++ + N++ +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 85
Query: 361 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 420
E +V ++ S+ + E E + V R+ + L++LH + ++I
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE-----CLQALDFLHSN---QVI 137
Query: 421 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERT 480
HRD+K+ N+LL D + DFG + ++ +T V GT +APE ++ +
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 481 DVFGYGIMLLELVTGQ 496
D++ GIM +E+V G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 10/207 (4%)
Query: 294 DNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
D++ + LG+G + VY+G +G VA+K + E G RE ++ H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 412
++ L T LV+ ++ Y + PG + V K RGL Y+H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKH--PGGLHPENV--KLFLFQLLRGLSYIH 120
Query: 413 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YL 471
+ I+HRD+K N+L+ + E + DFGLA+ V + +V T+ + P+ L
Sbjct: 121 QR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLL 176
Query: 472 STGKSSERTDVFGYGIMLLELVTGQRA 498
+ + S D++G G + +E++ G A
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 359
+G G +G V + G KVA+K+L+ F+S RE+ ++ H N++ L+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 360 CTTPT------ERLLVYPFMQ-NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 412
T+ + LV P+MQ +L ++ E + ++ + + GL+Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQ---KIMGHPLSEDKVQYLVYQML-----CGLKYIH 134
Query: 413 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN--VTTQVRGTMGHIAPEY 470
IIHRD+K N+ ++ED E + DFGLA+ D T VT R APE
Sbjct: 135 S---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYR------APEV 185
Query: 471 -LSTGKSSERTDVFGYGIMLLELVTGQ 496
L+ ++ D++ G ++ E++TG+
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 47/205 (22%), Positives = 95/205 (46%), Gaps = 7/205 (3%)
Query: 295 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQ--REVEMISVAVHR 351
NF + +G+G F +VYR L D VA+K++ FE A +E++++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 352 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 411
N+++ + E +V ++ ++ K + ++ T + + +E++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 471
H +++HRD+K ANV + +GD GL + KT + GT +++PE +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI 178
Query: 472 STGKSSERTDVFGYGIMLLELVTGQ 496
+ ++D++ G +L E+ Q
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 406 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD---VRKTNVTTQVRGT 462
RGL+Y+H +IHRD+K +N+L++ED E +GDFG+A+ + T+ T
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 463 MGHIAPE-YLSTGKSSERTDVFGYGIMLLELVTGQRAI 499
+ APE LS + + D++ G + E++ G+R +
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 302 LGQGGFGKVYRG--VLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 359
LG+G + VY+G L D VA+K + G REV ++ H N++ L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 360 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 419
T LV+ ++ Y + ++ K RGL Y H K+
Sbjct: 73 IHTEKSLTLVFEYLDKDLKQY----LDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KV 125
Query: 420 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKSSE 478
+HRD+K N+L++E E + DFGLA+ + + +V T+ + P+ L + S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYST 184
Query: 479 RTDVFGYGIMLLELVTGQRAIDFSRLEEE 507
+ D++G G + E+ TG+ S +EE+
Sbjct: 185 QIDMWGVGCIFYEMSTGRPLFPGSTVEEQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 74/304 (24%), Positives = 132/304 (43%), Gaps = 45/304 (14%)
Query: 295 NFSEKNVLGQGGFGKVY----------------RGVLADGTK-VAVKRLTDFESPGGDAA 337
NF EK LG+G FG+V+ AD VAVK L S
Sbjct: 8 NFVEK--LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65
Query: 338 FQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-------GEP 390
F +EV+++S N+ RL+G CT ++ +M+N + L++
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 391 VLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450
L + T +A A G+ YL +HRD+ N L+ +++ + DFG+++ +
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNL-- 180
Query: 451 RKTNVTTQVRG-TMGHI---APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE 506
++ +V+G I A E + GK + ++DV+ +G+ L E++T R + L +
Sbjct: 181 -YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239
Query: 507 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 566
+ ++++ R+ + R N +I E+ M++ C + EDRP E+
Sbjct: 240 QQ---VIENAGHFFRDDGRQIYLPRPPNCPKDIYEL--MLE----CWRRDEEDRPTFREI 290
Query: 567 VRML 570
L
Sbjct: 291 HLFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 64/230 (27%), Positives = 103/230 (44%), Gaps = 32/230 (13%)
Query: 288 ELQLATDNFSEKNVLGQGGFGKVYRGVL---ADGTK---VAVKRLTDFESPGGDAAFQRE 341
E+ L+T F E+ LG+ FGKVY+G L A G + VA+K L D F+ E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 342 VEMISVAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLR----------EIKPGE 389
M S H N++ L+G T P + Y +L +R + K +
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 390 PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV- 448
L+ + A G+E+L H ++H+D+ NVL+ + + D GL + V
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 449 --DVRKT--NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 494
D K N +R ++PE + GK S +D++ YG++L E+ +
Sbjct: 176 AADYYKLMGNSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 22/217 (10%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVE---MISVA 348
TD + +G+G +GKVY+ DG+ AVK L P D + E E + S+
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL----DPISDVDEEIEAEYNILQSLP 76
Query: 349 VHRNLLRLIGFCTTPTERL-----LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 403
H N+++ G + + LV SV ++ + LD + G
Sbjct: 77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYG 136
Query: 404 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 463
A GL++LH N +IIHRDVK N+LL + + DFG++ + + T V GT
Sbjct: 137 ALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTP 192
Query: 464 GHIAPEYLSTGKSSE-----RTDVFGYGIMLLELVTG 495
+APE ++ + + R DV+ GI +EL G
Sbjct: 193 FWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 4e-10
Identities = 51/196 (26%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 360
+GQG G V+ + +A G +VA+K++ + P + E+ ++ + N++ +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIIN-EILVMKELKNPNIVNFLDSF 85
Query: 361 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 420
E +V ++ S+ + E E + V R+ + LE+LH + ++I
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRE-----CLQALEFLHAN---QVI 137
Query: 421 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERT 480
HRD+K+ NVLL D + DFG + ++ +T V GT +APE ++ +
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 481 DVFGYGIMLLELVTGQ 496
D++ GIM +E+V G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 10/208 (4%)
Query: 302 LGQGGFGKVYRG-VLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 360
LG+G + V++G VA+K + G REV ++ H N++ L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 361 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 420
T LV+ ++ + Y + ++ K RGL Y H+ KI+
Sbjct: 73 HTERCLTLVFEYLDSDLKQY----LDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KIL 125
Query: 421 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKSSER 479
HRD+K N+L++E E + DFGLA+ V + +V T+ + P+ L + + S
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTP 184
Query: 480 TDVFGYGIMLLELVTGQRAIDFSRLEEE 507
D++G G +L E+ TG+ S ++EE
Sbjct: 185 IDMWGVGCILYEMATGRPMFPGSTVKEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 5e-10
Identities = 74/283 (26%), Positives = 121/283 (42%), Gaps = 37/283 (13%)
Query: 294 DNFSEK--NVLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMISV 347
DN S K +LG G FG++ RG L +K VA+ L S F E +
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ 62
Query: 348 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARG 407
H N++RL G T ++V +M N ++ LR+ E L + G A G
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASG 119
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI- 466
++YL E +H+ + A VL++ D + F +L + + + T + G +
Sbjct: 120 MKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLW 174
Query: 467 -APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAI-DFSRLEEEDDVLLLDHVKKLEREK 523
APE + S +DV+ +GI++ E+++ G+R D S D +K +E
Sbjct: 175 AAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---------QDVIKAVEDGF 225
Query: 524 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 566
RL A N + + Q+ L C Q +RP S++
Sbjct: 226 RLPAPR--------NCPNL--LHQLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 16/210 (7%)
Query: 295 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 354
NF VLG G +GKV+ G +L + A Q+ + RN+L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTG--KLYAMKVLQKAALVQKAKTVEHTRTERNVL 58
Query: 355 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR-------- 406
+ +P L Y F + L + GE R + R
Sbjct: 59 EHVR--QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIIL 116
Query: 407 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 466
LE+LH+ I++RD+K N+LLD + V+ DFGL+K + T GT+ ++
Sbjct: 117 ALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173
Query: 467 APEYL-STGKSSERTDVFGYGIMLLELVTG 495
APE + G + D + GI++ EL+TG
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 85/347 (24%), Positives = 132/347 (38%), Gaps = 91/347 (26%)
Query: 301 VLGQGGFGKVYRGVLADGTK------VAVKRLTDFESPGGDAAFQREVE-MISVAVHRNL 353
VLG G FGKV K VAVK L + + A E++ +I + H N+
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV 73
Query: 354 LRLIGFCTTPTERLLV---YPFMQNLS----------VAYRLREIKPGEPVLDWVT---- 396
+ L+G CT P L+V + NLS YR + K V
Sbjct: 74 VNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRV 133
Query: 397 RKRVALGAARGLEYLH-----EHCNP---------------------------------- 417
+R+ G A L NP
Sbjct: 134 DRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR 193
Query: 418 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-----DVRKTNVTTQVRGTMGHIAPEYLS 472
K IHRD+ A N+LL E+ + DFGLA+ + VRK + R + +APE +
Sbjct: 194 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS----ARLPLKWMAPESIF 249
Query: 473 TGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531
+ ++DV+ +G++L E+ + G ++ EE ++L+ R+ A
Sbjct: 250 DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-------FCQRLKDGTRMRA---- 298
Query: 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAER 578
E+ ++ L C Q P++RP S +V +L G+ L E
Sbjct: 299 ---PENATPEIY---RIMLACWQGDPKERPTFSALVEIL-GDLLQEN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 12/209 (5%)
Query: 302 LGQGGFGKVYRG--VLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 359
LG+G + V++G L + VA+K + G REV ++ H N++ L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 360 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 419
T LV+ ++ Y + ++ K RGL Y H K+
Sbjct: 73 VHTDKSLTLVFEYLDKDLKQY----MDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KV 125
Query: 420 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKSSE 478
+HRD+K N+L++E E + DFGLA+ V + +V T+ + P+ L + + S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYST 184
Query: 479 RTDVFGYGIMLLELVTGQRAIDFSRLEEE 507
+ D++G G + E+ +G+ S +E+E
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDE 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 9e-10
Identities = 49/196 (25%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 360
+GQG G VY + +A G +VA++++ + P + E+ ++ + N++ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 86
Query: 361 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 420
E +V ++ S+ + E E + V R+ + LE+LH + ++I
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE-----CLQALEFLHSN---QVI 138
Query: 421 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERT 480
HRD+K+ N+LL D + DFG + ++ +T V GT +APE ++ +
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 481 DVFGYGIMLLELVTGQ 496
D++ GIM +E++ G+
Sbjct: 198 DIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 9e-10
Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 15/215 (6%)
Query: 301 VLGQGGFGKVYRGVL-ADGTKVAVKRLT-DFESPGGDA-AFQREVEMISVAVHRNLLRLI 357
VLG+G FGKV L G AVK L D D E ++S+A + L +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 358 GFCTTPTERLL-VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 416
C +RL V F+ + + +++ + D + A L +LH+
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR----FDEARARFYAAEITSALMFLHDK-- 115
Query: 417 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKS 476
II+RD+K NVLLD + + DFG+ K + T+ GT +IAPE L
Sbjct: 116 -GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEILQEMLY 173
Query: 477 SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL 511
D + G++L E++ G + E EDD+
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFE---AENEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 16/214 (7%)
Query: 290 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVA 348
+L D+F + LG G G V + + ++L E P RE++++
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 349 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIK--PGEPVLDWVTRKRVALGAAR 406
++ G + E + M S+ L+E K P E + +V++ R
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEIL------GKVSIAVLR 114
Query: 407 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQVRGTMGH 465
GL YL E +I+HRDVK +N+L++ E + DFG++ +L+D ++ GT +
Sbjct: 115 GLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSY 168
Query: 466 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 499
++PE L S ++D++ G+ L+EL G+ I
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 36/224 (16%)
Query: 290 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV 349
+L D+F + + LG G G V++ + ++L E I A+
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE--------------IKPAI 46
Query: 350 HRNLLR---LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-------- 398
++R ++ C +P F + ++ + + G LD V +K
Sbjct: 47 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPEQI 104
Query: 399 --RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNV 455
+V++ +GL YL E KI+HRDVK +N+L++ E + DFG++ +L+D ++
Sbjct: 105 LGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SM 158
Query: 456 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 499
GT +++PE L S ++D++ G+ L+E+ G+ I
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 52/225 (23%), Positives = 102/225 (45%), Gaps = 40/225 (17%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKR----LTDFESPGGDAAFQREVEMISVAVHRNLLRL 356
+G+GG G+VY +VA+K+ L++ F RE ++ + +H ++ +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLL--KKRFLREAKIAADLIHPGIVPV 67
Query: 357 IGFCTTPTERLLVY---PFMQNLSVAYRLREIKPGEPVLDWVTRK-------RVALGAAR 406
C+ + VY P+++ ++ L+ + E + + K +
Sbjct: 68 YSICS---DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 407 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL----------VDVRKTNVT 456
+EY+H ++HRD+K N+LL E V+ D+G A +DV + N+
Sbjct: 125 TIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 457 T-------QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 494
++ GT ++APE L +SE TD++ G++L +++T
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 54/224 (24%), Positives = 101/224 (45%), Gaps = 44/224 (19%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
+ + +G+G +G V G KVA+K+++ FE RE++++ H N
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 353 LLRLIGFCTTPT-----ERLLVYPFM----------QNLS---VAYRLREIKPGEPVLDW 394
++ ++ P+ + +V M Q+LS + Y L +I
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQI--------- 115
Query: 395 VTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK-- 452
RGL+Y+H N ++HRD+K +N+LL+ + + + DFGLA++ D
Sbjct: 116 ----------LRGLKYIHS-AN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162
Query: 453 TNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTG 495
T T+ T + APE + K ++ D++ G +L E+++
Sbjct: 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 36/119 (30%), Positives = 65/119 (54%), Gaps = 17/119 (14%)
Query: 392 LDWVTRK----------RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD 441
LD V +K ++++ RGL YL E KI+HRDVK +N+L++ E + D
Sbjct: 86 LDQVLKKAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCD 143
Query: 442 FGLA-KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 499
FG++ +L+D ++ GT +++PE L + ++D++ G+ L+E+ G+ I
Sbjct: 144 FGVSGQLID----SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 52/218 (23%), Positives = 98/218 (44%), Gaps = 24/218 (11%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKR-LTDFESPGGDAAFQREV---EMISVA 348
D + + +G+G +GKVY+ G VA+K+ + + G RE+ +M+S +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 349 VHRNLLRLIGFCTTPTER-------LLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRV 400
++ ++RL+ E LV+ ++ +L PG P L T K
Sbjct: 61 IY--IVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP-LPAKTIKSF 115
Query: 401 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQV 459
+G+ + H+H ++HRD+K N+L+D+ + + D GL + + + T ++
Sbjct: 116 MYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEI 172
Query: 460 RGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQ 496
T+ + APE L S D++ G + E+ Q
Sbjct: 173 V-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 38/101 (37%), Positives = 56/101 (55%), Gaps = 11/101 (10%)
Query: 400 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVD-VRKTNVTT 457
+A+ + L YL E KIIHRDVK +N+LLD + + DFG++ +LVD + K T
Sbjct: 112 IAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK----T 165
Query: 458 QVRGTMGHIAPEYLSTGKSSE---RTDVFGYGIMLLELVTG 495
+ G ++APE + R+DV+ GI L E+ TG
Sbjct: 166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 51/181 (28%), Positives = 89/181 (49%), Gaps = 25/181 (13%)
Query: 389 EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KL 447
E VL R+A+ +GL YL + KI+HRDVK +N+L++ + + DFG++ +L
Sbjct: 94 EHVLG-----RIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL 145
Query: 448 VD-VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE 506
V+ + KT V GT ++APE +S + +DV+ GI +EL G+ + ++++
Sbjct: 146 VNSIAKTYV-----GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR--FPYPQIQK 198
Query: 507 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 566
L+ + L IVD + Q E + C + P++RPA +
Sbjct: 199 NQGSLMPLQL--------LQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENL 250
Query: 567 V 567
+
Sbjct: 251 M 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 52/191 (27%), Positives = 85/191 (44%), Gaps = 34/191 (17%)
Query: 318 GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS 377
G +VAVK++ + + F EV ++ H N++ + E +V F++
Sbjct: 44 GRQVAVKKMDLRKQQRRELLFN-EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE--- 99
Query: 378 VAYRLREIKPGEPVLDWVTRKR--------VALGAARGLEYLHEHCNPKIIHRDVKAANV 429
G + D VT R V L + L +LH +IHRD+K+ ++
Sbjct: 100 ----------GGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSI 146
Query: 430 LLDEDFEAVVGDFG----LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGY 485
LL D + DFG ++K V RK+ V GT +APE +S D++
Sbjct: 147 LLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-----GTPYWMAPEVISRLPYGTEVDIWSL 201
Query: 486 GIMLLELVTGQ 496
GIM++E+V G+
Sbjct: 202 GIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 302 LGQGGFGKVYRGVLAD-GTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGF 359
+G+G +G V++ + G VA+K+ + E P RE+ M+ H NL+ LI
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 360 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 419
+ LV+ + + +V L E++ + K++ + + + H+H
Sbjct: 69 FRRKRKLHLVFEYCDH-TV---LNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NC 121
Query: 420 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSER 479
IHRDVK N+L+ + + + DFG A+++ + T V T + APE L G +
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELL-VGDTQYG 179
Query: 480 T--DVFGYGIMLLELVTGQ 496
DV+ G + EL+TGQ
Sbjct: 180 PPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 49/164 (29%), Positives = 77/164 (46%), Gaps = 30/164 (18%)
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV------DVRKTNVTTQVRGTMGH 465
H H + +IHRD+K+AN+LL + +GDFG +K+ DV +T GT +
Sbjct: 158 HVH-SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC-----GTPYY 211
Query: 466 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525
+APE S++ D+F G++L EL+T +R D +EE V R
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE---------VMHKTLAGRY 262
Query: 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569
D + +I I ALL + P+ RP+ S+++ M
Sbjct: 263 DPLPP-------SISPEMQEIVTALLSSD--PKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 3e-09
Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVE-MISVAVHRNLLRLIG 358
LG G FG VY G VA+K++ F S + REV+ + + H N+++L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 359 FCTTPTERLLVYPFM-QNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLHEHCN 416
E V+ +M NL + R+ KP E V+ + + +GL ++H+H
Sbjct: 66 VFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVI-----RSIIYQILQGLAHIHKH-- 118
Query: 417 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL--STG 474
HRD+K N+L+ + DFGLA+ + R T V T + APE L ST
Sbjct: 119 -GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-YTDYV-STRWYRAPEILLRSTS 175
Query: 475 KSSERTDVFGYGIMLLELVTGQ 496
SS D++ G ++ EL T +
Sbjct: 176 YSSP-VDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 61/232 (26%), Positives = 103/232 (44%), Gaps = 54/232 (23%)
Query: 301 VLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 359
+LG+G FGKV+ L A+K A +++V ++ V
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIK------------ALKKDVVLMDDDVE--------- 40
Query: 360 CTTPTERLLV----YPFMQNLSVAYRLRE--------IKPGEPVLDWVTRKRVALGAAR- 406
CT +R+L +PF+ +L ++ +E + G+ + + + L A
Sbjct: 41 CTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF 100
Query: 407 -------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK---LVDVRKTNVT 456
GL++LH + I++RD+K N+LLD D + DFG+ K L D + T
Sbjct: 101 YAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK----T 153
Query: 457 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED 508
GT +IAPE L K + D + +G++L E++ GQ F +EE+
Sbjct: 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP--FHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 35/224 (15%)
Query: 301 VLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQR--------EVEMISVAVHR 351
VLG+G FGKV L +V A+K L D Q E ++++A
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKK------DVILQDDDVDCTMTEKRILALAAKH 55
Query: 352 NLLRLIGFCTTPTERLL-VYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAAR--- 406
L + C +RL V ++ + +++ R K EP R AA
Sbjct: 56 PFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEP--------RSRFYAAEVTL 107
Query: 407 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 466
L +LH H +I+RD+K N+LLD + + DFG+ K + TT GT +I
Sbjct: 108 ALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYI 163
Query: 467 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV 510
APE L + D + G+++ E++ GQ + + EDD+
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQPPFE---ADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 48/210 (22%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 295 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDA--AFQREVEMISVAVHRN 352
+ +G+G FGK+Y ++ V + D A ++EV +++ H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIK-------PGEPVLDWVTRKRVALGAA 405
+ + F + E ++ M+ ++ I + +L W + ++LG
Sbjct: 61 I---VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ--ISLG-- 113
Query: 406 RGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 464
L+++H+ KI+HRD+K+ N+ L ++ A +GDFG+A+ ++ + GT
Sbjct: 114 --LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPY 167
Query: 465 HIAPEYLSTGKSSERTDVFGYGIMLLELVT 494
+++PE + +TD++ G +L EL T
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 62/262 (23%), Positives = 116/262 (44%), Gaps = 52/262 (19%)
Query: 302 LGQGGFGKVYRGVLADGTKVAVKRLTDF-ESPGGD------AAFQREVEMIS-------V 347
LG+G FG VY ++ D VA +RL E P G+ +E +++S V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 348 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIK------PGEPVLDWVTRKRVA 401
H + L FC ++ + + + +L E+K V +W + +
Sbjct: 66 KFHASFLERDAFC-------IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL- 117
Query: 402 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 461
G+ Y+H+ +I+HRD+KA N+ L + +GDFG+++L+ + ++ T G
Sbjct: 118 -----GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTG 167
Query: 462 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS-------RLEEEDDVLLLD 514
T +++PE L ++D++ G +L E+ A + R+ E L +
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPE 227
Query: 515 HVKKLEREKRLDAIVDRNLNKN 536
++L++I+ LNK+
Sbjct: 228 TY-----SRQLNSIMQSMLNKD 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 40/116 (34%), Positives = 65/116 (56%), Gaps = 15/116 (12%)
Query: 405 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK--LVDVRKTNVTTQVR-G 461
+ GL +LH II+RD+K NV+LD + + DFG+ K +VD VTT+ G
Sbjct: 111 SVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD----GVTTRTFCG 163
Query: 462 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL--LLDH 515
T +IAPE ++ + D + YG++L E++ GQ D E+ED++ +++H
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG---EDEDELFQSIMEH 216
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 301 VLGQGGFGKVY--RGVLAD--GTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLR 355
VLGQG FGKV+ R + G A+K L D + I V H +++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 356 LIGFCTTPTERLLVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAAR---GLEYL 411
L T + L+ F++ + RL +E+ T + V A L++L
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM--------FTEEDVKFYLAELALALDHL 114
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTNVTTQVRGTMGHIAPEY 470
H + II+RD+K N+LLDE+ + DFGL+K +D K GT+ ++APE
Sbjct: 115 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEV 169
Query: 471 LSTGKSSERTDVFGYGIMLLELVTG 495
++ ++ D + +G+++ E++TG
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 59/215 (27%), Positives = 89/215 (41%), Gaps = 25/215 (11%)
Query: 295 NFSEKNVLGQGGFGKVY--RGVLA--DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH 350
NF VLG G +GKV+ R V G A+K L Q+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKK------ATIVQKAKTTEHTRTE 54
Query: 351 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---- 406
R +L I +P L Y F + + L I GE R+R +
Sbjct: 55 RQVLEHIR--QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG 112
Query: 407 ----GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT 462
LE+LH+ II+RD+K N+LLD + V+ DFGL+K + GT
Sbjct: 113 EIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGT 169
Query: 463 MGHIAPEYLSTGKS--SERTDVFGYGIMLLELVTG 495
+ ++AP+ + G + D + G+++ EL+TG
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 6e-09
Identities = 45/163 (27%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 467
L YLH+ +I+HRD+ N++L ED + + DFGLAK + + T V GT+ +
Sbjct: 126 LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILYSC 181
Query: 468 PEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527
PE + E+ DV+ +G +L ++ T Q +S ++L L K ++A
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPPF-YS-----TNMLSL-------ATKIVEA 228
Query: 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 570
+ + L + ++V +I C E RP + +V M+
Sbjct: 229 VYE-PLPEGMYSEDVTDVITS---CLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 27/219 (12%)
Query: 287 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGT--KVAVKRLTDFESPGGDAAFQREVEM 344
R+ ++ ++F+ LG G FG+V + VA+KR FE + ++ ++
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKR---FEK----SKIIKQKQV 75
Query: 345 ISVAVHRNLLRLIG--FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR--- 399
V R +L I FC +Y ++ S Y + E G ++ R +
Sbjct: 76 DHVFSERKILNYINHPFCVN------LYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFP 129
Query: 400 --VALGAARGLEYLHEHCNP-KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 456
V A + + E+ I++RD+K N+LLD+D + DFG AK+VD R T
Sbjct: 130 NDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----T 185
Query: 457 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 495
+ GT +IAPE L + D + GI + E++ G
Sbjct: 186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 360
LG+G + VY+G+ +G VA+K ++ G RE ++ H N++ L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 361 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 420
T V+ +M Y ++ PG L + RGL Y+H I+
Sbjct: 73 HTKETLTFVFEYMHTDLAQYMIQH--PGG--LHPYNVRLFMFQLLRGLAYIHGQ---HIL 125
Query: 421 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL--STGKSSE 478
HRD+K N+L+ E + DFGLA+ + +++V T+ + P+ L +T SS
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSA 184
Query: 479 RTDVFGYGIMLLELVTGQ 496
D++G G + +E++ GQ
Sbjct: 185 -LDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 59/251 (23%), Positives = 107/251 (42%), Gaps = 48/251 (19%)
Query: 296 FSEKNVLGQGGFGKVY----------------------RGVLADGTKVAVKRLTDFESPG 333
F EK LG+G FG+V+ R +L VAVK L +
Sbjct: 9 FKEK--LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLL-----VAVKILRPDANKN 61
Query: 334 GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN------LSVAYRLREIKP 387
F +EV+++S N++RL+G C ++ +M+N LS + + +
Sbjct: 62 ARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEEN 121
Query: 388 GE---------PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV 438
G P + + + VAL A G++YL + +HRD+ N L+ E+
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIK 178
Query: 439 VGDFGLAK-LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 497
+ DFG+++ L + + + +A E + GK + +DV+ +G+ L E++ +
Sbjct: 179 IADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238
Query: 498 AIDFSRLEEED 508
+ L +E
Sbjct: 239 EQPYGELTDEQ 249
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 38/218 (17%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQ---------REVEMISVAVHR 351
+G G FG V+ DG +VA+K++ + FQ RE++M+ H
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPN--------VFQNLVSCKRVFRELKMLCFFKHD 59
Query: 352 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE-------IKPGEPVLDWVTRKRVALGA 404
N+L + P + PF + + V L + + P D V K
Sbjct: 60 NVLSALDILQPP----HIDPF-EEIYVVTELMQSDLHKIIVSPQPLSSDHV--KVFLYQI 112
Query: 405 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 464
RGL+YLH + I+HRD+K N+L++ + + DFGLA++ + ++ TQ T
Sbjct: 113 LRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY 169
Query: 465 HIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDF 501
+ APE L + + D++ G + EL+ R I F
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELL--GRRILF 205
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 50/172 (29%), Positives = 82/172 (47%), Gaps = 30/172 (17%)
Query: 405 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-----DVRKTNVTTQV 459
A+G+E+L + K IHRD+ A N+LL E+ + DFGLA+ + VRK +
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD----A 241
Query: 460 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKK 518
R + +APE + + ++DV+ +G++L E+ + G +++EE ++
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCRR 294
Query: 519 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 570
L+ R+ A +Y E M Q L C P RP SE+V L
Sbjct: 295 LKEGTRMRA-------PDYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVK--RLTDFESPGGDAAFQREVEMISVAV---HRNLLR 355
+G G +G VY+ G VA+K R+ E G + REV ++ H N++R
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 356 LIGFCTT-----PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 410
L+ C T T+ LV+ + Y + PG P T K + RGL++
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPA---ETIKDLMRQFLRGLDF 123
Query: 411 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 470
LH +C I+HRD+K N+L+ + + DFGLA++ + T V T+ + APE
Sbjct: 124 LHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWYRAPEV 178
Query: 471 LSTGKSSERTDVFGYGIMLLEL 492
L + D++ G + E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 359
+G+G +G VY+G G VA+K++ + E G + RE+ ++ H N++ L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 360 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 419
+ L++ F+ + + L + G+ +D K +G+ + H ++
Sbjct: 68 LMQESRLYLIFEFLS-MDLKKYLDSLPKGQ-YMDAELVKSYLYQILQGILFCHSR---RV 122
Query: 420 IHRDVKAANVLLDEDFEAVVGDFGLAKL--VDVRKTNVTTQVRGTMGHIAPEYL-STGKS 476
+HRD+K N+L+D + DFGLA+ + VR V T T+ + APE L + +
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR---VYTHEVVTLWYRAPEVLLGSPRY 179
Query: 477 SERTDVFGYGIMLLELVT 494
S D++ G + E+ T
Sbjct: 180 STPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 25/206 (12%)
Query: 302 LGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 360
+G+G FG+VY+ D ++ A+K L+ E + E+ RN+L
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKE-------IVAKKEVAHTIGERNILVRTLLD 53
Query: 361 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARG----------LEY 410
+P L + F Q S Y + + G + W +K R LE+
Sbjct: 54 ESPFIVGLKFSF-QTDSDLYLVTDYMSGGELF-WHLQKEGRFSEDRAKFYIAELVLALEH 111
Query: 411 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 470
LH++ I++RD+K N+LLD + DFGL+K ++ T GT ++APE
Sbjct: 112 LHKY---DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEV 167
Query: 471 LSTGKS-SERTDVFGYGIMLLELVTG 495
L K ++ D + G+++ E+ G
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 54/191 (28%), Positives = 84/191 (43%), Gaps = 34/191 (17%)
Query: 318 GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS 377
G +VAVK++ D EV ++ H N++ + E +V F++
Sbjct: 47 GKQVAVKKM-DLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE--- 102
Query: 378 VAYRLREIKPGEPVLDWVTRKR--------VALGAARGLEYLHEHCNPKIIHRDVKAANV 429
G + D VT R V L R L YLH N +IHRD+K+ ++
Sbjct: 103 ----------GGALTDIVTHTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSI 149
Query: 430 LLDEDFEAVVGDFG----LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGY 485
LL D + DFG ++K V RK+ V GT +APE +S D++
Sbjct: 150 LLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-----GTPYWMAPEVISRLPYGTEVDIWSL 204
Query: 486 GIMLLELVTGQ 496
GIM++E++ G+
Sbjct: 205 GIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 39/148 (26%), Positives = 76/148 (51%), Gaps = 11/148 (7%)
Query: 302 LGQGGFGKVYRGVLAD-GTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 359
+G+G +G V++ + VA+KR+ D + G ++ RE+ ++ H+N++RL
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 360 CTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 418
+ + LV+ + Q+L + + G+ D K +GL + H H
Sbjct: 68 LHSDKKLTLVFEYCDQDLK---KYFDSCNGDI--DPEIVKSFMFQLLKGLAFCHSH---N 119
Query: 419 IIHRDVKAANVLLDEDFEAVVGDFGLAK 446
++HRD+K N+L++++ E + DFGLA+
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 40/120 (33%), Positives = 65/120 (54%), Gaps = 21/120 (17%)
Query: 384 EIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 443
E P E VL +R+ +GL++L E N IIHRDVK NVL++ + + + DFG
Sbjct: 97 EGIP-EDVL-----RRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFG 148
Query: 444 LA-KLV-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSER------TDVFGYGIMLLELVTG 495
++ LV + KTN+ G ++APE + +G ++ +DV+ G+ +LE+ G
Sbjct: 149 VSGNLVASLAKTNI-----GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 10/106 (9%)
Query: 392 LDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451
DW K+ G+E LH+ IIHRD+K N+L+D+ + DFGL++
Sbjct: 96 EDWA--KQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN 150
Query: 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 497
K V GT ++APE + + +D + G ++ E + G
Sbjct: 151 KKFV-----GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 57/237 (24%), Positives = 106/237 (44%), Gaps = 31/237 (13%)
Query: 296 FSEKNVLGQGGFGKVYRGVLADGTK----------------VAVKRLTDFESPGGDAAFQ 339
EK LG+G FG+V+ A+G VAVK L + F
Sbjct: 9 LKEK--LGEGQFGEVHL-CEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFL 65
Query: 340 REVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN--LSVAYRLREIKP------GEPV 391
+E++++S + N++RL+G C + ++ +M+N L+ REI+ P
Sbjct: 66 KEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS 125
Query: 392 LDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDV 450
+ +A+ A G++YL + +HRD+ N L+ + + DFG+++ L
Sbjct: 126 VSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSG 182
Query: 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE 507
+ + + +A E + GK + +DV+ +G+ L E+ T + +S L +E
Sbjct: 183 DYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 37/212 (17%)
Query: 301 VLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL-- 354
+LG+G FGKV +L A G A+K L ++EV + V L
Sbjct: 2 LLGKGTFGKV---ILVREKATGKYYAMKIL------------KKEVIIAKDEVAHTLTES 46
Query: 355 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRKRVA-------LGA-- 404
R++ P L Y F + + + + GE L + ++R+RV GA
Sbjct: 47 RVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE--LFFHLSRERVFSEDRARFYGAEI 104
Query: 405 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 464
L YLH +++RD+K N++LD+D + DFGL K + GT
Sbjct: 105 VSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPE 160
Query: 465 HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
++APE L D +G G+++ E++ G+
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 36/224 (16%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGVL--ADGTKVAVKRLTDFESPGGDAAFQREVE---MISV 347
+D + +G+G +GKV++ VL +G+K AVK L P D + E E + ++
Sbjct: 17 SDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKIL----DPIHDIDEEIEAEYNILKAL 71
Query: 348 AVHRNLLRLIGF-----CTTPTERLLVYPFMQNLSV-----AYRLREIKPGEPVLDWVTR 397
+ H N+++ G + LV SV + R + EP++ ++
Sbjct: 72 SDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILH 131
Query: 398 KRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL-AKLVDVRKTNVT 456
+ A GL++LH + K IHRDVK N+LL + + DFG+ A+L R T
Sbjct: 132 E-----ALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 183
Query: 457 TQVRGTMGHIAPEYLSTGKS-----SERTDVFGYGIMLLELVTG 495
+ GT +APE ++ + R DV+ GI +EL G
Sbjct: 184 SV--GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 32/223 (14%)
Query: 300 NVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 358
LG+G +GKV + G VA+K++ E ++ V M +H LR +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGM--CGIHFTTLRELK 72
Query: 359 FCTT---PTERLLVYPFMQ----NLSV---AYRLREIKPGEPVLDWVTRKRVALGAARGL 408
LV +++ NL + A L+++ + L K + L GL
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGL 132
Query: 409 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK------LVDV--------RKTN 454
LH +HRD+ AN+ ++ + DFGLA+ D R+
Sbjct: 133 NVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 455 VTTQVRGTMGHIAPEYL-STGKSSERTDVFGYGIMLLELVTGQ 496
+T++V T+ + APE L K D++ G + EL+TG+
Sbjct: 190 MTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 68/241 (28%), Positives = 117/241 (48%), Gaps = 45/241 (18%)
Query: 295 NFSEKNVLGQGGFGKVYRGVLAD--GTK--VAVKRLTDFESPGGDAAFQREVEMISVAVH 350
+F+ VLG+G FGKV +LA+ GT A+K L D Q + ++ V
Sbjct: 1 DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKK------DVVIQDD-DVECTMVE 50
Query: 351 RNLLRLIG---------FCTTPTERL-LVYPFMQNLSVAYRLREI-KPGEPVLDWVTRKR 399
+ +L L G C +RL V ++ + Y+++++ + EP +
Sbjct: 51 KRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY---- 106
Query: 400 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK--LVDVRKTNVTT 457
A A GL +LH + II+RD+K NV+LD + + DFG+ K + D VTT
Sbjct: 107 -AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD----GVTT 158
Query: 458 QVR-GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL--LLD 514
+ GT +IAPE ++ + D + +G++L E++ GQ + E+ED++ +++
Sbjct: 159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG---EDEDELFQSIME 215
Query: 515 H 515
H
Sbjct: 216 H 216
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 64/211 (30%), Positives = 91/211 (43%), Gaps = 36/211 (17%)
Query: 301 VLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR- 355
V+G+G FGKV LA DG AVK L A ++ E + RN+L
Sbjct: 2 VIGKGSFGKVL---LAKHKADGKFYAVKVLQK-------KAILKKKEQKHIMAERNVLLK 51
Query: 356 ------LIG--FCTTPTERL-LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRV-ALGA 404
L+G + ++L V ++ + + L RE EP R R A
Sbjct: 52 NVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP------RARFYAAEI 105
Query: 405 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 464
A L YLH II+RD+K N+LLD V+ DFGL K + + T+ GT
Sbjct: 106 ASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPE 161
Query: 465 HIAPEYLSTGKSSERTDVFGYGIMLLELVTG 495
++APE L D + G +L E++ G
Sbjct: 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 62/281 (22%), Positives = 117/281 (41%), Gaps = 38/281 (13%)
Query: 302 LGQGGFGKVYRGV---LADGTKV----AVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 354
LGQG F K+++G+ + D ++ + ++ D +F M+S H++L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 355 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 414
G C E ++V +++ S+ L++ K + W + VA A L +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINIS-W--KLEVAKQLAWALHFLEDK 119
Query: 415 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH----IAPEY 470
+ H +V A NVLL + + G+ KL D ++T + + + PE
Sbjct: 120 ---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD-PGISITVLPKEILLERIPWVPPEC 175
Query: 471 LSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529
+ ++ S D + +G L E+ +G + + LD KKL+ +
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSGG----------DKPLSALDSQKKLQFYE------ 219
Query: 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 570
DR+ E+ +I C P+ RP+ ++R L
Sbjct: 220 DRHQLPAPKWTELANLINQ---CMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 38/111 (34%), Positives = 53/111 (47%), Gaps = 5/111 (4%)
Query: 76 NNVASVTLSSMNFSGT-LSPRIGVL-RTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 133
+L N + T + P IG+L L L L N I +P L NL +L +LDL
Sbjct: 114 ELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172
Query: 134 NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNL 184
N L +P L NL L L LS N S +P + LS+L + L +N++
Sbjct: 173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSI 221
|
Length = 394 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 32/87 (36%), Positives = 46/87 (52%), Gaps = 7/87 (8%)
Query: 409 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 468
EYLH + II+RD+K N+LLD V DFG AK V R T + GT ++AP
Sbjct: 132 EYLHS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYLAP 184
Query: 469 EYLSTGKSSERTDVFGYGIMLLELVTG 495
E + + + D + G++L E + G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 31/224 (13%)
Query: 287 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFE--SPGGDAAFQREVE 343
R+LQ+ +++ V+G+G FG+V KV A+K L+ FE A F E +
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 344 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 403
+++ A +++L FC ++ L Y + E PG +++ ++ V
Sbjct: 96 IMAFANSPWVVQL--FCAFQDDKYL-----------YMVMEYMPGGDLVNLMSNYDVPEK 142
Query: 404 AAR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455
A+ L+ +H +IHRDVK N+LLD+ + DFG +D
Sbjct: 143 WAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR 199
Query: 456 TTQVRGTMGHIAPEYLST----GKSSERTDVFGYGIMLLELVTG 495
GT +I+PE L + G D + G+ L E++ G
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 31/88 (35%), Positives = 50/88 (56%), Gaps = 4/88 (4%)
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 467
LE LH+ +I+RD+K N+LLD + DFGL KL +++ + T GT ++A
Sbjct: 106 LENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLA 161
Query: 468 PEYLSTGKSSERTDVFGYGIMLLELVTG 495
PE L ++ D + G++L E++TG
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 4e-08
Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 29/215 (13%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHR 351
D + + N + +G +G VYR G VA+K+L + E G RE+ ++ H
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64
Query: 352 NLLRL--IGFCTTPTERLLVYPF--------MQNLSVAYRLREIKPGEPVLDWVTRKRVA 401
N++ + + + + +V + M+ + + E+K +
Sbjct: 65 NIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKC------------LM 112
Query: 402 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 461
L G+ +LH++ I+HRD+K +N+LL+ + DFGLA+ T V
Sbjct: 113 LQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV- 168
Query: 462 TMGHIAPE-YLSTGKSSERTDVFGYGIMLLELVTG 495
T+ + APE L + S D++ G + EL+T
Sbjct: 169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 5e-08
Identities = 33/89 (37%), Positives = 47/89 (52%), Gaps = 7/89 (7%)
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 467
EYLH II+RD+K N+LLD + + DFG AK + T GT ++A
Sbjct: 106 FEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG--QKTWTFCGTPEYVA 160
Query: 468 PEYLSTGKSSERT-DVFGYGIMLLELVTG 495
PE + K + + D + GI+L EL+TG
Sbjct: 161 PEIIL-NKGYDFSVDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 51/208 (24%), Positives = 101/208 (48%), Gaps = 13/208 (6%)
Query: 290 QLATDNFSEKNVLGQGGFGKVYRGVLAD--GTK--VAVKRLTDFESPGGDAAFQREVEMI 345
++ ++ + +G+G FG VY+GV K VAVK + SP F +E ++
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61
Query: 346 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE-IKPGEPVLDWVTRKRVALGA 404
H ++++LIG T V+ M+ L+ LR ++ + LD + +
Sbjct: 62 RQFDHPHIVKLIGVITENP----VWIVME-LAPLGELRSYLQVNKYSLDLASLILYSYQL 116
Query: 405 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 464
+ L YL + + +HRD+ A NVL+ +GDFGL++ ++ ++ + +
Sbjct: 117 STALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK 173
Query: 465 HIAPEYLSTGKSSERTDVFGYGIMLLEL 492
+APE ++ + + +DV+ +G+ + E+
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 6e-08
Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 302 LGQGGFGKVY--------------RGVLADGTKV--AVKRLTDFESPGGDAAFQREVEMI 345
L G FGK++ RGV + + + G AA Q E E++
Sbjct: 156 LPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEIL 215
Query: 346 SVAV--HRNLLRLIGFCTTPTERLLV--------YPFMQNLSVAYRLREIKPGEPVLDWV 395
++ H N+L++ + ++ Y FM + + ++ R P+L
Sbjct: 216 ALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDR------PLL-KQ 268
Query: 396 TRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455
TR + +EY+H+ K+IHRD+K N+ L+ D + V+GDFG A + +
Sbjct: 269 TR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF 324
Query: 456 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 494
GT+ +PE L+ E TD++ G++LL++++
Sbjct: 325 DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 68/260 (26%), Positives = 115/260 (44%), Gaps = 27/260 (10%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHR 351
+ + + +G G +G V G +VAVK+L+ F+S RE+ ++ H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 352 NLLRLIGFCTTPT---ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 408
N++ L+ T E VY + +L A +K + D V + + RGL
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVY-LVTHLMGADLNNIVKCQKLTDDHV--QFLIYQILRGL 133
Query: 409 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 468
+Y+H + IIHRD+K +N+ ++ED E + DFGLA+ D T T + AP
Sbjct: 134 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAP 186
Query: 469 E-YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527
E L+ ++ D++ G ++ EL+TG+ + DH+ +L+ RL
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT-----------DHIDQLKLILRLVG 235
Query: 528 IVDRNLNKNYNIQEVETMIQ 547
L K + + IQ
Sbjct: 236 TPGAELLKKISSESARNYIQ 255
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 62/239 (25%), Positives = 98/239 (41%), Gaps = 44/239 (18%)
Query: 281 LKRY-----SWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFES-PG 333
L RY +L++ ++F V+G+G FG+V +V A+K L+ FE
Sbjct: 25 LSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKR 84
Query: 334 GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD 393
D+AF E I + + L Y F Q+ Y + E PG +++
Sbjct: 85 SDSAFFWEERDI-----------MAHANSEWIVQLHYAF-QDDKYLYMVMEYMPGGDLVN 132
Query: 394 WVTRKRVALGAAR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 445
++ + AR L+ +H + IHRDVK N+LLD+ + DFG
Sbjct: 133 LMSNYDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC 189
Query: 446 KLVDVRKTNVTTQVR-----GTMGHIAPEYLST----GKSSERTDVFGYGIMLLELVTG 495
K + VR GT +I+PE L + G D + G+ L E++ G
Sbjct: 190 M-----KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 12/202 (5%)
Query: 298 EKNVLGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLR 355
EK +G+G +G VY+ G VA+K++ + E G + RE+ ++ H N++R
Sbjct: 5 EK--IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVR 62
Query: 356 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 415
L+ + + LV+ F+ +L + + LD K +G+ Y H H
Sbjct: 63 LLDVVHSENKLYLVFEFL-DLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH- 118
Query: 416 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK 475
+++HRD+K N+L+D + + DFGLA+ V T +V T+ + APE L +
Sbjct: 119 --RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSR 175
Query: 476 S-SERTDVFGYGIMLLELVTGQ 496
S D++ G + E+V +
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 38/216 (17%)
Query: 294 DNFSEKNVLGQGGFGKV-YRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
DNF + +G+G G V V + G VAVK++ D EV ++ H N
Sbjct: 23 DNFIK---IGEGSTGIVCIATVKSSGKLVAVKKM-DLRKQQRRELLFNEVVIMRDYQHEN 78
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR--------VALGA 404
++ + E +V F++ G + D VT R V L
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLE-------------GGALTDIVTHTRMNEEQIAAVCLAV 125
Query: 405 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG----LAKLVDVRKTNVTTQVR 460
+ L LH +IHRD+K+ ++LL D + DFG ++K V RK+ V
Sbjct: 126 LKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV----- 177
Query: 461 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
GT +APE +S D++ GIM++E+V G+
Sbjct: 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 53/191 (27%), Positives = 89/191 (46%), Gaps = 20/191 (10%)
Query: 318 GTKVAVKRLTDFESPGGD--AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 375
GT V V R+TD E+ + A Q EV + H N++ TT + ++ PFM
Sbjct: 25 GTLVTV-RITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83
Query: 376 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 435
S L+ P E + + + + GA RGL YLH++ IHR++KA+++L+ D
Sbjct: 84 GSANSLLKTYFP-EGMSEALIGN-ILFGALRGLNYLHQN---GYIHRNIKASHILISGD- 137
Query: 436 EAVVGDFGLAKLVDVRKTNVTTQV--------RGTMGHIAPEYLSTGKS--SERTDVFGY 485
+V GL+ L + + +V + ++PE L + ++D++
Sbjct: 138 -GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSV 196
Query: 486 GIMLLELVTGQ 496
GI EL TG+
Sbjct: 197 GITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 36/119 (30%), Positives = 60/119 (50%), Gaps = 4/119 (3%)
Query: 407 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 466
L YLHE II+RD+K NVLLD + + D+G+ K +R + T+ GT +I
Sbjct: 108 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYI 163
Query: 467 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525
APE L D + G+++ E++ G+ D + D D++ ++ EK++
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 4/94 (4%)
Query: 407 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 466
L +LHE II+RD+K NVLLD D + D+G+ K + + T+ GT +I
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYI 163
Query: 467 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 500
APE L + D + G+++ E++ G+ D
Sbjct: 164 APEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 64/228 (28%), Positives = 99/228 (43%), Gaps = 39/228 (17%)
Query: 287 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFES-PGGDAAFQREVEM 344
R+L++ +++ V+G+G FG+V KV A+K L+ FE D+AF E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE--- 92
Query: 345 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 404
R+++ F +P L Y F Q+ Y + E PG +++ ++ V
Sbjct: 93 -----ERDIM---AFANSPWVVQLFYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW 143
Query: 405 AR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 456
AR L+ +H IHRDVK N+LLD+ + DFG K N
Sbjct: 144 ARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM-----KMNKE 195
Query: 457 TQVR-----GTMGHIAPEYLST----GKSSERTDVFGYGIMLLELVTG 495
VR GT +I+PE L + G D + G+ L E++ G
Sbjct: 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 44/215 (20%)
Query: 301 VLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREV-----EMISVAVHR 351
V+G+G FGKV +LA DG AVK L Q+++ E + R
Sbjct: 2 VIGKGSFGKV---LLAKRKLDGKCYAVKVL------------QKKIVLNRKEQKHIMAER 46
Query: 352 NLLR-------LIG--FCTTPTERL-LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRV 400
N+L L+G + TE+L V F+ + + L RE EP +
Sbjct: 47 NVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP-----RARFY 101
Query: 401 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 460
A A L YLH + I++RD+K N+LLD V+ DFGL K + +++ TT
Sbjct: 102 AAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFC 157
Query: 461 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 495
GT ++APE + D + G +L E++ G
Sbjct: 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 38/223 (17%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 351
D F +G+G +G+VY+ D G VA+K++ D E G RE++++ HR
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66
Query: 352 NLLRLIGFCTTPTERL----------LVYPFM--------QNLSVAYRLREIKP-GEPVL 392
N++ L T + L LV+ +M ++ V + IK + +L
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL 126
Query: 393 DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452
+ GL Y H +HRD+K +N+LL+ + + DFGLA+L + +
Sbjct: 127 E-------------GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170
Query: 453 TNVTTQVRGTMGHIAPE-YLSTGKSSERTDVFGYGIMLLELVT 494
+ T T+ + PE L + DV+ G +L EL T
Sbjct: 171 SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 52/214 (24%), Positives = 90/214 (42%), Gaps = 32/214 (14%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVH 350
D+ +G G FG+V+ A+K + + + E ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 351 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV-TRKRVALGAAR--- 406
++RL F T +R L Y L E PG + ++ R +
Sbjct: 61 PFIIRL--FWTEHDQRFL-----------YMLMEYVPGGELFSYLRNSGRFSNSTGLFYA 107
Query: 407 -----GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 461
LEYLH +I++RD+K N+LLD++ + DFG AK + R T + G
Sbjct: 108 SEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCG 160
Query: 462 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 495
T ++APE + + ++ D + GI++ E++ G
Sbjct: 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 4/102 (3%)
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 467
L +LHE II+RD+K NVLLD + + D+G+ K +R + T+ GT +IA
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIA 164
Query: 468 PEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD 509
PE L D + G+++ E++ G+ D + + D
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD 206
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-07
Identities = 16/38 (42%), Positives = 23/38 (60%), Gaps = 1/38 (2%)
Query: 37 GDALFALRTSLRV-PNNQLRDWNQNQVNPCTWSNVICD 73
DAL A ++SL P+ L WN + +PC+W+ V CD
Sbjct: 5 RDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 2e-07
Identities = 25/60 (41%), Positives = 33/60 (55%)
Query: 125 SLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNL 184
+L SLDL NNRL + L L+ L LS NN + P++ + L SL S+ L NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 61/232 (26%), Positives = 103/232 (44%), Gaps = 35/232 (15%)
Query: 301 VLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL-- 354
+LG+G FGKV +L A G A+K L ++EV + V L
Sbjct: 2 LLGKGTFGKV---ILVREKASGKYYAMKIL------------KKEVIIAKDEVAHTLTES 46
Query: 355 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA-------LGA--A 405
R++ P L Y F + + + + GE ++R+RV GA
Sbjct: 47 RVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFH-LSRERVFSEDRTRFYGAEIV 105
Query: 406 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 465
L+YLH + KI++RD+K N++LD+D + DFGL K + GT +
Sbjct: 106 SALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEY 161
Query: 466 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 517
+APE L D +G G+++ E++ G+ E+ +++L++ +K
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK 213
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGD-AAFQREVEMISVAVHRN 352
++F +G G +G VY+ + ++A ++ E PG D A Q+E+ M+ H N
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE-PGEDFAVVQQEIIMMKDCKHSN 67
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYL 411
++ G + + F S+ P E + +V+R+ + +GL YL
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYL 122
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV----RKTNVTTQVRGTMGHIA 467
H + +HRD+K AN+LL ++ + DFG++ + RK+ + GT +A
Sbjct: 123 H---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-----GTPYWMA 174
Query: 468 PEYLST---GKSSERTDVFGYGIMLLEL 492
PE + G ++ D++ GI +EL
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 26/206 (12%)
Query: 302 LGQGGFGKVYRGVLAD-GTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 359
+G G +G V KVAVK+L+ F+S RE+ ++ H N++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 360 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA--------LGAARGLEYL 411
T T ++N + Y + + G + + V ++++ RGL+Y+
Sbjct: 83 FTPATS-------IENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYI 134
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-Y 470
H + IIHRD+K +NV ++ED E + DFGLA+ D T T + APE
Sbjct: 135 H---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYV----ATRWYRAPEIM 187
Query: 471 LSTGKSSERTDVFGYGIMLLELVTGQ 496
L+ ++ D++ G ++ EL+ G+
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 23/200 (11%)
Query: 302 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGD-AAFQREVEMISVAVHRNLLRLIGFC 360
+G G +G VY+ ++A ++ E PG D + Q+E+ M+ H N++ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLE-PGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 361 TTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 419
+ + + + S+ P E + +V R+ + +GL YLH
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGK--- 127
Query: 420 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR----GTMGHIAPEYLSTGK 475
+HRD+K AN+LL ++ + + DFG+A K T R GT +APE + K
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAA-----KITATIAKRKSFIGTPYWMAPEVAAVEK 182
Query: 476 S---SERTDVFGYGIMLLEL 492
+ ++ D++ GI +EL
Sbjct: 183 NGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 63/217 (29%), Positives = 91/217 (41%), Gaps = 48/217 (22%)
Query: 301 VLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 356
V+G+G FGKV +LA DG+ AVK L ++ E + RN+L
Sbjct: 2 VIGKGSFGKV---LLAKRKSDGSFYAVKVLQK-------KTILKKKEQNHIMAERNVLL- 50
Query: 357 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT---------RKRV------- 400
+ L +PF+ L +++ E VLD+V R+R
Sbjct: 51 ---------KNLKHPFLVGLHYSFQTAE--KLYFVLDYVNGGELFFHLQRERCFLEPRAR 99
Query: 401 --ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 458
A A + YLH II+RD+K N+LLD V+ DFGL K V T+
Sbjct: 100 FYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTST 155
Query: 459 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 495
GT ++APE L D + G +L E++ G
Sbjct: 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 57/238 (23%), Positives = 108/238 (45%), Gaps = 32/238 (13%)
Query: 296 FSEKNVLGQGGFGKVY----RGVLADGTK-------------VAVKRLTDFESPGGDAAF 338
F EK LG+G FG+V+ G+ K VAVK L + + F
Sbjct: 9 FKEK--LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDF 66
Query: 339 QREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD----- 393
+E++++S N++RL+ C T ++ +M+N + L +P E
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 394 --WVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451
+ T +A A G++YL + +HRD+ N L+ +++ + DFG+++ +
Sbjct: 127 ISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL-YS 182
Query: 452 KTNVTTQVRGTMG--HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE 507
Q R + ++ E + GK + +DV+ +G+ L E++T + +S+L +E
Sbjct: 183 GDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 12/199 (6%)
Query: 301 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 359
LG+G + VY+G G VA+K + G RE ++ H N++ L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 360 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 419
T LV+ ++ Y + G L + RGL Y H+ ++
Sbjct: 72 IHTKKTLTLVFEYLDTDLKQYM--DDCGG--GLSMHNVRLFLFQLLRGLAYCHQR---RV 124
Query: 420 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL--STGKSS 477
+HRD+K N+L+ E E + DFGLA+ V + +V T+ + P+ L ST S+
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 478 ERTDVFGYGIMLLELVTGQ 496
D++G G + E+ TG+
Sbjct: 184 S-LDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 301 VLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDAAFQREVEMISVAVHRNLLRLIG 358
V+G+G +G V + G KVA+K++ D FE RE++++ + H +++ +
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 359 FCTTPTERLLVYPFMQNLSVAYRLRE------IKPGEPVLDWVTRKRVAL---GAARGLE 409
P+ R +++ V + L E IK D +T + R L+
Sbjct: 67 IMLPPSRREF-----KDIYVVFELMESDLHQVIKAN----DDLTPEHHQFFLYQLLRALK 117
Query: 410 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK--LVDVRKTNVTTQVRGTMGHIA 467
Y+H + HRD+K N+L + D + + DFGLA+ D T T + A
Sbjct: 118 YIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 468 PEYLST--GKSSERTDVFGYGIMLLELVTGQ 496
PE + K + D++ G + E++TG+
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 49/203 (24%), Positives = 98/203 (48%), Gaps = 23/203 (11%)
Query: 301 VLGQGGFGK--VYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 358
V+G+G FG+ + + V +D K A+K + +S ++E +++ H N+ +
Sbjct: 7 VVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI---VA 62
Query: 359 FCTTPTERLLVYPFMQNLSVAYRLREIK-------PGEPVLDWVTRKRVALGAARGLEYL 411
F + +Y M+ +++IK P + +L W + G++++
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQHI 116
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 471
HE +++HRD+K+ N+ L ++ + +GDFG A+L+ T V GT ++ PE
Sbjct: 117 HEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIW 172
Query: 472 STGKSSERTDVFGYGIMLLELVT 494
+ ++D++ G +L EL T
Sbjct: 173 ENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 20/131 (15%)
Query: 406 RGLEYLHEHCNPKIIHRDVKAANVLLD-EDFEAVVGDFGLAKLVD--------VRKTNVT 456
RGL+Y+H + ++HRD+K ANV ++ ED +GDFGLA++VD + + VT
Sbjct: 125 RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 457 TQVRGTMGHIAPE-YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH 515
R +P LS ++ D++ G + E++TG+ + E E L+L+
Sbjct: 182 KWYR------SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH-ELEQMQLILES 234
Query: 516 VKKLEREKRLD 526
V + E R +
Sbjct: 235 VPVVREEDRNE 245
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 33/118 (27%), Positives = 66/118 (55%), Gaps = 18/118 (15%)
Query: 387 PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446
P + +LDW + +AL +++H+ KI+HRD+K+ N+ L +D +GDFG+A+
Sbjct: 99 PEDQILDWFVQICLAL------KHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIAR 149
Query: 447 L----VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 500
+ V++ +T + GT +++PE + ++D++ G +L E+ T + A +
Sbjct: 150 VLNSTVELARTCI-----GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 7e-07
Identities = 39/166 (23%), Positives = 75/166 (45%), Gaps = 30/166 (18%)
Query: 303 GQGGFGKVYRGVL---ADGTKVAVKRLTDFESP-----GGDAAFQREVEMISVAVHRNLL 354
G+G +G+VY+ DG + A+K+ F+ G + RE+ ++ H N++
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKK---FKGDKEQYTGISQSACREIALLRELKHENVV 65
Query: 355 RLIGFCTTPTERL--LVYPFMQNLSVAYRLREI-----KPGEPVLDWVTRKRVALGAARG 407
L+ ++ L++ + + + L +I + + K + G
Sbjct: 66 SLVEVFLEHADKSVYLLFDYAE-----HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 408 LEYLHEHCNPKIIHRDVKAANVLL--DEDFEAVV--GDFGLAKLVD 449
+ YLH + ++HRD+K AN+L+ + VV GD GLA+L +
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 48/183 (26%), Positives = 83/183 (45%), Gaps = 18/183 (9%)
Query: 318 GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS 377
G +VAVK + D EV ++ H+N++ + E ++ F+Q +
Sbjct: 46 GRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 378 VAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA 437
+ + + + E + V + L YLH +IHRD+K+ ++LL D
Sbjct: 105 LTDIVSQTRLNEEQI-----ATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRV 156
Query: 438 VVGDFG----LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 493
+ DFG ++K V RK+ V GT +APE +S D++ GIM++E+V
Sbjct: 157 KLSDFGFCAQISKDVPKRKSLV-----GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211
Query: 494 TGQ 496
G+
Sbjct: 212 DGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 48/183 (26%), Positives = 90/183 (49%), Gaps = 15/183 (8%)
Query: 318 GTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL 376
G VAVK+L+ F++ RE+ ++ H+N++ L+ TP + L + Q++
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLN-VFTPQKSLEEF---QDV 101
Query: 377 SVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDE 433
+ L + + + + +R++ + G+++LH + IIHRD+K +N+++
Sbjct: 102 YLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKS 158
Query: 434 DFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLEL 492
D + DFGLA+ TN + T T + APE + E D++ G ++ EL
Sbjct: 159 DCTLKILDFGLARTA---CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215
Query: 493 VTG 495
V G
Sbjct: 216 VKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 60/247 (24%), Positives = 117/247 (47%), Gaps = 59/247 (23%)
Query: 272 VDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLAD---GTKVAVKRLTD 328
+D+ I L++Y E+ LG+G +G V++ + D VA+K++ D
Sbjct: 1 IDKHI----LRKY---EIL---------QKLGKGAYGIVWKAI--DRRTKEVVALKKIFD 42
Query: 329 FESPGGDAAFQ---------REVEMIS-VAVHRNLLRLIGFCTTPTER--LLVYPFMQ-N 375
AF+ RE+ + + H N+++L+ ++ LV+ +M+ +
Sbjct: 43 --------AFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETD 94
Query: 376 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 435
L I+ +L+ V ++ + + L+Y+H + +IHRD+K +N+LL+ D
Sbjct: 95 LHAV-----IRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDC 144
Query: 436 EAVVGDFGLAKLV----DVRKTNVTTQVRGTMGHIAPEYL--STGKSSERTDVFGYGIML 489
+ DFGLA+ + + + V T T + APE L ST + ++ D++ G +L
Sbjct: 145 RVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGST-RYTKGVDMWSVGCIL 203
Query: 490 LELVTGQ 496
E++ G+
Sbjct: 204 GEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 9/94 (9%)
Query: 406 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 465
RGL+Y+H + ++HRD+K +N+LL+ + + + DFGLA+ + +T V T +
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174
Query: 466 IAPEYLSTGKSSERT---DVFGYGIMLLELVTGQ 496
APE L SE T DV+ G + EL+ +
Sbjct: 175 RAPELLLN--CSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 40/143 (27%), Positives = 66/143 (46%), Gaps = 20/143 (13%)
Query: 370 YPFMQNLSVAYRLR-------EIKPGEPVLDWVTRKRVA-------LGA--ARGLEYLHE 413
+PF+ L A++ E G + ++R+RV GA LEYLH
Sbjct: 54 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 113
Query: 414 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 473
+++RD+K N++LD+D + DFGL K + T GT ++APE L
Sbjct: 114 R---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLED 169
Query: 474 GKSSERTDVFGYGIMLLELVTGQ 496
D +G G+++ E++ G+
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 302 LGQGGFGKVYRG-VLADGTKVAVKRLTD-FESPGGDAAFQREVE-MISVAVHRNLLRLIG 358
+G+G F +V + G A+K + F+S RE++ + ++ H N+LRLI
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRLIE 65
Query: 359 FC-TTPTERL-LVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 415
T RL LV+ M NL Y L IK + L K + L+++H +
Sbjct: 66 VLFDRKTGRLALVFELMDMNL---YEL--IKGRKRPLPEKRVKSYMYQLLKSLDHMHRN- 119
Query: 416 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTG 474
I HRD+K N+L+ +D + DFG + + + T+ T + APE L+ G
Sbjct: 120 --GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPP--YTEYISTRWYRAPECLLTDG 174
Query: 475 KSSERTDVFGYGIMLLELVT 494
+ D++ G + E+++
Sbjct: 175 YYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 42/144 (29%), Positives = 72/144 (50%), Gaps = 17/144 (11%)
Query: 358 GFCTTPTERLL-VYPFMQNLSVAYRLREIKPGEPV--LDWVTRKRVALGAARGLEYL-HE 413
GF + ++ + + P + S + ++ + E LD R + A+G+++L +
Sbjct: 172 GFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK 231
Query: 414 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD-----VRKTNVTTQVRGTMGHIAP 468
+C IHRDV A NVLL + A + DFGLA+ + V K N V+ +AP
Sbjct: 232 NC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK----WMAP 283
Query: 469 EYLSTGKSSERTDVFGYGIMLLEL 492
E + + ++DV+ YGI+L E+
Sbjct: 284 ESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 62/208 (29%), Positives = 90/208 (43%), Gaps = 30/208 (14%)
Query: 301 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR---- 355
V+G+G FGKV A+ AVK L A ++ E + RN+L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQK-------KAILKKKEEKHIMSERNVLLKNVK 54
Query: 356 ---LIG--FCTTPTERL-LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRV-ALGAARG 407
L+G F ++L V ++ + Y L RE EP R R A A
Sbjct: 55 HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP------RARFYAAEIASA 108
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 467
L YLH + I++RD+K N+LLD V+ DFGL K ++ T+ GT ++A
Sbjct: 109 LGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLA 164
Query: 468 PEYLSTGKSSERTDVFGYGIMLLELVTG 495
PE L D + G +L E++ G
Sbjct: 165 PEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 15/207 (7%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHR 351
D + + +G+G +G VY+ +A+K++ + E G + RE+ ++ H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 352 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR--KRVALGAARGLE 409
N++RL + LV+ ++ L++ P R K RG+
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLD-----LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 410 YLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 468
Y H H +++HRD+K N+L+D A+ + DFGLA+ + T +V T+ + AP
Sbjct: 117 YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAP 172
Query: 469 EYLSTGKS-SERTDVFGYGIMLLELVT 494
E L + S D++ G + E+V
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 46/249 (18%), Positives = 111/249 (44%), Gaps = 28/249 (11%)
Query: 310 VYRGVLADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 367
+Y+G+ + +V ++ F + E++ + N+L++ GF + L
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAA 427
+ LRE+ E L + T+ +A+ +GL L+++ N ++++ +
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSV 152
Query: 428 NVLLDEDFEAVVGDFGLAKLVDV---RKTNVTTQVRGTMGHIAPEYLST--GKSSERTDV 482
+ L+ E+++ + GL K++ + N M + + + L+ + + + D+
Sbjct: 153 SFLVTENYKLKIICHGLEKILSSPPFKNVN-------FMVYFSYKMLNDIFSEYTIKDDI 205
Query: 483 FGYGIMLLELVTGQRAIDFSRLEEED--DVLLLDHVK-KLERE--KRLDAIVDRNLNKNY 537
+ G++L E+ TG+ I F L ++ D+++ + KL + + IV+ + +
Sbjct: 206 YSLGVVLWEIFTGK--IPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDS 263
Query: 538 ----NIQEV 542
NI+E+
Sbjct: 264 IKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTNVTTQVRGTMGHI 466
L+ +H ++HRD+K+AN+ L +GDFG +K D +V + GT ++
Sbjct: 182 LDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238
Query: 467 APEYLSTGKSSERTDVFGYGIMLLELVTGQR 497
APE + S++ D++ G++L EL+T R
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 28/90 (31%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 407 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 466
L+YLH N +++RD+K N++LD+D + DFGL K ++ GT ++
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYL 163
Query: 467 APEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
APE L D +G G+++ E++ G+
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 26/207 (12%)
Query: 302 LGQGGFGKVYRGVL-ADGTKVAVKRLTDFE------SPGG--DAAFQREVEMISVAVHRN 352
LGQG F +Y+GVL V + AF ++S H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 412
L++L G C E ++V +++ + L + L W + VA A L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHR-EKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 413 EHCNPKIIHRDVKAANVLL--DEDFEAVVGDFGLAKLVD--VRKTNVTTQVR-GTMGHIA 467
+ K++H +V N+L+ E V KL D + T ++ + R + IA
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPF---IKLSDPGIPITVLSREERVERIPWIA 172
Query: 468 PEYLSTGKSSERT--DVFGYGIMLLEL 492
PE + G++S D + +G LLE+
Sbjct: 173 PECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 41/152 (26%), Positives = 66/152 (43%), Gaps = 16/152 (10%)
Query: 45 TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVT--------LSSMNFSGTLSPRI 96
+L + N L D + N +N+ N ++ + L ++ S +
Sbjct: 166 KNLDLSFNDLSDLPKLLSNLSNLNNLDLSG-NKISDLPPEIELLSALEELDLSNNSIIEL 224
Query: 97 ----GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQF 152
L+ LS L L N + ++PE +GNLS+L +LDL NN++ SLG+L L+
Sbjct: 225 LSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQI--SSISSLGSLTNLRE 281
Query: 153 LTLSQNNFSGTIPDSLTTLSSLISIQLDSNNL 184
L LS N+ S +P L L + L
Sbjct: 282 LDLSGNSLSNALPLIALLLLLLELLLNLLLTL 313
|
Length = 394 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 3e-06
Identities = 22/60 (36%), Positives = 28/60 (46%), Gaps = 2/60 (3%)
Query: 102 LSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNF 160
L +L L N +T IP+ L +L LDL N L P + L L+ L LS NN
Sbjct: 2 LKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 4/89 (4%)
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 467
LE+LH+ II+RD+K N+LLD + DFGL K + + VT GT+ ++A
Sbjct: 113 LEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHTFCGTIEYMA 168
Query: 468 PEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
PE L + D + G ++ +++TG
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLTGA 197
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 25/217 (11%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
+F K+++G+G FG+V A G A+K + + E E R+
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEE-------RD 53
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 412
+L + +P L Y F ++ Y + E +PG +L + R YL
Sbjct: 54 ILSI---SNSPWIPQLQYAFQDKDNL-YLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA 109
Query: 413 E-----HCNPKI--IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 465
E H ++ +HRD+K NVL+D + DFG A + K + GT +
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDY 169
Query: 466 IAPEYLST----GKSSE--RTDVFGYGIMLLELVTGQ 496
IAPE L+T GK + D + G++ E++ G+
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 53/221 (23%), Positives = 97/221 (43%), Gaps = 31/221 (14%)
Query: 290 QLATDNFSE---KNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMI 345
A + SE N +G G G VY+ + G A+K + RE+E++
Sbjct: 67 PSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEIL 126
Query: 346 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV-AYRLREIKPGEPVLDWVTRKRVALGA 404
H N+++ E ++ FM S+ + + E L V R+ ++
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD----EQFLADVARQILS--- 179
Query: 405 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG----LAKLVDVRKTNVTTQVR 460
G+ YLH I+HRD+K +N+L++ + DFG LA+ +D ++V
Sbjct: 180 --GIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV----- 229
Query: 461 GTMGHIAPEYLSTGKSSER-----TDVFGYGIMLLELVTGQ 496
GT+ +++PE ++T + D++ G+ +LE G+
Sbjct: 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 3e-05
Identities = 44/198 (22%), Positives = 81/198 (40%), Gaps = 40/198 (20%)
Query: 350 HRNLLRLIGFCTTPTERLLV---------YPFMQNLSVAYRLREIKPGEPVLDWVTRKRV 400
+ N ++L TT +L+ + ++ E L K++
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK-------------EGKLSEAEVKKI 114
Query: 401 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQV 459
L LH+H IIH D+K NVL D + + + D+GL K++ T
Sbjct: 115 IRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG------TPSC 165
Query: 460 -RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 518
GT+ + +PE + D + G++ EL+TG+ E+ED+ L ++
Sbjct: 166 YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK----EDEDEEL---DLES 218
Query: 519 LEREKRLDAIVDRNLNKN 536
L + ++ +N++KN
Sbjct: 219 LLKRQQKKLPFIKNVSKN 236
|
Length = 267 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 36/126 (28%), Positives = 59/126 (46%), Gaps = 10/126 (7%)
Query: 368 LVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKA 426
LV P ++ Y ++P G + V R+ L A ++Y+H IIHRD+K
Sbjct: 237 LVLPKYRSDLYTYLGARLRPLGLAQVTAVARQ--LLSA---IDYIHGE---GIIHRDIKT 288
Query: 427 ANVLLDEDFEAVVGDFGLAKLVD-VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGY 485
NVL++ + +GDFG A T + GT+ APE L+ + D++
Sbjct: 289 ENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSA 348
Query: 486 GIMLLE 491
G+++ E
Sbjct: 349 GLVIFE 354
|
Length = 461 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 10/92 (10%)
Query: 405 ARGLEYL-HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN---VTTQVR 460
A+G+ +L ++C IHRD+ A N+LL + DFGLA+ D+R + V R
Sbjct: 224 AKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLAR--DIRNDSNYVVKGNAR 277
Query: 461 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLEL 492
+ +APE + + +DV+ YGI+L E+
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 33/110 (30%), Positives = 60/110 (54%), Gaps = 12/110 (10%)
Query: 390 PVLDWVTRKRVALGAARGLEYL-HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448
P L ++ + A G+E+L ++C +HRD+ A NVL+ E + DFGLA+ +
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDI 289
Query: 449 DVRKTNVTTQVRGT----MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 494
+R +N + +G+ + +APE + + +DV+ +GI+L E+ T
Sbjct: 290 -MRDSNYIS--KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 7e-05
Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 51/223 (22%)
Query: 302 LGQGGFGKV----YRGVLADGTKVAVKRLTDFESPGGDAAFQ---------REVE-MISV 347
LGQG +G V ++ VA+K++T+ F RE++ +
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKITN--------VFSKKILAKRALRELKLLRHF 58
Query: 348 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA-- 405
H+N+ L + F N + Y E E L + R L A
Sbjct: 59 RGHKNITCLYD---------MDIVFPGNFNELYLYEE--LMEADLHQIIRSGQPLTDAHF 107
Query: 406 --------RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT- 456
GL+Y+H + ++HRD+K N+L++ D E + DFGLA+
Sbjct: 108 QSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG 164
Query: 457 --TQVRGTMGHIAPE-YLSTGKSSERTDVFGYGIMLLELVTGQ 496
T+ T + APE LS ++ DV+ G +L EL+ +
Sbjct: 165 FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 65/304 (21%), Positives = 114/304 (37%), Gaps = 62/304 (20%)
Query: 302 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGD--AAFQREVEMISVAVHRNLLRLIGF 359
+ + T VAVK+ + +S + Q+E+ H N+L +
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKK-INLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 360 CTTPTERLLVYPFMQNLSVAYRLREIKPG---EPVLDWVTRKRVALGAARGLEYLH-EHC 415
+E +V P M S L+ P E + ++ + L+Y+H +
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK-----DVLNALDYIHSKGF 122
Query: 416 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-----RKTNVTTQVRGTMGHI---A 467
IHR VKA+++LL D + V+ GL V + R+ V + ++ ++ +
Sbjct: 123 ----IHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLS 176
Query: 468 PEYLSTGKS--SERTDVFGYGI-------------------MLLELVTG--QRAIDFSRL 504
PE L +E++D++ GI MLLE V G +D S
Sbjct: 177 PEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTY 236
Query: 505 EEEDDVLLLDHVKKLERE---KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP 561
+D + E +D R +++++ Q LC Q PE RP
Sbjct: 237 PLYEDSMS-QSRSSNEHPNNRDSVDHPYTRTFSEHFH--------QFVELCLQRDPESRP 287
Query: 562 AMSE 565
+ S+
Sbjct: 288 SASQ 291
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 34/103 (33%), Positives = 49/103 (47%), Gaps = 19/103 (18%)
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL---------------VDVRK 452
LEYLH N I+HRD+K N+L+ + DFGL+K+ D R+
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 495
+ QV GT +IAPE + + D + GI+L E + G
Sbjct: 171 F-LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 47/208 (22%), Positives = 90/208 (43%), Gaps = 16/208 (7%)
Query: 302 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 361
+G+G +G VY+ DG L E G + RE+ ++ H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 362 TPTER--LLVYPFMQN----LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 415
+ ++R L++ + ++ + +R + L K + G+ YLH +
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128
Query: 416 NPKIIHRDVKAANVLL----DEDFEAVVGDFGLAKLVD--VRKTNVTTQVRGTMGHIAPE 469
++HRD+K AN+L+ E + D G A+L + ++ V T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 470 YLSTGKS-SERTDVFGYGIMLLELVTGQ 496
L + ++ D++ G + EL+T +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 53/220 (24%), Positives = 98/220 (44%), Gaps = 24/220 (10%)
Query: 278 FGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDA 336
F LKRY N QG Y VL VA+K+L+ F++
Sbjct: 13 FTVLKRYQ---------NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAK 61
Query: 337 AFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT 396
RE+ ++ H+N++ L+ TP + L + Q++ + L + + + +
Sbjct: 62 RAYRELVLMKCVNHKNIISLLN-VFTPQKSLEEF---QDVYLVMELMDANLCQVIQMELD 117
Query: 397 RKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 453
+R++ + G+++LH + IIHRD+K +N+++ D + DFGLA+ +
Sbjct: 118 HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--S 172
Query: 454 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 493
+ T T + APE + E D++ G ++ E+V
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 52/223 (23%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 278 FGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDA 336
F LKRY N QG Y +L VA+K+L+ F++
Sbjct: 20 FTVLKRYQ---------NLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAK 68
Query: 337 AFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT 396
RE+ ++ H+N++ L+ TP + L + Q++ + L + + + +
Sbjct: 69 RAYRELVLMKCVNHKNIIGLLN-VFTPQKSLEEF---QDVYIVMELMDANLCQVIQMELD 124
Query: 397 RKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 453
+R++ + G+++LH + IIHRD+K +N+++ D + DFGLA+ +
Sbjct: 125 HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--S 179
Query: 454 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
+ T T + APE + E D++ G ++ E++ G
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 8/93 (8%)
Query: 405 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT-- 462
ARG+E+L + +HRD+ A NVLL + + DFGLA+ D+ + T
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR--DIMHDSNYVSKGSTFL 301
Query: 463 -MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 494
+ +APE + + +DV+ YGI+L E+ +
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 41/152 (26%), Positives = 61/152 (40%), Gaps = 48/152 (31%)
Query: 380 YRLREIKPGEPVLDWVTRKRVALGAAR--------GLEYLHEHCNPKIIHRDVKAANVLL 431
+RL + +PG K ++ AR LEYLH I++RD+K N+LL
Sbjct: 89 FRLLQRQPG---------KCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILL 136
Query: 432 DEDFEAVVGDFGLAKLVDVRKTNVTTQVR----------------------------GTM 463
E ++ DF L+K DV V+ +R GT
Sbjct: 137 HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTE 196
Query: 464 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 495
+IAPE +S D + GI+L E++ G
Sbjct: 197 EYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 63/217 (29%), Positives = 91/217 (41%), Gaps = 32/217 (14%)
Query: 302 LGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 360
+GQGG+G+V+ D G VA+KR+ + + E+ V R++L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKK-------SLLFKLNEVRHVLTERDIL-----T 56
Query: 361 TTPTERL--LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV-ALGAAR--------GLE 409
TT +E L L+Y F Q+ Y E PG + V + AR ++
Sbjct: 57 TTKSEWLVKLLYAF-QDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVD 115
Query: 410 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 469
LHE IHRD+K N L+D + DFGL+K + V N V G+ ++APE
Sbjct: 116 ALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGI-VTYAN---SVVGSPDYMAPE 168
Query: 470 YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE 506
L D + G ML E + G S E
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 6e-04
Identities = 47/208 (22%), Positives = 89/208 (42%), Gaps = 16/208 (7%)
Query: 302 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 361
+G+G +G VY+ DG L E G + RE+ ++ H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 362 TPTER--LLVYPFMQN----LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 415
+ +R L++ + ++ + +R + L K + G+ YLH +
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128
Query: 416 NPKIIHRDVKAANVLL----DEDFEAVVGDFGLAKLVD--VRKTNVTTQVRGTMGHIAPE 469
++HRD+K AN+L+ E + D G A+L + ++ V T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 470 YLSTGKS-SERTDVFGYGIMLLELVTGQ 496
L + ++ D++ G + EL+T +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 7e-04
Identities = 45/167 (26%), Positives = 70/167 (41%), Gaps = 41/167 (24%)
Query: 304 QGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMIS------VAVHRNLLRL 356
+G FGKVY G + +K+ AVK + ++ +MI+ V R+ L L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVV-------------KKADMINKNMVHQVQAERDALAL 60
Query: 357 IG--FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPV---------LDWVTRKRVALGAA 405
F +Y +Q+ + Y + E G V D + A
Sbjct: 61 SKSPFIVH------LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVA 114
Query: 406 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452
L+YLH H IIHRD+K N+L+ + + DFGL+K V + +
Sbjct: 115 LALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK-VTLNR 157
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.001
Identities = 26/93 (27%), Positives = 46/93 (49%), Gaps = 11/93 (11%)
Query: 407 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG---TM 463
G+++LH + IIHRD+K +N+++ D + DFGLA R + + T
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA-----RTAGTSFMMTPYVVTR 181
Query: 464 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
+ APE + E D++ G ++ E++ G
Sbjct: 182 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 50/206 (24%), Positives = 94/206 (45%), Gaps = 11/206 (5%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLADGTK-VAVKRLTDFE-SPGGDAAFQREVEMISVAVHR 351
+ F V+G+G +G V + + + VA+K+ D E + RE++M+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 352 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 411
N++ L + LV+ +++ ++ L E+ G P + V + + + +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPP-EKV--RSYIYQLIKAIHWC 116
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTNVTTQVRGTMGHIAPEY 470
H++ I+HRD+K N+L+ + + DFG A+ L + N T V T + +PE
Sbjct: 117 HKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPEL 172
Query: 471 LSTGKSSERTDVFGYGIMLLELVTGQ 496
L + D++ G +L EL GQ
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 28/218 (12%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFE--SPGGDAAFQREVEMISVAVH 350
D+F V+G+G FG+V + ++ A+K L +E A F+ E
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREE--------- 51
Query: 351 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 410
RN+L + G C T L Y F Q+ + Y + + G +L +++ L Y
Sbjct: 52 RNVL-VNGDCQWITT--LHYAF-QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY 107
Query: 411 LHEHC-------NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 463
+ E +HRD+K NVLLD + + DFG ++ T ++ GT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTP 167
Query: 464 GHIAPEYLST-----GKSSERTDVFGYGIMLLELVTGQ 496
+I+PE L GK D + G+ + E++ G+
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 50/215 (23%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFE--SPGGDAAFQREVEMISVAVH 350
++F V+G+G FG+V L + KV A+K L +E A F+ E +++ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 351 RNLLRLIGFCTTPTERLLVYPFMQN---LSVAYRLREIKPGEPVLDWVTRKRVALGAARG 407
+ + L LV + L++ + + P + ++ +A+ +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG-LAKLVDVRKTNVTTQVRGTMGHI 466
L Y +HRD+K N+L+D + + DFG KL++ + V GT +I
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYI 170
Query: 467 APEYLST-----GKSSERTDVFGYGIMLLELVTGQ 496
+PE L GK D + G+ + E++ G+
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 45/164 (27%), Positives = 72/164 (43%), Gaps = 28/164 (17%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV--LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 351
++F V+G+G FG+V R V G A+K L E F+++ ++ V R
Sbjct: 1 EDFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSE------MFKKD-QLAHVKAER 52
Query: 352 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW----------VTRKRVA 401
++L +P L Y F Q+ Y + E PG ++ VTR +A
Sbjct: 53 DVL---AESDSPWVVSLYYSF-QDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA 108
Query: 402 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 445
+E +H+ IHRD+K N+L+D + DFGL+
Sbjct: 109 -ECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 35.2 bits (82), Expect = 0.003
Identities = 16/37 (43%), Positives = 23/37 (62%), Gaps = 2/37 (5%)
Query: 125 SLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFS 161
+L +LDL NN++ +PP L NL L+ L LS N +
Sbjct: 2 NLETLDLSNNQIT-DLPP-LSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 30/131 (22%), Positives = 47/131 (35%), Gaps = 45/131 (34%)
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL----------------------- 444
+E +H IHRD+K N+L+D D + DFGL
Sbjct: 114 IESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170
Query: 445 ------------AKLVDVRKTNVTTQVR-------GTMGHIAPEYLSTGKSSERTDVFGY 485
+L + + R GT +IAPE L ++ D +
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230
Query: 486 GIMLLELVTGQ 496
G++L E++ GQ
Sbjct: 231 GVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 619 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.84 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.52 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.5 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.47 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.46 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.39 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.38 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.31 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.29 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.28 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.28 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.27 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.26 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.24 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.22 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.17 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.17 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.17 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.15 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.07 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.03 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.03 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.99 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.93 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.93 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.92 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.92 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.91 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.9 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.88 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.87 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.87 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.87 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.85 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.82 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.82 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.8 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.77 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.75 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.74 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.74 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.69 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.67 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.64 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.61 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.6 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.58 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.57 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.57 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.56 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.52 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.43 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.41 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.35 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.34 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.27 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.22 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.22 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.19 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.17 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.16 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-60 Score=559.94 Aligned_cols=467 Identities=28% Similarity=0.504 Sum_probs=344.8
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
.+|+.|+|++|++++.+|..+..+++|+.|+|++|++++.+|..+.++++|++|+|++|.++|.+|..|.++++|+.|+|
T Consensus 475 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 554 (968)
T PLN00113 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDL 554 (968)
T ss_pred ccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEEC
Confidence 46888899999998888888888999999999999999889988999999999999999999899999999999999999
Q ss_pred cCCcCCCCCCCccccccccccccCCCCcccccCCc--cccccCccccCCCCCCCCCCCC---CCCCCCCCCCCCCCCCcc
Q 007073 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV--HLFQIPKYNFTGNNLNCGKTLP---HSCESSSNDSGSSKKPKI 230 (619)
Q Consensus 156 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~l~~l~~l~~~~n~~~c~~~~~---~~c~~~~~~~~~~~~~~~ 230 (619)
++|+++|.+|..+..+++|+.|++++|+++|.+|. .+..+....+.||+..|+.+.. .+|... . .....
T Consensus 555 s~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~-----~-~~~~~ 628 (968)
T PLN00113 555 SQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV-----R-KTPSW 628 (968)
T ss_pred CCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccc-----c-cccee
Confidence 99999988999888899999999999999988884 3456666778899988876532 233211 1 11122
Q ss_pred eEEE-eeeechhhhhhcceeeeeecccccCccccccccccccchhh-hhcCcccccCHHHHHHHhcCCcccCccccCCCc
Q 007073 231 GIIV-GIVGGLIVLISGGLLFFLCKGRHKGYKREVFVDVAGEVDRR-IAFGQLKRYSWRELQLATDNFSEKNVLGQGGFG 308 (619)
Q Consensus 231 ~~i~-~i~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~el~~~~~~~~~~~~lg~G~fg 308 (619)
.+++ +++++++++++++++++++++|++...+... ...+..... ........+.+++ ....|...++||+|+||
T Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ig~G~~g 704 (968)
T PLN00113 629 WFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVE-NEDGTWELQFFDSKVSKSITIND---ILSSLKEENVISRGKKG 704 (968)
T ss_pred eeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccc-cccccccccccccccchhhhHHH---HHhhCCcccEEccCCCe
Confidence 2222 2222222222222222222222211111110 000000000 0000011222333 33467778899999999
Q ss_pred eEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccchhhhhhcccCC
Q 007073 309 KVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP 387 (619)
Q Consensus 309 ~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~ 387 (619)
.||+|.. .+|..||||++..... ....|++++++++|||||+++|+|..++..++||||+++|+|.++++.
T Consensus 705 ~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--- 776 (968)
T PLN00113 705 ASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--- 776 (968)
T ss_pred eEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc---
Confidence 9999997 4789999999864322 123468889999999999999999999999999999999999999964
Q ss_pred CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcceeeeccccccccc
Q 007073 388 GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 467 (619)
Q Consensus 388 ~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~a 467 (619)
++|..+.+++.|+|+||+|||+.+.++|+||||||+||+++.++.+++. ||.+...... ....||+.|+|
T Consensus 777 ----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~a 846 (968)
T PLN00113 777 ----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVA 846 (968)
T ss_pred ----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccC
Confidence 7899999999999999999997777799999999999999999888875 6655432211 12357899999
Q ss_pred cccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccC--CCCHHHHHHH
Q 007073 468 PEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK--NYNIQEVETM 545 (619)
Q Consensus 468 PE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~--~~~~~~~~~l 545 (619)
||++.+..++.++|||||||++|||+||+.||+.... ......+|............+.++.+.. .....+..++
T Consensus 847 PE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (968)
T PLN00113 847 PETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG---VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEV 923 (968)
T ss_pred cccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC---CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHH
Confidence 9999999999999999999999999999999864322 2234555655544444455555655433 2345667789
Q ss_pred HHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 546 IQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 546 ~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.+++.+||+.||++||||.||++.|++.
T Consensus 924 ~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 924 MNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred HHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 9999999999999999999999999875
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-55 Score=455.52 Aligned_cols=289 Identities=51% Similarity=0.846 Sum_probs=253.7
Q ss_pred cccccCHHHHHHHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeee
Q 007073 280 QLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 359 (619)
Q Consensus 280 ~~~~~~~~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 359 (619)
....|+++++..+|++|...++||+|+||.||+|...+|+.||||++....... ..+|.+|++++.+++|||+|+|+||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 467799999999999999999999999999999999999999999887544333 6679999999999999999999999
Q ss_pred eeCCCc-ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 007073 360 CTTPTE-RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV 438 (619)
Q Consensus 360 ~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 438 (619)
|.+.++ .+||||||++|+|.++|+..... .++|.+|.+||.++|+||+|||+.+.|+||||||||+|||+|+++++|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 999984 99999999999999999985443 789999999999999999999999999999999999999999999999
Q ss_pred EcccccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH
Q 007073 439 VGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 518 (619)
Q Consensus 439 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 518 (619)
|+|||+|+..........+...||.+|+|||++..+..|+|+|||||||+++|++||+.|.+.... .....+.+|...
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~--~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP--RGELSLVEWAKP 295 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC--cccccHHHHHHH
Confidence 999999975543122222211799999999999999999999999999999999999999886542 223348889888
Q ss_pred Hhhhcccchhcccccc-CCCCH-HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 519 LEREKRLDAIVDRNLN-KNYNI-QEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 519 ~~~~~~~~~~~~~~l~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
......+.+++|+.+. ..+.. .....+..++.+|++.+|++||+|.||+++|+..
T Consensus 296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 8888899999999987 55554 6888899999999999999999999999999653
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-49 Score=402.30 Aligned_cols=255 Identities=33% Similarity=0.504 Sum_probs=211.1
Q ss_pred CcccCccccCCCceEEEEEeCCCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCC-cceeEeccc
Q 007073 296 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT-ERLLVYPFM 373 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e~~ 373 (619)
+...+.||+|+||+||+|.+.....||||++.... .....++|.+|+.++.+++|||||+++|+|.++. ..++|||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 33445699999999999999744449999997543 2222679999999999999999999999999988 799999999
Q ss_pred ccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCcEEeCCCC-cEEEcccccceeeccC
Q 007073 374 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK-IIHRDVKAANVLLDEDF-EAVVGDFGLAKLVDVR 451 (619)
Q Consensus 374 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~ 451 (619)
++|+|.++++.. ....+++..+.+++.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++.....
T Consensus 123 ~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 123 PGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 999999999875 345699999999999999999999999 7 99999999999999997 9999999999876543
Q ss_pred Ccceeeecccccccccccccc--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLS--TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
. ...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||..... .+... .+.
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--------~~~~~---------~v~ 259 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--------VQVAS---------AVV 259 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--------HHHHH---------HHH
Confidence 2 2333467999999999999 66899999999999999999999999975332 01111 122
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
....+...+......+..++.+||+.||+.||++.+++..|+..
T Consensus 260 ~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 260 VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 22223333444667899999999999999999999999999864
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-49 Score=399.34 Aligned_cols=259 Identities=30% Similarity=0.446 Sum_probs=220.8
Q ss_pred HHHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
+...+.+...+.||+|.||.||.|.++....||+|.++.. ....++|.+|+++|++++|+|||+++|+|..++..+||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~--~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG--SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc--ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 3444445567889999999999999987779999999754 33467899999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
||||+.|+|.++|+. .++..+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||+|+...
T Consensus 280 tE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred EEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccC
Confidence 999999999999997 3456689999999999999999999999 99999999999999999999999999999665
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
.+.........-...|.|||.+..+.++.|||||||||+||||+| |+.|+... ...+.+..+.+..++.
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m--------sn~ev~~~le~GyRlp-- 424 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM--------SNEEVLELLERGYRLP-- 424 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC--------CHHHHHHHHhccCcCC--
Confidence 544444444445779999999999999999999999999999999 77776532 2334455555555553
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.+..++..++++|..||+.+|++||||+.+...|++.
T Consensus 425 --------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 425 --------RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred --------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 2455678899999999999999999999999988874
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=369.83 Aligned_cols=250 Identities=25% Similarity=0.370 Sum_probs=210.2
Q ss_pred CcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCc-ceeEeccc
Q 007073 296 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE-RLLVYPFM 373 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~lv~e~~ 373 (619)
++..+.||+|..|+||++.++ +++.+|+|.++....+...++..+|++++++.+||+||.++|.|..+.. ..++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 344678999999999999986 6889999999766666778899999999999999999999999999884 99999999
Q ss_pred ccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 374 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 374 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
.+|+|+..+... ..+++....+|+.++.+||.|||+ + +||||||||+|||++..|++||+|||.++.+...
T Consensus 161 DgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 161 DGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred CCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 999999999875 338999999999999999999996 6 9999999999999999999999999999876543
Q ss_pred cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
....++||..|||||.+++..|+.++||||||+.++|+.+|+.|+......... ..+. +..+++..
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~---~~~L---------l~~Iv~~p 298 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD---IFEL---------LCAIVDEP 298 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC---HHHH---------HHHHhcCC
Confidence 445678999999999999999999999999999999999999999764221111 1111 12233321
Q ss_pred ccCCCCH-HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 533 LNKNYNI-QEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 533 l~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. +..+. .++.++.+++..|+++||.+||++.|+++
T Consensus 299 p-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 299 P-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred C-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 11222 36678999999999999999999999984
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=405.55 Aligned_cols=263 Identities=26% Similarity=0.419 Sum_probs=219.6
Q ss_pred HHHhcCCcccCccccCCCceEEEEEeC------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCC
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP 363 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 363 (619)
+....+....+.||+|+||.||+|+.. +...||||.+++..+.+...+|++|+++++.++|||||+|+|+|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 344555666789999999999999852 35679999999888777899999999999999999999999999999
Q ss_pred CcceeEecccccchhhhhhcccCCC----------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC
Q 007073 364 TERLLVYPFMQNLSVAYRLREIKPG----------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE 433 (619)
Q Consensus 364 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 433 (619)
+..++|+|||..|||..+|+...+. ..+++..+.+.||.|||.||+||-++ .+|||||.++|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 9999999999999999999754322 23388899999999999999999999 9999999999999999
Q ss_pred CCcEEEcccccceeeccCCcceee-eccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchh
Q 007073 434 DFEAVVGDFGLAKLVDVRKTNVTT-QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVL 511 (619)
Q Consensus 434 ~~~~kl~DfGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~ 511 (619)
+..|||+|||+++..-..+.+... ...-..+|||||.+..++||++||||||||++||++| |+.||....-
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn------- 711 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN------- 711 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-------
Confidence 999999999999976544444332 3334679999999999999999999999999999999 8888864321
Q ss_pred HHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 512 LLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
+-+....+.+++ -..+..++.++++||..||+.+|++||+++||-..|++.
T Consensus 712 --~EVIe~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 712 --QEVIECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred --HHHHHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 111222222222 224566778999999999999999999999999999874
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=362.74 Aligned_cols=202 Identities=24% Similarity=0.403 Sum_probs=181.4
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
..+|...+.||+|+||+||+|+++ ++..||||.+.... .+...+.+..|+.+++.++|||||++++++..++..++||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 356888888999999999999975 68999999987543 4556677889999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC------CcEEEccccc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED------FEAVVGDFGL 444 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~DfGl 444 (619)
|||.+|+|.++++... .++..+.+.++.|+|.||++||++ +||||||||+|||++.. ..+||+|||+
T Consensus 89 EyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 9999999999999754 389999999999999999999999 99999999999999865 5689999999
Q ss_pred ceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 007073 445 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSR 503 (619)
Q Consensus 445 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~ 503 (619)
|+.+... ......+|++.|||||+++..+|+.|+|+||+|+++|+|++|+.||+...
T Consensus 162 AR~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 162 ARFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hhhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 9988633 33456789999999999999999999999999999999999999997543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=347.81 Aligned_cols=261 Identities=21% Similarity=0.324 Sum_probs=213.3
Q ss_pred cCCcccCccccCCCceEEEEE-eCCCcEEEEEEeccC-CCcchHHHHHHHHHHHHHccCCCccceee-eeeCCCc-ceeE
Q 007073 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDF-ESPGGDAAFQREVEMISVAVHRNLLRLIG-FCTTPTE-RLLV 369 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~-~~~g~~vAvK~l~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~~-~~~~~~~-~~lv 369 (619)
.+|.+.++||+|.||+||++. ..+|..||.|.++-. -+....++...|+.+|++++|||||++++ .+.++.+ ..+|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 456778899999999999999 468999999998722 23445677889999999999999999998 4444555 7899
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK-IIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
|||+..|+|...++..+.+...++..++++++.|+++||.++|.+...+ |+||||||.||+++.+|.|||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999999999888899999999999999999999999954322 889999999999999999999999999988
Q ss_pred ccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
....+ .....+|||.||+||.+....|+.||||||+||++|||+.-..||... .+.+...++... ..
T Consensus 179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--------n~~~L~~KI~qg-d~--- 245 (375)
T KOG0591|consen 179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--------NLLSLCKKIEQG-DY--- 245 (375)
T ss_pred cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--------cHHHHHHHHHcC-CC---
Confidence 65443 344578999999999999999999999999999999999999999643 233333333222 11
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
.+-....++.++..|+..|+..||+.||+.-.+++.+..
T Consensus 246 -----~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 246 -----PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -----CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 111125667899999999999999999985444444443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=372.58 Aligned_cols=248 Identities=24% Similarity=0.394 Sum_probs=211.7
Q ss_pred cCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccC--CCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
..|...++||+|||+.||+++. ..|..||+|++.+. ......+...+|+++.+.++|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999997 78999999999653 24556778899999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
|+|.+++|..+++.. .++++++++.+..||+.||.|||++ +|+|||||-.|++++++.++||+|||+|..+..
T Consensus 98 ELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 999999999988743 4499999999999999999999999 999999999999999999999999999998865
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
+.. .....+|||.|+|||++....++..+||||+||++|-|++|++||...... +.+..+....-
T Consensus 171 ~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk--------ety~~Ik~~~Y------ 235 (592)
T KOG0575|consen 171 DGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK--------ETYNKIKLNEY------ 235 (592)
T ss_pred ccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH--------HHHHHHHhcCc------
Confidence 433 344568999999999999999999999999999999999999999743221 22222211110
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..+...+.+..+|+.++++.||.+|||+++|+.
T Consensus 236 -----~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 236 -----SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -----ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 112344467889999999999999999999983
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=358.34 Aligned_cols=255 Identities=25% Similarity=0.363 Sum_probs=204.2
Q ss_pred HhcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcc------hHHHHHHHHHHHHHccCCCccceeeeeeCCC
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPG------GDAAFQREVEMISVAVHRNLLRLIGFCTTPT 364 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 364 (619)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||.+++..... ......+|+++|++++|||||++++++..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 345678889999999999999995 589999999997543222 2234569999999999999999999999999
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC---CcEEEcc
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED---FEAVVGD 441 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~D 441 (619)
..|+|||||+||+|.+.+-... .+....-+.++.|++.|+.|||+. ||+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk----~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK----YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc----ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence 9999999999999999987533 366677788999999999999999 99999999999999766 7899999
Q ss_pred cccceeeccCCcceeeeccccccccccccccCCCC---CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH
Q 007073 442 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKS---SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 518 (619)
Q Consensus 442 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 518 (619)
||+|+..+ ....+...+||+.|.|||++.+..+ ..++|+||+||++|-+++|.+||....- +..+.+.+.+
T Consensus 323 FGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~----~~sl~eQI~~ 396 (475)
T KOG0615|consen 323 FGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT----DPSLKEQILK 396 (475)
T ss_pred cchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC----CccHHHHHhc
Confidence 99999876 3455667899999999999976543 4588999999999999999999974321 1111111111
Q ss_pred HhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 519 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 519 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
++... -+.......++..+++.+|+..||++|||+.|+++.
T Consensus 397 ----G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 397 ----GRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ----Ccccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 11100 011234556788999999999999999999999853
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=341.48 Aligned_cols=263 Identities=22% Similarity=0.318 Sum_probs=207.2
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC-cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
+.|+...++|+|+||+||+++.+ +|+.||||++.+... +.-.+-.++|++++++++|+|+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45777889999999999999976 599999999987654 3344567799999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|++. ++.+.|+.+..+ ++.....+++.|+++|+.|+|++ ++|||||||+|||++.++.+||+|||+|+.+..
T Consensus 82 ~~dh-TvL~eLe~~p~G---~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNG---VPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecch-HHHHHHHhccCC---CCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 9987 454555554443 78889999999999999999999 999999999999999999999999999998864
Q ss_pred CcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh-hcccchhc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER-EKRLDAIV 529 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 529 (619)
.....+.++.|..|.|||.+.+ .+|+..+||||+||++.||+||.+-|...+.- ..+......+.. ..+-..++
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi----DQLy~I~ktLG~L~prhq~iF 229 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI----DQLYLIRKTLGNLIPRHQSIF 229 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH----HHHHHHHHHHcccCHHHHHHh
Confidence 4455677789999999999987 78999999999999999999999988754321 111111111100 00111111
Q ss_pred ccc---------------ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 530 DRN---------------LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 530 ~~~---------------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..+ ......+....-+.+++..|++.||++|++.++++.
T Consensus 230 ~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 230 SSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111 011112344457899999999999999999999874
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=349.99 Aligned_cols=259 Identities=24% Similarity=0.257 Sum_probs=210.3
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
..++|++.++||+|+||.||.++.+ +++.+|+|++++.. .....+....|..++.+++||.||+++-.+++++..++
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 4578999999999999999999965 68999999997643 23346778899999999999999999999999999999
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
|+||+.||.|..+|+.. ..+++...+-++..|+.||.|||++ +||||||||+|||+|.+|+++|+|||+++..
T Consensus 103 Vld~~~GGeLf~hL~~e----g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQRE----GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEeccCCccHHHHHHhc----CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 99999999999999863 3488898999999999999999999 9999999999999999999999999999854
Q ss_pred ccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
- .....+...+||+.|||||++.+..|+..+|+||+|+++|||+||.+||..... ..+...+....
T Consensus 176 ~-~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~--------~~~~~~I~~~k----- 241 (357)
T KOG0598|consen 176 L-KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV--------KKMYDKILKGK----- 241 (357)
T ss_pred c-cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH--------HHHHHHHhcCc-----
Confidence 2 233345557899999999999999999999999999999999999999975331 22333332222
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcc
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLA 576 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 576 (619)
....+.-...+..+++...++.||++|-....=...++...+.
T Consensus 242 -----~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF 284 (357)
T KOG0598|consen 242 -----LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFF 284 (357)
T ss_pred -----CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccc
Confidence 0111222346788999999999999996422222335555443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=384.40 Aligned_cols=256 Identities=27% Similarity=0.414 Sum_probs=220.4
Q ss_pred cCCcccCccccCCCceEEEEEeCC----CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
....+.++||.|.||.||+|.++- ...||||.++...+..+..+|+.|+.+|.+++||||++|.|+........+|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 345677899999999999999752 3579999999888888899999999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
.|||+||+|+.+|+... .++++.+...++++||.||.||.+. ++|||||.++|||++.+..+|++|||+++.+.
T Consensus 709 TEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecc
Confidence 99999999999999754 3488999999999999999999999 99999999999999999999999999999886
Q ss_pred cCCcceeeeccc--cccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 450 VRKTNVTTQVRG--TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 450 ~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
++.....+...| ..+|.|||.+..+++|.+|||||||++|||.++ |.+||-..+. .+.++.++...++
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN--------QdVIkaIe~gyRL- 853 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--------QDVIKAIEQGYRL- 853 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch--------HHHHHHHHhccCC-
Confidence 655444443333 468999999999999999999999999999888 8999753221 1233444444444
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
..+.+++..+++||..||++|-.+||+|.+|+..|.++
T Consensus 854 ---------PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 854 ---------PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred ---------CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 34667788999999999999999999999999999985
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=362.96 Aligned_cols=264 Identities=28% Similarity=0.461 Sum_probs=213.2
Q ss_pred HHHHHHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCc
Q 007073 287 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE 365 (619)
Q Consensus 287 ~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 365 (619)
+++++..+.+.+.+.||+|.||+||+|.|. -.||||++.... +++..+.|..|+.++++-+|.||+-++|+|..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 667777788888999999999999999985 469999997433 45577899999999999999999999999999887
Q ss_pred ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 445 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 445 (619)
.+|..+|+|-+|+.+++... ..++..+...||+|||+||.|||.+ +|||||||..||++.+++.|||+|||++
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred -eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccce
Confidence 99999999999999999744 4589999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCC-cceeeeccccccccccccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007073 446 KLVDVRK-TNVTTQVRGTMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 521 (619)
Q Consensus 446 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 521 (619)
..-..-. ........|...|||||++.. .+|++.+||||||+|+|||+||..||.....+ ..+. ...+
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d----qIif----mVGr 607 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD----QIIF----MVGR 607 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh----heEE----Eecc
Confidence 7543221 112233457889999999964 46899999999999999999999999732211 1110 1111
Q ss_pred hcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 522 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 522 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
++.+.+.. .....++.++.+|+..||+.++++||.+.+|+..|+.+
T Consensus 608 G~l~pd~s------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 608 GYLMPDLS------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred cccCccch------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 11111111 11345567899999999999999999999999988764
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=386.60 Aligned_cols=263 Identities=29% Similarity=0.443 Sum_probs=216.5
Q ss_pred HhcCCcccCccccCCCceEEEEEeC--CCc----EEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCc
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA--DGT----KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE 365 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~g~----~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 365 (619)
..++.+..+.||+|+||.||+|... +|. .||||.+++..+.+...+|.+|..+|+.++|||||+++|+|.....
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 3455666789999999999999975 343 4999999988888889999999999999999999999999999999
Q ss_pred ceeEecccccchhhhhhcccCCC---CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPG---EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 442 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 442 (619)
.++++|||++|+|..+|++.... ...++......++.|||+|+.||+++ ++|||||.++|+|++....|||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999985332 34588999999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcceeeec-cccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHh
Q 007073 443 GLAKLVDVRKTNVTTQV-RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLE 520 (619)
Q Consensus 443 Gla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 520 (619)
|+|+.+...+....... .-..+|||||.+..+.+|.|+|||||||++||++| |..||..... . +......
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-----~---~v~~~~~ 918 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-----F---EVLLDVL 918 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-----H---HHHHHHH
Confidence 99995543333322222 33568999999999999999999999999999999 7888753221 1 1111122
Q ss_pred hhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc
Q 007073 521 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGL 575 (619)
Q Consensus 521 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 575 (619)
..+++ ..+..++..++++|..||+.+|++||++..++++++....
T Consensus 919 ~ggRL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 919 EGGRL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred hCCcc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 22222 2245566789999999999999999999999998887643
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=358.15 Aligned_cols=264 Identities=26% Similarity=0.419 Sum_probs=206.6
Q ss_pred HHHhcCCcccCccccCCCceEEEEEe------CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeC
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTT 362 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 362 (619)
++..++|.+.+.||+|+||.||+|.+ .+++.||||+++..........+.+|+.++.++ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 34567899999999999999999974 235789999997544444567799999999999 89999999998876
Q ss_pred CC-cceeEecccccchhhhhhcccCCC-----------------------------------------------------
Q 007073 363 PT-ERLLVYPFMQNLSVAYRLREIKPG----------------------------------------------------- 388 (619)
Q Consensus 363 ~~-~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------- 388 (619)
.+ ..++||||+++|+|.+++......
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 54 578999999999999988653210
Q ss_pred -----CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcc-eeeecccc
Q 007073 389 -----EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGT 462 (619)
Q Consensus 389 -----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt 462 (619)
...+++.....++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++........ ......++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 13477888899999999999999999 9999999999999999999999999999865432221 12233466
Q ss_pred ccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHH
Q 007073 463 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQE 541 (619)
Q Consensus 463 ~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 541 (619)
..|+|||.+.+..++.++|||||||++|||+| |..||....... .. ......... ...+...
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----~~---~~~~~~~~~----------~~~~~~~ 302 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----EF---CQRLKDGTR----------MRAPENA 302 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH----HH---HHHHhcCCC----------CCCCCCC
Confidence 78999999999999999999999999999997 999986432211 11 111111110 0112223
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 542 VETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 542 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
+..+.+++.+||+.||++|||+.++++.|++.
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 45789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=342.35 Aligned_cols=254 Identities=26% Similarity=0.408 Sum_probs=203.0
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCC--cceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT--ERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lv~ 370 (619)
.++...+.||+|+||+||++... +|...|||.+....... .+.+.+|+.++++++|||||+.+|.....+ ...+.|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 34666889999999999999975 48999999886443222 677899999999999999999999865555 588999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-CCcEEEcccccceeec
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-DFEAVVGDFGLAKLVD 449 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~ 449 (619)
||+++|+|.+++..... .++...+..++.||++||+|||++ +||||||||+|||++. ++.+||+|||+++...
T Consensus 96 Ey~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 99999999999987542 499999999999999999999999 9999999999999999 7999999999998776
Q ss_pred c--CCcceeeeccccccccccccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 450 V--RKTNVTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 450 ~--~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
. ..........||+.|||||++..+. ...++||||+||++.||+||+.||... . ....+.-......
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~------~~~~~~~~ig~~~--- 239 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-F------EEAEALLLIGRED--- 239 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-c------chHHHHHHHhccC---
Confidence 3 2222344578999999999998643 345999999999999999999999642 0 0111111111111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 570 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 570 (619)
..+..+...+.+..+++..|++.+|++|||++++++..
T Consensus 240 ------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 240 ------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred ------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 11133444556889999999999999999999999654
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=350.26 Aligned_cols=264 Identities=27% Similarity=0.385 Sum_probs=225.9
Q ss_pred HHHHHHhcCCcccCccccCCCceEEEEEeCC-CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCc
Q 007073 287 RELQLATDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE 365 (619)
Q Consensus 287 ~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 365 (619)
++++....+..+.++||.|.||.||.|.|+. .-.||||.+++. ....++|+.|..+|+.++|||+|+|+|+|..+..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED--tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc--chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 6777777888899999999999999999974 567999999864 3457899999999999999999999999999999
Q ss_pred ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 445 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 445 (619)
.|+|.|||.+|+|.++|++... ..++-...+.++.||+.||+||..+ ++|||||.++|+|+.++..|||+|||++
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred eEEEEecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchh
Confidence 9999999999999999998654 3366777889999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 446 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 446 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
+++..+.........-.+.|.|||.+....++.|+|||+|||++||+.| |..||.. ..+.+.+.-++...+
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG--------idlSqVY~LLEkgyR 484 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG--------IDLSQVYGLLEKGYR 484 (1157)
T ss_pred hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC--------ccHHHHHHHHhcccc
Confidence 9987655444444445778999999999999999999999999999999 7777753 234444444444444
Q ss_pred cchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc
Q 007073 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGL 575 (619)
Q Consensus 525 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 575 (619)
+ ..+..+++.+++||+.||+++|.+||++.|+-+.++.+-.
T Consensus 485 M----------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 485 M----------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred c----------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 3 3356677899999999999999999999999999987643
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=352.78 Aligned_cols=247 Identities=24% Similarity=0.398 Sum_probs=203.5
Q ss_pred HhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
..+.....+-||+|+.|.||+|+++ ++.||||++++.. ..+++-|++++|+||+.+.|+|.....+++|||
T Consensus 122 PFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiME 192 (904)
T KOG4721|consen 122 PFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIME 192 (904)
T ss_pred CHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCceeEEeee
Confidence 3333444677999999999999995 7899999886422 356778999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
||..|-|...|+.. ..+.-.....+..+||.||.|||.+ .|||||||.-||||+.+..|||+|||.++.....
T Consensus 193 fCa~GqL~~VLka~----~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAG----RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK 265 (904)
T ss_pred ccccccHHHHHhcc----CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence 99999999999863 3477778889999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (619)
...-.++||..|||||++.+.+.++|+||||||||||||+||..||..-... ..+-.+-..
T Consensus 266 --STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-----------------AIIwGVGsN 326 (904)
T KOG4721|consen 266 --STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-----------------AIIWGVGSN 326 (904)
T ss_pred --hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-----------------eeEEeccCC
Confidence 2233567999999999999999999999999999999999999998532110 001111111
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 532 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.+.-..+..++..+.-|+++||+..|..||+|.+++..|+-.
T Consensus 327 sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 327 SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 222234556667888999999999999999999999999764
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=332.42 Aligned_cols=268 Identities=24% Similarity=0.360 Sum_probs=212.4
Q ss_pred HHhcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
...+.|++.++||.|..++||+|.. ..+..||||++.-.......+.+.+|+..++.++||||++++..|..+.+.++|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 3557899999999999999999995 468999999997544445578899999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|.||.+|++.+.+....+.+ +++..+..|.+++.+||.|||.+ |.||||||+.||||+.+|.|||+|||.+..+.
T Consensus 103 mpfMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred ehhhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 99999999999999876655 89999999999999999999999 99999999999999999999999999876664
Q ss_pred cCCcce---eeeccccccccccccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 450 VRKTNV---TTQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 450 ~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
...... ....+||+.|||||+++. ..|+.|+||||||++..||.+|..||...... .+.+ ..+. +.
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm---kvLl----~tLq--n~ 248 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM---KVLL----LTLQ--ND 248 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH---HHHH----HHhc--CC
Confidence 332221 145679999999999543 45899999999999999999999999643211 0111 1111 01
Q ss_pred cchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhc
Q 007073 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR--MLEG 572 (619)
Q Consensus 525 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~ 572 (619)
.....-..+...........+.+++..|++.||.+|||++++++ +++.
T Consensus 249 pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~ 298 (516)
T KOG0582|consen 249 PPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKK 298 (516)
T ss_pred CCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhh
Confidence 10000111111122344458899999999999999999999983 4443
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=358.18 Aligned_cols=265 Identities=28% Similarity=0.396 Sum_probs=215.0
Q ss_pred HHHHHHHhcCCcccCccccCCCceEEEEEeCC--C--cE-EEEEEecc--CCCcchHHHHHHHHHHHHHccCCCccceee
Q 007073 286 WRELQLATDNFSEKNVLGQGGFGKVYRGVLAD--G--TK-VAVKRLTD--FESPGGDAAFQREVEMISVAVHRNLLRLIG 358 (619)
Q Consensus 286 ~~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~~--g--~~-vAvK~l~~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 358 (619)
...++...++....++||+|+||.||+|.++. + .. ||||..+. ........+|.+|++++++++|||||+++|
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 34556667777778999999999999999652 2 23 89999874 345667889999999999999999999999
Q ss_pred eeeCCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 007073 359 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV 438 (619)
Q Consensus 359 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 438 (619)
++...+..++|||+|+||+|.++|+.... .++..++..++.++|+||+|||++ +++||||.++|+|++.++.+|
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEE
Confidence 99999999999999999999999998553 489999999999999999999999 999999999999999999999
Q ss_pred EcccccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHH
Q 007073 439 VGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVK 517 (619)
Q Consensus 439 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 517 (619)
|+|||+++.-...... .....-...|+|||.+..+.|++++|||||||++||+++ |..||...... +...
T Consensus 303 ISDFGLs~~~~~~~~~-~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------~v~~ 373 (474)
T KOG0194|consen 303 ISDFGLSRAGSQYVMK-KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------EVKA 373 (474)
T ss_pred eCccccccCCcceeec-cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--------HHHH
Confidence 9999998754311111 111234679999999999999999999999999999999 88888643321 1112
Q ss_pred HHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007073 518 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 574 (619)
Q Consensus 518 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 574 (619)
.... ...+...+...+..+..++.+||..+|++||+|.++.+.|+...
T Consensus 374 kI~~---------~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 374 KIVK---------NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred HHHh---------cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 2211 11122223355678889999999999999999999999998753
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=343.01 Aligned_cols=265 Identities=21% Similarity=0.290 Sum_probs=207.4
Q ss_pred HhcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc-CCCccceeeeeeCCC-ccee
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPT-ERLL 368 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~-~~~l 368 (619)
.-++|...+.||.|.||.||+|+. .+|..||||++++.--.-.+..=++|+..|+++. ||||+++.+++.+.+ ..++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 346788899999999999999995 5799999999975432222333468999999999 999999999999888 8999
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
|||||+. +|..++++. +..++...++.|+.||.+||+|+|++ |+.|||+||+|||+..+..+||+|||+|+.+
T Consensus 88 VfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 9999976 899988874 56799999999999999999999999 9999999999999999999999999999977
Q ss_pred ccCCcceeeeccccccccccccc-cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh-----
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYL-STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE----- 522 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 522 (619)
.... ..+.++.|..|.|||++ +.+-|+.+.||||+|||++|+.+-++.|.+...-. .+.....-+..+
T Consensus 161 ~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D----qi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 161 RSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID----QIYKICEVLGTPDKDSW 234 (538)
T ss_pred ccCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH----HHHHHHHHhCCCccccc
Confidence 5443 45677889999999977 45779999999999999999999998887543211 111111111000
Q ss_pred ---cccchhcc---cccc----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 523 ---KRLDAIVD---RNLN----KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 523 ---~~~~~~~~---~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
..+...+. +... ....+....+..+++.+|+++||++|||+.|.++.
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00001111 0000 01123466789999999999999999999999863
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=341.46 Aligned_cols=264 Identities=22% Similarity=0.298 Sum_probs=206.2
Q ss_pred cCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCC--CcceeE
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERLLV 369 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv 369 (619)
+.|+..++||+|.||.||+|+. .+|+.||+|+++-.. .++...-..+|+.+|++++||||++|.+...+. ...|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 4566678999999999999995 589999999997443 344456667999999999999999999998776 679999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
+|||++ +|..++.. .+..++..+++.++.|++.||+|+|++ +|+|||||.+|||||.+|.+||+|||+|+++.
T Consensus 197 FeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred Eecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence 999987 77777764 334589999999999999999999999 99999999999999999999999999999988
Q ss_pred cCCcceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHH---hhhccc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL---EREKRL 525 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 525 (619)
.......+..+-|..|.|||.+.+. .|+.++|+||.|||+.||++|++.+......++ +...++-+ ....+.
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ----l~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ----LHKIFKLCGSPTEDYWP 345 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH----HHHHHHHhCCCChhccc
Confidence 7777667777789999999998874 699999999999999999999998875432111 11111111 111111
Q ss_pred -chhcc-ccc--cCCC-------CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 526 -DAIVD-RNL--NKNY-------NIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 526 -~~~~~-~~l--~~~~-------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..+.. ..+ ...+ -...+...++|+..++..||++|.|+.++++
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 00000 000 0011 1223356788999999999999999999873
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=340.79 Aligned_cols=258 Identities=22% Similarity=0.333 Sum_probs=210.6
Q ss_pred HHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCc
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTE 365 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 365 (619)
....++|..++.||+|+|++||+|+.. .++.||||++.+.. .....+-...|-.+|.++ .||.|++|+-.|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 345678899999999999999999954 68999999985432 122345566888899998 79999999999999999
Q ss_pred ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 445 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 445 (619)
.|+|+||.++|+|.++++.... ++....+.++.+|+.||+|||++ |||||||||+|||+|+|+++||+|||.|
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gs----fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGS----FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCc----chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence 9999999999999999998644 88888999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcc----------ee--eeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHH
Q 007073 446 KLVDVRKTN----------VT--TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL 513 (619)
Q Consensus 446 ~~~~~~~~~----------~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~ 513 (619)
+.+...... .. ..++||..|.+||++..+..+..+|+|+|||++|+|+.|++||.... +....
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N-----eyliF 296 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN-----EYLIF 296 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc-----HHHHH
Confidence 988543221 11 34789999999999999999999999999999999999999996432 11121
Q ss_pred HHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCccc
Q 007073 514 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAE 577 (619)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 577 (619)
+.+..+ .-.+++..++.+.+|+.+.+..||++|+|.++| +...+++
T Consensus 297 qkI~~l--------------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qI----k~HpFF~ 342 (604)
T KOG0592|consen 297 QKIQAL--------------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQI----KAHPFFE 342 (604)
T ss_pred HHHHHh--------------cccCCCCCCHHHHHHHHHHHccCccccccHHHH----hhCcccc
Confidence 111111 112344445788999999999999999999555 4444544
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=342.43 Aligned_cols=268 Identities=20% Similarity=0.343 Sum_probs=218.9
Q ss_pred HHHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
+.......+.++||+|-||.|..+....+..||||+++.........+|.+|+++|.+++|||||+++|+|..++..++|
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 34556677889999999999999999878999999999888777889999999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
+|||++|+|..++....... ++.....+|+.|||.||+||.+. ++||||+.++|+|+|.++++||+|||+++.+-
T Consensus 614 ~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence 99999999999998764322 45555677999999999999999 99999999999999999999999999999665
Q ss_pred cCCcce-eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh--CCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 450 VRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT--GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 450 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
..+... ....+-..+|||||.+..+++|+++|||+||+++||+++ ...||.... +...++....+...+...
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt-----~e~vven~~~~~~~~~~~ 763 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT-----DEQVVENAGEFFRDQGRQ 763 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh-----HHHHHHhhhhhcCCCCcc
Confidence 444433 234456789999999999999999999999999999877 566764221 112222222332222222
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.++ ..+.-++..++++|..||..|-++||+++++...|++.
T Consensus 764 ~~l------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 764 VVL------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred eec------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 222 12445567889999999999999999999999988764
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=352.19 Aligned_cols=263 Identities=25% Similarity=0.363 Sum_probs=206.8
Q ss_pred HHHhcCCcccCccccCCCceEEEEEe------CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeC
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTT 362 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 362 (619)
....++|++.+.||+|+||.||+|.+ .++..||||+++........+.+.+|+++++.+ +||||+++++++..
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 33456788899999999999999974 246689999997554444567789999999999 89999999999999
Q ss_pred CCcceeEecccccchhhhhhcccCC-------------------------------------------------------
Q 007073 363 PTERLLVYPFMQNLSVAYRLREIKP------------------------------------------------------- 387 (619)
Q Consensus 363 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 387 (619)
....++||||+++|+|.++++....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 9999999999999999998864321
Q ss_pred ----------------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 388 ----------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 388 ----------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
....+++..+.+++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 112478888999999999999999999 9999999999999999999999999999866433
Q ss_pred Ccce-eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 452 KTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 452 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
.... .....++..|+|||.+.+..++.++|||||||++|||+| |..||...... ........ ....
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~----~~~~~~~~---~~~~----- 335 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD----SKFYKMIK---EGYR----- 335 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch----HHHHHHHH---hCcc-----
Confidence 2211 122335668999999999999999999999999999998 88888643211 11111111 1100
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
...+...+.++.+++.+||+.||++||++.+|++.|+.
T Consensus 336 -----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 336 -----MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred -----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 00111123578999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=334.00 Aligned_cols=256 Identities=24% Similarity=0.309 Sum_probs=206.2
Q ss_pred hcCCcccCccccCCCceEEEEEeC----CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
.++|++.+.||+|+||.||+|.++ .+..||+|+++...+......|.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 456888999999999999999863 3678999999765544556789999999999999999999999999999999
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999987532 3488999999999999999999999 9999999999999999999999999987654
Q ss_pred ccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccch
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (619)
............++..|+|||.+.+..++.++|||||||++||+++ |+.||...... +..........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--------~~~~~~~~~~~--- 226 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--------DVIKAVEDGFR--- 226 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHHCCCC---
Confidence 3222111222335678999999999999999999999999999775 99998643211 11111111100
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 528 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
...+...+..+.+++.+||+.+|++||++.+|.+.|++
T Consensus 227 -------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 227 -------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 11122345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=339.18 Aligned_cols=266 Identities=21% Similarity=0.333 Sum_probs=204.5
Q ss_pred hcCCcccCccccCCCceEEEEEeCC-----------------CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLAD-----------------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 355 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~~-----------------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 355 (619)
.++|.+.+.||+|+||.||+|.+++ +..||+|.+...........|.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578888999999999999998532 33699999876544455678999999999999999999
Q ss_pred eeeeeeCCCcceeEecccccchhhhhhcccCC---------------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 007073 356 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKP---------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 420 (619)
Q Consensus 356 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv 420 (619)
+++++...+..++||||+++|+|.+++..... ....+++....+++.|++.||+|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999999999999999999999998864321 123478888999999999999999999 999
Q ss_pred ecCCCCCcEEeCCCCcEEEcccccceeeccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhC--CC
Q 007073 421 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG--QR 497 (619)
Q Consensus 421 H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg--~~ 497 (619)
||||||+|||++.++.+||+|||+++........ ......++..|+|||.+.++.++.++||||||+++|||+++ ..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999866433221 12233457889999999888999999999999999999975 45
Q ss_pred CCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 498 AIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 498 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
||..... .................. ....++..+..+.+++.+||+.+|++|||+.+|.+.|++
T Consensus 241 p~~~~~~-----~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTD-----EQVIENAGEFFRDQGRQV------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCH-----HHHHHHHHHHhhhccccc------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 5543211 111111111111110000 001112234678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=309.09 Aligned_cols=263 Identities=22% Similarity=0.316 Sum_probs=205.6
Q ss_pred cCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCC-cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
++|...+.||+|.||.||+|.. ++|+.||||+++-... .+......+|++.++.++|+||+.+++++...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677789999999999999995 5799999999975433 3345678899999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
||+. +|...+++ ....++-.....++.++.+|++|||++ .|+||||||.|+|++.+|.+||+|||+|+.+...
T Consensus 82 fm~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9986 88888876 345688889999999999999999999 9999999999999999999999999999998765
Q ss_pred CcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh----cc--
Q 007073 452 KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE----KR-- 524 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~-- 524 (619)
....... +-|..|.|||.+.+ ..|+..+||||.||++.||+-|.+-|...+. ......+-+.... .+
T Consensus 155 ~~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD-----idQL~~If~~LGTP~~~~WP~ 228 (318)
T KOG0659|consen 155 NRIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD-----IDQLSKIFRALGTPTPDQWPE 228 (318)
T ss_pred Ccccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch-----HHHHHHHHHHcCCCCcccCcc
Confidence 5443333 57999999998876 4699999999999999999998876654332 1111111111100 00
Q ss_pred cchhcc-------cc-ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 525 LDAIVD-------RN-LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 525 ~~~~~~-------~~-l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
+..+.| +. .....-+....+..+++..++..||.+|+|++|++++
T Consensus 229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 000000 00 0011223445677999999999999999999999854
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=335.64 Aligned_cols=262 Identities=15% Similarity=0.230 Sum_probs=204.9
Q ss_pred CcccccCHHHHHHHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcc--hHHHHHHHHHHHHHccCCCccce
Q 007073 279 GQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRL 356 (619)
Q Consensus 279 ~~~~~~~~~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l 356 (619)
.+++..+.++++. .....||+|++|.||+|.+ +|+.||||+++...... ..+.|.+|+.++++++||||+++
T Consensus 10 ~~~~~i~~~~i~~-----~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~ 83 (283)
T PHA02988 10 NDIKCIESDDIDK-----YTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKI 83 (283)
T ss_pred CcceecCHHHcCC-----CCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEE
Confidence 3445555555522 2236799999999999998 68999999987543221 24678899999999999999999
Q ss_pred eeeeeC----CCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC
Q 007073 357 IGFCTT----PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD 432 (619)
Q Consensus 357 ~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 432 (619)
+|++.. ....++||||+++|+|.+++... ..+++....+++.|++.||.|||+.. +++||||||+||+++
T Consensus 84 ~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~ 157 (283)
T PHA02988 84 YGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVT 157 (283)
T ss_pred eeeEEecccCCCceEEEEEeCCCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEEC
Confidence 999866 34678999999999999999763 24888999999999999999999732 788999999999999
Q ss_pred CCCcEEEcccccceeeccCCcceeeeccccccccccccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccch
Q 007073 433 EDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV 510 (619)
Q Consensus 433 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~ 510 (619)
+++.+||+|||+++...... ....|+..|+|||.+.+ ..++.++|||||||++|||+||+.||......
T Consensus 158 ~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~----- 228 (283)
T PHA02988 158 ENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK----- 228 (283)
T ss_pred CCCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-----
Confidence 99999999999998654321 23457899999999976 67999999999999999999999999743211
Q ss_pred hHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 511 LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
+........ ......+...+..+.+++.+||+.||++|||++++++.|+..
T Consensus 229 ---~~~~~i~~~---------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 229 ---EIYDLIINK---------NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred ---HHHHHHHhc---------CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 111111110 011112223456789999999999999999999999999864
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=349.85 Aligned_cols=264 Identities=25% Similarity=0.372 Sum_probs=206.7
Q ss_pred HHHhcCCcccCccccCCCceEEEEEeC------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeC
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTT 362 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 362 (619)
....++|.+.+.||+|+||.||+|.+. ++..||||+++..........+.+|+++++.+ +|+||+++++++..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 445568889999999999999999842 34579999997554444566788999999999 89999999999999
Q ss_pred CCcceeEecccccchhhhhhcccCC-------------------------------------------------------
Q 007073 363 PTERLLVYPFMQNLSVAYRLREIKP------------------------------------------------------- 387 (619)
Q Consensus 363 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 387 (619)
....++||||+++|+|.++++....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 9999999999999999998854211
Q ss_pred -----------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcc-e
Q 007073 388 -----------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN-V 455 (619)
Q Consensus 388 -----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~ 455 (619)
....+++....+++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++........ .
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 112478888999999999999999999 9999999999999999999999999999865432221 1
Q ss_pred eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhcccccc
Q 007073 456 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN 534 (619)
Q Consensus 456 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 534 (619)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||...... ...... .. .. ..
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~----~~~~~~---~~-~~---------~~ 333 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN----SKFYKM---VK-RG---------YQ 333 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc----HHHHHH---HH-cc---------cC
Confidence 122335678999999998999999999999999999997 99998643211 011111 10 00 00
Q ss_pred CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 535 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 535 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
...+...+.++.+++.+||+.||++|||+.+|++.|+++
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 001111235789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=340.51 Aligned_cols=249 Identities=20% Similarity=0.296 Sum_probs=206.9
Q ss_pred cCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
..|...+.||+|+.|.||.|.. .+++.||||++... .....+-..+|+.+|+..+|+|||++++.+...++.+.||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~-~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR-KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEec-cCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 3577778999999999999994 57899999998532 233456677999999999999999999999989999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
|++|+|.+.+.... +++.+...|+..+++||+|||.+ +|+|||||.+|||++.++.+||+|||++..+....
T Consensus 352 m~ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred cCCCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 99999999887643 88899999999999999999999 99999999999999999999999999998876554
Q ss_pred cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
. .....+||+.|||||+.....|++|+||||||++++||+-|++||-..... .....+...+.
T Consensus 424 ~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl--------rAlyLIa~ng~-------- 486 (550)
T KOG0578|consen 424 S-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------RALYLIATNGT-------- 486 (550)
T ss_pred C-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH--------HHHHHHhhcCC--------
Confidence 4 445567999999999999999999999999999999999999998542210 00011111111
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..-......+..+.+++.+|++.||++||++.|+++
T Consensus 487 P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 487 PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 111224455678999999999999999999999984
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=340.38 Aligned_cols=266 Identities=22% Similarity=0.364 Sum_probs=221.9
Q ss_pred HHHHHHhcCCcccCccccCCCceEEEEEeCC---C--cEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeee
Q 007073 287 RELQLATDNFSEKNVLGQGGFGKVYRGVLAD---G--TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 361 (619)
Q Consensus 287 ~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~~---g--~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 361 (619)
++.+...+.....++||+|.||.||+|.+.+ | -.||||..+...+++..+.|++|..+|+.++||||++++|+|.
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~ 461 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV 461 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence 3445555666677899999999999999632 3 3589999988777788999999999999999999999999997
Q ss_pred CCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcc
Q 007073 362 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD 441 (619)
Q Consensus 362 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 441 (619)
+. ..++|||.++.|-|..+|+..+. .++..+...++.||+.||+|||++ ++|||||..+|||+.....||++|
T Consensus 462 e~-P~WivmEL~~~GELr~yLq~nk~---sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaD 534 (974)
T KOG4257|consen 462 EQ-PMWIVMELAPLGELREYLQQNKD---SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLAD 534 (974)
T ss_pred cc-ceeEEEecccchhHHHHHHhccc---cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecc
Confidence 54 57899999999999999987543 488889999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHh
Q 007073 442 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLE 520 (619)
Q Consensus 442 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 520 (619)
||+++.+..+.....+...-...|||||.+..+++|.++|||.|||.+||++. |..||..-...
T Consensus 535 FGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs--------------- 599 (974)
T KOG4257|consen 535 FGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS--------------- 599 (974)
T ss_pred cchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc---------------
Confidence 99999998776665555555778999999999999999999999999999988 99999643211
Q ss_pred hhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCccc
Q 007073 521 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAE 577 (619)
Q Consensus 521 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 577 (619)
..-..+...-+-..++.+++.++.|+.+||..+|.+||++.++...|.+....+
T Consensus 600 ---DVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 600 ---DVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred ---ceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 111112222223346677889999999999999999999999999998754433
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=332.05 Aligned_cols=250 Identities=27% Similarity=0.472 Sum_probs=196.1
Q ss_pred ccCccccCCCceEEEEEeC-----CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 298 EKNVLGQGGFGKVYRGVLA-----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 298 ~~~~lg~G~fg~Vy~~~~~-----~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
..+.||.|.||.||+|.+. .+..|+||.++........+.|.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999976 35789999997655555678999999999999999999999999988889999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++|+|.+++... ....+++..+.+|+.|+++||+|||++ +++|+||+++||+++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999875 234489999999999999999999999 99999999999999999999999999998763222
Q ss_pred c-ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 453 T-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 453 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
. .......+...|+|||.+.+..++.++||||||+++|||+| |+.|+.... ..+............
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~--------~~~~~~~~~~~~~~~---- 225 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD--------NEEIIEKLKQGQRLP---- 225 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC--------HHHHHHHHHTTEETT----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc--------cccccccccccccce----
Confidence 2 12223446789999999999999999999999999999999 678875321 112222222222211
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 570 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 570 (619)
.+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 226 ------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1122345788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=337.91 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=205.0
Q ss_pred HHhcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCC---c-chHHHHHHHHHHHHHcc-CCCccceeeeeeCCC
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFES---P-GGDAAFQREVEMISVAV-HRNLLRLIGFCTTPT 364 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~---~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~ 364 (619)
...+.|.+.+.||+|+||+|+.|.. .+|..||+|.+.+... . ...+...+|+.++++++ ||||+++++++..+.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456899999999999999999985 4789999996654211 1 23456668999999999 999999999999999
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-CcEEEcccc
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFG 443 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG 443 (619)
..++||||+.+|+|.+++... ..+......+++.|++.|++|+|++ +|+||||||+|||+|.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~----g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK----GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 999999999999999999873 2377799999999999999999999 99999999999999999 999999999
Q ss_pred cceeeccCCcceeeeccccccccccccccCCC-CC-cchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007073 444 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK-SS-ERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 521 (619)
Q Consensus 444 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 521 (619)
++.... .........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+.... ......+
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~--------~~l~~ki-- 235 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV--------PNLYRKI-- 235 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH--------HHHHHHH--
Confidence 999774 2333455678999999999999877 75 889999999999999999999975221 1111111
Q ss_pred hcccchhccccccCCCCHHH-HHHHHHHHHhccCCCCCCCCCHHHHH
Q 007073 522 EKRLDAIVDRNLNKNYNIQE-VETMIQVALLCTQASPEDRPAMSEVV 567 (619)
Q Consensus 522 ~~~~~~~~~~~l~~~~~~~~-~~~l~~l~~~Cl~~dP~~RPs~~evl 567 (619)
....+ .++... +.++.+++.+|+..||.+|+++.+|+
T Consensus 236 -------~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 236 -------RKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred -------hcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 11110 111112 57889999999999999999999998
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=330.33 Aligned_cols=254 Identities=24% Similarity=0.349 Sum_probs=212.8
Q ss_pred hcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
...|+..+.||+|.||.||+|.. +.++.||+|++.-.......++.++|+.++.+++++||.+++|.+..+...+++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 34577778999999999999996 46899999999766667778899999999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
||.+|++.+.+.... .++.....-++.++..|+.|||.+ +.+|||||+.|||+..++.+|++|||.+..+...
T Consensus 92 y~~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HhcCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeech
Confidence 999999999997532 245666667888999999999999 9999999999999999999999999999877654
Q ss_pred CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (619)
.... ..++||+.|||||++....|+.|+||||||++.+||.+|.+|+..... .+..-++-+
T Consensus 165 ~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP------------------mrvlflIpk 225 (467)
T KOG0201|consen 165 VKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP------------------MRVLFLIPK 225 (467)
T ss_pred hhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc------------------ceEEEeccC
Confidence 4433 567899999999999988999999999999999999999999864221 122222222
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH--HHHhc
Q 007073 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV--RMLEG 572 (619)
Q Consensus 532 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl--~~L~~ 572 (619)
...+....+++..+.+++..|+++||+.||++.+++ ++++.
T Consensus 226 ~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 226 SAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred CCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 223333445667899999999999999999999998 44554
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=329.05 Aligned_cols=258 Identities=24% Similarity=0.432 Sum_probs=207.8
Q ss_pred cCCcccCccccCCCceEEEEEeCC------CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcce
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 367 (619)
++|++.+.||+|+||.||+|.... ...||+|.+...........|.+|+.++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999998642 25799999875554455677899999999999999999999999888999
Q ss_pred eEecccccchhhhhhcccCCC------------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC
Q 007073 368 LVYPFMQNLSVAYRLREIKPG------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 435 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 435 (619)
++|||+++|+|.+++...... ...+++.....++.|++.||+|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 999999999999998754221 14578889999999999999999999 999999999999999999
Q ss_pred cEEEcccccceeeccCCc-ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHH
Q 007073 436 EAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLL 513 (619)
Q Consensus 436 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~ 513 (619)
.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||+| |..||......
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-------- 233 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-------- 233 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence 999999999986543222 12233456788999999998899999999999999999998 99998643211
Q ss_pred HHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 514 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
+...... ... ....+...+..+.+++.+||+.||++||++.+|++.|++
T Consensus 234 ~~~~~i~-~~~---------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 EVIEMIR-SRQ---------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHH-cCC---------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111111 111 111233445789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=310.79 Aligned_cols=239 Identities=23% Similarity=0.288 Sum_probs=203.1
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
..++|+..+.||.|+||.|..++.+ +|..+|+|++.+.. ...+.+...+|..+++.+.||+++++++.+.+....++
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 3456778899999999999999965 68899999996432 23345677889999999999999999999999999999
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||++||-|..+++.... ++....+-+|.+|+.||+|||+. +|++||+||+|||+|.+|.+||+|||+|+.+
T Consensus 122 vmeyv~GGElFS~Lrk~~r----F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v 194 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGR----FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRV 194 (355)
T ss_pred EEeccCCccHHHHHHhcCC----CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEe
Confidence 9999999999999997543 88999999999999999999999 9999999999999999999999999999987
Q ss_pred ccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
... +...+||+.|+|||+++...+..++|.|||||++|||+.|..||..... .+.+. .+
T Consensus 195 ~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~iY~---------KI 253 (355)
T KOG0616|consen 195 SGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQIYE---------KI 253 (355)
T ss_pred cCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHHHH---------HH
Confidence 543 5567899999999999999999999999999999999999999975432 11222 22
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCC
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDR 560 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 560 (619)
+...+ .++.....++.+|+...++.|-.+|
T Consensus 254 ~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 254 LEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 22222 2344455688999999999999999
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=325.53 Aligned_cols=256 Identities=25% Similarity=0.374 Sum_probs=207.6
Q ss_pred HhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
..++|++.+.||+|+||.||+|...++..||+|.+... ....+.+.+|+.+++.++|+||+++++++...+..+++||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG--TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC--chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 45678899999999999999999888899999987642 2235788999999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 82 YMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred cCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 999999999987542 23478889999999999999999999 9999999999999999999999999999876433
Q ss_pred CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
.........++..|+|||++.+..++.++|||||||++|||+| |+.||..... ... .........
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-----~~~---~~~~~~~~~------ 222 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN-----SDV---MSALQRGYR------ 222 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH-----HHH---HHHHHcCCC------
Confidence 2222223345678999999998899999999999999999999 8999853211 011 111111100
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
.......+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 223 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 223 ----MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ----CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01111234578899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=323.32 Aligned_cols=257 Identities=26% Similarity=0.369 Sum_probs=208.2
Q ss_pred HHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
...++|++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|+.++++++|+||+++++++...+..++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 3456788899999999999999998888899999986432 23567899999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++++|.+++.... ...+++..+..++.|++.|+.|||++ +++||||||+||++++++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 81 ELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred ecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 9999999999987643 34588999999999999999999999 999999999999999999999999999987653
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
..........++..|+|||++.+..++.++||||||+++|||+| |+.||..... .... ........
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~---~~~~~~~~----- 222 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-----AEVL---QQVDQGYR----- 222 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-----HHHH---HHHHcCCC-----
Confidence 32222222223457999999999999999999999999999999 9988853211 1111 11111000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
.......+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 223 -----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 -----MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -----CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 01122334678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=322.92 Aligned_cols=251 Identities=26% Similarity=0.398 Sum_probs=203.3
Q ss_pred cCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEeccc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 373 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 373 (619)
++|++.+.||+|+||.||++.++++..+|+|.+... ......|.+|++++++++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG--AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC--CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 467888999999999999999988889999987643 223567899999999999999999999999999999999999
Q ss_pred ccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCc
Q 007073 374 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 453 (619)
Q Consensus 374 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 453 (619)
++|+|.++++... ..+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||.++.......
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 82 ENGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 9999999887532 2478999999999999999999999 999999999999999999999999999986543322
Q ss_pred ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 454 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 454 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
.......++..|+|||.+.+..++.++||||||+++|||+| |+.||..... . +........... ..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-----~---~~~~~i~~~~~~---~~-- 222 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-----Y---EVVEMISRGFRL---YR-- 222 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-----H---HHHHHHHCCCCC---CC--
Confidence 22223345678999999988889999999999999999999 8888853221 1 111111111110 00
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 570 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 570 (619)
+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 223 -----~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 223 -----PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 111235789999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=303.49 Aligned_cols=265 Identities=25% Similarity=0.343 Sum_probs=215.1
Q ss_pred HHhcCCcccCccccCCCceEEEEE-eCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCC-----C
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-----T 364 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~ 364 (619)
+..++|.+.+.+|+|||+-||.++ ..+++-||+|++.- ...++.+..++|++..++++|||+++++++...+ .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c-~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILC-HSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeec-cchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 356789999999999999999999 56889999999853 3356678889999999999999999999887443 3
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 444 (619)
+.+++++|+..|+|.+.++.....+..++..+.+.|+.++++||++||+. .|++.||||||.|||+.+++.+++.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence 48999999999999999998887788899999999999999999999998 34599999999999999999999999999
Q ss_pred ceeeccCCcce--------eeecccccccccccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHH
Q 007073 445 AKLVDVRKTNV--------TTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL 513 (619)
Q Consensus 445 a~~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~ 513 (619)
++.....-... ......|..|.|||.+. +...++++|||||||++|+|+.|..||+....
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--------- 246 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--------- 246 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---------
Confidence 87653211111 11234689999999985 45679999999999999999999999974322
Q ss_pred HHHHHHhhhcccc-hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 514 DHVKKLEREKRLD-AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 514 ~~~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.++.+. .+....+..+-....++.+.+++.+|++.||.+||+..+++..++..
T Consensus 247 -------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 247 -------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 111221 22332332222333678999999999999999999999999988763
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=336.22 Aligned_cols=263 Identities=24% Similarity=0.295 Sum_probs=204.9
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.++|++.+.||+|+||.||++... +|..||+|.+...........+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999975 6889999998754334455779999999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++|+|.+++.... .+++.....++.|++.||.|||++. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999987532 3788899999999999999999852 5999999999999999999999999998765322
Q ss_pred CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh---h------
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER---E------ 522 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~------ 522 (619)
......|+..|+|||.+.+..++.++|||||||++|||+||+.||....... +......... .
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 229 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE-----LEAIFGRPVVDGEEGEPHSI 229 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHhcccccccccCCcccc
Confidence 1233468999999999999999999999999999999999999996432210 0000000000 0
Q ss_pred -------------------------cccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 523 -------------------------KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 523 -------------------------~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
.....+...............++.+++.+||+.||++|||+.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 230 SPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred CcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000000112245678999999999999999999999854
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=332.01 Aligned_cols=247 Identities=22% Similarity=0.352 Sum_probs=209.6
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC-cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+... ....+.+.+|+++++.++|||||.++++|++..+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46778899999999999999965 688999999865443 3456789999999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+.| +|...+.. +..+++..+..++.|++.||.|||+. +|+|||+||.|||++.++.+|++|||+|+.+..
T Consensus 82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST- 152 (808)
T ss_pred hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-
Confidence 9987 99999876 34489999999999999999999999 999999999999999999999999999998765
Q ss_pred CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (619)
.+...+...||+-|||||...+.+|+..+|.||+||++||+++|++||...+ +.+.++.+. ..
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--------i~~Lv~~I~---------~d 215 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--------ITQLVKSIL---------KD 215 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--------HHHHHHHHh---------cC
Confidence 3455667789999999999999999999999999999999999999995322 222222221 11
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 532 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.. ..+......+..++...+.+||.+|.+-.+++.
T Consensus 216 ~v--~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 216 PV--KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CC--CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 11 123455678899999999999999999888873
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=328.92 Aligned_cols=252 Identities=24% Similarity=0.348 Sum_probs=200.3
Q ss_pred CCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 295 NFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.|+..+.||+|+||.||+|.. .+|+.||+|.+.... .......+.+|+.++++++|+||+++++++...+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367788999999999999996 479999999886432 22334567899999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++|+|.+.+.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 999999988876432 23488899999999999999999999 9999999999999999999999999999875332
Q ss_pred CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (619)
. ......||..|+|||.+.+..++.++|||||||++|||+||+.||........ ......... ..
T Consensus 156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~----~~~~~~~~~---------~~ 220 (285)
T cd05631 156 E--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK----REEVDRRVK---------ED 220 (285)
T ss_pred C--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh----HHHHHHHhh---------cc
Confidence 2 22345689999999999999999999999999999999999999975332110 000001000 00
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007073 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVR 568 (619)
Q Consensus 532 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 568 (619)
...+....+..+.+++.+||+.||++||+ ++++++
T Consensus 221 --~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 --QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred --cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 01122233467899999999999999997 677664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=343.00 Aligned_cols=264 Identities=23% Similarity=0.355 Sum_probs=208.2
Q ss_pred HHHhcCCcccCccccCCCceEEEEEeC------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc-CCCccceeeeeeC
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTT 362 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~ 362 (619)
....++|.+.++||+|+||.||+|.+. .+..||||+++........+.+.+|+++++++. ||||+++++++..
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 345678889999999999999999853 234799999976554455678999999999996 9999999999999
Q ss_pred CCcceeEecccccchhhhhhcccCC-------------------------------------------------------
Q 007073 363 PTERLLVYPFMQNLSVAYRLREIKP------------------------------------------------------- 387 (619)
Q Consensus 363 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 387 (619)
....++||||+++|+|.++++....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 9999999999999999988864210
Q ss_pred -------------------------------------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 007073 388 -------------------------------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVL 430 (619)
Q Consensus 388 -------------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 430 (619)
....+++..+.+++.|+++||+|||+. +|+||||||+||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence 012477888899999999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccceeeccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccc
Q 007073 431 LDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEED 508 (619)
Q Consensus 431 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~ 508 (619)
++.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-- 347 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-- 347 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--
Confidence 999999999999999865432221 1223346788999999998899999999999999999997 889986422110
Q ss_pred chhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 509 DVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.. ........ ....+...+..+.+++.+||+.+|++||++.+|.++|+..
T Consensus 348 --~~---~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 348 --TF---YNKIKSGY----------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred --HH---HHHHhcCC----------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 01 11111110 0111223446789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=322.67 Aligned_cols=262 Identities=20% Similarity=0.348 Sum_probs=211.7
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++|++.+.||+|+||.||+|... +++.||||.+.... .......+.+|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47888999999999999999964 78999999875422 2334567889999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++|+|.+++.........++......++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998876544455688889999999999999999999 999999999999999999999999999987643
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
.... .....|+..|+|||.+.+..++.++||||||+++|||+||+.||...... ............
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~------~~~~~~~~~~~~------- 224 (267)
T cd08228 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LFSLCQKIEQCD------- 224 (267)
T ss_pred hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc------HHHHHHHHhcCC-------
Confidence 3221 22345888999999998888999999999999999999999998532211 111111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 574 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 574 (619)
.........+..+.+++.+||+.+|++||++.+|++.++.++
T Consensus 225 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 225 --YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 111112344567899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=326.97 Aligned_cols=261 Identities=24% Similarity=0.398 Sum_probs=205.7
Q ss_pred HHhcCCcccCccccCCCceEEEEEeC------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCC
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT 364 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 364 (619)
+..++|+..+.||+|+||.||+|.+. ++..||+|++..........+|.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999999853 356799999865443344567899999999999999999999999999
Q ss_pred cceeEecccccchhhhhhcccCCC------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPG------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV 438 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 438 (619)
..++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 999999999999999998753321 23467888899999999999999998 999999999999999999999
Q ss_pred EcccccceeeccCCcce-eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHH
Q 007073 439 VGDFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHV 516 (619)
Q Consensus 439 l~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 516 (619)
|+|||+++......... .....++..|+|||.+.++.++.++|||||||++|||+| |..||...... ...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--------~~~ 231 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--------QVL 231 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHH
Confidence 99999987654322211 112235778999999998899999999999999999999 68887543211 111
Q ss_pred HHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 517 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 517 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
.... ..... ..+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 232 ~~~~-~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 232 RFVM-EGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHH-cCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111 11110 1112234578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=322.42 Aligned_cols=257 Identities=27% Similarity=0.397 Sum_probs=207.4
Q ss_pred hcCCcccCccccCCCceEEEEEeCC----CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
.++|+..+.||+|+||+||+|.++. ...||||.++..........|.+|+.++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 4578889999999999999999742 457999998765555556789999999999999999999999999999999
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||+++++|.+++.... ..+++..+.+++.|++.|++|||+. +|+||||||+||++++++.++|+|||+++..
T Consensus 83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 999999999999987532 2588999999999999999999999 9999999999999999999999999999877
Q ss_pred ccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 449 DVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 449 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||..... ... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-----~~~---~~~~~~~~~~- 227 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-----QDV---IKAVEDGYRL- 227 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-----HHH---HHHHHcCCCC-
Confidence 522221 2222335678999999998999999999999999999998 9988853211 111 1111111000
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
..+...+..+.+++.+||+.+|++||++.+|++.|++.
T Consensus 228 ---------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 ---------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11223346789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=323.01 Aligned_cols=255 Identities=28% Similarity=0.410 Sum_probs=205.9
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
..+|...+.||+|+||.||+|.+. .++.||+|.+... ......+.+|++++++++|+||+++++++......+++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 345778899999999999999975 5889999988642 3345678999999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++++|.+++.... ...+++..+..++.|+++||+|||++ +++||||||+||++++++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 83 FMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred eCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 999999999986533 23478999999999999999999999 9999999999999999999999999999876433
Q ss_pred CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
.........++..|+|||.+.+..++.++|||||||++|||+| |..||...... +........
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--------~~~~~~~~~-------- 221 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYELLEKG-------- 221 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCC--------
Confidence 2222222334668999999999999999999999999999998 88888642211 111111110
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
.....+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 222 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 222 --YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 1111222334678999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=325.42 Aligned_cols=259 Identities=25% Similarity=0.417 Sum_probs=207.6
Q ss_pred hcCCcccCccccCCCceEEEEEeCC------CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 366 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 366 (619)
.++|.+.+.||+|+||.||+|...+ +..||||.+.........+.+.+|+++++.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3467788999999999999998643 4789999987655444567899999999999999999999999999999
Q ss_pred eeEecccccchhhhhhcccCC----------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc
Q 007073 367 LLVYPFMQNLSVAYRLREIKP----------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE 436 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 436 (619)
++||||+++++|.++++.... ....+++.....++.|++.|++|||++ +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 999999999999999976421 234578889999999999999999999 9999999999999999999
Q ss_pred EEEcccccceeeccCCc-ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHH
Q 007073 437 AVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLD 514 (619)
Q Consensus 437 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 514 (619)
+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... ....
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-----~~~~ 235 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-----EVIE 235 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-----HHHH
Confidence 99999999976533221 11223345788999999999999999999999999999999 99998532211 1111
Q ss_pred HHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 515 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
. .. .+.. ...+...+..+.+++.+||+.||++||++.||++.|++
T Consensus 236 ~---~~-~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 236 C---IT-QGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred H---HH-cCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1 11 1111 11122334678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=332.13 Aligned_cols=257 Identities=26% Similarity=0.408 Sum_probs=203.7
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCc----EEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcce
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGT----KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 367 (619)
..+|+..+.||+|+||.||+|.+. +|. .||+|.++........+.+.+|+.+++.++||||++++|++... ...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 356888999999999999999864 333 48999987544445567899999999999999999999998764 567
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
+++||+++|+|.+++.... ..+++.....++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 9999999999999987643 3478888999999999999999999 999999999999999999999999999987
Q ss_pred eccCCccee-eeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 448 VDVRKTNVT-TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 448 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
......... ....++..|+|||.+.+..++.++|||||||++|||+| |+.||+..... +...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~ 230 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------EISSILEKGERL 230 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHhCCCCC
Confidence 654332221 22234678999999999999999999999999999998 99998642211 111111111110
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 574 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 574 (619)
..+.....++.+++.+||+.+|++||++.+++..+....
T Consensus 231 ----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 231 ----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred ----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111123357889999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=325.87 Aligned_cols=264 Identities=19% Similarity=0.241 Sum_probs=202.0
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC-cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
++|++.+.||+|+||+||+|..+ +++.||+|++..... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999975 688999999875332 3345678899999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|++++.+...... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 9999877655432 23488889999999999999999999 9999999999999999999999999999876443
Q ss_pred CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHH-----------HHh
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK-----------KLE 520 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~~ 520 (619)
.........|++.|+|||++.+..++.++|||||||++|||++|+.||....... ....... ...
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID----QLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhhCCCCHHHHHhhh
Confidence 3333334568999999999998899999999999999999999999996432111 0000000 000
Q ss_pred hhcccchhcccccc------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 521 REKRLDAIVDRNLN------KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 521 ~~~~~~~~~~~~l~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..........+... .......+..+.+++.+|++.||++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000000 0001123457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=325.63 Aligned_cols=263 Identities=23% Similarity=0.309 Sum_probs=199.8
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
++|...+.||+|+||+||+|... +++.||+|.++..........+.+|++++++++||||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999965 68999999987544444456778999999999999999999999998889999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++ +|.+++... ...+++.....++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 985 888877643 23478889999999999999999999 99999999999999999999999999997654322
Q ss_pred cceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh----------
Q 007073 453 TNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER---------- 521 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 521 (619)
. ......|++.|+|||.+.+ ..++.++||||+||++|||+||+.||........ +.........
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE----LHLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred c-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCChHHhhccc
Confidence 2 1233457899999998865 5689999999999999999999999965332111 1111110000
Q ss_pred -hcccchhccccccCCC----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 522 -EKRLDAIVDRNLNKNY----NIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 522 -~~~~~~~~~~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.........+...... .+....+..+++.+|++.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000101000000 1122356789999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=328.87 Aligned_cols=263 Identities=19% Similarity=0.225 Sum_probs=209.8
Q ss_pred HHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcc
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 366 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 366 (619)
....++|+..++||+|+||.||.|+-+ +|..+|+|++++.. ...+.+....|-.+|...++|.||+++-.|++.+..
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 346678999999999999999999965 69999999998653 345667888999999999999999999999999999
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
||||||++||++..+|... ..++....+.++.+++-|+..+|+. |+|||||||+|+|||..|++||+|||++.
T Consensus 217 YLiMEylPGGD~mTLL~~~----~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRK----DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEEecCCccHHHHHHhc----CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccc
Confidence 9999999999999999863 3488899999999999999999999 99999999999999999999999999985
Q ss_pred eeccC----------------------Ccc-----e-------------------eeeccccccccccccccCCCCCcch
Q 007073 447 LVDVR----------------------KTN-----V-------------------TTQVRGTMGHIAPEYLSTGKSSERT 480 (619)
Q Consensus 447 ~~~~~----------------------~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~ 480 (619)
-+... +.. . ....+|||-|||||++.+..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 43110 000 0 0124699999999999999999999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCC
Q 007073 481 DVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDR 560 (619)
Q Consensus 481 Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 560 (619)
|+||+|||+|||+.|.+||......+.. ..+..|...+..+. ......+..+||.+|+. ||++|
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~-rkI~nwr~~l~fP~--------------~~~~s~eA~DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETY-RKIVNWRETLKFPE--------------EVDLSDEAKDLITRLLC-DPENR 433 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhhhccCCC--------------cCcccHHHHHHHHHHhc-CHHHh
Confidence 9999999999999999999765433221 12223332222111 11222578899999999 99999
Q ss_pred CCHHHHHHHHhcCCcc
Q 007073 561 PAMSEVVRMLEGEGLA 576 (619)
Q Consensus 561 Ps~~evl~~L~~~~~~ 576 (619)
-. ..=++.+++..++
T Consensus 434 LG-~~G~~EIK~HPfF 448 (550)
T KOG0605|consen 434 LG-SKGAEEIKKHPFF 448 (550)
T ss_pred cC-cccHHHHhcCCcc
Confidence 87 3334555555544
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=334.89 Aligned_cols=263 Identities=27% Similarity=0.415 Sum_probs=205.1
Q ss_pred HHhcCCcccCccccCCCceEEEEEeC------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeCC
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTP 363 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 363 (619)
+..++|++.+.||+|+||.||+|... +++.||+|+++........+.+.+|+.++.++ +|+||+++++++...
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 44567899999999999999999742 35789999987544444556788999999999 799999999988654
Q ss_pred -CcceeEecccccchhhhhhcccCCC------------------------------------------------------
Q 007073 364 -TERLLVYPFMQNLSVAYRLREIKPG------------------------------------------------------ 388 (619)
Q Consensus 364 -~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------ 388 (619)
...++++||+++++|.+++......
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 4577899999999999888542210
Q ss_pred ---CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcce-eeecccccc
Q 007073 389 ---EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV-TTQVRGTMG 464 (619)
Q Consensus 389 ---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~ 464 (619)
...+++..+.+++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.+....... .....++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 12578999999999999999999999 99999999999999999999999999998764332221 223346778
Q ss_pred ccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHH
Q 007073 465 HIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVE 543 (619)
Q Consensus 465 y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 543 (619)
|+|||++.+..++.++|||||||++|||+| |..||....... .+. .... ... ....+.....
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~----~~~---~~~~-~~~---------~~~~~~~~~~ 303 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE----EFC---RRLK-EGT---------RMRAPEYATP 303 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH----HHH---HHHh-ccC---------CCCCCccCCH
Confidence 999999999999999999999999999998 999986422110 011 1111 000 0011122346
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 544 TMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 544 ~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
++.+++.+||+.+|++||++.++++.|++.
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=347.21 Aligned_cols=252 Identities=29% Similarity=0.439 Sum_probs=211.0
Q ss_pred cccCccccCCCceEEEEEe-CCC----cEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 297 SEKNVLGQGGFGKVYRGVL-ADG----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 297 ~~~~~lg~G~fg~Vy~~~~-~~g----~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
...++||+|+||+||+|.| .+| -+||+|++.+........+++.|+-.|++++|||+++++|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3467999999999999996 333 4799999988888888899999999999999999999999998777 889999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
||+.|+|.++++..+. .+.....+.|..|||+||.|||++ ++|||||.++|||+..-..+||.|||+++....+
T Consensus 778 ~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred hcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 9999999999998543 477888899999999999999999 9999999999999999999999999999988765
Q ss_pred Ccceeee-ccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 452 KTNVTTQ-VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 452 ~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
....... ..-.+.|||-|.+....|+.++|||||||++||++| |..|++....++ .-..++.+.+
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e--------I~dlle~geR----- 918 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE--------IPDLLEKGER----- 918 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH--------hhHHHhcccc-----
Confidence 5443332 233568999999999999999999999999999999 899987544321 1111112222
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
-..++-+..++..++.+||..|++.||+++++...+.+.
T Consensus 919 -----LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 919 -----LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred -----CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 123555667899999999999999999999999887764
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=318.90 Aligned_cols=252 Identities=24% Similarity=0.364 Sum_probs=203.3
Q ss_pred cCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEeccc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 373 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 373 (619)
++|.+.+.||+|+||+||+|.+.++..+|+|.+.... ...+.|.+|+.++++++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 4577889999999999999998777789999886432 23567899999999999999999999999888899999999
Q ss_pred ccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCc
Q 007073 374 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 453 (619)
Q Consensus 374 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 453 (619)
++|+|.+++.... ..+++..+.+++.|++.||+|||+. +++|+||||+||+++.++.+||+|||.++.......
T Consensus 82 ~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 82 SNGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 9999999887532 2488999999999999999999999 999999999999999999999999999986643322
Q ss_pred ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 454 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 454 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
.......++..|+|||.+.+..++.++||||||+++|||+| |+.||...... .. ..........
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----~~---~~~~~~~~~~------- 220 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-----ET---VEKVSQGLRL------- 220 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----HH---HHHHhcCCCC-------
Confidence 22223345678999999998889999999999999999999 99998532211 11 1111111110
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 571 (619)
......+..+.+++.+||+.+|++||++.++++.|+
T Consensus 221 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 ---YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 011122468899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=323.70 Aligned_cols=258 Identities=24% Similarity=0.397 Sum_probs=204.6
Q ss_pred cCCcccCccccCCCceEEEEEe-----CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
++|++.+.||+|+||.||+|.+ .++..||+|.+...........+.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577789999999999999984 25678999999754444455788999999999999999999999999999999
Q ss_pred EecccccchhhhhhcccCC-------------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC
Q 007073 369 VYPFMQNLSVAYRLREIKP-------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 435 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 435 (619)
||||+++++|.+++..... ....+++.....++.|++.||+|||++ +++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999853221 123478888999999999999999999 999999999999999999
Q ss_pred cEEEcccccceeeccCCc-ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHH
Q 007073 436 EAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLL 513 (619)
Q Consensus 436 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~ 513 (619)
.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||+| |..||..... ....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-----~~~~ 236 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-----QEVI 236 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-----HHHH
Confidence 999999999986543222 11223345678999999988889999999999999999999 8888853221 1111
Q ss_pred HHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 514 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
+ ........ ..+...+..+.+++.+||+.+|++||++.+|.+.|++
T Consensus 237 ~---~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 E---MVRKRQLL----------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H---HHHcCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 11110000 1112234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=314.95 Aligned_cols=248 Identities=29% Similarity=0.418 Sum_probs=200.1
Q ss_pred CccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccchhh
Q 007073 300 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVA 379 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 379 (619)
++||+|+||.||+|...+++.||+|.+...........+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46899999999999988899999999875544444567899999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcceeeec
Q 007073 380 YRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 459 (619)
Q Consensus 380 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 459 (619)
+++.... ..+++..+..++.|++.||.|+|++ +++||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKKK---DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 9886532 3478999999999999999999999 999999999999999999999999999975433222222222
Q ss_pred cccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCC
Q 007073 460 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 538 (619)
Q Consensus 460 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 538 (619)
.++..|+|||++.++.++.++||||||+++||+++ |..||...... ........... ....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--------~~~~~~~~~~~----------~~~~ 216 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--------QAREQVEKGYR----------MSCP 216 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHHcCCC----------CCCC
Confidence 34668999999998999999999999999999999 89898643211 11111111111 1111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007073 539 IQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571 (619)
Q Consensus 539 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 571 (619)
...+..+.+++.+|++.+|++||++.++++.|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 223467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=334.37 Aligned_cols=249 Identities=20% Similarity=0.317 Sum_probs=194.1
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
++|+..+.||+|+||.||+|.+. +|+.||||.+...........+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34555788999999999999965 68999999986544444567889999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++|+|.... .........++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999986432 245667788999999999999999 99999999999999999999999999998764321
Q ss_pred cceeeeccccccccccccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccch
Q 007073 453 TNVTTQVRGTMGHIAPEYLST-----GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (619)
.......||..|+|||.+.. ...+.++|||||||++|||++|+.||....... ............
T Consensus 223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~---- 292 (353)
T PLN00034 223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-----WASLMCAICMSQ---- 292 (353)
T ss_pred -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-----HHHHHHHHhccC----
Confidence 12234568999999998743 234568999999999999999999997322110 001111110000
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 528 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
..........++.+++.+||+.||++||++.|+++.
T Consensus 293 ------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 ------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011122334678999999999999999999999863
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=329.09 Aligned_cols=202 Identities=24% Similarity=0.340 Sum_probs=176.0
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
..++|++.+.||+|+||.||++.+. +|..+|+|.+...........+.+|++++++++|+||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3578999999999999999999976 688999998865444445577899999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++|+|.+++... ..+++.....++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 83 EHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 999999999998753 23788888999999999999999742 699999999999999999999999999875532
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 502 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~ 502 (619)
. ......|+..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred h---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 2 123346899999999999888999999999999999999999999743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=333.21 Aligned_cols=254 Identities=20% Similarity=0.245 Sum_probs=203.4
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++|++.+.||+|+||.||+|... +|+.||+|++.... .......+.+|++++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999976 58999999986432 2234567889999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++|+|.+++... ..+++.....++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 999999999999753 2478889999999999999999999 999999999999999999999999999976533
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
......||+.|+|||++.+..++.++|||||||++|||+||+.||....... ......... ....
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~---~~~~ 218 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--------TWENLKYWK---ETLQ 218 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH--------HHHHHHhcc---cccc
Confidence 2234568999999999999999999999999999999999999997533211 111111000 0011
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
...........+.++.+++.+|++.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 219 RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000000012334678899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=320.35 Aligned_cols=257 Identities=28% Similarity=0.433 Sum_probs=209.4
Q ss_pred HHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
....+|+..+.||+|+||.||+|...++..+|+|.+.... ......+..|+.+++.++|+||+++++++...+..++||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 3456788899999999999999999889999999986432 234567889999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++++|.+++.... ...+++..+..++.|++.|++|||+. +++|+||||+||++++++.+||+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 82 ELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred eecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 9999999999997643 24488999999999999999999999 999999999999999999999999999986643
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
.... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... . +........
T Consensus 157 ~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~-----~---~~~~~~~~~------- 220 (261)
T cd05148 157 DVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-----H---EVYDQITAG------- 220 (261)
T ss_pred cccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH-----H---HHHHHHHhC-------
Confidence 2221 223346778999999998899999999999999999999 8888854321 1 111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
.....+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 221 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 221 ---YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred ---CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 0111123344678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=338.42 Aligned_cols=265 Identities=24% Similarity=0.355 Sum_probs=207.7
Q ss_pred HHHHhcCCcccCccccCCCceEEEEEeC------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc-CCCccceeeeee
Q 007073 289 LQLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCT 361 (619)
Q Consensus 289 l~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~ 361 (619)
++...++|.+.+.||+|+||.||+|.+. .++.||||+++..........+.+|++++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3445567888899999999999999863 346899999975444444567889999999997 999999999999
Q ss_pred CCCcceeEecccccchhhhhhcccCC------------------------------------------------------
Q 007073 362 TPTERLLVYPFMQNLSVAYRLREIKP------------------------------------------------------ 387 (619)
Q Consensus 362 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 387 (619)
.....++|+||+++|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999865321
Q ss_pred ----------------------------------------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 007073 388 ----------------------------------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAA 427 (619)
Q Consensus 388 ----------------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~ 427 (619)
....+++....+++.|++.||+|||+. +++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 112467788899999999999999998 9999999999
Q ss_pred cEEeCCCCcEEEcccccceeeccCCc-ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccc
Q 007073 428 NVLLDEDFEAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLE 505 (619)
Q Consensus 428 NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~ 505 (619)
|||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999986532221 11222346788999999998889999999999999999998 88888643211
Q ss_pred cccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 506 EEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
. .. ........ ....+...+.++.+++.+||+.+|++||++.+|++.|++.
T Consensus 349 ~----~~---~~~~~~~~----------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 349 E----QF---YNAIKRGY----------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred H----HH---HHHHHcCC----------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0 00 01111110 0111222346889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=327.70 Aligned_cols=244 Identities=21% Similarity=0.221 Sum_probs=198.6
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++|++.+.||+|+||.||+|... +|+.||+|++.... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999975 68999999986322 2234567889999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++|+|.+++.... .+++.....++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999987532 378888999999999999999999 999999999999999999999999999986532
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
. .....|++.|+|||.+.+..++.++|||||||++|||+||+.||...... ......... .
T Consensus 154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~-~------ 214 (291)
T cd05612 154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF--------GIYEKILAG-K------ 214 (291)
T ss_pred C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC-C------
Confidence 2 22346899999999999988999999999999999999999998643211 111111110 0
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHH
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVV 567 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl 567 (619)
. .++......+.+++.+|++.||.+||+ +.+++
T Consensus 215 --~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l 252 (291)
T cd05612 215 --L--EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVK 252 (291)
T ss_pred --c--CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHh
Confidence 0 111222457889999999999999995 66665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=317.54 Aligned_cols=255 Identities=25% Similarity=0.402 Sum_probs=204.5
Q ss_pred HhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
..++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 3457888899999999999999988888999999864322 3467899999999999999999999875 456789999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++++|.++++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 81 YMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred ecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 999999999987532 23478999999999999999999999 9999999999999999999999999999876443
Q ss_pred CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
.........++..|+|||.+.+..++.++||||||+++|||++ |+.||..... . +........
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----~---~~~~~~~~~-------- 219 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-----R---EVLEQVERG-------- 219 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-----H---HHHHHHHcC--------
Confidence 2222223345678999999988899999999999999999999 8888853211 1 111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
.....+...+..+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 220 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 --YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111122344678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=321.82 Aligned_cols=261 Identities=25% Similarity=0.403 Sum_probs=209.7
Q ss_pred HhcCCcccCccccCCCceEEEEEeCC-----CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeC-CCc
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLAD-----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT-PTE 365 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~ 365 (619)
..++|.+.++||+|+||.||+|.+.+ +..||+|++...........+.+|+.++++++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45788899999999999999999765 788999998765555566788999999999999999999998866 467
Q ss_pred ceeEecccccchhhhhhcccCCC----CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPG----EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD 441 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 441 (619)
.+++++|+++++|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 88999999999999998764332 25589999999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCcce-eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHH
Q 007073 442 FGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKL 519 (619)
Q Consensus 442 fGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 519 (619)
||+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||..... . +.....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~---~~~~~~ 232 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-----F---EMAAYL 232 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-----H---HHHHHH
Confidence 99998654333221 122345678999999988889999999999999999999 9999864221 1 111111
Q ss_pred hhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 520 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 520 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
...... ......+..+.+++.+||+.+|++|||+.++++.|++.
T Consensus 233 ~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 233 KDGYRL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred HcCCCC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111111 01112345789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=325.79 Aligned_cols=265 Identities=23% Similarity=0.302 Sum_probs=197.5
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.++|++.+.||+|+||.||+|... +|+.||||.+...........+.+|+.+++.++||||+++++++..+...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467899999999999999999975 6899999998754433444567889999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|++ ++|.+++... ...++...+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 5676666542 23378888999999999999999999 9999999999999999999999999999754322
Q ss_pred CcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc--ccc--
Q 007073 452 KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK--RLD-- 526 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-- 526 (619)
. .......|++.|+|||.+.+ ..++.++||||+||++|||+||+.||....... ..+........... ...
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 157 S-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ---DQLERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred C-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH---HHHHHHHHHhCCCChhhccch
Confidence 2 12233458899999998865 458899999999999999999999997432110 00000000000000 000
Q ss_pred -h--hccc-ccc---C-CC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 527 -A--IVDR-NLN---K-NY-----NIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 527 -~--~~~~-~l~---~-~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. ...+ ... . .. .......+.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0 0000 000 0 00 0011246789999999999999999999884
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=330.94 Aligned_cols=252 Identities=23% Similarity=0.344 Sum_probs=214.6
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccC-CCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCc-ceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF-ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE-RLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~lv~ 370 (619)
++|...+.+|+|+||.++..+++ +++.+++|.+.-. .+........+|+.++++++|||||.+.+.+..++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56888999999999999999965 6889999988633 233445578899999999999999999999999888 89999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
+|++||++.+.+.+.+ +..++.....+++.|++.|+.|||++ +|+|||||+.||+++.+..|||+|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998765 45689999999999999999999998 999999999999999999999999999999876
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
... ....+.||+.||.||.+.+.+|..|+||||+||++|||++-+++|....+.+ .+.+.. .
T Consensus 159 ~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~--------Li~ki~---------~ 220 (426)
T KOG0589|consen 159 EDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE--------LILKIN---------R 220 (426)
T ss_pred chh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH--------HHHHHh---------h
Confidence 552 3455779999999999999999999999999999999999999997654321 111111 1
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
. .....+..++.++..++..|++.+|..||++.+++.+
T Consensus 221 ~-~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 G-LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred c-cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1 1123456677899999999999999999999999976
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=315.38 Aligned_cols=248 Identities=28% Similarity=0.408 Sum_probs=197.7
Q ss_pred CccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccchh
Q 007073 300 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV 378 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 378 (619)
+.||+|+||.||+|... +|+.||+|.............+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999974 78999999886544455567899999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCccee-e
Q 007073 379 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT-T 457 (619)
Q Consensus 379 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~ 457 (619)
.+++... ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++........... .
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9998653 23478999999999999999999999 999999999999999999999999999875432211111 1
Q ss_pred eccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCC
Q 007073 458 QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKN 536 (619)
Q Consensus 458 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 536 (619)
...++..|+|||.+.++.++.++||||||+++|||++ |..||...... ........ .....
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--------~~~~~~~~----------~~~~~ 216 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--------QTREAIEQ----------GVRLP 216 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--------HHHHHHHc----------CCCCC
Confidence 1123457999999999999999999999999999998 88887532110 00011100 00111
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007073 537 YNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571 (619)
Q Consensus 537 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 571 (619)
.+...+..+.+++.+|++.+|++|||+.++.++|+
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 12233467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=316.00 Aligned_cols=261 Identities=22% Similarity=0.361 Sum_probs=212.6
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccC--CCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++|++.+.||+|+||.||+|... +|+.||+|.++.. ......+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999976 7999999988632 22334678899999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++++|..++.........++...+..++.+++.||+|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999876555556689999999999999999999999 999999999999999999999999999886543
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
.... .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...... ..+.......
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~--------- 222 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEK--------- 222 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc------HHHHHhhhhc---------
Confidence 3222 22345888999999999888999999999999999999999998543211 1111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
..............+.+++.+||+.+|++|||+.+|+++|+.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 223 CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 0011111224456889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=334.80 Aligned_cols=262 Identities=20% Similarity=0.241 Sum_probs=197.1
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
...+|++.+.||+|+||.||++... +++.||+|... ...+.+|++++++++||||+++++++......++|+
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 3457999999999999999999964 68899999653 235678999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
|++. ++|..++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 163 e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 163 PRYK-TDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred ecCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence 9986 5777777543 2378899999999999999999999 999999999999999999999999999975433
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccc---cchhHHHHHHHHhh---h--
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE---DDVLLLDHVKKLER---E-- 522 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~---~-- 522 (619)
..........||+.|+|||++.+..++.++|||||||++|||+||+.|+........ ....+......... .
T Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 222233445799999999999999999999999999999999999988643211100 00011111110000 0
Q ss_pred ----cccchhc---------cccccCC--CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 523 ----KRLDAIV---------DRNLNKN--YNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 523 ----~~~~~~~---------~~~l~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..+.... .+..... .....+.++.+++.+|++.||++|||++|+++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 0000000 01133467899999999999999999999984
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=322.14 Aligned_cols=267 Identities=25% Similarity=0.339 Sum_probs=202.5
Q ss_pred CcccCccccCCCceEEEEEe-----CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCC--Cccee
Q 007073 296 FSEKNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERLL 368 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l 368 (619)
|...+.||+|+||+||++.. .+++.||+|.++..........|.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37789999999999988653 367899999987544444567889999999999999999999988654 34789
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||+++++|.+++... .+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 99999999999998652 389999999999999999999999 9999999999999999999999999999866
Q ss_pred ccCCcce--eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 449 DVRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 449 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
....... .....++..|+|||.+.+..++.++||||||+++|||+||+.|+........ ................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE---EMIGPKQGQMTVVRLI 234 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh---hhhcccccccchhhhh
Confidence 4322211 1122356679999999888999999999999999999999999854321100 0000000000000111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
...+.......+...+..+.+++.+||+.+|++|||+++++++|+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111111112233456899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=325.94 Aligned_cols=265 Identities=28% Similarity=0.413 Sum_probs=210.2
Q ss_pred HHHHHhcCCcccCccccCCCceEEEEEeC------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeee
Q 007073 288 ELQLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFC 360 (619)
Q Consensus 288 el~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~ 360 (619)
++....++|+..+.||+|+||.||++... +...+|+|.+...........+.+|++++.++ +|+||+++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34456678889999999999999999864 23679999987544444556788999999999 799999999999
Q ss_pred eCCCcceeEecccccchhhhhhcccC------------CCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 007073 361 TTPTERLLVYPFMQNLSVAYRLREIK------------PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN 428 (619)
Q Consensus 361 ~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 428 (619)
......+++|||+++|+|..+++... .....+++..+.+++.|++.||+|||+. +|+||||||+|
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~N 162 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARN 162 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccceee
Confidence 99999999999999999999986532 2234688999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEcccccceeeccCCcce-eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccc
Q 007073 429 VLLDEDFEAVVGDFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEE 506 (619)
Q Consensus 429 Ill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~ 506 (619)
|++++++.+||+|||+++.+....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~- 241 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE- 241 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-
Confidence 999999999999999998664332211 122235678999999988899999999999999999998 88887532211
Q ss_pred ccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 507 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
+......... ....+......+.+++.+||+.+|++|||+.++++.|++.
T Consensus 242 -------~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 242 -------ELFKLLKEGY----------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred -------HHHHHHHcCC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 1111111110 0111223346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=316.87 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=201.8
Q ss_pred cCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEeccc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 373 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 373 (619)
.+|++.+.||+|+||.||+|.++++..+|+|.+.+.. .....|.+|++++++++|+||+++++++......++|+||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 3577789999999999999998877899999886432 23457889999999999999999999999999999999999
Q ss_pred ccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCc
Q 007073 374 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 453 (619)
Q Consensus 374 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 453 (619)
++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 82 ANGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 9999999987532 2488999999999999999999999 999999999999999999999999999986543222
Q ss_pred ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 454 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 454 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
.......++..|+|||.+.+..++.++||||||+++|||+| |+.||+..... +.........
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~--------- 218 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--------EVVESVSAGY--------- 218 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--------HHHHHHHcCC---------
Confidence 21222234567999999999999999999999999999999 78888643211 1111111100
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 570 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 570 (619)
....+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 219 -~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 219 -RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0011122356899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=315.66 Aligned_cols=254 Identities=26% Similarity=0.387 Sum_probs=204.1
Q ss_pred hcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
.++|++.+.||+|+||.||+|.+.++..||+|++.... ...+.|.+|++++++++|+||+++++++. ....++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc--cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 45688999999999999999998777789999986422 23467899999999999999999999874 4557899999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 82 MSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999997532 23478899999999999999999999 99999999999999999999999999998765433
Q ss_pred cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhccc
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (619)
........++..|+|||...+..++.++||||||+++|||+| |+.||...... ..........
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--------~~~~~~~~~~-------- 220 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQVERGY-------- 220 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--------HHHHHHhcCC--------
Confidence 322223446778999999998899999999999999999999 77787532210 0111111100
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 532 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
........+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 221 --~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 221 --RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred --CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 011123445678999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=323.72 Aligned_cols=263 Identities=24% Similarity=0.345 Sum_probs=195.0
Q ss_pred cCCcccCccccCCCceEEEEEeC--CCcEEEEEEeccCCC-cchHHHHHHHHHHHHHc---cCCCccceeeeeeC-----
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA--DGTKVAVKRLTDFES-PGGDAAFQREVEMISVA---VHRNLLRLIGFCTT----- 362 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~--~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~----- 362 (619)
++|++.+.||+|+||.||+|... +|+.||+|+++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 468899998864332 22345567788877765 69999999998852
Q ss_pred CCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007073 363 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 442 (619)
Q Consensus 363 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 442 (619)
....++||||+. ++|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 345789999997 588888865332 3478899999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh--
Q 007073 443 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE-- 520 (619)
Q Consensus 443 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 520 (619)
|+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .+........
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~----~~~~i~~~~~~~ 228 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD----QLGKILDVIGLP 228 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH----HHHHHHHHhCCC
Confidence 999865433 22334568999999999988899999999999999999999999997532211 1111111100
Q ss_pred hhccc-c------hhccccccC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 521 REKRL-D------AIVDRNLNK---NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 521 ~~~~~-~------~~~~~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.+... . ......... ...+.....+.+++.+|++.||++|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 0 000000000 001223456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=322.34 Aligned_cols=258 Identities=28% Similarity=0.392 Sum_probs=204.3
Q ss_pred CCcccCccccCCCceEEEEEeC------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
+|.+.+.||+|+||.||+|... ....+|+|.+...........+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677899999999999999853 2357899988754444455788999999999999999999999999999999
Q ss_pred EecccccchhhhhhcccCC--------------------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 007073 369 VYPFMQNLSVAYRLREIKP--------------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN 428 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 428 (619)
++||+.+++|.+++..... ....+++.....++.|++.||+|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 9999999999998864321 123478899999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEcccccceeeccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccc
Q 007073 429 VLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEE 506 (619)
Q Consensus 429 Ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~ 506 (619)
|++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||+| |+.||......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 99999999999999999865332221 1222345678999999988889999999999999999999 99998643211
Q ss_pred ccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 507 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.+... .... .....+...+.++.+++.+|++.+|++||++.++++.|+++
T Consensus 237 ----~~~~~---~~~~----------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 237 ----RLFNL---LKTG----------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred ----HHHHH---HhCC----------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 11111 1110 01111222345788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=319.84 Aligned_cols=255 Identities=22% Similarity=0.357 Sum_probs=199.7
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCc----EEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGT----KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
++|+..+.||+|+||+||+|.+. +|+ .+++|.+..........++..|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46778899999999999999974 344 4788887543333345677888889999999999999998754 45778
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
++||+++|+|.+++.... ..+++.....++.|++.||+|||++ +++||||||+||++++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 999999999999997532 3488999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 449 DVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 449 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
...... ......++..|+|||.+.++.++.++||||||+++|||+| |+.||...... ...+.. ..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----~~~~~~----~~~~~- 229 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-----EVPDLL----EKGER- 229 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHH----HCCCc-
Confidence 433221 2234457789999999998999999999999999999998 99998643211 111111 11110
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
... +......+.+++.+||+.+|++|||+.|+++.|+..
T Consensus 230 -~~~-------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 230 -LAQ-------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred -CCC-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 000 111234678899999999999999999999988773
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=314.64 Aligned_cols=259 Identities=24% Similarity=0.327 Sum_probs=197.4
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCC-----ccee
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT-----ERLL 368 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~l 368 (619)
.|...+++|.|+||.||+|... ++..||||+...... --.+|+.+|+.++|||||++.-++.... ...+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 4566789999999999999964 579999998853221 1136899999999999999988875432 2458
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-CcEEEccccccee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLAKL 447 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~~ 447 (619)
|||||+. +|.+.++.+...+..++...++-+..|+.+||+|||+. +|+||||||.|+|+|.+ +.+||+|||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999997 99999987665666688888889999999999999998 99999999999999977 9999999999998
Q ss_pred eccCCcceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh--cc
Q 007073 448 VDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE--KR 524 (619)
Q Consensus 448 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~ 524 (619)
+...... ..+..|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.+.. ..+...++-+..+ +.
T Consensus 176 L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~----dQL~eIik~lG~Pt~e~ 249 (364)
T KOG0658|consen 176 LVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV----DQLVEIIKVLGTPTRED 249 (364)
T ss_pred eccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH----HHHHHHHHHhCCCCHHH
Confidence 8665544 344568899999998774 6999999999999999999999998763321 1122222211111 00
Q ss_pred cc-------hhccccccC-----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 525 LD-------AIVDRNLNK-----NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 525 ~~-------~~~~~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
+. +...+.+.. -+......+..+++.++++.+|.+|.++.|++.
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 00 011111111 123345578899999999999999999999873
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=320.73 Aligned_cols=259 Identities=26% Similarity=0.384 Sum_probs=204.5
Q ss_pred HhcCCcccCccccCCCceEEEEEeCC------CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCc
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE 365 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 365 (619)
..++|.+.+.||+|+||.||+|.+.+ +..||+|.............|.+|+.+++.++|+||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45678889999999999999999753 567999988654444456779999999999999999999999998889
Q ss_pred ceeEecccccchhhhhhcccCCC---CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC---cEEE
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPG---EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF---EAVV 439 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl 439 (619)
.++||||+++++|.+++...... ...+++..+.+++.|++.||+|||++ +++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 99999999999999998765321 23589999999999999999999999 999999999999998654 6999
Q ss_pred cccccceeeccCCcce-eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHH
Q 007073 440 GDFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVK 517 (619)
Q Consensus 440 ~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 517 (619)
+|||+++......... ......+..|+|||++.+..++.++|||||||++|||+| |..||+..... ... .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-----~~~---~ 232 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-----EVM---E 232 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHH---H
Confidence 9999998663222111 112223568999999999999999999999999999997 99998643211 111 1
Q ss_pred HHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007073 518 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571 (619)
Q Consensus 518 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 571 (619)
....... ...+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 233 ~~~~~~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 FVTGGGR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHcCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111100 1112223467899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=329.89 Aligned_cols=240 Identities=23% Similarity=0.251 Sum_probs=196.2
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
.++|++.+.||+|+||.||+|.+. +|+.||+|.+.... .....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 356888999999999999999975 68999999986422 223456788999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||+++|+|.+++... ..++......++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 97 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 97 LEFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EcCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 9999999999998753 2378888889999999999999999 99999999999999999999999999998664
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
... ....||+.|+|||.+.+..++.++|||||||++|||+||+.||..... ......... +..
T Consensus 170 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~-~~~---- 232 (329)
T PTZ00263 170 DRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--------FRIYEKILA-GRL---- 232 (329)
T ss_pred CCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--------HHHHHHHhc-CCc----
Confidence 322 234689999999999999999999999999999999999999964221 011111111 110
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCC
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPA 562 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 562 (619)
.++......+.+++.+||+.||++||+
T Consensus 233 ------~~p~~~~~~~~~li~~~L~~dP~~R~~ 259 (329)
T PTZ00263 233 ------KFPNWFDGRARDLVKGLLQTDHTKRLG 259 (329)
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHHcCC
Confidence 011112346789999999999999997
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=331.27 Aligned_cols=242 Identities=21% Similarity=0.236 Sum_probs=195.3
Q ss_pred CccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccc
Q 007073 300 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL 376 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 376 (619)
+.||+|+||.||++... +|+.||+|+++... .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 78999999986432 2234456788999999999999999999999999999999999999
Q ss_pred hhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCccee
Q 007073 377 SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 456 (619)
Q Consensus 377 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 456 (619)
+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~ 152 (323)
T cd05571 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATM 152 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcc
Confidence 999888753 3478899999999999999999999 9999999999999999999999999998753222 1223
Q ss_pred eeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCC
Q 007073 457 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKN 536 (619)
Q Consensus 457 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 536 (619)
....||+.|+|||.+.+..++.++|||||||++|||+||+.||...... .. ...... +. ..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-----~~---~~~~~~-~~----------~~ 213 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KL---FELILM-EE----------IR 213 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-----HH---HHHHHc-CC----------CC
Confidence 3456999999999999999999999999999999999999999642211 01 111100 00 01
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007073 537 YNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 568 (619)
Q Consensus 537 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 568 (619)
++.....++.+++.+|++.||++|| ++.++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 1223346788999999999999999 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=322.20 Aligned_cols=269 Identities=28% Similarity=0.378 Sum_probs=200.9
Q ss_pred cCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHH--ccCCCccceeeeeeCCC----cce
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISV--AVHRNLLRLIGFCTTPT----ERL 367 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~----~~~ 367 (619)
......++||+|.||.||+|.+. ++.||||++. ....+.|..|-++++. ++|+||++++++-.... +++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecC----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 33445678999999999999995 6999999986 3457889999999874 67999999999876555 789
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhc------CCCCeEecCCCCCcEEeCCCCcEEEcc
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH------CNPKIIHRDVKAANVLLDEDFEAVVGD 441 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------~~~~ivH~Dlkp~NIll~~~~~~kl~D 441 (619)
||++|.++|+|.++|..+ .++|....+|+..+++||+|||+. .+|+|+|||||++|||+..|+++.|+|
T Consensus 285 LVt~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred EEeeeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 999999999999999863 489999999999999999999974 467899999999999999999999999
Q ss_pred cccceeeccCCcc-eeeeccccccccccccccCCC-C-----CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHH
Q 007073 442 FGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGK-S-----SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 514 (619)
Q Consensus 442 fGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~-----~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~ 514 (619)
||+|..+...... ..-..+||.+|||||++.+.. + -.+.||||+|.|+|||+++...++....++ ...-+-.
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~-Yqlpfe~ 438 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPE-YQLPFEA 438 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCc-ccCchhH
Confidence 9999988654332 223467999999999996542 2 246899999999999999776554211111 1111110
Q ss_pred HHHHHhhhcccch-hccccccCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 515 HVKKLEREKRLDA-IVDRNLNKNYN-----IQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 515 ~~~~~~~~~~~~~-~~~~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
-+.....-+.+++ ++..+.++.++ -..+..+.+.+..||..||+.|-|+.=|.+++..+
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l 503 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL 503 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence 1111111111111 11111122111 13456788999999999999999998888777654
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=316.54 Aligned_cols=256 Identities=27% Similarity=0.415 Sum_probs=206.2
Q ss_pred HHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
+..++|.+.++||+|+||.||+|..++++.||+|.+.... .....+.+|+.++++++|+||+++++++ ..+..+++|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~ 79 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS--MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIIT 79 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC--CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEE
Confidence 3456788899999999999999999889999999986433 2356789999999999999999999986 455689999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 80 EYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 9999999999886533 23588999999999999999999998 999999999999999999999999999987653
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
..........++..|+|||.+.+..++.++||||||+++|||+| |+.||...... +..........
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~----- 221 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--------EVIQNLERGYR----- 221 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--------HHHHHHHcCCC-----
Confidence 32222223345678999999998889999999999999999999 99998643211 11111111100
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
.......+.++.+++.+|++.+|++||+++++.+.|+.
T Consensus 222 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 -----MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 01112234579999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=322.20 Aligned_cols=258 Identities=22% Similarity=0.328 Sum_probs=203.5
Q ss_pred cCCcccCccccCCCceEEEEEeC------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcce
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 367 (619)
.+|.+.+.||+|+||.||+|... ++..||+|++.........+.+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 34667789999999999999863 357899999975443334567889999999999999999999999999999
Q ss_pred eEecccccchhhhhhcccCC------------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC
Q 007073 368 LVYPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 435 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 435 (619)
+++||+++++|.+++..... ....+++..+..++.|++.||+|||++ +|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 99999999999999853211 123478888999999999999999999 999999999999999999
Q ss_pred cEEEcccccceeeccCCc-ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHH
Q 007073 436 EAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLL 513 (619)
Q Consensus 436 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~ 513 (619)
.+||+|||+++....... .......+++.|+|||.+.++.++.++|||||||++|||+| |..||..... .
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~ 233 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--------Q 233 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--------H
Confidence 999999999886543221 11223346789999999988899999999999999999998 7777753211 1
Q ss_pred HHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 514 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
+.......... ...+.+.+..+.+++.+||+.+|++||++++|++.|+.
T Consensus 234 ~~~~~i~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 DVIEMIRNRQV----------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHHcCCc----------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111111110 11223345678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=321.93 Aligned_cols=263 Identities=25% Similarity=0.411 Sum_probs=207.2
Q ss_pred HHHhcCCcccCccccCCCceEEEEEeC------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCC
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP 363 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 363 (619)
+...++|++.+.||+|+||.||+|..+ .+..||+|.+...........+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 346788999999999999999999753 24589999886544444456788999999999999999999999999
Q ss_pred CcceeEecccccchhhhhhcccCC------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcE
Q 007073 364 TERLLVYPFMQNLSVAYRLREIKP------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA 437 (619)
Q Consensus 364 ~~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 437 (619)
...++||||+++|+|.+++..... +....++..+.+++.|++.||.|||++ +|+||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence 999999999999999999975332 123456778889999999999999999 99999999999999999999
Q ss_pred EEcccccceeeccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHH
Q 007073 438 VVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDH 515 (619)
Q Consensus 438 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 515 (619)
+|+|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||...... +.
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--------~~ 230 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--------QV 230 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HH
Confidence 99999999865332221 1122235678999999998899999999999999999999 78887532211 11
Q ss_pred HHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 516 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 516 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.......... ..+...+..+.+++.+|++.+|++|||+.++++.|++.
T Consensus 231 ~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 231 LKFVMDGGYL----------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHHHcCCCC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1111111100 11122246899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=332.50 Aligned_cols=247 Identities=27% Similarity=0.356 Sum_probs=205.1
Q ss_pred HHHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHcc-CCCccceeeeeeCCC
Q 007073 289 LQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPT 364 (619)
Q Consensus 289 l~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~ 364 (619)
.....++|...++||+|.||+|+++..+ +++.+|||++++.. ..+..+..+.|.+++.... ||.++.++..+++.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 3456678999999999999999999976 67899999998754 3456778889999987765 999999999999999
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 444 (619)
+.+.||||..||++..+.+ ...++.....-++..|+.||.|||++ +||+||||-+|||+|.+|++||+|||+
T Consensus 443 ~l~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGl 514 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGL 514 (694)
T ss_pred eEEEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccc
Confidence 9999999999999433333 23489999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 445 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 445 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
++..- .....++..+||+.|||||++.+..|+.++|+|||||+||||+.|..||.....++-
T Consensus 515 cKe~m-~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~----------------- 576 (694)
T KOG0694|consen 515 CKEGM-GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV----------------- 576 (694)
T ss_pred ccccC-CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-----------------
Confidence 98643 233356678999999999999999999999999999999999999999975443211
Q ss_pred cchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 007073 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAM 563 (619)
Q Consensus 525 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 563 (619)
...++... ..++...+.+...++.+.+..+|++|--+
T Consensus 577 FdsI~~d~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 577 FDSIVNDE--VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHhcCC--CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11111111 12344555788999999999999999766
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=317.10 Aligned_cols=258 Identities=26% Similarity=0.318 Sum_probs=203.5
Q ss_pred HHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC-------------cchHHHHHHHHHHHHHccCCCccce
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-------------PGGDAAFQREVEMISVAVHRNLLRL 356 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-------------~~~~~~~~~E~~~l~~l~H~niv~l 356 (619)
...++|++.+.||+|.||.|-+|... +++.||||++.+... ....+...+|+.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999964 799999999864211 1123578899999999999999999
Q ss_pred eeeeeCC--CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC
Q 007073 357 IGFCTTP--TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED 434 (619)
Q Consensus 357 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 434 (619)
+++..++ +..|+|+|||..|.+...=. ....+...+.++++.++..||+|||.+ +||||||||+|+|++++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCC
Confidence 9999876 46899999999887754322 223389999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccceeeccCC----cceeeeccccccccccccccCCC----CCcchhhHHHHHHHHHHHhCCCCCCCCcccc
Q 007073 435 FEAVVGDFGLAKLVDVRK----TNVTTQVRGTMGHIAPEYLSTGK----SSERTDVFGYGIMLLELVTGQRAIDFSRLEE 506 (619)
Q Consensus 435 ~~~kl~DfGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~ 506 (619)
+++||+|||.+....... .......+||+.|+|||...++. .+.+.||||+||+||.|+.|+.||-....
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~-- 324 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE-- 324 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--
Confidence 999999999998662221 11122367999999999987743 36789999999999999999999953221
Q ss_pred ccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 507 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
.. ....++...+.-...++..+.+.+|+.+++.+||++|.+..+|....--
T Consensus 325 ------~~---------l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 325 ------LE---------LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred ------HH---------HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 11 1223333333333344566889999999999999999999998765543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=305.04 Aligned_cols=263 Identities=23% Similarity=0.270 Sum_probs=201.5
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcch-HHHHHHHHHHHHHccCCCccceeeeeeC--CCcceeE
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGG-DAAFQREVEMISVAVHRNLLRLIGFCTT--PTERLLV 369 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv 369 (619)
++|+..+.|++|.||.||+|+++ +++.||+|+++-.....+ --.-.+|+.++.+.+|||||.+-.+... -+..++|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45777899999999999999965 788999999974332222 2356799999999999999999887754 4679999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
||||+. +|...++... .++...+++-+..|+.+|++|||+. .|+||||||+|+|+++.|.+||+|||+|+.++
T Consensus 156 Me~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999987 8888887644 4588889999999999999999999 89999999999999999999999999999886
Q ss_pred cCCcceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh--cc--
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE--KR-- 524 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~-- 524 (619)
... ...+..+-|..|.|||.+.+. .|+++.|+||+|||+.||+++++.|...+...+-+ ..+..+..+ ..
T Consensus 229 sp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~----~If~llGtPte~iwp 303 (419)
T KOG0663|consen 229 SPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLD----KIFKLLGTPSEAIWP 303 (419)
T ss_pred CCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHH----HHHHHhCCCccccCC
Confidence 543 335556679999999998875 59999999999999999999999887644322111 111111000 00
Q ss_pred ------------cchhccccccCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 525 ------------LDAIVDRNLNKNYNIQ-EVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 525 ------------~~~~~~~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
........++..+... ....-++|+...+..||.+|-|++|.++
T Consensus 304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0000111111222111 3466789999999999999999999874
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=331.36 Aligned_cols=247 Identities=24% Similarity=0.309 Sum_probs=205.9
Q ss_pred CCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 295 NFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
-|..++.||.|+.|.|-.|++ .+|+.+|||.+.+.. +........+|+.+|+.+.|||++++++++.+..+.|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 366788999999999999996 589999999997542 23345667899999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++|-|.+++....+ +...+..+++.||..|+.|+|.. +|+|||+||+|+|+|..+++||+|||+|.+...+
T Consensus 93 yv~gGELFdylv~kG~----l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGP----LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred ecCCchhHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999987443 88899999999999999999999 9999999999999999999999999999875443
Q ss_pred CcceeeeccccccccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
. .....+|.+.|.|||++.+.+| +.++||||.|||+|.|+||+.||+... -..+...+++ +. .
T Consensus 166 k--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-----ir~LLlKV~~---G~-f----- 229 (786)
T KOG0588|consen 166 K--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-----IRVLLLKVQR---GV-F----- 229 (786)
T ss_pred c--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-----HHHHHHHHHc---Cc-c-----
Confidence 3 2345679999999999999998 689999999999999999999997322 1112222211 10 0
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
+.+...+.+..+|+.+|+..||+.|.|++||++.
T Consensus 230 -----~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 -----EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -----cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 0122334678999999999999999999999864
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=313.93 Aligned_cols=254 Identities=28% Similarity=0.400 Sum_probs=203.4
Q ss_pred hcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
.++|.+.+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|++++++++|+|++++++++. ....+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 35688889999999999999998777789999876432 23567889999999999999999999875 4567899999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++++|.++++... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 82 MGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999997632 23478999999999999999999999 99999999999999999999999999998764332
Q ss_pred cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhccc
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (619)
........++..|+|||...+..++.++||||||+++|||+| |+.||...... ... .......
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~---~~~~~~~-------- 220 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-----EVL---EQVERGY-------- 220 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHH---HHHHcCC--------
Confidence 222223346778999999998899999999999999999999 88888642211 111 1111100
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 532 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
........+..+.+++.+||+.+|++||++++|+++|+.
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 221 --RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 011122345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=317.41 Aligned_cols=257 Identities=26% Similarity=0.398 Sum_probs=203.8
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCc----EEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcce
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGT----KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 367 (619)
.++|+..+.||+|+||+||+|.+. +|+ .||+|+++..........+.+|+.+++.+.|+||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 457888899999999999999853 444 48999987655555567889999999999999999999998754 567
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
+++||+++|+|.++++... ..+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 9999999999999987532 3488999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCcce-eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 448 VDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 448 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
........ .....++..|+|||...+..++.++|||||||++|||+| |..||+.... ........ ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~~~---~~~~- 229 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-----REIPDLLE---KGER- 229 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHH---CCCc-
Confidence 65332221 112234678999999998899999999999999999999 8888863221 11111111 1000
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 574 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 574 (619)
.......+.++.+++.+||+.||++||++.++++.|+.+.
T Consensus 230 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 230 ---------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred ---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 0112233457889999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=320.26 Aligned_cols=260 Identities=25% Similarity=0.382 Sum_probs=207.2
Q ss_pred HhcCCcccCccccCCCceEEEEEeC------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCc
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE 365 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 365 (619)
..++|.+.+.||+|+||.||+|... ++..||+|.+...........+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 4567888999999999999999864 2468999998654444455678899999999999999999999999999
Q ss_pred ceeEecccccchhhhhhcccCCC------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEE
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPG------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV 439 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 439 (619)
.++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence 99999999999999998754322 23478889999999999999999999 9999999999999999999999
Q ss_pred cccccceeeccCCc-ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHH
Q 007073 440 GDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVK 517 (619)
Q Consensus 440 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 517 (619)
+|||+++....... .......++..|+|||.+.+..++.++|||||||++||++| |+.||...... ... .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-----~~~---~ 232 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE-----EVL---K 232 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH-----HHH---H
Confidence 99999876543322 12223346789999999988889999999999999999998 88888532211 111 1
Q ss_pred HHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 518 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 518 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
... ..... ..+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 233 ~~~-~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 233 FVI-DGGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHh-cCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111 11100 1112225688999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=316.05 Aligned_cols=261 Identities=22% Similarity=0.361 Sum_probs=210.2
Q ss_pred cCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++|++.+.||+|+||.||+|.. .+|+.+|||.+.... .......+.+|+.+++.++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677889999999999999996 479999999876432 2233467889999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++++|.+++.........+++.....++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998876444455689999999999999999999999 999999999999999999999999999886643
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
.... .....|+..|+|||.+.+..++.++||||||+++|||++|..||...... .......... ...
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~------~~~ 225 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEQ------CDY 225 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch------HHHHhhhhhc------CCC
Confidence 3221 22345889999999999888999999999999999999999998532211 1111111110 001
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
+ .......+..+.+++.+||+.+|++|||+.+|++.++++
T Consensus 226 ~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 226 P---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred C---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1 111223456889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=345.27 Aligned_cols=259 Identities=22% Similarity=0.272 Sum_probs=206.6
Q ss_pred HHHhcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCC---
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT--- 364 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--- 364 (619)
....++|.+.+.||+|+||+||+|.. .+|+.||||++.... +......+.+|+..+..++|+|++++++.+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34557899999999999999999985 479999999986432 3344567889999999999999999887765432
Q ss_pred -----cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEE
Q 007073 365 -----ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV 439 (619)
Q Consensus 365 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 439 (619)
..++||||+++|+|.+++.........++......++.|++.||.|||+. +|+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence 25799999999999999976554456689999999999999999999999 9999999999999999999999
Q ss_pred cccccceeeccCCc-ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH
Q 007073 440 GDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 518 (619)
Q Consensus 440 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 518 (619)
+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||...... ..+..
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~--------~~~~~ 256 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME--------EVMHK 256 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHH
Confidence 99999987643221 2233456999999999999999999999999999999999999999643211 11111
Q ss_pred HhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 519 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 519 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
... +.. ...+...+.++.+++.+||+.||++||++.++++.
T Consensus 257 ~~~-~~~---------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLA-GRY---------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred Hhc-CCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111 000 01122334678999999999999999999998753
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=312.81 Aligned_cols=246 Identities=25% Similarity=0.377 Sum_probs=195.9
Q ss_pred ccccCCCceEEEEEeC---CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccc
Q 007073 301 VLGQGGFGKVYRGVLA---DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL 376 (619)
Q Consensus 301 ~lg~G~fg~Vy~~~~~---~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 376 (619)
.||+|+||.||+|.++ ++..+|+|+++... .....+.+..|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 57899999986432 2334578899999999999999999999875 45678999999999
Q ss_pred hhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCccee
Q 007073 377 SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 456 (619)
Q Consensus 377 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 456 (619)
+|.+++... ..+++..+.+++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 999998653 2488899999999999999999999 999999999999999999999999999987654332211
Q ss_pred --eeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhccccc
Q 007073 457 --TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 533 (619)
Q Consensus 457 --~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 533 (619)
....++..|+|||.+....++.++|||||||++|||+| |+.||..... . ...........
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~---~~~~~i~~~~~--------- 216 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-----N---EVTQMIESGER--------- 216 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----H---HHHHHHHCCCC---------
Confidence 12234578999999988889999999999999999998 9999864221 1 11111111110
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 534 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 534 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
...+...+.++.+++.+||+.||++||++.+|.+.|+.
T Consensus 217 -~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 217 -MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11122334678999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=319.88 Aligned_cols=244 Identities=25% Similarity=0.314 Sum_probs=193.9
Q ss_pred cccCCCceEEEEEeC-CCcEEEEEEeccCCC--cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccchh
Q 007073 302 LGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV 378 (619)
Q Consensus 302 lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 378 (619)
||+|+||+||++... +|+.||+|.+..... ....+.+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999965 789999999864321 22345678899999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcceeee
Q 007073 379 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 458 (619)
Q Consensus 379 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 458 (619)
.+.+.........+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988865444445689999999999999999999999 999999999999999999999999999986643322 2234
Q ss_pred ccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCC
Q 007073 459 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 538 (619)
Q Consensus 459 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 538 (619)
..||+.|+|||.+.+..++.++|||||||++|||+||+.||........ ....... +.... ...+
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~----~~~~~~~---------~~~~~--~~~~ 221 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE----NKELKQR---------ILNDS--VTYP 221 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh----HHHHHHh---------hcccC--CCCc
Confidence 5689999999999999999999999999999999999999964321110 0001111 11110 1122
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHH
Q 007073 539 IQEVETMIQVALLCTQASPEDRPAMS 564 (619)
Q Consensus 539 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ 564 (619)
...+..+.+++.+|++.||++||+++
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~ 247 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFR 247 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCC
Confidence 33456789999999999999999443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=319.55 Aligned_cols=258 Identities=25% Similarity=0.391 Sum_probs=204.9
Q ss_pred cCCcccCccccCCCceEEEEEeC------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcce
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 367 (619)
++|.+.+.||+|+||.||++... ++..+|+|.+... .......+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 56888899999999999999842 3456899988643 2344667999999999999999999999999999999
Q ss_pred eEecccccchhhhhhcccCC---------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 007073 368 LVYPFMQNLSVAYRLREIKP---------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV 438 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 438 (619)
+||||+++++|.+++..... ....+++..+..++.|++.||+|||++ +++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 99999999999999875432 123489999999999999999999999 999999999999999999999
Q ss_pred EcccccceeeccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHH
Q 007073 439 VGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHV 516 (619)
Q Consensus 439 l~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 516 (619)
|+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||+| |..||...... ...
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--------~~~ 232 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--------EVI 232 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHH
Confidence 9999999865332211 1122345778999999998899999999999999999999 88888543211 111
Q ss_pred HHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 517 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 517 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
..... +.... .....+..+.+++.+||+.+|.+|||+.++.+.|+++
T Consensus 233 ~~i~~-~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 233 ECITQ-GRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred HHHHc-CCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 11111 11000 0112235789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=322.53 Aligned_cols=263 Identities=27% Similarity=0.405 Sum_probs=208.6
Q ss_pred HHHhcCCcccCccccCCCceEEEEEeC--------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeee
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVLA--------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFC 360 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~ 360 (619)
....++|.+.+.||+|+||.||+|.+. ++..||+|.+.........+.+.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 345677888999999999999999741 34579999886544444567889999999999 799999999999
Q ss_pred eCCCcceeEecccccchhhhhhcccCCC------------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 007073 361 TTPTERLLVYPFMQNLSVAYRLREIKPG------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN 428 (619)
Q Consensus 361 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 428 (619)
......++||||+++|+|.+++...... ...+++..+..++.|++.||+|||++ +++||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence 9999999999999999999999764321 23578889999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEcccccceeeccCCcce-eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccc
Q 007073 429 VLLDEDFEAVVGDFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEE 506 (619)
Q Consensus 429 Ill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~ 506 (619)
|++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||+| |..||.....
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-- 245 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-- 245 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--
Confidence 999999999999999998764332221 222345678999999998889999999999999999999 7777753221
Q ss_pred ccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 507 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.+........... ..+...+..+.+++.+||+.+|++||++.++++.|++.
T Consensus 246 ------~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 246 ------EELFKLLKEGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred ------HHHHHHHHcCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 1122222111110 11223346789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=320.14 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=202.0
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCc--EEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcceeE
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGT--KVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~--~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 369 (619)
++|++.+.||+|+||.||+|..+ ++. .+++|.++........+.+.+|+.+++++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 46888899999999999999975 333 47888887544444567789999999999 799999999999998899999
Q ss_pred ecccccchhhhhhcccCC------------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcE
Q 007073 370 YPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA 437 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 437 (619)
+||+++++|.++++.... ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999965321 113488899999999999999999999 99999999999999999999
Q ss_pred EEcccccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHH
Q 007073 438 VVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHV 516 (619)
Q Consensus 438 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 516 (619)
||+|||++...... ........+..|+|||.+.+..++.++|||||||++|||+| |..||...... +..
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~--------~~~ 228 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA--------ELY 228 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--------HHH
Confidence 99999998643211 11111223557999999998899999999999999999998 99998643211 111
Q ss_pred HHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 517 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 517 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
...... .....+...+..+.+++.+||+.+|.+||++.++++.|+..
T Consensus 229 ~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 229 EKLPQG----------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred HHHhcC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111110 01111222345789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=325.06 Aligned_cols=244 Identities=21% Similarity=0.223 Sum_probs=195.4
Q ss_pred cccCCCceEEEEEeC-CCcEEEEEEeccC--CCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccchh
Q 007073 302 LGQGGFGKVYRGVLA-DGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV 378 (619)
Q Consensus 302 lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 378 (619)
||+|+||.||+|... +++.||+|.+... ........+.+|+.++++++||||+++++++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999975 5889999998642 1233456788999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcceeee
Q 007073 379 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 458 (619)
Q Consensus 379 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 458 (619)
.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQRE----GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 9988753 2388899999999999999999999 99999999999999999999999999997543222 22334
Q ss_pred ccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCC
Q 007073 459 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 538 (619)
Q Consensus 459 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 538 (619)
..||+.|+|||.+.+..++.++|||||||++|||+||+.||..... ......... .. ..++
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~--------~~~~~~~~~---------~~--~~~~ 213 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV--------NEMYRKILQ---------EP--LRFP 213 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH--------HHHHHHHHc---------CC--CCCC
Confidence 5699999999999999999999999999999999999999964321 111111111 00 0112
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 539 IQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 539 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
......+.+++.+||+.||++||++..+.+.|+.
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 2334578899999999999999875554444443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=312.50 Aligned_cols=247 Identities=25% Similarity=0.359 Sum_probs=196.2
Q ss_pred ccccCCCceEEEEEeC---CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccch
Q 007073 301 VLGQGGFGKVYRGVLA---DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS 377 (619)
Q Consensus 301 ~lg~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 377 (619)
.||+|+||.||+|.+. ++..||+|++.........+.|.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 356799999875544445577999999999999999999999885 456789999999999
Q ss_pred hhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcceee
Q 007073 378 VAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT 457 (619)
Q Consensus 378 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 457 (619)
|.+++... ...+++..+.+++.|++.||+|||++ +++||||||+||+++.++.+||+|||++............
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99988643 23488999999999999999999999 9999999999999999999999999999865433322211
Q ss_pred --eccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhcccccc
Q 007073 458 --QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN 534 (619)
Q Consensus 458 --~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 534 (619)
...++..|+|||.+.+..++.++|||||||++||+++ |..||...... +......... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~----------~ 216 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--------EVMSFIEQGK----------R 216 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHHCCC----------C
Confidence 1223578999999988889999999999999999996 99998643211 1111111111 1
Q ss_pred CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 535 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 535 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
...+...+.++.+++.+||+.+|++||++.+|.+.|+.
T Consensus 217 ~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 217 LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 11223335688899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=328.36 Aligned_cols=252 Identities=22% Similarity=0.251 Sum_probs=197.5
Q ss_pred CCcccCccccCCCceEEEEEe----CCCcEEEEEEeccCC---CcchHHHHHHHHHHHHHcc-CCCccceeeeeeCCCcc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFE---SPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTER 366 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~----~~g~~vAvK~l~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~ 366 (619)
+|++.+.||+|+||+||++.. .+|+.||+|++.+.. .....+.+..|+.++..++ |+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999985 358899999986421 2223456788999999995 89999999999999999
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
++||||+++|+|.+++... ..+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 9999999999999988753 2378899999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCcceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 447 LVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 447 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
..............||+.|+|||.+.+. .++.++|||||||++|||+||+.||........ ..........
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~~~~~~~~---- 225 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT----QSEVSRRILK---- 225 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC----HHHHHHHHhc----
Confidence 6544333333445799999999999765 478999999999999999999999964322111 0111111110
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 568 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 568 (619)
.++ ..+......+.+++.+|++.||++|| +++++++
T Consensus 226 ---~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 ---CDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ---CCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 011 11222345788999999999999999 5556653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=322.35 Aligned_cols=260 Identities=26% Similarity=0.366 Sum_probs=206.8
Q ss_pred HHhcCCcccCccccCCCceEEEEEeC------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeCC
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTP 363 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 363 (619)
...++|...+.||+|+||.||+|... ++..||||+++........+.+.+|+++++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 45567889999999999999999741 35589999987544444567789999999999 799999999999999
Q ss_pred CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007073 364 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 443 (619)
Q Consensus 364 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 443 (619)
+..++||||+++|+|.++++.... ..+++.+...++.|++.||+|||++ +|+|+||||+||+++.++.++++|||
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence 999999999999999999875332 3379999999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhh
Q 007073 444 LAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLER 521 (619)
Q Consensus 444 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 521 (619)
+++........ ......++..|+|||.+.+..++.++|||||||++|||+| |+.||....... .. .....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~----~~----~~~~~ 258 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS----KF----YKLIK 258 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH----HH----HHHHH
Confidence 99865433221 1222345778999999999999999999999999999998 999986432110 01 11111
Q ss_pred hcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 522 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 522 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
.+. ....+...+..+.+++.+|++.+|++|||+.++++.|++
T Consensus 259 ~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 259 EGY---------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred cCC---------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 110 001111223578999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=319.24 Aligned_cols=265 Identities=20% Similarity=0.337 Sum_probs=202.4
Q ss_pred hcCCcccCccccCCCceEEEEEeCC---------------CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCcccee
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLAD---------------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLI 357 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~~---------------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 357 (619)
.++|++.+.||+|+||.||++...+ ...||+|.++..........|.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578889999999999999987642 2358999987654455567899999999999999999999
Q ss_pred eeeeCCCcceeEecccccchhhhhhcccCC--------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 007073 358 GFCTTPTERLLVYPFMQNLSVAYRLREIKP--------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANV 429 (619)
Q Consensus 358 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 429 (619)
+++...+..++||||+++++|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999864321 112368889999999999999999999 999999999999
Q ss_pred EeCCCCcEEEcccccceeeccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh--CCCCCCCCcccc
Q 007073 430 LLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT--GQRAIDFSRLEE 506 (619)
Q Consensus 430 ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt--g~~p~~~~~~~~ 506 (619)
++++++.+||+|||++......... ......++..|+|||.+.++.++.++|||||||++|||+| |..||......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~- 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE- 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH-
Confidence 9999999999999999765332211 1122345678999999998899999999999999999998 45565432211
Q ss_pred ccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007073 507 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571 (619)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 571 (619)
................. ....+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 240 ----~~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 ----QVIENTGEFFRNQGRQI------YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ----HHHHHHHHhhhhccccc------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11111111111100000 00011123458999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=341.65 Aligned_cols=252 Identities=17% Similarity=0.232 Sum_probs=202.9
Q ss_pred CCcccCccccCCCceEEEEEeC-C-CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-D-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~-g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
.|.+.+.||+|+||.||+|... + +..||+|.+.. ........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML-NDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc-CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 4888999999999999999854 3 67888887643 2333445678899999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++|+|.+++.........+++.....++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999998875444445688899999999999999999999 99999999999999999999999999998764332
Q ss_pred c-ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccc
Q 007073 453 T-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531 (619)
Q Consensus 453 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (619)
. .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... ......... ..
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~--------~~~~~~~~~-~~------ 288 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR--------EIMQQVLYG-KY------ 288 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC-CC------
Confidence 2 1233456999999999999999999999999999999999999998642210 111111110 00
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 532 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
...+...+..+.+++.+||+.+|++||++.+++.
T Consensus 289 ---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 ---DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0111223457899999999999999999999874
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=326.84 Aligned_cols=261 Identities=20% Similarity=0.334 Sum_probs=194.5
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCC-----cce
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT-----ERL 367 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 367 (619)
+|++.+.||+|+||.||+|... +|..||||++.... .......+.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999964 68999999986432 2334457889999999999999999999885432 468
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
+||||+. ++|.+++... ..+++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999996 5788877643 2388999999999999999999999 999999999999999999999999999986
Q ss_pred eccCCc--ceeeeccccccccccccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh--
Q 007073 448 VDVRKT--NVTTQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER-- 521 (619)
Q Consensus 448 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 521 (619)
...... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... ....+.....
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~-----~~~~~~~~~~~~ 227 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-----QLDLITDLLGTP 227 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH-----HHHHHHHHhCCC
Confidence 532221 11234568999999999865 678999999999999999999999996432110 0000000000
Q ss_pred ---------hcccchhc---cccccCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 522 ---------EKRLDAIV---DRNLNKNY---NIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 522 ---------~~~~~~~~---~~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.......+ ........ .+.....+.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred CHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000000 00000000 0112356789999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=313.72 Aligned_cols=256 Identities=26% Similarity=0.401 Sum_probs=205.2
Q ss_pred hcCCcccCccccCCCceEEEEEeC----CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
..+|.+.+.||+|+||.||+|.+. .+..+|+|.++........+.|..|+.++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 356888899999999999999863 2347999998754444456789999999999999999999999999999999
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||+++++|.+++.... ..+++.+...++.|++.|++|||+. +++||||||+||+++.++.++++|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 999999999999997532 3478899999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCcceeee--ccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 449 DVRKTNVTTQ--VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 449 ~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
.......... ..++..|+|||.+.+..++.++||||||+++||+++ |+.||...... +..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--------~~~~~~~~~~~- 227 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--------DVIKAIEEGYR- 227 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--------HHHHHHhCCCc-
Confidence 5433222221 223568999999998899999999999999999887 99998532211 11111111100
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
.......+..+.+++.+|++.+|++||++.++++.|++
T Consensus 228 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 228 ---------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 01122234678999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=313.27 Aligned_cols=257 Identities=27% Similarity=0.407 Sum_probs=208.1
Q ss_pred HHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
...++|.+.+.||+|+||.||+|..++++.||||.+.... ...+++.+|+.++++++|+||+++++++......++||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 3567899999999999999999998888899999987432 34577899999999999999999999999888999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++++|.+++.... ...+++..+..++.|++.|+.|||++ +++|+||||+||++++++.+||+|||.+.....
T Consensus 81 e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 81 EYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999999997643 23488999999999999999999999 999999999999999999999999999987653
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
..........++..|+|||.+.+..++.++||||||+++|||+| |+.||..... .. .........
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~~---~~~~~~~~~------ 221 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-----RE---VLEQVERGY------ 221 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----HH---HHHHHHcCC------
Confidence 22222222335678999999998889999999999999999999 9999853211 11 111111100
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
....+...+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 222 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 ----RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 001111224578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=317.16 Aligned_cols=265 Identities=23% Similarity=0.358 Sum_probs=206.5
Q ss_pred hcCCcccCccccCCCceEEEEEeCC-----------------CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLAD-----------------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 355 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~~-----------------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 355 (619)
..+|++.+.||+|+||.||+|...+ +..||+|.+.........+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578889999999999999998642 24689999876555556678999999999999999999
Q ss_pred eeeeeeCCCcceeEecccccchhhhhhcccCC-------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 007073 356 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN 428 (619)
Q Consensus 356 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 428 (619)
+++++......++++||+++++|.+++..... ....+++.....++.|++.||+|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999876442 123589999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEcccccceeeccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh--CCCCCCCCccc
Q 007073 429 VLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT--GQRAIDFSRLE 505 (619)
Q Consensus 429 Ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt--g~~p~~~~~~~ 505 (619)
|+++.++.++|+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 99999999999999999865433221 2223446778999999988899999999999999999998 566664221
Q ss_pred cccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007073 506 EEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571 (619)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 571 (619)
.................... .......+.++.+++.+|++.+|++|||+.+|++.|+
T Consensus 239 ---~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 ---DQQVIENAGHFFRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ---hHHHHHHHHhcccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11111111111100000000 0112223468999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=327.33 Aligned_cols=247 Identities=23% Similarity=0.223 Sum_probs=199.3
Q ss_pred HhcCCcccCccccCCCceEEEEEeCC--CcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcce
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLAD--GTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~~--g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 367 (619)
..++|.+.+.||+|+||.||+|.+.+ +..||+|++.... .....+.+.+|+.+++.++||||+++++++......+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34578889999999999999998643 3689999986422 2334567889999999999999999999999999999
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 108 lv~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 9999999999999987532 388889999999999999999999 999999999999999999999999999986
Q ss_pred eccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccch
Q 007073 448 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527 (619)
Q Consensus 448 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (619)
.... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...... ........
T Consensus 181 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--------~~~~~i~~------ 242 (340)
T PTZ00426 181 VDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--------LIYQKILE------ 242 (340)
T ss_pred cCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--------HHHHHHhc------
Confidence 5432 22456899999999999888999999999999999999999999643211 11111111
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007073 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 568 (619)
Q Consensus 528 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 568 (619)
... .++......+.+++.+|++.||++|+ +++++++
T Consensus 243 ---~~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 243 ---GII--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred ---CCC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 000 01112235678999999999999995 7777664
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=322.65 Aligned_cols=261 Identities=29% Similarity=0.396 Sum_probs=205.9
Q ss_pred HhcCCcccCccccCCCceEEEEEeC--------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeC
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA--------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTT 362 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 362 (619)
..++|.+.+.||+|+||.||++... ++..+|+|.+...........+..|+++++.+ +||||+++++++..
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3467899999999999999999852 23579999987544444556788999999999 79999999999999
Q ss_pred CCcceeEecccccchhhhhhcccCC------------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 007073 363 PTERLLVYPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVL 430 (619)
Q Consensus 363 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 430 (619)
....++||||+++|+|.+++..... ....+++.++.+++.|++.||+|||+. +++||||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheE
Confidence 9999999999999999999976432 123488999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccceeeccCCcce-eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccc
Q 007073 431 LDEDFEAVVGDFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEED 508 (619)
Q Consensus 431 l~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~ 508 (619)
++.++.+||+|||.++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~--- 249 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 249 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH---
Confidence 9999999999999987654322111 112234568999999998889999999999999999998 88887532211
Q ss_pred chhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 509 DVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
+........ . ....+.....++.+++.+||+.+|++||++.+|++.|+..
T Consensus 250 -----~~~~~~~~~-~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 250 -----ELFKLLKEG-H---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred -----HHHHHHHcC-C---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111111111 0 0111223346888999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=324.98 Aligned_cols=246 Identities=22% Similarity=0.259 Sum_probs=192.6
Q ss_pred CccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcceeEeccccc
Q 007073 300 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVYPFMQN 375 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 375 (619)
++||+|+||.||+|... +++.||+|+++... .......+..|..++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999965 68899999997432 223345678899999888 699999999999999999999999999
Q ss_pred chhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcce
Q 007073 376 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455 (619)
Q Consensus 376 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 455 (619)
|+|..++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~ 152 (329)
T cd05588 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDT 152 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCc
Confidence 9998888653 3489999999999999999999999 9999999999999999999999999998743211 122
Q ss_pred eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccC
Q 007073 456 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 535 (619)
Q Consensus 456 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 535 (619)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||+.............++..........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 222 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI---------- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------
Confidence 3345689999999999999999999999999999999999999975332221111111111111111111
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 007073 536 NYNIQEVETMIQVALLCTQASPEDRPAM 563 (619)
Q Consensus 536 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 563 (619)
..+...+..+.+++.+|++.||.+||++
T Consensus 223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 223 RIPRSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 0112234578899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=321.49 Aligned_cols=256 Identities=25% Similarity=0.428 Sum_probs=201.7
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCc--EEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcceeE
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGT--KVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~--~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 369 (619)
++|++.+.||+|+||.||+|.++ +|. .+|+|.++..........+.+|++++.++ +|+||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 56788899999999999999974 454 46888776544445567889999999999 899999999999999999999
Q ss_pred ecccccchhhhhhcccCC------------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcE
Q 007073 370 YPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA 437 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 437 (619)
+||+++++|.++++.... ....+++..++.++.|++.|++|||++ +++||||||+||+++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 999999999999875321 123588999999999999999999999 99999999999999999999
Q ss_pred EEcccccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHH
Q 007073 438 VVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHV 516 (619)
Q Consensus 438 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 516 (619)
||+|||++...... .......++..|+|||.+.+..++.++|||||||++|||+| |..||...... +..
T Consensus 164 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~ 233 (303)
T cd05088 164 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------ELY 233 (303)
T ss_pred EeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--------HHH
Confidence 99999998643211 11111234668999999988889999999999999999998 99998532211 111
Q ss_pred HHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 517 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 517 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
....... ....+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 234 ~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 234 EKLPQGY----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred HHHhcCC----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1111100 001111234578999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=318.13 Aligned_cols=258 Identities=24% Similarity=0.401 Sum_probs=205.2
Q ss_pred cCCcccCccccCCCceEEEEEeC------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcce
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 367 (619)
.+|.+.+.||+|+||.||+|... ++..+++|.+... .....+.+.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc-cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 45777899999999999999842 3567899987542 2334567899999999999999999999999999999
Q ss_pred eEecccccchhhhhhcccCC------------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC
Q 007073 368 LVYPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 435 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 435 (619)
+||||+++++|.+++..... ....+++..+.+++.|++.|++|||++ +|+||||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 99999999999999975432 123488999999999999999999999 999999999999999999
Q ss_pred cEEEcccccceeeccCCc-ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHH
Q 007073 436 EAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLL 513 (619)
Q Consensus 436 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~ 513 (619)
.++|+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||+| |+.||......
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-------- 232 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-------- 232 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------
Confidence 999999999976543221 11223446788999999999999999999999999999999 99998543211
Q ss_pred HHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 514 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
....... .+... ......+..+.+++.+||+.+|++||++.+|+++|++.
T Consensus 233 ~~~~~~~-~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 233 EVIECIT-QGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred HHHHHHh-CCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 1111111 11111 01122345789999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=314.35 Aligned_cols=257 Identities=25% Similarity=0.427 Sum_probs=205.4
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CC---cEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DG---TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g---~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
.++|+..+.||+|+||.||+|... ++ ..+|+|.+.........+.+.+|++++++++|+|++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888899999999999999974 33 37999988654444456788999999999999999999999999999999
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++|+||||+||+++.++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 999999999999987532 3488999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCcceee--eccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 449 DVRKTNVTT--QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 449 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
......... ....+..|+|||++.+..++.++|||||||++|||+| |+.||..... .+..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--------~~~~~~i~~~~~- 228 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--------HEVMKAINDGFR- 228 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHHHhcCCC-
Confidence 433222211 1223457999999998899999999999999999998 9999853221 111111111110
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.......+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 229 ---------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 ---------LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111122346789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=317.11 Aligned_cols=266 Identities=21% Similarity=0.343 Sum_probs=204.0
Q ss_pred hcCCcccCccccCCCceEEEEEeC-----------------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-----------------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 355 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-----------------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 355 (619)
.++|++.+.||+|+||.||++... ++..||+|+++..........|.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 456889999999999999998642 234699999875544455678999999999999999999
Q ss_pred eeeeeeCCCcceeEecccccchhhhhhcccCCC-------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 007073 356 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG-------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN 428 (619)
Q Consensus 356 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 428 (619)
+++++...+..++||||+++|+|.+++...... ...+++.....++.|++.||+|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 999999999999999999999999998764322 13477889999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEcccccceeeccCCcce-eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh--CCCCCCCCccc
Q 007073 429 VLLDEDFEAVVGDFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT--GQRAIDFSRLE 505 (619)
Q Consensus 429 Ill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt--g~~p~~~~~~~ 505 (619)
|+++.++.++|+|||+++.+....... .....++..|+|||...++.++.++|||||||++|||+| |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999998654322211 122334678999999888899999999999999999998 66776432111
Q ss_pred cccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 506 EEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
................... ..+...+..+.+++.+||+.||++||++.+|.+.|+.
T Consensus 241 -----~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 -----QVIENTGEFFRDQGRQVYL------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred -----HHHHHHHHHHhhccccccC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111111111000000000 0112233678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=333.97 Aligned_cols=253 Identities=24% Similarity=0.277 Sum_probs=203.8
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++|.+.+.||+|+||+||+|... +|+.||||++.... .......+..|++++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999975 68999999986432 2244567889999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++++|.+++... ..++......++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999764 3488899999999999999999998 999999999999999999999999999986643
Q ss_pred CC----------------------------cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 007073 451 RK----------------------------TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 502 (619)
Q Consensus 451 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~ 502 (619)
.. ........||+.|+|||.+.+..++.++|||||||++|||+||+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 11223456899999999999999999999999999999999999999643
Q ss_pred ccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 007073 503 RLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-MSEVVRM 569 (619)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~ 569 (619)
... .......... ..+........+..+.+++.+|++ +|.+||+ +.++++.
T Consensus 234 ~~~--------~~~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQ--------ETYNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHH--------HHHHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 311 1111111100 000000011134678899999997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=324.92 Aligned_cols=246 Identities=22% Similarity=0.256 Sum_probs=191.4
Q ss_pred CccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcceeEeccccc
Q 007073 300 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVYPFMQN 375 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 375 (619)
+.||+|+||.||+|... +++.||+|.++... .......+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 67899999987532 223445677888888776 799999999999999999999999999
Q ss_pred chhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcce
Q 007073 376 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455 (619)
Q Consensus 376 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 455 (619)
|+|..++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~ 152 (329)
T cd05618 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 152 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cc
Confidence 9998887653 2488899999999999999999999 99999999999999999999999999987532211 12
Q ss_pred eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccC
Q 007073 456 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 535 (619)
Q Consensus 456 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 535 (619)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||...............+..........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------- 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------
Confidence 2345689999999999999999999999999999999999999964222111111111111111111110
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 007073 536 NYNIQEVETMIQVALLCTQASPEDRPAM 563 (619)
Q Consensus 536 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 563 (619)
..+......+.+++.+|++.||++||++
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1122334578899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=313.18 Aligned_cols=256 Identities=26% Similarity=0.377 Sum_probs=197.8
Q ss_pred CcccCccccCCCceEEEEEeCC-Cc--EEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCC------Cc
Q 007073 296 FSEKNVLGQGGFGKVYRGVLAD-GT--KVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------TE 365 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~~~-g~--~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~ 365 (619)
|.+.+.||+|+||.||+|.+.+ +. .||+|.++... .....+.+..|+++++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467899999999999999754 33 68999886432 334467889999999999999999999987432 24
Q ss_pred ceeEecccccchhhhhhcccC--CCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007073 366 RLLVYPFMQNLSVAYRLREIK--PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 443 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 443 (619)
.++++||+++|+|.+++.... .....+++.....++.|++.||+|||++ +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998874322 2234588999999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcce-eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhh
Q 007073 444 LAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLER 521 (619)
Q Consensus 444 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 521 (619)
+++.+....... .....+++.|+|||...+..++.++||||||+++|||++ |+.||..... . ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~---~~~~~~~~ 229 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-----S---EIYDYLRQ 229 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-----H---HHHHHHHc
Confidence 998764332211 122235678999999999999999999999999999999 7888853211 1 11111111
Q ss_pred hcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 522 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 522 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
.... ......+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 230 ~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 230 GNRL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1110 0112234568999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=323.55 Aligned_cols=242 Identities=22% Similarity=0.249 Sum_probs=194.3
Q ss_pred CccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccc
Q 007073 300 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL 376 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 376 (619)
+.||+|+||.||++... +|+.||+|.++... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999964 68999999986432 2234456788999999999999999999999999999999999999
Q ss_pred hhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCccee
Q 007073 377 SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 456 (619)
Q Consensus 377 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 456 (619)
+|..++... ..+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 152 (323)
T cd05595 81 ELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence 998888653 2488999999999999999999999 99999999999999999999999999987532221 122
Q ss_pred eeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCC
Q 007073 457 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKN 536 (619)
Q Consensus 457 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 536 (619)
....||+.|+|||.+.+..++.++|||||||++|||+||+.||...... ........ ... .
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--------~~~~~~~~---------~~~--~ 213 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLFELILM---------EEI--R 213 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHhc---------CCC--C
Confidence 3456899999999999999999999999999999999999998643211 01111110 000 1
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007073 537 YNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 568 (619)
Q Consensus 537 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 568 (619)
++...+.++.+++.+|++.||++|| ++.++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1222345788999999999999998 7777764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=318.38 Aligned_cols=260 Identities=25% Similarity=0.398 Sum_probs=206.2
Q ss_pred HhcCCcccCccccCCCceEEEEEeC------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCc
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE 365 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 365 (619)
..++|+..+.||+|+||.||+|... ++..||+|.+...........+.+|+.++++++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3467888999999999999999863 4678999998755444456779999999999999999999999999999
Q ss_pred ceeEecccccchhhhhhcccCC------------------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 007073 366 RLLVYPFMQNLSVAYRLREIKP------------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAA 427 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~ 427 (619)
.++|+||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 9999999999999999975321 123478888999999999999999999 9999999999
Q ss_pred cEEeCCCCcEEEcccccceeeccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccc
Q 007073 428 NVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLE 505 (619)
Q Consensus 428 NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~ 505 (619)
||++++++.++|+|||++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999998765332211 1122234678999999998899999999999999999998 77787532111
Q ss_pred cccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 506 EEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
+....... +... ..+...+..+.+++.+|++.+|++|||+.|+++.|++
T Consensus 240 --------~~~~~~~~-~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 --------EVIYYVRD-GNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --------HHHHHHhc-CCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111111 1110 0112234678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=312.89 Aligned_cols=257 Identities=26% Similarity=0.385 Sum_probs=201.2
Q ss_pred CcccCccccCCCceEEEEEeCC----CcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCc-----
Q 007073 296 FSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE----- 365 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 365 (619)
|.+.+.||+|+||.||+|.... +..||+|+++... .......+.+|+++++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4667899999999999999642 3679999987432 23345678999999999999999999998866554
Q ss_pred -ceeEecccccchhhhhhcccCC--CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007073 366 -RLLVYPFMQNLSVAYRLREIKP--GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 442 (619)
Q Consensus 366 -~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 442 (619)
.++++||+++|+|..++..... ....+++.....++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 7899999999999998855322 224588999999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcce-eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHh
Q 007073 443 GLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLE 520 (619)
Q Consensus 443 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 520 (619)
|+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... ... .....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-----~~~---~~~~~ 229 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-----HEI---YDYLR 229 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-----HHH---HHHHH
Confidence 9998764332221 112235678999999988889999999999999999999 8888753221 111 11111
Q ss_pred hhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 521 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 521 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.... ...+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus 230 ~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 HGNR----------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCCC----------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1100 111223446889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=326.44 Aligned_cols=243 Identities=23% Similarity=0.254 Sum_probs=195.8
Q ss_pred CccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccc
Q 007073 300 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL 376 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 376 (619)
+.||+|+||.||++... +|+.||+|++.... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999964 68999999986432 2334567889999999999999999999999999999999999999
Q ss_pred hhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCccee
Q 007073 377 SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 456 (619)
Q Consensus 377 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 456 (619)
+|..++... ..+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~ 152 (328)
T cd05593 81 ELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATM 152 (328)
T ss_pred CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccc
Confidence 998888653 2488999999999999999999999 9999999999999999999999999998753222 1222
Q ss_pred eeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCC
Q 007073 457 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKN 536 (619)
Q Consensus 457 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 536 (619)
....||+.|+|||.+.+..++.++|||||||++|||+||+.||...... ........ . +. .
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--------~~~~~~~~-~------~~----~ 213 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILM-E------DI----K 213 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--------HHHHHhcc-C------Cc----c
Confidence 3456999999999999999999999999999999999999999643211 11111100 0 00 1
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 007073 537 YNIQEVETMIQVALLCTQASPEDRP-----AMSEVVRM 569 (619)
Q Consensus 537 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 569 (619)
++.....++.+++.+|++.||++|| ++.++++.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1222345788999999999999997 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=333.77 Aligned_cols=257 Identities=21% Similarity=0.253 Sum_probs=202.6
Q ss_pred HHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcc
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 366 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 366 (619)
....++|++.+.||+|+||.||++... +++.||+|.+.... .....+.+.+|+.+++.++||||+++++++..+...
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 345678999999999999999999975 68899999986421 223345678899999999999999999999999999
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
++||||+++|+|.+++... .++......++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~ 190 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEecccee
Confidence 9999999999999988652 267778888999999999999999 99999999999999999999999999998
Q ss_pred eeccCCcceeeeccccccccccccccCC----CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh
Q 007073 447 LVDVRKTNVTTQVRGTMGHIAPEYLSTG----KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 522 (619)
Q Consensus 447 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 522 (619)
..............||+.|+|||.+.+. .++.++|||||||++|||+||+.||...... .........
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~i~~~ 262 (370)
T cd05596 191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSKIMDH 262 (370)
T ss_pred eccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--------HHHHHHHcC
Confidence 7644332223345799999999998653 4789999999999999999999999643211 111111110
Q ss_pred cccchhccccccCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 007073 523 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPED--RPAMSEVVRM 569 (619)
Q Consensus 523 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 569 (619)
.. .+........+..+.+++.+|++.+|++ ||++.++++.
T Consensus 263 ~~-------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 263 KN-------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CC-------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00 0000011123467889999999999988 9999998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=315.36 Aligned_cols=252 Identities=22% Similarity=0.290 Sum_probs=199.4
Q ss_pred cCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
++|+..++||+|+||.||+|.. .+++.||+|.+...........+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3577789999999999999996 478999999986544444567789999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++++|..+. .+++.....++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 9999886542 267788889999999999999999 9999999999999999999999999999865322
Q ss_pred cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
......|+..|+|||.+.+..++.++||||||+++|+|+||+.||.......... .......... +..
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~---------~~~ 216 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLLQCIV---------DED 216 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHHHHHHh---------ccC
Confidence 2233568999999999999899999999999999999999999986432211110 0011111110 000
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
...........++.+++.+|++.+|++||+++++++.
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 217 PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000111234578999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=338.99 Aligned_cols=263 Identities=22% Similarity=0.272 Sum_probs=215.2
Q ss_pred HHHhcCCcccCccccCCCceEEEEEeCCC-cEEEEEEeccCCCcchHHHHHHHHHHHHHcc-CCCccceee-eeeC----
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVLADG-TKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIG-FCTT---- 362 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g-~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~-~~~~---- 362 (619)
.+...++++.++|.+|||+.||.|....+ ..||+|++.-. .........+|+++|+++. |+|||.+++ ....
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 34556778889999999999999998765 99999998654 5667788899999999998 999999999 3321
Q ss_pred --CCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEc
Q 007073 363 --PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVG 440 (619)
Q Consensus 363 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 440 (619)
..+.+|.||||++|+|.+++....... |+..++++|+.|+++|+++||.. +|+|||||||.+||||+.+++.|||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeC
Confidence 235789999999999999998765544 99999999999999999999986 7789999999999999999999999
Q ss_pred ccccceeeccCCccee--------eeccccccccccccc---cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccc
Q 007073 441 DFGLAKLVDVRKTNVT--------TQVRGTMGHIAPEYL---STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD 509 (619)
Q Consensus 441 DfGla~~~~~~~~~~~--------~~~~gt~~y~aPE~~---~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~ 509 (619)
|||.|.-......... -...-|+-|.|||.+ .+..+++|+|||+|||+||-|+....||+...
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------ 262 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------ 262 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc------
Confidence 9999874322221100 012358999999976 56789999999999999999999999997432
Q ss_pred hhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCccc
Q 007073 510 VLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAE 577 (619)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 577 (619)
...|++....-...+.+...+.+||..||+.||++||++-+|+..+-.+.-.+
T Consensus 263 ---------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 263 ---------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ---------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 12445555544445788899999999999999999999999999888765433
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.14 Aligned_cols=263 Identities=29% Similarity=0.416 Sum_probs=206.4
Q ss_pred HHHhcCCcccCccccCCCceEEEEEeC--------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeee
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVLA--------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFC 360 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~ 360 (619)
....++|.+.+.||+|+||.||++... .+..+|+|.++..........+..|+++++++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 344567888999999999999999742 24579999987544444567788999999999 599999999999
Q ss_pred eCCCcceeEecccccchhhhhhcccCC------------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 007073 361 TTPTERLLVYPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN 428 (619)
Q Consensus 361 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 428 (619)
......+++|||+++|+|.+++..... ....+++....+++.|++.||.|||++ +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence 988889999999999999999976432 124588999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEcccccceeeccCCcce-eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccc
Q 007073 429 VLLDEDFEAVVGDFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEE 506 (619)
Q Consensus 429 Ill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~ 506 (619)
|+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||+| |..||......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~- 243 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE- 243 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 999999999999999998654322211 112234567999999998899999999999999999999 88887532211
Q ss_pred ccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 507 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
........... ...+...+.++.+++.+||+.+|++||++.++++.|++.
T Consensus 244 -------~~~~~~~~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 244 -------ELFKLLREGHR----------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred -------HHHHHHHcCCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11111111110 011222345788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=327.99 Aligned_cols=251 Identities=28% Similarity=0.397 Sum_probs=206.1
Q ss_pred cCCcccCccccCCCceEEEEEeC--CCc--EEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA--DGT--KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~--~g~--~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
+.....++||+|.||.|++|.|. +|+ .||||.++.........+|.+|+.+|.+++|||+++|||+..+ ....+|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 33445688999999999999985 344 5899999866555577899999999999999999999999987 778899
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
+|..+.|+|.+.|+.. ....+-......++.|||.||.||..+ ++|||||.++|+|+-....|||+|||+.+-+.
T Consensus 189 ~ELaplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhcccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccC
Confidence 9999999999999982 345588888999999999999999999 99999999999999999999999999999886
Q ss_pred cCCcce-ee-eccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 450 VRKTNV-TT-QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 450 ~~~~~~-~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
..+... +. ...-.+.|+|||.+..+.++.++|||+|||++|||+| |+.||..-. -.+..+.+...+++
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~--------g~qIL~~iD~~erL- 334 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR--------GIQILKNIDAGERL- 334 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC--------HHHHHHhccccccC-
Confidence 544332 22 1223568999999999999999999999999999999 788885422 11222222222222
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..+..++++++++++.||..+|.+||||..|.+
T Consensus 335 ---------pRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 335 ---------PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred ---------CCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 235667889999999999999999999999973
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=325.74 Aligned_cols=263 Identities=27% Similarity=0.402 Sum_probs=202.5
Q ss_pred HHhcCCcccCccccCCCceEEEEEe------CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeCC
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTP 363 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 363 (619)
...++|++.+.||+|+||.||+|.+ .+++.||||+++..........+.+|+.++.++ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 3456899999999999999999974 357899999997544444556788999999999 689999999988655
Q ss_pred -CcceeEecccccchhhhhhcccCC-------------------------------------------------------
Q 007073 364 -TERLLVYPFMQNLSVAYRLREIKP------------------------------------------------------- 387 (619)
Q Consensus 364 -~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 387 (619)
...+++|||+++|+|.++++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 457899999999999998864211
Q ss_pred --------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcc-eeee
Q 007073 388 --------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQ 458 (619)
Q Consensus 388 --------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~ 458 (619)
....+++..+.+++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++......... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 012367888899999999999999999 9999999999999999999999999999865322211 1122
Q ss_pred ccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCC
Q 007073 459 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNY 537 (619)
Q Consensus 459 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 537 (619)
..++..|+|||.+.+..++.++||||||+++|||++ |..||....... .. .......... . .
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~---~~~~~~~~~~-~---------~ 303 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----EF---CRRLKEGTRM-R---------A 303 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH----HH---HHHHhccCCC-C---------C
Confidence 345678999999988899999999999999999997 888886432110 01 1111111000 0 0
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 538 NIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 538 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
+......+.+++..||+.+|++|||+.+|++.|+.+
T Consensus 304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111234689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=326.66 Aligned_cols=253 Identities=18% Similarity=0.220 Sum_probs=201.9
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++|.+.+.||+|+||+||++... +|+.||+|+++... .....+.+.+|+.+++.++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999965 68999999987432 2234567889999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++|+|.+++.... ..+++.....++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 9999999999987642 3488899999999999999999999 999999999999999999999999999987654
Q ss_pred CCcceeeecccccccccccccc------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLS------TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
..........||+.|+|||++. ...++.++|||||||++|||+||+.||...... ...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--------~~~~~i~~~~~ 226 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA--------KTYNNIMNFQR 226 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH--------HHHHHHHcCCC
Confidence 4433334456899999999986 456789999999999999999999999643211 11111111111
Q ss_pred cchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 525 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.... ......+..+.+++..|++ +|++||++.++++
T Consensus 227 ~~~~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 FLKF-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ccCC-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0000 0011234578889999998 9999999998874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=323.72 Aligned_cols=242 Identities=24% Similarity=0.297 Sum_probs=193.3
Q ss_pred CccccCCCceEEEEEe----CCCcEEEEEEeccCC---CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 300 NVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFE---SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~----~~g~~vAvK~l~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
+.||+|+||.||++.. .+++.||||.++... .......+..|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 357899999986421 122345678899999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++|+|.+++... ..+.......++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 9999999988653 2367788888999999999999999 99999999999999999999999999987543222
Q ss_pred cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
.......||+.|+|||.+.+..++.++|||||||++|||+||+.||...... ........ ..
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~--------~~~~~~~~---------~~ 216 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK--------KTIDKILK---------GK 216 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH--------HHHHHHHc---------CC
Confidence 1223456899999999999888999999999999999999999999643211 11111111 10
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 568 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 568 (619)
. ..+......+.+++.+|++.+|++|| ++.++++
T Consensus 217 ~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 217 L--NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred C--CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 0 11222335788999999999999999 6777664
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=311.61 Aligned_cols=251 Identities=26% Similarity=0.438 Sum_probs=196.7
Q ss_pred CccccCCCceEEEEEeCC-Cc--EEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcceeEeccccc
Q 007073 300 NVLGQGGFGKVYRGVLAD-GT--KVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVYPFMQN 375 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~~-g~--~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 375 (619)
++||+|+||.||+|...+ |. .+|+|.++........+.+.+|++++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999753 43 46888887544445567889999999999 799999999999999999999999999
Q ss_pred chhhhhhcccCC------------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007073 376 LSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 443 (619)
Q Consensus 376 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 443 (619)
|+|.+++..... ....+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999875321 123478999999999999999999998 99999999999999999999999999
Q ss_pred cceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhh
Q 007073 444 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLERE 522 (619)
Q Consensus 444 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 522 (619)
++....... .......+..|+|||++.+..++.++|||||||++|||+| |..||...... +........
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--------~~~~~~~~~ 227 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------ELYEKLPQG 227 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--------HHHHHHhCC
Confidence 986322111 1111223567999999988889999999999999999997 99998532211 111111111
Q ss_pred cccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 523 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 523 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
... .........+.+++.+||+.+|.+|||+.+++..|+.+
T Consensus 228 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 YRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CCC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 110 11112335788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=330.68 Aligned_cols=260 Identities=21% Similarity=0.263 Sum_probs=202.1
Q ss_pred HHHHHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccC--CCcchHHHHHHHHHHHHHccCCCccceeeeeeCC
Q 007073 287 RELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP 363 (619)
Q Consensus 287 ~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 363 (619)
+++....++|++.+.||+|+||.||++... +++.||+|.+.+. ........+.+|+.+++.++||||+++++++..+
T Consensus 36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 344556678999999999999999999975 5889999998642 1223345678999999999999999999999999
Q ss_pred CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007073 364 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 443 (619)
Q Consensus 364 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 443 (619)
+..++||||+++|+|.+++... .++......++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG 187 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFG 187 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecc
Confidence 9999999999999999988642 267888899999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcceeeeccccccccccccccCC----CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHH
Q 007073 444 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG----KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL 519 (619)
Q Consensus 444 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 519 (619)
++...............||+.|+|||.+.+. .++.++||||+||++|||+||+.||...... ......
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~--------~~~~~i 259 (370)
T cd05621 188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV--------GTYSKI 259 (370)
T ss_pred cceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH--------HHHHHH
Confidence 9987653333233455799999999998654 3789999999999999999999999643211 111111
Q ss_pred hhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 007073 520 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPED--RPAMSEVVRM 569 (619)
Q Consensus 520 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 569 (619)
...... +........+..+.+++..|++.++.+ ||++.++++.
T Consensus 260 ~~~~~~-------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 260 MDHKNS-------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HhCCcc-------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 111000 000011123456788899999865544 8899988764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=313.18 Aligned_cols=264 Identities=25% Similarity=0.358 Sum_probs=201.0
Q ss_pred cCCcccCccccCCCceEEEEEeC-----CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCC--Ccc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TER 366 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-----~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 366 (619)
.+|++.+.||+|+||+||++..+ ++..||+|.+... .....+.+.+|++++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 46788899999999999999842 5789999998643 334457889999999999999999999987543 457
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
++|+||+++++|.+++.... ..+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||+++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence 89999999999999986532 3488999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCccee--eeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccc-------cchhHHHHHH
Q 007073 447 LVDVRKTNVT--TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE-------DDVLLLDHVK 517 (619)
Q Consensus 447 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~-------~~~~~~~~~~ 517 (619)
.......... ....++..|+|||.+.+..++.++|||||||++|||++|..++........ ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 234 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH-- 234 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH--
Confidence 7643322211 112234569999999988999999999999999999998876542211000 00000000
Q ss_pred HHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 518 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 518 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
+.+.+............+..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 235 -------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 235 -------LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred -------HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0011111111111223346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=310.66 Aligned_cols=256 Identities=24% Similarity=0.394 Sum_probs=205.8
Q ss_pred HHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
...++|.+.+.||+|+||.||++...++..+|+|.++.. ......+.+|++++++++|+||+++++++.. ...+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 345788999999999999999999888889999988642 2245678999999999999999999999877 7789999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||.+.....
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 80 EFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EeCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 9999999999997643 33478889999999999999999998 999999999999999999999999999986643
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
..........++..|+|||++....++.++|+|||||++|+++| |+.||...... .. .........
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-----~~---~~~~~~~~~----- 221 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-----EV---IRALERGYR----- 221 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-----HH---HHHHhCCCC-----
Confidence 32222223345678999999998889999999999999999999 88888632211 01 111111100
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
.......+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 222 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 -----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -----CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112334578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=310.77 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=201.9
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC----cchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES----PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
++|...+.||+|++|.||+|... ++++||+|.+..... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 56888999999999999999964 689999998864322 1123578899999999999999999999999999999
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
|+||+++++|.+.+.... .++......++.|++.||+|||+. +++||||+|+||++++++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999999999887532 378888899999999999999999 9999999999999999999999999999865
Q ss_pred ccCCccee--eeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 449 DVRKTNVT--TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 449 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
........ ....|+..|+|||.+.+..++.++||||||+++|||++|+.||...... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~---- 222 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM--------AAIFKIATQ---- 222 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH--------HHHHHHhcc----
Confidence 43222111 2345788999999999988999999999999999999999998532110 001111100
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
......+......+.+++.+||+.+|++|||+.++++.
T Consensus 223 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 223 -----PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -----CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 01111222344578899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=312.49 Aligned_cols=255 Identities=26% Similarity=0.412 Sum_probs=203.0
Q ss_pred cCCcccCccccCCCceEEEEEeC-CC---cEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DG---TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g---~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
..|.+.+.||+|+||.||+|... ++ ..||||.+...........|..|+.+++.++||||+++++++......++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 34778899999999999999965 33 369999987544455567899999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||+++++|.+++.... ..+++..+..++.|++.|++|||++ +++|+||||+||+++.++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 99999999999987532 3478999999999999999999999 99999999999999999999999999987654
Q ss_pred cCCcce--eeecc--ccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 450 VRKTNV--TTQVR--GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 450 ~~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
...... ..... .+..|+|||.+.+..++.++|||||||++|||++ |..||..... ..... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-----~~~~~---~i~~~~~ 229 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----QDVIN---AIEQDYR 229 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-----HHHHH---HHHcCCc
Confidence 322211 11111 2457999999999999999999999999999987 9999853221 11111 1111100
Q ss_pred cchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 525 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
...+.+.+..+.+++.+||+.+|++||++.+|+..|++
T Consensus 230 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 230 ----------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ----------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 11122334678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=310.19 Aligned_cols=255 Identities=28% Similarity=0.374 Sum_probs=193.4
Q ss_pred CccccCCCceEEEEEeCC---CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccc
Q 007073 300 NVLGQGGFGKVYRGVLAD---GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL 376 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~~---g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 376 (619)
+.||+|+||.||+|.+.+ +..+|+|.++..........+.+|+.++++++||||+++++++......++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 45799998875544445567889999999999999999999999999999999999999
Q ss_pred hhhhhhcccCCC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcce
Q 007073 377 SVAYRLREIKPG-EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455 (619)
Q Consensus 377 sL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 455 (619)
+|.++++..... ....++..+..++.|++.|++|||+. +++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 999999754322 23467778889999999999999999 99999999999999999999999999997543322211
Q ss_pred -eeeccccccccccccccCC-------CCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 456 -TTQVRGTMGHIAPEYLSTG-------KSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 456 -~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||....... .... ... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-----~~~~---~~~-~~~~ 228 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ-----VLTY---TVR-EQQL 228 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH-----HHHH---Hhh-cccC
Confidence 1234567889999998642 35789999999999999997 999986432111 0000 000 1111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 571 (619)
...++.+. ......+.+++..|| .+|++|||+.+|+..|+
T Consensus 229 ~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111111 112346788999999 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=308.27 Aligned_cols=250 Identities=30% Similarity=0.427 Sum_probs=204.7
Q ss_pred hcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
.++|++.+.||+|+||.||+|... |+.||+|.+..... ..+.+.+|+.+++.++|+||+++++++......++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 457888899999999999999975 89999999875432 467889999999999999999999999988899999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++++|.+++..... ..+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.+||+|||.++......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 999999999876432 3489999999999999999999999 99999999999999999999999999998663221
Q ss_pred cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhccc
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (619)
. ...++..|+|||.+.++.++.++||||||+++|||++ |..||...... .+..... ..
T Consensus 157 ~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~---~~--------- 215 (256)
T cd05039 157 D----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPHVE---KG--------- 215 (256)
T ss_pred c----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHh---cC---------
Confidence 1 2234668999999998899999999999999999998 99988543211 1111111 00
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 532 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
.....+...+..+.+++.+||+.+|++||++.+++++|+.
T Consensus 216 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 216 -YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred -CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0011122234678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.11 Aligned_cols=239 Identities=23% Similarity=0.307 Sum_probs=189.4
Q ss_pred CccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHH-ccCCCccceeeeeeCCCcceeEeccccc
Q 007073 300 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISV-AVHRNLLRLIGFCTTPTERLLVYPFMQN 375 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~ 375 (619)
+.||+|+||.||+|... +++.||+|.++... .....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 57899999986422 22334455667777764 4799999999999999999999999999
Q ss_pred chhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcce
Q 007073 376 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455 (619)
Q Consensus 376 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 455 (619)
|+|.+++... ..++......++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQSS----GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 9999888753 2378888999999999999999999 99999999999999999999999999998653322 22
Q ss_pred eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccC
Q 007073 456 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 535 (619)
Q Consensus 456 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 535 (619)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... +........ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~-----------~~ 213 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED--------ELFDSILND-----------RP 213 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcC-----------CC
Confidence 33456899999999999989999999999999999999999999643211 111111100 01
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 007073 536 NYNIQEVETMIQVALLCTQASPEDRPAMSE 565 (619)
Q Consensus 536 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 565 (619)
.++.....++.+++.+||+.+|++||++.+
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 112223456789999999999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=291.02 Aligned_cols=251 Identities=23% Similarity=0.333 Sum_probs=208.2
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
..++|++++.||+|-||.||.|+.+ ++-.||+|++.+.. ..+...++.+|+++-+.++||||+++++++.+....++
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 5678999999999999999999964 67889999987543 22335678899999999999999999999999999999
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
++||..+|.+...|++... ..++......++.|+|.|+.|+|.+ +|+||||||+|+|++.++..|++|||-+...
T Consensus 100 ilEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 9999999999999986432 3477888889999999999999999 9999999999999999999999999998754
Q ss_pred ccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
. .......+||.-|.|||...+..++..+|+|++|++.||++.|.+||...... +.++++..- ++
T Consensus 175 p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~--------etYkrI~k~----~~ 239 (281)
T KOG0580|consen 175 P---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS--------ETYKRIRKV----DL 239 (281)
T ss_pred C---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH--------HHHHHHHHc----cc
Confidence 3 33445678999999999999999999999999999999999999999643211 112221110 11
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
.++...+....+++.+|+..+|.+|.+..|++..
T Consensus 240 -------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 240 -------KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -------cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1123334578899999999999999999998863
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=315.48 Aligned_cols=252 Identities=25% Similarity=0.332 Sum_probs=199.9
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
+|+..+.||+|+||.||++... +++.||+|.+.... .......+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999964 68999999986432 12234567789999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999998886532 23488999999999999999999999 9999999999999999999999999999865432
Q ss_pred CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (619)
.. .....|+..|+|||.+.+..++.++||||+||++|||++|+.||....... ....+......
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-----~~~~~~~~~~~--------- 219 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-----KREEVERRVKE--------- 219 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-----HHHHHHHHhhh---------
Confidence 21 223468999999999998899999999999999999999999996432110 00011100000
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007073 532 NLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 568 (619)
Q Consensus 532 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 568 (619)
....+....+..+.+++.+||+.||++|| ++.++++
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 220 -DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred -cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 00112233456789999999999999999 6767654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=330.64 Aligned_cols=252 Identities=20% Similarity=0.254 Sum_probs=194.8
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.|+..+.||+|+||+||+|... +++.||+|++.... .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999964 68899999986432 22345678899999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999987532 378888889999999999999999 9999999999999999999999999997643110
Q ss_pred Cc----------------------------------------------ceeeeccccccccccccccCCCCCcchhhHHH
Q 007073 452 KT----------------------------------------------NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGY 485 (619)
Q Consensus 452 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~ 485 (619)
.. .......||+.|+|||.+.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 00123469999999999998889999999999
Q ss_pred HHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHh--ccCCCCCCCCCH
Q 007073 486 GIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALL--CTQASPEDRPAM 563 (619)
Q Consensus 486 Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPs~ 563 (619)
||++|||+||+.||........ ........ ..+..........++.+++.+ |+..+|..||++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~--------~~~i~~~~-------~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTET--------QLKVINWE-------NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHH--------HHHHHccc-------cccCCCCCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence 9999999999999964322110 00110000 000000011123466777777 556677779999
Q ss_pred HHHHH
Q 007073 564 SEVVR 568 (619)
Q Consensus 564 ~evl~ 568 (619)
.++++
T Consensus 300 ~~~l~ 304 (381)
T cd05626 300 DDIKA 304 (381)
T ss_pred HHHhc
Confidence 99985
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=313.36 Aligned_cols=254 Identities=24% Similarity=0.279 Sum_probs=198.6
Q ss_pred cccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccchh
Q 007073 302 LGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV 378 (619)
Q Consensus 302 lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 378 (619)
||+|+||.||++..+ +|+.||+|.+.... .......+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999965 68999999986422 122344566799999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcceeee
Q 007073 379 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 458 (619)
Q Consensus 379 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 458 (619)
.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 98886532 23478889999999999999999999 99999999999999999999999999998664322 2234
Q ss_pred ccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCC
Q 007073 459 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 538 (619)
Q Consensus 459 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 538 (619)
..|+..|+|||++.+..++.++||||+||++|||++|+.||....... .......... ...... ..
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~----~~~~~~~~~~---------~~~~~~-~~ 219 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV----AKEELKRRTL---------EDEVKF-EH 219 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh----hHHHHHHHhh---------cccccc-cc
Confidence 468999999999999889999999999999999999999986422110 0111111111 000000 01
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcc
Q 007073 539 IQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLA 576 (619)
Q Consensus 539 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 576 (619)
.....++.+++.+||+.||++||++.|+++.+......
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f 257 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFF 257 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhh
Confidence 12345789999999999999999998888666664444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=307.44 Aligned_cols=251 Identities=23% Similarity=0.302 Sum_probs=204.5
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
+|+..+.||+|++|.||+|... +|+.|++|.+.... .......+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999975 68999999886322 334567888999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++++|.++++... ...+++....+++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999997642 24588899999999999999999999 99999999999999999999999999998765432
Q ss_pred cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
. ......|++.|+|||+..+..++.++||||||+++|||+||+.||..... . ........ +..
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~---~~~~~~~~-~~~------- 218 (256)
T cd08529 156 N-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-----G---ALILKIIR-GVF------- 218 (256)
T ss_pred c-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----H---HHHHHHHc-CCC-------
Confidence 2 22334588999999999999999999999999999999999999864321 0 11111110 101
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
..........+.+++.+||+.+|++||++.++++.
T Consensus 219 --~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 --PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11122344678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=307.99 Aligned_cols=252 Identities=25% Similarity=0.426 Sum_probs=202.2
Q ss_pred cCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEeccc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 373 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 373 (619)
.+|+..+.||+|+||.||+|.+.+++.+|+|.+.... .....|.+|++++++++|||++++++++......++|+||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA--MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC--CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 4677789999999999999998778899999886432 23567899999999999999999999999989999999999
Q ss_pred ccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCc
Q 007073 374 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 453 (619)
Q Consensus 374 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 453 (619)
++++|.+++.... ..+++..+..++.|++.|++|||+. +++|+||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 82 EHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 9999999887532 2478889999999999999999999 999999999999999999999999999986543322
Q ss_pred ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 454 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 454 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
.......++.+|+|||.+.++.++.++||||||+++|||++ |+.||..... ............ ...
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~---~~~-- 222 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--------SEVVETINAGFR---LYK-- 222 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHhCCCC---CCC--
Confidence 22222335678999999998899999999999999999998 8998853221 011111111100 011
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 571 (619)
+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 223 -----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 -----PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -----CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1112367899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=329.94 Aligned_cols=252 Identities=19% Similarity=0.241 Sum_probs=198.0
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++|++.+.||+|+||+||+|... +|+.||||++.... .......+.+|+.++..++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999975 68999999986422 2234456788999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++|+|.+++... ..++...+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 999999999998753 2388899999999999999999999 999999999999999999999999999876532
Q ss_pred CCcc-------------------------------------eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHH
Q 007073 451 RKTN-------------------------------------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 493 (619)
Q Consensus 451 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ell 493 (619)
.... ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 011235899999999999999999999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 007073 494 TGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA---MSEVVR 568 (619)
Q Consensus 494 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~ 568 (619)
+|..||...... .......... ..+........+..+.+++.+|+. +|.+|++ +.++++
T Consensus 234 ~G~~Pf~~~~~~--------~~~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 234 VGYPPFCSDNPQ--------ETYRKIINWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCCCCCHH--------HHHHHHHcCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999999643211 1111111000 000000011223567888999986 9999998 777764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.25 Aligned_cols=201 Identities=20% Similarity=0.275 Sum_probs=173.8
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++|+..+.||+|+||+||++... +++.||+|++.+.. .......+..|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999865 68999999986422 1233456788999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++|+|.+++... ..+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 999999999998753 3488999999999999999999999 999999999999999999999999999875432
Q ss_pred CCc----------------------------------ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCC
Q 007073 451 RKT----------------------------------NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 496 (619)
Q Consensus 451 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~ 496 (619)
... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 0012346999999999999999999999999999999999999
Q ss_pred CCCCC
Q 007073 497 RAIDF 501 (619)
Q Consensus 497 ~p~~~ 501 (619)
.||..
T Consensus 234 ~Pf~~ 238 (363)
T cd05628 234 PPFCS 238 (363)
T ss_pred CCCCC
Confidence 99964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=315.39 Aligned_cols=264 Identities=25% Similarity=0.369 Sum_probs=203.8
Q ss_pred cCCcccCccccCCCceEEEEEe-----CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCC--Ccc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TER 366 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 366 (619)
..|.+.+.||+|+||.||++.+ .++..||+|.++..........+.+|++++++++|||++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467789999999999999984 357889999987554455567899999999999999999999998775 567
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 89999999999999986532 2478999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCcc--eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccc-------cccchhHHHHHH
Q 007073 447 LVDVRKTN--VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLE-------EEDDVLLLDHVK 517 (619)
Q Consensus 447 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~-------~~~~~~~~~~~~ 517 (619)
........ ......++..|+|||.+.+..++.++||||||+++|||+|++.|....... ............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 76433221 122345677899999998888999999999999999999987764321100 000000111111
Q ss_pred HHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 518 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 518 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
...... ........+..+.+++.+|++.+|++||++.++++.|++.
T Consensus 238 ~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGK----------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCc----------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111100 0111223456899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=313.04 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=202.6
Q ss_pred cCCcccCccccCCCceEEEEEeC------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcce
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 367 (619)
.+|...+.||+|+||.||++... ++..+|+|.+... .......+.+|+++++.++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 45677899999999999999742 4668999988643 3445678999999999999999999999999999999
Q ss_pred eEecccccchhhhhhcccCCC-----------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc
Q 007073 368 LVYPFMQNLSVAYRLREIKPG-----------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE 436 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 436 (619)
+++||+++++|.+++....+. ...+++..+..++.|++.|++|||+. +++||||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 999999999999998764321 13478999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceeeccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHH
Q 007073 437 AVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLD 514 (619)
Q Consensus 437 ~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 514 (619)
+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||+| |+.||...... +
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~ 232 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT--------E 232 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--------H
Confidence 999999999765432211 1122335678999999999999999999999999999999 88887532211 1
Q ss_pred HHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 515 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
........... ..+...+..+.+++.+||+.||++||++.+|.+.|++
T Consensus 233 ~~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 233 AIECITQGREL----------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHHHcCccC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 11111111000 0111233578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=325.77 Aligned_cols=262 Identities=23% Similarity=0.309 Sum_probs=197.9
Q ss_pred CCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCC-----cce
Q 007073 295 NFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT-----ERL 367 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 367 (619)
+|++.+.||+|+||.||++.. .+|+.||||++.... .....+.+.+|+++++.++|+||+++++++..+. ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999996 478999999986432 2234567889999999999999999999998776 789
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
+|+||+.+ +|...+.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~~-~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQS-DLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeecccc-CHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 99999974 67666643 23488999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCcceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh-----
Q 007073 448 VDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER----- 521 (619)
Q Consensus 448 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----- 521 (619)
.............++..|+|||.+.+. .++.++|||||||++|||++|+.||........ ...+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-----~~~i~~~~g~~~~~ 227 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ-----LDLITDLLGTPSLE 227 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH-----HHHHHHHcCCCCHH
Confidence 654433333445688999999998774 479999999999999999999999975432110 010000000
Q ss_pred ------hcccchhccccccC-------CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 522 ------EKRLDAIVDRNLNK-------NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 522 ------~~~~~~~~~~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
......+....... ........++.+++.+|++.||++|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 228 AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000000000 0111224578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=307.54 Aligned_cols=248 Identities=28% Similarity=0.441 Sum_probs=197.7
Q ss_pred CccccCCCceEEEEEeCC----CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEeccccc
Q 007073 300 NVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 375 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 375 (619)
++||+|+||.||+|.+.. +..+|+|.+.........+.+.+|+.+++.++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998532 36899999875544445678999999999999999999999875 4567999999999
Q ss_pred chhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcce
Q 007073 376 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455 (619)
Q Consensus 376 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 455 (619)
|+|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999997643 478999999999999999999999 99999999999999999999999999998764433222
Q ss_pred ee--eccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 456 TT--QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 456 ~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
.. ...++..|+|||.+.+..++.++||||||+++|||+| |+.||..... ........ .....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-----~~~~~~~~---~~~~~------- 217 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-----AEVIAMLE---SGERL------- 217 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-----HHHHHHHH---cCCcC-------
Confidence 11 1223567999999998999999999999999999998 9999864221 11111111 11110
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
..+...+..+.+++.+||+.+|++||++.++++.|++.
T Consensus 218 ---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 ---PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred ---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11122345788999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=321.80 Aligned_cols=265 Identities=28% Similarity=0.392 Sum_probs=208.2
Q ss_pred HHHHhcCCcccCccccCCCceEEEEEeC--------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeee
Q 007073 289 LQLATDNFSEKNVLGQGGFGKVYRGVLA--------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGF 359 (619)
Q Consensus 289 l~~~~~~~~~~~~lg~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~ 359 (619)
++....+|.+.+.||+|+||.||+|... ++..||+|.++........+.+.+|+++++++ +||||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 3445567889999999999999999742 12368999887544444567899999999999 79999999999
Q ss_pred eeCCCcceeEecccccchhhhhhcccCC------------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 007073 360 CTTPTERLLVYPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAA 427 (619)
Q Consensus 360 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~ 427 (619)
+......++++||+++|+|.+++..... ....+++..+..++.|++.||+|||++ +++||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence 9999999999999999999999875322 224588899999999999999999999 9999999999
Q ss_pred cEEeCCCCcEEEcccccceeeccCCcce-eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccc
Q 007073 428 NVLLDEDFEAVVGDFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLE 505 (619)
Q Consensus 428 NIll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~ 505 (619)
||+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~- 242 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV- 242 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-
Confidence 9999999999999999998664322111 122234567999999999999999999999999999999 7888753221
Q ss_pred cccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007073 506 EEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 574 (619)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 574 (619)
.+.......... .......+..+.+++.+||+.+|++||++.++++.|+...
T Consensus 243 -------~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 243 -------EELFKLLKEGHR----------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred -------HHHHHHHHcCCC----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 111111111110 0111223457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=334.41 Aligned_cols=261 Identities=21% Similarity=0.292 Sum_probs=192.7
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCC-------
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------- 363 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------- 363 (619)
..++|.+.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 3467999999999999999999974 68899999885321 2345799999999999999999876432
Q ss_pred -CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-cEEEcc
Q 007073 364 -TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-EAVVGD 441 (619)
Q Consensus 364 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~D 441 (619)
...++||||+++ ++.+++.........+++.....++.|++.||+|||++ +|+||||||+|||++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 125689999985 67666655444455689999999999999999999999 999999999999999664 799999
Q ss_pred cccceeeccCCcceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh
Q 007073 442 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 520 (619)
Q Consensus 442 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 520 (619)
||+|+.+..... .....||+.|+|||++.+. .++.++|||||||++|||+||+.||....... .+........
T Consensus 215 FGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~----~~~~i~~~~~ 288 (440)
T PTZ00036 215 FGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD----QLVRIIQVLG 288 (440)
T ss_pred cccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhC
Confidence 999986643222 2235689999999988654 68999999999999999999999996432211 1111111100
Q ss_pred hh--c------------ccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 007073 521 RE--K------------RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV 567 (619)
Q Consensus 521 ~~--~------------~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 567 (619)
.+ + ....+....+...++...+.++.+++.+||+.||.+|||+.|++
T Consensus 289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 00 0 00000001111111222346789999999999999999999988
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.54 Aligned_cols=239 Identities=25% Similarity=0.337 Sum_probs=191.5
Q ss_pred CccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcceeEeccccc
Q 007073 300 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVYPFMQN 375 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 375 (619)
+.||+|+||+||+|..+ +++.||||++.... .......+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999975 68899999986421 233456677888888876 699999999999999999999999999
Q ss_pred chhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcce
Q 007073 376 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455 (619)
Q Consensus 376 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 455 (619)
|+|.+++.... .++...+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 99998887532 388899999999999999999999 99999999999999999999999999987543221 22
Q ss_pred eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccC
Q 007073 456 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 535 (619)
Q Consensus 456 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 535 (619)
.....||+.|+|||.+.+..++.++|||||||++|||+||+.||...... ......... . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--------~~~~~i~~~-~--------~-- 213 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--------DLFEAILND-E--------V-- 213 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHhcC-C--------C--
Confidence 33456899999999999999999999999999999999999999643211 111111110 0 0
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 007073 536 NYNIQEVETMIQVALLCTQASPEDRPAMSE 565 (619)
Q Consensus 536 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 565 (619)
..+.....++.+++.+|++.||++||++.+
T Consensus 214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 214 VYPTWLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 011123457889999999999999999843
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=322.03 Aligned_cols=240 Identities=25% Similarity=0.314 Sum_probs=190.3
Q ss_pred CcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHH---HHccCCCccceeeeeeCCCcceeE
Q 007073 296 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMI---SVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
|++.+.||+|+||.||+|... +|+.||||+++... .....+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999965 68999999986432 222345666776665 466799999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||+++|+|...++. ..+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999888754 2489999999999999999999999 99999999999999999999999999987532
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... +.........
T Consensus 153 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--------~~~~~i~~~~------ 217 (324)
T cd05589 153 GFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--------EVFDSIVNDE------ 217 (324)
T ss_pred CCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC------
Confidence 221 2223456899999999999999999999999999999999999999643211 1111111100
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAM 563 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 563 (619)
..++...+..+.+++.+|++.||++||++
T Consensus 218 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 218 -----VRYPRFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred -----CCCCCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 01112234578899999999999999953
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=304.93 Aligned_cols=267 Identities=23% Similarity=0.276 Sum_probs=202.0
Q ss_pred cCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCC-cchHHHHHHHHHHHHHccCCC-ccceeeeeeCCC------
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRN-LLRLIGFCTTPT------ 364 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~------ 364 (619)
..|...++||+|+||+||+|+. .+|+.||+|+++-... ++.-....+|+.+++.++|+| ||++++++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4466677899999999999995 4789999999974332 233355679999999999999 999999998877
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 444 (619)
..++|+||++. +|..++.........++....+.++.|+.+||+|||++ +|+||||||.|||++++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 68899999976 88888887654323466688999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCcceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh-
Q 007073 445 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE- 522 (619)
Q Consensus 445 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 522 (619)
|+....... ..+..++|..|.|||++.+. .|++..||||+||++.||++++.-|+..... ..+......+..+
T Consensus 167 Ara~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~----~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 167 ARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI----DQLFRIFRLLGTPN 241 (323)
T ss_pred HHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH----HHHHHHHHHcCCCC
Confidence 996653322 24455689999999999886 6999999999999999999999888765431 1111111111111
Q ss_pred -cccchhc---ccc--ccCC-----CC---HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 523 -KRLDAIV---DRN--LNKN-----YN---IQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 523 -~~~~~~~---~~~--l~~~-----~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
.....+. +-. .... .. +....+..+++.+|++.+|.+|.|++.++++
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1111100 100 0000 00 1111478899999999999999999999875
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=321.49 Aligned_cols=242 Identities=23% Similarity=0.286 Sum_probs=193.5
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCC-CccceeeeeeCCCcceeEe
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHR-NLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lv~ 370 (619)
+|++.+.||+|+||.||+|... +++.||||++.... .....+.+..|.+++..+.|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999975 57899999986422 233456788899999999765 5888999999899999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 999999999888653 2378889999999999999999999 999999999999999999999999999875322
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
.. .......||+.|+|||++.+..++.++||||+||++|||+||+.||...... ........
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i~~--------- 215 (324)
T cd05587 154 GG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--------ELFQSIME--------- 215 (324)
T ss_pred CC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHc---------
Confidence 22 1233456999999999999999999999999999999999999999643211 11111110
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAM 563 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 563 (619)
.. ..++......+.+++.+|++.||.+||+.
T Consensus 216 ~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 216 HN--VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 00 01122234578899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=308.16 Aligned_cols=249 Identities=29% Similarity=0.394 Sum_probs=199.6
Q ss_pred CccccCCCceEEEEEeCC--C--cEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEeccccc
Q 007073 300 NVLGQGGFGKVYRGVLAD--G--TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 375 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~~--g--~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 375 (619)
+.||+|++|.||+|.+.+ + ..||+|.+.........+.+.+|+.++++++||||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999743 3 36999998754433556789999999999999999999999888 888999999999
Q ss_pred chhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcce
Q 007073 376 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455 (619)
Q Consensus 376 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 455 (619)
++|.+++..... ..+++.....++.|++.||+|||++ +++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999976432 4589999999999999999999999 99999999999999999999999999998765432221
Q ss_pred --eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 456 --TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 456 --~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
.....++..|+|||.+.+..++.++|||||||++|||+| |+.||...... +...........
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~------- 219 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--------QILKKIDKEGER------- 219 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHhcCCc-------
Confidence 112456789999999998899999999999999999999 99998532211 111111110000
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 571 (619)
...+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus 220 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 --LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0111223467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=307.99 Aligned_cols=251 Identities=17% Similarity=0.274 Sum_probs=203.6
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEeccc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 373 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 373 (619)
+|++.+.||+|+||.||++... ++..+|+|.++........+.+.+|+.+++.++|+||+++++++......+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999965 689999999864444445677889999999999999999999999999999999999
Q ss_pred ccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCc
Q 007073 374 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 453 (619)
Q Consensus 374 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 453 (619)
++++|.+++.... ...++......++.|++.||.|||++ +|+|+||||+||++++++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 9999998886532 23478888999999999999999999 999999999999999999999999999986643222
Q ss_pred ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccc
Q 007073 454 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 533 (619)
Q Consensus 454 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 533 (619)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ........ ....
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--------~~~~~~~~-~~~~------- 218 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK--------NLILKVCQ-GSYK------- 218 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH--------HHHHHHhc-CCCC-------
Confidence 223356889999999999888999999999999999999999999643211 11111111 1110
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 534 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 534 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
..+...+..+.+++.+||+.||++||++.+++..
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 --PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1122234578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=310.80 Aligned_cols=256 Identities=23% Similarity=0.368 Sum_probs=203.7
Q ss_pred hcCCcccCccccCCCceEEEEEeCC----CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
.++|.+.+.||+|+||.||+|.+.+ ...||||...........+.+.+|+.+++.++||||+++++++.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4567888999999999999999643 246899988654444456789999999999999999999998865 45789
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence 999999999999997532 2488999999999999999999998 9999999999999999999999999999876
Q ss_pred ccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccch
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (619)
............++..|+|||.+....++.++||||||+++||+++ |..||...... .. ..........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~---~~~~~~~~~~-- 227 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-----DV---IGRIENGERL-- 227 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-----HH---HHHHHcCCcC--
Confidence 5433222223334568999999988889999999999999999996 99998643211 11 1111111111
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 528 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
..+...+..+.+++.+|+..+|++|||+.++++.|+..
T Consensus 228 --------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 228 --------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11223346789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=318.60 Aligned_cols=263 Identities=22% Similarity=0.321 Sum_probs=198.8
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
++|...+.||+|+||.||+|..+ +++.||+|.++..........+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999965 67889999987544444456678999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++ +|..++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 986 777776543 23478888999999999999999999 99999999999999999999999999997653322
Q ss_pred cceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh-----------
Q 007073 453 TNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE----------- 520 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 520 (619)
. ......+++.|+|||.+.+ ..++.++|||||||++|||+||+.||........ .........
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 159 K-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE----LHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred c-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhCCCCHHHHhhhc
Confidence 2 1223457899999998865 4689999999999999999999999975432111 001100000
Q ss_pred hhcccchhccccccC----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 521 REKRLDAIVDRNLNK----NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 521 ~~~~~~~~~~~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..........+.... ...+....++.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000000000 001123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=318.74 Aligned_cols=241 Identities=23% Similarity=0.318 Sum_probs=192.1
Q ss_pred CccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcceeEeccccc
Q 007073 300 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVYPFMQN 375 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 375 (619)
++||+|+||.||+|... +|+.||+|++.... .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 57899999986432 233445677899988865 799999999999999999999999999
Q ss_pred chhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcce
Q 007073 376 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455 (619)
Q Consensus 376 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 455 (619)
|+|...+... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (321)
T cd05591 81 GDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT 152 (321)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence 9999888653 2378889999999999999999999 99999999999999999999999999987543222 22
Q ss_pred eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccC
Q 007073 456 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 535 (619)
Q Consensus 456 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 535 (619)
.....||+.|+|||.+.+..++.++|||||||++|||+||+.||...... .......... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--------~~~~~i~~~~---------~-- 213 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--------DLFESILHDD---------V-- 213 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCC---------C--
Confidence 33456899999999999999999999999999999999999999743211 1111111110 0
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCC-------CHHHHH
Q 007073 536 NYNIQEVETMIQVALLCTQASPEDRP-------AMSEVV 567 (619)
Q Consensus 536 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-------s~~evl 567 (619)
..+.....++.+++.+|++.||++|| ++.+++
T Consensus 214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~ 252 (321)
T cd05591 214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIK 252 (321)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHh
Confidence 01111235788999999999999999 666665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=306.14 Aligned_cols=248 Identities=28% Similarity=0.388 Sum_probs=199.8
Q ss_pred cCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeee-CCCcceeEecc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT-TPTERLLVYPF 372 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~lv~e~ 372 (619)
++|.+.+.||+|+||.||++... |+.||+|..+.. ...+.|.+|+.++++++|+|++++++++. ..+..++++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC---chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 46888899999999999999874 888999988642 23567899999999999999999999764 45668999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++++|.+++.... ...+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 82 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 99999999987532 23478999999999999999999999 99999999999999999999999999987543221
Q ss_pred cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhccc
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (619)
....++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+.........
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~~~~~-------- 216 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPRVEKGY-------- 216 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcCC--------
Confidence 22334668999999998899999999999999999998 8988853221 11111111110
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 532 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
........+..+.+++.+|++.+|++|||+.++++.|+.
T Consensus 217 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 217 --KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred --CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 011122334678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=304.71 Aligned_cols=249 Identities=29% Similarity=0.434 Sum_probs=199.5
Q ss_pred CccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccchhh
Q 007073 300 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVA 379 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 379 (619)
++||+|+||.||++...+++.||+|.+...........+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999987799999998875444445678999999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCccee-ee
Q 007073 380 YRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT-TQ 458 (619)
Q Consensus 380 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~~ 458 (619)
+++.... ..+++.....++.+++.|++|||++ +++||||||+||+++.++.+||+|||++........... ..
T Consensus 81 ~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKKK---NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 9986532 2478888999999999999999999 999999999999999999999999999986542211111 11
Q ss_pred ccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCC
Q 007073 459 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNY 537 (619)
Q Consensus 459 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 537 (619)
..++..|+|||.+.++.++.++||||||+++|||+| |..||...... .......... ....
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--------~~~~~~~~~~----------~~~~ 216 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--------QTRERIESGY----------RMPA 216 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--------HHHHHHhcCC----------CCCC
Confidence 223567999999998899999999999999999999 78887543211 1111111000 0111
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 538 NIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 538 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
+...+..+.+++.+|++.+|++||++.|+++.|++
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 22334679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=316.66 Aligned_cols=262 Identities=23% Similarity=0.303 Sum_probs=201.7
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
++|++.+.||+|+||.||++... +|..+|+|.++..........+.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999965 68889999886543334456788999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++++|.+++... ..+++.....++.|+++||.|||+.+ +++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 9999999999753 33788899999999999999999732 8999999999999999999999999998754322
Q ss_pred cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc---------
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK--------- 523 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 523 (619)
......|+..|+|||.+.+..++.++||||||+++|||+||+.||....... ............
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-----LEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-----HHHhhcCccccccccCCcccc
Confidence 1233468899999999988889999999999999999999999986432110 000000000000
Q ss_pred ---------------ccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 524 ---------------RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 524 ---------------~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
....+...............++.+++.+|++.+|++||++.++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000000011234578999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=324.01 Aligned_cols=242 Identities=21% Similarity=0.238 Sum_probs=194.1
Q ss_pred CccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccc
Q 007073 300 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL 376 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 376 (619)
+.||+|+||.||++... +|+.||+|.+.... .......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999964 78999999986422 2234466788999999999999999999999999999999999999
Q ss_pred hhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcce
Q 007073 377 SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455 (619)
Q Consensus 377 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 455 (619)
+|..++... ..+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (325)
T cd05594 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-AT 152 (325)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cc
Confidence 998888653 348899999999999999999997 7 99999999999999999999999999987543221 12
Q ss_pred eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccC
Q 007073 456 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 535 (619)
Q Consensus 456 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 535 (619)
.....||+.|+|||.+.+..++.++|||||||++|||+||+.||...... ........ .. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--------~~~~~i~~-~~----------~ 213 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILM-EE----------I 213 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--------HHHHHHhc-CC----------C
Confidence 23456999999999999999999999999999999999999999643211 01111100 00 0
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007073 536 NYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 568 (619)
Q Consensus 536 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 568 (619)
.++.....++.+++.+|++.||++|+ ++.++++
T Consensus 214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 11122345788999999999999996 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=305.97 Aligned_cols=251 Identities=32% Similarity=0.487 Sum_probs=204.8
Q ss_pred CccccCCCceEEEEEeCC----CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEeccccc
Q 007073 300 NVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 375 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 375 (619)
+.||+|+||.||+|...+ +..||+|.++........+.+.+|++++..++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999753 7899999997654444567899999999999999999999999998999999999999
Q ss_pred chhhhhhcccCCC-----CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 376 LSVAYRLREIKPG-----EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 376 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
++|.+++...... ...+++..+..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875322 35589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCc-ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 451 RKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 451 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
... .......++..|+|||.+....++.++||||+|+++|||++ |..||...... +.........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~----- 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--------EVLEYLRKGY----- 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCC-----
Confidence 321 12233457889999999988889999999999999999999 68988643211 1111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 571 (619)
....+...+.++.+++.+||+.+|++|||+.++++.|+
T Consensus 225 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 -----RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01112233568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=310.69 Aligned_cols=258 Identities=24% Similarity=0.382 Sum_probs=204.1
Q ss_pred cCCcccCccccCCCceEEEEEeC------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcce
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 367 (619)
++|+....||+|+||.||+|..+ +.+.||+|.+...........+.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888899999999999999964 346799998865333334678999999999999999999999999988999
Q ss_pred eEecccccchhhhhhcccCCCC-----CCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007073 368 LVYPFMQNLSVAYRLREIKPGE-----PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 442 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 442 (619)
+||||+++|+|.+++....... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997644221 2589999999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhh
Q 007073 443 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLER 521 (619)
Q Consensus 443 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 521 (619)
|++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ... +....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-----~~~---~~~~~- 232 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-----EEV---LNRLQ- 232 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-----HHH---HHHHH-
Confidence 9987543322222333456778999999988889999999999999999999 7778743211 111 11111
Q ss_pred hcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007073 522 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571 (619)
Q Consensus 522 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 571 (619)
..... .......+..+.+++.+||+.+|++||++.++++.|.
T Consensus 233 ~~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 233 AGKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cCCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 01110 0111223457899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=309.96 Aligned_cols=252 Identities=27% Similarity=0.457 Sum_probs=199.4
Q ss_pred CccccCCCceEEEEEeCC-------CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 300 NVLGQGGFGKVYRGVLAD-------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~~-------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
+.||+|+||.||+|...+ +..+|+|.+...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 468999999999999643 2579999886544445567899999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCC---CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-----cEEEccccc
Q 007073 373 MQNLSVAYRLREIKP---GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-----EAVVGDFGL 444 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DfGl 444 (619)
+++++|.+++..... ....+++..+..++.|++.||+|||+. +++|+||||+||+++.+. .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999975432 224478899999999999999999998 999999999999999877 899999999
Q ss_pred ceeeccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhh
Q 007073 445 AKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLERE 522 (619)
Q Consensus 445 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 522 (619)
++........ ......++..|+|||.+.++.++.++|||||||++|||+| |+.||..... . +........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-----~---~~~~~~~~~ 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-----Q---EVLQHVTAG 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-----H---HHHHHHhcC
Confidence 9765332211 1122345678999999999999999999999999999998 9999863221 1 111111111
Q ss_pred cccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 523 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 523 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
.. .......+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 230 ~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 GR----------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred Cc----------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 10 11122345678999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=326.69 Aligned_cols=261 Identities=20% Similarity=0.244 Sum_probs=202.9
Q ss_pred HHHHHHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeC
Q 007073 286 WRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT 362 (619)
Q Consensus 286 ~~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 362 (619)
.+++....++|++.+.||+|+||.||++... +++.||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4456667789999999999999999999975 68899999986321 22334567889999999999999999999999
Q ss_pred CCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007073 363 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 442 (619)
Q Consensus 363 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 442 (619)
+...++||||+++|+|.+++... .++...+..++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 99999999999999999988652 267788888999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcceeeeccccccccccccccCC----CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH
Q 007073 443 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG----KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 518 (619)
Q Consensus 443 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 518 (619)
|+++..............||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~ 258 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSK 258 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH--------HHHHH
Confidence 99987654333333455799999999998653 3789999999999999999999999743221 11111
Q ss_pred HhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 007073 519 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPED--RPAMSEVVRM 569 (619)
Q Consensus 519 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 569 (619)
.......... ......+..+.+++..|++.++.+ ||++.++++.
T Consensus 259 i~~~~~~~~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 259 IMNHKNSLTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HHcCCCcccC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 1111000000 011233457788999999844433 7788888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=302.40 Aligned_cols=263 Identities=23% Similarity=0.343 Sum_probs=201.0
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEecc-CCCcchHHHHHHHHHHHHHccCCCccceeeeeeC-----CC
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTD-FESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT-----PT 364 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~-~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~~ 364 (619)
....|...+.||+|+||.|+.+..+ +|+.||||++.+ .......+.-.+|+++++.++|+||+.+.+++.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 4455666789999999999999964 799999999873 3445556778899999999999999999998865 35
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 444 (619)
..++|+|+|+ -+|...++.. ..++......+..|+.+||.|+|+. +|+|||+||+|++++.+..+||+|||+
T Consensus 100 DvYiV~elMe-tDL~~iik~~----~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKSQ----QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHHh-hHHHHHHHcC----ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence 6899999994 4888877753 3388888999999999999999999 999999999999999999999999999
Q ss_pred ceeeccC-CcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHH---
Q 007073 445 AKLVDVR-KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL--- 519 (619)
Q Consensus 445 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~--- 519 (619)
|+..... .....+.++.|..|.|||++.. ..||.+.||||.||++.||++|+.-|.+...-.+ .......
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Q-----l~lI~~~lGt 246 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQ-----LQLILELLGT 246 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHH-----HHHHHHhcCC
Confidence 9987542 1223466778999999998754 6799999999999999999999999875432111 1111000
Q ss_pred hhhcccch--------hcc-------ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 520 EREKRLDA--------IVD-------RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 520 ~~~~~~~~--------~~~-------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..+..+.. .+. ..+..- -+...+...+|+.+|+..||.+|+|++|.++
T Consensus 247 P~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~-fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 247 PSEEDLQKIRSEKARPYIKSLPQIPKQPFSSI-FPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred CCHHHHHHhccHHHHHHHHhCCCCCCCCHHHH-cCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000 000 000000 1233457789999999999999999999985
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=308.44 Aligned_cols=255 Identities=23% Similarity=0.327 Sum_probs=203.0
Q ss_pred CCcccCccccCCCceEEEEEeCC--CcEEEEEEeccC---------CCcchHHHHHHHHHHHHH-ccCCCccceeeeeeC
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLAD--GTKVAVKRLTDF---------ESPGGDAAFQREVEMISV-AVHRNLLRLIGFCTT 362 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~~--g~~vAvK~l~~~---------~~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~ 362 (619)
+|++.+.||+|+||.||+|.... ++.+|+|.+... ........+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999764 688999987532 122234567788888765 799999999999999
Q ss_pred CCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEcc
Q 007073 363 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGD 441 (619)
Q Consensus 363 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~D 441 (619)
.+..+++|||+++++|.+++.........+++..+++++.|++.||.|||+ . +++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999886544445568899999999999999999996 5 899999999999999999999999
Q ss_pred cccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007073 442 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 521 (619)
Q Consensus 442 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 521 (619)
||.+....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ........
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--------~~~~~~~~ 227 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--------SLATKIVE 227 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--------HHHHHHhh
Confidence 99998764432 233456889999999999888999999999999999999999998633211 11111111
Q ss_pred hcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007073 522 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571 (619)
Q Consensus 522 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 571 (619)
. ... .......+..+.+++.+||+.||++||++.|+..+++
T Consensus 228 ~-~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 A-VYE--------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred c-cCC--------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0 000 0011123467899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=307.90 Aligned_cols=255 Identities=21% Similarity=0.272 Sum_probs=200.0
Q ss_pred hcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.++|++.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.++++++||||+++++++...+..++|+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 45788899999999999999996 478899999986432 2344567899999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++++|.++++.. ..+++..+..++.|++.|+.|||+. +|+|||+||+||+++.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 87 YCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 99999999988643 2478899999999999999999999 9999999999999999999999999999866432
Q ss_pred Ccceeeecccccccccccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 452 KTNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
.. ......|+..|+|||.+. ...++.++|||||||++|||+||+.||......... ..... ...
T Consensus 160 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--------~~~~~-~~~--- 226 (267)
T cd06646 160 IA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--------FLMSK-SNF--- 226 (267)
T ss_pred cc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--------eeeec-CCC---
Confidence 21 122345888999999884 445788999999999999999999998532211000 00000 000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 570 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 570 (619)
..+.. ......+..+.+++.+||+.+|++||+++++++.|
T Consensus 227 ~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 227 QPPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00000 01122346789999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=306.20 Aligned_cols=250 Identities=30% Similarity=0.432 Sum_probs=192.4
Q ss_pred CccccCCCceEEEEEeC----CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeC-CCcceeEecccc
Q 007073 300 NVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT-PTERLLVYPFMQ 374 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~~~ 374 (619)
+.||+|+||.||+|.+. ++..||+|++.........+.+.+|+.+++.++||||+++++++.. +...++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999863 2457999988644434456788899999999999999999998764 456789999999
Q ss_pred cchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcc
Q 007073 375 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 454 (619)
Q Consensus 375 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 454 (619)
+|+|.+++.... ...++.....++.|++.||+|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999987532 2256777889999999999999999 9999999999999999999999999999765332111
Q ss_pred ---eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCC-CCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 455 ---VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ-RAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 455 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
......++..|+|||.+.+..++.++|||||||++|||+||+ .||.... .. ............
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-----~~---~~~~~~~~~~~~----- 221 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-----SF---DITVYLLQGRRL----- 221 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-----HH---HHHHHHhcCCCC-----
Confidence 112234577899999998889999999999999999999965 4443211 11 111111111100
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
..+...+..+.+++.+||+.+|++||++.++++.|+..
T Consensus 222 -----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 222 -----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred -----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 01112235788999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=318.38 Aligned_cols=242 Identities=25% Similarity=0.319 Sum_probs=193.7
Q ss_pred CccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcceeEeccccc
Q 007073 300 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVYPFMQN 375 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 375 (619)
+.||+|+||+||+|... +++.||||.++... .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 57899999987432 233456677898998877 699999999999999999999999999
Q ss_pred chhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcce
Q 007073 376 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455 (619)
Q Consensus 376 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 455 (619)
|+|.+.+... ..+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (318)
T cd05570 81 GDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VT 152 (318)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cc
Confidence 9999888753 2488999999999999999999999 99999999999999999999999999987532222 12
Q ss_pred eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccC
Q 007073 456 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 535 (619)
Q Consensus 456 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 535 (619)
.....|++.|+|||.+.+..++.++|||||||++|||+||+.||...... ......... ..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--------~~~~~i~~~---------~~-- 213 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--------ELFQSILED---------EV-- 213 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--------HHHHHHHcC---------CC--
Confidence 23346899999999999999999999999999999999999999643211 111111110 00
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 007073 536 NYNIQEVETMIQVALLCTQASPEDRPAM-----SEVVR 568 (619)
Q Consensus 536 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~ 568 (619)
.++...+..+.+++.+||+.||++||++ .++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1112234578999999999999999998 66653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=311.20 Aligned_cols=259 Identities=21% Similarity=0.313 Sum_probs=205.2
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.++|++.+.||+|+||+||++... +|+.||+|.+.........+.+.+|+++++.++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356778899999999999999965 6889999988654445556789999999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++++|.+++... ..+++.....++.+++.||.|||+.. +++||||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 99999999888753 23789999999999999999999731 8999999999999999999999999998754221
Q ss_pred CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccc---chhHHHHHHHHhhhcccchh
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED---DVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 528 (619)
. .....|+..|+|||.+.+..++.++|||||||++|+|+||+.||+........ ..............
T Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 228 (284)
T cd06620 158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE------ 228 (284)
T ss_pred c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc------
Confidence 1 22346899999999998889999999999999999999999999754322110 01111111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
..........+..+.+++.+|++.||++|||+.|+++.
T Consensus 229 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 229 ---PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred ---cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000112244678999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=342.64 Aligned_cols=261 Identities=20% Similarity=0.302 Sum_probs=202.5
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC--cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++|++.++||+|+||.||+|... +|+.||+|++..... ....+.|.+|++++++++||||+++++++...+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47889999999999999999975 589999999874322 233567999999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCC-------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007073 371 PFMQNLSVAYRLREIKP-------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 443 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 443 (619)
||+++|+|.+++..... .....++....+++.|+++||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 123356778889999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCc-----------------ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccc
Q 007073 444 LAKLVDVRKT-----------------NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE 506 (619)
Q Consensus 444 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~ 506 (619)
+++....... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~- 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR- 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence 9987621110 0111246899999999999999999999999999999999999998642110
Q ss_pred ccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHhcC
Q 007073 507 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-AMSEVVRMLEGE 573 (619)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~ 573 (619)
... ..... .++. ........+..+.+++.+|++.||++|| +++++.+.|+..
T Consensus 238 ----ki~-~~~~i---------~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 238 ----KIS-YRDVI---------LSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred ----hhh-hhhhc---------cChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000 00000 0000 0000112345688999999999999996 567777777653
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=317.09 Aligned_cols=240 Identities=24% Similarity=0.323 Sum_probs=190.6
Q ss_pred CccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHH-ccCCCccceeeeeeCCCcceeEeccccc
Q 007073 300 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISV-AVHRNLLRLIGFCTTPTERLLVYPFMQN 375 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~ 375 (619)
+.||+|+||.||+|... +++.||||+++... .......+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999975 57899999986432 12334556778888875 5899999999999999999999999999
Q ss_pred chhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcce
Q 007073 376 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455 (619)
Q Consensus 376 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 455 (619)
|+|.+++... ..+++.....++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05619 81 GDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence 9999988753 2378889999999999999999999 999999999999999999999999999875422221 2
Q ss_pred eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccC
Q 007073 456 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 535 (619)
Q Consensus 456 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 535 (619)
.....||+.|+|||.+.+..++.++|||||||++|||+||+.||...... +......... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~~~i~~~~-------~---- 213 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--------ELFQSIRMDN-------P---- 213 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC-------C----
Confidence 33456899999999999989999999999999999999999999643211 1111111100 0
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHH-HH
Q 007073 536 NYNIQEVETMIQVALLCTQASPEDRPAMS-EV 566 (619)
Q Consensus 536 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-ev 566 (619)
.++......+.+++.+|++.||++||++. ++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l 245 (316)
T cd05619 214 CYPRWLTREAKDILVKLFVREPERRLGVKGDI 245 (316)
T ss_pred CCCccCCHHHHHHHHHHhccCHhhcCCChHHH
Confidence 01112235678999999999999999997 44
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=316.76 Aligned_cols=245 Identities=22% Similarity=0.238 Sum_probs=191.3
Q ss_pred CccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcceeEeccccc
Q 007073 300 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVYPFMQN 375 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 375 (619)
+.||+|+||.||+|... +++.||+|+++... .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 67899999997532 223345678899998887 699999999999999999999999999
Q ss_pred chhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcce
Q 007073 376 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455 (619)
Q Consensus 376 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 455 (619)
|+|..++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (327)
T cd05617 81 GDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDT 152 (327)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCc
Confidence 9998887643 2488999999999999999999999 9999999999999999999999999998753221 122
Q ss_pred eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccC
Q 007073 456 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 535 (619)
Q Consensus 456 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 535 (619)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||+........ ...............
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~---------- 220 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM--NTEDYLFQVILEKPI---------- 220 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc--ccHHHHHHHHHhCCC----------
Confidence 33456999999999999999999999999999999999999999643221111 011111111111100
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 007073 536 NYNIQEVETMIQVALLCTQASPEDRPAMS 564 (619)
Q Consensus 536 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 564 (619)
..+...+..+.+++.+|++.||++||++.
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 11122235678999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=306.66 Aligned_cols=253 Identities=26% Similarity=0.409 Sum_probs=198.8
Q ss_pred CcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchH-HHHHHHHHHHHHccCCCccceeeeeeCCCcceeEeccc
Q 007073 296 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGD-AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 373 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~-~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 373 (619)
|++.+.||+|+||+||++... +++.||+|.+......... ....+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567889999999999999976 5678999999754432222 23456999999999999999999999999999999999
Q ss_pred ccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCc
Q 007073 374 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 453 (619)
Q Consensus 374 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 453 (619)
++++|.+++.. ...+++..+..++.|+++||.+||+. +++|+||||+||+++.++.++|+|||.+.... ...
T Consensus 81 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENN 152 (260)
T ss_dssp TTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STT
T ss_pred ccccccccccc----cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccc
Confidence 99999999983 23489999999999999999999999 99999999999999999999999999998642 222
Q ss_pred ceeeecccccccccccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 454 NVTTQVRGTMGHIAPEYLS-TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 454 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
.......++..|+|||.+. +..++.++||||+|+++|+|++|+.||....... ...................
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~-- 225 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD-----QLEIIEKILKRPLPSSSQQ-- 225 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH-----HHHHHHHHHHTHHHHHTTS--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchh-----hhhhhhhcccccccccccc--
Confidence 3344566899999999998 7889999999999999999999999987541110 0011111100000000000
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.......+.+++.+|++.||++||++.++++
T Consensus 226 -----~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 -----SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -----HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -----cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001268999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=319.81 Aligned_cols=242 Identities=23% Similarity=0.281 Sum_probs=193.2
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcceeEe
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 370 (619)
+|.+.+.||+|+||.||+|... +++.||+|.+.+.. .......+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999975 57899999987432 122345567788888777 5899999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++|+|.+.+.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999998886532 378899999999999999999999 999999999999999999999999999975432
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... .. ......
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-----~~---~~~i~~--------- 215 (323)
T cd05616 154 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-----EL---FQSIME--------- 215 (323)
T ss_pred CC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-----HH---HHHHHh---------
Confidence 22 2233456899999999999999999999999999999999999999643211 11 111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAM 563 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 563 (619)
.. ..++...+.++.+++.+|++.+|++|++.
T Consensus 216 ~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 216 HN--VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CC--CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 00 01122334678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=305.62 Aligned_cols=254 Identities=22% Similarity=0.347 Sum_probs=190.6
Q ss_pred ccccCCCceEEEEEeCCC---cEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccch
Q 007073 301 VLGQGGFGKVYRGVLADG---TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS 377 (619)
Q Consensus 301 ~lg~G~fg~Vy~~~~~~g---~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 377 (619)
.||+|+||.||+|...++ ..+++|.+.........+.|.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999985433 35667776544444456789999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC-ccee
Q 007073 378 VAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK-TNVT 456 (619)
Q Consensus 378 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~-~~~~ 456 (619)
|.++++.........+......++.|+++||+|||+. +++||||||+||+++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999986543334467777889999999999999999 99999999999999999999999999986432111 1122
Q ss_pred eeccccccccccccccC-------CCCCcchhhHHHHHHHHHHHhC-CCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 457 TQVRGTMGHIAPEYLST-------GKSSERTDVFGYGIMLLELVTG-QRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 457 ~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~S~Gv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
....++..|+|||++.. ..++.++||||||+++|||+++ ..||..... . +........ .....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~---~~~~~~~~~-~~~~~ 229 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----R---EVLNHVIKD-QQVKL 229 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-----H---HHHHHHHhh-ccccc
Confidence 33457889999998753 2457899999999999999974 667643221 1 111111111 11122
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 571 (619)
.++.+.. .....+.+++..|| .+|++||++.+|++.|.
T Consensus 230 ~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2222221 23356788999999 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=325.74 Aligned_cols=253 Identities=19% Similarity=0.222 Sum_probs=195.6
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++|.+.+.||+|+||.||++... +|+.||||++.... .....+.+.+|++++++++||||+++++++..+...++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999864 78999999986422 2234567888999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++|+|.+++... ..++......++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 999999999998753 2378888899999999999999999 999999999999999999999999999964321
Q ss_pred CCcc----------------------------------------------eeeeccccccccccccccCCCCCcchhhHH
Q 007073 451 RKTN----------------------------------------------VTTQVRGTMGHIAPEYLSTGKSSERTDVFG 484 (619)
Q Consensus 451 ~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 484 (619)
.... ......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 001246899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCC---C
Q 007073 485 YGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDR---P 561 (619)
Q Consensus 485 ~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---P 561 (619)
|||++|||+||+.||...... +.......... .+.-+ . ......++.+++.+|+. +|.+| |
T Consensus 234 lGvil~elltG~~Pf~~~~~~--------~~~~~i~~~~~--~~~~p---~--~~~~s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSH--------ETYRKIINWRE--TLYFP---D--DIHLSVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHH--------HHHHHHHccCC--ccCCC---C--CCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 999999999999999643211 11111110000 00000 0 11223567899999997 66665 5
Q ss_pred CHHHHHHH
Q 007073 562 AMSEVVRM 569 (619)
Q Consensus 562 s~~evl~~ 569 (619)
++.++++.
T Consensus 298 ~~~~~l~h 305 (377)
T cd05629 298 GAHEIKSH 305 (377)
T ss_pred CHHHHhcC
Confidence 88888753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=314.09 Aligned_cols=256 Identities=27% Similarity=0.432 Sum_probs=200.6
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCc----EEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcce
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGT----KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 367 (619)
.++|+..+.||+|+||.||+|.+. +|. .||+|.+...........+.+|+.+++.++||||+++++++..+ ...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 456778899999999999999864 444 57899886544444455788999999999999999999998754 467
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
+++||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 8999999999999887532 2478889999999999999999999 999999999999999999999999999987
Q ss_pred eccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 448 VDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 448 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
....... ......++..|+|||.+.+..++.++||||||+++|||+| |+.||...... ...+.. ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~-----~~~~~~---~~~~~~ 230 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR-----EIPDLL---EKGERL 230 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHH---HCCCCC
Confidence 6432221 1222345678999999998899999999999999999998 88888532210 111111 111100
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.........+.+++..||..+|++||++.++++.|+..
T Consensus 231 ----------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 231 ----------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01122335788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=310.95 Aligned_cols=264 Identities=24% Similarity=0.372 Sum_probs=205.5
Q ss_pred cCCcccCccccCCCceEEEEEeC-----CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeC--CCcc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT--PTER 366 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-----~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~ 366 (619)
+.|...+.||+|+||.||+|.+. ++..||||.+...........|.+|+++++.+.|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45677789999999999999863 3689999998754333356789999999999999999999999877 5578
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
+++|||+++++|.+++.... ..+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||.+.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 99999999999999997643 2489999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCcce--eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccc-------chhHHHHHH
Q 007073 447 LVDVRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED-------DVLLLDHVK 517 (619)
Q Consensus 447 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~-------~~~~~~~~~ 517 (619)
......... .....++..|+|||.+.+..++.++||||||+++|||+||+.|+......... .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 765322211 11223456799999998889999999999999999999999997643221100 000111111
Q ss_pred HHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 518 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 518 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.. ............+..+.+++.+||+.+|++|||+.||+++|+.+
T Consensus 238 ~~----------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LL----------KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HH----------HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11 11111111223346799999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=308.41 Aligned_cols=256 Identities=26% Similarity=0.411 Sum_probs=203.9
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCc----EEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcce
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGT----KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 367 (619)
..+|.+.+.||+|+||.||+|.+. +|. .||+|.+...........+.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 356788899999999999999964 333 6899988755444456788999999999999999999999987 7789
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
+|+||+++|+|.+++.... ..+++.....++.|++.|++|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 9999999999999987632 2388999999999999999999998 999999999999999999999999999987
Q ss_pred eccCCccee-eeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 448 VDVRKTNVT-TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 448 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
......... ....++..|+|||.+....++.++||||||+++||++| |+.||...... +..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~- 229 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--------EIPDLLEKGER- 229 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHhCCCC-
Confidence 653322211 12223568999999988899999999999999999999 99998643211 11111111100
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
...+......+.+++.+||..+|++||++.++++.|+..
T Consensus 230 ---------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 230 ---------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 011112335788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=323.28 Aligned_cols=239 Identities=23% Similarity=0.280 Sum_probs=192.5
Q ss_pred CccccCCCceEEEEEe----CCCcEEEEEEeccCCC-cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccc
Q 007073 300 NVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQ 374 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~----~~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 374 (619)
+.||+|+||.||++.. .+|+.||+|++..... ......+..|++++++++||||+++++++..+...++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 3688999999864321 2234567789999999999999999999999999999999999
Q ss_pred cchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcc
Q 007073 375 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 454 (619)
Q Consensus 375 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 454 (619)
+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~ 153 (318)
T cd05582 82 GGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K 153 (318)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-C
Confidence 99999988653 3488999999999999999999999 99999999999999999999999999998654322 2
Q ss_pred eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcccccc
Q 007073 455 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN 534 (619)
Q Consensus 455 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 534 (619)
......|++.|+|||.+.+..++.++|||||||++|||+||+.||...... ......... ..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--------~~~~~i~~~-~~--------- 215 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--------ETMTMILKA-KL--------- 215 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH--------HHHHHHHcC-CC---------
Confidence 233456899999999999888999999999999999999999999643211 111111110 00
Q ss_pred CCCCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 007073 535 KNYNIQEVETMIQVALLCTQASPEDRPAMSE 565 (619)
Q Consensus 535 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 565 (619)
..+......+.+++.+||+.||++||++.+
T Consensus 216 -~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 -GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 112223457889999999999999999666
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=305.21 Aligned_cols=249 Identities=19% Similarity=0.315 Sum_probs=208.4
Q ss_pred hcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCC--cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
..+|++.+.||+|.||.|-+|.. ..|+.||||.+++..- .+..-.+.+|+++|+.++||||+.++.+|...+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 34677888999999999999994 6899999999986543 33445678999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||..+|.|.+++.+... ++..+...++.||..|+.|+|.+ +++|||||-+|||+|.++++||+|||++.++.
T Consensus 132 MEYaS~GeLYDYiSer~~----LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGS----LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999987543 89999999999999999999999 99999999999999999999999999998775
Q ss_pred cCCcceeeeccccccccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
.. .....++|++-|.+||+..+.+| .+.+|-||+||++|-|+.|..||+.... ...+..+....
T Consensus 205 ~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh--------k~lvrQIs~Ga----- 269 (668)
T KOG0611|consen 205 DK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH--------KRLVRQISRGA----- 269 (668)
T ss_pred cc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH--------HHHHHHhhccc-----
Confidence 43 23456789999999999999988 6899999999999999999999985321 12222222111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 570 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 570 (619)
.+ .+..+.+..-|+.+|+..+|++|-|..+|....
T Consensus 270 ----Yr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 270 ----YR---EPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ----cc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 11 122234556789999999999999999998764
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=307.58 Aligned_cols=248 Identities=23% Similarity=0.346 Sum_probs=203.7
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
++|+..+.||.|+||.||+|... +++.||+|.+...........+.+|+++++.++|+||+++++++..+...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36778899999999999999965 68999999986544445567789999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++++|.+++... .+++.....++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999998753 588999999999999999999999 99999999999999999999999999998775432
Q ss_pred cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
. ......|+..|+|||.+.+..++.++||||||+++|||+||+.||...... ....... ....
T Consensus 153 ~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--------~~~~~~~-~~~~------- 215 (274)
T cd06609 153 S-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--------RVLFLIP-KNNP------- 215 (274)
T ss_pred c-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--------HHHHHhh-hcCC-------
Confidence 2 223346888999999999888999999999999999999999998643210 0111111 0101
Q ss_pred ccCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 533 LNKNYNIQ-EVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 533 l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
...... .+..+.+++.+||..+|++|||++++++
T Consensus 216 --~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 216 --PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred --CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 011111 3457889999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=306.80 Aligned_cols=254 Identities=25% Similarity=0.367 Sum_probs=190.6
Q ss_pred ccccCCCceEEEEEeCC---CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccch
Q 007073 301 VLGQGGFGKVYRGVLAD---GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS 377 (619)
Q Consensus 301 ~lg~G~fg~Vy~~~~~~---g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 377 (619)
.||+|+||.||+|...+ ...+|+|.+...........|.+|+++++.++|+||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999998543 357888887654444455678899999999999999999999999999999999999999
Q ss_pred hhhhhcccCCC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcce-
Q 007073 378 VAYRLREIKPG-EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV- 455 (619)
Q Consensus 378 L~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~- 455 (619)
|.+++...... ....++.....++.|++.|++|||++ +|+||||||+||++++++.+||+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999764432 22356778889999999999999999 99999999999999999999999999987543222111
Q ss_pred eeeccccccccccccccC-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccch
Q 007073 456 TTQVRGTMGHIAPEYLST-------GKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527 (619)
Q Consensus 456 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (619)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||...... .. ........ ...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~----~~----~~~~~~~~-~~~ 229 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE----QV----LKQVVREQ-DIK 229 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH----HH----HHHHhhcc-Ccc
Confidence 122345678999998743 356889999999999999999 77787532211 01 11111111 111
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007073 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571 (619)
Q Consensus 528 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 571 (619)
...+. ........+.+++..|| .||++|||+++|++.|.
T Consensus 230 ~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11111 12233456678888998 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.61 Aligned_cols=249 Identities=20% Similarity=0.305 Sum_probs=201.1
Q ss_pred cCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
.+|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++|+||+++++.+......++||||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC-cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 5788889999999999999996 468999999886433 33456788999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++++|.+++.. ..+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999998864 2378889999999999999999999 99999999999999999999999999987654322
Q ss_pred cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
.. .....|++.|+|||.+.+..++.++|||||||++|+|+||+.||....... .... ......
T Consensus 171 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-------~~~~-~~~~~~-------- 233 (296)
T cd06654 171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-------ALYL-IATNGT-------- 233 (296)
T ss_pred cc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-------hHHH-HhcCCC--------
Confidence 21 223458899999999998889999999999999999999999996432110 0000 000000
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.....+......+.+++.+||..+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 000112234467889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=308.60 Aligned_cols=252 Identities=24% Similarity=0.335 Sum_probs=197.4
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeCC------
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTP------ 363 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~------ 363 (619)
+++.|+..+.||+|+||.||+|... +++.||+|.+... ......+.+|+.++.++ +|+||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC--CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 5667888899999999999999965 6889999998643 23456788999999988 699999999998653
Q ss_pred CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007073 364 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 443 (619)
Q Consensus 364 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 443 (619)
...++||||+++++|.+++.... ...+++.....++.|++.|++|||++ +|+|+||||+||++++++.++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence 34789999999999999987632 23488899999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcceeeecccccccccccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH
Q 007073 444 LAKLVDVRKTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 518 (619)
Q Consensus 444 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 518 (619)
++........ ......|+..|+|||++. ...++.++|||||||++|||++|+.||...... ... ..
T Consensus 157 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-------~~~-~~ 227 (272)
T cd06637 157 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------RAL-FL 227 (272)
T ss_pred Cceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-------HHH-HH
Confidence 9986543221 223456899999999986 345788999999999999999999998532210 000 00
Q ss_pred HhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 519 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 519 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
... . ..... .....+..+.+++.+||+.+|.+|||+.++++
T Consensus 228 ~~~-~-----~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 228 IPR-N-----PAPRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred Hhc-C-----CCCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000 0 00000 11123357889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=316.37 Aligned_cols=241 Identities=24% Similarity=0.310 Sum_probs=190.5
Q ss_pred CccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHH-ccCCCccceeeeeeCCCcceeEeccccc
Q 007073 300 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISV-AVHRNLLRLIGFCTTPTERLLVYPFMQN 375 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~ 375 (619)
++||+|+||.||+|... +|+.||+|.++... .......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999975 68899999986432 12334566778888775 4899999999999999999999999999
Q ss_pred chhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcce
Q 007073 376 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455 (619)
Q Consensus 376 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 455 (619)
|+|..++... ..+++.....++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 9999888653 2378889999999999999999999 99999999999999999999999999987532221 22
Q ss_pred eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccC
Q 007073 456 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 535 (619)
Q Consensus 456 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 535 (619)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ......... .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--------~~~~~~~~~-------~~---- 213 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--------ELFESIRVD-------TP---- 213 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC-------CC----
Confidence 33456899999999999999999999999999999999999999643211 111111100 00
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 007073 536 NYNIQEVETMIQVALLCTQASPEDRPAMS-EVV 567 (619)
Q Consensus 536 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl 567 (619)
..+.....++.+++.+|++.||++||++. ++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11112235788999999999999999984 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=309.46 Aligned_cols=248 Identities=24% Similarity=0.336 Sum_probs=200.9
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEeccc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 373 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 373 (619)
.|+..+.||+|+||.||+|... ++..||+|.+.........+.+.+|++++++++||||+++++++..+...++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4566788999999999999864 578999998865444445678899999999999999999999999999999999999
Q ss_pred ccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCc
Q 007073 374 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 453 (619)
Q Consensus 374 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 453 (619)
++++|.+++.. ..+++..+..++.|+++|+.|||++ +++|+||+|+||++++++.++++|||++........
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999988853 2378889999999999999999999 999999999999999999999999999986543221
Q ss_pred ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccc
Q 007073 454 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 533 (619)
Q Consensus 454 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 533 (619)
......|+..|+|||++.+..++.++||||||+++|||+||+.|+...... ...... ....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~~~~~----------~~~~ 217 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM--------RVLFLI----------PKNS 217 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh--------hHHhhh----------hcCC
Confidence 122345788999999999989999999999999999999999998532110 000000 0000
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 534 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 534 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
........+..+.+++.+||+.+|++||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 218 PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 111222345678999999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=307.88 Aligned_cols=262 Identities=22% Similarity=0.289 Sum_probs=204.8
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCC--CcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 370 (619)
++|+..+.||.|++|.||++... +++.+|+|.+...........+.+|++++++++||||+++++++... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36788899999999999999975 68899999987544444567889999999999999999999988654 4678999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++++|.+++.........++......++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988765444445588889999999999999999999 999999999999999999999999999875532
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
... ....++..|+|||.+.+..++.++||||+|+++|+|+||+.||+....+.........+..... ... +.
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~-~~ 229 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP----NPE-LK 229 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC----chh-hc
Confidence 211 2345788999999999999999999999999999999999999754321111112222211100 000 01
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
... ......+..+.+++.+||+.+|++|||+.|+++
T Consensus 230 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 230 DEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred cCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 000 001234567899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=324.42 Aligned_cols=264 Identities=21% Similarity=0.259 Sum_probs=196.2
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
....|.+.+.||+|+||.||+|.+. .++.||||... ...+.+|++++++++|+|||++++++......++||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 3457899999999999999999975 57899999642 234578999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
|++. ++|..++... ...+++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 240 e~~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 240 PKYR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred EccC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 9995 6787777542 23589999999999999999999999 999999999999999999999999999987643
Q ss_pred CCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccc---cchhHHHHHHHHhhh-ccc
Q 007073 451 RKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE---DDVLLLDHVKKLERE-KRL 525 (619)
Q Consensus 451 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~-~~~ 525 (619)
.... ......||..|+|||++.+..++.++|||||||++|||++|..++........ ....+...+...... ...
T Consensus 313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~ 392 (461)
T PHA03211 313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF 392 (461)
T ss_pred ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence 2221 22345699999999999999999999999999999999998876532211111 111111111111000 000
Q ss_pred ch---------hcc---ccccCCCC-------HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 526 DA---------IVD---RNLNKNYN-------IQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 526 ~~---------~~~---~~l~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
.. ... ........ ......+.+|+.+|++.||++|||+.|+++.
T Consensus 393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 000 00000000 0122468899999999999999999999863
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=328.00 Aligned_cols=252 Identities=20% Similarity=0.234 Sum_probs=194.6
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
+|++.+.||+|+||.||+|... +|+.||||.+.+.. .......+.+|++++++++|+||+++++.+..++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999964 68999999986421 12234668899999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++|+|.+++... ..++......++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|..+...
T Consensus 82 ~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 82 YIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999998753 2378888889999999999999999 9999999999999999999999999997532100
Q ss_pred C------------------------------------------cceeeeccccccccccccccCCCCCcchhhHHHHHHH
Q 007073 452 K------------------------------------------TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 489 (619)
Q Consensus 452 ~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l 489 (619)
. ........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 0001134699999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCC---CHHHH
Q 007073 490 LELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP---AMSEV 566 (619)
Q Consensus 490 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---s~~ev 566 (619)
|||+||+.||....... .......... . .........+..+.+++.+|+ .+|.+|+ ++.++
T Consensus 235 yell~G~~Pf~~~~~~~--------~~~~i~~~~~--~-----~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 235 YEMLVGQPPFLADTPAE--------TQLKVINWET--T-----LHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred eehhhCCCCCCCCCHHH--------HHHHHhccCc--c-----ccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 99999999997533211 1111100000 0 000001122345677777766 5999999 77887
Q ss_pred HHH
Q 007073 567 VRM 569 (619)
Q Consensus 567 l~~ 569 (619)
++.
T Consensus 299 l~h 301 (376)
T cd05598 299 KAH 301 (376)
T ss_pred hCC
Confidence 743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=327.49 Aligned_cols=251 Identities=21% Similarity=0.232 Sum_probs=192.4
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.|+..+.||+|+||+||+|... +++.||+|.+.... .......+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788999999999999999964 68899999986422 12345678899999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++|+|.+++... ..++......++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 99999999988753 2377888889999999999999999 9999999999999999999999999997532100
Q ss_pred C----------------------------------------------cceeeeccccccccccccccCCCCCcchhhHHH
Q 007073 452 K----------------------------------------------TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGY 485 (619)
Q Consensus 452 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~ 485 (619)
. ........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000112468999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC---
Q 007073 486 GIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA--- 562 (619)
Q Consensus 486 Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs--- 562 (619)
||++|||+||+.||...... ......... ..............+..+++.+++ .+|++|++
T Consensus 235 Gvil~elltG~~Pf~~~~~~--------~~~~~i~~~-------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~ 298 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPL--------ETQMKVINW-------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNG 298 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHH--------HHHHHHHcc-------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCC
Confidence 99999999999999643211 001111100 000000001122345667777765 49999997
Q ss_pred HHHHHH
Q 007073 563 MSEVVR 568 (619)
Q Consensus 563 ~~evl~ 568 (619)
+.++++
T Consensus 299 ~~ei~~ 304 (382)
T cd05625 299 ADEIKA 304 (382)
T ss_pred HHHHhc
Confidence 666653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=302.54 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=203.3
Q ss_pred hcCCcccCccccCCCceEEEEEeCC-CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.++|+..+.||+|+||.||+|...+ ++.||+|.+.... ..+.+.+|++++++++|+||+++++++......++++|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 3678889999999999999999864 7899999986432 26789999999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++++|.+++... ...+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 79 ~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 79 YCGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred cCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 99999999998653 24489999999999999999999999 9999999999999999999999999999876433
Q ss_pred CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (619)
.. ......|+..|+|||.+.+..++.++||||||+++|+|+||+.||........ .... .. ....
T Consensus 153 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--------~~~~-~~-----~~~~ 217 (256)
T cd06612 153 MA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--------IFMI-PN-----KPPP 217 (256)
T ss_pred cc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--------hhhh-cc-----CCCC
Confidence 22 22334578899999999988999999999999999999999999864321100 0000 00 0000
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 532 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
....+......+.+++.+||+.+|++|||+.++++
T Consensus 218 --~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 218 --TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred --CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 00112234467899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=318.63 Aligned_cols=243 Identities=23% Similarity=0.244 Sum_probs=190.3
Q ss_pred CccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHH-HHHHccCCCccceeeeeeCCCcceeEeccccc
Q 007073 300 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVE-MISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 375 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 375 (619)
+.||+|+||+||+|... +|+.||+|++.... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 68999999986422 1223344555555 46789999999999999999999999999999
Q ss_pred chhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcce
Q 007073 376 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455 (619)
Q Consensus 376 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 455 (619)
|+|..++... ..+++.....++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (323)
T cd05575 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKT 152 (323)
T ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCc
Confidence 9999888753 3478888999999999999999999 9999999999999999999999999998753221 122
Q ss_pred eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccC
Q 007073 456 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 535 (619)
Q Consensus 456 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 535 (619)
.....||+.|+|||.+.+..++.++|||||||++|||+||+.||...... +....... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~---------~~~-- 213 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA--------EMYDNILN---------KPL-- 213 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH--------HHHHHHHc---------CCC--
Confidence 33456899999999999999999999999999999999999999643211 11111111 000
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 536 NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 536 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
...+..+..+.+++.+|++.||++||++.+.+..
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (323)
T cd05575 214 RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLE 247 (323)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHH
Confidence 0111224678899999999999999998644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=310.07 Aligned_cols=252 Identities=24% Similarity=0.351 Sum_probs=198.6
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC--cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.|+..+.||+|+||.||++... +++.||||.+..... ......+.+|+.++++++|+|++++++.+...+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3667789999999999999965 689999999864322 2223567789999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++++|.+++.... ...++...+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 999999999886432 23488899999999999999999999 9999999999999999999999999998765432
Q ss_pred CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (619)
.. .....|+..|+|||.+.+..++.++|||||||++|||++|+.||......... ........ ..
T Consensus 156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-----~~~~~~~~-----~~--- 220 (285)
T cd05630 156 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-----EEVERLVK-----EV--- 220 (285)
T ss_pred cc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-----HHHHhhhh-----hh---
Confidence 21 22346899999999999999999999999999999999999999643211000 00000000 00
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007073 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVR 568 (619)
Q Consensus 532 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 568 (619)
...+......++.+++.+||+.||++||| ++|+++
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 221 --QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred --hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 00111223356889999999999999999 777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=316.30 Aligned_cols=256 Identities=20% Similarity=0.237 Sum_probs=196.3
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccC--CCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++|++.+.||+|+||.||++... +++.||+|.+.+. ......+.+.+|+.++..++|+||+++++++..++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999965 6899999998642 12234466889999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++|+|.+++... ...++...+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999998653 23478888999999999999999999 999999999999999999999999999976654
Q ss_pred CCcceeeeccccccccccccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLST-----GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
..........||+.|+|||++.. ..++.++|||||||++|||++|+.||...... +...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~--------~~~~~i~~~~~~ 226 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--------ETYGKIMNHKEH 226 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH--------HHHHHHHcCCCc
Confidence 33333333468999999999863 45788999999999999999999999643211 111111111100
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCC--CCCCHHHHHHH
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPE--DRPAMSEVVRM 569 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~--~RPs~~evl~~ 569 (619)
..+. ......+..+.+++.+|+..+++ .||++.++++.
T Consensus 227 ~~~~------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 227 FQFP------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ccCC------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0000 01112345677888887755333 37888888754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=304.65 Aligned_cols=249 Identities=24% Similarity=0.336 Sum_probs=204.1
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
..|+..+.||+|+||.||+|.+. ++..||+|.+...........+.+|+.++++++|+||+++++++..+...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34667789999999999999975 58899999986544445567889999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++++|.+++.. ..++......++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999998864 2377888899999999999999999 99999999999999999999999999997664332
Q ss_pred cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
. ......++..|+|||.+.+..++.++|||||||++|||+||+.||....... .... ....
T Consensus 156 ~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~----------~~~~ 216 (277)
T cd06640 156 I-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR--------VLFL----------IPKN 216 (277)
T ss_pred c-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--------Hhhh----------hhcC
Confidence 2 2233457889999999998889999999999999999999999986422110 0000 0111
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
.........+..+.+++.+||+.+|++||++.++++.
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1122344566789999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=307.52 Aligned_cols=264 Identities=20% Similarity=0.288 Sum_probs=197.8
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
+|+..+.||+|++|.||+|... +|..||+|.+.... .......+.+|+.++++++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999975 68999999986432 223456788999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
++ ++|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 578887765432 34588999999999999999999999 99999999999999999999999999998654322
Q ss_pred cceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh----------
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER---------- 521 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 521 (619)
.......+++.|+|||.+.+. .++.++||||||+++|||+||+.||........ ..........
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ----LFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHHHhCCCChhhhhcch
Confidence 122233578899999988654 578999999999999999999999864321110 0000000000
Q ss_pred -hcccchhcccccc---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 522 -EKRLDAIVDRNLN---KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 522 -~~~~~~~~~~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
............. .......+.++.+++.+||+.||++|||+.+|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000000 0001123457789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=305.28 Aligned_cols=261 Identities=24% Similarity=0.335 Sum_probs=201.4
Q ss_pred HHHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHH--HccCCCccceeeeeeCCC---
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMIS--VAVHRNLLRLIGFCTTPT--- 364 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~--~l~H~niv~l~~~~~~~~--- 364 (619)
.....+..+.+.||+|.||.||+|.|+ |..||||++.. ..++.+.+|.++++ .++|+||+.+++.-..++
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-CCceEEEEecc----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 345567788999999999999999996 89999999853 34678889999987 468999999998876553
Q ss_pred -cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEecCCCCCcEEeCCCCcEE
Q 007073 365 -ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-----HCNPKIIHRDVKAANVLLDEDFEAV 438 (619)
Q Consensus 365 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-----~~~~~ivH~Dlkp~NIll~~~~~~k 438 (619)
..+||.+|.++|||.++|.. ..++....++++..+|.||+|||. +.+|.|.|||||+.|||+..++.+.
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred EEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 47899999999999999986 338899999999999999999996 3578999999999999999999999
Q ss_pred EcccccceeeccCCcc---eeeeccccccccccccccCCC----C--CcchhhHHHHHHHHHHHhCC----------CCC
Q 007073 439 VGDFGLAKLVDVRKTN---VTTQVRGTMGHIAPEYLSTGK----S--SERTDVFGYGIMLLELVTGQ----------RAI 499 (619)
Q Consensus 439 l~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~--~~~~Dv~S~Gv~l~elltg~----------~p~ 499 (619)
|+|+|+|......... .....+||.+|||||++...- + -..+||||||.|+||+.-.. .||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 9999999876543221 233457999999999995431 1 24689999999999987632 343
Q ss_pred CCCccccccchhHHHHHHHHhhhcccch-hccccccCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 500 DFSRLEEEDDVLLLDHVKKLEREKRLDA-IVDRNLNKNY-----NIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
...- ..-+.-+.+.+ +-.+.+++.. .......+.++|+.||..+|.-|-|+--+-+.|.++
T Consensus 437 yd~V-------------p~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l 503 (513)
T KOG2052|consen 437 YDVV-------------PSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL 503 (513)
T ss_pred ccCC-------------CCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence 3211 11111111111 1122233222 356678899999999999999999999988888764
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=301.01 Aligned_cols=252 Identities=30% Similarity=0.480 Sum_probs=202.6
Q ss_pred CcccCccccCCCceEEEEEeCC-----CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 296 FSEKNVLGQGGFGKVYRGVLAD-----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
+++.+.||+|+||.||++.+.+ +..||+|++.........+.+..|++++..++|+||+++++++...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999999753 48899999976544446778999999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++++|.+++...... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++....
T Consensus 81 e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK--ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhhc--cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 999999999998763321 178999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
..........++..|+|||.+.+..++.++||||+|+++|||++ |..||..... . ...........
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-----~---~~~~~~~~~~~----- 222 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-----E---EVLEYLKKGYR----- 222 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-----H---HHHHHHhcCCC-----
Confidence 42222222346789999999988889999999999999999999 7777753211 1 11111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 570 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 570 (619)
.......+..+.+++.+|++.+|++|||+.++++.|
T Consensus 223 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 -----LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011122456789999999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=306.67 Aligned_cols=254 Identities=21% Similarity=0.305 Sum_probs=196.2
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHH-HHHccCCCccceeeeeeCCCcceeEec
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEM-ISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
++|++.+.||+|+||.||+|... +|+.||+|++...........+..|+.. ++..+||||+++++++..+...+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999975 6999999998754333344566667765 567789999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|++ |+|.+++.........+++..+..++.|++.||+|||+++ +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 5787777654444456899999999999999999999853 7999999999999999999999999999865322
Q ss_pred CcceeeeccccccccccccccC----CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccch
Q 007073 452 KTNVTTQVRGTMGHIAPEYLST----GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (619)
. ......|+..|+|||.+.+ ..++.++|+|||||++|||++|+.||...... .+......... .
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~-~-- 225 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-------FQQLKQVVEEP-S-- 225 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-------HHHHHHHHhcC-C--
Confidence 1 1223457889999998864 45689999999999999999999998532110 00111110000 0
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 528 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. .......+.++.+++.+||+.+|++||++.++++
T Consensus 226 ---~---~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 ---P---QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ---C---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0001123467899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=302.74 Aligned_cols=240 Identities=23% Similarity=0.349 Sum_probs=186.9
Q ss_pred CccccCCCceEEEEEeCC-------------CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcc
Q 007073 300 NVLGQGGFGKVYRGVLAD-------------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 366 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~~-------------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 366 (619)
+.||+|+||.||+|.+.+ ...||+|.+.... ......|.+|+.+++.++||||+++++++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 468999999999998532 2358889875432 33456788899999999999999999999999999
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc-------EEE
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE-------AVV 439 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl 439 (619)
++||||+++|+|..++... ...+++..+.+++.|+++||+|||++ +|+||||||+|||++.++. +++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence 9999999999998887642 23488899999999999999999999 9999999999999986654 899
Q ss_pred cccccceeeccCCcceeeecccccccccccccc-CCCCCcchhhHHHHHHHHHHH-hCCCCCCCCccccccchhHHHHHH
Q 007073 440 GDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS-TGKSSERTDVFGYGIMLLELV-TGQRAIDFSRLEEEDDVLLLDHVK 517 (619)
Q Consensus 440 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gv~l~ell-tg~~p~~~~~~~~~~~~~~~~~~~ 517 (619)
+|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..|+......+ . .
T Consensus 154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--------~-~ 219 (262)
T cd05077 154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--------K-E 219 (262)
T ss_pred CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--------H-H
Confidence 999998754321 2345788999999886 466899999999999999998 5787775322110 0 0
Q ss_pred HHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007073 518 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571 (619)
Q Consensus 518 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 571 (619)
..... .. . .......++.+++.+||+.||++||++.+|++.++
T Consensus 220 ~~~~~-~~--------~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 220 RFYEG-QC--------M--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHHhc-Cc--------c--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 10000 00 0 01112357889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=309.28 Aligned_cols=262 Identities=23% Similarity=0.317 Sum_probs=192.7
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC-cchHHHHHHHHHHHHHc---cCCCccceeeeeeCC-----C
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVA---VHRNLLRLIGFCTTP-----T 364 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~-----~ 364 (619)
+|++.+.||+|+||+||+|... +|+.||+|.++.... ......+.+|+++++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999975 689999998864322 22234566777776655 699999999988642 3
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 444 (619)
..++||||+++ +|..++..... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 46899999985 78777765332 3488999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh--
Q 007073 445 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE-- 522 (619)
Q Consensus 445 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 522 (619)
++...... ......||..|+|||.+.+..++.++||||+||++|||++|+.||....... .+..........
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~----~~~~~~~~~~~~~~ 228 (288)
T cd07863 155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD----QLGKIFDLIGLPPE 228 (288)
T ss_pred cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH----HHHHHHHHhCCCCh
Confidence 98664322 2233468899999999998899999999999999999999999986432111 111111110000
Q ss_pred -cccch--hcccccc-------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 523 -KRLDA--IVDRNLN-------KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 523 -~~~~~--~~~~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..... ....... ....+.....+.+++.+|++.||++|||+.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 0000000 0011233457789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=310.67 Aligned_cols=262 Identities=23% Similarity=0.333 Sum_probs=198.4
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
++|...+.||+|+||.||+|... +++.||+|.+...........+.+|+.+++.++||||+++++++..+...++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888999999999999999975 68899999986544444456678899999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
++ ++|..++... ...+++.....++.|+++||+|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 4888777653 23478889999999999999999999 99999999999999999999999999997643322
Q ss_pred cceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh---hhcccchh
Q 007073 453 TNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE---REKRLDAI 528 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 528 (619)
. ......+++.|+|||.+.+ ..++.++|||||||++|||+||+.||........ ........ .......+
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 159 K-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-----LHFIFRILGTPTEETWPGI 232 (301)
T ss_pred C-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHHcCCCChhhchhh
Confidence 1 1223357889999998865 4578999999999999999999999975432110 11111000 00000000
Q ss_pred cc---------ccccC----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 529 VD---------RNLNK----NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 529 ~~---------~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.. +.... ......+..+.+++.+|++.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 00000 001123456789999999999999999999885
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=300.98 Aligned_cols=251 Identities=22% Similarity=0.295 Sum_probs=204.6
Q ss_pred CCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
+|+..+.||+|+||.||.+.. .+++.+++|.+.... .......+.+|++++++++|+||+++++++...+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999999999985 468999999886432 344567788999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++++|.+++.... ...+++..+..++.|++.|++|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999987643 34578999999999999999999999 99999999999999999999999999998764433
Q ss_pred cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... +....... +.
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--------~~~~~~~~-~~-------- 217 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL--------NLVVKIVQ-GN-------- 217 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHc-CC--------
Confidence 2 223456899999999998888999999999999999999999998642211 11111111 11
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
.. ......+.++.+++.+||+.+|++||++.++++.
T Consensus 218 ~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 218 YT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 11 1112334678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=301.35 Aligned_cols=247 Identities=28% Similarity=0.430 Sum_probs=198.6
Q ss_pred cCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEeccc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 373 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 373 (619)
++|.+.+.||+|+||.||++.. +++.||+|..+.. .....+.+|+.++++++|||++++++++... ..++||||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD---VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc---chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 5688899999999999999986 6788999988542 2356789999999999999999999988654 578999999
Q ss_pred ccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCc
Q 007073 374 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 453 (619)
Q Consensus 374 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 453 (619)
++++|.+++.... ...+++..+.+++.|++.|+.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 81 SKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred CCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 9999999987532 23478899999999999999999998 9999999999999999999999999998754321
Q ss_pred ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 454 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 454 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
......+..|+|||.+.+..++.++||||||+++|||++ |+.||...... ..........
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~--------- 214 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--------EVKECVEKGY--------- 214 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--------HHHHHHhCCC---------
Confidence 112234568999999998899999999999999999998 89888643221 1111111110
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
........+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 215 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 -RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 111122334678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=307.68 Aligned_cols=247 Identities=23% Similarity=0.326 Sum_probs=195.4
Q ss_pred CcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 296 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
|+..+.||+|+||+||+|.+. +++.||+|.+.... .......+.+|++++++++|+|++++.+++...+..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999974 68999999986432 122345678899999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++++|.+++.... ...+++.....++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999998886532 23489999999999999999999999 99999999999999999999999999997654322
Q ss_pred cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
. .....|+..|+|||.+.+..++.++|+||||+++|||+||+.||........ .......... ..
T Consensus 157 ~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~----~~~~~~~~~~-~~-------- 221 (285)
T cd05632 157 S--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK----REEVDRRVLE-TE-------- 221 (285)
T ss_pred c--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhhhc-cc--------
Confidence 1 2334689999999999988999999999999999999999999964321100 0001111100 00
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMS 564 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 564 (619)
..+.......+.+++..|++.||++||++.
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 222 --EVYSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred --cccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 011222345778999999999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=303.57 Aligned_cols=258 Identities=21% Similarity=0.295 Sum_probs=199.9
Q ss_pred HHHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcce
Q 007073 289 LQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 289 l~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 367 (619)
++.+++++.....||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++..++..+
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 3456667777789999999999999964 67889999886433 334567899999999999999999999999999999
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-CCcEEEcccccce
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-DFEAVVGDFGLAK 446 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~ 446 (619)
+|+||+++++|.+++..... ....+...+..++.|++.||+|||++ +|+||||||+||+++. ++.++|+|||++.
T Consensus 82 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 99999999999999875321 11127778888999999999999999 9999999999999986 6799999999997
Q ss_pred eeccCCcceeeeccccccccccccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 447 LVDVRKTNVTTQVRGTMGHIAPEYLSTGK--SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 447 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
....... ......|+..|+|||++.+.. ++.++||||||+++|+|++|+.||........ ..+..... .
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-----~~~~~~~~---~ 228 (268)
T cd06624 158 RLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-----AMFKVGMF---K 228 (268)
T ss_pred ecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-----hHhhhhhh---c
Confidence 6543222 122345789999999986644 78999999999999999999999863221100 00000000 0
Q ss_pred cchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 525 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.....+.....++.+++.+||+.+|++|||+.++++
T Consensus 229 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 --------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred --------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 001122233467889999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=304.75 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=199.8
Q ss_pred CCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCC-----cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFES-----PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
+|...+.||+|+||.||+|...+|+.+|+|.+..... ......+.+|++++++++|+||+++++++...+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4677899999999999999988899999998863321 12235688999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
+||+++++|.+++.... .+++.....++.|++.||+|||+. +|+|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 99999999999986532 378888899999999999999999 99999999999999999999999999987653
Q ss_pred cCC-----cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 450 VRK-----TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 450 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
... ........|+..|+|||.+.+..++.++||||||+++|||+||+.||....... ...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~ 226 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-------AMFYIGAHRGL 226 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-------HHHHhhhccCC
Confidence 211 111223458899999999998889999999999999999999999996422100 00000000000
Q ss_pred cchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 525 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. ...+......+.+++.+||+.+|++||++.++++
T Consensus 227 ~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 M---------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred C---------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 1112233467899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=316.20 Aligned_cols=266 Identities=20% Similarity=0.262 Sum_probs=195.2
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCC-----
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT----- 364 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----- 364 (619)
..++|...+.||+|+||.||++... +|..||||++.... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999964 68999999986432 2334567889999999999999999999886543
Q ss_pred -cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007073 365 -ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 443 (619)
Q Consensus 365 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 443 (619)
..++||||+++ ++...+.. .++...+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 46899999976 45554432 267788889999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccc----------chhHH
Q 007073 444 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED----------DVLLL 513 (619)
Q Consensus 444 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~----------~~~~~ 513 (619)
+++..... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||......... .....
T Consensus 169 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 169 LARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred CccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 99754322 1223456899999999999999999999999999999999999999743211000 00000
Q ss_pred HH----HHHHhh-hccc-----chhcccccc---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 514 DH----VKKLER-EKRL-----DAIVDRNLN---KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 514 ~~----~~~~~~-~~~~-----~~~~~~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
.. ...... .... .+....... ..........+.+++.+|++.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 000000 0000 000000000 00011123568899999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=309.66 Aligned_cols=197 Identities=22% Similarity=0.324 Sum_probs=159.9
Q ss_pred cCccccCCCceEEEEEeC---CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeC--CCcceeEeccc
Q 007073 299 KNVLGQGGFGKVYRGVLA---DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT--PTERLLVYPFM 373 (619)
Q Consensus 299 ~~~lg~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~ 373 (619)
.++||+|+||+||+|... +++.||+|.+.... ....+.+|++++++++||||+++++++.. ....+++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 468999999999999964 46789999986432 23557889999999999999999998854 34578999998
Q ss_pred ccchhhhhhcccCC-----CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe----CCCCcEEEccccc
Q 007073 374 QNLSVAYRLREIKP-----GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL----DEDFEAVVGDFGL 444 (619)
Q Consensus 374 ~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGl 444 (619)
.+ +|..++..... ....++......++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 65 77666643211 123488889999999999999999999 99999999999999 4567899999999
Q ss_pred ceeeccCCc--ceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 007073 445 AKLVDVRKT--NVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFS 502 (619)
Q Consensus 445 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~ 502 (619)
++....... .......||+.|+|||++.+ ..++.++||||+||++|||+||+.||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 987643221 12234568999999999876 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=302.99 Aligned_cols=249 Identities=22% Similarity=0.384 Sum_probs=199.3
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcc--------hHHHHHHHHHHHHHccCCCccceeeeeeCCCc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPG--------GDAAFQREVEMISVAVHRNLLRLIGFCTTPTE 365 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 365 (619)
+|.+.+.||+|+||.||+|... +++.||+|.+....... ..+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677889999999999999964 68899999886432211 22568889999999999999999999999999
Q ss_pred ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 445 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 445 (619)
.++|+||+++++|.+++... ..+++.....++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 99999999999999999753 2378888999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcc-----eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh
Q 007073 446 KLVDVRKTN-----VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 520 (619)
Q Consensus 446 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 520 (619)
+........ ......|+..|+|||.+.+..++.++||||||+++|+|+||+.||...... ..+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~ 225 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--------QAIFKIG 225 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--------HHHHHHh
Confidence 876422111 111235788999999999888999999999999999999999999642110 0011100
Q ss_pred hhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 521 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 521 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. ......+...+..+.+++.+||+.+|++||++.++++
T Consensus 226 ~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 E----------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred c----------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0 0111122334567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=303.88 Aligned_cols=253 Identities=23% Similarity=0.340 Sum_probs=204.4
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
++|+..+.||+|+||.||++... +++.||+|++...........+.+|++++++++||||+++++++......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999976 68999999987654445667889999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
+++++|.+++.... ..++......++.|++.|++|||+ . +++|+||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999987643 347888899999999999999999 7 9999999999999999999999999998765322
Q ss_pred CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (619)
... ...++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ...+.........
T Consensus 155 ~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~-------- 220 (265)
T cd06605 155 LAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD---GIFELLQYIVNEP-------- 220 (265)
T ss_pred Hhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc---cHHHHHHHHhcCC--------
Confidence 211 15688899999999999999999999999999999999999864321111 1111111111110
Q ss_pred cccCCCCH-HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 532 NLNKNYNI-QEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 532 ~l~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. ..... .....+.+++.+||..+|++|||+.+++.
T Consensus 221 -~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 221 -P-PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred -C-CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 0 01111 14567899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=317.42 Aligned_cols=251 Identities=23% Similarity=0.257 Sum_probs=195.7
Q ss_pred CccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHH-HHHHccCCCccceeeeeeCCCcceeEeccccc
Q 007073 300 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVE-MISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 375 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 375 (619)
+.||+|+||.||+|... +|+.||+|++.... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999964 68999999986432 2233445566665 46779999999999999999999999999999
Q ss_pred chhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcce
Q 007073 376 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455 (619)
Q Consensus 376 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 455 (619)
|+|..++... ..+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~ 152 (325)
T cd05604 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDT 152 (325)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCC
Confidence 9998888643 3488899999999999999999999 9999999999999999999999999998753221 122
Q ss_pred eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccC
Q 007073 456 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 535 (619)
Q Consensus 456 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 535 (619)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... +....... ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~~~~~~---------~~~-- 213 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA--------EMYDNILH---------KPL-- 213 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH--------HHHHHHHc---------CCc--
Confidence 33456899999999999999999999999999999999999999643211 11111111 000
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCccc
Q 007073 536 NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAE 577 (619)
Q Consensus 536 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 577 (619)
...+.....+.+++.+|++.+|.+||++.+.++.+....+..
T Consensus 214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~ 255 (325)
T cd05604 214 VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFE 255 (325)
T ss_pred cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcC
Confidence 011123456789999999999999999876666665554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=317.44 Aligned_cols=248 Identities=22% Similarity=0.232 Sum_probs=192.5
Q ss_pred CccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHH-HHHHccCCCccceeeeeeCCCcceeEeccccc
Q 007073 300 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVE-MISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 375 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 375 (619)
+.||+|+||+||+|... +++.||+|++.... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 57889999986422 1222334444544 56788999999999999999999999999999
Q ss_pred chhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcce
Q 007073 376 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455 (619)
Q Consensus 376 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 455 (619)
|+|.+.+... ..+.......++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~ 152 (325)
T cd05602 81 GELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT 152 (325)
T ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence 9999988753 2367778888999999999999999 99999999999999999999999999997542221 22
Q ss_pred eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccC
Q 007073 456 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 535 (619)
Q Consensus 456 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 535 (619)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ......... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~~---------~~-- 213 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--------EMYDNILNK---------PL-- 213 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--------HHHHHHHhC---------Cc--
Confidence 33456999999999999999999999999999999999999999643211 111111110 00
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007073 536 NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 574 (619)
Q Consensus 536 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 574 (619)
...+.....+.+++.+|++.+|.+||++.+.+..+.+..
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~ 252 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHI 252 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCc
Confidence 111223457889999999999999999886665555543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=308.08 Aligned_cols=261 Identities=23% Similarity=0.307 Sum_probs=201.9
Q ss_pred HHHHHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeee---
Q 007073 287 RELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCT--- 361 (619)
Q Consensus 287 ~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~--- 361 (619)
+.+..+.++|++.+.||+|+||.||++... +++.+|+|.+... ......+..|+.+++++ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI--HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc--cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 445557789999999999999999999964 6889999987542 22346788899999998 6999999999874
Q ss_pred --CCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEE
Q 007073 362 --TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV 439 (619)
Q Consensus 362 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 439 (619)
..+..++||||+++++|.++++........+++..+..++.|+++||.|||+. +++||||||+||+++.++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEE
Confidence 33457999999999999998865433345688889999999999999999999 9999999999999999999999
Q ss_pred cccccceeeccCCcceeeeccccccccccccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHH
Q 007073 440 GDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST-----GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 514 (619)
Q Consensus 440 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~ 514 (619)
+|||+++....... ......|+..|+|||++.. ..++.++|||||||++|||+||+.||.......
T Consensus 166 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-------- 236 (286)
T cd06638 166 VDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-------- 236 (286)
T ss_pred ccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--------
Confidence 99999987643322 1223468999999998853 457899999999999999999999986432110
Q ss_pred HHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 515 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
........ ......+ +......+.+++.+||+.+|++|||+.|+++.
T Consensus 237 ~~~~~~~~-~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 237 ALFKIPRN-PPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred HHhhcccc-CCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00000000 0000001 11123468899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=316.94 Aligned_cols=238 Identities=23% Similarity=0.252 Sum_probs=187.4
Q ss_pred CccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHH-HHHHccCCCccceeeeeeCCCcceeEeccccc
Q 007073 300 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVE-MISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 375 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 375 (619)
++||+|+||.||+|... +|+.||+|++.... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 68899999986422 1223345555655 57889999999999999999999999999999
Q ss_pred chhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcce
Q 007073 376 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455 (619)
Q Consensus 376 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 455 (619)
|+|...+... ..++......++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (321)
T cd05603 81 GELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EET 152 (321)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCc
Confidence 9998887642 3377888889999999999999999 9999999999999999999999999998753221 122
Q ss_pred eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccC
Q 007073 456 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 535 (619)
Q Consensus 456 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 535 (619)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ........ ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~---------~~~~-- 213 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV--------SQMYDNIL---------HKPL-- 213 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH--------HHHHHHHh---------cCCC--
Confidence 3345689999999999988999999999999999999999999964321 11111111 1100
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 007073 536 NYNIQEVETMIQVALLCTQASPEDRPAMS 564 (619)
Q Consensus 536 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 564 (619)
..+......+.+++.+|++.+|++||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11223345788999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.53 Aligned_cols=243 Identities=23% Similarity=0.296 Sum_probs=193.1
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHcc-CCCccceeeeeeCCCcceeEe
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 370 (619)
+|+..+.||+|+||+||+|... +|+.||+|++.... .....+.+..|..+++.+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677889999999999999965 68999999986422 2334456788999988886 577888999999989999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 999999999988653 2388999999999999999999999 999999999999999999999999999875432
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... ........
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i~~--------- 215 (323)
T cd05615 154 DG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--------ELFQSIME--------- 215 (323)
T ss_pred CC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHh---------
Confidence 22 1223456899999999999989999999999999999999999999643211 11111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 564 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 564 (619)
... .++...+..+.+++.+|++.+|++|++..
T Consensus 216 ~~~--~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 216 HNV--SYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CCC--CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 000 11222345778999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=316.61 Aligned_cols=266 Identities=20% Similarity=0.245 Sum_probs=196.1
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCC------
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------ 363 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 363 (619)
..++|...+.||+|+||.||++... .++.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999964 68899999986533 233456778899999999999999999988543
Q ss_pred CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007073 364 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 443 (619)
Q Consensus 364 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 443 (619)
...++||||+++ ++...+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 246899999976 55555532 277888899999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHH-------HH-
Q 007073 444 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL-------DH- 515 (619)
Q Consensus 444 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~-------~~- 515 (619)
+++..... .......||..|+|||.+.+..++.++|||||||++|||++|+.||.............. ..
T Consensus 165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99865322 222345689999999999998999999999999999999999999964322110000000 00
Q ss_pred ------HHHH-hhhcccchhcccc-----cc---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 516 ------VKKL-EREKRLDAIVDRN-----LN---KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 516 ------~~~~-~~~~~~~~~~~~~-----l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
+... ...........+. .. ..........+.+++.+|++.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000 0000000000000 00 00111223577899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=306.52 Aligned_cols=250 Identities=20% Similarity=0.306 Sum_probs=202.1
Q ss_pred hcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
..+|...+.||+|+||.||+|.. .+|+.||+|.+.... ....+.+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 36788899999999999999996 479999999986433 3345678899999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 97 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 97 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred ccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 9999999998864 2368888999999999999999999 9999999999999999999999999999865433
Q ss_pred CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (619)
... .....+++.|+|||.+.+..++.++|||||||++|+|+||+.||......... . .. ....
T Consensus 169 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~---~-----~~--------~~~~ 231 (297)
T cd06656 169 QSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL---Y-----LI--------ATNG 231 (297)
T ss_pred ccC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe---e-----ee--------ccCC
Confidence 222 22345888999999999888999999999999999999999999643221100 0 00 0000
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 532 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
......+......+.+++.+||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 232 TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000112233456889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=299.46 Aligned_cols=250 Identities=23% Similarity=0.330 Sum_probs=200.4
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCC-cceeEec
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT-ERLLVYP 371 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e 371 (619)
+|++.+.||+|++|.||++... +++.||+|++.... .....+.+.+|++++++++|+|++++++.+...+ ..+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999965 57899999986432 2334567889999999999999999998876443 5789999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++++|.+++.... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999987632 23478999999999999999999999 9999999999999999999999999999876432
Q ss_pred CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (619)
.. ......|++.|+|||.+.+..++.++||||||++++||++|+.||+..... ........ +..
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--------~~~~~~~~-~~~------ 219 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN--------SLVYRIIE-GKL------ 219 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHh-cCC------
Confidence 22 223445889999999999999999999999999999999999998642211 11111111 111
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 532 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
...+......+.+++.+|++.+|++||++.++++
T Consensus 220 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 ---PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ---CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1122334467899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=306.06 Aligned_cols=254 Identities=20% Similarity=0.330 Sum_probs=201.2
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
++|++.+.||+|+||.||++... +|..||+|.++..........+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999975 78999999886433344457889999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++++|..++.... ....+++..+..++.|++.||.|||+.+ +|+|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999988887532 1235899999999999999999999632 8999999999999999999999999998765322
Q ss_pred cceeeeccccccccccccccCCC------CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGK------SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
......++..|+|||.+.+.. ++.++|||||||++|||+||+.||...... ........
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~~-------- 221 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-----NIFAQLSA-------- 221 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-----hHHHHHHH--------
Confidence 122345788999999985543 488999999999999999999998642211 11111111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
+.+.. ....+.....++.+++.+||+.+|++||++.+++.
T Consensus 222 -~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 222 -IVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -HhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 11110 11123345678899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=320.01 Aligned_cols=263 Identities=22% Similarity=0.278 Sum_probs=197.9
Q ss_pred HhcCCcccCccccCCCceEEEEEeC---CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA---DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
...+|.+.+.||+|+||.||++... .+..||+|.+... ..+.+|++++++++||||+++++++......++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 3457999999999999999999853 3578999987532 235689999999999999999999998899999
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
|||++. ++|..++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.++|+|||+++..
T Consensus 164 v~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 164 VMPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999986 577777743 23489999999999999999999999 9999999999999999999999999999765
Q ss_pred ccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc-ccc
Q 007073 449 DVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK-RLD 526 (619)
Q Consensus 449 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 526 (619)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+........... ...
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-SSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-cHHHHHHHHHHhccCccccC
Confidence 433222 2234569999999999999999999999999999999999999996543221 1111111111110000 000
Q ss_pred --------hh---ccccccCCC-------CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 527 --------AI---VDRNLNKNY-------NIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 527 --------~~---~~~~l~~~~-------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
.. ........+ ......++.+++.+|+..||++|||+.|++..
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 000000000 01123567889999999999999999999864
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=312.28 Aligned_cols=251 Identities=22% Similarity=0.286 Sum_probs=211.8
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCc--chHHHHHHHHHHHHHcc-CCCccceeeeeeCCCcce
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP--GGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 367 (619)
..+.|++.+.||+|.||.||+++.+ +|+.+|+|.+.+.... .....+.+|+++|+++. |||||.+.+++.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4457888899999999999999976 4999999999764432 24578899999999998 999999999999999999
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC----CcEEEcccc
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED----FEAVVGDFG 443 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfG 443 (619)
+|||++.||.|.+.+... .++......++.|++.++.|||+. +|+|||+||+|+|+... +.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999875 288889999999999999999999 99999999999999643 579999999
Q ss_pred cceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007073 444 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 523 (619)
Q Consensus 444 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (619)
++..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||........ ..
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~----~~---------- 248 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI----FL---------- 248 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH----HH----------
Confidence 9998765 4456677899999999999999999999999999999999999999975432111 00
Q ss_pred ccchhccc--cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 524 RLDAIVDR--NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 524 ~~~~~~~~--~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
.+... .......+.......+++..|+..||.+|+|+.++++.
T Consensus 249 ---~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 249 ---AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ---HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11111 12223345556788999999999999999999999984
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=315.42 Aligned_cols=255 Identities=19% Similarity=0.227 Sum_probs=196.5
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++|.+.+.||+|+||.||+++.. +++.||+|.+.+.. .......+.+|..++..++|+||+++++++...+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999975 67899999986421 2223456788999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999997532 2478888999999999999999999 999999999999999999999999999987654
Q ss_pred CCcceeeeccccccccccccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLST-----GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
..........||+.|+|||++.+ +.++.++|||||||++|||+||+.||...... +...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--------~~~~~i~~~~~~ 226 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--------ETYGKIMNHEER 226 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH--------HHHHHHHcCCCc
Confidence 43333334569999999999875 46789999999999999999999999643211 111111111000
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPED--RPAMSEVVR 568 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~ 568 (619)
.. + .....+.+..+.+++.+|+..++++ |++++++++
T Consensus 227 ~~-----~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 227 FQ-----F-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred cc-----C-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 00 0 0111123467888999998865544 456766653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=312.23 Aligned_cols=193 Identities=23% Similarity=0.330 Sum_probs=164.5
Q ss_pred HHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
....+|.+.+.||+|+||.||+|... +++.||+|..... ....|+.++++++||||+++++++......++|
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 44567999999999999999999975 5678999975321 235689999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
+||+. ++|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 136 ~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 136 LPHYS-SDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEccC-CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 99995 5777777542 23589999999999999999999999 99999999999999999999999999997533
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 499 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~ 499 (619)
.. .......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 209 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 209 VA--PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cC--cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 22 1223456899999999999999999999999999999999966554
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=314.77 Aligned_cols=256 Identities=19% Similarity=0.233 Sum_probs=196.9
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++|++.+.||+|+||.||++..+ +++.||+|.+.+.. .......+..|+.++..++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999975 57889999985321 1223455788999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 9999999999997532 2478888999999999999999999 999999999999999999999999999976543
Q ss_pred CCcceeeecccccccccccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||..... .+...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~--------~~~~~~i~~~~~~ 226 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNHKER 226 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH--------HHHHHHHhCCCcc
Confidence 3333333456999999999986 34678999999999999999999999964321 1111111111100
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPED--RPAMSEVVRM 569 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 569 (619)
.. . .......+..+.+++.+|+..++++ ||++.++++.
T Consensus 227 ~~-----~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 FQ-----F-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cc-----C-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 0 0111223457788888888655444 6888888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=302.51 Aligned_cols=263 Identities=22% Similarity=0.287 Sum_probs=200.3
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC-cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
++|+..+.||+|+||.||+|... +|+.||+|++..... ....+.+.+|+.++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999976 689999998864332 2334668899999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|++++++....... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 99999888776542 2388999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh----------
Q 007073 452 KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE---------- 520 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 520 (619)
.. ......++..|+|||.+.+ ..++.++||||||+++|||+||+.||......+. .........
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ----LYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhCCCChHHhhhc
Confidence 22 2223457889999999876 5578999999999999999999999964322110 101110000
Q ss_pred -hhcccchhccccccCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 521 -REKRLDAIVDRNLNKNY-----NIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 521 -~~~~~~~~~~~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..........+...... ....+..+.+++.+||+.+|++||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000000000000000 1123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=301.18 Aligned_cols=250 Identities=23% Similarity=0.341 Sum_probs=194.1
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC----CcchHHHHHHHHHHHHHccCCCccceeeeeeCC--Ccc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE----SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TER 366 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 366 (619)
.+|...+.||+|+||.||+|... +|+.||+|++.... .......+.+|+.++++++||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999964 68999999885322 122345688899999999999999999988653 456
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
++++||+++++|.+++.... .+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 78999999999999987532 378888899999999999999998 99999999999999999999999999997
Q ss_pred eeccCC--cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 447 LVDVRK--TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 447 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
...... ........++..|+|||.+.+..++.++|||||||++|||+||+.||...... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~--------~~~~~~~~~-- 224 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM--------AAIFKIATQ-- 224 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH--------HHHHHHhcC--
Confidence 653211 11112345788999999999888999999999999999999999998632110 111111100
Q ss_pred cchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 525 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
......+......+.+++ +||..+|++||+++||++
T Consensus 225 -------~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 225 -------PTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -------CCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 001122223345566666 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=313.56 Aligned_cols=262 Identities=18% Similarity=0.236 Sum_probs=193.0
Q ss_pred ccCccccC--CCceEEEEEeC-CCcEEEEEEeccCCC-cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEeccc
Q 007073 298 EKNVLGQG--GFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 373 (619)
Q Consensus 298 ~~~~lg~G--~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 373 (619)
+.++||+| +|++||++..+ +|+.||+|++..... ....+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 78899999964 789999999864432 233456778999999999999999999999999999999999
Q ss_pred ccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCc
Q 007073 374 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 453 (619)
Q Consensus 374 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 453 (619)
++|+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999999865322 2378899999999999999999999 999999999999999999999999986543321111
Q ss_pred c------eeeeccccccccccccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH-Hh----
Q 007073 454 N------VTTQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK-LE---- 520 (619)
Q Consensus 454 ~------~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~---- 520 (619)
. ......++..|+|||++.+ ..++.++|||||||++|||+||+.||........ ....... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~ 232 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM----LLEKLNGTVPCLLD 232 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH----HHHHhcCCcccccc
Confidence 0 0112346778999999976 4589999999999999999999999964321110 0000000 00
Q ss_pred ----hhccc----------chhcc------------ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 521 ----REKRL----------DAIVD------------RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 521 ----~~~~~----------~~~~~------------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..+.. ....+ ..............+.+++.+||+.||++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00000 00000 00000112233467899999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=290.45 Aligned_cols=252 Identities=22% Similarity=0.273 Sum_probs=202.5
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEecc-CCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTD-FESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~-~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++.|++.++||+|.|+.||++... +|+.+|+|.+.- .-+....+++.+|+++-+.++|||||++...+.+....++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 456788889999999999999864 789999998752 223446788999999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEEccccccee
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVVGDFGLAKL 447 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGla~~ 447 (619)
|+|.|++|..-+-.. ...+....-..++||.++|.|+|.+ +|||||+||+|+++.. .--+||+|||+|..
T Consensus 90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999998766432 3356677788999999999999999 9999999999999953 34589999999998
Q ss_pred eccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccch
Q 007073 448 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527 (619)
Q Consensus 448 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (619)
++ +.......+|||+|||||++...+|+..+|||+-||++|-++.|..||...... ..+.++...
T Consensus 163 l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~--------rlye~I~~g----- 227 (355)
T KOG0033|consen 163 VN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--------RLYEQIKAG----- 227 (355)
T ss_pred eC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH--------HHHHHHhcc-----
Confidence 87 445566778999999999999999999999999999999999999999642211 111111110
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 528 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..| +.+...+...++..+|+.+|+..||.+|.|+.|.+.
T Consensus 228 ~yd--~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 228 AYD--YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ccC--CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 000 111122334467889999999999999999999874
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=300.58 Aligned_cols=256 Identities=20% Similarity=0.300 Sum_probs=203.7
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeC--CCcceeEe
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT--PTERLLVY 370 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~ 370 (619)
+|++.+.||+|+||.||++... +|+.||+|.+.... .....+.+..|++++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999964 68899999986433 33345678899999999999999999998754 34578999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC--NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||+++++|.+++.........+++.....++.|++.||.|||..+ ..+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999775444566899999999999999999999221 229999999999999999999999999999876
Q ss_pred ccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
...... .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ....... ...
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~-~~~---- 226 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL--------QLASKIK-EGK---- 226 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH--------HHHHHHh-cCC----
Confidence 543321 23346899999999999988999999999999999999999998643210 1111111 011
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
....+...+..+.+++.+|++.+|++||++.+|++.
T Consensus 227 -----~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 -----FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 112233445688999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=299.66 Aligned_cols=238 Identities=24% Similarity=0.378 Sum_probs=188.4
Q ss_pred CccccCCCceEEEEEeCCCc-----------EEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 300 NVLGQGGFGKVYRGVLADGT-----------KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~~g~-----------~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
+.||+|+||.||+|.+.+.. .|++|.+..... ....|.+|+.++++++||||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR--DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh--hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 46899999999999976433 578887654322 26788999999999999999999999988 77899
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-------cEEEcc
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-------EAVVGD 441 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~D 441 (619)
||||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|
T Consensus 78 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence 9999999999999876432 488899999999999999999999 999999999999999887 799999
Q ss_pred cccceeeccCCcceeeeccccccccccccccCC--CCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHH
Q 007073 442 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG--KSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKK 518 (619)
Q Consensus 442 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 518 (619)
||++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..|+...... .....
T Consensus 152 fg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--------~~~~~ 218 (259)
T cd05037 152 PGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--------EKERF 218 (259)
T ss_pred CCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--------hHHHH
Confidence 999986533 2223467789999999876 78999999999999999999 46666432211 01111
Q ss_pred HhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007073 519 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571 (619)
Q Consensus 519 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 571 (619)
...... .. ......+.+++.+||..+|++|||+.++++.|+
T Consensus 219 ~~~~~~---------~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 YQDQHR---------LP---MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HhcCCC---------CC---CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 100000 00 001168899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=307.27 Aligned_cols=263 Identities=24% Similarity=0.346 Sum_probs=199.7
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC-cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
++|+..+.||+|+||.||+|.+. +++.||+|++..... ....+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999975 589999998865332 2245678899999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|++++++..+.... ..+++.....++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 99999888776542 2388999999999999999999999 9999999999999999999999999999866443
Q ss_pred CcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh-hccc----
Q 007073 452 KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER-EKRL---- 525 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~---- 525 (619)
.. ......++..|+|||++.+ ..++.++||||||+++|||+||+.||....... ........... ....
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 154 GE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID----QLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred cc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH----HHHHHHHHhCCCchhhHHHh
Confidence 32 2233457889999999875 457889999999999999999999886432110 00000000000 0000
Q ss_pred --chhccccccCC---------CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 526 --DAIVDRNLNKN---------YNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 526 --~~~~~~~l~~~---------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..+.+...... ..+..+..+.+++.+||+.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000000 01233567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=321.51 Aligned_cols=201 Identities=21% Similarity=0.285 Sum_probs=173.4
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++|+..+.||+|+||.||++... +|+.||+|.+.... .......+..|+.++..++|+||+++++.+...+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999975 68999999986422 2334567888999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++|+|.+++... ..++......++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 999999999998753 2378889999999999999999999 999999999999999999999999999875432
Q ss_pred CCc----------------------------------ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCC
Q 007073 451 RKT----------------------------------NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 496 (619)
Q Consensus 451 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~ 496 (619)
... .......||+.|+|||++.+..++.++|||||||++|||+||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 0011346999999999999999999999999999999999999
Q ss_pred CCCCC
Q 007073 497 RAIDF 501 (619)
Q Consensus 497 ~p~~~ 501 (619)
.||..
T Consensus 234 ~Pf~~ 238 (360)
T cd05627 234 PPFCS 238 (360)
T ss_pred CCCCC
Confidence 99964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=336.94 Aligned_cols=260 Identities=17% Similarity=0.259 Sum_probs=201.0
Q ss_pred HHHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeC--CC
Q 007073 289 LQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT--PT 364 (619)
Q Consensus 289 l~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~ 364 (619)
.+...++|.+.+.||+|+||+||+|... ++..||+|.+.... .......|..|+.++++++|||||++++++.. ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3445578999999999999999999975 57789999886432 23345678999999999999999999998754 35
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCC----CCeEecCCCCCcEEeCC-------
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN----PKIIHRDVKAANVLLDE------- 433 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~----~~ivH~Dlkp~NIll~~------- 433 (619)
..++||||+++|+|.+++.........+++..++.|+.||+.||+|||+... .+||||||||+|||++.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 6889999999999999997654444568999999999999999999998521 25999999999999964
Q ss_pred ----------CCcEEEcccccceeeccCCcceeeeccccccccccccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 007073 434 ----------DFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQRAIDF 501 (619)
Q Consensus 434 ----------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gv~l~elltg~~p~~~ 501 (619)
...+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 3458999999998654322 2234568999999999854 4589999999999999999999999964
Q ss_pred CccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 502 SRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
... .......+.... .+ .....+.++.+|+..||+.+|.+||++.+++.
T Consensus 246 ~~~-------~~qli~~lk~~p--------~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 246 ANN-------FSQLISELKRGP--------DL---PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCc-------HHHHHHHHhcCC--------CC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 221 111111111110 00 01122457899999999999999999999983
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=301.56 Aligned_cols=239 Identities=24% Similarity=0.321 Sum_probs=185.1
Q ss_pred ccccCCCceEEEEEeCC-------------------------CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccc
Q 007073 301 VLGQGGFGKVYRGVLAD-------------------------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 355 (619)
Q Consensus 301 ~lg~G~fg~Vy~~~~~~-------------------------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 355 (619)
.||+|+||.||+|.+.. ...||+|++.... ......|.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 69999999999997421 1358899885432 233467888999999999999999
Q ss_pred eeeeeeCCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC
Q 007073 356 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 435 (619)
Q Consensus 356 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 435 (619)
+++++......++||||+++|+|..++... ...+++..+..++.|+++||+|||++ +|+||||||+||+++..+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence 999999999999999999999999888652 23478889999999999999999999 999999999999997543
Q ss_pred -------cEEEcccccceeeccCCcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHH-hCCCCCCCCcccc
Q 007073 436 -------EAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELV-TGQRAIDFSRLEE 506 (619)
Q Consensus 436 -------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~ell-tg~~p~~~~~~~~ 506 (619)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.......
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred cccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 4899999988643221 12347888999998865 56899999999999999995 6888886432111
Q ss_pred ccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007073 507 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571 (619)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 571 (619)
...... .... . +......+.+++.+||+.+|++|||+.+|++.|.
T Consensus 230 -----~~~~~~---~~~~--------~----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 -----KERFYE---KKHR--------L----PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -----HHHHHH---hccC--------C----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 001100 0000 0 1111246889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=313.64 Aligned_cols=266 Identities=20% Similarity=0.251 Sum_probs=195.8
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCC------
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------ 363 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 363 (619)
..++|...+.||+|+||.||++... .++.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999964 68899999986432 233456788999999999999999999987543
Q ss_pred CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007073 364 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 443 (619)
Q Consensus 364 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 443 (619)
...++||||+++ ++...+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 346899999976 56555532 267888899999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHH-------HHH
Q 007073 444 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL-------DHV 516 (619)
Q Consensus 444 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~-------~~~ 516 (619)
+++..... .......||..|+|||++.+..++.++|||||||++|||+||+.||............+. ...
T Consensus 172 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 172 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred CccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99865332 122345689999999999999999999999999999999999999965332110000000 000
Q ss_pred HHH--------hhhccc-----chhcccccc---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 517 KKL--------EREKRL-----DAIVDRNLN---KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 517 ~~~--------~~~~~~-----~~~~~~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
... ...... ......... ..........+.+++.+|++.||++|||+.++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 000000 000000000 00011123578899999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=299.20 Aligned_cols=257 Identities=26% Similarity=0.390 Sum_probs=205.4
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
++|++.+.||.|+||+||+|... ++..+|+|++.........+.+.+|+++++.++|+|++++++.+...+..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999964 68899999987544444667899999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++++|.++++.... ...+++.....++.|++.|++|||+. +++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999976433 23488899999999999999999999 99999999999999999999999999987664432
Q ss_pred cc---eeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 453 TN---VTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 453 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
.. ......|+..|+|||.+... .++.++|||||||++|||++|+.||....... ....... ..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----~~~~~~~----~~----- 223 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK----VLMLTLQ----ND----- 223 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh----hHHHHhc----CC-----
Confidence 22 12334588999999998877 78999999999999999999999986432110 1111110 00
Q ss_pred ccccccCCC-CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 529 VDRNLNKNY-NIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 529 ~~~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.+...... ....+..+.+++.+||+.||++||++.++++
T Consensus 224 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 -PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred -CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00010000 1234467899999999999999999999885
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=300.82 Aligned_cols=257 Identities=27% Similarity=0.365 Sum_probs=198.0
Q ss_pred CcccCccccCCCceEEEEEeC----CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCC------
Q 007073 296 FSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT------ 364 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 364 (619)
|.+.+.||+|+||.||+|.+. ++..||||++.... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556789999999999999853 36889999986432 3344667889999999999999999999886542
Q ss_pred cceeEecccccchhhhhhcccC--CCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007073 365 ERLLVYPFMQNLSVAYRLREIK--PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 442 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 442 (619)
..+++++|+++|+|.+++.... .....+++....+++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2368899999999988875322 1223478889999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHh
Q 007073 443 GLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLE 520 (619)
Q Consensus 443 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 520 (619)
|+++........ ......++..|++||.+.+..++.++||||||+++|||++ |+.||..... ... .....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-----~~~---~~~~~ 229 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-----SEI---YNYLI 229 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-----HHH---HHHHH
Confidence 999865432211 1122345678999999998889999999999999999999 8888753211 111 11111
Q ss_pred hhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 521 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 521 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
..... ......+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 230 ~~~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 KGNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111 01122345889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=335.11 Aligned_cols=265 Identities=26% Similarity=0.397 Sum_probs=215.7
Q ss_pred HHHHHhcCCcccCccccCCCceEEEEEeC----C----CcEEEEEEeccCCCcchHHHHHHHHHHHHHcc-CCCccceee
Q 007073 288 ELQLATDNFSEKNVLGQGGFGKVYRGVLA----D----GTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIG 358 (619)
Q Consensus 288 el~~~~~~~~~~~~lg~G~fg~Vy~~~~~----~----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~ 358 (619)
.++...++..+.+.||+|+||.|++|... . ...||||++++.......+.+..|+++++.+. |+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 45666677777789999999999999842 1 45799999998777777899999999999875 999999999
Q ss_pred eeeCCCcceeEecccccchhhhhhcccC-----CC-----C--CCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 007073 359 FCTTPTERLLVYPFMQNLSVAYRLREIK-----PG-----E--PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKA 426 (619)
Q Consensus 359 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~-----~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp 426 (619)
+|......++|.||++.|+|..+++... .. . ..+.......++.|||.||+||+++ ++|||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999998765 00 1 2388899999999999999999999 999999999
Q ss_pred CcEEeCCCCcEEEcccccceeeccCCcceeeeccc--cccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCc
Q 007073 427 ANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG--TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSR 503 (619)
Q Consensus 427 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~ 503 (619)
+|||++++..+||+|||+|+..............| ...|||||.+....|+.|+|||||||++||++| |..||....
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999765544443333333 346999999999999999999999999999999 778875311
Q ss_pred cccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 504 LEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
. ..+.+..+....++. .+..+..+++++|..||+.+|++||++.++.+.++.
T Consensus 527 ~-------~~~l~~~l~~G~r~~----------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 527 P-------TEELLEFLKEGNRME----------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred c-------HHHHHHHHhcCCCCC----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 0 111122222222221 233345789999999999999999999999999988
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=282.29 Aligned_cols=253 Identities=22% Similarity=0.326 Sum_probs=202.8
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC----cc---hHHHHHHHHHHHHHc-cCCCccceeeeeeC
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES----PG---GDAAFQREVEMISVA-VHRNLLRLIGFCTT 362 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~----~~---~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 362 (619)
--..|...++||+|..++|-++.++ +|+.+|+|++..... +. -.++-.+|+.+++++ .||+|+.+.+++.+
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456788899999999999999865 688999998853221 11 124556899999987 59999999999999
Q ss_pred CCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007073 363 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 442 (619)
Q Consensus 363 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 442 (619)
+.-.++|+|.|+.|-|.++|.+.. .++.....+|+.|+.+|++|||.+ .||||||||+|||+|++.++||+||
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~V----tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKV----TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhhe----eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence 999999999999999999998744 388889999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcceeeeccccccccccccccC------CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHH
Q 007073 443 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLST------GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV 516 (619)
Q Consensus 443 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 516 (619)
|+|+.+... ......+||++|+|||.+.. ..|+..+|+||.||++|-++.|.+||.-.. +...
T Consensus 168 GFa~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-----QmlM---- 236 (411)
T KOG0599|consen 168 GFACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-----QMLM---- 236 (411)
T ss_pred ceeeccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-----HHHH----
Confidence 999977543 34556789999999998853 357889999999999999999999984210 0000
Q ss_pred HHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 517 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 517 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
-++..++... ....-..+.+.+..+|+.+|++.||.+|.|++|++.
T Consensus 237 LR~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 237 LRMIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 0111111110 111223456678999999999999999999999884
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=305.68 Aligned_cols=261 Identities=25% Similarity=0.336 Sum_probs=203.0
Q ss_pred HHHHHHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeCC
Q 007073 286 WRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTP 363 (619)
Q Consensus 286 ~~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 363 (619)
..++..+.++|.+.+.||+|+||.||++... +++.+|+|.+... ......+.+|+.++.++ +|||++++++++...
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI--SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc--ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 3455556888999999999999999999974 6889999988642 22356778899999988 799999999998654
Q ss_pred -----CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 007073 364 -----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV 438 (619)
Q Consensus 364 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 438 (619)
...++|+||+++++|.++++........+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEE
Confidence 357899999999999998875444445689999999999999999999999 999999999999999999999
Q ss_pred EcccccceeeccCCcceeeeccccccccccccccCC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHH
Q 007073 439 VGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-----KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL 513 (619)
Q Consensus 439 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~ 513 (619)
|+|||++......... .....|+..|+|||.+... .++.++|||||||++|||++|+.||......
T Consensus 169 l~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-------- 239 (291)
T cd06639 169 LVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-------- 239 (291)
T ss_pred Eeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--------
Confidence 9999998865432211 2234588999999988643 3689999999999999999999998632210
Q ss_pred HHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 514 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
......... ....+. ........+.+++.+||+.+|++||++.++++
T Consensus 240 ~~~~~~~~~-~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 240 KTLFKIPRN-PPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHHHhcC-CCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 001111000 000111 11223457899999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=301.22 Aligned_cols=252 Identities=22% Similarity=0.288 Sum_probs=199.2
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.+.|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++|+||+++++++..+...++|||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 356888999999999999999975 5889999998643 34456778899999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++++|...+.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 90 FCPGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred cCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 999999988775432 2488999999999999999999999 9999999999999999999999999998754322
Q ss_pred Ccceeeecccccccccccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
. .......++..|+|||++. ...++.++|||||||++|||+||+.||..... ............
T Consensus 164 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~~~-- 232 (292)
T cd06644 164 L-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSEP-- 232 (292)
T ss_pred c-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--------HHHHHHHhcCCC--
Confidence 1 1123345788999999984 34568899999999999999999999853221 011111111000
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
+. ...+...+.++.+++.+||+.+|++||++.++++
T Consensus 233 ----~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 ----PT--LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ----cc--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 0112233457889999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=297.93 Aligned_cols=248 Identities=25% Similarity=0.385 Sum_probs=200.3
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC----CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE----SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
+|+..+.||+|+||.||+|... +++.||+|.+.... .....+.+.+|+.+++.++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4667789999999999999976 78999999885432 123456789999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
+||+++++|.+++... ..+++.....++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 9999999999998753 2378889999999999999999999 99999999999999999999999999988654
Q ss_pred cCCcceeeeccccccccccccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
... ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||..... .............
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~--- 220 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--------VAAVFKIGRSKEL--- 220 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--------HHHHHHHHhcccC---
Confidence 332 223455889999999987766 89999999999999999999999864321 0111111110111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
...+......+.+++.+||+.+|++||++.++++
T Consensus 221 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 ------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1112223467889999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=296.58 Aligned_cols=253 Identities=21% Similarity=0.295 Sum_probs=202.5
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
++|+..+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++......+++|||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP-GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc-hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 57888999999999999999974 57889999986433 33567889999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++++|.+++.... ..++...+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 82 CGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 99999999887531 3488899999999999999999999 99999999999999999999999999987654321
Q ss_pred cceeeeccccccccccccccCC---CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTG---KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
.......++..|+|||.+.+. .++.++||||||+++|||+||+.||....... ....... ... .
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--------~~~~~~~-~~~---~ 222 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--------ALFLISK-SNF---P 222 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHh-ccC---C
Confidence 122334678899999999776 88999999999999999999999986422110 0000000 000 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
... .......+.++.+++.+||+.+|.+|||+.+|+.
T Consensus 223 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 223 PPK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred Ccc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 0112344568899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=300.58 Aligned_cols=248 Identities=22% Similarity=0.337 Sum_probs=200.1
Q ss_pred CCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc---CCCccceeeeeeCCCcceeEe
Q 007073 295 NFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV---HRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lv~ 370 (619)
.|+..+.||+|+||.||+|.+ .+++.||+|.+.........+.+.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999996 4789999999875444555677889999999987 999999999999888999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++++|.++++.. .+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999888642 488999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
.... .....|+..|+|||.+.++ .++.++|||||||++|+|++|+.||...... ....... ...
T Consensus 154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--------~~~~~~~------~~~ 218 (277)
T cd06917 154 NSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF--------RAMMLIP------KSK 218 (277)
T ss_pred Cccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh--------hhhhccc------cCC
Confidence 3322 2334688999999988754 4689999999999999999999999643211 0110000 000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.+.+.. ...+.++.+++.+||+.||++||++.++++
T Consensus 219 ~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 219 PPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 011111 113467899999999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=303.11 Aligned_cols=240 Identities=22% Similarity=0.351 Sum_probs=187.6
Q ss_pred CccccCCCceEEEEEeCC--------CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 300 NVLGQGGFGKVYRGVLAD--------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
+.||+|+||.||+|.... ..+||+|.+... .....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS-HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch-hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 469999999999998642 234888877432 23345678899999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc--------EEEcccc
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE--------AVVGDFG 443 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~DfG 443 (619)
|+++|+|..+++... ..+++..+.+++.|++.||+|||++ +|+||||||+||+++.++. ++++|||
T Consensus 80 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 80 YVKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cCCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence 999999999987533 2478899999999999999999999 9999999999999987765 6999999
Q ss_pred cceeeccCCcceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCC-CCCCCCccccccchhHHHHHHHHhh
Q 007073 444 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQ-RAIDFSRLEEEDDVLLLDHVKKLER 521 (619)
Q Consensus 444 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~ 521 (619)
++..... .....++..|+|||.+.+. .++.++||||||+++|||++|. .|+...... ........
T Consensus 154 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--------~~~~~~~~ 220 (258)
T cd05078 154 ISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--------KKLQFYED 220 (258)
T ss_pred cccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--------HHHHHHHc
Confidence 8865432 1234578899999999874 5799999999999999999995 444321110 00000000
Q ss_pred hcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007073 522 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571 (619)
Q Consensus 522 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 571 (619)
. ...+.....++.+++.+||+.+|++|||++++++.|+
T Consensus 221 ~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 R------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred c------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0111122357899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=305.17 Aligned_cols=249 Identities=20% Similarity=0.318 Sum_probs=201.3
Q ss_pred cCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
.+|+..+.||.|+||.||+|.. .+|+.||+|.+.... ....+.+.+|+.+++.++|||++++++++...+..++|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 4588899999999999999995 478999999886432 33457788999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++++|..++.. ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 98 LAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred cCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 999999998864 2378999999999999999999999 99999999999999999999999999987654332
Q ss_pred cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
.. .....|+..|+|||.+.+..++.++|||||||++|+|+||+.||....... ......... ...
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~--------~~~~~~~~~-~~~----- 234 (296)
T cd06655 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--------ALYLIATNG-TPE----- 234 (296)
T ss_pred cc-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhcC-Ccc-----
Confidence 21 223458889999999998889999999999999999999999986432210 001110000 000
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
...+...+..+.+++.+||+.+|++||++.+++.
T Consensus 235 --~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 235 --LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred --cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0012223457889999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=302.10 Aligned_cols=249 Identities=22% Similarity=0.296 Sum_probs=196.1
Q ss_pred CcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccc
Q 007073 296 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQ 374 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 374 (619)
|++.+.||+|+||.||+|... ++..+|+|.+... .....+.+.+|+++++.++|||++++++++...+..++|+||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC-CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 566788999999999999975 5778899988532 23456678899999999999999999999999999999999999
Q ss_pred cchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcc
Q 007073 375 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 454 (619)
Q Consensus 375 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 454 (619)
+++|...+... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....... .
T Consensus 86 ~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~ 158 (282)
T cd06643 86 GGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 158 (282)
T ss_pred CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-c
Confidence 99998887642 23488999999999999999999999 99999999999999999999999999987653221 1
Q ss_pred eeeecccccccccccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 455 VTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 455 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
......|+..|+|||.+. +..++.++|||||||++|||++|+.||...... ........... ...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~~~~~~~~-~~~- 228 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSEP-PTL- 228 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--------HHHHHHhhcCC-CCC-
Confidence 223346899999999984 345788999999999999999999998632210 11111111000 000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..+...+..+.+++.+||+.+|++||++.++++
T Consensus 229 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 229 ------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred ------CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011223467899999999999999999998874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=304.42 Aligned_cols=262 Identities=20% Similarity=0.284 Sum_probs=195.1
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
+|+..+.||+|+||.||+|... +|+.||+|++.... .......+.+|++++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999975 68999999986432 222345678899999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++ +|.+++... ...+++.....++.|+++||.|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CDQ-DLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 975 676666542 23489999999999999999999999 99999999999999999999999999998654322
Q ss_pred cceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc------cc
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK------RL 525 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 525 (619)
. ......++..|+|||.+.+. .++.++|||||||++|||+||+.|+........ .+ .......... ..
T Consensus 154 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~---~~-~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 154 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD---QL-KRIFRLLGTPTEESWPGV 228 (284)
T ss_pred C-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH---HH-HHHHHHhCCCChHHhHHh
Confidence 1 12234578899999988764 478999999999999999999998643221100 00 0000000000 00
Q ss_pred chhcccc----ccC-----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 526 DAIVDRN----LNK-----NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 526 ~~~~~~~----l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
....+.. ... ...+....++.+++.+||+.||.+|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000 000 011223467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=307.54 Aligned_cols=197 Identities=22% Similarity=0.324 Sum_probs=159.3
Q ss_pred cCccccCCCceEEEEEeC---CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeC--CCcceeEeccc
Q 007073 299 KNVLGQGGFGKVYRGVLA---DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT--PTERLLVYPFM 373 (619)
Q Consensus 299 ~~~lg~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~ 373 (619)
...||+|+||+||+|... ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++|+||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 357999999999999965 45789999886432 23567889999999999999999998854 45678999998
Q ss_pred ccchhhhhhcccC-----CCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe----CCCCcEEEccccc
Q 007073 374 QNLSVAYRLREIK-----PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL----DEDFEAVVGDFGL 444 (619)
Q Consensus 374 ~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGl 444 (619)
++ +|.+.+.... .....+++..+..++.|++.||.|||+. +|+||||||+||++ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 75 6666654221 1223478889999999999999999999 99999999999999 5667999999999
Q ss_pred ceeeccCCcc--eeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 007073 445 AKLVDVRKTN--VTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFS 502 (619)
Q Consensus 445 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~ 502 (619)
++........ ......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 9876433221 2234568999999999876 45799999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=298.34 Aligned_cols=250 Identities=23% Similarity=0.317 Sum_probs=195.7
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC----CcchHHHHHHHHHHHHHccCCCccceeeeeeCC--Ccc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE----SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TER 366 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 366 (619)
++|++.+.||+|+||.||+|... +|+.||+|.+.... .....+.+.+|+.++++++||||+++++++..+ ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999964 58999999875321 122345788899999999999999999988664 346
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
+++|||+++++|.+++.... .+++....+++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 78999999999999887532 367888899999999999999999 99999999999999999999999999988
Q ss_pred eeccCCc--ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 447 LVDVRKT--NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 447 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
....... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... .. .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~-~~~~~---- 222 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-------AA-IFKIA---- 222 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-------HH-HHHHh----
Confidence 6532111 1122345888999999998888999999999999999999999998532110 00 01110
Q ss_pred cchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 525 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
........+......+.+++.+|+. +|++||+++++++
T Consensus 223 -----~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 223 -----TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -----cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0001112234455678889999995 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=295.31 Aligned_cols=288 Identities=22% Similarity=0.212 Sum_probs=222.8
Q ss_pred HHhcCCcccCccccCCCceEEEEEeCC-CcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcce
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 367 (619)
...+.|+..+.||.|.-|+||++..++ +..+|+|++.+.. +.......+.|.+||+.++||.+..|++.++++...+
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c 153 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC 153 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence 344567778899999999999999864 5899999996432 2334556778999999999999999999999999999
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
++||||+||+|....+... +..++...++-++..+.-||+|||-. |||.|||||+||||.++|++.|+||.++..
T Consensus 154 l~meyCpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred EEEecCCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeecccccc
Confidence 9999999999999887643 45589999999999999999999999 999999999999999999999999998754
Q ss_pred eccC----------------------------------Cc---------------------ceeeecccccccccccccc
Q 007073 448 VDVR----------------------------------KT---------------------NVTTQVRGTMGHIAPEYLS 472 (619)
Q Consensus 448 ~~~~----------------------------------~~---------------------~~~~~~~gt~~y~aPE~~~ 472 (619)
.... .. ..+..++||-.|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 3110 00 0112356999999999999
Q ss_pred CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhc
Q 007073 473 TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLC 552 (619)
Q Consensus 473 ~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~C 552 (619)
+...+.++|+|+|||++|||+.|+.||......+ .+..++.+.+.-...+..+..+.+||.+.
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-----------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~L 371 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-----------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKL 371 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-----------------hHHHHhcCCCcCCCCCcchhHHHHHHHHH
Confidence 9999999999999999999999999997654321 22233333333222335567889999999
Q ss_pred cCCCCCCCCCHHHHHHHHhcCCcccchhhhhhhhhhhHHHHHhhccccCccc
Q 007073 553 TQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGE 604 (619)
Q Consensus 553 l~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~ 604 (619)
+.+||.+|-....=...+++..+++.. .|...+-..-+..|.+.|-+.
T Consensus 372 LvKdP~kRlg~~rGA~eIK~HpFF~gV----nWaLir~~~PP~iP~~~d~~~ 419 (459)
T KOG0610|consen 372 LVKDPSKRLGSKRGAAEIKRHPFFEGV----NWALIRCARPPEIPKPVDGGL 419 (459)
T ss_pred hccChhhhhccccchHHhhcCccccCC----ChhheeccCCCcCCCccccCc
Confidence 999999999855555566666555432 233344444445555555544
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=303.84 Aligned_cols=259 Identities=25% Similarity=0.321 Sum_probs=200.8
Q ss_pred CHHHHHHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeC
Q 007073 285 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTT 362 (619)
Q Consensus 285 ~~~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 362 (619)
++.++....+.|++.+.||+|+||.||+|... +++.+|+|.+... ......+..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC--hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 44555567788999999999999999999974 6889999987532 23446788899999988 69999999998853
Q ss_pred ------CCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc
Q 007073 363 ------PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE 436 (619)
Q Consensus 363 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 436 (619)
....+++|||+++|+|.+++..... ..+++..+..++.|++.|++|||+. +|+|+||||+||++++++.
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence 3467899999999999998875432 3477888889999999999999999 9999999999999999999
Q ss_pred EEEcccccceeeccCCcceeeecccccccccccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchh
Q 007073 437 AVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL 511 (619)
Q Consensus 437 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~ 511 (619)
++|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||+||+.||........
T Consensus 160 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~---- 234 (282)
T cd06636 160 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA---- 234 (282)
T ss_pred EEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh----
Confidence 99999999875532221 122346889999999875 34678899999999999999999999853221100
Q ss_pred HHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 512 LLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. ... .............+..+.+++.+||+.||.+||++.|+++
T Consensus 235 ~----~~~---------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 235 L----FLI---------PRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred h----hhH---------hhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 000 0000001111234467899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=300.69 Aligned_cols=253 Identities=21% Similarity=0.291 Sum_probs=198.2
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.++|...+.||+|+||.||+|... +++.||+|.++... ......+.+|+.+++.++||||+++++++...+..++|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 346777889999999999999964 68899999886432 3344567889999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++++|.+++... ..++......++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 87 FCGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred ccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 99999999988653 2488999999999999999999999 9999999999999999999999999998765432
Q ss_pred Ccceeeecccccccccccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 452 KTNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
. .......|+..|+|||.+. ...++.++|||||||++|||++|+.||....... .. ..... ...
T Consensus 160 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~----~~----~~~~~-~~~--- 226 (267)
T cd06645 160 I-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR----AL----FLMTK-SNF--- 226 (267)
T ss_pred c-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh----hH----Hhhhc-cCC---
Confidence 2 2223446899999999874 4568899999999999999999999985322110 00 00000 000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..+.... ....+..+.+++.+|++.+|++||++.++++
T Consensus 227 ~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 227 QPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0000000 0122356889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=297.86 Aligned_cols=250 Identities=20% Similarity=0.325 Sum_probs=202.1
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
+|+..+.||+|+||.||++... +|+.||+|++.... .....+++.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999964 68999999986432 233456789999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++++|.+.+.... ...+++....+++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 99999999887532 23478889999999999999999999 99999999999999999999999999998654322
Q ss_pred cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
. ......|++.|+|||.+.+..++.++|||||||++++|+||+.||...... +.+...... ..
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--------~~~~~~~~~-~~------- 218 (256)
T cd08218 156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK--------NLVLKIIRG-SY------- 218 (256)
T ss_pred h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH--------HHHHHHhcC-CC-------
Confidence 1 122345788999999999989999999999999999999999998642211 111111111 00
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
...+.....++.+++.+||+.+|++||++.+|++
T Consensus 219 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 219 --PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred --CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0112233467899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=302.37 Aligned_cols=252 Identities=24% Similarity=0.320 Sum_probs=200.7
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.++|++.+.||+|+||.||+|... ++..||+|..... .....+.|.+|++++++++|+||+++++++..+...++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 456888899999999999999975 6899999998532 33455678999999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++++|.+++.... ..+++.....++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 83 FCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred ccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 999999999887532 3488999999999999999999999 9999999999999999999999999998765332
Q ss_pred Ccceeeecccccccccccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
.. ......|++.|+|||.+. ...++.++||||||+++|||++|+.||...... ...........
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~-- 225 (280)
T cd06611 157 LQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--------RVLLKILKSEP-- 225 (280)
T ss_pred cc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--------HHHHHHhcCCC--
Confidence 22 223345899999999875 345678999999999999999999998642210 11111111000
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
+.+ ..+...+.++.+++.+||+.+|++||++.++++
T Consensus 226 ----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 226 ----PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred ----CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 000 012233457889999999999999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=304.46 Aligned_cols=264 Identities=23% Similarity=0.350 Sum_probs=196.4
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
++|+..+.||+|++|.||+|..+ +++.||+|.+...........+.+|++++++++|+||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999975 68999999986543333345677899999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++ +|.+++.... ..+++.....++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 985 8888876532 2478899999999999999999999 99999999999999999999999999987543221
Q ss_pred cceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh--hcccchhc
Q 007073 453 TNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER--EKRLDAIV 529 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 529 (619)
. ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||........ .+......... ......+.
T Consensus 158 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED---QLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred c-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH---HHHHHHHhcCCCChhhhhhhh
Confidence 1 1122346889999998865 4589999999999999999999999864321100 00000000000 00000000
Q ss_pred --------------cccccCCC-CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 530 --------------DRNLNKNY-NIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 530 --------------~~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
...+.... .......+.+++.+|++.+|++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000 0011257789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=299.50 Aligned_cols=255 Identities=26% Similarity=0.346 Sum_probs=201.0
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCc----
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTE---- 365 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~---- 365 (619)
++++|++.+.||+|+||.||+|... +++.+++|.+.... ...+.+.+|+.+++++ +|+||+++++++.....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 4678999999999999999999975 67899999886432 2456789999999998 69999999999976543
Q ss_pred --ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007073 366 --RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 443 (619)
Q Consensus 366 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 443 (619)
.++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 7899999999999999876543345689999999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcceeeeccccccccccccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH
Q 007073 444 LAKLVDVRKTNVTTQVRGTMGHIAPEYLST-----GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 518 (619)
Q Consensus 444 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 518 (619)
++....... .......|+..|+|||.+.. ..++.++||||||+++|+|+||+.||...... ... ..
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~----~~ 229 (275)
T cd06608 159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM----RAL----FK 229 (275)
T ss_pred cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH----HHH----HH
Confidence 987654322 22233458899999998753 34688999999999999999999998532110 001 11
Q ss_pred HhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 519 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 519 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.... .... ..........+.+++.+||..||++|||+.++++
T Consensus 230 ~~~~------~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IPRN------PPPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhcc------CCCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1000 0000 1112234568899999999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=299.39 Aligned_cols=248 Identities=24% Similarity=0.348 Sum_probs=201.3
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEeccc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 373 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 373 (619)
-|...+.||+|+||.||+|... ++..||+|...........+.+.+|+.++++++||||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4667789999999999999864 688999998864444445678889999999999999999999999999999999999
Q ss_pred ccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCc
Q 007073 374 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 453 (619)
Q Consensus 374 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 453 (619)
++++|..++.. ..+++.....++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999988864 2378899999999999999999999 999999999999999999999999999876643322
Q ss_pred ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccc
Q 007073 454 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 533 (619)
Q Consensus 454 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 533 (619)
. .....|+..|+|||.+.+..++.++|||||||++|+|+||..||..... . ........ ..
T Consensus 157 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~---~~~~~~~~-~~--------- 217 (277)
T cd06641 157 K-RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-----M---KVLFLIPK-NN--------- 217 (277)
T ss_pred h-hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-----H---HHHHHHhc-CC---------
Confidence 1 2234578899999999888899999999999999999999999853211 0 11111110 00
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 534 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 534 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
........+.++.+++.+||+.+|++||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 218 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 011222334678899999999999999999999973
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=315.19 Aligned_cols=245 Identities=24% Similarity=0.389 Sum_probs=196.2
Q ss_pred ccCccccCCCceEEEEEeC-CCcEEE---EEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCc--ceeEec
Q 007073 298 EKNVLGQGGFGKVYRGVLA-DGTKVA---VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE--RLLVYP 371 (619)
Q Consensus 298 ~~~~lg~G~fg~Vy~~~~~-~g~~vA---vK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--~~lv~e 371 (619)
...+||+|+|-+||+|.+. +|..|| ||.-.-..++...+.|..|+++|+.++||||++++.++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3468999999999999974 577776 3322222345556899999999999999999999999977655 678899
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-CcEEEcccccceeecc
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDV 450 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~~~~~ 450 (619)
.|..|+|..+..+... .+....++|+.||.+||.|||++ .|+|||||||-+||+|+.+ |.|||+|.|+|+....
T Consensus 124 L~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999988655 77788999999999999999998 6789999999999999865 8999999999997653
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
.. ...+.|||.|||||.+. ..|++.+||||||+.++||+|+..||..- .....+...+.....+..+..+-|
T Consensus 199 s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC----~n~AQIYKKV~SGiKP~sl~kV~d 270 (632)
T KOG0584|consen 199 SH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC----TNPAQIYKKVTSGIKPAALSKVKD 270 (632)
T ss_pred cc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh----CCHHHHHHHHHcCCCHHHhhccCC
Confidence 32 23378999999999886 78999999999999999999999998632 222223333332233333333333
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
+++.++|.+|+.. .++|||+.|++.
T Consensus 271 ------------Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 271 ------------PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ------------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 4788999999999 999999999983
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=304.12 Aligned_cols=264 Identities=22% Similarity=0.304 Sum_probs=202.0
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
++|+..+.||+|+||.||+|... +++.||+|.++... .....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999975 58899999886432 23345788999999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|++++.+....... ..+++.....++.|++.|++|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 99987776655432 2378899999999999999999999 9999999999999999999999999999876544
Q ss_pred CcceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHH---hh------
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL---ER------ 521 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~------ 521 (619)
.........++..|+|||++.+. .++.++||||||+++|+|++|+.||....... .+....... ..
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID----QLYLIQKCLGPLPPSHQELF 229 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCCHHHhhhc
Confidence 33233445678899999999888 78999999999999999999999986432110 010000000 00
Q ss_pred --hccc-----chhcccc-ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 522 --EKRL-----DAIVDRN-LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 522 --~~~~-----~~~~~~~-l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.... ....+.. ....+....+.++.+++.+||+.+|++||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000 0000000 000011122578999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=298.12 Aligned_cols=254 Identities=24% Similarity=0.389 Sum_probs=197.5
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC---------cchHHHHHHHHHHHHHccCCCccceeeeeeCCC
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES---------PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT 364 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 364 (619)
+|...+.||+|+||.||+|... +|+.||+|.++.... ....+.+.+|+.+++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667889999999999999864 689999998753211 011346788999999999999999999999999
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 444 (619)
..++|+||+++++|.++++.. ..+++..+..++.|++.||.|||++ +++||||+|+||+++.++.++++|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999998764 3488889999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCcc-eeeeccccccccccccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007073 445 AKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGK--SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 521 (619)
Q Consensus 445 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 521 (619)
++........ ......|+..|+|||.+.... ++.++||||||+++||+++|..||...... ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~ 226 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--------AAMFKLGN 226 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--------HHHHHhhc
Confidence 9765322111 122345888999999987654 789999999999999999999998532110 00011000
Q ss_pred hcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 522 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 522 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..... ..........+..+.+++.+||+.+|++||++.+|++
T Consensus 227 -~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 227 -KRSAP----PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred -cccCC----cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 00000 0111112233568899999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=301.98 Aligned_cols=249 Identities=22% Similarity=0.284 Sum_probs=210.7
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC-cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.-|...+.||+|.|+.|-.|++- +|.+||||++-+... ......+.+|++-|+.++|||||++|++..+....|+|.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 44777789999999999999854 799999999965442 2345678899999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-CCCcEEEcccccceeecc
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD-EDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla~~~~~ 450 (619)
.-.+|+|.+++.....+ +......+++.||..|+.|+|+. .+|||||||+||.+- .-|-|||+|||++..+.+
T Consensus 98 LGD~GDl~DyImKHe~G---l~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEG---LNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHhhhcc---ccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999876554 88899999999999999999999 999999999998775 568899999999987654
Q ss_pred CCcceeeeccccccccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
. ...+..+|+..|-|||++.+..| .+++||||+|||+|-|++|+.||...... +.+..++
T Consensus 172 G--~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-----------------ETLTmIm 232 (864)
T KOG4717|consen 172 G--KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-----------------ETLTMIM 232 (864)
T ss_pred c--chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-----------------hhhhhhh
Confidence 4 33455689999999999999888 57899999999999999999999754322 2334455
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
|.... .+...+.++.+|+..|+..||++|-+.++|+..
T Consensus 233 DCKYt--vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 233 DCKYT--VPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ccccc--CchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 55433 356677889999999999999999999998753
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=305.69 Aligned_cols=259 Identities=24% Similarity=0.251 Sum_probs=202.9
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCc--chHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP--GGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++|...+.||+|+||+||+|... +++.||+|.+...... ...+.+..|+++++.++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999975 5899999998754322 24567889999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+.+++|.+++.... ...+++.....++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999999887432 24588899999999999999999999 999999999999999999999999999875432
Q ss_pred CCcc----------------------------eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 007073 451 RKTN----------------------------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 502 (619)
Q Consensus 451 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~ 502 (619)
.... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 2110 111235788999999999888999999999999999999999998643
Q ss_pred ccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007073 503 RLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 574 (619)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 574 (619)
.... .. . .+.+...........+..+.+++.+|++.+|++||++...++.+....
T Consensus 236 ~~~~-------~~-~---------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~ 290 (316)
T cd05574 236 NRDE-------TF-S---------NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP 290 (316)
T ss_pred chHH-------HH-H---------HHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCc
Confidence 2110 00 0 011111111111114568999999999999999999555554444443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=296.60 Aligned_cols=252 Identities=26% Similarity=0.406 Sum_probs=200.6
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC-cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
+|...+.||+|+||.||+|... +++.||+|.++.... ....+.+..|+.+++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999964 689999999875432 23567889999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++++|.+++... ..+++..+..++.|+++|++|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 9999999998753 2378888999999999999999999 99999999999999999999999999998765433
Q ss_pred cceee---eccccccccccccccCCC---CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 453 TNVTT---QVRGTMGHIAPEYLSTGK---SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 453 ~~~~~---~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
..... ...++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... . ........ ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~----~---~~~~~~~~-~~-- 223 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE----F---QIMFHVGA-GH-- 223 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch----H---HHHHHHhc-CC--
Confidence 32221 345788999999998766 899999999999999999999999642210 0 00000000 00
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.+.+. ........+.+++.+||+.+|++||++.+++.
T Consensus 224 ---~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 ---KPPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---CCCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 01122457789999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=296.65 Aligned_cols=253 Identities=26% Similarity=0.406 Sum_probs=201.1
Q ss_pred CCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCC-----cchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 295 NFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFES-----PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
+|+..+.||+|+||.||+|.. .+++.||+|.+..... ....+.+.+|++++++++|+||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999995 5789999998864321 1134678899999999999999999999999999999
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-cEEEccccccee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-EAVVGDFGLAKL 447 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~ 447 (619)
|+||+++++|.+++.... .+++.....++.|++.||+|||++ +++|+||+|+||+++.++ .+||+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999987532 478899999999999999999999 999999999999998775 599999999876
Q ss_pred eccCCcc---eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 448 VDVRKTN---VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 448 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
....... ......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||........ .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~----- 223 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-----LALIFKI----- 223 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-----HHHHHHH-----
Confidence 6433111 12234578899999999888899999999999999999999999864321110 0111000
Q ss_pred cchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 525 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.........+.....++.+++.+|++.+|++||++.++++
T Consensus 224 ----~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 224 ----ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ----hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0011112233445578899999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=308.43 Aligned_cols=261 Identities=24% Similarity=0.268 Sum_probs=193.5
Q ss_pred HHhcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCC-----
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP----- 363 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----- 363 (619)
...++|...+.||+|+||.||+|.. .+++.||||++.... .......+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999999996 468899999986432 222345677899999999999999999887543
Q ss_pred -CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007073 364 -TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 442 (619)
Q Consensus 364 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 442 (619)
...+++++++ +++|.+.+.. ..++...+..++.|++.||.|||++ +|+||||||+||+++.++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 3468888887 6788777653 2388899999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007073 443 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 521 (619)
Q Consensus 443 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 521 (619)
|+++..... .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+.........
T Consensus 163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~~~~~~~~ 234 (343)
T cd07878 163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID----QLKRIMEVVGT 234 (343)
T ss_pred ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHHHhCC
Confidence 999865432 233468999999999876 568999999999999999999999996432110 00000000000
Q ss_pred --hcccchhcc-------ccccCCC-------CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 522 --EKRLDAIVD-------RNLNKNY-------NIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 522 --~~~~~~~~~-------~~l~~~~-------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
......+.. ..+.... .......+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000 0000000 0011245789999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=295.83 Aligned_cols=252 Identities=22% Similarity=0.337 Sum_probs=206.2
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
++|++.+.||+|++|.||+|... +|+.||||++...........+.+|+.++.+++|+|++++++++..+...++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999976 59999999987544334567899999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
+++++|.+++... ..++......++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999999764 348899999999999999999999 8 9999999999999999999999999999876443
Q ss_pred CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (619)
... .....++..|+|||.+.+..++.++||||||+++|+|+||+.||...... . ..+....... .
T Consensus 154 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~---~~~~~~~~~~---------~ 218 (264)
T cd06623 154 LDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--S---FFELMQAICD---------G 218 (264)
T ss_pred CCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--C---HHHHHHHHhc---------C
Confidence 322 22345788999999999889999999999999999999999998643210 1 1111111111 0
Q ss_pred cccCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 532 NLNKNYNIQ-EVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 532 ~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.. ...... .+..+.+++.+|++.+|++||++.++++
T Consensus 219 ~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 219 PP-PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred CC-CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 00 111222 4568999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=300.10 Aligned_cols=262 Identities=21% Similarity=0.301 Sum_probs=197.0
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
+|+..+.||+|++|.||+|... +|+.||||++.... .......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999975 68999999886433 233346788999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+. ++|..++.... ...+++.....++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 57888776533 23488999999999999999999999 99999999999999999999999999987654322
Q ss_pred cceeeeccccccccccccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc--------
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK-------- 523 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 523 (619)
. ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||....... ...........+.
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 155 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID----QLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred c-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHHHhCCCChhhhhhhh
Confidence 2 122334688999999887644 6889999999999999999999986432211 1111111110000
Q ss_pred -------ccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 524 -------RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 524 -------~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.........+. ...+.....+.+++.+|++.||++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 230 SLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000 001122356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=299.40 Aligned_cols=263 Identities=22% Similarity=0.274 Sum_probs=201.0
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC-cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
+|++.+.||+|+||.||+|... +|+.||+|++..... ......+.+|+.++++++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999974 689999999875432 33457889999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+ +++|.+++.... ..+++..+..++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999887533 4489999999999999999999999 99999999999999999999999999998765443
Q ss_pred cceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc--------
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK-------- 523 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 523 (619)
........|+..|+|||.+.+. .++.++||||+|+++|||+||..+|...... ..+.........+.
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI----EQLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH----HHHHHHHHHcCCCChHHHhhcc
Confidence 2223345689999999988654 4689999999999999999998777532211 00101111000000
Q ss_pred cc---chhcccccc----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 524 RL---DAIVDRNLN----KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 524 ~~---~~~~~~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.+ ..+...... ....+.....+.+++.+|++.+|++||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00 000000000 0001123478899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=291.96 Aligned_cols=249 Identities=21% Similarity=0.282 Sum_probs=206.7
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEeccc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 373 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 373 (619)
-|.+.++||+|+||.||+|.++ .|+.+|+|.+.- ....++..+|+.++++.+.|++|+++|.+......++|||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV---~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV---DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc---cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 4667789999999999999975 699999998853 335678899999999999999999999999999999999999
Q ss_pred ccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCc
Q 007073 374 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 453 (619)
Q Consensus 374 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 453 (619)
.-|+..+.++- ...++...+...++.+...||+|||.. .=+|||||+.|||++.+|.+||+|||.|-.+.. ..
T Consensus 111 GAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TM 183 (502)
T KOG0574|consen 111 GAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TM 183 (502)
T ss_pred CCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhh-hH
Confidence 99999999876 345689999999999999999999998 789999999999999999999999999976542 22
Q ss_pred ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccc
Q 007073 454 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 533 (619)
Q Consensus 454 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 533 (619)
.....+.||+.|||||+++.-.|..++||||+|+...||..|++||.....-.. ...-...+..
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA----------------IFMIPT~PPP 247 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA----------------IFMIPTKPPP 247 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce----------------eEeccCCCCC
Confidence 334467899999999999999999999999999999999999999864221100 0000011111
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 534 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 534 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
.-..+...+.++.+++++|+-++|++|-|+.++++.
T Consensus 248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 111256677889999999999999999999988753
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=308.14 Aligned_cols=245 Identities=27% Similarity=0.357 Sum_probs=198.7
Q ss_pred CCcccCccccCCCceEEEEEe-CCCcEEEEEEeccC--CCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 295 NFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
-|...+.||.|+||.||-|.. .+...||||++.-. .+...+.++.+|+..+.+++|||++.+-|+|-.....++|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 366678899999999999995 47889999998532 234456788999999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
||-| +-.+.+.-.+ .++....+..|+.+...||+|||+. +.||||||+.|||+++.|.|||+|||.|....+.
T Consensus 107 YClG-SAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHhc-cHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 9965 6667665432 3488889999999999999999999 9999999999999999999999999999876543
Q ss_pred Ccceeeecccccccccccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 452 KTNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
..++|||.|||||++. .+.|+-|+||||+|++..|+.-.++|.-.... +.....+..-
T Consensus 180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA--------------MSALYHIAQN 240 (948)
T KOG0577|consen 180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------------MSALYHIAQN 240 (948)
T ss_pred -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH--------------HHHHHHHHhc
Confidence 3468999999999885 57899999999999999999999998643211 0000111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
-.+.+ ...+++..+..++..|+++-|.+|||.++++.
T Consensus 241 esPtL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 241 ESPTL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCCC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 11111 14567778899999999999999999999885
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=293.86 Aligned_cols=249 Identities=23% Similarity=0.343 Sum_probs=200.4
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
+|+..+.||+|+||.||++... +++.+|+|++.... .......+.+|++++++++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999964 68899999986432 334567889999999999999999999999888899999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-CcEEEcccccceeeccC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~~~~~~ 451 (619)
+++++|.+++.... ...+++..+.+++.++++|++|||++ +++|+||+|+||+++++ ..+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997632 33478899999999999999999999 99999999999999855 56899999999876433
Q ss_pred CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (619)
.. .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ......... ...
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--------~~~~~~~~~-~~~----- 219 (256)
T cd08220 156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--------ALVLKIMSG-TFA----- 219 (256)
T ss_pred cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--------HHHHHHHhc-CCC-----
Confidence 21 22345888999999999888999999999999999999999998643211 111111100 000
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 532 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
......+..+.+++.+||+.+|++|||+.++++
T Consensus 220 ----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 220 ----PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ----CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111123457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=301.60 Aligned_cols=257 Identities=22% Similarity=0.332 Sum_probs=194.1
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc-CCCccceeeeeeCCCcceeEecc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
+|...+.||+|+||.||++... +|+.||+|.+...........+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4555678999999999999965 689999999875444445677889999999996 99999999999988899999999
Q ss_pred cccchhhhhhccc-CCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 373 MQNLSVAYRLREI-KPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 373 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
+.. ++.++.... ......+++....+++.+++.||+|||+.. +++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 443332211 112245888999999999999999999732 8999999999999999999999999999755332
Q ss_pred CcceeeeccccccccccccccCC---CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTG---KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
.. .....|+..|+|||.+.+. .++.++|||||||++|||++|+.||.... ............
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~------ 226 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQLTQVVKG------ 226 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHHHhhhcCC------
Confidence 21 2233578999999999776 68999999999999999999999986422 011111111100
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
..+.+........+..+.+++.+||+.+|++|||+.+|++.
T Consensus 227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111111122345678999999999999999999998853
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=300.92 Aligned_cols=266 Identities=21% Similarity=0.264 Sum_probs=196.2
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++++|.+.+.||+|+||.||+|... +|+.||+|++...........+.+|+.+++.++|+||+++++++..+...++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3567899999999999999999864 689999999865443444456789999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+. +++...+.... ..+.+.....++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9996 56666654322 2367778888999999999999999 999999999999999999999999999875432
Q ss_pred CCcceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHH----------
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL---------- 519 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------- 519 (619)
... ......++..|+|||.+.+. .++.++|||||||++|||+||+.||+...... ..+.+.....
T Consensus 156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 156 PSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF---EQLEKIWTVLGVPTEDTWPG 231 (291)
T ss_pred CCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH---HHHHHHHHHcCCCChhhhhh
Confidence 221 12233578899999998754 57899999999999999999999996432210 0111100000
Q ss_pred -hh-hcccchhccccccCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 520 -ER-EKRLDAIVDRNLNKNY-----NIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 520 -~~-~~~~~~~~~~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.. +............... .......+.+++.+|++.||++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00 0000000000000000 0012357789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=305.54 Aligned_cols=254 Identities=22% Similarity=0.352 Sum_probs=202.2
Q ss_pred HHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEecc-CCCcchHHHHHHHHHHHHHcc-CCCccceeeeeeCCCccee
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTD-FESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~-~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~l 368 (619)
+....|++.+.||+||.+.||++...+.+.||+|++.. ..+......|.+|++.|.+++ |.+||++++|-..++..|+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 34556888999999999999999998889999998763 334556788999999999996 9999999999999999999
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||-+ .+|...|...... ...| .++.+..|+..|+.++|++ ||||.||||.|+|+-. |.+||+|||+|..+
T Consensus 438 vmE~Gd-~DL~kiL~k~~~~--~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 438 VMECGD-IDLNKILKKKKSI--DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAI 509 (677)
T ss_pred Eeeccc-ccHHHHHHhccCC--CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhccc
Confidence 999865 4888888865432 2334 7788999999999999999 9999999999999854 58999999999988
Q ss_pred ccCCcce-eeeccccccccccccccCC-----------CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHH
Q 007073 449 DVRKTNV-TTQVRGTMGHIAPEYLSTG-----------KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV 516 (619)
Q Consensus 449 ~~~~~~~-~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 516 (619)
..+.+.. ....+||+.||+||.+... +.++++||||+||++|+|+.|+.||... ....
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~----------~n~~ 579 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI----------INQI 579 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH----------HHHH
Confidence 7665543 3456799999999998532 2578999999999999999999998521 1111
Q ss_pred HHHhhhcccchhccccccCCCCHHH-HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 517 KKLEREKRLDAIVDRNLNKNYNIQE-VETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 517 ~~~~~~~~~~~~~~~~l~~~~~~~~-~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.++..+.++.....++.-. ..+++++|+.|++.||++||+..++++
T Consensus 580 ------aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 ------AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ------HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 2344555554332332111 123899999999999999999999985
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=312.17 Aligned_cols=245 Identities=21% Similarity=0.222 Sum_probs=186.3
Q ss_pred cccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHc---cCCCccceeeeeeCCCcceeEeccccc
Q 007073 302 LGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA---VHRNLLRLIGFCTTPTERLLVYPFMQN 375 (619)
Q Consensus 302 lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~lv~e~~~~ 375 (619)
||+|+||+||+|... +|+.||||++.... .......+..|..++... +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999965 68999999985321 122234455677776655 699999999999999999999999999
Q ss_pred chhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcce
Q 007073 376 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455 (619)
Q Consensus 376 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 455 (619)
|+|.+++... ..++......++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 81 GELFWHLQKE----GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred ChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 9999888653 3488899999999999999999999 99999999999999999999999999987543222 12
Q ss_pred eeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcccccc
Q 007073 456 TTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN 534 (619)
Q Consensus 456 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 534 (619)
.....||..|+|||.+.+. .++.++|||||||++|||+||+.||...... +........ .. .+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~--------~~~~~i~~~-~~------~~~ 217 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ--------QMYRNIAFG-KV------RFP 217 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH--------HHHHHHHcC-CC------CCC
Confidence 2345699999999998764 4799999999999999999999998643211 111111110 00 000
Q ss_pred CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 535 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 535 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
.......+.+++.+|++.||++||++.+.++.+..
T Consensus 218 ---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 ---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 01123567899999999999999965433333333
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=321.15 Aligned_cols=265 Identities=17% Similarity=0.219 Sum_probs=191.0
Q ss_pred HHHHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCC------Cccceeeee
Q 007073 288 ELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR------NLLRLIGFC 360 (619)
Q Consensus 288 el~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~------niv~l~~~~ 360 (619)
++...+++|.+.++||+|+||+||+|... .++.||||+++.. ......+..|+.+++.++|. +++++++++
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV--PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc--hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 44456788999999999999999999964 5788999998642 22344566788887777654 588888888
Q ss_pred eCC-CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCC---
Q 007073 361 TTP-TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDF--- 435 (619)
Q Consensus 361 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~--- 435 (619)
... ...++||+++ +++|.+++... ..+++..+..++.|++.||+|||+ . +|+||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccc
Confidence 765 4678888887 66787777653 248889999999999999999997 5 899999999999998765
Q ss_pred -------------cEEEcccccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 007073 436 -------------EAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 502 (619)
Q Consensus 436 -------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~ 502 (619)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||+||+.||+..
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 49999999886432 2233457999999999999999999999999999999999999999753
Q ss_pred ccccccchhHH---------HHHHHH--------h-hhcccchhcccc-----ccC--CCCHHHHHHHHHHHHhccCCCC
Q 007073 503 RLEEEDDVLLL---------DHVKKL--------E-REKRLDAIVDRN-----LNK--NYNIQEVETMIQVALLCTQASP 557 (619)
Q Consensus 503 ~~~~~~~~~~~---------~~~~~~--------~-~~~~~~~~~~~~-----l~~--~~~~~~~~~l~~l~~~Cl~~dP 557 (619)
..... .... .|.... . ....+....++. ... .........+.+|+.+|++.||
T Consensus 349 ~~~~~--~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 426 (467)
T PTZ00284 349 DNLEH--LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR 426 (467)
T ss_pred ChHHH--HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence 32100 0000 000000 0 000000000000 000 0001123467899999999999
Q ss_pred CCCCCHHHHHH
Q 007073 558 EDRPAMSEVVR 568 (619)
Q Consensus 558 ~~RPs~~evl~ 568 (619)
++|||++|+++
T Consensus 427 ~~R~ta~e~L~ 437 (467)
T PTZ00284 427 QKRLNARQMTT 437 (467)
T ss_pred hhCCCHHHHhc
Confidence 99999999985
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=301.51 Aligned_cols=257 Identities=19% Similarity=0.224 Sum_probs=201.8
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC--cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++|+..+.||+|+||.||++... +++.||+|.+..... ......+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888899999999999999975 578999998865321 233467889999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++++|.+++... ..+++.....++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 999999999999653 2478888999999999999999999 999999999999999999999999999864211
Q ss_pred CC--------------cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHH
Q 007073 451 RK--------------TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV 516 (619)
Q Consensus 451 ~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 516 (619)
.. ........|+..|+|||.+.+..++.++|+||||+++|||+||+.||...... +..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~--------~~~ 225 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--------ELF 225 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHH
Confidence 00 00111235788999999998888999999999999999999999998632210 111
Q ss_pred HHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 517 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 517 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
....... . ..+. .....+..+.+++.+||+.+|++||++.++.+.|+..
T Consensus 226 ~~~~~~~-~---~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 226 GQVISDD-I---EWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred HHHHhcc-c---CCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 1111100 0 0000 0112345789999999999999999988888887773
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=298.79 Aligned_cols=263 Identities=23% Similarity=0.270 Sum_probs=198.5
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCc----chHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP----GGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
+|...+.||+|+||.||+|... +|+.||||.+...... .....+..|++++++++|+||+++++++...+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999965 6899999998754322 2345677899999999999999999999998899999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||+ +|+|..++.... ..+++..+..++.|+++||+|||++ +|+|+||||+||+++.++.++|+|||+++...
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 899999987533 2589999999999999999999999 99999999999999999999999999998764
Q ss_pred cCCcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh------
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE------ 522 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 522 (619)
.... ......++..|+|||.+.+ ..++.++|||||||++|||++|..+|....... .+..........
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 228 (298)
T cd07841 154 SPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID----QLGKIFEALGTPTEENWP 228 (298)
T ss_pred CCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH----HHHHHHHHcCCCchhhhh
Confidence 4322 1223346788999998865 457899999999999999999977775322110 011111100000
Q ss_pred --cccchhccccccCC-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 523 --KRLDAIVDRNLNKN-----YNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 523 --~~~~~~~~~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
.............. ........+.+++.+||+.+|++|||+.|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000000 012234678999999999999999999999973
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=300.41 Aligned_cols=246 Identities=21% Similarity=0.292 Sum_probs=196.1
Q ss_pred ccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccc
Q 007073 298 EKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL 376 (619)
Q Consensus 298 ~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 376 (619)
....||+|+||.||++... ++..||||.+.... ....+.+.+|+.+++.++|+||+++++.+...+..++||||++++
T Consensus 26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 3467999999999999964 68899999885422 334567889999999999999999999999999999999999999
Q ss_pred hhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCccee
Q 007073 377 SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 456 (619)
Q Consensus 377 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 456 (619)
+|.+++.. ..+++.....++.|++.||+|||++ +|+||||||+||++++++.++|+|||++........ ..
T Consensus 105 ~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~ 175 (292)
T cd06658 105 ALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KR 175 (292)
T ss_pred cHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cC
Confidence 99988753 2378889999999999999999999 999999999999999999999999999876533222 22
Q ss_pred eeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCC
Q 007073 457 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKN 536 (619)
Q Consensus 457 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 536 (619)
....|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ........ ...+.+..
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~~~~~------~~~~~~~~- 240 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--------QAMRRIRD------NLPPRVKD- 240 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHh------cCCCcccc-
Confidence 3345889999999998888999999999999999999999998642211 01111110 01111110
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 537 YNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 537 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
.......+.+++.+||..||++|||++++++.
T Consensus 241 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 -SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11234578899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=299.74 Aligned_cols=266 Identities=21% Similarity=0.268 Sum_probs=197.8
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCC--CcceeE
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERLLV 369 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv 369 (619)
++|+..+.||+|+||.||+|... +++.+|+|.++... .......+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999976 68899999986432 222334677899999999999999999998777 789999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
+||+++ +|.+.+.... ..+++.....++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 85 ~e~~~~-~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999985 8888876532 2589999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCcceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHH---------HH--H
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD---------HV--K 517 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~---------~~--~ 517 (619)
.... ......++..|+|||.+.+. .++.++|+||||+++|||++|+.||........... +.. |. .
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 158 SPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNK-IFKLLGTPTEKIWPGFS 235 (293)
T ss_pred CCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHhCCCchHHHHHhh
Confidence 4322 12234578899999998764 468999999999999999999999864322110000 000 00 0
Q ss_pred HHhhh--cccchhccccccCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 518 KLERE--KRLDAIVDRNLNKNYNIQ-EVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 518 ~~~~~--~~~~~~~~~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.+... ..........+...+... ....+.+++.+||+.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000 000000011111111111 3567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=293.23 Aligned_cols=250 Identities=22% Similarity=0.294 Sum_probs=205.1
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
+|++.+.||+|+||.||++... +++.+|+|.+.... .......+.+|++++++++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999864 68899999986433 233456778999999999999999999999988999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++++|..++.........+++.....++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999877544445689999999999999999999999 9999999999999999999999999999876543
Q ss_pred cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||...... ....... ...
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~-~~~-------- 217 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--------DLRYKVQ-RGK-------- 217 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHh-cCC--------
Confidence 222345788999999999989999999999999999999999998643211 0111110 011
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..........++.+++.+|++.+|++||++.++++
T Consensus 218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 218 -YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11122345578999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=299.43 Aligned_cols=248 Identities=27% Similarity=0.355 Sum_probs=195.5
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
.+.|...+.||+|+||+||+|... +|+.||+|.+.... .....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 345888899999999999999975 68999999886332 223346788999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
+||+.+ ++.+.+.... ..+++..+..++.|++.||.|||+. +|+||||+|+||++++++.++|+|||++....
T Consensus 94 ~e~~~g-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 94 MEYCLG-SASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HHhhCC-CHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 999974 6666554322 2488999999999999999999999 99999999999999999999999999987653
Q ss_pred cCCcceeeecccccccccccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
.. ....|+..|+|||.+. .+.++.++||||||+++|||+||+.||...... .........
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~--------~~~~~~~~~---- 229 (307)
T cd06607 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQN---- 229 (307)
T ss_pred CC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH--------HHHHHHhcC----
Confidence 32 2345788999999874 456889999999999999999999998532211 000011000
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
..........+..+.+++.+||+.+|++||++.+++..
T Consensus 230 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 230 -----DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -----CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00011122345678999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=296.83 Aligned_cols=264 Identities=23% Similarity=0.350 Sum_probs=199.7
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEeccc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 373 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 373 (619)
+|+..+.||+|++|.||+|... +|+.||||.+...........+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999975 689999999875444445567788999999999999999999999999999999999
Q ss_pred ccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCc
Q 007073 374 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 453 (619)
Q Consensus 374 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 453 (619)
++ +|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 78777765332 34589999999999999999999999 999999999999999999999999999976533211
Q ss_pred ceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh--hcccchhc-
Q 007073 454 NVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER--EKRLDAIV- 529 (619)
Q Consensus 454 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~- 529 (619)
......++..|+|||.+.+. .++.++||||||+++|||+||+.||........ .......... ......+.
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ----LLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH----HHHHHHHhCCCChhhHHHHhc
Confidence 12234578899999988654 578999999999999999999999865432111 0010000000 00000000
Q ss_pred ----ccccc-------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 530 ----DRNLN-------KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 530 ----~~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..... ....+..+..+.+++.+|++.||++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 0011223467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=309.22 Aligned_cols=246 Identities=23% Similarity=0.341 Sum_probs=198.2
Q ss_pred ccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccchhh
Q 007073 301 VLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVA 379 (619)
Q Consensus 301 ~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 379 (619)
+||+|.||+||.|++. +..++|||-+....+ ...+.+..|+.+-++++|.|||+++|.+.+++...+.||-++||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds-r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS-REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccc-hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 6999999999999975 466799998875443 34566788999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-CCCcEEEcccccceeeccCCcceeee
Q 007073 380 YRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD-EDFEAVVGDFGLAKLVDVRKTNVTTQ 458 (619)
Q Consensus 380 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~ 458 (619)
..++..-. .-.-...+.-.+..||.+||.|||+. .|||||||-+|||++ -.|.+||+|||.++.+..- ...+..
T Consensus 661 sLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TET 735 (1226)
T KOG4279|consen 661 SLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTET 735 (1226)
T ss_pred HHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-Cccccc
Confidence 99986432 11236677788899999999999999 999999999999996 5789999999999877432 223445
Q ss_pred ccccccccccccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCC
Q 007073 459 VRGTMGHIAPEYLSTGK--SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKN 536 (619)
Q Consensus 459 ~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 536 (619)
+.||.-|||||++..++ |+.++|||||||++.||.||++||.....+.. . +..-+- =..-++
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA------A----MFkVGm------yKvHP~ 799 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA------A----MFKVGM------YKVHPP 799 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH------h----hhhhcc------eecCCC
Confidence 67999999999997654 89999999999999999999999964322110 0 000000 011234
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 537 YNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 537 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.+...+++...++.+|+..||.+||+++++++
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 56777889999999999999999999999984
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=293.00 Aligned_cols=250 Identities=20% Similarity=0.331 Sum_probs=200.3
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
+|+..+.||+|+||.||+|... +|..||+|.+.... .....+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999975 58899999986432 223456788999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-cEEEcccccceeeccC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-EAVVGDFGLAKLVDVR 451 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~ 451 (619)
+++++|.+++.... ...+++..+..++.|+++||+|||+. +++|+||||+||++++++ .+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999987532 23478999999999999999999999 999999999999999885 5699999999866432
Q ss_pred CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (619)
.. ......|++.|+|||...+..++.++||||||+++|||++|+.||..... .+....... ... .
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~-~~~----~- 220 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL--------HQLVLKICQ-GYF----A- 220 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHhc-ccC----C-
Confidence 22 22234588999999999888899999999999999999999999863221 111111111 011 0
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 532 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
...+.....+.+++.+||+.+|++|||+.++++
T Consensus 221 ----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 221 ----PISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111223457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=297.05 Aligned_cols=250 Identities=21% Similarity=0.313 Sum_probs=201.0
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
++|...+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc-cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 57888899999999999999864 6889999988532 233456788999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++++|.+++... .+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 9999999988642 367888999999999999999999 99999999999999999999999999987654332
Q ss_pred cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
. ......|++.|+|||.+.+..++.++||||||+++|++++|+.||........ . ..... .+.
T Consensus 170 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~----~----~~~~~--------~~~ 232 (293)
T cd06647 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----L----YLIAT--------NGT 232 (293)
T ss_pred c-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh----e----eehhc--------CCC
Confidence 2 22234588899999999888899999999999999999999999964321100 0 00000 000
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
............+.+++.+||+.+|++||++.+++..
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001122334578899999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=296.48 Aligned_cols=252 Identities=22% Similarity=0.338 Sum_probs=203.6
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
.++.|+..+.||+|+||.||+|.+. ++..||+|.+..... ..+.+..|+++++.++|+|++++++++......++|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 4566888899999999999999976 689999999864332 4677889999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 9999999999998743 3589999999999999999999998 999999999999999999999999999875543
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
... ......++..|+|||.+.+..++.++||||||+++|+|+||+.||...... ........ ......
T Consensus 169 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--------~~~~~~~~-~~~~~~-- 236 (286)
T cd06614 169 EKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--------RALFLITT-KGIPPL-- 236 (286)
T ss_pred chh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHh-cCCCCC--
Confidence 221 122335788999999998888999999999999999999999998632211 00011100 000000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
......+..+.+++.+|++.+|.+||++.++++
T Consensus 237 -----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 237 -----KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred -----cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 011123467899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=295.91 Aligned_cols=262 Identities=22% Similarity=0.296 Sum_probs=197.0
Q ss_pred CcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEeccc
Q 007073 296 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 373 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 373 (619)
|+..+.||+|++|.||+|... +|+.||+|++.... .......+.+|+++++.++|||++++++++...+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999964 79999999986432 2233467889999999999999999999999999999999999
Q ss_pred ccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCc
Q 007073 374 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 453 (619)
Q Consensus 374 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 453 (619)
+ ++|.+++..... ..+++..+.+++.|+++||+|||++ +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 688888865432 3489999999999999999999999 999999999999999999999999999976543221
Q ss_pred ceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc--------c
Q 007073 454 NVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK--------R 524 (619)
Q Consensus 454 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------~ 524 (619)
. .....++..|+|||.+.+. .++.++||||||+++|||+||+.||....... ............. .
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID----QLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCChHHhhhhhh
Confidence 1 2223468899999988654 57899999999999999999999986432211 1111111100000 0
Q ss_pred cchh---cccc---ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 525 LDAI---VDRN---LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 525 ~~~~---~~~~---l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
+.+. .... ......+.....+.+++.+|++.+|++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000 0000 000011223357889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=295.76 Aligned_cols=244 Identities=24% Similarity=0.272 Sum_probs=198.4
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++|.+.+.||+|+||.||++... +++.||+|.++... .....+.+.+|++++++++||||+++++++......++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888899999999999999975 68999999986432 2234567889999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++++|.+++... ..++...+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 999999999998764 3488899999999999999999999 999999999999999999999999999987643
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
. .....|++.|+|||.+.+...+.++||||||+++|+|+||+.||...... ....... .+..
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~-~~~~----- 215 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI--------QIYEKIL-EGKV----- 215 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHh-cCCc-----
Confidence 3 23345889999999998888999999999999999999999998643210 1111111 0000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHH
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVV 567 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl 567 (619)
..+......+.+++.+||+.+|++|| +++|++
T Consensus 216 -----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 216 -----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred -----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 11122246788999999999999999 555554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=295.57 Aligned_cols=266 Identities=20% Similarity=0.250 Sum_probs=196.1
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC-cchHHHHHHHHHHHHHcc-CCCccceeeeeeCCCc-----
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTE----- 365 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~----- 365 (619)
++|+..+.||+|+||.||+|... +|+.||+|....... ......+.+|+.+++++. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999965 689999998764322 223467888999999995 6999999999877665
Q ss_pred ceeEecccccchhhhhhcccCCC-CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-CCcEEEcccc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPG-EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-DFEAVVGDFG 443 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG 443 (619)
.++||||+++ ++..++...... ...+++.....++.|++.||.|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 787777654322 34589999999999999999999999 9999999999999998 8999999999
Q ss_pred cceeeccCCcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh
Q 007073 444 LAKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 522 (619)
Q Consensus 444 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 522 (619)
++........ ......+++.|+|||.+.+ ..++.++||||||+++|||+||+.||....... ...........+
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~----~~~~~~~~~~~~ 231 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ----QLLHIFKLLGTP 231 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHHHhCCC
Confidence 9986533221 1222346888999998865 457999999999999999999999986432111 011111110000
Q ss_pred cc--cchh---cc----cccc----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 523 KR--LDAI---VD----RNLN----KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 523 ~~--~~~~---~~----~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.. .... .+ +... ....+.....+.+++.+|++.+|++||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0000 00 0000 0001234467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=294.69 Aligned_cols=262 Identities=22% Similarity=0.307 Sum_probs=198.0
Q ss_pred CcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCC--CcceeEec
Q 007073 296 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERLLVYP 371 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e 371 (619)
|++.+.||+|+||.||+|... +|+.+|+|++.... .......+.+|++++++++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999976 58999999997543 233456788999999999999999999999887 78999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++ +|..++.... ..+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9985 7877776532 3588999999999999999999999 9999999999999999999999999999877544
Q ss_pred CcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh--hcccchh
Q 007073 452 KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER--EKRLDAI 528 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 528 (619)
.........++..|+|||.+.+ ..++.++||||||+++|||+||+.||....... ........... .......
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE----QLEKIFELCGSPTDENWPGV 229 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCchhhcccc
Confidence 3222333456889999998765 457999999999999999999999986433211 01111110000 0000000
Q ss_pred --------------ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 529 --------------VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 529 --------------~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
....+...+....+..+.+++.+||+.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000001112567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=297.37 Aligned_cols=245 Identities=21% Similarity=0.276 Sum_probs=195.8
Q ss_pred ccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccc
Q 007073 298 EKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL 376 (619)
Q Consensus 298 ~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 376 (619)
....||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|+||++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 3457999999999999964 68999999985432 334567889999999999999999999999999999999999999
Q ss_pred hhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCccee
Q 007073 377 SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 456 (619)
Q Consensus 377 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 456 (619)
+|...+.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........ ..
T Consensus 104 ~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~ 174 (297)
T cd06659 104 ALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KR 174 (297)
T ss_pred CHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cc
Confidence 99887754 2378899999999999999999999 999999999999999999999999999875543221 22
Q ss_pred eeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCC
Q 007073 457 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKN 536 (619)
Q Consensus 457 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 536 (619)
....|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ......... .. ... .
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~-~~-----~~~--~ 238 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--------QAMKRLRDS-PP-----PKL--K 238 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhcc-CC-----CCc--c
Confidence 3356899999999999889999999999999999999999998642211 111111100 00 000 0
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 537 YNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 537 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
........+.+++.+|++.+|++||++.++++
T Consensus 239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 239 NAHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 01122356889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=291.43 Aligned_cols=243 Identities=22% Similarity=0.285 Sum_probs=194.9
Q ss_pred cccCCCceEEEEEeC-CCcEEEEEEeccCCC--cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccchh
Q 007073 302 LGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV 378 (619)
Q Consensus 302 lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 378 (619)
||.|+||.||++... +++.||+|.+..... ....+.+.+|+.+++.++||||+++++++..+...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 489999999864332 23457789999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcceeee
Q 007073 379 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 458 (619)
Q Consensus 379 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 458 (619)
.+++.... .++...+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDRG----LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 99997632 378889999999999999999998 99999999999999999999999999998765432 2223
Q ss_pred ccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCC
Q 007073 459 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 538 (619)
Q Consensus 459 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 538 (619)
..|+..|+|||.+.+..++.++|+||||+++|||++|+.||.....+ . ....... ........++
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~---~~~~~~~---------~~~~~~~~~~ 216 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED---P---MEIYNDI---------LKGNGKLEFP 216 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC---H---HHHHHHH---------hccCCCCCCC
Confidence 46788999999998888999999999999999999999999653310 0 1111111 1101111122
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007073 539 IQEVETMIQVALLCTQASPEDRPA-----MSEVVR 568 (619)
Q Consensus 539 ~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 568 (619)
......+.+++.+||+.+|++||+ ++|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 222568999999999999999999 555543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=297.90 Aligned_cols=259 Identities=25% Similarity=0.348 Sum_probs=206.9
Q ss_pred ccCHHHHHH-HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceee
Q 007073 283 RYSWRELQL-ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIG 358 (619)
Q Consensus 283 ~~~~~el~~-~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~ 358 (619)
.+.|-|.+. ..+.|+.-++||+|+||.||-+..+ +|+.+|.|++.+.. ...+..-.+.|-.|+.++..+.||.+--
T Consensus 173 QWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaY 252 (591)
T KOG0986|consen 173 QWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAY 252 (591)
T ss_pred HHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEee
Confidence 344445543 4456888899999999999999965 79999999885322 2334556778999999999999999998
Q ss_pred eeeCCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 007073 359 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV 438 (619)
Q Consensus 359 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 438 (619)
.+.+++..++|+..|.||+|..++.+... ..++...+.-++.+|+.||++||.. +||.||+||+|||+|+.|+++
T Consensus 253 AfeTkd~LClVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvR 327 (591)
T KOG0986|consen 253 AFETKDALCLVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVR 327 (591)
T ss_pred eecCCCceEEEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeE
Confidence 99999999999999999999999987543 5599999999999999999999999 999999999999999999999
Q ss_pred EcccccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH
Q 007073 439 VGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 518 (619)
Q Consensus 439 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 518 (619)
|+|.|+|..+..... ....+||.+|||||++++..|+...|.||+||++|||+.|+.||..... +
T Consensus 328 ISDLGLAvei~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke-------------K 392 (591)
T KOG0986|consen 328 ISDLGLAVEIPEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE-------------K 392 (591)
T ss_pred eeccceEEecCCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh-------------h
Confidence 999999998765443 3344799999999999999999999999999999999999999953211 0
Q ss_pred HhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 007073 519 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAM 563 (619)
Q Consensus 519 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 563 (619)
...++.-..+.. ....++...+++..++....+++||++|-..
T Consensus 393 vk~eEvdrr~~~--~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 393 VKREEVDRRTLE--DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hhHHHHHHHHhc--chhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 000000000010 0123445666788888889999999998543
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=289.24 Aligned_cols=252 Identities=21% Similarity=0.317 Sum_probs=206.4
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC-cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
+|...+.||+|+||.||++... +++.||+|++..... ....+.+.+|+++++.++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999975 689999999864332 24567788999999999999999999999988999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++++|.+.+.........+++.....++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999987544446689999999999999999999999 99999999999999999999999999998765432
Q ss_pred cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
.......|++.|+|||...+..++.++||||+|+++|+|++|+.||...... +........ ..
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~-~~------- 220 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL--------ELALKILKG-QY------- 220 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH--------HHHHHHhcC-CC-------
Confidence 2233346888999999998888999999999999999999999998643211 111111110 01
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
...+......+.+++.+||+.+|++||++.++++
T Consensus 221 --~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 221 --PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1112233467899999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=295.16 Aligned_cols=260 Identities=17% Similarity=0.193 Sum_probs=180.6
Q ss_pred HhcCCcccCccccCCCceEEEEEeCC----CcEEEEEEeccCCCcchH----------HHHHHHHHHHHHccCCCcccee
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGD----------AAFQREVEMISVAVHRNLLRLI 357 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~~~~----------~~~~~E~~~l~~l~H~niv~l~ 357 (619)
..++|.+.++||+|+||+||+|...+ +..+|+|........... .....+...+..+.|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 34679999999999999999999754 345666653221111101 1112233345567899999999
Q ss_pred eeeeCCC----cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC
Q 007073 358 GFCTTPT----ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE 433 (619)
Q Consensus 358 ~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 433 (619)
+++.... ..+++++++.. ++.+.+... ...++.....++.|++.||+|||++ +|+||||||+|||++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDG 161 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC
Confidence 9765443 23556666543 444444332 1246777889999999999999999 9999999999999999
Q ss_pred CCcEEEcccccceeeccCCcc------eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccc
Q 007073 434 DFEAVVGDFGLAKLVDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE 507 (619)
Q Consensus 434 ~~~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~ 507 (619)
++.++|+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 999999999999876432211 11234699999999999999999999999999999999999999975422111
Q ss_pred c-chhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007073 508 D-DVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571 (619)
Q Consensus 508 ~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 571 (619)
. .....++...... +... ....+..+.+++..|++.+|++||++.++.+.|+
T Consensus 242 ~~~~~~~~~~~~~~~---------~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKCDFIKRLHE---------GKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHHHHHHHhhh---------hhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0 0000111111111 1100 1112367899999999999999999999998763
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=321.00 Aligned_cols=272 Identities=19% Similarity=0.242 Sum_probs=187.6
Q ss_pred HhcCCcccCccccCCCceEEEEEeCC--CcEEEEEEe--------------cc--CCCcchHHHHHHHHHHHHHccCCCc
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLAD--GTKVAVKRL--------------TD--FESPGGDAAFQREVEMISVAVHRNL 353 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~~--g~~vAvK~l--------------~~--~~~~~~~~~~~~E~~~l~~l~H~ni 353 (619)
..++|++.+.||+|+||+||++..+. +..++.|.+ .+ .........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35689999999999999999987532 222222211 00 0112234568899999999999999
Q ss_pred cceeeeeeCCCcceeEecccccchhhhhhcccC-CCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC
Q 007073 354 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIK-PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD 432 (619)
Q Consensus 354 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 432 (619)
+++++++...+..++|++++.+ ++..++.... .............++.|++.||+|||++ +|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 9999999999999999999864 5555554321 1112234556778999999999999999 999999999999999
Q ss_pred CCCcEEEcccccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhH
Q 007073 433 EDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL 512 (619)
Q Consensus 433 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~ 512 (619)
.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|+.++...... .....+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~-~~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG-KPGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC-CHHHHH
Confidence 9999999999999877544333334467999999999999999999999999999999999987543221110 111111
Q ss_pred HHHHHHHhh--hc------ccchhcccc-c---cCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 513 LDHVKKLER--EK------RLDAIVDRN-L---NKNY-----NIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 513 ~~~~~~~~~--~~------~~~~~~~~~-l---~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
......... .. .+...++.. . .... ......++.+++.+|++.||++|||+.|+++
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 111111000 00 000000000 0 0000 0012245678899999999999999999985
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=293.96 Aligned_cols=248 Identities=24% Similarity=0.277 Sum_probs=201.4
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
+|++.+.||+|+||.||+|... +++.||+|.+.... .....+.+.+|++++++++||||+++++++..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999975 68999999986432 22356788999999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++++|.+++... ..++......++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999998763 3478889999999999999999999 9999999999999999999999999998865433
Q ss_pred CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (619)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||....... ..........
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~--------- 216 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI------RDQIRAKQET--------- 216 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH------HHHHHHHhcc---------
Confidence 2 2233458889999999988889999999999999999999999997543210 1111111100
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCH--HHHH
Q 007073 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPAM--SEVV 567 (619)
Q Consensus 532 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~--~evl 567 (619)
.....+...+..+.+++.+||+.||.+||++ +|++
T Consensus 217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0111222334688999999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=298.26 Aligned_cols=270 Identities=20% Similarity=0.285 Sum_probs=196.7
Q ss_pred CCcccCccccCCCceEEEEEeC---CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCC--Ccce
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA---DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERL 367 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~---~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 367 (619)
+|.+.+.||+|+||.||+|... +++.||+|.+.... .......+.+|+.++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4777889999999999999975 47899999987532 123346678899999999999999999999887 7789
Q ss_pred eEecccccchhhhhhcccCC-CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC----CCcEEEccc
Q 007073 368 LVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE----DFEAVVGDF 442 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Df 442 (619)
+||||+++ ++.+.+..... ....++......++.|++.||+|||++ +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 56555543322 223688899999999999999999999 9999999999999999 899999999
Q ss_pred ccceeeccCCc--ceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccc-----hhHHH
Q 007073 443 GLAKLVDVRKT--NVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD-----VLLLD 514 (619)
Q Consensus 443 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~-----~~~~~ 514 (619)
|+++....... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||.......... ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 122334678899999988664 57999999999999999999999997543322000 00001
Q ss_pred HHHHHhhh-----------cccchhccccccCCCC---------H--HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 515 HVKKLERE-----------KRLDAIVDRNLNKNYN---------I--QEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 515 ~~~~~~~~-----------~~~~~~~~~~l~~~~~---------~--~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.+..+... .......+......+. . .....+.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11100000 0000000000000000 0 23357889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=305.34 Aligned_cols=263 Identities=20% Similarity=0.335 Sum_probs=196.2
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCC-----Ccc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-----TER 366 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~ 366 (619)
.++|.+.+.||+|+||.||+|... +|+.||+|.+...........+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467999999999999999999964 68999999986544444556788999999999999999999987544 347
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
++|+||+.+ ++...+.. ..+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 899999975 67666643 2488899999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCcc--eeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh---
Q 007073 447 LVDVRKTN--VTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE--- 520 (619)
Q Consensus 447 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 520 (619)
........ ......|+..|+|||.+.+ ..++.++|||||||++|+|+||+.||....... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-----~~~~~~~~~~~~ 229 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-----QLNLILGVLGTP 229 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHcCCC
Confidence 65432221 1223468899999998754 568999999999999999999999996432110 000000000
Q ss_pred hhcccchhcccc-------cc--CC-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 521 REKRLDAIVDRN-------LN--KN-----YNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 521 ~~~~~~~~~~~~-------l~--~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
..+....+.+.. .. .. ..+.....+.+++.+||+.+|++|||+.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000000 00 00 011234678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=286.65 Aligned_cols=249 Identities=26% Similarity=0.383 Sum_probs=202.7
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEeccc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 373 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 373 (619)
+|+..+.||+|++|.||++... +++.+++|++..... .....+.+|++++++++|+|++++++++......++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 4677889999999999999975 689999999865432 45678999999999999999999999999999999999999
Q ss_pred ccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCc
Q 007073 374 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 453 (619)
Q Consensus 374 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 453 (619)
++++|.+++.... ..+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 80 SGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 9999999887642 3489999999999999999999998 999999999999999999999999999987654332
Q ss_pred ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccc
Q 007073 454 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 533 (619)
Q Consensus 454 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 533 (619)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ........ ........
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~-~~~~~~~~--- 219 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--------KALFKIAT-NGPPGLRN--- 219 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--------HHHHHHHh-cCCCCcCc---
Confidence 23446889999999998888999999999999999999999998643210 00001100 11111111
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 534 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 534 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.......+.+++.+||+.||++|||+.++++
T Consensus 220 ----~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 ----PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ----ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1112467899999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=289.90 Aligned_cols=250 Identities=22% Similarity=0.307 Sum_probs=196.7
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccC----CCcchHHHHHHHHHHHHHccCCCccceeeeeeCC--Ccc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF----ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TER 366 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~----~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 366 (619)
.+|.+.+.||+|+||.||+|... +|+.||+|.+... ........+.+|++++++++|+||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47888999999999999999964 6899999987532 1223456788999999999999999999998764 347
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
++++||+++++|.+++.... .+++....+++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 78999999999999887532 377888899999999999999999 99999999999999999999999999998
Q ss_pred eeccCC--cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 447 LVDVRK--TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 447 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
...... ........|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ..+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~---- 222 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--------AAIFKIA---- 222 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--------HHHHHHH----
Confidence 653211 11122345889999999998888999999999999999999999998632110 0111111
Q ss_pred cchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 525 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
........+......+.+++.+|++ +|..||+..+++.
T Consensus 223 -----~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 223 -----TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -----cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0111112233445678999999999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=292.76 Aligned_cols=258 Identities=19% Similarity=0.226 Sum_probs=192.7
Q ss_pred CcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc-CCCccceeeeeeCC--CcceeEec
Q 007073 296 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTP--TERLLVYP 371 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lv~e 371 (619)
|++.+.||+|+||.||+|... +++.||+|+++............+|+.++.++. |+|++++++++... +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566789999999999999964 689999999875433333344567888888885 99999999999877 78999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++ ++.+.+.... ..+++..+..++.|++.||+|||+. +++||||+|+||+++. +.+||+|||+++.....
T Consensus 81 ~~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMDM-NLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCCc-cHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 9974 7777776432 3489999999999999999999999 9999999999999999 99999999999866433
Q ss_pred CcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh---------
Q 007073 452 KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER--------- 521 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 521 (619)
.. .....++..|+|||.+.. ..++.++|||||||++|||++|+.||....... ..........
T Consensus 153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07831 153 PP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD-----QIAKIHDVLGTPDAEVLKK 225 (282)
T ss_pred CC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH-----HHHHHHHHcCCCCHHHHHh
Confidence 22 223457889999997654 557899999999999999999999996432211 1111111000
Q ss_pred --hcccchhcccccc----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 522 --EKRLDAIVDRNLN----KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 522 --~~~~~~~~~~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.........+... .......+..+.+++.+||+.+|++||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000000000000 0001234578999999999999999999999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=322.24 Aligned_cols=256 Identities=25% Similarity=0.341 Sum_probs=186.4
Q ss_pred HHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCC----
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT---- 364 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 364 (619)
..-..+|+..++||+||||.||+++.+ ||+.||||++.-..+........+|+..+++++|||||+++..+.+..
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 345677888999999999999999976 899999999975545556677889999999999999999875431110
Q ss_pred --------------------------------------------------------------------------------
Q 007073 365 -------------------------------------------------------------------------------- 364 (619)
Q Consensus 365 -------------------------------------------------------------------------------- 364 (619)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -----------------------------------cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHH
Q 007073 365 -----------------------------------ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 409 (619)
Q Consensus 365 -----------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~ 409 (619)
..|+-||||+..++.+.++...-.. .....++++.+|++||+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLA 711 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHH
Confidence 0134456666655555555422111 35567889999999999
Q ss_pred HHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec-----------------cCCcceeeecccccccccccccc
Q 007073 410 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD-----------------VRKTNVTTQVRGTMGHIAPEYLS 472 (619)
Q Consensus 410 ~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~ 472 (619)
|+|+. |||||||||.||++|++..|||+|||+|+... .......+..+||.-|+|||++.
T Consensus 712 YIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 99999 99999999999999999999999999998721 01111334567999999999997
Q ss_pred CC---CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHH
Q 007073 473 TG---KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVA 549 (619)
Q Consensus 473 ~~---~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~ 549 (619)
+. .|+.|+|+||+|||++||+. ||..... . ......+. .+.+..- ..+.......=.+++
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME----R---a~iL~~LR-~g~iP~~------~~f~~~~~~~e~slI 851 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME----R---ASILTNLR-KGSIPEP------ADFFDPEHPEEASLI 851 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc---cCCchHH----H---HHHHHhcc-cCCCCCC------cccccccchHHHHHH
Confidence 64 49999999999999999985 5543211 0 11111111 1111110 112233344557899
Q ss_pred HhccCCCCCCCCCHHHHHH
Q 007073 550 LLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 550 ~~Cl~~dP~~RPs~~evl~ 568 (619)
.++++.||++|||+.|++.
T Consensus 852 ~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 852 RWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHhcCCCccCCCHHHHhh
Confidence 9999999999999999885
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=303.71 Aligned_cols=196 Identities=24% Similarity=0.303 Sum_probs=170.0
Q ss_pred CCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc-C-----CCccceeeeeeCCCcce
Q 007073 295 NFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-H-----RNLLRLIGFCTTPTERL 367 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~~~~~~~~~~~ 367 (619)
+|++.++||+|+||.|-+|.. ++++.||||++++. +.-..+-..|+.+|..++ | -|+|++++++.-.++.+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~--k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK--KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC--hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 789999999999999999996 46999999999753 334456677999999887 4 48999999999999999
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC--CcEEEcccccc
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED--FEAVVGDFGLA 445 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfGla 445 (619)
+|+|.+.. +|.++++...-.+ ++....+.++.||+.||.+||+. +|||+||||+|||+.+. ..+||+|||.|
T Consensus 265 iVfELL~~-NLYellK~n~f~G--lsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 265 IVFELLST-NLYELLKNNKFRG--LSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeehhhhh-hHHHHHHhcCCCC--CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccc
Confidence 99999865 9999998765433 89999999999999999999999 99999999999999754 47999999999
Q ss_pred eeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 007073 446 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 502 (619)
Q Consensus 446 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~ 502 (619)
+...... ..+..+..|.|||++.+.+|+.+.||||||||+.||+||.+-|...
T Consensus 339 c~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 339 CFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred cccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 8654321 2456788999999999999999999999999999999998877654
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=295.50 Aligned_cols=254 Identities=23% Similarity=0.375 Sum_probs=194.7
Q ss_pred HhcCCcccCccccCCCceEEEEEeCC-CcEEEEEEeccCCCcchHHHHHHHHHHHHHcc-CCCccceeeeeeCCCcceeE
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv 369 (619)
..++|++.+.||+|+||.||+|.+.+ ++.||||+++..........+..|+.++.+.. |+||+++++++......+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34667888999999999999999864 89999999975544445566777888776665 99999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
|||+.+ ++.+...... ..+++..+.+++.|++.||+|||+ . +|+||||+|+||++++++.+||+|||++..+
T Consensus 93 ~e~~~~-~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 93 MELMST-CLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred eeccCc-CHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 999864 5655554422 258889999999999999999997 5 8999999999999999999999999998765
Q ss_pred ccCCcceeeeccccccccccccccCCC----CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYLSTGK----SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
..... .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... .+.........
T Consensus 166 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~- 235 (296)
T cd06618 166 VDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-------FEVLTKILQEE- 235 (296)
T ss_pred cCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-------HHHHHHHhcCC-
Confidence 43222 22334788999999987554 789999999999999999999998632110 01111111110
Q ss_pred cchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 525 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
... .. .......++.+++.+||+.||++||++.++++.
T Consensus 236 ~~~-----~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 236 PPS-----LP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCC-----CC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 00 011234578999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=292.66 Aligned_cols=247 Identities=21% Similarity=0.286 Sum_probs=197.6
Q ss_pred CcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccc
Q 007073 296 FSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQ 374 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 374 (619)
|...+.||+|++|.||++.. .+++.+|+|++... .....+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc-chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 44457899999999999996 47899999988532 23345668899999999999999999999999999999999999
Q ss_pred cchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcc
Q 007073 375 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 454 (619)
Q Consensus 375 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 454 (619)
+++|.+++.. ..+++..+..++.|++.|++|||++ +++||||+|+||+++.++.++|+|||.+........
T Consensus 100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~- 170 (285)
T cd06648 100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP- 170 (285)
T ss_pred CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence 9999998875 2378889999999999999999999 999999999999999999999999998875533221
Q ss_pred eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcccccc
Q 007073 455 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN 534 (619)
Q Consensus 455 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 534 (619)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... .......... .. +...
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--------~~~~~~~~~~-~~-----~~~~ 236 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--------LQAMKRIRDN-LP-----PKLK 236 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHHHhc-CC-----CCCc
Confidence 22234588999999999888899999999999999999999999864221 1111111111 00 0000
Q ss_pred CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 535 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 535 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.....+..+.+++.+||+.+|++||++.++++
T Consensus 237 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 --NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred --ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 01123457899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=285.73 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=204.5
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC-cchHHHHHHHHHHHHHccCCCccceeeeeeCC--CcceeEe
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERLLVY 370 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 370 (619)
+|...+.||+|++|.||+|... +++.|++|.+..... ....+.+.+|++++++++|+||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999976 789999999864332 24567889999999999999999999999888 7889999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++++|.+++.... .+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999999987643 589999999999999999999998 999999999999999999999999999987754
Q ss_pred CCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 451 RKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 451 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
.... ......++..|+|||.+.+...+.++||||||+++|+|++|+.||..... ..........
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~-------- 218 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-------PMAALYKIGS-------- 218 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHHHhccc--------
Confidence 4321 12334588899999999888899999999999999999999999865330 0111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.......+...+..+.+++.+|++.+|++||++.+++.
T Consensus 219 -~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 219 -SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred -cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11111223333578999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=295.03 Aligned_cols=265 Identities=23% Similarity=0.295 Sum_probs=197.7
Q ss_pred HHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCC----
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT---- 364 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 364 (619)
...++|++.+.||+|+||.||+|..+ +|+.||+|+++... .......+.+|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999975 68999999986432 2334457788999999999999999999987654
Q ss_pred ------cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 007073 365 ------ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV 438 (619)
Q Consensus 365 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 438 (619)
..++|+||+++ ++...+... ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 68899999986 555555542 23489999999999999999999999 999999999999999999999
Q ss_pred EcccccceeeccCCcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHH
Q 007073 439 VGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 517 (619)
Q Consensus 439 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 517 (619)
|+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .....+.
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-----~~~~~~~ 231 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-----AQLELIS 231 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHH
Confidence 99999998765433222233346788999998865 45789999999999999999999998643211 1111111
Q ss_pred HHhh---hcccchhcc--------------ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 518 KLER---EKRLDAIVD--------------RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 518 ~~~~---~~~~~~~~~--------------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.... ......+.. +..... ....+..+.+++.+||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHhCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1100 000000000 000000 0112467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=300.32 Aligned_cols=265 Identities=19% Similarity=0.269 Sum_probs=196.8
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccC-CCcchHHHHHHHHHHHHHccCCCccceeeeeeCC------
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF-ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------ 363 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 363 (619)
..++|+..+.||+|+||.||+|... +|+.||+|.+... ........+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999964 7899999998643 2233456678899999999999999999988644
Q ss_pred CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007073 364 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 443 (619)
Q Consensus 364 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 443 (619)
...++||||+.+ +|.+.+... ++......++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 346899999965 777766531 77888899999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccch----------hHH
Q 007073 444 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV----------LLL 513 (619)
Q Consensus 444 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~----------~~~ 513 (619)
+++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||........... .+.
T Consensus 164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 164 LARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred cceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9986543221 2334578899999999999999999999999999999999999864321100000 000
Q ss_pred HHHH----HHh-hhc-----ccchhccccc----cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 514 DHVK----KLE-REK-----RLDAIVDRNL----NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 514 ~~~~----~~~-~~~-----~~~~~~~~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.... ... ... .......... ...........+.+++.+|++.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 000 000 0000000000 00001233557889999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=292.24 Aligned_cols=249 Identities=24% Similarity=0.317 Sum_probs=194.1
Q ss_pred cccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccchh
Q 007073 302 LGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV 378 (619)
Q Consensus 302 lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 378 (619)
||+|+||+||++... +|+.||+|.+.... .......+..|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999864 68999999886422 223345677899999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcceeee
Q 007073 379 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 458 (619)
Q Consensus 379 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 458 (619)
.+++..... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.+...... .....
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKG 153 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccc
Confidence 999876432 3488999999999999999999999 9999999999999999999999999998765431 12233
Q ss_pred ccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCC
Q 007073 459 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 538 (619)
Q Consensus 459 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 538 (619)
..++..|+|||.+.+..++.++||||||+++|+|++|+.||......... ...... ... .....+
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~--------~~~--~~~~~~ 218 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK-----EELKRR--------TLE--MAVEYP 218 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH-----HHHHhc--------ccc--ccccCC
Confidence 45788999999998888999999999999999999999999643321110 000000 000 001122
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHH-HHHHHhc
Q 007073 539 IQEVETMIQVALLCTQASPEDRPAMSE-VVRMLEG 572 (619)
Q Consensus 539 ~~~~~~l~~l~~~Cl~~dP~~RPs~~e-vl~~L~~ 572 (619)
......+.+++.+||+.+|++||++++ ....|..
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 233567899999999999999995555 4444433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=290.79 Aligned_cols=242 Identities=25% Similarity=0.318 Sum_probs=186.2
Q ss_pred ccccCCCceEEEEEeC-CCcEEEEEEeccCCC--cchHHHHHHHHHHHH---HccCCCccceeeeeeCCCcceeEecccc
Q 007073 301 VLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMIS---VAVHRNLLRLIGFCTTPTERLLVYPFMQ 374 (619)
Q Consensus 301 ~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~---~l~H~niv~l~~~~~~~~~~~lv~e~~~ 374 (619)
+||+|+||.||++... +|+.+|+|.+..... ......+.+|..++. ..+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999974 689999998864322 222334455554444 3479999999999999999999999999
Q ss_pred cchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcc
Q 007073 375 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 454 (619)
Q Consensus 375 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 454 (619)
+|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 99999888653 2489999999999999999999999 99999999999999999999999999987553322
Q ss_pred eeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccc
Q 007073 455 VTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 533 (619)
Q Consensus 455 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 533 (619)
.....|+..|+|||.+.+ ..++.++|||||||++|||+||..||........ ......... .
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~----------~ 214 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK------HEIDRMTLT----------V 214 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH------HHHHHHhhc----------C
Confidence 123458999999999864 5589999999999999999999999964321110 001111000 0
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007073 534 NKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 568 (619)
Q Consensus 534 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 568 (619)
....+...+.++.+++.+|++.||++|| +++++++
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 1112233456789999999999999999 5887765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=295.70 Aligned_cols=248 Identities=25% Similarity=0.352 Sum_probs=195.0
Q ss_pred CcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 296 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
|...+.||+|+||.||+|... +|..||+|.+.... .......+.+|++++++++|||++++++++..+...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 666789999999999999964 68999999986432 223345788999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+.+ ++.+.+... ...+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~g-~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CLG-SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCC-CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 975 676666432 23488999999999999999999999 9999999999999999999999999998754322
Q ss_pred cceeeecccccccccccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 453 TNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
....|+..|+|||.+. .+.++.++|||||||++|||++|+.||...... ..........
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~~~~~~~------ 240 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNE------ 240 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHhcc------
Confidence 2345888999999874 456899999999999999999999998532110 0011111100
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
............+.+++.+||+.+|.+||++.++++..-.
T Consensus 241 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 241 ---SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred ---CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 0111122344578999999999999999999999975543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=292.88 Aligned_cols=257 Identities=20% Similarity=0.249 Sum_probs=201.1
Q ss_pred CCcccCccccCCCceEEEEEe----CCCcEEEEEEeccCC---CcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFE---SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTER 366 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~----~~g~~vAvK~l~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 366 (619)
+|++.+.||+|+||.||++.. .+++.||||.+++.. .....+.+.+|++++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999985 357889999986422 122345688999999999 599999999999988899
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
++||||+++|+|..++... ..+++.....++.|+++||.|||+. +++||||+|+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 9999999999999888642 2378888999999999999999999 99999999999999999999999999988
Q ss_pred eeccCCcceeeeccccccccccccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 447 LVDVRKTNVTTQVRGTMGHIAPEYLSTGK--SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 447 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
..............|+..|+|||.+.+.. .+.++||||||+++|||+||..||....... ............
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~~~~~~~~~~~-- 227 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN----SQSEISRRILKS-- 227 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc----hHHHHHHHHHcc--
Confidence 65443332233446889999999987665 7889999999999999999999985321110 011111111100
Q ss_pred cchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 525 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
. ...+......+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 228 -----~----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 -----K----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -----C----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0 011222345788999999999999999999998888764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=293.84 Aligned_cols=264 Identities=19% Similarity=0.268 Sum_probs=194.5
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC-cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
++|+..+.||+|++|+||+|... +|+.||+|.+..... ....+.+.+|++++++++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999975 689999998864322 2334678899999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-CCcEEEcccccceeecc
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-DFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~ 450 (619)
|+++ ++...+.... ...+++.....++.|++.||+|||++ +++|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLDL-DLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred cccc-cHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 9964 7777665422 22357788889999999999999999 9999999999999985 56799999999976543
Q ss_pred CCcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh--cccc-
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE--KRLD- 526 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~- 526 (619)
.. .......+++.|+|||.+.+ ..++.++||||||+++|+|+||+.||....... ...........+ ....
T Consensus 156 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 156 PV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID----ELFKIFRILGTPNEETWPG 230 (294)
T ss_pred Cc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCChhhccc
Confidence 21 11223457889999998866 457899999999999999999999986432110 111110000000 0000
Q ss_pred -----hhc--cccccC----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 527 -----AIV--DRNLNK----NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 527 -----~~~--~~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
... .+.... ...+.....+.+++.+|++.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 000000 001223456889999999999999999999985
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=289.25 Aligned_cols=247 Identities=22% Similarity=0.307 Sum_probs=196.7
Q ss_pred cccCCCceEEEEEeC-CCcEEEEEEeccCCC--cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccchh
Q 007073 302 LGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV 378 (619)
Q Consensus 302 lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 378 (619)
||+|+||.||++... +|+.+|+|.+..... ....+.+.+|++++++++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 499999999864321 23456788999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCc-----
Q 007073 379 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT----- 453 (619)
Q Consensus 379 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~----- 453 (619)
.+++.... .+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99987533 488999999999999999999999 999999999999999999999999999876533211
Q ss_pred --ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccc
Q 007073 454 --NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531 (619)
Q Consensus 454 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (619)
.......++..|+|||.......+.++||||||+++||++||+.||...... ........ +..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~-~~~------ 218 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE--------EIFQNILN-GKI------ 218 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhc-CCc------
Confidence 1223345788999999998888999999999999999999999998643211 11111111 000
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 532 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
........+..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 219 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 219 --EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred --CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 000001124678999999999999999999777666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=305.07 Aligned_cols=258 Identities=22% Similarity=0.252 Sum_probs=198.9
Q ss_pred CcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCC------ccee
Q 007073 296 FSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT------ERLL 368 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~l 368 (619)
+...+.||+|+||.||+|+. .+|+.||||.++........+.+.+|++++++++|+|||+++++-.+.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 45567899999999999995 5799999999987766777889999999999999999999998765543 5789
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC----CCCcEEEccccc
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD----EDFEAVVGDFGL 444 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~----~~~~~kl~DfGl 444 (619)
|||||.+|||...|+.-. +..-++..+.+.+..+++.||.|||++ +|+||||||.||++- ....-||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 999999999999998743 345599999999999999999999999 999999999999983 333569999999
Q ss_pred ceeeccCCcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007073 445 AKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 523 (619)
Q Consensus 445 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (619)
|+.++... .....+||..|.+||.+.. +.|+..+|.|||||++||..||..||-...-+... ....|......+.
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~--~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNN--KEIMWHIITKKPS 246 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcccc--chhhhhhhccCCC
Confidence 99876443 5667889999999999984 88999999999999999999999999643322111 0111111111111
Q ss_pred ccchhccccc------------cCCCCHHHHHHHHHHHHhccCCCCCCCC
Q 007073 524 RLDAIVDRNL------------NKNYNIQEVETMIQVALLCTQASPEDRP 561 (619)
Q Consensus 524 ~~~~~~~~~l------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 561 (619)
.......+.. ...........+.+.+..++..+|++|-
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1111111111 1122355556777788888888998887
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=297.64 Aligned_cols=260 Identities=23% Similarity=0.293 Sum_probs=191.9
Q ss_pred CccccC--CCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEeccccc
Q 007073 300 NVLGQG--GFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 375 (619)
Q Consensus 300 ~~lg~G--~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 375 (619)
..||+| +||+||++.+. +|+.||+|.+.... .....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456766 89999999974 79999999986433 233457788999999999999999999999999999999999999
Q ss_pred chhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcce
Q 007073 376 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455 (619)
Q Consensus 376 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 455 (619)
+++.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999998876432 2378888899999999999999999 99999999999999999999999998654332111100
Q ss_pred ------eeeccccccccccccccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH---------
Q 007073 456 ------TTQVRGTMGHIAPEYLSTG--KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK--------- 518 (619)
Q Consensus 456 ------~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~--------- 518 (619)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||....... ........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ----MLLQKLKGPPYSPLDIT 234 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH----HHHHHhcCCCCCCcccc
Confidence 0112346679999999763 47899999999999999999999986432110 00000000
Q ss_pred -------H----------------hhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 519 -------L----------------EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 519 -------~----------------~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. ..........+..+...........+.+++.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0 0000000011111111223345678999999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=293.77 Aligned_cols=264 Identities=23% Similarity=0.318 Sum_probs=193.0
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCc-----
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE----- 365 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 365 (619)
-++|+..+.||+|+||.||+|... +++.||||.+.... .......+.+|++++++++||||+++++++...+.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357888999999999999999975 68999999886432 22234456789999999999999999999876543
Q ss_pred ---ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007073 366 ---RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 442 (619)
Q Consensus 366 ---~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 442 (619)
.++||||+.+ ++.+.+... ...+++.....++.|++.||+|||++ +++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 4899999975 677766542 23488999999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcc---eeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH
Q 007073 443 GLAKLVDVRKTN---VTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 518 (619)
Q Consensus 443 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 518 (619)
|++......... ......++..|+|||.+.+. .++.++||||||+++|||+||+.||...... ........
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-----~~~~~~~~ 238 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-----HQLTLISQ 238 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHH
Confidence 999866432221 12234578899999988664 4789999999999999999999998643211 11111111
Q ss_pred Hhh---hcccch-----hccc-cccCCC---------CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 519 LER---EKRLDA-----IVDR-NLNKNY---------NIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 519 ~~~---~~~~~~-----~~~~-~l~~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
... ...... ..+. ...... .......+.+++.+||+.||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 239 LCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 100 000000 0000 000000 0011246679999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=292.89 Aligned_cols=264 Identities=24% Similarity=0.289 Sum_probs=194.8
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC-cchHHHHHHHHHHHHHccCCCccceeeeeeCC--Cccee
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERLL 368 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l 368 (619)
.++|++.+.||+|+||.||+|... +|+.||+|.++.... ......+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467889999999999999999975 689999999864322 22234567899999999999999999998654 45789
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||+.+ +|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999975 7777776532 3488999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh--ccc
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE--KRL 525 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 525 (619)
..... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||....... .+.........+ ...
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~----~~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 159 GLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE----QLDLIIQLLGTPNESIW 233 (309)
T ss_pred CCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcCCCChhhc
Confidence 54321 1222345788999998865 457999999999999999999999986432211 111111100000 000
Q ss_pred c---------hh-ccccccCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 526 D---------AI-VDRNLNKNY---NIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 526 ~---------~~-~~~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. .. ......... .......+.+++.+|++.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 00 000000000 0112457789999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=298.22 Aligned_cols=267 Identities=20% Similarity=0.339 Sum_probs=197.2
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccC-CCcchHHHHHHHHHHHHHc-cCCCccceeeeeeCC--Ccc
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF-ESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTP--TER 366 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~--~~~ 366 (619)
..++|++.+.||+|+||.||+|... +|+.+|+|++... ........+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888999999999999999975 6889999988542 2233445677899999999 999999999988654 357
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
++||||++ ++|..++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 89999997 4888877642 478889999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCc----ceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHH------
Q 007073 447 LVDVRKT----NVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH------ 515 (619)
Q Consensus 447 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~------ 515 (619)
....... .......|+..|+|||.+.+ ..++.++||||||+++|||+||+.||.......... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~-~~~~~~~~~~~ 234 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLE-KIIEVIGPPSA 234 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCCH
Confidence 6643322 12234568899999998765 457899999999999999999999986432211100 00000
Q ss_pred --HHHHhhhcccchhcc----cccc--CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 516 --VKKLEREKRLDAIVD----RNLN--KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 516 --~~~~~~~~~~~~~~~----~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
...... .....+++ .... ....+..+.++.+++.+||+.+|++|||+.++++.
T Consensus 235 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 235 EDIESIKS-PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHh-hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000 00000010 0000 00111235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=287.37 Aligned_cols=251 Identities=20% Similarity=0.322 Sum_probs=198.2
Q ss_pred CCcccCccccCCCceEEEEEeCC-CcEEEEEEeccCC----CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFE----SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~~-g~~vAvK~l~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
+|.+.+.||+|+||.||++.... +..+++|.++... .......+..|+.+++.++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999998653 4556666654321 223345677899999999999999999999988899999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
+||+++++|.+.+.........+++..+..++.|++.|+.|||+. +++|+||+|+||++++ +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999876555556689999999999999999999999 9999999999999976 569999999998764
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
... .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... ......... .
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--------~~~~~~~~~-~------ 220 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF--------LSVVLRIVE-G------ 220 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHc-C------
Confidence 322 222334578899999999888899999999999999999999999853211 111111110 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.....+...+.++.+++.+||+.+|++||++.++++
T Consensus 221 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 221 ---PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 011123345568899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=291.12 Aligned_cols=245 Identities=22% Similarity=0.275 Sum_probs=192.0
Q ss_pred CCcccCccccCCCceEEEEEe----CCCcEEEEEEeccCC---CcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFE---SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTER 366 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~----~~g~~vAvK~l~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 366 (619)
+|++.+.||+|+||.||++.. .+|..||+|++.... .....+.+.+|+.++.++ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477789999999999999986 368999999986422 122346778899999999 589999999999988889
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
++|+||+++++|.+++... ..+++.....++.|+++||.|||+. +++||||+|+||+++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 9999999999999998753 2378888889999999999999999 99999999999999999999999999998
Q ss_pred eeccCCcceeeeccccccccccccccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 447 LVDVRKTNVTTQVRGTMGHIAPEYLSTG--KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 447 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
..............|+..|+|||.+... .++.++||||||+++|+|+||+.||....... ............
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~----~~~~~~~~~~~~-- 227 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN----SQAEISRRILKS-- 227 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc----cHHHHHHHhhcc--
Confidence 7654333333345688999999998753 46889999999999999999999986322110 111111111100
Q ss_pred cchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCC
Q 007073 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP 561 (619)
Q Consensus 525 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 561 (619)
. ..++......+.+++.+|++.+|++||
T Consensus 228 -----~----~~~~~~~~~~~~~ll~~~l~~~p~~R~ 255 (290)
T cd05613 228 -----E----PPYPQEMSALAKDIIQRLLMKDPKKRL 255 (290)
T ss_pred -----C----CCCCccCCHHHHHHHHHHhcCCHHHhc
Confidence 0 011222345788999999999999997
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=294.96 Aligned_cols=260 Identities=22% Similarity=0.264 Sum_probs=191.0
Q ss_pred cCccccCCCceEEEEEeCCCcEEEEEEeccC-CCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccch
Q 007073 299 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDF-ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS 377 (619)
Q Consensus 299 ~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 377 (619)
.+.+|.|+++.||++.. +|+.||||++... ......+.+.+|+++++.++|+||+++++++...+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34445555555555555 6899999998754 234456789999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCc----
Q 007073 378 VAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT---- 453 (619)
Q Consensus 378 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~---- 453 (619)
|.+++..... ..++......++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 86 CEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred HHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999976432 2378888899999999999999999 999999999999999999999999999875532211
Q ss_pred --ceeeeccccccccccccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh---------
Q 007073 454 --NVTTQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE--------- 520 (619)
Q Consensus 454 --~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 520 (619)
.......++..|+|||.+.. ..++.++|||||||++|||++|+.||....... ...+......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ----MLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhccCccccccCch
Confidence 11123456788999999866 358899999999999999999999996432110 0111000000
Q ss_pred --hhcccch----hccc----cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 521 --REKRLDA----IVDR----NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 521 --~~~~~~~----~~~~----~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
....... ..+. ............++.+++.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0000000 0000 0011122344567899999999999999999999885
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=290.29 Aligned_cols=265 Identities=22% Similarity=0.253 Sum_probs=196.9
Q ss_pred CcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc-CCCccceeeeeeCCCcceeEeccc
Q 007073 296 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVYPFM 373 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~ 373 (619)
|.+.+.||+|+||+||+|... +++.||||++.............+|+..+++++ |+|++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999975 578999999865433333445567999999999 999999999999999999999999
Q ss_pred ccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCc
Q 007073 374 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 453 (619)
Q Consensus 374 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 453 (619)
+|+|.+.+.... ...+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 789988887543 23589999999999999999999999 999999999999999999999999999986643222
Q ss_pred ceeeecccccccccccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccch--------hHHHHHHHHhhhcc
Q 007073 454 NVTTQVRGTMGHIAPEYLS-TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV--------LLLDHVKKLEREKR 524 (619)
Q Consensus 454 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~--------~~~~~~~~~~~~~~ 524 (619)
.....++..|+|||.+. +..++.++|+||||+++|||+||+.||........... .-..|.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 22345788999999875 45579999999999999999999999864432111000 00001111000001
Q ss_pred cchhcccccc---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 525 LDAIVDRNLN---KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 525 ~~~~~~~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
....+..... ....+.....+.+++.+||+.+|++|||++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 1100000000 0001112467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=302.05 Aligned_cols=251 Identities=22% Similarity=0.328 Sum_probs=200.3
Q ss_pred cCCcccCccccCCCceEEEEEeCCCcEE-EEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~v-AvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
+.|+++..||.|+||.||+|..++.... |.|++ +..+....++|+-|+++|+.++||+||++++.|.-.+..++..||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvI-etkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVI-ETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhh-cccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 3455667899999999999998765554 44554 455566778999999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
|.||..+..+-+.. ..+...++..++.|++.||.|||++ .|||||||+.|||++-+|.++|+|||.+..... .
T Consensus 111 C~GGAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t 183 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-T 183 (1187)
T ss_pred cCCchHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-H
Confidence 99999998887643 4589999999999999999999999 999999999999999999999999998764321 2
Q ss_pred cceeeecccccccccccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccch
Q 007073 453 TNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (619)
......+.||+.|||||+.. ..+|+.++||||||+++.||..+.+|-..-. .....-.+... ....
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln--------pMRVllKiaKS-ePPT 254 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKS-EPPT 254 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc--------hHHHHHHHhhc-CCCc
Confidence 22345678999999999874 4679999999999999999999998854211 11111111111 1111
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 528 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
++ -+..+...+.+++..|+.+||..||++.++++
T Consensus 255 Ll-------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 255 LL-------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cc-------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 11 14566778999999999999999999999885
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=286.98 Aligned_cols=261 Identities=20% Similarity=0.272 Sum_probs=199.4
Q ss_pred CcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC-cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEeccc
Q 007073 296 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 373 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 373 (619)
|+..+.||+|++|.||+|... +|+.+|+|++..... ......+.+|++++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 556788999999999999974 789999999865432 234567889999999999999999999999999999999999
Q ss_pred ccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCc
Q 007073 374 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 453 (619)
Q Consensus 374 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 453 (619)
++ ++...+.... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 75 7877776532 3488999999999999999999999 99999999999999999999999999998765433
Q ss_pred ceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh--cccchhcc
Q 007073 454 NVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE--KRLDAIVD 530 (619)
Q Consensus 454 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 530 (619)
.......++..|+|||.+.+. .++.++||||||+++|+|+||+.||......+. ........... .......+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ----LFKIFRTLGTPDPEVWPKFTS 228 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHcCCCchHhcccchh
Confidence 122234578899999998776 789999999999999999999999864332110 00000000000 00000000
Q ss_pred -----------ccc--cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 531 -----------RNL--NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 531 -----------~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
... .....+..+..+.+++.+||+.||.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 00112234578999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=295.18 Aligned_cols=266 Identities=21% Similarity=0.284 Sum_probs=196.0
Q ss_pred HHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeC-CCcc
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT-PTER 366 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~ 366 (619)
...+++|+..+.||+|+||.||+|... +|+.||+|++.... .....+.+.+|++++++++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999965 78999999886432 23345678899999999999999999998866 4568
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
++++||+ +++|...+.. ..++......++.|+++||+|||+. +|+||||+|+||++++++.++|+|||.+.
T Consensus 86 ~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 8999998 4588777753 2367778888999999999999999 99999999999999999999999999987
Q ss_pred eeccCCcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHH--------HHH
Q 007073 447 LVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD--------HVK 517 (619)
Q Consensus 447 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~--------~~~ 517 (619)
..... .....++..|+|||.+.+ ..++.++||||||+++|||+||+.||........ .....+ +..
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ-FSIITDLLGTPPDDVIN 231 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHH
Confidence 54322 123457889999998766 5689999999999999999999999864321100 000000 000
Q ss_pred HHhhhcccchhccccccCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 518 KLEREKRLDAIVDRNLNKNYN-----IQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 518 ~~~~~~~~~~~~~~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
.............-......+ +.....+.+++.+|++.+|++||++.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000000000001 1234678999999999999999999998643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=282.66 Aligned_cols=248 Identities=23% Similarity=0.383 Sum_probs=201.7
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC-cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
+|+..+.||+|++|.||++... +++.||+|.+..... ......+.+|++++++++|+|++++++++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777899999999999999865 678999999875432 13457789999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++++|.+++... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999988754 3489999999999999999999999 99999999999999999999999999998775433
Q ss_pred cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
.. .....++..|+|||...+..++.++||||+|+++|+|++|+.||..... . ........ ...
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~---~~~~~~~~-~~~------- 216 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----M---AALFRIVQ-DDH------- 216 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----H---HHHHHHhc-cCC-------
Confidence 32 2334588899999999888889999999999999999999999863221 0 00111110 000
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
...+......+.+++.+|++.+|++||++.+++.
T Consensus 217 --~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 --PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1112223457889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=298.20 Aligned_cols=263 Identities=21% Similarity=0.319 Sum_probs=197.2
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCC----Ccc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP----TER 366 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----~~~ 366 (619)
.++|++.+.||+|+||.||+|... +|+.||+|++.... .......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888999999999999999965 69999999987532 223456778899999999999999999987543 457
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
++|+||+. ++|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 89999996 5888887642 2389999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCcc---eeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh-
Q 007073 447 LVDVRKTN---VTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER- 521 (619)
Q Consensus 447 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 521 (619)
........ ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||........ .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~-----~~~~~~~~g~ 230 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ-----LKLILSVLGS 230 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH-----HHHHHHHhCC
Confidence 66432221 1223468899999998865 4689999999999999999999999964322110 000000000
Q ss_pred ----------hcccchhcccc-ccCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 522 ----------EKRLDAIVDRN-LNKNY-----NIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 522 ----------~~~~~~~~~~~-l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
........+.. ..... .+..+..+.+++.+|++.+|++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00000000000 00000 1223578999999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=291.93 Aligned_cols=248 Identities=27% Similarity=0.342 Sum_probs=194.0
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccC--CCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.|...+.||+|+||.||+|... ++..+|+|.+... ........+.+|+++++.++|+|++++++++......++|+|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666788999999999999965 6789999988632 222334678899999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+. |++.+.+... ...+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 997 5777666532 23478899999999999999999999 9999999999999999999999999998765432
Q ss_pred Ccceeeecccccccccccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 452 KTNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
....|+..|+|||.+. ...++.++|||||||++|||++|+.||...... ..........
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~----- 230 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNE----- 230 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--------HHHHHHhhcC-----
Confidence 2345788999999874 356789999999999999999999997532110 0001111000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 571 (619)
............+.+++.+||+.+|++||++.++++.-.
T Consensus 231 ----~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 231 ----SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred ----CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 001112234467889999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=282.15 Aligned_cols=245 Identities=20% Similarity=0.228 Sum_probs=189.3
Q ss_pred HHhcCCcccCcc--ccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcc
Q 007073 291 LATDNFSEKNVL--GQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTER 366 (619)
Q Consensus 291 ~~~~~~~~~~~l--g~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 366 (619)
.-.++|++.+.+ |+|+||.||++..+ ++..+|+|......... .|+.....+ +||||+++++++..++..
T Consensus 11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 334567776666 99999999999964 68899999886422111 122222222 699999999999999999
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-cEEEcccccc
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-EAVVGDFGLA 445 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla 445 (619)
++||||+++++|.+++.... .+++.....++.|+++||.|||+. +++||||||+||+++.++ .++|+|||++
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 99999999999999987532 589999999999999999999999 999999999999999998 9999999998
Q ss_pred eeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 446 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 446 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
....... ...|+..|+|||++.+..++.++||||||+++|||+||+.||...... ......+.....
T Consensus 158 ~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~----- 224 (267)
T PHA03390 158 KIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE---ELDLESLLKRQQ----- 224 (267)
T ss_pred eecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc---hhhHHHHHHhhc-----
Confidence 8654321 235889999999999989999999999999999999999999743221 111111111110
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-MSEVVR 568 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~ 568 (619)
.. .......+..+.+++.+|++.+|.+||+ ++++++
T Consensus 225 -----~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 -----KK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -----cc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 0112234568899999999999999996 588773
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=285.11 Aligned_cols=261 Identities=24% Similarity=0.332 Sum_probs=195.0
Q ss_pred CcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCc-chHHHHHHHHHHHHHc---cCCCccceeeeeeCCCc-----
Q 007073 296 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP-GGDAAFQREVEMISVA---VHRNLLRLIGFCTTPTE----- 365 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~----- 365 (619)
|++.+.||+|+||.||+|.++ +++.||+|+++..... .....+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999986 4899999999743322 2235566788877665 59999999999987776
Q ss_pred ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 445 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 445 (619)
.+++|||+.+ +|.+++..... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||.+
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999975 78887765332 2488999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc-
Q 007073 446 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR- 524 (619)
Q Consensus 446 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 524 (619)
........ .....++..|+|||.+.+..++.++|||||||++|||+||+.||...... ...............
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 228 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA----DQLDKIFDVIGLPSEE 228 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH----HHHHHHHHHcCCCChH
Confidence 87643322 12334788999999999999999999999999999999999888643211 111111111100000
Q ss_pred --cc------hhcccccc---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 525 --LD------AIVDRNLN---KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 525 --~~------~~~~~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.. ........ ....+.....+.+++.+||+.||++||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00 00000000 0111234567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=294.98 Aligned_cols=261 Identities=21% Similarity=0.317 Sum_probs=199.7
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC-cchHHHHHHHHHHHHHccCCCccceeeeeeCCC-----cce
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT-----ERL 367 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 367 (619)
+|.+.+.||+|+||.||+|... +|+.||+|++..... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999975 589999999875432 344577899999999999999999999987765 789
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
++|||+++ +|...+... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++..
T Consensus 81 lv~e~~~~-~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELMET-DLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchhh-hHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 99999984 788877643 2589999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCc--ceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh---
Q 007073 448 VDVRKT--NVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER--- 521 (619)
Q Consensus 448 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 521 (619)
...... .......++..|+|||.+.+. .++.++||||||+++|+|+||+.||........ .........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-----~~~i~~~~~~~~ 227 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-----LNLIVEVLGTPS 227 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-----HHHHHHhcCCCC
Confidence 654321 122334578899999999887 789999999999999999999999965432110 000000000
Q ss_pred --------hcccchhccc-ccc-----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 522 --------EKRLDAIVDR-NLN-----KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 522 --------~~~~~~~~~~-~l~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.......+.. ... ....+..+..+.+++.+||+.+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0000000000 000 0001223567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=289.69 Aligned_cols=243 Identities=21% Similarity=0.280 Sum_probs=194.3
Q ss_pred CccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccchh
Q 007073 300 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV 378 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 378 (619)
..||+|+||.||++... +|+.||||++... .......+.+|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 57999999999999874 7899999987532 234566788999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcceeee
Q 007073 379 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 458 (619)
Q Consensus 379 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 458 (619)
.+++... .+++.....++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++........ ....
T Consensus 105 ~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~ 175 (292)
T cd06657 105 TDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 175 (292)
T ss_pred HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccc
Confidence 9877532 378888999999999999999999 999999999999999999999999999876543221 2233
Q ss_pred ccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCC
Q 007073 459 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 538 (619)
Q Consensus 459 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 538 (619)
..|+..|+|||.+.+..++.++|+||||+++|||++|+.||...... ......... ....+. ..
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--------~~~~~~~~~------~~~~~~--~~ 239 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------KAMKMIRDN------LPPKLK--NL 239 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhh------CCcccC--Cc
Confidence 45889999999998888999999999999999999999998642211 111111100 000000 01
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 539 IQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 539 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
......+.+++.+||+.+|.+||++.++++
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 122356789999999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=325.61 Aligned_cols=251 Identities=26% Similarity=0.339 Sum_probs=199.0
Q ss_pred CCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
++.....||.|.||.||.|.. .+|.-.|||-++-.. .....+...+|+.++..++|||+|+++|+-...+..++.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 456678999999999999994 578999999775322 233456788999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
|++|+|.+.++.. ...++.....+..|++.|++|||++ |||||||||.||+++.+|.+|++|||.|..+....
T Consensus 1316 C~~GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred hccCcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 9999999999763 2255666667889999999999999 99999999999999999999999999999875442
Q ss_pred cc---eeeeccccccccccccccCCC---CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 453 TN---VTTQVRGTMGHIAPEYLSTGK---SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 453 ~~---~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
.. ......||+.|||||++.+.. ...+.||||+|||+.||+||++||....-+ -.+.-++. .+.
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne----~aIMy~V~----~gh-- 1458 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE----WAIMYHVA----AGH-- 1458 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch----hHHHhHHh----ccC--
Confidence 11 123467999999999997643 567899999999999999999999632211 11111111 111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
.++.+...+.+-.+++..|+..||++|.++.|+++.
T Consensus 1459 -------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 -------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 123344456678899999999999999888877653
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=284.87 Aligned_cols=246 Identities=18% Similarity=0.222 Sum_probs=189.8
Q ss_pred CccccCCCceEEEEEeC-CCcEEEEEEeccCCC--cchHHHHHHHHHHH-HHccCCCccceeeeeeCCCcceeEeccccc
Q 007073 300 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMI-SVAVHRNLLRLIGFCTTPTERLLVYPFMQN 375 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 375 (619)
+.||+|+||.||+|... +|+.||+|++..... ......+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999964 689999999864321 12223445555544 455899999999999999999999999999
Q ss_pred chhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcce
Q 007073 376 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455 (619)
Q Consensus 376 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 455 (619)
++|.+++.... .++...+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+++....
T Consensus 82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 99999987532 378888999999999999999999 999999999999999999999999999875432
Q ss_pred eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccC
Q 007073 456 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 535 (619)
Q Consensus 456 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 535 (619)
.....|+..|+|||.+.+..++.++||||||+++|||+||..||...... ........ .... ...
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~-~~~~------~~~ 214 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD--------AVFDNILS-RRIN------WPE 214 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHh-cccC------CCC
Confidence 22345888999999998888999999999999999999999998643211 11111110 0000 001
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 536 NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 536 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
......+..+.+++.+||+.+|++||++.++.+.|..
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 1112334678999999999999999988766665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=282.93 Aligned_cols=265 Identities=23% Similarity=0.334 Sum_probs=218.1
Q ss_pred HHHHHHhcCCcccCccccCCCceEEEEEeC------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeee
Q 007073 287 RELQLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 360 (619)
Q Consensus 287 ~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 360 (619)
.++.+..++++...++-+|.||.||+|.|. +.+.|-||.++...++-+...+.+|.-++....|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 567778888999999999999999999764 34568899998877887888899999999999999999999998
Q ss_pred eCC-CcceeEecccccchhhhhhcccC----CCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC
Q 007073 361 TTP-TERLLVYPFMQNLSVAYRLREIK----PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 435 (619)
Q Consensus 361 ~~~-~~~~lv~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 435 (619)
.+. ...+.+|.++.-|+|..++...+ .....++..+...++.|++.|++|||++ +|||.||.++|.+||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhhe
Confidence 664 56788899999999999998432 2234467777888999999999999999 999999999999999999
Q ss_pred cEEEcccccceeeccCCcceee-eccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHH
Q 007073 436 EAVVGDFGLAKLVDVRKTNVTT-QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLL 513 (619)
Q Consensus 436 ~~kl~DfGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~ 513 (619)
++||+|=.+++.+.+.+.+... .......||+||.+.+..|+.++|||||||++|||+| |+.|+..-.+ .
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP--------f 505 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP--------F 505 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH--------H
Confidence 9999999999987665544322 2234678999999999999999999999999999999 8899853221 2
Q ss_pred HHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 514 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
+....+..+.++.. +..++.+++.+|.-||...|++||+++|++.-|.+
T Consensus 506 Em~~ylkdGyRlaQ----------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 506 EMEHYLKDGYRLAQ----------PFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HHHHHHhccceecC----------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 23334444444332 33456789999999999999999999999998865
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=297.59 Aligned_cols=262 Identities=20% Similarity=0.300 Sum_probs=196.2
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCC-----Cc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-----TE 365 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 365 (619)
.++|.+.+.||+|+||+||+|... +|+.||||.+.... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357888999999999999999964 68999999986432 233455677899999999999999999987654 34
Q ss_pred ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 445 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 445 (619)
.++|+||+. ++|.+++... ..++......++.|++.||.|||++ +++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 789999996 5787777642 3488999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh---
Q 007073 446 KLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER--- 521 (619)
Q Consensus 446 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 521 (619)
+...... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||....... ..........
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~~~ 229 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-----QLKLITELLGSPS 229 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-----HHHHHHHHhCCCC
Confidence 8664332 22233457889999998865 468999999999999999999999996432110 0000000000
Q ss_pred --------hcccchhc-------cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 522 --------EKRLDAIV-------DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 522 --------~~~~~~~~-------~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
........ +.... ...+..+..+.+++.+|++.+|++|||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 230 EEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000000 00000 0012334678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=267.57 Aligned_cols=248 Identities=23% Similarity=0.350 Sum_probs=192.6
Q ss_pred ccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcceeEeccccc
Q 007073 298 EKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVYPFMQN 375 (619)
Q Consensus 298 ~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 375 (619)
....||.|..|.|+++.++ .|...|||.+.+.......+..+..+.++.+. ++|.||+-+||+..+....+.||.|.-
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~ 175 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST 175 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence 3567999999999999975 68999999998776666777788888876655 489999999999999999999999863
Q ss_pred chhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcce
Q 007073 376 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455 (619)
Q Consensus 376 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 455 (619)
-...++.... .++++...-++...+..||.||.+++ +|+|||+||+|||+|+.|++|++|||++-++-... .
T Consensus 176 -C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--A 247 (391)
T KOG0983|consen 176 -CAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--A 247 (391)
T ss_pred -HHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc--c
Confidence 2333343322 23777777889999999999999875 89999999999999999999999999998765433 3
Q ss_pred eeecccccccccccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 456 TTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 456 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
.+...|-+.|||||.+. ...|+.++||||||+.++||.||..||..-..+ ... ...+..++. +.
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td----Fe~---ltkvln~eP------P~ 314 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD----FEV---LTKVLNEEP------PL 314 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc----HHH---HHHHHhcCC------CC
Confidence 44557899999999985 446899999999999999999999999753221 111 111111110 11
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
+.. ....+..+.+++..|+++|+.+||...++++
T Consensus 315 L~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 315 LPG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 111 1225578899999999999999999999875
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=288.57 Aligned_cols=249 Identities=23% Similarity=0.321 Sum_probs=201.5
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHcc-CCCccceeeeeeCCCcceeE
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv 369 (619)
++|.+.+.||+|+||.||+|... +|+.||+|++.... .....+.+..|+++++++. |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999975 79999999986422 2334567889999999998 99999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||+++++|.+++.... .+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999997642 489999999999999999999999 99999999999999999999999999998664
Q ss_pred cCCc-------------------ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccch
Q 007073 450 VRKT-------------------NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV 510 (619)
Q Consensus 450 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~ 510 (619)
.... .......|+..|+|||......++.++||||||++++++++|+.||..... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~ 228 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-----Y 228 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-----H
Confidence 3321 122234578899999999888899999999999999999999999864321 0
Q ss_pred hHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH----HHHHH
Q 007073 511 LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAM----SEVVR 568 (619)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~evl~ 568 (619)
........ .....+...+..+.+++.+||+.+|++||++ +++++
T Consensus 229 ---~~~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 ---LTFQKILK-----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ---HHHHHHHh-----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11111110 0011122334678999999999999999999 66553
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=284.71 Aligned_cols=242 Identities=25% Similarity=0.326 Sum_probs=186.1
Q ss_pred ccccCCCceEEEEEeC-CCcEEEEEEeccCCC--cchHHHHHHHHHH---HHHccCCCccceeeeeeCCCcceeEecccc
Q 007073 301 VLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEM---ISVAVHRNLLRLIGFCTTPTERLLVYPFMQ 374 (619)
Q Consensus 301 ~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~~E~~~---l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 374 (619)
+||+|+||.||+|... +|+.||+|.+..... ......+..|..+ ++...||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999964 588999998864321 1222334445444 444579999999999999999999999999
Q ss_pred cchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcc
Q 007073 375 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 454 (619)
Q Consensus 375 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 454 (619)
+|+|.+++... ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 99999888642 3489999999999999999999999 99999999999999999999999999987553221
Q ss_pred eeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccc
Q 007073 455 VTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 533 (619)
Q Consensus 455 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 533 (619)
.....|+..|+|||.+.++ .++.++||||+||++|||++|+.||......... . ....... ...
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-----~-~~~~~~~------~~~-- 216 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----E-IDRMTLT------MAV-- 216 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH-----H-HHHHhhc------cCC--
Confidence 1234689999999998754 6899999999999999999999999653221110 0 0000000 011
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007073 534 NKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 568 (619)
Q Consensus 534 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 568 (619)
..+...+..+.+++.+|++.+|.+|| ++.++++
T Consensus 217 --~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 217 --ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred --CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 11122346789999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=288.31 Aligned_cols=245 Identities=26% Similarity=0.363 Sum_probs=191.2
Q ss_pred CcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 296 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
|...+.||+|+||+||+|... +|+.||+|.+.... .......+.+|+++++.++|||++++++++......++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999964 68899999986432 223345788999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+. |++.+.+... ...+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 96 4666666542 23488999999999999999999999 999999999999999999999999999864321
Q ss_pred cceeeecccccccccccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 453 TNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
.....|+..|+|||.+. ...++.++|||||||++|||++|..||..... . .......... ..
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-----~---~~~~~~~~~~-~~--- 238 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----M---SALYHIAQND-SP--- 238 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-----H---HHHHHHHhcC-CC---
Confidence 22346888999999984 45688999999999999999999999853221 0 1111111100 00
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
..........+.+++.+||+.+|++||++.++++.
T Consensus 239 -----~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 239 -----TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01112223468899999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=288.04 Aligned_cols=265 Identities=25% Similarity=0.311 Sum_probs=192.0
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCc-chHHHHHHHHHHHHHccCCCccceeeeeeCCC------
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP-GGDAAFQREVEMISVAVHRNLLRLIGFCTTPT------ 364 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 364 (619)
.++|++.+.||+|+||.||+|... +++.||+|++...... .....+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999965 6899999988643322 22346778999999999999999999875443
Q ss_pred --cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007073 365 --ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 442 (619)
Q Consensus 365 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 442 (619)
..++|+||+.+ ++...+... ...+++..+..++.|+++||+|||++ +|+|+||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 35899999875 555555432 23489999999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcc----------eeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchh
Q 007073 443 GLAKLVDVRKTN----------VTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL 511 (619)
Q Consensus 443 Gla~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~ 511 (619)
|+++........ ..+...+++.|+|||.+.+. .++.++|||||||++|||++|+.||........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~---- 235 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ---- 235 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH----
Confidence 999765432211 11234568889999987654 579999999999999999999999864322110
Q ss_pred HHHHHHHHhh--h------cccchhcc----ccccCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 512 LLDHVKKLER--E------KRLDAIVD----RNLNKNY---NIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 512 ~~~~~~~~~~--~------~~~~~~~~----~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.......... + .......+ ....... .......+.+++.+|++.+|++|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000000 0 00000000 0000000 0112257889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=294.75 Aligned_cols=250 Identities=22% Similarity=0.323 Sum_probs=206.2
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC-cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
....|.+...||+|.|+.|..|.+. +|..||+|.+.+... ......+.+|+++|+.++|||||+++.+...+...++|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 4457888999999999999999964 699999999876543 23345688999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||..+|.+.+++..... ........++.|+.+|++|||++ .|+|||||++|||++.+.++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence 999999999999987543 44477888999999999999999 99999999999999999999999999999876
Q ss_pred cCCcceeeeccccccccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
. .......+|++.|.|||++++..| ++++|+||+|+++|-|+.|..||+.....+-. ..+
T Consensus 207 ~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-----------------~rv 267 (596)
T KOG0586|consen 207 Y--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-----------------PRV 267 (596)
T ss_pred c--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-----------------chh
Confidence 3 334456789999999999998876 78999999999999999999999854332211 111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
+...++- +.-...++.+++++++-.+|.+|++++++.+.
T Consensus 268 l~gk~rI--p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 268 LRGKYRI--PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eeeeecc--cceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 2222221 11223467889999999999999999998753
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=292.70 Aligned_cols=263 Identities=22% Similarity=0.315 Sum_probs=192.7
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCC------
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT------ 364 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 364 (619)
.++|...+.||+|+||.||+|... +|+.||||++.... .......+.+|++++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468989999999999999999964 68999999986432 2233456889999999999999999999886543
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 444 (619)
..++|+||+.. ++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 35899999864 5554432 2378889999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHH--hh
Q 007073 445 AKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL--ER 521 (619)
Q Consensus 445 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~ 521 (619)
++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ......... ..
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~ 235 (342)
T cd07879 164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD----QLTQILKVTGVPG 235 (342)
T ss_pred CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcCCCC
Confidence 8754321 223457889999999876 468999999999999999999999997432110 010000000 00
Q ss_pred hcccc--------hhcc---ccccCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HhcC
Q 007073 522 EKRLD--------AIVD---RNLNKNY---NIQEVETMIQVALLCTQASPEDRPAMSEVVRM--LEGE 573 (619)
Q Consensus 522 ~~~~~--------~~~~---~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~ 573 (619)
+.... .... ....... .+.....+.+++.+||+.||++||++.+++.. +++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00000 0000 0000000 01223568899999999999999999999843 5443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=283.57 Aligned_cols=261 Identities=24% Similarity=0.332 Sum_probs=198.0
Q ss_pred CcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEeccc
Q 007073 296 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 373 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 373 (619)
|+..+.||+|+||.||+|... +++.||+|.+.... .....+.+..|+.++++++|+|++++++++......++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999975 58999999987543 2334567889999999999999999999999999999999999
Q ss_pred ccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCc
Q 007073 374 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 453 (619)
Q Consensus 374 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 453 (619)
+ ++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||+|+||++++++.++|+|||.++.......
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 8 58999887642 3488999999999999999999999 999999999999999999999999999986643322
Q ss_pred ceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh--hc------c
Q 007073 454 NVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER--EK------R 524 (619)
Q Consensus 454 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~------~ 524 (619)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||....... .+......... +. .
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID----QLFKIFQILGTPTEESWPGVTK 228 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH----HHHHHHHHhCCCcHHHHHhhcc
Confidence 22233457789999998776 78999999999999999999999986432110 00000000000 00 0
Q ss_pred c---chhccccccC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 525 L---DAIVDRNLNK---NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 525 ~---~~~~~~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. .......... ...+.....+.+++.+||+.+|++||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0 0000000000 001122467999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=288.37 Aligned_cols=263 Identities=21% Similarity=0.239 Sum_probs=192.9
Q ss_pred cCCc-ccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcc-------------hHHHHHHHHHHHHHccCCCccceee
Q 007073 294 DNFS-EKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPG-------------GDAAFQREVEMISVAVHRNLLRLIG 358 (619)
Q Consensus 294 ~~~~-~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~-------------~~~~~~~E~~~l~~l~H~niv~l~~ 358 (619)
++|. +.+.||+|+||+||+|... +++.||||.+....... ....+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 3477999999999999965 68999999886432211 1125778999999999999999999
Q ss_pred eeeCCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 007073 359 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV 438 (619)
Q Consensus 359 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 438 (619)
++...+..++||||+. |+|.+++... ..++......++.|++.||+|||+. +++|+||+|+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 9999999999999997 5888887642 3378899999999999999999999 999999999999999999999
Q ss_pred EcccccceeeccCC-------------cceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcc
Q 007073 439 VGDFGLAKLVDVRK-------------TNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRL 504 (619)
Q Consensus 439 l~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~ 504 (619)
|+|||++....... ........++..|+|||.+.+. .++.++|||||||++|||+||+.||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999998664111 1111223467889999998764 469999999999999999999999864322
Q ss_pred ccccchhHHHHHHHHhhhcc--cchhc--------cccccC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 505 EEEDDVLLLDHVKKLEREKR--LDAIV--------DRNLNK---NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~--~~~~~--------~~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.. .+.........+.. ..... ...... .........+.+++.+|++.+|++||++++++.
T Consensus 240 ~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 240 ID----QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HH----HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 11 01111111000000 00000 000000 001122457889999999999999999999985
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=288.56 Aligned_cols=266 Identities=22% Similarity=0.285 Sum_probs=196.3
Q ss_pred HHHHHHhcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCC-
Q 007073 287 RELQLATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP- 363 (619)
Q Consensus 287 ~el~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~- 363 (619)
.++...+++|.+.+.||+|+||.||+|.. .+|+.||+|++.... .....+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 45666789999999999999999999985 478999999986432 223346678899999999999999999988543
Q ss_pred -----CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 007073 364 -----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV 438 (619)
Q Consensus 364 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 438 (619)
...+++++++ +++|.+.+.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+|
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEE
Confidence 2356777776 6788777653 2378899999999999999999999 999999999999999999999
Q ss_pred EcccccceeeccCCcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHH
Q 007073 439 VGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 517 (619)
Q Consensus 439 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 517 (619)
|+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+.....
T Consensus 161 l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~----~~~~~~~ 232 (345)
T cd07877 161 ILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID----QLKLILR 232 (345)
T ss_pred Eeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHH
Confidence 9999998754321 233457889999998866 568899999999999999999999985432110 0001000
Q ss_pred HHh--hhcccchh-----------ccccccCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 518 KLE--REKRLDAI-----------VDRNLNKNY---NIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 518 ~~~--~~~~~~~~-----------~~~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
... .......+ +.......+ .......+.+++.+|++.||++||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000 00000000 000000000 00124578899999999999999999988853
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=274.22 Aligned_cols=242 Identities=24% Similarity=0.287 Sum_probs=198.4
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
-++|...++||+|.||.|..++-+ +|+.+|+|++++.. ..+....-+.|-++++..+||.+..+--.+++.++.+.|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 356777899999999999999954 79999999998643 233455667899999999999999998889999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||..||.|..+|... ..++....+-+-..|..||.|||++ +||.||+|-+|.|+|.+|++||+|||+++.-
T Consensus 247 MeyanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~- 318 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE- 318 (516)
T ss_pred EEEccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc-
Confidence 9999999999998763 3478888888899999999999999 9999999999999999999999999999843
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
......+..++||+.|+|||++....|..++|.|.+||++|||++|+.||....-+ .+.+ -++
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-----kLFe------------LIl 381 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-----KLFE------------LIL 381 (516)
T ss_pred ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh-----HHHH------------HHH
Confidence 33445567789999999999999999999999999999999999999999642211 0111 011
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCC
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRP 561 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 561 (619)
-..+ .++.....+...|+...+.+||++|-
T Consensus 382 ~ed~--kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 382 MEDL--KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred hhhc--cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 1111 12333445678888899999999995
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=287.81 Aligned_cols=259 Identities=24% Similarity=0.335 Sum_probs=193.8
Q ss_pred HhcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCC-----
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT----- 364 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----- 364 (619)
..++|.+.+.||+|+||.||+|.. .+|+.||||++.... .......+.+|++++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 567899999999999999999985 478999999986432 2223456889999999999999999999886553
Q ss_pred -cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007073 365 -ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 443 (619)
Q Consensus 365 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 443 (619)
..++||||+ +++|..++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999998 6688777753 2378999999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHH-----
Q 007073 444 LAKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK----- 517 (619)
Q Consensus 444 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~----- 517 (619)
++...... .....+++.|+|||.+.+ ..++.++|+||||+++|++++|+.||....... .......
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~ 235 (343)
T cd07880 164 LARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD----QLMEIMKVTGTP 235 (343)
T ss_pred cccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcCCC
Confidence 99765322 223457889999998876 458899999999999999999999986432110 0000000
Q ss_pred ------HHhhhcccchhccc--ccc----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 518 ------KLEREKRLDAIVDR--NLN----KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 518 ------~~~~~~~~~~~~~~--~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.... ......... ... ..........+.+++.+|++.||++|||+.+++.
T Consensus 236 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 236 SKEFVQKLQS-EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CHHHHHhhcc-hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 000000000 000 0001123346889999999999999999999883
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=272.58 Aligned_cols=255 Identities=21% Similarity=0.300 Sum_probs=192.9
Q ss_pred ccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHH-HHccCCCccceeeeeeCCCcceeEeccccc
Q 007073 298 EKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMI-SVAVHRNLLRLIGFCTTPTERLLVYPFMQN 375 (619)
Q Consensus 298 ~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 375 (619)
....||.|+||+|++-.++ .|+..|||+++........++++.|.+.. +.-++||||+++|.+..++..++-||.|.-
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~ 147 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI 147 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh
Confidence 3467999999999999975 69999999998766666778899999875 455799999999999999999999999964
Q ss_pred chhhhhhcc-cCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcc
Q 007073 376 LSVAYRLRE-IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 454 (619)
Q Consensus 376 gsL~~~l~~-~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 454 (619)
|++.+-.. +.-....+++...-+|..-..+||.||.+.. .|||||+||+|||+|..|.+||+|||++-.+.. +.
T Consensus 148 -SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--Si 222 (361)
T KOG1006|consen 148 -SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--SI 222 (361)
T ss_pred -hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH--HH
Confidence 44433321 1122344777777888888899999998764 899999999999999999999999999875532 22
Q ss_pred eeeeccccccccccccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 455 VTTQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 455 ~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
..+.-+|-..|||||.+.. ..|+.+|||||+|+++||+.||+.|+..... +.+.+......... .+..
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-------vfeql~~Vv~gdpp-~l~~-- 292 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-------VFEQLCQVVIGDPP-ILLF-- 292 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-------HHHHHHHHHcCCCC-eecC--
Confidence 3344568889999999853 3489999999999999999999999863221 22222222211111 1110
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
..-.......+.+++.-|+.+|-++||++.++.++
T Consensus 293 --~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 --DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred --cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11123456789999999999999999999988753
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=290.62 Aligned_cols=261 Identities=22% Similarity=0.304 Sum_probs=190.5
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCC---------
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--------- 363 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------- 363 (619)
.+|...+.||+|+||.||+|... +|+.||+|.+.... ....+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC-CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 57888999999999999999964 68999999886433 34557788999999999999999999876543
Q ss_pred -----CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-CCCcE
Q 007073 364 -----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD-EDFEA 437 (619)
Q Consensus 364 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~ 437 (619)
...++|+||++ ++|.+.+.. ..+++.....++.|++.||.|||+. +|+||||||+||+++ +++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence 24689999997 478777653 2378899999999999999999999 999999999999997 45678
Q ss_pred EEcccccceeeccCCcc--eeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHH
Q 007073 438 VVGDFGLAKLVDVRKTN--VTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 514 (619)
Q Consensus 438 kl~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~ 514 (619)
|++|||+++........ ......++..|+|||.+.. ..++.++|||||||++|||++|+.||......... ..
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~----~~ 230 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM----QL 230 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HH
Confidence 99999999865432111 1123357889999997754 56789999999999999999999999643221110 00
Q ss_pred HHHHHh------hhcc---c-chhccccccCC-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 515 HVKKLE------REKR---L-DAIVDRNLNKN-----YNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 515 ~~~~~~------~~~~---~-~~~~~~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
...... .... . ........... ..+....++.+++.+|++.||++|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000 0000 0 00000000000 01123357889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=284.77 Aligned_cols=265 Identities=20% Similarity=0.239 Sum_probs=189.6
Q ss_pred CCcccCccccCCCceEEEEEeC-C--CcEEEEEEeccCC-CcchHHHHHHHHHHHHHc-cCCCccceeeeeeCC----Cc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-D--GTKVAVKRLTDFE-SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTP----TE 365 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~--g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~----~~ 365 (619)
+|++.+.||+|+||.||++... . +..||+|++.... .....+.+.+|+++++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777889999999999999965 3 7899999986432 223356788999999998 599999999875432 34
Q ss_pred ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 445 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 445 (619)
.+++++|+. ++|...+... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 677888876 5888877542 3488999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcc---eeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhH-------HH
Q 007073 446 KLVDVRKTN---VTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL-------LD 514 (619)
Q Consensus 446 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~-------~~ 514 (619)
+........ ......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||............. ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 865432211 1223468999999998765 468999999999999999999999986433210000000 00
Q ss_pred HHHHHhhhcc--cchhcccccc---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 007073 515 HVKKLEREKR--LDAIVDRNLN---KNYNIQEVETMIQVALLCTQASPEDRPAMSEVV 567 (619)
Q Consensus 515 ~~~~~~~~~~--~~~~~~~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 567 (619)
.......+.. .......... ....+.....+.+++.+|++.+|++|||+.+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0000000000 0000000000 000111245788999999999999999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=308.74 Aligned_cols=259 Identities=22% Similarity=0.279 Sum_probs=210.5
Q ss_pred HHHHHHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeC
Q 007073 286 WRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT 362 (619)
Q Consensus 286 ~~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 362 (619)
.+++....++|.+.++||+|+||.|..++++ +++.||+|++.+.. ......-|..|-.+|.-.+.+=|+.++-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4677888899999999999999999999975 68899999997633 13345678899999998889999999999999
Q ss_pred CCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007073 363 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 442 (619)
Q Consensus 363 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 442 (619)
+...|+|||||+||+|..++..+. .++...++-++..|.-||.-+|+. |+|||||||+|||+|..|++||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence 999999999999999999998754 488888889999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcceeeecccccccccccccc----C-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHH
Q 007073 443 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLS----T-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 517 (619)
Q Consensus 443 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 517 (619)
|.+-.+..+..-.....+|||-|++||+++ + +.|++.+|+||+||++|||+.|..||...+ ++.-+.
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads--------lveTY~ 291 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS--------LVETYG 291 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH--------HHHHHH
Confidence 999988877777777788999999999995 3 678999999999999999999999997543 223333
Q ss_pred HHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC---HHHHH
Q 007073 518 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA---MSEVV 567 (619)
Q Consensus 518 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl 567 (619)
++-.....-...+ ..+.+++..+||.+.+. +|+.|-. .+++-
T Consensus 292 KIm~hk~~l~FP~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 292 KIMNHKESLSFPD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred HHhchhhhcCCCc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 3222211111110 12344667778877664 6777776 55543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=288.63 Aligned_cols=260 Identities=24% Similarity=0.313 Sum_probs=195.0
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCc----
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE---- 365 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---- 365 (619)
..++|+..+.||+|+||.||+|... +++.||||++.... .......+.+|+.++++++|+|++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4567999999999999999999975 68899999886432 23344667789999999999999999998766554
Q ss_pred --ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007073 366 --RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 443 (619)
Q Consensus 366 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 443 (619)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 78999998 5688887764 2488999999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh-
Q 007073 444 LAKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER- 521 (619)
Q Consensus 444 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 521 (619)
++...... .....++..|+|||.+.+ ..++.++||||||+++|||+||+.||........ +.........
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~----~~~i~~~~~~~ 235 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ----LKRIMNLVGTP 235 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHhcCCC
Confidence 99865332 233457889999998865 4678999999999999999999999864321100 0000000000
Q ss_pred -hcc--------cchhcc---ccccCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 522 -EKR--------LDAIVD---RNLNKNY---NIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 522 -~~~--------~~~~~~---~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
+.. ....+. ......+ ....+..+.+++.+|++.+|++|||+.+|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000 000000 0000000 0112568899999999999999999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=273.89 Aligned_cols=237 Identities=24% Similarity=0.241 Sum_probs=192.6
Q ss_pred cccCCCceEEEEEeC-CCcEEEEEEeccCCC--cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccchh
Q 007073 302 LGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV 378 (619)
Q Consensus 302 lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 378 (619)
||+|+||.||++... +++.+|+|.+..... ......+..|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999975 589999999865332 22456788999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcceeee
Q 007073 379 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 458 (619)
Q Consensus 379 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 458 (619)
.+++.... .+++.....++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 99987532 488999999999999999999998 99999999999999999999999999998764332 12334
Q ss_pred ccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCC
Q 007073 459 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 538 (619)
Q Consensus 459 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 538 (619)
..++..|+|||...+...+.++|+||||+++||+++|+.||..... ......... . . ...+
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~-~--------~--~~~~ 213 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILK-D--------P--LRFP 213 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhc-C--------C--CCCC
Confidence 5678899999999888899999999999999999999999864321 111111111 0 0 0112
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHH
Q 007073 539 IQEVETMIQVALLCTQASPEDRPAMSE 565 (619)
Q Consensus 539 ~~~~~~l~~l~~~Cl~~dP~~RPs~~e 565 (619)
...+..+.+++.+||..||++||++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 222467889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=264.95 Aligned_cols=208 Identities=23% Similarity=0.336 Sum_probs=171.0
Q ss_pred HhcCCcccCccccCCCceEEEEEeCC-----CcEEEEEEeccCCCc-chHHHHHHHHHHHHHccCCCccceeeeeeC-CC
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLAD-----GTKVAVKRLTDFESP-GGDAAFQREVEMISVAVHRNLLRLIGFCTT-PT 364 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-----g~~vAvK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~ 364 (619)
....|+....||+|.||.||+|+-++ .+.+|+|+++..... +-.....+|+.+++.++|||++.+..++.+ +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 34568889999999999999997432 236999999754332 234567899999999999999999998877 67
Q ss_pred cceeEecccccchhhhhhcccCC-CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC----CcEEE
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED----FEAVV 439 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl 439 (619)
..++++||.+. +|...++.... ....++...+++|+.||..|+.|||++ =|+||||||.|||+..+ |.|||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEe
Confidence 78999999987 77777754322 234688889999999999999999999 79999999999999877 99999
Q ss_pred cccccceeeccCCc--ceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 007073 440 GDFGLAKLVDVRKT--NVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSR 503 (619)
Q Consensus 440 ~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~ 503 (619)
+|+|+++.+...-. .....++-|..|.|||.+.+. .||.+.||||.||+..||+|-++-|....
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 99999998854322 233456779999999998875 58999999999999999999988886543
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=261.68 Aligned_cols=255 Identities=21% Similarity=0.299 Sum_probs=194.7
Q ss_pred cCccccCCCceEEEEE-eCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc-CCCccceeeeeeCCCcceeEecccccc
Q 007073 299 KNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVYPFMQNL 376 (619)
Q Consensus 299 ~~~lg~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g 376 (619)
.++||+|+|+.|--++ ..+|..||||++.+. .........+|++++.+.+ |+||+.++++++++...|||||-|.||
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG 161 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence 3689999999999998 578999999999765 3456678889999998885 999999999999999999999999999
Q ss_pred hhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc---EEEcccccceeeccCC-
Q 007073 377 SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE---AVVGDFGLAKLVDVRK- 452 (619)
Q Consensus 377 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGla~~~~~~~- 452 (619)
.|..++++.+ .++..+..++..+||.||.|||.+ ||.|||+||+|||...... +||+||.+..-+....
T Consensus 162 plLshI~~~~----~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 162 PLLSHIQKRK----HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred hHHHHHHHhh----hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 9999998744 388899999999999999999999 9999999999999976544 7999999876542211
Q ss_pred -----cceeeecccccccccccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCcc---ccccchhHHHHHHHH
Q 007073 453 -----TNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRL---EEEDDVLLLDHVKKL 519 (619)
Q Consensus 453 -----~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~---~~~~~~~~~~~~~~~ 519 (619)
+......+|+..|||||+.. ...|+.++|.||+|||+|-|++|..||...-- ....+..- ...+
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C-r~CQ-- 311 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC-RVCQ-- 311 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc-HHHH--
Confidence 11223456888999999763 34588999999999999999999999964221 11111111 0011
Q ss_pred hhhcccchhccccccCCCCH----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 520 EREKRLDAIVDRNLNKNYNI----QEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 520 ~~~~~~~~~~~~~l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..-...+.++.. .++. ..+.+..+++...+..++.+|-++.++++
T Consensus 312 --~~LFesIQEGkY--eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 312 --NKLFESIQEGKY--EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred --HHHHHHHhccCC--cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 011112222221 1232 33456678888899999999999988886
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=264.05 Aligned_cols=254 Identities=22% Similarity=0.268 Sum_probs=196.1
Q ss_pred HhcCCccc-CccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHH-HHccCCCccceeeeeeCC----C
Q 007073 292 ATDNFSEK-NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMI-SVAVHRNLLRLIGFCTTP----T 364 (619)
Q Consensus 292 ~~~~~~~~-~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~~----~ 364 (619)
.+++|.+. ++||-|-.|.|-.+..+ +|+++|+|++.+. ....+|++.- ..-.|||||.+++++... .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 45566553 68999999999999965 7999999998642 3456788874 445699999999998653 4
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEEcc
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVVGD 441 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~D 441 (619)
..++|||.|+||.|...+.+.. ...+++.+...|+.||+.|+.|||+. +|.||||||+|+|.+. |-.+||+|
T Consensus 133 cLLiVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred eeEeeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence 5788999999999999998753 45689999999999999999999999 9999999999999964 56789999
Q ss_pred cccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007073 442 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 521 (619)
Q Consensus 442 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 521 (619)
||+|+..... ......+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||....- ..+....++...
T Consensus 208 fGFAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-----~aispgMk~rI~ 280 (400)
T KOG0604|consen 208 FGFAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-----LAISPGMKRRIR 280 (400)
T ss_pred cccccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-----ccCChhHHhHhh
Confidence 9999865432 223345679999999999999999999999999999999999999963221 111111121111
Q ss_pred hcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 522 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 522 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
.+... +...-..+.++...++++..++.+|.+|-|++++++.
T Consensus 281 ~gqy~------FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 281 TGQYE------FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ccCcc------CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 11110 0111134556788899999999999999999999853
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=306.02 Aligned_cols=146 Identities=26% Similarity=0.350 Sum_probs=130.3
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++|.+.+.||+|+||+||+|.+. +++.||||+++... .......+..|+.+++.++|+||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999976 68999999986432 2223467889999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
||+.+++|.+++.... .+++...+.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999987532 378888999999999999999999 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=267.87 Aligned_cols=220 Identities=20% Similarity=0.161 Sum_probs=175.8
Q ss_pred CCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccchhhhhhc
Q 007073 305 GGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLR 383 (619)
Q Consensus 305 G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 383 (619)
|.||.||++... +|+.||+|++.... .+.+|...+....||||+++++++...+..++||||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 899999999964 78999999986422 23445555566679999999999999999999999999999999887
Q ss_pred ccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcceeeeccccc
Q 007073 384 EIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 463 (619)
Q Consensus 384 ~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~ 463 (619)
... .+++.....++.|+++||+|||++ +|+||||||+||+++.++.++++|||.+...... .....++.
T Consensus 78 ~~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~ 146 (237)
T cd05576 78 KFL----NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVEN 146 (237)
T ss_pred Hhc----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCc
Confidence 532 388999999999999999999999 9999999999999999999999999987654322 12234577
Q ss_pred cccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHH
Q 007073 464 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVE 543 (619)
Q Consensus 464 ~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 543 (619)
.|+|||.+.+..++.++||||+|+++|||++|+.|+........ .... ...+.....
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-------------------~~~~----~~~~~~~~~ 203 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-------------------THTT----LNIPEWVSE 203 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-------------------cccc----cCCcccCCH
Confidence 89999999888899999999999999999999988653211000 0000 011122345
Q ss_pred HHHHHHHhccCCCCCCCCCHH
Q 007073 544 TMIQVALLCTQASPEDRPAMS 564 (619)
Q Consensus 544 ~l~~l~~~Cl~~dP~~RPs~~ 564 (619)
.+.+++.+|++.||++||++.
T Consensus 204 ~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 204 EARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHHHccCCHHHhcCCC
Confidence 788999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-33 Score=247.72 Aligned_cols=211 Identities=22% Similarity=0.320 Sum_probs=177.0
Q ss_pred HHHHHHhcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHH-HccCCCccceeeeeeCCC
Q 007073 287 RELQLATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMIS-VAVHRNLLRLIGFCTTPT 364 (619)
Q Consensus 287 ~el~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~ 364 (619)
+.+++..+.......||+|++|.|-+-++ .+|+..|||++......+..+..+.|+.+.. ...+|.+|.++|......
T Consensus 39 ~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 39 RNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred CccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 34556666677778899999999988885 4799999999986665666778888998754 567999999999999999
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 444 (619)
..++.||.|.- ||+.+-.+....+..+++...-+|+..+.+||.|||++- .++|||+||+|||++.+|++|++|||+
T Consensus 119 dvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 119 DVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred cEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccc
Confidence 99999999975 777777666556677899999999999999999999975 799999999999999999999999999
Q ss_pred ceeeccCCcceeeeccccccccccccccC----CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 007073 445 AKLVDVRKTNVTTQVRGTMGHIAPEYLST----GKSSERTDVFGYGIMLLELVTGQRAIDFS 502 (619)
Q Consensus 445 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~S~Gv~l~elltg~~p~~~~ 502 (619)
+-.+.+. -..+...|-..|||||.+.. ..|+.|+||||+|+.+.||.+++.||+..
T Consensus 196 sG~L~dS--iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 196 SGYLVDS--IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred ceeehhh--hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 9876432 22233457889999998853 36899999999999999999999999754
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-33 Score=271.25 Aligned_cols=244 Identities=24% Similarity=0.311 Sum_probs=197.3
Q ss_pred HHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCc--chHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcc
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP--GGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTER 366 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 366 (619)
+...+|....+||+|+||.|..|..+ +.+-+|||++++..-. +..+--+.|-++|+.. +-|.++.++.++++.++.
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 34457888899999999999999976 3467999999865422 2233345677777766 468899999999999999
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
+.||||+.||+|-+.++.... +..+.+.-+|..||-||-+||++ +|+.||||.+||++|.+|++||+|||+++
T Consensus 426 yFVMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eeEEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccc
Confidence 999999999999999987544 77778888999999999999999 99999999999999999999999999998
Q ss_pred eeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 447 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 447 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
.-- -+...+...+||+.|+|||++...+|+..+|+|||||++|||+.|..||+....++ + ..
T Consensus 499 Eni-~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-----l------------F~ 560 (683)
T KOG0696|consen 499 ENI-FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-----L------------FQ 560 (683)
T ss_pred ccc-cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-----H------------HH
Confidence 532 23344567889999999999999999999999999999999999999998643221 1 11
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCC
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP 561 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 561 (619)
.+.+.+. .++...+.+..++....+.+.|.+|-
T Consensus 561 aI~ehnv--syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 561 AIMEHNV--SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHHHccC--cCcccccHHHHHHHHHHhhcCCcccc
Confidence 2233222 34555566778888899999999994
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=238.03 Aligned_cols=262 Identities=21% Similarity=0.312 Sum_probs=193.1
Q ss_pred CCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCC-cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
+|...++||+|.||+||+|+. .+++.||+|+++-... .+--....+|+-+++.++|.|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 355567899999999999995 4688999999974433 33345678999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+.. +|..+..... ..++....++++.|+.+||.++|++ ++.|||+||.|.||+.+|++|++|||+++.++...
T Consensus 83 cdq-dlkkyfdsln---g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLN---GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHHhcC---CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 975 6666665432 2378889999999999999999999 99999999999999999999999999999776543
Q ss_pred cceeeeccccccccccccccCCC-CCcchhhHHHHHHHHHHHhCCCC-CCCCccccccchhHHHHHHHHh---hhcc--c
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRA-IDFSRLEEEDDVLLLDHVKKLE---REKR--L 525 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gv~l~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~---~~~~--~ 525 (619)
. ..+..+-|..|.+|.++.+.+ |++..|+||-||++.|+.....| |..... +..+....+.+. ...+ +
T Consensus 156 r-cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv----ddqlkrif~~lg~p~ed~wps~ 230 (292)
T KOG0662|consen 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV----DDQLKRIFRLLGTPTEDQWPSM 230 (292)
T ss_pred E-eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH----HHHHHHHHHHhCCCccccCCcc
Confidence 2 233445689999999998755 89999999999999999985444 443222 111222222111 1111 1
Q ss_pred chhccccccCCCC---------HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 526 DAIVDRNLNKNYN---------IQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 526 ~~~~~~~l~~~~~---------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..+.|-..-+.++ +.....-.+++...+.-+|.+|.++++.++
T Consensus 231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 1111211111111 222234457777888889999999988765
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=261.46 Aligned_cols=239 Identities=27% Similarity=0.333 Sum_probs=192.6
Q ss_pred CCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccchhhhhhcc
Q 007073 306 GFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE 384 (619)
Q Consensus 306 ~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 384 (619)
+||.||+|... +|+.+|+|++.........+.+.+|++.+++++|+|++++++++......++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 48999999987544333368899999999999999999999999999999999999999999998876
Q ss_pred cCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcceeeecccccc
Q 007073 385 IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 464 (619)
Q Consensus 385 ~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~ 464 (619)
... +++..+..++.++++++.|||+. +++|+||+|+||++++++.++++|||.+....... ......++..
T Consensus 81 ~~~----~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 RGR----LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred ccC----CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 332 78899999999999999999999 99999999999999999999999999998765432 2334457889
Q ss_pred ccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHH
Q 007073 465 HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVET 544 (619)
Q Consensus 465 y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 544 (619)
|++||.+.+..++.++||||||+++|+|++|..||..... .. ........... .. .........+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~----~~---~~~~~~~~~~~-~~-------~~~~~~~~~~ 216 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ----LL---ELFKKIGKPKP-PF-------PPPEWKISPE 216 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----HH---HHHHHHhccCC-CC-------ccccccCCHH
Confidence 9999999888899999999999999999999999864211 01 11111111000 00 0000013467
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHH
Q 007073 545 MIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 545 l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
+.+++.+|+..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 899999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=282.35 Aligned_cols=239 Identities=20% Similarity=0.278 Sum_probs=191.6
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHH-ccCCCccceeeeeeCCCcceeEe
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISV-AVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++.|.....+|.|+|+.|-.+... +++..+||++.+.. .+-.+|+.++.. -.||||+++.+.+....+.++||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 567788888999999999999864 68889999986542 223456766554 46999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe-CCCCcEEEcccccceeec
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL-DEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DfGla~~~~ 449 (619)
|.+.++-+.+.+..... .. ..+..|+.+++.|+.|||++ |+|||||||+|||+ ++.++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~~~~----~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPE----FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHhcch----hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 99999988888876432 23 67778999999999999999 99999999999999 588999999999998765
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
.+ ....+-|..|.|||++....|++++|+||||+++|+|+||+.||...... . +...++.
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~---ei~~~i~--------- 527 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----I---EIHTRIQ--------- 527 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----H---HHHHhhc---------
Confidence 44 22234588999999999999999999999999999999999999643321 1 1111111
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.+.+....+....+|+.+|++.||.+||+|.++..
T Consensus 528 ----~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 528 ----MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ----CCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 11222344567889999999999999999999874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=291.39 Aligned_cols=264 Identities=18% Similarity=0.217 Sum_probs=170.3
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-C----CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeee------e
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-D----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF------C 360 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~------~ 360 (619)
..++|+..+.||+|+||.||+|.+. + +..||||++.... ..+.+..| .+....+.++..+... +
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~---~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG---AVEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc---hhHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 5678999999999999999999975 4 6899999876422 11212211 1122222333322221 2
Q ss_pred eCCCcceeEecccccchhhhhhcccCCC----------------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 007073 361 TTPTERLLVYPFMQNLSVAYRLREIKPG----------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDV 424 (619)
Q Consensus 361 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl 424 (619)
....+.++||||+.+++|.+++...... ...........++.|++.||+|||++ +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 4556789999999999999988653210 01112234567999999999999999 9999999
Q ss_pred CCCcEEeCC-CCcEEEcccccceeeccCCcceeeeccccccccccccccCC----------------------CCCcchh
Q 007073 425 KAANVLLDE-DFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG----------------------KSSERTD 481 (619)
Q Consensus 425 kp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 481 (619)
||+|||++. ++.+||+|||+|+.+............+++.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999986 57999999999986654433344456789999999965322 2345679
Q ss_pred hHHHHHHHHHHHhCCCCCCCCccc-----cccchhHHHHHHHHhhhcccchhccccccCCC--CHHHHHHHHHHHHhccC
Q 007073 482 VFGYGIMLLELVTGQRAIDFSRLE-----EEDDVLLLDHVKKLEREKRLDAIVDRNLNKNY--NIQEVETMIQVALLCTQ 554 (619)
Q Consensus 482 v~S~Gv~l~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--~~~~~~~l~~l~~~Cl~ 554 (619)
||||||++|||+++..+++..... ...+.....|....... ..+.+...+ .........+|+.+|++
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHcc
Confidence 999999999999977664321000 00000011111110000 000000000 00011234589999999
Q ss_pred CCCCCCCCHHHHHHH
Q 007073 555 ASPEDRPAMSEVVRM 569 (619)
Q Consensus 555 ~dP~~RPs~~evl~~ 569 (619)
.||++|||+.++++.
T Consensus 436 ~dP~kR~ta~e~L~H 450 (566)
T PLN03225 436 FKGRQRISAKAALAH 450 (566)
T ss_pred CCcccCCCHHHHhCC
Confidence 999999999999863
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=274.27 Aligned_cols=246 Identities=23% Similarity=0.318 Sum_probs=196.3
Q ss_pred cCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccc
Q 007073 299 KNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL 376 (619)
Q Consensus 299 ~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 376 (619)
.++||+|.||+||-|+++ +|+.||||++.+.. ...+..++..|++++..++||.||.+.-.|+++++.++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 478999999999999964 79999999986543 3445678899999999999999999999999999999999999775
Q ss_pred hhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC---CcEEEcccccceeeccCCc
Q 007073 377 SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED---FEAVVGDFGLAKLVDVRKT 453 (619)
Q Consensus 377 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGla~~~~~~~~ 453 (619)
=|...|... ...++....+-++.||..||.|||.+ +|+|+||||+|||+... .++||+|||+|+.++..
T Consensus 649 MLEMILSsE---kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-- 720 (888)
T KOG4236|consen 649 MLEMILSSE---KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-- 720 (888)
T ss_pred HHHHHHHhh---cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh--
Confidence 555545432 23477777888999999999999999 99999999999999654 57999999999988643
Q ss_pred ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccc
Q 007073 454 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 533 (619)
Q Consensus 454 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 533 (619)
.....++||+.|+|||++.+..|...-|+||.||++|--++|..||..... +.+.++.. ..+ .
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-------IndQIQNA-------aFM---y 783 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-------INDQIQNA-------AFM---Y 783 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-------hhHHhhcc-------ccc---c
Confidence 334567899999999999999999999999999999999999999963221 11111110 000 0
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 534 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 534 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
......+......+++...++..=.+|-|..+-+..
T Consensus 784 Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 784 PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 122234555678899999999999999988776643
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=282.55 Aligned_cols=263 Identities=20% Similarity=0.208 Sum_probs=181.4
Q ss_pred HhcCCcccCccccCCCceEEEEEe-----------------CCCcEEEEEEeccCCCcchHH--------------HHHH
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVL-----------------ADGTKVAVKRLTDFESPGGDA--------------AFQR 340 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~-----------------~~g~~vAvK~l~~~~~~~~~~--------------~~~~ 340 (619)
..++|++.++||+|+||+||+|.. .+++.||||++.... ....+ .+..
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~-~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDR-QGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccc-hhhHHHHHhhhhhhhcccchhHH
Confidence 567899999999999999999964 245789999986322 11222 3344
Q ss_pred HHHHHHHccCCCc-----cceeeeeeC--------CCcceeEecccccchhhhhhcccCC--------------------
Q 007073 341 EVEMISVAVHRNL-----LRLIGFCTT--------PTERLLVYPFMQNLSVAYRLREIKP-------------------- 387 (619)
Q Consensus 341 E~~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~-------------------- 387 (619)
|+.++.+++|.++ ++++++|.. ....++||||+++++|.++++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777777876654 677887753 3467999999999999999875321
Q ss_pred CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcceeeeccccccccc
Q 007073 388 GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 467 (619)
Q Consensus 388 ~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~a 467 (619)
....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++..............+|+.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 012356778889999999999999999 99999999999999999999999999997654322222222335789999
Q ss_pred cccccCCCC----------------------CcchhhHHHHHHHHHHHhCCC-CCCCCcccc----ccchhHHHHHHHHh
Q 007073 468 PEYLSTGKS----------------------SERTDVFGYGIMLLELVTGQR-AIDFSRLEE----EDDVLLLDHVKKLE 520 (619)
Q Consensus 468 PE~~~~~~~----------------------~~~~Dv~S~Gv~l~elltg~~-p~~~~~~~~----~~~~~~~~~~~~~~ 520 (619)
||.+..... ..+.||||+||++++|++|.. |+.....-. ........|....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~- 457 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK- 457 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc-
Confidence 998754321 235799999999999999875 554211000 0001111111100
Q ss_pred hhcccchhccccccCCCCHHHHHHHHHHHHhccCCCC---CCCCCHHHHHH
Q 007073 521 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASP---EDRPAMSEVVR 568 (619)
Q Consensus 521 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPs~~evl~ 568 (619)
.. ...-...........+++.+++..+| .+|+|++|+++
T Consensus 458 -~~--------~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 458 -GQ--------KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred -cc--------CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 00 00001112234577889999998766 68999999985
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=268.70 Aligned_cols=258 Identities=23% Similarity=0.345 Sum_probs=196.5
Q ss_pred HHhcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCC------cchHHHHHHHHHHHHHccCCCccceeeeeeCC
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFES------PGGDAAFQREVEMISVAVHRNLLRLIGFCTTP 363 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 363 (619)
...++|-+.++||+|||+.||+|.+ ...+.||||+-+-... ....+...+|.++-+.++||.||++++++.-+
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 3455677889999999999999994 4678899997642111 11234567899999999999999999999655
Q ss_pred -CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEE
Q 007073 364 -TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVV 439 (619)
Q Consensus 364 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl 439 (619)
+..+-|.||++|.+|+-+|...+ .++..+.+.|+.||+.||.||.+. +++|||-||||.|||+-. -|.+||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 56789999999999999998644 388899999999999999999997 678999999999999954 478999
Q ss_pred cccccceeeccCCc------ceeeeccccccccccccccCC----CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccc
Q 007073 440 GDFGLAKLVDVRKT------NVTTQVRGTMGHIAPEYLSTG----KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD 509 (619)
Q Consensus 440 ~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~ 509 (619)
+|||+++.++.+.. ..+....||.+|++||.+.-+ +++.|+||||.||++|..+.|+.||..... .
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs----Q 690 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS----Q 690 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh----H
Confidence 99999999864432 235567899999999988533 478999999999999999999999964321 0
Q ss_pred hhHHHHHHHHhhhcccchhccc-cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 007073 510 VLLLDHVKKLEREKRLDAIVDR-NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV 567 (619)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 567 (619)
..+. .+. .++.. .+.-...+....+..+++.+|++..-++|....++.
T Consensus 691 QdIL-------qeN---TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 691 QDIL-------QEN---TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred HHHH-------hhh---chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1110 000 11110 011111233445778899999999999998766654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=252.07 Aligned_cols=265 Identities=25% Similarity=0.353 Sum_probs=190.5
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEecc-CCCcchHHHHHHHHHHHHHccCCCccceeeeeeCC--------C
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTD-FESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--------T 364 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~-~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------~ 364 (619)
.|+...+||+|.||.||+|+.+ +|++||+|++-- ....+--....+|++++..++|+|++.+++.|.+. .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4555678999999999999965 688899986532 22233335568999999999999999999988542 2
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 444 (619)
..++||.+++. +|...+.+. ...++..+..+++.++..||.|+|.. .|+|||+||.|+||+.++.+||+|||+
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence 37899999987 777777653 23488999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCcc---eeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHH-HHHHH
Q 007073 445 AKLVDVRKTN---VTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD-HVKKL 519 (619)
Q Consensus 445 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~-~~~~~ 519 (619)
++.+...+.. ..+..+-|..|.+||.+.+ ..|+++.|||+-||++.||.||.+-+..... .....+.. .....
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte--qqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE--QQQLHLISQLCGSI 248 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH--HHHHHHHHHHhccC
Confidence 9877533322 1334456999999998876 5699999999999999999999887754321 11111111 11111
Q ss_pred hhhcccc-------hhc-ccccc-CCC--CHHH------HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 520 EREKRLD-------AIV-DRNLN-KNY--NIQE------VETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 520 ~~~~~~~-------~~~-~~~l~-~~~--~~~~------~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..+-+.. ..+ -+.+. +.+ .++. ..+..+|+..++..||.+|+++.+++.
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 1110000 000 00000 000 0011 136678999999999999999999874
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=278.36 Aligned_cols=258 Identities=25% Similarity=0.317 Sum_probs=207.3
Q ss_pred HHHHHHhcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeC--
Q 007073 287 RELQLATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTT-- 362 (619)
Q Consensus 287 ~el~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~-- 362 (619)
+.+...++.|++.++||.|.+|.||+++. ++|+.+|+|++.... +.+++...|.++++.. .|||++.++|++..
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~--d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE--DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc--cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 33444567889999999999999999995 578999999886443 3456777888898876 59999999999853
Q ss_pred ---CCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEE
Q 007073 363 ---PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV 439 (619)
Q Consensus 363 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 439 (619)
++..+||||||.+||..+++.... +..+.|.....|+..+++|+.+||.. .++|||||-.|||++.++.||+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence 467899999999999999999877 55699999999999999999999999 9999999999999999999999
Q ss_pred cccccceeeccCCcceeeeccccccccccccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHH
Q 007073 440 GDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST-----GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 514 (619)
Q Consensus 440 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~ 514 (619)
.|||.+..+.... .......||+.|||||++.. ..|+..+|+||+|++..||--|.+|+......
T Consensus 165 vDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--------- 234 (953)
T KOG0587|consen 165 VDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--------- 234 (953)
T ss_pred eeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh---------
Confidence 9999998775433 23445679999999999954 34678999999999999999999997532211
Q ss_pred HHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 515 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..+. .-.-.+...-..+.....++.+++..|+.+|-++||++.++++
T Consensus 235 --raLF-----~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 235 --RALF-----LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred --hhhc-----cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 0000 0001111111225677889999999999999999999999874
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=257.33 Aligned_cols=260 Identities=20% Similarity=0.231 Sum_probs=197.9
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccC--CC----ccceeeeeeCCC
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH--RN----LLRLIGFCTTPT 364 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H--~n----iv~l~~~~~~~~ 364 (619)
.+++|.+...+|+|.||.|-.+.+. .+..||||+++.. ....+..+-|++++.++.+ |+ +|.+.+++.-.+
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 3678999999999999999999964 4789999998743 2334566789999999843 22 678888899999
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC------------
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD------------ 432 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~------------ 432 (619)
+.++|+|.+ |.|+.+++.+. +-.+++...+..|+.|++++++|||+. +++|-||||+|||+.
T Consensus 165 hiCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred ceEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCC
Confidence 999999987 45899999763 234588899999999999999999999 999999999999983
Q ss_pred --------CCCcEEEcccccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCcc
Q 007073 433 --------EDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRL 504 (619)
Q Consensus 433 --------~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~ 504 (619)
.+..++|+|||.|+.-.... ...+.|..|.|||++.+-.++.++||||+||||+|+.||...|..-..
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 13468999999998654332 455679999999999999999999999999999999999998865331
Q ss_pred ccccchhHHHHHHHHhhh-----------------ccc-----------chhcccccc----CCCCHHHHHHHHHHHHhc
Q 007073 505 EEEDDVLLLDHVKKLERE-----------------KRL-----------DAIVDRNLN----KNYNIQEVETMIQVALLC 552 (619)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~-----------------~~~-----------~~~~~~~l~----~~~~~~~~~~l~~l~~~C 552 (619)
. ..+ ..+.++..+ +++ ..+.+.... -.....+...+++|+..|
T Consensus 315 ~----EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m 389 (415)
T KOG0671|consen 315 L----EHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM 389 (415)
T ss_pred H----HHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence 1 111 111111110 000 000110000 011245557899999999
Q ss_pred cCCCCCCCCCHHHHHH
Q 007073 553 TQASPEDRPAMSEVVR 568 (619)
Q Consensus 553 l~~dP~~RPs~~evl~ 568 (619)
+..||.+|+|+.|+++
T Consensus 390 L~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 390 LEFDPARRITLREALS 405 (415)
T ss_pred HccCccccccHHHHhc
Confidence 9999999999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=281.87 Aligned_cols=246 Identities=27% Similarity=0.347 Sum_probs=186.2
Q ss_pred CcccCccccCCCc-eEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc-CCCccceeeeeeCCCcceeEeccc
Q 007073 296 FSEKNVLGQGGFG-KVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVYPFM 373 (619)
Q Consensus 296 ~~~~~~lg~G~fg-~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~ 373 (619)
|...+++|.|+.| .||+|.+ +|+.||||++-. +...-..+|+..++.-+ |||||++++.-.++...|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 5556789999998 6899999 589999999853 22345578999998774 999999998888888899999999
Q ss_pred ccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-----CCcEEEcccccceee
Q 007073 374 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-----DFEAVVGDFGLAKLV 448 (619)
Q Consensus 374 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfGla~~~ 448 (619)
.- +|.+++...........-.....+..|++.|+++||+. +||||||||.||||+. ...++|+|||+++.+
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 64 99999876311111111134567889999999999998 9999999999999975 257899999999998
Q ss_pred ccCCcce--eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 449 DVRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG-QRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 449 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
....... .....||-+|+|||.+....-+.++||||+||++|+.+|| ++||..... .+ ..-+.....+
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~---R~------~NIl~~~~~L 732 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE---RQ------ANILTGNYTL 732 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH---hh------hhhhcCccce
Confidence 7655443 3356799999999999998889999999999999999996 899963211 00 0001111111
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.. +. ...++ +..+|+.+|++.+|..||++.+|+.
T Consensus 733 ~~-----L~--~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 733 VH-----LE--PLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ee-----ec--cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 10 00 01111 6789999999999999999999983
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=248.54 Aligned_cols=253 Identities=21% Similarity=0.273 Sum_probs=196.5
Q ss_pred HHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccC--CCcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCc
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF--ESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTE 365 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 365 (619)
.....+|....+||+|+|+.|..++++ +.+.+|+|++++. .......=.+.|-.+..+. +||.+|-+..++.++.+
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 345678999999999999999999965 5788999998753 2222233344666676654 69999999999999999
Q ss_pred ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 445 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 445 (619)
.++|.||++||+|--+++.. ..++....+-+...|.-||.|||++ |||.||+|.+|||+|..|++|++|+|++
T Consensus 326 lffvieyv~ggdlmfhmqrq----rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmc 398 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMC 398 (593)
T ss_pred EEEEEEEecCcceeeehhhh----hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchh
Confidence 99999999999998777653 3388888888999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 446 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 446 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
+.- ..+...++.++||+.|+|||++.+..|...+|.|++||+++||+.|+.||+.-.+...+ ...-+......
T Consensus 399 ke~-l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d-~ntedylfqvi----- 471 (593)
T KOG0695|consen 399 KEG-LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPD-MNTEDYLFQVI----- 471 (593)
T ss_pred hcC-CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcc-cchhHHHHHHH-----
Confidence 853 33445567789999999999999999999999999999999999999999865443221 11112222221
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCCCC
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP 561 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 561 (619)
+.+.++. +...+.....+++.-+++||++|-
T Consensus 472 ---lekqiri--prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 472 ---LEKQIRI--PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ---hhhcccc--cceeehhhHHHHHHhhcCCcHHhc
Confidence 1111111 222223455677888999999984
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-31 Score=263.85 Aligned_cols=244 Identities=21% Similarity=0.230 Sum_probs=197.3
Q ss_pred hcCCcccCccccCCCceEEEEEeCCCc-EEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLADGT-KVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~-~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
..++.....||-|+||.|=.+..+... .+|+|.+++.. ...+.+....|-.+|...+.|.||++|-.+.+....|+.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 344555678999999999999875433 48999887543 344567788999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
||-|-||.+-..|++... ++..+..-++.-+.+|++|||++ +||.|||||+|.++|.+|-+||.|||+|+.+.
T Consensus 499 mEaClGGElWTiLrdRg~----Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRGS----FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred HHhhcCchhhhhhhhcCC----cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 999999999999987433 77888888999999999999999 99999999999999999999999999999876
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
.. ..+-.++||+.|.|||++.+..++.++|.||+|+++|||+||.+||.....-.. +..+...-..
T Consensus 572 ~g--~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt--------Yn~ILkGid~---- 637 (732)
T KOG0614|consen 572 SG--RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT--------YNLILKGIDK---- 637 (732)
T ss_pred cC--CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH--------HHHHHhhhhh----
Confidence 44 345567899999999999999999999999999999999999999975432111 1111111011
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCC
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPA 562 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 562 (619)
-.++........+++++.+..+|.+|-.
T Consensus 638 -----i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 638 -----IEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -----hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 1122333356778999999999999975
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=241.77 Aligned_cols=266 Identities=23% Similarity=0.312 Sum_probs=196.1
Q ss_pred cccCccccCCCceEEEEEe-CCCcEEEEEEeccC-CCcchHHHHHHHHHHHHHccCCCccceeeeeeCC-----CcceeE
Q 007073 297 SEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDF-ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-----TERLLV 369 (619)
Q Consensus 297 ~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lv 369 (619)
+..+.||.|+||.||...+ ++|+.||.|++... ..-...+.+.+|++++..++|.|++..+++..-+ ++.+++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3457899999999999996 58999999988643 2334567888999999999999999998877554 356778
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
.|.|.. +|...+- +...++-+..+-+..||.+||.|||+. +|.||||||.|.|++.+-.+||+|||+|+..+
T Consensus 136 TELmQS-DLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 136 TELMQS-DLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHh-hhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence 888764 5554443 344578888888999999999999999 99999999999999999999999999999887
Q ss_pred cCCcceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHH-------HHHhh
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV-------KKLER 521 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~ 521 (619)
.++....+..+-|..|.|||++++. .|+.+.||||.||+..|++..+..|.....-..-+. +.+.. .+..-
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~l-ItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQM-IIDLLGTPSQEAMKYAC 286 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHH-HHHHhCCCcHHHHHHHh
Confidence 7776667777788999999999875 589999999999999999998888765433211110 00000 00001
Q ss_pred hcccchhccccccC-C--------CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007073 522 EKRLDAIVDRNLNK-N--------YNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571 (619)
Q Consensus 522 ~~~~~~~~~~~l~~-~--------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 571 (619)
++--..++...... + .....-.+-.++...++..||+.|.+.++.+..+-
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11111122221111 1 01233345677888899999999999988876543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-28 Score=231.84 Aligned_cols=211 Identities=34% Similarity=0.507 Sum_probs=183.0
Q ss_pred cccCCCceEEEEEeCC-CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccchhhh
Q 007073 302 LGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAY 380 (619)
Q Consensus 302 lg~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 380 (619)
||+|++|.||++...+ |+.+++|++.........+.+.+|++.++.+.|++++++++++......++++||+++++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 899999998754322235789999999999999999999999999999999999999999999
Q ss_pred hhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-CCcEEEcccccceeeccCCcceeeec
Q 007073 381 RLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-DFEAVVGDFGLAKLVDVRKTNVTTQV 459 (619)
Q Consensus 381 ~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~ 459 (619)
++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 987642 3478899999999999999999999 9999999999999999 89999999999986644321 12234
Q ss_pred cccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCC
Q 007073 460 RGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 538 (619)
Q Consensus 460 ~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 538 (619)
.+...|++||..... .++.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 578899999999887 789999999999999999
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 539 IQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 539 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 257889999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=254.92 Aligned_cols=204 Identities=22% Similarity=0.273 Sum_probs=171.3
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
.-|..++.||-|+||.|.++... +...||+|.+++.. ..........|..||+..+.+=||+|+-.|.+.+..|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 34667788999999999999854 45679999987532 2334566778999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec-
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD- 449 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~- 449 (619)
+|++||++-.+|-.. ..+++...+-++..++.|+++.|.. |+|||||||+|||||.+|++||+|||+++-+.
T Consensus 709 dYIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred eccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccccccee
Confidence 999999999888753 3478888888899999999999999 99999999999999999999999999986441
Q ss_pred --------cCC-----cc---------------------------eeeeccccccccccccccCCCCCcchhhHHHHHHH
Q 007073 450 --------VRK-----TN---------------------------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 489 (619)
Q Consensus 450 --------~~~-----~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l 489 (619)
..+ +. .....+||+.|+|||++....|+..+|+||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 000 00 00123699999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCcc
Q 007073 490 LELVTGQRAIDFSRL 504 (619)
Q Consensus 490 ~elltg~~p~~~~~~ 504 (619)
|||+.|+.||.....
T Consensus 862 ~em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTP 876 (1034)
T ss_pred HHHhhCCCCccCCCC
Confidence 999999999976544
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=226.27 Aligned_cols=261 Identities=19% Similarity=0.300 Sum_probs=194.4
Q ss_pred HhcCCcccCccccCCCceEEEEE-eCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc-CCCccceeeeeeCCC--cce
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPT--ERL 367 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~~~ 367 (619)
..++|++.+.+|+|.++.||.|. ..+.++++||.++. ...+...+|+.++..+. ||||++++++..++. ...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 34678889999999999999999 45788999999974 44678899999999997 999999999997764 567
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-CcEEEcccccce
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLAK 446 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~ 446 (619)
+|+||+.+.+....... ++......++.++..||.|+|+. ||.|||+||.|++||.. ..++|+|||+|.
T Consensus 112 LiFE~v~n~Dfk~ly~t-------l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYPT-------LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred hHhhhhccccHHHHhhh-------hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHh
Confidence 99999998776655443 66667788999999999999999 99999999999999965 579999999999
Q ss_pred eeccCCcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHH--------
Q 007073 447 LVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK-------- 517 (619)
Q Consensus 447 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-------- 517 (619)
+..+..... -.+.+.-|.-||.+-. ..|+..-|+|||||++..|+..+.||-......+.-+.+.....
T Consensus 182 FYHp~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 182 FYHPGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred hcCCCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence 876554332 2234667888998865 45788999999999999999999999655433222222211111
Q ss_pred -HH--hhhcccchhccccccCC---C----CH-HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 518 -KL--EREKRLDAIVDRNLNKN---Y----NI-QEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 518 -~~--~~~~~~~~~~~~~l~~~---~----~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
+. ........++.+..+.. + +. -..++..+++...+..|..+|||++|...
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 10 11111222222211110 0 11 11257789999999999999999999874
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-29 Score=251.81 Aligned_cols=196 Identities=22% Similarity=0.333 Sum_probs=167.2
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC-------cchHHHHHHHHHHHHHcc---CCCccceeeeeeCC
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-------PGGDAAFQREVEMISVAV---HRNLLRLIGFCTTP 363 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-------~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~ 363 (619)
+|...+.+|+|+||.|+.|.++ +...|+||.+.+..- ....-..-.|+++|+.++ |+||++++++++++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 5788899999999999999986 467799998864221 111123446999999998 99999999999999
Q ss_pred CcceeEeccc-ccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007073 364 TERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 442 (619)
Q Consensus 364 ~~~~lv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 442 (619)
+.+++++|-. ++.+|.+++.... .+++.+...|+.||+.|+++||+. +|||||||-+||.++.+|-+||+||
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp----~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKP----RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccC----ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeec
Confidence 9999999875 4568888887643 389999999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcceeeeccccccccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCC
Q 007073 443 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAID 500 (619)
Q Consensus 443 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~elltg~~p~~ 500 (619)
|.|.+.. ......++||..|.|||++.+.+| ...-|||++|+++|-++....||.
T Consensus 715 gsaa~~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9998654 344566789999999999999887 667899999999999999888874
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=230.49 Aligned_cols=200 Identities=30% Similarity=0.422 Sum_probs=172.2
Q ss_pred CcccCccccCCCceEEEEEeCC-CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccc
Q 007073 296 FSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQ 374 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 374 (619)
|...+.||+|++|.||++...+ ++.+|+|.+.........+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999865 899999998754322256788899999999999999999999999899999999999
Q ss_pred cchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcc
Q 007073 375 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 454 (619)
Q Consensus 375 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 454 (619)
+++|.+++...... +++.....++.++++++.+||+. +++|+|++|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGGK---LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhcccC---CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 99999998764321 78889999999999999999999 9999999999999999999999999999877544311
Q ss_pred eeeeccccccccccccc-cCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 007073 455 VTTQVRGTMGHIAPEYL-STGKSSERTDVFGYGIMLLELVTGQRAIDF 501 (619)
Q Consensus 455 ~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~ 501 (619)
......++..|++||.+ ....++.++|||+||++++||++|+.||+.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22334578899999998 667788899999999999999999999953
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=235.84 Aligned_cols=133 Identities=22% Similarity=0.322 Sum_probs=109.9
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc-----C---CCccceeeeeeC
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-----H---RNLLRLIGFCTT 362 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~~~~~~ 362 (619)
...+|.+.++||-|.|++||++.+. +.+.||+|+.+.. ..-.+..+.|+++|++++ | ..||+|+++|..
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 3468889999999999999999964 5678999998642 334566788999999885 3 359999999854
Q ss_pred ----CCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe
Q 007073 363 ----PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL 431 (619)
Q Consensus 363 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 431 (619)
+.+.++|+|++ |.+|..++....-.+ ++...+++|+.||+.||.|||++| +|||-||||+|||+
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrG--lpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRG--LPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCCC--CcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 45789999998 457878876543333 888999999999999999999998 99999999999998
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=230.69 Aligned_cols=257 Identities=22% Similarity=0.264 Sum_probs=191.7
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccC-CCcchHHHHHHHHHHHHHccCCCccceeeeeeCC------C
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF-ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------T 364 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~ 364 (619)
..+|.....+|.|.- .|..+.+. .+++||+|++... ......+...+|...+..+.|+||++++.++.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 345666778888888 56666543 5899999987532 2334456778999999999999999999988533 4
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 444 (619)
+.++|||+|.. +|...+.. .++-.+...|..|+..|++|||+. +|+||||||+||++..+..+||.|||+
T Consensus 95 e~y~v~e~m~~-nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred hHHHHHHhhhh-HHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchh
Confidence 57999999964 77777762 167778899999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 445 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 445 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
|+..... ...+.++.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+.. .+-+|.+.....+.
T Consensus 165 ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-------~idQ~~ki~~~lgt 235 (369)
T KOG0665|consen 165 ARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-------HIDQWNKIIEQLGT 235 (369)
T ss_pred hcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-------HHHHHHHHHHHhcC
Confidence 9854332 35667788999999999998889999999999999999999998886321 11222221111111
Q ss_pred cc---------------------------hh-ccccccC--CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 525 LD---------------------------AI-VDRNLNK--NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 525 ~~---------------------------~~-~~~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
.. +. .|..... ..+.-......+++.+|+..+|++|.+.+++++.
T Consensus 236 pd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 236 PDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred CCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00 00 0100000 0112233467789999999999999999999853
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-27 Score=217.39 Aligned_cols=254 Identities=20% Similarity=0.301 Sum_probs=185.2
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeee-eeCCCcceeE
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGF-CTTPTERLLV 369 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~-~~~~~~~~lv 369 (619)
.+.|.+.+.+|+|.||.+-.++++ ..+.+++|-++... ...++|.+|...--.+ .|.||+.-+++ +++.+.++.+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 456888899999999999999986 56789999887543 3468899999874444 58999988765 5666778899
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC--CCCcEEEccccccee
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD--EDFEAVVGDFGLAKL 447 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfGla~~ 447 (619)
+||.+.|+|...+.... +-+....+++.|++.|+.|+|++ .+||||||.+||||- +...+||+|||+.+.
T Consensus 101 qE~aP~gdL~snv~~~G-----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAG-----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred eccCccchhhhhcCccc-----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccc
Confidence 99999999998876522 66677889999999999999999 999999999999993 335899999999875
Q ss_pred eccCCcceeeeccccccccccccccCC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh
Q 007073 448 VDVRKTNVTTQVRGTMGHIAPEYLSTG-----KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 522 (619)
Q Consensus 448 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 522 (619)
.+.. .....-+..|.+||..... ...+.+|||.||+++|.++||+.||...... +...+.|.....+
T Consensus 173 ~g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~---d~~Y~~~~~w~~r- 244 (378)
T KOG1345|consen 173 VGTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM---DKPYWEWEQWLKR- 244 (378)
T ss_pred cCce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc---CchHHHHHHHhcc-
Confidence 4321 1222346689999977432 3478899999999999999999999743332 2223333333221
Q ss_pred cccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007073 523 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571 (619)
Q Consensus 523 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 571 (619)
....+ ...+. ...+.+.++.++-+..+|++|=...++.++-.
T Consensus 245 --k~~~~----P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 245 --KNPAL----PKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred --cCccC----chhhc-ccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 11111 11111 12346677888899999999955555544433
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=230.01 Aligned_cols=267 Identities=21% Similarity=0.313 Sum_probs=198.4
Q ss_pred HHHHhcCCcccCccccCCCceEEEEEeC----CCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc-CCCccceeeeeeCC
Q 007073 289 LQLATDNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTP 363 (619)
Q Consensus 289 l~~~~~~~~~~~~lg~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~ 363 (619)
+....+.|...++||+|.|++||++... ..+.||+|.+.....+ .....|++++..+. +.||+++.+++...
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 4456677889999999999999999953 4678999998765443 45789999999885 89999999999999
Q ss_pred CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-CcEEEccc
Q 007073 364 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDF 442 (619)
Q Consensus 364 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df 442 (619)
+...+|+||++.....++... ++......++..+..||+++|.+ |||||||||+|+|.+.. +.-.|.||
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEec
Confidence 999999999999888888876 67888999999999999999999 99999999999999854 56789999
Q ss_pred ccceeeccCC-------------------------------------------cceeeeccccccccccccccCC-CCCc
Q 007073 443 GLAKLVDVRK-------------------------------------------TNVTTQVRGTMGHIAPEYLSTG-KSSE 478 (619)
Q Consensus 443 Gla~~~~~~~-------------------------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ 478 (619)
|+|...+... ........||+||.|||++... ..++
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 9997221000 0001123599999999998764 5699
Q ss_pred chhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHH------HHhhhcc--cch---------h------cc-ccc-
Q 007073 479 RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK------KLEREKR--LDA---------I------VD-RNL- 533 (619)
Q Consensus 479 ~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~------~~~~~~~--~~~---------~------~~-~~l- 533 (619)
++||||-||+++-+++++.||-.+..+...-..+..... .....+. +.+ . ++ ...
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 999999999999999999999655443332222211110 0111111 000 0 00 000
Q ss_pred --------cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 534 --------NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 534 --------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
........+..+++++.+|+..||.+|.|+++.+.
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 00111233347899999999999999999999884
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=247.10 Aligned_cols=253 Identities=22% Similarity=0.281 Sum_probs=197.1
Q ss_pred hcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.++|+....+|+|.+|.|||++. ..++..|||+++- ...+.....++|+-+++..+|||||.++|.+-..+..++.||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkL-ep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKL-EPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeec-cCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 45788889999999999999996 4789999999863 223445667889999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+.+|+|.+.-+-.. +++..+...+++...+|++|||+. +=+|||||-.||++++.+.+|++|||.+..+...
T Consensus 93 ycgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred ecCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh
Confidence 999999998777543 488888899999999999999999 8899999999999999999999999998755322
Q ss_pred Ccceeeeccccccccccccc---cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 452 KTNVTTQVRGTMGHIAPEYL---STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
......+.||+.|||||+. ..+.|..++|||+.|+...|+---..|.-.-. -.+.. .+-.. ..
T Consensus 166 -i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh--------pmr~l-~LmTk----S~ 231 (829)
T KOG0576|consen 166 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH--------PMRAL-FLMTK----SG 231 (829)
T ss_pred -hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc--------hHHHH-HHhhc----cC
Confidence 2233456799999999976 46779999999999999999876555531100 00000 00000 01
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.++...+ -.....+.+.++++.|+.++|++||+++.++.
T Consensus 232 ~qpp~lk-Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 232 FQPPTLK-DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCCccc-CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1111111 12344578899999999999999999987764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-27 Score=218.40 Aligned_cols=247 Identities=23% Similarity=0.314 Sum_probs=191.9
Q ss_pred cCccccCCCceEEEEEeCCCcEEEEEEecc-CCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccch
Q 007073 299 KNVLGQGGFGKVYRGVLADGTKVAVKRLTD-FESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS 377 (619)
Q Consensus 299 ~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~-~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 377 (619)
..+|.+...|..|+|+|. |..+++|++.- ..+....++|..|.-.++-+.||||++++|.|..+....++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 346889999999999996 56666777652 2334456789999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcceee
Q 007073 378 VAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT 457 (619)
Q Consensus 378 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 457 (619)
|...+++. .....+..+..+++.++|+|++|||+.. |-|.---+.+..|++|++.+++|+- +-+++- ....
T Consensus 274 lynvlhe~--t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kfs-----fqe~ 344 (448)
T KOG0195|consen 274 LYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKFS-----FQEV 344 (448)
T ss_pred HHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-ccceee-----eecc
Confidence 99999974 3456788889999999999999999973 2343446889999999999988752 111110 0001
Q ss_pred eccccccccccccccCCCC---CcchhhHHHHHHHHHHHhCCCCCCCCcc-ccccchhHHHHHHHHhhhcccchhccccc
Q 007073 458 QVRGTMGHIAPEYLSTGKS---SERTDVFGYGIMLLELVTGQRAIDFSRL-EEEDDVLLLDHVKKLEREKRLDAIVDRNL 533 (619)
Q Consensus 458 ~~~gt~~y~aPE~~~~~~~---~~~~Dv~S~Gv~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 533 (619)
...-.+.||+||.++..+. -.++|+|||++++||+.|...||..-+. +-. ..+--..+
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg------------------mkialegl 406 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG------------------MKIALEGL 406 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh------------------hhhhhccc
Confidence 1123678999999987764 4579999999999999999999975322 111 11222334
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 534 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 534 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
+...++..+..+.+++.-|++.||.+||.+..|+-.||++
T Consensus 407 rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 407 RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 5556777788999999999999999999999999999875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=231.85 Aligned_cols=209 Identities=22% Similarity=0.226 Sum_probs=173.8
Q ss_pred cCHHHHHHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc------CCCccce
Q 007073 284 YSWRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV------HRNLLRL 356 (619)
Q Consensus 284 ~~~~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~------H~niv~l 356 (619)
|.+.-.+....+|.+....|+|-|++|.+|... -|..||||++.... ...+.=+.|+++|+++. --+.+++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE--~M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE--VMHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch--HHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 344455667788999999999999999999964 47899999997543 23445578999999986 3578999
Q ss_pred eeeeeCCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-C
Q 007073 357 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-F 435 (619)
Q Consensus 357 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~ 435 (619)
+..|...++.|+|||-+. .+|.+.|..+.. ..-+....+..++.|+.-||..|... +|+|.||||+|||+++. .
T Consensus 500 ~r~F~hknHLClVFE~Ls-lNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPLS-LNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHhhhcceeEEEehhhh-chHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcc
Confidence 999999999999999775 488888887654 33478888999999999999999987 99999999999999976 5
Q ss_pred cEEEcccccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 007073 436 EAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 502 (619)
Q Consensus 436 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~ 502 (619)
.+||||||.|........ +.+.-+..|.|||++.+.+|+...|+||.||.|||+.||+..|+..
T Consensus 575 iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred eeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 679999999987654332 2334466899999999999999999999999999999999998754
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-26 Score=263.16 Aligned_cols=194 Identities=14% Similarity=0.157 Sum_probs=137.5
Q ss_pred ccC-CCccceeeeee-------CCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 007073 348 AVH-RNLLRLIGFCT-------TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 419 (619)
Q Consensus 348 l~H-~niv~l~~~~~-------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 419 (619)
++| +||+++++++. .....+.++||+ +++|.+++... ...++..+++.++.||++||+|||++ +|
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 445 57888888772 223466778877 55999999742 24489999999999999999999999 99
Q ss_pred EecCCCCCcEEeCC-------------------CCcEEEcccccceeeccCCc---------------ceeeeccccccc
Q 007073 420 IHRDVKAANVLLDE-------------------DFEAVVGDFGLAKLVDVRKT---------------NVTTQVRGTMGH 465 (619)
Q Consensus 420 vH~Dlkp~NIll~~-------------------~~~~kl~DfGla~~~~~~~~---------------~~~~~~~gt~~y 465 (619)
+||||||+|||++. ++.+|++|||+++....... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 45566777777654311000 001123578899
Q ss_pred cccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHH
Q 007073 466 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETM 545 (619)
Q Consensus 466 ~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 545 (619)
||||++.+..++.++|||||||++|||++|..|+.... ......... ...+. ........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~------~~~~~~~~~---------~~~~~-----~~~~~~~~ 241 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS------RTMSSLRHR---------VLPPQ-----ILLNWPKE 241 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH------HHHHHHHHh---------hcChh-----hhhcCHHH
Confidence 99999999999999999999999999999888754210 000000000 01110 01112345
Q ss_pred HHHHHhccCCCCCCCCCHHHHHH
Q 007073 546 IQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 546 ~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.+++.+||+.+|.+||++.|+++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhh
Confidence 68889999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.7e-25 Score=204.81 Aligned_cols=166 Identities=20% Similarity=0.190 Sum_probs=124.0
Q ss_pred chhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcce
Q 007073 376 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455 (619)
Q Consensus 376 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 455 (619)
|+|.++++.. +..+++..+..++.|++.||+|||++ + ||+||+++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 6788888753 23489999999999999999999998 5 999999999999999 99998764322
Q ss_pred eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccC
Q 007073 456 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 535 (619)
Q Consensus 456 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 535 (619)
..||+.|||||++.+..++.++|||||||++|||+||+.||...... .............. ...+ .
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~---~~~~~~~~~~~~~~----~~~~----~ 129 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL---SAILEILLNGMPAD----DPRD----R 129 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh---cHHHHHHHHHhccC----Cccc----c
Confidence 25899999999999999999999999999999999999998542211 11111111111000 0000 0
Q ss_pred CCCHHHHH--HHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 536 NYNIQEVE--TMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 536 ~~~~~~~~--~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
........ .+.+++.+||+.+|++||++.++++.+..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 01112222 68999999999999999999999987755
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-23 Score=213.05 Aligned_cols=257 Identities=20% Similarity=0.236 Sum_probs=190.3
Q ss_pred CCcccCccccCCCceEEEEEeCCC--cEEEEEEeccCCCcchHHHHHHHHHHHHHccC----CCccceeeee-eCCCcce
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLADG--TKVAVKRLTDFESPGGDAAFQREVEMISVAVH----RNLLRLIGFC-TTPTERL 367 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~~g--~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~~~~-~~~~~~~ 367 (619)
+|.+.+.||+|+||.||.+...+. ..+|+|........... .+..|..++..+.. +++..+++.. ..+...+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 799999999999999999997543 47888877543322222 67788998888863 6888888888 4667789
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-----CcEEEccc
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-----FEAVVGDF 442 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~Df 442 (619)
+||+.+ |.+|.+...... ...++..+...|+.|+..+|+++|+. |++||||||.|+++... ..+.|.||
T Consensus 98 iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 998866 668888776544 45699999999999999999999999 99999999999999865 46999999
Q ss_pred ccce--eeccCCc------ce-eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHH
Q 007073 443 GLAK--LVDVRKT------NV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL 513 (619)
Q Consensus 443 Gla~--~~~~~~~------~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~ 513 (619)
|+++ ....... .. .....||..|+++....+.+.+.+.|+||++.++.|++.|..||........ .
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-----~ 246 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-----K 246 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-----H
Confidence 9998 3321111 11 2345699999999999999999999999999999999999999964332211 1
Q ss_pred HHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 514 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
..+........... .....+..+.++...+-..+..++|....+...++.
T Consensus 247 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~ 296 (322)
T KOG1164|consen 247 SKFEKDPRKLLTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKD 296 (322)
T ss_pred HHHHHHhhhhcccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHH
Confidence 11111111111100 111122455566666666899999999999988766
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=215.75 Aligned_cols=167 Identities=26% Similarity=0.275 Sum_probs=130.0
Q ss_pred HHhcCCcccCccccCCCceEEEEEeC--CCcEEEEEEeccCC----CcchHHHHHHHHHHHHHccCCCccceeeeeeCCC
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLA--DGTKVAVKRLTDFE----SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT 364 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~g~~vAvK~l~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 364 (619)
...++|.+.+.||+|+||+||+|.+. +++.||||++.... .......|.+|++++++++|+|+++.+..+ .
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C
Confidence 45678999999999999999999864 57888999875321 122356789999999999999998633222 4
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCcEEeCCCCcEEEcccc
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDV-KAANVLLDEDFEAVVGDFG 443 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DfG 443 (619)
..++||||+++++|... . ... ...++.++++||.|||++ +|+|||| ||+|||++.++.+||+|||
T Consensus 92 ~~~LVmE~~~G~~L~~~-~---~~~-------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-R---PHG-------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CcEEEEEccCCCCHHHh-C---ccc-------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 57999999999999632 1 100 146788999999999999 9999999 9999999999999999999
Q ss_pred cceeeccCCccee-------eeccccccccccccccCC
Q 007073 444 LAKLVDVRKTNVT-------TQVRGTMGHIAPEYLSTG 474 (619)
Q Consensus 444 la~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~ 474 (619)
+|+.+........ ....+++.|+|||++...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9997754321111 245678899999998643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-23 Score=189.59 Aligned_cols=261 Identities=18% Similarity=0.227 Sum_probs=200.2
Q ss_pred HhcCCcccCccccCCCceEEEEE-eCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccC-CCccceeeeeeCCCcceeE
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH-RNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lv 369 (619)
...+|.+++.||+|+||.+|.|. ..+|..||||.-.. .....++..|.+++..++| ..|..+..+..+.....+|
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~---~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS---KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecc---cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 45679999999999999999999 46899999997643 2335677889999999985 7788888888888899999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC---CcEEEcccccce
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED---FEAVVGDFGLAK 446 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGla~ 446 (619)
|+.+ |.+|.+.+..... .++..+.+-++-|+..-++|+|.+ +++||||||+|+|..-+ ..+.++|||+|+
T Consensus 90 MdLL-GPsLEdLfnfC~R---~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSR---RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eecc-CccHHHHHHHHhh---hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence 9987 6688888876433 378889999999999999999999 99999999999998643 568999999999
Q ss_pred eeccCCcc------eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh
Q 007073 447 LVDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 520 (619)
Q Consensus 447 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 520 (619)
.+.+..+. ......||.+|.+--...+.+.+.+.|+-|+|.++.+.--|..||..-...... +.+..+.
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~-----QKyEkI~ 237 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK-----QKYEKIS 237 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH-----HHHHHHH
Confidence 87543322 223456999999999888888899999999999999999999999764432211 1111111
Q ss_pred hhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 521 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 521 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
+..+...+ .......+.++.-.+.-|-..--++-|...-+-+.++.+
T Consensus 238 -EkK~s~~i-----e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 238 -EKKMSTPI-----EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred -HhhcCCCH-----HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 11111111 112334456778888899999999999988877776654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.2e-21 Score=196.20 Aligned_cols=262 Identities=26% Similarity=0.330 Sum_probs=197.4
Q ss_pred CcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcc--hHHHHHHHHHHHHHccCC-CccceeeeeeCCCcceeEecc
Q 007073 296 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHR-NLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~--~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lv~e~ 372 (619)
|...+.||.|+||.||++... ..+++|.+....... ....+.+|+.+++.+.|+ +++++.+++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999986 889999987654443 477899999999999988 799999999777778999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-cEEEcccccceeeccC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-EAVVGDFGLAKLVDVR 451 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~ 451 (619)
+.++++.+.+...... ..+.......++.|++.++.|+|+. +++|||+||+||+++... .++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999666543211 3578889999999999999999999 999999999999999988 7999999999866443
Q ss_pred Ccc-----eeeeccccccccccccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007073 452 KTN-----VTTQVRGTMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 523 (619)
Q Consensus 452 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (619)
... ......|+..|+|||.+.+ ..++...|+||+|++++++++|..|+...... ................
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~- 233 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-SATSQTLKIILELPTP- 233 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-ccHHHHHHHHHhcCCc-
Confidence 322 2355679999999999987 57899999999999999999999996543321 0001111111111100
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 524 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 524 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
.................+.+++..|+..+|..|.+..+....
T Consensus 234 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 ----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223567889999999999999998887653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.5e-21 Score=183.31 Aligned_cols=258 Identities=18% Similarity=0.216 Sum_probs=195.3
Q ss_pred cCCcccCccccCCCceEEEEE-eCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc-CCCccceeeeeeCCCcceeEec
Q 007073 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e 371 (619)
-.|.++++||+|.||..+.|+ +-++.+||||.-.. .....++..|.+.++.+. .++|...+-+..++.+..+|+|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr---kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR---KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccc---cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 468899999999999999999 45799999996532 223567788999999886 6899998888888888999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-----CCcEEEcccccce
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-----DFEAVVGDFGLAK 446 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfGla~ 446 (619)
.+ |.||.++..-+. ..++..++..+|.|+..-++|+|++ ..|.|||||+|+||.. ...+.++|||+|+
T Consensus 105 LL-GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hh-CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 87 568888776543 3489999999999999999999999 9999999999999964 3468999999999
Q ss_pred eeccCCcce------eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh
Q 007073 447 LVDVRKTNV------TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 520 (619)
Q Consensus 447 ~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 520 (619)
.+.+.++.. .....||.+||+-....+.+-+.+.|.-|+|-+.++.+-|..||..-..+... +.+.++.
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK-----~kYeKIG 252 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK-----EKYEKIG 252 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH-----HHHHHhc
Confidence 875544332 23456999999999999999999999999999999999999999875543321 1122221
Q ss_pred hhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 521 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 521 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
..++...+- ......+.++...+.-.-..+-.+-|..+-+...+.+
T Consensus 253 e~Kr~T~i~------~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~d 298 (449)
T KOG1165|consen 253 ETKRSTPIE------VLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDD 298 (449)
T ss_pred cccccCCHH------HHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 111111000 0122334456666666667788888887766655544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.2e-22 Score=218.99 Aligned_cols=254 Identities=18% Similarity=0.209 Sum_probs=185.7
Q ss_pred cccCccccCCCceEEEEEeC-CCcEEEEEEec----cCCCcc-hHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 297 SEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLT----DFESPG-GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 297 ~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~----~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
...+++|.|++|.|+..... .....+.|..+ ...... ....+..|+-+-..+.|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34678999999988877743 34444444332 111111 1122555676777889999988887777766666669
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++ +|...+... ..+....+..++.|+..|++|+|+. ||.|||+|++|++++.++.+||+|||.+.....
T Consensus 401 E~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 999888763 2377778888999999999999999 999999999999999999999999999987754
Q ss_pred CCc---ceeeeccccccccccccccCCCCCc-chhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 451 RKT---NVTTQVRGTMGHIAPEYLSTGKSSE-RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 451 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
... ......+|+.+|+|||.+.+..|.+ ..||||.|+++..|++|+.||.......... .......+..
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-------~~~~~~~~~~ 545 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-------KTNNYSDQRN 545 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-------hhhccccccc
Confidence 332 4456778999999999999999865 5899999999999999999997655432210 0000000000
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. ..+ ........+.....++.++++.+|.+|.|+++|++
T Consensus 546 ~-~~~--~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 I-FEG--PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred c-ccC--hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0 000 01112344567788999999999999999999985
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3e-21 Score=214.44 Aligned_cols=158 Identities=36% Similarity=0.628 Sum_probs=117.9
Q ss_pred chhHHHHHHHHHhcCCCCCCCCCCCCCCCCCC-----CcceeEEcCC-----CCeEEEEeCCCCccccCCccccCCCCCC
Q 007073 34 SLSGDALFALRTSLRVPNNQLRDWNQNQVNPC-----TWSNVICDNS-----NNVASVTLSSMNFSGTLSPRIGVLRTLS 103 (619)
Q Consensus 34 ~~~~~al~~~k~~l~~~~~~l~~w~~~~~~~c-----~w~gv~c~~~-----~~l~~L~L~~n~l~~~~~~~~~~l~~L~ 103 (619)
..|..||+++|+++.++.. .+|++ +|| .|.||.|... ..++.|+|++|++.|.+|..++.|++|+
T Consensus 371 ~~~~~aL~~~k~~~~~~~~--~~W~g---~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~ 445 (623)
T PLN03150 371 LEEVSALQTLKSSLGLPLR--FGWNG---DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQ 445 (623)
T ss_pred chHHHHHHHHHHhcCCccc--CCCCC---CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCC
Confidence 4589999999999876542 48975 455 7999999631 1377888888888888888888888888
Q ss_pred EEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCCCc
Q 007073 104 TLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNN 183 (619)
Q Consensus 104 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 183 (619)
.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+|..+++|++|+.|+|++|+++|.+|..+..+
T Consensus 446 ~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~------------ 513 (623)
T PLN03150 446 SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR------------ 513 (623)
T ss_pred EEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhc------------
Confidence 88888888888888778888888888888888887777777777777777777777777777665432
Q ss_pred ccccCCccccccCccccCCCCCCCCCCCCCCCC
Q 007073 184 LSGQIPVHLFQIPKYNFTGNNLNCGKTLPHSCE 216 (619)
Q Consensus 184 l~~~~p~~l~~l~~l~~~~n~~~c~~~~~~~c~ 216 (619)
+.++..+++.+|+..|+.+....|.
T Consensus 514 --------~~~~~~l~~~~N~~lc~~p~l~~C~ 538 (623)
T PLN03150 514 --------LLHRASFNFTDNAGLCGIPGLRACG 538 (623)
T ss_pred --------cccCceEEecCCccccCCCCCCCCc
Confidence 0122346677888888876556675
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.2e-21 Score=225.82 Aligned_cols=171 Identities=37% Similarity=0.603 Sum_probs=125.0
Q ss_pred chhHHHHHHHHHhcCCCCCCCCCCCCCCCCCCCcceeEEcCCCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCC
Q 007073 34 SLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGIT 113 (619)
Q Consensus 34 ~~~~~al~~~k~~l~~~~~~l~~w~~~~~~~c~w~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 113 (619)
..|..||++||+++.+|.+.+.+|+. ..+||.|.||+|++.++|+.|+|++|++++.++..|..+++|+.|+|++|+++
T Consensus 28 ~~~~~~l~~~~~~~~~~~~~~~~w~~-~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~ 106 (968)
T PLN00113 28 AEELELLLSFKSSINDPLKYLSNWNS-SADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLS 106 (968)
T ss_pred HHHHHHHHHHHHhCCCCcccCCCCCC-CCCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccC
Confidence 46899999999999888888999975 45899999999998889999999999999999999999999999999999999
Q ss_pred CCCccccc-ccccCcEeeecCCCccccC----------------------CCcccccccchhhhccCCcCCCCCCCcccc
Q 007073 114 GEIPEELG-NLSSLTSLDLDNNRLVGKI----------------------PPSLGNLKKLQFLTLSQNNFSGTIPDSLTT 170 (619)
Q Consensus 114 ~~~p~~~~-~l~~L~~L~L~~N~l~~~~----------------------p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 170 (619)
+.+|..+. ++++|++|+|++|+++|.+ |..++++++|+.|+|++|.+.+.+|..+.+
T Consensus 107 ~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~ 186 (968)
T PLN00113 107 GPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTN 186 (968)
T ss_pred CcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhh
Confidence 88887654 6777777777777666544 444555555555555555555555555555
Q ss_pred ccccccccCCCCcccccCCccccc---cCccccCCCCC
Q 007073 171 LSSLISIQLDSNNLSGQIPVHLFQ---IPKYNFTGNNL 205 (619)
Q Consensus 171 l~~L~~L~l~~N~l~~~~p~~l~~---l~~l~~~~n~~ 205 (619)
+++|++|+|++|++++.+|..+.+ +..|++.+|..
T Consensus 187 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l 224 (968)
T PLN00113 187 LTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL 224 (968)
T ss_pred CcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCcc
Confidence 555555555555555555544332 33344555543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=177.97 Aligned_cols=140 Identities=16% Similarity=0.154 Sum_probs=107.6
Q ss_pred cCccccCCCceEEEEEeCCCcEEEEEEeccCCCc-ch-------HH-----------------HHHHHHHHHHHccCCCc
Q 007073 299 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESP-GG-------DA-----------------AFQREVEMISVAVHRNL 353 (619)
Q Consensus 299 ~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~-~~-------~~-----------------~~~~E~~~l~~l~H~ni 353 (619)
...||+|+||.||+|...+|+.||||+++..... .. .. ....|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999888999999998643211 11 11 22349999999988877
Q ss_pred cceeeeeeCCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCcEEeC
Q 007073 354 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL-HEHCNPKIIHRDVKAANVLLD 432 (619)
Q Consensus 354 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~Dlkp~NIll~ 432 (619)
.....+.. ...++||||++++++...... ...++.....+++.|++.+|.|+ |+. +|+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 44333222 234899999998776544322 12478888999999999999999 688 999999999999998
Q ss_pred CCCcEEEcccccceee
Q 007073 433 EDFEAVVGDFGLAKLV 448 (619)
Q Consensus 433 ~~~~~kl~DfGla~~~ 448 (619)
++.++|+|||+|...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.4e-21 Score=208.58 Aligned_cols=261 Identities=21% Similarity=0.249 Sum_probs=192.4
Q ss_pred CCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHH--HHHccCCCccceeeeeeCCCcceeEecc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEM--ISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
++...+.||++.|=+|.+|++++|. |+||++.+....-..+.|.++++- ...++|||.+++.-+-.+....++|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5666789999999999999998887 899998765544445555544443 5567899999987777777778899999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee--ecc
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL--VDV 450 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~--~~~ 450 (619)
+.+ +|.+.+.. .+-+...+.+-|+.|+..|+.-+|+. +|+|||||.+||||+.-.=+.|+||-.-+- +..
T Consensus 103 vkh-nLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 103 VKH-NLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred Hhh-hhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 876 88888764 34477888888999999999999999 999999999999999888899999976542 233
Q ss_pred CCcceeeecc----ccccccccccccCC-----------CCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHH
Q 007073 451 RKTNVTTQVR----GTMGHIAPEYLSTG-----------KSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLD 514 (619)
Q Consensus 451 ~~~~~~~~~~----gt~~y~aPE~~~~~-----------~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 514 (619)
++....+.+. .-..|+|||.+... ..+++.||||.||++.|+++ |+++|..++.-+....
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~---- 250 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSG---- 250 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhcc----
Confidence 3333222222 23479999987431 15788999999999999999 6777754322100000
Q ss_pred HHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcccchhhh
Q 007073 515 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEW 582 (619)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~ 582 (619)
.....+..+..+-| ..+.+++..|++.||++|-++++.++.-++..|.+-|..+
T Consensus 251 --~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~yFy~F 304 (1431)
T KOG1240|consen 251 --NADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFPEYFYSF 304 (1431)
T ss_pred --CccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhhhccccHHHHHHH
Confidence 00011111222222 2577899999999999999999999999999888877654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-20 Score=179.52 Aligned_cols=173 Identities=13% Similarity=0.099 Sum_probs=133.3
Q ss_pred HHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcch--HHH------HHHHHHHHHHccCCCccceeeeeeC
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGG--DAA------FQREVEMISVAVHRNLLRLIGFCTT 362 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~--~~~------~~~E~~~l~~l~H~niv~l~~~~~~ 362 (619)
...++|...+++|+|+||.||.+.. ++..+|||.+++...... ... +.+|+..+.++.|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4678899999999999999999766 577899999975432221 122 6789999999999999999887553
Q ss_pred C--------CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC
Q 007073 363 P--------TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED 434 (619)
Q Consensus 363 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 434 (619)
. ...++||||++|.+|.+... ++. ....+++.++..+|+. |++|||+||+||+++.+
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN 171 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence 2 35789999999999977632 221 2456899999999999 99999999999999998
Q ss_pred CcEEEcccccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHH
Q 007073 435 FEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 493 (619)
Q Consensus 435 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ell 493 (619)
+ ++++|||........... ..+.....+..++|+||||+.+....
T Consensus 172 g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 8 999999988644221111 11334455678999999999877654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.5e-20 Score=193.66 Aligned_cols=215 Identities=22% Similarity=0.356 Sum_probs=162.3
Q ss_pred HHccCCCccceeeeeeCCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCe-EecCC
Q 007073 346 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI-IHRDV 424 (619)
Q Consensus 346 ~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i-vH~Dl 424 (619)
+.+.|.|+.+++|.+..+...+.|.+|+..|+|.+.+.. ....+++.....+..+++.||+|+|.. +| .|+.+
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 567899999999999999999999999999999999987 334589999999999999999999987 55 89999
Q ss_pred CCCcEEeCCCCcEEEcccccceeeccC-CcceeeeccccccccccccccCC-------CCCcchhhHHHHHHHHHHHhCC
Q 007073 425 KAANVLLDEDFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGHIAPEYLSTG-------KSSERTDVFGYGIMLLELVTGQ 496 (619)
Q Consensus 425 kp~NIll~~~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~S~Gv~l~elltg~ 496 (619)
+++|.++|....+|++|||+....... .........-..-|.|||.+... ..+.++||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998766421 11111112234579999998763 1477899999999999999999
Q ss_pred CCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007073 497 RAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 574 (619)
Q Consensus 497 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 574 (619)
.||+........ ..+...+.. .....+.+.+... .+....+..++.+||..+|.+||++++|-..++...
T Consensus 156 ~~~~~~~~~~~~-~eii~~~~~-----~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 156 GPFDLRNLVEDP-DEIILRVKK-----GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred CccccccccCCh-HHHHHHHHh-----cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 999864443332 112222222 0111111111110 133347899999999999999999999998888653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-19 Score=170.94 Aligned_cols=140 Identities=17% Similarity=0.170 Sum_probs=110.0
Q ss_pred cCccccCCCceEEEEEeCCCcEEEEEEeccCCCc-ch------------------------HHHHHHHHHHHHHccCCCc
Q 007073 299 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESP-GG------------------------DAAFQREVEMISVAVHRNL 353 (619)
Q Consensus 299 ~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~-~~------------------------~~~~~~E~~~l~~l~H~ni 353 (619)
...||+|+||.||+|...+|+.||||+++..... .. ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998753211 00 1223578899999999987
Q ss_pred cceeeeeeCCCcceeEecccccchhhhh-hcccCCCCCCcCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEe
Q 007073 354 LRLIGFCTTPTERLLVYPFMQNLSVAYR-LREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLL 431 (619)
Q Consensus 354 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll 431 (619)
.....+... ..++||||++++++... +.. ..++.....+++.|++.++.++|+ . ||+||||||+||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 554444332 35899999998855433 322 236677888999999999999999 8 99999999999999
Q ss_pred CCCCcEEEcccccceeec
Q 007073 432 DEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 432 ~~~~~~kl~DfGla~~~~ 449 (619)
+ ++.++|+|||++....
T Consensus 152 ~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 152 H-DGKPYIIDVSQAVELD 168 (190)
T ss_pred E-CCCEEEEEcccceecC
Confidence 9 7899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-19 Score=177.80 Aligned_cols=233 Identities=23% Similarity=0.273 Sum_probs=149.7
Q ss_pred CcccCccccCCCceEEEEEeC-CCcEEEEEEeccC--CCcchHHHHHHHHHHHHHcc----------C-CCccceeeeee
Q 007073 296 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAV----------H-RNLLRLIGFCT 361 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~~E~~~l~~l~----------H-~niv~l~~~~~ 361 (619)
+...+.||.|+++.||.+++. +|+++|||...-. ......+++.+|.-....+. | +-++++ +...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~-d~~~ 92 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL-DLLR 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S-EEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee-EEEE
Confidence 345678999999999999976 5899999987532 23345667777765544432 2 222222 2211
Q ss_pred ---------CCC--------cceeEecccccchhhhhhcc---cCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 007073 362 ---------TPT--------ERLLVYPFMQNLSVAYRLRE---IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 421 (619)
Q Consensus 362 ---------~~~--------~~~lv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH 421 (619)
... ..+++|+-+ .++|.+.+.. .......+....+..+..|+++.+++||+. |++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence 111 124556655 3477666542 222233456667788889999999999999 9999
Q ss_pred cCCCCCcEEeCCCCcEEEcccccceeeccCCcceeeeccccccccccccccC--------CCCCcchhhHHHHHHHHHHH
Q 007073 422 RDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST--------GKSSERTDVFGYGIMLLELV 493 (619)
Q Consensus 422 ~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~S~Gv~l~ell 493 (619)
+||+|+|++++.+|.++|+||+.....+.. ......+..|.+||.... -.+|.+.|.|++|+++|.|.
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999999987654321 111335678999997743 24789999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCC
Q 007073 494 TGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDR 560 (619)
Q Consensus 494 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 560 (619)
+|..||+.......... ....+. +.++.+..|+..+++.+|.+|
T Consensus 245 C~~lPf~~~~~~~~~~~----------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW----------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG----------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc----------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999986543322211 111233 667889999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-19 Score=167.48 Aligned_cols=184 Identities=21% Similarity=0.110 Sum_probs=137.3
Q ss_pred ccCccccCCCceEEEEEeCCCcEEEEEEeccCCC---cchHHHHHHHHHHHHHcc-CCCccceeeeeeCCCcceeEeccc
Q 007073 298 EKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFES---PGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVYPFM 373 (619)
Q Consensus 298 ~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~ 373 (619)
+...|++|+||+||.+.. ++.+++.+.+..... .-....|.+|+++++++. |+++.+++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 467899999999997776 678888777754322 111225789999999996 5889999886 4568999999
Q ss_pred ccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 374 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDV-KAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 374 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
.|.+|...... ....++.|+++++.++|+. ||+|||| ||+|||++.++.++|+|||+|.......
T Consensus 81 ~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 81 AGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred cCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99888643321 1134678999999999999 9999999 7999999999999999999998654322
Q ss_pred cc----e--------eeeccccccccccccccCC-CCC-cchhhHHHHHHHHHHHhCCCCCC
Q 007073 453 TN----V--------TTQVRGTMGHIAPEYLSTG-KSS-ERTDVFGYGIMLLELVTGQRAID 500 (619)
Q Consensus 453 ~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~S~Gv~l~elltg~~p~~ 500 (619)
.. . ......++.|++|+...-- ..+ ...+.++-|+-+|.++|+..+.-
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 10 0 0112357778888754322 233 56788899999999999998764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.4e-20 Score=192.68 Aligned_cols=236 Identities=25% Similarity=0.251 Sum_probs=183.2
Q ss_pred ccccCCCceEEEEE----eCCCcEEEEEEeccCCCcchH-HHHHHHHHHHHHcc-CCCccceeeeeeCCCcceeEecccc
Q 007073 301 VLGQGGFGKVYRGV----LADGTKVAVKRLTDFESPGGD-AAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVYPFMQ 374 (619)
Q Consensus 301 ~lg~G~fg~Vy~~~----~~~g~~vAvK~l~~~~~~~~~-~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~ 374 (619)
.+|+|+||.|+.+. ...|+-+|+|.+++....... .....|..++...+ ||.+|++.-.+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999865 234778999988754322221 24456888888887 9999999999999999999999999
Q ss_pred cchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcc
Q 007073 375 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 454 (619)
Q Consensus 375 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 454 (619)
+|.+...+..... ++......+...++-+++++|+. +|+|||+|++||+++.+|++++.|||+++..-..+..
T Consensus 81 gg~lft~l~~~~~----f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM----FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhccccCCc----hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 9999888875332 66667777788899999999999 9999999999999999999999999999865332222
Q ss_pred eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcccccc
Q 007073 455 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN 534 (619)
Q Consensus 455 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 534 (619)
+||..|||||++. .+...+|.||||++++||+||-.||.. +....+. ...
T Consensus 154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il---------~~~-- 203 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRIL---------KAE-- 203 (612)
T ss_pred -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHh---------hhc--
Confidence 7999999999997 567889999999999999999999863 1111111 111
Q ss_pred CCCCHHHHHHHHHHHHhccCCCCCCCCCH--HHHHHHHhcC
Q 007073 535 KNYNIQEVETMIQVALLCTQASPEDRPAM--SEVVRMLEGE 573 (619)
Q Consensus 535 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~--~evl~~L~~~ 573 (619)
...+........+++..+...+|..|--. ..+.+..+..
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~ 244 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHE 244 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccc
Confidence 12355566778888889999999999765 3444444443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.2e-18 Score=192.32 Aligned_cols=201 Identities=19% Similarity=0.193 Sum_probs=164.0
Q ss_pred HHHHHHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc---CCCccceeeeeeCC
Q 007073 287 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV---HRNLLRLIGFCTTP 363 (619)
Q Consensus 287 ~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~ 363 (619)
.+.++..+.|.+.+.||+|+||+||+|...+|+.||+|+-+....-+ |.--.+++.+++ -+.|..+...+.-.
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 45677788899999999999999999998889999999876543321 222223344444 34566666677778
Q ss_pred CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-------CCCc
Q 007073 364 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD-------EDFE 436 (619)
Q Consensus 364 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-------~~~~ 436 (619)
+.-++|+||.+.|+|.+++.. ...+++.....++.|+++.+++||.. +||||||||+|+||. +...
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred CcceeeeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccc
Confidence 889999999999999999983 44589999999999999999999999 999999999999994 2356
Q ss_pred EEEcccccceeeccC-CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 007073 437 AVVGDFGLAKLVDVR-KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRA 498 (619)
Q Consensus 437 ~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p 498 (619)
++|+|||.+..+..- +.......++|-.+-.+|...++.++.+.|.|.++.+++-|+.|+..
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 899999999766432 22355667789999999999999999999999999999999999753
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.4e-18 Score=165.15 Aligned_cols=254 Identities=24% Similarity=0.330 Sum_probs=164.5
Q ss_pred HhcCCcccCccccCCCceEEEEEeCC-Cc-----------------------------------EEEEEEeccCCCcchH
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLAD-GT-----------------------------------KVAVKRLTDFESPGGD 335 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~-----------------------------------~vAvK~l~~~~~~~~~ 335 (619)
..++|++.+.||+|....||.+...+ |. +.|+|++.........
T Consensus 155 tiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~ 234 (598)
T KOG4158|consen 155 TIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGD 234 (598)
T ss_pred chhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCch
Confidence 44678889999999999999987531 10 3677777544333333
Q ss_pred HHHHH----HH------------HH--HHH--------ccCCCccceeeeeeCC--------------------------
Q 007073 336 AAFQR----EV------------EM--ISV--------AVHRNLLRLIGFCTTP-------------------------- 363 (619)
Q Consensus 336 ~~~~~----E~------------~~--l~~--------l~H~niv~l~~~~~~~-------------------------- 363 (619)
..+.+ |. .+ .+. -+|||||++.+++.+.
T Consensus 235 ~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~ 314 (598)
T KOG4158|consen 235 AHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGE 314 (598)
T ss_pred HHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCC
Confidence 32222 21 11 111 3599999998876332
Q ss_pred -CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe--CCC--CcEE
Q 007073 364 -TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL--DED--FEAV 438 (619)
Q Consensus 364 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~--~~~k 438 (619)
...++||.-++. +|..++... ..+...+.-|+.|+.+|..|||.+ ||.|||+|++|||+ |+| ..+.
T Consensus 315 ~~tlylvMkrY~~-tLr~yl~~~-----~~s~r~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LV 385 (598)
T KOG4158|consen 315 PKTLYLVMKRYRQ-TLREYLWTR-----HRSYRTGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLV 385 (598)
T ss_pred CceEEEehhcchh-hHHHHHhcC-----CCchHHHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEE
Confidence 224666655543 666666542 245556777899999999999999 99999999999998 344 3568
Q ss_pred EcccccceeeccC-----CcceeeeccccccccccccccCCCC------CcchhhHHHHHHHHHHHhCCCCCCCCccccc
Q 007073 439 VGDFGLAKLVDVR-----KTNVTTQVRGTMGHIAPEYLSTGKS------SERTDVFGYGIMLLELVTGQRAIDFSRLEEE 507 (619)
Q Consensus 439 l~DfGla~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~ 507 (619)
|+|||.+-.-+.. .....-...|...-||||+....+- -.|+|.|+.|.+.||+++...||.....
T Consensus 386 vaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe--- 462 (598)
T KOG4158|consen 386 VADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE--- 462 (598)
T ss_pred EcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch---
Confidence 9999986432210 0111112346778999999865432 4689999999999999999999964111
Q ss_pred cchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007073 508 DDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571 (619)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 571 (619)
..+ +... .++..+ +..+...+..+.+++...++.||++|++..-....|.
T Consensus 463 --m~L-~~r~--Yqe~qL---------Palp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 463 --MLL-DTRT--YQESQL---------PALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred --hee-chhh--hhhhhC---------CCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 000 0000 011111 1123344467888999999999999999776665554
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.1e-17 Score=157.69 Aligned_cols=136 Identities=21% Similarity=0.241 Sum_probs=103.8
Q ss_pred cccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-----cCCCccceeeeeeCCC---c-ce
Q 007073 297 SEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-----VHRNLLRLIGFCTTPT---E-RL 367 (619)
Q Consensus 297 ~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~~~~~~~~---~-~~ 367 (619)
...+.||+|+||.||. .-.++.. +||++.... ....+.+.+|+.+++.+ .||||++++|++.++. . ..
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 4467899999999996 2224444 799876432 23457789999999999 5799999999998874 2 23
Q ss_pred eEecc--cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCcEEeCC----CCcEEEc
Q 007073 368 LVYPF--MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL-EYLHEHCNPKIIHRDVKAANVLLDE----DFEAVVG 440 (619)
Q Consensus 368 lv~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~ 440 (619)
+|+|| +.+|+|.+++... .++.. ..++.++..++ +|||++ +|+||||||+||+++. +..++|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 68999 5579999999652 14444 35577777777 999999 9999999999999974 3489999
Q ss_pred ccccc
Q 007073 441 DFGLA 445 (619)
Q Consensus 441 DfGla 445 (619)
||+-+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.1e-17 Score=160.49 Aligned_cols=142 Identities=14% Similarity=0.097 Sum_probs=109.5
Q ss_pred CCcccCccccCCCceEEEEE--eCCCcEEEEEEeccCCCc-------------------c----hHHHHHHHHHHHHHcc
Q 007073 295 NFSEKNVLGQGGFGKVYRGV--LADGTKVAVKRLTDFESP-------------------G----GDAAFQREVEMISVAV 349 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~--~~~g~~vAvK~l~~~~~~-------------------~----~~~~~~~E~~~l~~l~ 349 (619)
.|.+.+.||+|+||.||+|. ..+|+.||+|+++..... . ....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 568999999998643210 0 0123568999999997
Q ss_pred CCC--ccceeeeeeCCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCC
Q 007073 350 HRN--LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK-IIHRDVKA 426 (619)
Q Consensus 350 H~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~Dlkp 426 (619)
+.. +.+++++ ...++||||++++++....... ..........++.|++.++.+||+. + |+||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 633 3344432 2458999999998886654221 2245556678999999999999999 9 99999999
Q ss_pred CcEEeCCCCcEEEcccccceee
Q 007073 427 ANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 427 ~NIll~~~~~~kl~DfGla~~~ 448 (619)
+||+++ ++.++|+|||.+...
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhcc
Confidence 999999 789999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.2e-17 Score=157.10 Aligned_cols=135 Identities=19% Similarity=0.267 Sum_probs=113.7
Q ss_pred CccccCCCceEEEEEeCCCcEEEEEEeccCCCcc-------hHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 300 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPG-------GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
+.||+|++|.||+|.+ +|..|++|+........ ....+.+|++++..+.|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999998 67889999865332111 124577899999999999998877777777888999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
++|++|.+.+... .. .+..++.+++.+|.++|+. +++|||++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999888642 11 7788999999999999999 999999999999999 78899999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.1e-17 Score=155.41 Aligned_cols=144 Identities=20% Similarity=0.148 Sum_probs=111.1
Q ss_pred HHHHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCc---------------------chHHHHHHHHHHHHH
Q 007073 289 LQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESP---------------------GGDAAFQREVEMISV 347 (619)
Q Consensus 289 l~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~---------------------~~~~~~~~E~~~l~~ 347 (619)
+......|...+.||+|+||.||++...+|+.||||++...... .....+..|..++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 33344447788999999999999999888999999987532100 011235678888988
Q ss_pred ccCCC--ccceeeeeeCCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 007073 348 AVHRN--LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVK 425 (619)
Q Consensus 348 l~H~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk 425 (619)
+.|++ +...++ ....++||||+++++|...... .....++.+++.++.++|+. +|+|||||
T Consensus 90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~ 152 (198)
T cd05144 90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLS 152 (198)
T ss_pred HHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence 88874 444443 2456899999999988764321 23457889999999999998 99999999
Q ss_pred CCcEEeCCCCcEEEcccccceeec
Q 007073 426 AANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 426 p~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|+||++++++.++|+|||++....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.6e-17 Score=155.90 Aligned_cols=131 Identities=19% Similarity=0.280 Sum_probs=107.5
Q ss_pred ccccCCCceEEEEEeCCCcEEEEEEeccCCCcc-------hHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEeccc
Q 007073 301 VLGQGGFGKVYRGVLADGTKVAVKRLTDFESPG-------GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 373 (619)
Q Consensus 301 ~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 373 (619)
.||+|+||.||+|.+ +|..|++|......... ....+.+|++++..+.|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 57899999865432111 1256778999999999988766655666667789999999
Q ss_pred ccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 374 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 374 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
++++|.+.+.... . .++.+++.+|.++|+. +++|||++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH-----H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988775411 0 7899999999999999 999999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.6e-18 Score=173.78 Aligned_cols=175 Identities=25% Similarity=0.339 Sum_probs=129.7
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 444 (619)
..++.|+++...+|.+++..... ....++.....++.|++.|+.| + +.+|+|+||.||+...+.++||+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 46789999999999999975433 3346788899999999999999 6 899999999999999999999999999
Q ss_pred ceeeccCC-----cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHH
Q 007073 445 AKLVDVRK-----TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL 519 (619)
Q Consensus 445 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 519 (619)
...+.... ....+...||..||+||.+.+..|+.|+||||+|++++|+++ +|....
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~---------------- 463 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQF---------------- 463 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHH----------------
Confidence 98775444 223456679999999999999999999999999999999987 121100
Q ss_pred hhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 007073 520 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 566 (619)
Q Consensus 520 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev 566 (619)
.....+.++-+..+.+.+..+. +.=..++.+++...|.+||++.++
T Consensus 464 er~~t~~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 464 ERIATLTDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred HHHHhhhhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHHH
Confidence 0111112222222221111111 123578889999999999955443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.2e-17 Score=177.63 Aligned_cols=140 Identities=16% Similarity=0.222 Sum_probs=113.0
Q ss_pred HHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEe-ccCCCc------chHHHHHHHHHHHHHccCCCccceeeeeeCC
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESP------GGDAAFQREVEMISVAVHRNLLRLIGFCTTP 363 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l-~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 363 (619)
.....|...+.||+|+||+||+|.+.+. .+++|+. .+.... ...+.+.+|+++++.++|++++....++..+
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 3344556789999999999999998544 4444433 221111 1235688999999999999999888888777
Q ss_pred CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007073 364 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 443 (619)
Q Consensus 364 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 443 (619)
...++||||+++++|.+++. ....++.+++++|.|||+. +++|||+||+||++ +++.++|+|||
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCc
Confidence 78899999999999988775 3467899999999999999 99999999999999 67789999999
Q ss_pred ccee
Q 007073 444 LAKL 447 (619)
Q Consensus 444 la~~ 447 (619)
+++.
T Consensus 473 la~~ 476 (535)
T PRK09605 473 LGKY 476 (535)
T ss_pred cccc
Confidence 9975
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.5e-17 Score=182.07 Aligned_cols=212 Identities=23% Similarity=0.252 Sum_probs=144.6
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
...+|+.++.|..|++|.||..+++ ..+++|+|+ .+... +.+- ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l------ilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL------ILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccch------hhhc--cccccCCccee----------------
Confidence 3467888999999999999999986 467788853 22110 0000 22222333333
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
|+-...+.... .++. +.+.+++|+|+. +|+|||+||+|.+|+.-|++|++|||+.+..-.
T Consensus 136 -----gDc~tllk~~g----~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 -----GDCATLLKNIG----PLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred -----chhhhhcccCC----CCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 33333333211 1222 227789999999 999999999999999999999999999875421
Q ss_pred CC--------------cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHH
Q 007073 451 RK--------------TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV 516 (619)
Q Consensus 451 ~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 516 (619)
.. .....+++||+.|.|||++....|...+|+|++|+++||.+-|+.||.....++-.+..+.+.+
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i 275 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI 275 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence 10 0112356899999999999999999999999999999999999999987655443332222211
Q ss_pred HHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 007073 517 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 564 (619)
Q Consensus 517 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 564 (619)
... .. ......+..+++.+.++.+|.+|--..
T Consensus 276 ~wp------E~----------dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 276 EWP------EE----------DEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred ccc------cc----------CcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 111 11 112235778899999999999995433
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=6e-15 Score=134.02 Aligned_cols=135 Identities=18% Similarity=0.157 Sum_probs=113.8
Q ss_pred ccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccC--CCccceeeeeeCCCcceeEeccccc
Q 007073 298 EKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH--RNLLRLIGFCTTPTERLLVYPFMQN 375 (619)
Q Consensus 298 ~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~ 375 (619)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.++..++| .++.+++++....+..++++||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 35679999999999999854 7899998764322 5678899999999987 5888999888888889999999998
Q ss_pred chhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 376 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 376 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
+.+... +......++.+++++++++|.....+++|+|++|+||+++..+.+++.|||.++.
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 766543 4456677899999999999986445799999999999999989999999999863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.6e-15 Score=141.22 Aligned_cols=137 Identities=20% Similarity=0.258 Sum_probs=97.7
Q ss_pred cCccccCCCceEEEEEeCCCcEEEEEEeccCCCc-chHHHH----------------------HHHHHHHHHccCCC--c
Q 007073 299 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESP-GGDAAF----------------------QREVEMISVAVHRN--L 353 (619)
Q Consensus 299 ~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~-~~~~~~----------------------~~E~~~l~~l~H~n--i 353 (619)
.+.||+|+||+||+|...+|+.||||+++..... .....+ ..|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999988643211 111111 24555555554433 3
Q ss_pred cceeeeeeCCCcceeEecccccchhhhh-hcccCCCCCCcCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEe
Q 007073 354 LRLIGFCTTPTERLLVYPFMQNLSVAYR-LREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLL 431 (619)
Q Consensus 354 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll 431 (619)
.+.+++ ...++||||++++++... +.... .. .....++.+++.++.++|. . +|+|+||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 334332 246899999999654321 21111 11 4567889999999999999 7 99999999999999
Q ss_pred CCCCcEEEcccccceeec
Q 007073 432 DEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 432 ~~~~~~kl~DfGla~~~~ 449 (619)
+ ++.++++|||.+....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 9 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=9.9e-17 Score=140.73 Aligned_cols=129 Identities=26% Similarity=0.465 Sum_probs=112.5
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
.++++.|.||+|.++ .+|+.++.|.+|+.|++++|+|+ .+|..++.+++|+.|+++-|++. .+|..|+.++.|+.||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 357888999999998 77888999999999999999999 88889999999999999999999 8999999999999999
Q ss_pred ccCCcCC-CCCCCccccccccccccCCCCcccccCCccccccCccccCCCCCCC
Q 007073 155 LSQNNFS-GTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNC 207 (619)
Q Consensus 155 l~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~l~~~~n~~~c 207 (619)
|++|++. ..+|..|+-++.|+.|+|+.|.+. .+|..++++++|.+.++..+-
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdnd 161 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDND 161 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCc
Confidence 9999986 357888999999999999999998 889888888887776665543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.8e-14 Score=137.67 Aligned_cols=136 Identities=18% Similarity=0.156 Sum_probs=104.6
Q ss_pred cCccc-cCCCceEEEEEeCCCcEEEEEEeccCC------------CcchHHHHHHHHHHHHHccCCCc--cceeeeeeCC
Q 007073 299 KNVLG-QGGFGKVYRGVLADGTKVAVKRLTDFE------------SPGGDAAFQREVEMISVAVHRNL--LRLIGFCTTP 363 (619)
Q Consensus 299 ~~~lg-~G~fg~Vy~~~~~~g~~vAvK~l~~~~------------~~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~ 363 (619)
..+|| .|+.|+||++... +..++||+..... +......+.+|++++..++|+++ .+.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8999999999885 7889999875311 01223567889999999998885 6677665433
Q ss_pred Cc----ceeEeccccc-chhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 007073 364 TE----RLLVYPFMQN-LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV 438 (619)
Q Consensus 364 ~~----~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 438 (619)
.. .++|+|++++ .+|.+++... .++.. .+.+++.++.+||+. ||+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 22 3599999997 6888877542 13332 357899999999999 999999999999999988999
Q ss_pred Eccccccee
Q 007073 439 VGDFGLAKL 447 (619)
Q Consensus 439 l~DfGla~~ 447 (619)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.3e-15 Score=165.18 Aligned_cols=254 Identities=21% Similarity=0.264 Sum_probs=184.1
Q ss_pred cCCcccCccccCCCceEEEEEeC--CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHcc-CCCccceeeeeeCCCcceeE
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA--DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~--~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv 369 (619)
..|...+.||+|+|+.|-..... ....+|+|.+.... ..........|..+-..+. |+|++++++....++..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 45666778999999999888753 34456667654332 2223344445777766666 99999999999999999999
Q ss_pred ecccccchhhhhhc-ccCCCCCCcCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCcEEeCCCC-cEEEcccccce
Q 007073 370 YPFMQNLSVAYRLR-EIKPGEPVLDWVTRKRVALGAARGLEYLH-EHCNPKIIHRDVKAANVLLDEDF-EAVVGDFGLAK 446 (619)
Q Consensus 370 ~e~~~~gsL~~~l~-~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~ 446 (619)
.+|..++++..-+. ... ...+......+..|+..++.|+| +. ++.|+|+||+|.+++..+ ..+++|||+|.
T Consensus 100 ~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence 99999999988883 221 12455566778999999999999 77 999999999999999999 99999999998
Q ss_pred eecc-C-Ccceeeeccc-cccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh
Q 007073 447 LVDV-R-KTNVTTQVRG-TMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 522 (619)
Q Consensus 447 ~~~~-~-~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 522 (619)
.+.. . .........| ++.|+|||...+. -..+..|+||.|+++.-+++|..|++........ ...|....
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~---~~~~~~~~--- 247 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR---YSSWKSNK--- 247 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc---ceeecccc---
Confidence 7765 2 2223334567 9999999999885 4478899999999999999999999865433211 11111110
Q ss_pred cccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 007073 523 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV 567 (619)
Q Consensus 523 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 567 (619)
.. ..............++..+++..+|+.|.+.+++.
T Consensus 248 ~~--------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 248 GR--------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cc--------cccCccccCChhhhhcccccccCCchhcccccccc
Confidence 00 00011122223566778888889999999977764
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.5e-15 Score=156.34 Aligned_cols=180 Identities=22% Similarity=0.259 Sum_probs=144.3
Q ss_pred CccccccchhcccchhHHHHHHHHHhcCCCCCCCCCCCCCCCCCCCcceeEEcCCCCeEEEEeCCCCccccCCccccCCC
Q 007073 21 DPDLHNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLR 100 (619)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~al~~~k~~l~~~~~~l~~w~~~~~~~c~w~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~ 100 (619)
..+|+-|.++.....-.-.|.++++ |+.++|.+..... -+|+- ..+|..|+|++|+|+...+..|..|.
T Consensus 273 ~l~L~~N~l~~vn~g~lfgLt~L~~-L~lS~NaI~rih~-----d~Wsf-----tqkL~~LdLs~N~i~~l~~~sf~~L~ 341 (873)
T KOG4194|consen 273 HLNLETNRLQAVNEGWLFGLTSLEQ-LDLSYNAIQRIHI-----DSWSF-----TQKLKELDLSSNRITRLDEGSFRVLS 341 (873)
T ss_pred eeecccchhhhhhcccccccchhhh-hccchhhhheeec-----chhhh-----cccceeEeccccccccCChhHHHHHH
Confidence 3456677777777766666666665 6667776654422 23432 24899999999999988889999999
Q ss_pred CCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCC---cccccccchhhhccCCcCCCCCCCccccccccccc
Q 007073 101 TLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP---SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISI 177 (619)
Q Consensus 101 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~---~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 177 (619)
.|++|+|++|+|+..-...|..+++|+.|||++|.|++.+.+ .|..|++|+.|+|.+|+|..+.-.+|..+++|+.|
T Consensus 342 ~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~L 421 (873)
T KOG4194|consen 342 QLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHL 421 (873)
T ss_pred HhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCccccee
Confidence 999999999999977777899999999999999999987764 57789999999999999994444589999999999
Q ss_pred cCCCCcccccCCcccc--ccCccccCCCCCCCCCCC
Q 007073 178 QLDSNNLSGQIPVHLF--QIPKYNFTGNNLNCGKTL 211 (619)
Q Consensus 178 ~l~~N~l~~~~p~~l~--~l~~l~~~~n~~~c~~~~ 211 (619)
||.+|.|-..-|..|. .+.+|-+..-.+.|+|++
T Consensus 422 dL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCql 457 (873)
T KOG4194|consen 422 DLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQL 457 (873)
T ss_pred cCCCCcceeecccccccchhhhhhhcccceEEeccH
Confidence 9999999977777776 456677888889999985
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.1e-15 Score=131.36 Aligned_cols=129 Identities=26% Similarity=0.435 Sum_probs=115.4
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCcc-ccCCCcccccccchhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLV-GKIPPSLGNLKKLQFL 153 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L 153 (619)
..+|+.|++++|+|+ .+|..+++|++|+.|+++-|++. .+|..|+.++.|+.|||.+|+++ ..+|+.|..++.|+.|
T Consensus 55 l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlral 132 (264)
T KOG0617|consen 55 LKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRAL 132 (264)
T ss_pred hhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHH
Confidence 458999999999998 88899999999999999999999 99999999999999999999987 4579999999999999
Q ss_pred hccCCcCCCCCCCccccccccccccCCCCcccccCCcccc---ccCccccCCCCCCC
Q 007073 154 TLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLNC 207 (619)
Q Consensus 154 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~---~l~~l~~~~n~~~c 207 (619)
+|+.|.|. .+|..++++++|+.|.+..|.+- .+|..++ ++..|.+.||...-
T Consensus 133 yl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~v 187 (264)
T KOG0617|consen 133 YLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTV 187 (264)
T ss_pred HhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeee
Confidence 99999999 89999999999999999999998 8997665 55667888888643
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=5.9e-14 Score=135.64 Aligned_cols=204 Identities=18% Similarity=0.275 Sum_probs=142.9
Q ss_pred HHHHHccCCCccceeeeeeCC-----CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCC
Q 007073 343 EMISVAVHRNLLRLIGFCTTP-----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 417 (619)
Q Consensus 343 ~~l~~l~H~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ 417 (619)
.-+-++.|.|||+++.|+.+. .+..++.|||.-|++..+|++.......+....-.+++.||..||.|||+ |.|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 345567799999999998654 34678999999999999999877777778888888999999999999998 478
Q ss_pred CeEecCCCCCcEEeCCCCcEEEcccccceeecc----CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHH
Q 007073 418 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV----RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 493 (619)
Q Consensus 418 ~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ell 493 (619)
+|+|+++.-+-|++..++-+|++----. .... ..........+-++|.|||+-.....+.++|||+||....||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 8999999999999999998887532111 1100 0011111234678999999887778889999999999999998
Q ss_pred hCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 494 TGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 494 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
-|..--..+......+....... ..+...+ =..++..|++..|..||+|.+++..
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~i----------~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANVI----------IGLENGL-----------QRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCCcceeehhhhhhhhe----------eeccCcc-----------ccCcCcccccCCCCCCcchhhhhcC
Confidence 87643221111111100000000 0000001 1246678999999999999998743
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.2e-13 Score=143.00 Aligned_cols=142 Identities=23% Similarity=0.260 Sum_probs=100.5
Q ss_pred cCccccCCCceEEEEEeCCCcEEEEEEeccCCCcch---------------------------------------HHHHH
Q 007073 299 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGG---------------------------------------DAAFQ 339 (619)
Q Consensus 299 ~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~---------------------------------------~~~~~ 339 (619)
.+.||.|++|.||+|+.++|+.||||+.+......- +-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999999864211000 01244
Q ss_pred HHHHHHHHcc----CCCccceeeee-eCCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHH-HHHHHHh
Q 007073 340 REVEMISVAV----HRNLLRLIGFC-TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR-GLEYLHE 413 (619)
Q Consensus 340 ~E~~~l~~l~----H~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-~L~~LH~ 413 (619)
+|.+.+.+++ |.+-+.+-.++ ......++||||++|+++.+.......+ . .+.+++..+++ .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~---~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG---L---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC---C---CHHHHHHHHHHHHHHHHHh
Confidence 4555554442 33333333333 2245679999999999998876532111 1 24456666666 4678898
Q ss_pred cCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 414 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 414 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
. |++|+|++|.||+++.++.++++|||++..+.
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8 99999999999999999999999999998664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3e-13 Score=139.53 Aligned_cols=177 Identities=24% Similarity=0.252 Sum_probs=111.8
Q ss_pred cCccccccchhcccchhHHHHHHHHHhcCCCCCCCCCCCCCCCCCCCcceeEEcCCCCeEEEEeCCCCccccCCccccCC
Q 007073 20 FDPDLHNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVL 99 (619)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~al~~~k~~l~~~~~~l~~w~~~~~~~c~w~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l 99 (619)
-..+|.+|.++.+.+.+..||.+++. ++.+.|.++.... ||.-.+ .++++|+|++|.|+..-...|..|
T Consensus 128 ~~L~L~~N~I~sv~se~L~~l~alrs-lDLSrN~is~i~~----~sfp~~------~ni~~L~La~N~It~l~~~~F~~l 196 (873)
T KOG4194|consen 128 EKLDLRHNLISSVTSEELSALPALRS-LDLSRNLISEIPK----PSFPAK------VNIKKLNLASNRITTLETGHFDSL 196 (873)
T ss_pred eEEeeeccccccccHHHHHhHhhhhh-hhhhhchhhcccC----CCCCCC------CCceEEeecccccccccccccccc
Confidence 34577799999999999999999987 7777777765532 232222 267777777777776666677777
Q ss_pred CCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccc------------------------hhhhc
Q 007073 100 RTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKL------------------------QFLTL 155 (619)
Q Consensus 100 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L------------------------~~L~l 155 (619)
.+|..|-|+.|+|+...+..|.+|++|+.|+|..|+|.-.-.-.|.+|++| ++|+|
T Consensus 197 nsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L 276 (873)
T KOG4194|consen 197 NSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNL 276 (873)
T ss_pred chheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeec
Confidence 777777777777774444556667777777777777762213444555554 45555
Q ss_pred cCCcCCCCCCCccccccccccccCCCCcccccCCcccc---ccCccccCCCCCCC
Q 007073 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLNC 207 (619)
Q Consensus 156 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~---~l~~l~~~~n~~~c 207 (619)
+.|+++..--.++.+|+.|+.|+||.|.|...-++... ++..|+++.|..+-
T Consensus 277 ~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~ 331 (873)
T KOG4194|consen 277 ETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITR 331 (873)
T ss_pred ccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEecccccccc
Confidence 55555433344555666666666666666533333332 34455666666543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.2e-14 Score=141.83 Aligned_cols=124 Identities=29% Similarity=0.450 Sum_probs=105.9
Q ss_pred CeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCccc-ccccchhhhc
Q 007073 77 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLG-NLKKLQFLTL 155 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l 155 (619)
+|++||.-+|-++ .+|+.++.|.+|.-|+|..|+|. .+| +|++++.|.+|+++.|+|+ .+|...+ ++++|.+|||
T Consensus 184 ~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDL 259 (565)
T KOG0472|consen 184 RLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDL 259 (565)
T ss_pred HHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeec
Confidence 7888888888777 78888999999999999999998 788 6889999999999999998 7887766 8899999999
Q ss_pred cCCcCCCCCCCccccccccccccCCCCcccccCCcccccc--CccccCCCCCC
Q 007073 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQI--PKYNFTGNNLN 206 (619)
Q Consensus 156 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l--~~l~~~~n~~~ 206 (619)
..|+++ ..|+.+..+.+|..||+++|.|+ .+|..++++ .+|.+.|||..
T Consensus 260 RdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnlhL~~L~leGNPlr 310 (565)
T KOG0472|consen 260 RDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNLHLKFLALEGNPLR 310 (565)
T ss_pred cccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccceeeehhhcCCchH
Confidence 999998 88999988999999999999998 688777765 55778888864
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2e-13 Score=141.58 Aligned_cols=132 Identities=28% Similarity=0.434 Sum_probs=75.1
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCC----------------------CCcccccccccCcEeeecC
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITG----------------------EIPEELGNLSSLTSLDLDN 133 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~----------------------~~p~~~~~l~~L~~L~L~~ 133 (619)
.+|..+|||.|++. .+|..+-++++|+.|+||+|+|+. .+|..+++|++|+.|++.+
T Consensus 222 ~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt~LP~avcKL~kL~kLy~n~ 300 (1255)
T KOG0444|consen 222 HNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLTVLPDAVCKLTKLTKLYANN 300 (1255)
T ss_pred hhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhccchHHHhhhHHHHHHHhcc
Confidence 35666666666665 556666666666666666555551 4555555555555555555
Q ss_pred CCcc-ccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCCCcccccCCccc---cccCccccCCCCCCCCC
Q 007073 134 NRLV-GKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLNCGK 209 (619)
Q Consensus 134 N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l---~~l~~l~~~~n~~~c~~ 209 (619)
|+++ .-+|..+++|.+|+.+..++|++. .+|..+..|..|+.|.|++|++. .+|+.+ ..+..|++..|+..-.+
T Consensus 301 NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMP 378 (1255)
T KOG0444|consen 301 NKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMP 378 (1255)
T ss_pred CcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCC
Confidence 5543 124555555555555555555555 56666666666666666666666 566543 34444566666655444
Q ss_pred C
Q 007073 210 T 210 (619)
Q Consensus 210 ~ 210 (619)
|
T Consensus 379 P 379 (1255)
T KOG0444|consen 379 P 379 (1255)
T ss_pred C
Confidence 3
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.31 E-value=9.8e-12 Score=115.62 Aligned_cols=130 Identities=22% Similarity=0.170 Sum_probs=96.6
Q ss_pred cCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccc-eeeeeeCCCcceeEecccccch
Q 007073 299 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR-LIGFCTTPTERLLVYPFMQNLS 377 (619)
Q Consensus 299 ~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~~~~~~~~~~~lv~e~~~~gs 377 (619)
.+.|+.|.++.||++... |..|++|....... ....+..|+.+++.+.+.++++ ++.+. ....++||||+++.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 356899999999999975 78899998754321 2345678999999887666554 44433 334689999999987
Q ss_pred hhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 378 VAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC--NPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 378 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
+... . . ....++.+++++|+.||+.. ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 78 l~~~--~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTE--D-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc--c-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 7543 0 1 11245678999999999982 22369999999999999 6689999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.7e-12 Score=136.45 Aligned_cols=146 Identities=20% Similarity=0.198 Sum_probs=93.6
Q ss_pred cCCcccCccccCCCceEEEEEeCC-CcEEEEEEeccCCCc---------------------------------chHH---
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESP---------------------------------GGDA--- 336 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~---------------------------------~~~~--- 336 (619)
..|+. +.||+|++|.||+|+.++ |+.||||+.+....+ +-.+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 789999999999999987 999999998743100 0011
Q ss_pred ---HHHHHHHHHHHcc----CCCccceeeeeeC-CCcceeEecccccchhhhhhcccCCC--CCCcCHHHHHHHHHHHHH
Q 007073 337 ---AFQREVEMISVAV----HRNLLRLIGFCTT-PTERLLVYPFMQNLSVAYRLREIKPG--EPVLDWVTRKRVALGAAR 406 (619)
Q Consensus 337 ---~~~~E~~~l~~l~----H~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~--~~~l~~~~~~~i~~~ia~ 406 (619)
+|.+|+..+.+++ +.+.+.+-.++.+ ..+.++||||++|+.+.+...-...+ ...+.......++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 2344444444332 3344444344432 45678999999999997642211111 011222222222233
Q ss_pred HHHHHHhcCCCCeEecCCCCCcEEeCCCC----cEEEcccccceeecc
Q 007073 407 GLEYLHEHCNPKIIHRDVKAANVLLDEDF----EAVVGDFGLAKLVDV 450 (619)
Q Consensus 407 ~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfGla~~~~~ 450 (619)
+... |++|+|+||.||+++.++ .+++.|||++..++.
T Consensus 276 ----if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 ----VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3446 999999999999999888 999999999987754
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.28 E-value=1e-12 Score=136.35 Aligned_cols=109 Identities=29% Similarity=0.427 Sum_probs=101.8
Q ss_pred CeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCC-CCcccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 77 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITG-EIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
+|.+|+||+|+++ .+|..+++|+.|+.|++.+|+++- -||..+++|.+|+.+..++|.+. .+|..++.|..|+.|.|
T Consensus 269 ~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L 346 (1255)
T KOG0444|consen 269 NLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKL 346 (1255)
T ss_pred hhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcc
Confidence 7889999999998 899999999999999999999873 48999999999999999999999 99999999999999999
Q ss_pred cCCcCCCCCCCccccccccccccCCCCcccccCC
Q 007073 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 189 (619)
Q Consensus 156 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 189 (619)
++|++. .+|+++.-|+.|+.||+..|.=- ..|
T Consensus 347 ~~NrLi-TLPeaIHlL~~l~vLDlreNpnL-VMP 378 (1255)
T KOG0444|consen 347 DHNRLI-TLPEAIHLLPDLKVLDLRENPNL-VMP 378 (1255)
T ss_pred ccccee-echhhhhhcCCcceeeccCCcCc-cCC
Confidence 999998 89999999999999999999765 444
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=6.9e-13 Score=131.19 Aligned_cols=144 Identities=27% Similarity=0.332 Sum_probs=126.8
Q ss_pred eEEcCC----------CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecC-CCccc
Q 007073 70 VICDNS----------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN-NRLVG 138 (619)
Q Consensus 70 v~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~ 138 (619)
|.|++. ...+.|+|..|+|+.+.|..|..+++|+.||||+|+|+.+-|++|..|.+|..|-+-+ |+|+.
T Consensus 51 VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~ 130 (498)
T KOG4237|consen 51 VDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITD 130 (498)
T ss_pred EEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhh
Confidence 888752 3789999999999988889999999999999999999988999999999998876655 99996
Q ss_pred cCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCCCcccccCCc----cccccCccccCCCCCCCCCCCCCC
Q 007073 139 KIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV----HLFQIPKYNFTGNNLNCGKTLPHS 214 (619)
Q Consensus 139 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~----~l~~l~~l~~~~n~~~c~~~~~~~ 214 (619)
...+.|++|.+|+.|.+.-|++.-...+.|..|++|..|.+..|.+. .|+. .+..++.+.+.-|++.|+|.++-.
T Consensus 131 l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wl 209 (498)
T KOG4237|consen 131 LPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWL 209 (498)
T ss_pred hhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchh
Confidence 55678999999999999999999777889999999999999999998 7774 345677788999999999987643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=6.3e-12 Score=132.11 Aligned_cols=247 Identities=19% Similarity=0.165 Sum_probs=175.1
Q ss_pred CCcccCcccc--CCCceEEEEEe---CCCcEEEEEEeccCCC-cchHHHHHHHHHHHHHcc-CCCccceeeeeeCCCcce
Q 007073 295 NFSEKNVLGQ--GGFGKVYRGVL---ADGTKVAVKRLTDFES-PGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 295 ~~~~~~~lg~--G~fg~Vy~~~~---~~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 367 (619)
.|...+.+|. |.+|.||.+.. .++..+|+|+-+..-+ +.....=.+|+...+.++ |+|.++.+..+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3455678999 99999999986 4688999997543222 222223345666666665 999999888888888888
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCcEEeCCC-CcEEEccc
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDF 442 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df 442 (619)
+-.|++. .++..+.+... ..++....+.+..+..+ |+.++|.. +++|-|+||.||+...+ ...+++||
T Consensus 195 iqtE~~~-~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeecccc-chhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence 8888876 56766665532 22555666777777777 99999999 99999999999999999 88999999
Q ss_pred ccceeeccCCcce----eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH
Q 007073 443 GLAKLVDVRKTNV----TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 518 (619)
Q Consensus 443 Gla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 518 (619)
|+...+....-.. .....|...|++||..+ +-++.++|+|++|.+..+..++.......... .|..
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--------~W~~- 337 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS--------SWSQ- 337 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC--------Cccc-
Confidence 9998886544221 12235788999999874 56789999999999999999987765432111 0100
Q ss_pred HhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 007073 519 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV 567 (619)
Q Consensus 519 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 567 (619)
..... +...+.......+...+.++++.+|-.|++.+.+.
T Consensus 338 ~r~~~---------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 338 LRQGY---------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred ccccc---------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 00000 11111222223455588899999999999977765
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.3e-10 Score=123.42 Aligned_cols=233 Identities=18% Similarity=0.180 Sum_probs=149.9
Q ss_pred eCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccchhhhhhcccCCCCCCcCH
Q 007073 315 LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW 394 (619)
Q Consensus 315 ~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~ 394 (619)
..++.+|.|...+.... .......+-++-++.++||||+++++...+....|+|+|-+.- |..++.+ +.-
T Consensus 34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~-------l~~ 103 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE-------LGK 103 (690)
T ss_pred eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH-------hHH
Confidence 44788888888764333 3345566778889999999999999999999999999998753 4444544 223
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcceeeeccccccccccccccCC
Q 007073 395 VTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG 474 (619)
Q Consensus 395 ~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 474 (619)
....-.+.||+.||.|||+.| +++|++|.-..|+++..|+.||++|-++.....-.. ......---.|..|+.+...
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence 445556889999999999776 899999999999999999999999998764322111 01111112246667655332
Q ss_pred CCCcchhhHHHHHHHHHHHhCCCCCCCCccc-cccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhcc
Q 007073 475 KSSERTDVFGYGIMLLELVTGQRAIDFSRLE-EEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCT 553 (619)
Q Consensus 475 ~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl 553 (619)
. -..|.|.||++++|++.|..+-...... ............. .+... ....+ ...+++..|.
T Consensus 181 ~--~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ipk~~~~~~~k--------~~~~~------~~~r~-n~~~~~~~~~ 243 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIPKALIELYCK--------KLGAT------ELKRP-NKLRFILECR 243 (690)
T ss_pred c--cchhhhhHHHHHHHHhCcccCcchhhhccCccchhHHHHHHH--------Hhccc------ccccc-chhhHHHHHH
Confidence 2 3459999999999999994332111100 0000011111100 00000 00001 1456666777
Q ss_pred CCCCCCCCCHHHHHHHHhcCCccc
Q 007073 554 QASPEDRPAMSEVVRMLEGEGLAE 577 (619)
Q Consensus 554 ~~dP~~RPs~~evl~~L~~~~~~~ 577 (619)
..-+--|=.+-+++.+|+...+.+
T Consensus 244 ~~~gff~n~fvd~~~fLeel~lks 267 (690)
T KOG1243|consen 244 LLGGFFRNDFVDTLLFLEELRLKS 267 (690)
T ss_pred hccccccchHHHHHHHHHhcccCc
Confidence 777777777888888888765543
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.6e-13 Score=134.11 Aligned_cols=187 Identities=22% Similarity=0.309 Sum_probs=146.7
Q ss_pred ccccccchhcccchhHHHHHHHHHhcCCCCCCCCCCCCCC-----------CCCCCcceeEEc------CCCCeEEEEeC
Q 007073 22 PDLHNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQ-----------VNPCTWSNVICD------NSNNVASVTLS 84 (619)
Q Consensus 22 ~~~~~~~~~~~~~~~~~al~~~k~~l~~~~~~l~~w~~~~-----------~~~c~w~gv~c~------~~~~l~~L~L~ 84 (619)
.|+++|++++|-++.+..|-++-+.+.+.+|.+++..... .++| -+.|- ...++..|.|-
T Consensus 96 LdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan---~i~Cir~~al~dL~~l~lLsly 172 (498)
T KOG4237|consen 96 LDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNAN---HINCIRQDALRDLPSLSLLSLY 172 (498)
T ss_pred ecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChh---hhcchhHHHHHHhhhcchhccc
Confidence 5788999999999988888888777777777776642211 1222 12332 24577788889
Q ss_pred CCCccccCCccccCCCCCCEEEccCCCCC--------------------C------------------------------
Q 007073 85 SMNFSGTLSPRIGVLRTLSTLTLKGNGIT--------------------G------------------------------ 114 (619)
Q Consensus 85 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~--------------------~------------------------------ 114 (619)
+|.+..+--..|..+.+++.+.+..|.+- |
T Consensus 173 Dn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~ 252 (498)
T KOG4237|consen 173 DNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLP 252 (498)
T ss_pred chhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHH
Confidence 99998554558888999999988888822 0
Q ss_pred -----------CCc-ccccccccCcEeeecCCCccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCCC
Q 007073 115 -----------EIP-EELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSN 182 (619)
Q Consensus 115 -----------~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 182 (619)
.-| ..|.+|++|+.|+|++|+|+++-+..|..+..|++|+|..|+|...-...|.++..|+.|+|.+|
T Consensus 253 s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N 332 (498)
T KOG4237|consen 253 SRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDN 332 (498)
T ss_pred HhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCC
Confidence 011 23778999999999999999988999999999999999999998555667889999999999999
Q ss_pred cccccCCccc---cccCccccCCCCCCCCCCC
Q 007073 183 NLSGQIPVHL---FQIPKYNFTGNNLNCGKTL 211 (619)
Q Consensus 183 ~l~~~~p~~l---~~l~~l~~~~n~~~c~~~~ 211 (619)
+|+..-|..| ..+..|++.+|||+|.|.+
T Consensus 333 ~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l 364 (498)
T KOG4237|consen 333 QITTVAPGAFQTLFSLSTLNLLSNPFNCNCRL 364 (498)
T ss_pred eeEEEecccccccceeeeeehccCcccCccch
Confidence 9997778655 4678899999999999975
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.24 E-value=6.8e-13 Score=131.36 Aligned_cols=127 Identities=30% Similarity=0.475 Sum_probs=108.5
Q ss_pred CeEEEEeCCCCccc-----------------------cCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecC
Q 007073 77 NVASVTLSSMNFSG-----------------------TLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 133 (619)
Q Consensus 77 ~l~~L~L~~n~l~~-----------------------~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 133 (619)
-++.++++.|++.. .+|..++.+++|..|+|++|-+. .+|.+++.+..|+.||||.
T Consensus 389 ~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~ 467 (565)
T KOG0472|consen 389 IVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSF 467 (565)
T ss_pred ceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccc
Confidence 37777887776552 44555677899999999999998 8999999999999999999
Q ss_pred CCccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCCCcccccCCccccccC---ccccCCCCCC
Q 007073 134 NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIP---KYNFTGNNLN 206 (619)
Q Consensus 134 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~---~l~~~~n~~~ 206 (619)
|+|. .+|..+..+..|+.+-.++|++....|+.+.+|.+|..|||.+|.+. .||..+++++ .|.+.|||+.
T Consensus 468 NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 468 NRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred cccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 9999 89999988889999999999998555666999999999999999999 8998877655 5789999985
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.22 E-value=5.2e-12 Score=140.81 Aligned_cols=95 Identities=41% Similarity=0.714 Sum_probs=91.6
Q ss_pred CCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCC
Q 007073 101 TLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLD 180 (619)
Q Consensus 101 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 180 (619)
.++.|+|++|.++|.+|..+++|++|+.|+|++|+|+|.+|..++++++|+.|+|++|+++|.+|+.+.+|++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCCcccccc
Q 007073 181 SNNLSGQIPVHLFQI 195 (619)
Q Consensus 181 ~N~l~~~~p~~l~~l 195 (619)
+|+++|.+|..+..+
T Consensus 499 ~N~l~g~iP~~l~~~ 513 (623)
T PLN03150 499 GNSLSGRVPAALGGR 513 (623)
T ss_pred CCcccccCChHHhhc
Confidence 999999999988754
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.1e-12 Score=142.29 Aligned_cols=174 Identities=26% Similarity=0.361 Sum_probs=132.1
Q ss_pred hccCccccccchhcccchhHHHHHHHHHhcCCCCCCCCCCCCCCCCCCCcceeEEcCCCCeEEEEeCCCCccccCCcccc
Q 007073 18 DNFDPDLHNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIG 97 (619)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~al~~~k~~l~~~~~~l~~w~~~~~~~c~w~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~ 97 (619)
.+-+.|+..|.+..-.......+..--..++.+.+.+.+. ||.=+ .....|+.|.|.+|.++...=+.+.
T Consensus 311 sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~l------p~~~e----~~~~~Lq~LylanN~Ltd~c~p~l~ 380 (1081)
T KOG0618|consen 311 SLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTL------PSYEE----NNHAALQELYLANNHLTDSCFPVLV 380 (1081)
T ss_pred eeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccccc------ccccc----hhhHHHHHHHHhcCcccccchhhhc
Confidence 3445566666666555543333333122233333333322 22111 1234799999999999988778899
Q ss_pred CCCCCCEEEccCCCCCCCCc-ccccccccCcEeeecCCCccccCCCcccccccchhhhccCCcCCCCCCCcccccccccc
Q 007073 98 VLRTLSTLTLKGNGITGEIP-EELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLIS 176 (619)
Q Consensus 98 ~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 176 (619)
++++|+.|+|++|+|. .+| ..+.++..|+.|+||+|+++ .+|..+.+++.|++|...+|++. ..| .+..++.|+.
T Consensus 381 ~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~ 456 (1081)
T KOG0618|consen 381 NFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKV 456 (1081)
T ss_pred cccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceE
Confidence 9999999999999999 565 46889999999999999999 89999999999999999999999 888 8899999999
Q ss_pred ccCCCCcccc-cCCccc--cccCccccCCCCC
Q 007073 177 IQLDSNNLSG-QIPVHL--FQIPKYNFTGNNL 205 (619)
Q Consensus 177 L~l~~N~l~~-~~p~~l--~~l~~l~~~~n~~ 205 (619)
+|++.|+|+- .+|..+ .+|+.|+++||.+
T Consensus 457 lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 457 LDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred EecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 9999999973 345443 5789999999996
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.1e-11 Score=128.20 Aligned_cols=247 Identities=19% Similarity=0.177 Sum_probs=173.8
Q ss_pred HHhcCCcccCccccCCCceEEEEEeC--CCcEEEEEEeccCCCcc-hHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcc
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLA--DGTKVAVKRLTDFESPG-GDAAFQREVEMISVA-VHRNLLRLIGFCTTPTER 366 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~g~~vAvK~l~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 366 (619)
....+|..+..||.|.|+.|+....+ ++..|++|.+.+..... .+..-..|+.+...+ .|.++++....+......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34567888899999999999998854 68899999886543222 222334566666655 489999988877777778
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-CcEEEcccccc
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLA 445 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla 445 (619)
++--||++++++.....- ...++...++++..|++.++.++|++ .++|+|+||+||++..+ +..+++|||.+
T Consensus 342 ~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence 888999999988776622 22367778889999999999999999 99999999999999886 78899999998
Q ss_pred eeeccCCcceeeecccccccc--ccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007073 446 KLVDVRKTNVTTQVRGTMGHI--APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 523 (619)
Q Consensus 446 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (619)
+.+... .....++-+++ +|+......+-.+.|+||||.-+.|..+|..--. ... .|
T Consensus 415 t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~-~~~---------~~-------- 472 (524)
T KOG0601|consen 415 TRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE-SGV---------QS-------- 472 (524)
T ss_pred ccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCc-ccc---------cc--------
Confidence 743211 11112333444 5555566778899999999999999999864321 100 00
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007073 524 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 570 (619)
Q Consensus 524 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 570 (619)
..+... .... .+.....+..+...+...++..||.+.+.....
T Consensus 473 --~~i~~~-~~p~-~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 473 --LTIRSG-DTPN-LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred --eeeecc-cccC-CCchHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence 000000 0011 112225667778888899999999988876543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.6e-10 Score=109.93 Aligned_cols=142 Identities=21% Similarity=0.272 Sum_probs=108.7
Q ss_pred CccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCC--CccceeeeeeCCC---cceeEecccc
Q 007073 300 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR--NLLRLIGFCTTPT---ERLLVYPFMQ 374 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~~~---~~~lv~e~~~ 374 (619)
+.|+.|.++.||++...+|+.+++|.............+..|+++++.+.+. ++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 5689999999999998777899999875433222356788999999998764 4566777766542 5689999999
Q ss_pred cchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 007073 375 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC--------------------------------------- 415 (619)
Q Consensus 375 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------------- 415 (619)
+.++...+.. ..++...+..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9888775531 12566677778888888888888521
Q ss_pred --------------CCCeEecCCCCCcEEeCC--CCcEEEcccccce
Q 007073 416 --------------NPKIIHRDVKAANVLLDE--DFEAVVGDFGLAK 446 (619)
Q Consensus 416 --------------~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~ 446 (619)
...++|+|++|.||+++. ++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 245799999999999998 6678999999876
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=6e-10 Score=104.58 Aligned_cols=137 Identities=15% Similarity=0.141 Sum_probs=97.4
Q ss_pred CccccCCCceEEEEEeCC-------CcEEEEEEeccCC---------------------CcchHHHHH----HHHHHHHH
Q 007073 300 NVLGQGGFGKVYRGVLAD-------GTKVAVKRLTDFE---------------------SPGGDAAFQ----REVEMISV 347 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~~-------g~~vAvK~l~~~~---------------------~~~~~~~~~----~E~~~l~~ 347 (619)
..||.|--+.||.|...+ +..+|||..+-.. .....+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999998643 4799999763200 011123333 79999988
Q ss_pred ccC--CCccceeeeeeCCCcceeEecccccchhhh-hhcccCCCCCCcCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecC
Q 007073 348 AVH--RNLLRLIGFCTTPTERLLVYPFMQNLSVAY-RLREIKPGEPVLDWVTRKRVALGAARGLEYL-HEHCNPKIIHRD 423 (619)
Q Consensus 348 l~H--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~D 423 (619)
+.. -++..++++ ...++||||+.+..+.. .+.+ ..++......+..+++.+|..+ |+. +++|||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 864 344555553 56889999998653321 2222 1234445567789999999999 777 999999
Q ss_pred CCCCcEEeCCCCcEEEcccccceeec
Q 007073 424 VKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 424 lkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
+++.||++++ +.++|+|||.+....
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeCC
Confidence 9999999974 679999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.4e-11 Score=113.30 Aligned_cols=117 Identities=31% Similarity=0.493 Sum_probs=45.7
Q ss_pred CeEEEEeCCCCccccCCcccc-CCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcc-cccccchhhh
Q 007073 77 NVASVTLSSMNFSGTLSPRIG-VLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLT 154 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~ 154 (619)
++++|+|++|.|+. +. .++ .+.+|+.|+|++|.|+ .++. +..+++|+.|+|++|+|+ .++..+ ..+++|+.|+
T Consensus 20 ~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~-~l~~-l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQIT-KLEG-LPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---TT-----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred cccccccccccccc-cc-chhhhhcCCCEEECCCCCCc-cccC-ccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence 67889999999984 33 455 5889999999999998 5654 888999999999999999 565545 4689999999
Q ss_pred ccCCcCCCCCC--CccccccccccccCCCCcccccCCc----cccccCcccc
Q 007073 155 LSQNNFSGTIP--DSLTTLSSLISIQLDSNNLSGQIPV----HLFQIPKYNF 200 (619)
Q Consensus 155 l~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~p~----~l~~l~~l~~ 200 (619)
|++|+|. .+. ..+..+++|+.|+|.+|+++ ..+. -+..+|.|..
T Consensus 95 L~~N~I~-~l~~l~~L~~l~~L~~L~L~~NPv~-~~~~YR~~vi~~lP~Lk~ 144 (175)
T PF14580_consen 95 LSNNKIS-DLNELEPLSSLPKLRVLSLEGNPVC-EKKNYRLFVIYKLPSLKV 144 (175)
T ss_dssp -TTS----SCCCCGGGGG-TT--EEE-TT-GGG-GSTTHHHHHHHH-TT-SE
T ss_pred CcCCcCC-ChHHhHHHHcCCCcceeeccCCccc-chhhHHHHHHHHcChhhe
Confidence 9999997 332 34667888999999999988 3442 2334555543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2e-09 Score=97.43 Aligned_cols=132 Identities=22% Similarity=0.305 Sum_probs=100.4
Q ss_pred CccccCCCceEEEEEeCCCcEEEEEEe-ccCCC-cch-----HHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 300 NVLGQGGFGKVYRGVLADGTKVAVKRL-TDFES-PGG-----DAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~~g~~vAvK~l-~~~~~-~~~-----~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
..+++|+-+.+|.+.+. |.++++|.- .+... +.- ...-.+|++++.+++--.|--..=+..++....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46899999999999885 445666643 22211 211 23456799999988766665555566778888999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
++|-.|.+.+... ...++..+-+.+.-||.. +|+|+|+.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998888888763 245666777788889999 999999999999998775 99999999873
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.6e-09 Score=97.47 Aligned_cols=144 Identities=19% Similarity=0.226 Sum_probs=105.7
Q ss_pred ccCccccCCCceEEEEEeCCCcEEEEEEec-cCC-Ccc-----hHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 298 EKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFE-SPG-----GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 298 ~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~-~~~-~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
...+|.+|+-+.|+++.+. |+...||.-. +.. .+. ......+|++.+.+++--.|.-..=++.+.....++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4578999999999999994 7887777432 211 111 2345678999999887666655555666777788999
Q ss_pred ccccc-chhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC---cEEEcccccce
Q 007073 371 PFMQN-LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF---EAVVGDFGLAK 446 (619)
Q Consensus 371 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGla~ 446 (619)
||+++ .++.+++....... ..-.....++..|-+.+.-||.. +|+||||.++||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99987 47777776644322 22222367888999999999999 999999999999996543 45899999986
Q ss_pred e
Q 007073 447 L 447 (619)
Q Consensus 447 ~ 447 (619)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 3
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.03 E-value=6e-11 Score=109.10 Aligned_cols=115 Identities=31% Similarity=0.497 Sum_probs=38.5
Q ss_pred eCCCCccccCCccccCCCCCCEEEccCCCCCCCCccccc-ccccCcEeeecCCCccccCCCcccccccchhhhccCCcCC
Q 007073 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELG-NLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFS 161 (619)
Q Consensus 83 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 161 (619)
|+.+.|. .++ .+.+..++++|+|++|+|+ .+.. ++ .+++|+.|||++|.|+ .++ .+..+++|++|++++|+|+
T Consensus 4 lt~~~i~-~~~-~~~n~~~~~~L~L~~n~I~-~Ie~-L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~ 77 (175)
T PF14580_consen 4 LTANMIE-QIA-QYNNPVKLRELNLRGNQIS-TIEN-LGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS 77 (175)
T ss_dssp -----------------------------------S---TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---
T ss_pred ccccccc-ccc-ccccccccccccccccccc-cccc-hhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC
Confidence 4455555 333 3456668999999999999 6654 66 6899999999999999 565 5889999999999999999
Q ss_pred CCCCCcc-ccccccccccCCCCcccccCC-----ccccccCccccCCCCC
Q 007073 162 GTIPDSL-TTLSSLISIQLDSNNLSGQIP-----VHLFQIPKYNFTGNNL 205 (619)
Q Consensus 162 ~~~p~~~-~~l~~L~~L~l~~N~l~~~~p-----~~l~~l~~l~~~~n~~ 205 (619)
.+++.+ ..+++|+.|+|++|+|. .+- ..+.++..|++.|||.
T Consensus 78 -~i~~~l~~~lp~L~~L~L~~N~I~-~l~~l~~L~~l~~L~~L~L~~NPv 125 (175)
T PF14580_consen 78 -SISEGLDKNLPNLQELYLSNNKIS-DLNELEPLSSLPKLRVLSLEGNPV 125 (175)
T ss_dssp -S-CHHHHHH-TT--EEE-TTS----SCCCCGGGGG-TT--EEE-TT-GG
T ss_pred -ccccchHHhCCcCCEEECcCCcCC-ChHHhHHHHcCCCcceeeccCCcc
Confidence 665555 46899999999999998 333 2345666788999997
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.3e-08 Score=104.97 Aligned_cols=220 Identities=14% Similarity=0.152 Sum_probs=152.0
Q ss_pred CCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeC----CCcceeEeccccc-chhh
Q 007073 306 GFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT----PTERLLVYPFMQN-LSVA 379 (619)
Q Consensus 306 ~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~ 379 (619)
...+.|++.. .||..|+.||++...... ...-..-+++++++.|+|+|++.+++.+ +...++||+|.++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~-~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQS-TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccC-cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 4468899985 489999999995433221 1112345788999999999999998863 3457899999986 3555
Q ss_pred hhhcccC-----------CCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 380 YRLREIK-----------PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 380 ~~l~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
+.-.... ..+...+....+.++.|++.||.++|+. |...+-|.+.+|+++.+.+++|+..|....+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 4432211 1234467788999999999999999999 9999999999999999999999999988777
Q ss_pred ccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
..++.. -+ +--.+-|.=.||.+++.|.||..---... ......+.
T Consensus 444 ~~d~~~---------------~l---e~~Qq~D~~~lG~ll~aLAt~~~ns~~~d---------------~~~~s~~~-- 488 (655)
T KOG3741|consen 444 QEDPTE---------------PL---ESQQQNDLRDLGLLLLALATGTENSNRTD---------------STQSSHLT-- 488 (655)
T ss_pred cCCCCc---------------ch---hHHhhhhHHHHHHHHHHHhhccccccccc---------------chHHHHHH--
Confidence 654411 11 11246788999999999999964311000 00000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
......+.++.+++.-....++++ -+..+++.++-+
T Consensus 489 -------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~ 524 (655)
T KOG3741|consen 489 -------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGS 524 (655)
T ss_pred -------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHH
Confidence 112344456677777777778876 567777766543
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.93 E-value=9.5e-11 Score=121.27 Aligned_cols=125 Identities=30% Similarity=0.520 Sum_probs=101.1
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
...++.|||+.|+++ .+|..++.|+ |+.|-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++.+.+|+.|.
T Consensus 120 L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~ 195 (722)
T KOG0532|consen 120 LEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLN 195 (722)
T ss_pred hhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHH
Confidence 347888888888888 7777777765 788888888888 88888888888888888888888 7888888888888888
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCCcccccc---CccccCCCCCC
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQI---PKYNFTGNNLN 206 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l---~~l~~~~n~~~ 206 (619)
+..|++. .+|..+..| .|..||++.|+++ .||-.|.+| ..|.|.+||..
T Consensus 196 vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 196 VRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred Hhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence 8888888 778877754 4788888888888 788766554 45667788764
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.93 E-value=4.9e-10 Score=84.76 Aligned_cols=57 Identities=40% Similarity=0.632 Sum_probs=21.9
Q ss_pred CCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhccCC
Q 007073 102 LSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158 (619)
Q Consensus 102 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 158 (619)
|++|+|++|+|+...+..|.++++|++|+|++|+|+...|..|.++++|+.|++++|
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N 59 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNN 59 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCC
Confidence 333444444443222233333444444444444443333333344444444444433
|
... |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=9.8e-10 Score=122.89 Aligned_cols=115 Identities=26% Similarity=0.361 Sum_probs=76.9
Q ss_pred CeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhcc
Q 007073 77 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 156 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 156 (619)
+|+.|+|++|+|++ +|.. .++|+.|++++|+|+ .+|.. .++|+.|+|++|+|+ .+|... ++|+.|+++
T Consensus 343 ~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS 410 (788)
T PRK15387 343 GLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLT-SLPVLP---SELKELMVS 410 (788)
T ss_pred ccceEecCCCccCC-CCCC---Ccccceehhhccccc-cCccc---ccccceEEecCCccc-CCCCcc---cCCCEEEcc
Confidence 45555555555552 3321 234445555555555 34432 246888888888888 466543 578889999
Q ss_pred CCcCCCCCCCccccccccccccCCCCcccccCCcccc---ccCccccCCCCCCCC
Q 007073 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLNCG 208 (619)
Q Consensus 157 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~---~l~~l~~~~n~~~c~ 208 (619)
+|+|+ .+|... .+|+.|++++|+|+ .+|..+. ++..+++++|++...
T Consensus 411 ~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~ 460 (788)
T PRK15387 411 GNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSER 460 (788)
T ss_pred CCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCch
Confidence 99998 577643 47889999999999 8997665 455688999998643
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.8e-09 Score=121.31 Aligned_cols=95 Identities=24% Similarity=0.469 Sum_probs=40.5
Q ss_pred CCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCC
Q 007073 101 TLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLD 180 (619)
Q Consensus 101 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 180 (619)
+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+++ .+|..+. ++|+.|+++
T Consensus 263 ~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls 333 (754)
T PRK15370 263 ALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLT-ALPETLP--PGLKTLEAG 333 (754)
T ss_pred CCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccc-cCCcccc--ccceecccc
Confidence 4444444444444 3443332 24455555555444 2333322 24444444444444 3333221 344444444
Q ss_pred CCcccccCCccc-cccCccccCCCCC
Q 007073 181 SNNLSGQIPVHL-FQIPKYNFTGNNL 205 (619)
Q Consensus 181 ~N~l~~~~p~~l-~~l~~l~~~~n~~ 205 (619)
+|.++ .+|..+ .++..|++++|.+
T Consensus 334 ~N~Lt-~LP~~l~~sL~~L~Ls~N~L 358 (754)
T PRK15370 334 ENALT-SLPASLPPELQVLDVSKNQI 358 (754)
T ss_pred CCccc-cCChhhcCcccEEECCCCCC
Confidence 44444 244322 2344444444443
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.2e-10 Score=111.53 Aligned_cols=127 Identities=27% Similarity=0.391 Sum_probs=101.5
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
..|++||||+|.|+ .+..+..-+|.++.|++|+|.|. .+-. +..|++|+.||||+|.++ .+.+.=.+|.|.++|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 47899999999999 67778888999999999999998 5554 889999999999999999 66666677888999999
Q ss_pred cCCcCCCCCCCccccccccccccCCCCcccccCC--ccccccC---ccccCCCCCCCCC
Q 007073 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP--VHLFQIP---KYNFTGNNLNCGK 209 (619)
Q Consensus 156 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p--~~l~~l~---~l~~~~n~~~c~~ 209 (619)
+.|.|. .+ +.+..|-+|..||+++|+|. .+. ..+++++ .+.+.+||..-..
T Consensus 360 a~N~iE-~L-SGL~KLYSLvnLDl~~N~Ie-~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 360 AQNKIE-TL-SGLRKLYSLVNLDLSSNQIE-ELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhhhHh-hh-hhhHhhhhheeccccccchh-hHHHhcccccccHHHHHhhcCCCccccc
Confidence 999987 33 45677788999999999997 333 3455554 4567788875433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.5e-10 Score=125.03 Aligned_cols=250 Identities=17% Similarity=0.190 Sum_probs=165.7
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
..+.+.+.+-+-+|+++.++.+.-. .|...+.|...... .....+....+-.++-..+||-++...--+.......+
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4456677778889999999888743 35445555433211 01112222333333333455666655444445567889
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
+++|..++++...++.... .+..-.......+..+++|||.. .+.|+|++|.|.++..+++.+++|||.....
T Consensus 882 ~~~~~~~~~~~Skl~~~~~----~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGC----LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhHHhccCCchhhhhcCCC----cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999999887542 33333344556678899999998 7999999999999999999999999844322
Q ss_pred ccC------------------------------CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 007073 449 DVR------------------------------KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRA 498 (619)
Q Consensus 449 ~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p 498 (619)
... +........||+.|.+||...+......+|+|+.|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 100 00011234689999999999999999999999999999999999999
Q ss_pred CCCCccccccchhHHHHHHHHhhhcccchhcccccc-CCCCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 007073 499 IDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN-KNYNIQEVETMIQVALLCTQASPEDRPAMSE 565 (619)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 565 (619)
|........ ...+...... ............+++...+..+|.+|-.+.-
T Consensus 1035 ~na~tpq~~-----------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~ 1085 (1205)
T KOG0606|consen 1035 FNAETPQQI-----------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKG 1085 (1205)
T ss_pred CCCcchhhh-----------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCccc
Confidence 864332110 0111111111 1123344456778888888999999977663
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.2e-09 Score=120.70 Aligned_cols=117 Identities=26% Similarity=0.475 Sum_probs=68.6
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
.+++.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|++|+++ .+|..+. ++|+.|+|
T Consensus 199 ~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~L 269 (754)
T PRK15370 199 EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDL 269 (754)
T ss_pred cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEEC
Confidence 36778888888877 4555443 47777777777777 5565443 35666666666666 5555543 35666666
Q ss_pred cCCcCCCCCCCccccccccccccCCCCcccccCCcccc-ccCccccCCCCC
Q 007073 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF-QIPKYNFTGNNL 205 (619)
Q Consensus 156 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~-~l~~l~~~~n~~ 205 (619)
++|+|+ .+|..+. ++|+.|++++|+|+ .+|..+. ++..|++++|.+
T Consensus 270 s~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp~sL~~L~Ls~N~L 316 (754)
T PRK15370 270 FHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLPSGITHLNVQSNSL 316 (754)
T ss_pred cCCccC-ccccccC--CCCcEEECCCCccc-cCcccchhhHHHHHhcCCcc
Confidence 666666 4555443 35666666666665 3443322 344445555444
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.9e-09 Score=81.53 Aligned_cols=61 Identities=34% Similarity=0.466 Sum_probs=56.9
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCc
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRL 136 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 136 (619)
++|+.|+|++|+|+.+.+..|..+++|++|+|++|+|+...|..|.++++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3789999999999988888999999999999999999977778999999999999999986
|
... |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.3e-07 Score=95.35 Aligned_cols=289 Identities=16% Similarity=0.131 Sum_probs=171.3
Q ss_pred cccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeee-------eCCCccee
Q 007073 297 SEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFC-------TTPTERLL 368 (619)
Q Consensus 297 ~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~-------~~~~~~~l 368 (619)
.....||+|+.+.+|-.-.- +.. +-|+.+..... .. .+.+++|... .||-+-.-+.+- .......+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa-~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPA-AQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchh-hch-hheeecCCCch-HH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 34678999999999965421 222 33655532211 11 2234444443 466543312111 11122456
Q ss_pred Eecccccch-hhhhhc--ccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007073 369 VYPFMQNLS-VAYRLR--EIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 445 (619)
Q Consensus 369 v~e~~~~gs-L~~~l~--~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 445 (619)
.|..+.+-- ...+.. .....-....|+-.++++..+|.+.+.||+. |.+-||+.++|+|+.+++.+.|.|=..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence 666665431 111111 1112234578999999999999999999999 9999999999999999999999886543
Q ss_pred eeeccCCcceeeecccccccccccccc-----CCCCCcchhhHHHHHHHHHHHhC-CCCCCCCccccccchhHHHHHHHH
Q 007073 446 KLVDVRKTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTG-QRAIDFSRLEEEDDVLLLDHVKKL 519 (619)
Q Consensus 446 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~ 519 (619)
... .........+|...|.+||.-. +-.-+...|-|.+||++++++.| ++||...........-.- ..
T Consensus 165 qi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E----~~ 238 (637)
T COG4248 165 QIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE----TD 238 (637)
T ss_pred eec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch----hh
Confidence 322 2233445667899999999764 33457789999999999999987 999975332111110000 00
Q ss_pred hhhcccchhcc------ccccCCCCHHHHHHHHHHHHhccCCC--CCCCCCHHHHHHHHhcCCcccchhhhhhhhhhhHH
Q 007073 520 EREKRLDAIVD------RNLNKNYNIQEVETMIQVALLCTQAS--PEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRRQ 591 (619)
Q Consensus 520 ~~~~~~~~~~~------~~l~~~~~~~~~~~l~~l~~~Cl~~d--P~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~ 591 (619)
...+......+ +........-.+.++..+..+|+... +.-|||++..+..|..... +.....+....
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~-----~L~~C~v~a~H 313 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ-----QLKKCTVSAMH 313 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH-----hhhhhhhcccc
Confidence 00011100000 00011112334467788888999764 5689999999888866321 22333344445
Q ss_pred HHHhhccccCcccC
Q 007073 592 EYERLQRRFDWGED 605 (619)
Q Consensus 592 ~~~~~~~~~~w~~~ 605 (619)
.|...--++.|++-
T Consensus 314 ~y~~hl~~CPwCa~ 327 (637)
T COG4248 314 VYPVHLTDCPWCAL 327 (637)
T ss_pred cccCCCCCCchhhh
Confidence 56666666788764
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.6e-08 Score=98.92 Aligned_cols=141 Identities=16% Similarity=0.073 Sum_probs=100.6
Q ss_pred CccccCCCceEEEEEeCCCcEEEEEEeccCCCcc----------hHHHHHHHHHHHHHccCCCc--cceeeeeeC-----
Q 007073 300 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPG----------GDAAFQREVEMISVAVHRNL--LRLIGFCTT----- 362 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~----------~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~----- 362 (619)
+.+-......|++..+ +|+.|.||+........ ....+.+|...+.++...+| ..++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4455445556778777 57899999774322111 11247789999888864443 344555532
Q ss_pred CCcceeEecccccc-hhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-------C
Q 007073 363 PTERLLVYPFMQNL-SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-------D 434 (619)
Q Consensus 363 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-------~ 434 (619)
....++|+|++++. +|.+++..... ...+...+..++.+++..+.-||+. ||+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23468999999986 78888753221 2245566778999999999999999 9999999999999975 4
Q ss_pred CcEEEcccccce
Q 007073 435 FEAVVGDFGLAK 446 (619)
Q Consensus 435 ~~~kl~DfGla~ 446 (619)
..+.++||+.+.
T Consensus 182 ~~~~LIDl~r~~ 193 (268)
T PRK15123 182 LKLSVIDLHRAQ 193 (268)
T ss_pred ceEEEEECCccc
Confidence 789999999885
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=3.3e-08 Score=92.52 Aligned_cols=126 Identities=20% Similarity=0.289 Sum_probs=82.1
Q ss_pred eEEEEEeCCCcEEEEEEeccCC--------------C------cc-----hHHHHHHHHHHHHHccCCC--ccceeeeee
Q 007073 309 KVYRGVLADGTKVAVKRLTDFE--------------S------PG-----GDAAFQREVEMISVAVHRN--LLRLIGFCT 361 (619)
Q Consensus 309 ~Vy~~~~~~g~~vAvK~l~~~~--------------~------~~-----~~~~~~~E~~~l~~l~H~n--iv~l~~~~~ 361 (619)
.||.|...+|..+|||..+... . .. ......+|.+.|.++..-+ +.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 4899999899999999764210 0 00 1234567999999998654 4555544
Q ss_pred CCCcceeEecccc--cchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHH-HHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 007073 362 TPTERLLVYPFMQ--NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY-LHEHCNPKIIHRDVKAANVLLDEDFEAV 438 (619)
Q Consensus 362 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~-LH~~~~~~ivH~Dlkp~NIll~~~~~~k 438 (619)
....+||||++ |..+.. +.... ++......++.++...+.. +|.. ||+|||+.+.||+++++ .+.
T Consensus 79 --~~~~ivME~I~~~G~~~~~-l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPR-LKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp --ETTEEEEE--EETTEEGGC-HHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred --eCCEEEEEecCCCccchhh-HHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 25689999998 545544 33211 1123445677788886665 4677 99999999999999988 999
Q ss_pred Ecccccceee
Q 007073 439 VGDFGLAKLV 448 (619)
Q Consensus 439 l~DfGla~~~ 448 (619)
++|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=6.4e-09 Score=116.44 Aligned_cols=112 Identities=22% Similarity=0.327 Sum_probs=52.5
Q ss_pred CeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhcc
Q 007073 77 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 156 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 156 (619)
+++.|+|++|+|+. +|. .+++|++|+|++|+|+ .+|.. .++|+.|+|++|.|+ .+|..+ ++|+.|+|+
T Consensus 223 ~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~L~-~Lp~lp---~~L~~L~Ls 290 (788)
T PRK15387 223 HITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNPLT-HLPALP---SGLCKLWIF 290 (788)
T ss_pred CCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccCc---ccccceeeccCCchh-hhhhch---hhcCEEECc
Confidence 34555555555552 332 1345555555555555 33431 234455555555554 333322 334445555
Q ss_pred CCcCCCCCCCccccccccccccCCCCcccccCCccccccCccccCCCCC
Q 007073 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNL 205 (619)
Q Consensus 157 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~l~~~~n~~ 205 (619)
+|+|+ .+|.. +++|+.|+|++|+|+ .+|....++..|.+.+|.+
T Consensus 291 ~N~Lt-~LP~~---p~~L~~LdLS~N~L~-~Lp~lp~~L~~L~Ls~N~L 334 (788)
T PRK15387 291 GNQLT-SLPVL---PPGLQELSVSDNQLA-SLPALPSELCKLWAYNNQL 334 (788)
T ss_pred CCccc-ccccc---ccccceeECCCCccc-cCCCCcccccccccccCcc
Confidence 55555 34432 245555566666555 3444334444444444443
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=4.3e-10 Score=122.60 Aligned_cols=121 Identities=26% Similarity=0.398 Sum_probs=100.2
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
..+|+.|+|++|.|.......+.++..|+.|+||+|+|+ .+|+.+.++..|++|...+|+|. ..| .+.++++|+.+|
T Consensus 382 ~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lD 458 (1081)
T KOG0618|consen 382 FKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLD 458 (1081)
T ss_pred ccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEe
Confidence 358999999999999666677889999999999999999 99999999999999999999999 888 999999999999
Q ss_pred ccCCcCCCC-CCCccccccccccccCCCCcccccCCccccccCccc
Q 007073 155 LSQNNFSGT-IPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYN 199 (619)
Q Consensus 155 l~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~l~ 199 (619)
+|.|+|+.. +|..... ++|++|||++|.-...--..|..+..+.
T Consensus 459 lS~N~L~~~~l~~~~p~-p~LkyLdlSGN~~l~~d~~~l~~l~~l~ 503 (1081)
T KOG0618|consen 459 LSCNNLSEVTLPEALPS-PNLKYLDLSGNTRLVFDHKTLKVLKSLS 503 (1081)
T ss_pred cccchhhhhhhhhhCCC-cccceeeccCCcccccchhhhHHhhhhh
Confidence 999999843 3544433 8999999999985322223344444333
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.2e-10 Score=117.38 Aligned_cols=124 Identities=28% Similarity=0.495 Sum_probs=93.1
Q ss_pred CeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhcc
Q 007073 77 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 156 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 156 (619)
.|..+.|.+|.+. ++|..+++|..|++|||+.|+++ .+|..++.|+ |+.|-+++|+++ .+|..++.+..|..||.+
T Consensus 99 ~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s 174 (722)
T KOG0532|consen 99 SLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVS 174 (722)
T ss_pred HHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhh
Confidence 3555556666666 66777777777888888888877 7777676654 777778888877 778788877888888888
Q ss_pred CCcCCCCCCCccccccccccccCCCCcccccCCcccccc--CccccCCCCCC
Q 007073 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQI--PKYNFTGNNLN 206 (619)
Q Consensus 157 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l--~~l~~~~n~~~ 206 (619)
.|.+. .+|..+..+.+|+.|.+..|++. .+|.++..| .+|+|+.|+..
T Consensus 175 ~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~LpLi~lDfScNkis 224 (722)
T KOG0532|consen 175 KNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLPLIRLDFSCNKIS 224 (722)
T ss_pred hhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCceeeeecccCcee
Confidence 88887 77888888888888888888887 677777654 45788888765
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=2e-10 Score=97.70 Aligned_cols=134 Identities=22% Similarity=0.397 Sum_probs=102.1
Q ss_pred EEcCCCCeEEEEeCCCCccccCCcc---ccCCCCCCEEEccCCCCCCCCcccc-cccccCcEeeecCCCccccCCCcccc
Q 007073 71 ICDNSNNVASVTLSSMNFSGTLSPR---IGVLRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPPSLGN 146 (619)
Q Consensus 71 ~c~~~~~l~~L~L~~n~l~~~~~~~---~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~ 146 (619)
+|++...+..++|+++.|. .++.. +.....|+..+|++|.+. ..|+.| .+.+.++.|+|++|.|+ .+|..+..
T Consensus 22 rcedakE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aa 98 (177)
T KOG4579|consen 22 RCEDAKELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAA 98 (177)
T ss_pred hhHHHHHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhh
Confidence 3666667888899999886 45543 445567777899999999 555544 45568999999999999 78999999
Q ss_pred cccchhhhccCCcCCCCCCCccccccccccccCCCCcccccCCcccc--ccCc-cccCCCCCCCCC
Q 007073 147 LKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF--QIPK-YNFTGNNLNCGK 209 (619)
Q Consensus 147 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~--~l~~-l~~~~n~~~c~~ 209 (619)
++.|+.|++++|.|. ..|..+..|.+|-.|+..+|.+. .||..+. .++- .++.++++.-++
T Consensus 99 m~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~ 162 (177)
T KOG4579|consen 99 MPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDET 162 (177)
T ss_pred hHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccC
Confidence 999999999999998 88888888999999999999998 7885532 2222 234555554443
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.7e-08 Score=121.04 Aligned_cols=126 Identities=21% Similarity=0.325 Sum_probs=76.1
Q ss_pred CeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhcc
Q 007073 77 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 156 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 156 (619)
+|+.|+|++|++. .++..+..+++|+.|+|++|...+.+|. ++.+++|+.|+|++|.....+|..++++++|+.|+++
T Consensus 612 ~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~ 689 (1153)
T PLN03210 612 NLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS 689 (1153)
T ss_pred CCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCC
Confidence 5666666666665 4555566666666666665543335554 5666666666666655444666666666666666666
Q ss_pred CCcCCCCCCCccccccccccccCCCCcccccCCccccccCccccCCCCC
Q 007073 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNL 205 (619)
Q Consensus 157 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~l~~~~n~~ 205 (619)
+|..-+.+|..+ ++++|+.|++++|...+.+|....++..|++.+|..
T Consensus 690 ~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i 737 (1153)
T PLN03210 690 RCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAI 737 (1153)
T ss_pred CCCCcCccCCcC-CCCCCCEEeCCCCCCccccccccCCcCeeecCCCcc
Confidence 654333566554 566666666666655555665555666666666653
|
syringae 6; Provisional |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=9.8e-08 Score=91.79 Aligned_cols=136 Identities=22% Similarity=0.177 Sum_probs=96.2
Q ss_pred CcccCccccCCCceEEEEEeCCCcEEEEEEeccCC-------------------C--cchHHHHHHHHHHHHHccCC--C
Q 007073 296 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-------------------S--PGGDAAFQREVEMISVAVHR--N 352 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~-------------------~--~~~~~~~~~E~~~l~~l~H~--n 352 (619)
..+++.||-|--+.||.|...+|.++|||.-+... + ........+|.++|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 34568999999999999999999999999542100 0 01223567788888888654 4
Q ss_pred ccceeeeeeCCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC
Q 007073 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD 432 (619)
Q Consensus 353 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 432 (619)
+.+.++ .+...+||||+++--|...- ++......++..|.+-+.-+-.. ||||+|+++-||+++
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCccc----cccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 555544 35678999999884443211 12223344555555555555566 999999999999999
Q ss_pred CCCcEEEccccccee
Q 007073 433 EDFEAVVGDFGLAKL 447 (619)
Q Consensus 433 ~~~~~kl~DfGla~~ 447 (619)
+++.+.++||--+..
T Consensus 237 ~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 237 EDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCCEEEEeCccccc
Confidence 999999999987653
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.74 E-value=9.8e-09 Score=71.18 Aligned_cols=40 Identities=40% Similarity=0.892 Sum_probs=30.8
Q ss_pred chhHHHHHHHHHhcC-CCCCCCCCCCCCC-CCCCCcceeEEc
Q 007073 34 SLSGDALFALRTSLR-VPNNQLRDWNQNQ-VNPCTWSNVICD 73 (619)
Q Consensus 34 ~~~~~al~~~k~~l~-~~~~~l~~w~~~~-~~~c~w~gv~c~ 73 (619)
..|.+||++||.++. +|.+.+.+|+... .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 368999999999998 5778999999864 799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.3e-09 Score=102.81 Aligned_cols=108 Identities=23% Similarity=0.293 Sum_probs=93.1
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
+.++.|++|+|.|... . .+..|++|+.||||+|.++ .+.+.-.+|-+.+.|.|+.|.|. .+ ..+++|-+|..||+
T Consensus 307 Pkir~L~lS~N~i~~v-~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE-~L-SGL~KLYSLvnLDl 381 (490)
T KOG1259|consen 307 PKLRRLILSQNRIRTV-Q-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIE-TL-SGLRKLYSLVNLDL 381 (490)
T ss_pred cceeEEeccccceeee-h-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHh-hh-hhhHhhhhheeccc
Confidence 5899999999999844 3 3889999999999999999 77777778999999999999988 33 36788999999999
Q ss_pred cCCcCCCCC--CCccccccccccccCCCCcccccCCc
Q 007073 156 SQNNFSGTI--PDSLTTLSSLISIQLDSNNLSGQIPV 190 (619)
Q Consensus 156 ~~N~l~~~~--p~~~~~l~~L~~L~l~~N~l~~~~p~ 190 (619)
++|+|. .+ -..+++||.|+.|.|.+|.+. .+|+
T Consensus 382 ~~N~Ie-~ldeV~~IG~LPCLE~l~L~~NPl~-~~vd 416 (490)
T KOG1259|consen 382 SSNQIE-ELDEVNHIGNLPCLETLRLTGNPLA-GSVD 416 (490)
T ss_pred cccchh-hHHHhcccccccHHHHHhhcCCCcc-ccch
Confidence 999998 44 246899999999999999999 4553
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=6.8e-10 Score=117.83 Aligned_cols=125 Identities=30% Similarity=0.393 Sum_probs=60.0
Q ss_pred CeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCC-cccccccchhhhc
Q 007073 77 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTL 155 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l 155 (619)
.|...+.+.|.+. ....++.-++.|+.|||++|+++..- .+..|++|++|||++|.+. .+|. ....++ |+.|.|
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence 3444455555554 33444555555555555555555222 3555555555555555555 3332 122222 555555
Q ss_pred cCCcCCCCCCCccccccccccccCCCCcccccCC----ccccccCccccCCCCCCCC
Q 007073 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP----VHLFQIPKYNFTGNNLNCG 208 (619)
Q Consensus 156 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p----~~l~~l~~l~~~~n~~~c~ 208 (619)
+||.++ .+ ..+.+|.+|+.||++.|-|.+--- ..+..+..|.+.|||.-|.
T Consensus 240 rnN~l~-tL-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 240 RNNALT-TL-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred cccHHH-hh-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 555555 22 224455555555555555542211 1233445555555555553
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.64 E-value=2e-09 Score=111.01 Aligned_cols=131 Identities=24% Similarity=0.343 Sum_probs=91.5
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCC---CCEEEccCCCCCC----CCccccccc-ccCcEeeecCCCcccc----CCC
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRT---LSTLTLKGNGITG----EIPEELGNL-SSLTSLDLDNNRLVGK----IPP 142 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~----~p~ 142 (619)
..+|+.|+|++|.+.+..+..+..+.+ |+.|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++.
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 458888899888887666666665555 8889998888873 233445566 8888899998888832 334
Q ss_pred cccccccchhhhccCCcCCCC----CCCccccccccccccCCCCcccccCCc-------cccccCccccCCCCC
Q 007073 143 SLGNLKKLQFLTLSQNNFSGT----IPDSLTTLSSLISIQLDSNNLSGQIPV-------HLFQIPKYNFTGNNL 205 (619)
Q Consensus 143 ~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~-------~l~~l~~l~~~~n~~ 205 (619)
.+..+++|+.|+|++|.+++. ++..+..+++|+.|++++|.+++.-.. .+.++..|++++|+.
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l 233 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNL 233 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcC
Confidence 556677888888888888742 333445556888888888888633221 233567777877764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.61 E-value=7.9e-08 Score=115.30 Aligned_cols=125 Identities=18% Similarity=0.300 Sum_probs=95.7
Q ss_pred CeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhcc
Q 007073 77 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 156 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 156 (619)
+|+.|++.++.+. .+|..| .+.+|+.|+|++|++. .+|..+..+++|+.|+|++|...+.+| .++.+++|+.|+|+
T Consensus 590 ~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~ 665 (1153)
T PLN03210 590 KLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLS 665 (1153)
T ss_pred ccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEec
Confidence 4777777777766 566666 5688888888888888 677778888899999998876444676 47888889999998
Q ss_pred CCcCCCCCCCccccccccccccCCCCcccccCCcc--ccccCccccCCCCC
Q 007073 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH--LFQIPKYNFTGNNL 205 (619)
Q Consensus 157 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--l~~l~~l~~~~n~~ 205 (619)
+|.....+|..+..+++|+.|++++|..-+.+|.. +.+|..|++.||..
T Consensus 666 ~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~ 716 (1153)
T PLN03210 666 DCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSR 716 (1153)
T ss_pred CCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCC
Confidence 87755688888888889999999886544477763 45677778877653
|
syringae 6; Provisional |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.7e-08 Score=107.44 Aligned_cols=128 Identities=33% Similarity=0.522 Sum_probs=105.9
Q ss_pred CCCeEEEEeCCCCccccCCccccCCC-CCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLR-TLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFL 153 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 153 (619)
...++.|++.+|+++ .+++....++ +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|...+.+++|+.|
T Consensus 115 ~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L 191 (394)
T COG4886 115 LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNL 191 (394)
T ss_pred ccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhe
Confidence 347999999999999 6677777785 9999999999999 88777899999999999999999 788887799999999
Q ss_pred hccCCcCCCCCCCccccccccccccCCCCcccccCCcccc---ccCccccCCCCCCC
Q 007073 154 TLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLNC 207 (619)
Q Consensus 154 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~---~l~~l~~~~n~~~c 207 (619)
++++|+++ .+|..+..+..|+.|.+++|++. .++..+. ++..+.+.+|+..+
T Consensus 192 ~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~ 246 (394)
T COG4886 192 DLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED 246 (394)
T ss_pred eccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee
Confidence 99999999 88887767777999999999655 4555444 44445566776655
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.58 E-value=3.9e-09 Score=108.79 Aligned_cols=130 Identities=22% Similarity=0.279 Sum_probs=98.1
Q ss_pred CCeEEEEeCCCCccc------cCCccccCCCCCCEEEccCCCCCCCCccccccccc---CcEeeecCCCccc----cCCC
Q 007073 76 NNVASVTLSSMNFSG------TLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSS---LTSLDLDNNRLVG----KIPP 142 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~------~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~ 142 (619)
.+++.|+++++.+.+ .++..+..+++|+.|+|++|.+.+..+..+..+.+ |++|++++|++++ .+..
T Consensus 51 ~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~ 130 (319)
T cd00116 51 PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAK 130 (319)
T ss_pred CCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHH
Confidence 468899999888772 34456777889999999999998777777777766 9999999999883 3334
Q ss_pred ccccc-ccchhhhccCCcCCCC----CCCccccccccccccCCCCccccc----CCcccc---ccCccccCCCCC
Q 007073 143 SLGNL-KKLQFLTLSQNNFSGT----IPDSLTTLSSLISIQLDSNNLSGQ----IPVHLF---QIPKYNFTGNNL 205 (619)
Q Consensus 143 ~~~~l-~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~l~---~l~~l~~~~n~~ 205 (619)
.+..+ ++|+.|+|++|.+++. ++..+..+++|+.|++++|.+++. ++..+. ++..|++++|.+
T Consensus 131 ~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i 205 (319)
T cd00116 131 GLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGL 205 (319)
T ss_pred HHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCcc
Confidence 55666 8999999999999843 233456677899999999999842 333344 778888888865
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=9.5e-09 Score=87.67 Aligned_cols=114 Identities=28% Similarity=0.360 Sum_probs=94.5
Q ss_pred CCeEEEEeCCCCccccCCcccc-CCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 76 NNVASVTLSSMNFSGTLSPRIG-VLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
.+|+.++|++|.+. ..|+.|. .++.++.|+|++|.|+ .+|.++..++.|+.|+++.|.|. ..|..+..|.+|..|+
T Consensus 53 ~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Ld 129 (177)
T KOG4579|consen 53 YELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLD 129 (177)
T ss_pred ceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhc
Confidence 47999999999999 4555554 5679999999999999 89999999999999999999999 7888898999999999
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCCcccc
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF 193 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~ 193 (619)
..+|.+. .+|-.+.--+.+-..++.+|.+.+.-|..+.
T Consensus 130 s~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klq 167 (177)
T KOG4579|consen 130 SPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQ 167 (177)
T ss_pred CCCCccc-cCcHHHhccccHHHHHhcCCcccccCccccc
Confidence 9999998 6776544333444556788889887775543
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.57 E-value=3e-08 Score=105.52 Aligned_cols=120 Identities=33% Similarity=0.538 Sum_probs=103.4
Q ss_pred EEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccc-cCcEeeecCCCccccCCCcccccccchhhhccCC
Q 007073 80 SVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLS-SLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158 (619)
Q Consensus 80 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 158 (619)
.|+++.|.+... ...+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 588888888533 345667789999999999999 7888788885 9999999999999 78888999999999999999
Q ss_pred cCCCCCCCccccccccccccCCCCcccccCCcc---ccccCccccCCCC
Q 007073 159 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH---LFQIPKYNFTGNN 204 (619)
Q Consensus 159 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~---l~~l~~l~~~~n~ 204 (619)
+++ .+|.....+++|+.|++++|+++ .+|.. ...+..+.+++|+
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCc
Confidence 999 88887778899999999999999 78874 3458899999996
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.8e-08 Score=107.85 Aligned_cols=150 Identities=15% Similarity=0.246 Sum_probs=99.8
Q ss_pred HHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcce--------eeeccccccccccccccC
Q 007073 402 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV--------TTQVRGTMGHIAPEYLST 473 (619)
Q Consensus 402 ~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~ 473 (619)
.+++.|+.|+|... ++||++|.|++|.++.++..||+.|+.+.......... .....-...|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34569999999874 89999999999999999999999999876543311111 011123457999999999
Q ss_pred CCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhc
Q 007073 474 GKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLC 552 (619)
Q Consensus 474 ~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~C 552 (619)
...+.++|+||+||++|-+.. |+.-+....... ...... ..+..-.-.+....+.++.+=+.+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-----~~~~~~----------~~~~~~~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-----SYSFSR----------NLLNAGAFGYSNNLPSELRESLKKL 248 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcc-----hhhhhh----------cccccccccccccCcHHHHHHHHHH
Confidence 888999999999999999984 554443221110 000000 0000000111233345677777788
Q ss_pred cCCCCCCCCCHHHHHH
Q 007073 553 TQASPEDRPAMSEVVR 568 (619)
Q Consensus 553 l~~dP~~RPs~~evl~ 568 (619)
+..++.-||++.++..
T Consensus 249 l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLS 264 (700)
T ss_pred hcCCcccCcchhhhhc
Confidence 9999999997766653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.52 E-value=5.8e-07 Score=86.26 Aligned_cols=124 Identities=19% Similarity=0.205 Sum_probs=90.2
Q ss_pred CCcEEEEEEeccCCC------cchHHHHHHHHHHHHHccCCC--ccceeeeeeCCC----cceeEecccccc-hhhhhhc
Q 007073 317 DGTKVAVKRLTDFES------PGGDAAFQREVEMISVAVHRN--LLRLIGFCTTPT----ERLLVYPFMQNL-SVAYRLR 383 (619)
Q Consensus 317 ~g~~vAvK~l~~~~~------~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~ 383 (619)
.++.+.+|....... +-......+|...+..+.... ..+.+++..... ..++|+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 356677775432111 123446778888887776433 345566655432 347899999874 7888887
Q ss_pred ccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC---cEEEccccccee
Q 007073 384 EIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF---EAVVGDFGLAKL 447 (619)
Q Consensus 384 ~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGla~~ 447 (619)
.... .+......++.++++.++-||+. ||+|+|+++.|||++.+. .+.++||+-++.
T Consensus 111 ~~~~----~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 111 QWEQ----LDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred hhcc----cchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 5322 45556788999999999999999 999999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.43 E-value=4.2e-06 Score=78.88 Aligned_cols=138 Identities=20% Similarity=0.194 Sum_probs=101.5
Q ss_pred cccCCCceEEEEEeCCCcEEEEEEeccC--CC---cchHHHHHHHHHHHHHccCCC--ccceeeeee---CC--CcceeE
Q 007073 302 LGQGGFGKVYRGVLADGTKVAVKRLTDF--ES---PGGDAAFQREVEMISVAVHRN--LLRLIGFCT---TP--TERLLV 369 (619)
Q Consensus 302 lg~G~fg~Vy~~~~~~g~~vAvK~l~~~--~~---~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~---~~--~~~~lv 369 (619)
-|+||-+-|++.... |+.+-+|+-... .+ +-+...|.+|+..+.++...+ +.+.. ++. .+ -.-.||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 477899999998874 567999976421 11 446789999999999886433 33443 332 11 235788
Q ss_pred eccccc-chhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc--EEEcccccce
Q 007073 370 YPFMQN-LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE--AVVGDFGLAK 446 (619)
Q Consensus 370 ~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfGla~ 446 (619)
+|-+.+ -+|.+++.+... .+.+...+..++.+++++++-||+. |+.|+|+.+.||+++.++. ++++||--++
T Consensus 104 Te~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 887764 477777754221 2356677789999999999999999 9999999999999986666 9999998665
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.1e-06 Score=94.51 Aligned_cols=142 Identities=23% Similarity=0.263 Sum_probs=92.8
Q ss_pred CccccCCCceEEEEEeCCCcEEEEEEeccCCCc---------------------c--------hHH----------HHHH
Q 007073 300 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESP---------------------G--------GDA----------AFQR 340 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~---------------------~--------~~~----------~~~~ 340 (619)
+-|+.++-|.||+|++++|+.||||+.+....+ . ..+ ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 679999999999999999999999987531110 0 001 2344
Q ss_pred HHHHHHHcc----CCCccceeeeee-CCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHH-HHHHHhc
Q 007073 341 EVEMISVAV----HRNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARG-LEYLHEH 414 (619)
Q Consensus 341 E~~~l~~l~----H~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~-L~~LH~~ 414 (619)
|..-+.+++ ...-+++=.++. -..+..++|||++|-.+.+...-...+ .+ +..++..++++ +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g---~d---~k~ia~~~~~~f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG---ID---RKELAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC---CC---HHHHHHHHHHHHHHHHHhc
Confidence 554444432 222223333333 356789999999998888774332222 33 23334333332 2223334
Q ss_pred CCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 415 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 415 ~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
|++|.|..|.||+++.++.+.+.|||+...++.
T Consensus 285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999877653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.35 E-value=6.9e-06 Score=79.88 Aligned_cols=138 Identities=14% Similarity=0.159 Sum_probs=84.7
Q ss_pred CccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCc--cceeeeeeCCCcceeEecccccch
Q 007073 300 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL--LRLIGFCTTPTERLLVYPFMQNLS 377 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~~~~~lv~e~~~~gs 377 (619)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-.+ .+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 46899999999984 25567888775422 23456889999988875443 566777777777789999999863
Q ss_pred -hhhh---------------------hcccCCCCCCcCHHHHHH-HHH----------HHH-HHHHHHHhc-CCCCeEec
Q 007073 378 -VAYR---------------------LREIKPGEPVLDWVTRKR-VAL----------GAA-RGLEYLHEH-CNPKIIHR 422 (619)
Q Consensus 378 -L~~~---------------------l~~~~~~~~~l~~~~~~~-i~~----------~ia-~~L~~LH~~-~~~~ivH~ 422 (619)
+... +|....... ....... +.. .+. ....+|... ..+.++|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~--~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTS--TFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCC--cHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 1111 121111111 1111000 000 011 112222221 13357899
Q ss_pred CCCCCcEEeCCCCcEEEcccccce
Q 007073 423 DVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 423 Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
|+.|.||++++++ +.++||+.+.
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcC
Confidence 9999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.5e-07 Score=95.17 Aligned_cols=110 Identities=25% Similarity=0.310 Sum_probs=58.5
Q ss_pred CCCeEEEEeCCCCcccc-CCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCC--Ccccccccch
Q 007073 75 SNNVASVTLSSMNFSGT-LSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIP--PSLGNLKKLQ 151 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~ 151 (619)
.++++.|.|++|+|+-. +-..+..+|+|..|+|..|..-+.-......+..|+.|||++|++. ..+ ...+.++.|+
T Consensus 196 l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~ 274 (505)
T KOG3207|consen 196 LSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLN 274 (505)
T ss_pred hhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchh
Confidence 34556666666655521 1112234566666666666422232333444566666666666665 333 3455666666
Q ss_pred hhhccCCcCCCC-CCCc-----cccccccccccCCCCccc
Q 007073 152 FLTLSQNNFSGT-IPDS-----LTTLSSLISIQLDSNNLS 185 (619)
Q Consensus 152 ~L~l~~N~l~~~-~p~~-----~~~l~~L~~L~l~~N~l~ 185 (619)
.|+++.+.+... .|+. ...+++|++|++..|++.
T Consensus 275 ~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 275 QLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred hhhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 666666666522 2333 344566666666666664
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=3.4e-07 Score=97.81 Aligned_cols=127 Identities=26% Similarity=0.315 Sum_probs=75.5
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
.++..|+|.+|+|..+ ...+..+++|++|+|++|.|+...+ +..++.|+.|++++|.|+ .++ .+..+++|+.+++
T Consensus 95 ~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~-~~~-~~~~l~~L~~l~l 169 (414)
T KOG0531|consen 95 KSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGNLIS-DIS-GLESLKSLKLLDL 169 (414)
T ss_pred cceeeeeccccchhhc-ccchhhhhcchheeccccccccccc--hhhccchhhheeccCcch-hcc-CCccchhhhcccC
Confidence 4677777777777643 2235667777777777777773332 566666777777777777 232 4455677777777
Q ss_pred cCCcCCCCCCCc-cccccccccccCCCCcccccCC--ccccccCccccCCCCCCCCC
Q 007073 156 SQNNFSGTIPDS-LTTLSSLISIQLDSNNLSGQIP--VHLFQIPKYNFTGNNLNCGK 209 (619)
Q Consensus 156 ~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~p--~~l~~l~~l~~~~n~~~c~~ 209 (619)
++|++. .+... ...+.+|+.+++.+|.+. .+. ..+..+..+++..|......
T Consensus 170 ~~n~i~-~ie~~~~~~~~~l~~l~l~~n~i~-~i~~~~~~~~l~~~~l~~n~i~~~~ 224 (414)
T KOG0531|consen 170 SYNRIV-DIENDELSELISLEELDLGGNSIR-EIEGLDLLKKLVLLSLLDNKISKLE 224 (414)
T ss_pred Ccchhh-hhhhhhhhhccchHHHhccCCchh-cccchHHHHHHHHhhcccccceecc
Confidence 777776 33332 356667777777777776 222 12233344455555554443
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.22 E-value=3.6e-07 Score=97.66 Aligned_cols=128 Identities=26% Similarity=0.330 Sum_probs=100.7
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
..+..+++..|.+.. +-..+..+++|..|+|.+|+|. .+...+..+++|++|+|++|.|+..- .+..++.|+.|++
T Consensus 72 ~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l 147 (414)
T KOG0531|consen 72 TSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNL 147 (414)
T ss_pred HhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhhhee
Confidence 467777788888874 4455788999999999999999 55555788999999999999999433 4677888999999
Q ss_pred cCCcCCCCCCCccccccccccccCCCCcccccCC---ccccccCccccCCCCCCCCC
Q 007073 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP---VHLFQIPKYNFTGNNLNCGK 209 (619)
Q Consensus 156 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p---~~l~~l~~l~~~~n~~~c~~ 209 (619)
++|.|+ .+ ..+..+++|+.+++++|+++..-+ ..+.++..+.+.+|......
T Consensus 148 ~~N~i~-~~-~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~i~ 202 (414)
T KOG0531|consen 148 SGNLIS-DI-SGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIREIE 202 (414)
T ss_pred ccCcch-hc-cCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhccc
Confidence 999998 44 345668999999999999995444 45567777888888875443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.22 E-value=3.4e-07 Score=92.66 Aligned_cols=62 Identities=27% Similarity=0.237 Sum_probs=31.0
Q ss_pred CCeEEEEeCCCCccccC--CccccCCCCCCEEEccCCCCCCCCccc-ccccccCcEeeecCCCcc
Q 007073 76 NNVASVTLSSMNFSGTL--SPRIGVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLV 137 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~ 137 (619)
.+++.||||+|-+..-. -.-...|++|+.|+|+.|++.-..... -..+++|+.|.|+.+.|+
T Consensus 146 ~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls 210 (505)
T KOG3207|consen 146 PNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLS 210 (505)
T ss_pred CcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCC
Confidence 35666666666554321 122345666666666666665222111 123445555555555554
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.3e-06 Score=60.63 Aligned_cols=37 Identities=43% Similarity=0.715 Sum_probs=22.1
Q ss_pred CCCCEEEccCCCCCCCCcccccccccCcEeeecCCCcc
Q 007073 100 RTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLV 137 (619)
Q Consensus 100 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 137 (619)
++|++|+|++|+|+ .+|..+++|++|+.|+|++|+|+
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 35666666666666 45555666666666666666666
|
... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.3e-05 Score=74.93 Aligned_cols=153 Identities=23% Similarity=0.257 Sum_probs=94.0
Q ss_pred CHHHHHHHhcCCcccC---ccccCCCceEEEEEeCCCcEEEEEEeccCCCc--------chHH--------------H-H
Q 007073 285 SWRELQLATDNFSEKN---VLGQGGFGKVYRGVLADGTKVAVKRLTDFESP--------GGDA--------------A-F 338 (619)
Q Consensus 285 ~~~el~~~~~~~~~~~---~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~--------~~~~--------------~-~ 338 (619)
++..+........+.. .|++|--+.||+|...++..+|||+.+..... .+.. . .
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 3444444444444444 46677777999999888999999988532110 0000 1 1
Q ss_pred HHHHHHHHHccCC--CccceeeeeeCCCcceeEecccccc-hhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcC
Q 007073 339 QREVEMISVAVHR--NLLRLIGFCTTPTERLLVYPFMQNL-SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 415 (619)
Q Consensus 339 ~~E~~~l~~l~H~--niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ 415 (619)
.+|+.-|.++... .+.+.+++ ....|||||+... .-.-.|.+ ..+.......+..++.+.+.-|-..+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 2344445444322 22222222 3468999998653 11111222 11222245667778888888887743
Q ss_pred CCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 416 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 416 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
++||+||+.-|||+. ++.+.|+|||-|....
T Consensus 187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred --CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 999999999999999 7899999999987543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.6e-05 Score=73.82 Aligned_cols=138 Identities=14% Similarity=0.142 Sum_probs=91.6
Q ss_pred HHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHH---------HHHHHHHHHccC---CCccceee
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAF---------QREVEMISVAVH---RNLLRLIG 358 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~---------~~E~~~l~~l~H---~niv~l~~ 358 (619)
....+|...+++.......|.+-.. +|..+++|..+.... ..++.| .+++..+.+++. -....++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~-r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENR-RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhh-hHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 4567788888888888777777776 589999998764321 122222 233333334432 22333333
Q ss_pred eeeC-----CCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC
Q 007073 359 FCTT-----PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE 433 (619)
Q Consensus 359 ~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 433 (619)
+... ....+++|||++|..|.+... ++. .++..+++++.-+|+. |++|+|..|.|+++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEEC
Confidence 3222 234578999999977765432 111 2456677889999999 9999999999999996
Q ss_pred CCcEEEcccccce
Q 007073 434 DFEAVVGDFGLAK 446 (619)
Q Consensus 434 ~~~~kl~DfGla~ 446 (619)
++ ++++||+..+
T Consensus 171 ~~-i~iID~~~k~ 182 (229)
T PF06176_consen 171 NG-IRIIDTQGKR 182 (229)
T ss_pred Cc-EEEEECcccc
Confidence 64 9999998665
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 619 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-124 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-122 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-45 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-44 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-39 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-35 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-17 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-13 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-13 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-13 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-13 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-04 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-04 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 570 bits (1472), Expect = 0.0
Identities = 230/326 (70%), Positives = 272/326 (83%)
Query: 265 FVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVK 324
F DV E D + GQLKR+S RELQ+A+DNFS KN+LG+GGFGKVY+G LADGT VAVK
Sbjct: 1 FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60
Query: 325 RLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE 384
RL + + GG+ FQ EVEMIS+AVHRNLLRL GFC TPTERLLVYP+M N SVA LRE
Sbjct: 61 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 385 IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444
+P LDW R+R+ALG+ARGL YLH+HC+PKIIHRDVKAAN+LLDE+FEAVVGDFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 445 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRL 504
AKL+D + T+VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYG+MLLEL+TGQRA D +RL
Sbjct: 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 505 EEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 564
+DDV+LLD VK L +EK+L+A+VD +L NY +EVE +IQVALLCTQ+SP +RP MS
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300
Query: 565 EVVRMLEGEGLAERWEEWQHVEVTRR 590
EVVRMLEG+GLAERWEEWQ E+ R+
Sbjct: 301 EVVRMLEGDGLAERWEEWQKEEMFRQ 326
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 416 bits (1072), Expect = e-143
Identities = 107/311 (34%), Positives = 182/311 (58%), Gaps = 22/311 (7%)
Query: 273 DRRIAFGQLKRYSWRELQLATDNFSEK------NVLGQGGFGKVYRGVLADGTKVAVKRL 326
++ + +S+ EL+ T+NF E+ N +G+GGFG VY+G + + T VAVK+L
Sbjct: 4 SLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKL 62
Query: 327 T---DFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLR 383
D + F +E+++++ H NL+ L+GF + + LVY +M N S+ RL
Sbjct: 63 AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122
Query: 384 EIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 443
G P L W R ++A GAA G+ +LHE+ IHRD+K+AN+LLDE F A + DFG
Sbjct: 123 C-LDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFG 178
Query: 444 LAKLVDV-RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 502
LA+ + +T +T+++ GT ++APE L G+ + ++D++ +G++LLE++TG A+D
Sbjct: 179 LARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEH 237
Query: 503 RLEEEDDVLLLDHVKKLEREKR-LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP 561
R + LLLD +++E E++ ++ +D+ +N + + VE M VA C RP
Sbjct: 238 R----EPQLLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 562 AMSEVVRMLEG 572
+ +V ++L+
Sbjct: 293 DIKKVQQLLQE 303
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 381 bits (982), Expect = e-129
Identities = 113/294 (38%), Positives = 171/294 (58%), Gaps = 7/294 (2%)
Query: 280 QLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQ 339
+ R +L+ AT+NF K ++G G FGKVY+GVL DG KVA+KR T ES G F+
Sbjct: 25 ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP-ESSQGIEEFE 83
Query: 340 REVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR 399
E+E +S H +L+ LIGFC E +L+Y +M+N ++ L + W R
Sbjct: 84 TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 400 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-DVRKTNVTTQ 458
+ +GAARGL YLH IIHRDVK+ N+LLDE+F + DFG++K ++ +T+++T
Sbjct: 144 ICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV 200
Query: 459 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 518
V+GT+G+I PEY G+ +E++DV+ +G++L E++ + AI S E V L + +
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM--VNLAEWAVE 258
Query: 519 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572
+L+ IVD NL + + A+ C S EDRP+M +V+ LE
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 1e-76
Identities = 74/310 (23%), Positives = 120/310 (38%), Gaps = 37/310 (11%)
Query: 287 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMIS 346
L + V +G FG V++ L VAVK ++Q E E+ S
Sbjct: 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIF----PIQDKQSWQNEYEVYS 71
Query: 347 VAV--HRNLLRLIGFCTTP----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV 400
+ H N+L+ IG + L+ F + S++ L+ V+ W +
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHI 126
Query: 401 ALGAARGLEYLHEH-------CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 453
A ARGL YLHE P I HRD+K+ NVLL + A + DFGLA + K+
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 454 NV-TTQVRGTMGHIAPEYLSTG-----KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE 507
T GT ++APE L + R D++ G++L EL + A D +E
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV--DE 244
Query: 508 DDVLLLDHV-KKLEREKRLDAIVDRNL-----NKNYNIQEVETMIQVALLCTQASPEDRP 561
+ + + + E + +V + + + + + C E R
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 562 AMSEVVRMLE 571
+ V +
Sbjct: 305 SAGCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 8e-64
Identities = 74/321 (23%), Positives = 117/321 (36%), Gaps = 44/321 (13%)
Query: 285 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEM 344
+ E L DN ++G+G +G VY+G L D VAVK S F E +
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF----SFANRQNFINEKNI 58
Query: 345 ISVAV--HRNLLRLIGFCTTP-----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR 397
V + H N+ R I E LLV + N S+ L DWV+
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSS 113
Query: 398 KRVALGAARGLEYLHE------HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD-- 449
R+A RGL YLH H P I HRD+ + NVL+ D V+ DFGL+ +
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 450 -----VRKTNVTTQVRGTMGHIAPEYL-------STGKSSERTDVFGYGIMLLELVTGQR 497
+ N GT+ ++APE L + ++ D++ G++ E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 498 AIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN-----LNKNYNIQEV--ETMIQVAL 550
+ E + V + + +V R + + + ++ +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 551 LCTQASPEDRPAMSEVVRMLE 571
C E R +
Sbjct: 294 DCWDQDAEARLTAQXAEERMA 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 6e-57
Identities = 84/287 (29%), Positives = 135/287 (47%), Gaps = 29/287 (10%)
Query: 286 WRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEM 344
W +L + K +G G FG V+R G+ VAVK L F REV +
Sbjct: 36 WCDLNI-------KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAI 87
Query: 345 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 404
+ H N++ +G T P +V ++ S+ L + E LD R +A
Sbjct: 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ-LDERRRLSMAYDV 146
Query: 405 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 464
A+G+ YLH + NP I+HR++K+ N+L+D+ + V DFGL++L + GT
Sbjct: 147 AKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA-STFLSSKSAAGTPE 204
Query: 465 HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524
+APE L S+E++DV+ +G++L EL T Q + L V + + KR
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQ--QPWGNLNPAQVVAAV-----GFKCKR 257
Query: 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
L+ + RNLN +V +I+ C P RP+ + ++ +L
Sbjct: 258 LE--IPRNLNP-----QVAAIIE---GCWTNEPWKRPSFATIMDLLR 294
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 7e-57
Identities = 71/283 (25%), Positives = 119/283 (42%), Gaps = 36/283 (12%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 353
+ V+G+G FG V + VA+K++ ES AF E+ +S H N+
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI---ESESERKAFIVELRQLSRVNHPNI 63
Query: 354 LRLIGFCTTP----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 409
++L G C P E + + S+ L +P P L ++G+
Sbjct: 64 VKLYGACLNPVCLVME------YAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVA 116
Query: 410 YLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 468
YLH +IHRD+K N+LL + + DFG A T +G+ +AP
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAP 172
Query: 469 EYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528
E SE+ DVF +GI+L E++T ++ F + + + R
Sbjct: 173 EVFEGSNYSEKCDVFSWGIILWEVITRRKP--FDEI----GGPAFRIMWAVHNGTRPP-- 224
Query: 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ +NL K +E+++ C P RP+M E+V+++
Sbjct: 225 LIKNLPK-----PIESLMT---RCWSKDPSQRPSMEEIVKIMT 259
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 2e-54
Identities = 71/299 (23%), Positives = 131/299 (43%), Gaps = 53/299 (17%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGD------AAFQREVEMIS 346
+ + +G+GGFG V++G + D + VA+K L +S G FQREV ++S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 347 VAVHRNLLRLIGFCTTP----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 402
H N+++L G P E F+ + +RL P + W + R+ L
Sbjct: 79 NLNHPNIVKLYGLMHNPPRMVME------FVPCGDLYHRLL--DKAHP-IKWSVKLRLML 129
Query: 403 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-----VGDFGLAKLVDVRKTNVTT 457
A G+EY+ + NP I+HRD+++ N+ L E V DFGL++ + +
Sbjct: 130 DIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVS 184
Query: 458 QVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQ---RAIDFSRLEEEDDVLL 512
+ G +APE + +E+ D + + ++L ++TG+ + +++ + +
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI-- 242
Query: 513 LDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
E R + ++ + +I+ LC P+ RP S +V+ L
Sbjct: 243 ------REEGLRPT------IPEDCP-PRLRNVIE---LCWSGDPKKRPHFSYIVKELS 285
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-52
Identities = 72/297 (24%), Positives = 124/297 (41%), Gaps = 44/297 (14%)
Query: 286 WRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL---TDFESPGGDAAFQREV 342
+ EL L + ++G GGFGKVYR G +VAVK D + ++E
Sbjct: 6 FAELTL-------EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEA 57
Query: 343 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 402
++ ++ H N++ L G C LV F + + L + + A+
Sbjct: 58 KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAV 112
Query: 403 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV--------VGDFGLAKLVDVRKTN 454
ARG+ YLH+ IIHRD+K++N+L+ + E + DFGLA+ +T
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTT 170
Query: 455 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 514
+ G +APE + S+ +DV+ YG++L EL+TG+ + F ++
Sbjct: 171 KMSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE--VPFRGIDGLAVA---- 223
Query: 515 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ L + + + + M C P RP+ + ++ L
Sbjct: 224 -YGVAMNKLALP--IPSTCPEPF----AKLMED----CWNPDPHSRPSFTNILDQLT 269
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 2e-51
Identities = 73/330 (22%), Positives = 122/330 (36%), Gaps = 46/330 (13%)
Query: 286 WRELQLATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEM 344
+L VLG+G FG+ + G + +K L F+ F +EV++
Sbjct: 9 PSDLIH-------GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE-TQRTFLKEVKV 60
Query: 345 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 404
+ H N+L+ IG + +++ ++ ++ + W R A
Sbjct: 61 MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDI 117
Query: 405 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD-------------VR 451
A G+ YLH IIHRD+ + N L+ E+ VV DFGLA+L+
Sbjct: 118 ASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174
Query: 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL 511
V G +APE ++ E+ DVF +GI+L E++ A
Sbjct: 175 DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA--DPDYLPRTMDF 232
Query: 512 LLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
L+ L+R + + + + C PE RP+ ++ LE
Sbjct: 233 GLNVRGFLDRYCPPNCP--------------PSFFPITVRCCDLDPEKRPSFVKLEHWLE 278
Query: 572 G--EGLAERWEEWQHVEVTRRQEYERLQRR 599
LA +E R +E +R
Sbjct: 279 TLRMHLAGHLPLGPQLEQLDRGFWETYRRG 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-51
Identities = 53/187 (28%), Positives = 77/187 (41%), Gaps = 13/187 (6%)
Query: 32 LCSLS-GDALFALRTSLRVPNNQLRDWNQN-QVNPCTWSNVICDNSNNVASVT---LSSM 86
LC+ AL ++ L P L W TW V+CD V LS +
Sbjct: 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGL 60
Query: 87 NFSGT--LSPRIGVLRTLSTLTL-KGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPS 143
N + + L L+ L + N + G IP + L+ L L + + + G IP
Sbjct: 61 NLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF 120
Query: 144 LGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK----YN 199
L +K L L S N SGT+P S+++L +L+ I D N +SG IP K
Sbjct: 121 LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMT 180
Query: 200 FTGNNLN 206
+ N L
Sbjct: 181 ISRNRLT 187
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 42/147 (28%), Positives = 63/147 (42%), Gaps = 5/147 (3%)
Query: 71 ICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLD 130
S S+T+S +G + P L L+ + L N + G+ G+ + +
Sbjct: 169 YGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIH 227
Query: 131 LDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV 190
L N L + +G K L L L N GT+P LT L L S+ + NNL G+IP
Sbjct: 228 LAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
Query: 191 --HLFQIPKYNFTGNNLNCGKTLPHSC 215
+L + + N CG LP +C
Sbjct: 287 GGNLQRFDVSAYANNKCLCGSPLP-AC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 41/108 (37%), Positives = 55/108 (50%), Gaps = 2/108 (1%)
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSL-TSLDLDNNRLVGKIP 141
S SGTL P I L L +T GN I+G IP+ G+ S L TS+ + NRL GKIP
Sbjct: 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191
Query: 142 PSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 189
P+ NL L F+ LS+N G + + I L N+L+ +
Sbjct: 192 PTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 3e-51
Identities = 68/316 (21%), Positives = 126/316 (39%), Gaps = 44/316 (13%)
Query: 281 LKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQR 340
++R +++Q+ +G+G +G+V+ G G KVAVK E +A++ R
Sbjct: 31 VQRTIAKQIQM-------VKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE----EASWFR 78
Query: 341 EVEMISVAV--HRNLLRLIGFCTTP----TERLLVYPFMQNLSVAYRLREIKPGEPVLDW 394
E E+ + H N+L I T+ L+ + +N S+ L+ LD
Sbjct: 79 ETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-----TTLDA 133
Query: 395 VTRKRVALGAARGLEYLHE-----HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449
+ ++A + GL +LH P I HRD+K+ N+L+ ++ + D GLA
Sbjct: 134 KSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFI 193
Query: 450 VRKTNV---TTQVRGTMGHIAPE------YLSTGKSSERTDVFGYGIMLLELVTGQRAID 500
V GT ++ PE + +S D++ +G++L E+ R +
Sbjct: 194 SDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR--RCVS 251
Query: 501 FSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL-----NKNYNIQEVETMIQVALLCTQA 555
+EE E + + + L N+ + + + M ++ C
Sbjct: 252 GGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAH 311
Query: 556 SPEDRPAMSEVVRMLE 571
+P R V + L
Sbjct: 312 NPASRLTALRVKKTLA 327
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 7e-51
Identities = 71/321 (22%), Positives = 134/321 (41%), Gaps = 54/321 (16%)
Query: 281 LKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQR 340
++R R++ L +G+G +G+V+RG G VAVK + + + ++ R
Sbjct: 2 MQRTVARDITL-------LECVGKGRYGEVWRGSW-QGENVAVKIFSSRD----EKSWFR 49
Query: 341 EVEMISVAV--HRNLLRLIGFCTT----PTERLLVYPFMQNLSVAYRLREIKPGEPVLDW 394
E E+ + + H N+L I T T+ L+ + + S+ L+ LD
Sbjct: 50 ETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDT 104
Query: 395 VTRKRVALGAARGLEYLHE-----HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449
V+ R+ L A GL +LH P I HRD+K+ N+L+ ++ + + D GLA +
Sbjct: 105 VSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS 164
Query: 450 ----VRKTNVTTQVRGTMGHIAPE------YLSTGKSSERTDVFGYGIMLLELVTGQRAI 499
+V GT ++APE + S +R D++ +G++L E+ R +
Sbjct: 165 QSTNQLDVGNNPRV-GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR--RMV 221
Query: 500 DFSRLEEE----DDVLLLDHVKKLEREKRLDAIVDRNL-----NKNYNIQEVETMIQVAL 550
+E+ DV+ D E + N+ ++ + ++ ++
Sbjct: 222 SNGIVEDYKPPFYDVVPNDPSF----EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK 277
Query: 551 LCTQASPEDRPAMSEVVRMLE 571
C +P R + + L
Sbjct: 278 ECWYQNPSARLTALRIKKTLT 298
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-50
Identities = 75/296 (25%), Positives = 131/296 (44%), Gaps = 44/296 (14%)
Query: 286 WRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEM 344
++ + +G G FG VY+G VAVK L +P AF+ EV +
Sbjct: 23 DGQITV-------GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGV 73
Query: 345 ISVAVHRNLLRLIGFCTTP-----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR 399
+ H N+L +G+ T P T+ + + S+ Y + E +
Sbjct: 74 LRKTRHVNILLFMGYSTAPQLAIVTQ------WCEGSSL-YHH--LHASETKFEMKKLID 124
Query: 400 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL-VDVRKTNVTTQ 458
+A ARG++YLH IIHRD+K+ N+ L ED +GDFGLA ++ Q
Sbjct: 125 IARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ 181
Query: 459 VRGTMGHIAPE---YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH 515
+ G++ +APE + S ++DV+ +GI+L EL+TGQ + +S + D ++ +
Sbjct: 182 LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIEM-- 237
Query: 516 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
V + L + + + M + C + ++RP+ ++ +E
Sbjct: 238 VGRGSLSPDLSKVRSNCPKRMKRL-----MAE----CLKKKRDERPSFPRILAEIE 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 4e-50
Identities = 58/292 (19%), Positives = 110/292 (37%), Gaps = 40/292 (13%)
Query: 286 WRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEM 344
+++L L + G++++G G + VK L + S F E
Sbjct: 9 FKQLNF-------LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 345 ISVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 402
+ + H N+L ++G C +P + +M S+ L + V+D + AL
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH--EGTNFVVDQSQAVKFAL 118
Query: 403 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT 462
ARG+ +LH P I + + +V++DED A + + +
Sbjct: 119 DMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYA 171
Query: 463 MGHIAPEYLSTGKS---SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL 519
+APE L D++ + ++L ELVT + + F+ L + +K
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE--VPFADLSNMEIG-----MKVA 224
Query: 520 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
R + ++ V +++ +C P RP +V +LE
Sbjct: 225 LEGLRPT--IPPGISP-----HVSKLMK---ICMNEDPAKRPKFDMIVPILE 266
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 9e-49
Identities = 67/300 (22%), Positives = 130/300 (43%), Gaps = 47/300 (15%)
Query: 286 WRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEM 344
+ +L++ ++G+G FG+VY G +VA++ + + ++ AF+REV
Sbjct: 32 FEQLEI-------GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMA 82
Query: 345 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 404
H N++ +G C +P ++ + ++ +R+ K VLD +++A
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIAQEI 139
Query: 405 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV----RKTNVTTQVR 460
+G+ YLH I+H+D+K+ NV D + V+ DFGL + V R+ +
Sbjct: 140 VKGMGYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQN 195
Query: 461 GTMGHIAPEYLSTGKS---------SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL 511
G + H+APE + S+ +DVF G + EL + F E +
Sbjct: 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE--WPFKTQPAEAIIW 253
Query: 512 LLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
++ + + + + K E+ ++ C E+RP ++++ MLE
Sbjct: 254 ------QMGTGMKPN-LSQIGMGK-----EISDILL---FCWAFEQEERPTFTKLMDMLE 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 4e-48
Identities = 71/316 (22%), Positives = 128/316 (40%), Gaps = 46/316 (14%)
Query: 282 KRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQRE 341
+R R + L + +G+G FG+V+RG G +VAVK + E + ++ RE
Sbjct: 37 QRTIARTIVL-------QESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE----ERSWFRE 84
Query: 342 VEMISVAV--HRNLLRLIGFCT----TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 395
E+ + H N+L I T T+ LV + ++ S+ L +
Sbjct: 85 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVE 139
Query: 396 TRKRVALGAARGLEYLHE-----HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450
++AL A GL +LH P I HRD+K+ N+L+ ++ + D GLA D
Sbjct: 140 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 199
Query: 451 RKTNVT---TQVRGTMGHIAPEYL------STGKSSERTDVFGYGIMLLELVTGQRAIDF 501
+ GT ++APE L +S +R D++ G++ E+
Sbjct: 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI--- 256
Query: 502 SRLEEEDDVLLLDHVK-KLEREKRLDAIVDRNL-----NKNYNIQEVETMIQVALLCTQA 555
+ E+ + D V E+ + ++ L N+ + + + M ++ C A
Sbjct: 257 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 316
Query: 556 SPEDRPAMSEVVRMLE 571
+ R + + L
Sbjct: 317 NGAARLTALRIKKTLS 332
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 7e-40
Identities = 48/156 (30%), Positives = 78/156 (50%), Gaps = 2/156 (1%)
Query: 74 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 133
+ ++S + G SP ++ L + N ++G IP+E+G++ L L+L +
Sbjct: 606 RLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGH 665
Query: 134 NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH-L 192
N + G IP +G+L+ L L LS N G IP +++ L+ L I L +NNLSG IP
Sbjct: 666 NDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQ 725
Query: 193 FQ-IPKYNFTGNNLNCGKTLPHSCESSSNDSGSSKK 227
F+ P F N CG LP S+++ ++
Sbjct: 726 FETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHHQR 761
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-36
Identities = 49/146 (33%), Positives = 72/146 (49%), Gaps = 2/146 (1%)
Query: 74 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 133
+ + + + L G + + ++TL TL L N +TGEIP L N ++L + L N
Sbjct: 440 SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSN 499
Query: 134 NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF 193
NRL G+IP +G L+ L L LS N+FSG IP L SLI + L++N +G IP +F
Sbjct: 500 NRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMF 559
Query: 194 QIPKYNFTGNNLNCGKTLPHSCESSS 219
+ N GK +
Sbjct: 560 KQS--GKIAANFIAGKRYVYIKNDGM 583
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-36
Identities = 64/193 (33%), Positives = 89/193 (46%), Gaps = 24/193 (12%)
Query: 29 LTFL----CSLSG----DALFALR--TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNV 78
L L + SG D L +R L + N+ + + S ++
Sbjct: 320 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSG---------ELPESLTNLSASL 370
Query: 79 ASVTLSSMNFSGTLSPRIG--VLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRL 136
++ LSS NFSG + P + TL L L+ NG TG+IP L N S L SL L N L
Sbjct: 371 LTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYL 430
Query: 137 VGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIP 196
G IP SLG+L KL+ L L N G IP L + +L ++ LD N+L+G+IP L
Sbjct: 431 SGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCT 490
Query: 197 K---YNFTGNNLN 206
+ + N L
Sbjct: 491 NLNWISLSNNRLT 503
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-36
Identities = 52/151 (34%), Positives = 76/151 (50%), Gaps = 5/151 (3%)
Query: 74 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 133
N + + S+ LS SGT+ +G L L L L N + GEIP+EL + +L +L LD
Sbjct: 416 NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF 475
Query: 134 NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF 193
N L G+IP L N L +++LS N +G IP + L +L ++L +N+ SG IP L
Sbjct: 476 NDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELG 535
Query: 194 QIPK---YNFTGNNLNCGKTLPHSCESSSND 221
+ N N G T+P + S
Sbjct: 536 DCRSLIWLDLNTNLFN-G-TIPAAMFKQSGK 564
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-34
Identities = 41/115 (35%), Positives = 63/115 (54%)
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 142
L + F+G + P + L +L L N ++G IP LG+LS L L L N L G+IP
Sbjct: 401 LQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQ 460
Query: 143 SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK 197
L +K L+ L L N+ +G IP L+ ++L I L +N L+G+IP + ++
Sbjct: 461 ELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLEN 515
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-32
Identities = 48/130 (36%), Positives = 68/130 (52%), Gaps = 8/130 (6%)
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIP 141
+SS F G + P L++L L+L N TGEIP+ L G +LT LDL N G +P
Sbjct: 254 ISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVP 311
Query: 142 PSLGNLKKLQFLTLSQNNFSGTIP-DSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKY-- 198
P G+ L+ L LS NNFSG +P D+L + L + L N SG++P L +
Sbjct: 312 PFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLL 371
Query: 199 --NFTGNNLN 206
+ + NN +
Sbjct: 372 TLDLSSNNFS 381
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-32
Identities = 38/144 (26%), Positives = 61/144 (42%), Gaps = 9/144 (6%)
Query: 67 WSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSL 126
V+ D + + +S SG + + L L + N + IP LG+ S+L
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSAL 225
Query: 127 TSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSG 186
LD+ N+L G ++ +L+ L +S N F G IP L SL + L N +G
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTG 283
Query: 187 QIPVHLFQIPKY----NFTGNNLN 206
+IP L + +GN+
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFY 307
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-31
Identities = 43/131 (32%), Positives = 64/131 (48%), Gaps = 4/131 (3%)
Query: 71 ICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSL 129
+ + + + LS +F G + P G L +L L N +GE+P + L + L L
Sbjct: 289 LSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVL 348
Query: 130 DLDNNRLVGKIPPSLGNLK-KLQFLTLSQNNFSGTIPDSL--TTLSSLISIQLDSNNLSG 186
DL N G++P SL NL L L LS NNFSG I +L ++L + L +N +G
Sbjct: 349 DLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTG 408
Query: 187 QIPVHLFQIPK 197
+IP L +
Sbjct: 409 KIPPTLSNCSE 419
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-30
Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 4/133 (3%)
Query: 74 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 133
+ ++ L + +G + + L+ ++L N +TGEIP+ +G L +L L L N
Sbjct: 464 YVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSN 523
Query: 134 NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF 193
N G IP LG+ + L +L L+ N F+GTIP ++ S I+ +N ++G+ V++
Sbjct: 524 NSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIA----ANFIAGKRYVYIK 579
Query: 194 QIPKYNFTGNNLN 206
N
Sbjct: 580 NDGMKKECHGAGN 592
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 41/159 (25%), Positives = 61/159 (38%), Gaps = 27/159 (16%)
Query: 37 GDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRI 96
L + + L N L DW+ N+ NPCT+ V C + V S+ LSS +
Sbjct: 14 IHQLISFKDVL-PDKNLLPDWSSNK-NPCTFDGVTCRDDK-VTSIDLSSKPLNVGF---- 66
Query: 97 GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 156
+ L +L+ L SL L N+ + G + L L LS
Sbjct: 67 -----------------SAVSSSLLSLTGLESLFLSNSHINGSV-SGFKCSASLTSLDLS 108
Query: 157 QNNFSGTIPD--SLTTLSSLISIQLDSNNLSGQIPVHLF 193
+N+ SG + SL + S L + + SN L V
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGG 147
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 31/137 (22%), Positives = 49/137 (35%), Gaps = 9/137 (6%)
Query: 74 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 133
N+A + LS+ +FSG + +G R+L L L N G IP + S +
Sbjct: 512 RLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAA 567
Query: 134 NRLVGKIPPSLGNLKKLQFLTLSQN--NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH 191
N + GK + N + + N F G + L LS+ + S G
Sbjct: 568 NFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT 627
Query: 192 LFQIPKY---NFTGNNL 205
+ + N L
Sbjct: 628 FDNNGSMMFLDMSYNML 644
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-38
Identities = 82/290 (28%), Positives = 124/290 (42%), Gaps = 47/290 (16%)
Query: 298 EKNVLGQGGFGKVYRGVLADG----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 353
V+G+G FG VY G D + A+K L+ AF RE ++ H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 354 LRLIGFCTTPTERLL-VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 412
L LIG P + P+M + + +R + V D ++ L ARG+EYL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS---FGLQVARGMEYLA 141
Query: 413 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI-----A 467
E K +HRD+ A N +LDE F V DFGLA+ D+ + + + A
Sbjct: 142 EQ---KFVHRDLAARNCMLDESFTVKVADFGLAR--DILDREYYSVQQHRHARLPVKWTA 196
Query: 468 PEYLSTGKSSERTDVFGYGIMLLELVT-GQR---AIDFSRLEEEDDVLLLDHVKKLEREK 523
E L T + + ++DV+ +G++L EL+T G ID D+ L + +
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID------PFDLT-----HFLAQGR 245
Query: 524 RLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
RL +L Y + M Q C +A P RP +V +E
Sbjct: 246 RLPQPEYCPDSL---YQV-----MQQ----CWEADPAVRPTFRVLVGEVE 283
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-38
Identities = 80/288 (27%), Positives = 123/288 (42%), Gaps = 47/288 (16%)
Query: 300 NVLGQGGFGKVYRGVLADG----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 355
V+G+G FG VY G L D AVK L G + F E ++ H N+L
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 356 LIGFCTTPTE-RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 414
L+G C L+V P+M++ + +R V D + L A+G++YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI---GFGLQVAKGMKYLASK 147
Query: 415 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI-----APE 469
K +HRD+ A N +LDE F V DFGLA+ D+ + T + A E
Sbjct: 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 470 YLSTGKSSERTDVFGYGIMLLELVT-GQR---AIDFSRLEEEDDVLLLDHVKKLEREKRL 525
L T K + ++DV+ +G++L EL+T G ++ D+ L + +RL
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DIT-----VYLLQGRRL 251
Query: 526 DAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
L Y + M++ C E RP+ SE+V +
Sbjct: 252 LQPEYCPDPL---YEV-----MLK----CWHPKAEMRPSFSELVSRIS 287
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 79/288 (27%), Positives = 123/288 (42%), Gaps = 47/288 (16%)
Query: 300 NVLGQGGFGKVYRGVLADG----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 355
V+G+G FG VY G L D AVK L G + F E ++ H N+L
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 356 LIGFCTTPTE-RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 414
L+G C L+V P+M++ + +R V D + L A+G+++L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI---GFGLQVAKGMKFLASK 211
Query: 415 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI-----APE 469
K +HRD+ A N +LDE F V DFGLA+ D+ + T + A E
Sbjct: 212 ---KFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 470 YLSTGKSSERTDVFGYGIMLLELVT-GQR---AIDFSRLEEEDDVLLLDHVKKLEREKRL 525
L T K + ++DV+ +G++L EL+T G ++ D+ L + +RL
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN------TFDIT-----VYLLQGRRL 315
Query: 526 DAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
L Y + M++ C E RP+ SE+V +
Sbjct: 316 LQPEYCPDPL---YEV-----MLK----CWHPKAEMRPSFSELVSRIS 351
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-37
Identities = 78/292 (26%), Positives = 122/292 (41%), Gaps = 49/292 (16%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
++ +G+G FG+V+ G L AD T VAVK + P A F +E ++ H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 412
++RLIG CT +V +Q LR L T ++ AA G+EYL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 413 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI-----A 467
IHRD+ A N L+ E + DFG+++ V G + + A
Sbjct: 231 SK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEA---DGVYAA-SGGLRQVPVKWTA 283
Query: 468 PEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL- 525
PE L+ G+ S +DV+ +GI+L E + G + L + + +E+ RL
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASP--YPNLSNQ-QTR-----EFVEKGGRLP 335
Query: 526 ------DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
DA+ + + M Q C P RP+ S + + L+
Sbjct: 336 CPELCPDAV--------FRL-----MEQ----CWAYEPGQRPSFSTIYQELQ 370
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 68/299 (22%), Positives = 121/299 (40%), Gaps = 42/299 (14%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLA-----DGTKVAVKRLTDFESPGGDAAFQREVEMISVA 348
LG+G FGKV G +VAVK L A ++E+E++
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 349 VHRNLLRLIGFCTTPTER--LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR 406
H N+++ G CT L+ F+ + S+ L + + ++ + + A+ +
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICK 137
Query: 407 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT---- 462
G++YL + +HRD+ A NVL++ + + +GDFGL K ++ K T +
Sbjct: 138 GMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF 194
Query: 463 -MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEED------DVLLLD 514
APE L K +DV+ +G+ L EL+T L + + +
Sbjct: 195 WY---APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251
Query: 515 HVKKLEREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
V L+ KRL + + Y + M + C + P +R + ++ E
Sbjct: 252 LVNTLKEGKRLPCPPNCPDEV---YQL-----MRK----CWEFQPSNRTSFQNLIEGFE 298
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 72/293 (24%), Positives = 118/293 (40%), Gaps = 47/293 (16%)
Query: 299 KNVLGQGGFGKVYRGVLADG----TKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNL 353
+LG+G FG V G L KVAVK + D S F E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 354 LRLIGFCT-----TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK--RVALGAAR 406
+RL+G C + +++ PFM+ + L + + + + A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 407 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 466
G+EYL +HRD+ A N +L +D V DFGL+K + + Q R +
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSK--KIYSGDYYRQGRIAKMPV 213
Query: 467 ---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLERE 522
A E L+ + ++DV+ +G+ + E+ T G + ++ + + D++ R
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGM--TPYPGVQNHE---MYDYLLHGHRL 268
Query: 523 KR----LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
K+ LD + Y I M C + P DRP S + LE
Sbjct: 269 KQPEDCLDEL--------YEI-----MYS----CWRTDPLDRPTFSVLRLQLE 304
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-36
Identities = 74/299 (24%), Positives = 112/299 (37%), Gaps = 54/299 (18%)
Query: 299 KNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 353
LG+G FGKV G VAVK L P + +++E++++ H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 354 LRLIGFCTTPTER--LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 411
++ G C LV ++ S+ L G L A G+ YL
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYL 150
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT-----MGHI 466
H IHRD+ A NVLLD D +GDFGLAK V + G
Sbjct: 151 HAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY--- 204
Query: 467 APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEE------DDVLLLDHVKKL 519
APE L K +DV+ +G+ L EL+T + E + +L + L
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264
Query: 520 EREKRL-------DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
ER +RL + Y++ M C + RP ++ +L+
Sbjct: 265 ERGERLPRPDKCPAEV--------YHL-----MKN----CWETEASFRPTFENLIPILK 306
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 43/294 (14%)
Query: 299 KNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 353
+ LG+G FG V G VAVK+L P FQRE++++ +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH-SGPDQQRDFQREIQILKALHSDFI 86
Query: 354 LRLIGFCTTPTER--LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 411
++ G P + LV ++ + + L+ LD + +G+EYL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYL 143
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI----- 466
+ +HRD+ A N+L++ + + DFGLAKL+ + K V G
Sbjct: 144 GSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK---DYYVVREPGQSPIFWY 197
Query: 467 APEYLSTGKSSERTDVFGYGIMLLELVT-------GQRAIDFSRLEEEDDVLLLDHVKKL 519
APE LS S ++DV+ +G++L EL T E D L ++ L
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257
Query: 520 EREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
E +RL A + + + M C SP+DRP+ S + L+
Sbjct: 258 EEGQRLPAPPACPAEV---HEL-----MKL----CWAPSPQDRPSFSALGPQLD 299
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 72/294 (24%), Positives = 124/294 (42%), Gaps = 48/294 (16%)
Query: 299 KNVLGQGGFGKVYRGVLADG----TKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNL 353
+LG+G FG V L KVAVK L D + F RE + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 354 LRLIGFCT------TPTERLLVYPFMQNLSVAYRLREIKPGE--PVLDWVTRKRVALGAA 405
+L+G +++ PFM++ + L + GE L T R + A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 406 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 465
G+EYL IHRD+ A N +L ED V DFGL++ + + Q +
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSR--KIYSGDYYRQGCASKLP 202
Query: 466 I---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLER 521
+ A E L+ + +DV+ +G+ + E++T GQ ++ +E + + +++ R
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQ--TPYAGIENAE---IYNYLIGGNR 257
Query: 522 EKR----LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
K+ ++ + Y++ M Q C A P+ RP+ + + LE
Sbjct: 258 LKQPPECMEEV--------YDL-----MYQ----CWSADPKQRPSFTCLRMELE 294
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 71/292 (24%), Positives = 131/292 (44%), Gaps = 45/292 (15%)
Query: 299 KNVLGQGGFGKVYRGVLADG------TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
LGQG FG VY GV T+VA+K + + S F E ++ +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP---GEPVLDWVTRKR---VALGAAR 406
++RL+G + L++ M + LR ++P PVL + + +A A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 407 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 466
G+ YL+ + K +HRD+ A N ++ EDF +GDFG+ + D+ +T+ +G G +
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR--KGGKGLL 202
Query: 467 -----APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLE 520
+PE L G + +DV+ +G++L E+ T ++ + L E + + L+
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFVMEGGLLD 260
Query: 521 R-EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ + D + + + M C Q +P+ RP+ E++ ++
Sbjct: 261 KPDNCPDML--------FEL-----MRM----CWQYNPKMRPSFLEIISSIK 295
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 66/295 (22%), Positives = 119/295 (40%), Gaps = 44/295 (14%)
Query: 299 KNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 353
LG+G FG V G VAVK+L + F+RE+E++ H N+
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-STEEHLRDFEREIEILKSLQHDNI 104
Query: 354 LRLIGFCTTPTER--LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 411
++ G C + R L+ ++ S+ L++ + +D + + +G+EYL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYL 161
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT-----MGHI 466
+ IHRD+ N+L++ + +GDFGL K++ K + G
Sbjct: 162 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY--- 215
Query: 467 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED--------DVLLLDHVKK 518
APE L+ K S +DV+ +G++L EL T E +++ ++
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275
Query: 519 LEREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
L+ RL + Y I M + C + RP+ ++ ++
Sbjct: 276 LKNNGRLPRPDGCPDEI---YMI-----MTE----CWNNNVNQRPSFRDLALRVD 318
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 66/295 (22%), Positives = 119/295 (40%), Gaps = 44/295 (14%)
Query: 299 KNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 353
LG+G FG V G VAVK+L + F+RE+E++ H N+
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-STEEHLRDFEREIEILKSLQHDNI 73
Query: 354 LRLIGFCTTPTER--LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 411
++ G C + R L+ ++ S+ L++ + +D + + +G+EYL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYL 130
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT-----MGHI 466
+ IHRD+ N+L++ + +GDFGL K++ K + G
Sbjct: 131 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY--- 184
Query: 467 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED--------DVLLLDHVKK 518
APE L+ K S +DV+ +G++L EL T E +++ ++
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244
Query: 519 LEREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
L+ RL + Y I M + C + RP+ ++ ++
Sbjct: 245 LKNNGRLPRPDGCPDEI---YMI-----MTE----CWNNNVNQRPSFRDLALRVD 287
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 70/300 (23%), Positives = 134/300 (44%), Gaps = 60/300 (20%)
Query: 299 KNVLGQGGFGKVYRGVLADG---TKVAVKRLTDFESPGGDAAFQREVE-MISVAVHRNLL 354
++V+G+G FG+V + + A+KR+ ++ S F E+E + + H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 355 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK------------RVAL 402
L+G C L + + ++ LR+ + E + A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 403 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT 462
ARG++YL + + IHRD+ A N+L+ E++ A + DFGL++ +V V+ T
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKT 199
Query: 463 MGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT-GQR---AIDFSRLEEEDDVLLL 513
MG + A E L+ + +DV+ YG++L E+V+ G + + L
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--------- 250
Query: 514 DHVKKLEREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+KL + RL+ ++ + Y++ M Q C + P +RP+ ++++ L
Sbjct: 251 --YEKLPQGYRLEKPLNCDDEV---YDL-----MRQ----CWREKPYERPSFAQILVSLN 296
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 68/307 (22%), Positives = 119/307 (38%), Gaps = 56/307 (18%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLAD--------GTKVAVKRLTDFESPGGDAAFQREVE-M 344
D + LG+G FG+V VAVK L D + + E+E M
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 345 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQN------------LSVAYRLREIKPGEPVL 392
+ H+N++ L+G CT ++ + + Y + E +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 393 DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452
+ ARG+EYL K IHRD+ A NVL+ E+ + DFGLA+ D+
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR--DINN 209
Query: 453 TNVTTQVRGTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEED 508
+ + + APE L + ++DV+ +G+++ E+ T G + + E+
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG--SPYPGIPVEE 267
Query: 509 DVLLLDHVKK---LER-EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 564
L +K+ +++ + + Y + M C A P RP
Sbjct: 268 ---LFKLLKEGHRMDKPANCTNEL--------YMM-----MRD----CWHAVPSQRPTFK 307
Query: 565 EVVRMLE 571
++V L+
Sbjct: 308 QLVEDLD 314
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 69/301 (22%), Positives = 120/301 (39%), Gaps = 54/301 (17%)
Query: 299 KNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVE-MISVAVHR 351
LG+G FG+V VAVK L + + A E++ +I + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 352 NLLRLIGFCTTPTE-RLLVYPFMQN------------LSVAYRLREIKPGEPVLDWVTRK 398
N++ L+G CT P +++ F + V Y++ + L
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 399 RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 458
+ A+G+E+L K IHRD+ A N+LL E + DFGLA+ D+ K
Sbjct: 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPD--Y 204
Query: 459 VRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLL 512
VR + APE + + ++DV+ +G++L E+ + G + ++ +++
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA--SPYPGVKIDEEFC- 261
Query: 513 LDHVKKLEREKRLD--AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 570
++L+ R+ + Y M+ C P RP SE+V L
Sbjct: 262 ----RRLKEGTRMRAPDYTTPEM---YQT-----MLD----CWHGEPSQRPTFSELVEHL 305
Query: 571 E 571
Sbjct: 306 G 306
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 72/294 (24%), Positives = 117/294 (39%), Gaps = 62/294 (21%)
Query: 300 NVLGQGGFGKVYRGVLADG-----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 354
VLG G FG VY+G+ VA+K L + SP + E +++ + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 355 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPV---LDWVTRKRVALGAARGLEYL 411
RL+G C T T L+ M + +RE K L+W + A+G+ YL
Sbjct: 81 RLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 133
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---AP 468
+ +++HRD+ A NVL+ + DFGLAKL+ G I A
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMAL 188
Query: 469 EYLSTGKSSERTDVFGYGIMLLELVT-GQR---AIDFSRLEEEDDVLLLDHVKKLEREKR 524
E + + ++DV+ YG+ + EL+T G + I S ++ LE+ +R
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------EIS-----SILEKGER 237
Query: 525 L-------DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
L + Y I M + C + RP E++
Sbjct: 238 LPQPPICTIDV--------YMI-----MRK----CWMIDADSRPKFRELIIEFS 274
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 77/293 (26%), Positives = 123/293 (41%), Gaps = 47/293 (16%)
Query: 299 KNVLGQGGFGKVYRGVLADG------TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
LG G FG+VY G ++ +VAVK L + S + F E +IS H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR---VALGAARGLE 409
++R IG R ++ M + LRE +P + VA A G +
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 410 YLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 466
YL E+ IHRD+ A N LL A +GDFG+A+ D+ + + +G +
Sbjct: 155 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYR--KGGCAML 207
Query: 467 -----APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLE 520
PE G + +TD + +G++L E+ + G + + +VL + +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQ-EVL-----EFVT 259
Query: 521 REKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
R+D + + Y I M Q C Q PEDRP + ++ +E
Sbjct: 260 SGGRMDPPKNCPGPV---YRI-----MTQ----CWQHQPEDRPNFAIILERIE 300
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 71/317 (22%), Positives = 120/317 (37%), Gaps = 56/317 (17%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLAD--------GTKVAVKRLTDFESPGGDAAFQREVE-M 344
D + LG+G FG+V VAVK L D + + E+E M
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 345 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQN------------LSVAYRLREIKPGEPVL 392
+ H+N++ L+G CT ++ + + Y + E +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 393 DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452
+ ARG+EYL K IHRD+ A NVL+ E+ + DFGLA+ D+
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR--DINN 255
Query: 453 TNVTTQVRGTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEED 508
+ + + APE L + ++DV+ +G+++ E+ T G + + E+
Sbjct: 256 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG--SPYPGIPVEE 313
Query: 509 DVLLLDHVKKLEREKR----LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 564
L +K+ R + + + Y + M C A P RP
Sbjct: 314 ---LFKLLKEGHRMDKPANCTNEL--------YMM-----MRD----CWHAVPSQRPTFK 353
Query: 565 EVVRMLEGEGLAERWEE 581
++V L+ EE
Sbjct: 354 QLVEDLDRILTLTTNEE 370
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 77/293 (26%), Positives = 121/293 (41%), Gaps = 47/293 (16%)
Query: 299 KNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
LG G FG+VY G + +VAVK L + S + F E +IS H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR---VALGAARGLE 409
++R IG R ++ M + LRE +P + VA A G +
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 410 YLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 466
YL E+ IHRD+ A N LL A +GDFG+A+ D+ + +G +
Sbjct: 196 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYR--KGGCAML 248
Query: 467 -----APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLE 520
PE G + +TD + +G++L E+ + G + ++ +L+ V
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQE---VLEFVTS-- 301
Query: 521 REKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
R+D + + Y I M Q C Q PEDRP + ++ +E
Sbjct: 302 -GGRMDPPKNCPGPV---YRI-----MTQ----CWQHQPEDRPNFAIILERIE 341
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 68/307 (22%), Positives = 114/307 (37%), Gaps = 60/307 (19%)
Query: 299 KNVLGQGGFGKVYRGVLADG------TKVAVKRLTDFESPGGDAAFQREVE-MISVAVHR 351
VLG G FGKV +VAVK L + A E++ M + H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 352 NLLRLIGFCTTPTERLLVYPFMQN----------------LSVAYRLREIKPGEPVLDWV 395
N++ L+G CT L++ + + Y ++ E L+ +
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 396 TRKR---VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452
T + A A+G+E+L +HRD+ A NVL+ + DFGLA+ D+
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLAR--DIMS 224
Query: 453 TNVTTQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEE 506
+ V + APE L G + ++DV+ YGI+L E+ + G + +
Sbjct: 225 DSN--YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG--VNPYPGIPV 280
Query: 507 EDDVLLLDHVKKLEREKRLD--AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 564
+ + K ++ ++D + Y I M C RP+
Sbjct: 281 DANFY-----KLIQNGFKMDQPFYATEEI---YII-----MQS----CWAFDSRKRPSFP 323
Query: 565 EVVRMLE 571
+ L
Sbjct: 324 NLTSFLG 330
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 71/302 (23%), Positives = 120/302 (39%), Gaps = 56/302 (18%)
Query: 299 KNVLGQGGFGKVYRGVLAD--------GTKVAVKRLTDFESPGGDAAFQREVE-MISVAV 349
LG+G FG+V TKVAVK L + + E+E M +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 350 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR---------- 399
H+N++ L+G CT ++ + ++ L+ +P +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 400 --VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT 457
A ARG+EYL K IHRD+ A NVL+ ED + DFGLA+ D+ +
Sbjct: 194 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHHIDYYK 248
Query: 458 QVRGTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLL 513
+ + APE L + ++DV+ +G++L E+ T G + + E+ L
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG--SPYPGVPVEE---LF 303
Query: 514 DHVKK---LER-EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569
+K+ +++ + + Y + M C A P RP ++V
Sbjct: 304 KLLKEGHRMDKPSNCTNEL--------YMM-----MRD----CWHAVPSQRPTFKQLVED 346
Query: 570 LE 571
L+
Sbjct: 347 LD 348
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 66/289 (22%), Positives = 117/289 (40%), Gaps = 52/289 (17%)
Query: 299 KNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 354
+LG+G FG+VY GV + VAVK + F E ++ H +++
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 355 RLIGFCTT-PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 413
+LIG PT ++ + + L K VL V +L + + YL
Sbjct: 77 KLIGIIEEEPT--WIIMELYPYGELGHYLERNKNSLKVLTLV---LYSLQICKAMAYLES 131
Query: 414 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEY 470
+HRD+ N+L+ +GDFGL++ ++ + T I +PE
Sbjct: 132 I---NCVHRDIAVRNILVASPECVKLGDFGLSRYIE---DEDYYKASVTRLPIKWMSPES 185
Query: 471 LSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL---- 525
++ + + +DV+ + + + E+++ G++ F LE + DV+ LE+ RL
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQP--FFWLENK-DVI-----GVLEKGDRLPKPD 237
Query: 526 ---DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ Y + M + C P DRP +E+V L
Sbjct: 238 LCPPVL--------YTL-----MTR----CWDYDPSDRPRFTELVCSLS 269
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 70/313 (22%), Positives = 118/313 (37%), Gaps = 61/313 (19%)
Query: 279 GQLKRYSW----RELQLATDNFSEKNVLGQGGFGKVYRGVLADG-----TKVAVKRLTDF 329
G +K + EL+ VLG G FG V++GV V +K + D
Sbjct: 1 GAMKVLARIFKETELRK-------LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK 53
Query: 330 ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGE 389
A + I H +++RL+G C + LV ++ S+ +R+ +
Sbjct: 54 SGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGAL 112
Query: 390 PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449
+ + A+G+ YL EH ++HR++ A NVLL + V DFG+A L+
Sbjct: 113 GPQLLLN---WGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166
Query: 450 VRKTNVTTQVRGTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLE 505
+ I A E + GK + ++DV+ YG+ + EL+T G
Sbjct: 167 --PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY------ 218
Query: 506 EEDDVLLLDHVKKLEREKRL-------DAIVDRNLNKNYNIQEVETMIQVALLCTQASPE 558
+ L + LE+ +RL + Y + M++ C
Sbjct: 219 --AGLRLAEVPDLLEKGERLAQPQICTIDV--------YMV-----MVK----CWMIDEN 259
Query: 559 DRPAMSEVVRMLE 571
RP E+
Sbjct: 260 IRPTFKELANEFT 272
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 69/302 (22%), Positives = 108/302 (35%), Gaps = 49/302 (16%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVE-MIS 346
+N LG G FGKV KVAVK L A E++ M
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 347 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-------- 398
+ H N++ L+G CT L++ + + LR
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 399 --RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 456
+ A+G+ +L IHRDV A NVLL A +GDFGLA+ D+ +
Sbjct: 166 LLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLAR--DIMNDSN- 219
Query: 457 TQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDV 510
+ + APE + + ++DV+ YGI+L E+ + G + +
Sbjct: 220 -YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLG--LNPYPGILVNSKF 276
Query: 511 LLLDHVKKLEREKRLDAIVDRNLNKN-YNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569
K ++ ++ KN Y+I M C P RP ++
Sbjct: 277 Y-----KLVKDGYQMAQ--PAFAPKNIYSI-----MQA----CWALEPTHRPTFQQICSF 320
Query: 570 LE 571
L+
Sbjct: 321 LQ 322
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 71/279 (25%), Positives = 119/279 (42%), Gaps = 37/279 (13%)
Query: 299 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 358
+G G FG V+ G + KVA+K + + + F E E++ H L++L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 359 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 418
C LV FM++ ++ LR + T + L G+ YL E
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---C 124
Query: 419 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYLSTGK 475
+IHRD+ A N L+ E+ V DFG+ + V + T GT + +PE S +
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVL---DDQYTSSTGTKFPVKWASPEVFSFSR 181
Query: 476 SSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--RN 532
S ++DV+ +G+++ E+ + G+ + +V+ + + RL +
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIP--YENRSNS-EVV-----EDISTGFRLYKPRLASTH 233
Query: 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ Y I M C + PEDRPA S ++R L
Sbjct: 234 V---YQI-----MNH----CWRERPEDRPAFSRLLRQLA 260
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 58/298 (19%), Positives = 111/298 (37%), Gaps = 37/298 (12%)
Query: 280 QLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQ 339
+ ++ + + LG G FG V G VA+K + + + F
Sbjct: 10 STAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFI 67
Query: 340 REVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR 399
E +++ H L++L G CT ++ +M N + LRE
Sbjct: 68 EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLE 124
Query: 400 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 459
+ +EYL + +HRD+ A N L+++ V DFGL++ V + T
Sbjct: 125 MCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSS 178
Query: 460 RGTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDH 515
G+ + PE L K S ++D++ +G+++ E+ + G+ + R +
Sbjct: 179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP--YERFTNS-ETA---- 231
Query: 516 VKKLEREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ + + RL + Y I M C ++RP ++ +
Sbjct: 232 -EHIAQGLRLYRPHLASEKV---YTI-----MYS----CWHEKADERPTFKILLSNIL 276
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-32
Identities = 70/275 (25%), Positives = 123/275 (44%), Gaps = 31/275 (11%)
Query: 300 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 359
LGQG FG+V+ G T+VA+K L F +E +++ H L++L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAV 247
Query: 360 CTT-PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 418
+ P +V +M S+ L+ L +A A G+ Y+
Sbjct: 248 VSEEPI--YIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM---N 300
Query: 419 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 478
+HRD++AAN+L+ E+ V DFGLA+L++ + + + APE G+ +
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 479 RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--RNLNKN 536
++DV+ +GI+L EL T R + + + +V + ++ER R+ + +L
Sbjct: 361 KSDVWSFGILLTELTTKGR-VPYPGMVNR-EV-----LDQVERGYRMPCPPECPESL--- 410
Query: 537 YNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+++ M Q C + PE+RP + LE
Sbjct: 411 HDL-----MCQ----CWRKEPEERPTFEYLQAFLE 436
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-32
Identities = 72/312 (23%), Positives = 129/312 (41%), Gaps = 61/312 (19%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLADG------TKVAVKRLTDFESPGGDAAFQREVEMISV 347
N LG+G FGKV + T VAVK L + SP E ++
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 348 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--- 404
H ++++L G C+ LL+ + + S+ LRE + P R +
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 405 -----------------ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447
++G++YL E K++HRD+ A N+L+ E + + DFGL++
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSR- 198
Query: 448 VDVRKTNVTTQVRGTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSR 503
DV + + + + A E L + ++DV+ +G++L E+VT G +
Sbjct: 199 -DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG--NPYPG 255
Query: 504 LEEEDDVLLLDHVKK---LER-EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPED 559
+ E L + +K +ER + + + Y + M+Q C + P+
Sbjct: 256 IPPER---LFNLLKTGHRMERPDNCSEEM--------YRL-----MLQ----CWKQEPDK 295
Query: 560 RPAMSEVVRMLE 571
RP +++ + LE
Sbjct: 296 RPVFADISKDLE 307
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-32
Identities = 70/275 (25%), Positives = 123/275 (44%), Gaps = 31/275 (11%)
Query: 300 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 359
LGQG FG+V+ G T+VA+K L F +E +++ H L++L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAV 330
Query: 360 CTT-PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 418
+ P +V +M S+ L+ L +A A G+ Y+
Sbjct: 331 VSEEPI--YIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM---N 383
Query: 419 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 478
+HRD++AAN+L+ E+ V DFGLA+L++ + + + APE G+ +
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 479 RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--RNLNKN 536
++DV+ +GI+L EL T R + + + +V + ++ER R+ + +L
Sbjct: 444 KSDVWSFGILLTELTTKGR-VPYPGMVNR-EV-----LDQVERGYRMPCPPECPESL--- 493
Query: 537 YNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+++ M Q C + PE+RP + LE
Sbjct: 494 HDL-----MCQ----CWRKEPEERPTFEYLQAFLE 519
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-32
Identities = 70/289 (24%), Positives = 118/289 (40%), Gaps = 40/289 (13%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLADG-----TKVAVKRLTDFESPGGDAAFQREVEMISVA 348
F + VLG G FG VY+G+ VA+K L + SP + E +++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 349 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 408
+ ++ RL+G C T T L+ M + +RE K + + A+G+
Sbjct: 75 DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLL---NWCVQIAKGM 130
Query: 409 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI-- 466
YL + +++HRD+ A NVL+ + DFGLAKL+ G I
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKW 185
Query: 467 -APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524
A E + + ++DV+ YG+ + EL+T G + D + + LE+ +R
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY--------DGIPASEISSILEKGER 237
Query: 525 LDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
L ++ Y I M++ C + RP E++
Sbjct: 238 LPQPPICTIDV---YMI-----MVK----CWMIDADSRPKFRELIIEFS 274
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-31
Identities = 73/346 (21%), Positives = 126/346 (36%), Gaps = 55/346 (15%)
Query: 243 LISGGLLFFLCKGRHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVL 302
L S G + R + +D + +LK + + L
Sbjct: 287 LNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKR--DNLLIADIEL 344
Query: 303 GQGGFGKVYRGVLADG---TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 359
G G FG V +GV VA+K L RE +++ + ++RLIG
Sbjct: 345 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 404
Query: 360 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 419
C +LV + L + + + + G++YL E
Sbjct: 405 CQAEA-LMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK---NF 457
Query: 420 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG------TMGHIAPEYLST 473
+HR++ A NVLL A + DFGL+K + + T + G APE ++
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECINF 513
Query: 474 GKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL------- 525
K S R+DV+ YG+ + E ++ GQ+ + +++ +V+ +E+ KR+
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKP--YKKMKGP-EVM-----AFIEQGKRMECPPECP 565
Query: 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ Y + M C EDRP V + +
Sbjct: 566 PEL--------YAL-----MSD----CWIYKWEDRPDFLTVEQRMR 594
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 301 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDA-AFQREVEMISVAVHRNLLRLIG 358
+G+G F VY+G+ +VA L D + + F+ E EM+ H N++R
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 359 FCTTPTE---RLLVYP-FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 414
+ + +++ M + ++ L+ K + + +GL++LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTR 148
Query: 415 CNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 473
P IIHRD+K N+ + +V +GD GLA L + + V GT +APE
Sbjct: 149 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYEE 204
Query: 474 GKSSERTDVFGYGIMLLELVTGQ 496
E DV+ +G+ +LE+ T +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-31
Identities = 59/298 (19%), Positives = 119/298 (39%), Gaps = 46/298 (15%)
Query: 287 RELQLATDNFSEKNVLGQGGFGKVYRGVLADG----TKVAVKRLTDFESPGGDAAFQREV 342
R+ ++ + +G+G FG V++G+ VA+K + S F +E
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442
Query: 343 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 402
+ H ++++LIG T ++ + L+ K + + A
Sbjct: 443 LTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLI---LYAY 498
Query: 403 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ---- 458
+ L YL + +HRD+ A NVL+ + +GDFGL++ + +
Sbjct: 499 QLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDSTYYKASKGK 553
Query: 459 --VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDH 515
++ APE ++ + + +DV+ +G+ + E++ G + F ++ DV+
Sbjct: 554 LPIKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVKP--FQGVKNN-DVI---- 602
Query: 516 VKKLEREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
++E +RL + L Y++ M + C P RP +E+ L
Sbjct: 603 -GRIENGERLPMPPNCPPTL---YSL-----MTK----CWAYDPSRRPRFTELKAQLS 647
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 68/286 (23%), Positives = 114/286 (39%), Gaps = 43/286 (15%)
Query: 298 EKNVLGQGGFGKVYRGVLADG---TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 354
LG G FG V +GV VA+K L RE +++ + ++
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 355 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 414
RLIG C +LV + L + + + + G++YL E
Sbjct: 74 RLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK 129
Query: 415 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG------TMGHIAP 468
+HRD+ A NVLL A + DFGL+K + + T + G AP
Sbjct: 130 ---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----AP 182
Query: 469 EYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527
E ++ K S R+DV+ YG+ + E ++ GQ+ + +++ +V+ +E+ KR++
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQKP--YKKMKGP-EVM-----AFIEQGKRMEC 234
Query: 528 IVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ L Y + M C EDRP V + +
Sbjct: 235 PPECPPEL---YAL-----MSD----CWIYKWEDRPDFLTVEQRMR 268
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 65/305 (21%), Positives = 108/305 (35%), Gaps = 51/305 (16%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVE-MIS 346
+ S LG G FGKV VAVK L A E++ +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 347 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV------ 400
+ H N++ L+G CT L++ + + LR +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 401 --------ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452
+ A+G+ +L IHRD+ A N+LL + DFGLA+ D++
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR--DIKN 197
Query: 453 TNVTTQVRGTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEED 508
+ + APE + + +DV+ YGI L EL + G + + +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS--SPYPGMPVDS 255
Query: 509 DVLLLDHVKKLEREKRLD--AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 566
K ++ R+ + Y+I M C A P RP ++
Sbjct: 256 KFY-----KMIKEGFRMLSPEHAPAEM---YDI-----MKT----CWDADPLKRPTFKQI 298
Query: 567 VRMLE 571
V+++E
Sbjct: 299 VQLIE 303
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 65/279 (23%), Positives = 108/279 (38%), Gaps = 37/279 (13%)
Query: 299 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 358
LG G FG V G VAVK + + + F +E + + H L++ G
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 359 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 418
C+ +V ++ N + LR G + + G+ +L H +
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLL---EMCYDVCEGMAFLESH---Q 124
Query: 419 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYLSTGK 475
IHRD+ A N L+D D V DFG+ + V + GT + APE K
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYV---LDDQYVSSVGTKFPVKWSAPEVFHYFK 181
Query: 476 SSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--RN 532
S ++DV+ +GI++ E+ + G+ + +V+ K+ + RL
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMP--YDLYTNS-EVV-----LKVSQGHRLYRPHLASDT 233
Query: 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ Y I M C PE RP +++ +E
Sbjct: 234 I---YQI-----MYS----CWHELPEKRPTFQQLLSSIE 260
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 59/281 (20%), Positives = 115/281 (40%), Gaps = 40/281 (14%)
Query: 301 VLGQGGFGKVYRGVLADG----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 356
+G+G FG V++G+ VA+K + S F +E + H ++++L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 357 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 416
IG T ++ + L+ K + + A + L YL
Sbjct: 82 IGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLI---LYAYQLSTALAYLESK-- 135
Query: 417 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYLST 473
+ +HRD+ A NVL+ + +GDFGL++ ++ + + I APE ++
Sbjct: 136 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME---DSTYYKASKGKLPIKWMAPESINF 191
Query: 474 GKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD-- 530
+ + +DV+ +G+ + E++ G + F ++ DV+ ++E +RL +
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVKP--FQGVKNN-DVI-----GRIENGERLPMPPNCP 243
Query: 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
L Y++ M + C P RP +E+ L
Sbjct: 244 PTL---YSL-----MTK----CWAYDPSRRPRFTELKAQLS 272
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 64/297 (21%), Positives = 115/297 (38%), Gaps = 49/297 (16%)
Query: 299 KNVLGQGGFGKVYRGVLADG------TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
LG+ FGKVY+G L VA+K L D F+ E + + H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK------------RV 400
++ L+G T +++ + + + L P V + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 401 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 460
A G+EYL H ++H+D+ NVL+ + + D GL + +V + +
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFR--EVYAADYYKLLG 188
Query: 461 GTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHV 516
++ I APE + GK S +D++ YG++L E+ + G + + + DV+
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--YCGYSNQ-DVV----- 240
Query: 517 KKLEREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ + + L D + Y + MI+ C P RP ++ L
Sbjct: 241 EMIRNRQVLPCPDDCPAWV---YAL-----MIE----CWNEFPSRRPRFKDIHSRLR 285
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 70/298 (23%), Positives = 125/298 (41%), Gaps = 53/298 (17%)
Query: 299 KNVLGQGGFGKVYRGVLADG------TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
K LG+G FGKV+ + VAVK L + S FQRE E++++ H++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTMLQHQH 104
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR-----------VA 401
++R G CT L+V+ +M++ + LR P +L VA
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 402 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 461
A G+ YL +HRD+ N L+ + +GDFG+++ D+ T+ G
Sbjct: 165 SQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYR--VG 217
Query: 462 TMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDH 515
+ PE + K + +DV+ +G++L E+ T G++ + +L + +
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--WYQLSNT-EAI---- 270
Query: 516 VKKLEREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ + + L+ + Y I M C Q P+ R ++ +V L+
Sbjct: 271 -DCITQGRELERPRACPPEV---YAI-----MRG----CWQREPQQRHSIKDVHARLQ 315
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-31
Identities = 78/277 (28%), Positives = 122/277 (44%), Gaps = 37/277 (13%)
Query: 299 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 358
+G+G FG V G G KVAVK + + + AF E +++ H NL++L+G
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA---QAFLAEASVMTQLRHSNLVQLLG 253
Query: 359 FCTTPTERL-LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 417
L +V +M S+ LR G VL + +L +EYL +
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 308
Query: 418 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 477
+HRD+ A NVL+ ED A V DFGL K + V+ T APE L K S
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFS 364
Query: 478 ERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--RNLN 534
++DV+ +GI+L E+ + G+ + R+ + DV V ++E+ ++DA +
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVP--YPRIPLK-DV-----VPRVEKGYKMDAPDGCPPAV- 415
Query: 535 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
Y++ M C RP ++ LE
Sbjct: 416 --YDV-----MKN----CWHLDAATRPTFLQLREQLE 441
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 4e-31
Identities = 77/277 (27%), Positives = 122/277 (44%), Gaps = 37/277 (13%)
Query: 299 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 358
+G+G FG V G G KVAVK + + + AF E +++ H NL++L+G
Sbjct: 26 LQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATA---QAFLAEASVMTQLRHSNLVQLLG 81
Query: 359 FCTTPTERL-LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 417
L +V +M S+ LR G VL + +L +EYL +
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 136
Query: 418 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 477
+HRD+ A NVL+ ED A V DFGL K + V+ T APE L K S
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFS 192
Query: 478 ERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--RNLN 534
++DV+ +GI+L E+ + G+ + R+ + DV+ ++E+ ++DA +
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVP--YPRIPLK-DVV-----PRVEKGYKMDAPDGCPPAV- 243
Query: 535 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
Y + M C RP+ ++ LE
Sbjct: 244 --YEV-----MKN----CWHLDAAMRPSFLQLREQLE 269
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 5e-31
Identities = 72/276 (26%), Positives = 121/276 (43%), Gaps = 31/276 (11%)
Query: 300 NVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 358
+ LG G +G+VY GV VAVK L E F +E ++ H NL++L+G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 359 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 418
CT ++ FM ++ LR + + V +A + +EYL +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKK---N 338
Query: 419 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 478
IHR++ A N L+ E+ V DFGL++L+ + + APE L+ K S
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 479 RTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--RNLNK 535
++DV+ +G++L E+ T G L + + LE++ R++ +
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQV--------YELLEKDYRMERPEGCPEKV-- 448
Query: 536 NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
Y + M C Q +P DRP+ +E+ + E
Sbjct: 449 -YEL-----MRA----CWQWNPSDRPSFAEIHQAFE 474
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-31
Identities = 64/291 (21%), Positives = 115/291 (39%), Gaps = 59/291 (20%)
Query: 301 VLGQGGFGKVYRGVL---ADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNLLRL 356
LG G FG V +G VAVK L + P E ++ + ++R+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 357 IGFCTTPTERLLVYPFMQNLSVAYRLREIK--PGEPVLDWVTRKRVALGAARGLEYLHEH 414
IG C + +LV + + L++ + + +++ + G++YL E
Sbjct: 84 IGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIEL------VHQVSMGMKYLEES 136
Query: 415 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG------TMGHIAP 468
+HRD+ A NVLL A + DFGL+K + + Q G AP
Sbjct: 137 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----AP 189
Query: 469 EYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL-- 525
E ++ K S ++DV+ +G+++ E + GQ+ + ++ +V LE+ +R+
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGS-EVT-----AMLEKGERMGC 241
Query: 526 -----DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ Y++ M C E+RP + V L
Sbjct: 242 PAGCPREM--------YDL-----MNL----CWTYDVENRPGFAAVELRLR 275
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 68/286 (23%), Positives = 120/286 (41%), Gaps = 43/286 (15%)
Query: 299 KNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 354
+ ++G G G+V G L VA+K L + F E ++ H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 355 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 414
RL G T ++V +M+N S+ LR + + + G G+ YL +
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 415 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG------TMGHIAP 468
+HRD+ A NVL+D + V DFGL+++++ T G T AP
Sbjct: 171 ---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----AP 223
Query: 469 EYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527
E ++ S +DV+ +G+++ E++ G+R + + DV+ +E RL A
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERP--YWNMTNR-DVI-----SSVEEGYRLPA 275
Query: 528 IVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ L + + M+ C RP S++V +L+
Sbjct: 276 PMGCPHAL---HQL-----MLD----CWHKDRAQRPRFSQIVSVLD 309
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 80/280 (28%), Positives = 126/280 (45%), Gaps = 39/280 (13%)
Query: 299 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 358
LG G FG+V+ G TKVAVK L F E ++ H+ L+RL
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVRLYA 75
Query: 359 FCTT-PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 417
T P ++ +M+N S+ L+ P L +A A G+ ++ E
Sbjct: 76 VVTQEPI--YIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER--- 128
Query: 418 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYLSTG 474
IHRD++AAN+L+ + + DFGLA+L+ + N T G I APE ++ G
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 475 KSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--R 531
+ ++DV+ +GI+L E+VT G+ + + +V+ + LER R+ +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIP--YPGMTNP-EVI-----QNLERGYRMVRPDNCPE 237
Query: 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
L Y + M LC + PEDRP + +LE
Sbjct: 238 EL---YQL-----M----RLCWKERPEDRPTFDYLRSVLE 265
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 70/309 (22%), Positives = 125/309 (40%), Gaps = 65/309 (21%)
Query: 299 KNVLGQGGFGKVYRGVLADG------TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
+G+G FG+V++ T VAVK L + S A FQRE +++ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 353 LLRLIGFCTTPTERLLVYPFMQN--------------------LSVAYRLREIKPGEPVL 392
+++L+G C L++ +M ++ R R PG P L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 393 DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452
+ +A A G+ YL E K +HRD+ N L+ E+ + DFGL++ ++
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR--NIYS 226
Query: 453 TNVTTQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEE 506
+ I PE + + + +DV+ YG++L E+ + G + + +
Sbjct: 227 ADYYK--ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP--YYGMAH 282
Query: 507 EDDVLLLDHVKK---LER-EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA 562
E+ ++ +V+ L E + YN+ M C P DRP+
Sbjct: 283 EE---VIYYVRDGNILACPENCPLEL--------YNL-----MRL----CWSKLPADRPS 322
Query: 563 MSEVVRMLE 571
+ R+L+
Sbjct: 323 FCSIHRILQ 331
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 79/281 (28%), Positives = 127/281 (45%), Gaps = 39/281 (13%)
Query: 299 KNVLGQGGFGKVYRGVL-ADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNLLRL 356
K+ LG G +G+VY GV VAVK L D F +E ++ H NL++L
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQL 74
Query: 357 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 416
+G CT ++ FM ++ LRE E + V +A + +EYL +
Sbjct: 75 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEKK-- 130
Query: 417 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYLST 473
IHRD+ A N L+ E+ V DFGL++L+ + T G I APE L+
Sbjct: 131 -NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAY 186
Query: 474 GKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD-- 530
K S ++DV+ +G++L E+ T G + ++ V + LE++ R++
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSP--YPGIDLS-QVY-----ELLEKDYRMERPEGCP 238
Query: 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ Y + M C Q +P DRP+ +E+ + E
Sbjct: 239 EKV---YEL-----MRA----CWQWNPSDRPSFAEIHQAFE 267
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 69/302 (22%), Positives = 128/302 (42%), Gaps = 60/302 (19%)
Query: 299 KNVLGQGGFGKVYRGVLADG------TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
K LG+G FGKV+ + VAVK L D + FQRE E+++ H +
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAARKDFQREAELLTNLQHEH 78
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR------------V 400
+++ G C ++V+ +M++ + LR P +L ++ +
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 401 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 460
A A G+ YL +HRD+ N L+ + +GDFG+++ DV T+
Sbjct: 139 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTDYYRVGG 193
Query: 461 GTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHV 516
TM I PE + K + +DV+ +G++L E+ T G++ + +L +V+
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--WFQLSNT-EVI----- 245
Query: 517 KKLEREKRL-------DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569
+ + + + L + Y++ M+ C Q P+ R + E+ ++
Sbjct: 246 ECITQGRVLERPRVCPKEV--------YDV-----MLG----CWQREPQQRLNIKEIYKI 288
Query: 570 LE 571
L
Sbjct: 289 LH 290
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 9e-30
Identities = 71/279 (25%), Positives = 121/279 (43%), Gaps = 39/279 (13%)
Query: 300 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 359
LG G FG+V+ TKVAVK + F E ++ H L++L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKLVKLHAV 251
Query: 360 CT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 418
T P ++ FM S+ L+ + A G+ ++ +
Sbjct: 252 VTKEPI--YIITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFIEQR---N 304
Query: 419 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYLSTGK 475
IHRD++AAN+L+ + DFGLA++++ N T G I APE ++ G
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGS 361
Query: 476 SSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--RN 532
+ ++DV+ +GI+L+E+VT G+ + + +V+ + LER R+ +
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIP--YPGMSNP-EVI-----RALERGYRMPRPENCPEE 413
Query: 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
L YNI M++ C + PE+RP + +L+
Sbjct: 414 L---YNI-----MMR----CWKNRPEERPTFEYIQSVLD 440
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 73/283 (25%), Positives = 128/283 (45%), Gaps = 37/283 (13%)
Query: 299 KNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 354
V+G G FG+V G L VA+K L + F E ++ H N++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 355 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 414
RL G T ++V +M+N S+ LR+ + + + G A G++YL +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 415 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYL 471
+HRD+ A N+L++ + V DFGL ++++ T RG I +PE +
Sbjct: 167 ---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT-RGGKIPIRWTSPEAI 222
Query: 472 STGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530
+ K + +DV+ YGI+L E+++ G+R + + + DV+ K ++ RL +D
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERP--YWEMSNQ-DVI-----KAVDEGYRLPPPMD 274
Query: 531 --RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
L Y + M+ C Q +RP ++V +L+
Sbjct: 275 CPAAL---YQL-----MLD----CWQKDRNNRPKFEQIVSILD 305
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 74/287 (25%), Positives = 133/287 (46%), Gaps = 44/287 (15%)
Query: 299 KNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 353
+ V+G G FG+VY+G+L VA+K L + F E ++ H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 354 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 413
+RL G + +++ +M+N ++ LRE + + + G A G++YL
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 414 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-DVRKTNVTTQ-----VRGTMGHIA 467
+HRD+ A N+L++ + V DFGL++++ D + TT +R T A
Sbjct: 166 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----A 218
Query: 468 PEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526
PE +S K + +DV+ +GI++ E++T G+R + L +V+ K + RL
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERP--YWELSNH-EVM-----KAINDGFRLP 270
Query: 527 AIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+D + Y + M+Q C Q RP +++V +L+
Sbjct: 271 TPMDCPSAI---YQL-----MMQ----CWQQERARRPKFADIVSILD 305
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 82/295 (27%), Positives = 113/295 (38%), Gaps = 63/295 (21%)
Query: 301 VLGQGGFGKVYRGVL----ADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVHRNLL 354
LG G FG V RG VAVK L P F REV + HRNL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 355 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPV---LDWVTRKRVALGAARGLEYL 411
RL G TP +V S+ RLR+ + + + A+ A G+ YL
Sbjct: 85 RLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY------AVQVAEGMGYL 137
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG------TMGH 465
+ IHRD+ A N+LL +GDFGL + + + Q
Sbjct: 138 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC--- 191
Query: 466 IAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLERE-K 523
APE L T S +D + +G+ L E+ T GQ + L +L K+++E +
Sbjct: 192 -APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGS-QIL-----HKIDKEGE 242
Query: 524 RL-------DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
RL I YN+ M+Q C PEDRP + L
Sbjct: 243 RLPRPEDCPQDI--------YNV-----MVQ----CWAHKPEDRPTFVALRDFLL 280
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 52/219 (23%), Positives = 88/219 (40%), Gaps = 25/219 (11%)
Query: 288 ELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK--RLTDFESPGGDAAFQREVEM 344
E + + + +G+G FG+V+R G + AVK RL F E+
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVA 103
Query: 345 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALG 403
+ ++ L G + ++ S+ ++++ E + + AL
Sbjct: 104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQ--AL- 160
Query: 404 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQ---- 458
GLEYLH +I+H DVKA NVLL D + DFG A + +
Sbjct: 161 --EGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215
Query: 459 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 497
+ GT H+APE + + D++ M+L ++ G
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 63/292 (21%), Positives = 117/292 (40%), Gaps = 52/292 (17%)
Query: 299 KNVLGQGGFGKVYRGVL--------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH 350
LGQG F K+++GV T+V +K L +F M+S H
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK-AHRNYSESFFEAASMMSKLSH 71
Query: 351 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 410
++L+ G C E +LV F++ S+ L++ + ++ + + VA A + +
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHF 128
Query: 411 LHEHCNPKIIHRDVKAANVLLDEDFEAV--------VGDFGLAKLVDVRKTNVTTQ-VRG 461
L E+ +IH +V A N+LL + + + D G++ V ++ + +
Sbjct: 129 LEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI--TVLPKDILQERIPW 183
Query: 462 TMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKL 519
PE + K+ + TD + +G L E+ + G + S L+ + L +
Sbjct: 184 V----PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP--LSALDSQ-RKL-----QFY 231
Query: 520 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
E +L A L N+ + C P+ RP+ ++R L
Sbjct: 232 EDRHQLPAPKAAEL---ANL-----INN----CMDYEPDHRPSFRAIIRDLN 271
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-28
Identities = 43/306 (14%), Positives = 76/306 (24%), Gaps = 65/306 (21%)
Query: 301 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDA--AFQREVEMI----------SV 347
VLGQ G V E P +A + EV +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 348 AVHRNLLRLIGFCTTP-----------------TERLLVYPFMQ--NLSVAYRLREIKPG 388
VH + P R +YP MQ + L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 389 EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448
L R ++ L R L LH + ++H ++ +++LD+ + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 449 DVRKTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSR 503
+ + A L + D + G+ + + +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--NTD 319
Query: 504 LEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNI-QEVETMIQVALLCTQASPEDRPA 562
+ NI Q V +++ L + EDR
Sbjct: 320 DAAL-------------------GGSEWIFRSCKNIPQPVRALLEGFL---RYPKEDRLL 357
Query: 563 MSEVVR 568
+ +
Sbjct: 358 PLQAME 363
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 67/309 (21%), Positives = 117/309 (37%), Gaps = 52/309 (16%)
Query: 287 RELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMI 345
+ + ++ LG+GGF V L DG A+KR+ QRE +M
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI-LCHEQQDREEAQREADMH 80
Query: 346 SVAVHRNLLRLIGFCTTPTER----LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA 401
+ H N+LRL+ +C L+ PF + ++ + +K L +
Sbjct: 81 RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140
Query: 402 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT---- 457
LG RGLE +H HRD+K N+LL ++ + V+ D G +
Sbjct: 141 LGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 458 ----QVRGTMGHIAPEYLSTGKS----SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD 509
R T+ + APE L + +S ERTDV+ G +L ++ G+ + + ++ D
Sbjct: 198 QDWAAQRCTISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP--YDMVFQKGD 254
Query: 510 VLLLDHVKKLEREKRLDAIVDRNLNKNYNI-------QEVETMIQVALLCTQASPEDRPA 562
+ L + +I + ++ + P RP
Sbjct: 255 SVAL------------------AVQNQLSIPQSPRHSSALWQLLNSMM---TVDPHQRPH 293
Query: 563 MSEVVRMLE 571
+ ++ LE
Sbjct: 294 IPLLLSQLE 302
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-27
Identities = 48/281 (17%), Positives = 93/281 (33%), Gaps = 51/281 (18%)
Query: 301 VLGQGGFGKVYRGV--LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 358
+ GG G +Y + +G V +K L A E + ++ VH +++++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 359 FCTTPTERLLVYPF--MQNLSVAY----RLREIKPGEPVLDWVTRKRVALGAARGLEYLH 412
F + M+ Y L+ K + + L L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVME-----YVGGQSLKRSKGQKLPVAEAIA--YLLEILPALSYLH 199
Query: 413 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS 472
+++ D+K N++L E+ + + D G + N + GT G APE +
Sbjct: 200 SI---GLVYNDLKPENIMLTEE-QLKLIDLGAV-----SRINSFGYLYGTPGFQAPE-IV 249
Query: 473 TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532
+ TD++ G L L + ++ + + L+ ++ R
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPV-----LKTYDSYGRLLRRA 304
Query: 533 LNKNYNIQEVETMIQVALLCTQASPEDRPA-MSEVVRMLEG 572
++ + P R E+ L G
Sbjct: 305 IDPD--------------------PRQRFTTAEEMSAQLTG 325
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 29/301 (9%), Positives = 65/301 (21%), Gaps = 50/301 (16%)
Query: 301 VLGQGGFGKVYRGV-LADGTKVAVK--RLTDFESPGGDAAFQREVEMISVAVHRNLLRLI 357
L G V+ + A+K + S + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 358 GFC--------------------------TTPTERLLVYPFMQ--NLSVAYRLREIKPGE 389
LL+ P + L +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 390 PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449
+ + R L ++H N+ + D ++GD
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSAL---- 241
Query: 450 VRKTNVTTQVRGTMGHIAPEYLSTGKS--SERTDVFGYGIMLLELVTGQRAIDFSRLEEE 507
+ + + E+L+ + + + + G+ + + F +
Sbjct: 242 WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP--FGLVTPG 299
Query: 508 DDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV 567
++ L L V+T+I L R E +
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLP-----DFVKTLIG-RFL--NFDRRRRLLPLEAM 351
Query: 568 R 568
Sbjct: 352 E 352
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 50/290 (17%), Positives = 93/290 (32%), Gaps = 42/290 (14%)
Query: 287 RELQLATDNFSEKNVLGQGGFGKVYRGV------LADGTKVAVKRLTDFESPGGDAAFQR 340
E QL + ++LG+G F +VY + K +K +P +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-ANPWEFYIGTQ 116
Query: 341 EVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIK-PGEPVLDWVTRKR 399
+E + ++ ++ +LV ++ + K E V+
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176
Query: 400 VALGAARGLEYLHEHCNPKIIHRDVKAANVLL-----------DEDFEAVVGDFGLAKLV 448
A+ +E +H+ +IIH D+K N +L D + D G + +
Sbjct: 177 FAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233
Query: 449 DVRKTNVT-TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG------------ 495
+ T T G E LS + + D FG + ++ G
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293
Query: 496 QRAIDFSRLEEED------DVLL-LDHVKKLEREKRLDAIVDRNLNKNYN 538
+ F RL D V+L + L L + + ++Y
Sbjct: 294 KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 64/302 (21%), Positives = 110/302 (36%), Gaps = 54/302 (17%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
+F LG+GGFG V+ D A+KR+ REV+ ++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 353 LLRLIGF---------CTTPTERLLVYPFMQ---NLSVAYRLREIKPGEPVLDWVTRKRV 400
++R + ++ +Y MQ ++ + E + +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE-RERSVCLHI 123
Query: 401 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD----------- 449
L A +E+LH ++HRD+K +N+ D VGDFGL +D
Sbjct: 124 FLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 450 -VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED 508
T QV GT +++PE + S + D+F G++L EL+ FS
Sbjct: 181 MPAYARHTGQV-GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP-----FS------ 228
Query: 509 DVLLLDHVKKLEREKRLDAIVDRNLNKNYNI--QEVETMIQVALLCTQASPEDRPAMSEV 566
++ER + L + + + M+Q SP +RP +
Sbjct: 229 --------TQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQ---DMLSPSPMERPEAINI 277
Query: 567 VR 568
+
Sbjct: 278 IE 279
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 62/298 (20%), Positives = 122/298 (40%), Gaps = 60/298 (20%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
+F E ++G GGFG+V++ DG +KR+ + + +REV+ ++ H N
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-KYNN----EKAEREVKALAKLDHVN 65
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRL-------------REIK-------PGEPVL 392
++ G + S L + I+ L
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 393 DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452
+ + +G++Y+H K+I+RD+K +N+ L + + +GDFGL +
Sbjct: 126 ELFEQ------ITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK--N 174
Query: 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL 512
T+ +GT+ +++PE +S+ + D++ G++L EL+
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD--------------- 219
Query: 513 LDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 570
E K + D ++ ++ ++ +T++Q PEDRP SE++R L
Sbjct: 220 ----TAFETSKFFTDLRDGIISDIFD-KKEKTLLQ---KLLSKKPEDRPNTSEILRTL 269
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 53/221 (23%), Positives = 101/221 (45%), Gaps = 24/221 (10%)
Query: 288 ELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMIS 346
E D ++ VLG+G +G VY G L++ ++A+K + E+ +
Sbjct: 16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI-PERDSRYSQPLHEEIALHK 74
Query: 347 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE----IKPGEPVLDWVTRKRVAL 402
H+N+++ +G + + + S++ LR +K E + + T++ +
Sbjct: 75 HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-- 132
Query: 403 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRG 461
GL+YLH++ +I+HRD+K NVL++ + + DFG +K + T G
Sbjct: 133 ---EGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTG 185
Query: 462 T---MGHIAPEYLSTGKS--SERTDVFGYGIMLLELVTGQR 497
T M APE + G + D++ G ++E+ TG+
Sbjct: 186 TLQYM---APEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 18/209 (8%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAA-FQREVEMISVAVH 350
+ F++ +G+G FG+V++G+ VA+K + D E + Q+E+ ++S
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDS 79
Query: 351 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 410
+ + G T+ ++ ++ S L E + + R +GL+Y
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDY 134
Query: 411 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT---MGHIA 467
LH K IHRD+KAANVLL E E + DFG+A + + T V GT M A
Sbjct: 135 LHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWM---A 187
Query: 468 PEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
PE + + D++ GI +EL G+
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 49/214 (22%), Positives = 93/214 (43%), Gaps = 19/214 (8%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK--RLTDFESPGGDAAFQREVEMISVAVH 350
NF + +G+G F +VYR L DG VA+K ++ D A +E++++ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 351 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIK------PGEPVLDWVTRKRVALGA 404
N+++ E +V ++ ++ K P V + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ------L 145
Query: 405 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 464
LE++H +++HRD+K ANV + +GD GL + + T + V GT
Sbjct: 146 CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPY 201
Query: 465 HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRA 498
+++PE + + ++D++ G +L E+ Q
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 1e-25
Identities = 62/310 (20%), Positives = 120/310 (38%), Gaps = 41/310 (13%)
Query: 285 SWRELQLATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVE 343
+ +L D+F + + LG G G V++ G +A K + P RE++
Sbjct: 24 KQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ 83
Query: 344 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVAL 402
++ ++ G + E + M S+ L++ E +L +V++
Sbjct: 84 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL-----GKVSI 138
Query: 403 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVD-VRKTNVTTQVR 460
+GL YL E KI+HRDVK +N+L++ E + DFG++ +L+D + + V
Sbjct: 139 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----- 191
Query: 461 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ-------RAIDFSRLEEEDDVLLL 513
GT +++PE L S ++D++ G+ L+E+ G+ + +
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 251
Query: 514 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMI---QVALL---------------CTQA 555
+ + R + I E+ I L C
Sbjct: 252 ETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 311
Query: 556 SPEDRPAMSE 565
+P +R + +
Sbjct: 312 NPAERADLKQ 321
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 55/206 (26%), Positives = 85/206 (41%), Gaps = 29/206 (14%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVHRNLLRLIG 358
LG+GGF K + A K + + P E+ + H++++ G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 359 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD-WVTRKRVALGAAR--------GLE 409
F V+ + E+ +L+ RK + AR G +
Sbjct: 83 FFEDNDF---VFVVL----------ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 129
Query: 410 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 469
YLH + ++IHRD+K N+ L+ED E +GDFGLA V+ GT +IAPE
Sbjct: 130 YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPE 185
Query: 470 YLSTGKSSERTDVFGYGIMLLELVTG 495
LS S DV+ G ++ L+ G
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVG 211
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 59/313 (18%), Positives = 136/313 (43%), Gaps = 37/313 (11%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 351
+ + +G+G FGK DG + +K + S +REV +++ H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 352 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG----EPVLDWVTRKRVALGAARG 407
N+++ +V + + + R+ K + +LDW +
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ------ICLA 137
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 467
L+++H+ KI+HRD+K+ N+ L +D +GDFG+A++++ + GT +++
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLS 193
Query: 468 PEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527
PE + ++D++ G +L EL T + A + ++ L+ +
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-----LVLKIISGSFPP---- 244
Query: 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEV 587
++ +Y+ ++ +++ + +P DRP+++ + LE +A+R E++ ++
Sbjct: 245 -----VSLHYS-YDLRSLVS---QLFKRNPRDRPSVNSI---LEKGFIAKRIEKFLSPQL 292
Query: 588 TRRQEYERLQRRF 600
+ + +F
Sbjct: 293 IAEEFCLKTFSKF 305
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 25/219 (11%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAA-FQREVEMISVAVHR 351
D++ + V+G G V KVA+KR+ + E +E++ +S H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHP 73
Query: 352 NLLRLIGFCTTPTERLLVYPFMQNLSVA------YRLREIKPG---EPVLDWVTRKRVAL 402
N++ E LV + SV E K G E + + R+
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE---- 129
Query: 403 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT 462
GLEYLH++ IHRDVKA N+LL ED + DFG++ + +VR T
Sbjct: 130 -VLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 463 M-GH---IAPEYLSTGKS-SERTDVFGYGIMLLELVTGQ 496
G +APE + + + D++ +GI +EL TG
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 55/206 (26%), Positives = 85/206 (41%), Gaps = 29/206 (14%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVHRNLLRLIG 358
LG+GGF K + A K + + P E+ + H++++ G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 359 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD-WVTRKRVALGAAR--------GLE 409
F V+ + E+ +L+ RK + AR G +
Sbjct: 109 FFEDNDF---VFVVL----------ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 155
Query: 410 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 469
YLH + ++IHRD+K N+ L+ED E +GDFGLA V+ GT +IAPE
Sbjct: 156 YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPE 211
Query: 470 YLSTGKSSERTDVFGYGIMLLELVTG 495
LS S DV+ G ++ L+ G
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVG 237
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 66/320 (20%), Positives = 119/320 (37%), Gaps = 71/320 (22%)
Query: 287 RELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVE-M 344
+ ++L + VL +GGF VY + G + A+KRL + A +EV M
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL-LSNEEEKNRAIIQEVCFM 79
Query: 345 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR----- 399
++ H N+++ + E + L E+ G+ +++++ +
Sbjct: 80 KKLSGHPNIVQFCSAASIGKEES-----DTGQAEFLLLTELCKGQ-LVEFLKKMESRGPL 133
Query: 400 -------VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452
+ R ++++H P IIHRD+K N+LL + DFG A +
Sbjct: 134 SCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYP 192
Query: 453 TNVTT-----------QVRGTMGHIAPEYLSTGKS---SERTDVFGYGIMLLELVTGQRA 498
+ T + PE + + E+ D++ G +L L Q
Sbjct: 193 DYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
Query: 499 IDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNI-------QEVETMIQVALL 551
F ED L I +N Y+I ++I+ L
Sbjct: 253 --F-----EDGAKL--------------RI----VNGKYSIPPHDTQYTVFHSLIRAML- 286
Query: 552 CTQASPEDRPAMSEVVRMLE 571
Q +PE+R +++EVV L+
Sbjct: 287 --QVNPEERLSIAEVVHQLQ 304
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 60/304 (19%), Positives = 105/304 (34%), Gaps = 69/304 (22%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAA----FQREVEMISVAVHRNLLR 355
LG GG VY KVA+K + F+REV S H+N++
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPP---REKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 356 LIGFCTTPTERLLVYPFMQNLSVAY---------RLREIKPGEPVLDWVTRKRVALGAAR 406
+ + Y L E L T
Sbjct: 76 -------------MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILD 122
Query: 407 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 466
G+++ H+ +I+HRD+K N+L+D + + DFG+AK + T V GT+ +
Sbjct: 123 GIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYF 179
Query: 467 APEYLSTGKSSERTDVFGYGIMLLELVTGQR--------AIDFSRLEEEDDVLLLDHVKK 518
+PE + E TD++ GI+L E++ G+ +I +++ + D K
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKD 239
Query: 519 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVRMLEGE 573
+ + L ++ R K+ +R ++ +L
Sbjct: 240 IPQS--LSNVILRATEKD--------------------KANRYKTIQEMKDDLSSVLHEN 277
Query: 574 GLAE 577
E
Sbjct: 278 RANE 281
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-25
Identities = 33/130 (25%), Positives = 49/130 (37%), Gaps = 5/130 (3%)
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEI-PEELGNLSSLTSLDLDNNRLVGKIP 141
+S + + L +L L + GN P+ L +LT LDL +L P
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487
Query: 142 PSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKY--- 198
+ +L LQ L +S NNF L+SL + N++ L P
Sbjct: 488 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAF 547
Query: 199 -NFTGNNLNC 207
N T N+ C
Sbjct: 548 LNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 22/112 (19%), Positives = 34/112 (30%)
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 142
LS S L L L I +LS L++L L N +
Sbjct: 35 LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALG 94
Query: 143 SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
+ L LQ L + N + + L +L + + N + F
Sbjct: 95 AFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 36/213 (16%), Positives = 72/213 (33%), Gaps = 24/213 (11%)
Query: 4 IDLLLYCLKCFRFFDNFDPDLHNGWLTFL-------CSLSGDALFALRTSLR-------- 48
+ + + L ++ + DL N LT + ++ F+ +
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFN-CLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCK 315
Query: 49 ---VPNNQLRDWNQNQVNPCTWSNVICD-NSNNVASVTLS--SMNFSGTLSPRIGVLRTL 102
P +L+ + N + + ++ + LS ++F G S +L
Sbjct: 316 FGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375
Query: 103 STLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPS-LGNLKKLQFLTLSQNNFS 161
L L NG+ + L L LD ++ L S +L+ L +L +S +
Sbjct: 376 KYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
Query: 162 GTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
LSSL +++ N+ +F
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-22
Identities = 28/114 (24%), Positives = 42/114 (36%), Gaps = 2/114 (1%)
Query: 83 LSSMNFSGTLSPRI-GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIP 141
++ +F P I LR L+ L L + P +LSSL L++ +N
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 511
Query: 142 PSLGNLKKLQFLTLSQNNFSGTIPDSLTTL-SSLISIQLDSNNLSGQIPVHLFQ 194
L LQ L S N+ + L SSL + L N+ + F
Sbjct: 512 FPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFL 565
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-21
Identities = 23/134 (17%), Positives = 40/134 (29%), Gaps = 10/134 (7%)
Query: 64 PCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNL 123
PC + N +NF + + + L L N + +
Sbjct: 2 PC-----VEVVPNITYQ--CMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSF 51
Query: 124 SSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNN 183
L LDL + + +L L L L+ N + + LSSL + N
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 184 LSGQIPVHLFQIPK 197
L+ + +
Sbjct: 112 LASLENFPIGHLKT 125
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-21
Identities = 32/125 (25%), Positives = 48/125 (38%), Gaps = 1/125 (0%)
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 142
LS L LSTL L GN I LSSL L L
Sbjct: 59 LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118
Query: 143 SLGNLKKLQFLTLSQNNF-SGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFT 201
+G+LK L+ L ++ N S +P+ + L++L + L SN + L + +
Sbjct: 119 PIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178
Query: 202 GNNLN 206
+L+
Sbjct: 179 NLSLD 183
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-18
Identities = 26/129 (20%), Positives = 43/129 (33%), Gaps = 6/129 (4%)
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 142
LS L +L L + N L+SL LD N ++
Sbjct: 477 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 536
Query: 143 SLGNL-KKLQFLTLSQNNFSGTIP--DSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYN 199
L + L FL L+QN+F+ T L + + ++ + P +P +
Sbjct: 537 ELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLS 596
Query: 200 FTGNNLNCG 208
N+ C
Sbjct: 597 L---NITCQ 602
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-17
Identities = 30/117 (25%), Positives = 49/117 (41%), Gaps = 6/117 (5%)
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITG-EIPEELGNLSSLTSLDLDNNRLVGKIP 141
N + + IG L+TL L + N I ++PE NL++L LDL +N++
Sbjct: 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166
Query: 142 PSLGNLKKLQF----LTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
L L ++ L LS N + P + + L + L +N S + Q
Sbjct: 167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQ 222
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 22/134 (16%), Positives = 36/134 (26%), Gaps = 12/134 (8%)
Query: 83 LSSMNFSGTLSPR-IGVLRTLSTLTLKGNGITGEIPEE---LGNLSSLTSLDLDNNRL-- 136
L + S + I L L L E E L L +L ++ RL
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 137 ----VGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL 192
+ I L + +L S ++L + + L
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFGQFPTLKL 324
Query: 193 FQIPKYNFTGNNLN 206
+ + FT N
Sbjct: 325 KSLKRLTFTSNKGG 338
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 51/208 (24%), Positives = 71/208 (34%), Gaps = 17/208 (8%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMI-SVAVH 350
+F + LG G +G+V++ DG AVKR F P A EV V H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 351 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG--EPVLDWVTRKRVALGAARGL 408
+RL L S+ E + L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCGP-SLQQHCEAWGASLPEAQV-----WGYLRDTLLAL 170
Query: 409 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 468
+LH ++H DVK AN+ L +GDFGL + G ++AP
Sbjct: 171 AHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG--TAGAGEVQEGDPRYMAP 225
Query: 469 EYLSTGKSSERTDVFGYGIMLLELVTGQ 496
E L G DVF G+ +LE+
Sbjct: 226 ELLQ-GSYGTAADVFSLGLTILEVACNM 252
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 55/229 (24%), Positives = 94/229 (41%), Gaps = 32/229 (13%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 351
+F E VLGQG FG+V + D A+K++ + + EV +++ H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKLSTILSEVMLLASLNHQ 62
Query: 352 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL---GAAR-- 406
++R + ++ S + E + D + + + R
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 407 -----GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD------------ 449
L Y+H IIHRD+K N+ +DE +GDFGLAK V
Sbjct: 123 RQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 450 --VRKTNVTTQVRGTMGHIAPEYLS-TGKSSERTDVFGYGIMLLELVTG 495
N+T+ + GT ++A E L TG +E+ D++ GI+ E++
Sbjct: 180 LPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 41/220 (18%), Positives = 82/220 (37%), Gaps = 25/220 (11%)
Query: 293 TDNFSEKNVLGQG--GFGKVYRGV-LADGTKVAVKRLTDFESPGGDA--AFQREVEMISV 347
+ V+G+G V G V V+R+ + E+ + Q E+ + +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI-NLEACSNEMVTFLQGELHVSKL 82
Query: 348 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG---EPVLDWVTRKRVALGA 404
H N++ E +V FM S + E + ++ + G
Sbjct: 83 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ-----GV 137
Query: 405 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG-LAKLVD--VRKTNVTTQVRG 461
+ L+Y+H +HR VKA+++L+ D + + ++ R+ V +
Sbjct: 138 LKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194
Query: 462 TMGHI---APEYLSTGKS--SERTDVFGYGIMLLELVTGQ 496
++ + +PE L ++D++ GI EL G
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 34/238 (14%), Positives = 64/238 (26%), Gaps = 51/238 (21%)
Query: 301 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAA---------------------- 337
VLGQ G V E P +A
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 338 -----FQREVEMISVAVHRNLLRLIGFCTTPT--ERLLVYPFMQ--NLSVAYRLREIKPG 388
F +++ + ++R+ R +YP MQ + L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 389 EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448
L R ++ L R L LH + ++H ++ +++LD+ + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 449 DVRKTNVTTQVRGTMGHIAPEYLST-----------GKSSERTDVFGYGIMLLELVTG 495
R + G PE + + D + G+++ +
Sbjct: 257 GARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 55/222 (24%), Positives = 87/222 (39%), Gaps = 42/222 (18%)
Query: 295 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVE-MISVAVHRNL 353
+F K+VLG G G + + D VAVKR+ P + REV+ + H N+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI----LPECFSFADREVQLLRESDEHPNV 80
Query: 354 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG---------- 403
+R Y + E+ + ++V +K A
Sbjct: 81 IRYFCTEKDRQF---QYIAI----------ELCAAT-LQEYVEQKDFAHLGLEPITLLQQ 126
Query: 404 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE-----AVVGDFGLAKLV--DVRKTNVT 456
GL +LH I+HRD+K N+L+ A++ DFGL K + +
Sbjct: 127 TTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 457 TQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTG 495
+ V GT G IAPE LS + D+F G + +++
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 60/215 (27%), Positives = 90/215 (41%), Gaps = 28/215 (13%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKR--LTDFESPGGDAAFQREVEMISVAV 349
FS+ +G G FG VY + + VA+K+ + +S +EV +
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 350 HRNLLRLIGFCTTPTERLLVYPFMQNLSVA--YRLREIKPGEPVLDWVTRKRVALGAARG 407
H N ++ G LV + S + + + E + VT GA +G
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTH-----GALQG 166
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT---MG 464
L YLH H +IHRDVKA N+LL E +GDFG A ++ + V GT M
Sbjct: 167 LAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWM- 217
Query: 465 HIAPEYLSTGKSSE---RTDVFGYGIMLLELVTGQ 496
APE + + + DV+ GI +EL +
Sbjct: 218 --APEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 25/212 (11%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 351
+G+G G V G +VAVK + D EV ++ H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM-DLRKQQRRELLFNEVVIMRDYQHF 102
Query: 352 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 411
N++ + E ++ F+Q ++ + +++ E + V + L YL
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEA-----VLQALAYL 157
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL-AKLVDV---RKTNVTTQVRGT---MG 464
H +IHRD+K+ ++LL D + DFG A++ RK+ V GT M
Sbjct: 158 HAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-----GTPYWM- 208
Query: 465 HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
APE +S + D++ GIM++E+V G+
Sbjct: 209 --APEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-24
Identities = 19/119 (15%), Positives = 44/119 (36%), Gaps = 9/119 (7%)
Query: 80 SVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLV-- 137
+ T + L+ L+ + + ++P L L + +++ NR +
Sbjct: 229 NENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISG 288
Query: 138 ------GKIPPSLGNLKKLQFLTLSQNNF-SGTIPDSLTTLSSLISIQLDSNNLSGQIP 189
+ +K+Q + + NN + + SL + L ++ N L G++P
Sbjct: 289 EQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-23
Identities = 32/183 (17%), Positives = 70/183 (38%), Gaps = 14/183 (7%)
Query: 33 CSLSG---DALFALR--TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMN 87
C L AL + V N+ Q + + ++ + + + N
Sbjct: 259 CPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADA--PVGEKIQIIYIGYNN 316
Query: 88 F-SGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSL-G 145
+ + + ++ L L N + G++P G+ L SL+L N++ IP + G
Sbjct: 317 LKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITE-IPANFCG 374
Query: 146 NLKKLQFLTLSQNNFSGTIPDSL--TTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGN 203
++++ L+ + N IP+ ++S + +I N + + + F G
Sbjct: 375 FTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGI 433
Query: 204 NLN 206
N++
Sbjct: 434 NVS 436
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 32/185 (17%), Positives = 60/185 (32%), Gaps = 22/185 (11%)
Query: 37 GDALFALRTSLRVPNNQLRDWNQNQVNPCTWS-NVICDNSNNVASVTLSSMNFSGTLSPR 95
AL + +L N + + W+ N D V+L+S
Sbjct: 32 YLALKEIWDALNGKNWSQQGFGTQP--GANWNFNKELDMWGAQPGVSLNSNGR------- 82
Query: 96 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVG----KIPPSLGNLKKLQ 151
++ L+L+G G +G +P+ +G L+ L L L ++ P + +
Sbjct: 83 ------VTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 152 FLTLSQNNFSGTIPDSLT--TLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGK 209
+ ++ T D S LI ++S+ I K G N
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196
Query: 210 TLPHS 214
+ +
Sbjct: 197 FVSKA 201
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 6e-20
Identities = 20/136 (14%), Positives = 39/136 (28%), Gaps = 17/136 (12%)
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 142
+ + F + NL LT +++ N + K+P
Sbjct: 213 MGNSPFVAENICEAWENENSEYAQQ-----YKTEDLKWDNLKDLTDVEVYNCPNLTKLPT 267
Query: 143 SLGNLKKLQFLTLSQNNF--------SGTIPDSLTTLSSLISIQLDSNNL-SGQIPVHLF 193
L L ++Q + ++ N + I + NNL + + L
Sbjct: 268 FLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQ 327
Query: 194 QIPK---YNFTGNNLN 206
++ K N L
Sbjct: 328 KMKKLGMLECLYNQLE 343
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 22/110 (20%), Positives = 40/110 (36%), Gaps = 10/110 (9%)
Query: 96 IGVLRTLSTLTLKGNGITGEIPE--ELGNLSSLTSLDLDNNRLVG-------KIPPSLGN 146
G + L+ N + IP + ++S ++++D N + + P+
Sbjct: 373 CGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFK 431
Query: 147 LKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIP 196
+ + LS N S + +T S L SI L N L+ L
Sbjct: 432 GINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDEN 481
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-18
Identities = 18/134 (13%), Positives = 41/134 (30%), Gaps = 16/134 (11%)
Query: 71 ICDNSNNVASVTLSSMNFSGTLSPR-IGVLRTLSTLTLKGNGITG-------EIPEELGN 122
C + V +++ + + + +S + N I +
Sbjct: 372 FCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFK 431
Query: 123 LSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSG-------TIPDSLTTLSSLI 175
+++S++L NN++ L + L N + ++ L
Sbjct: 432 GINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLT 491
Query: 176 SIQLDSNNLSGQIP 189
SI L N L+ +
Sbjct: 492 SIDLRFNKLTK-LS 504
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 28/178 (15%), Positives = 61/178 (34%), Gaps = 23/178 (12%)
Query: 45 TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGV--LRTL 102
+S+ + N L + +N + + N+ + S+ L + LS L L
Sbjct: 460 SSINLMGNMLTEIPKNSLKDE--NENFK-NTYLLTSIDLRFNKLTK-LSDDFRATTLPYL 515
Query: 103 STLTLKGNGITGEIPEELGNLSSLTSLDLDN------NRLVGKIPPSLGNLKKLQFLTLS 156
+ L N + P + N S+L + N NR + + P + L L +
Sbjct: 516 VGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIG 574
Query: 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK-------YNFTGNNLNC 207
N+ + + + ++ + + N ++ + Y+ T + C
Sbjct: 575 SNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDIRGC 629
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 58/289 (20%), Positives = 114/289 (39%), Gaps = 39/289 (13%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 351
+++ +G G +G+ + +DG + K L + EV ++ H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 352 NLLRLIGFCTTPTERLLVYPFM---------QNLSVAYRLREIKPGEPVLDWVTRKRVAL 402
N++R T L Y M ++ + R+ E VL +T+
Sbjct: 66 NIVRYYDRIIDRTNTTL-YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ----- 119
Query: 403 GAARGLEYLHEHCNP--KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 460
L+ H + ++HRD+K ANV LD +GDFGLA++++ + T V
Sbjct: 120 -LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV- 177
Query: 461 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 520
GT +++PE ++ +E++D++ G +L EL +E L +++ +
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-----LAGKIREGK 232
Query: 521 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569
+ + Y+ E+ +I RP++ E++
Sbjct: 233 FRR---------IPYRYS-DELNEIIT---RMLNLKDYHRPSVEEILEN 268
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 49/220 (22%), Positives = 94/220 (42%), Gaps = 30/220 (13%)
Query: 295 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNL 353
+S +G GG KV++ + A+K + + +++ E+ ++ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 354 --LRLIGFCTTPTERLLVYPFM--QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 409
+RL + T +Y M N+ + L++ K +D RK +
Sbjct: 89 KIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVH 141
Query: 410 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV--TTQVRGTMGHIA 467
+H+H I+H D+K AN L+ + + DFG+A + T+V +QV GT+ ++
Sbjct: 142 TIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMP 196
Query: 468 PEYL-----------STGKSSERTDVFGYGIMLLELVTGQ 496
PE + S K S ++DV+ G +L + G+
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 51/212 (24%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 351
++ +GQG G VY + +A G +VA++++ + + E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNP 77
Query: 352 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 411
N++ + E +V ++ S+ + E E + V R+ + LE+L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE-----CLQALEFL 132
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL-AKLVDV---RKTNVTTQVRGT---MG 464
H + ++IHRD+K+ N+LL D + DFG A++ R T V GT M
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----GTPYWM- 183
Query: 465 HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
APE ++ + D++ GIM +E++ G+
Sbjct: 184 --APEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 3e-23
Identities = 56/215 (26%), Positives = 87/215 (40%), Gaps = 25/215 (11%)
Query: 290 QLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMIS 346
Q A ++F LG+G FG VY +A+K L E G + +REVE+ S
Sbjct: 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 347 VAVHRNLLRLIGFCTTPTERLLVYPFMQN------LSVAYRLREIKPGEPVLDWVTRKRV 400
H N+LRL G+ T L+ + L + E T +
Sbjct: 65 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---------QRTATYI 115
Query: 401 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 460
A L Y H ++IHRD+K N+LL E + DFG + +
Sbjct: 116 TE-LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC--- 168
Query: 461 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 495
GT+ ++ PE + E+ D++ G++ E + G
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 4e-23
Identities = 53/201 (26%), Positives = 84/201 (41%), Gaps = 18/201 (8%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVHRNLLRLIG 358
LG+G F VYR + G +VA+K + G Q EV++ H ++L L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 359 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 418
+ LV N + L+ +P + R + G+ YLH H
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEARHFMH-QIITGMLYLHSH---G 132
Query: 419 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV----RKTNVTTQVRGTMGHIAPEYLSTG 474
I+HRD+ +N+LL + + DFGLA + + T + GT +I+PE +
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-----LCGTPNYISPEIATRS 187
Query: 475 KSSERTDVFGYGIMLLELVTG 495
+DV+ G M L+ G
Sbjct: 188 AHGLESDVWSLGCMFYTLLIG 208
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 45/212 (21%), Positives = 75/212 (35%), Gaps = 34/212 (16%)
Query: 301 VLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAA----FQREVEMISVAVHRNLL 354
++G+GG G VY VA+K + D QRE +++
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETL---SSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 355 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK---------RVALGAA 405
++ F + Y + G + + R+ +
Sbjct: 98 P-------------IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIG 144
Query: 406 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 465
L+ H HRDVK N+L+ D A + DFG+A K GT+ +
Sbjct: 145 SALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYY 201
Query: 466 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 497
+APE S ++ R D++ +L E +TG
Sbjct: 202 MAPERFSESHATYRADIYALTCVLYECLTGSP 233
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 5e-23
Identities = 47/230 (20%), Positives = 84/230 (36%), Gaps = 40/230 (17%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLA--DGTKVAVK----------------RLTDFESPGGD 335
+++ L QG F K+ L D A+K
Sbjct: 31 NDYRIIRTLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 336 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN------LSVAYRLREIKPGE 389
F+ E+++I+ + L G T E ++Y +M+N + L +
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC- 146
Query: 390 PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV- 448
+ V + + Y+H N I HRDVK +N+L+D++ + DFG ++ +
Sbjct: 147 FIPIQVIKCIIK-SVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203
Query: 449 -DVRKTNVTTQVRGTMGHIAPEYLSTGK--SSERTDVFGYGIMLLELVTG 495
K RGT + PE+ S + + D++ GI L +
Sbjct: 204 DKKIKG-----SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 32/219 (14%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 351
+ + LG G FGKVY+ G A K + + +S + E+E+++ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI-ETKSEEELEDYIVEIEILATCDHP 76
Query: 352 NLLRLIGFCTTPTERLLVYPFMQNLSVA--YRLREIKPGEPVLDWVTRKRVALGAARGLE 409
+++L+G + ++ F +V + EP + V R L
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR-----QMLEALN 131
Query: 410 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL-AKLVDV---RKTNVTTQVRGT--- 462
+LH +IIHRD+KA NVL+ + + + DFG+ AK + R + + GT
Sbjct: 132 FLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYW 183
Query: 463 MGHIAPEYLSTGKSSE-----RTDVFGYGIMLLELVTGQ 496
M APE + + + D++ GI L+E+ +
Sbjct: 184 M---APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 7e-23
Identities = 54/228 (23%), Positives = 91/228 (39%), Gaps = 30/228 (13%)
Query: 277 AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPG 333
A ++ + + D+F LG+G FG VY + +A+K L + E G
Sbjct: 2 ALAEMPKRKFT-----IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG 56
Query: 334 GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN------LSVAYRLREIKP 387
+ +RE+E+ S H N+LR+ + L+ F L R E
Sbjct: 57 VEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE--- 113
Query: 388 GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447
+ + A L Y HE K+IHRD+K N+L+ E + DFG +
Sbjct: 114 ------QRSATFMEE-LADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVH 163
Query: 448 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 495
+ GT+ ++ PE + E+ D++ G++ E + G
Sbjct: 164 APSLRRRTMC---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 9e-23
Identities = 75/287 (26%), Positives = 116/287 (40%), Gaps = 43/287 (14%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQR--EVEMISVA--VHRNLLR 355
LG GG +V+ L D VAVK L D D +F E + A H ++
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADL---ARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 356 L--IGFCTTPTERLLVYPFMQNLSVAY----RLREIKPGEPVLDWVTRKRVALGAARGLE 409
+ G L Y M+ Y LR+I E + V A + L
Sbjct: 77 VYDTG-EAETPAGPLPYIVME-----YVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 410 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT--QVRGTMGHIA 467
+ H++ IIHRDVK AN+++ V DFG+A+ + +VT V GT +++
Sbjct: 131 FSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 468 PEYLSTGKSSERTDVFGYGIMLLELVTGQR--------AIDFSRLEEEDDVLLLDHVKKL 519
PE R+DV+ G +L E++TG+ ++ + + ED + + L
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV-REDPIPPSARHEGL 246
Query: 520 EREKRLDAIVDRNLNKN----YNIQEVETMIQVALLCTQASPEDRPA 562
+ LDA+V + L KN Y Q M + P + P
Sbjct: 247 SAD--LDAVVLKALAKNPENRY--QTAAEMRADLVRVHNGEPPEAPK 289
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 48/215 (22%), Positives = 93/215 (43%), Gaps = 30/215 (13%)
Query: 300 NVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNL--LRL 356
+G GG KV++ + A+K + + +++ E+ ++ + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 357 IGFCTTPTERLLVYPFMQ--NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 414
+ T +Y M+ N+ + L++ K +D RK + +H+H
Sbjct: 75 YDYEITDQY---IYMVMECGNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQH 127
Query: 415 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV--TTQVRGTMGHIAPEYL- 471
I+H D+K AN L+ + + DFG+A + T+V +QV GT+ ++ PE +
Sbjct: 128 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIK 182
Query: 472 ----------STGKSSERTDVFGYGIMLLELVTGQ 496
S K S ++DV+ G +L + G+
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 61/305 (20%), Positives = 110/305 (36%), Gaps = 58/305 (19%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDAAFQREVE-MISVAVHR 351
+ + +LG G G V G VAVKR+ DF E++ + H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD-----IALMEIKLLTESDDHP 69
Query: 352 NLLRLIGFCTTPTERLLVYPFMQ--NLSVAYRLREIKPGEPVLDWVTR---KRVALGAAR 406
N++R TT + ++ NL++ + + L + A
Sbjct: 70 NVIRYYCSETTDRFLYIA---LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 407 GLEYLHEHCNPKIIHRDVKAANVLLD-------------EDFEAVVGDFGLAKLVDVRKT 453
G+ +LH KIIHRD+K N+L+ E+ ++ DFGL K +D ++
Sbjct: 127 GVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 454 NVTTQVR---GTMGHIAPEYLSTGKSSERT-------DVFGYGIMLLELVTGQRAIDFSR 503
+ T + GT G APE L + + D+F G + +++ + +
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243
Query: 504 LEEEDDVLLLDHVKKLEREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRP 561
E +++ + +++ +L + MI P RP
Sbjct: 244 YSRESNIIRGIFSLDEMKCLHDRSLIAEATDL--------ISQMIDH-------DPLKRP 288
Query: 562 AMSEV 566
+V
Sbjct: 289 TAMKV 293
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 1e-22
Identities = 47/220 (21%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 295 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNL 353
+S +G GG KV++ + A+K + + +++ E+ ++ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 354 --LRLIGFCTTPTERLLVYPFMQ--NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 409
+RL + T +Y M+ N+ + L++ K +D RK +
Sbjct: 117 KIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVH 169
Query: 410 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV--TTQVRGTMGHIA 467
+H+H I+H D+K AN L+ + + DFG+A + T+V +QV G + ++
Sbjct: 170 TIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GAVNYMP 224
Query: 468 PEYLS-----------TGKSSERTDVFGYGIMLLELVTGQ 496
PE + K S ++DV+ G +L + G+
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 35/217 (16%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL---TDFESPGGDAAFQREVEMISVA 348
+ F LG+G +G VY+ + G VA+K++ +D + +E+ ++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE------IIKEISIMQQC 81
Query: 349 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVA--YRLREIKPGEPVLDWVTRKRVALGAAR 406
++++ G T+ +V + SV+ RLR E + + + +
Sbjct: 82 DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQ-----STLK 136
Query: 407 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL-AKLVDV---RKTNVTTQVRGT 462
GLEYLH + IHRD+KA N+LL+ + A + DFG+ +L D R T + GT
Sbjct: 137 GLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-----GT 188
Query: 463 ---MGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
M APE + + D++ GI +E+ G+
Sbjct: 189 PFWM---APEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 24/231 (10%)
Query: 279 GQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAA 337
G+LK + ++ + +G+G +G V + V G +AVKR+
Sbjct: 7 GKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQ 66
Query: 338 FQREVEMI-SVAVHRNLLRLIGFCTTPTERLLVYPFM-----QNLSVAYRLREIKPGEPV 391
+++++ + +++ G + + M + Y + + E +
Sbjct: 67 LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI 126
Query: 392 LDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL-AKLVD- 449
L +T V + L +L E N KIIHRD+K +N+LLD + DFG+ +LVD
Sbjct: 127 LGKITLATV-----KALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179
Query: 450 VRKTNVTTQVRGTMGHIAPEYLSTGKS----SERTDVFGYGIMLLELVTGQ 496
+ KT G ++APE + S R+DV+ GI L EL TG+
Sbjct: 180 IAKTRDA----GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 33/223 (14%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMIS-VAVH 350
F ++G G +G+VY+G + G A+K + D + ++E+ M+ + H
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTG-DEEEEIKQEINMLKKYSHH 80
Query: 351 RNLLRLIG-----FCTTPTERL-LVYPFMQNLSVAYRLREIKPG---EPVLDWVTRKRVA 401
RN+ G ++L LV F SV ++ K E + ++ R
Sbjct: 81 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR---- 136
Query: 402 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 461
RGL +LH+H K+IHRD+K NVLL E+ E + DFG++ +D T + G
Sbjct: 137 -EILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-G 191
Query: 462 T---MGHIAPEYLSTGKSSE-----RTDVFGYGIMLLELVTGQ 496
T M APE ++ ++ + ++D++ GI +E+ G
Sbjct: 192 TPYWM---APEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 44/230 (19%), Positives = 74/230 (32%), Gaps = 37/230 (16%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAV- 349
T F E +G G FG V++ V DG A+KR + REV +V
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 350 HRNLLRLIGFCTTPTERLLVYPFM---QNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR 406
H +++R E + S+A + E K + L R
Sbjct: 70 HSHVVRYFSAWA---EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 407 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV-------------------GDFGLAKL 447
GL Y+H ++H D+K +N+ + GD G
Sbjct: 127 GLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 448 VDVRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQ 496
+ + G +A E L + + D+F + ++ +
Sbjct: 184 ISSPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 40/213 (18%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK--------RLTDFESPGGDAAFQREVE 343
+N+ K +LG+G V R + + AVK + E A +EV+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 344 -MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK---- 398
+ V+ H N+++L T T LV+ M+ GE + D++T K
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKK------------GE-LFDYLTEKVTLS 122
Query: 399 -RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 453
+ R + LH+ I+HRD+K N+LLD+D + DFG + +D
Sbjct: 123 EKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PG 177
Query: 454 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYG 486
+V GT ++APE + + GYG
Sbjct: 178 EKLREVCGTPSYLAPEIIECSMNDNHP---GYG 207
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-22
Identities = 29/145 (20%), Positives = 49/145 (33%), Gaps = 12/145 (8%)
Query: 65 CTWSNVICDNSNN------------VASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGI 112
CT S+ + D S+ + + L+ + L++L + N I
Sbjct: 2 CTVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 113 TGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLS 172
+ PE L L L+L +N L + L L L N+ +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 173 SLISIQLDSNNLSGQIPVHLFQIPK 197
+LI++ L N LS Q+
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLEN 146
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-20
Identities = 23/107 (21%), Positives = 37/107 (34%)
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 142
+ S L L L L+ N ++ + ++LT L L +N +
Sbjct: 56 VGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNN 115
Query: 143 SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 189
K L L LS N S T + L +L + L +N +
Sbjct: 116 PFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKS 162
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-20
Identities = 28/137 (20%), Positives = 47/137 (34%), Gaps = 12/137 (8%)
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGIT--------GEIPEELGNLSSLTSLDLDNN 134
LS+ N + + L L L L+ N + G L LS L L+L++N
Sbjct: 487 LSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESN 546
Query: 135 RLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
+L +L+ + L NN + SL S+ L N ++
Sbjct: 547 GFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGP 606
Query: 195 IPKY----NFTGNNLNC 207
+ + N +C
Sbjct: 607 AFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 8e-20
Identities = 29/117 (24%), Positives = 40/117 (34%), Gaps = 2/117 (1%)
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 142
L S L+ L L N I +L +LDL +N L
Sbjct: 80 LQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLG 139
Query: 143 SLGNLKKLQFLTLSQNNFSGTIPDSLTTL--SSLISIQLDSNNLSGQIPVHLFQIPK 197
+ L+ LQ L LS N + L SSL ++L SN + P I +
Sbjct: 140 TQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGR 196
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-19
Identities = 30/158 (18%), Positives = 56/158 (35%), Gaps = 8/158 (5%)
Query: 56 DWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGE 115
+ + T + + + + L+ S S L L L L N I E
Sbjct: 361 SNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQE 420
Query: 116 IP-EELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSG--TIPDSLTTLS 172
+ +E L ++ + L N+ + S + LQ L L + + P L
Sbjct: 421 LTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480
Query: 173 SLISIQLDSNNLSGQIPVHLFQIPKY----NFTGNNLN 206
+L + L +NN++ I + + + + NNL
Sbjct: 481 NLTILDLSNNNIAN-INDDMLEGLEKLEILDLQHNNLA 517
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-18
Identities = 34/134 (25%), Positives = 51/134 (38%), Gaps = 10/134 (7%)
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELG--NLSSLTSLDLDNNRLVGKI 140
LS S T L L L L N I EEL SSL L+L +N++
Sbjct: 128 LSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFS 187
Query: 141 PPSLGNLKKLQFLTLSQNNFSGTIPDSLT---TLSSLISIQLDSNNLSGQIPVHLFQIPK 197
P + +L L L+ ++ + L +S+ ++ L ++ LS +
Sbjct: 188 PGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKW 247
Query: 198 YNFT-----GNNLN 206
N T NNLN
Sbjct: 248 TNLTMLDLSYNNLN 261
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 7e-18
Identities = 26/136 (19%), Positives = 55/136 (40%), Gaps = 6/136 (4%)
Query: 73 DNSNNVASVTLSSMNFSGTLSPRIGV---LRTLSTLTLKGNGITGEIPEELGNL--SSLT 127
+ + L+++ +L+ ++ + ++ L+L + ++ L ++LT
Sbjct: 192 HAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLT 251
Query: 128 SLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQ 187
LDL N L S L +L++ L NN SL L ++ + L +
Sbjct: 252 MLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQS 311
Query: 188 IPV-HLFQIPKYNFTG 202
I + L +I ++F
Sbjct: 312 ISLASLPKIDDFSFQW 327
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 23/149 (15%), Positives = 44/149 (29%), Gaps = 37/149 (24%)
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGN---------GITGEIPEELGNLSSLTSLDLDN 133
L N S + L + L LK + + L L L++++
Sbjct: 279 LEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMED 338
Query: 134 NRLVGKIPPSLGNLKKLQFLTLSQN----------------------------NFSGTIP 165
N + G L L++L+LS + S
Sbjct: 339 NDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIES 398
Query: 166 DSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
D+ + L L + L N + ++ ++
Sbjct: 399 DAFSWLGHLEVLDLGLNEIGQELTGQEWR 427
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 5e-12
Identities = 28/136 (20%), Positives = 41/136 (30%), Gaps = 7/136 (5%)
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 142
L S F L L + L N + N SL SL+L N +
Sbjct: 543 LESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKK 602
Query: 143 SLG-NLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQI----PVHLFQIPK 197
G + L L + N F T ++ + + LS P H P
Sbjct: 603 VFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPV 662
Query: 198 YNFTGNNLNCGKTLPH 213
F + +C + H
Sbjct: 663 RLF--DTSSCKDSAHH 676
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 39/212 (18%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK-------RLTDFESPGGDAAFQREVE- 343
+ K+V+G+G V R V A G + AVK RL+ + A +RE
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 344 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK----- 398
+ VA H +++ LI + + LV+ M+ GE + D++T K
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRK------------GE-LFDYLTEKVALSE 199
Query: 399 RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 454
+ R + +LH + I+HRD+K N+LLD++ + + DFG + +
Sbjct: 200 KETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGE 254
Query: 455 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYG 486
++ GT G++APE L K S GYG
Sbjct: 255 KLRELCGTPGYLAPEIL---KCSMDETHPGYG 283
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 55/293 (18%), Positives = 98/293 (33%), Gaps = 28/293 (9%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
+ ++LGQG V+RG G A+K + RE E++ H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 353 LLRLIGFCTTPTERL--LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 410
+++L T R L+ F S+ L E + + V G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI-VLRDVVGGMNH 127
Query: 411 LHEHCNPKIIHRDVKAANVLL----DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 466
L E+ I+HR++K N++ D + DFG A+ ++ + GT ++
Sbjct: 128 LREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLYGTEEYL 182
Query: 467 APEYLSTGKS--------SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 518
P+ D++ G+ TG + ++ K
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM----YK 238
Query: 519 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ K AI +N I M L P ++ +LE
Sbjct: 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA---NILE 288
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 96.7 bits (240), Expect = 4e-21
Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 16/215 (7%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 351
+ K LG GGFG V R + G +VA+K+ SP + E++++ H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 352 NLLRLIGFCTTPTE------RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 405
N++ + LL + + + L + + + + R + +
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDIS 131
Query: 406 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV---VGDFGLAKLVDVRKTNVTTQVRGT 462
L YLHE+ +IIHRD+K N++L + + + D G AK +D + + T+ GT
Sbjct: 132 SALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGELCTEFVGT 186
Query: 463 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 497
+ ++APE L K + D + +G + E +TG R
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 5e-21
Identities = 48/221 (21%), Positives = 93/221 (42%), Gaps = 25/221 (11%)
Query: 289 LQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMI-S 346
+++ D+ LG+G +G V + + G +AVKR+ + ++++
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 347 VAVHRNLLRLIGFCTTPTERLLVYPFMQ-NLSVAYRLREIKPG---EPVLDWVTRKRVAL 402
+ G + + M +L Y+ K E +L + V
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIV-- 119
Query: 403 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL-AKLVD--VRKTNVTTQV 459
+ LE+LH +IHRDVK +NVL++ + + DFG+ LVD + +
Sbjct: 120 ---KALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA---- 170
Query: 460 RGTMGHIAPEYLSTGKS----SERTDVFGYGIMLLELVTGQ 496
G ++APE ++ + S ++D++ GI ++EL +
Sbjct: 171 -GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 59/228 (25%), Positives = 99/228 (43%), Gaps = 22/228 (9%)
Query: 279 GQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAA 337
G L R Q ++ +G G G+V++ G +AVK++ + +
Sbjct: 11 GYLTIGGQR-YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKR 69
Query: 338 FQREVE-MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWV 395
+++ ++ +++ G T T+ + M + + R P E +L +
Sbjct: 70 ILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKM 129
Query: 396 TRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL-AKLVD-VRKT 453
T V + L YL E +IHRDVK +N+LLDE + + DFG+ +LVD K
Sbjct: 130 TVAIV-----KALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD 182
Query: 454 NVTTQVRGTMGHIAPEYLSTGKSSE-----RTDVFGYGIMLLELVTGQ 496
G ++APE + ++ R DV+ GI L+EL TGQ
Sbjct: 183 RSA----GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 39/216 (18%)
Query: 301 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREVE-MISV---AVH 350
+LG+GGFG V+ G L D +VA+K R+ + EV + V H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 351 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-RVALGAAR--- 406
++RL+ + T +LV P + + D++T K + G +R
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERP------------LPAQDLFDYITEKGPLGEGPSRCFF 145
Query: 407 -----GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVR 460
+++ H ++HRD+K N+L+D + DFG L + T
Sbjct: 146 GQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGAL--LHDEPYTDFD- 199
Query: 461 GTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTG 495
GT + PE++S + + V+ GI+L ++V G
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 3e-20
Identities = 57/293 (19%), Positives = 102/293 (34%), Gaps = 28/293 (9%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
+ ++LGQG V+RG G A+K + RE E++ H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 353 LLRLIGFCTTPTERL--LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 410
+++L T R L+ F S+ L E + + V G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI-VLRDVVGGMNH 127
Query: 411 LHEHCNPKIIHRDVKAANVLL--DEDFEAVV--GDFGLAKLVDVRKTNVTTQVRGTMGHI 466
L E+ I+HR++K N++ ED ++V DFG A+ ++ + GT ++
Sbjct: 128 LREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYL 182
Query: 467 APEYLSTGKSSERT--------DVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 518
P+ + D++ G+ TG + ++ K
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM----YK 238
Query: 519 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ K AI +N I M L P ++ +LE
Sbjct: 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA---NILE 288
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 6e-20
Identities = 64/235 (27%), Positives = 100/235 (42%), Gaps = 32/235 (13%)
Query: 278 FGQLKRYSWRELQLAT-DNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGD 335
F + ++ W E Q D F + VLG+GGFG+V+ + K+ A K+L
Sbjct: 168 FLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNK------K 221
Query: 336 AAFQR-EVEMISVAVHRNLLRLIG--FCT-------TPTERLLVYPFMQNLSVAYRLREI 385
+R + V + +L + F T T+ LV M + Y + +
Sbjct: 222 RLKKRKGYQG--AMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNV 279
Query: 386 KPGEPVLDWVTRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 442
P R A+ GLE+LH+ II+RD+K NVLLD+D + D
Sbjct: 280 DEDNPGFQ---EPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDL 333
Query: 443 GLAKLVDVRKTNVTTQVR-GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
GLA +++ T+ GT G +APE L + D F G+ L E++ +
Sbjct: 334 GLAV--ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 1e-19
Identities = 33/214 (15%), Positives = 58/214 (27%), Gaps = 47/214 (21%)
Query: 23 DLHNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPC---TWSNVICDNSNNVA 79
T L GD S + + + ++ S+++ D N
Sbjct: 353 SFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNP 412
Query: 80 SVT---------------LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITG---------- 114
+ + N +S I L L + + T
Sbjct: 413 EMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDA 472
Query: 115 ---------EIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSG--- 162
NL LT ++L N + ++P L +L +LQ L ++ N
Sbjct: 473 NSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQ 532
Query: 163 ------TIPDSLTTLSSLISIQLDSNNLSGQIPV 190
+ D T + + NNL P
Sbjct: 533 LKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPA 565
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 2e-17
Identities = 31/186 (16%), Positives = 54/186 (29%), Gaps = 21/186 (11%)
Query: 37 GDALFALRTSLRVPNNQLR-DWNQNQVNPCTWS-NVICDNSNNVASVTLSSMNFSGTLSP 94
AL A+ +L N + N ++ W+ N D + V L +
Sbjct: 271 YKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNG------- 323
Query: 95 RIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154
++ L+L G G G +P+ +G L+ L L +
Sbjct: 324 ------RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSE 377
Query: 155 LSQNNFSGTIP------DSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCG 208
++ D LS L+ ++ N I K GN N
Sbjct: 378 ERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI 437
Query: 209 KTLPHS 214
+ +
Sbjct: 438 TFISKA 443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 1e-16
Identities = 22/122 (18%), Positives = 36/122 (29%), Gaps = 8/122 (6%)
Query: 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEE--LGNLSSLTSLDLD 132
+ N L+ + + N + E P L + L LD
Sbjct: 523 ACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCV 581
Query: 133 NNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSL-TTLSSLISIQLDSNNLSGQIPVH 191
+N++ + + G KL L L N IP+ + + N L IP
Sbjct: 582 HNKV--RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNI 637
Query: 192 LF 193
Sbjct: 638 FN 639
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 1e-14
Identities = 16/137 (11%), Positives = 37/137 (27%), Gaps = 16/137 (11%)
Query: 71 ICDNSNNVASVTLSSMNFSGTLSPRIGV--LRTLSTLTLKGNGITGEIPE-----ELGNL 123
C ++ V + S + + + ++ N I E +
Sbjct: 614 FCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKG 672
Query: 124 SSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFS-------GTIPDSLTTLSSLIS 176
+ +++ L N + + + LS N + + L +
Sbjct: 673 INASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTT 732
Query: 177 IQLDSNNLSGQIPVHLF 193
I L N L+ +
Sbjct: 733 IDLRFNKLTS-LSDDFR 748
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 1e-14
Identities = 25/149 (16%), Positives = 56/149 (37%), Gaps = 16/149 (10%)
Query: 45 TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGV--LRTL 102
+++ + NN + +N + P + N+ + ++ L + +LS L L
Sbjct: 700 STIILSNNLMTSIPENSLKP---KDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYL 755
Query: 103 STLTLKGNGITGEIPEELGNLSSLTSLDL------DNNRLVGKIPPSLGNLKKLQFLTLS 156
S + + N + P + N S L + + + NR++ + P + L L +
Sbjct: 756 SNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIG 814
Query: 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLS 185
N+ + + L L + + N
Sbjct: 815 SNDIR-KVDEKL--TPQLYILDIADNPNI 840
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 33/213 (15%)
Query: 301 VLGQGGFGKVYRGV-LADGTKVAVK---RLTDFESPGGDAAFQREVEMISVAVHRNLLRL 356
+LG+G +GKV + + AVK + P G+A ++E++++ H+N+++L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 357 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEP-VLDWVTRKRVALGAAR--------G 407
+ ++ + Y M+ Y G +LD V KR + A G
Sbjct: 72 VDVLYNEEKQKM-YMVME-----Y----CVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDG 121
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV---TTQVRGTMG 464
LEYLH I+H+D+K N+LL + G+A+ + + T+Q G+
Sbjct: 122 LEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--GSPA 176
Query: 465 HIAPEYLSTGK--SSERTDVFGYGIMLLELVTG 495
PE + S + D++ G+ L + TG
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 50/243 (20%), Positives = 91/243 (37%), Gaps = 56/243 (23%)
Query: 275 RIAFGQLKRYSWR-------ELQLATDNFSEK----NVLGQGGFGKVYRGV-LADGTKVA 322
IA + + + + ++ LG G G+V KVA
Sbjct: 105 EIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVA 164
Query: 323 VK-------RLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 375
++ + + E+E++ H ++++ F Y +
Sbjct: 165 IRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED----YYIVL-- 218
Query: 376 LSVAYRLREIKPGEPVLDW-VTRKRVALGAAR--------GLEYLHEHCNPKIIHRDVKA 426
E+ G + D V KR+ + ++YLHE+ IIHRD+K
Sbjct: 219 --------ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKP 267
Query: 427 ANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVF 483
NVLL +ED + DFG +K++ +T++ + GT ++APE L + ++
Sbjct: 268 ENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTA------ 319
Query: 484 GYG 486
GY
Sbjct: 320 GYN 322
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 50/214 (23%), Positives = 93/214 (43%), Gaps = 37/214 (17%)
Query: 301 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREVEMISVAVHR--N 352
+LG GGFG VY G+ ++D VA+K R++D+ EV ++
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-RVALGAAR----- 406
++RL+ + P +L+ +P + + D++T + + AR
Sbjct: 110 VIRLLDWFERPDSFVLILER------------PEPVQDLFDFITERGALQEELARSFFWQ 157
Query: 407 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGT 462
+ + H ++HRD+K N+L+D + + + DFG L ++ T T GT
Sbjct: 158 VLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL--LKDTVYTDFD-GT 211
Query: 463 MGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTG 495
+ PE++ + V+ GI+L ++V G
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-19
Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 17/226 (7%)
Query: 278 FGQLKRYSWRELQLAT-DNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRL--TDFESPG 333
F + ++ W E Q T + F + VLG+GGFG+V + K+ A K+L +
Sbjct: 167 FNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK 226
Query: 334 GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD 393
G+A E +++ R ++ L T LV M + + + G+
Sbjct: 227 GEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFP 284
Query: 394 WVTRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450
R AA GLE LH +I++RD+K N+LLD+ + D GLA V
Sbjct: 285 ---EARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAV--HV 336
Query: 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
+ GT+G++APE + + + D + G +L E++ GQ
Sbjct: 337 PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 8e-19
Identities = 62/238 (26%), Positives = 101/238 (42%), Gaps = 39/238 (16%)
Query: 278 FGQLKRYSWRELQ--LATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGG 334
F + ++ EL L ++FS ++G+GGFG+VY AD K+ A+K L
Sbjct: 171 FTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK------ 224
Query: 335 DAAFQR-EVEM----------ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRL- 382
+ + +S ++ + TP + + M + Y L
Sbjct: 225 KRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 284
Query: 383 REIKPGEPVLDWVTRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV 439
+ E + AA GLE++H +++RD+K AN+LLDE +
Sbjct: 285 QHGVFSEA--------DMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRI 333
Query: 440 GDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERT-DVFGYGIMLLELVTGQ 496
D GLA +K + V GT G++APE L G + + + D F G ML +L+ G
Sbjct: 334 SDLGLACDFSKKKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 8e-19
Identities = 26/103 (25%), Positives = 40/103 (38%), Gaps = 3/103 (2%)
Query: 91 TLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDL-DNNRLVGKIPPSLGNLKK 149
L P I L L L L+G P G + L L L D + L+ +P + L +
Sbjct: 220 ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQ 278
Query: 150 LQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL 192
L+ L L +P + L + I + +L Q+ H
Sbjct: 279 LEKLDLRGCVNLSRLPSLIAQLPANCIILV-PPHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 7e-18
Identities = 26/128 (20%), Positives = 51/128 (39%), Gaps = 5/128 (3%)
Query: 91 TLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKL 150
+L I L+ L +L ++ + ++ + + +L L LDL + PP G L
Sbjct: 197 SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPL 255
Query: 151 QFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIP--KYNFTGNNL--N 206
+ L L + T+P + L+ L + L ++P + Q+P +L
Sbjct: 256 KRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ 315
Query: 207 CGKTLPHS 214
+ P +
Sbjct: 316 LDQHRPVA 323
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 24/118 (20%), Positives = 51/118 (43%), Gaps = 6/118 (5%)
Query: 74 NSNNVASVTLSSMNFSGTLSPRIGVLR--TLSTLTLKGNGITGEIPEELGNLSSLTSLDL 131
NSNN T + + + L L+ + + P++ LS L + +
Sbjct: 54 NSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTI 111
Query: 132 DNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 189
D L+ ++P ++ L+ LTL++N +P S+ +L+ L + + + ++P
Sbjct: 112 DAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELP 167
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 25/104 (24%), Positives = 45/104 (43%), Gaps = 11/104 (10%)
Query: 91 TLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGN---- 146
L + L TLTL N + +P + +L+ L L + + ++P L +
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176
Query: 147 -----LKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLS 185
L LQ L L ++P S+ L +L S+++ ++ LS
Sbjct: 177 GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS 219
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 15/95 (15%), Positives = 31/95 (32%), Gaps = 5/95 (5%)
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKG-NGITGEIPEELGNLSSLTSLDLDNNRLVGKIP 141
L P G L L LK + + +P ++ L+ L LDL + ++P
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLP 294
Query: 142 PSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLIS 176
+ L + + + + + +
Sbjct: 295 SLIAQLPANCIILVP-PHLQAQLDQHR--PVARPA 326
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 21/140 (15%), Positives = 35/140 (25%), Gaps = 29/140 (20%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKI------------------ 140
L +G+ + L + D + +
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKA 70
Query: 141 -PPSLGNLK--KLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIP- 196
L + L L PD LS L + +D+ L ++P + Q
Sbjct: 71 TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAG 128
Query: 197 --KYNFTGNNLNCGKTLPHS 214
N L + LP S
Sbjct: 129 LETLTLARNPL---RALPAS 145
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 33/130 (25%), Positives = 47/130 (36%), Gaps = 6/130 (4%)
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIP 141
+S N L +L+TL + GN N ++LT LDL +L
Sbjct: 431 ISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISW 490
Query: 142 PSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKY--- 198
L +LQ L +S NN L SL ++ N + L PK
Sbjct: 491 GVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAF 549
Query: 199 -NFTGNNLNC 207
N T N++ C
Sbjct: 550 FNLTNNSVAC 559
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-17
Identities = 23/133 (17%), Positives = 41/133 (30%), Gaps = 10/133 (7%)
Query: 64 PCTWSNVICDNSNNVASVTLSSMNFSGTLSPRI--GVLRTLSTLTLKGNGITGEIPEELG 121
P + + I N + S ++ + + + L N +
Sbjct: 1 PGSLNPCIEVVPNI--TYQCMDQKLS-----KVPDDIPSSTKNIDLSFNPLKILKSYSFS 53
Query: 122 NLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDS 181
N S L LDL + + L L L L+ N P S + L+SL ++
Sbjct: 54 NFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVE 113
Query: 182 NNLSGQIPVHLFQ 194
L+ +
Sbjct: 114 TKLAS-LESFPIG 125
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-17
Identities = 20/104 (19%), Positives = 32/104 (30%)
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 142
LS S L L L I + L L++L L N + P
Sbjct: 39 LSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPG 98
Query: 143 SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSG 186
S L L+ L + + + L +L + + N +
Sbjct: 99 SFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS 142
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-16
Identities = 26/111 (23%), Positives = 44/111 (39%), Gaps = 1/111 (0%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
L LS L L GN I P L+SL +L +L +G L L+ L ++ N
Sbjct: 79 LHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHN 138
Query: 159 NFSG-TIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCG 208
+P + L++L+ + L N + L + + +L+
Sbjct: 139 FIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMS 189
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 20/112 (17%), Positives = 35/112 (31%), Gaps = 3/112 (2%)
Query: 85 SMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPPS 143
S N + +S L L L + + + +L L LD+
Sbjct: 384 SFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGI 443
Query: 144 LGNLKKLQFLTLSQNNFSGTIP-DSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
L L L ++ N+F + ++L + L L I +F
Sbjct: 444 FLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ-ISWGVFD 494
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-12
Identities = 36/206 (17%), Positives = 67/206 (32%), Gaps = 30/206 (14%)
Query: 25 HNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICD--------NSN 76
N + + L L R+ + +D ++ + +CD
Sbjct: 213 GNFNSSNIMKTCLQNLAGLH-VHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYT 271
Query: 77 NVASVT---------LSSMNFSG---TLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLS 124
N S +S+M+ +G + +L++ + + P +L
Sbjct: 272 NDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLK-QFPT--LDLP 328
Query: 125 SLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLT--TLSSLISIQLDSN 182
L SL L N+ I L L +L LS+N S + S + +SL + L N
Sbjct: 329 FLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFN 386
Query: 183 NLSGQIPV--HLFQIPKYNFTGNNLN 206
L ++ +F + L
Sbjct: 387 GAIIMSANFMGLEELQHLDFQHSTLK 412
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 33/202 (16%), Positives = 50/202 (24%), Gaps = 31/202 (15%)
Query: 23 DLHNGWLTFLCSLSGDALFALR--TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVAS 80
T L SL + L L V +N + N N+
Sbjct: 110 VAVE---TKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAY---------FSNLTNLVH 157
Query: 81 VTLSSMNFSG----TLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRL 136
V LS L + +L + N I I ++ L L L N
Sbjct: 158 VDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFN 216
Query: 137 VGKIPP-SLGNLKKLQFLTLSQNNFSGTI------PDSLTTLSSLISIQLD-SNNLSGQI 188
I L NL L L F P + L + + +
Sbjct: 217 SSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSD 276
Query: 189 PVHLFQIPKY----NFTGNNLN 206
+ F + G ++
Sbjct: 277 DIVKFHCLANVSAMSLAGVSIK 298
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-18
Identities = 26/120 (21%), Positives = 41/120 (34%), Gaps = 1/120 (0%)
Query: 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNN 134
N+ + S + L L+ L L I + + L +L L N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 135 RLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
L+ +L K L+ L Q S L +L S+ L SN++S I +
Sbjct: 92 PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS-IKLPKGF 150
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-17
Identities = 26/128 (20%), Positives = 44/128 (34%), Gaps = 3/128 (2%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
+ L L GI+ L N +L SL L +N + P +KL+ L N
Sbjct: 104 PKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNN 163
Query: 159 NFSGTIPDSLTTLSSLISIQLD-SNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHSCES 217
+ +++L ++ L+ + N I F F N + L +
Sbjct: 164 AIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSA--VFQSLNFGGTQNLLVIFKG 221
Query: 218 SSNDSGSS 225
N + S
Sbjct: 222 LKNSTIQS 229
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-17
Identities = 30/159 (18%), Positives = 49/159 (30%), Gaps = 11/159 (6%)
Query: 29 LTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNF 88
L L + +L + D + +V S+ L F
Sbjct: 216 LVIFKGLKNSTIQSLW-LGTFEDMDDEDISPAVFEGLCEMSVE--------SINLQKHYF 266
Query: 89 SGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLK 148
S L L L ++ E+P L LS+L L L N+ S N
Sbjct: 267 FNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFP 325
Query: 149 KLQFLTLSQNNFSGTI-PDSLTTLSSLISIQLDSNNLSG 186
L L++ N + L L +L + L +++
Sbjct: 326 SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET 364
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-17
Identities = 26/147 (17%), Positives = 47/147 (31%), Gaps = 3/147 (2%)
Query: 50 PNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLS--TLTL 107
Q ++ Q + + ++ T M+ L +S ++ L
Sbjct: 202 AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINL 261
Query: 108 KGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDS 167
+ + S L LDL L ++P L L L+ L LS N F S
Sbjct: 262 QKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANKFENLCQIS 320
Query: 168 LTTLSSLISIQLDSNNLSGQIPVHLFQ 194
+ SL + + N ++ +
Sbjct: 321 ASNFPSLTHLSIKGNTKRLELGTGCLE 347
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-17
Identities = 18/132 (13%), Positives = 40/132 (30%), Gaps = 5/132 (3%)
Query: 66 TWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSS 125
+ I N + ++ + + + + L N + L +
Sbjct: 4 SDQKCIEKEVNKTYN--CENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLIN 58
Query: 126 LTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLS 185
LT LDL ++ + + +L L L+ N +L+ +L + +S
Sbjct: 59 LTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS 118
Query: 186 GQIPVHLFQIPK 197
+ L
Sbjct: 119 SIDFIPLHNQKT 130
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 7e-17
Identities = 18/96 (18%), Positives = 27/96 (28%), Gaps = 1/96 (1%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
L TL L N + L +L L + L N K L+ L L N
Sbjct: 80 QHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSN 139
Query: 159 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
+ S L + +N + +
Sbjct: 140 HISSIKLPKGFPTEKLKVLDFQNNAIHY-LSKEDMS 174
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 32/131 (24%), Positives = 49/131 (37%), Gaps = 7/131 (5%)
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEI---PEELGNLSSLTSLDLDNNRLVGK 139
LS + L L L L+GN L L L L L L
Sbjct: 432 LSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSI 491
Query: 140 IPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP---VHLFQIP 196
+ +LK + + LS N + + ++L+ L + + L SN++S +P L Q
Sbjct: 492 DQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQR 550
Query: 197 KYNFTGNNLNC 207
N N L+C
Sbjct: 551 TINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 27/100 (27%), Positives = 37/100 (37%), Gaps = 5/100 (5%)
Query: 99 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQ 157
L L L + + + NL L L+L ++ L L LQ L L
Sbjct: 399 CPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQG 458
Query: 158 NNFSGTI---PDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
N+F +SL TL L + L +LS I H F
Sbjct: 459 NHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS-IDQHAFT 497
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 27/190 (14%), Positives = 55/190 (28%), Gaps = 17/190 (8%)
Query: 23 DLHNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVT 82
DL + ++ + + L T L + N L + ++ + +
Sbjct: 63 DLTRCQIYWIHEDTFQSQHRLDT-LVLTANPLIFMAETALSGPK----------ALKHLF 111
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 142
S + +TL +L L N I+ + L LD NN +
Sbjct: 112 FIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKE 171
Query: 143 SLGNLKKLQFLTLS-QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP-----VHLFQIP 196
+ +L++ L+L+ N I + S+ I + +
Sbjct: 172 DMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLW 231
Query: 197 KYNFTGNNLN 206
F +
Sbjct: 232 LGTFEDMDDE 241
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 9e-09
Identities = 20/81 (24%), Positives = 35/81 (43%), Gaps = 1/81 (1%)
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 142
LS + S L+ ++ + L N +T E L +L + L+L +N + +P
Sbjct: 483 LSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPS 541
Query: 143 SLGNLKKLQFLTLSQNNFSGT 163
L L + + + L QN T
Sbjct: 542 LLPILSQQRTINLRQNPLDCT 562
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 48/210 (22%), Positives = 91/210 (43%), Gaps = 33/210 (15%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 351
F VLG G F +V+ G A+K + D++ + E+ ++ H
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCI-KKSPAFRDSSLENEIAVLKKIKHE 66
Query: 352 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVALGAAR 406
N++ L + T Y M ++ G + D + + + A +
Sbjct: 67 NIVTLEDIYESTTH---YYLVM----------QLVSGGELFDRILERGVYTEKDASLVIQ 113
Query: 407 ----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQV 459
++YLHE+ I+HRD+K N+L +E+ + ++ DFGL+K+ + + +
Sbjct: 114 QVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMSTA 167
Query: 460 RGTMGHIAPEYLSTGKSSERTDVFGYGIML 489
GT G++APE L+ S+ D + G++
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 4e-18
Identities = 53/219 (24%), Positives = 91/219 (41%), Gaps = 33/219 (15%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVH 350
++ + LG G +G+V + A+K + S ++ EV ++ + H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 351 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVALGAA 405
N+++L F LV E G + D + + A
Sbjct: 96 PNIMKLYDFFEDKRNYYLVM-------------ECYKGGELFDEIIHRMKFNEVDAAVII 142
Query: 406 R----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQ 458
+ G+ YLH+H I+HRD+K N+LL ++D + DFGL+ + + +
Sbjct: 143 KQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKE 197
Query: 459 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 497
GT +IAPE L K E+ DV+ G++L L+ G
Sbjct: 198 RLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYP 235
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 7e-18
Identities = 48/251 (19%), Positives = 77/251 (30%), Gaps = 51/251 (20%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK----RLTDFESPGGDAAFQREVEMISV 347
+ K +GQG +G V + A+K +P + EV ++
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 348 AVHRNLLRLIGFCTTPTERLLV------------------YPFMQNLSVAYRLREIKPGE 389
H N+ RL LV + + + E
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 390 PVLDWVTRKRVALG-----------AAR-------GLEYLHEHCNPKIIHRDVKAANVLL 431
+ + + L YLH I HRD+K N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLF 201
Query: 432 --DEDFEAVVGDFGLAKLVDVRKTNVTTQVR---GTMGHIAPEYLSTG--KSSERTDVFG 484
++ FE + DFGL+K + GT +APE L+T + D +
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 485 YGIMLLELVTG 495
G++L L+ G
Sbjct: 262 AGVLLHLLLMG 272
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 7e-18
Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 37/228 (16%)
Query: 280 QLKRYSWRELQLATDNFSEK----NVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGG 334
S RE F+E+ +LG+G FG+V + + AVK + +
Sbjct: 4 HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 335 D-AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD 393
D + REVE++ H N+++L + +V E+ G + D
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV---G----------ELYTGGELFD 110
Query: 394 WVTRK-----RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGD 441
+ ++ A + G+ Y+H+H I+HRD+K N+LL ++D + + D
Sbjct: 111 EIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIID 167
Query: 442 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 489
FGL+ + GT +IAPE L G E+ DV+ G++L
Sbjct: 168 FGLSTCFQ--QNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVIL 212
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 8e-18
Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 38/226 (16%)
Query: 289 LQLATDNFSEK----NVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQRE 341
+Q +T FS++ VLG+G FG+V G + AVK + + + RE
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 342 VEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK--- 398
V+++ H N+++L F LV E+ G + D + +
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVG-------------EVYTGGELFDEIISRKRF 123
Query: 399 --RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVD 449
A R G+ Y+H++ KI+HRD+K N+LL +D + DFGL+ +
Sbjct: 124 SEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180
Query: 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 495
+ GT +IAPE L G E+ DV+ G++L L++G
Sbjct: 181 --ASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 9e-18
Identities = 47/222 (21%), Positives = 86/222 (38%), Gaps = 37/222 (16%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREVEMIS 346
D + LG G F V + + G + A K + +REV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 347 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVA 401
+H N++ L T+ +L+ + GE + D++ +K A
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSG------------GE-LFDFLAQKESLSEEEA 117
Query: 402 LGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAV-VGDFGLAKLVDVRKT 453
+ G+ YLH KI H D+K N++L + + + DFGLA ++
Sbjct: 118 TSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DG 172
Query: 454 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 495
+ GT +APE ++ D++ G++ L++G
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 51/214 (23%), Positives = 87/214 (40%), Gaps = 45/214 (21%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGD--AAFQREVEM 344
D + LG G G+V KVA+K + + D + E+E+
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 345 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRKRVALG 403
+ H ++++ F Y + E+ G + D V KR+
Sbjct: 69 LKKLNHPCIIKIKNFFDAED----YYIVL----------ELMEGGELFDKVVGNKRLKEA 114
Query: 404 AAR--------GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRK 452
+ ++YLHE+ IIHRD+K NVLL +ED + DFG +K++ +
Sbjct: 115 TCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--E 169
Query: 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYG 486
T++ + GT ++APE L + ++ GY
Sbjct: 170 TSLMRTLCGTPTYLAPEVLVSVGTA------GYN 197
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 48/222 (21%), Positives = 86/222 (38%), Gaps = 37/222 (16%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREVEMIS 346
D++ LG G F V + G + A K RL+ +REV ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 347 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVA 401
H N++ L T+ +L+ + GE + D++ K A
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSG------------GE-LFDFLAEKESLTEDEA 110
Query: 402 LGAAR----GLEYLHEHCNPKIIHRDVKAANVLL----DEDFEAVVGDFGLAKLVDVRKT 453
+ G+ YLH +I H D+K N++L + + DFG+A ++
Sbjct: 111 TQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE--AG 165
Query: 454 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 495
N + GT +APE ++ D++ G++ L++G
Sbjct: 166 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 2e-17
Identities = 59/259 (22%), Positives = 99/259 (38%), Gaps = 51/259 (19%)
Query: 282 KRYSWRELQLATDNFSEK----NVLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFES 331
K+Y + +++ D+ + LG G FG V+R A G A K +D E+
Sbjct: 141 KQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET 200
Query: 332 PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPV 391
++E++ +SV H L+ L E +++Y FM GE +
Sbjct: 201 ------VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG------------GE-L 241
Query: 392 LDWVTRKRVALG---AAR-------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV-- 439
+ V + + A GL ++HE+ +H D+K N++ +
Sbjct: 242 FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKL 298
Query: 440 GDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 499
DFGL +D GT APE TD++ G++ L++G
Sbjct: 299 IDFGLTAHLD--PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG---- 352
Query: 500 DFSRLEEEDDVLLLDHVKK 518
S E+D L +VK
Sbjct: 353 -LSPFGGENDDETLRNVKS 370
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 48/231 (20%), Positives = 90/231 (38%), Gaps = 36/231 (15%)
Query: 282 KRYSWRELQLATDNFSEK----NVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDA 336
K+Y + +++ + + LG G FG V+R V A G K + + P
Sbjct: 35 KKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFI-NTPYPLDKY 93
Query: 337 AFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT 396
+ E+ +++ H L+ L E +L+ F+ GE + D +
Sbjct: 94 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG------------GE-LFDRIA 140
Query: 397 RKRVALG---AAR-------GLEYLHEHCNPKIIHRDVKAANVLL--DEDFEAVVGDFGL 444
+ + GL+++HEH I+H D+K N++ + + DFGL
Sbjct: 141 AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGL 197
Query: 445 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 495
A ++ + T APE + TD++ G++ L++G
Sbjct: 198 ATKLN--PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 47/222 (21%), Positives = 86/222 (38%), Gaps = 37/222 (16%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREVEMIS 346
D + LG G F V + + G + A K + +REV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 347 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVA 401
+H N++ L T+ +L+ + GE + D++ +K A
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSG------------GE-LFDFLAQKESLSEEEA 117
Query: 402 LGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAV-VGDFGLAKLVDVRKT 453
+ G+ YLH KI H D+K N++L + + + DFGLA ++
Sbjct: 118 TSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DG 172
Query: 454 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 495
+ GT +APE ++ D++ G++ L++G
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 40/175 (22%), Positives = 70/175 (40%), Gaps = 36/175 (20%)
Query: 407 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD------------VRKTN 454
+E+LH ++HRD+K +N+ D VGDFGL +D
Sbjct: 176 AVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232
Query: 455 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 514
T QV GT +++PE + S + D+F G++L EL+ FS E ++
Sbjct: 233 HTGQV-GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS-----FSTQMERVRII--- 283
Query: 515 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569
+ R + + + + M+Q SP +RP ++++
Sbjct: 284 --TDV-RNLKFPLLFTQ------KYPQEHMMVQ---DMLSPSPTERPEATDIIEN 326
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 16/86 (18%), Positives = 28/86 (32%), Gaps = 1/86 (1%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
+F +G+GGFG V+ D A+KR+ REV+ ++ H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSV 378
++R +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLK 91
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 31/276 (11%), Positives = 71/276 (25%), Gaps = 57/276 (20%)
Query: 301 VLGQGGFGKVYRGVLAD---GTKVAVK--RLTDFESPGGDAAFQREVEMISVAVHRNLLR 355
G + ++ + D +VA+ +S + R
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 356 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 415
++ T L+V + L+E+ P R A + H
Sbjct: 96 VLDVVHTRAGGLVV---AE-WIRGGSLQEVADTSPSPVGAIR--AMQSLAAAADAAHRA- 148
Query: 416 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK 475
+ + V + D + V+ +
Sbjct: 149 --GVALSIDHPSRVRVSIDGDVVLAYPA--------------------------TMPD-- 178
Query: 476 SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 535
++ + D+ G G L L+ + + + + D + +D + ++
Sbjct: 179 ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS- 237
Query: 536 NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
VA Q R A S ++ +++
Sbjct: 238 -----------AVAARSVQGDGGIRSA-STLLNLMQ 261
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 53/251 (21%), Positives = 98/251 (39%), Gaps = 43/251 (17%)
Query: 287 RELQLATDNFSE----KNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQRE 341
++L + F++ K +G G + R + A + AVK + + E
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP-----TEE 65
Query: 342 VE-MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-- 398
+E ++ H N++ L +V M+ GE +LD + R+
Sbjct: 66 IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG------------GE-LLDKILRQKF 112
Query: 399 ---RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAV-VGDFGLAKL 447
R A +EYLH ++HRD+K +N+L + E++ + DFG AK
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169
Query: 448 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE 507
+ + T T +APE L D++ G++L ++TG F+ ++
Sbjct: 170 LRAENGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP--FANGPDD 226
Query: 508 DDVLLLDHVKK 518
+L +
Sbjct: 227 TPEEILARIGS 237
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 43/211 (20%), Positives = 84/211 (39%), Gaps = 31/211 (14%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGD-AAFQREVEMISVAVH 350
T+ + LG+G F V R V + G + A + + D +RE + + H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 351 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVALGAA 405
N++RL + L++ + GE + + + + A
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTG------------GE-LFEDIVAREYYSEADASHCI 116
Query: 406 R----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQ 458
+ + + H+ ++HR++K N+LL + + DFGLA V+ +
Sbjct: 117 QQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF 173
Query: 459 VRGTMGHIAPEYLSTGKSSERTDVFGYGIML 489
GT G+++PE L + D++ G++L
Sbjct: 174 A-GTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 59/232 (25%), Positives = 93/232 (40%), Gaps = 52/232 (22%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVK-------------------------RLTDFESPGGD 335
+G+G +G V D T A+K + G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 336 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 395
+E+ ++ H N+++L+ P E L Y + E+ PV++
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-----------YMVFELVNQGPVMEVP 129
Query: 396 TRKRVALGAAR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447
T K ++ AR G+EYLH KIIHRD+K +N+L+ ED + DFG++
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 448 VDVRKTNVTTQVRGTMGHIAPEYLSTGK---SSERTDVFGYGIMLLELVTGQ 496
++ V GT +APE LS + S + DV+ G+ L V GQ
Sbjct: 187 FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 4e-17
Identities = 47/220 (21%), Positives = 83/220 (37%), Gaps = 36/220 (16%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 351
D F K LG G FG V+ + G + +K + S + E+E++ H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 352 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG------AA 405
N++++ +V M E G +L+ + + A
Sbjct: 81 NIIKIFEVFEDYHNMYIV---M----------ETCEGGELLERIVSAQARGKALSEGYVA 127
Query: 406 R-------GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNV 455
L Y H ++H+D+K N+L + DFGLA+L
Sbjct: 128 ELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK--SDEH 182
Query: 456 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 495
+T GT ++APE + + D++ G+++ L+TG
Sbjct: 183 STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTG 221
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 47/217 (21%), Positives = 85/217 (39%), Gaps = 33/217 (15%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 351
+ + + +G+G +G V++ G VA+K+ + P RE+ M+ H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 352 NLLRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 410
NL+ L+ LV+ + + L E+ + + K + + + +
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDHTV-----LHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 411 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV-----RGTMGH 465
H+H IHRDVK N+L+ + + DFG A+L+ +V R
Sbjct: 118 CHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR----- 169
Query: 466 IAPEYL------STGKSSERTDVFGYGIMLLELVTGQ 496
+PE L DV+ G + EL++G
Sbjct: 170 -SPELLVGDTQYGPP-----VDVWAIGCVFAELLSGV 200
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 47/212 (22%), Positives = 88/212 (41%), Gaps = 23/212 (10%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 351
+ + ++G+G +G V + G VA+K+ + RE++++ H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 352 NLLRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 410
NL+ L+ C LV+ F+ + L +++ LD+ ++ G+ +
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDHTI-----LDDLELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 411 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV-----RGTMGH 465
H H IIHRD+K N+L+ + + DFG A+ + +V R
Sbjct: 140 CHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR----- 191
Query: 466 IAPEYLSTGKS-SERTDVFGYGIMLLELVTGQ 496
APE L + DV+ G ++ E+ G+
Sbjct: 192 -APELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 47/225 (20%), Positives = 84/225 (37%), Gaps = 44/225 (19%)
Query: 287 RELQLATDNFSE-----KNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQR 340
+ + ++ K VLG G GKV G K A+K L D ++
Sbjct: 17 QGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD------SPKARQ 70
Query: 341 EVE-MISVAVHRNLLRLIG-FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK 398
EV+ + +++ ++ + + + M E G + + +
Sbjct: 71 EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM----------ECMEGGELFSRIQER 120
Query: 399 RVAL----GAAR-------GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGL 444
AA +++LH H I HRDVK N+L ++D + DFG
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177
Query: 445 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 489
AK + + T T ++APE L K + D++ G+++
Sbjct: 178 AKETT--QNALQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 6e-17
Identities = 58/225 (25%), Positives = 91/225 (40%), Gaps = 35/225 (15%)
Query: 292 ATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDA----AFQREV--- 342
AT + +G G +G VY+ G VA+K + GG REV
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTV-REVALL 65
Query: 343 EMISVAVHRNLLRLIGFCTTPTERL-----LVYPFM-QNLSVAYRLREIKPGEPVLDWVT 396
+ H N++RL+ C T LV+ + Q+L + P P L T
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLR---TYLDKAPP-PGLPAET 121
Query: 397 RKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 456
K + RGL++LH + I+HRD+K N+L+ + DFGLA++ + +T
Sbjct: 122 IKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LT 177
Query: 457 TQV-----RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
V R APE L + D++ G + E+ +
Sbjct: 178 PVVVTLWYR------APEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 48/213 (22%), Positives = 77/213 (36%), Gaps = 37/213 (17%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKRLT-------DFESPGGDAAFQREVEMISVAVHRNL 353
LG G FG V+ V +V VK + + E+ ++S H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 354 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRKRVALGAAR------ 406
++++ LV G + + R+ A
Sbjct: 92 IKVLDIFENQGFFQLVMEKH------------GSGLDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 407 --GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 464
+ YL IIHRD+K N+++ EDF + DFG A ++ K T GT+
Sbjct: 140 VSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--GTIE 194
Query: 465 HIAPEYLSTGKSSE--RTDVFGYGIMLLELVTG 495
+ APE L G +++ G+ L LV
Sbjct: 195 YCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFE 226
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 83.4 bits (205), Expect = 9e-17
Identities = 56/369 (15%), Positives = 118/369 (31%), Gaps = 89/369 (24%)
Query: 263 EVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVL--GQGGFGKVYRGVLADGTK 320
+VF V R + +L++ + EL+ KNVL G G GK +A
Sbjct: 124 QVFAK--YNVSRLQPYLKLRQ-ALLELR------PAKNVLIDGVLGSGK---TWVA---- 167
Query: 321 VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAY 380
+ V + ++ +++ C +P L + +Q L Y
Sbjct: 168 LDVCLSYKVQC-----KMDFKIFWLNL----------KNCNSPETVLEM---LQKLL--Y 207
Query: 381 RLREIKPGEPVLDWVTRKRVALGAA----RGLEYLHEHCNPKIIHRDVKAANVLLDEDFE 436
++ D + ++ + + R L + N ++ +V+ A F
Sbjct: 208 QID--PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW--NAF- 262
Query: 437 AVVGDFGLAKLVDVRKTNVTTQVRG-TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 495
+ L+ R VT + T HI+ ++ S + + LL
Sbjct: 263 ----NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK------SLLLKYLD 312
Query: 496 QRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN-KNYNIQEVETMIQVALLCTQ 554
R D R + L + + R+ + N K+ N ++ T+I+ +L +
Sbjct: 313 CRPQDLPREVLTTNPRRLSIIAESIRDG-----LATWDNWKHVNCDKLTTIIESSLNVLE 367
Query: 555 AS------------PEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRR--- 599
+ P + ++ ++ W + +V +L +
Sbjct: 368 PAEYRKMFDRLSVFPPSAHIPTILLSLI--------WFDVIKSDV--MVVVNKLHKYSLV 417
Query: 600 FDWGEDSVY 608
++S
Sbjct: 418 EKQPKESTI 426
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 47/219 (21%), Positives = 82/219 (37%), Gaps = 47/219 (21%)
Query: 293 TDNFSEK----NVLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREV 342
+ ++ N +G+G +G+V V + A K + D + F++E+
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR------FKQEI 57
Query: 343 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK---- 398
E++ H N++RL T+ LV M E+ G + + V K
Sbjct: 58 EIMKSLDHPNIIRLYETFEDNTDIYLV---M----------ELCTGGELFERVVHKRVFR 104
Query: 399 -RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDV 450
A + + Y H+ + HRD+K N L D + DFGLA
Sbjct: 105 ESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK- 160
Query: 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 489
+ GT +++P+ L G D + G+M+
Sbjct: 161 -PGKMMRTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMM 197
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 57/234 (24%), Positives = 98/234 (41%), Gaps = 37/234 (15%)
Query: 280 QLKRYSWRELQLATDNFSEK----NVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPG 333
S RE F+E+ +LG+G FG+V + + AVK +
Sbjct: 4 HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 334 GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD 393
+ REVE++ H N+++L + Y + + G + D
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSS---FYIVGELYT----------GGELFD 110
Query: 394 WVTRK-----RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGD 441
+ ++ A + G+ Y+H+H I+HRD+K N+LL ++D + + D
Sbjct: 111 EIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIID 167
Query: 442 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 495
FGL+ + GT +IAPE L G E+ DV+ G++L L++G
Sbjct: 168 FGLSTCFQ--QNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 49/222 (22%), Positives = 83/222 (37%), Gaps = 37/222 (16%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREVEMIS 346
D + LG G F V + + G + A K R +REV ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 347 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVA 401
H N++ L T+ +L+ + GE + D++ K A
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAG------------GE-LFDFLAEKESLTEEEA 116
Query: 402 LGAAR----GLEYLHEHCNPKIIHRDVKAANVLL----DEDFEAVVGDFGLAKLVDVRKT 453
+ G+ YLH +I H D+K N++L + DFGLA +D
Sbjct: 117 TEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FG 171
Query: 454 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 495
N + GT +APE ++ D++ G++ L++G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 45/205 (21%), Positives = 82/205 (40%), Gaps = 35/205 (17%)
Query: 299 KNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVE-MISVAVHRNLLRL 356
LG+G F + V AVK ++ +A Q+E+ + H N+++L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKL 71
Query: 357 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVALGAAR----G 407
LV M E+ G + + + +K A R
Sbjct: 72 HEVFHDQLHTFLV---M----------ELLNGGELFERIKKKKHFSETEASYIMRKLVSA 118
Query: 408 LEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 464
+ ++H+ ++HRD+K N+L +++ E + DFG A+L + T T+
Sbjct: 119 VSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLH 174
Query: 465 HIAPEYLSTGKSSERTDVFGYGIML 489
+ APE L+ E D++ G++L
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVIL 199
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 50/211 (23%), Positives = 86/211 (40%), Gaps = 32/211 (15%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGD-AAFQREVEMISVAVH 350
+DN+ K LG+G F V R V G + A K + + D +RE + H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 351 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVALGAA 405
N++RL + LV+ + GE + + + + A
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTG------------GE-LFEDIVAREFYSEADASHCI 134
Query: 406 R----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQ 458
+ + Y H + I+HR++K N+LL + + DFGLA V+ +
Sbjct: 135 QQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHG 189
Query: 459 VRGTMGHIAPEYLSTGKSSERTDVFGYGIML 489
GT G+++PE L S+ D++ G++L
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 2e-16
Identities = 50/211 (23%), Positives = 86/211 (40%), Gaps = 32/211 (15%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDA-AFQREVEMISVAVH 350
+DN+ K LG+G F V R V G + A K + + D +RE + H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 351 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVALGAA 405
N++RL + LV+ + GE + + + + A
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTG------------GE-LFEDIVAREFYSEADASHCI 111
Query: 406 R----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQ 458
+ + Y H + I+HR++K N+LL + + DFGLA V+ +
Sbjct: 112 QQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHG 166
Query: 459 VRGTMGHIAPEYLSTGKSSERTDVFGYGIML 489
GT G+++PE L S+ D++ G++L
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRN 352
+ + + +G+G +G VY+ + G VA+KR+ D E G + RE+ ++ H N
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 353 LLRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 411
++ LI + LV+ FM ++L + + + L K RG+ +
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEKDLK-----KVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV-----RGTMGHI 466
H+H +I+HRD+K N+L++ D + DFGLA+ + + T +V R
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR------ 186
Query: 467 APEYLSTGKS-SERTDVFGYGIMLLELVTGQ 496
AP+ L K S D++ G + E++TG+
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 32/208 (15%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 360
LG+G +G+V V VAVK + + ++E+ + + H N+++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 361 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRKRVALGAAR--------GLEYL 411
Y F++ Y GE + D + A+ G+ YL
Sbjct: 75 REGNI---QYLFLE-----Y----CSGGE-LFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN--VTTQVRGTMGHIAPE 469
H I HRD+K N+LLDE + DFGLA + + GT+ ++APE
Sbjct: 122 HGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE 177
Query: 470 YLSTGK--SSERTDVFGYGIMLLELVTG 495
L + +E DV+ GI+L ++ G
Sbjct: 178 LLK-RREFHAEPVDVWSCGIVLTAMLAG 204
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 47/228 (20%), Positives = 86/228 (37%), Gaps = 44/228 (19%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL------------TDFESPGGDAAFQ 339
+++ + LG G +G+V ++ A+K + +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 340 REVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK- 398
E+ ++ H N+++L LV + G + + + +
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLV---TEFYE----------GGELFEQIINRH 141
Query: 399 ----RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKL 447
A + G+ YLH+H I+HRD+K N+LL + + DFGL+
Sbjct: 142 KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198
Query: 448 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 495
K GT +IAPE L K +E+ DV+ G+++ L+ G
Sbjct: 199 FS--KDYKLRDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCG 243
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-16
Identities = 29/123 (23%), Positives = 49/123 (39%), Gaps = 13/123 (10%)
Query: 74 NSNNVASVT-------LSSMNFSGT----LSPRIGVLRTLSTLTLKGNGITGEIPEELGN 122
+ NV +T + + + +P I L L L + G +T + L
Sbjct: 52 ANINVTDLTGIEYAHNIKDLTINNIHATNYNP-ISGLSNLERLRIMGKDVTSDKIPNLSG 110
Query: 123 LSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSN 182
L+SLT LD+ ++ I + L K+ + LS N I L TL L S+ + +
Sbjct: 111 LTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFD 169
Query: 183 NLS 185
+
Sbjct: 170 GVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 9e-13
Identities = 17/99 (17%), Positives = 42/99 (42%), Gaps = 4/99 (4%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
+ +L+ +TL +T ++ + ++ L ++N P + L L+ L +
Sbjct: 43 MNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHA-TNYNP-ISGLSNLERLRIMGK 98
Query: 159 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK 197
+ + +L+ L+SL + + + I + +PK
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPK 137
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 19/118 (16%), Positives = 41/118 (34%), Gaps = 13/118 (11%)
Query: 45 TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLST 104
LR+ + ++ T ++ + +S ++ +I L +++
Sbjct: 91 ERLRIMGKDVTSDKIPNLSGLT----------SLTLLDISHSAHDDSILTKINTLPKVNS 140
Query: 105 LTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSG 162
+ L NG +I L L L SL++ + + + + KL L G
Sbjct: 141 IDLSYNGAITDI-MPLKTLPELKSLNIQFDGVH-DYRG-IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 14/99 (14%), Positives = 38/99 (38%), Gaps = 7/99 (7%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
+ L + ++SLT + L N V + + ++ LT++
Sbjct: 22 FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANIN-VTDLTG-IEYAHNIKDLTINNI 76
Query: 159 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK 197
+ + P ++ LS+L +++ +++ +L +
Sbjct: 77 HATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTS 113
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 5e-16
Identities = 23/111 (20%), Positives = 51/111 (45%), Gaps = 5/111 (4%)
Query: 96 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155
+ L L+ L + N I+ + +L+ L L++ +N++ L NL +L L L
Sbjct: 239 LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQI--SDISVLNNLSQLNSLFL 294
Query: 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV-HLFQIPKYNFTGNNL 205
+ N + + L++L ++ L N+++ P+ L ++ +F +
Sbjct: 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 6e-15
Identities = 24/96 (25%), Positives = 42/96 (43%), Gaps = 5/96 (5%)
Query: 94 PRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFL 153
+ L L L L + I+ L NL+ + SL+L N + L N+ L +L
Sbjct: 104 SALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYL 160
Query: 154 TLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 189
T++++ P + L+ L S+ L+ N + P
Sbjct: 161 TVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP 194
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 2e-14
Identities = 29/90 (32%), Positives = 42/90 (46%), Gaps = 4/90 (4%)
Query: 96 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155
+ L L L + N I+ L NLS L SL L+NN+L + +G L L L L
Sbjct: 261 VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFL 318
Query: 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLS 185
SQN+ + P L +LS + S + +
Sbjct: 319 SQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 9e-14
Identities = 22/95 (23%), Positives = 41/95 (43%), Gaps = 5/95 (5%)
Query: 96 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155
+ L L+ L + N IT L NL++L L L+ + + L NL K+ L L
Sbjct: 84 LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNL 139
Query: 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV 190
N+ + L+ ++ L + + + + P+
Sbjct: 140 GANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTPI 173
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 2e-13
Identities = 24/91 (26%), Positives = 40/91 (43%), Gaps = 6/91 (6%)
Query: 96 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155
I L L +L+L N I P L +L+SL N++ + N+ +L L +
Sbjct: 173 IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKI 228
Query: 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSG 186
N + P L LS L +++ +N +S
Sbjct: 229 GNNKITDLSP--LANLSQLTWLEIGTNQISD 257
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 5e-13
Identities = 23/91 (25%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 96 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155
L +++ L + G + + + L++L L+L+ N++ P L NL KL L +
Sbjct: 40 QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYI 95
Query: 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSG 186
N T +L L++L + L+ +N+S
Sbjct: 96 GTNKI--TDISALQNLTNLRELYLNEDNISD 124
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 49/218 (22%), Positives = 83/218 (38%), Gaps = 38/218 (17%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK----RLTDFESPGGDAAFQREVEMISV 347
D + V+G+G F V R + G + AVK +RE + +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 348 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK--------- 398
H +++ L+ ++ +V+ FM + + + ++
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDG------------AD-LCFEIVKRADAGFVYSE 129
Query: 399 RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVR 451
VA R L Y H++ IIHRDVK VLL + +G FG+A +
Sbjct: 130 AVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES 186
Query: 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 489
+V GT +APE + + DV+G G++L
Sbjct: 187 GLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 6e-16
Identities = 49/219 (22%), Positives = 91/219 (41%), Gaps = 42/219 (19%)
Query: 295 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREVEMISVA 348
S+ +LG G FG+V++ A G K+A K + D E + E+ +++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE------VKNEISVMNQL 143
Query: 349 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG---AA 405
H NL++L + + +LV ++ GE + D + + L
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDG------------GE-LFDRIIDESYNLTELDTI 190
Query: 406 R-------GLEYLHEHCNPKIIHRDVKAANVLL--DEDFEAVVGDFGLAKLVDVRKTNVT 456
G+ ++H+ I+H D+K N+L + + + DFGLA+
Sbjct: 191 LFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYK--PREKL 245
Query: 457 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 495
GT +APE ++ S TD++ G++ L++G
Sbjct: 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 7e-16
Identities = 41/220 (18%), Positives = 82/220 (37%), Gaps = 41/220 (18%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK----RLTDFESPGGDAAFQREVEMISV 347
+ + LG+G FG V+R V + K + TD ++E+ ++++
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL------VKKEISILNI 57
Query: 348 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG---A 404
A HRN+L L + E ++++ F+ + + + + L
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISG------------LD-IFERINTSAFELNEREI 104
Query: 405 AR-------GLEYLHEHCNPKIIHRDVKAANVLL--DEDFEAVVGDFGLAKLVDVRKTNV 455
L++LH H I H D++ N++ + +FG A+ +
Sbjct: 105 VSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-F 160
Query: 456 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 495
+ APE S TD++ G ++ L++G
Sbjct: 161 RLLF-TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 7e-16
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 29/219 (13%)
Query: 294 DNFSEKNVLGQGGFGKVYRG--VLADGTKVAVKRL-TDFESPGGDAAFQREV---EMISV 347
+ +G+G +GKV++ + G VA+KR+ G + REV +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 348 AVHRNLLRLIGFCTTPTERL-----LVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVA 401
H N++RL CT LV+ + Q+L+ + P EP + T K +
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT---TYLDKVP-EPGVPTETIKDMM 126
Query: 402 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL--VDVRKTN--VTT 457
RGL++LH H +++HRD+K N+L+ + + DFGLA++ + T+ VT
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL 183
Query: 458 QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
R APE L + D++ G + E+ +
Sbjct: 184 WYR------APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 45/209 (21%), Positives = 77/209 (36%), Gaps = 43/209 (20%)
Query: 299 KNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVE-MISVAVHRNLLRL 356
++VLG+G +V + L + AVK + + + REVE + HRN+L L
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEK-QPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 357 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVALGAAR----G 407
I F LV+ M+ G +L + ++ A +
Sbjct: 77 IEFFEEEDRFYLVFEKMRG------------GS-ILSHIHKRRHFNELEASVVVQDVASA 123
Query: 408 LEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLV-------DVRKTNVTT 457
L++LH I HRD+K N+L ++ + DF L + + + T
Sbjct: 124 LDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 458 QVRGTMGHIAPEYLSTGKSSERTDVFGYG 486
G+ ++APE + Y
Sbjct: 181 PC-GSAEYMAPEVVEAFSEEAS----IYD 204
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 56/213 (26%), Positives = 89/213 (41%), Gaps = 40/213 (18%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLT---DFESPGGDAAFQREVEMISVA 348
+D F ++ LG+G VYR A+K L D + + E+ ++
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK------IVRTEIGVLLRL 105
Query: 349 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVALG 403
H N+++L TPTE + + E+ G + D + K R A
Sbjct: 106 SHPNIIKLKEIFETPTE---ISLVL----------ELVTGGELFDRIVEKGYYSERDAAD 152
Query: 404 AAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVT 456
A + + YLHE+ I+HRD+K N+L D + DFGL+K+V+ +
Sbjct: 153 AVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVLM 207
Query: 457 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 489
V GT G+ APE L D++ GI+
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 1e-15
Identities = 49/215 (22%), Positives = 92/215 (42%), Gaps = 23/215 (10%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 351
+ + +G+G +G V++ VA+KR+ D + G ++ RE+ ++ H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 352 NLLRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 410
N++RL + + LV+ F Q+L + LD K +GL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLK-----KYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 411 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV-----RGTMGH 465
H ++HRD+K N+L++ + E + +FGLA+ + + +V R
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR----- 168
Query: 466 IAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAI 499
P+ L K S D++ G + EL R +
Sbjct: 169 -PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 20/90 (22%), Positives = 37/90 (41%), Gaps = 4/90 (4%)
Query: 96 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155
TL L L+ N I ++ ++ + L +LDL +N+L + P + + +++L
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISL 221
Query: 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLS 185
N I +L +L L N
Sbjct: 222 RNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 24/122 (19%), Positives = 45/122 (36%), Gaps = 10/122 (8%)
Query: 74 NSNNVASVTLSSMNFSGTLSPRIGV-LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLD 132
N N ++ + + + L L GN ++ +L + L L+L
Sbjct: 8 NGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 133 NNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL 192
+N L L +L L+ L L+ N L S+ ++ +NN+S ++
Sbjct: 67 SNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR 118
Query: 193 FQ 194
Q
Sbjct: 119 GQ 120
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 6e-14
Identities = 26/117 (22%), Positives = 44/117 (37%), Gaps = 5/117 (4%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
L TL L N + + E + + +T + L NN+LV I +L + L+ L N
Sbjct: 190 FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGN 247
Query: 159 NFS-GTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHS 214
F GT+ D + + ++ + +P G C + LP
Sbjct: 248 GFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGA--YCCEDLPAP 302
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 27/179 (15%), Positives = 64/179 (35%), Gaps = 13/179 (7%)
Query: 23 DLHNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCT-------WSNVICDNS 75
+ + L + + + ++ L + N L + + P T SNV+ +
Sbjct: 16 KVTDSSLKQALASLRQSAWNVKE-LDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL 74
Query: 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNR 135
+ + TL +++ + + V ++ TL N I+ + ++ L NN+
Sbjct: 75 DLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNIS-RVSCS--RGQGKKNIYLANNK 131
Query: 136 LVGKIPPSLGNLKKLQFLTLSQNNFSG-TIPDSLTTLSSLISIQLDSNNLSGQIPVHLF 193
+ G ++Q+L L N + + +L + L N + + +
Sbjct: 132 ITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV 189
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 15/70 (21%), Positives = 25/70 (35%)
Query: 116 IPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLI 175
I E N + + ++ L + + ++ L LS N S L + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 176 SIQLDSNNLS 185
+ L SN L
Sbjct: 62 LLNLSSNVLY 71
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 52/223 (23%), Positives = 85/223 (38%), Gaps = 43/223 (19%)
Query: 289 LQLATDNFSE-----KNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREV 342
LQ+ + + VLG G GKV + K A+K L D +REV
Sbjct: 52 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK------ARREV 105
Query: 343 E-MISVAVHRNLLRLIG-FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-- 398
E + +++R++ + R + M+ L G + + +
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD----------GGELFSRIQDRGD 155
Query: 399 -----RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL-DEDFEAVV--GDFGLAK 446
R A + ++YLH I HRDVK N+L + A++ DFG AK
Sbjct: 156 QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212
Query: 447 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 489
N T T ++APE L K + D++ G+++
Sbjct: 213 E--TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 53/208 (25%), Positives = 85/208 (40%), Gaps = 32/208 (15%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 360
LG+G +G+V V VAVK + + ++E+ + + H N+++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 361 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRKRVALGAAR--------GLEYL 411
Y F++ Y GE + D + A+ G+ YL
Sbjct: 75 REGNI---QYLFLE-----Y----CSGGE-LFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV--TTQVRGTMGHIAPE 469
H I HRD+K N+LLDE + DFGLA + GT+ ++APE
Sbjct: 122 HGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE 177
Query: 470 YLSTGK--SSERTDVFGYGIMLLELVTG 495
L + +E DV+ GI+L ++ G
Sbjct: 178 LLK-RREFHAEPVDVWSCGIVLTAMLAG 204
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 52/236 (22%), Positives = 99/236 (41%), Gaps = 51/236 (21%)
Query: 285 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQ-REVE 343
+ + ++ V+G G FG V++ L + +VA+K++ D F+ RE++
Sbjct: 31 DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ------DKRFKNRELQ 84
Query: 344 MISVAVHRNLLRLIGFCTTPTERL------LVYPFM-QNLSVAYRLREIKPGEPVLDWVT 396
++ + H N++ L F + ++ LV ++ + + YR
Sbjct: 85 IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETV---YR---------ASRHYA 132
Query: 397 RKRVALGAA----------RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLA 445
+ + + R L Y+H I HRD+K N+LLD + + DFG A
Sbjct: 133 KLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA 189
Query: 446 KLVDVRKTNVTTQV----RGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQ 496
K++ + NV+ R APE + + + D++ G ++ EL+ GQ
Sbjct: 190 KILIAGEPNVSYICSRYYR------APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 2e-15
Identities = 53/211 (25%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRN 352
+ + +G+G +G VY+ G A+K++ + E G + RE+ ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 353 LLRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 411
+++L T +LV+ + Q+L + + E L+ VT K L G+ Y
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLK-----KLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV-----RGTMGHI 466
H+ +++HRD+K N+L++ + E + DFGLA+ + T ++ R
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR------ 167
Query: 467 APEYLSTGKS-SERTDVFGYGIMLLELVTGQ 496
AP+ L K S D++ G + E+V G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 33/208 (15%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVHRNLLRLIG 358
LG G FGKV G G KVAVK L S +RE++ + + H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 359 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRKRVALGAAR--------GLE 409
+TPT+ +V ++ GE + D+ RV AR ++
Sbjct: 79 VISTPTDFFMVMEYVSG------------GE-LFDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 410 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 469
Y H H ++HRD+K NVLLD A + DFGL+ ++ + T+ G+ + APE
Sbjct: 126 YCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GSPNYAAPE 180
Query: 470 YLSTGK--SSERTDVFGYGIMLLELVTG 495
+S G+ + D++ G++L L+ G
Sbjct: 181 VIS-GRLYAGPEVDIWSCGVILYALLCG 207
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 407 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 466
L+YL +IIHRD+K N+LLDE + DF +A + + T + GT ++
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAA--MLPRETQITTMAGTKPYM 181
Query: 467 APEYLSTGKS---SERTDVFGYGIMLLELVTGQR 497
APE S+ K S D + G+ EL+ G+R
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 36/125 (28%), Positives = 54/125 (43%), Gaps = 14/125 (11%)
Query: 74 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 133
+N + S + + F G ++ LS + + IT IP+ L SLT L LD
Sbjct: 153 GTNPLKSSGIENGAFQG--------MKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDG 201
Query: 134 NRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL 192
N++ K+ SL L L L LS N+ S SL L + L++N L ++P L
Sbjct: 202 NKI-TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259
Query: 193 FQIPK 197
Sbjct: 260 ADHKY 264
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 32/105 (30%), Positives = 47/105 (44%), Gaps = 12/105 (11%)
Query: 99 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQ 157
L L+ L L N I+ + L N L L L+NN+LV K+P L + K +Q + L
Sbjct: 215 LNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHN 272
Query: 158 NNFSGTIPDS-------LTTLSSLISIQLDSNNLS-GQIPVHLFQ 194
NN S I + T +S + L SN + +I F+
Sbjct: 273 NNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 316
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 30/108 (27%), Positives = 52/108 (48%), Gaps = 15/108 (13%)
Query: 97 GVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLT 154
+ + L L+ N IT EI + NL +L +L L NN++ KI P + L KL+ L
Sbjct: 49 DLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLY 106
Query: 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTG 202
LS+N +P+ + +L +++ N ++ ++ K F G
Sbjct: 107 LSKNQLK-ELPEKM--PKTLQELRVHENEIT--------KVRKSVFNG 143
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 29/97 (29%), Positives = 43/97 (44%), Gaps = 4/97 (4%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
L+ L TL L N I+ P L L L L N+L ++P + K LQ L + +N
Sbjct: 75 LKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHEN 131
Query: 159 NFSGTIPDSLTTLSSLISIQLDSNNL-SGQIPVHLFQ 194
+ L+ +I ++L +N L S I FQ
Sbjct: 132 EITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 8e-10
Identities = 15/93 (16%), Positives = 30/93 (32%), Gaps = 11/93 (11%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPS-------LGNLKKLQ 151
L L L N + ++P L + + + L NN + I +
Sbjct: 239 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYS 296
Query: 152 FLTLSQNNFSGTI--PDSLTTLSSLISIQLDSN 182
++L N P + + ++QL +
Sbjct: 297 GVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 45/179 (25%), Positives = 80/179 (44%), Gaps = 34/179 (18%)
Query: 401 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD-----VRKTNV 455
+ A+G+E+L K IHRD+ A N+LL E + DFGLA+ + VRK +
Sbjct: 199 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 456 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLD 514
++ APE + + ++DV+ +G++L E+ + G A + ++ +++
Sbjct: 256 RLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLG--ASPYPGVKIDEEFC--- 306
Query: 515 HVKKLEREKRLDA--IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
++L+ R+ A + Y M+ C P RP SE+V L
Sbjct: 307 --RRLKEGTRMRAPDYTTPEM---YQT-----MLD----CWHGEPSQRPTFSELVEHLG 351
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 63/232 (27%), Positives = 103/232 (44%), Gaps = 58/232 (25%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQ-REVEMISVAVH 350
++++ V+G G FG VY+ L D G VA+K++ D F+ RE++++ H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDH 106
Query: 351 RNLLRLIGFCTTPTERL------LVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALG 403
N++RL F + E+ LV ++ + + YR V +R + L
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV---YR---------VARHYSRAKQTLP 154
Query: 404 AA----------RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRK 452
R L Y+H I HRD+K N+LLD D + + DFG AK + +
Sbjct: 155 VIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211
Query: 453 TNVTTQV-----RGTMGHIAPEYLSTGKSSERT---DVFGYGIMLLELVTGQ 496
N + + R APE + +++ T DV+ G +L EL+ GQ
Sbjct: 212 PN-VSYICSRYYR------APELIFG--ATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 24/212 (11%)
Query: 294 DNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 351
+ + + + LG+G + VY+G VA+K + + E G REV ++ H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHA 60
Query: 352 NLLRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 410
N++ L T LV+ ++ ++L + + +++ K RGL Y
Sbjct: 61 NIVTLHDIIHTEKSLTLVFEYLDKDLK-----QYLDDCGNIINMHNVKLFLFQLLRGLAY 115
Query: 411 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV-----RGTMGH 465
H K++HRD+K N+L++E E + DFGLA+ + +V R
Sbjct: 116 CHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR----- 167
Query: 466 IAPEYLSTGKS-SERTDVFGYGIMLLELVTGQ 496
P+ L S + D++G G + E+ TG+
Sbjct: 168 -PPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 29/219 (13%)
Query: 292 ATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAV 349
++ F + LG G + VY+G+ G VA+K + D E G + RE+ ++
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE-GTPSTAIREISLMKELK 61
Query: 350 HRNLLRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 408
H N++RL T + LV+ FM +L R + L+ K +GL
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 409 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV-----RGTM 463
+ HE+ KI+HRD+K N+L+++ + +GDFGLA+ + +++V R
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR--- 175
Query: 464 GHIAPEYL------STGKSSERTDVFGYGIMLLELVTGQ 496
AP+ L ST D++ G +L E++TG+
Sbjct: 176 ---APDVLMGSRTYSTS-----IDIWSCGCILAEMITGK 206
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 47/193 (24%), Positives = 72/193 (37%), Gaps = 25/193 (12%)
Query: 23 DLHNGWLTFLCSLSGDALFALR--TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVAS 80
+L + LT ++ A L L + NN + + ++ + ++
Sbjct: 118 ELFDNRLT---TIPNGAFVYLSKLKELWLRNNPIE-----SIPSYAFNRI-----PSLRR 164
Query: 81 VTLSSMNFSGTLSPRI-GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGK 139
+ L + +S L L L L + EIP L L L LDL N L
Sbjct: 165 LDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS-A 221
Query: 140 IPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKY 198
I P S L LQ L + Q+ ++ L SL+ I L NNL+ +P LF +
Sbjct: 222 IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHH 280
Query: 199 ----NFTGNNLNC 207
+ N NC
Sbjct: 281 LERIHLHHNPWNC 293
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 29/126 (23%), Positives = 41/126 (32%), Gaps = 10/126 (7%)
Query: 72 CDNSNNVASVTLSSMNFSGTLSPRI--GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSL 129
C SN + V N + G+ L L N I +L L L
Sbjct: 39 CSCSNQFSKVICVRKNLR-----EVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEIL 93
Query: 130 DLDNNRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQI 188
L N + I + L L L L N + + LS L + L +N + I
Sbjct: 94 QLSRNHI-RTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SI 151
Query: 189 PVHLFQ 194
P + F
Sbjct: 152 PSYAFN 157
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-15
Identities = 65/222 (29%), Positives = 95/222 (42%), Gaps = 40/222 (18%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL---TDFESPGG---DAAFQREVEMIS 346
+ + + LG+G F VY+ VA+K++ E+ G A RE++++
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL--REIKLLQ 67
Query: 347 VAVHRNLLRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 405
H N++ L+ + LV+ FM +L IK VL K L
Sbjct: 68 ELSHPNIIGLLDAFGHKSNISLVFDFMETDLE-----VIIKDNSLVLTPSHIKAYMLMTL 122
Query: 406 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV-----R 460
+GLEYLH+H I+HRD+K N+LLDE+ + DFGLAK T QV R
Sbjct: 123 QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYR 179
Query: 461 GTMGHIAPEYL------STGKSSERTDVFGYGIMLLELVTGQ 496
APE L G D++ G +L EL+
Sbjct: 180 ------APELLFGARMYGVG-----VDMWAVGCILAELLLRV 210
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 57/211 (27%), Positives = 87/211 (41%), Gaps = 40/211 (18%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREVEMISVAVHRNLLR 355
+G+G F KV + G +VA+K +L REV ++ + H N+++
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ----KLFREVRIMKILNHPNIVK 78
Query: 356 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRKRVALGAAR-------- 406
L T L+ M E G V D+ V R+ AR
Sbjct: 79 LFEVIETEKTLYLI---M----------EYASGGEVFDYLVAHGRMKEKEARSKFRQIVS 125
Query: 407 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 466
++Y H+ I+HRD+KA N+LLD D + DFG + V + G +
Sbjct: 126 AVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-LDAFC-GAPPYA 180
Query: 467 APEYLSTGKSSE--RTDVFGYGIMLLELVTG 495
APE GK + DV+ G++L LV+G
Sbjct: 181 APELFQ-GKKYDGPEVDVWSLGVILYTLVSG 210
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 8e-15
Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 35/224 (15%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 351
+ + +GQG FG+V++ G KVA+K++ + E G RE++++ + H
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76
Query: 352 NLLRLIGFCTTPTERL--------LVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVAL 402
N++ LI C T LV+ F +L+ L + KRV
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA---GLLSNVLVK--FTLSEIKRVMQ 131
Query: 403 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL----VDVRKTNVTTQ 458
GL Y+H + KI+HRD+KAANVL+ D + DFGLA+ + + T +
Sbjct: 132 MLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188
Query: 459 V-----RGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQ 496
V R PE L + D++G G ++ E+ T
Sbjct: 189 VVTLWYR------PPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 8e-15
Identities = 42/184 (22%), Positives = 69/184 (37%), Gaps = 22/184 (11%)
Query: 32 LCSLSGDALFALR--TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFS 89
L + A L L + NN + + ++ V ++ + L +
Sbjct: 135 LTVIPSGAFEYLSKLRELWLRNNPIE-----SIPSYAFNRV-----PSLMRLDLGELKKL 184
Query: 90 GTLSPRIGV-LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP-SLGNL 147
+S L L L L I ++P L L L L++ N +I P S L
Sbjct: 185 EYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFP-EIRPGSFHGL 241
Query: 148 KKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKY----NFTGN 203
L+ L + + S ++ L+SL+ + L NNLS +P LF +Y + N
Sbjct: 242 SSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
Query: 204 NLNC 207
NC
Sbjct: 301 PWNC 304
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 29/124 (23%), Positives = 45/124 (36%), Gaps = 6/124 (4%)
Query: 72 CDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDL 131
C SN + V + + P+ G+ L L N I + +L L L L
Sbjct: 50 CSCSNQFSKVVCTRRGL--SEVPQ-GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQL 106
Query: 132 DNNRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV 190
N + +I + L L L L N + + LS L + L +N + IP
Sbjct: 107 GRNSI-RQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPS 164
Query: 191 HLFQ 194
+ F
Sbjct: 165 YAFN 168
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 25/121 (20%), Positives = 46/121 (38%), Gaps = 8/121 (6%)
Query: 74 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 133
N N ++ + L+ + L L GN ++ +L + L L+L +
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 134 NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF 193
N L L +L L+ L L+ N L S+ ++ +NN+S ++
Sbjct: 68 NVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRG 119
Query: 194 Q 194
Q
Sbjct: 120 Q 120
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 27/118 (22%), Positives = 45/118 (38%), Gaps = 7/118 (5%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
L TL L N + + E + + +T + L NN+LV I +L + L+ L N
Sbjct: 190 FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGN 247
Query: 159 NFS-GTIPDSLTTLSSLISIQLDSN-NLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHS 214
F GT+ D + + ++ + L+GQ C + LP
Sbjct: 248 GFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP---TLGHYGAYCCEDLPAP 302
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 9e-11
Identities = 16/99 (16%), Positives = 35/99 (35%), Gaps = 5/99 (5%)
Query: 96 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155
+ V ++ TL N I+ + ++ L NN++ G ++Q+L L
Sbjct: 95 LLVGPSIETLHAANNNIS-RVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 156 SQNNFSG-TIPDSLTTLSSLISIQLDSNNLSGQIPVHLF 193
N + + +L + L N + + +
Sbjct: 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV 189
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 15/71 (21%), Positives = 25/71 (35%)
Query: 116 IPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLI 175
I E N + + ++ L + + ++ L LS N S L + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 176 SIQLDSNNLSG 186
+ L SN L
Sbjct: 62 LLNLSSNVLYE 72
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 23/99 (23%), Positives = 40/99 (40%), Gaps = 11/99 (11%)
Query: 96 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155
+ L L L N + E + L +LS+L +LDL+NN + L ++ L
Sbjct: 54 LAPFTKLELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHA 106
Query: 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
+ NN S + S +I L +N ++ +
Sbjct: 107 ANNNIS-RVSCS--RGQGKKNIYLANNKIT-MLRDLDEG 141
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 13/143 (9%), Positives = 33/143 (23%), Gaps = 4/143 (2%)
Query: 82 TLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRL----V 137
T++ + L +L +
Sbjct: 266 TVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSET 325
Query: 138 GKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK 197
++ N + + + + + I + I+++ L Q+ +
Sbjct: 326 ERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAE 385
Query: 198 YNFTGNNLNCGKTLPHSCESSSN 220
+ T L H+ E S
Sbjct: 386 LDGTLQQAVGQIELQHATEEQSP 408
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 11/146 (7%), Positives = 33/146 (22%), Gaps = 2/146 (1%)
Query: 45 TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLST 104
VP + P +++ + ++ + + L
Sbjct: 281 EECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQRE 340
Query: 105 LTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS--QNNFSG 162
+ I + + +L+ L ++ +L
Sbjct: 341 IDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQ 400
Query: 163 TIPDSLTTLSSLISIQLDSNNLSGQI 188
+ + L L +I + +
Sbjct: 401 HATEEQSPLQLLRAIVKRYEEMYVEQ 426
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 47/217 (21%), Positives = 84/217 (38%), Gaps = 29/217 (13%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 351
D + LG+G +G+VY+ + VA+KR+ + E G REV ++ HR
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 352 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 411
N++ L L++ + + L++ P + K G+ +
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYAE-----NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFC 148
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVG-----DFGLAKLVDVRKTNVTTQV-----RG 461
H + +HRD+K N+LL + DFGLA+ + T ++ R
Sbjct: 149 HSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR- 204
Query: 462 TMGHIAPEYL--STGKSSERTDVFGYGIMLLELVTGQ 496
PE L S S+ D++ + E++
Sbjct: 205 -----PPEILLGSRHYSTS-VDIWSIACIWAEMLMKT 235
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 44/225 (19%), Positives = 85/225 (37%), Gaps = 40/225 (17%)
Query: 293 TDNFSEK-----NVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVE-M 344
+NF+ LG+G F V + + + G + A K L A E+ +
Sbjct: 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL 82
Query: 345 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK------ 398
++ L +E +L+ + GE + +
Sbjct: 83 ELAKSCPRVINLHEVYENTSEIILILEYAAG------------GE-IFSLCLPELAEMVS 129
Query: 399 -RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDV 450
+ + G+ YLH++ I+H D+K N+LL + + DFG+++ +
Sbjct: 130 ENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG- 185
Query: 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 495
++ GT ++APE L+ + TD++ GI+ L+T
Sbjct: 186 -HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 34/208 (16%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVHRNLLRLIG 358
LG+G FGKV KVA+K + + +RE+ + + H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 359 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRKRVALGAAR--------GLE 409
TTPT+ ++V + E GE + D+ V +KR+ R +E
Sbjct: 77 VITTPTDIVMV---I----------EYAGGE-LFDYIVEKKRMTEDEGRRFFQQIICAIE 122
Query: 410 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 469
Y H H KI+HRD+K N+LLD++ + DFGL+ ++ T+ G+ + APE
Sbjct: 123 YCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC--GSPNYAAPE 177
Query: 470 YLSTGKSSE--RTDVFGYGIMLLELVTG 495
++ GK DV+ GI+L ++ G
Sbjct: 178 VIN-GKLYAGPEVDVWSCGIVLYVMLVG 204
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 39/211 (18%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVHRNLLRLIG 358
LG G FGKV G G KVAVK L S +RE++ + + H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 359 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRKRVALGAAR--------GLE 409
+TP++ +V ++ GE + D+ R+ +R G++
Sbjct: 84 VISTPSDIFMVMEYVSG------------GE-LFDYICKNGRLDEKESRRLFQQILSGVD 130
Query: 410 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV---DVRKTNVTTQVRGTMGHI 466
Y H H ++HRD+K NVLLD A + DFGL+ ++ + +T+ G+ +
Sbjct: 131 YCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-----GSPNYA 182
Query: 467 APEYLSTGKSSE--RTDVFGYGIMLLELVTG 495
APE +S G+ D++ G++L L+ G
Sbjct: 183 APEVIS-GRLYAGPEVDIWSSGVILYALLCG 212
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 31/131 (23%), Positives = 59/131 (45%), Gaps = 9/131 (6%)
Query: 77 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRL 136
L N + T+S L ++TL GI + + L++LT ++ NN+L
Sbjct: 25 EKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQL 80
Query: 137 VGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV-HLFQI 195
P L NL KL + ++ N + P L L++L + L +N ++ P+ +L +
Sbjct: 81 TDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPLKNLTNL 136
Query: 196 PKYNFTGNNLN 206
+ + N ++
Sbjct: 137 NRLELSSNTIS 147
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 36/111 (32%), Positives = 55/111 (49%), Gaps = 7/111 (6%)
Query: 96 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155
+G+L L L+L GN + L +L++LT LDL NN++ P L L KL L L
Sbjct: 217 LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL 272
Query: 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV-HLFQIPKYNFTGNNL 205
N S P L L++L +++L+ N L P+ +L + NN+
Sbjct: 273 GANQISNISP--LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNI 321
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 6e-13
Identities = 23/130 (17%), Positives = 47/130 (36%), Gaps = 8/130 (6%)
Query: 78 VASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLV 137
+ S T++ + L L +T + +L +T+L D +
Sbjct: 3 LGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI- 58
Query: 138 GKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV-HLFQIP 196
K + L L + S N + P L L+ L+ I +++N ++ P+ +L +
Sbjct: 59 -KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLT 115
Query: 197 KYNFTGNNLN 206
N +
Sbjct: 116 GLTLFNNQIT 125
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 35/165 (21%), Positives = 64/165 (38%), Gaps = 23/165 (13%)
Query: 45 TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLST 104
T+L + NQL D + N N+ +TL N S +SP + L L
Sbjct: 290 TNLELNENQLEDIS------------PISNLKNLTYLTLYFNNISD-ISP-VSSLTKLQR 335
Query: 105 LTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTI 164
L N ++ L NL+++ L +N++ P L NL ++ L L+ ++
Sbjct: 336 LFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAP 391
Query: 165 PDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKY---NFTGNNLN 206
+ +S +++ + L P + Y + T N +
Sbjct: 392 VNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 27/93 (29%), Positives = 43/93 (46%), Gaps = 7/93 (7%)
Query: 94 PRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFL 153
+ L +L L+ GN +T P L NL++L LD+ +N++ L L L+ L
Sbjct: 150 SALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKV--SDISVLAKLTNLESL 204
Query: 154 TLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSG 186
+ N S P L L++L + L+ N L
Sbjct: 205 IATNNQISDITP--LGILTNLDELSLNGNQLKD 235
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 11/61 (18%), Positives = 23/61 (37%), Gaps = 3/61 (4%)
Query: 125 SLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNL 184
L S + + + +I L + L + N + T+ T L + ++Q D +
Sbjct: 2 PLGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58
Query: 185 S 185
Sbjct: 59 K 59
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 3e-04
Identities = 27/169 (15%), Positives = 52/169 (30%), Gaps = 42/169 (24%)
Query: 23 DLHNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVT 82
L+ ++ + +S L L L NN++ D + N N+ ++
Sbjct: 315 TLYFNNISDISPVSS--LTKL-QRLFFYNNKVSDVS------------SLANLTNINWLS 359
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 142
S L+P + L ++ L L T N+S ++ L+ P
Sbjct: 360 AGHNQISD-LTP-LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APA 415
Query: 143 SLGNLKKLQFLTLSQN-----------------------NFSGTIPDSL 168
++ + ++ N FSGT+ L
Sbjct: 416 TISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTVTQPL 464
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 33/112 (29%), Positives = 48/112 (42%), Gaps = 6/112 (5%)
Query: 97 GVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLT 154
+ TL+ L L N I I E L S L L L +N++ I SL L L+ L
Sbjct: 190 DLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQI-RMIENGSLSFLPTLRELH 247
Query: 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLN 206
L N S +P L L L + L +NN++ ++ V+ F + N
Sbjct: 248 LDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYN 297
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 28/105 (26%), Positives = 43/105 (40%), Gaps = 12/105 (11%)
Query: 99 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQ 157
L L L N I I L L +L L LDNN+L ++P L +LK LQ + L
Sbjct: 216 YSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHT 273
Query: 158 NNFSGTIPDS-------LTTLSSLISIQLDSNNLS-GQIPVHLFQ 194
NN + + + + I L +N + ++ F+
Sbjct: 274 NNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFR 317
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 32/125 (25%), Positives = 50/125 (40%), Gaps = 15/125 (12%)
Query: 74 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 133
N + + F G L+ L + +T IP++L +L L LD+
Sbjct: 155 GGNPLENSGFEPGAFDG---------LKLNYLRISEAKLT-GIPKDL--PETLNELHLDH 202
Query: 134 NRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL 192
N++ I L KL L L N SL+ L +L + LD+N LS ++P L
Sbjct: 203 NKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGL 260
Query: 193 FQIPK 197
+
Sbjct: 261 PDLKL 265
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 29/100 (29%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 97 GVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLT 154
+ + L L+ N I+ E+ ++ L L +L L NN++ KI + L+KLQ L
Sbjct: 51 EISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLY 108
Query: 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
+S+N+ IP +L SSL+ +++ N + ++P +F
Sbjct: 109 ISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFS 144
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 26/98 (26%), Positives = 40/98 (40%), Gaps = 6/98 (6%)
Query: 99 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQ 157
L+ L L L N I+ +I E+ L L L + N LV +IPP+L L L +
Sbjct: 77 LQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHD 132
Query: 158 NNFSGTIPDSLTTLSSLISIQLDSNNL-SGQIPVHLFQ 194
N + L ++ I++ N L + F
Sbjct: 133 NRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 9e-08
Identities = 18/93 (19%), Positives = 34/93 (36%), Gaps = 11/93 (11%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPS-------LGNLKKLQ 151
L TL L L N ++ +P L +L L + L N + K+ +
Sbjct: 240 LPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYN 297
Query: 152 FLTLSQNNFSGTI--PDSLTTLSSLISIQLDSN 182
++L N P + ++ ++IQ +
Sbjct: 298 GISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 57/230 (24%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDA--AFQREVEMISVA 348
+ +G G +G V + G KVA+K+L+ F+S A A+ RE+ ++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI-FAKRAY-RELLLLKHM 80
Query: 349 VHRNLLRLIGFCTTPTERL-------LVYPFM---------QNLS---VAYRLREIKPGE 389
H N++ L+ TP L LV PFM S + Y + ++
Sbjct: 81 QHENVIGLLD-VFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQM---- 135
Query: 390 PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449
+GL+Y+H + ++HRD+K N+ ++ED E + DFGLA+ D
Sbjct: 136 ---------------LKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177
Query: 450 VRKTN-VTTQ-VRGTMGHIAPE-YLSTGKSSERTDVFGYGIMLLELVTGQ 496
T V T+ R APE LS ++ D++ G ++ E++TG+
Sbjct: 178 AEMTGYVVTRWYR------APEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 56/213 (26%), Positives = 79/213 (37%), Gaps = 45/213 (21%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 360
+G G FG VAVK + D QRE+ H N++R
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE--RGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 361 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-RVALGAAR--------GLEYL 411
TPT ++ M E G + + + R + AR G+ Y
Sbjct: 86 LTPTHLAII---M----------EYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYC 132
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAV--VGDFGLAKLV---DVRKTNVTTQVRGTMGHI 466
H +I HRD+K N LLD + DFG +K K+ V GT +I
Sbjct: 133 HSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-----GTPAYI 184
Query: 467 APEYLS----TGKSSERTDVFGYGIMLLELVTG 495
APE L GK + DV+ G+ L ++ G
Sbjct: 185 APEVLLRQEYDGKIA---DVWSCGVTLYVMLVG 214
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 7e-14
Identities = 47/226 (20%), Positives = 90/226 (39%), Gaps = 44/226 (19%)
Query: 298 EKNVLGQGGFGKVYRGV---LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 354
E +G+G +G VY+ D A+K+ E G + RE+ ++ H N++
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQ---IEGTGISMSACREIALLRELKHPNVI 81
Query: 355 RLIGFCTTPTERL--LVYPFMQN----LSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 408
L + +R L++ + ++ + +R + L K + G+
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 409 EYLHEHCNPKIIHRDVKAANVLLDEDFEAV----VGDFGLAKL--VDVRK-TNVTTQV-- 459
YLH + ++HRD+K AN+L+ + + D G A+L ++ ++ V
Sbjct: 142 HYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198
Query: 460 ---RGTMGHIAPEYL------STGKSSERTDVFGYGIMLLELVTGQ 496
R APE L + D++ G + EL+T +
Sbjct: 199 FWYR------APELLLGARHYTKA-----IDIWAIGCIFAELLTSE 233
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 28/182 (15%), Positives = 56/182 (30%), Gaps = 12/182 (6%)
Query: 28 WLTFL-CSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSM 86
LT + LF L + Q +V ++ ++ + L ++
Sbjct: 72 RLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNV 131
Query: 87 NFSGTLSP----RIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 142
+++ + + + L L++ E++ +L++LDL +N +G+
Sbjct: 132 SWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGL 191
Query: 143 S----LGNLKKLQFLTLSQNNF---SGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQI 195
LQ L L SG L + L N+L
Sbjct: 192 ISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW 251
Query: 196 PK 197
P
Sbjct: 252 PS 253
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 9e-13
Identities = 34/172 (19%), Positives = 53/172 (30%), Gaps = 12/172 (6%)
Query: 33 CSLSGDALFAL--RTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSG 90
++G A L T + LR+ + + + ++++ +
Sbjct: 105 LEVTGTAPPPLLEATGPDLNILNLRN-VSWATRDAWLAELQQWLKPGLKVLSIAQAHSLN 163
Query: 91 TLSPRIGVLRTLSTLTLKGNGITGEIPEE----LGNLSSLTSLDLDNNR---LVGKIPPS 143
++ V LSTL L N GE +L L L N G
Sbjct: 164 FSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSAL 223
Query: 144 LGNLKKLQFLTLSQNNFSGTIPDSLTT-LSSLISIQLDSNNLSGQIPVHLFQ 194
+LQ L LS N+ S L S+ L L Q+P L
Sbjct: 224 AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA 274
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 35/173 (20%), Positives = 50/173 (28%), Gaps = 15/173 (8%)
Query: 25 HNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLS 84
+L L L+ L + +++ QV + D S+N L
Sbjct: 133 WATRDAWLAELQQWLKPGLK-VLSIAQAHSLNFSCEQVRVFP-ALSTLDLSDNP---ELG 187
Query: 85 SMNFSGTLSPRIGVLRTLSTLTLKGNGIT---GEIPEELGNLSSLTSLDLDNNRLVGKIP 141
L P TL L L+ G+ G L LDL +N L
Sbjct: 188 ERGLISALCP--LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245
Query: 142 PSL-GNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF 193
+L L LS +P L + L + L N L P
Sbjct: 246 APSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDR-NPSPDE 294
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 27/146 (18%), Positives = 48/146 (32%), Gaps = 14/146 (9%)
Query: 83 LSSMNFSGTLSPRIGVLRTLST--LTLKGNGITGEIPE---ELGNLSSLTSLDLDNNRLV 137
L ++ L ++++LS LT++ I I + +S L L L+N +
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 138 GKIPPSLGNLKKLQFLTLSQNNFS-GTIPDSLTTLSSLISIQLD----SNNLSGQIPVHL 192
G PP L L+ N S T L L + L + S
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168
Query: 193 FQIPKY----NFTGNNLNCGKTLPHS 214
++ + + N + L +
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISA 194
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 29/145 (20%), Positives = 52/145 (35%), Gaps = 18/145 (12%)
Query: 23 DLHN----GWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNV 78
DL + G + +L L+ L + N + + + + +
Sbjct: 179 DLSDNPELGERGLISALCPLKFPTLQV-LALRNAGMETPSGV-------CSALAAARVQL 230
Query: 79 ASVTLSSMNFSGTLSPRIGV-LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLV 137
+ LS + L++L L G+ ++P+ L + L+ LDL NRL
Sbjct: 231 QGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLD 287
Query: 138 GKIPPSLGNLKKLQFLTLSQNNFSG 162
PS L ++ L+L N F
Sbjct: 288 RN--PSPDELPQVGNLSLKGNPFLD 310
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 44/221 (19%), Positives = 84/221 (38%), Gaps = 27/221 (12%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTD-FESPGGDAAFQ---------REV 342
++ + + G +G V GV ++G VA+KR+ + RE+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 343 EMISVAVHRNLLRLIGFCTTPTERL-----LVYPFMQ-NLSVAYRLREIKPGEPVLDWVT 396
+++ H N+L L E LV M+ +L+ + I V+
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLA-----QVIHDQRIVISPQH 135
Query: 397 RKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 456
+ GL LH ++HRD+ N+LL ++ + + DF LA+
Sbjct: 136 IQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDT--ADANK 190
Query: 457 TQVRGTMGHIAPEY-LSTGKSSERTDVFGYGIMLLELVTGQ 496
T + APE + ++ D++ G ++ E+ +
Sbjct: 191 THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 57/235 (24%), Positives = 94/235 (40%), Gaps = 58/235 (24%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAF-QREVEMI---SV 347
D F + + GQG FG V G G VA+K++ D F RE++++ +V
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ------DPRFRNRELQIMQDLAV 75
Query: 348 AVHRNLLRLIGFCTTPTER-------LLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKR 399
H N+++L + T ER +V ++ L +R R++
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTL---HR---------CCRNYYRRQ 123
Query: 400 VALGAA----------RGLEYLHEHCNPKIIHRDVKAANVLLD-EDFEAVVGDFGLAKLV 448
VA R + LH + HRD+K NVL++ D + DFG AK +
Sbjct: 124 VAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182
Query: 449 DVRKTNV----TTQVRGTMGHIAPEYLSTGKSSERT---DVFGYGIMLLELVTGQ 496
+ NV + R APE + + T D++ G + E++ G+
Sbjct: 183 SPSEPNVAYICSRYYR------APELIFG--NQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 31/122 (25%), Positives = 48/122 (39%), Gaps = 13/122 (10%)
Query: 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDN 133
S+N ++ F G L L TL L G+ E+ L++L L L +
Sbjct: 88 SDNAQLRSVDPATFHG--------LGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQD 138
Query: 134 NRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL 192
N L +P + +L L L L N S + L SL + L N ++ + H
Sbjct: 139 NALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHA 196
Query: 193 FQ 194
F+
Sbjct: 197 FR 198
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 31/115 (26%), Positives = 49/115 (42%), Gaps = 9/115 (7%)
Query: 99 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLS 156
L L L L+ N + +P++ +L +LT L L NR+ +P + L L L L
Sbjct: 128 LAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLH 185
Query: 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ----IPKYNFTGNNLNC 207
QN + P + L L+++ L +NNLS +P + N C
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWVC 239
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 25/100 (25%), Positives = 41/100 (41%), Gaps = 4/100 (4%)
Query: 97 GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTL 155
G+ + L GN I+ +LT L L +N L +I + L L+ L L
Sbjct: 29 GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDL 87
Query: 156 SQNNFSGTIP-DSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
S N ++ + L L ++ LD L ++ LF+
Sbjct: 88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFR 126
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 4e-08
Identities = 17/87 (19%), Positives = 31/87 (35%), Gaps = 5/87 (5%)
Query: 109 GNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPDS 167
G+ +P + ++ + L NR+ +P S + L L L N + +
Sbjct: 20 QQGLQ-AVPVGI--PAASQRIFLHGNRI-SHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 168 LTTLSSLISIQLDSNNLSGQIPVHLFQ 194
T L+ L + L N + F
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFH 102
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 48/226 (21%), Positives = 89/226 (39%), Gaps = 48/226 (21%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDA--AFQREVEMISVA 348
+ +G G G V VA+K+L+ F++ A A+ RE+ ++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT-HAKRAY-RELVLMKCV 81
Query: 349 VHRNLLRLIGFCTTPTERL------LVYPFM---------QNLS---VAYRLREIKPGEP 390
H+N++ L+ T +V M L ++Y L ++
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM----- 136
Query: 391 VLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450
G+++LH + IIHRD+K +N+++ D + DFGLA+
Sbjct: 137 --------------LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG- 178
Query: 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
+ + T T + APE + E D++ G ++ E++ G
Sbjct: 179 -TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 28/132 (21%), Positives = 44/132 (33%), Gaps = 15/132 (11%)
Query: 65 CTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLS 124
C++ I L+ + P++ L T L L N I L
Sbjct: 2 CSFDGRIAFYRFC----NLTQV-------PQV--LNTTERLLLSFNYIRTVTASSFPFLE 48
Query: 125 SLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNN 183
L L+L + I + NL L+ L L + PD+ L L ++L
Sbjct: 49 QLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCG 108
Query: 184 LS-GQIPVHLFQ 194
LS + F+
Sbjct: 109 LSDAVLKDGYFR 120
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 30/131 (22%), Positives = 48/131 (36%), Gaps = 8/131 (6%)
Query: 83 LSSMNFSGTLSPRI-GVLRTLSTLTLKGNGITGEIPEEL-----GNLSSLTSLDLDNNRL 136
L+ FS + +L L L N + EL LS L L L++N L
Sbjct: 433 LNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYL 492
Query: 137 VGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIP 196
P +L L+ L+L+ N + + L ++L + + N L P +
Sbjct: 493 NSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNPDVFVSLS 550
Query: 197 KYNFTGNNLNC 207
+ T N C
Sbjct: 551 VLDITHNKFIC 561
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 41/215 (19%), Positives = 78/215 (36%), Gaps = 7/215 (3%)
Query: 7 LLYCLKCFRFFDNFDPDL-HNGWLTFLCSLSGDALFALRTSLRVPNNQLR--DWNQNQVN 63
C+ FR D+ NGW + +A+ + + + + + + +
Sbjct: 194 WGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK 253
Query: 64 PCTWSNVICDNSNNVASVTLSSMNFSGTLSPRI-GVLRTLSTLTLKGNGITGEIPEELGN 122
+ ++V + LS +L+ R+ L+ L L L N I E
Sbjct: 254 DPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYG 312
Query: 123 LSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSN 182
L +L L+L N L + L K+ ++ L +N+ + + L L ++ L N
Sbjct: 313 LDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDN 372
Query: 183 NLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHSCES 217
L+ I + IP +GN L + +
Sbjct: 373 ALT-TIH-FIPSIPDIFLSGNKLVTLPKINLTANL 405
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 28/134 (20%), Positives = 50/134 (37%), Gaps = 15/134 (11%)
Query: 74 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITG-EIPEELGNLSSLTSLDLD 132
++ L F L+ L+ L L N I + G L+SL S+D
Sbjct: 105 YFCGLSDAVLKDGYFRN--------LKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFS 156
Query: 133 NNRLVGKIPPSLGNL--KKLQFLTLSQNNFSGTIP-DSLTTLSSLISIQLDSNNLSGQIP 189
+N++ L L K L F +L+ N+ + D ++ ++ L+ ++SG
Sbjct: 157 SNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGN-- 214
Query: 190 VHLFQIPKYNFTGN 203
NF+
Sbjct: 215 -GWTVDITGNFSNA 227
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 29/139 (20%), Positives = 48/139 (34%), Gaps = 19/139 (13%)
Query: 92 LSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNL---- 147
++PR L + +T E+P E N+ S T + PP G
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 148 ---------KKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKY 198
++ L L+ S ++P+ L SL+ N+L+ ++P +
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSL 116
Query: 199 NFTGNNLNCGKTLPHSCES 217
NNL LP E
Sbjct: 117 LVDNNNLKALSDLPPLLEY 135
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 32/119 (26%), Positives = 46/119 (38%), Gaps = 9/119 (7%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
+L + N + E+PE L NL LT++ DNN L K+P +L+ + N
Sbjct: 172 PPSLEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLSLES---IVAGNN 225
Query: 159 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHSCES 217
L L L +I D+N L +P + N N L LP S
Sbjct: 226 IL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDLPELPQSLTF 281
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 29/104 (27%), Positives = 47/104 (45%), Gaps = 9/104 (8%)
Query: 102 LSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFS 161
L L + N + ++PE L N S L +D+DNN L K+P +L+ + N
Sbjct: 133 LEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLPPSLEF---IAAGNNQLE 186
Query: 162 GTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNL 205
+P+ L L L +I D+N+L ++P + N L
Sbjct: 187 -ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLSLESIVAGNNIL 227
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 19/120 (15%), Positives = 38/120 (31%), Gaps = 18/120 (15%)
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLS-------------SLTSL 129
L + + +++ + + P G L
Sbjct: 17 LRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHEL 76
Query: 130 DLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 189
+L+N L +P +L+ L S N+ + +P+ +L SL+ + LS P
Sbjct: 77 ELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP 131
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 25/119 (21%), Positives = 46/119 (38%), Gaps = 14/119 (11%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
+L ++ N + EL NL LT++ DNN L +P +L+ L + N
Sbjct: 214 PLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEA---LNVRDN 267
Query: 159 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHSCES 217
+ +P+ +L+ L S N+ + + N + N + +L S
Sbjct: 268 YLT-DLPELPQSLTFLDV----SENIFSGLSELPPNLYYLNASSNEIR---SLCDLPPS 318
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 8e-11
Identities = 22/116 (18%), Positives = 46/116 (39%), Gaps = 17/116 (14%)
Query: 102 LSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFS 161
L L N I + + +L L++ NN+L+ ++P L++ L S N+ +
Sbjct: 299 LYYLNASSNEIR-SLCDLPPSL---EELNVSNNKLI-ELPALPPRLER---LIASFNHLA 350
Query: 162 GTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHSCES 217
+P+ L L ++ N L + P + ++L +P ++
Sbjct: 351 -EVPELPQNLKQL---HVEYNPLR-EFPDIPESVEDLRM-NSHLA---EVPELPQN 397
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 13/103 (12%), Positives = 34/103 (33%), Gaps = 21/103 (20%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNL----------------SSLTSLDLDNNRLVGKIPP 142
+ L L ++ N + E P+ ++ +L L ++ N L + P
Sbjct: 356 PQNLKQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPD 413
Query: 143 SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLS 185
+++ L+ ++ + T L + ++
Sbjct: 414 IPESVEDLR---MNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 46/223 (20%), Positives = 93/223 (41%), Gaps = 20/223 (8%)
Query: 285 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGD--AAFQRE 341
++++L ++F V+G+G FG+V L + KV A+K L +E A F+ E
Sbjct: 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124
Query: 342 VEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA 401
+++ + + L LV + + L + + D + +
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE------DRLPEEMAR 178
Query: 402 LGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 458
A ++ +H+ +HRD+K N+L+D + + DFG + T ++
Sbjct: 179 FYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV 235
Query: 459 VRGTMGHIAPEYLSTGKSSERT-----DVFGYGIMLLELVTGQ 496
GT +I+PE L + + D + G+ + E++ G+
Sbjct: 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 20/116 (17%), Positives = 43/116 (37%), Gaps = 5/116 (4%)
Query: 81 VTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGK 139
V + L +T K + + ++P L + + L+L++ ++ +
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-E 83
Query: 140 IPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
I + +Q L + N P + L + L+ N+LS +P +F
Sbjct: 84 IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFH 138
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 24/102 (23%), Positives = 42/102 (41%), Gaps = 6/102 (5%)
Query: 97 GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTL 155
V L+ L L+ N +T + L N L +DL N L KI +++L+ L +
Sbjct: 223 PVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYI 279
Query: 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK 197
S N + + +L + L N+L + + Q +
Sbjct: 280 SNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDR 319
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 32/111 (28%), Positives = 51/111 (45%), Gaps = 6/111 (5%)
Query: 99 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLS 156
T+ L + N I +P N+ LT L L+ N L +P + N KL L++S
Sbjct: 92 AHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMS 149
Query: 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF-QIPKYNFTGNNLN 206
NN D+ +SL ++QL SN L+ + + L + N + N L+
Sbjct: 150 NNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 21/104 (20%), Positives = 37/104 (35%), Gaps = 6/104 (5%)
Query: 91 TLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKL 150
L+ + TL L L N + + L +L LD+N +V + L
Sbjct: 286 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTL 341
Query: 151 QFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
+ LTLS N++ ++ +D + +I L
Sbjct: 342 KNLTLSHNDWDCN--SLRALFRNVARPAVDDADQHCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 9/79 (11%), Positives = 21/79 (26%), Gaps = 1/79 (1%)
Query: 116 IPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLI 175
I L + +D L + +T + L + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 176 SIQLDSNNLSGQIPVHLFQ 194
+ L+ + +I + F
Sbjct: 73 LLNLNDLQIE-EIDTYAFA 90
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 51/228 (22%), Positives = 101/228 (44%), Gaps = 48/228 (21%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDA--AFQREVEMISVAV 349
++ + +G+G +G V + +VA+K+++ FE RE++++
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT-YCQRTL-REIKILLRFR 83
Query: 350 HRNLLRLIGFCTTPTERL-----LVYPFM----------QNLS---VAYRLREIKPGEPV 391
H N++ + PT +V M Q+LS + Y L +I
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------ 137
Query: 392 LDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451
RGL+Y+H + ++HRD+K +N+LL+ + + DFGLA++ D
Sbjct: 138 -------------LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181
Query: 452 KTNVT--TQVRGTMGHIAPEY-LSTGKSSERTDVFGYGIMLLELVTGQ 496
+ T+ T + APE L++ ++ D++ G +L E+++ +
Sbjct: 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 31/225 (13%)
Query: 287 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFE--SPGGDAAFQREVE 343
R+L++ +++ V+G+G FG+V KV A+K L+ FE A F E +
Sbjct: 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121
Query: 344 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 403
+++ A +++L +V +M PG +++ ++ V
Sbjct: 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYM-------------PGGDLVNLMSNYDVPEK 168
Query: 404 AAR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455
AR L+ +H IHRDVK N+LLD+ + DFG ++
Sbjct: 169 WARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225
Query: 456 TTQVRGTMGHIAPEYL-STGKSSERT---DVFGYGIMLLELVTGQ 496
GT +I+PE L S G D + G+ L E++ G
Sbjct: 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 31/116 (26%), Positives = 50/116 (43%), Gaps = 13/116 (11%)
Query: 81 VTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGK 139
V +S FSG L +L LTL+ +T IP E L +L L L L + +
Sbjct: 141 VYISHRAFSG--------LNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-A 190
Query: 140 IPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
I S L +L+ L +S + T+ + +L S+ + NL+ +P +
Sbjct: 191 IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVR 245
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 25/97 (25%), Positives = 39/97 (40%), Gaps = 3/97 (3%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLSQ 157
L L L + + +LTSL + + L +P ++ +L L+FL LS
Sbjct: 199 LYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSY 257
Query: 158 NNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
N S L L L IQL L+ + + F+
Sbjct: 258 NPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFR 293
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 28/98 (28%), Positives = 45/98 (45%), Gaps = 5/98 (5%)
Query: 99 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLS 156
L L TL L+ N + IP LS+LT LD+ N++V + +L L+ L +
Sbjct: 79 LFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVG 136
Query: 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
N+ + + L+SL + L+ NL+ IP
Sbjct: 137 DNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALS 173
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 24/99 (24%), Positives = 40/99 (40%), Gaps = 3/99 (3%)
Query: 97 GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTL 155
G+ L L N I +E + L L+L+ N + + P + NL L+ L L
Sbjct: 29 GIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGL 87
Query: 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
N T LS+L + + N + + ++FQ
Sbjct: 88 RSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQ 125
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 33/191 (17%), Positives = 67/191 (35%), Gaps = 43/191 (22%)
Query: 23 DLHNGWLTFLCSLSGDALFALR--TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVAS 80
L LT S+ +AL L LR+ + + + ++ + +
Sbjct: 158 TLEKCNLT---SIPTEALSHLHGLIVLRLRHLNIN-----AIRDYSFKRL-----YRLKV 204
Query: 81 VTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEE--------------------- 119
+ +S + T++P L++L++ +T +P
Sbjct: 205 LEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTI 263
Query: 120 ----LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSL 174
L L L + L +L + P + L L+ L +S N + ++ +L
Sbjct: 264 EGSMLHELLRLQEIQLVGGQL-AVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNL 322
Query: 175 ISIQLDSNNLS 185
++ LDSN L+
Sbjct: 323 ETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 19/97 (19%), Positives = 36/97 (37%), Gaps = 3/97 (3%)
Query: 99 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQ 157
L L L L+ I I + L L L++ + + + P+ L L+++
Sbjct: 175 LHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITH 233
Query: 158 NNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
N + ++ L L + L N +S I +
Sbjct: 234 CNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLH 269
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 22/91 (24%), Positives = 37/91 (40%), Gaps = 4/91 (4%)
Query: 104 TLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGT 163
+ +PE + + LDL NR+ + L+ L L++N S
Sbjct: 15 AVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAV 71
Query: 164 IPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
P + L +L ++ L SN L IP+ +F
Sbjct: 72 EPGAFNNLFNLRTLGLRSNRLK-LIPLGVFT 101
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 19/96 (19%), Positives = 31/96 (32%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
L L L I +LS L++L L N + + L LQ L +
Sbjct: 51 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET 110
Query: 159 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
N + + L +L + + N + F
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 30/110 (27%), Positives = 46/110 (41%), Gaps = 1/110 (0%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
L LSTL L GN I LSSL L L +G+LK L+ L ++ N
Sbjct: 75 LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHN 134
Query: 159 NF-SGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNC 207
S +P+ + L++L + L SN + L + + +L+
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 23/131 (17%), Positives = 38/131 (29%), Gaps = 11/131 (8%)
Query: 64 PCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNL 123
PC N + +NF + + L L N + +
Sbjct: 2 PCV-----EVVPNI--TYQCMELNFYKIPD---NLPFSTKNLDLSFNPLRHLGSYSFFSF 51
Query: 124 SSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNN 183
L LDL + + +L L L L+ N + + LSSL + N
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 184 LSGQIPVHLFQ 194
L+ +
Sbjct: 112 LA-SLENFPIG 121
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 35/193 (18%), Positives = 71/193 (36%), Gaps = 7/193 (3%)
Query: 5 DLLLYCLKCFRFFDNFDPDLHNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNP 64
+ L+ P L L L + + + + + +P+ + D ++N ++
Sbjct: 303 NFGWQHLELVNCKFGQFPTLKLKSLKRL-TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSF 361
Query: 65 CTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEE--LGN 122
+ + ++ + LS N T+S L L L + + + ++ E +
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSF-NGVITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLS 419
Query: 123 LSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTI-PDSLTTLSSLISIQLDS 181
L +L LD+ + L L+ L ++ N+F PD T L +L + L
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479
Query: 182 NNLSGQIPVHLFQ 194
L Q+ F
Sbjct: 480 CQLE-QLSPTAFN 491
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 24/89 (26%), Positives = 37/89 (41%), Gaps = 3/89 (3%)
Query: 99 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPPS-LGNLKKLQFLTLS 156
L +L L + GN + L +LT LDL +L ++ P+ +L LQ L ++
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL-EQLSPTAFNSLSSLQVLNMA 502
Query: 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLS 185
N L+SL I L +N
Sbjct: 503 SNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 27/100 (27%), Positives = 41/100 (41%), Gaps = 4/100 (4%)
Query: 99 LRTLSTLTLKGNGIT-GEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS- 156
L+TL L + N I ++PE NL++L LDL +N++ L L ++ L LS
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
Query: 157 --QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
N I L + L +N S + Q
Sbjct: 183 DLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 28/129 (21%), Positives = 37/129 (28%), Gaps = 12/129 (9%)
Query: 89 SGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLT----SLDLDNNRLVGKIPPSL 144
S L L L L L N I +L L + SLDL N + I P
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGA 196
Query: 145 GNLKKLQFLTLSQNNFSGTIPD-------SLTTLSSLISIQLDSNNLSGQIPVHLFQIPK 197
+L LTL N S + L ++ + NL L +
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 198 YNFTGNNLN 206
L
Sbjct: 257 LTIEEFRLA 265
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 23/86 (26%), Positives = 37/86 (43%), Gaps = 3/86 (3%)
Query: 83 LSSMNFSGTLSPRI-GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIP 141
++ +F P I LR L+ L L + P +LSSL L++ +N+L +P
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVP 510
Query: 142 PS-LGNLKKLQFLTLSQNNFSGTIPD 166
L LQ + L N + + P
Sbjct: 511 DGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 33/210 (15%), Positives = 67/210 (31%), Gaps = 37/210 (17%)
Query: 30 TFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFS 89
T + L+G + L L ++++ + + +A + +
Sbjct: 219 TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI---EEFRLAYLDYYLDDII 275
Query: 90 GTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVG----------- 138
+ L +S+ +L I + + N L+L N +
Sbjct: 276 DLFNC----LTNVSSFSLVSVTIE-RVKDFSYN-FGWQHLELVNCKFGQFPTLKLKSLKR 329
Query: 139 --------KIPPSLGNLKKLQFLTLSQN--NFSGTIPDSLTTLSSLISIQLDSNNLSGQI 188
S +L L+FL LS+N +F G S +SL + L N + +
Sbjct: 330 LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TM 388
Query: 189 PVHLFQIPK---YNFTGNNLNCGKTLPHSC 215
+ + + +F +NL K +
Sbjct: 389 SSNFLGLEQLEHLDFQHSNL---KQMSEFS 415
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 49/226 (21%), Positives = 89/226 (39%), Gaps = 48/226 (21%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDA--AFQREVEMISVA 348
+ +G G G V VA+K+L+ F++ A A+ RE+ ++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT-HAKRAY-RELVLMKCV 118
Query: 349 VHRNLLRLIGFCTTPTERL------LVYPFM---------QNLS---VAYRLREIKPGEP 390
H+N++ L+ T LV M L ++Y L ++
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM----- 173
Query: 391 VLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450
G+++LH + IIHRD+K +N+++ D + DFGLA+
Sbjct: 174 --------------LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG- 215
Query: 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
+ + T T + APE + E D++ G ++ E+V +
Sbjct: 216 -TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 9e-13
Identities = 47/249 (18%), Positives = 89/249 (35%), Gaps = 60/249 (24%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAF-QREVEMISVAVH 350
+ +S LG G FG V + G + A+K++ D + RE++++ V H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDH 59
Query: 351 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEP-------------------- 390
N+++L+ + T + P + +
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 391 -------VLDWVTRKRVALGAA----------RGLEYLHEHCNPKIIHRDVKAANVLLD- 432
VL R ++ R + ++H I HRD+K N+L++
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNS 176
Query: 433 EDFEAVVGDFGLAKLVDVRKTNV----TTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGI 487
+D + DFG AK + + +V + R APE + + D++ G
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR------APELMLGATEYTPSIDLWSIGC 230
Query: 488 MLLELVTGQ 496
+ EL+ G+
Sbjct: 231 VFGELILGK 239
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 67/254 (26%), Positives = 107/254 (42%), Gaps = 50/254 (19%)
Query: 256 RHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGV- 314
G+ R+ A EV + + +G G +G V V
Sbjct: 7 ARSGFYRQEVTKTAWEVRAV--------------------YRDLQPVGSGAYGAVCSAVD 46
Query: 315 LADGTKVAVKRLTD-FESPGGDA--AFQREVEMISVAVHRNLLRLIGFCTTPTERL---- 367
G KVA+K+L F+S A A+ RE+ ++ H N++ L+ T
Sbjct: 47 GRTGAKVAIKKLYRPFQSEL-FAKRAY-RELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104
Query: 368 --LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVK 425
LV PFM L ++ E L + + +GL Y+H IIHRD+K
Sbjct: 105 FYLVMPFMG-----TDLGKLMKHEK-LGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLK 155
Query: 426 AANVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQ-VRGTMGHIAPEY-LSTGKSSERTDV 482
N+ ++ED E + DFGLA+ D T V T+ R APE L+ + ++ D+
Sbjct: 156 PGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYR------APEVILNWMRYTQTVDI 209
Query: 483 FGYGIMLLELVTGQ 496
+ G ++ E++TG+
Sbjct: 210 WSVGCIMAEMITGK 223
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 38/206 (18%), Positives = 74/206 (35%), Gaps = 39/206 (18%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDA--AFQREVEMISVA 348
D + ++++G G +G V + VA+K++ FE D RE+ +++
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLI-DCKRIL-REIAILNRL 109
Query: 349 VHRNLLRLIGFCTTPTERL-----LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 403
H ++++++ +V + + R V L
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA---------------DSDFKKLFRTPVYLT 154
Query: 404 AA----------RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 453
G++Y+H I+HRD+K AN L+++D V DFGLA+ VD +
Sbjct: 155 ELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 454 NVTTQVRGTMGHIAPEYLSTGKSSER 479
+ + +
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNLK 237
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 43/186 (23%), Positives = 67/186 (36%), Gaps = 41/186 (22%)
Query: 289 LQLATDNFSEK-----NVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREV 342
LQ+ + + VLG G GKV + K A+K L D +REV
Sbjct: 8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK------ARREV 61
Query: 343 E-MISVAVHRNLLRLIG-FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-- 398
E + +++R++ + R + M+ L GE + + +
Sbjct: 62 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD---------GGE-LFSRIQDRGD 111
Query: 399 -----RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAK 446
R A + ++YLH I HRDVK N+L + + DFG AK
Sbjct: 112 QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
Query: 447 LVDVRK 452
K
Sbjct: 169 ETTGEK 174
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 29/116 (25%), Positives = 45/116 (38%), Gaps = 9/116 (7%)
Query: 99 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLS 156
L +L L + GN + L +LT LDL +L ++ P + +L LQ L +S
Sbjct: 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMS 207
Query: 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYN-----FTGNNLNC 207
NNF L+SL + N++ Q + T N+ C
Sbjct: 208 HNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFAC 262
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 28/140 (20%), Positives = 49/140 (35%), Gaps = 22/140 (15%)
Query: 74 NSNNVASVTLSSMNFSG---------------TLSPRIGVLRTLSTLTLKGNGITGEIPE 118
+SN ++ S + G T+S L L L + + + ++ E
Sbjct: 60 SSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK-QMSE 118
Query: 119 E--LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTI-PDSLTTLSSL 174
+L +L LD+ + L L+ L ++ N+F PD T L +L
Sbjct: 119 FSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 177
Query: 175 ISIQLDSNNLSGQIPVHLFQ 194
+ L L Q+ F
Sbjct: 178 TFLDLSQCQLE-QLSPTAFN 196
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 25/98 (25%), Positives = 35/98 (35%), Gaps = 4/98 (4%)
Query: 99 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLS 156
LR L L + LSSL L + N P L+ L FL LS
Sbjct: 125 LRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 183
Query: 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
Q P + +LSSL + + NN + ++
Sbjct: 184 QCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYK 220
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 24/100 (24%), Positives = 38/100 (38%), Gaps = 3/100 (3%)
Query: 97 GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRL--VGKIPPSLGNLKKLQFLT 154
G+ + + L L+ N + L+ LT L L +N L G S L++L
Sbjct: 25 GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84
Query: 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
LS N T+ + L L + +NL +F
Sbjct: 85 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 123
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 54/219 (24%), Positives = 89/219 (40%), Gaps = 35/219 (15%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
++F +LG+G F V ++ A+K L +E ++ V R+
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEK-------RHIIKENKVPYVTRERD 82
Query: 353 LLRLIG--FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR--- 406
++ + F L + F Q+ Y +L ++ + R
Sbjct: 83 VMSRLDHPFFVK-----LYFTF-QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT 136
Query: 407 -----GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-DVRKTNVTTQVR 460
LEYLH IIHRD+K N+LL+ED + DFG AK++ K
Sbjct: 137 AEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 193
Query: 461 GTMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTGQ 496
GT +++PE L+ KSS D++ G ++ +LV G
Sbjct: 194 GTAQYVSPELLTEKSACKSS---DLWALGCIIYQLVAGL 229
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 28/219 (12%)
Query: 290 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVA 348
++ + F +LG+G FGKV + A+K L + ++ E+
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK------EVIVAKD-EVAHTL 196
Query: 349 VHRNLLRLIG--FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV-ALGAA 405
+L+ F T L Y F Q + E G + ++R+RV + A
Sbjct: 197 TENRVLQNSRHPFLTA-----LKYSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRA 250
Query: 406 R--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT 457
R L+YLH N +++RD+K N++LD+D + DFGL K ++
Sbjct: 251 RFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGATMK 307
Query: 458 QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
GT ++APE L D +G G+++ E++ G+
Sbjct: 308 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 57/222 (25%), Positives = 95/222 (42%), Gaps = 34/222 (15%)
Query: 290 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVA 348
++ +F+ VLG+G FGKV ++ AVK L D Q + ++
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKK------DVVIQDD-DVECTM 389
Query: 349 VHRNLLRLIG---------FCTTPTERL-LVYPFMQNLSVAYRL-REIKPGEPVLDWVTR 397
V + +L L G C +RL V ++ + Y + + + EP
Sbjct: 390 VEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP------- 442
Query: 398 KRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 454
AA GL +L II+RD+K NV+LD + + DFG+ K ++
Sbjct: 443 -HAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGV 497
Query: 455 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
T GT +IAPE ++ + D + +G++L E++ GQ
Sbjct: 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 20/116 (17%), Positives = 43/116 (37%), Gaps = 5/116 (4%)
Query: 81 VTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGK 139
V + L +T K + + ++P L + + L+L++ ++ +
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-E 89
Query: 140 IPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
I + +Q L + N P + L + L+ N+LS +P +F
Sbjct: 90 IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFH 144
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 24/102 (23%), Positives = 42/102 (41%), Gaps = 6/102 (5%)
Query: 97 GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTL 155
V L+ L L+ N +T + L N L +DL N L KI +++L+ L +
Sbjct: 229 PVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYI 285
Query: 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK 197
S N + + +L + L N+L + + Q +
Sbjct: 286 SNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDR 325
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 32/111 (28%), Positives = 52/111 (46%), Gaps = 6/111 (5%)
Query: 99 LRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLS 156
T+ L + N I +P + N+ LT L L+ N L +P + N KL L++S
Sbjct: 98 AHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMS 155
Query: 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF-QIPKYNFTGNNLN 206
NN D+ +SL ++QL SN L+ + + L + N + N L+
Sbjct: 156 NNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 24/115 (20%), Positives = 39/115 (33%), Gaps = 6/115 (5%)
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 142
L N S L + + + L N I + + LT L L +N L
Sbjct: 194 LFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TA 248
Query: 143 SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK 197
L N L + LS N + + L + + +N L + ++ IP
Sbjct: 249 WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPT 302
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 7e-09
Identities = 24/103 (23%), Positives = 41/103 (39%), Gaps = 8/103 (7%)
Query: 91 TLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKL 150
L+ + TL L L N + + L +L LD+N +V + L
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTL 347
Query: 151 QFLTLSQNNFSGTIPDSLTTL-SSLISIQLDSNNLSGQIPVHL 192
+ LTLS N++ +SL L ++ +D + +I L
Sbjct: 348 KNLTLSHNDWD---CNSLRALFRNVARPAVDDADQHCKIDYQL 387
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 20/99 (20%), Positives = 37/99 (37%), Gaps = 11/99 (11%)
Query: 96 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155
+ ++ +L + N ++ L ++ LD +N + + + +L L L
Sbjct: 188 LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKL 239
Query: 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
NN T L L+ + L N L +I H F
Sbjct: 240 QHNNL--TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFV 275
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 9/80 (11%), Positives = 21/80 (26%), Gaps = 1/80 (1%)
Query: 115 EIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSL 174
I L + +D L + +T + L + +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 175 ISIQLDSNNLSGQIPVHLFQ 194
+ L+ + +I + F
Sbjct: 78 ELLNLNDLQIE-EIDTYAFA 96
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 34/168 (20%), Positives = 62/168 (36%), Gaps = 11/168 (6%)
Query: 47 LRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLT 106
N L D+N ++ + S + + + + + LS +L + +T
Sbjct: 259 DDCTLNGLGDFNPSESD--VVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRIT 316
Query: 107 LKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPS---LGNLKKLQFLTLSQNNFS-- 161
++ + + +L SL LDL N +V + + G LQ L LSQN+
Sbjct: 317 VENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSM 376
Query: 162 GTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKY---NFTGNNLN 206
+ L TL +L S+ + N +P K N + +
Sbjct: 377 QKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 23/98 (23%), Positives = 36/98 (36%), Gaps = 3/98 (3%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVG-KIPPSLGNLKKLQFLTLSQ 157
L +L L L N ++ G LSSL L+L N + NL LQ L +
Sbjct: 73 LGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGN 132
Query: 158 NNFSGTIP-DSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
I L+SL +++ + +L +
Sbjct: 133 VETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLK 169
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 31/171 (18%), Positives = 61/171 (35%), Gaps = 9/171 (5%)
Query: 23 DLHNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVT 82
LH FL + D L ++R L + + L + + + S+ + + + +T
Sbjct: 178 TLHLSESAFLLEIFADILSSVRY-LELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLT 236
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITG------EIPEELGNLS--SLTSLDLDNN 134
S N L I L + NG+ ++ ELG + ++ L +
Sbjct: 237 DESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQF 296
Query: 135 RLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLS 185
L + L+K++ +T+ + L SL + L N +
Sbjct: 297 YLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV 347
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 34/124 (27%), Positives = 49/124 (39%), Gaps = 8/124 (6%)
Query: 72 CDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDL 131
CD S S +F T P G+ + +L L N IT +L ++L L L
Sbjct: 4 CDASG---VCDGRSRSF--TSIPS-GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLIL 57
Query: 132 DNNRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV 190
++R+ I + +L L+ L LS N+ S LSSL + L N
Sbjct: 58 KSSRI-NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVT 116
Query: 191 HLFQ 194
LF
Sbjct: 117 SLFP 120
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 27/213 (12%), Positives = 64/213 (30%), Gaps = 29/213 (13%)
Query: 23 DLHNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVT 82
L + W L SL L + N + + N N+ ++
Sbjct: 88 SLSSSWFGPLSSL---------KYLNLMGNPYQTLGVTSL---------FPNLTNLQTLR 129
Query: 83 LSSMNFSGTLSPR-IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIP 141
+ ++ + L +L+ L +K + + L ++ + L L + +
Sbjct: 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLE 189
Query: 142 PSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSG----------QIPVH 191
L +++L L N + L ++ + S ++ +
Sbjct: 190 IFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRY 249
Query: 192 LFQIPKYNFTGNNLNCGKTLPHSCESSSNDSGS 224
+ ++ + F LN S ++ G
Sbjct: 250 ILELSEVEFDDCTLNGLGDFNPSESDVVSELGK 282
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 29/127 (22%), Positives = 49/127 (38%), Gaps = 14/127 (11%)
Query: 85 SMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSL 144
S N + + L L GI + + +L LD+ NN L
Sbjct: 395 SRNTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNL-DSFSL-- 448
Query: 145 GNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ----IPKYNF 200
L +LQ L +S+N T+PD+ + L+ +++ N L +P +F + K
Sbjct: 449 -FLPRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWL 504
Query: 201 TGNNLNC 207
N +C
Sbjct: 505 HTNPWDC 511
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 14/73 (19%), Positives = 26/73 (35%), Gaps = 4/73 (5%)
Query: 122 NLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDS 181
+ + D + IP L ++ L LS N + L ++L + L S
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 182 NNLSGQIPVHLFQ 194
+ ++ I F
Sbjct: 60 SRIN-TIEGDAFY 71
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 60/224 (26%), Positives = 87/224 (38%), Gaps = 46/224 (20%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
DNF VLG+G FGKV + + + AVK L D Q + ++ +
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKK------DVILQDD-DVECTMTEKR 75
Query: 353 LLRLIG---------FCTTPTERL-LVYPF------MQNLSVAYRLREIKPGEPVLDWVT 396
+L L C +RL V F M ++ + R E
Sbjct: 76 ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE------------ 123
Query: 397 RKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 453
R AA L +LH+ II+RD+K NVLLD + + DFG+ K +
Sbjct: 124 -ARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GICNG 178
Query: 454 NVTTQVRGTMGHIAPEYLSTGKSSERT-DVFGYGIMLLELVTGQ 496
T GT +IAPE L D + G++L E++ G
Sbjct: 179 VTTATFCGTPDYIAPEIL-QEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 4e-12
Identities = 52/220 (23%), Positives = 87/220 (39%), Gaps = 35/220 (15%)
Query: 294 DNFSEKNVLGQGGFGKVY--RGVLADGTKV--AVKRLTDFESPGGDAAFQREVEMISVAV 349
+ F VLG+GG+GKV+ R V T A+K L + +
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKK------AMIVRNAKDTAHTKA 70
Query: 350 HRNLLRLIG--------FCTTPTERL-LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKR 399
RN+L + + +L L+ ++ + +L RE E
Sbjct: 71 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED--------T 122
Query: 400 VALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 456
A L +LH+ II+RD+K N++L+ + DFGL K + VT
Sbjct: 123 ACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVT 178
Query: 457 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
GT+ ++APE L + D + G ++ +++TG
Sbjct: 179 HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 4e-12
Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 39/221 (17%)
Query: 294 DNFSEKNVLGQGGFGKVY--RGVLADGTKV--AVKRLTDFESPGGDAAFQR-EVEMISVA 348
F VLGQG FGKV+ + + + A+K L R V
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK------ATLKVRDRVRTKM-- 75
Query: 349 VHRNLLRLIG--------FCTTPTERL-LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRK 398
R++L + + +L L+ F++ + RL +E+ E
Sbjct: 76 -ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-------- 126
Query: 399 RVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455
V A L++LH II+RD+K N+LLDE+ + DFGL+K +
Sbjct: 127 DVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKK 182
Query: 456 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
GT+ ++APE ++ ++ D + +G+++ E++TG
Sbjct: 183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 38/184 (20%), Positives = 57/184 (30%), Gaps = 28/184 (15%)
Query: 23 DLHNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVT 82
+ LT L L T L N L + D S+N
Sbjct: 112 NCDTNKLT---KLDVSQNPLL-TYLNCARNTLTEI---------------DVSHNTQLTE 152
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 142
L + L+TL N IT E+ + L L+ D N + K+
Sbjct: 153 LDCHLNKKITKLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD- 207
Query: 143 SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTG 202
L +L FL S N + I +T L+ L N L+ L ++ +
Sbjct: 208 -LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQ 263
Query: 203 NNLN 206
+L
Sbjct: 264 TDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 27/162 (16%), Positives = 50/162 (30%), Gaps = 31/162 (19%)
Query: 45 TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLST 104
T+L L + D ++N + + + L
Sbjct: 257 TTLHCIQTDLLEI---------------DLTHNTQLIYFQAEGCRKIKELDVTHNTQLYL 301
Query: 105 LTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTI 164
L + GIT E+ L L L L+N L ++ + + KL+ L+ +
Sbjct: 302 LDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DF 354
Query: 165 PDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLN 206
S+ + +L + +PK T N+L
Sbjct: 355 S-SVGKIPALNNNFEAEGQTI--------TMPKETLTNNSLT 387
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 23/110 (20%), Positives = 44/110 (40%), Gaps = 11/110 (10%)
Query: 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNR 135
+ S+ + + + ++ I L L+ L N IT + L ++LT L D+N+
Sbjct: 42 ATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNK 96
Query: 136 LVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLS 185
L + + L KL +L N + ++ L + N L+
Sbjct: 97 LT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT 140
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 35/162 (21%), Positives = 61/162 (37%), Gaps = 26/162 (16%)
Query: 45 TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLST 104
T+L N++ + + V+ N + ++NN+ + L+ L+
Sbjct: 173 TTLDCSFNKITELD---VSQNKLLNRLNCDTNNITKLDLNQ-------------NIQLTF 216
Query: 105 LTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTI 164
L N +T EI + L+ LT D N L ++ S L KL L Q + I
Sbjct: 217 LDCSSNKLT-EID--VTPLTQLTYFDCSVNPL-TELDVS--TLSKLTTLHCIQTDLL-EI 269
Query: 165 PDSLTTLSSLISIQLDSNNLSGQIPV-HLFQIPKYNFTGNNL 205
LT + LI Q + ++ V H Q+ + +
Sbjct: 270 D--LTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGI 309
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 17/112 (15%), Positives = 34/112 (30%), Gaps = 10/112 (8%)
Query: 96 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155
+ L +L+ I + +G + +L + + + +L N ++
Sbjct: 335 VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSP 392
Query: 156 SQNNFSG---TIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNN 204
+ G I + + + NLS P Y FT N
Sbjct: 393 DLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNP-----AVTYTFTSEN 439
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 60/230 (26%), Positives = 100/230 (43%), Gaps = 56/230 (24%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDA--AFQREVEMISVA 348
+ + + +G G +G V G +VAVK+L+ F+S A + RE+ ++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII-HAKRTY-RELRLLKHM 85
Query: 349 VHRNLLRLIGFCTTPTERL------LVYPFM----------QNLS---VAYRLREIKPGE 389
H N++ L+ T LV M Q L+ V + + +I
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI---- 141
Query: 390 PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449
RGL+Y+H + IIHRD+K +N+ ++ED E + DFGLA+
Sbjct: 142 ---------------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183
Query: 450 VRKTN-VTTQ-VRGTMGHIAPE-YLSTGKSSERTDVFGYGIMLLELVTGQ 496
T V T+ R APE L+ ++ D++ G ++ EL+TG+
Sbjct: 184 DEMTGYVATRWYR------APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 8e-12
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 31/220 (14%)
Query: 290 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVA 348
++ ++F +LG+G FGKV + A+K L + ++ E+
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK------EVIIAKD-EVAHTV 53
Query: 349 VHRNLLRLIG--FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV-ALGAA 405
+L+ F T L Y F Q + E G + ++R+RV A
Sbjct: 54 TESRVLQNTRHPFLTA-----LKYAF-QTHDRLCFVMEYANGGELFFHLSRERVFTEERA 107
Query: 406 R--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT 457
R LEYLH +++RD+K N++LD+D + DFGL K +
Sbjct: 108 RFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMK 163
Query: 458 QVRGTMGHIAPEYLSTGKSSERT-DVFGYGIMLLELVTGQ 496
GT ++APE L R D +G G+++ E++ G+
Sbjct: 164 TFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 28/116 (24%), Positives = 45/116 (38%), Gaps = 9/116 (7%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
L L + GN +T +P L L + NRL +P L L ++ +N
Sbjct: 220 PSGLKELIVSGNRLT-SLPVLPSEL---KELMVSGNRLT-SLPMLPSGLLSL---SVYRN 271
Query: 159 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHS 214
+ +P+SL LSS ++ L+ N LS + L +I + S
Sbjct: 272 QLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGAS 326
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 33/173 (19%), Positives = 59/173 (34%), Gaps = 34/173 (19%)
Query: 45 TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLST 104
L + NQL + + +++S + +L L
Sbjct: 124 CKLWIFGNQLTS--------------LPVLPPGLQELSVSDNQLA-SLPALPS---ELCK 165
Query: 105 LTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTI 164
L N +T +P L L + +N+L +P L K L N + ++
Sbjct: 166 LWAYNNQLT-SLPMLPSGL---QELSVSDNQLA-SLPTLPSELYK---LWAYNNRLT-SL 216
Query: 165 PDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHSCES 217
P + L LI + N L+ +PV ++ + +GN L +LP
Sbjct: 217 PALPSGLKELI---VSGNRLT-SLPVLPSELKELMVSGNRL---TSLPMLPSG 262
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 18/91 (19%), Positives = 35/91 (38%), Gaps = 8/91 (8%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
+ L + +G+T +P+ L +T+L + +N L +P L+ L +S N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPELRT---LEVSGN 91
Query: 159 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 189
+ ++P L L +L
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLPALPS 121
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 29/142 (20%), Positives = 50/142 (35%), Gaps = 20/142 (14%)
Query: 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNR 135
++ ++ + N + +L LRTL + GN +T +P L L+
Sbjct: 61 AHITTLVIPDNNLT-SLPALPPELRTL---EVSGNQLT-SLPVLPPGLLELSIFSNPLTH 115
Query: 136 LVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQI 195
L P L K L + N + ++P L L + N L+ +P ++
Sbjct: 116 L----PALPSGLCK---LWIFGNQLT-SLPVLPPGLQEL---SVSDNQLA-SLPALPSEL 163
Query: 196 PKYNFTGNNLNCGKTLPHSCES 217
K N L +LP
Sbjct: 164 CKLWAYNNQLT---SLPMLPSG 182
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 22/96 (22%), Positives = 38/96 (39%), Gaps = 4/96 (4%)
Query: 85 SMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSL 144
S N +L L +LS + N +T +PE L +LSS T+++L+ N L + +L
Sbjct: 249 SGNRLTSLPMLPSGLLSLS---VYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 304
Query: 145 GNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLD 180
+ + F + +L D
Sbjct: 305 REITSAPGYSGPIIRFDMAGASAPRETRALHLAAAD 340
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 32/221 (14%)
Query: 290 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVA 348
L +F V+G+G + KV L ++ A+K + + E ++ V
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKK------ELVNDDE-DIDWVQ 57
Query: 349 VHRNLLRLIG---FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV-ALGA 404
+++ F L F Q S + + E G ++ + R+R
Sbjct: 58 TEKHVFEQASNHPFLVG-----LHSCF-QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH 111
Query: 405 AR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 456
AR L YLHE II+RD+K NVLLD + + D+G+ K +R + T
Sbjct: 112 ARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTT 167
Query: 457 TQVRGTMGHIAPEYLSTGKSSERT-DVFGYGIMLLELVTGQ 496
+ GT +IAPE L G+ + D + G+++ E++ G+
Sbjct: 168 STFCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 25/100 (25%), Positives = 45/100 (45%), Gaps = 10/100 (10%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQ----FLT 154
+L L+++ N +T +PE +L +LD+ N L +P + F
Sbjct: 159 PTSLEVLSVRNNQLT-FLPELPESL---EALDVSTNLLES-LPAVPVRNHHSEETEIFFR 213
Query: 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
+N + IP+++ +L +I L+ N LS +I L Q
Sbjct: 214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQ 252
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 32/142 (22%), Positives = 57/142 (40%), Gaps = 19/142 (13%)
Query: 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNR 135
N + + L+ +N S +L + ++ L + N + +PE +L LD +NR
Sbjct: 59 NQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASL---EYLDACDNR 111
Query: 136 LVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQI 195
L +P +LK L + N + +P+ L + D+N L+ +P +
Sbjct: 112 LS-TLPELPASLKHLD---VDNNQLT-MLPELPALLEYIN---ADNNQLT-MLPELPTSL 162
Query: 196 PKYNFTGNNLNCGKTLPHSCES 217
+ N L LP ES
Sbjct: 163 EVLSVRNNQLT---FLPELPES 181
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 25/153 (16%), Positives = 53/153 (34%), Gaps = 35/153 (22%)
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNL-----------------SS 125
++ +L +L L N ++ +PE +L +
Sbjct: 87 ITQNALI-SLPELPA---SLEYLDACDNRLS-TLPELPASLKHLDVDNNQLTMLPELPAL 141
Query: 126 LTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLS 185
L ++ DNN+L +P +L+ L++ N + +P+ +L +L + +N L
Sbjct: 142 LEYINADNNQLT-MLPELPTSLEV---LSVRNNQLT-FLPELPESLEAL---DVSTNLLE 193
Query: 186 GQIPVHLFQIPKYNFTGNNLNCG----KTLPHS 214
+P + T C +P +
Sbjct: 194 -SLPAVPVRNHHSEETEIFFRCRENRITHIPEN 225
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 16/97 (16%), Positives = 29/97 (29%), Gaps = 6/97 (6%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTS----LDLDNNRLVGKIPPSLGNLKKLQFLT 154
+L L + N + +P NR+ IP ++ +L +
Sbjct: 179 PESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTII 236
Query: 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH 191
L N S I +SL+ ++ S
Sbjct: 237 LEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 22/114 (19%), Positives = 41/114 (35%), Gaps = 13/114 (11%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
+ N + E L ++ + L L+ L +P +L ++ L ++QN
Sbjct: 36 WEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLS-SLPDNLP--PQITVLEITQN 90
Query: 159 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLP 212
++P+ +L L N LS +P + + N L LP
Sbjct: 91 ALI-SLPELPASLEYL---DACDNRLS-TLPELPASLKHLDVDNNQL---TMLP 136
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 18/95 (18%), Positives = 29/95 (30%), Gaps = 5/95 (5%)
Query: 91 TLSPRIGVLRTLST----LTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGN 146
+L + N IT IPE + +L ++ L++N L +I SL
Sbjct: 194 SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQ 252
Query: 147 LKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDS 181
+ FS + T L
Sbjct: 253 QTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAW 287
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 24/97 (24%), Positives = 39/97 (40%), Gaps = 10/97 (10%)
Query: 407 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 466
++ +H +HRD+K N+LLD + DFG + T + GT ++
Sbjct: 174 AIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYL 230
Query: 467 APEYLSTGKSSERTDVFG-------YGIMLLELVTGQ 496
+PE L T +G G+ E+ GQ
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 4/90 (4%)
Query: 407 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 466
GL++LH I++RD+K N+LLD+D + DFG+ K ++ T GT +I
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGDAKTNTFCGTPDYI 185
Query: 467 APEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
APE L K + D + +G++L E++ GQ
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 53/220 (24%), Positives = 91/220 (41%), Gaps = 30/220 (13%)
Query: 290 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVA 348
L +F V+G+G + KV L ++ A++ + + E ++ V
Sbjct: 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKK------ELVNDDE-DIDWVQ 100
Query: 349 VHRNLLRLIG---FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV-ALGA 404
+++ F L F Q S + + E G ++ + R+R
Sbjct: 101 TEKHVFEQASNHPFLVG-----LHSCF-QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH 154
Query: 405 AR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 456
AR L YLHE II+RD+K NVLLD + + D+G+ K +R + T
Sbjct: 155 ARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTT 210
Query: 457 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
+ GT +IAPE L D + G+++ E++ G+
Sbjct: 211 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 50/222 (22%), Positives = 82/222 (36%), Gaps = 46/222 (20%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVE-------MI 345
D F LG G FG+V + A+K L +++E ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTLNEKRIL 95
Query: 346 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 405
L++L + +V ++ + LR R + A
Sbjct: 96 QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR------------IGRFSEPHA 143
Query: 406 R--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT 457
R EYLH +I+RD+K N+L+D+ V DFG AK V R T
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TW 196
Query: 458 QVRGTMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTGQ 496
+ GT +APE + + K+ D + G+++ E+ G
Sbjct: 197 TLCGTPEALAPEIILSKGYNKA---VDWWALGVLIYEMAAGY 235
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 32/91 (35%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 407 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 466
L YLH I++RD+K N+LLD V+ DFGL K ++ + T+ GT ++
Sbjct: 151 ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFCGTPEYL 206
Query: 467 APEYLSTGKSSERT-DVFGYGIMLLELVTGQ 496
APE L + +RT D + G +L E++ G
Sbjct: 207 APEVL-HKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 46/225 (20%), Positives = 86/225 (38%), Gaps = 46/225 (20%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVE-MISVAVH 350
D++ LG+G + +V+ + + + KV VK L + +RE++ + ++
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGG 90
Query: 351 RNLLRLIGFCTTPTERLLVYPF-----------MQNLS---VAYRLREIKPGEPVLDWVT 396
N++ L P R F Q L+ + + + EI
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEI----------- 139
Query: 397 RKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD-EDFEAVVGDFGLAKLVDVRKTNV 455
+ L+Y H I+HRDVK NV++D E + + D+GLA+ +
Sbjct: 140 --------LKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-Y 187
Query: 456 TTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAI 499
+V + PE L + D++ G ML ++ +
Sbjct: 188 NVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 64.0 bits (155), Expect = 4e-11
Identities = 21/97 (21%), Positives = 38/97 (39%), Gaps = 5/97 (5%)
Query: 115 EIPEELGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSS 173
+ L +LT L ++N + + + L L +L+ LT+ ++ PD+
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 174 LISIQLDSNNLSGQIPVHLFQIPKY---NFTGNNLNC 207
L + L N L + Q +GN L+C
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHC 117
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.1 bits (145), Expect = 7e-10
Identities = 22/123 (17%), Positives = 40/123 (32%), Gaps = 17/123 (13%)
Query: 65 CTWSN-VICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEE-LGN 122
S+ + C + S+ + G L+ L ++ + L
Sbjct: 7 PHGSSGLRCTRDGALDSLH----HLPG--------AENLTELYIENQQHLQHLELRDLRG 54
Query: 123 LSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDS 181
L L +L + + L + P + +L L LS N ++ SL + L
Sbjct: 55 LGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSG 112
Query: 182 NNL 184
N L
Sbjct: 113 NPL 115
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 5/92 (5%)
Query: 407 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 466
LE+LH+ II+RD+K N+LLD + V+ DFGL+K +T GT+ ++
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 467 APEYLSTGKSSERTDV--FGYGIMLLELVTGQ 496
AP+ + G S V + G+++ EL+TG
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 5e-11
Identities = 56/224 (25%), Positives = 96/224 (42%), Gaps = 38/224 (16%)
Query: 290 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVA 348
++ +F+ VLG+G FGKV ++ AVK L D Q + ++
Sbjct: 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKK------DVVIQDD-DVECTM 68
Query: 349 VHRNLLRLIG---------FCTTPTERL-LVYPFMQNLSVAYRL-REIKPGEPVLDWVTR 397
V + +L L G C +RL V ++ + Y + + + EP
Sbjct: 69 VEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP------H 122
Query: 398 KR-----VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452
+A+G L +L II+RD+K NV+LD + + DFG+ K ++
Sbjct: 123 AVFYAAEIAIG----LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWD 174
Query: 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 496
T GT +IAPE ++ + D + +G++L E++ GQ
Sbjct: 175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 5e-11
Identities = 53/236 (22%), Positives = 98/236 (41%), Gaps = 57/236 (24%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDA--AFQREVEMISVAV 349
+ +F K++LG+G +G V G VA+K++ F+ P A RE++++
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL-FALRTL-REIKILKHFK 67
Query: 350 HRNLLRLIGFCTTPTERL-----LVYPFM----------QNLS---VAYRLREIKPGEPV 391
H N++ + + ++ M Q LS + Y + +
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT------ 121
Query: 392 LDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451
R ++ LH +IHRD+K +N+L++ + + V DFGLA+++D
Sbjct: 122 -------------LRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165
Query: 452 KTNVTTQVRGTMGHI----------APEY-LSTGKSSERTDVFGYGIMLLELVTGQ 496
+ ++ G + APE L++ K S DV+ G +L EL +
Sbjct: 166 AAD-NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 43/196 (21%), Positives = 71/196 (36%), Gaps = 39/196 (19%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDA--AFQREVEMISVA 348
DN+ K+++G+G +G VY VA+K++ FE D RE+ +++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI-DCKRIL-REITILNRL 82
Query: 349 VHRNLLRLIGFCTTPTERL-----LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 403
++RL +V + L + + + L
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIA---------------DSDLKKLFKTPIFLT 127
Query: 404 AA----------RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 453
G ++HE IIHRD+K AN LL++D V DFGLA+ ++ K
Sbjct: 128 EEHIKTILYNLLLGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184
Query: 454 NVTTQVRGTMGHIAPE 469
P
Sbjct: 185 TNIVNDLEENEEPGPH 200
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.0 bits (152), Expect = 7e-11
Identities = 36/223 (16%), Positives = 66/223 (29%), Gaps = 45/223 (20%)
Query: 279 GQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVK--RLTDFESPGGDA 336
Q + L T+ +G+G FG+V++ + AD T VA+K + + G
Sbjct: 6 SQKGPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSH 63
Query: 337 -----------AFQREVEMISVAV---HRNLLRLIGFC----TTPTERLLVY-------- 370
+E+ ++S V + L + P L +
Sbjct: 64 QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123
Query: 371 -----PFMQNLSVAYRLREIKPGEPVL--------DWVTRKRVALGAARGLEYLHEHCNP 417
P + + E + G L T K + L +
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SL 181
Query: 418 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 460
+ HRD+ NVLL + + K + + +
Sbjct: 182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 62.5 bits (153), Expect = 9e-11
Identities = 36/93 (38%), Positives = 51/93 (54%), Gaps = 13/93 (13%)
Query: 407 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 466
LEYLH II+RD+K N+LLD++ + DFG AK V T + GT +I
Sbjct: 118 ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYI 170
Query: 467 APEYLST---GKSSERTDVFGYGIMLLELVTGQ 496
APE +ST KS D + +GI++ E++ G
Sbjct: 171 APEVVSTKPYNKS---IDWWSFGILIYEMLAGY 200
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 23/94 (24%), Positives = 36/94 (38%), Gaps = 6/94 (6%)
Query: 94 PRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFL 153
+ L ++ L L N + +P L L L L +N L + + NL +LQ L
Sbjct: 457 CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQEL 513
Query: 154 TLSQNNFSGTIPD--SLTTLSSLISIQLDSNNLS 185
L N L + L+ + L N+L
Sbjct: 514 LLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 6e-07
Identities = 22/86 (25%), Positives = 32/86 (37%), Gaps = 4/86 (4%)
Query: 91 TLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVG-KIPPSLGNLKK 149
L P + LR L L N + + + NL L L L NNRL L + +
Sbjct: 477 ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPR 534
Query: 150 LQFLTLSQNNFSGTIPDSLTTLSSLI 175
L L L N+ L+ ++
Sbjct: 535 LVLLNLQGNSLC-QEEGIQERLAEML 559
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 27/117 (23%), Positives = 47/117 (40%), Gaps = 13/117 (11%)
Query: 82 TLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKI 140
T+ S FS L +S + + + ++ NLS +T +++ N R + I
Sbjct: 45 TIPSHAFSN--------LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYI 96
Query: 141 PPS-LGNLKKLQFLTLSQNNFSGTIPD--SLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
P L L L+FL + PD + + +++ N IPV+ FQ
Sbjct: 97 DPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQ 152
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 17/92 (18%), Positives = 36/92 (39%), Gaps = 4/92 (4%)
Query: 97 GVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLT 154
+ + TL L + IP NL +++ + + + + ++ S NL K+ +
Sbjct: 28 SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIE 86
Query: 155 LSQNNFSGTIP-DSLTTLSSLISIQLDSNNLS 185
+ I D+L L L + + + L
Sbjct: 87 IRNTRNLTYIDPDALKELPLLKFLGIFNTGLK 118
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 7e-09
Identities = 20/102 (19%), Positives = 36/102 (35%), Gaps = 10/102 (9%)
Query: 99 LRTLSTLTLKGNGITGEIPEE--LGNLSSLTSLDLDNNRLVGKIPP----SLGNLKKLQF 152
L L L + G+ P+ + + L++ +N + IP L N
Sbjct: 104 LPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNE--TLT 160
Query: 153 LTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
L L N F+ ++ + L ++ L+ N I F
Sbjct: 161 LKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFG 201
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 35/157 (22%), Positives = 57/157 (36%), Gaps = 17/157 (10%)
Query: 25 HNGWLTFLCSLSGDALFALR--TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVT 82
+ LT + DAL L L + N L+ + T I + ++N +
Sbjct: 89 NTRNLT---YIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTS 145
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 142
+ F G L TL L NG T + N + L ++ L+ N+ + I
Sbjct: 146 IPVNAFQG-LCNE------TLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDK 197
Query: 143 SL--GNLKKLQFLTLSQNNFSGTIP-DSLTTLSSLIS 176
G L +SQ + + +P L L LI+
Sbjct: 198 DAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIA 233
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 17/95 (17%), Positives = 30/95 (31%), Gaps = 7/95 (7%)
Query: 102 LSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLSQNNF 160
+ I IP S +L L L IP + NL + + +S +
Sbjct: 13 EEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVT 67
Query: 161 SGTIP-DSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
+ S LS + I++ + I +
Sbjct: 68 LQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALK 102
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 33/121 (27%), Positives = 51/121 (42%), Gaps = 16/121 (13%)
Query: 99 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLS 156
+ L L L N + + E +L +L L L NN +V + + ++ +LQ L LS
Sbjct: 87 VPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLS 144
Query: 157 QNNFSGTIP----DSLTTLSSLISIQLDSNNLSGQIPVHLFQ-IPKY-----NFTGNNLN 206
QN S P L L+ + L SN L ++P+ Q +P + N L
Sbjct: 145 QNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLHNNPLE 202
Query: 207 C 207
C
Sbjct: 203 C 203
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 25/98 (25%), Positives = 43/98 (43%), Gaps = 5/98 (5%)
Query: 99 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLS 156
L L +L L N + I E + +L LDL +N L + +L+ L+ L L
Sbjct: 63 LTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLY 120
Query: 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
N+ ++ ++ L + L N +S + PV L +
Sbjct: 121 NNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIK 157
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 23/95 (24%), Positives = 41/95 (43%), Gaps = 9/95 (9%)
Query: 103 STLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP--SLGNLKKLQFLTLSQNNF 160
+ L+ + +P+ L S LDL +N L ++ + L L L LS N+
Sbjct: 21 NILSCSKQQLP-NVPQSL--PSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHL 76
Query: 161 SGTIP-DSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
+ I ++ + +L + L SN+L + LF
Sbjct: 77 N-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFS 109
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 30/140 (21%), Positives = 44/140 (31%), Gaps = 19/140 (13%)
Query: 99 LRTLSTLTLKGNGITGEIPEE----LGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154
+ L L L N I+ P E L L LDL +N+L L L
Sbjct: 135 MAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNG 193
Query: 155 LS-QNN-----------FSGTIPDSLTTLSSLIS--IQLDSNNLSGQIPVHLFQIPKYNF 200
L NN FS L+++ + S L + F +Y
Sbjct: 194 LYLHNNPLECDCKLYQLFSHWQYRQLSSVMDFQEDLYCMHSKKLHNIFSLDFFNCSEYKE 253
Query: 201 TGNNLNCGKTLPHSCESSSN 220
+ + G TL C++
Sbjct: 254 SAWEAHLGDTLTIRCDTKQQ 273
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 49/241 (20%), Positives = 80/241 (33%), Gaps = 41/241 (17%)
Query: 3 LIDLLLYCLKCFRFFDNFDPDLHNGWLTFLCSLSGDALFALRTSLRVPNNQLR------- 55
L++ R D++ WL + + ++ T L + N +
Sbjct: 174 LLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITT-LDLSGNGFKESMAKRF 232
Query: 56 --------------DWNQNQVNPCTWSNVIC--------DNSNNVASVTLSSMNFSGTLS 93
+ N + +N ++ V + LS + L
Sbjct: 233 FDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSK-SKIFALL 291
Query: 94 PRI-GVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKL 150
+ L LTL N I +I + L+ L L+L N L G I NL KL
Sbjct: 292 KSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKL 349
Query: 151 QFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF----QIPKYNFTGNNLN 206
+ L LS N+ S L +L + LD+N L +P +F + K N +
Sbjct: 350 EVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 408
Query: 207 C 207
C
Sbjct: 409 C 409
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 21/97 (21%), Positives = 35/97 (36%), Gaps = 4/97 (4%)
Query: 101 TLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLSQN 158
++ + L N I E+ E L L L ++ I + L L L L N
Sbjct: 31 HVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 159 NFSGTIPDSLTTLSSLISIQLDSNNL-SGQIPVHLFQ 194
F + L++L + L NL + + F+
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFK 126
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 26/111 (23%), Positives = 39/111 (35%), Gaps = 7/111 (6%)
Query: 99 LRTLSTLTLKGNGITG-EIPEEL-GNLSSLTSLDLDNNRLVGKIPPS--LGNLKKLQFLT 154
L L LTL + G + L+SL L L +N + KI P+ N+++ L
Sbjct: 102 LANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFFLNMRRFHVLD 160
Query: 155 LSQNNFSGTIPDSLTTLSS--LISIQLDSNNLSGQIPVHLFQIPKYNFTGN 203
L+ N + L ++L S L L N N
Sbjct: 161 LTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN 211
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 20/122 (16%), Positives = 42/122 (34%), Gaps = 16/122 (13%)
Query: 99 LRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVG----KIPP----SLGNLKK 149
++ +S L L + E SS+ L+L + L ++ SL
Sbjct: 197 IQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFT 255
Query: 150 LQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKY----NFTGNNL 205
+ + ++ + + L +S L+ ++ N L +P +F N
Sbjct: 256 FRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313
Query: 206 NC 207
+C
Sbjct: 314 DC 315
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 9e-10
Identities = 19/106 (17%), Positives = 37/106 (34%), Gaps = 3/106 (2%)
Query: 99 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLS 156
L L L + +I + L+ L L++D + L P SL +++ + L L
Sbjct: 148 LTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILH 206
Query: 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTG 202
+ + SS+ ++L +L L +
Sbjct: 207 MKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIK 252
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 33/128 (25%), Positives = 50/128 (39%), Gaps = 8/128 (6%)
Query: 68 SNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLT 127
+++ CD + SS + + S G+ + +L L N IT +L +L
Sbjct: 26 ASLSCDRNG---ICKGSSGSLN---SIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQ 79
Query: 128 SLDLDNNRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSG 186
+L L +N + I S +L L+ L LS N S LSSL + L N
Sbjct: 80 ALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT 138
Query: 187 QIPVHLFQ 194
LF
Sbjct: 139 LGETSLFS 146
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 26/164 (15%), Positives = 53/164 (32%), Gaps = 7/164 (4%)
Query: 24 LHNGWLTFLCSLSGDALFALR--TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASV 81
L G + + L L + + L+ + + + + +
Sbjct: 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL- 212
Query: 82 TLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIP 141
L + T S LR T + ++ L + ++ + + L ++
Sbjct: 213 -LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVM 270
Query: 142 PSLGNLKKLQFLTLSQNNFSGTIPDS-LTTLSSLISIQLDSNNL 184
L + L L S+N ++PD L+SL I L +N
Sbjct: 271 KLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 9e-10
Identities = 26/86 (30%), Positives = 44/86 (51%), Gaps = 4/86 (4%)
Query: 99 LRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLS 156
LR+L++L L GN IT E+P+ L L SL L L+ N++ + + +L L L+L
Sbjct: 79 LRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLY 136
Query: 157 QNNFSGTIPDSLTTLSSLISIQLDSN 182
N + + L ++ ++ L N
Sbjct: 137 DNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 29/97 (29%), Positives = 43/97 (44%), Gaps = 5/97 (5%)
Query: 99 LRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLS 156
+ L + L N I+ E+ + L SL SL L N++ ++P SL L LQ L L+
Sbjct: 55 YKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLN 112
Query: 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF 193
N + D+ L +L + L N L I F
Sbjct: 113 ANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTF 148
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 22/76 (28%), Positives = 38/76 (50%), Gaps = 11/76 (14%)
Query: 124 SSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIP----DSLTTLSSLISIQ 178
++T + L+ N + IPP + KKL+ + LS N S + L +L+SL
Sbjct: 32 ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSL---V 86
Query: 179 LDSNNLSGQIPVHLFQ 194
L N ++ ++P LF+
Sbjct: 87 LYGNKIT-ELPKSLFE 101
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 18/63 (28%), Positives = 30/63 (47%), Gaps = 2/63 (3%)
Query: 99 LRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQ 157
L +L L L N I + + +L +L L L +N+L + L+ +Q + L+Q
Sbjct: 103 LFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQ 161
Query: 158 NNF 160
N F
Sbjct: 162 NPF 164
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 20/135 (14%), Positives = 42/135 (31%), Gaps = 19/135 (14%)
Query: 64 PCTWSNVICD-NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEE-LG 121
C SN + + V + P + R L + I +
Sbjct: 6 ICHCSNRVFLCQESKVTEI------------PS-DLPRNAIELRFVLTKLR-VIQKGAFS 51
Query: 122 NLSSLTSLDLDNNRLVGKIPPS-LGNLKKLQFLTLSQNNFSGTIP-DSLTTLSSLISIQL 179
L +++ N ++ I NL KL + + + N I ++ L +L + +
Sbjct: 52 GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLI 111
Query: 180 DSNNLSGQIPVHLFQ 194
+ + +P
Sbjct: 112 SNTGIK-HLPDVHKI 125
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 30/138 (21%), Positives = 49/138 (35%), Gaps = 19/138 (13%)
Query: 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTL-KGNGITGEIPEE-LGNLSSLTSLDLD 132
S N + + FS L L + + K N + I E NL +L L +
Sbjct: 62 SQNDVLEVIEADVFSN--------LPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLIS 112
Query: 133 NNRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPD-SLTTLSS-LISIQLDSNNLSGQIP 189
N + +P + + L + N TI S LS + + L+ N + +I
Sbjct: 113 NTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIH 170
Query: 190 VHLFQIPK---YNFTGNN 204
F + N + NN
Sbjct: 171 NSAFNGTQLDELNLSDNN 188
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 23/99 (23%), Positives = 39/99 (39%), Gaps = 5/99 (5%)
Query: 99 LRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPP-SLGNL-KKLQFLTL 155
L L L + GI +P+ + LD+ +N + I S L + L L
Sbjct: 103 LPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL 161
Query: 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
++N I +S + L + L NN ++P +F
Sbjct: 162 NKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFH 199
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 19/86 (22%), Positives = 32/86 (37%), Gaps = 8/86 (9%)
Query: 99 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLS 156
+ N + E+P + S LD+ R+ +P L NLKKL+ +
Sbjct: 177 TQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTY 234
Query: 157 QNNFSGTIPDSLTTLSSLISIQLDSN 182
+P +L L +L+ L
Sbjct: 235 NLK---KLP-TLEKLVALMEASLTYP 256
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 51/244 (20%), Positives = 97/244 (39%), Gaps = 71/244 (29%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDA--AFQREVEMISVAV 349
+ + LG GG G V+ V +VA+K++ P A RE+++I
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV-LTDPQ-SVKHAL-REIKIIRRLD 66
Query: 350 HRNLLRLIGFCTTPTERL--------------LVYPFM----------QNLS---VAYRL 382
H N++++ +L +V +M L +
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFM 126
Query: 383 REIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD-EDFEAVVGD 441
++ RGL+Y+H + ++HRD+K AN+ ++ ED +GD
Sbjct: 127 YQL-------------------LRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGD 164
Query: 442 FGLAKLVDVRKTN-------VTTQ-VRGTMGHIAPE-YLSTGKSSERTDVFGYGIMLLEL 492
FGLA+++D ++ + T+ R +P LS ++ D++ G + E+
Sbjct: 165 FGLARIMDPHYSHKGHLSEGLVTKWYR------SPRLLLSPNNYTKAIDMWAAGCIFAEM 218
Query: 493 VTGQ 496
+TG+
Sbjct: 219 LTGK 222
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 29/108 (26%), Positives = 52/108 (48%), Gaps = 7/108 (6%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
L ++TL+ G G+T I E + L++L L+L +N++ + P L NL K+ L LS N
Sbjct: 40 LDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGN 95
Query: 159 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV-HLFQIPKYNFTGNNL 205
++ L S+ ++ L S ++ P+ L + N +
Sbjct: 96 PL--KNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQI 141
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 23/87 (26%), Positives = 40/87 (45%), Gaps = 6/87 (6%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
L ++ L L GN + + L S+ +LDL + ++ + P L L LQ L L N
Sbjct: 84 LTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQI-TDVTP-LAGLSNLQVLYLDLN 139
Query: 159 NFSGTIPDSLTTLSSLISIQLDSNNLS 185
+ P L L++L + + + +S
Sbjct: 140 QITNISP--LAGLTNLQYLSIGNAQVS 164
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 9e-08
Identities = 17/87 (19%), Positives = 31/87 (35%), Gaps = 6/87 (6%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
L + + +T + +L +T+L + I + L L L L N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDN 73
Query: 159 NFSGTIPDSLTTLSSLISIQLDSNNLS 185
+ P L L+ + ++L N L
Sbjct: 74 QITDLAP--LKNLTKITELELSGNPLK 98
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 12/79 (15%), Positives = 30/79 (37%), Gaps = 6/79 (7%)
Query: 107 LKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPD 166
+ I P L++ + + + + +L + L+ + TI
Sbjct: 4 TQPTAINVIFP--DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIE- 57
Query: 167 SLTTLSSLISIQLDSNNLS 185
+ L++LI ++L N ++
Sbjct: 58 GVQYLNNLIGLELKDNQIT 76
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 19/87 (21%), Positives = 32/87 (36%), Gaps = 4/87 (4%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
L L + LK N I+ L N S+L + L N + + NL +
Sbjct: 194 LPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVP--NVVKGP 249
Query: 159 NFSGTIPDSLTTLSSLISIQLDSNNLS 185
+ + P +++ + S L N S
Sbjct: 250 SGAPIAPATISDNGTYASPNLTWNLTS 276
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 26/87 (29%), Positives = 43/87 (49%), Gaps = 6/87 (6%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
L ++ + + I + + + L ++T L L+ N+L I P L NLK L +L L +N
Sbjct: 42 LNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDEN 97
Query: 159 NFSGTIPDSLTTLSSLISIQLDSNNLS 185
+ SL L L S+ L+ N +S
Sbjct: 98 KIK-DL-SSLKDLKKLKSLSLEHNGIS 122
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 33/106 (31%), Positives = 49/106 (46%), Gaps = 10/106 (9%)
Query: 96 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155
+ L L +L L N IT L L+ L +L L++N++ I P L L KLQ L L
Sbjct: 127 LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYL 182
Query: 156 SQNNFSGTIPD--SLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYN 199
S+N+ I D +L L +L ++L S + H + N
Sbjct: 183 SKNH----ISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPN 224
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 2e-09
Identities = 27/87 (31%), Positives = 43/87 (49%), Gaps = 6/87 (6%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
L+ L L L N I ++ L +L L SL L++N + I L +L +L+ L L N
Sbjct: 86 LKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNN 141
Query: 159 NFSGTIPDSLTTLSSLISIQLDSNNLS 185
T L+ L+ L ++ L+ N +S
Sbjct: 142 KI--TDITVLSRLTKLDTLSLEDNQIS 166
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 1e-08
Identities = 18/87 (20%), Positives = 34/87 (39%), Gaps = 6/87 (6%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
LK +T + L+S+ + +N+ + + + L + L L+ N
Sbjct: 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGN 75
Query: 159 NFSGTIPDSLTTLSSLISIQLDSNNLS 185
+ P LT L +L + LD N +
Sbjct: 76 KLTDIKP--LTNLKNLGWLFLDENKIK 100
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 24/108 (22%), Positives = 40/108 (37%), Gaps = 8/108 (7%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
L L TL+L+ N I+ +I L L+ L +L L N + + L LK L L L
Sbjct: 152 LTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQ 207
Query: 159 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLN 206
+ + L ++ N G + ++ N+
Sbjct: 208 ECLNKPINHQSNLVVPNTV----KNTDGSLVTPEIISDDGDYEKPNVK 251
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 41/202 (20%), Positives = 80/202 (39%), Gaps = 44/202 (21%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDA--AFQREVEMIS-V 347
+ LG+G +G V++ + G VAVK++ D F++ DA F RE+ +++ +
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNST-DAQRTF-REIMILTEL 65
Query: 348 AVHRNLLRLIGFCTTPTER--LLVYPFM----------QNLS---VAYRLREIKPGEPVL 392
+ H N++ L+ +R LV+ +M L Y + ++
Sbjct: 66 SGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQL------- 118
Query: 393 DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452
+ ++YLH ++HRD+K +N+LL+ + V DFGL++ +
Sbjct: 119 ------------IKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163
Query: 453 TNVTTQVRGTMGHIAPEYLSTG 474
+
Sbjct: 164 RVTNNIPLSINENTENFDDDQP 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 28/86 (32%), Positives = 35/86 (40%), Gaps = 5/86 (5%)
Query: 99 LRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLS 156
L L L LKGN + +P L L L L NN L ++P L L+ L L L
Sbjct: 123 LGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQ 180
Query: 157 QNNFSGTIPDSLTTLSSLISIQLDSN 182
+N+ TIP L L N
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 27/99 (27%), Positives = 41/99 (41%), Gaps = 12/99 (12%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
L+ L L +T ++ + G L L +LDL +N+L +P L L L +S N
Sbjct: 54 YTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFN 110
Query: 159 NFSGTIP----DSLTTLSSLISIQLDSNNLSGQIPVHLF 193
+ ++P L L L L N L +P L
Sbjct: 111 RLT-SLPLGALRGLGELQEL---YLKGNELK-TLPPGLL 144
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 28/123 (22%), Positives = 45/123 (36%), Gaps = 7/123 (5%)
Query: 72 CDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDL 131
+ V N + L P + + + L L N + L + LT L+L
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 132 DNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH 191
D L G L L L LS N ++P TL +L + + N L+ +P+
Sbjct: 63 DRAEL--TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLG 118
Query: 192 LFQ 194
+
Sbjct: 119 ALR 121
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 41/178 (23%), Positives = 63/178 (35%), Gaps = 21/178 (11%)
Query: 23 DLHNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVT 82
L L + L T L + +L + + ++
Sbjct: 37 HLSENLLYTFSLATLMPYTRL-TQLNLDRAELT------------KLQVDGTLPVLGTLD 83
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIP 141
LS N +L L L+ L + N +T +P L L L L N L +P
Sbjct: 84 LSH-NQLQSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLP 140
Query: 142 PSL-GNLKKLQFLTLSQNNFSGTIPDSL-TTLSSLISIQLDSNNLSGQIPVHLFQIPK 197
P L KL+ L+L+ NN + +P L L +L ++ L N+L IP F
Sbjct: 141 PGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHL 196
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 8e-09
Identities = 26/87 (29%), Positives = 43/87 (49%), Gaps = 6/87 (6%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
L+ L L L N + ++ L +L L SL L++N + I L +L +L+ L L N
Sbjct: 89 LKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNN 144
Query: 159 NFSGTIPDSLTTLSSLISIQLDSNNLS 185
T L+ L+ L ++ L+ N +S
Sbjct: 145 KI--TDITVLSRLTKLDTLSLEDNQIS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 32/90 (35%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 96 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155
I L ++ L L GN +T +I + L NL +L L LD N++ + L +LKKL+ L+L
Sbjct: 64 IQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSL 119
Query: 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLS 185
N S I + L L L S+ L +N ++
Sbjct: 120 EHNGIS-DI-NGLVHLPQLESLYLGNNKIT 147
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 15/87 (17%), Positives = 30/87 (34%), Gaps = 4/87 (4%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
L L L L N I+ ++ L L +L L+L + + K NL + +
Sbjct: 177 LTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 234
Query: 159 NFSGTIPDSLTTLSSLISIQLDSNNLS 185
+ P+ ++ + +
Sbjct: 235 SL--VTPEIISDDGDYEKPNVKWHLPE 259
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 23 DLHNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVIC-DNSNNVASV 81
D N LT + L L T L + NQL++ ++ ++ D S N S
Sbjct: 330 DFSNNLLTDTVFENCGHLTELET-LILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSY 388
Query: 82 TLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIP 141
+ S ++L +L + N +T I L + LDL +N++ IP
Sbjct: 389 DEKKGDCSW--------TKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIP 437
Query: 142 PSLGNLKKLQFLTLSQNNFSGTIPD-SLTTLSSLISIQLDSNNL 184
+ L+ LQ L ++ N ++PD L+SL I L +N
Sbjct: 438 KQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 22/99 (22%), Positives = 41/99 (41%), Gaps = 7/99 (7%)
Query: 91 TLSPRIGVLRTLSTLT---LKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPPSLGN 146
LS + + +L + N ++ + + SL SL++ +N L I L
Sbjct: 362 ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL-- 419
Query: 147 LKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLS 185
+++ L L N +IP + L +L + + SN L
Sbjct: 420 PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK 457
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 22/110 (20%), Positives = 40/110 (36%), Gaps = 8/110 (7%)
Query: 77 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRL 136
+ V S P+ + + + L + N I+ ++ +LS L L + +NR+
Sbjct: 1 SEFLVDRSKNGL--IHVPK-DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRI 57
Query: 137 VGKIPPS-LGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLS 185
+ S ++L++L LS N L L L N
Sbjct: 58 -QYLDISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHL---DLSFNAFD 103
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 21/189 (11%), Positives = 49/189 (25%), Gaps = 25/189 (13%)
Query: 1 MLLIDLLLYCLKCFRFFDNFDPDLHNGWLTFLC----SLSGDALFALRTSLRVPNNQLRD 56
+ I +L KC F N L+ L + ++ + +
Sbjct: 194 LSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFS 253
Query: 57 WNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEI 116
+ ++ + + L+ LS + +
Sbjct: 254 ISNVKLQGQLDFRDFDYSGTS---------------------LKALSIHQVVSDVFGFPQ 292
Query: 117 PEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLIS 176
S++ + + + L S N + T+ ++ L+ L +
Sbjct: 293 SYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELET 352
Query: 177 IQLDSNNLS 185
+ L N L
Sbjct: 353 LILQMNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 22/130 (16%), Positives = 39/130 (30%), Gaps = 5/130 (3%)
Query: 99 LRTLSTLTLKGNGITGEIPE--ELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 156
L L L N +P E GN+S L L L L + +L + L +
Sbjct: 89 TVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVL 147
Query: 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHSCE 216
+ + L + L + + + + L+ K + +
Sbjct: 148 GETY--GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNK 205
Query: 217 SSSNDSGSSK 226
S S +K
Sbjct: 206 CSYFLSILAK 215
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 21/198 (10%), Positives = 58/198 (29%), Gaps = 6/198 (3%)
Query: 19 NFDPDLHNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNV 78
F + ++ + + L + +N+ + T + NN+
Sbjct: 171 VFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNI 230
Query: 79 ASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVG 138
+ S + + ++S + L+G + +L +L+ + ++
Sbjct: 231 ETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGF 290
Query: 139 KIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLS---GQIPVHLFQI 195
+ + + + +S + + +N L+ + HL ++
Sbjct: 291 PQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTEL 350
Query: 196 PKYNFTGNNLNCGKTLPH 213
N L K L
Sbjct: 351 ETLILQMNQL---KELSK 365
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 28/125 (22%), Positives = 49/125 (39%), Gaps = 16/125 (12%)
Query: 99 LRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLS 156
L +L L + + G+L +L L++ +N + P NL L+ L LS
Sbjct: 99 LSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157
Query: 157 QNNFSGTIP----DSLTTLSSL-ISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLNCG 208
N +I L + L +S+ L N ++ I F ++ + N L
Sbjct: 158 SNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQL--- 212
Query: 209 KTLPH 213
K++P
Sbjct: 213 KSVPD 217
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 19/101 (18%), Positives = 31/101 (30%), Gaps = 9/101 (8%)
Query: 101 TLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLSQN- 158
+ L L N + + L LDL + I +L L L L+ N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNP 87
Query: 159 --NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK 197
+ + L++L L NL+ + K
Sbjct: 88 IQSLALGAFSGLSSLQKL---VAVETNLA-SLENFPIGHLK 124
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 5e-07
Identities = 26/89 (29%), Positives = 32/89 (35%), Gaps = 7/89 (7%)
Query: 99 LRTLSTLTLKGNGITGEIPEE-LGNLSSLT----SLDLDNNRLVGKIPPSLGNLKKLQFL 153
L L L L N I I L L + SLDL N + I P +L+ L
Sbjct: 148 LTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLKEL 205
Query: 154 TLSQNNFSGTIPDSLTTLSSLISIQLDSN 182
L N L+SL I L +N
Sbjct: 206 ALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 25/118 (21%), Positives = 40/118 (33%), Gaps = 22/118 (18%)
Query: 74 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLD 132
+ N + L S +F L L L I I + +LS L++L L
Sbjct: 36 SFNPLRH--LGSYSFFS--------FPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILT 84
Query: 133 NNRLVGKIPPSL-GNLKKLQFLTLSQNNFSGTIP----DSLTTLSSLISIQLDSNNLS 185
N + + L LQ L + N + ++ L TL L + N +
Sbjct: 85 GNPI-QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKEL---NVAHNLIQ 137
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 21/87 (24%), Positives = 41/87 (47%), Gaps = 6/87 (6%)
Query: 99 LRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLS 156
++ + L N + + ++ L SL +L L +NR+ + S L ++ L+L
Sbjct: 80 ASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLY 137
Query: 157 QNNFSGTIPD-SLTTLSSLISIQLDSN 182
N + T+ + TL SL ++ L +N
Sbjct: 138 DNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 25/98 (25%), Positives = 40/98 (40%), Gaps = 5/98 (5%)
Query: 99 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLS 156
L L + N IT +I E S + + L +NRL + + L+ L+ L L
Sbjct: 56 LPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLR 113
Query: 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 194
N + DS LSS+ + L N ++ + F
Sbjct: 114 SNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFD 150
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 18/97 (18%), Positives = 33/97 (34%), Gaps = 14/97 (14%)
Query: 104 TLTLKGNGITGEIPEE--LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLSQNNF 160
L L N T + L L ++ NN++ I + + + L+ N
Sbjct: 36 ELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL 93
Query: 161 SGTIP----DSLTTLSSLISIQLDSNNLSGQIPVHLF 193
+ L +L +L L SN ++ + F
Sbjct: 94 E-NVQHKMFKGLESLKTL---MLRSNRIT-CVGNDSF 125
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 31/86 (36%), Positives = 41/86 (47%), Gaps = 11/86 (12%)
Query: 105 LTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLSQNNFSGT 163
L L GN T +P+EL N LT +DL NNR+ + N+ +L L LS N
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-C 92
Query: 164 IP----DSLTTLSSLISIQLDSNNLS 185
IP D L +L L L N++S
Sbjct: 93 IPPRTFDGLKSLRLL---SLHGNDIS 115
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 29/131 (22%), Positives = 50/131 (38%), Gaps = 26/131 (19%)
Query: 96 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP------------- 142
+ L L L N I+ ++ L +L+ L L ++ NRL +
Sbjct: 59 MQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK-NLNGIPSACLSRLFLDN 115
Query: 143 -------SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV-HLFQ 194
SL +LK L+ L++ N +I L LS L + L N ++ + L +
Sbjct: 116 NELRDTDSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNTGGLTRLKK 173
Query: 195 IPKYNFTGNNL 205
+ + TG
Sbjct: 174 VNWIDLTGQKC 184
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 25/86 (29%), Positives = 40/86 (46%), Gaps = 4/86 (4%)
Query: 99 LRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLS 156
L L+ L+L N + +P+ + L+SL L L NN+L ++P L +L+ L L
Sbjct: 132 LTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQL-KRVPEGAFDKLTELKTLKLD 189
Query: 157 QNNFSGTIPDSLTTLSSLISIQLDSN 182
N + +L L +QL N
Sbjct: 190 NNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 4e-07
Identities = 42/174 (24%), Positives = 72/174 (41%), Gaps = 18/174 (10%)
Query: 23 DLHNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVT 82
DL + L+ L S + L L L + +N+L+ T I N+ ++
Sbjct: 43 DLQSNKLSSLPSKAFHRLTKL-RLLYLNDNKLQ----------TLPAGIFKELKNLETLW 91
Query: 83 LSSMNFSGTLSPRI-GVLRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKI 140
++ N L + L L+ L L N + +P + +L+ LT L L N L +
Sbjct: 92 VTD-NKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SL 148
Query: 141 PPSL-GNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF 193
P + L L+ L L N + L+ L +++LD+N L ++P F
Sbjct: 149 PKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAF 201
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 5e-07
Identities = 33/128 (25%), Positives = 56/128 (43%), Gaps = 14/128 (10%)
Query: 71 ICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLD 130
+C +NN SV SS + + + L L+ N ++ + L+ L L
Sbjct: 11 VCSCNNNKNSVDCSSKKLT---AIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLY 67
Query: 131 LDNNRLVGKIPPSL-GNLKKLQFLTLSQNNFSGTIP----DSLTTLSSLISIQLDSNNLS 185
L++N+L +P + LK L+ L ++ N +P D L L+ L +LD N L
Sbjct: 68 LNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAEL---RLDRNQLK 122
Query: 186 GQIPVHLF 193
+P +F
Sbjct: 123 -SLPPRVF 129
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 29/156 (18%), Positives = 58/156 (37%), Gaps = 23/156 (14%)
Query: 23 DLHNGWLTFLCSLSGDALFALRTSLRVPNNQLR---------------DWNQNQVN--PC 65
+ T L L +L + N L+ + +N
Sbjct: 359 NFTQNVFTDSVFQGCSTLKRL-QTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNS 417
Query: 66 TWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSS 125
+ C + ++ + LSS +G++ + + L L N I IP+++ +L +
Sbjct: 418 HAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQA 474
Query: 126 LTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLSQNNF 160
L L++ +N+L +P L LQ++ L N +
Sbjct: 475 LQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 20/90 (22%), Positives = 37/90 (41%), Gaps = 5/90 (5%)
Query: 97 GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTL 155
+ L+L N I+ ++ LS L L L +NR+ + + + L++L +
Sbjct: 49 DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDV 107
Query: 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLS 185
S N I ++SL + L N+
Sbjct: 108 SHNRLQ-NISCC--PMASLRHLDLSFNDFD 134
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 32/200 (16%), Positives = 69/200 (34%), Gaps = 27/200 (13%)
Query: 23 DLHNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNS-NNVASV 81
+ N F + + + + ++C S ++ +
Sbjct: 311 HVKNQVFLFSKEALYSVF----AEMNIKMLSI---SDTPFIH-----MVCPPSPSSFTFL 358
Query: 82 TLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLV---- 137
+ F+ ++ L+ L TL L+ NG+ + +++SL+ + L
Sbjct: 359 NFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNS 417
Query: 138 GKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV---HLFQ 194
+ + + L LS N +G++ L + + L +N + IP HL
Sbjct: 418 HAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQA 474
Query: 195 IPKYNFTGNNLNCGKTLPHS 214
+ + N N L K++P
Sbjct: 475 LQELNVASNQL---KSVPDG 491
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 20/139 (14%), Positives = 47/139 (33%), Gaps = 5/139 (3%)
Query: 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNN 134
N+ ++T++ + L++L +K + + L +
Sbjct: 280 YLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSIS 339
Query: 135 RLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLS-----GQIP 189
+ FL +QN F+ ++ +TL L ++ L N L +
Sbjct: 340 DTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMT 399
Query: 190 VHLFQIPKYNFTGNNLNCG 208
++ + + + N+LN
Sbjct: 400 KNMSSLETLDVSLNSLNSH 418
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 22/128 (17%), Positives = 44/128 (34%), Gaps = 4/128 (3%)
Query: 97 GVLRTLSTLTLKGNGITGEIPE--ELGNLSSLTSLDLDNNRLVGKIPPSLGNLK-KLQFL 153
+ +L L L N +P E GNL+ LT L L + + +L L
Sbjct: 118 CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILL 176
Query: 154 TLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPH 213
L + G +SL ++ + + N + V++ + +N+
Sbjct: 177 DLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQ 236
Query: 214 SCESSSND 221
+ ++
Sbjct: 237 RLMTFLSE 244
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 35/181 (19%), Positives = 62/181 (34%), Gaps = 57/181 (31%)
Query: 302 LGQGGFGKVYRGVLADGTKVAVKR-----LTDFESPGGDAAFQREVEM-----------I 345
+GQGGFG +Y + V + ++ E+ I
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG------PLFTELKFYQRAAKPEQI 96
Query: 346 SVAVHRNLLRLIGFCT-----TPTERLLVYPFM------QNLSVAYRLREIKPGEPVLDW 394
+ L+ +G + Y FM +L + + +
Sbjct: 97 QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDL------------QKIYEA 144
Query: 395 VTRK-------RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV--GDFGLA 445
++ +++L LEY+HEH +H D+KA+N+LL+ V D+GLA
Sbjct: 145 NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
Query: 446 K 446
Sbjct: 202 Y 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 9e-07
Identities = 34/179 (18%), Positives = 61/179 (34%), Gaps = 53/179 (29%)
Query: 302 LGQGGFGKVYRGV---------LADGTKVAVKRLTDFESPGGD-----AAFQREVEMISV 347
+ G +Y K ++K ++ G FQR + + V
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK----LDAKDGRLFNEQNFFQRAAKPLQV 105
Query: 348 AVHRNLL--------RLIGFCTTPTE-RLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTR 397
+ L +GF + R LV P + ++L + LD +
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSL------------QSALDVSPK 153
Query: 398 K--------RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV--GDFGLAK 446
+VA LE+LHE+ +H +V A N+ +D + ++ V +G A
Sbjct: 154 HVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-06
Identities = 21/86 (24%), Positives = 31/86 (36%), Gaps = 3/86 (3%)
Query: 101 TLSTLTLKGNGIT-GEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNN 159
+ L L + G++ L L N L I +L L KL+ L LS N
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELSDNR 75
Query: 160 FSGTIPDSLTTLSSLISIQLDSNNLS 185
SG + +L + L N +
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-06
Identities = 23/85 (27%), Positives = 35/85 (41%), Gaps = 3/85 (3%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
L L+ G+T I L L+ L L+L +NR+ G + L L LS N
Sbjct: 41 FEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGN 98
Query: 159 NFSG-TIPDSLTTLSSLISIQLDSN 182
+ + L L +L S+ L +
Sbjct: 99 KIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 4e-04
Identities = 27/97 (27%), Positives = 45/97 (46%), Gaps = 8/97 (8%)
Query: 116 IPEELG--NLSSLTSLDLDNNRL-VGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLS 172
I EL S + L LDN+R GK+ ++L+FL+ + +I + L L+
Sbjct: 7 IHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLN 64
Query: 173 SLISIQLDSNNLSGQIPVHLFQIPK---YNFTGNNLN 206
L ++L N +SG + V + P N +GN +
Sbjct: 65 KLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 54/247 (21%), Positives = 98/247 (39%), Gaps = 43/247 (17%)
Query: 301 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMI-----------SVA 348
LG G F V+ + + T VA+K + + +AA + E++++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAA-EDEIKLLQRVNDADNTKEDSM 83
Query: 349 VHRNLLRLIG---FCTTPTERL-LVYPFM-QNLSVAYRLREIKPGEPV-LDWVTRKRVAL 402
++L+L+ + +V+ + +NL L + + L +V K+++
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENL---LALIKKYEHRGIPLIYV--KQISK 138
Query: 403 GAARGLEYLHEHCNPKIIHRDVKAANVLLDE------DFEAVVGDFGLAKLVDVRKTN-- 454
GL+Y+H C IIH D+K NVL++ + + D G A D TN
Sbjct: 139 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 196
Query: 455 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 514
T + R +PE L D++ ++ EL+TG F E D
Sbjct: 197 QTREYR------SPEVLLGAPWGCGADIWSTACLIFELITGDFL--FEPDEGHSYTKDDD 248
Query: 515 HVKKLER 521
H+ ++
Sbjct: 249 HIAQIIE 255
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 3e-06
Identities = 24/86 (27%), Positives = 34/86 (39%), Gaps = 5/86 (5%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
L L+L G+ + L L L L+L NR+ G + L L L LS N
Sbjct: 48 FVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGN 105
Query: 159 NFS--GTIPDSLTTLSSLISIQLDSN 182
T+ + L L L S+ L +
Sbjct: 106 KLKDISTL-EPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 3e-06
Identities = 23/86 (26%), Positives = 33/86 (38%), Gaps = 3/86 (3%)
Query: 101 TLSTLTLKGNGIT-GEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNN 159
+ L L G+I +L L L N L+ + L L KL+ L LS+N
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENR 82
Query: 160 FSGTIPDSLTTLSSLISIQLDSNNLS 185
G + L +L + L N L
Sbjct: 83 IFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 22/89 (24%), Positives = 39/89 (43%), Gaps = 6/89 (6%)
Query: 122 NLSSLTSLDLDNNRL-VGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLD 180
+++ L LDN + GKI L+FL+L ++ +L L L ++L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79
Query: 181 SNNLSGQIPVHLFQIPK---YNFTGNNLN 206
N + G + + ++P N +GN L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 26/121 (21%), Positives = 46/121 (38%), Gaps = 9/121 (7%)
Query: 68 SNVICDNSNNVASVTLSSMNFSGTLSPRI----GVLRTLSTLTLKGNGITGEIPEELGNL 123
+ +I + +V ++ G P I L + N I ++ + L
Sbjct: 6 AELIEQAAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLL 63
Query: 124 SSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFS--GTIPDSLTTLSSLISIQLDS 181
L +L ++NNR+ L L L L+ N+ G + D L +L SL + +
Sbjct: 64 RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILR 122
Query: 182 N 182
N
Sbjct: 123 N 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 5e-06
Identities = 18/87 (20%), Positives = 32/87 (36%), Gaps = 3/87 (3%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
L L+G I I L ++D +N + K+ L++L+ L ++ N
Sbjct: 18 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNN 74
Query: 159 NFSGTIPDSLTTLSSLISIQLDSNNLS 185
L L + L +N+L
Sbjct: 75 RICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 7e-06
Identities = 25/101 (24%), Positives = 40/101 (39%), Gaps = 13/101 (12%)
Query: 98 VLRTLSTLTLKGNGITGE----IPEELGNLSSLTSLDLDNNRL----VGKIPPSLGNLK- 148
+L+ + L G+T I L +L L+L +N L V + L
Sbjct: 26 LLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSC 85
Query: 149 KLQFLTLSQNNFSGT----IPDSLTTLSSLISIQLDSNNLS 185
K+Q L+L +G + +L TL +L + L N L
Sbjct: 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 126
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 9e-05
Identities = 18/98 (18%), Positives = 34/98 (34%), Gaps = 13/98 (13%)
Query: 101 TLSTLTLKGNGITGE----IPEELGNLSSLTSLDLDNNRL----VGKIPPSLGNLK-KLQ 151
L L L+ ++ + L L + NN + V + L + +L+
Sbjct: 143 RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLE 202
Query: 152 FLTLSQNNFS----GTIPDSLTTLSSLISIQLDSNNLS 185
L L + + + + +SL + L SN L
Sbjct: 203 ALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 22/99 (22%), Positives = 36/99 (36%), Gaps = 13/99 (13%)
Query: 100 RTLSTLTLKGNGITGE----IPEELGNLSSLTSLDLDNNRL----VGKIPPSLGN-LKKL 150
L TL + GIT + + L SL L L N L + +L +L
Sbjct: 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQL 315
Query: 151 QFLTLSQNNFSGT----IPDSLTTLSSLISIQLDSNNLS 185
+ L + +F+ L L+ +Q+ +N L
Sbjct: 316 ESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLE 354
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 22/99 (22%), Positives = 33/99 (33%), Gaps = 13/99 (13%)
Query: 100 RTLSTLTLKGNGITGE----IPEELGNLSSLTSLDLDNNRLVGKIPPSLG-----NLKKL 150
L +L +K T L L L + NNRL L L
Sbjct: 313 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVL 372
Query: 151 QFLTLSQNNFS----GTIPDSLTTLSSLISIQLDSNNLS 185
+ L L+ + S ++ +L SL + L +N L
Sbjct: 373 RVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 9e-06
Identities = 17/81 (20%), Positives = 32/81 (39%), Gaps = 4/81 (4%)
Query: 105 LTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTI 164
L I ++ L L + L L N + KI L ++ L+ L+L +N I
Sbjct: 30 LHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK-KI 85
Query: 165 PDSLTTLSSLISIQLDSNNLS 185
+ +L + + N ++
Sbjct: 86 ENLDAVADTLEELWISYNQIA 106
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 29/138 (21%), Positives = 45/138 (32%), Gaps = 27/138 (19%)
Query: 64 PCTWSNVICDNSNNVASV----------TLSSMNFSGTLSPRIGVLRTLSTLTLKGNGIT 113
+V + + N I L + L L GN +
Sbjct: 18 FAETIKANL-KKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLH 76
Query: 114 GEIPEELG---NLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLSQNNFS---GTIPD 166
++ L++LT L L N+L +P + L L+ L L +N + D
Sbjct: 77 -----DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFD 130
Query: 167 SLTTLSSLISIQLDSNNL 184
LT L+ L L N L
Sbjct: 131 KLTNLTYL---NLAHNQL 145
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 27/87 (31%), Positives = 38/87 (43%), Gaps = 6/87 (6%)
Query: 99 LRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLS 156
L L L LK N +T I S + L L N++ +I + L +L+ L L
Sbjct: 53 LPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI-KEISNKMFLGLHQLKTLNLY 110
Query: 157 QNNFSGTIPD-SLTTLSSLISIQLDSN 182
N S + S L+SL S+ L SN
Sbjct: 111 DNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 8e-05
Identities = 24/87 (27%), Positives = 33/87 (37%), Gaps = 11/87 (12%)
Query: 105 LTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLSQNNFSG 162
L L N + + L G L L L+L N+L I P+ +Q L L +N
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK- 91
Query: 163 TIP----DSLTTLSSLISIQLDSNNLS 185
I L L +L L N +S
Sbjct: 92 EISNKMFLGLHQLKTL---NLYDNQIS 115
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 19/105 (18%), Positives = 39/105 (37%), Gaps = 20/105 (19%)
Query: 100 RTLSTLTLKGNGITGE----IPEELGNLSSLTSLDLDNNRL----VGKIPPSLGNLKKLQ 151
++ +LK + IT E + L S+ + L N + + ++ + K L+
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 152 FLTLSQNNFSGTIPD-----------SLTTLSSLISIQLDSNNLS 185
S + F+G + D +L L +++L N
Sbjct: 64 IAEFS-DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG 107
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 15/116 (12%), Positives = 40/116 (34%), Gaps = 13/116 (11%)
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGE----IPEELGNLSSLTSLDLDNNRL-- 136
++ ++ + L ++ N + + + L ++ + N +
Sbjct: 142 IARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 201
Query: 137 ---VGKIPPSLGNLKKLQFLTLSQNNFSGT----IPDSLTTLSSLISIQLDSNNLS 185
+ L ++L+ L L N F+ + +L + +L + L+ LS
Sbjct: 202 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 24/105 (22%), Positives = 40/105 (38%), Gaps = 15/105 (14%)
Query: 96 IGVLRTLSTLTLKGNGITGE-----IPEELGNLSSLTSLDLDNNRL----VGKIPPSLGN 146
R L T+ + NGI E + E L L LDL +N + +L +
Sbjct: 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 242
Query: 147 LKKLQFLTLSQNNFSGT----IPDSLTTLS--SLISIQLDSNNLS 185
L+ L L+ S + D+ + L L +++L N +
Sbjct: 243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 27/94 (28%), Positives = 40/94 (42%), Gaps = 11/94 (11%)
Query: 105 LTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLSQNNF--- 160
L L+ G+ L+ LT L+LD N+L + + +L +L L L+ N
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLASL 98
Query: 161 -SGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF 193
G + D LT L L L N L +P +F
Sbjct: 99 PLG-VFDHLTQLDKL---YLGGNQLKS-LPSGVF 127
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 27/86 (31%), Positives = 36/86 (41%), Gaps = 4/86 (4%)
Query: 99 LRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLS 156
L L L L GN + +P + L+ L L L+ N+L IP L LQ L+LS
Sbjct: 106 LTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDKLTNLQTLSLS 163
Query: 157 QNNFSGTIPDSLTTLSSLISIQLDSN 182
N + L L +I L N
Sbjct: 164 TNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 31/99 (31%), Positives = 45/99 (45%), Gaps = 15/99 (15%)
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV--GDFGLAKLVDVRKTNVTTQVRGTMGH 465
LEY+HE+ +H D+KAAN+LL V D+GL+ + Q GH
Sbjct: 164 LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGH 220
Query: 466 I-APEYLST----GKS-SERTDV--FGYGIMLLELVTGQ 496
E+ S G + S R+DV GY +L + G+
Sbjct: 221 NGTIEFTSLDAHKGVALSRRSDVEILGY--CMLRWLCGK 257
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.9 bits (105), Expect = 5e-05
Identities = 13/77 (16%), Positives = 25/77 (32%), Gaps = 7/77 (9%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGN---LSSLTSLDLDNNRL----VGKIPPSLGNLKKLQ 151
L L + + E L L ++D+ L + + +K L+
Sbjct: 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLK 310
Query: 152 FLTLSQNNFSGTIPDSL 168
F+ + N S + L
Sbjct: 311 FINMKYNYLSDEMKKEL 327
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 35/162 (21%), Positives = 54/162 (33%), Gaps = 37/162 (22%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAA-FQREVEMISVAVH-RNLLRLIG 358
+G G FG++ G L VA+K E A E + ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK----LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYY 72
Query: 359 FCTTPTERLLVYPFMQNL--SVAYRLREIKPGEPVLDWVTRK-------RVALGAARGLE 409
F +V ++ L S+ E + D R +A+ +E
Sbjct: 73 FGPCGKYNAMV---LELLGPSL----------EDLFDLCDRTFSLKTVLMIAIQLISRME 119
Query: 410 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVG-----DFGLAK 446
Y+H +I+RDVK N L+ DF LAK
Sbjct: 120 YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 33/161 (20%), Positives = 62/161 (38%), Gaps = 35/161 (21%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKR-LTDFESPGGDAAFQREVEMISVAVH-RNLLRLIG 358
+G+G FG ++ G L + +VA+K ++P + E + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAGCTGIPNVYY 73
Query: 359 FCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRK-------RVALGAARGLEY 410
F +LV + +L E +LD RK A ++
Sbjct: 74 FGQEGLHNVLVIDLLGPSL------------EDLLDLCGRKFSVKTVAMAAKQMLARVQS 121
Query: 411 LHEHCNPKIIHRDVKAANVLL----DEDFEAV-VGDFGLAK 446
+HE +++RD+K N L+ ++ + V DFG+ K
Sbjct: 122 IHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 39/169 (23%), Positives = 66/169 (39%), Gaps = 35/169 (20%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKR-LTDFESPGGDAAFQREVEMISV-AVHRNLLRLIG 358
+G G FG +Y G +A G +VA+K + P E ++ + + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQGGVGIPTIRW 72
Query: 359 FCTTPTERLLVYPFMQNL--SVAYRLREIKPGEPVLDWVTRK-------RVALGAARGLE 409
++V M+ L S+ E + ++ +RK +A +E
Sbjct: 73 CGAEGDYNVMV---MELLGPSL----------EDLFNFCSRKFSLKTVLLLADQMISRIE 119
Query: 410 YLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNV 455
Y+H IHRDVK N L+ + + DFGLAK +T+
Sbjct: 120 YIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 31/102 (30%), Positives = 46/102 (45%), Gaps = 11/102 (10%)
Query: 97 GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGN-LKKLQFLTL 155
G+ + L L+ N + L+SLT L L N+L +P + N L L +L L
Sbjct: 25 GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNL 83
Query: 156 SQNNFSGTIP----DSLTTLSSLISIQLDSNNLSGQIPVHLF 193
S N ++P D LT L L L++N L +P +F
Sbjct: 84 STNQLQ-SLPNGVFDKLTQLKEL---ALNTNQLQ-SLPDGVF 120
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 35/168 (20%), Positives = 63/168 (37%), Gaps = 33/168 (19%)
Query: 302 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDA-AFQREVEMISV-AVHRNLLRLIG 358
+G G FG++Y G + +VA+K E+ E ++ + + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLLYESKIYRILQGGTGIPNVRW 70
Query: 359 FCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRK-------RVALGAARGLEY 410
F +LV + +L E + ++ +RK +A +E+
Sbjct: 71 FGVEGDYNVLVMDLLGPSL------------EDLFNFCSRKLSLKTVLMLADQMINRVEF 118
Query: 411 LHEHCNPKIIHRDVKAANVLLDEDFEA---VVGDFGLAKLVDVRKTNV 455
+H +HRD+K N L+ A + DFGLAK T+
Sbjct: 119 VHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 19/101 (18%), Positives = 32/101 (31%), Gaps = 13/101 (12%)
Query: 98 VLRTLSTLTLKGNGITGEIPEELG-----NLSSLTSLDLDNNRL----VGKIPPSLGNLK 148
V L L+ N + E ++L + +T+L L NN L V + L
Sbjct: 124 VFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNT 183
Query: 149 KLQFLTLSQNNFSGT----IPDSLTTLSSLISIQLDSNNLS 185
+ L+L + L L + + N
Sbjct: 184 SVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG 224
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 25/85 (29%), Positives = 36/85 (42%), Gaps = 10/85 (11%)
Query: 105 LTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLSQNNFSGT 163
L L N IT P +L +L L L +N+L +P + +L +L L L N +
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-V 102
Query: 164 IP----DSLTTLSSLISIQLDSNNL 184
+P D L L L + N L
Sbjct: 103 LPSAVFDRLVHLKEL---FMCCNKL 124
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 619 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.87 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.87 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.86 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.84 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.83 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.81 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.79 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.78 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.76 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.75 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.75 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.75 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.73 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.73 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.73 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.72 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.72 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.71 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.71 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.7 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.69 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.68 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.68 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.67 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.66 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.66 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.66 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.66 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.65 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.65 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.64 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.64 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.63 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.63 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.63 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.63 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.63 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.61 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.6 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.6 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.6 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.59 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.59 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.59 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.59 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.58 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.57 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.57 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.57 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.57 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.57 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.57 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.57 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.56 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.56 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.56 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.56 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.55 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.55 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.55 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.55 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.55 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.55 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.54 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.54 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.54 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.53 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.53 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.53 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.53 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.53 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.52 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.52 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.52 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.52 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.52 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.51 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.51 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.51 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.51 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.51 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.51 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.51 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.49 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.49 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.49 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.48 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.48 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.47 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.47 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.47 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.47 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.47 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.47 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.44 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.43 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.43 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.41 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.41 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.41 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.4 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.4 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.39 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.39 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.38 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.38 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.36 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.36 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.34 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.33 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.33 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.32 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.31 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.31 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.29 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.26 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.25 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.25 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.25 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.24 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.24 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.21 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.19 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.19 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.17 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.15 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.15 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.15 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.13 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.07 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.96 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.93 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.93 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.78 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.75 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.64 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.63 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.63 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.62 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.58 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.46 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.41 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.4 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.35 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.33 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.28 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.23 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.16 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.14 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.11 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.07 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.98 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.98 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.94 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.94 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.86 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.86 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.74 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.74 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.69 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.44 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.29 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.28 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.28 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.24 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.16 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.08 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.04 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.96 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.92 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 96.83 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.83 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.81 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.76 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.7 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.69 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.58 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.47 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.37 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 96.19 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.12 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.64 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.6 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.98 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.37 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.74 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 86.62 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.69 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-55 Score=446.41 Aligned_cols=259 Identities=22% Similarity=0.319 Sum_probs=213.3
Q ss_pred cCCcccCccccCCCceEEEEEeC------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcce
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 367 (619)
.++++.+.||+|+||+||+|.+. +++.||||+++........++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34566789999999999999963 468899999986665666789999999999999999999999999999999
Q ss_pred eEecccccchhhhhhcccCCC------------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC
Q 007073 368 LVYPFMQNLSVAYRLREIKPG------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 435 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 435 (619)
+|||||++|+|.++|....+. ...+++..+.+|+.|||+||+|||++ +||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 999999999999999653221 24589999999999999999999999 999999999999999999
Q ss_pred cEEEcccccceeeccCCc-ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHH
Q 007073 436 EAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLL 513 (619)
Q Consensus 436 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~ 513 (619)
++||+|||+|+.....+. ...+...||+.|||||++.++.|+.++|||||||++|||+| |+.||..... .
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-----~--- 254 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----Q--- 254 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-----H---
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-----H---
Confidence 999999999987644332 23345679999999999999999999999999999999999 8999864321 1
Q ss_pred HHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 514 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
+....+..... ...+.+.+..+.+|+.+||+.||++||||.||++.|+..
T Consensus 255 ~~~~~i~~~~~----------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 255 DVVEMIRNRQV----------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHcCCC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11222221111 112334456789999999999999999999999999874
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-55 Score=441.38 Aligned_cols=259 Identities=24% Similarity=0.369 Sum_probs=212.3
Q ss_pred hcCCcccCccccCCCceEEEEEeC------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 366 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 366 (619)
.++|.+.+.||+|+||+||+|++. +|+.||||+++.. +....++|.+|++++++++|||||+++|+|.+++..
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 357888899999999999999864 4788999999753 445678899999999999999999999999999999
Q ss_pred eeEecccccchhhhhhcccC---------CCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcE
Q 007073 367 LLVYPFMQNLSVAYRLREIK---------PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA 437 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 437 (619)
++|||||++|+|.++++... .....+++..+.+++.|||+||+|||++ +|+||||||+|||+++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcE
Confidence 99999999999999997642 2235699999999999999999999999 99999999999999999999
Q ss_pred EEcccccceeeccCCcce-eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHH
Q 007073 438 VVGDFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDH 515 (619)
Q Consensus 438 kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 515 (619)
||+|||+|+......... .....||+.|||||++.+..|+.++|||||||++|||+| |+.||..... . +.
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-----~---~~ 239 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----N---EV 239 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----H---HH
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----H---HH
Confidence 999999998765433322 233568999999999999999999999999999999999 8999964321 1 11
Q ss_pred HHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 516 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 516 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.......... ..+...+.++.+|+.+||+.||++||||++|++.|++.
T Consensus 240 ~~~i~~~~~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 240 IECITQGRVL----------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HHHHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHcCCCC----------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 2222211111 12233456789999999999999999999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=443.30 Aligned_cols=259 Identities=25% Similarity=0.398 Sum_probs=206.9
Q ss_pred hcCCcccCccccCCCceEEEEEeC------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 366 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 366 (619)
.++|.+.+.||+|+||+||+|++. +++.||||+++. .+....++|.+|++++++++|||||+++|+|.+++..
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC-CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 356777889999999999999864 478999999975 3455668899999999999999999999999999999
Q ss_pred eeEecccccchhhhhhcccCCC-----------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC
Q 007073 367 LLVYPFMQNLSVAYRLREIKPG-----------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 435 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 435 (619)
++|||||++|+|.++++..... ...++|.++.+|+.|||+||+|||++ +||||||||+|||+++++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCC
Confidence 9999999999999999764321 24589999999999999999999999 999999999999999999
Q ss_pred cEEEcccccceeeccCCc-ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHH
Q 007073 436 EAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLL 513 (619)
Q Consensus 436 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~ 513 (619)
.+||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||..... .
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-----~--- 267 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-----T--- 267 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-----H---
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-----H---
Confidence 999999999987644332 23345679999999999999999999999999999999999 8999964321 1
Q ss_pred HHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 514 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
+....+....++ ..+...+.++.+|+.+||+.||++||||.||++.|+.+
T Consensus 268 ~~~~~i~~g~~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 268 EAIDCITQGREL----------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp HHHHHHHHTCCC----------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHcCCCC----------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 111222211111 12233446789999999999999999999999999874
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-54 Score=434.48 Aligned_cols=262 Identities=27% Similarity=0.432 Sum_probs=205.1
Q ss_pred HHHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
++..+++.+.+.||+|+||+||+|+++ ..||||+++... +....+.|.+|++++++++|||||+++|++.. +..++
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 345677888999999999999999975 369999987433 34456789999999999999999999998865 56899
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
|||||++|+|.++++... ..+++..+..|+.|||+||+|||++ +||||||||+|||+++++++||+|||+|+..
T Consensus 109 VmEy~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEECCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEcCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 999999999999997532 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCC-cceeeeccccccccccccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 449 DVRK-TNVTTQVRGTMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 449 ~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
.... ........||+.|||||++.+ +.|+.++|||||||++|||+||+.||...... ..+... ... +.
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~----~~~~~~---~~~-~~ 254 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR----DQIIFM---VGR-GY 254 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH----HHHHHH---HHT-TC
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH----HHHHHH---Hhc-CC
Confidence 5332 223445679999999999863 46899999999999999999999999643211 111111 111 10
Q ss_pred cchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 525 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
..+.+ ...+...+..+.+++.+||+.||++||||.||++.|+.+
T Consensus 255 ----~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 255 ----ASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp ----CCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred ----CCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11111 112234456889999999999999999999999998764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=439.99 Aligned_cols=271 Identities=25% Similarity=0.373 Sum_probs=221.7
Q ss_pred ccCHHHHHHHhcCCcccCccccCCCceEEEEEeCC------CcEEEEEEeccCCCcchHHHHHHHHHHHHHccC-CCccc
Q 007073 283 RYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVH-RNLLR 355 (619)
Q Consensus 283 ~~~~~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H-~niv~ 355 (619)
.+...++++..++|++.+.||+|+||+||+|.+.. ++.||||+++........+.|.+|++++++++| ||||+
T Consensus 53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 35567788888999999999999999999998642 468999999876666667889999999999975 89999
Q ss_pred eeeeeeCC-CcceeEecccccchhhhhhcccCC------------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 007073 356 LIGFCTTP-TERLLVYPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHR 422 (619)
Q Consensus 356 l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~ 422 (619)
++|+|.++ +..++|||||++|+|.++|+.... ....+++..+..++.|||+||+|||++ +||||
T Consensus 133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHR 209 (353)
T 4ase_A 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 209 (353)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecC
Confidence 99999765 568999999999999999975321 134589999999999999999999999 99999
Q ss_pred CCCCCcEEeCCCCcEEEcccccceeeccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCC
Q 007073 423 DVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 500 (619)
Q Consensus 423 Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~ 500 (619)
||||+|||+++++.+||+|||+|+.+...... ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999976544333 3345679999999999999999999999999999999998 899997
Q ss_pred CCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 501 FSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
..... ..+.. .+....++ ..+...+.++.+++.+||+.||++||||.||++.|+.+
T Consensus 290 ~~~~~----~~~~~---~i~~g~~~----------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 290 GVKID----EEFCR---RLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp TCCCS----HHHHH---HHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCHH----HHHHH---HHHcCCCC----------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 53321 11111 11111111 12223346789999999999999999999999998764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=427.13 Aligned_cols=251 Identities=20% Similarity=0.326 Sum_probs=203.0
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
++|++.+.||+|+||+||+|++. +|+.||||++.... .....+.|.+|++++++++|||||++++++.+++..++|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57999999999999999999974 69999999996543 33456789999999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++|+|.+++.... ...+++.....++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999997532 33478889999999999999999999 9999999999999999999999999999876432
Q ss_pred CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (619)
. ...+..+||+.|||||++.+..|+.++|||||||++|||+||+.||...... +......... ..
T Consensus 179 ~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--------~~~~~i~~~~-~~----- 243 (350)
T 4b9d_A 179 V-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK--------NLVLKIISGS-FP----- 243 (350)
T ss_dssp H-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHTC-CC-----
T ss_pred c-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHHcCC-CC-----
Confidence 1 2234567999999999999999999999999999999999999999743211 1111211111 10
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 532 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..+...+.++.+|+.+||+.||++|||++|+++
T Consensus 244 ----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 ----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112233467899999999999999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=419.09 Aligned_cols=265 Identities=23% Similarity=0.342 Sum_probs=199.7
Q ss_pred cCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHH--HHHHHHHHccCCCccceeeeeeCCC----cce
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQ--REVEMISVAVHRNLLRLIGFCTTPT----ERL 367 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~--~E~~~l~~l~H~niv~l~~~~~~~~----~~~ 367 (619)
++|.+.+.||+|+||+||+|++ +|+.||||++... ..+.+. .|+..+.+++|||||+++|++..++ ..+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~----~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc----chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 4577889999999999999998 5899999998632 233444 4555567889999999999997654 468
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCcEEeCCCCcEEEccc
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC-----NPKIIHRDVKAANVLLDEDFEAVVGDF 442 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~Df 442 (619)
+|||||++|+|.++++.. .+++..+.+++.|+|+||+|||+++ .++|+||||||+|||++.++++||+||
T Consensus 78 lV~Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEecCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 999999999999999753 3899999999999999999999862 558999999999999999999999999
Q ss_pred ccceeeccCCcce---eeeccccccccccccccCC------CCCcchhhHHHHHHHHHHHhCCCCCCCCccccc------
Q 007073 443 GLAKLVDVRKTNV---TTQVRGTMGHIAPEYLSTG------KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE------ 507 (619)
Q Consensus 443 Gla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~------ 507 (619)
|+|+......... .....||+.|||||++.+. .++.++|||||||++|||+||+.|+........
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 9999875443322 2345799999999999754 467899999999999999999888753221110
Q ss_pred -cchhHHHHHHHHhhhcccchhccccccCC-CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 508 -DDVLLLDHVKKLEREKRLDAIVDRNLNKN-YNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 508 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
..... ........... .++.+... ...+.+..+.+|+.+||+.||++||||.||++.|+.+
T Consensus 233 ~~~~~~-~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 233 PSDPSV-EEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CSSCCH-HHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccchH-HHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 00011 11111111111 11111111 1235567899999999999999999999999999874
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-51 Score=416.29 Aligned_cols=249 Identities=20% Similarity=0.268 Sum_probs=206.6
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
+.|+..+.||+|+||+||+|.+. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 56889999999999999999975 79999999996432 23456688999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++|+|.+++... .+++.....++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 153 ~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 153 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 9999999998752 389999999999999999999999 99999999999999999999999999999775433
Q ss_pred cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
. .....+||+.|||||++.+..|+.++||||+||++|||+||+.||..... ... ...+.... .+.
T Consensus 225 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~---~~~i~~~~------~~~ 289 (346)
T 4fih_A 225 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKA---MKMIRDNL------PPR 289 (346)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHH---HHHHHHSS------CCC
T ss_pred C-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHH---HHHHHcCC------CCC
Confidence 2 34456899999999999999999999999999999999999999964321 111 11111110 000
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
+ ......+.++.+++.+||+.||++|||+.|+++
T Consensus 290 ~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 290 L--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp C--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 111233467899999999999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=412.00 Aligned_cols=247 Identities=23% Similarity=0.389 Sum_probs=196.1
Q ss_pred cccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeC----CCcceeEe
Q 007073 297 SEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT----PTERLLVY 370 (619)
Q Consensus 297 ~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~ 370 (619)
...+.||+|+||+||+|.+. ++..||+|++.... .....+.|.+|++++++++|||||++++++.+ +...++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55678999999999999975 68999999996433 34456789999999999999999999999865 24478999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-CCcEEEcccccceeec
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-DFEAVVGDFGLAKLVD 449 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~ 449 (619)
|||++|+|.+++.... .+++..+..++.||+.||+|||++ +++|+||||||+|||++. ++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999998643 489999999999999999999998 113999999999999984 7899999999998543
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
. ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||...... ............ ....
T Consensus 184 ~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-------~~~~~~i~~~~~-~~~~ 251 (290)
T 3fpq_A 184 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTSGVK-PASF 251 (290)
T ss_dssp T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTTTCC-CGGG
T ss_pred C---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-------HHHHHHHHcCCC-CCCC
Confidence 2 23445689999999998865 6999999999999999999999999642211 111111111111 0001
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
+...++++.+++.+||+.||++|||++|+++
T Consensus 252 --------~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 252 --------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112246889999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=418.73 Aligned_cols=250 Identities=22% Similarity=0.227 Sum_probs=203.2
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
+.|...+.||+|+||+||+|++. +|+.||||+++.... +.+|+.++++++|||||++++++.+++..++||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 56788889999999999999975 699999999974321 24799999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-cEEEcccccceeeccC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-EAVVGDFGLAKLVDVR 451 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~ 451 (619)
+++|+|.++++... .+++.....++.||+.||+|||++ +||||||||+|||++.++ ++||+|||+|+.+...
T Consensus 132 ~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 99999999998643 389999999999999999999999 999999999999999987 6999999999987543
Q ss_pred Ccc----eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccch
Q 007073 452 KTN----VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527 (619)
Q Consensus 452 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (619)
... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||....... .. ..+.. .....
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~-~~i~~--~~~~~-- 275 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP----LC-LKIAS--EPPPI-- 275 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC----CH-HHHHH--SCCGG--
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH----HH-HHHHc--CCCCc--
Confidence 221 1234579999999999999999999999999999999999999997533211 11 11111 00000
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 528 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
...++..+..+.+++.+||+.||++|||+.|+++.|..
T Consensus 276 -------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 276 -------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp -------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 01223344678999999999999999999999988765
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-51 Score=420.36 Aligned_cols=319 Identities=71% Similarity=1.128 Sum_probs=269.6
Q ss_pred cccchhhhhcCcccccCHHHHHHHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHc
Q 007073 269 AGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVA 348 (619)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l 348 (619)
+.+.......++...+++.+++...++|+..+.||+|+||+||+|...+|+.||||++...........+.+|+++++.+
T Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l 84 (326)
T 3uim_A 5 PAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMA 84 (326)
T ss_dssp ----------CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTC
T ss_pred CcccCcccccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhc
Confidence 34445555667788899999999999999999999999999999998889999999997654444445789999999999
Q ss_pred cCCCccceeeeeeCCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 007073 349 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN 428 (619)
Q Consensus 349 ~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 428 (619)
+||||+++++++..+...++||||+++|+|.+++.........+++..+..++.|++.||+|||+++.++|+||||||+|
T Consensus 85 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~N 164 (326)
T 3uim_A 85 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAAN 164 (326)
T ss_dssp CCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGG
T ss_pred cCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhh
Confidence 99999999999999999999999999999999998876666779999999999999999999999888899999999999
Q ss_pred EEeCCCCcEEEcccccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccc
Q 007073 429 VLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED 508 (619)
Q Consensus 429 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~ 508 (619)
|+++.++.+||+|||+++..............||+.|+|||.+.+..++.++||||||+++|||+||+.||+........
T Consensus 165 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 244 (326)
T 3uim_A 165 ILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244 (326)
T ss_dssp EEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTS
T ss_pred EEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccccc
Confidence 99999999999999999987665555566667999999999999889999999999999999999999999765544555
Q ss_pred chhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcccchhhhhhhhh
Q 007073 509 DVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEV 587 (619)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~ 587 (619)
.....++............+.+..+........+..+.+++.+||+.||++|||+.+|++.|++....+.++++...+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~ 323 (326)
T 3uim_A 245 DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEM 323 (326)
T ss_dssp CSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC-------
T ss_pred chhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhhhhhHHHh
Confidence 5667777777777777777888877788889999999999999999999999999999999999999998888765544
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=414.89 Aligned_cols=248 Identities=21% Similarity=0.283 Sum_probs=208.0
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++|++.+.||+|+||+||+|+.. +|+.||||++.+.. .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999974 79999999996421 2334678999999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++|+|.+++.... .+++.....++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999998643 389999999999999999999999 999999999999999999999999999998754
Q ss_pred CCc-ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 451 RKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 451 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
... ......+||+.|||||++.+..|+.++||||+||++|||+||+.||..... . +........ ..
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~---~~~~~i~~~-~~---- 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----G---LIFAKIIKL-EY---- 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----H---HHHHHHHHT-CC----
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----H---HHHHHHHcC-CC----
Confidence 332 334567899999999999999999999999999999999999999964321 1 111111111 10
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV 567 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 567 (619)
.++...+.++.+++.+|++.||++|||++|++
T Consensus 252 ------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 ------DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ------CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11222345789999999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=417.37 Aligned_cols=250 Identities=20% Similarity=0.266 Sum_probs=207.3
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.+.|+..+.||+|+||+||+|.+. +|+.||||++.... ....+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT-CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 356999999999999999999975 69999999996433 3345678899999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
||++|+|.+++... .+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+...
T Consensus 229 y~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 229 FLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp CCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred CCCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence 99999999998652 388999999999999999999999 9999999999999999999999999999977543
Q ss_pred CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (619)
.. .....+||+.|||||++.+..|+.++|||||||++|||+||+.||..... ... ...+.... .+
T Consensus 301 ~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~---~~~i~~~~------~~ 365 (423)
T 4fie_A 301 VP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKA---MKMIRDNL------PP 365 (423)
T ss_dssp CC-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHH---HHHHHHSC------CC
T ss_pred Cc-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHH---HHHHHcCC------CC
Confidence 32 34456799999999999999999999999999999999999999964321 111 11111110 00
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 532 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.+ ......+.++.+|+.+||+.||++|||+.|+++
T Consensus 366 ~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 366 RL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 011223467899999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=395.71 Aligned_cols=246 Identities=22% Similarity=0.329 Sum_probs=190.8
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++|++.+.||+|+||+||+|... +|+.||||++.+.. .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999964 79999999996432 2334577999999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+ +|+|.+++... ..++......++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 67999988763 3489999999999999999999999 999999999999999999999999999987643
Q ss_pred CCcceeeeccccccccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
.. ......||+.|||||++.+..+ +.++||||+||++|||+||+.||...... ......... ..
T Consensus 165 ~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~--------~~~~~i~~~-~~---- 229 (275)
T 3hyh_A 165 GN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP--------VLFKNISNG-VY---- 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHT-CC----
T ss_pred CC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHcC-CC----
Confidence 22 2345679999999999988876 58999999999999999999999643211 111111111 10
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.++...+.++.+++.+|++.||++|||++|+++
T Consensus 230 ------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 ------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111223457889999999999999999999986
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=399.67 Aligned_cols=251 Identities=21% Similarity=0.309 Sum_probs=189.5
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCc-------
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE------- 365 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------- 365 (619)
++|++.+.||+|+||+||+|++. +|+.||||+++........+.+.+|++++++++|||||++++++...+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45889999999999999999975 7999999999765555556789999999999999999999999865432
Q ss_pred -----ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEc
Q 007073 366 -----RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVG 440 (619)
Q Consensus 366 -----~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 440 (619)
.++||||+++|+|.+++..... ....++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 5899999999999999976432 22356677889999999999999999 99999999999999999999999
Q ss_pred ccccceeeccCCcc-----------eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccc
Q 007073 441 DFGLAKLVDVRKTN-----------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD 509 (619)
Q Consensus 441 DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~ 509 (619)
|||+|+........ ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||....
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~------ 231 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM------ 231 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH------
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc------
Confidence 99999877543221 1234579999999999999999999999999999999996 664211
Q ss_pred hhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 510 VLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
........... .... .......+...+++.+||+.||++|||+.|+++
T Consensus 232 -~~~~~~~~~~~-~~~p---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 -ERVRTLTDVRN-LKFP---------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -HHHHHHHHHHT-TCCC---------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHHhc-CCCC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00111111110 0000 011233356778999999999999999999876
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=406.98 Aligned_cols=243 Identities=22% Similarity=0.273 Sum_probs=193.6
Q ss_pred cCCcccCccccCCCceEEEEEeC----CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
++|++.+.||+|+||+||+|+.. +++.||||++++.. .......+.+|++++++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999862 47899999986432 12233468899999999999999999999999999999
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||+++|+|.+++.... .+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999998643 389999999999999999999999 9999999999999999999999999999865
Q ss_pred ccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
..... .....+||+.|||||++.+..|+.++||||+||++|||+||+.||...... +....... ...
T Consensus 177 ~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--------~~~~~i~~-~~~--- 243 (304)
T 3ubd_A 177 IDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK--------ETMTMILK-AKL--- 243 (304)
T ss_dssp ----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHH-CCC---
T ss_pred cCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH--------HHHHHHHc-CCC---
Confidence 43222 234567999999999999999999999999999999999999999743221 11111111 110
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAM 563 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 563 (619)
.++...+.++.+++.+||+.||++|||+
T Consensus 244 -------~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 -------GMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred -------CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 1122234678999999999999999985
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=388.71 Aligned_cols=262 Identities=18% Similarity=0.263 Sum_probs=200.0
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC-cchHHHHHHHHHHHHHccCCCccceeeeeeCC------Cc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------TE 365 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~ 365 (619)
++|++.+.||+|+||+||+|.+. +|+.||||+++.... ....+.+.+|+++++.++|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999975 799999999975432 33456788999999999999999999987543 56
Q ss_pred ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 445 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 445 (619)
.++|||||+ |+|.+++... ..+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 799999996 6788888753 3489999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCC---cceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007073 446 KLVDVRK---TNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 521 (619)
Q Consensus 446 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 521 (619)
+.+.... .......+||+.|||||++.+. .++.++||||+||++|||+||+.||...... .....+.....
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-----~~l~~I~~~~g 280 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-----HQLQLIMMVLG 280 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-----HHHHHHHHHHC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-----HHHHHHHHhcC
Confidence 8764322 2233456899999999998775 4699999999999999999999999753321 11111111110
Q ss_pred hcccc-----------hhccccc-cCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 522 EKRLD-----------AIVDRNL-NKNYN-----IQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 522 ~~~~~-----------~~~~~~l-~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..... ....... ....+ +..+.++.+|+.+||+.||++|||+.|+++
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000 0000000 00000 112357889999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=380.33 Aligned_cols=283 Identities=39% Similarity=0.640 Sum_probs=240.0
Q ss_pred CHHHHHHHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCC
Q 007073 285 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT 364 (619)
Q Consensus 285 ~~~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 364 (619)
++.++...+++|+..+.||+|+||+||+|.+++|+.||||++... .....+.+.+|+++++.++||||+++++++...+
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC-CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 334455577899999999999999999999888999999988653 3455778999999999999999999999999999
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 444 (619)
..++||||+++|+|.+++.........+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999987554455689999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCC-cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007073 445 AKLVDVRK-TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 523 (619)
Q Consensus 445 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (619)
++...... ........||+.|+|||.+.+..++.++||||||+++|||+||+.||....... ......+........
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE--MVNLAEWAVESHNNG 263 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS--CCCHHHHTHHHHTTT
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHH--HHHHHHHhhhccccc
Confidence 98754322 222334568999999999999999999999999999999999999997543322 223344544445555
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 524 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 524 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.+...+++.+........+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 66667777777777889999999999999999999999999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=387.53 Aligned_cols=198 Identities=24% Similarity=0.377 Sum_probs=170.5
Q ss_pred HhcCCcccCccccCCCceEEEEEeC----CCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcc
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTER 366 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 366 (619)
..+.|++.+.||+|+||+||+|+.+ +++.||||++... .....+.+|+++++.+ +|||||++++++.+.+..
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~---~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT---SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT---SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc---cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 4578999999999999999999853 4678999998653 2345688999999988 699999999999999999
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-CcEEEcccccc
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLA 445 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla 445 (619)
++||||+++|+|.+++.. +++.....++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|
T Consensus 96 ~lvmE~~~g~~L~~~~~~-------l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILNS-------LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEECCCCCCHHHHHTT-------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeCCCcccHHHHHcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 999999999999998853 78899999999999999999999 99999999999999876 79999999999
Q ss_pred eeeccCCc---------------------------ceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCC
Q 007073 446 KLVDVRKT---------------------------NVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQR 497 (619)
Q Consensus 446 ~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~ 497 (619)
+....... ...+..+||+.|||||++.+. .++.++||||+||++|||+||+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 86543221 112345799999999999775 48999999999999999999999
Q ss_pred CCCCC
Q 007073 498 AIDFS 502 (619)
Q Consensus 498 p~~~~ 502 (619)
||...
T Consensus 246 Pf~~~ 250 (361)
T 4f9c_A 246 PFYKA 250 (361)
T ss_dssp SSSCC
T ss_pred CCCCC
Confidence 99643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=396.59 Aligned_cols=249 Identities=24% Similarity=0.296 Sum_probs=198.3
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHH---HHHHHHccCCCccceeeeeeCCCcc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQRE---VEMISVAVHRNLLRLIGFCTTPTER 366 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E---~~~l~~l~H~niv~l~~~~~~~~~~ 366 (619)
.++|++.++||+|+||+||+|+.. +|+.||||++.+.. .......+.+| +.+++.++|||||++++++.+++..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 467999999999999999999975 69999999986321 11223334444 5556677899999999999999999
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
++||||++||+|.+++.... .++......++.||+.||+|||++ +||||||||+|||++.++++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999998643 389999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 447 LVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 447 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
.+.... ....+||+.|||||++.+ ..|+.++||||+||++|||+||+.||....... .......... ..
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-----~~~i~~~i~~-~~- 410 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMTLT-MA- 410 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-----HHHHHHHHHH-CC-
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHhhcC-CC-
Confidence 765432 334679999999999975 579999999999999999999999996432211 1111111110 00
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHH
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVV 567 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl 567 (619)
..++...+.++.+|+.+|++.||++|++ ++||.
T Consensus 411 ---------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 411 ---------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred ---------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 0112233467899999999999999998 56665
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=396.38 Aligned_cols=252 Identities=20% Similarity=0.273 Sum_probs=207.0
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.++|++.+.||+|+||.||+|..+ +|+.||+|++.... ....+.+.+|+++|+.++|||||++++++.++...++|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 368999999999999999999975 79999999986432 3345678899999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC--CcEEEcccccceeec
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED--FEAVVGDFGLAKLVD 449 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfGla~~~~ 449 (619)
||++|+|.+++... ...+++.....++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+.
T Consensus 235 ~~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 235 FMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp CCCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred ecCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 99999999988652 23489999999999999999999999 99999999999999854 899999999999875
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||...... +....+.... . -+
T Consensus 309 ~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--------~~~~~i~~~~-~--~~ 375 (573)
T 3uto_A 309 PKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--------ETLRNVKSCD-W--NM 375 (573)
T ss_dssp TTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHTTC-C--CC
T ss_pred CCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHHhCC-C--CC
Confidence 433 334567999999999999999999999999999999999999999743221 1111111110 0 00
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
... .....+.++.+|+.+||+.||++|||+.|+++
T Consensus 376 ~~~----~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 376 DDS----AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CSG----GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Ccc----cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 11122357889999999999999999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=372.63 Aligned_cols=261 Identities=27% Similarity=0.404 Sum_probs=213.3
Q ss_pred HhcCCcccCccccCCCceEEEEEeC--------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeC
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA--------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTT 362 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 362 (619)
..++|.+.+.||+|+||.||+|.+. ++..||||+++........+.+.+|+++++++ +||||+++++++..
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 4578899999999999999999852 35679999997655455567899999999999 89999999999999
Q ss_pred CCcceeEecccccchhhhhhcccCC------------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 007073 363 PTERLLVYPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVL 430 (619)
Q Consensus 363 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 430 (619)
.+..++||||+++|+|.+++..... ....+++..+..++.|+++||+|||++ +|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEE
Confidence 9999999999999999999986432 123588999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccceeeccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccc
Q 007073 431 LDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEED 508 (619)
Q Consensus 431 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~ 508 (619)
++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||......
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--- 312 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--- 312 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence 999999999999999876543221 2233457889999999999999999999999999999999 99998653221
Q ss_pred chhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 509 DVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.+. ....... ....+...+..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 313 --~~~---~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 313 --ELF---KLLKEGH----------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp --GHH---HHHHTTC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHH---HHHhcCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 1111111 1112223346789999999999999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=351.86 Aligned_cols=283 Identities=36% Similarity=0.653 Sum_probs=230.6
Q ss_pred cccccCHHHHHHHhcCCccc------CccccCCCceEEEEEeCCCcEEEEEEeccCC---CcchHHHHHHHHHHHHHccC
Q 007073 280 QLKRYSWRELQLATDNFSEK------NVLGQGGFGKVYRGVLADGTKVAVKRLTDFE---SPGGDAAFQREVEMISVAVH 350 (619)
Q Consensus 280 ~~~~~~~~el~~~~~~~~~~------~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~---~~~~~~~~~~E~~~l~~l~H 350 (619)
....+++.++..++++|... +.||+|+||.||+|.. +++.||||++.... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34678899999999999877 8999999999999997 58999999986432 23456789999999999999
Q ss_pred CCccceeeeeeCCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 007073 351 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVL 430 (619)
Q Consensus 351 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 430 (619)
|||+++++++...+..++||||+++++|.+++..... ...+++..+..++.|++.||+|||++ +|+||||||+||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence 9999999999999999999999999999999875432 34589999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccceeeccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccc
Q 007073 431 LDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD 509 (619)
Q Consensus 431 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~ 509 (619)
++.++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|||+||+.||........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-- 242 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-- 242 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--
Confidence 999999999999999876543222 2334568999999998864 589999999999999999999999975433211
Q ss_pred hhHHHHHHHHhh-hcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 510 VLLLDHVKKLER-EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 510 ~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
...+...... ...+...+++.+ .......+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 243 --~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 243 --LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp --TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1122222221 122333444433 234677788999999999999999999999999999874
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=357.30 Aligned_cols=258 Identities=26% Similarity=0.403 Sum_probs=210.7
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.++|...+.||+|+||+||+|.+. +|+.||+|++.. ......+.|.+|++++++++||||+++++++..++..++|||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR-FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 467888999999999999999975 689999999854 334566789999999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++|+|.+++... ...+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 88 YIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 99999999999863 23489999999999999999999999 9999999999999999999999999999876433
Q ss_pred Ccce-------------eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccc-hhHHHHHH
Q 007073 452 KTNV-------------TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD-VLLLDHVK 517 (619)
Q Consensus 452 ~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~-~~~~~~~~ 517 (619)
.... .....||+.|+|||.+.+..++.++||||||+++|||++|..|+.......... ........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 2221 114569999999999999999999999999999999999999986533222111 11111100
Q ss_pred HHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007073 518 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 574 (619)
Q Consensus 518 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 574 (619)
.. .+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 242 -------------~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 242 -------------RY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp -------------HT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------------cc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 11122346889999999999999999999999998753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=363.32 Aligned_cols=258 Identities=24% Similarity=0.366 Sum_probs=210.0
Q ss_pred HhcCCcccCccccCCCceEEEEEeC----CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcce
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 367 (619)
..++|.+.+.||+|+||+||+|.+. .+..||||+++........+.|.+|++++++++||||+++++++...+..+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 3467888999999999999999974 345699999986555566778999999999999999999999999999999
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
+||||+++|+|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 127 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 999999999999999653 23489999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCcc--eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 448 VDVRKTN--VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 448 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
....... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...... +.........
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--------~~~~~~~~~~- 271 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--------DVISSVEEGY- 271 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--------HHHHHHHTTC-
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHHcCC-
Confidence 7543222 2223346788999999998999999999999999999999 99998643211 1111111111
Q ss_pred cchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 525 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
....+...+..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 272 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 272 ---------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1112223446789999999999999999999999999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=363.54 Aligned_cols=265 Identities=26% Similarity=0.395 Sum_probs=205.1
Q ss_pred HHHHHHHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCC
Q 007073 286 WRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT 364 (619)
Q Consensus 286 ~~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 364 (619)
..++....++|++.+.||+|+||+||+|.+ +|+.||||++.... .....+.+.+|++++++++||||+++++++....
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 344555677899999999999999999988 58999999987543 2334567899999999999999999999999999
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEeCCCCcEEEccc
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK--IIHRDVKAANVLLDEDFEAVVGDF 442 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~Df 442 (619)
..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||++ + |+||||||+||+++.++.+||+||
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCC
Confidence 99999999999999999975321 22388999999999999999999999 8 999999999999999999999999
Q ss_pred ccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh
Q 007073 443 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 522 (619)
Q Consensus 443 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 522 (619)
|+++...... .......||+.|+|||.+.+..++.++||||||+++|||+||+.||...... +........
T Consensus 184 g~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--------~~~~~~~~~ 254 (309)
T 3p86_A 184 GLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--------QVVAAVGFK 254 (309)
T ss_dssp C------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--------HHHHHHHHS
T ss_pred CCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhc
Confidence 9998654322 2233456999999999999999999999999999999999999999643211 111111100
Q ss_pred cccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 523 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 523 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.. ....+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 255 ~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~ 296 (309)
T 3p86_A 255 CK---------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296 (309)
T ss_dssp CC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00 0112223345789999999999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=373.98 Aligned_cols=260 Identities=27% Similarity=0.372 Sum_probs=211.5
Q ss_pred HHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
....++|.+.+.||+|+||.||+|.+. +++.||||+++........+.|.+|++++++++||||+++++++...+..++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 345578889999999999999999986 7899999999765444455678999999999999999999999999999999
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||+++|+|.++++... ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 190 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 999999999999997532 3488999999999999999999999 9999999999999999999999999999865
Q ss_pred ccCCccee-eeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 449 DVRKTNVT-TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 449 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
........ ....+++.|+|||.+.++.++.++|||||||++|||+| |..||...... +..........
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--------~~~~~~~~~~~-- 333 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--------QTREFVEKGGR-- 333 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--------HHHHHHHTTCC--
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCC--
Confidence 43211111 11235778999999998999999999999999999999 99998643211 11111111111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
...+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 334 --------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 334 --------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 111222346789999999999999999999999999874
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=369.76 Aligned_cols=258 Identities=26% Similarity=0.403 Sum_probs=200.5
Q ss_pred HhcCCcccCccccCCCceEEEEEeC----CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcce
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 367 (619)
..++|.+.+.||+|+||.||+|.+. ++..||||+++........+.|.+|+.++++++||||+++++++......+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3467899999999999999999964 577899999976555556678999999999999999999999999999999
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
+||||+++|+|.++++.. ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 999999999999999753 23489999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCcce--eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 448 VDVRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 448 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
........ .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... +.........
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--------~~~~~i~~~~- 267 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--------DVIKAVDEGY- 267 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--------HHHHHHHTTE-
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCC-
Confidence 65432221 122345778999999999999999999999999999998 99998643211 1111111111
Q ss_pred cchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 525 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
....+...+..+.+++.+||+.||++||++.+|++.|+..
T Consensus 268 ---------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 268 ---------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp ---------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 1111223446789999999999999999999999999875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=369.28 Aligned_cols=271 Identities=26% Similarity=0.384 Sum_probs=217.8
Q ss_pred ccCHHHHHHHhcCCcccCccccCCCceEEEEEe------CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccc
Q 007073 283 RYSWRELQLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLR 355 (619)
Q Consensus 283 ~~~~~el~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~ 355 (619)
.+...+++...++|.+.+.||+|+||.||+|.+ .+++.||||+++........+.+.+|+++++++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 345667778889999999999999999999984 246899999998655555667899999999999 7899999
Q ss_pred eeeeeeCCCc-ceeEecccccchhhhhhcccCCC----------------------------------------------
Q 007073 356 LIGFCTTPTE-RLLVYPFMQNLSVAYRLREIKPG---------------------------------------------- 388 (619)
Q Consensus 356 l~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------- 388 (619)
+++++...+. .++||||+++|+|.+++......
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987654 88999999999999999764321
Q ss_pred ----------------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 389 ----------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 389 ----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 12288999999999999999999999 99999999999999999999999999998664332
Q ss_pred c-ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 453 T-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 453 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
. .......||+.|+|||++.+..++.++||||||+++|||+| |+.||....... .... .......
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~---~~~~~~~------ 314 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----EFCR---RLKEGTR------ 314 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH----HHHH---HHHHTCC------
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH----HHHH---HHHcCCC------
Confidence 2 23344568999999999999999999999999999999999 999996533211 1111 1111110
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
...+...+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 315 ----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 315 ----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 111222335789999999999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=349.52 Aligned_cols=257 Identities=24% Similarity=0.370 Sum_probs=213.6
Q ss_pred HhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
..++|++.+.||+|+||.||+|.+.++..||||+++... ...+.+.+|++++++++||||+++++++......++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT--BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC--CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 457889999999999999999999888899999997533 345779999999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 84 YISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp CCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred ccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 999999999997642 3488999999999999999999999 9999999999999999999999999999877554
Q ss_pred CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
.........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||+..... ...........
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~------ 223 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--------EVVLKVSQGHR------ 223 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHHHTTCC------
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH--------HHHHHHHcCCC------
Confidence 4444444557788999999998899999999999999999999 99998643221 11111111110
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 574 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 574 (619)
...+...+..+.+++.+||+.||++|||+.++++.|+...
T Consensus 224 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 224 ----LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp ----CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred ----CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 0011122357899999999999999999999999998854
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=351.39 Aligned_cols=256 Identities=26% Similarity=0.398 Sum_probs=211.8
Q ss_pred HhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
..++|+..+.||+|+||+||+|.+.+++.||+|++.... ...+.+.+|++++++++||||+++++++......++|||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc--cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 456788999999999999999999889999999997532 345779999999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++++|.+++... ...+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp CCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eCCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999999753 23488999999999999999999999 9999999999999999999999999999866443
Q ss_pred CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
.........+|+.|+|||.+.+..++.++||||+|+++|||+| |+.||...... +..........
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--------~~~~~~~~~~~------ 225 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--------EVVEDISTGFR------ 225 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTTCC------
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHhcCcc------
Confidence 3333334457788999999999999999999999999999999 99998643211 11111111100
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
...+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 226 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 226 ----LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 111122245789999999999999999999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=365.65 Aligned_cols=266 Identities=24% Similarity=0.376 Sum_probs=212.1
Q ss_pred HHHHhcCCcccCccccCCCceEEEEEe------CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeee
Q 007073 289 LQLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCT 361 (619)
Q Consensus 289 l~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~ 361 (619)
++...++|.+.+.||+|+||.||+|.+ .++..||||++.........+.+.+|+.+++++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 445678899999999999999999996 245689999997554445567899999999999 8999999999999
Q ss_pred CCCcceeEecccccchhhhhhcccCCC-------------------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 007073 362 TPTERLLVYPFMQNLSVAYRLREIKPG-------------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHR 422 (619)
Q Consensus 362 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~ 422 (619)
..+..++||||+++|+|.+++...... ...+++..+..++.|++.||+|||++ +|+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 999999999999999999999764321 13478999999999999999999999 99999
Q ss_pred CCCCCcEEeCCCCcEEEcccccceeeccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCC
Q 007073 423 DVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 500 (619)
Q Consensus 423 Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~ 500 (619)
||||+||+++.++.+||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||+| |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 99999999999999999999999876543332 2334457889999999999999999999999999999998 999996
Q ss_pred CCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007073 501 FSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 574 (619)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 574 (619)
...... ..... .. .. .....+...+..+.+++.+||+.||++|||+.++++.|+...
T Consensus 277 ~~~~~~----~~~~~---~~-~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 277 GIPVDA----NFYKL---IQ-NG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp TCCCSH----HHHHH---HH-TT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cCCcHH----HHHHH---Hh-cC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 543211 11111 11 11 111112223467899999999999999999999999998753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=352.64 Aligned_cols=250 Identities=20% Similarity=0.301 Sum_probs=206.5
Q ss_pred hcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.++|+..+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 46799999999999999999996 478999999986433 3346778999999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++|+|.+++... .++...+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 98 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 99999999999753 378899999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (619)
.. ......||+.|+|||.+.+..++.++|||||||++|||+||+.||...... ............ .
T Consensus 170 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~~~~~~~~-~---- 235 (297)
T 3fxz_A 170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--------RALYLIATNGTP-E---- 235 (297)
T ss_dssp TC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHHCSC-C----
T ss_pred cc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCC-C----
Confidence 33 233457999999999999999999999999999999999999999643211 111111111110 0
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 532 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
...+...+..+.+++.+||+.||++|||+.|+++
T Consensus 236 ---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 236 ---LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp ---CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0112233457889999999999999999999985
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=367.93 Aligned_cols=262 Identities=29% Similarity=0.398 Sum_probs=214.8
Q ss_pred HHhcCCcccCccccCCCceEEEEEeC--------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeee
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLA--------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCT 361 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~ 361 (619)
...++|.+.+.||+|+||+||+|.+. ++..||||+++..........+.+|+++++++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 35578899999999999999999852 34679999998665555668899999999999 8999999999999
Q ss_pred CCCcceeEecccccchhhhhhcccCCC------------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 007073 362 TPTERLLVYPFMQNLSVAYRLREIKPG------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANV 429 (619)
Q Consensus 362 ~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 429 (619)
..+..++||||+++|+|.+++...... ...+++..+..++.|++.||+|||++ +|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceE
Confidence 999999999999999999999865421 24589999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEcccccceeeccCCc-ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccc
Q 007073 430 LLDEDFEAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEE 507 (619)
Q Consensus 430 ll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~ 507 (619)
|++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||......
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~-- 300 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-- 300 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999987643322 22334457889999999999999999999999999999999 99998643211
Q ss_pred cchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 508 DDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
+.......... ...+...+..+.+++.+||+.||++|||+.+|++.|+++
T Consensus 301 ------~~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 301 ------ELFKLLKEGHR----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp ------HHHHHHHTTCC----------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------HHHHHHHcCCC----------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111111111 111222345789999999999999999999999999885
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=366.62 Aligned_cols=260 Identities=27% Similarity=0.381 Sum_probs=211.5
Q ss_pred hcCCcccCccccCCCceEEEEEeC------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 366 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 366 (619)
.++|.+.+.||+|+||+||+|.+. +++.||||+++..........+.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467888999999999999999953 46789999997665566677899999999999999999999999999999
Q ss_pred eeEecccccchhhhhhcccCC---CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC---cEEEc
Q 007073 367 LLVYPFMQNLSVAYRLREIKP---GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF---EAVVG 440 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~ 440 (619)
++||||+++|+|.+++..... ....+++..+..++.|+++||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999986542 224589999999999999999999999 999999999999999554 59999
Q ss_pred ccccceeeccCC-cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHH
Q 007073 441 DFGLAKLVDVRK-TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKK 518 (619)
Q Consensus 441 DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 518 (619)
|||+++...... ........||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... +....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--------~~~~~ 298 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------EVLEF 298 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHH
Confidence 999998653222 222334568899999999999999999999999999999998 99998643211 11111
Q ss_pred HhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 519 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 519 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
...... ...+...+..+.+++.+||+.||++|||+.+|++.|+..
T Consensus 299 i~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 299 VTSGGR----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCC----------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111111 111222345789999999999999999999999999873
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=377.91 Aligned_cols=260 Identities=27% Similarity=0.412 Sum_probs=214.9
Q ss_pred HHHhcCCcccCccccCCCceEEEEEeCC-CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
+...++|.+.+.||+|+||.||+|.+.. +..||||+++... ...+.|.+|+.++++++||||+++++++......++
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 3456778889999999999999999864 8899999997532 346789999999999999999999999999999999
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||+++|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 294 v~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp EEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred EEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceec
Confidence 999999999999997643 23488999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccch
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (619)
............++..|+|||.+.+..++.++|||||||++|||+| |+.||...... .+.. .....
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-----~~~~---~~~~~----- 435 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYE---LLEKD----- 435 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----GHHH---HHHTT-----
T ss_pred cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHH---HHHcC-----
Confidence 5433333334456789999999999999999999999999999999 99998653321 1111 11111
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007073 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 574 (619)
Q Consensus 528 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 574 (619)
.....+...+..+.+++.+||+.||++|||+.+|++.|+...
T Consensus 436 -----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 436 -----YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 111122334467899999999999999999999999999864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=358.97 Aligned_cols=263 Identities=28% Similarity=0.395 Sum_probs=215.1
Q ss_pred HHHhcCCcccCccccCCCceEEEEEe------CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCC
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP 363 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 363 (619)
+...++|.+.+.||+|+||.||+|.. .+++.||||+++........+.+.+|++++++++||||+++++++...
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 34567899999999999999999986 245889999997655555667899999999999999999999999999
Q ss_pred CcceeEecccccchhhhhhcccCC--------------------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 007073 364 TERLLVYPFMQNLSVAYRLREIKP--------------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRD 423 (619)
Q Consensus 364 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D 423 (619)
+..++||||+++|+|.+++..... ....+++..+..++.|+++||+|||++ +|+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccc
Confidence 999999999999999999986433 123488999999999999999999999 999999
Q ss_pred CCCCcEEeCCCCcEEEcccccceeeccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCC
Q 007073 424 VKAANVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDF 501 (619)
Q Consensus 424 lkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~ 501 (619)
|||+||+++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876543332 2233457889999999999899999999999999999999 9999865
Q ss_pred CccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 502 SRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.... ..... ..... ....+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 256 ~~~~-----~~~~~---~~~~~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 256 IPPE-----RLFNL---LKTGH----------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp CCGG-----GHHHH---HHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHH-----HHHHH---hhcCC----------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 3321 11111 11110 1111223346789999999999999999999999999873
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=363.52 Aligned_cols=266 Identities=24% Similarity=0.400 Sum_probs=215.8
Q ss_pred HHHHHhcCCcccCccccCCCceEEEEEeC------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeee
Q 007073 288 ELQLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 361 (619)
Q Consensus 288 el~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 361 (619)
.+....++|.+.+.||+|+||.||+|.+. +++.||||+++........+.+.+|+.++++++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34456788999999999999999999974 348899999986555556678999999999999999999999999
Q ss_pred CCCcceeEecccccchhhhhhcccCCC--------------------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 007073 362 TPTERLLVYPFMQNLSVAYRLREIKPG--------------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 421 (619)
Q Consensus 362 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH 421 (619)
..+..++||||+++|+|.+++...... ...+++..+..++.|+++||.|||++ +|+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 999999999999999999999764321 24689999999999999999999999 9999
Q ss_pred cCCCCCcEEeCCCCcEEEcccccceeeccCCc-ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCC
Q 007073 422 RDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAI 499 (619)
Q Consensus 422 ~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~ 499 (619)
|||||+||+++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||+| |+.||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999986643322 22234568899999999999999999999999999999999 99998
Q ss_pred CCCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007073 500 DFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 574 (619)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 574 (619)
...... +........ ... ..+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 278 ~~~~~~--------~~~~~~~~~-~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 278 YGMAHE--------EVIYYVRDG-NIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp TTSCHH--------HHHHHHHTT-CCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCChH--------HHHHHHhCC-CcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 643211 111111111 110 112233457899999999999999999999999999853
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=352.18 Aligned_cols=262 Identities=22% Similarity=0.292 Sum_probs=206.8
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
.++|++.+.||+|+||.||+|... +++.||+|.+.... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999964 68999999985432 233457889999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 90 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999997643 389999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
...........||+.|+|||.+.+..++.++||||||+++|||+||+.||...... .......... ...
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~--------~~~~~~~~~~-~~~-- 231 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV--------SIAIKHIQDS-VPN-- 231 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH--------HHHHHHHSSC-CCC--
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHhhcc-CCC--
Confidence 44433444567999999999999999999999999999999999999999753221 0111111110 000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHhcCCc
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRP-AMSEVVRMLEGEGL 575 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~~~ 575 (619)
.........+..+.+++.+|++.||++|| +++++.+.|+....
T Consensus 232 ---~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 232 ---VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp ---HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred ---cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 00011222346789999999999999998 89999999987543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=349.64 Aligned_cols=275 Identities=17% Similarity=0.208 Sum_probs=216.9
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCC--cceeE
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT--ERLLV 369 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lv 369 (619)
.++|.+.+.||+|+||+||+|... +|+.||||++.........+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467899999999999999999976 589999999976544455678899999999999999999999987765 67899
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe----CCCCcEEEcccccc
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL----DEDFEAVVGDFGLA 445 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGla 445 (619)
|||+++++|.+++..... ...+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 999999999999986432 23389999999999999999999999 99999999999999 88889999999999
Q ss_pred eeeccCCcceeeecccccccccccccc--------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHH
Q 007073 446 KLVDVRKTNVTTQVRGTMGHIAPEYLS--------TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 517 (619)
Q Consensus 446 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 517 (619)
+....... .....||+.|+|||.+. +..++.++|||||||++|||+||+.||..................
T Consensus 164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred eecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 87654332 23456999999999886 577899999999999999999999999643332222222222111
Q ss_pred HHhhhcccchhc---c------c--cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007073 518 KLEREKRLDAIV---D------R--NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 574 (619)
Q Consensus 518 ~~~~~~~~~~~~---~------~--~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 574 (619)
. ........+. . + .............+.+++.+||+.||++|||++|+++...+..
T Consensus 242 ~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 242 G-KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp H-CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred C-CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 1 1111111000 0 0 1112345778889999999999999999999999999887643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=377.48 Aligned_cols=260 Identities=24% Similarity=0.385 Sum_probs=212.7
Q ss_pred HHHHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 289 LQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 289 l~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
++...++|.+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|++++++++||||+++++++. .+..++
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 345667889999999999999999999888999999997532 35788999999999999999999999986 567899
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||+++|+|.++++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 260 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 999999999999997532 12378889999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccch
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (619)
............++..|+|||.+....++.++|||||||++|||+| |+.||...... +.........++
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--------~~~~~i~~~~~~-- 404 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--------EVIRALERGYRM-- 404 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HHHHHHHHTCCC--
T ss_pred CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCC--
Confidence 4322222233456789999999999999999999999999999999 99999643211 111122111111
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007073 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 574 (619)
Q Consensus 528 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 574 (619)
..+...+..+.+++.+||+.||++|||+.+|++.|+...
T Consensus 405 --------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 405 --------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred --------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 112233467899999999999999999999999999863
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=351.41 Aligned_cols=262 Identities=24% Similarity=0.370 Sum_probs=203.5
Q ss_pred HhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHH--ccCCCccceeeeeeCC----Cc
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISV--AVHRNLLRLIGFCTTP----TE 365 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~----~~ 365 (619)
..++|++.+.||+|+||+||+|.+ +|+.||||++.. .....+..|.+++.. ++||||+++++++... ..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc----ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 356899999999999999999998 689999999853 345667778888776 7899999999986543 45
Q ss_pred ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCcEEeCCCCcE
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH--------EHCNPKIIHRDVKAANVLLDEDFEA 437 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~~ 437 (619)
.++||||+++|+|.++++. ..+++..+.+++.|++.||+||| +. +|+||||||+|||++.++.+
T Consensus 81 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~ 152 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQC 152 (301)
T ss_dssp EEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCE
T ss_pred eEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCE
Confidence 7899999999999999954 24899999999999999999999 77 99999999999999999999
Q ss_pred EEcccccceeeccCCcce---eeeccccccccccccccCC------CCCcchhhHHHHHHHHHHHhC----------CCC
Q 007073 438 VVGDFGLAKLVDVRKTNV---TTQVRGTMGHIAPEYLSTG------KSSERTDVFGYGIMLLELVTG----------QRA 498 (619)
Q Consensus 438 kl~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~S~Gv~l~elltg----------~~p 498 (619)
||+|||+++......... .....||+.|+|||.+.+. .++.++|||||||++|||+|| +.|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 999999998765443322 2234699999999999876 456799999999999999999 777
Q ss_pred CCCCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 499 IDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
|......... ................... .......+..+.+++.+||+.||++|||+.+|++.|+++
T Consensus 233 f~~~~~~~~~---~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 233 FYDVVPNDPS---FEDMRKVVCVDQQRPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTTSCSSCC---HHHHHHHHTTSCCCCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCCCCcc---hhhhhHHHhccCCCCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 7543221111 1111111111111111000 112235667899999999999999999999999999863
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=353.41 Aligned_cols=249 Identities=22% Similarity=0.333 Sum_probs=206.3
Q ss_pred HhcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
..++|.+.+.||+|+||.||+|.+ .+|+.||||++.... .....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 346799999999999999999997 579999999986533 334556788999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||+++|+|.+++.... .++......++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 93 ~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp ECCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 99999999999997643 388999999999999999999999 99999999999999999999999999998654
Q ss_pred cCCcceeeeccccccccccccccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSS-ERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
... ......||+.|+|||.+.+..++ .++||||+||++|||+||+.||+..... ......... ..
T Consensus 166 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~~-~~--- 231 (328)
T 3fe3_A 166 VGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK--------ELRERVLRG-KY--- 231 (328)
T ss_dssp SSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC-CC---
T ss_pred CCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC-CC---
Confidence 332 23455799999999999888775 8999999999999999999999753321 111111111 00
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..+...+.++.+++.+||+.||++|||++|+++
T Consensus 232 -------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 232 -------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp -------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred -------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 011123457889999999999999999999985
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=349.92 Aligned_cols=258 Identities=20% Similarity=0.339 Sum_probs=209.7
Q ss_pred HHHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
+...++|++.+.||+|+||+||+|.+.++..||||+++... ...+.+.+|++++++++||||+++++++...+..++|
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC--CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 34567899999999999999999999888899999997532 3457799999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||+++++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 98 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 98 TEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp ECCCTTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred EeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 99999999999997632 2389999999999999999999999 99999999999999999999999999998664
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
...........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...... ..........
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~~----- 238 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------ETAEHIAQGL----- 238 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHHHTTC-----
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--------HHHHHHhccc-----
Confidence 333223334457788999999999999999999999999999999 99998643211 1111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
....+...+..+.+++.+||+.||++|||+.++++.|++.
T Consensus 239 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 239 -----RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp -----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0111122235788999999999999999999999999873
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=355.74 Aligned_cols=254 Identities=22% Similarity=0.285 Sum_probs=202.7
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.++|++.+.||+|+||+||+|... +++.||||++.........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 367999999999999999999976 7899999998654444445678899999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 99999999998753 3489999999999999999999999 9999999999999999999999999999876433
Q ss_pred Cc-ceeeeccccccccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 452 KT-NVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 452 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
.. .......||+.|+|||.+.+..+ +.++|||||||++|||+||+.||....... .....+. ..... .
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~~----~~~~~---~ 228 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYSDWK----EKKTY---L 228 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS---HHHHHHH----TTCTT---S
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH---HHHHHHh----ccccc---C
Confidence 22 22335579999999999988775 789999999999999999999997533211 1111111 00000 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
.........+.+++.+||+.||++|||+.|+++.
T Consensus 229 ------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 ------NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ------CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0012233577899999999999999999999753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=348.59 Aligned_cols=261 Identities=20% Similarity=0.261 Sum_probs=211.9
Q ss_pred cccCHHHHHHHhcC----------CcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccC
Q 007073 282 KRYSWRELQLATDN----------FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH 350 (619)
Q Consensus 282 ~~~~~~el~~~~~~----------~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H 350 (619)
..++++++..+++. |...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCC
Confidence 45677777776654 666779999999999999976 79999999986433 4456788999999999999
Q ss_pred CCccceeeeeeCCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 007073 351 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVL 430 (619)
Q Consensus 351 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 430 (619)
|||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+||+
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl 173 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL 173 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence 9999999999999999999999999999998864 2389999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccch
Q 007073 431 LDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV 510 (619)
Q Consensus 431 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~ 510 (619)
++.++.+||+|||++........ ......||+.|+|||.+.+..++.++||||||+++|||+||+.||......
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~----- 247 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV----- 247 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----
T ss_pred ECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----
Confidence 99999999999999987654322 233457999999999999999999999999999999999999999643211
Q ss_pred hHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 511 LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.......... .+.+. .....+..+.+++.+||+.||++|||+.++++
T Consensus 248 ---~~~~~~~~~~------~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 248 ---QAMKRLRDSP------PPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp ---HHHHHHHHSS------CCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HHHHHHhcCC------CCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111110 00000 01122357889999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=348.79 Aligned_cols=258 Identities=21% Similarity=0.326 Sum_probs=199.1
Q ss_pred HHhcCCcccCccccCCCceEEEEEeCC----CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcc
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 366 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 366 (619)
...++|++.+.||+|+||.||+|.+.. +..||+|++.........+.+.+|+.++++++||||+++++++. .+..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 455789999999999999999999742 45799999876555556678999999999999999999999984 5678
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
++||||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp EEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccc
Confidence 8999999999999999753 23488999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 447 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 447 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
..............+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... ... ........
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~-----~~~---~~i~~~~~- 235 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DVI---GRIENGER- 235 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GHH---HHHHTTCC-
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH-----HHH---HHHHcCCC-
Confidence 765443333344457889999999998999999999999999999997 99998643321 111 11111111
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
...+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 236 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 236 ---------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111223346789999999999999999999999999873
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=358.68 Aligned_cols=256 Identities=25% Similarity=0.405 Sum_probs=201.5
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCc----EEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcce
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGT----KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 367 (619)
.++|+..+.||+|+||+||+|.+. +|+ +||+|.+.........+.|.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 467888999999999999999964 444 468888875555566788999999999999999999999998754 78
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
+|+||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 9999999999999997643 3488999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 448 VDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 448 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
....... ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||+...... .... .....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~~~~---~~~~~-- 236 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISSI---LEKGE-- 236 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HHHH---HHTTC--
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-----HHHH---HHcCC--
Confidence 6543322 2234457889999999999999999999999999999999 999997533211 1111 11111
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
....+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus 237 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 237 --------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp --------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1111223346789999999999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=356.20 Aligned_cols=271 Identities=27% Similarity=0.305 Sum_probs=207.6
Q ss_pred HHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCc----c
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE----R 366 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----~ 366 (619)
...++|++.+.||+|+||+||+|.+. ++.||||++... ......+..|+.++++++||||+++++++..... .
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ--DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC--chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 34578999999999999999999985 799999998642 2334556678888999999999999999977543 5
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcC-------CCCeEecCCCCCcEEeCCCCcEEE
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC-------NPKIIHRDVKAANVLLDEDFEAVV 439 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------~~~ivH~Dlkp~NIll~~~~~~kl 439 (619)
++||||+++|+|.++++.. .+++..+..++.|+++||+|||+.+ .++|+||||||+|||++.++.+||
T Consensus 98 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 8999999999999999752 3899999999999999999999862 348999999999999999999999
Q ss_pred cccccceeeccCCcc-eeeeccccccccccccccCC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccch---
Q 007073 440 GDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTG-----KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV--- 510 (619)
Q Consensus 440 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~--- 510 (619)
+|||+++........ ......||+.|+|||.+.+. .++.++|||||||++|||+||+.||...........
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 999999877543322 23335799999999999763 456789999999999999999999975432211100
Q ss_pred -----hHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 511 -----LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 511 -----~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
....+..... .......+... ......+..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 253 ~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 253 IGQHPSLEDMQEVVV-HKKKRPVLRDY---WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp HCSSCCHHHHHHHHT-TSCCCCCCCGG---GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hccCCchhhhhhhhh-cccCCCCcccc---ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0111111111 01110000000 01234556799999999999999999999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=354.37 Aligned_cols=264 Identities=25% Similarity=0.376 Sum_probs=214.8
Q ss_pred HHHhcCCcccCccccCCCceEEEEEe------CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeC
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTT 362 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 362 (619)
+...++|.+.+.||+|+||.||+|.+ .+++.||||+++........+.+.+|+++++++ +||||+++++++..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 34567899999999999999999985 356889999997655555567899999999999 89999999999999
Q ss_pred CCcceeEecccccchhhhhhcccCCC--------------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 007073 363 PTERLLVYPFMQNLSVAYRLREIKPG--------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN 428 (619)
Q Consensus 363 ~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 428 (619)
++..++||||+++|+|.+++...... ...+++..+..++.|+++||+|||++ +|+||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence 99999999999999999999764321 23589999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEcccccceeeccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccc
Q 007073 429 VLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEE 506 (619)
Q Consensus 429 Ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~ 506 (619)
|+++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||.......
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 99999999999999999876544332 2234457889999999999999999999999999999999 999986533211
Q ss_pred ccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 507 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
........ . .....+...+..+.+++.+||+.||++|||+.++++.|++.
T Consensus 256 ----~~~~~~~~----~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 256 ----KFYKMIKE----G---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp ----HHHHHHHH----T---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHhcc----C---------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 11111111 0 00111222346789999999999999999999999999873
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=361.37 Aligned_cols=266 Identities=25% Similarity=0.357 Sum_probs=213.9
Q ss_pred HHHHHhcCCcccCccccCCCceEEEEEeCC------CcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeee
Q 007073 288 ELQLATDNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFC 360 (619)
Q Consensus 288 el~~~~~~~~~~~~lg~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~ 360 (619)
+++...++|.+.+.||+|+||.||+|.... +..||+|.+.........+.+.+|+++++++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345567889999999999999999999642 2479999997655555677899999999999 899999999999
Q ss_pred eCCCcceeEecccccchhhhhhcccCC----------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 007073 361 TTPTERLLVYPFMQNLSVAYRLREIKP----------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVL 430 (619)
Q Consensus 361 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 430 (619)
...+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||++ +|+||||||+||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence 999999999999999999999875321 123478999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccceeeccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccc
Q 007073 431 LDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEED 508 (619)
Q Consensus 431 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~ 508 (619)
++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||+| |..||.......
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-- 274 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-- 274 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--
Confidence 999999999999999866443322 2234457889999999999999999999999999999999 899986432211
Q ss_pred chhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 509 DVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
........ .. ....+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 275 --~~~~~~~~----~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 275 --KFYKLVKD----GY---------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp --HHHHHHHH----TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHHhc----CC---------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 11111111 10 0011112245789999999999999999999999999873
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=371.55 Aligned_cols=259 Identities=26% Similarity=0.383 Sum_probs=206.3
Q ss_pred HHHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
+...++|.+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|++++++++||||+++++++.. +..++|
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 34557788899999999999999999888899999997533 345789999999999999999999999876 678999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||+++|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 257 ~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp ECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 99999999999997532 23488999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
...........++..|+|||.+.+..++.++||||||+++|||+| |+.||...... +.........+
T Consensus 332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--------~~~~~i~~~~~---- 399 (452)
T 1fmk_A 332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQVERGYR---- 399 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTCC----
T ss_pred CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCC----
Confidence 433333334457889999999999999999999999999999999 99998643211 11112211111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 574 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 574 (619)
...+...+..+.+++.+||+.||++|||+.++++.|+...
T Consensus 400 ------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 400 ------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 1122334567899999999999999999999999999853
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=350.03 Aligned_cols=261 Identities=28% Similarity=0.421 Sum_probs=216.5
Q ss_pred HHHHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcc
Q 007073 288 ELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 366 (619)
Q Consensus 288 el~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 366 (619)
+++...++|++.+.||+|+||+||+|.+. ++..||+|.+... ....+.+.+|++++++++||||+++++++......
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC--STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 34456778999999999999999999976 4889999998642 34567899999999999999999999999999999
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
++||||+++++|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred EEEEEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccce
Confidence 99999999999999997643 24489999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 447 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 447 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
..............+|+.|+|||.+.+..++.++||||||+++|+|+| |..||....... ... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-----~~~---~~~~~--- 228 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYE---LLEKD--- 228 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----HHH---HHHTT---
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHH---HHhcc---
Confidence 766554444445567889999999999999999999999999999999 999986533211 111 11111
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.....+...+..+.+++.+|++.||++|||+.++++.|+..
T Consensus 229 -------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 229 -------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 11111223346789999999999999999999999999873
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=347.72 Aligned_cols=265 Identities=23% Similarity=0.305 Sum_probs=202.0
Q ss_pred HhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
..++|++.+.||+|+||+||+|...+|+.||+|++.... .......+.+|++++++++||||+++++++..+...++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 446799999999999999999999889999999996433 2334577889999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++ +|.+.+... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 99 e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 99 EFMEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp ECCSE-EHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred cCCCC-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99985 777777653 23488999999999999999999999 999999999999999999999999999987643
Q ss_pred CCcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc--ccch
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK--RLDA 527 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 527 (619)
... ......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||....... .+........... ....
T Consensus 172 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 172 PVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD----QLPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp CCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT----HHHHHHHHHCCCCTTTSGG
T ss_pred Ccc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHHCCCChHHhhh
Confidence 322 2334568999999999876 568999999999999999999999997533221 1111111111000 0000
Q ss_pred hc------cccc---cC----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 528 IV------DRNL---NK----NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 528 ~~------~~~l---~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.. +... .. ...+....++.+++.+|++.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 0000 00 001122357889999999999999999999985
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=354.34 Aligned_cols=263 Identities=27% Similarity=0.412 Sum_probs=213.4
Q ss_pred HHHhcCCcccCccccCCCceEEEEEeC--------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeee
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVLA--------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFC 360 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~ 360 (619)
....++|.+.+.||+|+||.||+|.+. ++..||||+++........+.+.+|+++++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 345678999999999999999999863 46789999997655555667899999999999 899999999999
Q ss_pred eCCCcceeEecccccchhhhhhcccCCC------------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 007073 361 TTPTERLLVYPFMQNLSVAYRLREIKPG------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN 428 (619)
Q Consensus 361 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 428 (619)
...+..++||||+++|+|.+++...... ...+++..+..++.|+++||+|||++ +|+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccce
Confidence 9999999999999999999999864421 23488999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEcccccceeeccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccc
Q 007073 429 VLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEE 506 (619)
Q Consensus 429 Ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~ 506 (619)
|+++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~- 266 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE- 266 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH-
Confidence 99999999999999999876543322 2233457889999999998889999999999999999999 99998643211
Q ss_pred ccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 507 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
+.......... ...+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 267 -------~~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 267 -------ELFKLLKEGHR----------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp -------HHHHHHHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------HHHHHHhcCCC----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111111110 111222345789999999999999999999999999885
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=342.96 Aligned_cols=261 Identities=15% Similarity=0.176 Sum_probs=208.7
Q ss_pred HhcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcceeE
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 369 (619)
..++|.+.+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|+.+++.+ +|+|++++++++......++|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 346799999999999999999996 578999999986433 234578899999999 799999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc-----EEEccccc
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE-----AVVGDFGL 444 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfGl 444 (619)
|||+ +++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+
T Consensus 85 ~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEec-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 9999 999999997632 3489999999999999999999999 9999999999999987766 99999999
Q ss_pred ceeeccCCcc------eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH
Q 007073 445 AKLVDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 518 (619)
Q Consensus 445 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 518 (619)
++........ ......||+.|+|||.+.+..++.++||||||+++|||+||+.||........ .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~ 235 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN--KQKYERIGE 235 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH--HHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc--HHHHHHHHh
Confidence 9877543321 23445699999999999999999999999999999999999999975432211 111111111
Q ss_pred HhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 519 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 519 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.......... ....+..+.+++.+||+.||++||++.+|++.|+..
T Consensus 236 ~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 236 KKQSTPLREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp HHHHSCHHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred hccCccHHHH---------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 1111111111 112235789999999999999999999999999873
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=347.46 Aligned_cols=259 Identities=17% Similarity=0.166 Sum_probs=207.1
Q ss_pred hcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcceeEe
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 370 (619)
.++|.+.+.||+|+||+||+|.. .+|+.||||.+..... .+.+.+|+++++++ +||||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 46789999999999999999996 5789999999864332 34578999999999 8999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc-----EEEcccccc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE-----AVVGDFGLA 445 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfGla 445 (619)
||+ +++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||++
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 85 ELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred EeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 999 99999999864 23589999999999999999999999 9999999999999998887 999999999
Q ss_pred eeeccCCcc------eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHH
Q 007073 446 KLVDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL 519 (619)
Q Consensus 446 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 519 (619)
+........ ......||+.|+|||.+.+..++.++|||||||++|||+||+.||........ ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~--~~~~~~i~~~ 235 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL--KERYQKIGDT 235 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH--HHHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH--HHHHHHHHhh
Confidence 876443322 12356799999999999999999999999999999999999999975432111 1111111111
Q ss_pred hhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 520 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 520 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
......... ....+ .+.+++..||+.||.+||++.+|.+.|+..
T Consensus 236 ~~~~~~~~~---------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 236 KRATPIEVL---------CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HHHSCHHHH---------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred hccCCHHHH---------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 111000000 00112 789999999999999999999999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=366.66 Aligned_cols=252 Identities=28% Similarity=0.388 Sum_probs=207.0
Q ss_pred HHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCC-cceeE
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT-ERLLV 369 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lv 369 (619)
...++|.+.+.||+|+||.||+|.+. |+.||||+++... ..+.|.+|++++++++||||+++++++.... ..++|
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 45577888999999999999999985 7899999997533 4578999999999999999999999987665 68999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||+++|+|.+++.... ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 266 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 99999999999998643 23478899999999999999999999 99999999999999999999999999998543
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
.. .....+++.|+|||.+.+..++.++|||||||++|||+| |+.||....... . ........+
T Consensus 341 ~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-----~---~~~i~~~~~---- 404 (450)
T 1k9a_A 341 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----V---VPRVEKGYK---- 404 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-----H---HHHHHTTCC----
T ss_pred cc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----H---HHHHHcCCC----
Confidence 22 122357889999999999999999999999999999999 999997533211 1 111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
...+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 405 ------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 405 ------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 112233456889999999999999999999999999874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=347.75 Aligned_cols=266 Identities=23% Similarity=0.357 Sum_probs=205.3
Q ss_pred HhcCCcccCccccCCCceEEEEEe-----CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCC--C
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--T 364 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~ 364 (619)
..++|++.+.||+|+||+||+|.+ .+|+.||||++... .....+.+.+|++++++++||||+++++++... .
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 457789999999999999999984 36889999998643 344557899999999999999999999998553 5
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 444 (619)
..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred ceEEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 5889999999999999997642 3488999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCcc--eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccc-------ccchhHHHH
Q 007073 445 AKLVDVRKTN--VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE-------EDDVLLLDH 515 (619)
Q Consensus 445 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~-------~~~~~~~~~ 515 (619)
++........ ......++..|+|||.+.+..++.++||||||+++|||+||..|+....... .........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 9876543221 2223457788999999999999999999999999999999999986432110 000000000
Q ss_pred HHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 516 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 516 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
... .+........+...+..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 241 ~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 241 LIE---------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHH---------HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH---------HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 000 0111111112334456889999999999999999999999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=353.26 Aligned_cols=252 Identities=20% Similarity=0.300 Sum_probs=200.2
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCc------
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE------ 365 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------ 365 (619)
.++|++.+.||+|+||.||+|.+. +|+.||||++.........+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 357889999999999999999986 7999999999765555667889999999999999999999998855432
Q ss_pred ---------------------------------------------------ceeEecccccchhhhhhcccCCCCCCcCH
Q 007073 366 ---------------------------------------------------RLLVYPFMQNLSVAYRLREIKPGEPVLDW 394 (619)
Q Consensus 366 ---------------------------------------------------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~ 394 (619)
.++||||+++|+|.+++..... ....++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence 6899999999999999986433 233566
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCc-----------ceeeeccccc
Q 007073 395 VTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT-----------NVTTQVRGTM 463 (619)
Q Consensus 395 ~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~gt~ 463 (619)
..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 77899999999999999999 999999999999999999999999999987754321 1123356999
Q ss_pred cccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHH
Q 007073 464 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVE 543 (619)
Q Consensus 464 ~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 543 (619)
.|+|||.+.+..++.++|||||||++|||+||..|+.. .......... ... .........
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----------~~~~~~~~~~-~~~---------~~~~~~~~~ 300 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----------RVRIITDVRN-LKF---------PLLFTQKYP 300 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----------HHHHHHHHHT-TCC---------CHHHHHHCH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----------HHHHHHHhhc-cCC---------CcccccCCh
Confidence 99999999999999999999999999999998766320 0001111100 000 001123446
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 544 TMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 544 ~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.+.+++.+||+.||++|||+.|+++
T Consensus 301 ~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 301 QEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHccCCCCcCCCHHHHhh
Confidence 7789999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=342.16 Aligned_cols=254 Identities=28% Similarity=0.488 Sum_probs=203.1
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchH------HHHHHHHHHHHHccCCCccceeeeeeCCC
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGD------AAFQREVEMISVAVHRNLLRLIGFCTTPT 364 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~------~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 364 (619)
..++|++.+.||+|+||+||+|.+. +++.||||++......... +.+.+|++++++++||||+++++++....
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 3467899999999999999999974 7899999998643322211 67899999999999999999999986554
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEeCCCCc-----E
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK--IIHRDVKAANVLLDEDFE-----A 437 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~-----~ 437 (619)
++||||+++|+|.+.+... ...+++..+..++.|++.||+|||++ + |+||||||+||+++.++. +
T Consensus 97 --~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred --eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeE
Confidence 7999999999998888653 33589999999999999999999999 8 999999999999988776 9
Q ss_pred EEcccccceeeccCCcceeeeccccccccccccc--cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHH
Q 007073 438 VVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL--STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH 515 (619)
Q Consensus 438 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~ 515 (619)
||+|||+++.... ......||+.|+|||.+ ....++.++||||||+++|||+||+.||....... . ..
T Consensus 169 kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~---~~ 238 (287)
T 4f0f_A 169 KVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK---I---KF 238 (287)
T ss_dssp EECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH---H---HH
T ss_pred EeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH---H---HH
Confidence 9999999974332 23445799999999998 34567899999999999999999999997433211 1 11
Q ss_pred HHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 516 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 516 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
....... ......+...+..+.+++.+||+.||++|||+.++++.|++
T Consensus 239 ~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 239 INMIREE---------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHHHS---------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHhcc---------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1111111 11112223344678999999999999999999999999976
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=342.15 Aligned_cols=254 Identities=26% Similarity=0.383 Sum_probs=195.7
Q ss_pred hcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCC---cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFES---PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
.++|+..+.||+|+||.||+|.+. |+.||||+++.... ....+.+.+|+++++.++||||+++++++..++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 467889999999999999999985 89999999864322 23357789999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC--------CCcEEEcc
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE--------DFEAVVGD 441 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--------~~~~kl~D 441 (619)
|||+++++|.+++.. ..+++..+..++.|+++||+|||++...+|+||||||+||+++. ++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999998853 24889999999999999999999992122999999999999986 67899999
Q ss_pred cccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007073 442 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 521 (619)
Q Consensus 442 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 521 (619)
||+++...... .....||+.|+|||.+.+..++.++||||||+++|||+||+.||...... ........
T Consensus 160 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~ 228 (271)
T 3dtc_A 160 FGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL--------AVAYGVAM 228 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH--------HHHHHHHT
T ss_pred CCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHhhhc
Confidence 99998654322 22346899999999999999999999999999999999999999643211 01111111
Q ss_pred hcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 522 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 522 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
.......+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus 229 ---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 229 ---------NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp ---------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred ---------CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 111111223334678999999999999999999999999976
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=351.45 Aligned_cols=249 Identities=22% Similarity=0.259 Sum_probs=205.0
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
.++|++.+.||+|+||+||+|... +|+.||+|++++.. .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467899999999999999999975 68999999986421 233456788999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||+++|+|..++.... .++...+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999987633 388999999999999999999999 99999999999999999999999999998543
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
.. ........||+.|+|||.+.+..++.++|||||||++|||+||+.||...... ......... ..
T Consensus 157 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~~~-~~---- 222 (337)
T 1o6l_A 157 SD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLFELILME-EI---- 222 (337)
T ss_dssp CT-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC-CC----
T ss_pred cC-CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH--------HHHHHHHcC-CC----
Confidence 22 22234567999999999999999999999999999999999999999643211 111111111 00
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 568 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 568 (619)
.++...+.++.+++.+||+.||++|| ++.|+++
T Consensus 223 ------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 ------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 11222346789999999999999999 8888874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=350.50 Aligned_cols=271 Identities=26% Similarity=0.391 Sum_probs=217.7
Q ss_pred ccCHHHHHHHhcCCcccCccccCCCceEEEEEe------CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccc
Q 007073 283 RYSWRELQLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLR 355 (619)
Q Consensus 283 ~~~~~el~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~ 355 (619)
.+...+++...++|.+.+.||+|+||+||+|.+ .+++.||||+++........+.+.+|+++++++ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 345566677788999999999999999999984 356899999998655555667899999999999 6999999
Q ss_pred eeeeeeCCC-cceeEecccccchhhhhhcccCCC------------CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 007073 356 LIGFCTTPT-ERLLVYPFMQNLSVAYRLREIKPG------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHR 422 (619)
Q Consensus 356 l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~ 422 (619)
+++++...+ ..++||||+++|+|.+++...... ...+++..+..++.|++.||.|||++ +|+||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence 999987765 489999999999999999864432 22388999999999999999999999 99999
Q ss_pred CCCCCcEEeCCCCcEEEcccccceeeccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCC
Q 007073 423 DVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 500 (619)
Q Consensus 423 Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~ 500 (619)
||||+||+++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 99999999999999999999999876443322 2334567889999999999999999999999999999999 999986
Q ss_pred CCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 501 FSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
...... .. ......... ...+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 253 ~~~~~~----~~---~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 253 GVKIDE----EF---CRRLKEGTR----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp TCCCSH----HH---HHHHHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccchhH----HH---HHHhccCcc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 533211 11 111111111 011122335789999999999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=341.49 Aligned_cols=256 Identities=26% Similarity=0.391 Sum_probs=210.7
Q ss_pred HhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
..++|.+.+.||+|+||.||+|.+.+++.||+|++.... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 356788899999999999999999888999999997533 235789999999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++++|.+++.... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CCTTCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 999999999997632 3488999999999999999999999 9999999999999999999999999999865432
Q ss_pred CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
.........++..|+|||.+.+..++.++||||||+++|||+| |+.||...... ...........
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~i~~~~~------ 223 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--------EVVEDISTGFR------ 223 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTTCC------
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH--------HHHHHHhcCCc------
Confidence 2222233457789999999998999999999999999999999 89998643211 11111111100
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
...+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 224 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 224 ----LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011122345789999999999999999999999999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=356.55 Aligned_cols=254 Identities=22% Similarity=0.259 Sum_probs=200.2
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcce
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 367 (619)
..++|++.++||+|+||+||+|+.+ +++.||||++++.. .......+..|..++.++ +||||+++++++.+.+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 4568999999999999999999975 57899999997532 222335678899999877 8999999999999999999
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
+||||+++|+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 130 lV~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 9999999999999987643 389999999999999999999999 999999999999999999999999999985
Q ss_pred eccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccch
Q 007073 448 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527 (619)
Q Consensus 448 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (619)
.... ........||+.|+|||++.+..++.++|||||||++|||+||+.||..........................
T Consensus 203 ~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-- 279 (396)
T 4dc2_A 203 GLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-- 279 (396)
T ss_dssp CCCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--
T ss_pred cccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--
Confidence 3222 2234456799999999999999999999999999999999999999964322211111111111111111110
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 007073 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAM 563 (619)
Q Consensus 528 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 563 (619)
.++...+.++.+++.+||+.||++||++
T Consensus 280 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 --------RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred --------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1122334678999999999999999996
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=368.11 Aligned_cols=264 Identities=19% Similarity=0.239 Sum_probs=210.9
Q ss_pred CHHHHHHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeee
Q 007073 285 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCT 361 (619)
Q Consensus 285 ~~~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 361 (619)
.++++....++|++.++||+|+||+||+|... +++.||||++.+.. .......+.+|..++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34566677889999999999999999999976 57899999986421 1122334889999999999999999999999
Q ss_pred CCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcc
Q 007073 362 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD 441 (619)
Q Consensus 362 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 441 (619)
+.+..++||||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence 999999999999999999999763 23489999999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCcceeeecccccccccccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHH
Q 007073 442 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV 516 (619)
Q Consensus 442 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 516 (619)
||+++..............||+.|+|||++. ...++.++|||||||++|||+||+.||...... +..
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~--------~~~ 290 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--------ETY 290 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHH
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh--------HHH
Confidence 9999877655544455568999999999997 567899999999999999999999999743221 111
Q ss_pred HHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 007073 517 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPED--RPAMSEVVR 568 (619)
Q Consensus 517 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~ 568 (619)
..+..... ....+ ......+.++.+++.+|+..+|++ ||+++|+++
T Consensus 291 ~~i~~~~~--~~~~p----~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 291 GKIMNHKE--RFQFP----TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHHTHHH--HCCCC----SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred Hhhhhccc--cccCC----cccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 11111000 00000 001112357889999999998888 999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=351.64 Aligned_cols=267 Identities=25% Similarity=0.340 Sum_probs=208.6
Q ss_pred CcccCccccCCCceEEEEEeC-----CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCC--Cccee
Q 007073 296 FSEKNVLGQGGFGKVYRGVLA-----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERLL 368 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~~-----~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l 368 (619)
|++.+.||+|+||+||++.+. +|+.||||+++........+.+.+|++++++++||||+++++++... ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488999999999999998753 68899999998665555677899999999999999999999999874 56789
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999753 288999999999999999999999 9999999999999999999999999999877
Q ss_pred ccCCcc--eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 449 DVRKTN--VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 449 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
...... ......||..|+|||.+.+..++.++||||||+++|||+||+.||......... ...+...........
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE---LIGIAQGQMTVLRLT 261 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH---HHCSCCHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh---hhcccccchhHHHHH
Confidence 544322 223445788899999999999999999999999999999999998643211000 000000000000111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
..+........+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11111112222334456899999999999999999999999999873
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=350.00 Aligned_cols=256 Identities=21% Similarity=0.298 Sum_probs=205.6
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccC----CCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcce
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF----ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~----~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 367 (619)
.+.|++.+.||+|+||+||+|... +|+.||||++... ......+.+.+|+.+++.++||||+++++++...+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 457999999999999999999975 6899999998531 11224678999999999999999999999999999999
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc---EEEccccc
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE---AVVGDFGL 444 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGl 444 (619)
+||||+++|+|.+.+.........+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999988876544445589999999999999999999999 9999999999999986654 99999999
Q ss_pred ceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 445 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 445 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
++....... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||..... .. ........
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~---~~~i~~~~- 248 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE------RL---FEGIIKGK- 248 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH------HH---HHHHHHTC-
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH------HH---HHHHHcCC-
Confidence 987654322 23345699999999999999999999999999999999999999964211 11 11111110
Q ss_pred cchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 525 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.. ..+... ...+..+.+++.+||+.||++|||+.++++
T Consensus 249 ~~--~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 249 YK--MNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CC--CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC--CCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 000000 112357899999999999999999999985
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=349.18 Aligned_cols=253 Identities=20% Similarity=0.246 Sum_probs=205.5
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCc-----chHHHHHHHHHHHHHccCCCccceeeeeeCCCc
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP-----GGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE 365 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 365 (619)
..+.|.+.+.||+|+||.||+|... +|+.||+|.+...... ...+.+.+|+.++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3467999999999999999999975 6899999999754322 235789999999999999999999999999999
Q ss_pred ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC----cEEEcc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF----EAVVGD 441 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~D 441 (619)
.++||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++ .+||+|
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 99999999999999999753 3489999999999999999999999 999999999999998876 799999
Q ss_pred cccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007073 442 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 521 (619)
Q Consensus 442 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 521 (619)
||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ........
T Consensus 163 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~--------~~~~~i~~ 232 (361)
T 2yab_A 163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANITA 232 (361)
T ss_dssp CSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHT
T ss_pred cCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHh
Confidence 99998765432 234457999999999999999999999999999999999999999643211 11111111
Q ss_pred hcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 522 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 522 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.. . -.+... ....+..+.+++.+|++.||++|||+.|+++
T Consensus 233 ~~-~--~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 233 VS-Y--DFDEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp TC-C--CCCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cC-C--CCCchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0 000000 0112357889999999999999999999885
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=345.33 Aligned_cols=259 Identities=28% Similarity=0.418 Sum_probs=211.1
Q ss_pred HHHHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 289 LQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 289 l~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
+++..++|.+.+.||+|+||.||+|...++..||||.++... ...+.+.+|++++++++||||+++++++. .+..++
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 84 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI 84 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence 345567899999999999999999999888899999986432 34678999999999999999999999886 456899
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||+++++|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 85 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp EEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 999999999999997532 12488999999999999999999999 9999999999999999999999999999877
Q ss_pred ccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccch
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (619)
............++..|+|||.+.+..++.++||||||+++|||+| |+.||...... +..........
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~~~~~~~~~~--- 228 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--------EVIQNLERGYR--- 228 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTCC---
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--------HHHHHHhcccC---
Confidence 5443333334457889999999998899999999999999999999 89998643211 11111111110
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 528 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
...+...+..+.+++.+|++.||++|||+.++++.|+..
T Consensus 229 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 229 -------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 111222346789999999999999999999999999873
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=344.15 Aligned_cols=250 Identities=24% Similarity=0.326 Sum_probs=195.8
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCc-------------------------chHHHHHHHHHHHH
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP-------------------------GGDAAFQREVEMIS 346 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-------------------------~~~~~~~~E~~~l~ 346 (619)
.++|.+.+.||+|+||.||+|... +|+.||||++...... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467999999999999999999964 6899999998643211 12356889999999
Q ss_pred HccCCCccceeeeeeC--CCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 007073 347 VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDV 424 (619)
Q Consensus 347 ~l~H~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl 424 (619)
+++||||+++++++.. ....++||||+++++|.+++.. ..+++..+..++.|+++||+|||++ +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999986 4568999999999999876543 3489999999999999999999999 9999999
Q ss_pred CCCcEEeCCCCcEEEcccccceeeccCCcceeeeccccccccccccccCCC---CCcchhhHHHHHHHHHHHhCCCCCCC
Q 007073 425 KAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK---SSERTDVFGYGIMLLELVTGQRAIDF 501 (619)
Q Consensus 425 kp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gv~l~elltg~~p~~~ 501 (619)
||+||+++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++|||||||++|||+||+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999987654332 234457999999999997765 37899999999999999999999964
Q ss_pred CccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 502 SRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
... ......... .... .......+..+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~--------~~~~~~~~~-~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERI--------MCLHSKIKS-QALE--------FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSH--------HHHHHHHHH-CCCC--------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccH--------HHHHHHHhc-ccCC--------CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 321 111111111 1100 0001122357899999999999999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=342.78 Aligned_cols=257 Identities=21% Similarity=0.350 Sum_probs=205.5
Q ss_pred HhcCCcccCccccCCCceEEEEEeCC----CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcce
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 367 (619)
..++|.+.+.||+|+||+||+|.+.+ +..||||.+.........+.+.+|+.++++++||||+++++++.. +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45789999999999999999998642 346999999765555567889999999999999999999999865 4568
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
+||||+++++|.+++.... ..+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 9999999999999997632 3488999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 448 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 448 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
.............+++.|+|||.+.+..++.++||||||+++|||+| |+.||...... ...... ......
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-----~~~~~~---~~~~~~- 233 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-----DVIGVL---EKGDRL- 233 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-----GHHHHH---HHTCCC-
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-----HHHHHH---hcCCCC-
Confidence 65443333344567889999999998999999999999999999999 99999643221 111111 111110
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
..+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 234 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 234 ---------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 11122345789999999999999999999999999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=356.28 Aligned_cols=267 Identities=16% Similarity=0.180 Sum_probs=202.1
Q ss_pred HhcCCcccCccccCCCceEEEEEeCC------CcEEEEEEeccCCCcc----------hHHHHHHHHHHHHHccCCCccc
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPG----------GDAAFQREVEMISVAVHRNLLR 355 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~~~----------~~~~~~~E~~~l~~l~H~niv~ 355 (619)
..++|.+.+.||+|+||+||+|.+.+ ++.||||++....... ....+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999999754 4789999986432100 0012334445566678999999
Q ss_pred eeeeeeCC----CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe
Q 007073 356 LIGFCTTP----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL 431 (619)
Q Consensus 356 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 431 (619)
+++++... ...++||||+ +++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence 99998764 3479999999 99999999763 24489999999999999999999999 99999999999999
Q ss_pred C--CCCcEEEcccccceeeccCCcce------eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 007073 432 D--EDFEAVVGDFGLAKLVDVRKTNV------TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSR 503 (619)
Q Consensus 432 ~--~~~~~kl~DfGla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~ 503 (619)
+ .++.+||+|||+++.+....... .....||+.|+|||.+.+..++.++|||||||++|||+||+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 88999999999998765332211 133459999999999999999999999999999999999999997422
Q ss_pred cccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 504 LEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.. ......... .....+..++++.+.. ...+.++.+++..||+.+|++||++.+|++.|+..
T Consensus 266 ~~----~~~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 266 KD----PKYVRDSKI-RYRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp TC----HHHHHHHHH-HHHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cC----HHHHHHHHH-HhhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 11 111111111 1112233333333221 12235789999999999999999999999999874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=349.75 Aligned_cols=265 Identities=24% Similarity=0.356 Sum_probs=207.8
Q ss_pred hcCCcccCccccCCCceEEEEEe-----CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCC--Cc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TE 365 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~ 365 (619)
.+.|+..+.||+|+||.||+|.+ .+|+.||||+++........+.+.+|++++++++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35688899999999999999984 368999999998655555678899999999999999999999999876 56
Q ss_pred ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 445 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 445 (619)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence 789999999999999996533 3389999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcc--eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccc-------cccchhHHHHH
Q 007073 446 KLVDVRKTN--VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLE-------EEDDVLLLDHV 516 (619)
Q Consensus 446 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~-------~~~~~~~~~~~ 516 (619)
......... ......||..|+|||.+.+..++.++||||||+++|||+||+.|+...... ...........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 877544332 223456888899999999999999999999999999999999986432110 00000011111
Q ss_pred HHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 517 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 517 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.... .......+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 254 ~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 254 NTLK----------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHH----------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHh----------ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 1111 1111112333456889999999999999999999999999863
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=364.26 Aligned_cols=260 Identities=20% Similarity=0.249 Sum_probs=208.6
Q ss_pred HHHHHHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeC
Q 007073 286 WRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT 362 (619)
Q Consensus 286 ~~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 362 (619)
.+++....++|++.+.||+|+||+||+|... +|+.||+|++.+.. .......+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3455667789999999999999999999976 58899999986421 11223457889999999999999999999999
Q ss_pred CCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007073 363 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 442 (619)
Q Consensus 363 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 442 (619)
....++||||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence 99999999999999999998752 378899999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcceeeeccccccccccccccCCC----CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH
Q 007073 443 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK----SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 518 (619)
Q Consensus 443 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 518 (619)
|+++..............||+.|+|||++.+.. ++.++|||||||++|||+||+.||...... .....
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~ 284 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSK 284 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHH
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh--------hHHHH
Confidence 999877654444444667999999999997665 789999999999999999999999743221 11111
Q ss_pred HhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 007073 519 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPED--RPAMSEVVR 568 (619)
Q Consensus 519 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~ 568 (619)
+...... ...+ .....+.++.+++.+|++.+|++ ||+++||++
T Consensus 285 i~~~~~~--~~~p-----~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 285 IMNHKNS--LTFP-----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHTHHHH--CCCC-----TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred HHhcccc--ccCC-----CcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 1111000 0000 01122357889999999999998 999999885
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=353.82 Aligned_cols=256 Identities=27% Similarity=0.395 Sum_probs=203.2
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcE----EEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcce
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTK----VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~----vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 367 (619)
.++|++.+.||+|+||+||+|.+. +|+. ||+|.+...........+.+|+.++++++||||+++++++. ....+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 457888999999999999999964 4443 88888765444444567788999999999999999999886 45688
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
+||||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence 999999999999999753 23488889999999999999999999 999999999999999999999999999987
Q ss_pred eccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 448 VDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 448 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
....... ......||..|+|||.+.+..++.++||||||+++|||+| |+.||...... .... ........
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~---~~~~~~~~ 236 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-----EVPD---LLEKGERL 236 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-----HHHH---HHHTTCBC
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH-----HHHH---HHHcCCCC
Confidence 6543322 2344567889999999999999999999999999999999 99999753321 1111 11111110
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
..+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 237 ----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~ 274 (325)
T 3kex_A 237 ----------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274 (325)
T ss_dssp ----------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred ----------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111234678899999999999999999999999875
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=343.03 Aligned_cols=252 Identities=19% Similarity=0.248 Sum_probs=204.8
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCc-----chHHHHHHHHHHHHHccCCCccceeeeeeCCCcc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP-----GGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 366 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 366 (619)
.+.|.+.+.||+|+||.||+|... +|+.||+|.+...... ...+.+.+|+.++++++||||+++++++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456889999999999999999975 6899999998653321 2467899999999999999999999999999999
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC----cEEEccc
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF----EAVVGDF 442 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df 442 (619)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 9999999999999999753 3489999999999999999999999 999999999999999887 8999999
Q ss_pred ccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh
Q 007073 443 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 522 (619)
Q Consensus 443 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 522 (619)
|+++...... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||...... .........
T Consensus 163 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~~~~~ 232 (326)
T 2y0a_A 163 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANVSAV 232 (326)
T ss_dssp TTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHHT
T ss_pred CCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--------HHHHHHHhc
Confidence 9998765332 233456999999999999999999999999999999999999999643211 111111110
Q ss_pred cccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 523 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 523 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. . . ..... ....+..+.+++.+||+.||++|||+.++++
T Consensus 233 ~-~-~-~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 233 N-Y-E-FEDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp C-C-C-CCHHH----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C-C-C-cCccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 0 0 00000 0112357889999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=352.68 Aligned_cols=264 Identities=25% Similarity=0.357 Sum_probs=196.7
Q ss_pred HHHHhcCCcccCccccCCCceEEEEEeCC-C---cEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCC
Q 007073 289 LQLATDNFSEKNVLGQGGFGKVYRGVLAD-G---TKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP 363 (619)
Q Consensus 289 l~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-g---~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 363 (619)
+....++|++.+.||+|+||+||+|.+.. + ..||||+++... .....+.+.+|++++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 34456789999999999999999999753 3 279999987532 344567899999999999999999999999877
Q ss_pred Ccc------eeEecccccchhhhhhcccCC--CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC
Q 007073 364 TER------LLVYPFMQNLSVAYRLREIKP--GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 435 (619)
Q Consensus 364 ~~~------~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 435 (619)
... ++||||+++|+|.+++..... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCC
Confidence 655 899999999999999965432 223589999999999999999999999 999999999999999999
Q ss_pred cEEEcccccceeeccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHH
Q 007073 436 EAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLL 513 (619)
Q Consensus 436 ~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~ 513 (619)
.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||+| |+.||...... ...
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----~~~ 249 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA-----EIY 249 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GHH
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH-----HHH
Confidence 9999999999876433222 2233457889999999999999999999999999999999 89998653321 111
Q ss_pred HHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 514 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
........ ...+...+..+.+++.+||+.||++|||+.++++.|++.
T Consensus 250 ---~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 250 ---NYLIGGNR----------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp ---HHHHTTCC----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHhcCCC----------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111110 111223346789999999999999999999999999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=341.27 Aligned_cols=256 Identities=25% Similarity=0.343 Sum_probs=208.5
Q ss_pred hcCCcccC-ccccCCCceEEEEEeC---CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 293 TDNFSEKN-VLGQGGFGKVYRGVLA---DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 293 ~~~~~~~~-~lg~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
.++|.+.+ .||+|+||.||+|.+. ++..||||+++........+.+.+|++++++++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 45566666 8999999999999864 57889999998655555678899999999999999999999999 4556899
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||+++++|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 87 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 99999999999998742 33489999999999999999999999 9999999999999999999999999999877
Q ss_pred ccCCcce--eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 449 DVRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 449 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
....... .....||+.|+|||.+.+..++.++||||||+++|||+| |+.||...... +.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~~~i~~~~-- 230 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQGK-- 230 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------HHHHHHHTTC--
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHhcCC--
Confidence 5433322 223346889999999988889999999999999999999 99999643221 1111111111
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
....+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus 231 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 231 --------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp --------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0112233446889999999999999999999999999874
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=342.88 Aligned_cols=251 Identities=18% Similarity=0.231 Sum_probs=205.1
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.++|.+.+.||+|+||+||+|... +|+.||+|.+... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 467899999999999999999975 6889999998632 3345678899999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC--CCcEEEcccccceeec
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE--DFEAVVGDFGLAKLVD 449 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~~~ 449 (619)
|+++|+|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+||+++. ++.+||+|||+++...
T Consensus 82 ~~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 82 FISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred eCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 99999999998753 23488999999999999999999999 9999999999999987 7899999999998765
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||...... +........... .
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~~~---~ 222 (321)
T 1tki_A 156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--------QIIENIMNAEYT---F 222 (321)
T ss_dssp TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCCC---C
T ss_pred CCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--------HHHHHHHcCCCC---C
Confidence 432 334456999999999999888999999999999999999999999643211 111111111000 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.... ....+.++.+++.+|++.||++|||+.|+++
T Consensus 223 ~~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 223 DEEA----FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Chhh----hccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000 0112357899999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=352.01 Aligned_cols=268 Identities=24% Similarity=0.381 Sum_probs=216.3
Q ss_pred CHHHHHHHhcCCcccCccccCCCceEEEEEeC------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceee
Q 007073 285 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 358 (619)
Q Consensus 285 ~~~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 358 (619)
..++++...++|.+.+.||+|+||.||+|.+. +++.||||.+...........+.+|++++++++||||+++++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 33455667889999999999999999999864 368899999976555555678999999999999999999999
Q ss_pred eeeCCCcceeEecccccchhhhhhcccC------CCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC
Q 007073 359 FCTTPTERLLVYPFMQNLSVAYRLREIK------PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD 432 (619)
Q Consensus 359 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 432 (619)
++...+..++||||+++|+|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+||+++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~ 172 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 172 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEEC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEc
Confidence 9999999999999999999999987532 1123478899999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccceeeccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccch
Q 007073 433 EDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDV 510 (619)
Q Consensus 433 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~ 510 (619)
.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||......
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----- 247 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----- 247 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-----
T ss_pred CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH-----
Confidence 9999999999999865433221 1223356889999999999999999999999999999999 88888643211
Q ss_pred hHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 511 LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
+......... . .......+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 248 ---~~~~~~~~~~-~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 248 ---QVLRFVMEGG-L---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp ---HHHHHHHTTC-C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred ---HHHHHHHcCC-c---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 1111111111 1 011223345789999999999999999999999999885
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=348.34 Aligned_cols=253 Identities=22% Similarity=0.260 Sum_probs=200.7
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCccee
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 368 (619)
.++|++.+.||+|+||.||+|+.. +|+.||+|++++.. .....+.+.+|..++.++ +||||+++++++......++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 367889999999999999999975 68999999997532 233456688999999987 89999999999999999999
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||+++|+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 999999999999997643 388999999999999999999999 9999999999999999999999999999854
Q ss_pred ccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
.... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||..........................
T Consensus 161 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~--- 236 (345)
T 3a8x_A 161 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--- 236 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC---
T ss_pred cCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC---
Confidence 3222 223456799999999999999999999999999999999999999964322111110001111111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAM 563 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 563 (619)
.++...+..+.+++.+||+.||++||++
T Consensus 237 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 -------RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -------CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1122334678999999999999999996
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=341.35 Aligned_cols=264 Identities=20% Similarity=0.255 Sum_probs=200.8
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
++|++.+.||+|+||+||+|... +|+.||||++.... .......+.+|+.++++++||||+++++++..++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57889999999999999999975 68999999997543 33345788899999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|++++.+ ..+... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~~l~-~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQDLK-KYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHH-HHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCCCHH-HHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9987444 444332 23489999999999999999999999 9999999999999999999999999999876433
Q ss_pred CcceeeeccccccccccccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc--cc---
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK--RL--- 525 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~--- 525 (619)
. .......||+.|+|||.+.+.. ++.++|||||||++|||+||+.|+...... ...+........... ..
T Consensus 155 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~---~~~~~~i~~~~~~~~~~~~~~~ 230 (292)
T 3o0g_A 155 V-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV---DDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp C-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH---HHHHHHHHHHHCCCCTTTCTTG
T ss_pred c-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH---HHHHHHHHHHhCCCChhhhhhh
Confidence 2 2233456899999999997766 799999999999999999998886432211 111111111111000 00
Q ss_pred chhcc---------ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 526 DAIVD---------RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 526 ~~~~~---------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
....+ ........+.....+.+++.+|++.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000 00001112234567889999999999999999999985
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=344.04 Aligned_cols=267 Identities=23% Similarity=0.319 Sum_probs=191.3
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.++|++.+.||+|+||+||+|... +|+.||+|+++..........+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467889999999999999999965 6899999999754444455778899999999999999999999999999999999
Q ss_pred ccccchhhhhhcccC--CCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 372 FMQNLSVAYRLREIK--PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|++ |+|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 58888886532 2223488999999999999999999999 99999999999999999999999999998764
Q ss_pred cCCcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh--cccc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE--KRLD 526 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 526 (619)
.... ......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||....... .+.......... ....
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE----QLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCSCCTTTCG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCChhHhh
Confidence 3222 2234568999999999976 468999999999999999999999997533211 111111111000 0000
Q ss_pred hh-----ccccc------------cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 527 AI-----VDRNL------------NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 527 ~~-----~~~~l------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.+ ..+.. ........+..+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00 00000 00001122357899999999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=349.36 Aligned_cols=256 Identities=25% Similarity=0.399 Sum_probs=202.0
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCc----EEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcce
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGT----KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 367 (619)
.++|++.+.||+|+||+||+|.+. +++ +||+|.+.........+.+.+|+.++++++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467899999999999999999964 444 368888876555667888999999999999999999999998754 78
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
+|++|+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 9999999999999997643 3488999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 448 VDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 448 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
....... ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||....... .... .....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----~~~~---~~~~~-- 236 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISSI---LEKGE-- 236 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HHHH---HHTTC--
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----HHHH---HHcCC--
Confidence 6433222 2233456889999999999999999999999999999999 999997533211 1111 11111
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
....+...+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 237 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 276 (327)
T 3lzb_A 237 --------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp --------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111223345789999999999999999999999999875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=340.25 Aligned_cols=263 Identities=22% Similarity=0.325 Sum_probs=199.4
Q ss_pred cCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCC-cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
++|++.+.||+|+||+||+|...+|+.||+|++..... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57889999999999999999998899999999864332 22346788999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++ +|.+++.... ..++...+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 986 8888886532 3488899999999999999999999 99999999999999999999999999998654322
Q ss_pred cceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc--ccch--
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK--RLDA-- 527 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-- 527 (619)
.......||+.|+|||.+.+. .++.++|||||||++|||+||+.||...... ..+........... ....
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA----DQLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHHHCCCCTTTSTTGG
T ss_pred -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHHCCCChhhchhhh
Confidence 122344689999999998764 5899999999999999999999999743211 11111111110000 0000
Q ss_pred ---hcccccc-------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 528 ---IVDRNLN-------KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 528 ---~~~~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..++... .......+..+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000 0011223467889999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=347.37 Aligned_cols=257 Identities=25% Similarity=0.414 Sum_probs=202.9
Q ss_pred hcCCcccCccccCCCceEEEEEeCC-----CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcce
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLAD-----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 367 (619)
.++|...+.||+|+||.||+|.+.. +..||||.++..........+.+|++++++++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4567778999999999999998642 24699999976555555678999999999999999999999999999999
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
+||||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999763 23489999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCcc--eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 448 VDVRKTN--VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 448 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
....... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...... +..........
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--------~~~~~~~~~~~ 268 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--------EVMKAINDGFR 268 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTTCC
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHHCCCc
Confidence 6543221 1223346788999999999999999999999999999999 99998643211 11111111111
Q ss_pred cchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 525 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
...+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus 269 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 269 ----------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp ----------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111223346789999999999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=374.71 Aligned_cols=261 Identities=26% Similarity=0.385 Sum_probs=212.8
Q ss_pred HHHHHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcce
Q 007073 288 ELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 288 el~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 367 (619)
.+++..++|.+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|++++++++||||+++++++.. +..+
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 3455677889999999999999999999888899999997533 345789999999999999999999999876 6789
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
+||||+++|+|.+++.... ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 338 lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp EEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred EeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 9999999999999997532 13388999999999999999999999 999999999999999999999999999986
Q ss_pred eccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 448 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 448 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
.............++..|+|||.+.+..++.++|||||||++|||+| |+.||...... +....+....++
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--------~~~~~i~~~~~~- 483 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQVERGYRM- 483 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--------HHHHHHHTTCCC-
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCC-
Confidence 54322222233456789999999999999999999999999999999 89998643211 111222111111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 574 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 574 (619)
..+...+..+.+++.+||+.||++|||+.+|+++|+...
T Consensus 484 ---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 484 ---------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 112233467899999999999999999999999999853
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=358.85 Aligned_cols=254 Identities=18% Similarity=0.227 Sum_probs=204.5
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC-cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
..++|++.+.||+|+||+||+|... +|+.||+|++..... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4567999999999999999999964 789999999865432 23456788999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC---CCCcEEEcccccce
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGDFGLAK 446 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGla~ 446 (619)
|||+++|+|.+.+... ..+++.....++.|++.||+|||++ +|+||||||+|||++ .++.+||+|||+++
T Consensus 89 ~E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 9999999999998763 3389999999999999999999999 999999999999998 56789999999998
Q ss_pred eeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 447 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 447 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||..... . ......... ...
T Consensus 162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-----~---~~~~~i~~~-~~~ 231 (444)
T 3soa_A 162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-----H---RLYQQIKAG-AYD 231 (444)
T ss_dssp CCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----H---HHHHHHHHT-CCC
T ss_pred EecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-----H---HHHHHHHhC-CCC
Confidence 7654322 23346799999999999999999999999999999999999999964321 1 111111111 000
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.........+..+.+++.+||+.||++|||+.|+++
T Consensus 232 ------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 232 ------FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp ------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ------CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000011223467899999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=338.44 Aligned_cols=254 Identities=21% Similarity=0.287 Sum_probs=201.4
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.++|.+.+.||+|+||+||+|... +|..||+|++.........+.+.+|++++++++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 467889999999999999999974 6899999999765555567889999999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe---CCCCcEEEcccccceee
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~~ 448 (619)
|+++|+|.+.+.........+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999999876543345589999999999999999999999 99999999999999 45688999999999865
Q ss_pred ccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
.... ......||+.|+|||.+. +.++.++||||||+++|||+||+.||...... ..............
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~--------~~~~~~~~~~~~~~- 245 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE--------EVQQKATYKEPNYA- 245 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCCC-
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH--------HHHhhhccCCcccc-
Confidence 4332 233456899999999885 57899999999999999999999999743221 11111111100000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.. ....+..+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~-------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 246 VE-------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp C---------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cc-------cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0012357889999999999999999999985
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=351.85 Aligned_cols=250 Identities=23% Similarity=0.309 Sum_probs=203.2
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
.++|.+.+.||+|+||.||+|... +|+.||+|++.... .......+.+|+++++.++|||||++++++...+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467899999999999999999975 58899999986421 233457788999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||+.+|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 9999999999999753 3489999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCcceeeeccccccccccccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
.. .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... ............
T Consensus 167 ~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-----~~~~~~~~~~~~--- 236 (384)
T 4fr4_A 167 RE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS-----SKEIVHTFETTV--- 236 (384)
T ss_dssp TT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC-----HHHHHHHHHHCC---
T ss_pred CC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc-----HHHHHHHHhhcc---
Confidence 33 22345679999999999964 458999999999999999999999997432211 111111111100
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHH
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-MSEVV 567 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl 567 (619)
..++...+..+.+++.+||+.||++||+ ++++.
T Consensus 237 --------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 237 --------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp --------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred --------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 1112233467899999999999999998 66654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=340.02 Aligned_cols=252 Identities=22% Similarity=0.315 Sum_probs=204.7
Q ss_pred hcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCC--CcceeE
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERLLV 369 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv 369 (619)
.++|.+.+.||+|+||+||+|.+. |+.||||+++... .....+.|.+|+.++++++||||+++++++..+ ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 467888999999999999999985 8999999997543 334457799999999999999999999999887 678999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK--IIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
|||+++|+|.+++.... ...+++..+..++.|++.||+|||++ + |+||||||+||+++.++.++|+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence 99999999999998632 23589999999999999999999998 7 99999999999999999999999998764
Q ss_pred eccCCcceeeeccccccccccccccCCCCCc---chhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 448 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE---RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 448 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
... ....||+.|+|||.+.+..++. ++||||||+++|||+||+.||...... ..........
T Consensus 163 ~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~- 227 (271)
T 3kmu_A 163 FQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM--------EIGMKVALEG- 227 (271)
T ss_dssp TSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH--------HHHHHHHHSC-
T ss_pred ecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH--------HHHHHHHhcC-
Confidence 322 2245899999999998765544 899999999999999999999643211 1111111111
Q ss_pred cchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 525 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.....+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 228 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 228 --------LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 11112223346789999999999999999999999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=334.70 Aligned_cols=261 Identities=18% Similarity=0.241 Sum_probs=201.9
Q ss_pred HhcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeee-eCCCcceeE
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC-TTPTERLLV 369 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lv 369 (619)
..++|.+.+.||+|+||+||+|.. .+++.||||++..... ...+.+|+++++.++|++++..++++ ......++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 457899999999999999999996 5789999998754322 23578899999999998888777766 556677999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe---CCCCcEEEcccccce
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAK 446 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~ 446 (619)
|||+ +++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++
T Consensus 84 ~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EECC-CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEcc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 9999 999999987532 3489999999999999999999999 99999999999999 788999999999998
Q ss_pred eeccCCcc------eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh
Q 007073 447 LVDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 520 (619)
Q Consensus 447 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 520 (619)
........ ......||+.|+|||.+.+..++.++|||||||++|||+||+.||........... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~ 234 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK--YERISEKK 234 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH--HHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhh--hhhhhccc
Confidence 77543321 22345789999999999999999999999999999999999999975433222111 11111111
Q ss_pred hhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 521 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 521 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
........ ....+..+.+++.+||+.||++|||+.++++.|++.
T Consensus 235 ~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 235 MSTPIEVL---------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHSCHHHH---------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred ccchhhhh---------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 11000000 011235789999999999999999999999999873
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=350.15 Aligned_cols=253 Identities=22% Similarity=0.312 Sum_probs=197.5
Q ss_pred HhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccC--CCccceeeeeeCCCccee
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVH--RNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~l 368 (619)
..++|++.+.||+|+||.||++...+++.||||++.... .....+.+.+|++++++++| +||+++++++......++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 346789999999999999999999889999999986433 33345788999999999986 999999999999999999
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||| +.+++|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++ ++.+||+|||+++..
T Consensus 87 v~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEC-CCSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEe-CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 999 5688999999863 2488999999999999999999999 999999999999997 578999999999876
Q ss_pred ccCCcc-eeeeccccccccccccccC-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHH
Q 007073 449 DVRKTN-VTTQVRGTMGHIAPEYLST-----------GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV 516 (619)
Q Consensus 449 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 516 (619)
...... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...... ....
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~ 230 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISKL 230 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHHH
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-------HHHH
Confidence 543322 2334579999999999864 67899999999999999999999999632110 0111
Q ss_pred HHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 517 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 517 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
. .+.++.....++......+.+++.+||+.||++|||+.|+++.
T Consensus 231 ~---------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 231 H---------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp H---------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred H---------HHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1 1111111111222223578899999999999999999999853
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=347.63 Aligned_cols=254 Identities=20% Similarity=0.258 Sum_probs=205.2
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
..++|.+.+.||+|+||.||+|... +|+.||+|++.... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3567999999999999999999975 68999999997533 233456788999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC---CcEEEcccccce
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED---FEAVVGDFGLAK 446 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGla~ 446 (619)
|||+++|+|.+.+... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||++.
T Consensus 107 ~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 9999999999988753 3488999999999999999999999 99999999999999865 459999999998
Q ss_pred eeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 447 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 447 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..... . ......... ...
T Consensus 180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-----~---~~~~~i~~~-~~~ 248 (362)
T 2bdw_A 180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----H---RLYAQIKAG-AYD 248 (362)
T ss_dssp CCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H---HHHHHHHHT-CCC
T ss_pred EecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----H---HHHHHHHhC-CCC
Confidence 765332 23345799999999999999999999999999999999999999964321 1 111111111 000
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
.. .......+..+.+++.+||+.||++|||+.++++.
T Consensus 249 -~~-----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 -YP-----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -CC-----TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -CC-----cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 00011224578999999999999999999999853
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=354.61 Aligned_cols=274 Identities=18% Similarity=0.210 Sum_probs=214.8
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCC--cceeE
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT--ERLLV 369 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lv 369 (619)
.++|.+.+.||+|+||+||+|.+. +|+.||||++.........+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467899999999999999999976 589999999976544455678889999999999999999999998765 67899
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe----CCCCcEEEcccccc
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL----DEDFEAVVGDFGLA 445 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGla 445 (619)
|||+++|+|.+++..... ...+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999986432 23389999999999999999999999 99999999999999 78888999999999
Q ss_pred eeeccCCcceeeeccccccccccccccC--------CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHH
Q 007073 446 KLVDVRKTNVTTQVRGTMGHIAPEYLST--------GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 517 (619)
Q Consensus 446 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 517 (619)
+...... ......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||..................
T Consensus 164 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 164 RELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp EECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred eEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 8764432 2334569999999999865 56788999999999999999999999643322222111111111
Q ss_pred HHhhhcccchh---cc--------ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 518 KLEREKRLDAI---VD--------RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 518 ~~~~~~~~~~~---~~--------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
. ........+ .. -.............+.+++.+||+.||++||++.++++.++++
T Consensus 242 ~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 242 G-KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp S-CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred C-CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 1 111000000 00 0111234577888999999999999999999999999988874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=375.94 Aligned_cols=255 Identities=25% Similarity=0.351 Sum_probs=203.3
Q ss_pred cCCcccC-ccccCCCceEEEEEeC---CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 294 DNFSEKN-VLGQGGFGKVYRGVLA---DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 294 ~~~~~~~-~lg~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
+++.+.+ .||+|+||.||+|.+. ++..||||+++........+.|.+|++++++++|||||++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3444444 7999999999999864 4678999999866555667899999999999999999999999976 568999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 414 ~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EECCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEeCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 9999999999999753 34589999999999999999999999 99999999999999999999999999998764
Q ss_pred cCCccee--eeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 450 VRKTNVT--TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 450 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
....... ....+++.|+|||++.+..++.++|||||||++|||+| |+.||...... +....+....+
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------~~~~~i~~~~~-- 557 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQGKR-- 557 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--------HHHHHHHTTCC--
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--------HHHHHHHcCCC--
Confidence 3332221 22345689999999999999999999999999999998 99999753221 11112211111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
...+...+..+.+++.+||+.||++||++.+|++.|+..
T Consensus 558 --------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 558 --------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp --------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred --------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 112233456889999999999999999999999999873
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=344.58 Aligned_cols=247 Identities=21% Similarity=0.224 Sum_probs=193.8
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCccee
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 368 (619)
..++|+..+.||+|+||+||+|... +|+.||||++.... .......+..|+..+.++ +||||+++++++...+..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3467999999999999999999976 79999999986433 223344556666666555 89999999999999999999
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||+ +++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 135 v~e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 99999 668888877642 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+..... ....... ..
T Consensus 208 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-----------~~~~~~~-~~--- 269 (311)
T 3p1a_A 208 GTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-----------WQQLRQG-YL--- 269 (311)
T ss_dssp C--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----------HHHHTTT-CC---
T ss_pred ccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------HHHHhcc-CC---
Confidence 4332 2334569999999999875 799999999999999999999776542110 1111110 00
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.+.. ....+..+.+++.+||+.||++|||+.|+++
T Consensus 270 -~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 270 -PPEF----TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -Cccc----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0001 1122367899999999999999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=354.80 Aligned_cols=255 Identities=29% Similarity=0.428 Sum_probs=195.0
Q ss_pred CCcccCccccCCCceEEEEEeC--CC--cEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeC-CCcceeE
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA--DG--TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT-PTERLLV 369 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~--~g--~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lv 369 (619)
.|...+.||+|+||+||+|.+. ++ ..||||.++........+.|.+|+.++++++||||+++++++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4667789999999999999963 22 46899998765556667889999999999999999999998754 4578899
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||+++|+|.+++... ...+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999753 23478899999999999999999999 99999999999999999999999999998664
Q ss_pred cCCcc---eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 450 VRKTN---VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 450 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
..... ......+|+.|+|||.+.+..++.++|||||||++|||+| |..||....... ... ........
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-----~~~---~~~~~~~~ 315 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----ITV---YLLQGRRL 315 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-----HHH---HHHTTCCC
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-----HHH---HHHcCCCC
Confidence 33211 1233457889999999999999999999999999999999 666765432111 111 11111110
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
..+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 316 ----------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 316 ----------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01122345789999999999999999999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=339.27 Aligned_cols=262 Identities=28% Similarity=0.457 Sum_probs=197.5
Q ss_pred HHHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
++..++|++.+.||+|+||+||+|.+. ..||||+++... .....+.|.+|++++++++||||+++++++ .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 345678999999999999999999974 369999987443 334457899999999999999999999965 4566899
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||+++++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 97 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccc
Confidence 99999999999998653 34489999999999999999999999 9999999999999999999999999999865
Q ss_pred ccCC-cceeeecccccccccccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 449 DVRK-TNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 449 ~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
.... ........||+.|+|||.+. +..++.++||||||+++|||+||+.||...... ......... ..
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~----~~ 242 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR----DQIIEMVGR----GS 242 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH----HHHHHHHHH----TS
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH----HHHHHHhcc----cc
Confidence 4322 22233456899999999986 567899999999999999999999999643211 111111111 11
Q ss_pred cchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 525 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
... .+ .......+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 243 ~~~----~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 243 LSP----DL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp CCC----CT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred cCc----ch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 110 00 111223346789999999999999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=344.11 Aligned_cols=262 Identities=22% Similarity=0.363 Sum_probs=201.2
Q ss_pred hcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... .......+.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35789999999999999999996 479999999987432 334557789999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||+++++|.+++.........++...+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999976544455689999999999999999999999 99999999999999999999999999998664
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
.... ......|++.|+|||.+.+..++.++||||||+++|||+||+.||...... ............ ..
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~-~~--- 256 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEQCD-YP--- 256 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC------HHHHHHHHHTTC-SC---
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh------HHHHHHHhhccc-CC---
Confidence 3322 223446899999999999999999999999999999999999998643211 111122211111 10
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.......+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 257 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 257 -----PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp -----CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 001122345789999999999999999999999999875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=359.42 Aligned_cols=263 Identities=19% Similarity=0.228 Sum_probs=208.2
Q ss_pred CHHHHHHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeee
Q 007073 285 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCT 361 (619)
Q Consensus 285 ~~~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 361 (619)
.+++.....++|++.+.||+|+||+||+|..+ +|+.||||++.+.. .....+.+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34566667889999999999999999999975 79999999986421 1122345788999999999999999999999
Q ss_pred CCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcc
Q 007073 362 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD 441 (619)
Q Consensus 362 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 441 (619)
+.+..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence 9999999999999999999997642 2488999999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCcceeeecccccccccccccc-------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHH
Q 007073 442 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS-------TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 514 (619)
Q Consensus 442 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~ 514 (619)
||+++..............||+.|+|||++. ...++.++|||||||++|||+||+.||...... +
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~ 277 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA--------E 277 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------H
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH--------H
Confidence 9999877654443444567999999999997 456899999999999999999999999643221 1
Q ss_pred HHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCC---CCHHHHHH
Q 007073 515 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDR---PAMSEVVR 568 (619)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~evl~ 568 (619)
....+..... ....+ ......+.++.+++.+|+. +|++| |+++|+++
T Consensus 278 ~~~~i~~~~~--~~~~p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 278 TYGKIVHYKE--HLSLP----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHHHTHHH--HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHHHHhccc--CcCCC----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 1111111000 00000 0112234678999999999 99998 58888763
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=345.49 Aligned_cols=265 Identities=25% Similarity=0.342 Sum_probs=207.9
Q ss_pred HhcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeee----CCCcc
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT----TPTER 366 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~----~~~~~ 366 (619)
..++|++.+.||+|+||.||++.. .+|+.||||++... .....+.+.+|+++++.++||||+++++++. .....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 456899999999999999999997 57999999988642 3445678899999999999999999999986 33467
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
++||||+++|+|.+++.........+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 899999999999999987655556699999999999999999999999 99999999999999999999999999987
Q ss_pred eeccCCcc--------eeeeccccccccccccccCCC---CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHH
Q 007073 447 LVDVRKTN--------VTTQVRGTMGHIAPEYLSTGK---SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH 515 (619)
Q Consensus 447 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~ 515 (619)
........ ......||+.|+|||.+.+.. ++.++||||||+++|||+||+.||......... ....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~ 259 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS---VALA 259 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC---HHHH
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch---hhHH
Confidence 65321110 012345799999999987654 689999999999999999999998532111100 0000
Q ss_pred HHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcc
Q 007073 516 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLA 576 (619)
Q Consensus 516 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 576 (619)
.. . ..........+..+.+++.+||+.||++|||+.++++.|+.....
T Consensus 260 ~~---~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 260 VQ---N----------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp HH---C----------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred hh---c----------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 00 0 000111122346789999999999999999999999999987543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=353.43 Aligned_cols=246 Identities=26% Similarity=0.333 Sum_probs=196.8
Q ss_pred HHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcc
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTER 366 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 366 (619)
...++|++.+.||+|+||+||+|... +|+.||||++++.. .......+.+|..+++.+ +||||+++++++...+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 45578999999999999999999975 68999999986421 223456788999999988 699999999999999999
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
++||||+++|+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccccee
Confidence 99999999999999997643 389999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 447 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 447 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
..... ........||+.|+|||++.+..++.++|||||||++|||+||+.||...... +........
T Consensus 173 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~---- 239 (353)
T 3txo_A 173 EGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED--------DLFEAILND---- 239 (353)
T ss_dssp CSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC----
T ss_pred ecccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH--------HHHHHHHcC----
Confidence 54322 22334567999999999999888999999999999999999999999743221 111111111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAM 563 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 563 (619)
.. .++......+.+++.+|++.||++||++
T Consensus 240 -----~~--~~p~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 240 -----EV--VYPTWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp -----CC--CCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred -----CC--CCCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence 00 1122234578899999999999999998
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=342.98 Aligned_cols=254 Identities=26% Similarity=0.400 Sum_probs=197.6
Q ss_pred hcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
.++|++.+.||+|+||+||+|.+. ++.||||++.. ....+.|.+|++++++++||||+++++++. +..++||||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~ 80 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES---ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEY 80 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS---TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEEC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC---hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEc
Confidence 357888999999999999999985 78999999863 345678999999999999999999999887 458999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc-EEEcccccceeeccC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE-AVVGDFGLAKLVDVR 451 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~DfGla~~~~~~ 451 (619)
+++|+|.+++..... ...+++..+..++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 999999999976432 234788889999999999999999932228999999999999988876 799999999755322
Q ss_pred CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (619)
.....||+.|+|||.+.+..++.++||||||+++|||+||+.||+...... ............
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~------- 222 (307)
T 2eva_A 160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA------FRIMWAVHNGTR------- 222 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH------HHHHHHHHTTCC-------
T ss_pred ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH------HHHHHHHhcCCC-------
Confidence 223458999999999999999999999999999999999999996432110 011111111110
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 532 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.......+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 223 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 223 ---PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp ---CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 011122335788999999999999999999999999875
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=348.56 Aligned_cols=246 Identities=23% Similarity=0.317 Sum_probs=201.1
Q ss_pred cCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++|.+.+.||+|+||.||+|.+ .+|+.||||++.... .......+.+|+.+++.++||||+++++++..+...++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5789999999999999999997 578999999986321 1222457889999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+ +|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 89 E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp CCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred ECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 999 678888886543 389999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcceeeeccccccccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
.. ......||+.|+|||.+.+..+ +.++|||||||++|+|+||+.||+........ ..+.
T Consensus 161 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-----------------~~i~ 221 (336)
T 3h4j_B 161 GN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-----------------KKVN 221 (336)
T ss_dssp SB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-----------------CCCC
T ss_pred Cc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-----------------HHHH
Confidence 32 2334569999999999988776 78999999999999999999999753322110 0111
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
... ...+...+..+.+++.+||+.||++|||+.|+++
T Consensus 222 ~~~--~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 222 SCV--YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp SSC--CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred cCC--CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 100 0112223467889999999999999999999975
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=339.87 Aligned_cols=256 Identities=29% Similarity=0.374 Sum_probs=203.8
Q ss_pred CCcccCccccCCCceEEEEEeC-C---CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcc-eeE
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-D---GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER-LLV 369 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~---g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~-~lv 369 (619)
.|...+.||+|+||+||+|.+. + +..||+|.+.........+.+.+|+.++++++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4556689999999999999853 2 2379999997655555668899999999999999999999999876665 899
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
+||+.+|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999999762 33478999999999999999999999 99999999999999999999999999998654
Q ss_pred cCC---cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 450 VRK---TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 450 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
... ........+|+.|+|||.+.+..++.++||||||+++|||+||..|+...... ........ ....
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~----~~~~~~~~---~~~~-- 246 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP----FDLTHFLA---QGRR-- 246 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG----GGHHHHHH---TTCC--
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH----HHHHHHhh---cCCC--
Confidence 322 11223456789999999999999999999999999999999966665322111 11111111 1110
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
...+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 247 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 247 --------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111222345789999999999999999999999999874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=335.40 Aligned_cols=260 Identities=19% Similarity=0.243 Sum_probs=204.7
Q ss_pred hcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeee-eCCCcceeEe
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC-TTPTERLLVY 370 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lv~ 370 (619)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..... .+.+.+|+.+++.++|++++..++++ ......++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 46899999999999999999996 5799999999864332 34688999999999998877777666 4556679999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC---CCCcEEEccccccee
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGDFGLAKL 447 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGla~~ 447 (619)
||+ +++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++ .++.+||+|||+++.
T Consensus 85 e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 999 899999997532 3489999999999999999999999 999999999999994 788999999999987
Q ss_pred eccCCcc------eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007073 448 VDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 521 (619)
Q Consensus 448 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 521 (619)
....... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||........... . ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~-~~~~~~~~ 235 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-Y-ERISEKKM 235 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH-H-HHHHHHHH
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhh-h-hhhccccc
Confidence 7544321 12345799999999999999999999999999999999999999975433222111 1 11111110
Q ss_pred hcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 522 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 522 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
...... + ....+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 236 ~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 236 STPIEV-----L----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HSCHHH-----H----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred CCchHH-----H----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 000000 0 011235789999999999999999999999999873
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=342.12 Aligned_cols=260 Identities=25% Similarity=0.350 Sum_probs=206.4
Q ss_pred HHHHHhcCCcccC-ccccCCCceEEEEEe---CCCcEEEEEEeccCCC-cchHHHHHHHHHHHHHccCCCccceeeeeeC
Q 007073 288 ELQLATDNFSEKN-VLGQGGFGKVYRGVL---ADGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTT 362 (619)
Q Consensus 288 el~~~~~~~~~~~-~lg~G~fg~Vy~~~~---~~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 362 (619)
++....++|.+.+ .||+|+||+||+|.+ .+++.||||+++.... ....+.+.+|+++++.++||||+++++++ .
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 3344566788887 999999999999964 2478899999975432 33467899999999999999999999999 5
Q ss_pred CCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007073 363 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 442 (619)
Q Consensus 363 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 442 (619)
.+..++||||+++++|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Df 161 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDF 161 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccC
Confidence 56788999999999999999763 2388999999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCccee--eeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHH
Q 007073 443 GLAKLVDVRKTNVT--TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKL 519 (619)
Q Consensus 443 Gla~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 519 (619)
|++........... ....+++.|+|||.+.+..++.++||||||+++|||+| |+.||...... +.....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~ 233 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAML 233 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHH
T ss_pred CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHH
Confidence 99987754433222 22346789999999998889999999999999999999 99998643211 111111
Q ss_pred hhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 520 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 520 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
..... ...+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus 234 ~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 234 EKGER----------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp HTTCC----------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HcCCC----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11110 111223346789999999999999999999999999873
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=349.33 Aligned_cols=253 Identities=21% Similarity=0.249 Sum_probs=194.2
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
..++|.+.+.||+|+||+||++... +|+.||||++.... ...+.+.+|+.+++.++||||+++++++..+...++||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA--AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST--TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc--cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 3568999999999999999999976 78999999997533 23466889999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc--EEEcccccceee
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE--AVVGDFGLAKLV 448 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfGla~~~ 448 (619)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+++..
T Consensus 96 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 96 EYASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EeCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 9999999999987643 389999999999999999999999 9999999999999987765 999999999743
Q ss_pred ccCCcceeeeccccccccccccccCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccch
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSER-TDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (619)
... .......||+.|+|||.+.+..++.+ +|||||||++|||+||+.||........ ............
T Consensus 169 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~~~~~~~~~~---- 238 (361)
T 3uc3_A 169 VLH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD----YRKTIQRILSVK---- 238 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC----HHHHHHHHHTTC----
T ss_pred ccc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH----HHHHHHHHhcCC----
Confidence 222 22234569999999999988887665 8999999999999999999975332111 111111111110
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 528 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.........+..+.+++.+||+.||++|||+.|+++
T Consensus 239 -----~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 239 -----YSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp -----CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred -----CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 000001112357889999999999999999999985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=348.32 Aligned_cols=269 Identities=17% Similarity=0.194 Sum_probs=200.9
Q ss_pred hcCCcccCccccCCCceEEEEEeC----CCcEEEEEEeccCCCcc----------hHHHHHHHHHHHHHccCCCccceee
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPG----------GDAAFQREVEMISVAVHRNLLRLIG 358 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~~~----------~~~~~~~E~~~l~~l~H~niv~l~~ 358 (619)
.++|.+.+.||+|+||.||+|... ++..||||+........ ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467899999999999999999975 57889999986533211 1124667888899999999999999
Q ss_pred eeeC----CCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC
Q 007073 359 FCTT----PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED 434 (619)
Q Consensus 359 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 434 (619)
++.. ....++||||+ +++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 9877 67789999999 999999998643 589999999999999999999999 99999999999999887
Q ss_pred C--cEEEcccccceeeccCCcc------eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccc
Q 007073 435 F--EAVVGDFGLAKLVDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE 506 (619)
Q Consensus 435 ~--~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~ 506 (619)
+ .+||+|||+++.+...... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~- 266 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD- 266 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC-
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc-
Confidence 7 9999999999876432211 113456999999999999999999999999999999999999999532111
Q ss_pred ccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCccc
Q 007073 507 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAE 577 (619)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 577 (619)
.... ......... .....+..... ....+..+.+++.+||+.||++|||+.+|++.|+...+..
T Consensus 267 --~~~~-~~~~~~~~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 330 (345)
T 2v62_A 267 --PVAV-QTAKTNLLD-ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPL 330 (345)
T ss_dssp --HHHH-HHHHHHHHH-TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCC
T ss_pred --cHHH-HHHHHhhcc-cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcc
Confidence 1111 111111111 01110100000 0122357899999999999999999999999999866543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=344.42 Aligned_cols=262 Identities=20% Similarity=0.208 Sum_probs=202.5
Q ss_pred HHHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccC----CCcchHHHHHHHHHHHHHccCCCccceeeeeeCC
Q 007073 289 LQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF----ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP 363 (619)
Q Consensus 289 l~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~----~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 363 (619)
+....++|.+.+.||+|+||.||+|... +++.||+|++... ......+.+.+|++++++++||||+++++++...
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3456778999999999999999999974 6889999998632 1345567899999999999999999999999999
Q ss_pred CcceeEecccccchhhhhhcccCCC------------------------------------CCCcCHHHHHHHHHHHHHH
Q 007073 364 TERLLVYPFMQNLSVAYRLREIKPG------------------------------------EPVLDWVTRKRVALGAARG 407 (619)
Q Consensus 364 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~ia~~ 407 (619)
+..++||||+++|+|.+++...... ...+++..+..++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999998632111 1224567788899999999
Q ss_pred HHHHHhcCCCCeEecCCCCCcEEeCCCC--cEEEcccccceeeccCCcc---eeeeccccccccccccccC--CCCCcch
Q 007073 408 LEYLHEHCNPKIIHRDVKAANVLLDEDF--EAVVGDFGLAKLVDVRKTN---VTTQVRGTMGHIAPEYLST--GKSSERT 480 (619)
Q Consensus 408 L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~ 480 (619)
|+|||++ +|+||||||+||+++.++ .+||+|||+++........ ......||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 999999999999998776 8999999999876432221 2345569999999999975 6789999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCC
Q 007073 481 DVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDR 560 (619)
Q Consensus 481 Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 560 (619)
||||||+++|||+||+.||...... +........... ...+ .....+..+.+++.+||+.||++|
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~--------~~~~~~~~~~~~--~~~~-----~~~~~~~~~~~li~~~l~~~p~~R 322 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDA--------DTISQVLNKKLC--FENP-----NYNVLSPLARDLLSNLLNRNVDER 322 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCC--TTSG-----GGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChH--------HHHHHHHhcccc--cCCc-----ccccCCHHHHHHHHHHcCCChhHC
Confidence 9999999999999999999643321 111111111100 0000 011224578999999999999999
Q ss_pred CCHHHHHH
Q 007073 561 PAMSEVVR 568 (619)
Q Consensus 561 Ps~~evl~ 568 (619)
||+.++++
T Consensus 323 ps~~~~l~ 330 (345)
T 3hko_A 323 FDAMRALQ 330 (345)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHhc
Confidence 99999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=334.20 Aligned_cols=253 Identities=22% Similarity=0.294 Sum_probs=205.8
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.++|++.+.||+|+||.||+|... +|+.||||.+.........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467899999999999999999975 7899999998754445566889999999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++++|.+++... ..++...+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+......
T Consensus 86 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 99999999988652 3488999999999999999999999 9999999999999999999999999999876433
Q ss_pred Cc-ceeeeccccccccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 452 KT-NVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 452 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
.. .......||+.|+|||.+.+..+ +.++||||||+++|||+||+.||....... .....+ ...... .
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~----~~~~~~---~ 228 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYSDW----KEKKTY---L 228 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS---HHHHHH----HTTCTT---S
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH---HHHHHh----hhcccc---c
Confidence 22 12334568999999999987765 789999999999999999999997533211 111111 110000 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
......+..+.+++.+||+.||++|||+.|+++
T Consensus 229 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 ------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 001122357889999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=341.47 Aligned_cols=257 Identities=28% Similarity=0.390 Sum_probs=202.3
Q ss_pred hcCCcccCccccCCCceEEEEEeCC----CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeee-CCCcce
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT-TPTERL 367 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~ 367 (619)
..+|.+.+.||+|+||+||+|.+.+ +..||+|.+.........+.+.+|+.++++++||||+++++++. .+...+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3468888999999999999999642 23689999976555556788999999999999999999999864 456788
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
+||||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccc
Confidence 999999999999999753 23478899999999999999999999 999999999999999999999999999986
Q ss_pred eccCCc---ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCccccccchhHHHHHHHHhhhc
Q 007073 448 VDVRKT---NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG-QRAIDFSRLEEEDDVLLLDHVKKLEREK 523 (619)
Q Consensus 448 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (619)
...... .......||+.|+|||.+.+..++.++||||||+++|||+|| ..||...... .... ......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-----~~~~---~~~~~~ 249 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITV---YLLQGR 249 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT-----THHH---HHHTTC
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH-----HHHH---HHhcCC
Confidence 643321 123345578899999999999999999999999999999995 5555432211 1111 111110
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 524 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 524 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
. ...+...+..+.+++.+||+.||++|||+.++++.|++.
T Consensus 250 ~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 250 R----------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp C----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 001112235789999999999999999999999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=339.68 Aligned_cols=246 Identities=25% Similarity=0.297 Sum_probs=203.5
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
.++|++.+.||+|+||.||+|... +|+.||+|++++.. .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467899999999999999999975 69999999986421 123456788999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||+++|+|.+++.... .++...+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 99999999999997632 388999999999999999999999 99999999999999999999999999998754
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
.. .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ..........
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~~~------ 219 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--------KTYEKILNAE------ 219 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHCC------
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC------
Confidence 32 23457999999999999999999999999999999999999999643211 1111111110
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 568 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 568 (619)
. .++...+.++.+++.+|++.||++|| +++++++
T Consensus 220 ---~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 220 ---L--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ---C--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---C--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 0 11222345789999999999999999 7777763
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=352.14 Aligned_cols=272 Identities=18% Similarity=0.200 Sum_probs=204.2
Q ss_pred HhcCCcccCccccC--CCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcce
Q 007073 292 ATDNFSEKNVLGQG--GFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 292 ~~~~~~~~~~lg~G--~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 367 (619)
..++|++.+.||+| +||+||+|... +|+.||||++.... .....+.+.+|+.+++.++|||||++++++...+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 45679999999999 99999999976 79999999997433 2334567888999999999999999999999999999
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
+||||+++|+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.+..
T Consensus 103 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 99999999999999976432 3388999999999999999999999 999999999999999999999999999875
Q ss_pred eccCCc------ceeeeccccccccccccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHH
Q 007073 448 VDVRKT------NVTTQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL 519 (619)
Q Consensus 448 ~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 519 (619)
...... .......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||....................
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 532211 11122468999999999987 5799999999999999999999999965332111000000000000
Q ss_pred hhh-----c-------------ccchhcc---------ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 520 ERE-----K-------------RLDAIVD---------RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 520 ~~~-----~-------------~~~~~~~---------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
... . ....... ...........+..+.+++.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 000 0 0000000 00000112234467899999999999999999999985
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=352.93 Aligned_cols=252 Identities=21% Similarity=0.311 Sum_probs=197.8
Q ss_pred hcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCC-CcchHHHHHHHHHHHHHcc--CCCccceeeeeeCCCcceeE
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAV--HRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lv 369 (619)
.++|.+.+.||+|+||.||+|...+|+.||||++.... .....+.+.+|++++++++ ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 35699999999999999999998889999999986433 3345578999999999997 59999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|| +.+++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++ ++.+||+|||+++...
T Consensus 135 ~E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EE-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred Ee-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 99 67889999997643 478889999999999999999999 999999999999996 5789999999998765
Q ss_pred cCCcc-eeeeccccccccccccccC-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHH
Q 007073 450 VRKTN-VTTQVRGTMGHIAPEYLST-----------GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 517 (619)
Q Consensus 450 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 517 (619)
..... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...... .....
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~ 278 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISKLH 278 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHH
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-------HHHHH
Confidence 43322 2334579999999999865 46899999999999999999999999642110 01111
Q ss_pred HHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 518 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 518 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
. ++++.....++...+..+.+++.+||+.||++|||+.|+++.
T Consensus 279 ~---------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 279 A---------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp H---------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred H---------HhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1 111111111111223578899999999999999999999853
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=341.63 Aligned_cols=272 Identities=23% Similarity=0.322 Sum_probs=204.8
Q ss_pred cCHHHHHHHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHc--cCCCccceeeeee
Q 007073 284 YSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVA--VHRNLLRLIGFCT 361 (619)
Q Consensus 284 ~~~~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~ 361 (619)
.+........++|++.+.||+|+||.||+|.+. |+.||||++.. .....+..|.+++... +||||+++++++.
T Consensus 27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~----~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 101 (337)
T 3mdy_A 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT----TEEASWFRETEIYQTVLMRHENILGFIAADI 101 (337)
T ss_dssp SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEG----GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred CCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEec----cccchhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence 344444556788999999999999999999985 89999999853 2345556666666554 8999999999997
Q ss_pred CC----CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCcEEeC
Q 007073 362 TP----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC-----NPKIIHRDVKAANVLLD 432 (619)
Q Consensus 362 ~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlkp~NIll~ 432 (619)
.. ...++||||+++|+|.++++.. .+++..+..++.|++.||+|||+++ .++|+||||||+||+++
T Consensus 102 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 102 KGTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK 176 (337)
T ss_dssp ESCGGGCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred cCCCCCCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence 76 6789999999999999999652 3889999999999999999999762 34899999999999999
Q ss_pred CCCcEEEcccccceeeccCCcce---eeeccccccccccccccCCCCCcc------hhhHHHHHHHHHHHhC--------
Q 007073 433 EDFEAVVGDFGLAKLVDVRKTNV---TTQVRGTMGHIAPEYLSTGKSSER------TDVFGYGIMLLELVTG-------- 495 (619)
Q Consensus 433 ~~~~~kl~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~S~Gv~l~elltg-------- 495 (619)
.++.+||+|||+++......... .....||+.|+|||.+.+...+.+ +|||||||++|||+||
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~ 256 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256 (337)
T ss_dssp TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence 99999999999998764433221 124469999999999987766654 9999999999999999
Q ss_pred --CCCCCCCccccccchhHHHHHHHHhhhcccchhccccccC-CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 496 --QRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK-NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 496 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
+.||......... . ............ .+.... ......+..+.+++.+||+.||++|||+.++++.|+.
T Consensus 257 ~~~~p~~~~~~~~~~---~-~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 257 EYQLPYHDLVPSDPS---Y-EDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp CCCCTTTTTSCSSCC---H-HHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred cccccHhhhcCCCCc---h-hhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 5555432211111 1 111111111111 111110 0123667889999999999999999999999999987
Q ss_pred C
Q 007073 573 E 573 (619)
Q Consensus 573 ~ 573 (619)
+
T Consensus 329 l 329 (337)
T 3mdy_A 329 M 329 (337)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=349.34 Aligned_cols=253 Identities=20% Similarity=0.254 Sum_probs=205.6
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.++|.+.+.||+|+||.||+|... +|+.||+|.+.... ......+.+|+++++.++||||+++++++......++|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 467999999999999999999975 68999999986432 3345678899999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC--CCcEEEcccccceeec
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE--DFEAVVGDFGLAKLVD 449 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~~~ 449 (619)
|+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 129 FLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp CCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 99999999988753 23489999999999999999999999 9999999999999974 5789999999998765
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
.... .....||+.|+|||++.+..++.++|||||||++|||+||+.||..... . ........... ..
T Consensus 203 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~---~~~~~i~~~~~---~~ 269 (387)
T 1kob_A 203 PDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----L---ETLQNVKRCDW---EF 269 (387)
T ss_dssp TTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----H---HHHHHHHHCCC---CC
T ss_pred CCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-----H---HHHHHHHhCCC---CC
Confidence 4332 3344699999999999999999999999999999999999999964321 1 11111111100 00
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
+ .......+..+.+++.+||+.||++|||+.++++.
T Consensus 270 ~----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 270 D----EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp C----SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred C----ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1 11112234678999999999999999999999863
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=337.75 Aligned_cols=262 Identities=20% Similarity=0.225 Sum_probs=200.0
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC--cchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
..++|.+.+.||+|+||.||+|... +++.||+|++..... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3468999999999999999999975 689999999864322 2234778999999999999999999999999999999
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 112 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 999999999999997643 388999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
............|++.|+|||.+.+..++.++||||||+++|||+||+.||...... .............
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~-- 254 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--------VMGAHINQAIPRP-- 254 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--------HHHHHHHSCCCCG--
T ss_pred cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--------HHHHHhccCCCCc--
Confidence 544333344556899999999999999999999999999999999999999643211 0111111100000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHhcCCcc
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-AMSEVVRMLEGEGLA 576 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~~~~ 576 (619)
.......+..+.+++.+||+.||++|| +++++++.|+.....
T Consensus 255 ------~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 255 ------STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp ------GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred ------cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 011122335788999999999999999 999999999985433
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=350.40 Aligned_cols=260 Identities=18% Similarity=0.218 Sum_probs=202.6
Q ss_pred hcCCcccCccccCCCceEEEEEeCC---------CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccc--------
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLAD---------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR-------- 355 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~~---------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~-------- 355 (619)
.++|.+.+.||+|+||.||+|.... ++.||||++... ..+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 3679999999999999999999763 789999998642 36789999999999999998
Q ss_pred -------eeeeeeC-CCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 007073 356 -------LIGFCTT-PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAA 427 (619)
Q Consensus 356 -------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~ 427 (619)
+++++.. ....++||||+ +++|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~ 188 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAE 188 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGG
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHH
Confidence 5666665 67789999999 999999998642 23489999999999999999999999 9999999999
Q ss_pred cEEeCCCC--cEEEcccccceeeccCCcc------eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 007073 428 NVLLDEDF--EAVVGDFGLAKLVDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 499 (619)
Q Consensus 428 NIll~~~~--~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~ 499 (619)
||+++.++ .+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+||+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 9999999999876433221 123347999999999999999999999999999999999999999
Q ss_pred CCCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 500 DFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
...... ............ .......+.... ....+..+.+++.+||+.||++|||+.++++.|+.
T Consensus 269 ~~~~~~---~~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 333 (352)
T 2jii_A 269 TNCLPN---TEDIMKQKQKFV--DKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333 (352)
T ss_dssp GGGTTC---HHHHHHHHHHHH--HSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred ccCCcC---HHHHHHHHHhcc--CChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence 743211 111111111111 111111111100 01123578999999999999999999999999987
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=344.35 Aligned_cols=251 Identities=23% Similarity=0.288 Sum_probs=189.3
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
..++|++.+.||+|+||+||+|... +++.||||+++... ..+.+.+|++++++++||||+++++++..+...++||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 4567999999999999999999976 58899999997532 3466889999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEEccccccee
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVVGDFGLAKL 447 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGla~~ 447 (619)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++.
T Consensus 128 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 128 ELVTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp CCCCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 999999999988753 3488999999999999999999999 9999999999999975 88999999999986
Q ss_pred eccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccch
Q 007073 448 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527 (619)
Q Consensus 448 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (619)
.... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||...... ... ........ .
T Consensus 201 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~---~~~i~~~~-~-- 268 (349)
T 2w4o_A 201 VEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD----QFM---FRRILNCE-Y-- 268 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH----HHH---HHHHHTTC-C--
T ss_pred cCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc----HHH---HHHHHhCC-C--
Confidence 5432 2233456899999999999999999999999999999999999999643211 101 11111110 0
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 528 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..........+..+.+++.+||+.||++|||+.++++
T Consensus 269 ----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 269 ----YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp ----CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001111233467899999999999999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=347.59 Aligned_cols=246 Identities=21% Similarity=0.259 Sum_probs=203.8
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
.++|++.+.||+|+||.||+|... +|+.||||++.... .....+.+.+|+.+++.++||||+++++++......++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 467999999999999999999975 68999999986421 223456788999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||+++|+|.+++.... .++...+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceecc
Confidence 99999999999998643 388999999999999999999999 99999999999999999999999999998764
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
.. .....||+.|+|||.+.+..++.++|||||||++|||+||+.||..... .......... ..
T Consensus 193 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~-~~---- 255 (350)
T 1rdq_E 193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSG-KV---- 255 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC-CC----
T ss_pred CC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--------HHHHHHHHcC-CC----
Confidence 32 2345699999999999999999999999999999999999999964321 1111111111 10
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVR 568 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 568 (619)
.++...+..+.+++.+||+.||++||+ ++++++
T Consensus 256 ------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 ------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 112223467899999999999999998 666653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=346.19 Aligned_cols=258 Identities=25% Similarity=0.423 Sum_probs=204.9
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcE--EEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCccee
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTK--VAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~--vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 368 (619)
.++|.+.+.||+|+||.||+|... +|.. ||+|+++........+.+.+|+++++++ +||||+++++++...+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 367889999999999999999964 5664 4999987655555667899999999999 89999999999999999999
Q ss_pred EecccccchhhhhhcccC------------CCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc
Q 007073 369 VYPFMQNLSVAYRLREIK------------PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE 436 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 436 (619)
||||+++|+|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence 999999999999997643 2234589999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHH
Q 007073 437 AVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDH 515 (619)
Q Consensus 437 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 515 (619)
+||+|||+++..... .......+++.|+|||.+.+..++.++||||||+++|||+| |+.||...... ..
T Consensus 181 ~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--------~~ 250 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------EL 250 (327)
T ss_dssp EEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HH
T ss_pred EEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH--------HH
Confidence 999999998743221 11223456889999999998889999999999999999998 99999643211 11
Q ss_pred HHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 516 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 516 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
........ ....+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 251 ~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 251 YEKLPQGY----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp HHHGGGTC----------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhhcCC----------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111110 1111223346789999999999999999999999999873
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=342.71 Aligned_cols=250 Identities=19% Similarity=0.269 Sum_probs=180.2
Q ss_pred cCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc-CCCccceeeeeeCCCcceeEecccccc
Q 007073 299 KNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVYPFMQNL 376 (619)
Q Consensus 299 ~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g 376 (619)
.+.||+|+||+||+|... +|+.||||++.. .....+.+|+.+++.+. ||||+++++++......++||||+++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 478999999999999975 689999999863 34567889999999997 999999999999999999999999999
Q ss_pred hhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC---cEEEcccccceeeccCCc
Q 007073 377 SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF---EAVVGDFGLAKLVDVRKT 453 (619)
Q Consensus 377 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGla~~~~~~~~ 453 (619)
+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||+++.......
T Consensus 92 ~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 92 ELFERIKKK----KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp BHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 999999863 3489999999999999999999999 999999999999997665 899999999986643322
Q ss_pred ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccc
Q 007073 454 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 533 (619)
Q Consensus 454 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 533 (619)
......||+.|+|||.+.+..++.++|||||||++|||+||+.||......... ....+......... .. .
T Consensus 165 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~i~~~~-~~------~ 235 (325)
T 3kn6_A 165 -PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC-TSAVEIMKKIKKGD-FS------F 235 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C-CCHHHHHHHHTTTC-CC------C
T ss_pred -cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc-ccHHHHHHHHHcCC-CC------C
Confidence 233456899999999999999999999999999999999999999753321110 11111111111110 00 0
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 534 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 534 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
........+.++.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 00001123467899999999999999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=344.42 Aligned_cols=261 Identities=27% Similarity=0.384 Sum_probs=207.2
Q ss_pred HhcCCcccCccccCCCceEEEEEe------CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCc
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE 365 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 365 (619)
..++|.+.+.||+|+||.||+|.+ .++..||||++...........+.+|+.++++++||||+++++++.....
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 457899999999999999999984 25778999999765555667789999999999999999999999999999
Q ss_pred ceeEecccccchhhhhhcccCCC---CCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEE
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPG---EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVV 439 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl 439 (619)
.++||||+++++|.+++...... ...+++..+..++.|++.||.|||++ +|+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999865422 24588999999999999999999999 9999999999999984 456999
Q ss_pred cccccceeeccCCc-ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHH
Q 007073 440 GDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVK 517 (619)
Q Consensus 440 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 517 (619)
+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||+| |+.||...... ....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~~ 256 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------EVLE 256 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HHHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--------HHHH
Confidence 99999975533222 12234567899999999999999999999999999999999 99998643211 1111
Q ss_pred HHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 518 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 518 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
....... ...+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus 257 ~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 257 FVTSGGR----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhcCCC----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1111111 111222345789999999999999999999999998763
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=343.35 Aligned_cols=250 Identities=22% Similarity=0.257 Sum_probs=194.1
Q ss_pred HhcCCcccCccccCCCceEEEEEe----CCCcEEEEEEeccCC---CcchHHHHHHHHHHHHHccCCCccceeeeeeCCC
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFE---SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT 364 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~----~~g~~vAvK~l~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 364 (619)
..++|++.+.||+|+||.||++.. .+|+.||+|+++... .......+.+|+.+++.++||||+++++++...+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 356899999999999999999997 478999999997532 1223456788999999999999999999999999
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 444 (619)
..++||||+++|+|.+++.... .++......++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 9999999999999999997643 378889999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 445 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 445 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ......... .
T Consensus 168 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~~-~ 237 (327)
T 3a62_A 168 CKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK--------KTIDKILKC-K 237 (327)
T ss_dssp C-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHT-C
T ss_pred ccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhC-C
Confidence 97543222 2233456999999999999999999999999999999999999999643211 111111111 0
Q ss_pred cchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007073 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 568 (619)
Q Consensus 525 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 568 (619)
...+...+..+.+++.+||+.||++|| ++.++++
T Consensus 238 ----------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 ----------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ----------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 011222346789999999999999999 6667654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=349.76 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=203.1
Q ss_pred HHHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCC
Q 007073 289 LQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPT 364 (619)
Q Consensus 289 l~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 364 (619)
.....++|.+.+.||+|+||.||+|..+ +|+.||||+++... .......+..|..++..+ +||||+++++++.+.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 3456788999999999999999999975 68999999996421 123456778899999876 8999999999999999
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 444 (619)
..++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~ 164 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGM 164 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChh
Confidence 9999999999999999997643 388999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 445 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 445 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
++...... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||...... ..........
T Consensus 165 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~~~~- 234 (345)
T 1xjd_A 165 CKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--------ELFHSIRMDN- 234 (345)
T ss_dssp CBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCC-
T ss_pred hhhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHhCC-
Confidence 98543222 2234567999999999999999999999999999999999999999643211 1111111110
Q ss_pred cchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 007073 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS-EVV 567 (619)
Q Consensus 525 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl 567 (619)
. .++...+..+.+++.+||+.||++||++. +++
T Consensus 235 ------~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 ------P----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ------C----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ------C----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 0 11122345788999999999999999987 443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=336.40 Aligned_cols=263 Identities=19% Similarity=0.260 Sum_probs=198.8
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC-cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
++|++.+.||+|+||+||+|... +|+.||||++..... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57899999999999999999975 589999999865433 2335678899999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++++|..++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 99999999887653 3388999999999999999999999 9999999999999999999999999999876533
Q ss_pred CcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH-----------H
Q 007073 452 KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK-----------L 519 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~ 519 (619)
.. ......||+.|+|||.+.+ ..++.++||||||+++|||+||+.||........ ....... .
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 230 (311)
T 4agu_A 156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ----LYLIRKTLGDLIPRHQQVF 230 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCSCCHHHHHHH
T ss_pred cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhccccccccccc
Confidence 22 2334568999999999876 6689999999999999999999999975432111 0000000 0
Q ss_pred hhhcccchhccccccCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 520 EREKRLDAIVDRNLNKNY-----NIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 520 ~~~~~~~~~~~~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
...........+...... .+..+..+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000000000000000 0123456889999999999999999999985
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=348.93 Aligned_cols=272 Identities=25% Similarity=0.314 Sum_probs=210.5
Q ss_pred hcCCcccCccccCCCceEEEEEe-----CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeC--CCc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT--PTE 365 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~ 365 (619)
.++|++.+.||+|+||.||+|.+ .+++.||||++... .....+.+.+|++++++++||||+++++++.. ...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 46788999999999999999984 36889999999753 34456779999999999999999999998864 455
Q ss_pred ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 445 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 445 (619)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred EEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccc
Confidence 789999999999999997632 2489999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcc--eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007073 446 KLVDVRKTN--VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 523 (619)
Q Consensus 446 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (619)
+........ ......||..|+|||.+.+..++.++||||||+++|||+||+.||............ .........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~---~~~~~~~~~ 251 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG---CERDVPALS 251 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-------CCHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc---cccccccHH
Confidence 877543332 122345788899999999989999999999999999999999998643211000000 000000000
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007073 524 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 574 (619)
Q Consensus 524 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 574 (619)
..............+...+..+.+++.+||+.||++|||+.++++.|+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 011111111112223344568899999999999999999999999999863
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=341.14 Aligned_cols=270 Identities=23% Similarity=0.319 Sum_probs=211.6
Q ss_pred ccCHHHHHHHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHH--ccCCCccceeeee
Q 007073 283 RYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISV--AVHRNLLRLIGFC 360 (619)
Q Consensus 283 ~~~~~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~ 360 (619)
..++.......++|.+.+.||+|+||.||+|.+ +|+.||||++.. .....+.+|.+++.. ++||||+++++++
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~ 105 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIAAD 105 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc----hhHHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence 344445556778999999999999999999998 589999999853 345678889999887 7899999999999
Q ss_pred eCCC----cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCc
Q 007073 361 TTPT----ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH--------EHCNPKIIHRDVKAAN 428 (619)
Q Consensus 361 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~Dlkp~N 428 (619)
.... ..++||||+++|+|.+++... .+++..+..++.|++.||+||| +. +|+||||||+|
T Consensus 106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~N 177 (342)
T 1b6c_B 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKN 177 (342)
T ss_dssp ECCCSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGG
T ss_pred cccCCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHH
Confidence 8776 789999999999999999752 3889999999999999999999 77 99999999999
Q ss_pred EEeCCCCcEEEcccccceeeccCCcc---eeeeccccccccccccccCCC------CCcchhhHHHHHHHHHHHhC----
Q 007073 429 VLLDEDFEAVVGDFGLAKLVDVRKTN---VTTQVRGTMGHIAPEYLSTGK------SSERTDVFGYGIMLLELVTG---- 495 (619)
Q Consensus 429 Ill~~~~~~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~S~Gv~l~elltg---- 495 (619)
|+++.++.+||+|||++......... ......||+.|+|||.+.+.. ++.++||||||+++|||+||
T Consensus 178 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~ 257 (342)
T 1b6c_B 178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 257 (342)
T ss_dssp EEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred EEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcC
Confidence 99999999999999999877544332 123456899999999997652 34789999999999999999
Q ss_pred ------CCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCC-CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 496 ------QRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKN-YNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 496 ------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..||......... ...+..... ... ..+.+... ........+.+++.+||+.||++|||+.+|++
T Consensus 258 ~~~~~~~~p~~~~~~~~~~---~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~ 329 (342)
T 1b6c_B 258 GIHEDYQLPYYDLVPSDPS---VEEMRKVVC-EQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329 (342)
T ss_dssp TBCCCCCCTTTTTSCSSCC---HHHHHHHHT-TSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CcccccccCccccCcCccc---HHHHHHHHH-HHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 6676543221111 111111111 111 11111110 12356678999999999999999999999999
Q ss_pred HHhcC
Q 007073 569 MLEGE 573 (619)
Q Consensus 569 ~L~~~ 573 (619)
.|+.+
T Consensus 330 ~L~~i 334 (342)
T 1b6c_B 330 TLSQL 334 (342)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=339.63 Aligned_cols=258 Identities=20% Similarity=0.275 Sum_probs=206.6
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeee--CCCccee
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCT--TPTERLL 368 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~~l 368 (619)
.++|++.+.||+|+||.||+|... +|+.||+|.+.... .....+.+.+|++++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467889999999999999999975 78999999997543 3345577899999999999999999999874 3567899
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEecCCCCCcEEeCCCCcEEEcccc
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK-----IIHRDVKAANVLLDEDFEAVVGDFG 443 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~kl~DfG 443 (619)
||||+++++|.+++.........+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999987554455689999999999999999999999 7 9999999999999999999999999
Q ss_pred cceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007073 444 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 523 (619)
Q Consensus 444 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (619)
+++....... ......|++.|+|||.+.+..++.++||||||+++|||+||+.||..... . ........ +
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~---~~~~~i~~-~ 231 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----K---ELAGKIRE-G 231 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----H---HHHHHHHH-T
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-----H---HHHHHHhh-c
Confidence 9986543221 12234689999999999999999999999999999999999999864321 1 11111111 1
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 524 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 524 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
... ..+...+..+.+++.+||+.||++|||+.|+++.+..
T Consensus 232 ~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 232 KFR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ccc---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 111 1122334678999999999999999999999987654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=339.97 Aligned_cols=265 Identities=25% Similarity=0.376 Sum_probs=200.4
Q ss_pred HHHHHhcCCcccCccccCCCceEEEEEeC----CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeC
Q 007073 288 ELQLATDNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT 362 (619)
Q Consensus 288 el~~~~~~~~~~~~lg~G~fg~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 362 (619)
++....++|.+.+.||+|+||.||+|... ++..||||+++... .....+.+.+|+.++++++||||+++++++..
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 44456778999999999999999999864 34589999987433 33345778999999999999999999999977
Q ss_pred CCc-----ceeEecccccchhhhhhcccC--CCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC
Q 007073 363 PTE-----RLLVYPFMQNLSVAYRLREIK--PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 435 (619)
Q Consensus 363 ~~~-----~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 435 (619)
... .++||||+++|+|.+++.... .....+++..+..++.|+++||.|||++ +|+||||||+||+++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCC
Confidence 653 489999999999999985422 2345689999999999999999999999 999999999999999999
Q ss_pred cEEEcccccceeeccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHH
Q 007073 436 EAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLL 513 (619)
Q Consensus 436 ~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~ 513 (619)
.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||+| |..||...... ...
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~~~ 259 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH-----EMY 259 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----GHH
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH-----HHH
Confidence 9999999999876433221 2233457889999999999999999999999999999999 88888643321 111
Q ss_pred HHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 514 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
........ ...+...+..+.+++.+||+.||++|||+.++++.|++.
T Consensus 260 ---~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 260 ---DYLLHGHR----------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp ---HHHHTTCC----------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHcCCC----------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111110 111223345789999999999999999999999999874
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=341.87 Aligned_cols=257 Identities=23% Similarity=0.289 Sum_probs=195.6
Q ss_pred hcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCC--cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcc---
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER--- 366 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~--- 366 (619)
.++|++.+.||+|+||.||+|.. .+|+.||||+++.... ......+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46799999999999999999996 5789999999975432 23346788999999999999999999998766544
Q ss_pred -eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007073 367 -LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 445 (619)
Q Consensus 367 -~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 445 (619)
++||||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 99999999999999997643 389999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcc--eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007073 446 KLVDVRKTN--VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 523 (619)
Q Consensus 446 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (619)
+........ ......||+.|+|||.+.+..++.++||||||+++|||+||+.||...... ..........
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~--------~~~~~~~~~~ 235 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--------SVAYQHVRED 235 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHhcCC
Confidence 876443221 223456899999999999999999999999999999999999999643321 1111111111
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH-HHHh
Q 007073 524 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV-RMLE 571 (619)
Q Consensus 524 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl-~~L~ 571 (619)
.... .. .....+.++.+++.+||+.||++||++.+++ +.+.
T Consensus 236 ~~~~---~~----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 236 PIPP---SA----RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp CCCH---HH----HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred CCCc---cc----ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 0000 00 0111235788999999999999999766655 4443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=347.41 Aligned_cols=210 Identities=20% Similarity=0.263 Sum_probs=182.9
Q ss_pred ccccCHHHHHHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc-----CCCcc
Q 007073 281 LKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-----HRNLL 354 (619)
Q Consensus 281 ~~~~~~~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-----H~niv 354 (619)
...+++++.+...++|.+.+.||+|+||+||+|... +++.||||+++. .......+..|+.+++.+. ||||+
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN--IKKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CHHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc--chhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 345666677777889999999999999999999974 689999999863 2344567788999999986 99999
Q ss_pred ceeeeeeCCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-
Q 007073 355 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE- 433 (619)
Q Consensus 355 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~- 433 (619)
++++++...+..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDP 173 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCT
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccc
Confidence 9999999999999999999 8999999976432 3488999999999999999999999 9999999999999975
Q ss_pred ------------------------CCcEEEcccccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHH
Q 007073 434 ------------------------DFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 489 (619)
Q Consensus 434 ------------------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l 489 (619)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 789999999999864432 2345689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCC
Q 007073 490 LELVTGQRAIDFS 502 (619)
Q Consensus 490 ~elltg~~p~~~~ 502 (619)
|||+||+.||...
T Consensus 250 ~ell~g~~pf~~~ 262 (360)
T 3llt_A 250 AELYTGSLLFRTH 262 (360)
T ss_dssp HHHHHSSCSCCCS
T ss_pred HHHHHCCCCCCCC
Confidence 9999999999753
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=336.02 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=207.6
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.+.|...+.||+|+||.||+|... +|+.||||++.........+.+.+|+.+++.++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 456888999999999999999964 6899999999765555667889999999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+++++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 101 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 9999999999864 2488999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccc
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (619)
.. ......||+.|+|||.+.+..++.++||||||+++|||+||+.||...... ........ ... +
T Consensus 173 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~-~~~-----~ 237 (303)
T 3a7i_A 173 QI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--------KVLFLIPK-NNP-----P 237 (303)
T ss_dssp BC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHH-SCC-----C
T ss_pred cc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--------HHHHHhhc-CCC-----C
Confidence 22 223456899999999999999999999999999999999999998643211 11111111 100 1
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 532 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
......+..+.+++.+||+.||++|||+.++++.
T Consensus 238 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 238 ----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ----CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ----CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1112223578999999999999999999999863
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=328.60 Aligned_cols=252 Identities=21% Similarity=0.269 Sum_probs=204.3
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
.++|++.+.||+|+||.||+|... +|+.||+|++.... .....+.+.+|++++++++||||+++++++..+...++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 468999999999999999999975 68999999986433 3344577889999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc---EEEccccccee
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE---AVVGDFGLAKL 447 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGla~~ 447 (619)
||+++++|.+.+.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999988887643 388999999999999999999999 9999999999999986655 99999999987
Q ss_pred eccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccch
Q 007073 448 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527 (619)
Q Consensus 448 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (619)
..... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... .......... ..
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--------~~~~~~~~~~-~~- 225 (284)
T 3kk8_A 158 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--------RLYAQIKAGA-YD- 225 (284)
T ss_dssp CCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTC-CC-
T ss_pred cccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--------HHHHHHHhcc-cc-
Confidence 65332 233456999999999999999999999999999999999999999643211 1111111110 00
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 528 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. ........+..+.+++.+|++.||++|||+.|+++
T Consensus 226 ~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 226 Y-----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp C-----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C-----CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 00011123357889999999999999999999985
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=335.10 Aligned_cols=252 Identities=20% Similarity=0.247 Sum_probs=205.3
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCc-----chHHHHHHHHHHHHHccCCCccceeeeeeCCCcc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP-----GGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 366 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 366 (619)
.++|.+.+.||+|+||.||+|... +|+.||||.+...... ...+.+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467899999999999999999975 6899999998753322 2467899999999999999999999999999999
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC----cEEEccc
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF----EAVVGDF 442 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df 442 (619)
++||||+++++|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 9999999999999999753 3489999999999999999999999 999999999999999887 7999999
Q ss_pred ccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh
Q 007073 443 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 522 (619)
Q Consensus 443 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 522 (619)
|++....... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||...... +........
T Consensus 164 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~ 233 (321)
T 2a2a_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANITSV 233 (321)
T ss_dssp TTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHTT
T ss_pred ccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhc
Confidence 9998765432 223456899999999999999999999999999999999999999643211 111111110
Q ss_pred cccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 523 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 523 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.. ...+... ...+..+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~---~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 234 SY---DFDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CC---CCCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cc---ccChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 0000000 112357889999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=336.06 Aligned_cols=253 Identities=23% Similarity=0.345 Sum_probs=201.9
Q ss_pred hcCCcccCccccCCCceEEEEEeCC-C-------cEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCC
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLAD-G-------TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT 364 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~~-g-------~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 364 (619)
.++|.+.+.||+|+||+||+|.... + ..||+|++... .....+.+.+|+.++++++||||+++++++..++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 4678889999999999999999652 3 57999998643 3445678999999999999999999999999999
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc--------
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE-------- 436 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------- 436 (619)
..++||||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence 999999999999999999763 23388999999999999999999999 9999999999999998877
Q ss_pred EEEcccccceeeccCCcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHH
Q 007073 437 AVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH 515 (619)
Q Consensus 437 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~ 515 (619)
+||+|||++..... .....||+.|+|||.+.+ ..++.++||||||+++|||+||..|+...... . ..
T Consensus 160 ~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~----~---~~ 227 (289)
T 4fvq_A 160 IKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS----Q---RK 227 (289)
T ss_dssp EEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH----H---HH
T ss_pred eeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch----H---HH
Confidence 99999999864422 123458899999999987 67899999999999999999965554322110 0 11
Q ss_pred HHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcc
Q 007073 516 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLA 576 (619)
Q Consensus 516 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 576 (619)
.......... +...+..+.+++.+||+.||++|||+.++++.|+++.-.
T Consensus 228 ~~~~~~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 228 LQFYEDRHQL------------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp HHHHHTTCCC------------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred HHHhhccCCC------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 1111111111 111124678999999999999999999999999986443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=343.91 Aligned_cols=244 Identities=21% Similarity=0.256 Sum_probs=202.1
Q ss_pred HhcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCc-------chHHHHHHHHHHHHHccCCCccceeeeeeCC
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESP-------GGDAAFQREVEMISVAVHRNLLRLIGFCTTP 363 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 363 (619)
..++|.+.+.||+|+||+||+|.. .+|+.||||++...... .....+.+|++++++++||||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 356799999999999999999996 47899999998754311 1234677899999999999999999999999
Q ss_pred CcceeEecccccc-hhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007073 364 TERLLVYPFMQNL-SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 442 (619)
Q Consensus 364 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 442 (619)
+..++||||+.+| +|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999777 9999887532 389999999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcceeeeccccccccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007073 443 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 521 (619)
Q Consensus 443 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 521 (619)
|+++....... .....||+.|+|||.+.+..+ +.++|||||||++|||+||+.||......
T Consensus 175 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------- 236 (335)
T 3dls_A 175 GSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------- 236 (335)
T ss_dssp TTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred ccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence 99987654332 334569999999999988877 88999999999999999999999632110
Q ss_pred hcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 522 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 522 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
...... .+...+..+.+++.+||+.||++|||+.++++.
T Consensus 237 ---~~~~~~------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ---VEAAIH------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---TTTCCC------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---HhhccC------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 011123578999999999999999999999874
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=345.82 Aligned_cols=268 Identities=26% Similarity=0.371 Sum_probs=198.3
Q ss_pred HhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHH--HHccCCCccceeeeeeC-----CC
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMI--SVAVHRNLLRLIGFCTT-----PT 364 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l--~~l~H~niv~l~~~~~~-----~~ 364 (619)
..++|.+.+.||+|+||+||+|.. +++.||||++.. .....+..|.++. ..++||||+++++++.. ..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~----~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSF----ANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEG----GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeec----cchhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 457899999999999999999987 689999999863 2344555555554 45899999999985532 23
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCcEEeCCCCcEE
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC------NPKIIHRDVKAANVLLDEDFEAV 438 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~k 438 (619)
..++||||+++|+|.+++.... .++..+..++.|+++||+|||+.+ .++|+||||||+|||++.++.+|
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred eEEEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 4689999999999999997532 478889999999999999999873 33899999999999999999999
Q ss_pred EcccccceeeccCCc-------ceeeeccccccccccccccC-------CCCCcchhhHHHHHHHHHHHhCCCCCCCCcc
Q 007073 439 VGDFGLAKLVDVRKT-------NVTTQVRGTMGHIAPEYLST-------GKSSERTDVFGYGIMLLELVTGQRAIDFSRL 504 (619)
Q Consensus 439 l~DfGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~ 504 (619)
|+|||+++.+..... .......||+.|+|||.+.+ ..++.++|||||||++|||+||+.|+.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987653221 12224469999999999976 3567899999999999999999877644322
Q ss_pred ccccchhHHH---------HHHHHhhhcccchhccccccC--CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 505 EEEDDVLLLD---------HVKKLEREKRLDAIVDRNLNK--NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 505 ~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.......... ........... .+.+.. ......+..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQ----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCC----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhccccc----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 2111111110 00111000000 011111 11234667899999999999999999999999999884
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=345.24 Aligned_cols=248 Identities=27% Similarity=0.358 Sum_probs=199.4
Q ss_pred hcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCC--cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
.+.|...+.||+|+||+||+|.. .+|+.||||++..... ....+.+.+|++++++++||||+++++++..++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 34588899999999999999996 5789999999864322 22346789999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||+. |++.+.+.... ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 133 ~e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 99998 57777775432 3489999999999999999999999 99999999999999999999999999998654
Q ss_pred cCCcceeeecccccccccccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
.. ....||+.|+|||.+. ...++.++|||||||++|||+||+.||...... ...........
T Consensus 206 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--------~~~~~~~~~~~-- 270 (348)
T 1u5q_A 206 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNES-- 270 (348)
T ss_dssp SB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSCC--
T ss_pred CC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHHhcCC--
Confidence 32 2356999999999984 567899999999999999999999998643211 11111111111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
+.. .....+..+.+++.+||+.||++|||+.++++.
T Consensus 271 ----~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 271 ----PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ----CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ----CCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 111223578899999999999999999999853
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=342.92 Aligned_cols=254 Identities=17% Similarity=0.164 Sum_probs=206.2
Q ss_pred HHHhcCCcccCccccCCCceEEEEE------eCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc---CCCccceeeee
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGV------LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV---HRNLLRLIGFC 360 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~------~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~ 360 (619)
+...++|.+.+.||+|+||+||+|. ..+++.||||++.. ....++..|+++++.++ |+||+++++++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP----ANPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS----CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC----CChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 3456789999999999999999994 44689999999864 23567888999888887 99999999999
Q ss_pred eCCCcceeEecccccchhhhhhcccCC-CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC------
Q 007073 361 TTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE------ 433 (619)
Q Consensus 361 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~------ 433 (619)
...+..++||||+++|+|.+++..... ....+++..+..++.|+++||+|||++ +|+||||||+|||++.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcc
Confidence 999999999999999999999975432 245599999999999999999999999 9999999999999998
Q ss_pred -----CCcEEEcccccceeeccC-CcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccc
Q 007073 434 -----DFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE 507 (619)
Q Consensus 434 -----~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~ 507 (619)
++.+||+|||+|+.+... .........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~- 292 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE- 292 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-
Confidence 899999999999876422 2334455679999999999999999999999999999999999999985321100
Q ss_pred cchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHHhcC
Q 007073 508 DDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDR-PAMSEVVRMLEGE 573 (619)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~evl~~L~~~ 573 (619)
... ...+..... ...+.+++..|++.+|.+| |+++++.+.|++.
T Consensus 293 ---------------~~~----~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 293 ---------------CKP----EGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp ---------------EEE----CSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred ---------------eee----chhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 001 111111111 3466788889999999998 6788888888774
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=334.21 Aligned_cols=248 Identities=25% Similarity=0.401 Sum_probs=201.1
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
..++|++.+.||+|+||+||+|... ++..||||++.... .......+.+|+.++++++||||+++++++......++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4578999999999999999999975 57799999985421 12235678899999999999999999999999999999
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||+++|+|.+.+.... .++...+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 87 v~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 999999999999997643 388999999999999999999999 9999999999999999999999999998654
Q ss_pred ccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... ..........
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~----- 223 (279)
T 3fdn_A 160 PSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--------ETYKRISRVE----- 223 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTC-----
T ss_pred Ccc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--------HHHHHHHhCC-----
Confidence 322 223456899999999999999999999999999999999999999643211 1111111100
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
...+...+..+.+++.+||+.||++|||+.|+++
T Consensus 224 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 224 ------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp ------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0112223357889999999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=345.53 Aligned_cols=246 Identities=22% Similarity=0.272 Sum_probs=200.2
Q ss_pred HHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcc
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTER 366 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 366 (619)
...++|++.+.||+|+||.||+|... +|+.||||+++... .....+.+..|..++..+ +||||+++++++...+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 35578999999999999999999986 47899999986421 123456788999999887 799999999999999999
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 99999999999999997643 388999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 447 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 447 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
..... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+...
T Consensus 170 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~---- 236 (353)
T 2i0e_A 170 ENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIMEH---- 236 (353)
T ss_dssp CCCCT-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC----
T ss_pred ccccC-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH--------HHHHHHHhC----
Confidence 54322 22234567999999999999999999999999999999999999999643211 111111111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAM 563 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 563 (619)
.. .++...+.++.+++.+|++.||++||++
T Consensus 237 -----~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 237 -----NV--AYPKSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp -----CC--CCCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred -----CC--CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 00 1122334678999999999999999964
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=355.81 Aligned_cols=248 Identities=25% Similarity=0.367 Sum_probs=204.6
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
.++|.+.+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.+++.++||||+++++++..++..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357888999999999999999975 79999999986421 123356789999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 95 ~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 9999999999998753 3489999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCcceeeeccccccccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
... ......||+.|+|||.+.+..+ +.++||||+||++|||+||+.||+..... .........
T Consensus 168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--------~~~~~i~~~------ 231 (476)
T 2y94_A 168 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--------TLFKKICDG------ 231 (476)
T ss_dssp TTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--------HHHHHHHTT------
T ss_pred ccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHhcC------
Confidence 432 2334579999999999988776 78999999999999999999999743221 111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.. ..+...+..+.+++.+||+.||++|||+.++++
T Consensus 232 ---~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 232 ---IF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ---CC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---Cc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 00 011122357889999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=348.46 Aligned_cols=255 Identities=21% Similarity=0.267 Sum_probs=203.6
Q ss_pred hcCCcccCccccCCCceEEEEEe----CCCcEEEEEEeccCC---CcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCC
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFE---SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPT 364 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~----~~g~~vAvK~l~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 364 (619)
.++|++.+.||+|+||.||+|.. .+|+.||||+++... .....+.+.+|+++++++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46799999999999999999997 378999999986432 122345677899999999 5999999999999999
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 444 (619)
..++||||+++|+|.+++.... .+++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 9999999999999999997643 388999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCcceeeeccccccccccccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh
Q 007073 445 AKLVDVRKTNVTTQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 522 (619)
Q Consensus 445 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 522 (619)
++..............||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ ...........
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~----~~~~~~~~~~~ 281 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS----QAEISRRILKS 281 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC----HHHHHHHHHHC
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch----HHHHHHHHhcc
Confidence 98765444444445679999999999986 3478999999999999999999999974332211 11111111110
Q ss_pred cccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 007073 523 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVRM 569 (619)
Q Consensus 523 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 569 (619)
. ..++...+..+.+++.+||+.||++|| ++.++++.
T Consensus 282 -------~----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 282 -------E----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp -------C----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -------C----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 0 112223345788999999999999999 88888754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=359.15 Aligned_cols=254 Identities=26% Similarity=0.330 Sum_probs=206.9
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
..++|...++||+|+||.||+|... +|+.||+|++.+.. .......+.+|+.++++++||||+++++++......++
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 3467899999999999999999975 69999999986421 12345678899999999999999999999999999999
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||+++|+|.+++.........+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 9999999999999987654455699999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||........ ........... .
T Consensus 340 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~----~~~~~~~i~~~-~---- 409 (543)
T 3c4z_A 340 KAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE----NKELKQRVLEQ-A---- 409 (543)
T ss_dssp CTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC----HHHHHHHHHHC-C----
T ss_pred cCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh----HHHHHHHHhhc-c----
Confidence 54322 23345799999999999999999999999999999999999999975322111 11111111110 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 564 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 564 (619)
..++...+..+.+++.+||+.||++||++.
T Consensus 410 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 410 ------VTYPDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred ------cCCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 011223346789999999999999999763
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=334.93 Aligned_cols=247 Identities=21% Similarity=0.309 Sum_probs=200.7
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcceeE
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 369 (619)
.++|++.+.||+|+||+||+|... +++.||||++.... .......+.+|+..+..+ +||||+++++++..++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467999999999999999999976 79999999987543 334567788999999999 899999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC----------------
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---------------- 433 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---------------- 433 (619)
|||+++++|.+++.........+++..+..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999986543334589999999999999999999999 9999999999999984
Q ss_pred ---CCcEEEcccccceeeccCCcceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccc
Q 007073 434 ---DFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD 509 (619)
Q Consensus 434 ---~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~ 509 (619)
...+||+|||.+....... ...||+.|+|||.+.+. .++.++||||||+++|||++|..++....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------ 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------ 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------
Confidence 4479999999998765332 23589999999999776 56789999999999999999987753211
Q ss_pred hhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 510 VLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
....... .... ..+...+..+.+++.+||+.||++|||+.++++
T Consensus 236 -----~~~~~~~-~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 -----QWHEIRQ-GRLP---------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -----HHHHHHT-TCCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----HHHHHHc-CCCC---------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 0011111 1111 112223457899999999999999999999875
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=332.01 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=183.7
Q ss_pred hcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
.++|.+.+.||+|+||.||+|.. .+|+.||||.+.... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35788999999999999999997 479999999986321 122346789999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||+++++|.+++... ...+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 9999999999998753 23489999999999999999999999 99999999999999999999999999998764
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
.... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||......... ..+.
T Consensus 164 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----------------~~~~ 225 (278)
T 3cok_A 164 MPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-----------------NKVV 225 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------------CC
T ss_pred CCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-----------------HHHh
Confidence 3322 223356899999999999989999999999999999999999999753321110 0000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.... ..+...+.++.+++.+||+.||++|||+.++++
T Consensus 226 ~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 226 LADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SSCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hccc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0000 111223457889999999999999999999885
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=337.78 Aligned_cols=264 Identities=21% Similarity=0.342 Sum_probs=199.7
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC-cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
.++|++.+.||+|+||.||+|... +|+.||||++..... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357888999999999999999975 589999999865432 233566789999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++++|.++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 104 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 999999998876542 2389999999999999999999999 999999999999999999999999999986643
Q ss_pred CCcceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH-----------
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK----------- 518 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~----------- 518 (619)
... ......||+.|+|||.+.+. .++.++|||||||++|||+||+.||....... ........
T Consensus 177 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 177 PGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID----QLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCSCCHHHHHH
T ss_pred Ccc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHHHhCCCChhhhhH
Confidence 322 23345689999999999775 78999999999999999999999997543211 11111100
Q ss_pred HhhhcccchhccccccCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 519 LEREKRLDAIVDRNLNKNY-----NIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 519 ~~~~~~~~~~~~~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
............+...... .+..+..+.+++.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000111111111111 1123467899999999999999999999885
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=334.08 Aligned_cols=251 Identities=27% Similarity=0.381 Sum_probs=198.4
Q ss_pred HhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCC-CcceeEe
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-TERLLVY 370 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lv~ 370 (619)
..++|++.+.||+|+||+||+|.+. |+.||||.++.. ...+.+.+|++++++++||||+++++++... +..++||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch---hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 4578999999999999999999984 899999998643 3457889999999999999999999987654 4789999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++++|.+++.... ...+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 9999999999997532 12378888999999999999999999 999999999999999999999999999975533
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
. .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||....... . .......
T Consensus 170 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-----~---~~~~~~~------- 230 (278)
T 1byg_A 170 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----V---VPRVEKG------- 230 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-----H---HHHHTTT-------
T ss_pred c----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-----H---HHHHhcC-------
Confidence 2 123357889999999999999999999999999999999 999986433211 1 1111111
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.....+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 231 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 231 ---YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 01112223346789999999999999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=370.39 Aligned_cols=247 Identities=25% Similarity=0.363 Sum_probs=197.8
Q ss_pred CccccCCCceEEEEEeC---CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEeccccc
Q 007073 300 NVLGQGGFGKVYRGVLA---DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 375 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~---~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 375 (619)
+.||+|+||+||+|.+. .++.||||+++... .....+.|.+|++++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 46789999997532 33456789999999999999999999999964 458899999999
Q ss_pred chhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcc-
Q 007073 376 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN- 454 (619)
Q Consensus 376 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~- 454 (619)
|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 454 g~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 9999999753 3488999999999999999999999 9999999999999999999999999999876543321
Q ss_pred -eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 455 -VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 455 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
......+|+.|+|||++.+..++.++|||||||++|||+| |+.||...... +..........
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------~~~~~i~~~~~-------- 590 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAMLEKGER-------- 590 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTCC--------
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCC--------
Confidence 2233456789999999999999999999999999999999 99999643221 11111111111
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
...+...+.++.+++..||+.||++||++.+|++.|++
T Consensus 591 --~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 591 --MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11222344688999999999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=348.44 Aligned_cols=268 Identities=22% Similarity=0.269 Sum_probs=205.6
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
..++|++.+.||+|+||+||+|.+. +|+.||+|++.........+.+.+|+.++++++||||+++++++..++..++||
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 3567999999999999999999975 689999999976555556678999999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++++|.+++.... .+++..+..++.|++.||+|||+++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 111 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred ECCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999997643 3889999999999999999999831 799999999999999999999999999975532
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHH--------------
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV-------------- 516 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~-------------- 516 (619)
. ......||+.|+|||.+.+..++.++|||||||++|||+||+.||.................
T Consensus 185 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 185 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp H---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred c---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 2 22345689999999999999999999999999999999999999975332110000000000
Q ss_pred -------HHHhhhc----ccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 517 -------KKLEREK----RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 517 -------~~~~~~~----~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
....... ....+.............+..+.+++.+||+.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000000 000000000001111223457899999999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=343.49 Aligned_cols=202 Identities=25% Similarity=0.400 Sum_probs=163.2
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHcc-CCCccceeeeeeCCC--cc
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPT--ER 366 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~~ 366 (619)
..++|++.+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.+++.+. ||||+++++++..++ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999964 78999999986432 3344567889999999997 999999999997554 67
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
++||||++ ++|...+... .++...+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+
T Consensus 87 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999998 5888888752 488899999999999999999999 99999999999999999999999999998
Q ss_pred eeccC--------------------CcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 007073 447 LVDVR--------------------KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFS 502 (619)
Q Consensus 447 ~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~ 502 (619)
..... .....+...||+.|+|||++.+ ..++.++||||+||++|||+||+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 75321 1112334579999999999976 67899999999999999999999999754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=335.92 Aligned_cols=266 Identities=23% Similarity=0.300 Sum_probs=198.5
Q ss_pred HHhcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCC----CcchHHHHHHHHHHHHHcc---CCCccceeeeeeC
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE----SPGGDAAFQREVEMISVAV---HRNLLRLIGFCTT 362 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~----~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~ 362 (619)
...++|++.+.||+|+||+||+|.. .+|+.||||++.... .......+.+|++++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4567899999999999999999996 478999999986322 1122356677888877665 9999999999976
Q ss_pred CC-----cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcE
Q 007073 363 PT-----ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA 437 (619)
Q Consensus 363 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 437 (619)
.. ..++||||+. ++|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence 55 4789999997 599998876432 3389999999999999999999999 99999999999999999999
Q ss_pred EEcccccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHH
Q 007073 438 VVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 517 (619)
Q Consensus 438 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 517 (619)
||+|||+++..... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||....... .......
T Consensus 160 kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~i~~ 233 (308)
T 3g33_A 160 KLADFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD----QLGKIFD 233 (308)
T ss_dssp EECSCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH----HHHHHHH
T ss_pred EEeeCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHH
Confidence 99999999865432 22345578999999999999999999999999999999999999996533211 1111111
Q ss_pred HHhhhc--ccch---hccccccC-------CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 518 KLEREK--RLDA---IVDRNLNK-------NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 518 ~~~~~~--~~~~---~~~~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
...... .... ........ ...+.....+.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 110000 0000 00000000 001123467889999999999999999999885
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=342.09 Aligned_cols=247 Identities=20% Similarity=0.231 Sum_probs=195.1
Q ss_pred ccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecccccc
Q 007073 298 EKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL 376 (619)
Q Consensus 298 ~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 376 (619)
..+.||+|+||.||+|... +|+.||+|+++... ....+.+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 3568999999999999964 68999999986532 345678999999999999999999999999999999999999999
Q ss_pred hhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe--CCCCcEEEcccccceeeccCCcc
Q 007073 377 SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL--DEDFEAVVGDFGLAKLVDVRKTN 454 (619)
Q Consensus 377 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~DfGla~~~~~~~~~ 454 (619)
+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 172 ~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~- 244 (373)
T 2x4f_A 172 ELFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK- 244 (373)
T ss_dssp EEHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-
T ss_pred cHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-
Confidence 999888652 23488999999999999999999999 99999999999999 6778999999999987654322
Q ss_pred eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcccccc
Q 007073 455 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN 534 (619)
Q Consensus 455 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 534 (619)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||...... ........... .....
T Consensus 245 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~~~i~~~~~--~~~~~--- 310 (373)
T 2x4f_A 245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--------ETLNNILACRW--DLEDE--- 310 (373)
T ss_dssp -CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCC--CSCSG---
T ss_pred -cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhccC--CCChh---
Confidence 23346999999999999889999999999999999999999999643211 11111111110 00000
Q ss_pred CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 535 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 535 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.....+..+.+++.+|++.||++|||+.|+++
T Consensus 311 --~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 311 --EFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp --GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 01122357899999999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.76 Aligned_cols=258 Identities=21% Similarity=0.233 Sum_probs=199.4
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHH-HHHccCCCccceeeeeeCCCccee
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEM-ISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
.++|++.+.||+|+||.||+|+.+ +++.||||++++.. .......+..|..+ ++.++||||+++++++...+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 467999999999999999999975 58899999996532 22334556677776 567899999999999999999999
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||+++|+|.+++.... .++......++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 999999999999997643 378889999999999999999999 9999999999999999999999999999853
Q ss_pred ccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... +........
T Consensus 190 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~------ 254 (373)
T 2r5t_A 190 IEH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--------EMYDNILNK------ 254 (373)
T ss_dssp BCC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH--------HHHHHHHHS------
T ss_pred ccC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHhc------
Confidence 322 22334567999999999999999999999999999999999999999643211 111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCccc
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAE 577 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 577 (619)
.+ .++...+..+.+++.+|++.||++||++.+.++.+....+..
T Consensus 255 ---~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~ 298 (373)
T 2r5t_A 255 ---PL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFS 298 (373)
T ss_dssp ---CC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGT
T ss_pred ---cc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCcccc
Confidence 00 111223357889999999999999999977666666655543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=355.57 Aligned_cols=250 Identities=21% Similarity=0.249 Sum_probs=194.8
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccC--CCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
..++|++.+.||+|+||.||+|... +|+.||||++... ........+.+|+.+++.++||||+++++++...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 4467999999999999999999964 6899999998642 233345677889999999999999999999999999999
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+ + +|+||||||+|||++.++.+||+|||+++.
T Consensus 226 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp EECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EEeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 999999999999987643 38999999999999999999998 7 999999999999999999999999999975
Q ss_pred eccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccch
Q 007073 448 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527 (619)
Q Consensus 448 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (619)
.... ........||+.|+|||++.+..++.++|||||||++|||+||+.||...... ......... ..
T Consensus 299 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~~~-~~-- 366 (446)
T 4ejn_A 299 GIKD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILME-EI-- 366 (446)
T ss_dssp TCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC-CC--
T ss_pred ccCC-CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHHhC-CC--
Confidence 4322 22234567999999999999999999999999999999999999999643211 111111111 00
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007073 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 568 (619)
Q Consensus 528 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 568 (619)
.++...+..+.+++.+||+.||++|| +++|+++
T Consensus 367 --------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 --------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11222346789999999999999999 9988874
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=358.79 Aligned_cols=255 Identities=23% Similarity=0.311 Sum_probs=207.1
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
..++|...+.||+|+||.||+|... +|+.||||++.... .......+.+|+++++.++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 4567999999999999999999975 79999999986421 22345678899999999999999999999999999999
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||+++|+|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 262 VmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceec
Confidence 999999999999987643 23489999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||........ .......... .
T Consensus 337 ~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~----~~~i~~~i~~-~----- 404 (576)
T 2acx_A 337 PEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK----REEVERLVKE-V----- 404 (576)
T ss_dssp CTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC----HHHHHHHHHH-C-----
T ss_pred ccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh----HHHHHHHhhc-c-----
Confidence 5432 23345799999999999998999999999999999999999999975332111 0111111110 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 568 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 568 (619)
...++...+.++.+++.+||+.||++|| ++.|+++
T Consensus 405 -----~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 405 -----PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -----cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 0111223346789999999999999999 6777764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=333.60 Aligned_cols=248 Identities=24% Similarity=0.373 Sum_probs=202.8
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeC--------
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT-------- 362 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-------- 362 (619)
..++|++.+.||+|+||.||+|.+. +|+.||+|++.... ..+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 3467899999999999999999986 79999999986432 356789999999999999999998854
Q ss_pred --------CCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC
Q 007073 363 --------PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED 434 (619)
Q Consensus 363 --------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 434 (619)
....++||||+++|+|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT 158 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence 344789999999999999997542 23488999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHH
Q 007073 435 FEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 514 (619)
Q Consensus 435 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~ 514 (619)
+.+||+|||++....... ......||+.|+|||.+.+..++.++||||||+++|||+||..|+... ..
T Consensus 159 ~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----------~~ 226 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----------SK 226 (284)
T ss_dssp TEEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----------HH
T ss_pred CCEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----------HH
Confidence 999999999998765432 223446899999999999999999999999999999999999886310 01
Q ss_pred HHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007073 515 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 574 (619)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 574 (619)
...... ...... ..+..+.+++.+||+.||++|||+.|+++.|+...
T Consensus 227 ~~~~~~---------~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 227 FFTDLR---------DGIISD----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHHHH---------TTCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHHHhh---------cccccc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 111111 111111 12346789999999999999999999999998743
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=337.85 Aligned_cols=266 Identities=23% Similarity=0.351 Sum_probs=208.2
Q ss_pred HhcCCcccCccccCCCceEEEEEe-----CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCC--
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT-- 364 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-- 364 (619)
..++|++.+.||+|+||.||+|.+ .+|+.||||++... .....+.+.+|++++++++||||+++++++...+
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 456788999999999999999984 36899999999753 3455678999999999999999999999986654
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 444 (619)
..++||||+++++|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred ceEEEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence 6789999999999999997642 3488999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCcce--eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccc-------ccchhHHHH
Q 007073 445 AKLVDVRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE-------EDDVLLLDH 515 (619)
Q Consensus 445 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~-------~~~~~~~~~ 515 (619)
++......... .....++..|+|||.+.+..++.++||||||+++|||+||..|+.....+. .........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 98775443321 223456778999999998889999999999999999999999875321100 000000000
Q ss_pred HHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 516 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 516 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.. ..+........+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 272 ~~---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 272 LI---------ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HH---------HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HH---------HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00 11111111112233446789999999999999999999999999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=344.44 Aligned_cols=252 Identities=21% Similarity=0.255 Sum_probs=190.8
Q ss_pred cCCccc-CccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHH-HccCCCccceeeeeeC----CCcc
Q 007073 294 DNFSEK-NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMIS-VAVHRNLLRLIGFCTT----PTER 366 (619)
Q Consensus 294 ~~~~~~-~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~----~~~~ 366 (619)
++|.+. ++||+|+||+||+|... +|+.||||++.. ...+.+|++++. ..+||||+++++++.. ....
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 456555 68999999999999975 689999999863 245678888874 5589999999998865 4568
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEEcccc
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVVGDFG 443 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG 443 (619)
++||||+++|+|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence 89999999999999997632 24589999999999999999999999 9999999999999997 7899999999
Q ss_pred cceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007073 444 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 523 (619)
Q Consensus 444 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (619)
+++...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||........... ....+. . +
T Consensus 210 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~i~---~-~ 282 (400)
T 1nxk_A 210 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-MKTRIR---M-G 282 (400)
T ss_dssp TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS-HHHHHH---H-T
T ss_pred cccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH-HHHHHH---c-C
Confidence 998654322 23345789999999999999999999999999999999999999975432211110 111111 0 0
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 524 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 524 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
... .........+.++.+++.+||+.||++|||+.|+++.
T Consensus 283 ~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 283 QYE------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCC------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccc------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 0000012234678999999999999999999999863
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=328.80 Aligned_cols=247 Identities=20% Similarity=0.280 Sum_probs=202.5
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
..++|.+.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|++++++++||||+++++++......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF-VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 3467899999999999999999975 57799999986533 234678999999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe---CCCCcEEEccccccee
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKL 447 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~ 447 (619)
||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++..
T Consensus 86 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 86 ELCTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp ECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred eccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 9999999999887633 388999999999999999999999 99999999999999 7889999999999987
Q ss_pred eccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccch
Q 007073 448 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527 (619)
Q Consensus 448 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (619)
..... ......||+.|+|||.+.+ .++.++||||||+++|||+||+.||...... ......... ..
T Consensus 159 ~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~-~~-- 224 (277)
T 3f3z_A 159 FKPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS--------EVMLKIREG-TF-- 224 (277)
T ss_dssp CCTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC-CC--
T ss_pred ccCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhC-CC--
Confidence 65432 2334568999999999865 4999999999999999999999999643211 111111111 00
Q ss_pred hccccccCCCCH----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 528 IVDRNLNKNYNI----QEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 528 ~~~~~l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..+. ..+..+.+++.+|++.||++|||+.++++
T Consensus 225 --------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 225 --------TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp --------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --------CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011 12357899999999999999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=334.92 Aligned_cols=260 Identities=29% Similarity=0.382 Sum_probs=198.8
Q ss_pred HhcCCcccCccccCCCceEEEEEeC--CCc--EEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCc
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA--DGT--KVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE 365 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~g~--~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 365 (619)
..++|++.+.||+|+||+||+|.+. +++ .||||+++... .....+.+.+|++++++++||||+++++++..+.
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 3467899999999999999999863 333 68999886432 2345678999999999999999999999997765
Q ss_pred ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 445 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 445 (619)
.++|+||+++++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ceeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccc
Confidence 889999999999999997632 3488999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcce--eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhh
Q 007073 446 KLVDVRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLERE 522 (619)
Q Consensus 446 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 522 (619)
.......... .....+|..|+|||.+.+..++.++||||||+++|||+| |+.||...... +........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~ 240 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--------QILHKIDKE 240 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTS
T ss_pred ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--------HHHHHHHcc
Confidence 8775433321 223457889999999998889999999999999999999 99998643211 111111111
Q ss_pred cccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc
Q 007073 523 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGL 575 (619)
Q Consensus 523 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 575 (619)
.. ........+..+.+++.+||+.||++|||+.++++.|++...
T Consensus 241 ~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 241 GE---------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CC---------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 10 011122334678999999999999999999999999987543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=337.55 Aligned_cols=256 Identities=20% Similarity=0.258 Sum_probs=195.9
Q ss_pred cCCccc-CccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEK-NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~-~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 370 (619)
+.|.+. +.||+|+||+||+|... +|+.||||++.... ......+.+|++++.++ +||||+++++++...+..++||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 567774 78999999999999964 78999999996532 34567889999999884 7999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc---EEEccccccee
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE---AVVGDFGLAKL 447 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGla~~ 447 (619)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||++..
T Consensus 91 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 9999999999997643 388999999999999999999999 9999999999999998766 99999999976
Q ss_pred eccCCc------ceeeeccccccccccccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccch------
Q 007073 448 VDVRKT------NVTTQVRGTMGHIAPEYLST-----GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV------ 510 (619)
Q Consensus 448 ~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~------ 510 (619)
...... .......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 532211 11223458999999999875 5588999999999999999999999975432110000
Q ss_pred -hHHHHHHHHhhhcccchhccccccCCCCH----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 511 -LLLDHVKKLEREKRLDAIVDRNLNKNYNI----QEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 511 -~~~~~~~~~~~~~~~~~~~~~~l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
........... ... .++. ..+..+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~i~~-~~~----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 244 ACQNMLFESIQE-GKY----------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHH-CCC----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHhc-cCc----------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 00001111111 000 0111 12357899999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=341.27 Aligned_cols=262 Identities=22% Similarity=0.328 Sum_probs=194.2
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
++|.+.+.||+|+||+||+|... +|+.||||++...........+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999975 78999999986433332233456799999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
++ |+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 98 5888887753 23488999999999999999999999 99999999999999999999999999998654322
Q ss_pred cceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh---cccchh
Q 007073 453 TNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE---KRLDAI 528 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 528 (619)
.......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||....... ....+...... ......
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~~i~~~~~~~~~~~~~~~ 228 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-----QLHFIFRILGTPTEETWPGI 228 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCCCCTTTSTTG
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHhCCCChHhchhh
Confidence 22334468999999999876 568999999999999999999999997543211 11111111100 000000
Q ss_pred ccc---------cccCC----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 529 VDR---------NLNKN----YNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 529 ~~~---------~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
... ..... ..+....++.+++.+|++.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000 00000 01123357889999999999999999999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=349.25 Aligned_cols=260 Identities=20% Similarity=0.234 Sum_probs=194.0
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCC------
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT------ 364 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 364 (619)
.++|++.+.||+|+||+||+|... +|+.||||++.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467999999999999999999965 68999999996432 3344677889999999999999999999996553
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 444 (619)
..++||||++++ +...+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCCC-HHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 469999999875 4444432 278899999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh--
Q 007073 445 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE-- 522 (619)
Q Consensus 445 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 522 (619)
++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... .+.........+
T Consensus 211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~----~~~~i~~~lg~p~~ 284 (464)
T 3ttj_A 211 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID----QWNKVIEQLGTPCP 284 (464)
T ss_dssp C-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCSCCH
T ss_pred eeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcCCCCH
Confidence 9866432 22345679999999999999999999999999999999999999997533211 111111110000
Q ss_pred c-------cc---------------chhccccccCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 523 K-------RL---------------DAIVDRNLNKNY---NIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 523 ~-------~~---------------~~~~~~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. .. .......+.... ......++.+|+.+||+.||++|||++|+++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 00 000000000000 1122567899999999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=334.40 Aligned_cols=256 Identities=19% Similarity=0.243 Sum_probs=188.8
Q ss_pred HhcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHH-HHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAF-QREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~-~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
..++|++.+.||+|+||+||+|.. .+|+.||||+++..........+ .++...++.++||||+++++++..++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 457899999999999999999997 47899999999754433333333 4444457788999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||++ |+|.+++.........+++..+..++.|++.||+|||+++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99998 4887777654444556999999999999999999999853 89999999999999999999999999998664
Q ss_pred cCCcceeeeccccccccccccc----cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYL----STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
.... .....||+.|+|||.+ .+..++.++||||||+++|||+||+.||+...... ...........
T Consensus 162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~- 231 (290)
T 3fme_A 162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-------QQLKQVVEEPS- 231 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-------HHHHHHHHSCC-
T ss_pred cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-------HHHHHHhccCC-
Confidence 3322 2334689999999996 56678999999999999999999999996422110 11111111110
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
........+..+.+++.+||+.||++|||+.|+++
T Consensus 232 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 --------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp --------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 01111223457899999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=325.44 Aligned_cols=252 Identities=19% Similarity=0.256 Sum_probs=201.6
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC-----cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-----PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 366 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 366 (619)
.++|++.+.||+|+||.||+|... +|+.||+|.++.... ....+.+.+|+.++++++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 457899999999999999999976 689999999864321 12467899999999999999999999999999999
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC----cEEEccc
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF----EAVVGDF 442 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df 442 (619)
++||||+++++|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+||+++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence 99999999999999997532 389999999999999999999999 999999999999998877 8999999
Q ss_pred ccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh
Q 007073 443 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 522 (619)
Q Consensus 443 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 522 (619)
|++....... ......|++.|+|||.+.+..++.++||||||+++|||+||+.||...... .........
T Consensus 157 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~ 226 (283)
T 3bhy_A 157 GIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--------ETLTNISAV 226 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTT
T ss_pred ccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--------HHHHHhHhc
Confidence 9998764332 223456899999999999999999999999999999999999999643211 111111100
Q ss_pred cccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 523 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 523 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. . ...... ....+..+.+++.+||+.||++|||+.++++
T Consensus 227 ~-~--~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 227 N-Y--DFDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp C-C--CCCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c-c--CCcchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0 0 000000 0112357889999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=351.38 Aligned_cols=244 Identities=14% Similarity=0.111 Sum_probs=191.6
Q ss_pred hcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccC--CCcchHHHHHHHHH---HHHHccCCCcccee-------ee
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDF--ESPGGDAAFQREVE---MISVAVHRNLLRLI-------GF 359 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~~E~~---~l~~l~H~niv~l~-------~~ 359 (619)
.++|.+.+.||+|+||.||+|.+ .+|+.||||++... ......+.+.+|++ ++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999996 46999999998643 23445678999995 55566899999998 55
Q ss_pred eeCCCc-----------------ceeEecccccchhhhhhcccC---CCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 007073 360 CTTPTE-----------------RLLVYPFMQNLSVAYRLREIK---PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 419 (619)
Q Consensus 360 ~~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 419 (619)
+..++. .++||||+ +|+|.+++.... .....+++..+..++.|++.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 554432 78999999 689999997532 1123455688889999999999999999 99
Q ss_pred EecCCCCCcEEeCCCCcEEEcccccceeeccCCcceeeeccccccccccccccCC-----------CCCcchhhHHHHHH
Q 007073 420 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-----------KSSERTDVFGYGIM 488 (619)
Q Consensus 420 vH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~S~Gv~ 488 (619)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999985322 3344567 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 489 LLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 489 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
+|||+||+.||........ ...+... ....+..+.+++.+||+.||++|||+.++++
T Consensus 303 l~elltg~~Pf~~~~~~~~-----------------~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGG-----------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------CC-----------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccccc-----------------hhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999964322111 1111111 0112357889999999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=332.90 Aligned_cols=257 Identities=19% Similarity=0.263 Sum_probs=199.8
Q ss_pred hcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc-CCCccceeeeeeC--CCccee
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTT--PTERLL 368 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--~~~~~l 368 (619)
.++|++.+.||+|+||+||+|.. .+|+.||||++.. ...+.+.+|++++++++ ||||+++++++.. ....++
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 36789999999999999999996 4789999999863 33577899999999997 9999999999987 556889
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-cEEEccccccee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-EAVVGDFGLAKL 447 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~ 447 (619)
||||+++++|..++.. ++...+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 111 v~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~ 180 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180 (330)
T ss_dssp EEECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence 9999999999998864 78889999999999999999999 999999999999999776 899999999987
Q ss_pred eccCCcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc--
Q 007073 448 VDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR-- 524 (619)
Q Consensus 448 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 524 (619)
...... .....||..|+|||.+.+ ..++.++|||||||++|||+||+.||........ .+............
T Consensus 181 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~---~l~~~~~~~~~~~~~~ 255 (330)
T 3nsz_A 181 YHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD---QLVRIAKVLGTEDLYD 255 (330)
T ss_dssp CCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH---HHHHHHHHHCHHHHHH
T ss_pred cCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH---HHHHHHHhcCCchhhh
Confidence 654322 334468999999999877 6789999999999999999999999954322111 11111111100000
Q ss_pred ------------cchhcc--------ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 525 ------------LDAIVD--------RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 525 ------------~~~~~~--------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
...... ...........+..+.+++.+||+.||++|||++|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 00001111123468899999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=341.06 Aligned_cols=252 Identities=19% Similarity=0.289 Sum_probs=200.0
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcceeE
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 369 (619)
..++|++.+.||+|+||.||+|..+ +|+.||||++..... .+.+|++++.++ +||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 3567999999999999999999975 689999999965332 235688888877 799999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC----CcEEEcccccc
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED----FEAVVGDFGLA 445 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGla 445 (619)
|||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||+.++ +.+||+|||++
T Consensus 95 ~E~~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 95 TELMKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp ECCCCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 9999999999998753 3489999999999999999999999 99999999999998543 35999999999
Q ss_pred eeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 446 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 446 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
+....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ........... ..
T Consensus 168 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~~~~~~i~~~-~~ 240 (342)
T 2qr7_A 168 KQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT-----PEEILARIGSG-KF 240 (342)
T ss_dssp EECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC-----HHHHHHHHHHC-CC
T ss_pred ccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC-----HHHHHHHHccC-Cc
Confidence 87654332 2334568999999999988889999999999999999999999997432111 11111221111 11
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. +........+..+.+++.+||+.||++|||+.++++
T Consensus 241 ~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 241 S------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp C------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred c------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 011112233467899999999999999999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=330.47 Aligned_cols=248 Identities=23% Similarity=0.374 Sum_probs=197.1
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeC----CCcce
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT----PTERL 367 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~ 367 (619)
..|.+.+.||+|+||+||+|... ++..||+|.+.... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34777889999999999999974 68899999986433 34456778999999999999999999998864 34578
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEeC-CCCcEEEccccc
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK--IIHRDVKAANVLLD-EDFEAVVGDFGL 444 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DfGl 444 (619)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||+. + |+||||||+||+++ .++.+||+|||+
T Consensus 106 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 9999999999999997643 388999999999999999999998 7 99999999999998 789999999999
Q ss_pred ceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 445 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 445 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
+...... ......||+.|+|||.+. +.++.++||||||+++|+|+||+.||...... ............
T Consensus 179 ~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~ 247 (290)
T 1t4h_A 179 ATLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTSGVK 247 (290)
T ss_dssp GGGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTTTCC
T ss_pred ccccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-------HHHHHHHhccCC
Confidence 9754332 233456899999999886 46999999999999999999999999643211 111111111111
Q ss_pred cchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 525 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.... ....+..+.+++.+||+.||++|||+.++++
T Consensus 248 -~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 248 -PASF--------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -CGGG--------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -cccc--------CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0001 1112247899999999999999999999985
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=335.38 Aligned_cols=264 Identities=25% Similarity=0.338 Sum_probs=199.0
Q ss_pred hcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCC-------
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------- 363 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------- 363 (619)
.++|++.+.||+|+||+||+|.. .+|+.||||++.... .......+.+|+++++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36789999999999999999997 478999999986433 233356788999999999999999999998763
Q ss_pred -CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007073 364 -TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 442 (619)
Q Consensus 364 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 442 (619)
+..++||||+++ ++...+.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence 457899999986 6666665432 3489999999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCC---cceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH
Q 007073 443 GLAKLVDVRK---TNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 518 (619)
Q Consensus 443 Gla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 518 (619)
|+++...... ........||+.|+|||.+.+ ..++.++|||||||++|||+||+.||...... .....+..
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~ 243 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-----HQLALISQ 243 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHH
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHH
Confidence 9998765322 222334568999999999876 45899999999999999999999999753321 11111111
Q ss_pred Hhhh---cccchhccccc-------cC-CCC-HH------HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 519 LERE---KRLDAIVDRNL-------NK-NYN-IQ------EVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 519 ~~~~---~~~~~~~~~~l-------~~-~~~-~~------~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.... ........... .. ... .. ....+.+++.+|++.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 1100 00000000000 00 000 01 1346889999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=349.27 Aligned_cols=195 Identities=24% Similarity=0.349 Sum_probs=154.3
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCC-----Cc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-----TE 365 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 365 (619)
.++|++.+.||+|+||+||+|... +|+.||||++.... .....+.+.+|+++++.++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999965 78999999986532 233457789999999999999999999998433 56
Q ss_pred ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 445 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 445 (619)
.++||||+. ++|..++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccc-cchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 899999975 6888888653 3489999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCc--------------------------ceeeeccccccccccccc-cCCCCCcchhhHHHHHHHHHHHhC
Q 007073 446 KLVDVRKT--------------------------NVTTQVRGTMGHIAPEYL-STGKSSERTDVFGYGIMLLELVTG 495 (619)
Q Consensus 446 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~S~Gv~l~elltg 495 (619)
+....... ...+..+||+.|+|||++ .+..++.++|||||||++|||+||
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 87642211 123445789999999976 556799999999999999999994
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=346.20 Aligned_cols=254 Identities=21% Similarity=0.307 Sum_probs=190.9
Q ss_pred HHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-------CcchHHHHHHHHHHHHHccCCCccceeeeeeC
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-------SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT 362 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-------~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 362 (619)
...++|.+.+.||+|+||+||+|... +++.||||++.... .......+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34678999999999999999999975 68999999986421 11122358899999999999999999999864
Q ss_pred CCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC---CcEEE
Q 007073 363 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED---FEAVV 439 (619)
Q Consensus 363 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl 439 (619)
+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.+ ..+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -CceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence 4578999999999999988753 3489999999999999999999999 99999999999999754 45999
Q ss_pred cccccceeeccCCcceeeeccccccccccccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHH
Q 007073 440 GDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV 516 (619)
Q Consensus 440 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 516 (619)
+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... .+....
T Consensus 284 ~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~----~~~~~i 357 (419)
T 3i6u_A 284 TDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV----SLKDQI 357 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC----CHHHHH
T ss_pred eecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH----HHHHHH
Confidence 999999876432 22345679999999999853 668899999999999999999999997432211 111111
Q ss_pred HHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 517 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 517 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. ...... .+.. ....+..+.+++.+||+.||++|||+.|+++
T Consensus 358 ~----~~~~~~--~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 358 T----SGKYNF--IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp H----TTCCCC--CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred h----cCCCCC--Cchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1 010000 0000 0112357899999999999999999999886
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=339.47 Aligned_cols=267 Identities=27% Similarity=0.374 Sum_probs=187.3
Q ss_pred HHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
....++|.+.+.||+|+||.||+|... +++.||||++.........+.+.+|+.++++++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 456678999999999999999999964 6899999988654444456778899999999999999999999999999999
Q ss_pred EecccccchhhhhhcccC----CCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007073 369 VYPFMQNLSVAYRLREIK----PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 444 (619)
||||+++++|.+++.... .....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 999999999999987421 1234589999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCc----ceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHH
Q 007073 445 AKLVDVRKT----NVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL 519 (619)
Q Consensus 445 a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 519 (619)
+........ .......||+.|+|||.+.+ ..++.++||||||+++|||+||+.||....... ... ...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~---~~~ 240 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK----VLM---LTL 240 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----HHH---HHH
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh----HHH---HHh
Confidence 876543211 11234568999999999875 568999999999999999999999997533211 000 000
Q ss_pred hhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 520 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 520 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. ...................+..+.+++.+||+.||++|||+.++++
T Consensus 241 ~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 241 Q--NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp T--SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred c--cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0 0000000000001111223357889999999999999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=327.91 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=205.1
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
.++|.+.+.||+|+||.||+|... +++.||+|.+.... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467888999999999999999976 58899999986432 233457788999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||+++++|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999887532 388999999999999999999999 99999999999999999999999999998764
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
.... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||...... +......... .
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~-~---- 232 (294)
T 2rku_A 167 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--------ETYLRIKKNE-Y---- 232 (294)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTTC-C----
T ss_pred cCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhhcc-C----
Confidence 3322 233456899999999999989999999999999999999999999643321 1111111110 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..+......+.+++.+||+.||++|||+.++++
T Consensus 233 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 ------SIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ------CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 011222357889999999999999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=329.14 Aligned_cols=247 Identities=23% Similarity=0.338 Sum_probs=203.8
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
.++|.+.+.||+|+||.||+|... +++.||+|.+.... .......+.+|++++++++||||+++++++...+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 467899999999999999999975 57899999985321 122356789999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||+++|+|.+++.... .+++.....++.|+++||.|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999997643 388999999999999999999999 99999999999999999999999999997654
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
... .....|++.|+|||.+.+..++.++||||||+++|||+||+.||...... .........
T Consensus 166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~------- 227 (284)
T 2vgo_A 166 SLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--------ETHRRIVNV------- 227 (284)
T ss_dssp SSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTT-------
T ss_pred ccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--------HHHHHHhcc-------
Confidence 322 23456899999999999999999999999999999999999999643211 111111110
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
+. .++...+..+.+++.+|++.||++|||+.++++
T Consensus 228 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 228 DL----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CC----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 00 112223457889999999999999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=367.13 Aligned_cols=261 Identities=21% Similarity=0.340 Sum_probs=208.2
Q ss_pred HHHHHhcCCcccCccccCCCceEEEEEeC----CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCC
Q 007073 288 ELQLATDNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP 363 (619)
Q Consensus 288 el~~~~~~~~~~~~lg~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 363 (619)
+.+...++|.+.+.||+|+||.||+|.+. .+..||||+++........+.|.+|+.++++++||||+++++++. .
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 44455678889999999999999999974 256799999876555555678999999999999999999999985 4
Q ss_pred CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007073 364 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 443 (619)
Q Consensus 364 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 443 (619)
+..++||||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecC
Confidence 5689999999999999999753 23488999999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhh
Q 007073 444 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLERE 522 (619)
Q Consensus 444 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 522 (619)
+++..............+|+.|+|||.+.+..++.++|||||||++|||++ |..||...... +........
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--------~~~~~i~~~ 608 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------DVIGRIENG 608 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHHT
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHcC
Confidence 998765443333344557889999999999999999999999999999997 99998643211 111121111
Q ss_pred cccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 523 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 523 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
... ..+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 609 ~~~----------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 609 ERL----------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp CCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC----------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111 11223346789999999999999999999999999873
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.18 Aligned_cols=264 Identities=18% Similarity=0.226 Sum_probs=197.2
Q ss_pred HHHhcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCC-----
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP----- 363 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----- 363 (619)
+...++|.+.+.||+|+||+||+|.. .+|+.||||++..... ...+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 45677899999999999999999996 4799999999864322 224799999999999999999998443
Q ss_pred ---------------------------------CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHH
Q 007073 364 ---------------------------------TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 410 (619)
Q Consensus 364 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~ 410 (619)
...++||||++ |+|.+.+.........+++..+..++.|+++||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 23779999998 58887777544445568999999999999999999
Q ss_pred HHhcCCCCeEecCCCCCcEEeC-CCCcEEEcccccceeeccCCcceeeeccccccccccccccCC-CCCcchhhHHHHHH
Q 007073 411 LHEHCNPKIIHRDVKAANVLLD-EDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIM 488 (619)
Q Consensus 411 LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~ 488 (619)
||++ +|+||||||+||+++ .++.+||+|||+++....... .....||+.|+|||.+.+. .++.++||||+||+
T Consensus 157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9999 999999999999997 688999999999987644332 3345689999999998765 48999999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc---------ccchh-----ccccccCCCCHHHHHHHHHHHHhccC
Q 007073 489 LLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK---------RLDAI-----VDRNLNKNYNIQEVETMIQVALLCTQ 554 (619)
Q Consensus 489 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~-----~~~~l~~~~~~~~~~~l~~l~~~Cl~ 554 (619)
+|||++|+.||...... ..+...+.....+. ..... ........++...+..+.+++.+||+
T Consensus 232 l~ell~g~~pf~~~~~~----~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 232 FGELILGKPLFSGETSI----DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHSSCSSCCSSHH----HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHhCCCCCCCCChH----HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence 99999999999753221 11111111110000 00000 00000001122334678999999999
Q ss_pred CCCCCCCCHHHHHH
Q 007073 555 ASPEDRPAMSEVVR 568 (619)
Q Consensus 555 ~dP~~RPs~~evl~ 568 (619)
.||++|||+.|+++
T Consensus 308 ~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 308 YEPDLRINPYEAMA 321 (383)
T ss_dssp SSGGGSCCHHHHHT
T ss_pred CChhhCCCHHHHhc
Confidence 99999999999984
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=335.47 Aligned_cols=259 Identities=18% Similarity=0.227 Sum_probs=203.5
Q ss_pred HHHHHhcCCccc-CccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHcc-CCCccceeeeeeCC
Q 007073 288 ELQLATDNFSEK-NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTP 363 (619)
Q Consensus 288 el~~~~~~~~~~-~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~ 363 (619)
..+.-.+.|.+. +.||+|+||.||+|... +|+.||+|++.... .......+.+|+.++..+. ||||+++++++...
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 334455667776 89999999999999975 68999999987532 2344678999999999985 69999999999999
Q ss_pred CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEEc
Q 007073 364 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVVG 440 (619)
Q Consensus 364 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 440 (619)
...++||||+++|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred CeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEe
Confidence 99999999999999999986532 24589999999999999999999999 9999999999999998 7899999
Q ss_pred ccccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh
Q 007073 441 DFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 520 (619)
Q Consensus 441 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 520 (619)
|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||...... .......
T Consensus 177 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~ 246 (327)
T 3lm5_A 177 DFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ--------ETYLNIS 246 (327)
T ss_dssp CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHH
T ss_pred eCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--------HHHHHHH
Confidence 999998764332 223456999999999999999999999999999999999999999643221 1111111
Q ss_pred hhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 521 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 521 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
... ...........+..+.+++.+||+.||++|||++++++
T Consensus 247 ~~~-------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 247 QVN-------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HTC-------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcc-------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 100 00011111233457889999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=336.94 Aligned_cols=258 Identities=24% Similarity=0.315 Sum_probs=194.7
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCC------
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT------ 364 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 364 (619)
.++|...+.||+|+||.||+|... +|+.||||++.... .....+.+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467889999999999999999974 79999999986433 2334567889999999999999999999997653
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 444 (619)
..++||||+ +++|.+++.. ..++...+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 7899998875 2388899999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh-
Q 007073 445 AKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE- 522 (619)
Q Consensus 445 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 522 (619)
++..... .....||+.|+|||.+.+ ..++.++||||+||++|||+||+.||....... .+..........
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~l~~i~~~~g~~~ 246 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD----QLKEIMKVTGTPP 246 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCCCC
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcCCCC
Confidence 9875432 334568999999999877 679999999999999999999999997533211 011111100000
Q ss_pred -c---------------ccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 523 -K---------------RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 523 -~---------------~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. .+.......+. .........+.+++.+|++.||++|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0 00000000000 111233467899999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=338.95 Aligned_cols=256 Identities=23% Similarity=0.290 Sum_probs=187.4
Q ss_pred HHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc-CCCccceeeeee-------
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCT------- 361 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~------- 361 (619)
....+|.+.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 34568999999999999999999974 7899999998543 3445677899999999996 999999999984
Q ss_pred -CCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEeCCCCcEE
Q 007073 362 -TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK--IIHRDVKAANVLLDEDFEAV 438 (619)
Q Consensus 362 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~k 438 (619)
.....++||||+. |+|.+++..... ...+++..+..++.|++.||+|||++ + |+||||||+|||++.++.+|
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEE
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEE
Confidence 2334789999996 688888865332 23489999999999999999999998 7 99999999999999999999
Q ss_pred EcccccceeeccCCcce-----------eeeccccccccccccc---cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCcc
Q 007073 439 VGDFGLAKLVDVRKTNV-----------TTQVRGTMGHIAPEYL---STGKSSERTDVFGYGIMLLELVTGQRAIDFSRL 504 (619)
Q Consensus 439 l~DfGla~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~ 504 (619)
|+|||+++......... .....||+.|+|||.+ .+..++.++||||||+++|||+||+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 99999998765332211 1134589999999998 566789999999999999999999999863221
Q ss_pred ccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 505 EEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.. +................+.+++.+||+.||++|||+.|+++.|+..
T Consensus 259 ~~---------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 259 LR---------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp ----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HH---------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 10 0000000001111123578999999999999999999999999875
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=334.22 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=205.1
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
.++|.+.+.||+|+||.||++... +++.||+|.+.... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 357888999999999999999975 57899999986432 234567788999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||+++++|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 120 ~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999887532 388999999999999999999999 99999999999999999999999999998764
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
.... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||...... +......... .
T Consensus 193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~-~---- 258 (335)
T 2owb_A 193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--------ETYLRIKKNE-Y---- 258 (335)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTC-C----
T ss_pred cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH--------HHHHHHhcCC-C----
Confidence 3322 233456899999999999999999999999999999999999999643211 1111111110 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..+......+.+++.+||+.||++|||+.|+++
T Consensus 259 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 ------SIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011122357889999999999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=332.87 Aligned_cols=259 Identities=22% Similarity=0.333 Sum_probs=205.4
Q ss_pred HHHHHHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCc-------chHHHHHHHHHHHHHc-cCCCccce
Q 007073 286 WRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP-------GGDAAFQREVEMISVA-VHRNLLRL 356 (619)
Q Consensus 286 ~~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-------~~~~~~~~E~~~l~~l-~H~niv~l 356 (619)
+.......++|.+.+.||+|+||.||+|... +|+.||||++...... ...+.+.+|+.+++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3444455678999999999999999999985 7999999998643211 1145678999999999 79999999
Q ss_pred eeeeeCCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc
Q 007073 357 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE 436 (619)
Q Consensus 357 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 436 (619)
++++......++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence 99999999999999999999999999753 2389999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceeeccCCcceeeeccccccccccccccC------CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccch
Q 007073 437 AVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST------GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV 510 (619)
Q Consensus 437 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~ 510 (619)
+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..... .
T Consensus 239 ikl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-----~ 311 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-----I 311 (365)
T ss_dssp EEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----H
T ss_pred EEEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-----H
Confidence 9999999998765432 2334579999999999863 3588999999999999999999999964221 1
Q ss_pred hHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 511 LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
......... .... ..+. . ...+..+.+++.+||+.||++|||+.++++
T Consensus 312 ---~~~~~i~~~-~~~~-~~~~-~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 312 ---LMLRMIMEG-QYQF-SSPE-W----DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ---HHHHHHHHT-CCCC-CHHH-H----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---HHHHHHHhC-CCCC-CCcc-c----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111110 0000 0000 0 012356889999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=335.80 Aligned_cols=265 Identities=19% Similarity=0.269 Sum_probs=193.1
Q ss_pred HHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC-cchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
...++|.+.+.||+|+||+||+|... +|+.||||+++.... ......+.+|++++++++||||+++++++......++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 45678999999999999999999964 789999999964332 2234567899999999999999999999999999999
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe-----CCCCcEEEcccc
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL-----DEDFEAVVGDFG 443 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll-----~~~~~~kl~DfG 443 (619)
||||+++ +|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||
T Consensus 111 v~e~~~~-~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEECCSE-EHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEecCCC-CHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 9999985 8988887643 388999999999999999999999 99999999999999 555679999999
Q ss_pred cceeeccCCcceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh
Q 007073 444 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 522 (619)
Q Consensus 444 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 522 (619)
+++....... ......||+.|+|||.+.+. .++.++|||||||++|||+||+.||...... ..+..........
T Consensus 183 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~~~~~~~~~ 257 (329)
T 3gbz_A 183 LARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI----DQLFKIFEVLGLP 257 (329)
T ss_dssp HHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHCCC
T ss_pred CccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH----HHHHHHHHHhCCC
Confidence 9986643322 23345689999999999874 4899999999999999999999999653221 1111111111100
Q ss_pred cc--cchhc-----ccc---ccCC-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 523 KR--LDAIV-----DRN---LNKN-----YNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 523 ~~--~~~~~-----~~~---l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.. ..... ... .... .......++.+++.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00 00000 000 0000 00112367889999999999999999999985
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=334.81 Aligned_cols=266 Identities=23% Similarity=0.276 Sum_probs=196.5
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcc----hHHHHHHHHHHHHHccCCCccceeeeeeCCCcc
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPG----GDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 366 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 366 (619)
..++|.+.+.||+|+||.||+|... +|+.||||++....... ..+.+.+|++++++++||||+++++++......
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4578999999999999999999975 68999999986432211 124678999999999999999999999999999
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
++||||+++ +|...+... ...+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 88 ~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999986 787777652 33478889999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCcceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc--
Q 007073 447 LVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK-- 523 (619)
Q Consensus 447 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 523 (619)
...... .......||+.|+|||.+.+. .++.++|||||||++|||++|..||...... ..+...........
T Consensus 161 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~----~~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 161 SFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL----DQLTRIFETLGTPTEE 235 (346)
T ss_dssp TTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHCCCCTT
T ss_pred eccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHHcCCCChh
Confidence 664332 223345689999999998764 5899999999999999999999998643211 11111111111000
Q ss_pred ccch---hccc---cccCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 524 RLDA---IVDR---NLNKNYN-----IQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 524 ~~~~---~~~~---~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
.... ..+. ......+ ...+..+.+++.+|++.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 0000 0000001 2233678999999999999999999999863
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=346.09 Aligned_cols=255 Identities=10% Similarity=0.014 Sum_probs=181.8
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC--cchHHHHHHHHHHHHHc--cCCCcccee-------eee
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVA--VHRNLLRLI-------GFC 360 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l--~H~niv~l~-------~~~ 360 (619)
..+|...+.||+|+||.||+|.+. +|+.||||++..... ....+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345888999999999999999975 789999999976432 23456677886655555 599988754 444
Q ss_pred eCC-----------------CcceeEecccccchhhhhhcccCCCCCCcCHHHH------HHHHHHHHHHHHHHHhcCCC
Q 007073 361 TTP-----------------TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR------KRVALGAARGLEYLHEHCNP 417 (619)
Q Consensus 361 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~~~ 417 (619)
..+ ...++||||++ |+|.+++..... .+++..+ ..++.|++.||+|||++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--- 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSK--- 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence 332 23799999999 899999986421 2344445 67889999999999999
Q ss_pred CeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcceeeeccccccccccccccC--CCCCcchhhHHHHHHHHHHHhC
Q 007073 418 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTG 495 (619)
Q Consensus 418 ~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gv~l~elltg 495 (619)
+|+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||.+.+ ..++.++|||||||++|||+||
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999986532 1224457799999999987 6799999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 496 QRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 496 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
+.||........... .....................+..+.+++.+||+.||++|||+.++++
T Consensus 290 ~~Pf~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGSW----------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTCC----------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccch----------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999975432111000 000000000111111111233468899999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=327.10 Aligned_cols=252 Identities=22% Similarity=0.329 Sum_probs=197.2
Q ss_pred CCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEeccc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 373 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 373 (619)
+|....+||+|+||.||+|.. .+++.||||.+.... ....+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 344556899999999999996 468899999986533 345677899999999999999999999999999999999999
Q ss_pred ccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-CCcEEEcccccceeeccCC
Q 007073 374 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-DFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 374 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~~~ 452 (619)
++++|.+++.... ....+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 102 PGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp SEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 9999999997642 233467888899999999999999999 9999999999999987 8999999999998764322
Q ss_pred cceeeeccccccccccccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGK--SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
. ......||+.|+|||.+.+.. ++.++||||||+++|||+||+.||....... . ..... .... ..
T Consensus 178 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~---~~~~~-~~~~-----~~ 244 (295)
T 2clq_A 178 P-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ---A---AMFKV-GMFK-----VH 244 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH---H---HHHHH-HHHC-----CC
T ss_pred C-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh---H---HHHhh-cccc-----cc
Confidence 2 223456899999999997653 7899999999999999999999985321110 0 00000 0000 01
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
...+...+..+.+++.+||+.||++||++.++++
T Consensus 245 ----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 245 ----PEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ----CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ----ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1122233467889999999999999999999974
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=341.24 Aligned_cols=270 Identities=20% Similarity=0.258 Sum_probs=198.7
Q ss_pred HHHHHHHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcc----------hHHHHHHHHHHHHHccCCCccc
Q 007073 286 WRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPG----------GDAAFQREVEMISVAVHRNLLR 355 (619)
Q Consensus 286 ~~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~----------~~~~~~~E~~~l~~l~H~niv~ 355 (619)
..++....++|.+.+.||+|+||.||+|...+|+.||||++....... ..+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 467888899999999999999999999998889999999986432211 2378899999999999999999
Q ss_pred eeeeeeCC-----CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 007073 356 LIGFCTTP-----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVL 430 (619)
Q Consensus 356 l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 430 (619)
+++++... ...++||||++ |+|.+.+... ...+++..+..++.|++.||.|||++ +|+||||||+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL 166 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence 99998442 35789999998 5777777642 33589999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccceeeccCCcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccc
Q 007073 431 LDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD 509 (619)
Q Consensus 431 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~ 509 (619)
++.++.+||+|||+++..... .......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||.......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--- 241 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN--- 241 (362)
T ss_dssp ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---
T ss_pred EcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH---
Confidence 999999999999999754332 22334568999999999877 678999999999999999999999997543211
Q ss_pred hhHHHHHHHHhhhc----------ccchhccccccC-------CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 510 VLLLDHVKKLEREK----------RLDAIVDRNLNK-------NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 510 ~~~~~~~~~~~~~~----------~~~~~~~~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
............. ............ ...+.....+.+++.+||+.||++|||+.|+++
T Consensus 242 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 242 -QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp -HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 1111111000000 000000000000 001122457899999999999999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=343.24 Aligned_cols=260 Identities=18% Similarity=0.228 Sum_probs=204.0
Q ss_pred hcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCC-CccceeeeeeCCCcceeEe
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR-NLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lv~ 370 (619)
.++|.+.+.||+|+||.||+|.+ .+|+.||||++..... ...+..|+++++.++|+ ++..+..++...+..++||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 46899999999999999999996 4789999998764332 23578899999999874 5555556667777889999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe---CCCCcEEEccccccee
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKL 447 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~ 447 (619)
||+ +++|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 83 e~~-g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp ECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ECC-CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 999 899999997532 3489999999999999999999999 99999999999999 5889999999999987
Q ss_pred eccCCcc------eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007073 448 VDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 521 (619)
Q Consensus 448 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 521 (619)
....... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||........ ............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~i~~~~~ 233 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK--KQKYEKISEKKV 233 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH--HHHHHHHHHHHH
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH--HHHHHHHhhccc
Confidence 7543322 12256799999999999999999999999999999999999999975432211 111111111111
Q ss_pred hcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 522 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 522 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
......+.. ..+.++.+++..||+.+|++||++.+|++.|+.+
T Consensus 234 ~~~~~~l~~---------~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 234 ATSIEALCR---------GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HSCHHHHHT---------TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cccHHHHhc---------CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 111111111 1235789999999999999999999999999876
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=329.79 Aligned_cols=255 Identities=22% Similarity=0.328 Sum_probs=203.6
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
..++|.+.+.||+|+||.||+|... +|+.||+|.+.... ......+.+|+.++++++||||+++++++......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc-ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 3467899999999999999999975 78999999987432 233467889999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe---CCCCcEEEccccccee
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKL 447 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~ 447 (619)
||+++++|.+++.... .+++.....++.|++.||.|||++ +|+||||||+||++ +.++.+||+|||++..
T Consensus 86 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 86 QLVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp CCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EcCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 9999999999887643 388999999999999999999999 99999999999999 7889999999999975
Q ss_pred eccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccch
Q 007073 448 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527 (619)
Q Consensus 448 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (619)
.... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||...... .......... ..
T Consensus 159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~~-~~- 225 (304)
T 2jam_A 159 EQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES--------KLFEKIKEGY-YE- 225 (304)
T ss_dssp CCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHCC-CC-
T ss_pred cCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHcCC-CC-
Confidence 4322 223346899999999999999999999999999999999999998643211 1111111110 00
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhc
Q 007073 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR--MLEG 572 (619)
Q Consensus 528 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~ 572 (619)
.........+..+.+++.+|++.||++|||+.++++ .+++
T Consensus 226 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 226 -----FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp -----CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred -----CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 001112233467899999999999999999999985 4444
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=333.71 Aligned_cols=263 Identities=19% Similarity=0.300 Sum_probs=201.5
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCC-----Ccc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-----TER 366 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~ 366 (619)
.++|++.+.||+|+||.||+|... +++.||||++.........+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 467999999999999999999965 68899999997655555567899999999999999999999998655 357
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
++||||+. |+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 106 ~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 89999998 4888888652 388999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCcce--eeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007073 447 LVDVRKTNV--TTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 523 (619)
Q Consensus 447 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (619)
......... .....||+.|+|||.+.+ ..++.++|||||||++|||+||+.||........ +.........+.
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~~~~ 252 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ----LNHILGILGSPS 252 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH----HHHHHHHHCSCC
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH----HHHHHHHhCCCC
Confidence 765432221 234579999999998754 4589999999999999999999999975432211 111111000000
Q ss_pred --ccc------------hhcccccc--CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 524 --RLD------------AIVDRNLN--KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 524 --~~~------------~~~~~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
... ....+... ....+.....+.+++.+|++.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 00000000 0001122357899999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=345.61 Aligned_cols=200 Identities=25% Similarity=0.333 Sum_probs=167.6
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCC-----Cc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-----TE 365 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 365 (619)
.++|.+.+.||+|+||.||+|... +|+.||||++.... .....+.+.+|+++++.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999975 68899999997533 233457889999999999999999999998766 56
Q ss_pred ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 445 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 445 (619)
.++||||+. |+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999987 5999888753 3489999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcc---------------------eeeeccccccccccccc-cCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 007073 446 KLVDVRKTN---------------------VTTQVRGTMGHIAPEYL-STGKSSERTDVFGYGIMLLELVTGQRAID 500 (619)
Q Consensus 446 ~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~S~Gv~l~elltg~~p~~ 500 (619)
+........ ..+...||+.|+|||++ ....++.++||||+||++|||+||..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 976533211 23456799999999986 55679999999999999999998665553
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=327.89 Aligned_cols=253 Identities=21% Similarity=0.284 Sum_probs=198.8
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
..++|++.+.||+|+||.||+|... +|+.||+|.+... .....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC-CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 4567899999999999999999986 5899999998643 3445678999999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++++|.+++.... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 96 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp ECCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred EeCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999887532 3388999999999999999999999 999999999999999999999999998764321
Q ss_pred CCcceeeeccccccccccccc-----cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYL-----STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
. ........||+.|+|||.+ .+..++.++||||||+++|||+||+.||...... ............
T Consensus 170 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~ 240 (302)
T 2j7t_A 170 T-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSDPP 240 (302)
T ss_dssp H-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSCCC
T ss_pred c-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH--------HHHHHHhccCCc
Confidence 1 1112334689999999998 4677899999999999999999999998643211 111111111100
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.. ..+...+..+.+++.+||+.||++|||+.++++
T Consensus 241 -~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 241 -TL-------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -CC-------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -cc-------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 011223457899999999999999999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=347.52 Aligned_cols=253 Identities=22% Similarity=0.292 Sum_probs=202.2
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
..++|.+.+.||+|+||+||+|... +|+.||||++.... .......+.+|++++++++||||+++++++......++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3467999999999999999999975 78999999986321 233467889999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC---CCCcEEEcccccce
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGDFGLAK 446 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGla~ 446 (619)
|||+++|+|.+.+.... .+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|||+++
T Consensus 100 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 99999999999887643 388999999999999999999999 999999999999995 45679999999998
Q ss_pred eeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 447 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 447 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
..... .......||+.|+|||++.+ .++.++||||+||++|+|+||+.||..... . +............
T Consensus 173 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~---~~~~~i~~~~~~~ 241 (486)
T 3mwu_A 173 CFQQN--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----Y---DILKRVETGKYAF 241 (486)
T ss_dssp TBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----H---HHHHHHHHTCCCS
T ss_pred ECCCC--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----H---HHHHHHHhCCCCC
Confidence 65432 22334569999999999875 599999999999999999999999964321 1 1111111111000
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
. .......+..+.+++.+||+.||++|||+.++++.
T Consensus 242 ~-------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 D-------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp C-------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred C-------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00011223578899999999999999999999863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=337.07 Aligned_cols=259 Identities=20% Similarity=0.284 Sum_probs=203.6
Q ss_pred hcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCc----------------chHHHHHHHHHHHHHccCCCccce
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESP----------------GGDAAFQREVEMISVAVHRNLLRL 356 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~----------------~~~~~~~~E~~~l~~l~H~niv~l 356 (619)
.++|.+.+.||+|+||.||+|.. +|+.||||++...... ...+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46799999999999999999999 8999999998632111 112789999999999999999999
Q ss_pred eeeeeCCCcceeEecccccchhhhh------hcccCCCCCCcCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcE
Q 007073 357 IGFCTTPTERLLVYPFMQNLSVAYR------LREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANV 429 (619)
Q Consensus 357 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NI 429 (619)
++++...+..++||||+++|+|.++ +... ....+++..+..++.|++.||.|||+ . +|+||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 9999999999999999999999998 4431 13558999999999999999999999 8 999999999999
Q ss_pred EeCCCCcEEEcccccceeeccCCcceeeeccccccccccccccCC-CCCc-chhhHHHHHHHHHHHhCCCCCCCCccccc
Q 007073 430 LLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSE-RTDVFGYGIMLLELVTGQRAIDFSRLEEE 507 (619)
Q Consensus 430 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~S~Gv~l~elltg~~p~~~~~~~~~ 507 (619)
+++.++.+||+|||.+...... ......||..|+|||.+.+. .++. ++||||||+++|||+||+.||......
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-- 258 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-- 258 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence 9999999999999999876433 33455789999999999887 6666 999999999999999999999753321
Q ss_pred cchhHHHHHHHHhhhcccchhcc------ccc---cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 508 DDVLLLDHVKKLEREKRLDAIVD------RNL---NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~------~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. ......... ......+ +.. ........+..+.+++.+||+.||++|||+.|+++
T Consensus 259 --~---~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 --V---ELFNNIRTK-NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp --H---HHHHHHTSC-CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --H---HHHHHHhcc-CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 111111111 1100000 000 00001234467899999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=325.32 Aligned_cols=252 Identities=22% Similarity=0.305 Sum_probs=199.4
Q ss_pred HHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
...++|++.+.||+|+||.||+|... +|+.||||.+.... ....+.+|+.++++++||||+++++++......++|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 34567999999999999999999975 58999999986432 346789999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||+++++|.+++... ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++....
T Consensus 103 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 103 MEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred eecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 9999999999998742 23488999999999999999999999 99999999999999999999999999998764
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
.... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||...... .......... ...
T Consensus 177 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~-~~~-- 244 (314)
T 3com_A 177 DTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM--------RAIFMIPTNP-PPT-- 244 (314)
T ss_dssp TTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSC-CCC--
T ss_pred hhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHhcCC-Ccc--
Confidence 3322 233456899999999999999999999999999999999999999643211 0111111100 000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. ..+...+..+.+++.+||+.||++|||+.++++
T Consensus 245 ---~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 245 ---F--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---C--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---c--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0 011222457899999999999999999999985
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=338.13 Aligned_cols=265 Identities=20% Similarity=0.237 Sum_probs=200.6
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc--------CCCccceeeeee--
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV--------HRNLLRLIGFCT-- 361 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~~~~~-- 361 (619)
.++|.+.+.||+|+||+||+|... +|+.||||+++.. ....+.+.+|+++++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 478999999999999999999964 6889999998632 334577889999999886 788999999987
Q ss_pred --CCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC----
Q 007073 362 --TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF---- 435 (619)
Q Consensus 362 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---- 435 (619)
.....++||||+.+ ++.+.+.... ...+++..+..++.|++.||+|||+++ +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 114 GVNGTHICMVFEVLGH-HLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp ETTEEEEEEEECCCCC-BHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHH
T ss_pred CCCCceEEEEEeccCc-cHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhh
Confidence 55678999999955 5555554322 234899999999999999999999964 799999999999999775
Q ss_pred ---------------------------------------------cEEEcccccceeeccCCcceeeecccccccccccc
Q 007073 436 ---------------------------------------------EAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 470 (619)
Q Consensus 436 ---------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~ 470 (619)
.+||+|||+++..... .....||+.|+|||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence 7999999999876432 233468999999999
Q ss_pred ccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccc-chhHHHHHHHHhhh--------c-ccchhcccc--------
Q 007073 471 LSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED-DVLLLDHVKKLERE--------K-RLDAIVDRN-------- 532 (619)
Q Consensus 471 ~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~--------~-~~~~~~~~~-------- 532 (619)
+.+..++.++|||||||++|||+||+.||......... .............. . .........
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99999999999999999999999999999754332211 11111111111000 0 000000000
Q ss_pred -----------ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 533 -----------LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 533 -----------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
-...........+.+|+.+||+.||++|||+.|+++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 001235677788999999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=347.44 Aligned_cols=252 Identities=22% Similarity=0.294 Sum_probs=200.5
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCc------------chHHHHHHHHHHHHHccCCCccceee
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP------------GGDAAFQREVEMISVAVHRNLLRLIG 358 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~------------~~~~~~~~E~~~l~~l~H~niv~l~~ 358 (619)
..++|.+.+.||+|+||+||+|... +++.||||++...... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999975 6889999998653211 34567899999999999999999999
Q ss_pred eeeCCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC---
Q 007073 359 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF--- 435 (619)
Q Consensus 359 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 435 (619)
++......++||||+++|+|.+.+.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence 9999999999999999999999887643 389999999999999999999999 999999999999998775
Q ss_pred cEEEcccccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHH
Q 007073 436 EAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH 515 (619)
Q Consensus 436 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~ 515 (619)
.+||+|||+++...... ......||+.|+|||.+. +.++.++||||+||++|+|++|+.||...... ..
T Consensus 187 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~ 255 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--------DI 255 (504)
T ss_dssp SEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HH
T ss_pred cEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--------HH
Confidence 69999999998765432 233456999999999986 56999999999999999999999999753221 11
Q ss_pred HHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 516 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 516 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.......... ..... ....+..+.+++.+|++.||++|||+.|+++
T Consensus 256 ~~~i~~~~~~---~~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 256 IKKVEKGKYY---FDFND----WKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHHCCCC---CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHcCCCC---CCccc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1111111100 00000 0112357899999999999999999999984
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=337.66 Aligned_cols=257 Identities=24% Similarity=0.339 Sum_probs=197.7
Q ss_pred HHHHHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeC--
Q 007073 287 RELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTT-- 362 (619)
Q Consensus 287 ~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~-- 362 (619)
.++....++|++.+.||+|+||.||+|.+. +|+.||||++... ......+.+|+.+++++ +||||+++++++..
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC--cccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 344456788999999999999999999974 7899999998643 23457789999999998 79999999999876
Q ss_pred ----CCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 007073 363 ----PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV 438 (619)
Q Consensus 363 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 438 (619)
....++||||+++|+|.+++.... ...++...+..++.|++.||.|||++ +|+||||||+||+++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEE
Confidence 456899999999999999997642 23488899999999999999999999 999999999999999999999
Q ss_pred EcccccceeeccCCcceeeecccccccccccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHH
Q 007073 439 VGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL 513 (619)
Q Consensus 439 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~ 513 (619)
|+|||++........ ......||+.|+|||.+. +..++.++||||||+++|||+||+.||......
T Consensus 170 l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------- 240 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------- 240 (326)
T ss_dssp ECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--------
T ss_pred EeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--------
Confidence 999999986543221 223446899999999987 567899999999999999999999998643211
Q ss_pred HHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 514 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.......... ... . .....+..+.+++.+||+.||++||++.++++
T Consensus 241 ~~~~~~~~~~-~~~-----~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 241 RALFLIPRNP-APR-----L---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHHHHSC-CCC-----C---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHhhcCc-ccc-----C---CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111111110 000 0 01122357889999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=346.82 Aligned_cols=251 Identities=23% Similarity=0.325 Sum_probs=198.1
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
.++|.+.+.||+|+||+||+|... ++..||+|++.... .......+.+|+.+++.++||||+++++++......++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457899999999999999999975 68999999987533 2334577899999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEEccccccee
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVVGDFGLAKL 447 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGla~~ 447 (619)
||+++|+|.+.+.... .+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++.
T Consensus 116 e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999998887643 388999999999999999999999 9999999999999976 45599999999987
Q ss_pred eccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccch
Q 007073 448 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527 (619)
Q Consensus 448 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (619)
..... ......||+.|+|||++. +.++.++||||+||++|+|++|+.||...... +...........
T Consensus 189 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~~~-- 255 (494)
T 3lij_A 189 FENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--------EILRKVEKGKYT-- 255 (494)
T ss_dssp CBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCCC--
T ss_pred CCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCC--
Confidence 65432 233456999999999886 56999999999999999999999999743221 111111111100
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 528 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..... ....+..+.+++.+||+.||++|||+.++++
T Consensus 256 -~~~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 256 -FDSPE----WKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp -CCSGG----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CCchh----cccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 00000 1122357889999999999999999999884
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=349.00 Aligned_cols=252 Identities=25% Similarity=0.325 Sum_probs=204.6
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
..++|.+.+.||+|+||.||+|... +|+.||||++.... .......+.+|+.++++++||||+++++++......++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467999999999999999999975 78999999986432 23456789999999999999999999999999999999
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe---CCCCcEEEcccccc
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLA 445 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla 445 (619)
||||+.+|+|.+.+... ..+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 99999999999988753 3489999999999999999999999 99999999999999 56789999999999
Q ss_pred eeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 446 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 446 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
+...... ......||+.|+|||.+.+ .++.++||||+||++|+|+||+.||..... . +...........
T Consensus 177 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~---~~~~~i~~~~~~ 245 (484)
T 3nyv_A 177 THFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-----Y---DILKKVEKGKYT 245 (484)
T ss_dssp HHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H---HHHHHHHHCCCC
T ss_pred EEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-----H---HHHHHHHcCCCC
Confidence 8664332 2334569999999999865 699999999999999999999999974321 1 111111111100
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.. .......+..+.+++.+||+.||++|||+.++++
T Consensus 246 ~~-------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 FE-------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CC-------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC-------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00 0001123467899999999999999999999984
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=337.55 Aligned_cols=262 Identities=24% Similarity=0.419 Sum_probs=202.7
Q ss_pred HHHHHHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCc
Q 007073 287 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE 365 (619)
Q Consensus 287 ~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 365 (619)
.++....++|++.+.||+|+||.||+|.+.+ .||+|.++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 3445567889999999999999999999853 59999986432 23334567889999999999999999999999999
Q ss_pred ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 445 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 445 (619)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++ ++.+||+|||++
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred eEEEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCc
Confidence 99999999999999999763 23488999999999999999999999 999999999999998 679999999998
Q ss_pred eeeccCC----cceeeeccccccccccccccC---------CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhH
Q 007073 446 KLVDVRK----TNVTTQVRGTMGHIAPEYLST---------GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL 512 (619)
Q Consensus 446 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~ 512 (619)
+...... ........||+.|+|||.+.+ ..++.++||||||+++|||+||+.||......
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------- 249 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------- 249 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-------
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------
Confidence 7653211 112233458999999999864 45789999999999999999999999643211
Q ss_pred HHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007073 513 LDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 574 (619)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 574 (619)
.......... ..... ....+..+.+++.+||+.||++|||+.++++.|+...
T Consensus 250 -~~~~~~~~~~-~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 250 -AIIWQMGTGM-KPNLS--------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp -HHHHHHHTTC-CCCCC--------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred -HHHHHhccCC-CCCCC--------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 1111111111 00100 1112346889999999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=321.35 Aligned_cols=249 Identities=23% Similarity=0.364 Sum_probs=196.0
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
..++|.+.+.||+|+||.||+|... +|+.||||.+.... .....+.+.+|+.+++.++||||+++++++..++..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3467899999999999999999976 79999999986421 22345678999999999999999999999999999999
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||+++++|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 89 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 999999999999997643 388999999999999999999999 9999999999999999999999999999865
Q ss_pred ccCCcceeeeccccccccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccch
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (619)
.... ......|++.|+|||.+.+..+ +.++||||||+++|+|+||+.||...... ......... ..
T Consensus 162 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~-~~-- 228 (276)
T 2h6d_A 162 SDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--------TLFKKIRGG-VF-- 228 (276)
T ss_dssp CC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC-CC--
T ss_pred CCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--------HHHHHhhcC-cc--
Confidence 4322 2234468999999999987765 68999999999999999999999643211 111111111 00
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 528 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..+......+.+++.+|++.||++|||+.++++
T Consensus 229 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 229 --------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 011122357889999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=330.76 Aligned_cols=263 Identities=22% Similarity=0.302 Sum_probs=199.5
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCC-----Ccc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-----TER 366 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~ 366 (619)
.++|.+.+.||+|+||.||+|... +|+.||||++...........+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999975 68999999997555455567788999999999999999999988654 568
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
++||||+. ++|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999997 588888865 2388999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCcc---------eeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHH
Q 007073 447 LVDVRKTN---------VTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV 516 (619)
Q Consensus 447 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 516 (619)
........ ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~ 236 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH----QLLLIF 236 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHH
Confidence 76532211 1223468999999998764 678999999999999999999999997543210 010111
Q ss_pred HHHhhhc---cc--------chhcccc--ccC----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 517 KKLEREK---RL--------DAIVDRN--LNK----NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 517 ~~~~~~~---~~--------~~~~~~~--l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
....... .. .+..... ... ...+..+..+.+++.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000 00 0000000 000 001123467889999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=342.90 Aligned_cols=261 Identities=21% Similarity=0.274 Sum_probs=194.0
Q ss_pred hcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCc------c
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE------R 366 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------~ 366 (619)
..+|...+.||+|+||+||+|...++..||+|++...... ..+|+++++.++||||+++++++..... .
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 3568889999999999999999987778999988643221 2369999999999999999999855433 6
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-CCCcEEEcccccc
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD-EDFEAVVGDFGLA 445 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla 445 (619)
++||||++++.+..... .......+++..+..++.|+++||+|||++ +|+||||||+|||++ .++.+||+|||++
T Consensus 114 ~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRH-YAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEECCSEEHHHHHHH-HHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEeeccCccHHHHHHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 79999998765444332 222234588999999999999999999999 999999999999999 7999999999999
Q ss_pred eeeccCCcceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc-
Q 007073 446 KLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK- 523 (619)
Q Consensus 446 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 523 (619)
+....... .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... ..+.........+.
T Consensus 190 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~----~~l~~i~~~~g~p~~ 263 (394)
T 4e7w_A 190 KILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI----DQLVEIIKVLGTPSR 263 (394)
T ss_dssp EECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHCCCCH
T ss_pred ccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCCH
Confidence 87643322 3345689999999998765 5899999999999999999999999753321 11111111110000
Q ss_pred --------c-----cchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 524 --------R-----LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 524 --------~-----~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. ...+....+...+....+.++.+++.+||+.||++|||+.|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0 00000000000111223468899999999999999999999985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=328.67 Aligned_cols=254 Identities=21% Similarity=0.312 Sum_probs=197.2
Q ss_pred HHHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCC-CcchHHHHHHHHHHHHHcc--CCCccceeeeeeCCCcc
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAV--HRNLLRLIGFCTTPTER 366 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~ 366 (619)
....++|++.+.||+|+||.||++...+|+.||||.+.... .....+.+.+|++++++++ |+||+++++++...+..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 34567899999999999999999999889999999986433 3345578899999999997 59999999999999999
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
++||| +.+++|.+++.... .+++..+..++.|+++||.|||++ +|+||||||+||++++ +.+||+|||+++
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~ 174 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIAN 174 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred EEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccc
Confidence 99999 67889999997632 488899999999999999999999 9999999999999964 899999999998
Q ss_pred eeccCCcc-eeeeccccccccccccccC-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHH
Q 007073 447 LVDVRKTN-VTTQVRGTMGHIAPEYLST-----------GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 514 (619)
Q Consensus 447 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~ 514 (619)
........ ......||+.|+|||.+.+ ..++.++||||||+++|||+||+.||...... ..
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-------~~ 247 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------IS 247 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HH
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-------HH
Confidence 76433222 2234568999999999875 46889999999999999999999999642210 01
Q ss_pred HHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 515 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.... ..++.....++...+..+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 248 KLHA---------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHH---------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHH---------HHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 1111 11111111112222357899999999999999999999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=328.01 Aligned_cols=253 Identities=23% Similarity=0.308 Sum_probs=195.9
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC-------cchHHHHHHHHHHHHHccCCCccceeeeeeCC
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-------PGGDAAFQREVEMISVAVHRNLLRLIGFCTTP 363 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 363 (619)
..++|.+.+.||+|+||.||+|... +|+.||||.+..... ......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3567999999999999999999975 688999999864321 12234588999999999999999999998765
Q ss_pred CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc---EEEc
Q 007073 364 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE---AVVG 440 (619)
Q Consensus 364 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~ 440 (619)
. .++||||+++++|.+++... ..+++.....++.|++.||.|||++ +|+||||||+||+++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence 5 89999999999999988753 3488999999999999999999999 9999999999999987654 9999
Q ss_pred ccccceeeccCCcceeeecccccccccccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHH
Q 007073 441 DFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 517 (619)
Q Consensus 441 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 517 (619)
|||+++..... .......||+.|+|||.+. ...++.++|||||||++|||+||+.||....... .+.....
T Consensus 160 Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~ 233 (322)
T 2ycf_A 160 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV----SLKDQIT 233 (322)
T ss_dssp CCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS----CHHHHHH
T ss_pred cCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH----HHHHHHH
Confidence 99999876432 2223456899999999874 5678999999999999999999999997433211 1111111
Q ss_pred HHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 518 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 518 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. +.... .+.. ....+..+.+++.+||+.||++|||+.++++
T Consensus 234 ~----~~~~~--~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 S----GKYNF--IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp H----TCCCC--CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred h----Ccccc--Cchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1 10000 0000 0112357899999999999999999999885
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=341.85 Aligned_cols=198 Identities=20% Similarity=0.252 Sum_probs=171.5
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHc------cCCCccceeeeeeCCCc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA------VHRNLLRLIGFCTTPTE 365 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~~~~~~~~~ 365 (619)
..+|++.+.||+|+||+||+|... +++.||||+++.. ......+.+|+++++.+ .|+||+++++++.....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 457999999999999999999865 5899999999642 33456788899998877 46799999999999999
Q ss_pred ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc--EEEcccc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE--AVVGDFG 443 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfG 443 (619)
.++||||+. ++|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence 999999997 588888876432 3389999999999999999999999 9999999999999999887 9999999
Q ss_pred cceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 007073 444 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 502 (619)
Q Consensus 444 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~ 502 (619)
+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 248 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 248 SSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 99764322 23456899999999999999999999999999999999999999754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=343.69 Aligned_cols=260 Identities=24% Similarity=0.288 Sum_probs=193.3
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCC----C--cc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP----T--ER 366 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----~--~~ 366 (619)
.+|+..+.||+|+||.||+|.+. +|+.||||++.... ..+.+|+++++.++|||||++++++... + ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 46888899999999999999985 68999999986432 1234799999999999999999988432 1 25
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-CcEEEcccccc
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLA 445 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla 445 (619)
++||||+++ ++.+.+.........+++..+..++.|+++||+|||++ +|+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhh
Confidence 689999986 55555554333345589999999999999999999999 99999999999999955 67899999999
Q ss_pred eeeccCCcceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh--
Q 007073 446 KLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE-- 522 (619)
Q Consensus 446 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 522 (619)
+....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.........+
T Consensus 205 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~----~~l~~i~~~lg~p~~ 278 (420)
T 1j1b_A 205 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTPTR 278 (420)
T ss_dssp EECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHCSCCH
T ss_pred hhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCCH
Confidence 87643322 2345689999999998765 7899999999999999999999999753211 1112222111100
Q ss_pred -------cccchhccccccC-----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 523 -------KRLDAIVDRNLNK-----NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 523 -------~~~~~~~~~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
........+.+.. .+....+.++.+|+.+||+.||++|||+.|+++
T Consensus 279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0000000000000 011223467899999999999999999999984
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=362.10 Aligned_cols=246 Identities=22% Similarity=0.275 Sum_probs=201.7
Q ss_pred HHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcc
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTER 366 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 366 (619)
...++|++.++||+|+||.||+|... +++.||||++++.. .....+.+..|..++..+ +||+|+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 45578999999999999999999975 68899999986421 223456778899999877 699999999999999999
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceee
Confidence 99999999999999998643 389999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 447 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 447 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... +....+.
T Consensus 491 ~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~--------~~~~~i~------ 555 (674)
T 3pfq_A 491 ENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIM------ 555 (674)
T ss_dssp ECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHH------
T ss_pred ccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH--------HHHHHHH------
Confidence 643322 2344567999999999999999999999999999999999999999743211 1111111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAM 563 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 563 (619)
...+ .++...+.++.+|+.+||+.||++||++
T Consensus 556 ---~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 556 ---EHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp ---SSCC--CCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred ---hCCC--CCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 1111 1222344678999999999999999997
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.14 Aligned_cols=270 Identities=20% Similarity=0.229 Sum_probs=190.8
Q ss_pred HHHHHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCc
Q 007073 287 RELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE 365 (619)
Q Consensus 287 ~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 365 (619)
.+.....++|.+.+.||+|+||+||+|... +|+.||||++.... .....+.+|++.++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT--TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc--cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 345567789999999999999999999975 68999999986432 223456778888999999999999999865433
Q ss_pred -------ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHH--hcCCCCeEecCCCCCcEEeCC-CC
Q 007073 366 -------RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH--EHCNPKIIHRDVKAANVLLDE-DF 435 (619)
Q Consensus 366 -------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--~~~~~~ivH~Dlkp~NIll~~-~~ 435 (619)
.++||||++++ +...+.........+++..+..++.|++.||.||| ++ +|+||||||+|||++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence 68999999874 44444433334455888999999999999999999 87 9999999999999996 89
Q ss_pred cEEEcccccceeeccCCcceeeeccccccccccccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHH
Q 007073 436 EAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 514 (619)
Q Consensus 436 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~ 514 (619)
.+||+|||+++....... .....||+.|+|||.+.+.. ++.++|||||||++|||+||+.||...... ..+..
T Consensus 170 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~----~~~~~ 243 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA----GQLHE 243 (360)
T ss_dssp EEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH
T ss_pred cEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH----HHHHH
Confidence 999999999987654322 33456899999999986654 899999999999999999999999753321 11111
Q ss_pred HHHHHhhh-----------cccchhcc------ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 515 HVKKLERE-----------KRLDAIVD------RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 515 ~~~~~~~~-----------~~~~~~~~------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
........ .......+ ...........+..+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11111000 00000000 00001112224578999999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=333.36 Aligned_cols=259 Identities=23% Similarity=0.294 Sum_probs=182.3
Q ss_pred hcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCC------C
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------T 364 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~ 364 (619)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... .....+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46789999999999999999996 468999999986532 333457788999999999999999999998654 5
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 444 (619)
..++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 578999998 6899888764 2489999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh-
Q 007073 445 AKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE- 522 (619)
Q Consensus 445 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 522 (619)
++..... .....||+.|+|||.+.+ ..++.++|||||||++|||+||+.||....... .+.........+
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~l~~i~~~~g~p~ 250 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID----QLKLILRLVGTPG 250 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCSCC
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCC
Confidence 9865422 334578999999999877 678999999999999999999999997533211 111111110000
Q ss_pred -cccchhccc-------ccc--CCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 523 -KRLDAIVDR-------NLN--KNYN-----IQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 523 -~~~~~~~~~-------~l~--~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.....+... .+. .... ......+.+|+.+|++.||++|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 000000000 000 0000 112357889999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=320.59 Aligned_cols=251 Identities=18% Similarity=0.289 Sum_probs=197.7
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC---CcchHHHHHHHHHHHHHccCCCccceeeeee--CCCcc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE---SPGGDAAFQREVEMISVAVHRNLLRLIGFCT--TPTER 366 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~ 366 (619)
.++|.+.+.||+|+||.||+|... +++.||+|+++... .......+.+|++++++++||||+++++++. .....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999974 68999999986421 1345678999999999999999999999984 44578
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
++||||++++ +.+.+.... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999987 666665432 23588999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCC-cceeeeccccccccccccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007073 447 LVDVRK-TNVTTQVRGTMGHIAPEYLSTGK--SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 523 (619)
Q Consensus 447 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (619)
...... ........||+.|+|||.+.+.. ++.++||||||+++|||+||+.||..... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~i~~~- 228 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--------YKLFENIGKG- 228 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHC-
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH--------HHHHHHHhcC-
Confidence 764322 22233456899999999997654 37899999999999999999999974321 1111111111
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 524 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 524 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.. ..+...+..+.+++.+||+.||++|||+.++++
T Consensus 229 ~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 229 SY----------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp CC----------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CC----------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 111223457889999999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=330.97 Aligned_cols=260 Identities=19% Similarity=0.235 Sum_probs=191.0
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCC------
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT------ 364 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 364 (619)
.++|.+.+.||+|+||.||+|... +|+.||||++.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 367899999999999999999965 68999999987533 2334567889999999999999999999997664
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 444 (619)
..++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 57999999985 67777642 278889999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH------
Q 007073 445 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK------ 518 (619)
Q Consensus 445 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~------ 518 (619)
++..... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||....... ........
T Consensus 174 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~~~~~~~ 247 (371)
T 2xrw_A 174 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID----QWNKVIEQLGTPCP 247 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHC-CCCCCH
T ss_pred ccccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCCH
Confidence 9865432 22334578999999999999999999999999999999999999997533210 00000000
Q ss_pred ------------H-hhhc-----ccchhccccccCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 519 ------------L-EREK-----RLDAIVDRNLNKNY---NIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 519 ------------~-~~~~-----~~~~~~~~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. .... ...........+.. .......+.+++.+|++.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0 0000 00000000000000 1233578999999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=338.82 Aligned_cols=268 Identities=19% Similarity=0.264 Sum_probs=181.7
Q ss_pred cCCcc-cCccccCCCceEEEEEeC---CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeee--CCCcce
Q 007073 294 DNFSE-KNVLGQGGFGKVYRGVLA---DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT--TPTERL 367 (619)
Q Consensus 294 ~~~~~-~~~lg~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~~ 367 (619)
+.|++ .++||+|+||+||+|.+. +++.||||++.... ....+.+|++++++++||||+++++++. .....+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS---CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC---CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 34555 568999999999999965 57899999986432 2356889999999999999999999994 466789
Q ss_pred eEecccccchhhhhhcccC-----CCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe----CCCCcEE
Q 007073 368 LVYPFMQNLSVAYRLREIK-----PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL----DEDFEAV 438 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~k 438 (619)
+||||+.+ +|.+.+.... .....+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEE
Confidence 99999975 6776665321 1123488999999999999999999999 99999999999999 6778999
Q ss_pred EcccccceeeccCCc--ceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccc-----cch
Q 007073 439 VGDFGLAKLVDVRKT--NVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE-----DDV 510 (619)
Q Consensus 439 l~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~-----~~~ 510 (619)
|+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||........ ...
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999999987653221 223446789999999999874 589999999999999999999999965332110 001
Q ss_pred hHHHHHHHHhhhc--ccchh------------ccccccCCCCH---------HHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 007073 511 LLLDHVKKLEREK--RLDAI------------VDRNLNKNYNI---------QEVETMIQVALLCTQASPEDRPAMSEVV 567 (619)
Q Consensus 511 ~~~~~~~~~~~~~--~~~~~------------~~~~l~~~~~~---------~~~~~l~~l~~~Cl~~dP~~RPs~~evl 567 (619)
.+......+..+. ....+ ........... .....+.+|+.+||+.||++|||++|++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 1111111110000 00000 00000000000 0134678999999999999999999998
Q ss_pred H
Q 007073 568 R 568 (619)
Q Consensus 568 ~ 568 (619)
+
T Consensus 333 ~ 333 (405)
T 3rgf_A 333 Q 333 (405)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=322.44 Aligned_cols=253 Identities=21% Similarity=0.277 Sum_probs=203.1
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC--------cchHHHHHHHHHHHHHcc-CCCccceeeeee
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--------PGGDAAFQREVEMISVAV-HRNLLRLIGFCT 361 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--------~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~ 361 (619)
..++|.+.+.||+|+||.||+|... +|+.||||.+..... ....+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3568999999999999999999975 689999999864321 112456789999999996 999999999999
Q ss_pred CCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcc
Q 007073 362 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD 441 (619)
Q Consensus 362 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 441 (619)
.....++||||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence 999999999999999999999763 2388999999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCcceeeecccccccccccccc------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHH
Q 007073 442 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS------TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH 515 (619)
Q Consensus 442 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~ 515 (619)
||++....... ......|++.|+|||.+. ...++.++||||||+++|||++|+.||...... ..
T Consensus 168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~ 237 (298)
T 1phk_A 168 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--------LM 237 (298)
T ss_dssp CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HH
T ss_pred ccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH--------HH
Confidence 99998765332 233456899999999885 456899999999999999999999998643211 11
Q ss_pred HHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 516 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 516 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
........ .. .........+..+.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~-~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 238 LRMIMSGN-YQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHHTC-CC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHhcCC-cc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11111110 00 000011233467899999999999999999999875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=331.91 Aligned_cols=265 Identities=23% Similarity=0.327 Sum_probs=200.2
Q ss_pred HhcCCcccCccccCCCceEEEEEe--CCCcEEEEEEeccCC-CcchHHHHHHHHHHHHHc---cCCCccceeeeee----
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVL--ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVA---VHRNLLRLIGFCT---- 361 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~---- 361 (619)
..++|++.+.||+|+||.||+|.. .+|+.||+|+++... .......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 468899999986432 122234566788777766 8999999999987
Q ss_pred -CCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEc
Q 007073 362 -TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVG 440 (619)
Q Consensus 362 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 440 (619)
.....++||||++ |+|.+++..... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 4567889999998 599998876432 3488999999999999999999999 99999999999999999999999
Q ss_pred ccccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh
Q 007073 441 DFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 520 (619)
Q Consensus 441 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 520 (619)
|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||...... ...........
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~i~~~~~ 236 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV----DQLGKILDVIG 236 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHHHC
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHHHcC
Confidence 999998654322 233456899999999999999999999999999999999999999753321 11111111110
Q ss_pred hhc--cc-ch------hccc---cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 521 REK--RL-DA------IVDR---NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 521 ~~~--~~-~~------~~~~---~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
... .. .. .... ..........+..+.+++.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 00 00 0000 0000112233467889999999999999999999984
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=329.70 Aligned_cols=258 Identities=21% Similarity=0.290 Sum_probs=194.9
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcc----
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER---- 366 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~---- 366 (619)
.++|...+.||+|+||.||+|... +|+.||||++.... .....+.+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467888999999999999999965 68999999997543 233457788999999999999999999999877654
Q ss_pred --eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007073 367 --LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444 (619)
Q Consensus 367 --~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 444 (619)
++||||+. ++|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999998 577776632 288999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007073 445 AKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 523 (619)
Q Consensus 445 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (619)
++..... .....||+.|+|||.+.+ ..++.++|||||||++|||+||+.||....... .+...........
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~~~~~~ 262 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD----QLTQILKVTGVPG 262 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCC
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCc
Confidence 9865432 334568999999999877 678999999999999999999999997532211 1111111000000
Q ss_pred --ccch--------h---ccccccCC---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 524 --RLDA--------I---VDRNLNKN---YNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 524 --~~~~--------~---~~~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.... . ........ ..+..+..+.+++.+|++.||++|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0000 0 00000000 01123467899999999999999999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=338.12 Aligned_cols=252 Identities=22% Similarity=0.279 Sum_probs=187.5
Q ss_pred CCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcceeEeccc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVYPFM 373 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~ 373 (619)
.|...++||+|+||+||.+...+|+.||||++.. ...+.+.+|+++++++ +||||+++++++......++||||+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~----~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI----DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEG----GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcH----HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 4555688999999999877667899999999863 2345678999999876 8999999999999999999999999
Q ss_pred ccchhhhhhcccCCCCCC---cCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-------------CcE
Q 007073 374 QNLSVAYRLREIKPGEPV---LDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-------------FEA 437 (619)
Q Consensus 374 ~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~~~ 437 (619)
. |+|.+++......... .++..+..++.|++.||+|||++ +|+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 6999999764332211 13334578999999999999999 99999999999999653 589
Q ss_pred EEcccccceeeccCCcc---eeeeccccccccccccccC-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccc
Q 007073 438 VVGDFGLAKLVDVRKTN---VTTQVRGTMGHIAPEYLST-------GKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEE 506 (619)
Q Consensus 438 kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~ 506 (619)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999977543322 1234579999999999965 678999999999999999999 999986432110
Q ss_pred ccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 507 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..... ..... +..........+.++.+++.+||+.||++|||+.++++
T Consensus 248 ------~~i~~---~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 ------SNIIR---GIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ------HHHHH---TCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------HHHhc---CCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 00100 00000 11111224566788999999999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=324.32 Aligned_cols=259 Identities=20% Similarity=0.262 Sum_probs=202.1
Q ss_pred hcCCcccCccccCCCceEEEEEe--CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCC------ccceeeeeeCCC
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVL--ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN------LLRLIGFCTTPT 364 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~--~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~ 364 (619)
.++|++.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+++++.++|++ ++++++++...+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 46899999999999999999996 36889999998642 334577889999999887765 999999999999
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-----------
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE----------- 433 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~----------- 433 (619)
..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred cEEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcc
Confidence 999999999 889999887643 23488999999999999999999999 9999999999999987
Q ss_pred --------CCcEEEcccccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccc
Q 007073 434 --------DFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLE 505 (619)
Q Consensus 434 --------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~ 505 (619)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||+||+.||......
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred ccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 668999999999864332 23456899999999999999999999999999999999999999753321
Q ss_pred cccchhHHHHHHHHhhhc--------ccch---------------------hcccc-ccCCCCHHHHHHHHHHHHhccCC
Q 007073 506 EEDDVLLLDHVKKLEREK--------RLDA---------------------IVDRN-LNKNYNIQEVETMIQVALLCTQA 555 (619)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~--------~~~~---------------------~~~~~-l~~~~~~~~~~~l~~l~~~Cl~~ 555 (619)
. ............ .... ...+. -........+..+.+++.+||+.
T Consensus 241 ~-----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 241 E-----HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp H-----HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred H-----HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 1 111111110000 0000 00000 00111335567899999999999
Q ss_pred CCCCCCCHHHHHH
Q 007073 556 SPEDRPAMSEVVR 568 (619)
Q Consensus 556 dP~~RPs~~evl~ 568 (619)
||++|||+.|+++
T Consensus 316 dP~~Rpt~~ell~ 328 (339)
T 1z57_A 316 DPAKRITLREALK 328 (339)
T ss_dssp STTTSCCHHHHTT
T ss_pred CcccccCHHHHhc
Confidence 9999999999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=328.06 Aligned_cols=256 Identities=22% Similarity=0.333 Sum_probs=180.5
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHH-HHHHccCCCccceeeeeeCCCcceeE
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVE-MISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
..++|...+.||+|+||.||+|... +|+.||||++...........+..|+. +++.++||||+++++++..++..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 3478889999999999999999975 789999999976544445556666776 66778999999999999999999999
Q ss_pred ecccccchhhhhhccc-CCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 370 YPFMQNLSVAYRLREI-KPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
|||+++ +|.+++... ......+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+++..
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 999986 777666532 112345889999999999999999999852 7999999999999999999999999999866
Q ss_pred ccCCcceeeeccccccccccccc----cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYL----STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
.... ......||+.|+|||.+ .+..++.++||||||+++|||+||+.||........ .
T Consensus 177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----------------~ 238 (327)
T 3aln_A 177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD----------------Q 238 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------------
T ss_pred cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH----------------H
Confidence 4322 22334689999999998 456789999999999999999999999964221100 0
Q ss_pred cchhcc---ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 525 LDAIVD---RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 525 ~~~~~~---~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
+..+.. +.+........+..+.+++.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 239 LTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 001111 01111111223467899999999999999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=321.32 Aligned_cols=251 Identities=23% Similarity=0.363 Sum_probs=192.2
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeC---------
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT--------- 362 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------- 362 (619)
.++|++.+.||+|+||.||+|... +|+.||||++.. .....+.+.+|+.++++++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE--EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec--cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 467899999999999999999974 799999999853 23345778999999999999999999998754
Q ss_pred ----CCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 007073 363 ----PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV 438 (619)
Q Consensus 363 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 438 (619)
....++||||+++|+|.+++... ...+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence 34578999999999999999753 23477888999999999999999999 999999999999999999999
Q ss_pred EcccccceeeccCC-------------cceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcc
Q 007073 439 VGDFGLAKLVDVRK-------------TNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRL 504 (619)
Q Consensus 439 l~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~ 504 (619)
|+|||+++...... ........||+.|+|||.+.+. .++.++||||||+++|||+| ||....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~- 232 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM- 232 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-
Confidence 99999998654221 1122345689999999999764 68999999999999999998 443211
Q ss_pred ccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 505 EEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. ........... ............+..+.+++.+||+.||++|||+.++++
T Consensus 233 ---~---~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 ---E---RVNILKKLRSV-------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp ---H---HHHHHHHHHST-------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---h---HHHHHHhcccc-------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 0 01111111110 111112233344567899999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=328.76 Aligned_cols=265 Identities=19% Similarity=0.274 Sum_probs=199.8
Q ss_pred hcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc-----------CCCccceeeee
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-----------HRNLLRLIGFC 360 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~ 360 (619)
.++|.+.+.||+|+||+||+|.. .+|+.||||++.. .....+.+.+|+++++++. |+||+++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG--DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC--CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 46799999999999999999996 4789999999863 2334567889999998876 89999999998
Q ss_pred eCCC----cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC----
Q 007073 361 TTPT----ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD---- 432 (619)
Q Consensus 361 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---- 432 (619)
.... ..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||+++ +|+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCC
Confidence 7543 678999999 8899999976433 33889999999999999999999953 899999999999994
Q ss_pred --CCCcEEEcccccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccc--c
Q 007073 433 --EDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE--D 508 (619)
Q Consensus 433 --~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~--~ 508 (619)
..+.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||+||+.||........ .
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4558999999999876432 2334689999999999999999999999999999999999999975432111 0
Q ss_pred chhHHHHHHHHhhh--------cccchhccc-------------------cccCCCCHHHHHHHHHHHHhccCCCCCCCC
Q 007073 509 DVLLLDHVKKLERE--------KRLDAIVDR-------------------NLNKNYNIQEVETMIQVALLCTQASPEDRP 561 (619)
Q Consensus 509 ~~~~~~~~~~~~~~--------~~~~~~~~~-------------------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 561 (619)
...+.......... .......+. .-...++...+..+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 11111111110000 000000000 001124567788999999999999999999
Q ss_pred CHHHHHH
Q 007073 562 AMSEVVR 568 (619)
Q Consensus 562 s~~evl~ 568 (619)
|+.|+++
T Consensus 327 t~~ell~ 333 (373)
T 1q8y_A 327 DAGGLVN 333 (373)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=315.78 Aligned_cols=252 Identities=22% Similarity=0.298 Sum_probs=201.9
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
..++|.+.+.||+|+||.||+|... +++.||||++.... .......+.+|++++++++||||+++++++......++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 4568999999999999999999975 78999999986432 234567899999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC---CcEEEcccccce
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED---FEAVVGDFGLAK 446 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGla~ 446 (619)
+||+++++|.+.+.... .+++..+..++.|++.||.|||++ +|+||||||+||+++.+ +.+||+|||++.
T Consensus 100 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 99999999998887543 388999999999999999999999 99999999999999754 479999999998
Q ss_pred eeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 447 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 447 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
...... ......||+.|+|||.+.+ .++.++||||||+++|+|+||+.||...... +......... ..
T Consensus 173 ~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~-~~ 240 (287)
T 2wei_A 173 CFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--------DILKRVETGK-YA 240 (287)
T ss_dssp TBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCC-CC
T ss_pred eecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCC-CC
Confidence 654322 1233458999999998865 5899999999999999999999998643211 1111111111 00
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. +.. .....+..+.+++.+||+.||++|||+.++++
T Consensus 241 ~--~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 F--DLP----QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp C--CSG----GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C--Cch----hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0 000 00122357899999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=323.38 Aligned_cols=257 Identities=21% Similarity=0.297 Sum_probs=195.4
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCc-----
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE----- 365 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 365 (619)
.++|...+.||+|+||.||+|... +|+.||||++.... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 357888999999999999999975 68999999997543 23345678899999999999999999999987654
Q ss_pred -ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007073 366 -RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444 (619)
Q Consensus 366 -~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 444 (619)
.++||||+. ++|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999998 588777642 288999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh-
Q 007073 445 AKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE- 522 (619)
Q Consensus 445 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 522 (619)
++..... .....||+.|+|||.+.+ ..++.++||||||+++|||+||+.||....... .+.........+
T Consensus 173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~----~~~~i~~~~~~~~ 244 (353)
T 3coi_A 173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD----QLTQILKVTGVPG 244 (353)
T ss_dssp TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH----HHHHHHHHHCBCC
T ss_pred ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCC
Confidence 9865322 234568999999999877 678999999999999999999999997533211 111111100000
Q ss_pred -ccc------------chhc---cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 523 -KRL------------DAIV---DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 523 -~~~------------~~~~---~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
... ..+. ...+ .......+..+.+++.+|++.||++|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 245 TEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 0000 0000 0112234568899999999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=321.67 Aligned_cols=262 Identities=21% Similarity=0.306 Sum_probs=191.1
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeee----------
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT---------- 361 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~---------- 361 (619)
.++|.+.+.||+|+||.||+|... +|+.||||++... .....+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 467889999999999999999976 5899999998643 3445678899999999999999999999874
Q ss_pred ----CCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-CCCc
Q 007073 362 ----TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD-EDFE 436 (619)
Q Consensus 362 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~ 436 (619)
.....++||||++ |+|.+++.. ..++...+..++.|++.||+|||++ +|+||||||+||+++ +++.
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCe
Confidence 3356789999998 699988864 2378899999999999999999999 999999999999997 5679
Q ss_pred EEEcccccceeeccCCc--ceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHH
Q 007073 437 AVVGDFGLAKLVDVRKT--NVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL 513 (619)
Q Consensus 437 ~kl~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~ 513 (619)
+||+|||+++....... .......+|..|+|||.+.+ ..++.++||||||+++|||+||+.||........ ..
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~----~~ 235 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ----MQ 235 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HH
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH----HH
Confidence 99999999987643221 12233457899999998865 6789999999999999999999999975432110 00
Q ss_pred HHHHHHhh---------hcccchhcccccc-CC-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 514 DHVKKLER---------EKRLDAIVDRNLN-KN-----YNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 514 ~~~~~~~~---------~~~~~~~~~~~l~-~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
........ ............. .. .....+..+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 01100000 0000000000000 00 01123467899999999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=326.47 Aligned_cols=202 Identities=21% Similarity=0.237 Sum_probs=170.9
Q ss_pred HHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc-CC-----CccceeeeeeCC
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HR-----NLLRLIGFCTTP 363 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~~~~~~~ 363 (619)
...++|.+.+.||+|+||+||+|... +|+.||||+++.. ......+..|+.+++.++ |+ +|+++++++...
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 34578999999999999999999975 6889999999632 334567788999988885 45 499999999999
Q ss_pred CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC--CCCcEEEcc
Q 007073 364 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD--EDFEAVVGD 441 (619)
Q Consensus 364 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~D 441 (619)
+..++||||+++ +|.+++..... ..+++..+..++.|++.||.|||.+ ..+|+||||||+|||++ .++.+||+|
T Consensus 129 ~~~~lv~e~~~~-~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 129 NHLCLVFEMLSY-NLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp TEEEEEEECCCC-BHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred CceEEEEecCCC-CHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 999999999964 99998876432 3388999999999999999999952 12899999999999994 578899999
Q ss_pred cccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 007073 442 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 502 (619)
Q Consensus 442 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~ 502 (619)
||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 205 FG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 205 FGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999876432 23456899999999999999999999999999999999999999753
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=329.99 Aligned_cols=247 Identities=22% Similarity=0.367 Sum_probs=199.0
Q ss_pred HHHHHHhcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCc-----chHHHHHHHHHHHHHcc--CCCccceee
Q 007073 287 RELQLATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESP-----GGDAAFQREVEMISVAV--HRNLLRLIG 358 (619)
Q Consensus 287 ~el~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~-----~~~~~~~~E~~~l~~l~--H~niv~l~~ 358 (619)
.+.+...++|.+.+.||+|+||.||+|.. .+|+.||||++...... .....+.+|+.++++++ |+||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 34445667899999999999999999996 47899999998643221 12345678999999996 599999999
Q ss_pred eeeCCCcceeEeccccc-chhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-CCCc
Q 007073 359 FCTTPTERLLVYPFMQN-LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD-EDFE 436 (619)
Q Consensus 359 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~ 436 (619)
++..++..++|+|++.+ ++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++ +++.
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTE
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCC
Confidence 99999999999999986 89999987632 388999999999999999999999 999999999999999 7899
Q ss_pred EEEcccccceeeccCCcceeeeccccccccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHH
Q 007073 437 AVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH 515 (619)
Q Consensus 437 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~ 515 (619)
+||+|||+++..... ......||+.|+|||.+.+..+ +.++||||||+++|||+||+.||.....
T Consensus 189 ~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----------- 254 (320)
T 3a99_A 189 LKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------- 254 (320)
T ss_dssp EEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------
T ss_pred EEEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----------
Confidence 999999999876532 2234568999999999987766 7889999999999999999999863210
Q ss_pred HHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 516 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 516 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.... .. . .....+..+.+++.+||+.||++|||+.++++
T Consensus 255 ---~~~~-~~--~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 ---IIRG-QV--F--------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ---HHHC-CC--C--------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---hhcc-cc--c--------ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00 0 11122357889999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=320.21 Aligned_cols=247 Identities=22% Similarity=0.327 Sum_probs=191.2
Q ss_pred HHHHHHhcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCc-----chHHHHHHHHHHHHHc----cCCCccce
Q 007073 287 RELQLATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESP-----GGDAAFQREVEMISVA----VHRNLLRL 356 (619)
Q Consensus 287 ~el~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~-----~~~~~~~~E~~~l~~l----~H~niv~l 356 (619)
.+.+...++|.+.+.||+|+||.||+|.. .+|+.||||++...... .....+.+|+.++.++ +||||+++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 34455678899999999999999999996 47899999998643321 1233456799999988 89999999
Q ss_pred eeeeeCCCcceeEecc-cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-CC
Q 007073 357 IGFCTTPTERLLVYPF-MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD-ED 434 (619)
Q Consensus 357 ~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~ 434 (619)
++++...+..++|+|| +.+++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++ .+
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRR 176 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTT
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCC
Confidence 9999999999999999 78999999997643 389999999999999999999999 999999999999999 88
Q ss_pred CcEEEcccccceeeccCCcceeeeccccccccccccccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCccccccchhHH
Q 007073 435 FEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS-ERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL 513 (619)
Q Consensus 435 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~ 513 (619)
+.+||+|||+++...... .....||..|+|||.+.+..+. .++||||||+++|||+||+.||.....
T Consensus 177 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------- 244 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--------- 244 (312)
T ss_dssp TEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------
T ss_pred CeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH---------
Confidence 999999999998765432 2345689999999999877764 589999999999999999999863210
Q ss_pred HHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 514 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. .. .. ..........+.+++.+||+.||++|||+.|+++
T Consensus 245 -~---~~--~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 -I---LE--AE----------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -H---HH--TC----------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -H---hh--hc----------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00 00 0111223457889999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=324.11 Aligned_cols=253 Identities=21% Similarity=0.255 Sum_probs=173.2
Q ss_pred HhcCCccc-CccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeC----CCc
Q 007073 292 ATDNFSEK-NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT----PTE 365 (619)
Q Consensus 292 ~~~~~~~~-~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~ 365 (619)
..++|.+. ++||+|+||+||+|... +|+.||||++... .....+....++.+.||||+++++++.. ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 45678875 46999999999999976 6899999998642 1222223334677899999999999865 344
Q ss_pred ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEEccc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVVGDF 442 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Df 442 (619)
.++||||+++|+|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+||+++. ++.+||+||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecc
Confidence 789999999999999998643 24589999999999999999999999 9999999999999976 456999999
Q ss_pred ccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh
Q 007073 443 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 522 (619)
Q Consensus 443 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 522 (619)
|+++..... ......||+.|+|||.+.+..++.++||||||+++|+|+||+.||.......... ....... .
T Consensus 176 g~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~~~~~~~-~ 247 (336)
T 3fhr_A 176 GFAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP----GMKRRIR-L 247 (336)
T ss_dssp TTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred ccceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh----hHHHhhh-c
Confidence 999865432 2234568999999999988889999999999999999999999996432211100 0000000 0
Q ss_pred cccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 523 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 523 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.. ...........+..+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 248 GQ------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ---------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cc------cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 00000111233467899999999999999999999996
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=315.74 Aligned_cols=252 Identities=21% Similarity=0.321 Sum_probs=178.7
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHH-HHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAF-QREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~-~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
.++|+..+.||+|+||.||+|.+. +|+.||||++...........+ .++..+++.++||||+++++++..++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888999999999999999975 7899999999754433333334 44455678889999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
||+ ++.+....... ...+++..+..++.|+++||.|||+ . +|+||||||+||+++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 44554444332 2348899999999999999999998 6 89999999999999999999999999997654
Q ss_pred cCCcceeeecccccccccccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
... ......||+.|+|||.+. ...++.++||||||+++|||+||+.||...... . ...........
T Consensus 177 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~---~~~~~~~~~~~ 247 (318)
T 2dyl_A 177 DDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD----F---EVLTKVLQEEP 247 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH----H---HHHHHHHHSCC
T ss_pred CCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc----H---HHHHHHhccCC
Confidence 322 223446899999999984 556899999999999999999999999642211 1 11111111110
Q ss_pred cchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 525 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.. ... ....+..+.+++.+||+.||++||++.++++
T Consensus 248 -~~-----~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 -PL-----LPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp -CC-----CCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -CC-----CCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00 000 1122357889999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=320.28 Aligned_cols=259 Identities=18% Similarity=0.230 Sum_probs=197.9
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CC-cEEEEEEeccCCCcchHHHHHHHHHHHHHccCCC------ccceeeeeeCCC
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DG-TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN------LLRLIGFCTTPT 364 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g-~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~ 364 (619)
.++|.+.+.||+|+||+||+|... ++ +.||+|+++.. ....+.+.+|+.++++++|++ ++.+++++....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 468999999999999999999974 34 68999998632 344577889999999998766 899999999999
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe-------------
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL------------- 431 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll------------- 431 (619)
..++||||+ ++++.+.+.... ...+++..+..++.|++.||+|||++ +|+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eEEEEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccc
Confidence 999999999 456666665432 23488999999999999999999999 99999999999999
Q ss_pred ------CCCCcEEEcccccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccc
Q 007073 432 ------DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLE 505 (619)
Q Consensus 432 ------~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~ 505 (619)
+.++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||+||+.||......
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 56789999999999864332 23456899999999999999999999999999999999999999753321
Q ss_pred cccchhHHHHHHHHhhhc---------ccchhccc---------------------cccCCCCHHHHHHHHHHHHhccCC
Q 007073 506 EEDDVLLLDHVKKLEREK---------RLDAIVDR---------------------NLNKNYNIQEVETMIQVALLCTQA 555 (619)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~---------~~~~~~~~---------------------~l~~~~~~~~~~~l~~l~~~Cl~~ 555 (619)
. ............ ........ .............+.+++.+||+.
T Consensus 246 ~-----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 246 E-----HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp H-----HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred H-----HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 1 111111110000 00000000 000011234456899999999999
Q ss_pred CCCCCCCHHHHHH
Q 007073 556 SPEDRPAMSEVVR 568 (619)
Q Consensus 556 dP~~RPs~~evl~ 568 (619)
||++|||+.|+++
T Consensus 321 dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 321 DPAQRITLAEALL 333 (355)
T ss_dssp STTTSCCHHHHTT
T ss_pred ChhhCcCHHHHhc
Confidence 9999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=332.21 Aligned_cols=250 Identities=24% Similarity=0.312 Sum_probs=186.1
Q ss_pred HhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcceeEe
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 370 (619)
...+|...++||+|+||+||.....+|+.||||++.... ...+.+|+++++++ +|||||++++++......++||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC----FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT----EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 445688899999999999665555679999999986432 12356899999999 7999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-----CCcEEEcccccc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-----DFEAVVGDFGLA 445 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfGla 445 (619)
||+. |+|.+++..... .........++.|++.||+|||++ +|+||||||+|||++. ...+||+|||++
T Consensus 98 E~~~-g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp ECCS-EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred ECCC-CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9997 599998876432 233445678999999999999999 9999999999999953 346889999999
Q ss_pred eeeccCCc--ceeeecccccccccccccc---CCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHH
Q 007073 446 KLVDVRKT--NVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKL 519 (619)
Q Consensus 446 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 519 (619)
+....... .......||+.|+|||++. ...++.++|||||||++|||+| |..||...... .....
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---------~~~~~ 241 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---------QANIL 241 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---------HHHHH
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---------HHHHH
Confidence 87653322 2234467999999999997 4567889999999999999999 88888532110 00111
Q ss_pred hhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 520 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 520 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
...... . . ..........+.+++.+||+.||++|||+.++++
T Consensus 242 ~~~~~~-~----~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 242 LGACSL-D----C--LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTCCCC-T----T--SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccCCc-c----c--cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 100000 0 0 0112344556889999999999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=345.71 Aligned_cols=260 Identities=22% Similarity=0.260 Sum_probs=199.6
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeC------CCc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT------PTE 365 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~ 365 (619)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++........+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 368999999999999999999974 6899999998765555567789999999999999999999998765 667
Q ss_pred ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc---EEEccc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE---AVVGDF 442 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Df 442 (619)
.++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 8999999999999999986432 23488889999999999999999999 9999999999999986654 999999
Q ss_pred ccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh
Q 007073 443 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 522 (619)
Q Consensus 443 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 522 (619)
|++....... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||....... .|.......
T Consensus 169 G~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-------~~~~~i~~~ 239 (676)
T 3qa8_A 169 GYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-------QWHGKVREK 239 (676)
T ss_dssp CCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-------HSSTTCC--
T ss_pred cccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-------hhhhhhhcc
Confidence 9998764332 2344579999999999999999999999999999999999999996432110 000000000
Q ss_pred cc----cchhccc--------cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 007073 523 KR----LDAIVDR--------NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSE 565 (619)
Q Consensus 523 ~~----~~~~~~~--------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 565 (619)
.. ....... ..........+..+.+++..|++.||++|||+.+
T Consensus 240 ~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 240 SNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp ----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred cchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 00 0000000 0011234556788999999999999999999966
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=348.59 Aligned_cols=239 Identities=20% Similarity=0.303 Sum_probs=194.4
Q ss_pred hcCCcccCccccCCCceEEEEEeC--CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCc-----
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA--DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE----- 365 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~--~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 365 (619)
.++|.+.+.||+|+||+||+|.+. +|+.||||++...........+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999975 6899999998765555566788999999999999999999999987665
Q ss_pred ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 445 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 445 (619)
.++||||+++++|.+++.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccc
Confidence 6999999999999887653 489999999999999999999999 99999999999999986 8999999999
Q ss_pred eeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 446 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 446 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
+..... ....||+.|+|||++.++. +.++|||||||++|||++|..|+........
T Consensus 229 ~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------------------ 284 (681)
T 2pzi_A 229 SRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------------------ 284 (681)
T ss_dssp EETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC------------------
T ss_pred hhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc------------------
Confidence 876432 3456999999999987654 8999999999999999999888753211100
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHHhc
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-MSEVVRMLEG 572 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~L~~ 572 (619)
. ...........+.+++.+||+.||++||+ ++++.+.|.+
T Consensus 285 ---~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 285 ---P----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ---C----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ---c----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0 00001123357889999999999999995 6666666654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=302.72 Aligned_cols=231 Identities=11% Similarity=0.026 Sum_probs=183.6
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC--cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
.++|.+.+.||+|+||.||+|.+. +|+.||||++..... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467999999999999999999975 589999999975433 23347899999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||+++++|.+++... .......+++.|++.||+|||++ +|+||||||+||+++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc------
Confidence 9999999999998541 24446788999999999999999 99999999999999999999998543
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
|++ .++.++|||||||++|||+||+.||........... .....
T Consensus 175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~--------------~~~~~ 218 (286)
T 3uqc_A 175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP--------------AERDT 218 (286)
T ss_dssp ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE--------------CCBCT
T ss_pred ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH--------------HHHHh
Confidence 333 368999999999999999999999975432211000 00000
Q ss_pred ccccc--CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc
Q 007073 530 DRNLN--KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGL 575 (619)
Q Consensus 530 ~~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 575 (619)
..... .......+..+.+++.+||+.||++| |+.|+++.|+....
T Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 219 AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 00000 00011234578999999999999999 99999999988543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=321.48 Aligned_cols=244 Identities=15% Similarity=0.100 Sum_probs=181.1
Q ss_pred hcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCc--chHHHHHHHHHHHHHccC-CCcccee---------ee
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESP--GGDAAFQREVEMISVAVH-RNLLRLI---------GF 359 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~--~~~~~~~~E~~~l~~l~H-~niv~l~---------~~ 359 (619)
...|...++||+|+||+||+|.+ .+|+.||||++...... ...+.|.+|+.+++.++| +|..... ..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34577788999999999999995 47999999998733322 235778999999999987 3222111 11
Q ss_pred e------------eC-----CCcceeEecccccchhhhhhccc---CCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 007073 360 C------------TT-----PTERLLVYPFMQNLSVAYRLREI---KPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 419 (619)
Q Consensus 360 ~------------~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 419 (619)
. .. ....+++|++ .+++|.+++... ......+++..+..++.|+++||+|||++ +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 1 11 1123455554 467888888532 23345588889999999999999999999 99
Q ss_pred EecCCCCCcEEeCCCCcEEEcccccceeeccCCcceeeeccccccccccccc----------cCCCCCcchhhHHHHHHH
Q 007073 420 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL----------STGKSSERTDVFGYGIML 489 (619)
Q Consensus 420 vH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~S~Gv~l 489 (619)
+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999999865432 344567 999999999 555688999999999999
Q ss_pred HHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 490 LELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 490 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
|||+||+.||........ ...++... . ..+..+.+++.+||+.||++||++.++++
T Consensus 308 ~elltg~~Pf~~~~~~~~-----------------~~~~~~~~--~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGG-----------------SEWIFRSC--K----NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHSSCCCCTTGGGSC-----------------SGGGGSSC--C----CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcchhhh-----------------HHHHHhhc--c----cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999975332111 11111111 1 12357899999999999999999888864
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=296.23 Aligned_cols=226 Identities=21% Similarity=0.277 Sum_probs=177.6
Q ss_pred cCCccc-CccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHH-HHccCCCccceeeeeeC----CCcc
Q 007073 294 DNFSEK-NVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMI-SVAVHRNLLRLIGFCTT----PTER 366 (619)
Q Consensus 294 ~~~~~~-~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~----~~~~ 366 (619)
++|.+. +.||+|+||.||+|.. .+|+.||+|++.. ...+.+|++++ +..+||||+++++++.. ....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 456665 7899999999999997 4789999999863 24567889887 66689999999999876 5678
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEEcccc
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVVGDFG 443 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG 443 (619)
++||||+++|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 99999999999999998643 23589999999999999999999999 9999999999999998 7899999999
Q ss_pred cceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007073 444 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 523 (619)
Q Consensus 444 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (619)
++.... +..++.++|||||||++|||+||+.||......... ..
T Consensus 166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-------------~~ 209 (299)
T 3m2w_A 166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------------PG 209 (299)
T ss_dssp TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------------CC
T ss_pred cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-------------HH
Confidence 987432 234678999999999999999999999643211100 00
Q ss_pred ccchhccccccCCCC----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 524 RLDAIVDRNLNKNYN----IQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 524 ~~~~~~~~~l~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
....+..... ..+ ...+..+.+++.+||+.||++|||+.|+++
T Consensus 210 ~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 210 MKTRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SCCSSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000000000 011 123467899999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=311.02 Aligned_cols=243 Identities=15% Similarity=0.120 Sum_probs=183.8
Q ss_pred HhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCC-------CcchHHHHHHHHHHHHHcc---------CCCccc
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-------SPGGDAAFQREVEMISVAV---------HRNLLR 355 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~-------~~~~~~~~~~E~~~l~~l~---------H~niv~ 355 (619)
..++|++.+.||+|+||+||+|++ +|+.||||++.... .....+.+.+|+.+++.++ ||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 346788899999999999999998 68999999997542 2334578899999999886 666666
Q ss_pred eeee-----------------eeC-------------CCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHH
Q 007073 356 LIGF-----------------CTT-------------PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 405 (619)
Q Consensus 356 l~~~-----------------~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia 405 (619)
+.++ +.. ....++||||+++|++.+.+.. ..+++..+..++.|++
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence 5554 332 6788999999999977776643 3378999999999999
Q ss_pred HHHHHHH-hcCCCCeEecCCCCCcEEeCCCC--------------------cEEEcccccceeeccCCcceeeecccccc
Q 007073 406 RGLEYLH-EHCNPKIIHRDVKAANVLLDEDF--------------------EAVVGDFGLAKLVDVRKTNVTTQVRGTMG 464 (619)
Q Consensus 406 ~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~ 464 (619)
.||+||| ++ +|+||||||+|||++.++ .+||+|||+|+..... ...||+.
T Consensus 172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 89 999999999999999887 8999999999876532 3369999
Q ss_pred ccccccccCCCCCcchhhHHHHHH-HHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccch-hccccccCCCCHHHH
Q 007073 465 HIAPEYLSTGKSSERTDVFGYGIM-LLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA-IVDRNLNKNYNIQEV 542 (619)
Q Consensus 465 y~aPE~~~~~~~~~~~Dv~S~Gv~-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~~~~~~~~ 542 (619)
|+|||.+.+.. +.++||||+|++ .+++++|..||... .|....... .... ..............+
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-----------~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s 309 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-----------LWLHYLTDK-MLKQMTFKTKCNTPAMKQIK 309 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-----------HHHHHHHHH-HHHTCCCSSCCCSHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-----------hhhhHHHHh-hhhhhccCcccchhhhhhcC
Confidence 99999998666 899999998777 77888898887310 111111000 0000 001111111234567
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHH
Q 007073 543 ETMIQVALLCTQASPEDRPAMSEVV 567 (619)
Q Consensus 543 ~~l~~l~~~Cl~~dP~~RPs~~evl 567 (619)
.++.+++.+||+.| |++|++
T Consensus 310 ~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 310 RKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHHHhccC-----CHHHHH
Confidence 88999999999966 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-29 Score=278.20 Aligned_cols=186 Identities=14% Similarity=0.045 Sum_probs=129.9
Q ss_pred ccccCCCceEEEEE-eCCCcEEEEEEeccCCC---------cchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcceeE
Q 007073 301 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFES---------PGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 301 ~lg~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~---------~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 369 (619)
..+.|++|.+..+. .-.|+.||||.+..... ....++|.+|+++|+++ .|+||+++++++.++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 34566666666554 23589999999864321 12345799999999999 699999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||++|++|.+.+.... .++. .+|+.||+.||+|+|++ |||||||||+|||+++++.+||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~~~~----~l~~---~~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE----EIDR---EKILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHTTC----CCCH---HHHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHhCC----CCCH---HHHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 99999999999998643 2444 35899999999999999 99999999999999999999999999998765
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRA 498 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p 498 (619)
.... .....+||+.|||||.+.+ .+..++|+||+|++++++.++..+
T Consensus 391 ~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 4322 2345679999999999865 567789999999998887665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.6e-27 Score=256.13 Aligned_cols=186 Identities=15% Similarity=0.188 Sum_probs=146.7
Q ss_pred CcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcc-------hHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 296 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPG-------GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
+...++||+|+||.||+|.. .++.+|+|+........ ..+.+.+|++++++++||||+++..++...+..++
T Consensus 338 ~~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ----------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 34567999999999999965 57889999875422111 13458999999999999999977777777788899
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||+++++|.+++.. +..++.|+++||+|||++ +|+||||||+|||++. .+||+|||+++..
T Consensus 417 VmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 417 MMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 9999999999999875 457899999999999999 9999999999999999 9999999999987
Q ss_pred ccCCcce------eeeccccccccccccccC--CCCCcchhhHHHHHHHHHHHhCCCCC
Q 007073 449 DVRKTNV------TTQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQRAI 499 (619)
Q Consensus 449 ~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gv~l~elltg~~p~ 499 (619)
....... .....||+.|||||++.. ..|+..+|+||..+-..+.+.++.+|
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 5432211 235679999999999976 56888899999999988888877665
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.92 E-value=6.5e-26 Score=231.88 Aligned_cols=171 Identities=30% Similarity=0.559 Sum_probs=157.6
Q ss_pred chhHHHHHHHHHhcCCCCCCCCCCCCCCCCCCC--cceeEEcCC---CCeEEEEeCCCCccc--cCCccccCCCCCCEEE
Q 007073 34 SLSGDALFALRTSLRVPNNQLRDWNQNQVNPCT--WSNVICDNS---NNVASVTLSSMNFSG--TLSPRIGVLRTLSTLT 106 (619)
Q Consensus 34 ~~~~~al~~~k~~l~~~~~~l~~w~~~~~~~c~--w~gv~c~~~---~~l~~L~L~~n~l~~--~~~~~~~~l~~L~~L~ 106 (619)
..|.+||++||+++.+|. .+.+|.. +.+||. |.||+|+.. .+|+.|+|++|++++ .+|..|..+++|++|+
T Consensus 5 ~~~~~aL~~~k~~~~~~~-~l~~W~~-~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~ 82 (313)
T 1ogq_A 5 PQDKQALLQIKKDLGNPT-TLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLY 82 (313)
T ss_dssp HHHHHHHHHHHHHTTCCG-GGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEE
T ss_pred HHHHHHHHHHHHhcCCcc-cccCCCC-CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCeee
Confidence 568999999999998886 7899976 468998 999999864 699999999999999 8999999999999999
Q ss_pred ccC-CCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCCCccc
Q 007073 107 LKG-NGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLS 185 (619)
Q Consensus 107 L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 185 (619)
|++ |.+++.+|..|+++++|++|+|++|++++.+|..|.++++|++|+|++|++++.+|..+..+++|+.|++++|+++
T Consensus 83 L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 162 (313)
T 1ogq_A 83 IGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162 (313)
T ss_dssp EEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCE
T ss_pred CCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCccc
Confidence 995 9999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCccccc----cCccccCCCCCC
Q 007073 186 GQIPVHLFQ----IPKYNFTGNNLN 206 (619)
Q Consensus 186 ~~~p~~l~~----l~~l~~~~n~~~ 206 (619)
+.+|..+.+ +..|++++|...
T Consensus 163 ~~~p~~l~~l~~~L~~L~L~~N~l~ 187 (313)
T 1ogq_A 163 GAIPDSYGSFSKLFTSMTISRNRLT 187 (313)
T ss_dssp EECCGGGGCCCTTCCEEECCSSEEE
T ss_pred CcCCHHHhhhhhcCcEEECcCCeee
Confidence 999987764 456788888753
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-23 Score=210.89 Aligned_cols=152 Identities=13% Similarity=0.038 Sum_probs=122.4
Q ss_pred HHHHHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCc-----------------chHHHHHHHHHHHHHccC
Q 007073 288 ELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESP-----------------GGDAAFQREVEMISVAVH 350 (619)
Q Consensus 288 el~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~-----------------~~~~~~~~E~~~l~~l~H 350 (619)
.+......|.+.+.||+|+||.||+|.+.+|+.||||.++..... .....+.+|++++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 444455567778999999999999999977999999998642211 13467899999999999
Q ss_pred CCccceeeeeeCCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 007073 351 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVL 430 (619)
Q Consensus 351 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 430 (619)
| +++.+++.. +..++||||+++|+|.+ +.. .....++.|++.||.|||+. +|+||||||+|||
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NIL 225 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL 225 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEE
Confidence 5 666665543 56799999999999988 421 12346999999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccceeeccCCcceeeecccccccccccccc
Q 007073 431 LDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS 472 (619)
Q Consensus 431 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 472 (619)
++ ++.+||+|||+|+ .+..|+|||++.
T Consensus 226 l~-~~~vkl~DFG~a~--------------~~~~~~a~e~l~ 252 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSV--------------EVGEEGWREILE 252 (282)
T ss_dssp EE-TTEEEECCCTTCE--------------ETTSTTHHHHHH
T ss_pred EE-CCcEEEEECCCCe--------------ECCCCCHHHHHH
Confidence 99 9999999999996 345688999874
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.87 E-value=6.1e-23 Score=234.96 Aligned_cols=168 Identities=24% Similarity=0.313 Sum_probs=151.1
Q ss_pred chhHHHHHHHHHhcCCCCCCCCCCCCCC----CCC--CCc------------ceeEEcCCCCeEEEEeCCCCccccCCcc
Q 007073 34 SLSGDALFALRTSLRVPNNQLRDWNQNQ----VNP--CTW------------SNVICDNSNNVASVTLSSMNFSGTLSPR 95 (619)
Q Consensus 34 ~~~~~al~~~k~~l~~~~~~l~~w~~~~----~~~--c~w------------~gv~c~~~~~l~~L~L~~n~l~~~~~~~ 95 (619)
..|..||++||+++.+| +|+.++ .+| |.| .||+|+...+|+.|+|++|++.|.+|+.
T Consensus 268 ~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip~~ 342 (876)
T 4ecn_A 268 IKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDA 342 (876)
T ss_dssp HHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEECGG
T ss_pred hHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCchH
Confidence 35999999999999877 887654 456 999 9999998789999999999999999999
Q ss_pred ccCCCCCCEEEc-cCCCCCCC-----------------------------------------------------------
Q 007073 96 IGVLRTLSTLTL-KGNGITGE----------------------------------------------------------- 115 (619)
Q Consensus 96 ~~~l~~L~~L~L-~~N~l~~~----------------------------------------------------------- 115 (619)
|++|++|+.|+| ++|.++|.
T Consensus 343 l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~ 422 (876)
T 4ecn_A 343 IGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422 (876)
T ss_dssp GGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCC
T ss_pred HhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccccc
Confidence 999999999999 77765443
Q ss_pred -----------------CcccccccccCcEeeecCCCccc-----------------cCCCccc--ccccchhhhccCCc
Q 007073 116 -----------------IPEELGNLSSLTSLDLDNNRLVG-----------------KIPPSLG--NLKKLQFLTLSQNN 159 (619)
Q Consensus 116 -----------------~p~~~~~l~~L~~L~L~~N~l~~-----------------~~p~~~~--~l~~L~~L~l~~N~ 159 (619)
+|..|++|++|++|+|++|+|+| .+|..++ ++++|+.|+|++|+
T Consensus 423 l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~ 502 (876)
T 4ecn_A 423 ISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCP 502 (876)
T ss_dssp CCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCT
T ss_pred cchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCC
Confidence 88899999999999999999998 3999988 99999999999999
Q ss_pred CCCCCCCccccccccccccCCCCc-ccc-cCCcccc----------ccCccccCCCCCC
Q 007073 160 FSGTIPDSLTTLSSLISIQLDSNN-LSG-QIPVHLF----------QIPKYNFTGNNLN 206 (619)
Q Consensus 160 l~~~~p~~~~~l~~L~~L~l~~N~-l~~-~~p~~l~----------~l~~l~~~~n~~~ 206 (619)
+.+.+|..+.++++|+.|+|++|+ ++| .+|..+. ++..|++++|.+.
T Consensus 503 l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 503 NMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp TCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred CCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 999999999999999999999998 998 8887554 6777889999876
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.9e-22 Score=226.16 Aligned_cols=170 Identities=25% Similarity=0.304 Sum_probs=153.2
Q ss_pred hhHHHHHHHHHhcCCCCCC--------CCCCCCCCCCCCCc---ceeEEcCCCCeEEEEeCCCCccccCCccccCCCCCC
Q 007073 35 LSGDALFALRTSLRVPNNQ--------LRDWNQNQVNPCTW---SNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLS 103 (619)
Q Consensus 35 ~~~~al~~~k~~l~~~~~~--------l~~w~~~~~~~c~w---~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~ 103 (619)
.|..||.+|+.++..++.. ..+|+. +.+||.| .||+|+..++|+.|+|++|++.|.+|+.|++|++|+
T Consensus 30 ~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~-~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~~L~ 108 (636)
T 4eco_A 30 KDYLALKEIWDALNGKNWSQQGFGTQPGANWNF-NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELE 108 (636)
T ss_dssp HHHHHHHHHHHHTTGGGCCCCC------CCCCC-SSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCTTCC
T ss_pred HHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC-CCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCccce
Confidence 4899999999999866433 337986 4799999 999998878999999999999999999999999999
Q ss_pred EEEccCCC------------------------------------------------------------------------
Q 007073 104 TLTLKGNG------------------------------------------------------------------------ 111 (619)
Q Consensus 104 ~L~L~~N~------------------------------------------------------------------------ 111 (619)
+|+|++|.
T Consensus 109 ~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l 188 (636)
T 4eco_A 109 VLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQI 188 (636)
T ss_dssp EEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTTTT
T ss_pred EEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhhhh
Confidence 99999984
Q ss_pred ------CCCCCcccccccccCcEeeecCCCcccc-----------------CCCccc--ccccchhhhccCCcCCCCCCC
Q 007073 112 ------ITGEIPEELGNLSSLTSLDLDNNRLVGK-----------------IPPSLG--NLKKLQFLTLSQNNFSGTIPD 166 (619)
Q Consensus 112 ------l~~~~p~~~~~l~~L~~L~L~~N~l~~~-----------------~p~~~~--~l~~L~~L~l~~N~l~~~~p~ 166 (619)
++| +|..|+++++|++|+|++|+|+|. +|..++ ++++|++|+|++|++.|.+|.
T Consensus 189 ~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~ 267 (636)
T 4eco_A 189 GQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPT 267 (636)
T ss_dssp TCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCT
T ss_pred ccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChH
Confidence 445 888999999999999999999986 999999 999999999999999999999
Q ss_pred ccccccccccccCCCCc-ccc-cCCccc---------cccCccccCCCCCC
Q 007073 167 SLTTLSSLISIQLDSNN-LSG-QIPVHL---------FQIPKYNFTGNNLN 206 (619)
Q Consensus 167 ~~~~l~~L~~L~l~~N~-l~~-~~p~~l---------~~l~~l~~~~n~~~ 206 (619)
.+.++++|+.|++++|+ ++| .+|..+ .++..|++++|.+.
T Consensus 268 ~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~ 318 (636)
T 4eco_A 268 FLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318 (636)
T ss_dssp TTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS
T ss_pred HHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC
Confidence 99999999999999999 998 899765 56777889999876
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.3e-22 Score=230.64 Aligned_cols=169 Identities=27% Similarity=0.393 Sum_probs=114.9
Q ss_pred chhHHHHHHHHHhcCCCCCCCCCCCCCCCCCCCcceeEEcCCCCeEEEEeCCCCcccc---CCc----------------
Q 007073 34 SLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGT---LSP---------------- 94 (619)
Q Consensus 34 ~~~~~al~~~k~~l~~~~~~l~~w~~~~~~~c~w~gv~c~~~~~l~~L~L~~n~l~~~---~~~---------------- 94 (619)
..|.+||++||+++.+|. .+++|+. +.+||.|.||+|+ .++|+.|+|+++.+.|. +|+
T Consensus 11 ~~~~~all~~k~~~~~~~-~l~~W~~-~~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~ 87 (768)
T 3rgz_A 11 YREIHQLISFKDVLPDKN-LLPDWSS-NKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNS 87 (768)
T ss_dssp HHHHHHHHHHHTTCSCTT-SSTTCCT-TSCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTS
T ss_pred HHHHHHHHHHHhhCCCcc-cccCCCC-CCCCcCCcceEEC-CCcEEEEECCCCCcCCccCccChhHhccCcccccCCcCC
Confidence 458999999999999988 9999974 5699999999999 67999999999999987 554
Q ss_pred -------cccCCCCCCEEEccCCCCCCCCcc--cccccccCcEeeecCCCccccCCCcc-cccccchhhhccCCcCCCCC
Q 007073 95 -------RIGVLRTLSTLTLKGNGITGEIPE--ELGNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLSQNNFSGTI 164 (619)
Q Consensus 95 -------~~~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~ 164 (619)
.|+.+++|++|+|++|.++|.+|. .++++++|++|+|++|.+++.+|..+ .++++|++|+|++|++++..
T Consensus 88 ~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 167 (768)
T 3rgz_A 88 HINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGAN 167 (768)
T ss_dssp CEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEET
T ss_pred CcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcC
Confidence 555666666666666666666666 66666666666666666666666554 56666666666666665554
Q ss_pred CCc---cccccccccccCCCCcccccCCc-cccccCccccCCCCC
Q 007073 165 PDS---LTTLSSLISIQLDSNNLSGQIPV-HLFQIPKYNFTGNNL 205 (619)
Q Consensus 165 p~~---~~~l~~L~~L~l~~N~l~~~~p~-~l~~l~~l~~~~n~~ 205 (619)
|.. +.++++|+.|++++|++++.+|. .+.++..|++++|..
T Consensus 168 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l 212 (768)
T 3rgz_A 168 VVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNF 212 (768)
T ss_dssp HHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCC
T ss_pred ChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcC
Confidence 443 44444555555555554444432 233444445555544
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.84 E-value=6.3e-21 Score=185.60 Aligned_cols=149 Identities=21% Similarity=0.274 Sum_probs=132.7
Q ss_pred CCCCCCcceeEEcCC----------CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEee
Q 007073 61 QVNPCTWSNVICDNS----------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLD 130 (619)
Q Consensus 61 ~~~~c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 130 (619)
+...|+|.+|.|++. .+|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|.++++|++|+
T Consensus 15 ~~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~ 94 (229)
T 3e6j_A 15 SQCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLD 94 (229)
T ss_dssp TTCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEE
Confidence 347899999999752 4799999999999999999999999999999999999966667789999999999
Q ss_pred ecCCCccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCCCcccccCCccc---cccCccccCCCCCCC
Q 007073 131 LDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLNC 207 (619)
Q Consensus 131 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l---~~l~~l~~~~n~~~c 207 (619)
|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..+ .++..|++.+|++.|
T Consensus 95 Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 95 LGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred CCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 9999999777777899999999999999999 899999999999999999999995444444 466778899999999
Q ss_pred CCC
Q 007073 208 GKT 210 (619)
Q Consensus 208 ~~~ 210 (619)
.|.
T Consensus 174 ~c~ 176 (229)
T 3e6j_A 174 ECR 176 (229)
T ss_dssp TBG
T ss_pred Ccc
Confidence 885
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.1e-20 Score=182.66 Aligned_cols=147 Identities=22% Similarity=0.281 Sum_probs=131.3
Q ss_pred CCcceeEEcCC----------CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCC
Q 007073 65 CTWSNVICDNS----------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNN 134 (619)
Q Consensus 65 c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 134 (619)
|.|..+.|.+. .+++.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus 11 C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp EETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred ECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 67888988752 37999999999999888889999999999999999999888999999999999999999
Q ss_pred CccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCCCcccccCCcccc---ccCccccCCCCCCCCCCC
Q 007073 135 RLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLNCGKTL 211 (619)
Q Consensus 135 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~---~l~~l~~~~n~~~c~~~~ 211 (619)
+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+. ++..|++.+|++.|+|.+
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~l 170 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCHL 170 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCcc
Confidence 99965556689999999999999999988899999999999999999999965555454 566788999999999864
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.82 E-value=3e-21 Score=198.50 Aligned_cols=169 Identities=19% Similarity=0.318 Sum_probs=148.1
Q ss_pred chhHHHHHHHHHhc-CCCCCCCCCCC---CCCCCCCCcceeEEcC---------CCCeEEEEeCCCCccccCCccccCCC
Q 007073 34 SLSGDALFALRTSL-RVPNNQLRDWN---QNQVNPCTWSNVICDN---------SNNVASVTLSSMNFSGTLSPRIGVLR 100 (619)
Q Consensus 34 ~~~~~al~~~k~~l-~~~~~~l~~w~---~~~~~~c~w~gv~c~~---------~~~l~~L~L~~n~l~~~~~~~~~~l~ 100 (619)
.++..||++||..+ .++.+.+.+|. ....++|.|.|+.|+. ..+|+.|+|++|+++ .+|+.++.++
T Consensus 26 ~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~l~ 104 (328)
T 4fcg_A 26 RPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLS 104 (328)
T ss_dssp CCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGGGT
T ss_pred chHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhhCC
Confidence 56899999999988 46777788894 4466899999999952 468999999999999 7888899999
Q ss_pred CCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhccCCcCCCCCCCcccc---------c
Q 007073 101 TLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTT---------L 171 (619)
Q Consensus 101 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~---------l 171 (619)
+|++|+|++|.|+ .+|..++++++|++|+|++|+|+ .+|..++++++|+.|+|++|++.+.+|..+.. +
T Consensus 105 ~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l 182 (328)
T 4fcg_A 105 HLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGL 182 (328)
T ss_dssp TCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEES
T ss_pred CCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccC
Confidence 9999999999999 89999999999999999999999 88999999999999999999988899988765 8
Q ss_pred cccccccCCCCcccccCCcccc---ccCccccCCCCCC
Q 007073 172 SSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLN 206 (619)
Q Consensus 172 ~~L~~L~l~~N~l~~~~p~~l~---~l~~l~~~~n~~~ 206 (619)
++|+.|++++|+++ .+|..+. ++..|++++|.+.
T Consensus 183 ~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~ 219 (328)
T 4fcg_A 183 VNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS 219 (328)
T ss_dssp TTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC
T ss_pred CCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC
Confidence 99999999999999 8887665 4556778888765
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.6e-20 Score=180.05 Aligned_cols=147 Identities=24% Similarity=0.290 Sum_probs=130.5
Q ss_pred CCcceeEEcCC----------CCeEEEEeCCCCccccCC-ccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecC
Q 007073 65 CTWSNVICDNS----------NNVASVTLSSMNFSGTLS-PRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 133 (619)
Q Consensus 65 c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 133 (619)
|.|..+.|++. ..++.|+|++|+|++..+ ..|..+++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 56777887642 368899999999998865 4589999999999999999987788999999999999999
Q ss_pred CCccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCCCcccccCCcccc---ccCccccCCCCCCCCCC
Q 007073 134 NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLNCGKT 210 (619)
Q Consensus 134 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~---~l~~l~~~~n~~~c~~~ 210 (619)
|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|++++..|..+. ++..|++++|++.|+|+
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 999987778899999999999999999988899999999999999999999977787665 56678899999999987
Q ss_pred C
Q 007073 211 L 211 (619)
Q Consensus 211 ~ 211 (619)
+
T Consensus 171 l 171 (220)
T 2v70_A 171 L 171 (220)
T ss_dssp G
T ss_pred h
Confidence 4
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.79 E-value=2.3e-19 Score=171.75 Aligned_cols=147 Identities=20% Similarity=0.262 Sum_probs=128.3
Q ss_pred CCCcceeEEcCC----------CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecC
Q 007073 64 PCTWSNVICDNS----------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 133 (619)
Q Consensus 64 ~c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 133 (619)
.|.|.++.|+.. .+++.|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 6 ~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 6 SCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence 478999999752 3799999999999988777889999999999999999977677789999999999999
Q ss_pred CCccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCCCcccccCCccc---cccCccccCCCCCCCCCC
Q 007073 134 NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLNCGKT 210 (619)
Q Consensus 134 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l---~~l~~l~~~~n~~~c~~~ 210 (619)
|+|++..+..|.++++|+.|+|++|+|++..+..+..+++|+.|++++|++++..+..+ .++..|++++|++.|.++
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 165 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 165 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT
T ss_pred CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC
Confidence 99997666778999999999999999997667778999999999999999995444434 467778999999998775
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=3.6e-19 Score=176.40 Aligned_cols=137 Identities=18% Similarity=0.163 Sum_probs=105.8
Q ss_pred CcccCccccCCCceEEEEEe-CCCcE--EEEEEeccCCCc-----------------------chHHHHHHHHHHHHHcc
Q 007073 296 FSEKNVLGQGGFGKVYRGVL-ADGTK--VAVKRLTDFESP-----------------------GGDAAFQREVEMISVAV 349 (619)
Q Consensus 296 ~~~~~~lg~G~fg~Vy~~~~-~~g~~--vAvK~l~~~~~~-----------------------~~~~~~~~E~~~l~~l~ 349 (619)
|.+.+.||+|+||.||+|.. .+|+. ||||+++..... .....+.+|+.++.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 66788999999999999998 68999 999987532111 01236789999999999
Q ss_pred CCCc--cceeeeeeCCCcceeEeccccc-c----hhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHH-hcCCCCeEe
Q 007073 350 HRNL--LRLIGFCTTPTERLLVYPFMQN-L----SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH-EHCNPKIIH 421 (619)
Q Consensus 350 H~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~ivH 421 (619)
|+++ ..++++ ...++||||+.+ | +|.+.... .+......++.|++.||.||| +. +|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 8864 333332 367899999943 4 44444322 224456789999999999999 88 9999
Q ss_pred cCCCCCcEEeCCCCcEEEcccccceee
Q 007073 422 RDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 422 ~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999754
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.7e-19 Score=206.82 Aligned_cols=122 Identities=36% Similarity=0.637 Sum_probs=108.3
Q ss_pred CCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhccCCcCCCCCCCccccccccccc
Q 007073 98 VLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISI 177 (619)
Q Consensus 98 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 177 (619)
.+++|+.|+|++|+++|.+|..|+++++|+.|+|++|+|+|.+|..|+++++|+.|||++|+++|.+|..+..+++|++|
T Consensus 630 ~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L 709 (768)
T 3rgz_A 630 NNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEI 709 (768)
T ss_dssp SSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEE
T ss_pred ccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEE
Confidence 35678888999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCcccccCCc--cccccCccccCCCCCCCCCCCCCCCCCCCC
Q 007073 178 QLDSNNLSGQIPV--HLFQIPKYNFTGNNLNCGKTLPHSCESSSN 220 (619)
Q Consensus 178 ~l~~N~l~~~~p~--~l~~l~~l~~~~n~~~c~~~~~~~c~~~~~ 220 (619)
++++|+++|.||. .+..++.+.+.||++.|+.+++ +|.....
T Consensus 710 ~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~~~~ 753 (768)
T 3rgz_A 710 DLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDPSNA 753 (768)
T ss_dssp ECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCSCC-
T ss_pred ECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCCCcc
Confidence 9999999999995 4677888899999999999987 8876543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.76 E-value=1.3e-18 Score=164.39 Aligned_cols=125 Identities=27% Similarity=0.364 Sum_probs=88.0
Q ss_pred CCcceeEEcCC----------CCeEEEEeCCCCccccCCc-cccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecC
Q 007073 65 CTWSNVICDNS----------NNVASVTLSSMNFSGTLSP-RIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 133 (619)
Q Consensus 65 c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 133 (619)
|.|..+.|++. .+++.|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 8 C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 56666666531 2677777777777755553 367777777777777777766677777777777777777
Q ss_pred CCccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCCCcccccCC
Q 007073 134 NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 189 (619)
Q Consensus 134 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 189 (619)
|+|++..|..|.++++|+.|+|++|+|++..|..+..+++|+.|+|++|++++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 77776666667777777777777777776667777777777777777777776555
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.75 E-value=5.2e-18 Score=167.37 Aligned_cols=134 Identities=20% Similarity=0.257 Sum_probs=117.7
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
..+|+.|+|++|.+++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|+.|+
T Consensus 58 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 137 (251)
T 3m19_A 58 LTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELR 137 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEE
Confidence 46899999999999988888899999999999999999977778889999999999999999976666789999999999
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCCccc---cccCccccCCCCCCCC
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLNCG 208 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l---~~l~~l~~~~n~~~c~ 208 (619)
|++|+|++..+..|..+++|+.|+|++|++++..|..+ .++..|++.+|++.|.
T Consensus 138 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 138 LNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 99999996666689999999999999999996555444 4667788999999987
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.75 E-value=7.3e-20 Score=198.37 Aligned_cols=141 Identities=23% Similarity=0.277 Sum_probs=108.7
Q ss_pred CCcceeEEcCCCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCccccc-ccccCcEeeecCCCccccCCCc
Q 007073 65 CTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELG-NLSSLTSLDLDNNRLVGKIPPS 143 (619)
Q Consensus 65 c~w~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~ 143 (619)
|.+.++.|...++|+.|+|++|.+++..|..++.+++|+.|+|++|.|++.+|..+. ++++|+.|+|++|.|++. |.
T Consensus 109 N~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~- 186 (487)
T 3oja_A 109 NNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG- 186 (487)
T ss_dssp SCCCCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-
T ss_pred CcCCCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-
Confidence 456667777777888888888888888788888888888888888888877777775 688888888888888855 32
Q ss_pred ccccccchhhhccCCcCCCCCCCccccccccccccCCCCcccccCCcccc---ccCccccCCCCCCCCC
Q 007073 144 LGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLNCGK 209 (619)
Q Consensus 144 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~---~l~~l~~~~n~~~c~~ 209 (619)
+..+++|+.|+|++|+|++ +|..+..+++|+.|+|++|+++ .+|..+. ++..|++++|++.|++
T Consensus 187 ~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~l~~N~l~c~~ 253 (487)
T 3oja_A 187 QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGT 253 (487)
T ss_dssp CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCBCHHH
T ss_pred cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCc-ccchhhccCCCCCEEEcCCCCCcCcc
Confidence 3458888888888888884 5555788888888888888888 4776554 4556778888887764
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.75 E-value=8.3e-19 Score=176.90 Aligned_cols=135 Identities=27% Similarity=0.292 Sum_probs=119.2
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
..+|+.|+|++|.++ .+|..+..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+
T Consensus 76 l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 154 (290)
T 1p9a_G 76 LPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLS 154 (290)
T ss_dssp CTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEE
Confidence 468999999999998 7788899999999999999999977778899999999999999999977777789999999999
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCCcccc---ccCccccCCCCCCCCCCC
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLNCGKTL 211 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~---~l~~l~~~~n~~~c~~~~ 211 (619)
|++|+|++..+..+..+++|+.|+|++|+++ .+|..+. ++..+.+.+|+|.|+|..
T Consensus 155 L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~~ 213 (290)
T 1p9a_G 155 LANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEI 213 (290)
T ss_dssp CTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred CCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcCcc
Confidence 9999999555556788999999999999999 7887665 466788999999999853
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.73 E-value=3.2e-18 Score=170.81 Aligned_cols=136 Identities=20% Similarity=0.244 Sum_probs=112.0
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
..+|++|+|++|.+++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+
T Consensus 84 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 163 (270)
T 2o6q_A 84 LKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELR 163 (270)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeE
Confidence 35788889998888877777788889999999999999877777788899999999999999866566688899999999
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCCccc---cccCccccCCCCCCCCCC
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLNCGKT 210 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l---~~l~~l~~~~n~~~c~~~ 210 (619)
|++|++++..+..|..+++|+.|++++|++++..+..+ .++..|++.+|++.|+|.
T Consensus 164 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 164 LYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred ecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 99999986666678889999999999999984333334 456678899999999885
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.73 E-value=9e-18 Score=165.65 Aligned_cols=131 Identities=20% Similarity=0.249 Sum_probs=115.1
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
.+++.|+|++|++++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 114 (251)
T 3m19_A 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL 114 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence 36899999999999888889999999999999999999888888999999999999999999777788899999999999
Q ss_pred cCCcCCCCCCCccccccccccccCCCCcccccCCccc---cccCccccCCCCCC
Q 007073 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLN 206 (619)
Q Consensus 156 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l---~~l~~l~~~~n~~~ 206 (619)
++|+|++..+..|..+++|+.|+|++|++++..|..+ .++..|++++|.+.
T Consensus 115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 168 (251)
T 3m19_A 115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQ 168 (251)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCC
Confidence 9999996666678899999999999999995545445 46677889998875
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=5.8e-18 Score=159.80 Aligned_cols=130 Identities=22% Similarity=0.348 Sum_probs=115.8
Q ss_pred EEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcc-cccccccCcEeeecCCCccccCCCcccccccchhhhccC
Q 007073 79 ASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPE-ELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQ 157 (619)
Q Consensus 79 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 157 (619)
+.|++++|+++ .+|..+.. +|++|+|++|+|++..+. .|.++++|++|+|++|+|++..|..|.++++|+.|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 68999999997 67766543 999999999999966654 489999999999999999988899999999999999999
Q ss_pred CcCCCCCCCccccccccccccCCCCcccccCCcccc---ccCccccCCCCCCCCCCC
Q 007073 158 NNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLNCGKTL 211 (619)
Q Consensus 158 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~---~l~~l~~~~n~~~c~~~~ 211 (619)
|+|++..|..|..+++|+.|+|++|++++.+|..+. ++..|++++|++.|+|++
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 144 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence 999988888899999999999999999988887665 566788999999999863
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.72 E-value=2.1e-18 Score=176.04 Aligned_cols=136 Identities=30% Similarity=0.476 Sum_probs=107.2
Q ss_pred CeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhcc
Q 007073 77 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 156 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 156 (619)
+|+.|+|++|.+++.+|..+..++ |+.|+|++|++++.+|..|.++++|+.|+|++|++++.+|. +..+++|++|+|+
T Consensus 175 ~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls 252 (313)
T 1ogq_A 175 LFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLR 252 (313)
T ss_dssp TCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECC
T ss_pred cCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECc
Confidence 566666666666666666666665 67777777777666777777788888888888888765554 7788889999999
Q ss_pred CCcCCCCCCCccccccccccccCCCCcccccCCcc--ccccCccccCCCCCCCCCCCCCCC
Q 007073 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH--LFQIPKYNFTGNNLNCGKTLPHSC 215 (619)
Q Consensus 157 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--l~~l~~l~~~~n~~~c~~~~~~~c 215 (619)
+|+|++.+|..+..+++|+.|+|++|+++|.+|.. +.++..+++.+|++.|+.+++ .|
T Consensus 253 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~-~C 312 (313)
T 1ogq_A 253 NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp SSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred CCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCC-CC
Confidence 99998889999999999999999999999999864 567778889999999998765 45
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=1e-17 Score=158.13 Aligned_cols=128 Identities=30% Similarity=0.427 Sum_probs=112.2
Q ss_pred EEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhccCC
Q 007073 79 ASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158 (619)
Q Consensus 79 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 158 (619)
+.+++++|+++ .+|..+ .++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGI--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCC--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCC--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 46788899998 566655 368999999999999 88899999999999999999999877888999999999999999
Q ss_pred cCCCCCCCccccccccccccCCCCcccccCCc-cc---cccCccccCCCCCCCCCCC
Q 007073 159 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV-HL---FQIPKYNFTGNNLNCGKTL 211 (619)
Q Consensus 159 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~l---~~l~~l~~~~n~~~c~~~~ 211 (619)
+|++..|..|..+++|+.|+|++|+|++ +|. .+ .++..|++.+|++.|+|.+
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~~~C~c~l 144 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGANPLYCDCNM 144 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCB-CCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCe-eChhhhhcCccccEEEeCCCCeecCCcC
Confidence 9997778889999999999999999994 554 34 4677789999999999863
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.71 E-value=2.1e-17 Score=165.12 Aligned_cols=136 Identities=20% Similarity=0.206 Sum_probs=115.5
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
..+|++|+|++|.+++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+
T Consensus 84 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 163 (272)
T 3rfs_A 84 LTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELD 163 (272)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEE
Confidence 45899999999999988777788999999999999999977777788999999999999999977677788999999999
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCCccc---cccCccccCCCCCCCCCC
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLNCGKT 210 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l---~~l~~l~~~~n~~~c~~~ 210 (619)
|++|++++..|..+..+++|+.|++++|++++..|..+ .++..|++.+|++.|.++
T Consensus 164 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 164 LSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 99999997777778889999999999999997666444 456678899999988765
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=4.4e-18 Score=171.21 Aligned_cols=137 Identities=22% Similarity=0.248 Sum_probs=110.2
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
..+|+.|+|++|++++..|..|..+++|++|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|+.|+
T Consensus 104 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 183 (285)
T 1ozn_A 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183 (285)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEE
Confidence 35788888888888877778888888888888888888866666788888888888888888865556688888888888
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCCccc---cccCccccCCCCCCCCCCC
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLNCGKTL 211 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l---~~l~~l~~~~n~~~c~~~~ 211 (619)
|++|++++..|..+..+++|+.|++++|++++..|..+ .++..|++++|++.|+|+.
T Consensus 184 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~ 243 (285)
T 1ozn_A 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243 (285)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred CCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc
Confidence 88888887778888888889999999998885443334 4566678899999888763
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.70 E-value=2.4e-17 Score=153.32 Aligned_cols=125 Identities=23% Similarity=0.309 Sum_probs=74.3
Q ss_pred CCcceeEEcCC----------CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCC
Q 007073 65 CTWSNVICDNS----------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNN 134 (619)
Q Consensus 65 c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 134 (619)
|.|.++.|++. .+++.|+|++|++++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 7 C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp EETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred eCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 57888877642 25666666666666555555566666666666666666444444566666666666666
Q ss_pred CccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCCCcccccCC
Q 007073 135 RLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 189 (619)
Q Consensus 135 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 189 (619)
+|++..+..|.++++|+.|+|++|+|++..+..+..+++|+.|++++|++++..|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 6664444455666666666666666664333344556666666666666665443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.69 E-value=5.4e-17 Score=161.86 Aligned_cols=129 Identities=21% Similarity=0.221 Sum_probs=76.2
Q ss_pred CeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhcc
Q 007073 77 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 156 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 156 (619)
+++.|+|++|++++..+..|..+++|++|+|++|+|+...+..|.++++|++|+|++|++++..+..|.++++|+.|+|+
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 45666666666665555566666666666666666664444445666666666666666665444555666666666666
Q ss_pred CCcCCCCCCCccccccccccccCCCCcccccCCccc---cccCccccCCCCC
Q 007073 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNL 205 (619)
Q Consensus 157 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l---~~l~~l~~~~n~~ 205 (619)
+|++++..|..|..+++|+.|+|++|++++..+..+ .++..|++++|..
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l 169 (270)
T 2o6q_A 118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQL 169 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcC
Confidence 666665555556666666666666666663222222 3444555666554
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.68 E-value=3.4e-17 Score=168.71 Aligned_cols=141 Identities=12% Similarity=0.085 Sum_probs=100.7
Q ss_pred CCcccCccccCCCceEEEEEeCCCcEEEEEEeccCC-------------CcchHHHHHHHHHHHHHccCCCccceeeeee
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-------------SPGGDAAFQREVEMISVAVHRNLLRLIGFCT 361 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~-------------~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 361 (619)
-|++.+.||+|+||.||+|...+|+.||||+++... ..........++++.+...|+|+++++....
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 388999999999999999999899999999875311 0111223333444444444444444432211
Q ss_pred C------CCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC
Q 007073 362 T------PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 435 (619)
Q Consensus 362 ~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 435 (619)
. ....++||||+++++|...... .....++.|++.+|.|||+. |||||||||.|||+++++
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEK 242 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEE
T ss_pred CCCeeeeccCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCC
Confidence 1 1234799999999888665431 12356789999999999999 999999999999998776
Q ss_pred ----------cEEEcccccceee
Q 007073 436 ----------EAVVGDFGLAKLV 448 (619)
Q Consensus 436 ----------~~kl~DfGla~~~ 448 (619)
.+.|+||+-+...
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEET
T ss_pred CcccccccccceEEEEeCCcccC
Confidence 3899999987643
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.9e-17 Score=172.54 Aligned_cols=134 Identities=28% Similarity=0.312 Sum_probs=101.6
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
..+|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+
T Consensus 63 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 142 (361)
T 2xot_A 63 LTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLY 142 (361)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred ccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEE
Confidence 45788888888888877777788888888888888888866666778888888888888888877777888888888888
Q ss_pred ccCCcCCCCCCCcc----ccccccccccCCCCcccccCC-cccccc-----CccccCCCCCCCCCC
Q 007073 155 LSQNNFSGTIPDSL----TTLSSLISIQLDSNNLSGQIP-VHLFQI-----PKYNFTGNNLNCGKT 210 (619)
Q Consensus 155 l~~N~l~~~~p~~~----~~l~~L~~L~l~~N~l~~~~p-~~l~~l-----~~l~~~~n~~~c~~~ 210 (619)
|++|+|+ .+|..+ ..+++|+.|+|++|+|+ .+| ..+..+ ..|++.+|++.|+|.
T Consensus 143 L~~N~l~-~l~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~ 206 (361)
T 2xot_A 143 LSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLHNNPLECDCK 206 (361)
T ss_dssp CCSSCCC-SCCGGGTC----CTTCCEEECCSSCCC-CCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred CCCCcCC-eeCHHHhcCcccCCcCCEEECCCCCCC-ccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence 8888888 455443 46788888888888888 455 344444 457889999999885
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=5.7e-17 Score=181.45 Aligned_cols=159 Identities=18% Similarity=0.189 Sum_probs=124.9
Q ss_pred CCCCCCCCCCC---CCCCCCcc----eeEEcCC----------CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCC
Q 007073 50 PNNQLRDWNQN---QVNPCTWS----NVICDNS----------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGI 112 (619)
Q Consensus 50 ~~~~l~~w~~~---~~~~c~w~----gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 112 (619)
+...+++|+.. ...||.+. .+.|.+. .+++.|||++|+|+++.+..|.++++|++|+|++|+|
T Consensus 9 ~~~~~~~~~~~~p~~~~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i 88 (635)
T 4g8a_A 9 DDDKLAAANSSIPESWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI 88 (635)
T ss_dssp ----------------CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CcchhhcccCCCCCCCCCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcC
Confidence 33445555432 12456442 4778642 3799999999999988888999999999999999999
Q ss_pred CCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCCCcccc-cCCcc
Q 007073 113 TGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSG-QIPVH 191 (619)
Q Consensus 113 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~ 191 (619)
++..|..|.+|++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|++++|++++ .+|..
T Consensus 89 ~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~ 168 (635)
T 4g8a_A 89 QTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 168 (635)
T ss_dssp CEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGG
T ss_pred CCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchh
Confidence 97778889999999999999999997666789999999999999999997667789999999999999999985 35655
Q ss_pred c---cccCccccCCCCCCCC
Q 007073 192 L---FQIPKYNFTGNNLNCG 208 (619)
Q Consensus 192 l---~~l~~l~~~~n~~~c~ 208 (619)
+ .++..|++++|.+...
T Consensus 169 ~~~l~~L~~L~L~~N~l~~~ 188 (635)
T 4g8a_A 169 FSNLTNLEHLDLSSNKIQSI 188 (635)
T ss_dssp GGGCTTCCEEECCSSCCCEE
T ss_pred hccchhhhhhcccCcccccc
Confidence 4 4566788999987543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=3.5e-17 Score=175.24 Aligned_cols=134 Identities=26% Similarity=0.313 Sum_probs=110.9
Q ss_pred CCeEEEEeCCC-CccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 76 NNVASVTLSSM-NFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 76 ~~l~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
.+|+.|+|++| .+....+..|..+++|++|+|++|+|+ .+|. +..+++|+.|+|++|+|++..|..|.++++|+.|+
T Consensus 160 ~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 237 (440)
T 3zyj_A 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLW 237 (440)
T ss_dssp TTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCCC-CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-cccc-cCCCcccCEEECCCCccCccChhhhccCccCCEEE
Confidence 46677777763 334333446778888999999999988 6664 88899999999999999988899999999999999
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCCccc---cccCccccCCCCCCCCCCC
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLNCGKTL 211 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l---~~l~~l~~~~n~~~c~~~~ 211 (619)
|++|+|++..|..|..+++|+.|+|++|++++..+..+ .++..|++.+|++.|+|.+
T Consensus 238 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 238 MIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDI 297 (440)
T ss_dssp CTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTT
T ss_pred CCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCc
Confidence 99999998888899999999999999999995444443 4677789999999999964
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.66 E-value=6.9e-17 Score=164.15 Aligned_cols=135 Identities=24% Similarity=0.320 Sum_probs=84.5
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCC-CCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITG-EIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
.+|+.|+|++|.+.+..+..+..+++|++|+|++|.+++ .+|..+..+++|++|+|++|+|++..|..|.++++|+.|+
T Consensus 126 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 205 (306)
T 2z66_A 126 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 205 (306)
T ss_dssp TTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEE
Confidence 356666666666665555666666666666666666654 3556666666666666666666655566666666666666
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCCcccc----ccCccccCCCCCCCCCC
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF----QIPKYNFTGNNLNCGKT 210 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~----~l~~l~~~~n~~~c~~~ 210 (619)
|++|++++..+..+..+++|+.|++++|++++..|..+. ++..|++++|++.|+|.
T Consensus 206 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 206 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp CTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGG
T ss_pred CCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccC
Confidence 666666644444566666666666666666665555443 34456666777666654
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=8.8e-17 Score=172.79 Aligned_cols=135 Identities=26% Similarity=0.258 Sum_probs=124.4
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
.+|+.|+|++|++++.+|..+..+++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|+.|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 47999999999999999999999999999999999999888999999999999999999999888899999999999999
Q ss_pred cCCcCCCCCCCccccccccccccCCCCcccccCCcc---ccccCccccCCCCCCCCCC
Q 007073 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH---LFQIPKYNFTGNNLNCGKT 210 (619)
Q Consensus 156 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~---l~~l~~l~~~~n~~~c~~~ 210 (619)
++|++++..|..+..+++|+.|++++|++++..+.. +.++..|++++|++.|+|+
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 999999888999999999999999999999544433 3467778999999999987
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.1e-16 Score=166.78 Aligned_cols=141 Identities=23% Similarity=0.292 Sum_probs=124.3
Q ss_pred CCcceeEEcC----------CCCeEEEEeCCCCccccCCcccc-CCCCCCEEEccCCCCCCCCcccccccccCcEeeecC
Q 007073 65 CTWSNVICDN----------SNNVASVTLSSMNFSGTLSPRIG-VLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 133 (619)
Q Consensus 65 c~w~gv~c~~----------~~~l~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 133 (619)
|.+..+.|.+ ...++.|+|++|+|++..+..+. .+++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 4677778864 23689999999999988888887 999999999999999977778899999999999999
Q ss_pred CCccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCCCcccccCCcc-------ccccCccccCCCCCC
Q 007073 134 NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH-------LFQIPKYNFTGNNLN 206 (619)
Q Consensus 134 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-------l~~l~~l~~~~n~~~ 206 (619)
|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|+ .+|.. +.++..|++++|.+.
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 9999777778999999999999999999777899999999999999999999 57754 346777889998864
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.8e-16 Score=149.69 Aligned_cols=123 Identities=25% Similarity=0.381 Sum_probs=109.3
Q ss_pred CCcceeEEcC----------CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCC
Q 007073 65 CTWSNVICDN----------SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNN 134 (619)
Q Consensus 65 c~w~gv~c~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 134 (619)
|.|..+.|++ ..+++.|+|++|+|+ .+|..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus 10 C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 10 CLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred eCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 4566666654 237999999999998 77789999999999999999999888889999999999999999
Q ss_pred CccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCCCcccccC
Q 007073 135 RLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQI 188 (619)
Q Consensus 135 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 188 (619)
+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++...-
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence 999888889999999999999999999555567899999999999999998543
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.65 E-value=6.4e-17 Score=173.82 Aligned_cols=134 Identities=22% Similarity=0.263 Sum_probs=108.9
Q ss_pred CCeEEEEeCCC-CccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 76 NNVASVTLSSM-NFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 76 ~~l~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
.+|+.|+|++| .+....+..|..+++|++|+|++|+|+ .+|. +..+++|+.|+|++|+|++..|..|.++++|+.|+
T Consensus 171 ~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 248 (452)
T 3zyi_A 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLW 248 (452)
T ss_dssp TTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS-SCCC-CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEE
T ss_pred CcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc-cccc-ccccccccEEECcCCcCcccCcccccCccCCCEEE
Confidence 35666666653 333333345777888888888889888 4554 88899999999999999988899999999999999
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCCccc---cccCccccCCCCCCCCCCC
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLNCGKTL 211 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l---~~l~~l~~~~n~~~c~~~~ 211 (619)
|++|++++..|..|..+++|+.|+|++|+|++..+..+ .++..|++.+|++.|+|.+
T Consensus 249 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 249 VMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTT
T ss_pred eCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCc
Confidence 99999998889999999999999999999995444443 4677789999999999974
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=2.8e-16 Score=151.56 Aligned_cols=115 Identities=19% Similarity=0.228 Sum_probs=109.1
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
..+|+.|+|++|.|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|+.|+
T Consensus 56 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 135 (220)
T 2v70_A 56 LPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLS 135 (220)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEE
T ss_pred CCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEE
Confidence 46899999999999998888999999999999999999988888899999999999999999988899999999999999
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCC
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 189 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 189 (619)
|++|+|++..|..|..+++|+.|+|++|++++..+
T Consensus 136 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 136 LYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 99999998889999999999999999999997665
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=1.4e-16 Score=178.34 Aligned_cols=137 Identities=24% Similarity=0.309 Sum_probs=124.7
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCC-CCCcccccccccCcEeeecCCCccccCCCcccccccchhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGIT-GEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFL 153 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 153 (619)
..+++.++++.|.+.+..+..+..++.|+.|+|++|++. +.+|..|..+++|++|+|++|+|++..|..|.++++|++|
T Consensus 444 l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L 523 (635)
T 4g8a_A 444 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 523 (635)
T ss_dssp CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred ccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEE
Confidence 457899999999999999999999999999999999854 4578889999999999999999999889999999999999
Q ss_pred hccCCcCCCCCCCccccccccccccCCCCcccccCCcccc----ccCccccCCCCCCCCCCC
Q 007073 154 TLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF----QIPKYNFTGNNLNCGKTL 211 (619)
Q Consensus 154 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~----~l~~l~~~~n~~~c~~~~ 211 (619)
+|++|+|++..|..|..+++|+.|+|++|+|++..|..+. ++..|++++|||.|+|.+
T Consensus 524 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~ 585 (635)
T 4g8a_A 524 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 585 (635)
T ss_dssp ECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred ECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence 9999999987788899999999999999999988887664 566789999999999973
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=1.3e-16 Score=159.54 Aligned_cols=134 Identities=20% Similarity=0.258 Sum_probs=72.9
Q ss_pred CeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCcccc-CCCcccccccchhhhc
Q 007073 77 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGK-IPPSLGNLKKLQFLTL 155 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~l 155 (619)
+|+.|+|++|.+++..+..|..+++|++|+|++|++++..+..+.++++|++|+|++|++++. +|..|.++++|+.|+|
T Consensus 77 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~L 156 (276)
T 2z62_A 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL 156 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEEC
T ss_pred CCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEEC
Confidence 455555555555544444455555555555555555543333444555555555555555431 3444555555555555
Q ss_pred cCCcCCCC---------------------------CCCccccccccccccCCCCcccccCCcc---ccccCccccCCCCC
Q 007073 156 SQNNFSGT---------------------------IPDSLTTLSSLISIQLDSNNLSGQIPVH---LFQIPKYNFTGNNL 205 (619)
Q Consensus 156 ~~N~l~~~---------------------------~p~~~~~l~~L~~L~l~~N~l~~~~p~~---l~~l~~l~~~~n~~ 205 (619)
++|++++. +|.......+|+.|++++|++++..+.. +.++..|++++|++
T Consensus 157 s~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~ 236 (276)
T 2z62_A 157 SSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 236 (276)
T ss_dssp CSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCB
T ss_pred CCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcc
Confidence 55444432 2222333347788888888888433333 34566678889998
Q ss_pred CCCCC
Q 007073 206 NCGKT 210 (619)
Q Consensus 206 ~c~~~ 210 (619)
.|+|+
T Consensus 237 ~c~c~ 241 (276)
T 2z62_A 237 DCSCP 241 (276)
T ss_dssp CCCTT
T ss_pred cccCC
Confidence 88875
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=5.3e-16 Score=144.22 Aligned_cols=130 Identities=21% Similarity=0.268 Sum_probs=111.0
Q ss_pred eEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhccC
Q 007073 78 VASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQ 157 (619)
Q Consensus 78 l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 157 (619)
.+.+++++|+++ .+|..+ .++|+.|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|+.|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 468999999998 455444 47999999999999977777789999999999999999976667789999999999999
Q ss_pred CcCCCCCCCccccccccccccCCCCcccccCCcc---ccccCccccCCCCCCCCCC
Q 007073 158 NNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH---LFQIPKYNFTGNNLNCGKT 210 (619)
Q Consensus 158 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~---l~~l~~l~~~~n~~~c~~~ 210 (619)
|+|++..+..+..+++|+.|++++|++++..+.. +.++..|++++|++.|.++
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 9999777777899999999999999999543333 3467778999999998875
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.63 E-value=3.8e-16 Score=160.35 Aligned_cols=130 Identities=22% Similarity=0.306 Sum_probs=109.6
Q ss_pred CCCeEEEEeCCCCccccCCccccC---------CCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCccc
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGV---------LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLG 145 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~---------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 145 (619)
..+|+.|+|++|++.+.+|..+.. +++|++|+|++|+|+ .+|..++++++|++|+|++|+++ .+|..++
T Consensus 149 l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~ 226 (328)
T 4fcg_A 149 LNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIH 226 (328)
T ss_dssp CTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGG
T ss_pred CcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhc
Confidence 458899999998888888887664 889999999999998 88888889999999999999998 4777888
Q ss_pred ccccchhhhccCCcCCCCCCCccccccccccccCCCCcccccCCccccc---cCccccCCCCCC
Q 007073 146 NLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ---IPKYNFTGNNLN 206 (619)
Q Consensus 146 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~---l~~l~~~~n~~~ 206 (619)
++++|+.|+|++|++.+.+|..+..+++|+.|++++|++.+.+|..+.+ +..|++++|+..
T Consensus 227 ~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~ 290 (328)
T 4fcg_A 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290 (328)
T ss_dssp GCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTC
T ss_pred cCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCch
Confidence 8999999999998888888888888999999999998888888876654 455778887764
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=8.1e-16 Score=153.79 Aligned_cols=130 Identities=18% Similarity=0.180 Sum_probs=112.0
Q ss_pred CeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhcc
Q 007073 77 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 156 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 156 (619)
+++.|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|+.|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 69999999999998887789999999999999999997777789999999999999999998777889999999999999
Q ss_pred CCcCCCCCCCccccccccccccCCCCcccc-cCCcccc---ccCccccCCCCCC
Q 007073 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLSG-QIPVHLF---QIPKYNFTGNNLN 206 (619)
Q Consensus 157 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~l~---~l~~l~~~~n~~~ 206 (619)
+|++++..+..+..+++|+.|++++|++++ .+|..+. ++..|++++|...
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~ 162 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCC
Confidence 999997666688999999999999999985 3676665 4566778888653
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=2e-16 Score=176.43 Aligned_cols=136 Identities=23% Similarity=0.244 Sum_probs=117.6
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCC-CCcccccccccCcEeeecCCCccccCCCcccccccchhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITG-EIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFL 153 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 153 (619)
..+|+.|+|++|.+.+..|..+..+++|++|+|++|++++ .+|..+..+++|+.|+|++|++++..|..|.++++|+.|
T Consensus 423 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 502 (606)
T 3vq2_A 423 LEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLL 502 (606)
T ss_dssp CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred cccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEE
Confidence 4578888888888888888888889999999999999887 478888999999999999999998888889999999999
Q ss_pred hccCCcCCCCCCCccccccccccccCCCCcccccCCccccc----cCccccCCCCCCCCCCC
Q 007073 154 TLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ----IPKYNFTGNNLNCGKTL 211 (619)
Q Consensus 154 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~----l~~l~~~~n~~~c~~~~ 211 (619)
+|++|++++..|..+..+++|+.|++++|+++ .+|..+.. +..+++.+|++.|+|+.
T Consensus 503 ~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 503 NMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp ECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred ECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 99999999888889999999999999999998 78876543 56688999999998874
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=2.5e-16 Score=158.35 Aligned_cols=131 Identities=22% Similarity=0.261 Sum_probs=91.2
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCC-CCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNG-ITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
.+|+.|+|++|.+++..|..|..+++|++|+|++|+ ++...|..|.++++|++|+|++|++++..|..|.++++|+.|+
T Consensus 56 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 135 (285)
T 1ozn_A 56 RNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135 (285)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEE
Confidence 467777777777777767777777777777777776 6655566777777777777777777766667777777777777
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCCccc---cccCccccCCCCCC
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLN 206 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l---~~l~~l~~~~n~~~ 206 (619)
|++|++++..+..+..+++|+.|++++|++++..+..+ .++..|++++|...
T Consensus 136 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 190 (285)
T 1ozn_A 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190 (285)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccc
Confidence 77777775555557777777777777777774333333 34555667776653
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.62 E-value=3.6e-16 Score=143.97 Aligned_cols=127 Identities=22% Similarity=0.287 Sum_probs=110.6
Q ss_pred CCeEEEEeCCCCcc-ccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 76 NNVASVTLSSMNFS-GTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 76 ~~l~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
.+|+.|+|++|+++ +.+|..+..+++|+.|+|++|.|++. ..+..+++|++|+|++|++++.+|..+.++++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 47999999999998 78888899999999999999999965 6799999999999999999977888888899999999
Q ss_pred ccCCcCCCCCC--CccccccccccccCCCCcccccCCc----cc---cccCccccCCCCCC
Q 007073 155 LSQNNFSGTIP--DSLTTLSSLISIQLDSNNLSGQIPV----HL---FQIPKYNFTGNNLN 206 (619)
Q Consensus 155 l~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~p~----~l---~~l~~l~~~~n~~~ 206 (619)
|++|+|++ +| ..+..+++|+.|++++|++++ +|. .+ .++..|++.+|...
T Consensus 102 Ls~N~l~~-~~~~~~l~~l~~L~~L~l~~N~l~~-~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKD-ISTLEPLKKLECLKSLDLFNCEVTN-LNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCS-SGGGGGGSSCSCCCEEECCSSGGGT-STTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCc-chhHHHHhcCCCCCEEEeeCCcCcc-hHHHHHHHHHhCccCcEecCCCCChh
Confidence 99999994 44 788999999999999999995 554 44 45666777777654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=9.8e-16 Score=170.83 Aligned_cols=146 Identities=18% Similarity=0.217 Sum_probs=118.6
Q ss_pred CCCCCcc----eeEEcC----------CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCc
Q 007073 62 VNPCTWS----NVICDN----------SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLT 127 (619)
Q Consensus 62 ~~~c~w~----gv~c~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 127 (619)
.+||.+. .+.|.+ ..+++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|+
T Consensus 4 ~~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~ 83 (606)
T 3vq2_A 4 LNPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLS 83 (606)
T ss_dssp --CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCC
T ss_pred CCCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcC
Confidence 3566552 466754 24789999999999988888899999999999999999977788899999999
Q ss_pred EeeecCCCccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCCCcccc-cCCcccc---ccCccccCCC
Q 007073 128 SLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSG-QIPVHLF---QIPKYNFTGN 203 (619)
Q Consensus 128 ~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~l~---~l~~l~~~~n 203 (619)
+|+|++|++++..|..|+++++|++|+|++|++++..|..+..+++|++|++++|++++ .+|..+. ++..|++++|
T Consensus 84 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n 163 (606)
T 3vq2_A 84 NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163 (606)
T ss_dssp EEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSS
T ss_pred EeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCC
Confidence 99999999997778899999999999999999986666888899999999999999885 5687665 4555678887
Q ss_pred CCCC
Q 007073 204 NLNC 207 (619)
Q Consensus 204 ~~~c 207 (619)
....
T Consensus 164 ~l~~ 167 (606)
T 3vq2_A 164 YIQT 167 (606)
T ss_dssp CCCE
T ss_pred ccee
Confidence 6643
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.3e-15 Score=146.91 Aligned_cols=113 Identities=23% Similarity=0.284 Sum_probs=105.0
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
..+|+.|+|++|.|++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+
T Consensus 55 l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 134 (220)
T 2v9t_B 55 YKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLS 134 (220)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEE
Confidence 46899999999999999999999999999999999999966666689999999999999999988899999999999999
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCccccc
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQ 187 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 187 (619)
|++|+|++..+..|..+++|+.|+|++|++...
T Consensus 135 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 135 LYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 999999977777899999999999999999753
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.3e-15 Score=169.41 Aligned_cols=153 Identities=16% Similarity=0.183 Sum_probs=108.1
Q ss_pred CCCCCCCCCCCCCC----cceeEEcC-----------------CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCC
Q 007073 53 QLRDWNQNQVNPCT----WSNVICDN-----------------SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNG 111 (619)
Q Consensus 53 ~l~~w~~~~~~~c~----w~gv~c~~-----------------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 111 (619)
.+++|.+. .+||. |.++.|+. ..+++.|++++|.+....+..|..+++|++|+|++|.
T Consensus 8 ~l~~~~~~-~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~ 86 (597)
T 3oja_B 8 NVKPRQPE-YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 86 (597)
T ss_dssp ---CCCSE-ECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSC
T ss_pred cccCCCCC-CcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCC
Confidence 56788763 45653 66655541 1357778888888876666667778888888888888
Q ss_pred CCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCCCcccccCCcc
Q 007073 112 ITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH 191 (619)
Q Consensus 112 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 191 (619)
|++..|..|+.+++|++|+|++|.|++..|..|+++++|+.|+|++|.|++..+..|..+++|+.|+|++|++++..|..
T Consensus 87 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 166 (597)
T 3oja_B 87 IEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDT 166 (597)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTT
T ss_pred CCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhh
Confidence 88766777888888888888888888776777788888888888888887444445677888888888888888666655
Q ss_pred cc---ccCccccCCCCCC
Q 007073 192 LF---QIPKYNFTGNNLN 206 (619)
Q Consensus 192 l~---~l~~l~~~~n~~~ 206 (619)
+. ++..|++++|.+.
T Consensus 167 ~~~l~~L~~L~L~~N~l~ 184 (597)
T 3oja_B 167 FQATTSLQNLQLSSNRLT 184 (597)
T ss_dssp TTTCTTCCEEECTTSCCS
T ss_pred hhcCCcCcEEECcCCCCC
Confidence 54 4555667777654
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=3.4e-16 Score=141.08 Aligned_cols=121 Identities=22% Similarity=0.290 Sum_probs=105.9
Q ss_pred CCeEEEEeCCCCcc-ccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 76 NNVASVTLSSMNFS-GTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 76 ~~l~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
.+++.|++++|+++ +.+|..+..+++|+.|+|++|++++. ..++++++|++|+|++|++++.+|..+.++++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 47999999999998 78899999999999999999999965 6799999999999999999977888888899999999
Q ss_pred ccCCcCCCC-CCCccccccccccccCCCCcccccCC---ccccccCcc
Q 007073 155 LSQNNFSGT-IPDSLTTLSSLISIQLDSNNLSGQIP---VHLFQIPKY 198 (619)
Q Consensus 155 l~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p---~~l~~l~~l 198 (619)
+++|++++. .|..+..+++|+.|++++|++++..+ ..+..+++|
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L 142 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQL 142 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCc
Confidence 999999953 34889999999999999999995444 245555444
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=8.3e-16 Score=165.12 Aligned_cols=145 Identities=26% Similarity=0.322 Sum_probs=124.9
Q ss_pred CCCCcce--eEEcCC---------CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCC-cccccccccCcEee
Q 007073 63 NPCTWSN--VICDNS---------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEI-PEELGNLSSLTSLD 130 (619)
Q Consensus 63 ~~c~w~g--v~c~~~---------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~ 130 (619)
..|.|.+ +.|++. .+|++|+|++|++++..|..|.++++|++|+|++|.+.+.+ |..|.++++|++|+
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 4566665 788652 47999999999999998999999999999999999998666 56799999999999
Q ss_pred ecCCCccccCCCcccccccchhhhccCCcCCCCCCCc--cccccccccccCCCCcccccCCcc-c---cccCccccCCCC
Q 007073 131 LDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDS--LTTLSSLISIQLDSNNLSGQIPVH-L---FQIPKYNFTGNN 204 (619)
Q Consensus 131 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~~p~~-l---~~l~~l~~~~n~ 204 (619)
|++|++++..|..|+++++|++|+|++|++++.+|.. +..+++|+.|+|++|++++..|.. + .++..|++++|.
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence 9999999888999999999999999999999755544 899999999999999999777764 3 456678899988
Q ss_pred CCC
Q 007073 205 LNC 207 (619)
Q Consensus 205 ~~c 207 (619)
...
T Consensus 166 l~~ 168 (455)
T 3v47_A 166 VKS 168 (455)
T ss_dssp BSC
T ss_pred ccc
Confidence 653
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=3.3e-16 Score=172.49 Aligned_cols=142 Identities=22% Similarity=0.323 Sum_probs=119.9
Q ss_pred CCCcceeEEcCC------------CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeee
Q 007073 64 PCTWSNVICDNS------------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDL 131 (619)
Q Consensus 64 ~c~w~gv~c~~~------------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 131 (619)
+|.|.|+ |+.. .+|++|+|++|++++..|..|..+++|++|+|++|++++..|..|.++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 5888888 7632 37999999999999888889999999999999999999888888999999999999
Q ss_pred cCCCccccCCCcccccccchhhhccCCcCCC-CCCCccccccccccccCCCCcccccCC-cccc---ccCccccCCCCCC
Q 007073 132 DNNRLVGKIPPSLGNLKKLQFLTLSQNNFSG-TIPDSLTTLSSLISIQLDSNNLSGQIP-VHLF---QIPKYNFTGNNLN 206 (619)
Q Consensus 132 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~l~---~l~~l~~~~n~~~ 206 (619)
++|++++..|..|+++++|++|+|++|++++ .+|..+..+++|+.|++++|++.+.+| ..+. ++..|++++|...
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 161 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence 9999997766779999999999999999986 357788999999999999998655776 3444 5556778887764
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.59 E-value=8.5e-16 Score=150.20 Aligned_cols=129 Identities=18% Similarity=0.209 Sum_probs=111.4
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCC-CCCCCcccccccccCcEeeecC-CCccccCCCcccccccchhh
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNG-ITGEIPEELGNLSSLTSLDLDN-NRLVGKIPPSLGNLKKLQFL 153 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L 153 (619)
.+++.|+|++|++++..+..|..+++|++|+|++|+ +++..+..|.++++|++|+|++ |+|++..+..|.++++|+.|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 479999999999998888899999999999999997 8866666899999999999999 99997777889999999999
Q ss_pred hccCCcCCCCCCCccccccccc---cccCCCC-cccccCCcccc---ccC-ccccCCCCCC
Q 007073 154 TLSQNNFSGTIPDSLTTLSSLI---SIQLDSN-NLSGQIPVHLF---QIP-KYNFTGNNLN 206 (619)
Q Consensus 154 ~l~~N~l~~~~p~~~~~l~~L~---~L~l~~N-~l~~~~p~~l~---~l~-~l~~~~n~~~ 206 (619)
+|++|++++ +|+ +..+++|+ .|++++| ++++..+..+. ++. .|++++|.+.
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~ 169 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc
Confidence 999999994 787 88888888 9999999 99854444454 555 7778888764
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.59 E-value=3.4e-15 Score=148.91 Aligned_cols=131 Identities=21% Similarity=0.269 Sum_probs=114.5
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
..+|+.|+|++|.+++. +.+..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|.++++|+.|+
T Consensus 62 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 139 (272)
T 3rfs_A 62 LPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139 (272)
T ss_dssp CTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence 46899999999999864 4789999999999999999987788889999999999999999977777799999999999
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCCccc---cccCccccCCCCCCC
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLNC 207 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l---~~l~~l~~~~n~~~c 207 (619)
|++|++++..|..+..+++|+.|++++|++++..|..+ .++..|++++|.+..
T Consensus 140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 195 (272)
T 3rfs_A 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKS 195 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCc
Confidence 99999997777778999999999999999996555443 467778899988753
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.59 E-value=4.4e-15 Score=144.12 Aligned_cols=114 Identities=24% Similarity=0.234 Sum_probs=104.8
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
..+|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+
T Consensus 63 l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~ 141 (229)
T 3e6j_A 63 LINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLA 141 (229)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEE
T ss_pred ccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEE
Confidence 468999999999999777778899999999999999999777777899999999999999999 8999999999999999
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCC
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 189 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 189 (619)
|++|+|++..+..+..+++|+.|++++|++++..+
T Consensus 142 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 142 LDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 99999996666789999999999999999997654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=2.5e-16 Score=182.28 Aligned_cols=135 Identities=21% Similarity=0.232 Sum_probs=113.7
Q ss_pred CCCeEEEEeCCCCccccCCc-cccCCCCCCEEEccCCCCC-----CCCcccccccccCcEeeecCCCccccCCCcccccc
Q 007073 75 SNNVASVTLSSMNFSGTLSP-RIGVLRTLSTLTLKGNGIT-----GEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLK 148 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 148 (619)
..+|+.|+|++|++++..+. .+..+++|+.|+|++|.++ +..|..|.++++|+.|+|++|+|++..|..|.+++
T Consensus 425 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 504 (844)
T 3j0a_A 425 VPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLT 504 (844)
T ss_dssp CTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCC
T ss_pred CCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchh
Confidence 45788888888888765443 3556788888888888887 34456688899999999999999988888899999
Q ss_pred cchhhhccCCcCCCCCCCccccccccccccCCCCcccccCCccccccCccccCCCCCCCCCCC
Q 007073 149 KLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTL 211 (619)
Q Consensus 149 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~l~~~~n~~~c~~~~ 211 (619)
+|+.|+|++|+|++..|..+. ++|+.|+|++|++++.+|..+.++..+++++|++.|+|++
T Consensus 505 ~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 505 ALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECEL 565 (844)
T ss_dssp SCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSSC
T ss_pred hhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCccccccc
Confidence 999999999999966566555 8999999999999999999999999999999999999874
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.57 E-value=5.3e-15 Score=148.94 Aligned_cols=127 Identities=28% Similarity=0.345 Sum_probs=80.8
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
.+|+.|+|++|+|++..+. +.+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..|..|.++++|+.|+|
T Consensus 55 ~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L 131 (290)
T 1p9a_G 55 TRLTQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL 131 (290)
T ss_dssp TTCCEEECTTSCCCEEECC--SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCcccCC--CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEEC
Confidence 4666666666666644332 56666666666666666 56666666777777777777777555566677777777777
Q ss_pred cCCcCCCCCCCccccccccccccCCCCcccccCCc-c---ccccCccccCCCCCC
Q 007073 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV-H---LFQIPKYNFTGNNLN 206 (619)
Q Consensus 156 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~---l~~l~~l~~~~n~~~ 206 (619)
++|+|++..+..|..+++|+.|+|++|+|+ .+|. . +.++..|++++|.+.
T Consensus 132 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~L~~N~l~ 185 (290)
T 1p9a_G 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY 185 (290)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECTTSCCS-CCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCCCccChhhcccccCCCEEECCCCcCC-ccCHHHhcCcCCCCEEECCCCcCC
Confidence 777776555555666677777777777776 3443 2 234555666666654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.57 E-value=4.9e-15 Score=141.49 Aligned_cols=127 Identities=21% Similarity=0.196 Sum_probs=108.6
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
..+|+.|+|++|++++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|+.|+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 130 (208)
T 2o6s_A 51 LTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLR 130 (208)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEE
Confidence 46899999999999987777789999999999999999977777789999999999999999977677789999999999
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCCccccccCccccCCCCC
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNL 205 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~l~~~~n~~ 205 (619)
|++|++++..+..+..+++|+.|++++|++.+..| ++..|++.+|.+
T Consensus 131 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~----~l~~L~~~~n~~ 177 (208)
T 2o6s_A 131 LYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP----GIRYLSEWINKH 177 (208)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT----TTHHHHHHHHHC
T ss_pred CCCCccceeCHHHhccCCCccEEEecCCCeecCCC----CHHHHHHHHHhC
Confidence 99999997666678999999999999999987655 334444444443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=2e-15 Score=168.38 Aligned_cols=134 Identities=24% Similarity=0.279 Sum_probs=102.2
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCC---CcccccccccCcEeeecCCCccccCCCcccccccchh
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGE---IPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQF 152 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 152 (619)
.+|+.|+|++|.+++..|..+..+++|++|+|++|++++. .+..+..+++|++|+|++|++++..|..|.++++|+.
T Consensus 425 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 504 (606)
T 3t6q_A 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNH 504 (606)
T ss_dssp TTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred ccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCE
Confidence 4677777777777777777777777777777777777652 2345777788888888888888777778888888888
Q ss_pred hhccCCcCCCCCCCccccccccccccCCCCcccccCCccc---cccCccccCCCCCCCCCC
Q 007073 153 LTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLNCGKT 210 (619)
Q Consensus 153 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l---~~l~~l~~~~n~~~c~~~ 210 (619)
|+|++|++++..|..+..+++| .|++++|++++..|..+ .++..+++++|++.|+|+
T Consensus 505 L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 505 VDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp EECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred EECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 8888888887777788888888 88888888886666544 456778889999988875
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=2.9e-15 Score=162.00 Aligned_cols=141 Identities=20% Similarity=0.213 Sum_probs=118.5
Q ss_pred CcceeEEcC----------CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCC
Q 007073 66 TWSNVICDN----------SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNR 135 (619)
Q Consensus 66 ~w~gv~c~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 135 (619)
.|..|.|.+ ..+++.|+|++|++++..+..|..+++|++|+|++|.+++..|..|.++++|++|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 356777754 2378999999999998888899999999999999999998888899999999999999999
Q ss_pred ccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCCCcccccCCcccc---ccCccccCCCCCC
Q 007073 136 LVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLN 206 (619)
Q Consensus 136 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~---~l~~l~~~~n~~~ 206 (619)
|++..+..|.++++|+.|+|++|++++..|..|..+++|+.|++++|++++..|..+. ++..|++++|...
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 165 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT 165 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCS
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCc
Confidence 9965556788999999999999999977888899999999999999999876665554 5566778888654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=3.1e-15 Score=169.22 Aligned_cols=137 Identities=20% Similarity=0.216 Sum_probs=113.2
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCc--------ccccccccCcEeeecCCCccccCCCcccc
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIP--------EELGNLSSLTSLDLDNNRLVGKIPPSLGN 146 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p--------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 146 (619)
..+|+.|+|++|++++..+..|..+++|++|+|++|++++..+ ..|.++++|++|+|++|+|+...+..|.+
T Consensus 479 l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~ 558 (680)
T 1ziw_A 479 LRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKD 558 (680)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred CCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHccc
Confidence 3578899999999988777788889999999999999885321 23788899999999999999444456899
Q ss_pred cccchhhhccCCcCCCCCCCccccccccccccCCCCcccccCCc----cccccCccccCCCCCCCCCCC
Q 007073 147 LKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV----HLFQIPKYNFTGNNLNCGKTL 211 (619)
Q Consensus 147 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~----~l~~l~~l~~~~n~~~c~~~~ 211 (619)
+++|+.|+|++|+|++..+..|..+++|+.|++++|++++..|. .+.++..+++++|+|.|+|+.
T Consensus 559 l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 559 LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred ccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 99999999999999966666678999999999999999966554 356788899999999999873
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.2e-15 Score=158.34 Aligned_cols=143 Identities=21% Similarity=0.318 Sum_probs=119.6
Q ss_pred CCCCCcceeEEcC------------CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEe
Q 007073 62 VNPCTWSNVICDN------------SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSL 129 (619)
Q Consensus 62 ~~~c~w~gv~c~~------------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 129 (619)
..+|.|.|+ |+. ..+|+.|+|++|++++..+..|..+++|++|+|++|++++..|..|.++++|++|
T Consensus 27 ~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 27 SLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 467889887 653 1379999999999998877799999999999999999998788889999999999
Q ss_pred eecCCCccccCCCcccccccchhhhccCCcCCCCCCC--ccccccccccccCCCCc-ccccCCcccc---ccCccccCCC
Q 007073 130 DLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPD--SLTTLSSLISIQLDSNN-LSGQIPVHLF---QIPKYNFTGN 203 (619)
Q Consensus 130 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~-l~~~~p~~l~---~l~~l~~~~n 203 (619)
+|++|+|++..+..|.++++|++|+|++|+++ .+|. .+..+++|+.|++++|+ +++..|..+. ++..|++++|
T Consensus 106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n 184 (353)
T 2z80_A 106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS 184 (353)
T ss_dssp ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEET
T ss_pred ECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCC
Confidence 99999999544445899999999999999999 5665 78899999999999995 6644455554 5566788888
Q ss_pred CCC
Q 007073 204 NLN 206 (619)
Q Consensus 204 ~~~ 206 (619)
...
T Consensus 185 ~l~ 187 (353)
T 2z80_A 185 DLQ 187 (353)
T ss_dssp TCC
T ss_pred CcC
Confidence 764
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.57 E-value=4.6e-15 Score=136.87 Aligned_cols=108 Identities=29% Similarity=0.312 Sum_probs=95.6
Q ss_pred EEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhccCC
Q 007073 79 ASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158 (619)
Q Consensus 79 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 158 (619)
+.|++++|+++ .+|..+ .++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 57888999998 466655 489999999999999888999999999999999999999777777899999999999999
Q ss_pred cCCCCCCCccccccccccccCCCCcccccCC
Q 007073 159 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 189 (619)
Q Consensus 159 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 189 (619)
+|++..+..|..+++|+.|+|++|+++...+
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9997666679999999999999999985443
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.56 E-value=2.6e-15 Score=157.96 Aligned_cols=151 Identities=17% Similarity=0.219 Sum_probs=116.3
Q ss_pred CCCCCCCCCCCCC----cceeEEcC-----------------CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCC
Q 007073 54 LRDWNQNQVNPCT----WSNVICDN-----------------SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGI 112 (619)
Q Consensus 54 l~~w~~~~~~~c~----w~gv~c~~-----------------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 112 (619)
+++|... .+||. |.++.|+. ..+++.|++++|.++...+..|..+++|++|+|++|.+
T Consensus 3 ~~~~~~~-~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i 81 (390)
T 3o6n_A 3 VKPRQPE-YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI 81 (390)
T ss_dssp ----CCE-ECBCC------EEEESCEECSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCC
T ss_pred cCCCCCc-cceehhhhhhccceeeeeeecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcc
Confidence 5678763 56663 55544441 25788999999999866666678899999999999999
Q ss_pred CCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhccCCcCCCCCCC-ccccccccccccCCCCcccccCCcc
Q 007073 113 TGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPD-SLTTLSSLISIQLDSNNLSGQIPVH 191 (619)
Q Consensus 113 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~ 191 (619)
++..|..|..+++|++|+|++|++++..|..|+++++|++|+|++|+++ .+|. .|..+++|+.|++++|++++..|..
T Consensus 82 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 160 (390)
T 3o6n_A 82 EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDT 160 (390)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTT
T ss_pred cccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhh
Confidence 9777778999999999999999999877888999999999999999999 4554 4688999999999999998666655
Q ss_pred cc---ccCccccCCCCCC
Q 007073 192 LF---QIPKYNFTGNNLN 206 (619)
Q Consensus 192 l~---~l~~l~~~~n~~~ 206 (619)
+. ++..|++++|...
T Consensus 161 ~~~l~~L~~L~l~~n~l~ 178 (390)
T 3o6n_A 161 FQATTSLQNLQLSSNRLT 178 (390)
T ss_dssp TSSCTTCCEEECCSSCCS
T ss_pred ccCCCCCCEEECCCCcCC
Confidence 54 5666788888764
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.56 E-value=5.4e-15 Score=136.93 Aligned_cols=110 Identities=22% Similarity=0.251 Sum_probs=96.1
Q ss_pred EEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhccCC
Q 007073 79 ASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158 (619)
Q Consensus 79 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 158 (619)
+.+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 68999999997 6676664 89999999999999888999999999999999999999765666899999999999999
Q ss_pred cCCCCCCCccccccccccccCCCCcccccCCccc
Q 007073 159 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL 192 (619)
Q Consensus 159 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l 192 (619)
+|++..+..|..+++|+.|+|++|++. ..|..+
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~-c~~~~~ 124 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD-CECRDI 124 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC-TTBGGG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc-cccccH
Confidence 999655556999999999999999998 445433
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=1e-15 Score=165.65 Aligned_cols=136 Identities=18% Similarity=0.190 Sum_probs=115.3
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
.+|+.|+|++|.+.+.+|..+....+|+.|+|++|+|++..+..+.++++|+.|+|++|.|++..+..|.++++|+.|+|
T Consensus 200 ~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 279 (477)
T 2id5_A 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQL 279 (477)
T ss_dssp TTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEEC
T ss_pred cccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEEC
Confidence 46777777777777677766666678888888889998555567999999999999999999888888999999999999
Q ss_pred cCCcCCCCCCCccccccccccccCCCCcccccCCccc---cccCccccCCCCCCCCCCC
Q 007073 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLNCGKTL 211 (619)
Q Consensus 156 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l---~~l~~l~~~~n~~~c~~~~ 211 (619)
++|++++..|..|..+++|+.|+|++|++++..+..+ .++..|++++|++.|+|..
T Consensus 280 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~ 338 (477)
T 2id5_A 280 VGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRL 338 (477)
T ss_dssp CSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGG
T ss_pred CCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccch
Confidence 9999998889999999999999999999995444444 4677889999999999863
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.56 E-value=2.4e-15 Score=153.62 Aligned_cols=138 Identities=23% Similarity=0.298 Sum_probs=102.9
Q ss_pred ceeEEcCCCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccc-cccccCcEeeecCCCccccCCCcccc
Q 007073 68 SNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPPSLGN 146 (619)
Q Consensus 68 ~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~ 146 (619)
.++.+....+|+.|+|++|++++..+..+..+++|++|+|++|++++..|..+ ..+++|++|+|++|+|++. |. ...
T Consensus 112 ~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~ 189 (317)
T 3o53_A 112 SRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVV 189 (317)
T ss_dssp SEEEECCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCC
T ss_pred CCcCccccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccc
Confidence 34444555677888888888887777778888888888888888886666666 3678888888888888844 33 334
Q ss_pred cccchhhhccCCcCCCCCCCccccccccccccCCCCcccccCCcccc---ccCccccCCCCCCCCC
Q 007073 147 LKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLNCGK 209 (619)
Q Consensus 147 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~---~l~~l~~~~n~~~c~~ 209 (619)
+++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++ .+|..+. ++..|++++|++.|++
T Consensus 190 l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~ 253 (317)
T 3o53_A 190 FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGT 253 (317)
T ss_dssp CTTCCEEECCSSCCC-EECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHH
T ss_pred cccCCEEECCCCcCC-cchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcC
Confidence 788888888888888 55666888888888888888888 5776553 5566778888887654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=4.5e-15 Score=165.49 Aligned_cols=132 Identities=21% Similarity=0.188 Sum_probs=115.6
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
.+++.|+|++|+|++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 112 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112 (606)
T ss_dssp TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence 47999999999999888999999999999999999999888999999999999999999999888999999999999999
Q ss_pred cCCcCCCCCCCccccccccccccCCCCccccc-CCcc--ccccCccccCCCCCCC
Q 007073 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQ-IPVH--LFQIPKYNFTGNNLNC 207 (619)
Q Consensus 156 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~--l~~l~~l~~~~n~~~c 207 (619)
++|++++..|..+..+++|++|++++|++++. +|.. +.++..|++++|....
T Consensus 113 ~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 167 (606)
T 3t6q_A 113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167 (606)
T ss_dssp TTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCE
T ss_pred cccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccc
Confidence 99999976678899999999999999999862 3432 3567778888887653
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.55 E-value=2.6e-15 Score=170.16 Aligned_cols=112 Identities=32% Similarity=0.463 Sum_probs=58.2
Q ss_pred CeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhcc
Q 007073 77 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 156 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 156 (619)
.|+.|+|++|.+. .+|..+..+++|++|+|++|+|+ .+|..|++|++|++|+|++|+|+ .+|..|++|++|+.|+|+
T Consensus 225 ~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~ 301 (727)
T 4b8c_D 225 LWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFF 301 (727)
T ss_dssp CCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECC
T ss_pred CCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECC
Confidence 3445555555554 44444445555555555555555 45555555555555555555555 445555555555555555
Q ss_pred CCcCCCCCCCccccccccccccCCCCcccccCCccc
Q 007073 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL 192 (619)
Q Consensus 157 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l 192 (619)
+|.|+ .+|..|..|++|+.|+|++|+|++.+|..+
T Consensus 302 ~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~ 336 (727)
T 4b8c_D 302 DNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKIL 336 (727)
T ss_dssp SSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHH
T ss_pred CCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHH
Confidence 55554 445555555555555555555555444444
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.55 E-value=7.7e-15 Score=157.54 Aligned_cols=142 Identities=23% Similarity=0.241 Sum_probs=122.1
Q ss_pred cceeEEcCC----------CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCc
Q 007073 67 WSNVICDNS----------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRL 136 (619)
Q Consensus 67 w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 136 (619)
|..+.|.+. .+++.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l 135 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcC
Confidence 567888642 4799999999999999999999999999999999999988889999999999999999999
Q ss_pred cccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCCCcccccCCc----cccccCccccCCCCCCCC
Q 007073 137 VGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV----HLFQIPKYNFTGNNLNCG 208 (619)
Q Consensus 137 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~----~l~~l~~l~~~~n~~~c~ 208 (619)
++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|++++|+..+.+|. .+.++..|++++|.....
T Consensus 136 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 211 (452)
T 3zyi_A 136 TVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM 211 (452)
T ss_dssp SBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC
T ss_pred CccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc
Confidence 976677799999999999999999966666889999999999999555446764 345677788998877543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=3.6e-15 Score=164.87 Aligned_cols=136 Identities=22% Similarity=0.271 Sum_probs=105.8
Q ss_pred CCCeEEEEeCCCCccccCC-ccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCcc-ccCCCcccccccchh
Q 007073 75 SNNVASVTLSSMNFSGTLS-PRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLV-GKIPPSLGNLKKLQF 152 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~ 152 (619)
..+|+.|+|++|.+.+..+ ..+..+++|++|+|++|.+++..|..+.++++|++|+|++|.++ +.+|..+..+++|+.
T Consensus 395 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~ 474 (570)
T 2z63_A 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 474 (570)
T ss_dssp CTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred cCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCE
Confidence 3466667777777765554 45777888888888888888777777888888888888888887 568888888888888
Q ss_pred hhccCCcCCCCCCCccccccccccccCCCCcccccCCcccc---ccCccccCCCCCCCCCC
Q 007073 153 LTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLNCGKT 210 (619)
Q Consensus 153 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~---~l~~l~~~~n~~~c~~~ 210 (619)
|+|++|++++..|..+..+++|+.|++++|++++..|..+. ++..|++++|++.|.|+
T Consensus 475 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred EECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 88888888877788888888888888888888866555444 45667788888888875
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=3.1e-15 Score=163.60 Aligned_cols=134 Identities=23% Similarity=0.330 Sum_probs=84.7
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCC--CCcccccccccCcEeeecCCCccccCCCc-ccccc---
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITG--EIPEELGNLSSLTSLDLDNNRLVGKIPPS-LGNLK--- 148 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~--- 148 (619)
..+|+.|+|++|.+++.+|..+..+++|++|+|++|++++ .+|..+.++++|++|+|++|++++.+|.. +..++
T Consensus 323 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~ 402 (520)
T 2z7x_B 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402 (520)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred CCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence 4567777777777776667677777777777777777764 34455666777777777777766534432 44444
Q ss_pred -------------------cchhhhccCCcCCCCCCCccccccccccccCCCCcccccCCcc-c---cccCccccCCCCC
Q 007073 149 -------------------KLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH-L---FQIPKYNFTGNNL 205 (619)
Q Consensus 149 -------------------~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-l---~~l~~l~~~~n~~ 205 (619)
+|+.|+|++|+|+ .+|..+..+++|+.|++++|+++ .+|.. + .++..|++++|++
T Consensus 403 ~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~ 480 (520)
T 2z7x_B 403 SLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480 (520)
T ss_dssp EEECCSSCCCGGGGGSCCTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCB
T ss_pred EEECcCCCCCcchhhhhcccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCC
Confidence 5555555555555 55655566667777777777776 45543 3 3445566777777
Q ss_pred CCCCC
Q 007073 206 NCGKT 210 (619)
Q Consensus 206 ~c~~~ 210 (619)
.|+|+
T Consensus 481 ~c~c~ 485 (520)
T 2z7x_B 481 DCSCP 485 (520)
T ss_dssp CCCHH
T ss_pred cccCC
Confidence 76664
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=4.4e-15 Score=171.92 Aligned_cols=141 Identities=21% Similarity=0.235 Sum_probs=92.2
Q ss_pred CCcceeEEcCCCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCC-cccccccccCcEeeecCCCccccCCCc
Q 007073 65 CTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEI-PEELGNLSSLTSLDLDNNRLVGKIPPS 143 (619)
Q Consensus 65 c~w~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~ 143 (619)
|.|..|.+ ...+++.|+|++|.|++..|..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|+|++..|..
T Consensus 14 ~~L~~vP~-lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~ 92 (844)
T 3j0a_A 14 CNLTQVPQ-VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDA 92 (844)
T ss_dssp CCSSCCCS-SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTS
T ss_pred CCCCCCCC-CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhH
Confidence 34555555 4457777777777777777777777777777777777555454 566777777777777777777666777
Q ss_pred ccccccchhhhccCCcCCCCCCCc--cccccccccccCCCCcccccCC-ccc---cccCccccCCCCCC
Q 007073 144 LGNLKKLQFLTLSQNNFSGTIPDS--LTTLSSLISIQLDSNNLSGQIP-VHL---FQIPKYNFTGNNLN 206 (619)
Q Consensus 144 ~~~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~~p-~~l---~~l~~l~~~~n~~~ 206 (619)
|+++++|++|+|++|.+++.+|.. +..+++|+.|+|++|++++..| ..+ .+|..|++++|.+.
T Consensus 93 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~ 161 (844)
T 3j0a_A 93 FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF 161 (844)
T ss_dssp SCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCC
T ss_pred ccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCC
Confidence 777777777777777776655544 6677777777777777765443 233 34444556666543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.54 E-value=5.9e-15 Score=163.02 Aligned_cols=134 Identities=23% Similarity=0.326 Sum_probs=89.3
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCC--CcccccccccCcEeeecCCCccccCCCc-cccc----
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGE--IPEELGNLSSLTSLDLDNNRLVGKIPPS-LGNL---- 147 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l---- 147 (619)
..+|+.|+|++|.+++.+|..+..+++|++|+|++|++++. +|..+.++++|++|+|++|++++.+|.. +..+
T Consensus 352 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~ 431 (562)
T 3a79_B 352 PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL 431 (562)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCC
T ss_pred CCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCC
Confidence 44666667777666666666666666666666666666642 2345666666666666666666534432 3333
Q ss_pred ------------------ccchhhhccCCcCCCCCCCccccccccccccCCCCcccccCCcc-cc---ccCccccCCCCC
Q 007073 148 ------------------KKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH-LF---QIPKYNFTGNNL 205 (619)
Q Consensus 148 ------------------~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-l~---~l~~l~~~~n~~ 205 (619)
++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++ .+|.. +. ++..|++++|++
T Consensus 432 ~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~ 509 (562)
T 3a79_B 432 VLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509 (562)
T ss_dssp EEECCSSCCCGGGGSSCCTTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCB
T ss_pred EEECCCCCCCcchhhhhcCcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCc
Confidence 56777777777777 67777778888888888888888 67754 43 455677888888
Q ss_pred CCCCC
Q 007073 206 NCGKT 210 (619)
Q Consensus 206 ~c~~~ 210 (619)
.|+|+
T Consensus 510 ~c~c~ 514 (562)
T 3a79_B 510 DCTCP 514 (562)
T ss_dssp CCCHH
T ss_pred CCCcc
Confidence 88875
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.1e-14 Score=149.58 Aligned_cols=140 Identities=22% Similarity=0.307 Sum_probs=121.0
Q ss_pred CCcceeEEcCC----------CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCC
Q 007073 65 CTWSNVICDNS----------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNN 134 (619)
Q Consensus 65 c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 134 (619)
|.|..+.|++. .+++.|+|++|++++..|..|..+++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 68999999742 37999999999999888889999999999999999999888999999999999999999
Q ss_pred CccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCCCccc--ccCCcccc--ccCccccCCCCCCC
Q 007073 135 RLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLS--GQIPVHLF--QIPKYNFTGNNLNC 207 (619)
Q Consensus 135 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~--~~~p~~l~--~l~~l~~~~n~~~c 207 (619)
+++ .+|..+. ++|++|++++|++++..+..+..+++|+.|++++|+++ +..|..+. ++..|++++|....
T Consensus 113 ~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~ 186 (332)
T 2ft3_A 113 HLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG 186 (332)
T ss_dssp CCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSS
T ss_pred cCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCc
Confidence 999 7787766 89999999999999665667899999999999999996 35555554 67778888887643
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=4e-15 Score=152.77 Aligned_cols=127 Identities=29% Similarity=0.362 Sum_probs=67.0
Q ss_pred CCeEEEEeCCCCccc--cCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhh
Q 007073 76 NNVASVTLSSMNFSG--TLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFL 153 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 153 (619)
.+|+.|+|++|.+.. ..+..+..+++|+.|++++|+++ .+|..+. ++|++|+|++|++++..|..|.++++|+.|
T Consensus 145 ~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 221 (330)
T 1xku_A 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKL 221 (330)
T ss_dssp TTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEE
T ss_pred ccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEE
Confidence 355666666665542 44555555555555555555555 3443332 455555555555554445555555555555
Q ss_pred hccCCcCCCCCCCccccccccccccCCCCcccccCCcccc---ccCccccCCCCCC
Q 007073 154 TLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLN 206 (619)
Q Consensus 154 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~---~l~~l~~~~n~~~ 206 (619)
+|++|++++..+..+..+++|+.|++++|+++ .+|..+. ++..|++++|++.
T Consensus 222 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~ 276 (330)
T 1xku_A 222 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 276 (330)
T ss_dssp ECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred ECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCC
Confidence 55555555444445555555555555555555 4554333 2333445555443
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.53 E-value=4.3e-15 Score=140.66 Aligned_cols=124 Identities=23% Similarity=0.346 Sum_probs=69.3
Q ss_pred CeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhcc
Q 007073 77 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 156 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 156 (619)
+|+.|+|++|+++ .+| .+..+++|++|+|++|.++ .++ .+..+++|++|+|++|++++..|..|+.+++|+.|+|+
T Consensus 45 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls 120 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-NYN-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120 (197)
T ss_dssp TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-CCG-GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-cch-hhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence 5566666666665 333 4555666666666666554 222 45556666666666666665555556666666666666
Q ss_pred CCcCCCCCCCccccccccccccCCCCc-ccccCCc--cccccCccccCCCCC
Q 007073 157 QNNFSGTIPDSLTTLSSLISIQLDSNN-LSGQIPV--HLFQIPKYNFTGNNL 205 (619)
Q Consensus 157 ~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~--~l~~l~~l~~~~n~~ 205 (619)
+|++++..|..+..+++|+.|++++|+ ++ .+|. .+.++..|++++|..
T Consensus 121 ~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~~l~~l~~L~~L~l~~n~i 171 (197)
T 4ezg_A 121 HSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIMPLKTLPELKSLNIQFDGV 171 (197)
T ss_dssp SSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCGGGGGCSSCCEEECTTBCC
T ss_pred CCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccHhhcCCCCCCEEECCCCCC
Confidence 666655455555566666666666665 33 4441 223344455555544
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.53 E-value=7.9e-15 Score=148.87 Aligned_cols=128 Identities=21% Similarity=0.274 Sum_probs=60.0
Q ss_pred CeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCc-ccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 77 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIP-EELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
+|+.|+|++|.+. .+|..+..+++|++|+|++|++++..+ ..+.++++|++|+|++|.+++..|..|.++++|+.|+|
T Consensus 79 ~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 157 (306)
T 2z66_A 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 157 (306)
T ss_dssp CCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEEC
T ss_pred ccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEEC
Confidence 4555555555554 233344455555555555555543322 24444555555555555554444444445555555555
Q ss_pred cCCcCCC-CCCCccccccccccccCCCCcccccCCcccc---ccCccccCCCCC
Q 007073 156 SQNNFSG-TIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNL 205 (619)
Q Consensus 156 ~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~---~l~~l~~~~n~~ 205 (619)
++|.+++ .+|..+..+++|+.|++++|++++..|..+. ++..|++++|.+
T Consensus 158 ~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l 211 (306)
T 2z66_A 158 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF 211 (306)
T ss_dssp TTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred CCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCcc
Confidence 5555443 2444444455555555555555433333332 233344444443
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.6e-14 Score=151.82 Aligned_cols=132 Identities=24% Similarity=0.206 Sum_probs=116.9
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
..+|+.|+|++|.+++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|+++...+..|.++++|++|+
T Consensus 68 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 147 (390)
T 3o6n_A 68 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS 147 (390)
T ss_dssp CCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEE
Confidence 35899999999999988888999999999999999999988888899999999999999999944444579999999999
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCCccccccCccccCCCCCC
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLN 206 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~l~~~~n~~~ 206 (619)
|++|++++..|..+..+++|+.|++++|++++.-...+.++..|++++|...
T Consensus 148 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~ 199 (390)
T 3o6n_A 148 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLS 199 (390)
T ss_dssp CCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCS
T ss_pred CCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeeccccccc
Confidence 9999999777888999999999999999999654466778888888888654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=1.4e-14 Score=163.73 Aligned_cols=131 Identities=19% Similarity=0.227 Sum_probs=98.8
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
.++++|+|++|++++..+..|.++++|++|+|++|.+++..|..|+++++|++|+|++|++++..+..|+++++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 36888888888888777777888888888888888888777777888888888888888888544446788888888888
Q ss_pred cCCcCCCCCCCccccccccccccCCCCcccccCCcccc---ccCccccCCCCCC
Q 007073 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLN 206 (619)
Q Consensus 156 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~---~l~~l~~~~n~~~ 206 (619)
++|++++..|..|..+++|++|++++|++++..|..+. ++..|++++|...
T Consensus 105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 158 (680)
T 1ziw_A 105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQ 158 (680)
T ss_dssp CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCC
T ss_pred CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCccc
Confidence 88888766667778888888888888888766665443 4555667776553
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.53 E-value=4.2e-15 Score=165.34 Aligned_cols=131 Identities=18% Similarity=0.240 Sum_probs=114.5
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
.+|+.|+|++|++++. +.+..+++|+.|+|++|.|++.+|..|+++++|+.|+|++|+|++ +|..+..+++|+.|+|
T Consensus 232 ~~L~~L~L~~n~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L 308 (597)
T 3oja_B 232 VELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDL 308 (597)
T ss_dssp SCCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEEC
T ss_pred CCCCEEECCCCCCCCC--hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEEC
Confidence 4688888888888863 678899999999999999998889999999999999999999994 6888888999999999
Q ss_pred cCCcCCCCCCCccccccccccccCCCCcccccCCccccccCccccCCCCCCCCCC
Q 007073 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKT 210 (619)
Q Consensus 156 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~l~~~~n~~~c~~~ 210 (619)
++|.++ .+|..+..+++|+.|+|++|++++..+..+.++..|++++|++.|.+.
T Consensus 309 s~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~~~~~~~ 362 (597)
T 3oja_B 309 SHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCNSL 362 (597)
T ss_dssp CSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCCCTTCCCSEEECCSSCEEHHHH
T ss_pred CCCCCC-ccCcccccCCCCCEEECCCCCCCCcChhhcCCCCEEEeeCCCCCChhH
Confidence 999999 788888899999999999999996555677788899999999998763
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.52 E-value=2.5e-15 Score=168.34 Aligned_cols=130 Identities=19% Similarity=0.327 Sum_probs=117.3
Q ss_pred CCCeEEEEeCCCCcccc-----------------CCcccc--CCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCC
Q 007073 75 SNNVASVTLSSMNFSGT-----------------LSPRIG--VLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNR 135 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~-----------------~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 135 (619)
..+|++|+|++|.+++. +|..++ ++++|++|+|++|++.+.+|..|+++++|++|+|++|+
T Consensus 205 l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred ccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence 56899999999999986 899999 99999999999999999999999999999999999998
Q ss_pred -ccc-cCCCccccc------ccchhhhccCCcCCCCCCC--ccccccccccccCCCCcccccCCcccc---ccCccccCC
Q 007073 136 -LVG-KIPPSLGNL------KKLQFLTLSQNNFSGTIPD--SLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTG 202 (619)
Q Consensus 136 -l~~-~~p~~~~~l------~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~~l~---~l~~l~~~~ 202 (619)
++| .+|..++++ ++|+.|+|++|+++ .+|. .+..+++|+.|++++|+++|.+| .+. ++..|++++
T Consensus 285 ~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~ 362 (636)
T 4eco_A 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAY 362 (636)
T ss_dssp TSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCS
T ss_pred CCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCC
Confidence 998 899988887 99999999999999 8998 89999999999999999999999 554 566678888
Q ss_pred CCCC
Q 007073 203 NNLN 206 (619)
Q Consensus 203 n~~~ 206 (619)
|.+.
T Consensus 363 N~l~ 366 (636)
T 4eco_A 363 NQIT 366 (636)
T ss_dssp SEEE
T ss_pred Cccc
Confidence 8765
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.52 E-value=3.6e-15 Score=169.03 Aligned_cols=170 Identities=20% Similarity=0.221 Sum_probs=109.1
Q ss_pred chhHHHHHHHHHhcCCC-CCCCCCCCCCCCCCCCcceeEE-----------------cCCCCeEEEEeCCCCccc-----
Q 007073 34 SLSGDALFALRTSLRVP-NNQLRDWNQNQVNPCTWSNVIC-----------------DNSNNVASVTLSSMNFSG----- 90 (619)
Q Consensus 34 ~~~~~al~~~k~~l~~~-~~~l~~w~~~~~~~c~w~gv~c-----------------~~~~~l~~L~L~~n~l~~----- 90 (619)
..+..+|+.+...+..+ .+.-..|......++.|.+.++ .....+..++|++|.|.+
T Consensus 131 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~~~~ 210 (727)
T 4b8c_D 131 DCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVSTPLTPKIELFANGKDEANQALLQHKKLSQYSIDEDDDIE 210 (727)
T ss_dssp -CCCHHHHHHHHHHHHHHTTC-----------------------------------------------------------
T ss_pred ccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecCCccceEEeeCCCCCcchhhHhhcCccCcccccCccccc
Confidence 33677888888666321 1222345444444455654332 122356666666666654
Q ss_pred ----cCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhccCCcCCCCCCC
Q 007073 91 ----TLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPD 166 (619)
Q Consensus 91 ----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 166 (619)
..+..+..+++|+.|+|++|+|. .+|..+.++++|++|+|++|.|+ .+|..|++|++|+.|+|++|+|+ .+|.
T Consensus 211 n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~ 287 (727)
T 4b8c_D 211 NRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPA 287 (727)
T ss_dssp -----------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCS
T ss_pred cceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccCh
Confidence 44778899999999999999999 88888889999999999999999 89999999999999999999999 8899
Q ss_pred ccccccccccccCCCCcccccCCcccc---ccCccccCCCCCCC
Q 007073 167 SLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLNC 207 (619)
Q Consensus 167 ~~~~l~~L~~L~l~~N~l~~~~p~~l~---~l~~l~~~~n~~~c 207 (619)
.|..|++|+.|+|++|.|+ .+|..|. +|..|++++|++..
T Consensus 288 ~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~ 330 (727)
T 4b8c_D 288 ELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEK 330 (727)
T ss_dssp SGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCS
T ss_pred hhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCC
Confidence 9999999999999999998 8997665 55667899998764
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=1.8e-14 Score=154.17 Aligned_cols=141 Identities=25% Similarity=0.227 Sum_probs=117.9
Q ss_pred cceeEEcC----------CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCc
Q 007073 67 WSNVICDN----------SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRL 136 (619)
Q Consensus 67 w~gv~c~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 136 (619)
|..|.|.+ ..+++.|+|++|++++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|
T Consensus 45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 56777764 24789999999999988889999999999999999999977788899999999999999999
Q ss_pred cccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCCCcccccCCc-c---ccccCccccCCCCCCC
Q 007073 137 VGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV-H---LFQIPKYNFTGNNLNC 207 (619)
Q Consensus 137 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~---l~~l~~l~~~~n~~~c 207 (619)
++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|+..+.+|. . +.++..|++++|....
T Consensus 125 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~ 199 (440)
T 3zyj_A 125 TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE 199 (440)
T ss_dssp SSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS
T ss_pred CeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc
Confidence 966666899999999999999999966666888999999999998555446664 2 4466777888887653
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.52 E-value=8.5e-15 Score=135.91 Aligned_cols=125 Identities=18% Similarity=0.240 Sum_probs=103.4
Q ss_pred CCCeEEEEeCCCCccccCCccccCCC-CCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLR-TLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFL 153 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 153 (619)
..+|+.|+|++|+++. +|. +..+. +|+.|+|++|+|++. ..+..+++|++|+|++|+|++..+..|..+++|+.|
T Consensus 18 ~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 93 (176)
T 1a9n_A 18 AVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 93 (176)
T ss_dssp TTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred cCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEE
Confidence 3589999999999995 454 55555 999999999999954 579999999999999999996544556999999999
Q ss_pred hccCCcCCCCCCC--ccccccccccccCCCCcccccCCcc----ccc---cCccccCCCCC
Q 007073 154 TLSQNNFSGTIPD--SLTTLSSLISIQLDSNNLSGQIPVH----LFQ---IPKYNFTGNNL 205 (619)
Q Consensus 154 ~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~~----l~~---l~~l~~~~n~~ 205 (619)
+|++|+|+ .+|. .+..+++|+.|++++|+++ .+|.. +.. +..|++.+|..
T Consensus 94 ~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 94 ILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp ECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred ECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCH
Confidence 99999997 6776 8899999999999999998 67764 544 45566666653
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.52 E-value=2.9e-15 Score=152.66 Aligned_cols=132 Identities=18% Similarity=0.238 Sum_probs=108.4
Q ss_pred CCCeEEEEeCCCCccccCCccc--cCCCCCCEEEccCCCCCCCCccccccc-----ccCcEeeecCCCccccCCCccccc
Q 007073 75 SNNVASVTLSSMNFSGTLSPRI--GVLRTLSTLTLKGNGITGEIPEELGNL-----SSLTSLDLDNNRLVGKIPPSLGNL 147 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l 147 (619)
..+|++|+|++|++++.+|..+ ..+++|++|+|++|++++. |..++.+ ++|++|+|++|+|++..|..|+++
T Consensus 94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l 172 (312)
T 1wwl_A 94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF 172 (312)
T ss_dssp TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccC
Confidence 4589999999999998888876 8899999999999999966 8888887 899999999999998777899999
Q ss_pred ccchhhhccCCcCCCC--CCCcc--ccccccccccCCCCcccc--cCCcc----ccccCccccCCCCCCC
Q 007073 148 KKLQFLTLSQNNFSGT--IPDSL--TTLSSLISIQLDSNNLSG--QIPVH----LFQIPKYNFTGNNLNC 207 (619)
Q Consensus 148 ~~L~~L~l~~N~l~~~--~p~~~--~~l~~L~~L~l~~N~l~~--~~p~~----l~~l~~l~~~~n~~~c 207 (619)
++|+.|+|++|++.+. +|..+ ..+++|+.|+|++|++++ .++.. +.++..|++++|.+..
T Consensus 173 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 242 (312)
T 1wwl_A 173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD 242 (312)
T ss_dssp SSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCS
T ss_pred CCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCc
Confidence 9999999999998765 33344 788899999999999983 23322 3578888899887754
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.51 E-value=1.1e-14 Score=137.93 Aligned_cols=126 Identities=21% Similarity=0.320 Sum_probs=109.6
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
..+|+.|+|++|.++. ++.+..+++|++|+|++|++++..|..++++++|++|+|++|++++..|..++++++|+.|+
T Consensus 65 l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~ 142 (197)
T 4ezg_A 65 AHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142 (197)
T ss_dssp CTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEE
T ss_pred CCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEE
Confidence 4589999999997763 34789999999999999999987888999999999999999999988889999999999999
Q ss_pred ccCCc-CCCCCCCccccccccccccCCCCcccccCC--ccccccCccccCCCCC
Q 007073 155 LSQNN-FSGTIPDSLTTLSSLISIQLDSNNLSGQIP--VHLFQIPKYNFTGNNL 205 (619)
Q Consensus 155 l~~N~-l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p--~~l~~l~~l~~~~n~~ 205 (619)
|++|+ ++ .+| .+..+++|+.|++++|++++ +| ..+.++..|++.+|++
T Consensus 143 L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 143 LSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YRGIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp CCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CTTGGGCSSCCEEEECBC--
T ss_pred ccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hHHhccCCCCCEEEeeCccc
Confidence 99998 66 666 68999999999999999995 54 3455677788999875
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=1.3e-14 Score=159.46 Aligned_cols=108 Identities=24% Similarity=0.361 Sum_probs=99.7
Q ss_pred CeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhcc
Q 007073 77 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 156 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 156 (619)
.|+.|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +| .|+++++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 58899999999996 565 999999999999999999 889999999999999999999995 77 89999999999999
Q ss_pred CCcCCCCC-CCccccccccccccCCCCcccccCC
Q 007073 157 QNNFSGTI-PDSLTTLSSLISIQLDSNNLSGQIP 189 (619)
Q Consensus 157 ~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p 189 (619)
+|+|++.. |..+..+++|+.|+|++|++++..|
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 99999776 9999999999999999999996554
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.51 E-value=1.7e-14 Score=148.26 Aligned_cols=107 Identities=21% Similarity=0.321 Sum_probs=58.2
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCC--CCCcccccccccCcEeeecCCCccccCCCcccccccchhh
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGIT--GEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFL 153 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 153 (619)
.+|++|+|++|.+++..+..|..+++|+.|+|++|.++ +..|..+..+ +|++|++++|+++ .+|..+. ++|+.|
T Consensus 123 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~-~l~~~~~--~~L~~L 198 (332)
T 2ft3_A 123 SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT-GIPKDLP--ETLNEL 198 (332)
T ss_dssp TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS-SCCSSSC--SSCSCC
T ss_pred ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC-ccCcccc--CCCCEE
Confidence 36777777777777655556777777777777777774 2455555554 4444444444444 2333222 344444
Q ss_pred hccCCcCCCCCCCccccccccccccCCCCcccc
Q 007073 154 TLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSG 186 (619)
Q Consensus 154 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 186 (619)
+|++|++++..|..+..+++|+.|++++|++++
T Consensus 199 ~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~ 231 (332)
T 2ft3_A 199 HLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM 231 (332)
T ss_dssp BCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCC
T ss_pred ECCCCcCCccCHHHhcCCCCCCEEECCCCcCCc
Confidence 444454444444444444555555555555543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.51 E-value=2.1e-14 Score=132.38 Aligned_cols=106 Identities=18% Similarity=0.278 Sum_probs=93.0
Q ss_pred CCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCC
Q 007073 102 LSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDS 181 (619)
Q Consensus 102 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 181 (619)
.+.|++++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 578999999999 6887664 8999999999999988899999999999999999999976677789999999999999
Q ss_pred CcccccCCccc---cccCccccCCCCCCCCCC
Q 007073 182 NNLSGQIPVHL---FQIPKYNFTGNNLNCGKT 210 (619)
Q Consensus 182 N~l~~~~p~~l---~~l~~l~~~~n~~~c~~~ 210 (619)
|+|++..|..+ .++..|++++|++.|.|.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 99996544444 466778999999999985
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.51 E-value=5.6e-15 Score=150.52 Aligned_cols=131 Identities=18% Similarity=0.235 Sum_probs=83.7
Q ss_pred CCCeEEEEeCCCCccccCCccccCC-----CCCCEEEccCCCCCCCCcccccccccCcEeeecCCCcccc--CCCcc--c
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVL-----RTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGK--IPPSL--G 145 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~--~ 145 (619)
..+|+.|+|++|++++. |..++.+ ++|++|+|++|+|++..|..|+++++|++|+|++|++.+. +|..+ .
T Consensus 120 l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 198 (312)
T 1wwl_A 120 GPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198 (312)
T ss_dssp SCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred CCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence 34677777777777766 6666666 7777777777777766667777777777777777776654 22233 6
Q ss_pred ccccchhhhccCCcCCC--CCC-CccccccccccccCCCCcccccCCc-c---ccccCccccCCCCCC
Q 007073 146 NLKKLQFLTLSQNNFSG--TIP-DSLTTLSSLISIQLDSNNLSGQIPV-H---LFQIPKYNFTGNNLN 206 (619)
Q Consensus 146 ~l~~L~~L~l~~N~l~~--~~p-~~~~~l~~L~~L~l~~N~l~~~~p~-~---l~~l~~l~~~~n~~~ 206 (619)
++++|+.|+|++|+|++ .++ ..+..+++|+.|++++|++++.+|. . +.++..|++++|...
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~ 266 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC
Confidence 66777777777777762 111 2233556677777777777655532 1 245666666666654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=1.3e-14 Score=147.68 Aligned_cols=131 Identities=20% Similarity=0.233 Sum_probs=107.5
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCC--Cc--ccccccccCcEeeecCCCccccCCC----cccc
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGE--IP--EELGNLSSLTSLDLDNNRLVGKIPP----SLGN 146 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~p--~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~ 146 (619)
..+|+.|+|++|++.+..+..|..+++|++|+|++|++.+. ++ ..+.++++|++|+|++|+|+ .+|. .+.+
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~ 222 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAA 222 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhc
Confidence 45899999999999988888999999999999999998742 22 23468899999999999997 4444 3577
Q ss_pred cccchhhhccCCcCCCCCCCccccc---cccccccCCCCcccccCCccc-cccCccccCCCCCCC
Q 007073 147 LKKLQFLTLSQNNFSGTIPDSLTTL---SSLISIQLDSNNLSGQIPVHL-FQIPKYNFTGNNLNC 207 (619)
Q Consensus 147 l~~L~~L~l~~N~l~~~~p~~~~~l---~~L~~L~l~~N~l~~~~p~~l-~~l~~l~~~~n~~~c 207 (619)
+++|++|+|++|+|++..|..+..+ ++|+.|+|++|+|+ .+|..+ .++..|++++|....
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~l~~ 286 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNRLNR 286 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCCCCS
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhcCCCCEEECCCCcCCC
Confidence 8999999999999997778877776 69999999999999 778655 478888899988763
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=3.1e-14 Score=157.36 Aligned_cols=131 Identities=18% Similarity=0.171 Sum_probs=95.0
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
.+++.|+|++|++++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 36777888888887777777777888888888888777666677777788888888888777666677777777888888
Q ss_pred cCCcCCCCCCCccccccccccccCCCCcccc-cCCcccc---ccCccccCCCCCC
Q 007073 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSG-QIPVHLF---QIPKYNFTGNNLN 206 (619)
Q Consensus 156 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~l~---~l~~l~~~~n~~~ 206 (619)
++|++++..+..+..+++|++|++++|++++ .+|..+. ++..|++++|...
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~ 162 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccc
Confidence 7777774444467777777777777777775 3566554 4455667776654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=3e-14 Score=146.23 Aligned_cols=139 Identities=22% Similarity=0.331 Sum_probs=118.8
Q ss_pred CCcceeEEcC----------CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCC
Q 007073 65 CTWSNVICDN----------SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNN 134 (619)
Q Consensus 65 c~w~gv~c~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 134 (619)
|.|..+.|++ ..+++.|+|++|++++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 31 c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n 110 (330)
T 1xku_A 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 110 (330)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred CCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCC
Confidence 5788898874 247999999999999888889999999999999999999888999999999999999999
Q ss_pred CccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCCCcccc--cCCcccc---ccCccccCCCCCC
Q 007073 135 RLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSG--QIPVHLF---QIPKYNFTGNNLN 206 (619)
Q Consensus 135 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~l~---~l~~l~~~~n~~~ 206 (619)
+|+ .+|..+. ++|+.|++++|++++..+..+..+++|+.|++++|+++. ..|..+. ++..|++++|...
T Consensus 111 ~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~ 184 (330)
T 1xku_A 111 QLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184 (330)
T ss_dssp CCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred cCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc
Confidence 999 6787765 799999999999996666778999999999999999963 5555554 5566778888764
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.49 E-value=3.3e-14 Score=147.00 Aligned_cols=132 Identities=19% Similarity=0.173 Sum_probs=103.9
Q ss_pred CCcceeEEcCCCCeEEEEeCCC-CccccCCccccCCCCCCEEEccC-CCCCCCCcccccccccCcEeeecCCCccccCCC
Q 007073 65 CTWSNVICDNSNNVASVTLSSM-NFSGTLSPRIGVLRTLSTLTLKG-NGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 142 (619)
Q Consensus 65 c~w~gv~c~~~~~l~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 142 (619)
|.|..+.|+ ++ +|+ .+|. |..+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|.
T Consensus 8 C~~~~v~~~-----------~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 74 (347)
T 2ifg_A 8 HGSSGLRCT-----------RDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (347)
T ss_dssp SSSSCEECC-----------SSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred ccCCEEEcC-----------CCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence 777766664 44 787 4677 99999999999996 999988788999999999999999999998899
Q ss_pred cccccccchhhhccCCcCCCCCCCccccccccccccCCCCcccccCC-ccccc---cCccccCCCCCCCCCC
Q 007073 143 SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP-VHLFQ---IPKYNFTGNNLNCGKT 210 (619)
Q Consensus 143 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~---l~~l~~~~n~~~c~~~ 210 (619)
.|.+|++|+.|+|++|+|++..|..+..++ |+.|+|++|+|...-. .+|.. .....+..+...|..+
T Consensus 75 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~ 145 (347)
T 2ifg_A 75 AFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQ 145 (347)
T ss_dssp GGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSS
T ss_pred HhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCC
Confidence 999999999999999999955555555555 9999999999984322 12222 2233444566667654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.6e-14 Score=159.54 Aligned_cols=127 Identities=21% Similarity=0.199 Sum_probs=99.2
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
.+++.|+|++|++++..|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|+ .+|.. .+++|++|+|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 47888888888888777778888888888888888888777788888888888888888888 67766 7888888888
Q ss_pred cCCcCCC-CCCCccccccccccccCCCCcccccCCcccccc--CccccCCCCC
Q 007073 156 SQNNFSG-TIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQI--PKYNFTGNNL 205 (619)
Q Consensus 156 ~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l--~~l~~~~n~~ 205 (619)
++|++++ .+|..|.++++|+.|++++|++++.....+.++ ..|++++|..
T Consensus 129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~L~~n~l 181 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSY 181 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTSCEEEEEEEESSC
T ss_pred CCCCccccCchHhhcccCcccEEecCCCccccCchhhhhhceeeEEEeecccc
Confidence 8888875 245778888888888888888875433445555 6677777765
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.48 E-value=4.6e-14 Score=130.61 Aligned_cols=105 Identities=17% Similarity=0.270 Sum_probs=91.3
Q ss_pred CEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCCC
Q 007073 103 STLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSN 182 (619)
Q Consensus 103 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 182 (619)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 68999999998 8888775 89999999999999888999999999999999999999655566789999999999999
Q ss_pred cccccCCccc---cccCccccCCCCCCCCCC
Q 007073 183 NLSGQIPVHL---FQIPKYNFTGNNLNCGKT 210 (619)
Q Consensus 183 ~l~~~~p~~l---~~l~~l~~~~n~~~c~~~ 210 (619)
+|++..|..+ .++..|++.+|++.|.|.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 9995433334 466778999999999874
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=2.4e-14 Score=148.49 Aligned_cols=130 Identities=22% Similarity=0.240 Sum_probs=113.5
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCC--cccccccchh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP--SLGNLKKLQF 152 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~ 152 (619)
..+|+.|+|++|++++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+++ .+|. .|.++++|+.
T Consensus 75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~ 153 (353)
T 2z80_A 75 CVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQI 153 (353)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCE
T ss_pred CCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcE
Confidence 468999999999999988889999999999999999999655566999999999999999999 5665 7999999999
Q ss_pred hhccCC-cCCCCCCCccccccccccccCCCCcccccCCccccc---cCccccCCCCC
Q 007073 153 LTLSQN-NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ---IPKYNFTGNNL 205 (619)
Q Consensus 153 L~l~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~---l~~l~~~~n~~ 205 (619)
|++++| .+++..|..+..+++|+.|++++|++++..|..+.+ +..|++++|..
T Consensus 154 L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l 210 (353)
T 2z80_A 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH 210 (353)
T ss_dssp EEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCS
T ss_pred EECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcc
Confidence 999999 477556788999999999999999999887877765 45577887764
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.47 E-value=2.6e-14 Score=131.49 Aligned_cols=112 Identities=23% Similarity=0.276 Sum_probs=101.0
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCC--Ccccccccchh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIP--PSLGNLKKLQF 152 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~ 152 (619)
..+|+.|+|++|.+++. ..+..+++|++|+|++|++++.+|..+.++++|++|+|++|+|++ +| ..+..+++|+.
T Consensus 48 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~l~~l~~L~~ 124 (168)
T 2ell_A 48 FVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD-ISTLEPLKKLECLKS 124 (168)
T ss_dssp GGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCS-SGGGGGGSSCSCCCE
T ss_pred CCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCc-chhHHHHhcCCCCCE
Confidence 35899999999999976 789999999999999999997789888889999999999999995 44 78999999999
Q ss_pred hhccCCcCCCCCCC----ccccccccccccCCCCcccccCCcc
Q 007073 153 LTLSQNNFSGTIPD----SLTTLSSLISIQLDSNNLSGQIPVH 191 (619)
Q Consensus 153 L~l~~N~l~~~~p~----~~~~l~~L~~L~l~~N~l~~~~p~~ 191 (619)
|++++|.+++ +|. .+..+++|+.|++++|.+. .+|..
T Consensus 125 L~l~~N~l~~-~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~ 165 (168)
T 2ell_A 125 LDLFNCEVTN-LNDYRESVFKLLPQLTYLDGYDREDQ-EAPDS 165 (168)
T ss_dssp EECCSSGGGT-STTHHHHHHTTCSSCCEETTEETTSC-BCCSS
T ss_pred EEeeCCcCcc-hHHHHHHHHHhCccCcEecCCCCChh-hcccc
Confidence 9999999994 554 7899999999999999998 67754
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.47 E-value=2.1e-14 Score=146.13 Aligned_cols=132 Identities=18% Similarity=0.175 Sum_probs=108.6
Q ss_pred CCCeEEEEeCCCCccccCC----ccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCcccc--C--CCcccc
Q 007073 75 SNNVASVTLSSMNFSGTLS----PRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGK--I--PPSLGN 146 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~--p~~~~~ 146 (619)
..+|++|+|++|.+++..+ ..+..+++|++|+|++|++++..|..|.++++|++|+|++|++.+. + +..+.+
T Consensus 116 ~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 195 (310)
T 4glp_A 116 GLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHK 195 (310)
T ss_dssp CBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTS
T ss_pred CCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhc
Confidence 4589999999999997655 4456799999999999999988888999999999999999998752 2 233578
Q ss_pred cccchhhhccCCcCCCCCCC----ccccccccccccCCCCcccccCCccc------cccCccccCCCCCCC
Q 007073 147 LKKLQFLTLSQNNFSGTIPD----SLTTLSSLISIQLDSNNLSGQIPVHL------FQIPKYNFTGNNLNC 207 (619)
Q Consensus 147 l~~L~~L~l~~N~l~~~~p~----~~~~l~~L~~L~l~~N~l~~~~p~~l------~~l~~l~~~~n~~~c 207 (619)
+++|++|+|++|+++ .+|. .+..+++|+.|+|++|++++.+|..+ .++..|++++|.+..
T Consensus 196 l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~ 265 (310)
T 4glp_A 196 FPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQ 265 (310)
T ss_dssp SCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCS
T ss_pred CCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCc
Confidence 999999999999997 4544 24678999999999999998777554 367778899998863
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.47 E-value=1.5e-14 Score=165.76 Aligned_cols=130 Identities=18% Similarity=0.288 Sum_probs=113.0
Q ss_pred CCCCeEEEEeCCCCccc-----------------cCCcccc--CCCCCCEEEccCCCCCCCCcccccccccCcEeeecCC
Q 007073 74 NSNNVASVTLSSMNFSG-----------------TLSPRIG--VLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNN 134 (619)
Q Consensus 74 ~~~~l~~L~L~~n~l~~-----------------~~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 134 (619)
+..+|+.|+|++|+|++ .+|..++ ++++|++|+|++|++.+.+|..|+++++|+.|+|++|
T Consensus 446 ~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N 525 (876)
T 4ecn_A 446 RLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN 525 (876)
T ss_dssp GCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTC
T ss_pred cCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCC
Confidence 35689999999999998 3888887 9999999999999999999999999999999999999
Q ss_pred C-ccc-cCCCcccccc-------cchhhhccCCcCCCCCCC--ccccccccccccCCCCcccccCCcccc---ccCcccc
Q 007073 135 R-LVG-KIPPSLGNLK-------KLQFLTLSQNNFSGTIPD--SLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNF 200 (619)
Q Consensus 135 ~-l~~-~~p~~~~~l~-------~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~~l~---~l~~l~~ 200 (619)
+ |+| .+|..+++++ +|+.|+|++|+++ .+|. .+..+++|+.|+|++|+++ .+| .+. ++..|++
T Consensus 526 ~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~L 602 (876)
T 4ecn_A 526 RGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKL 602 (876)
T ss_dssp TTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEEC
T ss_pred CCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEEC
Confidence 8 998 7888777766 9999999999999 8888 8899999999999999998 888 554 4566778
Q ss_pred CCCCCC
Q 007073 201 TGNNLN 206 (619)
Q Consensus 201 ~~n~~~ 206 (619)
++|.+.
T Consensus 603 s~N~l~ 608 (876)
T 4ecn_A 603 DYNQIE 608 (876)
T ss_dssp CSSCCS
T ss_pred cCCccc
Confidence 888765
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.47 E-value=1.9e-14 Score=157.52 Aligned_cols=136 Identities=25% Similarity=0.388 Sum_probs=112.6
Q ss_pred CCCCCCCCCCCC-----Cccee-EEcCCCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCc
Q 007073 54 LRDWNQNQVNPC-----TWSNV-ICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLT 127 (619)
Q Consensus 54 l~~w~~~~~~~c-----~w~gv-~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 127 (619)
+.+|.. +.+|| .|.|+ .|.. ++|+.|+|++|+|++ +|..+ +++|++|+|++|+|+ .+| ..+++|+
T Consensus 33 l~~W~~-~~~~~~~~~~~~~~l~~C~~-~~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~ 103 (571)
T 3cvr_A 33 WDKWEK-QALPGENRNEAVSLLKECLI-NQFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLE 103 (571)
T ss_dssp HHHHHT-TCCTTCCHHHHHHHHHHHHH-TTCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCC
T ss_pred HHHHhc-cCCccccccchhhhcccccc-CCccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCC
Confidence 446754 45778 79999 6864 489999999999997 66655 488999999999999 777 4579999
Q ss_pred EeeecCCCccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCCCcccccCCccccccCccccCCCCCCC
Q 007073 128 SLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNC 207 (619)
Q Consensus 128 ~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~l~~~~n~~~c 207 (619)
+|+|++|+|++ +|. +.+ +|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|..+.++..|++++|.+..
T Consensus 104 ~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~~l~~L~~L~Ls~N~L~~ 174 (571)
T 3cvr_A 104 YLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPELPTSLEVLSVRNNQLTF 174 (571)
T ss_dssp EEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSC
T ss_pred EEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCCcCCCcCEEECCCCCCCC
Confidence 99999999996 777 665 89999999999995 776 67899999999999994 88877788889999988654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.47 E-value=3e-14 Score=139.08 Aligned_cols=127 Identities=16% Similarity=0.194 Sum_probs=102.0
Q ss_pred CCCeEEEEeCCCC-ccccCCccccCCCCCCEEEccC-CCCCCCCcccccccccCcEeeecCCCccccCCCcccccccch-
Q 007073 75 SNNVASVTLSSMN-FSGTLSPRIGVLRTLSTLTLKG-NGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQ- 151 (619)
Q Consensus 75 ~~~l~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~- 151 (619)
..+|+.|+|++|+ ++++.+..|..+++|++|+|++ |+|++..+..|.++++|++|+|++|++++ +|. |..+++|+
T Consensus 54 l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~ 131 (239)
T 2xwt_C 54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDI 131 (239)
T ss_dssp CTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCS
T ss_pred CCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccccccccc
Confidence 4578899999986 8877777888899999999988 88886666778888999999999998884 776 78888887
Q ss_pred --hhhccCC-cCCCCCCCccccccccc-cccCCCCcccccCCccc---cccCccccCCCC
Q 007073 152 --FLTLSQN-NFSGTIPDSLTTLSSLI-SIQLDSNNLSGQIPVHL---FQIPKYNFTGNN 204 (619)
Q Consensus 152 --~L~l~~N-~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~l---~~l~~l~~~~n~ 204 (619)
.|++++| ++++..+..|..+++|+ .|++++|+++ .+|... .++..|++++|+
T Consensus 132 L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~ 190 (239)
T 2xwt_C 132 FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNK 190 (239)
T ss_dssp EEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCT
T ss_pred ccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCC
Confidence 8899998 88855556688888888 8999999888 677543 256677888884
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.47 E-value=1.5e-14 Score=158.26 Aligned_cols=127 Identities=23% Similarity=0.209 Sum_probs=111.6
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
.+|+.|+|++|++++..|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|+ .+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 58999999999999888889999999999999999999877889999999999999999999 67766 8999999999
Q ss_pred cCCcCCC-CCCCccccccccccccCCCCcccccCCcccccc--CccccCCCCC
Q 007073 156 SQNNFSG-TIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQI--PKYNFTGNNL 205 (619)
Q Consensus 156 ~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l--~~l~~~~n~~ 205 (619)
++|++++ .+|..+..+++|+.|++++|++++.....+.++ ..|++++|..
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~l~~n~l 150 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGET 150 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGGGGGGGTTSCEEEEEEEECTT
T ss_pred cCCccccccchhhhccCCcceEEEecCcccchhhccccccceeeEEEeecccc
Confidence 9999986 478899999999999999999987444556666 7788888876
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=7.5e-14 Score=153.60 Aligned_cols=130 Identities=22% Similarity=0.209 Sum_probs=109.3
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccc-cCCCcccccccchhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVG-KIPPSLGNLKKLQFL 153 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L 153 (619)
..+|++|+|++|++++..|..|..+++|++|+|++|++++..|..|+++++|++|+|++|++++ .+|..++++++|++|
T Consensus 49 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L 128 (549)
T 2z81_A 49 CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128 (549)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred CCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEE
Confidence 4589999999999998888899999999999999999998777789999999999999999986 357789999999999
Q ss_pred hccCCcCCCCCC-CccccccccccccCCCCcccccCCcccccc---CccccCCCC
Q 007073 154 TLSQNNFSGTIP-DSLTTLSSLISIQLDSNNLSGQIPVHLFQI---PKYNFTGNN 204 (619)
Q Consensus 154 ~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l---~~l~~~~n~ 204 (619)
++++|++.+.+| ..+..+++|+.|++++|++++.+|..+.++ ..|++.+|.
T Consensus 129 ~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~ 183 (549)
T 2z81_A 129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE 183 (549)
T ss_dssp EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSB
T ss_pred ECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCc
Confidence 999998555665 578999999999999999998888765543 334444444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.43 E-value=3.8e-14 Score=153.39 Aligned_cols=122 Identities=20% Similarity=0.117 Sum_probs=68.9
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
..+|+.|+|++|.+++.+| +..+++|++|+|++|.|++ +|. .++|++|+|++|.|++..+. .+++|+.|+
T Consensus 57 l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~~----~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~ 126 (487)
T 3oja_A 57 FTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-LLV----GPSIETLHAANNNISRVSCS---RGQGKKNIY 126 (487)
T ss_dssp CTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEE-EEE----CTTCCEEECCSSCCCCEEEC---CCSSCEEEE
T ss_pred CCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCC-CCC----CCCcCEEECcCCcCCCCCcc---ccCCCCEEE
Confidence 3467777777777766554 6677777777777776663 221 13444444444444433222 235566666
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCCccc----cccCccccCCCCCC
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL----FQIPKYNFTGNNLN 206 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l----~~l~~l~~~~n~~~ 206 (619)
|++|.|++..|..+..+++|+.|+|++|++++.+|..+ .++..|++++|.+.
T Consensus 127 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~ 182 (487)
T 3oja_A 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182 (487)
T ss_dssp CCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred CCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccc
Confidence 66666665555566666666666666666665555433 34455556665543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.43 E-value=1.8e-13 Score=137.73 Aligned_cols=125 Identities=25% Similarity=0.389 Sum_probs=97.5
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
..+|+.|+|++|++++..+ +..+++|++|+|++|++++ +|. +..+++|++|+|++|+|++ + +.+..+++|+.|+
T Consensus 67 l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~ 140 (291)
T 1h6t_A 67 LPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LSS-LKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLY 140 (291)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GGG-GTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEE
T ss_pred CCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Chh-hccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEE
Confidence 4588899999998886544 8888999999999998884 444 8888899999999998885 3 4688888899999
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCC-ccccccCccccCCCCCCC
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP-VHLFQIPKYNFTGNNLNC 207 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~l~~~~n~~~c 207 (619)
|++|++++. ..+..+++|+.|++++|++++..| ..+.++..|++++|.+..
T Consensus 141 l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~L~~N~i~~ 192 (291)
T 1h6t_A 141 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD 192 (291)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB
T ss_pred ccCCcCCcc--hhhccCCCCCEEEccCCccccchhhcCCCccCEEECCCCcCCC
Confidence 999988854 567888889999999998885444 233456667788887643
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.41 E-value=1.6e-13 Score=135.99 Aligned_cols=100 Identities=25% Similarity=0.341 Sum_probs=45.4
Q ss_pred CeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhcc
Q 007073 77 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 156 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 156 (619)
+|+.|++++|+++. ++ .+..+++|+.|+|++|+|++ +|. +.++++|++|+|++|+|++ +|.... ++|+.|+|+
T Consensus 42 ~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L~ 114 (263)
T 1xeu_A 42 GVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFLD 114 (263)
T ss_dssp TCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEECC
T ss_pred cCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCC-cCcccc--CcccEEEcc
Confidence 44455555554442 22 34445555555555555542 222 4445555555555555542 332211 445555555
Q ss_pred CCcCCCCCCCccccccccccccCCCCccc
Q 007073 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLS 185 (619)
Q Consensus 157 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 185 (619)
+|+|++ +| .+..+++|+.|++++|+++
T Consensus 115 ~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~ 141 (263)
T 1xeu_A 115 NNELRD-TD-SLIHLKNLEILSIRNNKLK 141 (263)
T ss_dssp SSCCSB-SG-GGTTCTTCCEEECTTSCCC
T ss_pred CCccCC-Ch-hhcCcccccEEECCCCcCC
Confidence 555442 22 3444445555555555544
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.41 E-value=1.5e-13 Score=139.61 Aligned_cols=128 Identities=27% Similarity=0.424 Sum_probs=103.4
Q ss_pred CCCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhh
Q 007073 74 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFL 153 (619)
Q Consensus 74 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 153 (619)
...+|+.|+|++|.+++. +.+..+++|+.|+|++|++++ +|. +..+++|++|+|++|++++. +. +.++++|+.|
T Consensus 83 ~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L 156 (308)
T 1h6u_A 83 NLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNI-SP-LAGLTNLQYL 156 (308)
T ss_dssp TCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GG-GGGCTTCCEE
T ss_pred cCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcC-cc-ccCCCCccEE
Confidence 356899999999999864 368899999999999999985 554 88999999999999999954 43 8899999999
Q ss_pred hccCCcCCCCCCCccccccccccccCCCCcccccCC-ccccccCccccCCCCCCCCC
Q 007073 154 TLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP-VHLFQIPKYNFTGNNLNCGK 209 (619)
Q Consensus 154 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~l~~~~n~~~c~~ 209 (619)
+|++|++++ ++. +..+++|+.|++++|++++..| ..+.++..|++++|......
T Consensus 157 ~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~N~l~~~~ 211 (308)
T 1h6u_A 157 SIGNAQVSD-LTP-LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVS 211 (308)
T ss_dssp ECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCBCG
T ss_pred EccCCcCCC-Chh-hcCCCCCCEEECCCCccCcChhhcCCCCCCEEEccCCccCccc
Confidence 999999985 444 8889999999999999985333 24456777888888876443
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.41 E-value=4.2e-13 Score=132.99 Aligned_cols=124 Identities=26% Similarity=0.333 Sum_probs=105.0
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
..+|+.|+|++|++++..+ +..+++|+.|+|++|++++ +|. +.. ++|+.|+|++|+|++ ++ .+.++++|+.|+
T Consensus 62 l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~ 134 (263)
T 1xeu_A 62 FTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILS 134 (263)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCC-Ch-hhcCcccccEEE
Confidence 4689999999999997655 9999999999999999995 555 333 999999999999995 44 699999999999
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCC--ccccccCccccCCCCCCCC
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP--VHLFQIPKYNFTGNNLNCG 208 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p--~~l~~l~~l~~~~n~~~c~ 208 (619)
|++|+|++ +| .+..+++|+.|++++|++++. + ..+.++..|++++|++.+.
T Consensus 135 Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 135 IRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp CTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred CCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCC
Confidence 99999994 55 689999999999999999965 3 2345667788999987654
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.40 E-value=7.9e-14 Score=125.45 Aligned_cols=105 Identities=17% Similarity=0.224 Sum_probs=93.8
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCcccc-CCCcccccccchhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGK-IPPSLGNLKKLQFL 153 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L 153 (619)
..+|+.|+|++|++++. ..+..+++|++|+|++|++++.+|..+.++++|++|+|++|++++. .+..+..+++|+.|
T Consensus 41 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L 118 (149)
T 2je0_A 41 FEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSL 118 (149)
T ss_dssp CTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEE
T ss_pred cCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEE
Confidence 46899999999999976 7899999999999999999987999888999999999999999963 34889999999999
Q ss_pred hccCCcCCCCCC---CccccccccccccCCC
Q 007073 154 TLSQNNFSGTIP---DSLTTLSSLISIQLDS 181 (619)
Q Consensus 154 ~l~~N~l~~~~p---~~~~~l~~L~~L~l~~ 181 (619)
++++|++++..+ ..+..+++|+.|++++
T Consensus 119 ~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 119 DLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred eCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 999999995544 3788999999999874
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.40 E-value=2.5e-13 Score=136.72 Aligned_cols=125 Identities=29% Similarity=0.393 Sum_probs=107.0
Q ss_pred CCCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhh
Q 007073 74 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFL 153 (619)
Q Consensus 74 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 153 (619)
...+|+.|+|++|.+++. + .+..+++|++|+|++|++++ ++ .+..+++|+.|+|++|++++. ..+..+++|+.|
T Consensus 88 ~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~L~~n~i~~-~~-~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L 161 (291)
T 1h6t_A 88 NLKNLGWLFLDENKVKDL-S-SLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTL 161 (291)
T ss_dssp TCTTCCEEECCSSCCCCG-G-GGTTCTTCCEEECTTSCCCC-CG-GGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred cCCCCCEEECCCCcCCCC-h-hhccCCCCCEEECCCCcCCC-Ch-hhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEE
Confidence 456899999999999863 3 49999999999999999995 44 589999999999999999954 689999999999
Q ss_pred hccCCcCCCCCCCccccccccccccCCCCcccccCCc--cccccCccccCCCCCCC
Q 007073 154 TLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV--HLFQIPKYNFTGNNLNC 207 (619)
Q Consensus 154 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~l~~l~~l~~~~n~~~c 207 (619)
+|++|++++..| +..+++|+.|++++|+++ .+|. .+.++..|++++|+..+
T Consensus 162 ~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~-~l~~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 162 SLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp ECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-BCGGGTTCTTCSEEEEEEEEEEC
T ss_pred EccCCccccchh--hcCCCccCEEECCCCcCC-CChhhccCCCCCEEECcCCcccC
Confidence 999999996544 899999999999999999 4663 34466778889887653
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.39 E-value=1.8e-13 Score=141.40 Aligned_cols=105 Identities=22% Similarity=0.313 Sum_probs=93.7
Q ss_pred CEEEccCC-CCCCCCcccccccccCcEeeecC-CCccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCC
Q 007073 103 STLTLKGN-GITGEIPEELGNLSSLTSLDLDN-NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLD 180 (619)
Q Consensus 103 ~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 180 (619)
..+++++| +|+ .+|. |..+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|..|..|++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35789998 999 6888 99999999999996 99998777899999999999999999998888899999999999999
Q ss_pred CCcccccCCc-ccc--ccCccccCCCCCCCCCC
Q 007073 181 SNNLSGQIPV-HLF--QIPKYNFTGNNLNCGKT 210 (619)
Q Consensus 181 ~N~l~~~~p~-~l~--~l~~l~~~~n~~~c~~~ 210 (619)
+|+|++ +|. .+. .|..|++.+|++.|+|.
T Consensus 89 ~N~l~~-~~~~~~~~~~L~~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 89 FNALES-LSWKTVQGLSLQELVLSGNPLHCSCA 120 (347)
T ss_dssp SSCCSC-CCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred CCccce-eCHHHcccCCceEEEeeCCCccCCCc
Confidence 999995 554 333 37889999999999987
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.39 E-value=5.5e-13 Score=135.39 Aligned_cols=125 Identities=22% Similarity=0.401 Sum_probs=104.1
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
..+|+.|+|++|++++..+ +..+++|++|+|++|++++ +| .+..+++|++|+|++|++++ ++. +..+++|+.|+
T Consensus 62 l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~ 135 (308)
T 1h6u_A 62 LNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLY 135 (308)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEE
T ss_pred cCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEE
Confidence 4689999999999996554 8999999999999999984 55 58999999999999999995 443 89999999999
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCCc--cccccCccccCCCCCCCC
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV--HLFQIPKYNFTGNNLNCG 208 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~l~~l~~l~~~~n~~~c~ 208 (619)
|++|++++..+ +..+++|+.|++++|++++ +|. .+.++..|++++|.....
T Consensus 136 l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~l~~n~l~~~ 188 (308)
T 1h6u_A 136 LDLNQITNISP--LAGLTNLQYLSIGNAQVSD-LTPLANLSKLTTLKADDNKISDI 188 (308)
T ss_dssp CCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGGGTTCTTCCEEECCSSCCCCC
T ss_pred CCCCccCcCcc--ccCCCCccEEEccCCcCCC-ChhhcCCCCCCEEECCCCccCcC
Confidence 99999995433 8899999999999999995 543 345667788888887543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.38 E-value=9.7e-14 Score=128.71 Aligned_cols=106 Identities=23% Similarity=0.284 Sum_probs=95.8
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCC--cccccccchhh
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP--SLGNLKKLQFL 153 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L 153 (619)
.+|+.|+|++|.|++. +.|..+++|++|+|++|+|++..|..+..+++|++|+|++|+|+ .+|. .+..+++|+.|
T Consensus 42 ~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L 118 (176)
T 1a9n_A 42 DQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL 118 (176)
T ss_dssp TCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred CCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEE
Confidence 4899999999999976 68999999999999999999555555699999999999999997 6776 89999999999
Q ss_pred hccCCcCCCCCCCc----cccccccccccCCCCccc
Q 007073 154 TLSQNNFSGTIPDS----LTTLSSLISIQLDSNNLS 185 (619)
Q Consensus 154 ~l~~N~l~~~~p~~----~~~l~~L~~L~l~~N~l~ 185 (619)
++++|.++ .+|.. +..+++|+.|++++|.+.
T Consensus 119 ~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 119 CILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp ECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred EecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 99999998 77875 889999999999999886
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.38 E-value=3.4e-13 Score=139.30 Aligned_cols=125 Identities=25% Similarity=0.346 Sum_probs=70.2
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
.+|+.|++++|.+.+..+ +..+++|++|+|++|++++ +|. +..+++|++|+|++|.+++ + +.+..+++|+.|++
T Consensus 199 ~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l 272 (347)
T 4fmz_A 199 TSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNV 272 (347)
T ss_dssp TTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEEC
T ss_pred CccceeecccCCCCCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEc
Confidence 456666666666664433 5566666666666666663 332 5566666666666666663 2 34556666666666
Q ss_pred cCCcCCCCCCCccccccccccccCCCCcccccCCccc---cccCccccCCCCCCCC
Q 007073 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLNCG 208 (619)
Q Consensus 156 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l---~~l~~l~~~~n~~~c~ 208 (619)
++|++++ + +.+..+++|+.|++++|++++..|..+ .++..|++++|++...
T Consensus 273 ~~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 326 (347)
T 4fmz_A 273 GSNQISD-I-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI 326 (347)
T ss_dssp CSSCCCC-C-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCC
T ss_pred cCCccCC-C-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccc
Confidence 6666653 2 235556666666666666665444433 2344455666655433
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.36 E-value=7e-13 Score=146.63 Aligned_cols=122 Identities=26% Similarity=0.409 Sum_probs=66.3
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
.+|+.|+|++|.|++..+ +..+++|+.|+|++|+|++ +| .+..+++|+.|+|++|+|++ + +.+..|++|+.|+|
T Consensus 65 ~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~L 138 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 138 (605)
T ss_dssp TTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEEC
T ss_pred CCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEEC
Confidence 456666666666664433 5566666666666666652 33 35556666666666666653 2 23555566666666
Q ss_pred cCCcCCCCCCCccccccccccccCCCCcccccCC-ccccccCccccCCCCC
Q 007073 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP-VHLFQIPKYNFTGNNL 205 (619)
Q Consensus 156 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~l~~~~n~~ 205 (619)
++|+|++. ..+..+++|+.|+|++|+|++..| ..+.+|..|++++|.+
T Consensus 139 s~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~i 187 (605)
T 1m9s_A 139 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHI 187 (605)
T ss_dssp CSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCC
T ss_pred CCCccCCc--hhhcccCCCCEEECcCCcCCCchhhccCCCCCEEECcCCCC
Confidence 66665532 345555556666666665554333 1223344455555544
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.36 E-value=2.7e-15 Score=142.11 Aligned_cols=86 Identities=23% Similarity=0.332 Sum_probs=42.0
Q ss_pred cccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhccCCcCCCCCCCcccccccc
Q 007073 95 RIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSL 174 (619)
Q Consensus 95 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 174 (619)
.+..+++|++|+|++|+|++ +| .+.++++|++|+|++|+|+ .+|..+..+++|+.|+|++|++++ +| .+..+++|
T Consensus 43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L 117 (198)
T 1ds9_A 43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNL 117 (198)
T ss_dssp HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHS
T ss_pred HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCC
Confidence 44445555555555555542 34 4445555555555555554 344444444555555555555542 33 34444555
Q ss_pred ccccCCCCccc
Q 007073 175 ISIQLDSNNLS 185 (619)
Q Consensus 175 ~~L~l~~N~l~ 185 (619)
+.|++++|+++
T Consensus 118 ~~L~l~~N~i~ 128 (198)
T 1ds9_A 118 RVLYMSNNKIT 128 (198)
T ss_dssp SEEEESEEECC
T ss_pred CEEECCCCcCC
Confidence 55555555554
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.34 E-value=3.4e-13 Score=137.57 Aligned_cols=125 Identities=18% Similarity=0.218 Sum_probs=106.8
Q ss_pred CCCeEEEEeCCCCccccCCcccc-CCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIG-VLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFL 153 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 153 (619)
..+|+.|+|++|.+++..+..+. .+++|++|+|++|+|++ +|. ...+++|++|+|++|+|+ .+|..+..+++|+.|
T Consensus 143 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L 219 (317)
T 3o53_A 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWI 219 (317)
T ss_dssp GSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE-EEC-CCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEE
T ss_pred cCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc-ccc-ccccccCCEEECCCCcCC-cchhhhcccCcccEE
Confidence 35899999999999988887774 79999999999999994 454 446999999999999999 566679999999999
Q ss_pred hccCCcCCCCCCCccccccccccccCCCCccc-ccCCccccccCc---cccCCC
Q 007073 154 TLSQNNFSGTIPDSLTTLSSLISIQLDSNNLS-GQIPVHLFQIPK---YNFTGN 203 (619)
Q Consensus 154 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~~p~~l~~l~~---l~~~~n 203 (619)
+|++|+|+ .+|..+..+++|+.|++++|+++ +.+|..+..++. +++.+|
T Consensus 220 ~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~ 272 (317)
T 3o53_A 220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272 (317)
T ss_dssp ECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHH
T ss_pred ECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCc
Confidence 99999999 78999999999999999999999 777776665544 445533
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.33 E-value=1.3e-12 Score=144.59 Aligned_cols=125 Identities=29% Similarity=0.393 Sum_probs=107.6
Q ss_pred CCCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhh
Q 007073 74 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFL 153 (619)
Q Consensus 74 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 153 (619)
...+|+.|+|++|.|++. | .+..+++|+.|+|++|+|++ +| .+..|++|+.|+|++|+|++. ..+..+++|+.|
T Consensus 85 ~l~~L~~L~Ls~N~l~~l-~-~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L 158 (605)
T 1m9s_A 85 NLKNLGWLFLDENKIKDL-S-SLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTL 158 (605)
T ss_dssp GCTTCCEEECCSSCCCCC-T-TSTTCTTCCEEECTTSCCCC-CG-GGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEE
T ss_pred cCCCCCEEECcCCCCCCC-h-hhccCCCCCEEEecCCCCCC-Cc-cccCCCccCEEECCCCccCCc--hhhcccCCCCEE
Confidence 356899999999999863 3 78999999999999999995 44 499999999999999999954 689999999999
Q ss_pred hccCCcCCCCCCCccccccccccccCCCCcccccCCc--cccccCccccCCCCCCC
Q 007073 154 TLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV--HLFQIPKYNFTGNNLNC 207 (619)
Q Consensus 154 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~l~~l~~l~~~~n~~~c 207 (619)
+|++|+|++..| +..+++|+.|+|++|+|++ +|. .+.+|..|++++|++..
T Consensus 159 ~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~-l~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 159 SLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp ECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEECCSEEEEC
T ss_pred ECcCCcCCCchh--hccCCCCCEEECcCCCCCC-ChHHccCCCCCEEEccCCcCcC
Confidence 999999997666 8999999999999999995 553 34567778899888754
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.33 E-value=1.5e-12 Score=134.71 Aligned_cols=141 Identities=16% Similarity=0.202 Sum_probs=111.2
Q ss_pred CCcceeEEcCC----------CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCc-ccccccccCcE-eeec
Q 007073 65 CTWSNVICDNS----------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIP-EELGNLSSLTS-LDLD 132 (619)
Q Consensus 65 c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~L~ 132 (619)
|.|..|.|++. .+++.|+|++|+|+.+.+..|.++++|++|+|++|++.+.+| ..|.++++|+. +.++
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 67888999642 378999999999997767789999999999999999876666 46788988775 6777
Q ss_pred CCCccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCC-CcccccCCc-ccc----ccCccccCCCCCC
Q 007073 133 NNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDS-NNLSGQIPV-HLF----QIPKYNFTGNNLN 206 (619)
Q Consensus 133 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~-~l~----~l~~l~~~~n~~~ 206 (619)
+|+|++..|..|.++++|+.|++++|+|++..+..+....++..|++.+ |+++ .+|. .+. .+..|++++|.+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~-~l~~~~f~~~~~~l~~L~L~~N~i~ 167 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-TIERNSFVGLSFESVILWLNKNGIQ 167 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCC-EECTTSSTTSBSSCEEEECCSSCCC
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccc-cccccchhhcchhhhhhcccccccc
Confidence 8999977788999999999999999999966566666777788888855 5666 5553 333 3445778887764
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.32 E-value=3.8e-13 Score=149.00 Aligned_cols=137 Identities=20% Similarity=0.294 Sum_probs=90.9
Q ss_pred CCCCCCCCCCCCCCcceeEEc------C-CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCccccccccc
Q 007073 53 QLRDWNQNQVNPCTWSNVICD------N-SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSS 125 (619)
Q Consensus 53 ~l~~w~~~~~~~c~w~gv~c~------~-~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 125 (619)
..++|.. +.+||.|.|..|. . ..+++.|++++|+|+ .+|..+. ++|+.|+|++|+|+ .+|. .+++
T Consensus 11 ~w~~W~~-~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~ 82 (622)
T 3g06_A 11 VWSAWRR-AAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPE 82 (622)
T ss_dssp HHHHHHH-TCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTT
T ss_pred HHHHHHh-cCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCC
Confidence 3445754 3467888654321 1 125778888888887 6666554 67888888888877 5665 4677
Q ss_pred CcEeeecCCCccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCCCcccccCCccccccCccccCCCCC
Q 007073 126 LTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNL 205 (619)
Q Consensus 126 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~l~~~~n~~ 205 (619)
|++|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|. .+++|+.|++++|+++ .+|..+.++..|++++|.+
T Consensus 83 L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~l~~---~l~~L~~L~L~~N~l~-~lp~~l~~L~~L~Ls~N~l 153 (622)
T 3g06_A 83 LRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLT-HLPA---LPSGLCKLWIFGNQLT-SLPVLPPGLQELSVSDNQL 153 (622)
T ss_dssp CCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCC-CCCC---CCTTCCEEECCSSCCS-CCCCCCTTCCEEECCSSCC
T ss_pred CCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCC-CCCC---CCCCcCEEECCCCCCC-cCCCCCCCCCEEECcCCcC
Confidence 888888888877 4665 5677777777777777 4554 4456677777777776 4666666666666666655
Q ss_pred C
Q 007073 206 N 206 (619)
Q Consensus 206 ~ 206 (619)
.
T Consensus 154 ~ 154 (622)
T 3g06_A 154 A 154 (622)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.31 E-value=1.7e-12 Score=139.70 Aligned_cols=122 Identities=30% Similarity=0.442 Sum_probs=72.4
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
.+|+.|+|++|.+++..+ +..+++|+.|+|++|++++..| +..+++|+.|+|++|++++..| +..+++|+.|+|
T Consensus 243 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L 316 (466)
T 1o6v_A 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTL 316 (466)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEEC
T ss_pred CCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEEC
Confidence 467777777777765443 6666677777777776664333 6666666666666666664332 566666666666
Q ss_pred cCCcCCCCCCCccccccccccccCCCCcccccCC--ccccccCccccCCCCCC
Q 007073 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP--VHLFQIPKYNFTGNNLN 206 (619)
Q Consensus 156 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p--~~l~~l~~l~~~~n~~~ 206 (619)
++|++++..| +..+++|+.|++++|++++. + ..+.++..|++++|+..
T Consensus 317 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~ 366 (466)
T 1o6v_A 317 YFNNISDISP--VSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHNQIS 366 (466)
T ss_dssp CSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCC
T ss_pred cCCcCCCchh--hccCccCCEeECCCCccCCc-hhhccCCCCCEEeCCCCccC
Confidence 6666665444 55566666666666666632 2 12234444555555543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.31 E-value=2.9e-12 Score=140.29 Aligned_cols=115 Identities=22% Similarity=0.346 Sum_probs=76.6
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
..+|+.|+|++|+|++ +|. +.. +|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+
T Consensus 99 l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~ 166 (571)
T 3cvr_A 99 PASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLS 166 (571)
T ss_dssp CTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEE
T ss_pred cCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEE
Confidence 4577888888888876 555 544 77777777777774 555 56777777777777774 555 456777777
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCCcccccc-------CccccCCCCCC
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQI-------PKYNFTGNNLN 206 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l-------~~l~~~~n~~~ 206 (619)
|++|+|++ +|. |. ++|+.|+|++|+|+ .+|....++ ..|++++|.+.
T Consensus 167 Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~~~~~L~~~~~~L~~L~Ls~N~l~ 220 (571)
T 3cvr_A 167 VRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT 220 (571)
T ss_dssp CCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCCCC--------CCEEEECCSSCCC
T ss_pred CCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhhHHHhhhcccccceEEecCCCcce
Confidence 77777774 665 44 67777777777777 566522245 55666766665
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.29 E-value=1.7e-14 Score=136.54 Aligned_cols=125 Identities=22% Similarity=0.296 Sum_probs=106.5
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
..+|+.|+|++|++++ +| .+..+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++ +| .+.++++|+.|+
T Consensus 47 l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~ 121 (198)
T 1ds9_A 47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLY 121 (198)
T ss_dssp TTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEE
T ss_pred CCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEE
Confidence 4689999999999997 66 8999999999999999999 788888889999999999999995 56 699999999999
Q ss_pred ccCCcCCCCCC--CccccccccccccCCCCcccccCCcc----------ccccCcccc-CCCCC
Q 007073 155 LSQNNFSGTIP--DSLTTLSSLISIQLDSNNLSGQIPVH----------LFQIPKYNF-TGNNL 205 (619)
Q Consensus 155 l~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~p~~----------l~~l~~l~~-~~n~~ 205 (619)
|++|+++ .+| ..+..+++|+.|++++|++++.+|.. +..++.|.. .+|+.
T Consensus 122 l~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld~~~i 184 (198)
T 1ds9_A 122 MSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLDGMPV 184 (198)
T ss_dssp ESEEECC-CHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEECCGGG
T ss_pred CCCCcCC-chhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEECCccc
Confidence 9999999 444 47889999999999999999776653 556666543 34443
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.26 E-value=7.1e-12 Score=134.34 Aligned_cols=124 Identities=23% Similarity=0.245 Sum_probs=102.3
Q ss_pred CCCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhh
Q 007073 74 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFL 153 (619)
Q Consensus 74 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 153 (619)
...+|+.|+|++|++++ +| +..+++|+.|++++|++++. + ++.+++|++|+|++|+|++ +| ++.+++|+.|
T Consensus 168 ~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~--l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L 238 (457)
T 3bz5_A 168 PQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL-D--LNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYF 238 (457)
T ss_dssp TCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEE
T ss_pred cCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee-c--cccCCCCCEEECcCCcccc-cC--ccccCCCCEE
Confidence 34689999999999997 44 88899999999999999964 3 8899999999999999996 66 8899999999
Q ss_pred hccCCcCCCCCCCcccccc-------ccccccCCCCcccccCCc-cccccCccccCCCCCC
Q 007073 154 TLSQNNFSGTIPDSLTTLS-------SLISIQLDSNNLSGQIPV-HLFQIPKYNFTGNNLN 206 (619)
Q Consensus 154 ~l~~N~l~~~~p~~~~~l~-------~L~~L~l~~N~l~~~~p~-~l~~l~~l~~~~n~~~ 206 (619)
++++|++++..+..+..++ +|+.|++++|++.|.+|. .+.++..|++++|+..
T Consensus 239 ~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~~~~l~~L~~L~Ls~n~~l 299 (457)
T 3bz5_A 239 DCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQL 299 (457)
T ss_dssp ECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCTTCCCCCCTTCTTC
T ss_pred EeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCcccccccccCCEEECCCCccc
Confidence 9999999977666666655 567888888888878873 4567888888888743
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.25 E-value=7.3e-12 Score=134.81 Aligned_cols=126 Identities=27% Similarity=0.403 Sum_probs=102.2
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
..+|+.|+|++|.+++. +.+..+++|+.|+|++|++++..| +..+++|+.|+|++|++++..+ +..+++|+.|+
T Consensus 220 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 293 (466)
T 1o6v_A 220 LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLE 293 (466)
T ss_dssp CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEE
T ss_pred cCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEE
Confidence 45899999999998864 468889999999999999986554 8889999999999999985443 88899999999
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCC-ccccccCccccCCCCCCCC
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP-VHLFQIPKYNFTGNNLNCG 208 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~l~~~~n~~~c~ 208 (619)
|++|++++..| +..+++|+.|++++|++++..| ..+.++..|++++|+....
T Consensus 294 L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 294 LNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp CCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC
T ss_pred cCCCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCccCCc
Confidence 99999986544 7888999999999999987665 3455677788888877654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.3e-11 Score=132.41 Aligned_cols=123 Identities=19% Similarity=0.211 Sum_probs=91.7
Q ss_pred cCCCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchh
Q 007073 73 DNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQF 152 (619)
Q Consensus 73 ~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 152 (619)
....+|+.|+|++|++++. .++.+++|++|++++|+..+.+ .+..+++|++|+|++|+|++ +| ++.+++|+.
T Consensus 124 ~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~ 195 (457)
T 3bz5_A 124 SQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNR 195 (457)
T ss_dssp TTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCE
T ss_pred CCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCE
Confidence 3456889999999998874 2778888888888888655566 37788888888888888885 55 777888888
Q ss_pred hhccCCcCCCCCCCccccccccccccCCCCcccccCC-ccccccCccccCCCCCCC
Q 007073 153 LTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP-VHLFQIPKYNFTGNNLNC 207 (619)
Q Consensus 153 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~l~~~~n~~~c 207 (619)
|++++|++++. .+..+++|+.|++++|++++ +| ..+.++..|++++|.+..
T Consensus 196 L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip~~~l~~L~~L~l~~N~l~~ 247 (457)
T 3bz5_A 196 LNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-IDVTPLTQLTYFDCSVNPLTE 247 (457)
T ss_dssp EECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CCCTTCTTCSEEECCSSCCSC
T ss_pred EECcCCcCCee---ccccCCCCCEEECcCCcccc-cCccccCCCCEEEeeCCcCCC
Confidence 88888888753 37777888888888888885 56 234456667777777654
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=6.5e-12 Score=137.99 Aligned_cols=104 Identities=29% Similarity=0.406 Sum_probs=92.6
Q ss_pred CCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCC
Q 007073 101 TLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLD 180 (619)
Q Consensus 101 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 180 (619)
.|+.|+|++|+|++ +|. |+++++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +| .+..+++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 58899999999994 787 999999999999999999 899999999999999999999995 77 89999999999999
Q ss_pred CCcccccC-Ccccc---ccCccccCCCCCCCCC
Q 007073 181 SNNLSGQI-PVHLF---QIPKYNFTGNNLNCGK 209 (619)
Q Consensus 181 ~N~l~~~~-p~~l~---~l~~l~~~~n~~~c~~ 209 (619)
+|+|++.+ |..+. +|..|++++|++....
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 549 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE 549 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCc
Confidence 99999766 87665 4556789999875443
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.24 E-value=9e-12 Score=128.51 Aligned_cols=122 Identities=28% Similarity=0.451 Sum_probs=78.3
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
.+|+.|++++|.+.+..+ +..+++|+.|++++|.+++..+ +..+++|++|+|++|++++ ++. +..+++|+.|++
T Consensus 177 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l 250 (347)
T 4fmz_A 177 TDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEI 250 (347)
T ss_dssp TTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEEC
T ss_pred CCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEEC
Confidence 467777777777764433 6667777777777777764333 6667777777777777773 333 667777777777
Q ss_pred cCCcCCCCCCCccccccccccccCCCCcccccCC--ccccccCccccCCCCCC
Q 007073 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP--VHLFQIPKYNFTGNNLN 206 (619)
Q Consensus 156 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p--~~l~~l~~l~~~~n~~~ 206 (619)
++|++++ + +.+..+++|+.|++++|++++ +| ..+.++..|++++|+..
T Consensus 251 ~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~~~~~~l~~L~~L~L~~n~l~ 300 (347)
T 4fmz_A 251 GTNQISD-I-NAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLFLNNNQLG 300 (347)
T ss_dssp CSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-CGGGGGCTTCSEEECCSSCCC
T ss_pred CCCccCC-C-hhHhcCCCcCEEEccCCccCC-ChhhcCCCCCCEEECcCCcCC
Confidence 7777763 3 346667777777777777763 34 23345556666666653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=3.7e-11 Score=118.75 Aligned_cols=145 Identities=12% Similarity=0.073 Sum_probs=112.6
Q ss_pred HHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc-CCCccceeeeeeCCCcceeE
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv 369 (619)
...+.|.....++.|+.+.||++... |..+++|+...... .....+.+|+++++.+. +..+.++++++...+..++|
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 34456887888898999999999864 78999999864211 12345889999999885 66778899998888889999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC---------------------------------- 415 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---------------------------------- 415 (619)
|||++|.++...+.. ......++.+++++++.||+..
T Consensus 89 ~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 89 MSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 999999998765321 1123467889999999999810
Q ss_pred ----------------------CCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 416 ----------------------NPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 416 ----------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
.+.++|+|++|.||+++++..+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876667799999875
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.24 E-value=1.6e-11 Score=131.54 Aligned_cols=118 Identities=24% Similarity=0.286 Sum_probs=79.0
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
.+|++|+|++|++++ +| .|+.+++|++|++++|++++ +|..+ .+|++|+|++|++++ +| .++++++|+.|++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l 202 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA 202 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence 467777777777775 55 47777888888888887774 55433 477777777777774 55 5777777777777
Q ss_pred cCCcCCCCCCCccccccccccccCCCCcccccCCc--cccccCccccCCCCCC
Q 007073 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV--HLFQIPKYNFTGNNLN 206 (619)
Q Consensus 156 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~l~~l~~l~~~~n~~~ 206 (619)
++|++++ +|... ++|+.|++++|+++ .+|. .+.++..|++++|...
T Consensus 203 ~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~~~~l~~L~~L~l~~N~l~ 250 (454)
T 1jl5_A 203 DNNSLKK-LPDLP---LSLESIVAGNNILE-ELPELQNLPFLTTIYADNNLLK 250 (454)
T ss_dssp CSSCCSS-CCCCC---TTCCEEECCSSCCS-SCCCCTTCTTCCEEECCSSCCS
T ss_pred CCCcCCc-CCCCc---CcccEEECcCCcCC-cccccCCCCCCCEEECCCCcCC
Confidence 7777773 44432 36666777777766 5663 2234555667777654
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.21 E-value=4.8e-13 Score=140.38 Aligned_cols=129 Identities=21% Similarity=0.310 Sum_probs=65.0
Q ss_pred CeEEEEeCCCCcc-ccCC---ccccCCCCCCEEEccCCCCC--C---CCcccccccccCcEeeecCCCcc----ccCCCc
Q 007073 77 NVASVTLSSMNFS-GTLS---PRIGVLRTLSTLTLKGNGIT--G---EIPEELGNLSSLTSLDLDNNRLV----GKIPPS 143 (619)
Q Consensus 77 ~l~~L~L~~n~l~-~~~~---~~~~~l~~L~~L~L~~N~l~--~---~~p~~~~~l~~L~~L~L~~N~l~----~~~p~~ 143 (619)
+|++|+|++|+++ +.++ ..+..+++|++|+|++|+|+ | ..|..+..+++|+.|+|++|.|+ +.+|..
T Consensus 160 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~ 239 (386)
T 2ca6_A 160 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 239 (386)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred CCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHH
Confidence 4555555555554 2222 23444555555555555554 1 22334555555555555555553 345555
Q ss_pred ccccccchhhhccCCcCCCC----CCCccc--cccccccccCCCCcccc----cCCccc----cccCccccCCCCC
Q 007073 144 LGNLKKLQFLTLSQNNFSGT----IPDSLT--TLSSLISIQLDSNNLSG----QIPVHL----FQIPKYNFTGNNL 205 (619)
Q Consensus 144 ~~~l~~L~~L~l~~N~l~~~----~p~~~~--~l~~L~~L~l~~N~l~~----~~p~~l----~~l~~l~~~~n~~ 205 (619)
+..+++|+.|+|++|+|++. +|..+. .+++|+.|+|++|++++ .+|..+ .++..|++.+|++
T Consensus 240 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l 315 (386)
T 2ca6_A 240 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315 (386)
T ss_dssp GGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBS
T ss_pred HccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcC
Confidence 55555555555555555533 333332 25555556666665554 244332 3444555555554
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.19 E-value=5.7e-11 Score=117.03 Aligned_cols=137 Identities=13% Similarity=0.040 Sum_probs=101.1
Q ss_pred CCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCc--cceeeeeeCCCcceeEecc
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL--LRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~~~~~lv~e~ 372 (619)
.+....+.+.|..+.||++...+|+.+++|..... ....+.+|+++++.+.+.++ .+++++...++..++||||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 34433333456679999998877889999987542 22457789999998876554 4588888877788999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC------------------------------------- 415 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------- 415 (619)
++|.++. ... .+ ...++.++++.|+.||+..
T Consensus 97 i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 97 VPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred cCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 9998884 211 11 2356778888888888742
Q ss_pred ------------------CCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 416 ------------------NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 416 ------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
.+.++|+|++|.||+++++..+.|+|||.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998876678999998763
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.19 E-value=4.2e-13 Score=137.87 Aligned_cols=128 Identities=21% Similarity=0.218 Sum_probs=91.6
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCC-CcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGE-IPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
.+++.|++++|.+.+..+. +..+++|++|+|++|.+++. +|..+..+++|++|+|++|++++..|..++++++|+.|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 4677788888877766554 55678888888888887754 677777788888888888887777777777788888888
Q ss_pred ccCC-cCCCC-CCCccccccccccccCCCC-ccccc-CCcc---cc-ccCccccCCCC
Q 007073 155 LSQN-NFSGT-IPDSLTTLSSLISIQLDSN-NLSGQ-IPVH---LF-QIPKYNFTGNN 204 (619)
Q Consensus 155 l~~N-~l~~~-~p~~~~~l~~L~~L~l~~N-~l~~~-~p~~---l~-~l~~l~~~~n~ 204 (619)
|++| .+++. +|..+..+++|+.|++++| .+++. +|.. +. ++..|++++|.
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~ 206 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR 206 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCG
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCc
Confidence 8887 56642 5556677778888888888 77743 3433 33 55666777764
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.19 E-value=1.4e-12 Score=135.51 Aligned_cols=129 Identities=27% Similarity=0.337 Sum_probs=72.4
Q ss_pred CeEEEEeCCCCccccCC----ccccCCC-CCCEEEccCCCCCCCCccccccc-----ccCcEeeecCCCccccCCCcccc
Q 007073 77 NVASVTLSSMNFSGTLS----PRIGVLR-TLSTLTLKGNGITGEIPEELGNL-----SSLTSLDLDNNRLVGKIPPSLGN 146 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~ 146 (619)
+|+.|+|++|.+++..+ ..+..++ +|++|+|++|+|++..+..+..+ ++|++|+|++|+|++..+..+..
T Consensus 23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~ 102 (362)
T 3goz_A 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK 102 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence 46666666666665544 4555566 66666666666665555555554 66666666666666544443333
Q ss_pred c-----ccchhhhccCCcCCCCCCCccc----c-ccccccccCCCCcccccCCccc--------cccCccccCCCCC
Q 007073 147 L-----KKLQFLTLSQNNFSGTIPDSLT----T-LSSLISIQLDSNNLSGQIPVHL--------FQIPKYNFTGNNL 205 (619)
Q Consensus 147 l-----~~L~~L~l~~N~l~~~~p~~~~----~-l~~L~~L~l~~N~l~~~~p~~l--------~~l~~l~~~~n~~ 205 (619)
. ++|+.|+|++|+|++..+..+. . .++|+.|+|++|++++..+..+ .++..|++++|..
T Consensus 103 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l 179 (362)
T 3goz_A 103 TLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNL 179 (362)
T ss_dssp HHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCG
T ss_pred HHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCC
Confidence 2 5666666666666643333322 2 2466666666666663322211 2455566666654
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.17 E-value=5.5e-11 Score=127.28 Aligned_cols=120 Identities=25% Similarity=0.314 Sum_probs=94.5
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
..+|+.|++++|++++ +|.. .++|++|+|++|++++ +| .++++++|++|++++|++++ +|... ++|+.|+
T Consensus 152 l~~L~~L~l~~N~l~~-lp~~---~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~ 221 (454)
T 1jl5_A 152 SSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIV 221 (454)
T ss_dssp CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEE
T ss_pred CCCCCEEECCCCcCcc-cCCC---cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEE
Confidence 4578999999999885 5543 3588899999999885 66 58888999999999998884 56543 5788888
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCCccccccCccccCCCCCCC
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNC 207 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~l~~~~n~~~c 207 (619)
+++|+++ .+|. +..+++|+.|++++|+++ .+|..+.++..|++++|....
T Consensus 222 l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~-~l~~~~~~L~~L~l~~N~l~~ 271 (454)
T 1jl5_A 222 AGNNILE-ELPE-LQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTD 271 (454)
T ss_dssp CCSSCCS-SCCC-CTTCTTCCEEECCSSCCS-SCCSCCTTCCEEECCSSCCSC
T ss_pred CcCCcCC-cccc-cCCCCCCCEEECCCCcCC-cccccccccCEEECCCCcccc
Confidence 8888888 6774 788888888888888888 477777788888888887653
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.15 E-value=6.1e-11 Score=131.33 Aligned_cols=111 Identities=22% Similarity=0.318 Sum_probs=55.6
Q ss_pred CeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhcc
Q 007073 77 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 156 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 156 (619)
+|+.|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|. .+++|+.|+|+
T Consensus 62 ~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~l~~---~l~~L~~L~L~ 129 (622)
T 3g06_A 62 HITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLT-HLPA---LPSGLCKLWIF 129 (622)
T ss_dssp TCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCC-CCCC---CCTTCCEEECC
T ss_pred CCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCC-CCCC---CCCCcCEEECC
Confidence 5666666666665 3333 3556666666666665 3443 4455666666666555 2343 33445555555
Q ss_pred CCcCCCCCCCccccccccccccCCCCcccccCCccccccCccccCCCC
Q 007073 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNN 204 (619)
Q Consensus 157 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~l~~~~n~ 204 (619)
+|+|+ .+|.. +++|+.|++++|+++ .+|..+.++..|++++|.
T Consensus 130 ~N~l~-~lp~~---l~~L~~L~Ls~N~l~-~l~~~~~~L~~L~L~~N~ 172 (622)
T 3g06_A 130 GNQLT-SLPVL---PPGLQELSVSDNQLA-SLPALPSELCKLWAYNNQ 172 (622)
T ss_dssp SSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCCCTTCCEEECCSSC
T ss_pred CCCCC-cCCCC---CCCCCEEECcCCcCC-CcCCccCCCCEEECCCCC
Confidence 55555 34432 244455555555554 234333444444444433
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.15 E-value=1.4e-12 Score=133.83 Aligned_cols=131 Identities=18% Similarity=0.260 Sum_probs=100.9
Q ss_pred CCCeEEEEeCCCCcccc-CCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCC-Ccccc-CCCcccccccch
Q 007073 75 SNNVASVTLSSMNFSGT-LSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNN-RLVGK-IPPSLGNLKKLQ 151 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~ 151 (619)
..+|++|+|++|.+++. ++..+..+++|++|+|++|++++..|..++++++|++|+|++| .+++. ++..+.++++|+
T Consensus 92 ~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~ 171 (336)
T 2ast_B 92 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 171 (336)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCC
Confidence 35788889998888765 7777888888889999888888778888888888888888888 67752 666678888888
Q ss_pred hhhccCC-cCCCC-CCCcccccc-ccccccCCCC--ccc-ccCCcc---ccccCccccCCCCC
Q 007073 152 FLTLSQN-NFSGT-IPDSLTTLS-SLISIQLDSN--NLS-GQIPVH---LFQIPKYNFTGNNL 205 (619)
Q Consensus 152 ~L~l~~N-~l~~~-~p~~~~~l~-~L~~L~l~~N--~l~-~~~p~~---l~~l~~l~~~~n~~ 205 (619)
.|+|++| .+++. ++..+..++ +|+.|++++| .++ +.+|.. +.++..|++++|..
T Consensus 172 ~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~ 234 (336)
T 2ast_B 172 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVM 234 (336)
T ss_dssp EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTT
T ss_pred EEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCc
Confidence 8888888 88743 566677788 8888888888 454 345543 34666777887773
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.15 E-value=1.3e-12 Score=137.03 Aligned_cols=130 Identities=21% Similarity=0.318 Sum_probs=75.6
Q ss_pred CCeEEEEeCCCCccc----cCCccccCCCCCCEEEccCCCCCCCCccccc----cc---------ccCcEeeecCCCcc-
Q 007073 76 NNVASVTLSSMNFSG----TLSPRIGVLRTLSTLTLKGNGITGEIPEELG----NL---------SSLTSLDLDNNRLV- 137 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~----~l---------~~L~~L~L~~N~l~- 137 (619)
.+|++|+|++|.+++ .+|..+..+++|++|+|++|.|++..+..+. .+ ++|++|+|++|+|+
T Consensus 94 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~ 173 (386)
T 2ca6_A 94 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 173 (386)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred CcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCc
Confidence 466777777777665 3555666667777777777766533332222 23 66666666666665
Q ss_pred ccCC---CcccccccchhhhccCCcCC--C---CCCCccccccccccccCCCCccc----ccCCccc---cccCccccCC
Q 007073 138 GKIP---PSLGNLKKLQFLTLSQNNFS--G---TIPDSLTTLSSLISIQLDSNNLS----GQIPVHL---FQIPKYNFTG 202 (619)
Q Consensus 138 ~~~p---~~~~~l~~L~~L~l~~N~l~--~---~~p~~~~~l~~L~~L~l~~N~l~----~~~p~~l---~~l~~l~~~~ 202 (619)
+.+| ..+..+++|+.|+|++|+|+ | .+|..+..+++|+.|+|++|+++ +.+|..+ .++..|++++
T Consensus 174 ~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~ 253 (386)
T 2ca6_A 174 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 253 (386)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred HHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCC
Confidence 3333 34556666666666666665 2 23445566666666666666664 3455433 2444555666
Q ss_pred CCC
Q 007073 203 NNL 205 (619)
Q Consensus 203 n~~ 205 (619)
|.+
T Consensus 254 n~i 256 (386)
T 2ca6_A 254 CLL 256 (386)
T ss_dssp CCC
T ss_pred CCC
Confidence 654
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.13 E-value=4.5e-12 Score=131.76 Aligned_cols=127 Identities=24% Similarity=0.261 Sum_probs=107.3
Q ss_pred EEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCc----ccccccc-cCcEeeecCCCccccCCCccccc-----cc
Q 007073 80 SVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIP----EELGNLS-SLTSLDLDNNRLVGKIPPSLGNL-----KK 149 (619)
Q Consensus 80 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~ 149 (619)
.++|+.|+++|.+|..+...++|++|+|++|+|++..+ ..+.+++ +|++|+|++|+|++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46899999999999888878889999999999997766 7788898 99999999999998778788776 99
Q ss_pred chhhhccCCcCCCCCCCcccc----c-cccccccCCCCcccccCCccc--------cccCccccCCCCCC
Q 007073 150 LQFLTLSQNNFSGTIPDSLTT----L-SSLISIQLDSNNLSGQIPVHL--------FQIPKYNFTGNNLN 206 (619)
Q Consensus 150 L~~L~l~~N~l~~~~p~~~~~----l-~~L~~L~l~~N~l~~~~p~~l--------~~l~~l~~~~n~~~ 206 (619)
|++|+|++|++++..+..+.. + ++|+.|+|++|++++..+..+ .++..|++++|.+.
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~ 151 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG 151 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGG
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCC
Confidence 999999999999766665444 3 899999999999986554332 37888999999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.07 E-value=6.7e-10 Score=115.11 Aligned_cols=143 Identities=14% Similarity=0.193 Sum_probs=105.8
Q ss_pred ccCccccCCCceEEEEEeCCCcEEEEEEec--cCCCcchHHHHHHHHHHHHHcc--CCCccceeeeeeCC---CcceeEe
Q 007073 298 EKNVLGQGGFGKVYRGVLADGTKVAVKRLT--DFESPGGDAAFQREVEMISVAV--HRNLLRLIGFCTTP---TERLLVY 370 (619)
Q Consensus 298 ~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~--~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~---~~~~lv~ 370 (619)
..+.|+.|.++.||+.... +..+++|+.. ..........+.+|+++++.+. +..+.++++++... +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3567899999999999875 4678888765 3221223456788999999987 45577888888766 3478999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC----------------------------------- 415 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----------------------------------- 415 (619)
||++|..+.+... ..++...+..++.+++++|+.||+..
T Consensus 121 e~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999977754211 12567788889999999999999731
Q ss_pred --------------------CCCeEecCCCCCcEEeCCCCc--EEEccccccee
Q 007073 416 --------------------NPKIIHRDVKAANVLLDEDFE--AVVGDFGLAKL 447 (619)
Q Consensus 416 --------------------~~~ivH~Dlkp~NIll~~~~~--~kl~DfGla~~ 447 (619)
.+.++|||+++.||+++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997653 68999999875
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.00 E-value=3.7e-10 Score=116.60 Aligned_cols=170 Identities=17% Similarity=0.120 Sum_probs=89.0
Q ss_pred CccccccchhcccchhHHHHHHHHHhcCCCCCCCCCCCCCCCCCCCcceeEEcCCCC-eEEEEeCCCCccccCCccccCC
Q 007073 21 DPDLHNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNN-VASVTLSSMNFSGTLSPRIGVL 99 (619)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~al~~~k~~l~~~~~~l~~w~~~~~~~c~w~gv~c~~~~~-l~~L~L~~n~l~~~~~~~~~~l 99 (619)
..++++|.++.+....+..|-.++. |+..+|.+...-+ +-.+. +..+ ++.+.++.|+|+.+.|..|..+
T Consensus 34 ~L~Ls~N~i~~i~~~~f~~l~~L~~-L~Ls~N~i~~~i~----~~~f~-----~L~~l~~~l~~~~N~l~~l~~~~f~~l 103 (350)
T 4ay9_X 34 ELRFVLTKLRVIQKGAFSGFGDLEK-IEISQNDVLEVIE----ADVFS-----NLPKLHEIRIEKANNLLYINPEAFQNL 103 (350)
T ss_dssp EEEEESCCCSEECTTSSTTCTTCCE-EEEECCTTCCEEC----TTSBC-----SCTTCCEEEEEEETTCCEECTTSBCCC
T ss_pred EEEccCCcCCCcCHHHHcCCCCCCE-EECcCCCCCCccC----hhHhh-----cchhhhhhhcccCCcccccCchhhhhc
Confidence 3456677777776655554444443 3334443322110 01111 1122 3345556667776666666777
Q ss_pred CCCCEEEccCCCCCCCCcccccccc--------------------------cCcEeeecCCCccccCCCcccccccchhh
Q 007073 100 RTLSTLTLKGNGITGEIPEELGNLS--------------------------SLTSLDLDNNRLVGKIPPSLGNLKKLQFL 153 (619)
Q Consensus 100 ~~L~~L~L~~N~l~~~~p~~~~~l~--------------------------~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 153 (619)
++|++|++++|+|++..+..+.... .|+.|+|++|+|+ .+|.......+|+.|
T Consensus 104 ~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l 182 (350)
T 4ay9_X 104 PNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDEL 182 (350)
T ss_dssp TTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEE
T ss_pred cccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhHH
Confidence 7777777777776644333333333 3555666666666 344444445556666
Q ss_pred hccC-CcCCCCCC-CccccccccccccCCCCcccccCC-ccccccCccccCCC
Q 007073 154 TLSQ-NNFSGTIP-DSLTTLSSLISIQLDSNNLSGQIP-VHLFQIPKYNFTGN 203 (619)
Q Consensus 154 ~l~~-N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~l~~~~n 203 (619)
++++ |.++ .+| +.|..+++|+.|+|++|+|+ .+| ..+.++++|...++
T Consensus 183 ~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l~-~lp~~~~~~L~~L~~l~~ 233 (350)
T 4ay9_X 183 NLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARST 233 (350)
T ss_dssp ECTTCTTCC-CCCTTTTTTEECCSEEECTTSCCC-CCCSSSCTTCCEEECTTC
T ss_pred hhccCCccc-CCCHHHhccCcccchhhcCCCCcC-ccChhhhccchHhhhccC
Confidence 6653 4444 443 34566666666666666666 444 33555555555444
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.96 E-value=1.5e-11 Score=132.04 Aligned_cols=132 Identities=19% Similarity=0.216 Sum_probs=98.7
Q ss_pred CCCeEEEEeCCCCcccc----CCccccCCCCCCEEEccCCCCCCCCccccccc-----ccCcEeeecCCCcccc----CC
Q 007073 75 SNNVASVTLSSMNFSGT----LSPRIGVLRTLSTLTLKGNGITGEIPEELGNL-----SSLTSLDLDNNRLVGK----IP 141 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~----~p 141 (619)
..+|+.|+|++|+++.. ++..+..+++|++|+|++|.+++..+..+... ++|++|+|++|.+++. ++
T Consensus 255 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 334 (461)
T 1z7x_W 255 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS 334 (461)
T ss_dssp TCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHH
Confidence 45899999999998864 56777788999999999998875544444432 6889999999988854 45
Q ss_pred CcccccccchhhhccCCcCCCCCCCcccc-----ccccccccCCCCcccc----cCCccc---cccCccccCCCCCC
Q 007073 142 PSLGNLKKLQFLTLSQNNFSGTIPDSLTT-----LSSLISIQLDSNNLSG----QIPVHL---FQIPKYNFTGNNLN 206 (619)
Q Consensus 142 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~L~l~~N~l~~----~~p~~l---~~l~~l~~~~n~~~ 206 (619)
..+..+++|+.|+|++|++++..+..+.. .++|+.|++++|++++ .+|..+ .++..|++++|++.
T Consensus 335 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 335 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp HHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred HHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 66777788999999998887544443332 5688888999988885 667554 46667788888764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.93 E-value=1.2e-09 Score=110.43 Aligned_cols=186 Identities=16% Similarity=0.183 Sum_probs=120.2
Q ss_pred cCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc-CCC--ccceeeeeeCCC---cceeEecc
Q 007073 299 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRN--LLRLIGFCTTPT---ERLLVYPF 372 (619)
Q Consensus 299 ~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~~~~~~~~---~~~lv~e~ 372 (619)
.+.++.|.+..||+.. ..+++|+-.. ......+.+|.++++.+. +.. +.+++....... ..++||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~---~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH---SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS---HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC---cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4568999999999864 5688897642 234567889999998884 333 334444443332 34788999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH-------------------------------------- 414 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------------------------------------- 414 (619)
++|.++...... .++..++..++.++++.++.||+.
T Consensus 98 i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 98 IKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 999888653321 155666777888888888888861
Q ss_pred -----------------CCCCeEecCCCCCcEEeCC--CCcEEEcccccceeeccCCcceee-e------------cccc
Q 007073 415 -----------------CNPKIIHRDVKAANVLLDE--DFEAVVGDFGLAKLVDVRKTNVTT-Q------------VRGT 462 (619)
Q Consensus 415 -----------------~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~~~~~~~~~~~-~------------~~gt 462 (619)
..+.++|+|++|.||++++ +..+.|+||+.+..-.....-... . ....
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 1245899999999999998 566889999998754321000000 0 0000
Q ss_pred ccccc-cccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 007073 463 MGHIA-PEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 499 (619)
Q Consensus 463 ~~y~a-PE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~ 499 (619)
.++.. |+.... .....+.|++|.++|++.+|..+|
T Consensus 252 Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11111 222111 122368999999999999998764
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.93 E-value=1.6e-11 Score=131.86 Aligned_cols=132 Identities=19% Similarity=0.169 Sum_probs=105.5
Q ss_pred CCCeEEEEeCCCCccccC-----CccccCCCCCCEEEccCCCCCCC----CcccccccccCcEeeecCCCccccCCCccc
Q 007073 75 SNNVASVTLSSMNFSGTL-----SPRIGVLRTLSTLTLKGNGITGE----IPEELGNLSSLTSLDLDNNRLVGKIPPSLG 145 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 145 (619)
..+|+.|+|++|.+++.. +..+..+++|++|+|++|++++. ++..+.++++|++|+|++|.+++..+..+.
T Consensus 226 ~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~ 305 (461)
T 1z7x_W 226 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLC 305 (461)
T ss_dssp CTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHH
T ss_pred CCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHH
Confidence 468999999999988642 22334689999999999999953 677888899999999999999865444444
Q ss_pred cc-----ccchhhhccCCcCCCC----CCCccccccccccccCCCCcccccCCccc--------cccCccccCCCCCC
Q 007073 146 NL-----KKLQFLTLSQNNFSGT----IPDSLTTLSSLISIQLDSNNLSGQIPVHL--------FQIPKYNFTGNNLN 206 (619)
Q Consensus 146 ~l-----~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~l--------~~l~~l~~~~n~~~ 206 (619)
.. ++|+.|+|++|.+++. +|..+..+++|+.|++++|++++..+..+ .++..|++++|...
T Consensus 306 ~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~ 383 (461)
T 1z7x_W 306 ETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383 (461)
T ss_dssp HHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred HHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCC
Confidence 33 6999999999999865 46667788999999999999986545433 37888999999764
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.78 E-value=1.2e-10 Score=121.06 Aligned_cols=130 Identities=18% Similarity=0.206 Sum_probs=94.2
Q ss_pred CCeEEEEeCCCCccccCCccc-cCCCCCCEEEccCCCCCCCCcccc-----cccccCcEeeecCCCccc----cCCCccc
Q 007073 76 NNVASVTLSSMNFSGTLSPRI-GVLRTLSTLTLKGNGITGEIPEEL-----GNLSSLTSLDLDNNRLVG----KIPPSLG 145 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~----~~p~~~~ 145 (619)
.+|+.|+|++|.++......+ ..+++|+.|+|++|+|+......+ ...++|++|+|++|.|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 479999999998875433333 346788999999999875443444 246789999999999873 2445557
Q ss_pred ccccchhhhccCCcCCCC----CCCccccccccccccCCCCccccc----CCccc---cccCccccCCCCC
Q 007073 146 NLKKLQFLTLSQNNFSGT----IPDSLTTLSSLISIQLDSNNLSGQ----IPVHL---FQIPKYNFTGNNL 205 (619)
Q Consensus 146 ~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~l---~~l~~l~~~~n~~ 205 (619)
.+++|++|+|++|.|+.. ++..+...++|+.|+|++|.|+.. ++..+ .++..|++++|++
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i 251 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNEL 251 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSC
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCC
Confidence 788999999999998732 345566778899999999999743 22222 4677888888875
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.75 E-value=2.1e-10 Score=112.52 Aligned_cols=99 Identities=24% Similarity=0.265 Sum_probs=72.6
Q ss_pred CCCCCE--EEccCCCCCCCCcc----cccccccCcEeeecCCCccc--cCCCcccccccchhhhccCCcCCCCCCCcccc
Q 007073 99 LRTLST--LTLKGNGITGEIPE----ELGNLSSLTSLDLDNNRLVG--KIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTT 170 (619)
Q Consensus 99 l~~L~~--L~L~~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 170 (619)
.+.|.. ++++.|+.. .++. ...++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..
T Consensus 140 dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~ 216 (267)
T 3rw6_A 140 DPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDK 216 (267)
T ss_dssp CHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGG
T ss_pred CcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhh
Confidence 344444 666777544 3332 22568899999999999997 5567788999999999999999954 34555
Q ss_pred cc--ccccccCCCCcccccCCc-------cccccCcccc
Q 007073 171 LS--SLISIQLDSNNLSGQIPV-------HLFQIPKYNF 200 (619)
Q Consensus 171 l~--~L~~L~l~~N~l~~~~p~-------~l~~l~~l~~ 200 (619)
+. +|+.|+|++|.+++.+|. .+..+++|..
T Consensus 217 l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~ 255 (267)
T 3rw6_A 217 IKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLR 255 (267)
T ss_dssp GTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCE
T ss_pred cccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCe
Confidence 55 899999999999988873 2456666653
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.64 E-value=2.8e-09 Score=104.48 Aligned_cols=80 Identities=24% Similarity=0.344 Sum_probs=66.5
Q ss_pred cCCCCCCEEEccCCCCCC--CCcccccccccCcEeeecCCCccccCCCcccccc--cchhhhccCCcCCCCCCC------
Q 007073 97 GVLRTLSTLTLKGNGITG--EIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLK--KLQFLTLSQNNFSGTIPD------ 166 (619)
Q Consensus 97 ~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~l~~N~l~~~~p~------ 166 (619)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..++ +|++|+|++|.+++.+|+
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 468999999999999997 4557778999999999999999954 4456666 999999999999987774
Q ss_pred -cccccccccccc
Q 007073 167 -SLTTLSSLISIQ 178 (619)
Q Consensus 167 -~~~~l~~L~~L~ 178 (619)
.+..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 366788888776
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.63 E-value=1.4e-09 Score=112.94 Aligned_cols=117 Identities=22% Similarity=0.197 Sum_probs=91.3
Q ss_pred CCeEEEEeCCCCccccCCccc-----cCCCCCCEEEccCCCCCC----CCcccccccccCcEeeecCCCcccc----CCC
Q 007073 76 NNVASVTLSSMNFSGTLSPRI-----GVLRTLSTLTLKGNGITG----EIPEELGNLSSLTSLDLDNNRLVGK----IPP 142 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~ 142 (619)
.+++.|+|++|+|+......+ ...++|++|+|++|.|+. .++..+..+++|++|+|++|.|+.. ++.
T Consensus 126 ~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~ 205 (372)
T 3un9_A 126 LRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAA 205 (372)
T ss_dssp HTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHH
T ss_pred HhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHH
Confidence 479999999999986544444 246889999999999974 2455567899999999999999842 356
Q ss_pred cccccccchhhhccCCcCCCC----CCCccccccccccccCCCCcccccCCccc
Q 007073 143 SLGNLKKLQFLTLSQNNFSGT----IPDSLTTLSSLISIQLDSNNLSGQIPVHL 192 (619)
Q Consensus 143 ~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~l 192 (619)
.+...++|+.|+|++|.|+.. ++..+...++|+.|+|++|+|+..-...+
T Consensus 206 ~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L 259 (372)
T 3un9_A 206 QLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVL 259 (372)
T ss_dssp HGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred HHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence 677888999999999999842 33445567899999999999985433334
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.63 E-value=4.2e-08 Score=100.15 Aligned_cols=81 Identities=16% Similarity=0.220 Sum_probs=58.1
Q ss_pred cccCcEeeecCCCccccCCCcccccccchhhhccCCcCCCCCCCccccccccc-cccCCCCcccccCC-ccccc---cCc
Q 007073 123 LSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLI-SIQLDSNNLSGQIP-VHLFQ---IPK 197 (619)
Q Consensus 123 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p-~~l~~---l~~ 197 (619)
+++|+.|+|++|+++...+..|.+|++|+.|+|.+| ++..-+.+|.+|++|+ .+++.+ +++ .|+ ..|.+ |..
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~-~I~~~aF~~c~~L~~ 301 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVT-AIEFGAFMGCDNLRY 301 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCC-EECTTTTTTCTTEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cce-EEchhhhhCCccCCE
Confidence 678888888888888555567888888888888887 6644456788888888 888887 676 454 45544 444
Q ss_pred cccCCCCCC
Q 007073 198 YNFTGNNLN 206 (619)
Q Consensus 198 l~~~~n~~~ 206 (619)
+++.+|...
T Consensus 302 l~l~~n~i~ 310 (329)
T 3sb4_A 302 VLATGDKIT 310 (329)
T ss_dssp EEECSSCCC
T ss_pred EEeCCCccC
Confidence 566666554
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.58 E-value=4.1e-08 Score=100.25 Aligned_cols=85 Identities=14% Similarity=0.125 Sum_probs=44.9
Q ss_pred CCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccch-hhhccCCcCCCCCCCccccccccccc
Q 007073 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQ-FLTLSQNNFSGTIPDSLTTLSSLISI 177 (619)
Q Consensus 99 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~~~~l~~L~~L 177 (619)
+++|+.|+|++|+++...+..|.++++|+.|+|++| ++..-+..|.++++|+ .|++.+ +++..-+.+|.+|++|+.|
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 455555555555555333344555555555555555 4433444555555555 555555 4442334455555555555
Q ss_pred cCCCCccc
Q 007073 178 QLDSNNLS 185 (619)
Q Consensus 178 ~l~~N~l~ 185 (619)
++++|+++
T Consensus 303 ~l~~n~i~ 310 (329)
T 3sb4_A 303 LATGDKIT 310 (329)
T ss_dssp EECSSCCC
T ss_pred EeCCCccC
Confidence 55555555
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.41 E-value=1.2e-08 Score=94.90 Aligned_cols=111 Identities=15% Similarity=0.245 Sum_probs=84.5
Q ss_pred CCCeEEEEeCCC-Cccc----cCCccccCCCCCCEEEccCCCCCCC----CcccccccccCcEeeecCCCcccc----CC
Q 007073 75 SNNVASVTLSSM-NFSG----TLSPRIGVLRTLSTLTLKGNGITGE----IPEELGNLSSLTSLDLDNNRLVGK----IP 141 (619)
Q Consensus 75 ~~~l~~L~L~~n-~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p 141 (619)
..+|++|+|++| .|.. .+...+...++|++|+|++|+|... +...+...++|++|+|++|.|... +.
T Consensus 35 ~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 35 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 357999999999 8874 2445566778999999999999742 344556668899999999999843 45
Q ss_pred Ccccccccchhhhc--cCCcCCCC----CCCccccccccccccCCCCccc
Q 007073 142 PSLGNLKKLQFLTL--SQNNFSGT----IPDSLTTLSSLISIQLDSNNLS 185 (619)
Q Consensus 142 ~~~~~l~~L~~L~l--~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 185 (619)
..+...++|+.|+| ++|.|... +...+...++|+.|+|++|.+.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 56777889999999 88998732 2334555678999999999886
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=2e-06 Score=84.78 Aligned_cols=135 Identities=18% Similarity=0.128 Sum_probs=95.6
Q ss_pred ccccCCCc-eEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc-CCCccceeeeeeCCCcceeEecccccch
Q 007073 301 VLGQGGFG-KVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVYPFMQNLS 377 (619)
Q Consensus 301 ~lg~G~fg-~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~gs 377 (619)
.+..|..| .||+.... ++..+++|+-. ......+.+|...++.+. +--+-++++++...+..++|||++++.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~----~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGK----GSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEE----THHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECC----CCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 45556666 69998864 56789999764 234567889999998875 3235677888888888999999999987
Q ss_pred hhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 007073 378 VAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC------------------------------------------ 415 (619)
Q Consensus 378 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------------ 415 (619)
+.+..... ......++.++++.|+.||...
T Consensus 107 ~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 107 AFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 76654321 1122345555666666666421
Q ss_pred -------------CCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 416 -------------NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 416 -------------~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
.+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12378999999999999887778999998863
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=3.8e-06 Score=84.57 Aligned_cols=136 Identities=19% Similarity=0.212 Sum_probs=92.3
Q ss_pred cCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCC---Cccceeeeee-CCCcceeEecccc
Q 007073 299 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR---NLLRLIGFCT-TPTERLLVYPFMQ 374 (619)
Q Consensus 299 ~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~-~~~~~~lv~e~~~ 374 (619)
.+.++.|....||+. |..+++|.-. .......+.+|.++++.+.+. .+.+.+.++. ..+..++||+|++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~---~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK---SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES---SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC---CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 456888999999988 5778888742 223456788999999998753 2445666664 3455789999999
Q ss_pred cchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 007073 375 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH---------------------------------------- 414 (619)
Q Consensus 375 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------------------------------------- 414 (619)
|.++...... .++...+..++.++++.|+.||+.
T Consensus 97 G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 97 GQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp SEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 9887653211 023333444444444444444432
Q ss_pred -----------------CCCCeEecCCCCCcEEeCC---CCc-EEEccccccee
Q 007073 415 -----------------CNPKIIHRDVKAANVLLDE---DFE-AVVGDFGLAKL 447 (619)
Q Consensus 415 -----------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~DfGla~~ 447 (619)
..+.++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2335799999999999997 345 58999998874
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.33 E-value=7.7e-08 Score=106.40 Aligned_cols=127 Identities=14% Similarity=0.109 Sum_probs=68.1
Q ss_pred CCeEEEEeCCCCcccc----CCccccCCCCCCEEEccCCCCCC----CCcccccccccCcEeeecCCCccccCCCccccc
Q 007073 76 NNVASVTLSSMNFSGT----LSPRIGVLRTLSTLTLKGNGITG----EIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNL 147 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 147 (619)
++|++|+|++|.+++. ++..+..+++|+.|+|++|.+++ .++..+.++++|+.|+|++|.+.+ +|..+.++
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~ 242 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAA 242 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHC
T ss_pred CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhh
Confidence 3566666666665543 22333455666666666666652 233334456666666666666663 55556666
Q ss_pred ccchhhhccCCcCC---CCCCCccccccccccccCCCCcccccCCccc---cccCccccCCCC
Q 007073 148 KKLQFLTLSQNNFS---GTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNN 204 (619)
Q Consensus 148 ~~L~~L~l~~N~l~---~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l---~~l~~l~~~~n~ 204 (619)
++|+.|+++++... +..+..+..+++|+.|+++++... .+|..+ .++..|++++|.
T Consensus 243 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~ 304 (592)
T 3ogk_B 243 ANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYAL 304 (592)
T ss_dssp TTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCC
T ss_pred hHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCc
Confidence 66666666543222 122334555556666666554333 444333 355666666665
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.28 E-value=1.5e-07 Score=103.97 Aligned_cols=125 Identities=13% Similarity=0.014 Sum_probs=95.0
Q ss_pred CCCeEEEEeCCCCcc----ccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCcc---ccCCCccccc
Q 007073 75 SNNVASVTLSSMNFS----GTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLV---GKIPPSLGNL 147 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~----~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~---~~~p~~~~~l 147 (619)
.++|+.|+|++|.++ +.++..+.++++|+.|+|++|.+. .+|..+.++++|+.|+++.+... +..+..+..+
T Consensus 191 ~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~ 269 (592)
T 3ogk_B 191 NTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEIL-ELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFP 269 (592)
T ss_dssp CCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGG-GGHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCC
T ss_pred CCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHH-HHHHHHhhhhHHHhhcccccccccchHHHHHHhhcc
Confidence 468999999999997 344556678899999999999998 58888999999999999864433 3445667788
Q ss_pred ccchhhhccCCcCCCCCCCccccccccccccCCCCcccccCC----ccccccCccccC
Q 007073 148 KKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP----VHLFQIPKYNFT 201 (619)
Q Consensus 148 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p----~~l~~l~~l~~~ 201 (619)
++|+.|+++++... .+|..+..+++|+.|++++|.+++... ..+.++..|++.
T Consensus 270 ~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~ 326 (592)
T 3ogk_B 270 RKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR 326 (592)
T ss_dssp TTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE
T ss_pred ccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc
Confidence 88888888886544 677778888888888888888764433 233455555555
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=4.3e-06 Score=86.10 Aligned_cols=82 Identities=10% Similarity=0.015 Sum_probs=55.3
Q ss_pred cCcc-ccCCCceEEEEEeC-------CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccC---CCccceeeeeeCC--
Q 007073 299 KNVL-GQGGFGKVYRGVLA-------DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVH---RNLLRLIGFCTTP-- 363 (619)
Q Consensus 299 ~~~l-g~G~fg~Vy~~~~~-------~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H---~niv~l~~~~~~~-- 363 (619)
.+.| +.|....+|+.... ++..+++|+-.... .......+.+|+++++.+.. -.+.++++++...
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88989999998764 26788898764321 00012456788888887753 2456777777654
Q ss_pred -CcceeEecccccchhhh
Q 007073 364 -TERLLVYPFMQNLSVAY 380 (619)
Q Consensus 364 -~~~~lv~e~~~~gsL~~ 380 (619)
...++||||++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 34689999999877654
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.14 E-value=3.3e-08 Score=109.35 Aligned_cols=128 Identities=15% Similarity=0.140 Sum_probs=68.1
Q ss_pred CeEEEEeCCCCccccCCcccc-CCCCCCEEEcc--C----CCCCCC-----CcccccccccCcEeeecCCCccccCCCcc
Q 007073 77 NVASVTLSSMNFSGTLSPRIG-VLRTLSTLTLK--G----NGITGE-----IPEELGNLSSLTSLDLDNNRLVGKIPPSL 144 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~--~----N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 144 (619)
+|+.|+++.|++++.....+. .+++|+.|+|+ + |.+++. ++..+.++++|+.|+|++ .+++..+..+
T Consensus 373 ~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l 451 (594)
T 2p1m_B 373 KLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYI 451 (594)
T ss_dssp TCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHH
T ss_pred hHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHH
Confidence 455555555555544333343 35666666666 3 444421 111244556666666655 4444433444
Q ss_pred cc-cccchhhhccCCcCCCCCCCcc-ccccccccccCCCCcccccCC----ccccccCccccCCCCC
Q 007073 145 GN-LKKLQFLTLSQNNFSGTIPDSL-TTLSSLISIQLDSNNLSGQIP----VHLFQIPKYNFTGNNL 205 (619)
Q Consensus 145 ~~-l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~p----~~l~~l~~l~~~~n~~ 205 (619)
.. +++|+.|+|++|.+++..+..+ ..+++|+.|++++|++++..+ ..+.++..|++++|+.
T Consensus 452 ~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 452 GTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp HHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred HHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 43 6667777777777654333333 446677777777777653322 2244566666666653
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.11 E-value=6.4e-08 Score=89.98 Aligned_cols=116 Identities=19% Similarity=0.222 Sum_probs=87.4
Q ss_pred ccCCccccCCCCCCEEEccCC-CCCCC----CcccccccccCcEeeecCCCcccc----CCCcccccccchhhhccCCcC
Q 007073 90 GTLSPRIGVLRTLSTLTLKGN-GITGE----IPEELGNLSSLTSLDLDNNRLVGK----IPPSLGNLKKLQFLTLSQNNF 160 (619)
Q Consensus 90 ~~~~~~~~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l 160 (619)
..+...+...++|++|+|++| .|... +...+...++|++|+|++|+|... +...+...++|++|+|++|.|
T Consensus 26 ~~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i 105 (185)
T 1io0_A 26 ETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFI 105 (185)
T ss_dssp HHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCC
T ss_pred HHHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcC
Confidence 344556777899999999999 88742 445567789999999999999732 334556668999999999999
Q ss_pred CCC----CCCccccccccccccC--CCCcccccCC----ccc---cccCccccCCCCC
Q 007073 161 SGT----IPDSLTTLSSLISIQL--DSNNLSGQIP----VHL---FQIPKYNFTGNNL 205 (619)
Q Consensus 161 ~~~----~p~~~~~l~~L~~L~l--~~N~l~~~~p----~~l---~~l~~l~~~~n~~ 205 (619)
... +...+...++|+.|+| ++|.|+..-- ..+ ..+..|++++|..
T Consensus 106 ~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i 163 (185)
T 1io0_A 106 SGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 163 (185)
T ss_dssp CHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred CHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence 842 4556777789999999 8899984322 222 3577788888764
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.07 E-value=1.8e-07 Score=96.47 Aligned_cols=128 Identities=14% Similarity=0.209 Sum_probs=77.8
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCccccc--ccccCcEeeecC--CCcccc-----CCCcc-
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELG--NLSSLTSLDLDN--NRLVGK-----IPPSL- 144 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~--N~l~~~-----~p~~~- 144 (619)
.++|+.|+|++|.-. .+++ + .+++|+.|+|..|.++......+. .+++|+.|+|+. |...+. +...+
T Consensus 171 ~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~ 247 (362)
T 2ra8_A 171 MPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFS 247 (362)
T ss_dssp CTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSC
T ss_pred CCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHh
Confidence 458889998877311 2333 3 378888888888877643333343 678888888753 221111 11122
Q ss_pred -cccccchhhhccCCcCCCCCCCccc---cccccccccCCCCccccc----CCc---cccccCccccCCCCC
Q 007073 145 -GNLKKLQFLTLSQNNFSGTIPDSLT---TLSSLISIQLDSNNLSGQ----IPV---HLFQIPKYNFTGNNL 205 (619)
Q Consensus 145 -~~l~~L~~L~l~~N~l~~~~p~~~~---~l~~L~~L~l~~N~l~~~----~p~---~l~~l~~l~~~~n~~ 205 (619)
..+++|+.|+|++|.+.+..+..+. .+++|+.|+|+.|.+++. ++. .+.+|..|++++|.+
T Consensus 248 ~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i 319 (362)
T 2ra8_A 248 KDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319 (362)
T ss_dssp TTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBC
T ss_pred cCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcC
Confidence 2467888888888887643222222 467888888888888753 332 245667777777654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.98 E-value=2.5e-05 Score=79.61 Aligned_cols=141 Identities=16% Similarity=0.232 Sum_probs=79.9
Q ss_pred CccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCC--Cccceee------eeeCCCcceeEec
Q 007073 300 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR--NLLRLIG------FCTTPTERLLVYP 371 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~------~~~~~~~~~lv~e 371 (619)
+.|+.|..+.||+....+| .+++|+... ....+..|.++++.+... .+.+++. +....+..+++|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~-----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR-----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS-----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC-----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 4566678899999988654 589998864 123344566666555321 2233332 1123456789999
Q ss_pred ccccchhh--------------hhhcccCCC-----C-----CCcCHHHH------------------------------
Q 007073 372 FMQNLSVA--------------YRLREIKPG-----E-----PVLDWVTR------------------------------ 397 (619)
Q Consensus 372 ~~~~gsL~--------------~~l~~~~~~-----~-----~~l~~~~~------------------------------ 397 (619)
|++|..+. ..+|..... . ..-.|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 112211110 0 01122211
Q ss_pred -HHHHHHHHHHHHHHHh----------cCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 398 -KRVALGAARGLEYLHE----------HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 398 -~~i~~~ia~~L~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
..+...+.+++.+|++ ...+.++|+|+++.||+++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111223446666763 124589999999999999888899999999875
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.98 E-value=3.2e-07 Score=101.41 Aligned_cols=116 Identities=18% Similarity=0.224 Sum_probs=72.9
Q ss_pred CCCeEEEEeCCCCccccCCcccc-CCCCCCEEEccCC-CCCCC-CcccccccccCcEeeecCCCccccCCCcc----ccc
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIG-VLRTLSTLTLKGN-GITGE-IPEELGNLSSLTSLDLDNNRLVGKIPPSL----GNL 147 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~----~~l 147 (619)
..+|++|+|++|.+++..+..+. .+++|+.|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+ ..+
T Consensus 104 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~ 183 (594)
T 2p1m_B 104 YTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTY 183 (594)
T ss_dssp CTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTC
T ss_pred CCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcC
Confidence 34778888888877766655554 5778888888877 44422 44444577888888888887765443333 356
Q ss_pred ccchhhhccCCcCCCCCC-Cc----cccccccccccCCCC-cccccCCcccc
Q 007073 148 KKLQFLTLSQNNFSGTIP-DS----LTTLSSLISIQLDSN-NLSGQIPVHLF 193 (619)
Q Consensus 148 ~~L~~L~l~~N~l~~~~p-~~----~~~l~~L~~L~l~~N-~l~~~~p~~l~ 193 (619)
++|+.|+|++|. . .++ .. +..+++|+.|++++| .++ .+|..+.
T Consensus 184 ~~L~~L~l~~~~-~-~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~ 232 (594)
T 2p1m_B 184 TSLVSLNISCLA-S-EVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLLQ 232 (594)
T ss_dssp CCCCEEECTTCC-S-CCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHH
T ss_pred CcCcEEEecccC-C-cCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHh
Confidence 678888888776 1 222 11 234577888888877 344 3554443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.94 E-value=9.5e-06 Score=84.89 Aligned_cols=124 Identities=14% Similarity=0.128 Sum_probs=90.7
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCcc-----ccCCCcccccccc
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLV-----GKIPPSLGNLKKL 150 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L 150 (619)
.+|+.|+|..| ++.+-...|.. .+|+.+.| .|.++..-+..|.++++|+.++|.+|.+. ..-+..|.+|++|
T Consensus 226 ~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L 302 (401)
T 4fdw_A 226 SQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKL 302 (401)
T ss_dssp TTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTC
T ss_pred CCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccC
Confidence 47888888864 66566667777 78999999 45566455778889999999999888775 3556788889999
Q ss_pred hhhhccCCcCCCCCCCccccccccccccCCCCcccccCC-cccc--ccCccccCCCCC
Q 007073 151 QFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP-VHLF--QIPKYNFTGNNL 205 (619)
Q Consensus 151 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~l~--~l~~l~~~~n~~ 205 (619)
+.++|. |.++..-..+|.+|++|+.+++.+| ++ .|+ ..|. +|..+.+.+|..
T Consensus 303 ~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~-~I~~~aF~~~~L~~l~l~~n~~ 357 (401)
T 4fdw_A 303 ARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VT-QINFSAFNNTGIKEVKVEGTTP 357 (401)
T ss_dssp CEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CC-EECTTSSSSSCCCEEEECCSSC
T ss_pred CeEEeC-CceEEEhhhhhcCCCCccEEEECcc-cc-EEcHHhCCCCCCCEEEEcCCCC
Confidence 999998 4577444567888899999998655 65 444 3343 566677777754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.94 E-value=4.4e-05 Score=79.72 Aligned_cols=76 Identities=13% Similarity=0.126 Sum_probs=49.8
Q ss_pred cCccccCCCceEEEEEeC-CCcEEEEEEeccCCC------cchHHHHHHHHHHHHHccC--CCcc-ceeeeeeCCCccee
Q 007073 299 KNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES------PGGDAAFQREVEMISVAVH--RNLL-RLIGFCTTPTERLL 368 (619)
Q Consensus 299 ~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~------~~~~~~~~~E~~~l~~l~H--~niv-~l~~~~~~~~~~~l 368 (619)
.+.||.|.++.||++... +++.++||....... ......+..|.++++.+.. +..+ +++.+ ..+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999754 468899998653211 1123456779999887743 4444 44443 3455789
Q ss_pred Eecccccc
Q 007073 369 VYPFMQNL 376 (619)
Q Consensus 369 v~e~~~~g 376 (619)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.86 E-value=4e-05 Score=80.72 Aligned_cols=80 Identities=13% Similarity=0.033 Sum_probs=49.1
Q ss_pred CCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcceeeeccccccccccccccCC---CCCcchhhHHHHHHHHHH
Q 007073 416 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG---KSSERTDVFGYGIMLLEL 492 (619)
Q Consensus 416 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~S~Gv~l~el 492 (619)
.+.++|||++|.||+++.++ ++++||+.+..-.....-......-...|++|+..... ......++.+....+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 34799999999999999876 99999999875431100000000012346676655321 112345566788888887
Q ss_pred HhCC
Q 007073 493 VTGQ 496 (619)
Q Consensus 493 ltg~ 496 (619)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7653
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.86 E-value=2e-06 Score=88.56 Aligned_cols=128 Identities=16% Similarity=0.216 Sum_probs=75.0
Q ss_pred CCCeEEEEeCCCCcc---------ccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCccc
Q 007073 75 SNNVASVTLSSMNFS---------GTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLG 145 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~---------~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 145 (619)
..+|+.|.+.++... +.++..+..+|+|+.|+|++|.-. .+|. + .+++|+.|+|..|.++...-..+.
T Consensus 138 l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~ 214 (362)
T 2ra8_A 138 FAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDIL 214 (362)
T ss_dssp HTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHH
T ss_pred cchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHH
Confidence 357777877655331 123344566788888888877311 2333 3 377888888887776633223333
Q ss_pred --ccccchhhhccC--CcCCCC-----CCCcc--ccccccccccCCCCcccccCCc------cccccCccccCCCCC
Q 007073 146 --NLKKLQFLTLSQ--NNFSGT-----IPDSL--TTLSSLISIQLDSNNLSGQIPV------HLFQIPKYNFTGNNL 205 (619)
Q Consensus 146 --~l~~L~~L~l~~--N~l~~~-----~p~~~--~~l~~L~~L~l~~N~l~~~~p~------~l~~l~~l~~~~n~~ 205 (619)
.+++|+.|+|+. |...+. +...+ ..+++|+.|+|++|.+.+..+. .+.++..|+++.|..
T Consensus 215 ~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L 291 (362)
T 2ra8_A 215 GSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVL 291 (362)
T ss_dssp HSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCC
T ss_pred HccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCC
Confidence 677888888753 222111 11112 2467888888888887643332 244677777777654
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.74 E-value=4.4e-05 Score=79.80 Aligned_cols=104 Identities=10% Similarity=0.119 Sum_probs=49.1
Q ss_pred CeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhcc
Q 007073 77 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 156 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 156 (619)
+|+.++|++|+++.+....|. ..+|+.+.|.+| ++..-...|.++++|+.++|.+| ++..-...|.+ .+|+.+.|
T Consensus 181 ~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l- 255 (401)
T 4fdw_A 181 NLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL- 255 (401)
T ss_dssp TCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-
T ss_pred cCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-
Confidence 444444444444433333332 344444444422 33233344555555555555543 33222233333 34444444
Q ss_pred CCcCCCCCCCccccccccccccCCCCccc
Q 007073 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLS 185 (619)
Q Consensus 157 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 185 (619)
.|.++..-+.+|.+|++|+.+++.+|.+.
T Consensus 256 p~~i~~I~~~aF~~c~~L~~l~l~~~~~~ 284 (401)
T 4fdw_A 256 PNGVTNIASRAFYYCPELAEVTTYGSTFN 284 (401)
T ss_dssp ETTCCEECTTTTTTCTTCCEEEEESSCCC
T ss_pred CCCccEEChhHhhCCCCCCEEEeCCcccc
Confidence 23344233556777777877777776654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00016 Score=72.63 Aligned_cols=140 Identities=16% Similarity=0.182 Sum_probs=92.2
Q ss_pred ccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc---CCCccceeeeeeCCCcceeEecccc
Q 007073 298 EKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV---HRNLLRLIGFCTTPTERLLVYPFMQ 374 (619)
Q Consensus 298 ~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lv~e~~~ 374 (619)
..+.|+.|....+|+... ++..+++|+... .....+..|.+.++.+. ...+.++++++...+..++||||++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~----~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINER----SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEG----GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCc----ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 346789999999999986 467889998653 23567889999988875 2557788888887788999999999
Q ss_pred cchhhh-----------hhcccCC-C-----------------CCCcCHHHHH---HHHH----------------HHHH
Q 007073 375 NLSVAY-----------RLREIKP-G-----------------EPVLDWVTRK---RVAL----------------GAAR 406 (619)
Q Consensus 375 ~gsL~~-----------~l~~~~~-~-----------------~~~l~~~~~~---~i~~----------------~ia~ 406 (619)
+..+.. .|+.... . ...-+|.... ++.. .+.+
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 875421 2232211 0 0012344321 1111 1111
Q ss_pred -HHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007073 407 -GLEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGDFG 443 (619)
Q Consensus 407 -~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 443 (619)
....|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1223321 2356899999999999999887 8899974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00012 Score=72.88 Aligned_cols=78 Identities=24% Similarity=0.288 Sum_probs=55.8
Q ss_pred CCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCC---CccceeeeeeCCCcceeEec
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR---NLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~~~~~~~lv~e 371 (619)
.....+.+|.|..+.||+....||+.|.||+-.... ......|..|.+.|+.+.-. -+.+++++. ..++|||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 455567899999999999999999999999865322 23345678999999988532 234444432 3578999
Q ss_pred ccccch
Q 007073 372 FMQNLS 377 (619)
Q Consensus 372 ~~~~gs 377 (619)
|++++.
T Consensus 91 ~l~~~~ 96 (288)
T 3f7w_A 91 WVDERP 96 (288)
T ss_dssp CCCCCC
T ss_pred eecccC
Confidence 987653
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.44 E-value=2.8e-05 Score=70.65 Aligned_cols=83 Identities=16% Similarity=0.171 Sum_probs=50.5
Q ss_pred CeEEEEeCCCCccccCCccccCCCCCCEEEccCCC-CCCCCccccccc----ccCcEeeecCCC-ccccCCCcccccccc
Q 007073 77 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNG-ITGEIPEELGNL----SSLTSLDLDNNR-LVGKIPPSLGNLKKL 150 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~p~~~~~l~~L 150 (619)
+|++|||+++.++..--..+..+++|+.|+|+++. |+..--..+..+ ++|++|+|+++. |+..--..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 57888888777765433456677777777777774 553333334443 367777777763 653222345566666
Q ss_pred hhhhccCCc
Q 007073 151 QFLTLSQNN 159 (619)
Q Consensus 151 ~~L~l~~N~ 159 (619)
+.|+|++..
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 666666653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00073 Score=68.07 Aligned_cols=158 Identities=12% Similarity=0.080 Sum_probs=86.5
Q ss_pred CHHHHHHHhcCCcc-----cCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCc--ccee
Q 007073 285 SWRELQLATDNFSE-----KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL--LRLI 357 (619)
Q Consensus 285 ~~~el~~~~~~~~~-----~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~ 357 (619)
+.+++......|.. .+.|+.|....+|+....+| .+++|....... ...+..|++++..+...++ .+++
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCCccc
Confidence 34455544445544 24567788899999987655 688998764211 2345567777776643222 2333
Q ss_pred ee------eeCCCcceeEecccccchhhh--------------hhcccCC----CC----CCcCHHHHHH----------
Q 007073 358 GF------CTTPTERLLVYPFMQNLSVAY--------------RLREIKP----GE----PVLDWVTRKR---------- 399 (619)
Q Consensus 358 ~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~----~~----~~l~~~~~~~---------- 399 (619)
.. ....+..+++++|++|..+.. .++.... .. ....|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 112345678999998764321 1221110 00 0012222110
Q ss_pred --HHHHHHHHHHHHHhc----CCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 400 --VALGAARGLEYLHEH----CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 400 --i~~~ia~~L~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
+...+.+.++++++. ...+++|+|+.+.||+++++..+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244555666532 13479999999999999987666899999876
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00091 Score=67.80 Aligned_cols=143 Identities=17% Similarity=0.081 Sum_probs=72.1
Q ss_pred cCccccCCCce-EEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCC--ccceeeeeeCCCcceeEeccccc
Q 007073 299 KNVLGQGGFGK-VYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN--LLRLIGFCTTPTERLLVYPFMQN 375 (619)
Q Consensus 299 ~~~lg~G~fg~-Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~ 375 (619)
.+.|+.|+... +|+....+|..+++|...... ...+..|+++++.+.... +.+++.+... ..+++||++.+
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~----~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~--~g~ll~e~l~~ 96 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE----GGDTQPFVDLAQYLRNLDISAPEIYAEEHA--RGLLLIEDLGD 96 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTT----TCCSHHHHHHHHHHHHTTCBCCCEEEEETT--TTEEEECCCCS
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCC----CccccHHHHHHHHHHhCCCCCCceeeecCC--CCEEEEeeCCC
Confidence 34566665554 678776447778787643221 023345677766664323 4456665332 23789999876
Q ss_pred chhhhhhcc---------------------cCCC-CCCcCHHHHH-------H-------------HHHHHHHHHHHHHh
Q 007073 376 LSVAYRLRE---------------------IKPG-EPVLDWVTRK-------R-------------VALGAARGLEYLHE 413 (619)
Q Consensus 376 gsL~~~l~~---------------------~~~~-~~~l~~~~~~-------~-------------i~~~ia~~L~~LH~ 413 (619)
..+.+.+.. .... ...++..... . ....+.+.+..+.+
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 555433211 1000 0111111000 0 00111222233311
Q ss_pred ---cCCCCeEecCCCCCcEEeCCC----CcEEEccccccee
Q 007073 414 ---HCNPKIIHRDVKAANVLLDED----FEAVVGDFGLAKL 447 (619)
Q Consensus 414 ---~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGla~~ 447 (619)
...+.++|||+.+.||+++.+ ..+.|+||+.+..
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 123479999999999999875 6899999998874
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.28 E-value=2.1e-05 Score=71.45 Aligned_cols=91 Identities=10% Similarity=0.013 Sum_probs=67.1
Q ss_pred CccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCC-ccccCCCccccc----ccchhhhccCCc-CCCCCCC
Q 007073 93 SPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNR-LVGKIPPSLGNL----KKLQFLTLSQNN-FSGTIPD 166 (619)
Q Consensus 93 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~l~~N~-l~~~~p~ 166 (619)
|.....-.+|+.|||+++.|+..--..+.++++|+.|+|+++. |+..--..++.+ ++|+.|+|+++. |+..-=.
T Consensus 54 P~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~ 133 (176)
T 3e4g_A 54 PTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGII 133 (176)
T ss_dssp CCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHH
T ss_pred CcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHH
Confidence 4433233579999999999986655668899999999999995 774333345543 479999999975 7632223
Q ss_pred ccccccccccccCCCCc
Q 007073 167 SLTTLSSLISIQLDSNN 183 (619)
Q Consensus 167 ~~~~l~~L~~L~l~~N~ 183 (619)
.+..+++|+.|+++++.
T Consensus 134 ~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 134 ALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HGGGCTTCCEEEEESCT
T ss_pred HHhcCCCCCEEECCCCC
Confidence 46788999999999885
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00098 Score=70.15 Aligned_cols=73 Identities=12% Similarity=0.167 Sum_probs=50.5
Q ss_pred cCccccCCCceEEEEEeCC--------CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCc-cceeeeeeCCCcceeE
Q 007073 299 KNVLGQGGFGKVYRGVLAD--------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL-LRLIGFCTTPTERLLV 369 (619)
Q Consensus 299 ~~~lg~G~fg~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv 369 (619)
.+.|+.|....||+....+ +..+++|+.... .....+..|..+++.+...++ .++++.+.. .+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v 150 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 150 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence 4568889999999998753 578999987431 122456689999888764444 456665432 389
Q ss_pred ecccccchh
Q 007073 370 YPFMQNLSV 378 (619)
Q Consensus 370 ~e~~~~gsL 378 (619)
+||++|.++
T Consensus 151 ~e~l~G~~l 159 (429)
T 1nw1_A 151 EEYIPSRPL 159 (429)
T ss_dssp ECCCCEEEC
T ss_pred EEEeCCccc
Confidence 999986544
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.002 Score=64.18 Aligned_cols=71 Identities=10% Similarity=0.058 Sum_probs=45.0
Q ss_pred cCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCcc-ceeeeeeCCCcceeEeccc-ccc
Q 007073 299 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL-RLIGFCTTPTERLLVYPFM-QNL 376 (619)
Q Consensus 299 ~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lv~e~~-~~g 376 (619)
.+.|+.|....+|+. ..+++|+-...... .....+|+.+++.+...++. +++++ .++..++++||+ ++.
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 567899999999999 56888877532111 11235688887777543443 45543 344467899999 654
Q ss_pred hh
Q 007073 377 SV 378 (619)
Q Consensus 377 sL 378 (619)
++
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 44
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.08 E-value=0.00047 Score=59.47 Aligned_cols=56 Identities=23% Similarity=0.275 Sum_probs=39.1
Q ss_pred EEEeCCCCcc-ccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCcc
Q 007073 80 SVTLSSMNFS-GTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLV 137 (619)
Q Consensus 80 ~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 137 (619)
.++.++++|+ ..+|..+ -++|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 6777788876 3445432 346788888888888555566777888888888888665
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0044 Score=62.41 Aligned_cols=143 Identities=15% Similarity=0.149 Sum_probs=82.0
Q ss_pred CccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCC--ccceeee-----eeCCCcceeEecc
Q 007073 300 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN--LLRLIGF-----CTTPTERLLVYPF 372 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~-----~~~~~~~~lv~e~ 372 (619)
..++ |....||+....+|+.+++|...... .....+..|..++..+.... +.+++.. ....+..+++|+|
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 3466 88889999887778889999885321 13456677888887775322 3344433 1113345679999
Q ss_pred cccchhhh--------------hhcccCC-----CCCCcCHHHH----HHH---------------HHHHHHHHHHHHhc
Q 007073 373 MQNLSVAY--------------RLREIKP-----GEPVLDWVTR----KRV---------------ALGAARGLEYLHEH 414 (619)
Q Consensus 373 ~~~gsL~~--------------~l~~~~~-----~~~~l~~~~~----~~i---------------~~~ia~~L~~LH~~ 414 (619)
++|..+.. .+|.... ....+++... ..+ ...+.+.++.+.+.
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 98755421 0111100 0111222111 000 11111223333321
Q ss_pred ----CCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 415 ----CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 415 ----~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234688999999999999 4 899999998763
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.00073 Score=70.29 Aligned_cols=88 Identities=10% Similarity=0.164 Sum_probs=45.8
Q ss_pred cCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhccCCcCCCCCCCcccc
Q 007073 91 TLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTT 170 (619)
Q Consensus 91 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 170 (619)
+-...|....+|+.+.+.++..+ .-...|.++++|+.+.+. +.++..-...|.++++|+.++|..| ++..-..+|.+
T Consensus 256 i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~ 332 (394)
T 4gt6_A 256 IETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAG 332 (394)
T ss_dssp ECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT
T ss_pred cccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhC
Confidence 33445555666666666544433 344455566666666664 3344233445556666666666543 43222345556
Q ss_pred ccccccccCCC
Q 007073 171 LSSLISIQLDS 181 (619)
Q Consensus 171 l~~L~~L~l~~ 181 (619)
|.+|+.+.+..
T Consensus 333 C~~L~~i~ip~ 343 (394)
T 4gt6_A 333 CEQLERIAIPS 343 (394)
T ss_dssp CTTCCEEEECT
T ss_pred CCCCCEEEECc
Confidence 66666666543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0013 Score=56.60 Aligned_cols=57 Identities=25% Similarity=0.325 Sum_probs=47.6
Q ss_pred CEEEccCCCCC-CCCcccccccccCcEeeecCCCccccCCCcccccccchhhhccCCcCC
Q 007073 103 STLTLKGNGIT-GEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFS 161 (619)
Q Consensus 103 ~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 161 (619)
..++.+++.|+ ..+|..+. ++|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 47899999997 46775443 57999999999999666677899999999999999885
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0024 Score=65.88 Aligned_cols=102 Identities=15% Similarity=0.127 Sum_probs=54.1
Q ss_pred CeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhcc
Q 007073 77 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 156 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 156 (619)
.++.+.+..+ +..+....|.....|+.+.+..+ ++..-...|.++.+|+.+.+..+ ++..-...|.++++|+.+.+.
T Consensus 218 ~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~ 294 (379)
T 4h09_A 218 NLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMD 294 (379)
T ss_dssp SCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEEC
T ss_pred ccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccccccccc
Confidence 4555555433 33344455556666666666544 44233445555666666666443 332334455666666666666
Q ss_pred CCcCCCCCCCccccccccccccCCC
Q 007073 157 QNNFSGTIPDSLTTLSSLISIQLDS 181 (619)
Q Consensus 157 ~N~l~~~~p~~~~~l~~L~~L~l~~ 181 (619)
+|.++..-+.+|.+|.+|+.+.|..
T Consensus 295 ~~~i~~I~~~aF~~c~~L~~i~lp~ 319 (379)
T 4h09_A 295 NSAIETLEPRVFMDCVKLSSVTLPT 319 (379)
T ss_dssp CTTCCEECTTTTTTCTTCCEEECCT
T ss_pred ccccceehhhhhcCCCCCCEEEcCc
Confidence 6655523344555666666666643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0036 Score=64.38 Aligned_cols=74 Identities=9% Similarity=0.038 Sum_probs=44.4
Q ss_pred cCccccCCCceEEEEEeCC---------CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCcc-ceeeeeeCCCccee
Q 007073 299 KNVLGQGGFGKVYRGVLAD---------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL-RLIGFCTTPTERLL 368 (619)
Q Consensus 299 ~~~lg~G~fg~Vy~~~~~~---------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~l 368 (619)
.+.|+.|....+|+....+ +..+++|+..... ........|.++++.+...+++ ++++.. ...+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV--DELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG--GGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc--cceecHHHHHHHHHHHHhcCCCCceEEec----CCcE
Confidence 3567888899999998754 2678888764321 1111235788888877644443 565543 2478
Q ss_pred Eecccccchh
Q 007073 369 VYPFMQNLSV 378 (619)
Q Consensus 369 v~e~~~~gsL 378 (619)
||+|++|.++
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999987544
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0001 Score=68.21 Aligned_cols=110 Identities=14% Similarity=0.188 Sum_probs=66.2
Q ss_pred CCeEEEEeCCC-Cccc----cCCccccCCCCCCEEEccCCCCCC----CCcccccccccCcEeeecCCCcccc----CCC
Q 007073 76 NNVASVTLSSM-NFSG----TLSPRIGVLRTLSTLTLKGNGITG----EIPEELGNLSSLTSLDLDNNRLVGK----IPP 142 (619)
Q Consensus 76 ~~l~~L~L~~n-~l~~----~~~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~ 142 (619)
..|++|+|++| +|.. .+...+..=+.|+.|+|++|+|.. .+...+..-+.|+.|+|++|+|... +-.
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~ 120 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 120 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence 46888888875 6653 233455556778888888888873 2334455567788888888888732 122
Q ss_pred cccccccchhhhccCCcC---CC----CCCCccccccccccccCCCCccc
Q 007073 143 SLGNLKKLQFLTLSQNNF---SG----TIPDSLTTLSSLISIQLDSNNLS 185 (619)
Q Consensus 143 ~~~~l~~L~~L~l~~N~l---~~----~~p~~~~~l~~L~~L~l~~N~l~ 185 (619)
.+..-+.|+.|+|++|.. .. .+-..+..-+.|+.|+++.|.+.
T Consensus 121 aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 121 STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 344445677777776533 21 01122333356667777666543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0079 Score=63.60 Aligned_cols=75 Identities=12% Similarity=0.116 Sum_probs=48.4
Q ss_pred cCccccCCCceEEEEEeCC-CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCcc-ceeeeeeCCCcceeEecccccc
Q 007073 299 KNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL-RLIGFCTTPTERLLVYPFMQNL 376 (619)
Q Consensus 299 ~~~lg~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lv~e~~~~g 376 (619)
.+.|+.|-...+|+....+ +..+++|+..... .. ..+..+|..+++.+...++. ++++++. ...|+||++|.
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~----~G~v~e~I~G~ 186 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DE-IINREREKKISCILYNKNIAKKIYVFFT----NGRIEEFMDGY 186 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CS-CSCHHHHHHHHHHHTTSSSBCCEEEEET----TEEEEECCCSE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC----CeEEEEeeCCc
Confidence 4568889999999999865 4788888764321 11 11125789999988765554 5666652 23599999876
Q ss_pred hhh
Q 007073 377 SVA 379 (619)
Q Consensus 377 sL~ 379 (619)
++.
T Consensus 187 ~l~ 189 (458)
T 2qg7_A 187 ALS 189 (458)
T ss_dssp ECC
T ss_pred cCC
Confidence 553
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0082 Score=61.77 Aligned_cols=143 Identities=15% Similarity=0.182 Sum_probs=82.9
Q ss_pred cCccccCCCceEEEEEeC--------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCc-cceeeeeeCCCcceeE
Q 007073 299 KNVLGQGGFGKVYRGVLA--------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL-LRLIGFCTTPTERLLV 369 (619)
Q Consensus 299 ~~~lg~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv 369 (619)
.+.|..|-...+|+.... +++.+++|+-.. . ......+.+|.++++.+...++ .++++++.. .+|
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-I-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-c-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 356778999999999874 257899987532 1 2234566789999988763333 456665543 389
Q ss_pred ecccccchhhhh-----------------hcccC-CCCCCcC--HHHHHHHHHHHH-------------------HHHHH
Q 007073 370 YPFMQNLSVAYR-----------------LREIK-PGEPVLD--WVTRKRVALGAA-------------------RGLEY 410 (619)
Q Consensus 370 ~e~~~~gsL~~~-----------------l~~~~-~~~~~l~--~~~~~~i~~~ia-------------------~~L~~ 410 (619)
|||++|.++... +|... +...... +.+..++..++. ..+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 999998665421 11111 1111112 333344433321 12333
Q ss_pred HHh----c-CCCCeEecCCCCCcEEeCCC----CcEEEccccccee
Q 007073 411 LHE----H-CNPKIIHRDVKAANVLLDED----FEAVVGDFGLAKL 447 (619)
Q Consensus 411 LH~----~-~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGla~~ 447 (619)
|.+ . ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 322 1 23368899999999999876 7899999998863
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0095 Score=60.41 Aligned_cols=31 Identities=26% Similarity=0.348 Sum_probs=27.8
Q ss_pred CCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 417 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 417 ~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999888899999988764
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0016 Score=67.71 Aligned_cols=114 Identities=15% Similarity=0.109 Sum_probs=83.1
Q ss_pred CeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhcc
Q 007073 77 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 156 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 156 (619)
.++.+.+..+. +....|..+.+|+.+.+.++ ++..-..+|.++++|+.++|.++ ++..-...|.+|++|+.+++.
T Consensus 277 ~l~~~~~~~~~---i~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp 351 (394)
T 4fs7_A 277 GLKKVIYGSVI---VPEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFP 351 (394)
T ss_dssp TCCEEEECSSE---ECTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCC
T ss_pred ccceeccCcee---eccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEEC
Confidence 55666665543 33456788999999999765 66455677999999999999765 774556789999999999998
Q ss_pred CCcCCCCCCCccccccccccccCCCCcccccCCccccccCcc
Q 007073 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKY 198 (619)
Q Consensus 157 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~l 198 (619)
.| ++..-..+|.+|++|+.+++..| ++ .+...+.+.++|
T Consensus 352 ~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L 390 (394)
T 4fs7_A 352 LS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKF 390 (394)
T ss_dssp TT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEE
T ss_pred cc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCC
Confidence 77 66344668999999999998654 33 344445554444
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.47 E-value=0.0024 Score=66.32 Aligned_cols=114 Identities=13% Similarity=0.045 Sum_probs=87.8
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
..++.+.+..+... +....|.....|+.+.+..+.+. ...|..+.+|+.+.+.+| ++..-...|.++++|+.++|
T Consensus 253 ~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~l 327 (394)
T 4fs7_A 253 TDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDL 327 (394)
T ss_dssp SSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECC
T ss_pred ccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEe
Confidence 46888888877554 77778899999999998876543 346889999999999876 66455678999999999999
Q ss_pred cCCcCCCCCCCccccccccccccCCCCcccccCC-ccccccCc
Q 007073 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP-VHLFQIPK 197 (619)
Q Consensus 156 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~ 197 (619)
.++ ++..-..+|.+|++|+.+++..| ++ .|+ ..|.++.+
T Consensus 328 p~~-v~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~ 367 (394)
T 4fs7_A 328 PYL-VEEIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQGCIN 367 (394)
T ss_dssp CTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTBTTCTT
T ss_pred CCc-ccEEhHHhccCCCCCCEEEECcc-cc-EehHHHhhCCCC
Confidence 754 76344678999999999999877 76 555 45554433
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.37 E-value=0.002 Score=67.02 Aligned_cols=106 Identities=13% Similarity=0.167 Sum_probs=84.2
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
..|+.+.+.++... +-...|.++++|+.+.+. +.++..-...|.++++|+.++|..| ++..-...|.+|++|+.+.|
T Consensus 265 ~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~i 341 (394)
T 4gt6_A 265 AYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAI 341 (394)
T ss_dssp SSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEE
T ss_pred ccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEE
Confidence 46888888765443 667788899999999996 5566455678999999999999876 66455678999999999999
Q ss_pred cCCcCCCCCCCccccccccccccCCCCccc
Q 007073 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLS 185 (619)
Q Consensus 156 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 185 (619)
..+ ++..-..+|.+|++|+.+++.+|...
T Consensus 342 p~s-v~~I~~~aF~~C~~L~~i~~~~~~~~ 370 (394)
T 4gt6_A 342 PSS-VTKIPESAFSNCTALNNIEYSGSRSQ 370 (394)
T ss_dssp CTT-CCBCCGGGGTTCTTCCEEEESSCHHH
T ss_pred Ccc-cCEEhHhHhhCCCCCCEEEECCceee
Confidence 755 66344568999999999999988654
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=96.19 E-value=0.0082 Score=61.79 Aligned_cols=100 Identities=16% Similarity=0.114 Sum_probs=45.7
Q ss_pred CeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhcc
Q 007073 77 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 156 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 156 (619)
.|+.+.+..+ ++.+-...|....+|+.+.+..+ ++......|.++++|+.+.+.+|.++..-...|.++++|+.+.|.
T Consensus 241 ~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp 318 (379)
T 4h09_A 241 ALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLP 318 (379)
T ss_dssp SCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECC
T ss_pred cceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcC
Confidence 3444444433 33333444445555555555432 332223345555555555555555543333445555555555554
Q ss_pred CCcCCCCCCCccccccccccccC
Q 007073 157 QNNFSGTIPDSLTTLSSLISIQL 179 (619)
Q Consensus 157 ~N~l~~~~p~~~~~l~~L~~L~l 179 (619)
.| ++..-..+|.+|++|+.+.+
T Consensus 319 ~~-l~~I~~~aF~~C~~L~~i~i 340 (379)
T 4h09_A 319 TA-LKTIQVYAFKNCKALSTISY 340 (379)
T ss_dssp TT-CCEECTTTTTTCTTCCCCCC
T ss_pred cc-ccEEHHHHhhCCCCCCEEEE
Confidence 32 33122334555555555544
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.12 E-value=0.018 Score=53.55 Aligned_cols=104 Identities=16% Similarity=0.096 Sum_probs=67.0
Q ss_pred cchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcc
Q 007073 375 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 454 (619)
Q Consensus 375 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 454 (619)
.-+|.+.|..+ +.+++..+++.++.|.+.+|.-+-.+..+ ..+=+.|..|++..+|.|...+ +.+.
T Consensus 32 ~vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 32 ALSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred cccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc--------
Confidence 44788888764 35699999999999999998776321111 1233457889999999887763 1110
Q ss_pred eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 007073 455 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRA 498 (619)
Q Consensus 455 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p 498 (619)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1233567888763 3557889999999999998865444
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.60 E-value=0.0011 Score=61.24 Aligned_cols=89 Identities=12% Similarity=0.140 Sum_probs=63.2
Q ss_pred cccCCCCCCEEEccCC-CCCC----CCcccccccccCcEeeecCCCccccC----CCcccccccchhhhccCCcCCCC--
Q 007073 95 RIGVLRTLSTLTLKGN-GITG----EIPEELGNLSSLTSLDLDNNRLVGKI----PPSLGNLKKLQFLTLSQNNFSGT-- 163 (619)
Q Consensus 95 ~~~~l~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~l~~N~l~~~-- 163 (619)
.+.+-+.|+.|+|++| +|.. .+-..+..-+.|+.|+|++|+|...- -..+..-+.|+.|+|++|.|...
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga 115 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL 115 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence 3445678999999986 7763 24455667789999999999998332 23344567899999999999732
Q ss_pred --CCCccccccccccccCCCCc
Q 007073 164 --IPDSLTTLSSLISIQLDSNN 183 (619)
Q Consensus 164 --~p~~~~~l~~L~~L~l~~N~ 183 (619)
+-.++..-+.|+.|+|++|.
T Consensus 116 ~ala~aL~~N~tL~~L~L~n~~ 137 (197)
T 1pgv_A 116 ARLLRSTLVTQSIVEFKADNQR 137 (197)
T ss_dssp HHHHHHTTTTCCCSEEECCCCS
T ss_pred HHHHHHHhhCCceeEEECCCCc
Confidence 22234444679999998763
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.98 E-value=0.078 Score=55.26 Aligned_cols=74 Identities=7% Similarity=0.038 Sum_probs=48.3
Q ss_pred cCccccCCCceEEEEEeCC--------CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCc-cceeeeeeCCCcceeE
Q 007073 299 KNVLGQGGFGKVYRGVLAD--------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL-LRLIGFCTTPTERLLV 369 (619)
Q Consensus 299 ~~~lg~G~fg~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv 369 (619)
.+.+..|-...+|+....+ +..+++|+.... +. ..-+..+|.++++.+...++ .++++.+ ..+.|
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~-t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I 148 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH-VG-KFYDSKVELDVFRYLSNINIAPNIIADF----PEGRI 148 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC-C--CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC-cc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEE
Confidence 4567788899999999753 578888875432 11 11223578888887754344 3455433 24789
Q ss_pred ecccccchh
Q 007073 370 YPFMQNLSV 378 (619)
Q Consensus 370 ~e~~~~gsL 378 (619)
++|++|.++
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.37 E-value=0.15 Score=52.70 Aligned_cols=29 Identities=28% Similarity=0.470 Sum_probs=25.1
Q ss_pred eEecCCCCCcEEe------CCCCcEEEccccccee
Q 007073 419 IIHRDVKAANVLL------DEDFEAVVGDFGLAKL 447 (619)
Q Consensus 419 ivH~Dlkp~NIll------~~~~~~kl~DfGla~~ 447 (619)
++|+|+.+.||++ +++..++++||-+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567899999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.74 E-value=0.91 Score=42.02 Aligned_cols=116 Identities=11% Similarity=0.097 Sum_probs=79.4
Q ss_pred cCCCccceeeeeeCCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 007073 349 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN 428 (619)
Q Consensus 349 ~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 428 (619)
.||+++.. .+-.+.+...+.|+.-+.+.=...++. .+...+++++.+|+....+++.. +|=-+.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~-------~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS-------FTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG-------SCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh-------cCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 57888765 455556666666665443222222333 67889999999999988777655 788899999
Q ss_pred EEeCCCCcEEEcccccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 007073 429 VLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 500 (619)
Q Consensus 429 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~ 500 (619)
++++.++.+++.=.|+... ++|. ..++..=.-.+=+++..+++++..|+
T Consensus 110 L~f~~~~~p~i~~RGik~~------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNV------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTT------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccC------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999986665322 2222 12222334478889999999988774
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=86.62 E-value=0.12 Score=54.67 Aligned_cols=62 Identities=10% Similarity=0.007 Sum_probs=18.5
Q ss_pred cccCccccCCCceEEEEEeCC-CcEEEE------EEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeee
Q 007073 297 SEKNVLGQGGFGKVYRGVLAD-GTKVAV------KRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCT 361 (619)
Q Consensus 297 ~~~~~lg~G~fg~Vy~~~~~~-g~~vAv------K~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 361 (619)
.+.+.|| ||.||+|.+.. ..+||| |..+... +.+....|.+|..+++..+|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3456676 99999999864 368899 7765422 2334457888999999999999999988764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.69 E-value=1.7 Score=40.38 Aligned_cols=115 Identities=14% Similarity=0.165 Sum_probs=77.0
Q ss_pred cCCCccceeeeeeCCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHH-HHHhcCCCCeEecCCCCC
Q 007073 349 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE-YLHEHCNPKIIHRDVKAA 427 (619)
Q Consensus 349 ~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~-~LH~~~~~~ivH~Dlkp~ 427 (619)
.||.+ -..+-.+.+...+.|+.-+++.=...++. .+...+++++.+++.... +++.. +|--+.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-------~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-------TTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-------SCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-------cCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCc
Confidence 47777 34444666666676765544333333332 678889999999988777 66654 78889999
Q ss_pred cEEeCCCCcEEEcccccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 007073 428 NVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 500 (619)
Q Consensus 428 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~ 500 (619)
|+++|.++.+++.-.|+-. -++|.-+ ++.-=.-.+=+++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~------------------~lpP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKE------------------SLPPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETT------------------TBSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCcc------------------cCCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999998666532 3334321 222223478888899998887663
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 619 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-63 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-59 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-57 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-56 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-52 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-52 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-48 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-48 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-47 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-42 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-42 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-42 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-36 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-34 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-33 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-13 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 0.004 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-10 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-10 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-07 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 4e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 7e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 6e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 7e-04 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 2e-63
Identities = 72/278 (25%), Positives = 124/278 (44%), Gaps = 25/278 (8%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 353
+ LG G FG+V+ G TKVAVK L + AF E ++ H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQRL 70
Query: 354 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 413
+RL T ++ +M+N S+ L+ P L +A A G+ ++ E
Sbjct: 71 VRLYAVVTQE-PIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 414 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 473
IHRD++AAN+L+ + + DFGLA+L++ + + + APE ++
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 474 GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 533
G + ++DV+ +GI+L E+VT R + ++ ++++ R R D +
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPY----PGMTNPEVIQNLERGYRMVRPDNCPEE-- 238
Query: 534 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ Q+ LC + PEDRP + +LE
Sbjct: 239 -----------LYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 2e-62
Identities = 72/283 (25%), Positives = 127/283 (44%), Gaps = 27/283 (9%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRN 352
+ +G G FG VY+G VAVK L +P AF+ EV ++ H N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 412
+L +G+ T P +V + + S+ + L I+ + + +A A+G++YLH
Sbjct: 66 ILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLH 121
Query: 413 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD-VRKTNVTTQVRGTMGHIAPEYL 471
IIHRD+K+ N+ L ED +GDFGLA + ++ Q+ G++ +APE +
Sbjct: 122 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 472 STGKS---SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528
S ++DV+ +GI+L EL+TGQ + ++ V + L +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS----NINNRDQIIFMVGRGYLSPDLSKV 234
Query: 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ M ++ C + ++RP +++ +E
Sbjct: 235 RS---------NCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 4e-60
Identities = 68/278 (24%), Positives = 120/278 (43%), Gaps = 25/278 (8%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 353
+ +G G FG V+ G + KVA+K + E + F E E++ H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR--EGAMSEEDFIEEAEVMMKLSHPKL 62
Query: 354 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 413
++L G C LV+ FM++ ++ LR + T + L G+ YL E
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 414 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 473
C +IHRD+ A N L+ E+ V DFG+ + V + +T + + +PE S
Sbjct: 120 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 474 GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 533
+ S ++DV+ +G+++ E+ + + +R E +++ + R +
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE----VVEDISTGFRLYKPRLASTH-- 230
Query: 534 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ Q+ C + PEDRPA S ++R L
Sbjct: 231 -----------VYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (505), Expect = 2e-59
Identities = 67/311 (21%), Positives = 122/311 (39%), Gaps = 47/311 (15%)
Query: 288 ELQLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQRE 341
L+ +N +G+G FG+V++ T VAVK L + S A FQRE
Sbjct: 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 66
Query: 342 VEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIK--------------- 386
+++ + N+++L+G C L++ +M + LR +
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 387 -----PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD 441
PG P L + +A A G+ YL E K +HRD+ N L+ E+ + D
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIAD 183
Query: 442 FGLAKLV-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 500
FGL++ + + + PE + + + +DV+ YG++L E+ +
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 501 FSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDR 560
+ EE ++ +V+ + + + LC P DR
Sbjct: 244 YGMAHEE----VIYYVRDGNILACPENCPLE-------------LYNLMRLCWSKLPADR 286
Query: 561 PAMSEVVRMLE 571
P+ + R+L+
Sbjct: 287 PSFCSIHRILQ 297
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 3e-59
Identities = 67/278 (24%), Positives = 115/278 (41%), Gaps = 25/278 (8%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 353
++ + LGQG FG+V+ G T+VA+K L AF +E +++ H L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKL 74
Query: 354 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 413
++L + +V +M S L +A A G+ Y+
Sbjct: 75 VQLYAVVSEE-PIYIVTEYMSKGS--LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 414 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 473
+HRD++AAN+L+ E+ V DFGLA+L++ + + + APE
Sbjct: 132 MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
Query: 474 GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 533
G+ + ++DV+ +GI+L EL T R + E +LD V++ R +
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQVERGYRMPCPPECPES-- 242
Query: 534 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ + C + PE+RP + LE
Sbjct: 243 -----------LHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (503), Expect = 3e-59
Identities = 69/305 (22%), Positives = 131/305 (42%), Gaps = 40/305 (13%)
Query: 284 YSWRELQLATDNFSEK---------NVLGQGGFGKVYRGVLADGTK----VAVKRLTDFE 330
+++ + A F+++ V+G G FG+V G L K VA+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 331 SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEP 390
+ F E ++ H N++ L G T T +++ FM+N S+ LR+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 391 VLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450
+ + G A G++YL + +HRD+ A N+L++ + V DFGL++ ++
Sbjct: 127 ---VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 451 RKTNVTT----QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE 506
++ T + + APE + K + +DV+ YGI++ E+++ + +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP-YWDMTN 239
Query: 507 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 566
+ D + +E++ RL +D + Q+ L C Q RP ++
Sbjct: 240 Q------DVINAIEQDYRLPPPMD----------CPSALHQLMLDCWQKDRNHRPKFGQI 283
Query: 567 VRMLE 571
V L+
Sbjct: 284 VNTLD 288
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 5e-59
Identities = 63/290 (21%), Positives = 126/290 (43%), Gaps = 30/290 (10%)
Query: 290 QLATDNFSEKNVLGQGGFGKVYRGVLADGT-----KVAVKRLTDFESPGGDAAFQREVEM 344
++ + + V+G G FG+VY+G+L + VA+K L + F E +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 345 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 404
+ H N++RL G + +++ +M+N ++ LRE + + + G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGI 119
Query: 405 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGT 462
A G++YL +HRD+ A N+L++ + V DFGL++++ D T T+ +
Sbjct: 120 AAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 463 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 522
+ APE +S K + +DV+ +GI++ E++T + E
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--------------- 221
Query: 523 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572
+ ++ + + Q+ + C Q RP +++V +L+
Sbjct: 222 --VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 4e-58
Identities = 62/291 (21%), Positives = 113/291 (38%), Gaps = 30/291 (10%)
Query: 287 RELQLATDNFSEKNV-LGQGGFGKVYRGVLA---DGTKVAVKRLTDFESPGGDAAFQREV 342
++L L DN ++ LG G FG V +GV VA+K L RE
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 343 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 402
+++ + ++RLIG C +LV + L + + +
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLH 116
Query: 403 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT--NVTTQVR 460
+ G++YL E +HRD+ A NVLL A + DFGL+K + + + +
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 461 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 520
+ APE ++ K S R+DV+ YG+ + E ++ + ++ ++ +++ +
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP----YKKMKGPEVMAFIEQGK 229
Query: 521 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
R + + + C EDRP V + +
Sbjct: 230 RMECPPECPPE-------------LYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-57
Identities = 52/278 (18%), Positives = 103/278 (37%), Gaps = 25/278 (8%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 353
+ + LG G FG V G VA+K + E + F E +++ H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLSHEKL 61
Query: 354 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 413
++L G CT ++ +M N + L ++ + +EYL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCL---LNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 414 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 473
+HRD+ A N L+++ V DFGL++ V + + + + PE L
Sbjct: 119 KQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 474 GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 533
K S ++D++ +G+++ E+ + + + R + + +L R
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMP-YERFTNSETAEHIAQGLRLYRPHLAS------- 227
Query: 534 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
E + + C ++RP ++ +
Sbjct: 228 ---------EKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (490), Expect = 2e-57
Identities = 70/291 (24%), Positives = 127/291 (43%), Gaps = 25/291 (8%)
Query: 282 KRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQR 340
++ + ++ + + K+ LG G +G+VY GV VAVK L E F +
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLK 62
Query: 341 EVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV 400
E ++ H NL++L+G CT ++ FM ++ LRE E + V +
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYM 120
Query: 401 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 460
A + +EYL + IHRD+ A N L+ E+ V DFGL++L+ +
Sbjct: 121 ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177
Query: 461 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 520
+ APE L+ K S ++DV+ +G++L E+ T + +
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------------- 224
Query: 521 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ +++++ E + ++ C Q +P DRP+ +E+ + E
Sbjct: 225 ----VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 2e-57
Identities = 60/306 (19%), Positives = 121/306 (39%), Gaps = 35/306 (11%)
Query: 289 LQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISV 347
++L D+F + + LG G G V++ G +A K + P RE++++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 348 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARG 407
++ G + E + M S+ L++ + +V++ +G
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKG 116
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 467
L YL E KI+HRDVK +N+L++ E + DFG++ + ++ GT +++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMS 171
Query: 468 PEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL---------------- 511
PE L S ++D++ G+ L+E+ G+ I +E + +
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 512 ---------LLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA 562
+D + + LD IV+ K + C +P +R
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 563 MSEVVR 568
+ +++
Sbjct: 292 LKQLMV 297
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 3e-57
Identities = 65/302 (21%), Positives = 109/302 (36%), Gaps = 41/302 (13%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMIS- 346
+ S LG G FGKV VAVK L A E++++S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 347 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE--------------IKPGEPVL 392
+ H N++ L+G CT L++ + + LR ++ E L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 393 DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-DVR 451
D + A+G+ +L IHRD+ A N+LL + DFGLA+ + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 452 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL 511
V R + +APE + + +DV+ YGI L EL + + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---- 255
Query: 512 LLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ ++ M + C A P RP ++V+++E
Sbjct: 256 ------------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
Query: 572 GE 573
+
Sbjct: 304 KQ 305
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 1e-56
Identities = 71/279 (25%), Positives = 112/279 (40%), Gaps = 31/279 (11%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 353
+G+G FG V G G KVAVK + + AF E +++ H NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNL 62
Query: 354 LRLIGFCTTPTERL-LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 412
++L+G L +V +M S+ LR G VL + +L +EYL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 413 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS 472
+ +HRD+ A NVL+ ED A V DFGL K + + + APE L
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEALR 173
Query: 473 TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532
K S ++DV+ +GI+L E+ + R ++ ++ V+K + D
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRVEKGYKMDAPDGCPPA- 228
Query: 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ +V C RP+ ++ LE
Sbjct: 229 ------------VYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 3e-56
Identities = 64/307 (20%), Positives = 111/307 (36%), Gaps = 46/307 (14%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMIS- 346
+N VLG G FGKV +VAVK L + A E++M++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 347 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP------------------- 387
+ H N++ L+G CT L++ + + LR +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 388 GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447
VL + A A+G+E+L +HRD+ A NVL+ + DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 448 VDVRKTNVT-TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE 506
+ V R + +APE L G + ++DV+ YGI+L E+ + + +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-YPGIPV 272
Query: 507 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 566
+ + ++ + E + + C RP+ +
Sbjct: 273 DANFY---------------KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317
Query: 567 VRMLEGE 573
L +
Sbjct: 318 TSFLGCQ 324
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 3e-56
Identities = 77/304 (25%), Positives = 130/304 (42%), Gaps = 37/304 (12%)
Query: 295 NFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVH 350
+F+E V+G+G FG VY G L D AVK L G + F E ++ H
Sbjct: 30 HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 351 RNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 409
N+L L+G C + L+V P+M++ + + P L A+G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNP--TVKDLIGFGLQVAKGM- 143
Query: 410 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV---DVRKTNVTTQVRGTMGHI 466
+ K +HRD+ A N +LDE F V DFGLA+ + + + T + + +
Sbjct: 144 --KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 467 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526
A E L T K + ++DV+ +G++L EL+T + + + ++ + R + +
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY----PDVNTFDITVYLLQGRRLLQPE 257
Query: 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERW--EEWQH 584
D + +V L C E RP+ SE+V + + + E + H
Sbjct: 258 YCPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRI--SAIFSTFIGEHYVH 302
Query: 585 VEVT 588
V T
Sbjct: 303 VNAT 306
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 1e-55
Identities = 64/294 (21%), Positives = 118/294 (40%), Gaps = 29/294 (9%)
Query: 299 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 358
+ +G+G FG+V+RG G +VAVK + E + E+ + H N+L I
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIA 64
Query: 359 FCT----TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 414
T T+ LV + ++ S+ L + ++AL A GL +LH
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHME 119
Query: 415 C-----NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV---TTQVRGTMGHI 466
P I HRD+K+ N+L+ ++ + D GLA D + GT ++
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 467 APEYLST------GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE--DDVLLLDHVKK 518
APE L +S +R D++ G++ E+ + D++ D +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 519 LEREKRLDAIVDRNLNKNY-NIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
R+ + + N+ + + + + M ++ C A+ R + + L
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 2e-55
Identities = 63/294 (21%), Positives = 127/294 (43%), Gaps = 38/294 (12%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLADG---TKVAVKRLTDFESPGGDAAFQREVEMIS-VAV 349
++ ++V+G+G FG+V + + A+KR+ ++ S F E+E++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 350 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEP------------VLDWVTR 397
H N++ L+G C L + + ++ LR+ + E L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 398 KRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT 457
A ARG++YL + + IHRD+ A N+L+ E++ A + DFGL++ +V T
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 458 QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 517
R + +A E L+ + +DV+ YG++L E+V+ + L + +
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG----TPYCGMTCAELYEKLP 240
Query: 518 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ R ++ D + + C + P +RP+ ++++ L
Sbjct: 241 QGYRLEKPLNCDDE-------------VYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 4e-54
Identities = 60/280 (21%), Positives = 110/280 (39%), Gaps = 31/280 (11%)
Query: 298 EKNVLGQGGFGKVYRGVLAD---GTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNL 353
E LG G FG V +G VAVK L + P E ++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 354 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 413
+R+IG C + +LV + + L++ + + + + G++YL E
Sbjct: 71 VRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEE 125
Query: 414 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYL 471
+HRD+ A NVLL A + DFGL+K + D T + + APE +
Sbjct: 126 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 472 STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531
+ K S ++DV+ +G+++ E + + + ++ + +L+ +++
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSEVTAMLEKGERMGCPAGCP----- 236
Query: 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
M + LC E+RP + V L
Sbjct: 237 -----------REMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 8e-54
Identities = 53/281 (18%), Positives = 108/281 (38%), Gaps = 25/281 (8%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 351
+++ +G G +G+ + +DG + K L + EV ++ H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 352 NLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 409
N++R T L V + + +A + + LD RV L+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 410 YLHEH--CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 467
H ++HRD+K ANV LD +GDFGLA++++ T+ GT +++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKAFVGTPYYMS 182
Query: 468 PEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527
PE ++ +E++D++ G +L EL L +++ + +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-----AFSQKELAGKIREGKFRR---- 233
Query: 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568
+ Y+ + + ++ RP++ E++
Sbjct: 234 -----IPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 4e-53
Identities = 68/309 (22%), Positives = 129/309 (41%), Gaps = 33/309 (10%)
Query: 278 FGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFES 331
F Y E ++A + + LGQG FG VY GV T+VA+K + + S
Sbjct: 4 FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 63
Query: 332 PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGE-- 389
F E ++ +++RL+G + L++ M + LR ++P
Sbjct: 64 MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 123
Query: 390 ----PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 445
++A A G+ YL+ + K +HRD+ A N ++ EDF +GDFG+
Sbjct: 124 NPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 180
Query: 446 KLV-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRL 504
+ + + + + ++PE L G + +DV+ +G++L E+ T
Sbjct: 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY---- 236
Query: 505 EEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 564
+ + +L V + + D D + ++ +C Q +P+ RP+
Sbjct: 237 QGLSNEQVLRFVMEGGLLDKPDNCPDM-------------LFELMRMCWQYNPKMRPSFL 283
Query: 565 EVVRMLEGE 573
E++ ++ E
Sbjct: 284 EIISSIKEE 292
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 1e-52
Identities = 59/277 (21%), Positives = 111/277 (40%), Gaps = 32/277 (11%)
Query: 299 KNVLGQGGFGKVYRGVLAD-GTKVAVKRLTD-FESPGGDAAFQREVEMISVAVHRNLLRL 356
+G+G F VY+G+ + +VA L D + F+ E EM+ H N++R
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 357 IGFCTTPTER----LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 412
+ + +LV M + ++ L+ K + + +GL++LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLH 129
Query: 413 EHCNPKIIHRDVKAANVLL-DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 471
P IIHRD+K N+ + +GD GLA L + V GT +APE
Sbjct: 130 TR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMY 185
Query: 472 STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531
K E DV+ +G+ +LE+ T + E ++ + V + D +
Sbjct: 186 E-EKYDESVDVYAFGMCMLEMATSEYPYS----ECQNAAQIYRRVTSGVKPASFDKVAIP 240
Query: 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568
+ ++ C + + ++R ++ +++
Sbjct: 241 EV------------KEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 3e-52
Identities = 57/278 (20%), Positives = 110/278 (39%), Gaps = 26/278 (9%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
+++ LG+G +G+V V VAVK + + ++E+ + + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 412
+++ G + L + + R+ + +R G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLH 120
Query: 413 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYL 471
I HRD+K N+LLDE + DFGLA + + + ++ GT+ ++APE L
Sbjct: 121 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 472 STGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530
+ +E DV+ GI+L ++ G+ D ++ + L K++D+
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237
Query: 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568
L+K +P R + ++ +
Sbjct: 238 ALLHK----------------ILVENPSARITIPDIKK 259
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 7e-52
Identities = 63/280 (22%), Positives = 109/280 (38%), Gaps = 36/280 (12%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVH 350
++F LG+G FG VY +A+K L E G + +REVE+ S H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 351 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 410
N+LRL G+ T L+ + +V L+++ D A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSY 121
Query: 411 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 470
H ++IHRD+K N+LL E + DFG + ++ T + GT+ ++ PE
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEM 175
Query: 471 LSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530
+ E+ D++ G++ E + G+ + + +E
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---------------------TYK 214
Query: 531 RNLNKNYNIQEV--ETMIQVALLCTQASPEDRPAMSEVVR 568
R + + E + + +P RP + EV+
Sbjct: 215 RISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 177 bits (450), Expect = 2e-51
Identities = 71/282 (25%), Positives = 107/282 (37%), Gaps = 35/282 (12%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAV 349
FS+ +G G FG VY + + VA+K++ + +S +EV +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 350 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 409
H N ++ G LV + + KP L V V GA +GL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLA 129
Query: 410 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 469
YLH H +IHRDVKA N+LL E +GDFG A ++ GT +APE
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMAPE 181
Query: 470 YLST---GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526
+ G+ + DV+ GI +EL + L + + L H+ + E
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPP-----LFNMNAMSALYHIAQNESPALQS 236
Query: 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568
E C Q P+DRP +++
Sbjct: 237 GHWS------------EYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 1e-50
Identities = 64/304 (21%), Positives = 122/304 (40%), Gaps = 32/304 (10%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLAD-----GTKVAVKRLTDFESPGGDAAFQREVEMISVA 348
F + VLG G FG VY+G+ VA+K L + SP + E +++
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 349 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 408
+ ++ RL+G C T T +L+ M + +RE K + A+G+
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIG---SQYLLNWCVQIAKGM 124
Query: 409 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGHIA 467
YL + +++HRD+ A NVL+ + DFGLAKL+ K + + +A
Sbjct: 125 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 468 PEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527
E + + ++DV+ YG+ + EL+T + + + +L+ ++L +
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP-YDGIPASEISSILEKGERLPQPPICT- 239
Query: 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEV 587
+ + + C + RP E++ +A + + ++
Sbjct: 240 ---------------IDVYMIMVKCWMIDADSRPKFRELIIEF--SKMARDPQRYLVIQG 282
Query: 588 TRRQ 591
R
Sbjct: 283 DERM 286
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 3e-49
Identities = 76/286 (26%), Positives = 107/286 (37%), Gaps = 31/286 (10%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRL--TDFESPGGDAAFQREVEMISV 347
+ LG G FG V RG VAVK L P F REV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 348 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARG 407
HRNL+RL G TP ++ V S+ RLR+ + T R A+ A G
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEG 123
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN--VTTQVRGTMGH 465
+ YL IHRD+ A N+LL +GDFGL + + + + +
Sbjct: 124 MGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 466 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525
APE L T S +D + +G+ L E+ T + + +L K+ ER R
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKIDKEGERLPRP 237
Query: 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ + V + C PEDRP + L
Sbjct: 238 EDCPQD-------------IYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-48
Identities = 53/282 (18%), Positives = 108/282 (38%), Gaps = 28/282 (9%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAV 349
+ +G+G FG V++G+ VA+K + S F +E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 350 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 409
H ++++LIG T ++ + L+ K LD + A + L
Sbjct: 67 HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALA 122
Query: 410 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 469
YL + +HRD+ A NVL+ + +GDFGL++ ++ ++ + + +APE
Sbjct: 123 YLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 470 YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529
++ + + +DV+ +G+ + E++ + ++ ++ ER
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIGRIENGERLPMPPNC- 234
Query: 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
T+ + C P RP +E+ L
Sbjct: 235 ------------PPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-48
Identities = 71/299 (23%), Positives = 117/299 (39%), Gaps = 40/299 (13%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV------LADGTKVAVKRLTDFESPGGDAAFQREVEMISV 347
D LG+G FG+V A VAVK L + + A E++++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 348 AVHR-NLLRLIGFCTTPTERL-LVYPFMQNLSVAYRLREIKP------------GEPVLD 393
H N++ L+G CT P L ++ F + +++ LR + + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 394 WVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 453
+ A+G+E+L K IHRD+ A N+LL E + DFGLA+ +
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 454 NV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL 512
V R + +APE + + ++DV+ +G++L E+ + + + D
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP---GVKIDEEF 246
Query: 513 LDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+K+ R + D M Q L C P RP SE+V L
Sbjct: 247 CRRLKEGTRMRAPDYTTPE-------------MYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 3e-48
Identities = 74/300 (24%), Positives = 118/300 (39%), Gaps = 42/300 (14%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVL--------ADGTKVAVKRLTDFESPGGDAAFQREVEMI 345
D LG+G FG+V TKVAVK L + + E+EM+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 346 S-VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG------------EPVL 392
+ H+N++ L+G CT ++ + ++ L+ +P E L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 393 DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452
A ARG+EYL K IHRD+ A NVL+ ED + DFGLA+ +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 453 TNVTTQV-RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL 511
T R + +APE L + ++DV+ +G++L E+ T + EE
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 245
Query: 512 LLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
L +K+ R + + + + C A P RP ++V L+
Sbjct: 246 LFKLLKEGHRMDKPSNCTNE-------------LYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 5e-47
Identities = 57/277 (20%), Positives = 116/277 (41%), Gaps = 27/277 (9%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 351
++ +GQG G VY + +A G +VA++++ + + E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNP 77
Query: 352 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 411
N++ + E +V ++ S+ + E D V + LE+L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-----DEGQIAAVCRECLQALEFL 132
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 471
H + ++IHRD+K+ N+LL D + DFG + ++ +T V GT +APE +
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVV 188
Query: 472 STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531
+ + D++ GIM +E++ G+ ++ + +L+ ++L AI
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248
Query: 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568
LN+ C E R + E+++
Sbjct: 249 FLNR----------------CLDMDVEKRGSAKELLQ 269
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 5e-46
Identities = 58/282 (20%), Positives = 103/282 (36%), Gaps = 30/282 (10%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 351
D + LG G FGKVY+ A K + D +S + E+++++ H
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI-DTKSEEELEDYMVEIDILASCDHP 69
Query: 352 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 411
N+++L+ ++ F +V + E++ L + V L YL
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLDALNYL 126
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 471
H++ KIIHRD+KA N+L D + + DFG++ R GT +APE +
Sbjct: 127 HDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT-RTIQRRDSFIGTPYWMAPEVV 182
Query: 472 STGKS-----SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526
S + DV+ GI L+E+ + + L + R
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 242
Query: 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568
C + + + R S++++
Sbjct: 243 ----------------SNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 1e-42
Identities = 58/282 (20%), Positives = 106/282 (37%), Gaps = 30/282 (10%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVH 350
++F +LG+G F V LA + A+K L RE +++S H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 351 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 410
++L + + +N + +R+I D + LEY
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 123
Query: 411 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPE 469
LH IIHRD+K N+LL+ED + DFG AK++ K GT +++PE
Sbjct: 124 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 470 YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529
L+ + + +D++ G ++ +LV G ++ L+ + KLE +
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPP-----FRAGNEYLIFQKIIKLEYD------- 228
Query: 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ + + +++ R E+
Sbjct: 229 ---FPEKFF-PKARDLVE---KLLVLDATKRLGCEEMEGYGP 263
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 154 bits (390), Expect = 2e-42
Identities = 59/299 (19%), Positives = 111/299 (37%), Gaps = 31/299 (10%)
Query: 275 RIAFGQLKRYSWRELQLAT----DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDF 329
F K+Y + +++ D++ LG G FG V+R A G A K +
Sbjct: 3 NYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV-MT 61
Query: 330 ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGE 389
++E++ +SV H L+ L E +++Y FM + ++ +
Sbjct: 62 PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK- 120
Query: 390 PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL--DEDFEAVVGDFGLAKL 447
+ +GL ++HE+ +H D+K N++ E + DFGL
Sbjct: 121 --MSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175
Query: 448 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE 507
+D +++ T GT APE TD++ G++ L++G E
Sbjct: 176 LDPKQSVKVT--TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP-----FGGE 228
Query: 508 DDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 566
+D L +VK + +D ++++ A P R + +
Sbjct: 229 NDDETLRNVKSCDW--NMDDSAFSGISED--------GKDFIRKLLLADPNTRMTIHQA 277
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (386), Expect = 2e-42
Identities = 55/284 (19%), Positives = 111/284 (39%), Gaps = 22/284 (7%)
Query: 286 WRELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEM 344
W++ + D + ++VLG G F +V VA+K + G + + + E+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 345 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 404
+ H N++ L + L+ + + R+ E R+
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF----YTERDASRLIFQV 116
Query: 405 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 464
++YLH+ + LDED + ++ DFGL+K+ D +V + GT G
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACGTPG 174
Query: 465 HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524
++APE L+ S+ D + G++ L+ G +E+D L + + L+ E
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP-----FYDENDAKLFEQI--LKAEYE 227
Query: 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568
D+ +++ + + PE R + ++
Sbjct: 228 FDSPYWDDISDS--------AKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 151 bits (382), Expect = 2e-41
Identities = 64/308 (20%), Positives = 110/308 (35%), Gaps = 35/308 (11%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
D + LG G FG V+R V A G K + + P + E+ +++ H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFI-NTPYPLDKYTVKNEISIMNQLHHPK 87
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 412
L+ L E +L+ F+ + R+ + A GL+++H
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK---MSEAEVINYMRQACEGLKHMH 144
Query: 413 EHCNPKIIHRDVKAANVLLD--EDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 470
EH I+H D+K N++ + + + DFGLA ++ + T APE
Sbjct: 145 EH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEI 199
Query: 471 LSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530
+ TD++ G++ L++G EDD+ L +VK+ + E DA
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSP-----FAGEDDLETLQNVKRCDWEFDEDAFSS 254
Query: 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRR 590
+ Q P R + + L W + H +T R
Sbjct: 255 VS----------PEAKDFIKNLLQKEPRKRLTVHDA--------LEHPWLKGDHSNLTSR 296
Query: 591 QEYERLQR 598
R +
Sbjct: 297 IPSSRYNK 304
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 148 bits (375), Expect = 4e-41
Identities = 54/286 (18%), Positives = 113/286 (39%), Gaps = 18/286 (6%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRN 352
+ + +G+G +G VY+ G A+K++ + E G + RE+ ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 412
+++L T +LV+ + + + E L+ VT K L G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 413 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS 472
+ +++HRD+K N+L++ + E + DFGLA+ + T ++ +
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 473 TGKSSERTDVFGYGIMLLELVTGQRAIDFS----------RLEEEDDVLLLDHVKKLERE 522
+ K S D++ G + E+V G R+ + +V +L +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 523 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568
+ + +++ E+ I + + P R + +
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 148 bits (374), Expect = 6e-41
Identities = 59/289 (20%), Positives = 109/289 (37%), Gaps = 40/289 (13%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--------TDFESPGGDAAFQREVE- 343
+N+ K +LG+G V R + + AVK + + E A +EV+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 344 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 403
+ V+ H N+++L T T LV+ M+ + L E L +++
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRA 118
Query: 404 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 463
+ LH+ I+HRD+K N+LLD+D + DFG + +D +V GT
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTP 173
Query: 464 GHIAPEYLSTG------KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 517
++APE + + D++ G+++ L+ G +L+L +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-----FWHRKQMLMLRMIM 228
Query: 518 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 566
+ D + +T+ + P+ R E
Sbjct: 229 SGNYQFGSPEWDDYS----------DTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 149 bits (378), Expect = 1e-40
Identities = 60/254 (23%), Positives = 107/254 (42%), Gaps = 21/254 (8%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRL--TDFESPGGDAAFQREVEMISVAV- 349
++FS ++G+GGFG+VY AD G A+K L + G+ E M+S+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 350 --HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARG 407
++ + TP + + M + Y L + + A G
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF----SEADMRFYAAEIILG 119
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 467
LE++H +++RD+K AN+LLDE + D GLA +K GT G++A
Sbjct: 120 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMA 173
Query: 468 PEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526
PE L G + D F G ML +L+ G + +++ ++ + +E
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233
Query: 527 ----AIVDRNLNKN 536
++++ L ++
Sbjct: 234 PELRSLLEGLLQRD 247
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 144 bits (365), Expect = 8e-40
Identities = 64/289 (22%), Positives = 115/289 (39%), Gaps = 32/289 (11%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAV 349
+D + +LG GG +V+ L VAVK L P F+RE + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 350 HRNLLRLIGFCTTPTERL----LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 405
H ++ + T +V ++ +++ + P + V A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADAC 121
Query: 406 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV--TTQVRGTM 463
+ L + H++ IIHRDVK AN+++ V DFG+A+ + +V T V GT
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 464 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 523
+++PE R+DV+ G +L E++TG+ + + HV++
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT----GDSPVSVAYQHVRE----- 229
Query: 524 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-AMSEVVRMLE 571
D I ++ + + V L +PE+R +E+ L
Sbjct: 230 --DPIPPSARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 3e-39
Identities = 58/286 (20%), Positives = 107/286 (37%), Gaps = 20/286 (6%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 351
+NF + +G+G +G VY+ G VA+K++ D E+ G + RE+ ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 352 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 411
N+++L+ T + LV+ F+ + G + K +GL +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAFC 118
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 471
H H ++HRD+K N+L++ + + DFGLA+ V T +V L
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 472 STGKSSERTDVFGYGIMLLELVTGQRAID-----------FSRLEEEDDVLLLDHVKKLE 520
S D++ G + E+VT + F L D+V+ +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 521 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 566
+ ++ +K E + P R +
Sbjct: 236 YKPSFPKWARQDFSKVVP-PLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (361), Expect = 5e-39
Identities = 54/295 (18%), Positives = 94/295 (31%), Gaps = 33/295 (11%)
Query: 288 ELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMIS 346
EL++ + + +G G FG +Y G +A G +VA+K E ++
Sbjct: 2 ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC---VKTKHPQLHIESKIYK 57
Query: 347 VAVHRNLLRLIGFCTTPTERL-LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 405
+ + I +C + +V + + T +A
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMI 113
Query: 406 RGLEYLHEHCNPKIIHRDVKAANVL---LDEDFEAVVGDFGLAKLVDVRKTNV------T 456
+EY+H IHRDVK N L + + DFGLAK +T+
Sbjct: 114 SRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170
Query: 457 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV 516
+ GT + + + S R D+ G +L+ G + +
Sbjct: 171 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230
Query: 517 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
KK+ L K Y C +D+P S + ++
Sbjct: 231 KKMS-------TPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 7e-39
Identities = 53/283 (18%), Positives = 118/283 (41%), Gaps = 13/283 (4%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 351
++ + +G+G +G V + +VA+K+++ FE RE++++ H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 352 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 411
N++ + PT + ++ + L ++ + L RGL+Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYI 125
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT--TQVRGTMGHIAPE 469
H ++HRD+K +N+LL+ + + DFGLA++ D + T+ T + APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 470 YLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528
+ ++ D++ G +L E+++ + F D + + + ++ L+ I
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI--FPGKHYLDQLNHILGILGSPSQEDLNCI 240
Query: 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
++ + + L A + A+ + +ML
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSK---ALDLLDKMLT 280
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 142 bits (360), Expect = 1e-38
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 14/207 (6%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVH 350
+F LG G FG+V+ +G A+K L E M+S+ H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 351 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 410
++R+ G + ++ +++ L + K A LEY
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 411 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 470
LH II+RD+K N+LLD++ + DFG AK V +VT + GT +IAPE
Sbjct: 120 LHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEV 172
Query: 471 LSTGKSSERTDVFGYGIMLLELVTGQR 497
+ST ++ D + +GI++ E++ G
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 1e-38
Identities = 65/291 (22%), Positives = 116/291 (39%), Gaps = 21/291 (7%)
Query: 292 ATDNFSEKNVLGQGGFGKVYRG--VLADGTKVAVKRL-TDFESPGGDAAFQREVE---MI 345
A + +G+G +GKV++ + G VA+KR+ G + REV +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 346 SVAVHRNLLRLIGFCTTPT--ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 403
H N++RL CT + +++ K EP + T K +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 404 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 463
RGL++LH H +++HRD+K N+L+ + + DFGLA++ + T V T+
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTL 179
Query: 464 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 523
+ APE L + D++ G + E+ + S ++ +L E +
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 524 RLDAIVDRNLNKNYNIQEVETMIQ------VALL--CTQASPEDRPAMSEV 566
D + R + + Q +E + LL C +P R +
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-38
Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 12/208 (5%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAV- 349
++F +LG+G FGKV+ A+K L E ++S+A
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 350 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 409
H L + T V ++ + Y ++ D A GL+
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQ 117
Query: 410 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 469
+LH I++RD+K N+LLD+D + DFG+ K + T GT +IAPE
Sbjct: 118 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPE 173
Query: 470 YLSTGKSSERTDVFGYGIMLLELVTGQR 497
L K + D + +G++L E++ GQ
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQS 201
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 139 bits (352), Expect = 7e-38
Identities = 40/291 (13%), Positives = 88/291 (30%), Gaps = 34/291 (11%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
++ +G+G FG ++ G L + +VA+K + E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCT 61
Query: 353 LL-RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 411
+ + F +LV + + T A ++ +
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK----FSVKTVAMAAKQMLARVQSI 117
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVG-----DFGLAKLVDVRKTNV------TTQVR 460
HE +++RD+K N L+ DFG+ K T +
Sbjct: 118 HEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174
Query: 461 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 520
GT +++ + S R D+ G + + + G + L+ + + + + +
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL--PWQGLKAATNKQKYERIGEKK 232
Query: 521 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+ L R L + E + + + P + +
Sbjct: 233 QSTPL-----RELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-37
Identities = 49/278 (17%), Positives = 103/278 (37%), Gaps = 28/278 (10%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
+ + LG+G FG V+R V + K + ++E+ ++++A HRN
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHRN 62
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 412
+L L + E ++++ F+ L + R+ L+ L++LH
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFE---LNEREIVSYVHQVCEALQFLH 119
Query: 413 EHCNPKIIHRDVKAANVLLDEDFEAVV--GDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 470
H I H D++ N++ + + +FG A+ + + + + APE
Sbjct: 120 SH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--PGDNFRLLFTAPEYYAPEV 174
Query: 471 LSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530
S TD++ G ++ L++G E + +++++ E D
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINP-----FLAETNQQIIENIMNAEYT------FD 223
Query: 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568
K + E + + R SE ++
Sbjct: 224 EEAFKEIS-IEAMDFVD---RLLVKERKSRMTASEALQ 257
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-37
Identities = 70/281 (24%), Positives = 114/281 (40%), Gaps = 23/281 (8%)
Query: 298 EK-NVLGQGGFGKVYRGV-LADGTKVAVKRL----TDFESPGGDAAFQREVEMISVAVHR 351
EK + LG+G F VY+ VA+K++ G + RE++++ H
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 352 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 411
N++ L+ + LV+ FM+ IK VL K L +GLEYL
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 116
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 471
H+H I+HRD+K N+LLDE+ + DFGLAK T QV T + APE L
Sbjct: 117 HQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELL 172
Query: 472 STGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530
+ D++ G +L EL+ L + D+ L + + + D
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPF-----LPGDSDLDQLTRIFETLGTPTEEQWPD 227
Query: 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571
+Y + I + + + A + + + +
Sbjct: 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDD---LLDLIQGLFL 265
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 1e-36
Identities = 63/293 (21%), Positives = 106/293 (36%), Gaps = 32/293 (10%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 352
++++ V+G G FG VY+ L D G VA+K++ RE++++ H N
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCN 74
Query: 353 LLRLIGFCTTPTER------LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR 406
++RL F + E+ LV ++ + + L + K R
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-LPVIYVKLYMYQLFR 133
Query: 407 GLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 465
L Y+H I HRD+K N+LLD D + DFG AK + VR + +
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICSRYYR 189
Query: 466 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL------------L 513
+ DV+ G +L EL+ GQ F D ++ +
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 514 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 566
+ E + I K + + I + + +P R E
Sbjct: 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 2e-35
Identities = 53/285 (18%), Positives = 93/285 (32%), Gaps = 34/285 (11%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREVEMISV 347
D + LG G F V + + G + A K R +REV ++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 348 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARG 407
H N++ L T+ +L+ + L + + L G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLDED----FEAVVGDFGLAKLVDVRKTNVTTQVRGTM 463
+ YLH I H D+K N++L + + DFGLA +D N + GT
Sbjct: 126 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTP 180
Query: 464 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 523
+APE ++ D++ G++ L++G +E L +V
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----TLANVSA----- 230
Query: 524 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568
V+ Y P+ R + + ++
Sbjct: 231 -----VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 4e-35
Identities = 50/289 (17%), Positives = 110/289 (38%), Gaps = 22/289 (7%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 351
+ + +G+G +G V++ VA+KR+ D + G ++ RE+ ++ H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 352 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 411
N++RL + + LV+ F Y + + V + L+ L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG-------DLDPEIVKSFLFQLLKGL 114
Query: 412 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 471
+ ++HRD+K N+L++ + E + +FGLA+ + + +V
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 472 STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531
S D++ G + EL R + F + +D + + + E++ ++
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPL-FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 532 NLNKNYNIQEVETMIQVALL------------CTQASPEDRPAMSEVVR 568
K Y + T + + + +P R + E ++
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-34
Identities = 54/277 (19%), Positives = 96/277 (34%), Gaps = 33/277 (11%)
Query: 301 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVE-MISVAVHRNLLRLIG 358
VLG G GKV + K A+K L D +REVE + +++R++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK------ARREVELHWRASQCPHIVRIVD 72
Query: 359 FCTTPTER----LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 414
L+V + + R++ G+ + ++YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 415 CNPKIIHRDVKAANVLLDEDFE---AVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 471
I HRDVK N+L + DFG AK + T T ++APE L
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVL 185
Query: 472 STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531
K + D++ G+++ L+ G + + +K R + +
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFY-----SNHGLAISPGMKTRIRMGQYE----- 235
Query: 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568
+ E + + + P R ++E +
Sbjct: 236 -FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 2e-33
Identities = 55/278 (19%), Positives = 99/278 (35%), Gaps = 44/278 (15%)
Query: 301 VLGQGGFGKVYRGV-LADGTKVAVKRL-----TDFESPGGDAAFQREVEMIS--VAVHRN 352
+LG GGFG VY G+ ++D VA+K + +D+ EV ++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 353 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 412
++RL+ + P +L+ + + + + L + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 127
Query: 413 EHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 471
++HRD+K N+L+D + E + DFG L+ K V T GT + PE++
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 181
Query: 472 STGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530
+ V+ GI+L ++V G + V V ++
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS-----SECQHLIR 236
Query: 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568
L P DRP E+
Sbjct: 237 WCLALR--------------------PSDRPTFEEIQN 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 7e-33
Identities = 48/207 (23%), Positives = 80/207 (38%), Gaps = 11/207 (5%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVH 350
++F +LG+G FGKV A G A+K L + A E ++ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 351 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 410
L L T V + + + L + T +R A +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-------FTEERARFYGAEIVSA 117
Query: 411 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 470
L + +++RD+K N++LD+D + DFGL K GT ++APE
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEV 176
Query: 471 LSTGKSSERTDVFGYGIMLLELVTGQR 497
L D +G G+++ E++ G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 1e-32
Identities = 66/302 (21%), Positives = 115/302 (38%), Gaps = 38/302 (12%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 351
+ + +GQG FG+V++ G KVA+K++ + E G RE++++ + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 352 NLLRLIGFCTTPTER--------LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 403
N++ LI C T LV+ F ++ + KRV
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQM 125
Query: 404 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT---NVTTQVR 460
GL Y+H + KI+HRD+KAANVL+ D + DFGLA+ + K N T
Sbjct: 126 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 461 GTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL 519
T+ + PE L + D++G G ++ E+ T E+ + L+ +
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI--MQGNTEQHQLALISQLCGS 240
Query: 520 EREKRLDAIVDRNLNKNYNIQEVETMIQVALL---------------CTQASPEDRPAMS 564
+ + + L + + + + L P R
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300
Query: 565 EV 566
+
Sbjct: 301 DA 302
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 123 bits (310), Expect = 1e-31
Identities = 51/221 (23%), Positives = 82/221 (37%), Gaps = 16/221 (7%)
Query: 280 QLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDA 336
+ + S QL D F LG G FG+V G A+K L
Sbjct: 29 KWETPSQNTAQL--DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 337 AFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT 396
E ++ L++L + +V ++ + LR I
Sbjct: 87 HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPH 142
Query: 397 RKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 456
+ A EYLH +I+RD+K N+L+D+ V DFG AK R T
Sbjct: 143 ARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRT 195
Query: 457 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 497
+ GT +APE + + ++ D + G+++ E+ G
Sbjct: 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 3e-31
Identities = 65/293 (22%), Positives = 116/293 (39%), Gaps = 32/293 (10%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 351
+ + +G G +G V V G KVA+K+L F+S RE+ ++ H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 352 NLLRLIGFCTTP------TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 405
N++ L+ T T+ LV PFM +L + + L + +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDL--GKLMKHEK----LGEDRIQFLVYQML 131
Query: 406 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 465
+GL Y+H HRD+K N+ ++ED E + DFGLA+ D + +T V
Sbjct: 132 KGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVVTRWYR 185
Query: 466 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRA-IDFSRLEEEDDVLLLDHVKKLEREKR 524
L+ + ++ D++ G ++ E++TG+ L++ +++ + E +R
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245
Query: 525 LDAIVDRNLNKNYNIQEVETMIQV---------ALL--CTQASPEDRPAMSEV 566
L + +N K E + + LL E R E
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 2e-29
Identities = 52/214 (24%), Positives = 89/214 (41%), Gaps = 17/214 (7%)
Query: 294 DNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRL---TDFESPGGDAAFQREVEMIS 346
+NF VLG G +GKV+ G A+K L T + + E +++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 347 VAVHR-NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 405
L+ L T T+ L+ ++ + L + + T V +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-------FTEHEVQIYVG 136
Query: 406 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 465
+ L II+RD+K N+LLD + V+ DFGL+K +T GT+ +
Sbjct: 137 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
Query: 466 IAPEYLSTGKS--SERTDVFGYGIMLLELVTGQR 497
+AP+ + G S + D + G+++ EL+TG
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 113 bits (283), Expect = 4e-28
Identities = 55/289 (19%), Positives = 106/289 (36%), Gaps = 30/289 (10%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVE-MISVAVHR 351
D++ LG+G + +V+ + + + KV VK L P +RE++ + ++
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL----KPVKKKKIKREIKILENLRGGP 90
Query: 352 NLLRLIGFCTTPTERL--LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 409
N++ L P R LV+ + N + L + + L+
Sbjct: 91 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALD 143
Query: 410 YLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 468
Y H I+HRDVK NV++D + + + D+GLA+ + + P
Sbjct: 144 YCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGP 198
Query: 469 E-YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527
E + D++ G ML ++ + F + D L+ K L E D
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEP--FFHGHDNYDQLVRI-AKVLGTEDLYDY 255
Query: 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSE-----VVRMLE 571
I N+ + ++ E++ +S + ++L
Sbjct: 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 304
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 1e-27
Identities = 47/206 (22%), Positives = 82/206 (39%), Gaps = 8/206 (3%)
Query: 293 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVH 350
+ + + +G G +G V G +VAVK+L F+S RE+ ++ H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 351 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 410
N++ L+ T + L + + RGL+Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 411 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 470
+H HRD+K +N+ ++ED E + DFGLA+ D T V
Sbjct: 137 IHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIM 190
Query: 471 LSTGKSSERTDVFGYGIMLLELVTGQ 496
L+ ++ D++ G ++ EL+TG+
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 4e-27
Identities = 44/207 (21%), Positives = 82/207 (39%), Gaps = 12/207 (5%)
Query: 294 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHR 351
+ +G G G V VA+K+L+ F++ RE+ ++ H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 352 NLLRLIGFCTTPT--ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 409
N++ L+ T E + L A + I+ + G++
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---HERMSYLLYQMLCGIK 133
Query: 410 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 469
+LH IHRD+K +N+++ D + DFGLA+ + + T T + APE
Sbjct: 134 HLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPE 188
Query: 470 YLSTGKSSERTDVFGYGIMLLELVTGQ 496
+ E D++ G ++ E+V +
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (261), Expect = 4e-25
Identities = 47/236 (19%), Positives = 87/236 (36%), Gaps = 21/236 (8%)
Query: 301 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMIS-----------VA 348
LG G F V+ + + T VA+K + A + E++++
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVR--GDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 349 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVL-DWVTRKRVALGAARG 407
++L+L+ + + + L IK E + K+++ G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 408 LEYLHEHCNPKIIHRDVKAANVLLD-EDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGTMGH 465
L+Y+H C IIH D+K NVL++ D + +A L + + T +
Sbjct: 138 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 466 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 521
+PE L D++ ++ EL+TG F E DH+ ++
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFL--FEPDEGHSYTKDDDHIAQIIE 249
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.0 bits (212), Expect = 6e-20
Identities = 24/159 (15%), Positives = 47/159 (29%), Gaps = 20/159 (12%)
Query: 300 NVLGQGGFGKVYRGVLADGTKVAVK---------RLTDFESPGGDAAFQREVEMISVAVH 350
++G+G V+ + VK + + GD F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 351 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 410
R L +L G Y + N + + + ++ V +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVEN--PDEVLDMILEEVAK 118
Query: 411 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449
+ I+H D+ NVL+ + + DF + V
Sbjct: 119 FYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVG 153
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 75.8 bits (185), Expect = 2e-15
Identities = 24/84 (28%), Positives = 39/84 (46%), Gaps = 6/84 (7%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
L+ L+ LTL N I+ P + +L+ L L NN++ SL NL + +L+ N
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361
Query: 159 NFSGTIPDSLTTLSSLISIQLDSN 182
S P L L+ + + L+
Sbjct: 362 QISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 63.5 bits (153), Expect = 3e-11
Identities = 40/212 (18%), Positives = 67/212 (31%), Gaps = 36/212 (16%)
Query: 9 YCLKCFRFFDNFDPDLHNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWS 68
+ + + + +S A SL NNQ+ D +
Sbjct: 164 QVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNLDE 223
Query: 69 NVICDNS----------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIP- 117
+ N N+ + L++ S + L L+ L L N I+ P
Sbjct: 224 LSLNGNQLKDIGTLASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISNISPL 281
Query: 118 -------------------EELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
+ NL +LT L L N + P + +L KLQ L + N
Sbjct: 282 AGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANN 339
Query: 159 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV 190
S SL L+++ + N +S P+
Sbjct: 340 KVSD--VSSLANLTNINWLSAGHNQISDLTPL 369
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 52.7 bits (125), Expect = 7e-08
Identities = 16/77 (20%), Positives = 28/77 (36%), Gaps = 5/77 (6%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
L L +T + + +L +T+L D + K + L L + S N
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNN 76
Query: 159 NFSGTIP-DSLTTLSSL 174
+ P +LT L +
Sbjct: 77 QLTDITPLKNLTKLVDI 93
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 50.8 bits (120), Expect = 3e-07
Identities = 22/88 (25%), Positives = 36/88 (40%), Gaps = 6/88 (6%)
Query: 73 DNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLD 132
L N + T+S L ++TL GI + + L++LT ++
Sbjct: 19 TALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFS 74
Query: 133 NNRLVGKIPPSLGNLKKLQFLTLSQNNF 160
NN+L P L NL KL + ++ N
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQI 100
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 70.6 bits (171), Expect = 7e-14
Identities = 20/59 (33%), Positives = 29/59 (49%), Gaps = 1/59 (1%)
Query: 107 LKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIP 165
L+ N I G +P+ L L L SL++ N L G+I P GNL++ + N P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 70.2 bits (170), Expect = 1e-13
Identities = 54/189 (28%), Positives = 79/189 (41%), Gaps = 15/189 (7%)
Query: 32 LCSLS-GDALFALRTSLRVPNNQLRDWNQNQVNPC--TWSNVICDNSNNVASVT---LSS 85
LC+ AL ++ L P L W + C TW V+CD V LS
Sbjct: 2 LCNPQDKQALLQIKKDLGNPTT-LSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSG 59
Query: 86 MNFSG--TLSPRIGVLRTLSTLTLKGN-GITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 142
+N + + L L+ L + G + G IP + L+ L L + + + G IP
Sbjct: 60 LNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD 119
Query: 143 SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK----Y 198
L +K L L S N SGT+P S+++L +L+ I D N +SG IP K
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM 179
Query: 199 NFTGNNLNC 207
+ N L
Sbjct: 180 TISRNRLTG 188
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 65.2 bits (157), Expect = 5e-12
Identities = 23/66 (34%), Positives = 28/66 (42%), Gaps = 1/66 (1%)
Query: 124 SSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNN 183
+L LDL NNR+ G +P L LK L L +S NN G IP L +N
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302
Query: 184 LSGQIP 189
P
Sbjct: 303 CLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.0 bits (141), Expect = 5e-10
Identities = 23/88 (26%), Positives = 35/88 (39%), Gaps = 2/88 (2%)
Query: 57 WNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEI 116
N + S N+ + L + GTL + L+ L +L + N + GEI
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 117 PEELGNLSSLTSLDLDNNR-LVGKIPPS 143
P + GNL NN+ L G P+
Sbjct: 285 P-QGGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 67.8 bits (164), Expect = 6e-13
Identities = 32/156 (20%), Positives = 53/156 (33%), Gaps = 14/156 (8%)
Query: 65 CTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLS 124
C V C + + V P+ + + L L+ N IT + NL
Sbjct: 10 CHLRVVQCSD-LGLEKV------------PK-DLPPDTALLDLQNNKITEIKDGDFKNLK 55
Query: 125 SLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNL 184
+L +L L NN++ P + L KL+ L LS+N TL L + + +
Sbjct: 56 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKV 115
Query: 185 SGQIPVHLFQIPKYNFTGNNLNCGKTLPHSCESSSN 220
+ L Q+ N L + +
Sbjct: 116 RKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 151
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 55.0 bits (131), Expect = 9e-09
Identities = 46/200 (23%), Positives = 74/200 (37%), Gaps = 19/200 (9%)
Query: 23 DLHNGWLTFLCSLSGDALFALRTSLRVPNNQLRD-------------WNQNQVNPCTWSN 69
L N ++ + + L L L + NQL++ ++N++ S
Sbjct: 61 ILINNKISKISPGAFAPLVKLER-LYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSV 119
Query: 70 VICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSL 129
N V + + + SG + ++ LS + + IT IP+ G SLT L
Sbjct: 120 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTEL 176
Query: 130 DLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 189
LD N++ SL L L L LS N+ S SL L + L++N L
Sbjct: 177 HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPG 236
Query: 190 VH--LFQIPKYNFTGNNLNC 207
I NN++
Sbjct: 237 GLADHKYIQVVYLHNNNISA 256
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 47.3 bits (111), Expect = 3e-06
Identities = 35/195 (17%), Positives = 64/195 (32%), Gaps = 19/195 (9%)
Query: 23 DLHNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVT 82
DL N +T + L L T L + NN++ + P + + N + +
Sbjct: 37 DLQNNKITEIKDGDFKNLKNLHT-LILINNKISKISPGAFAPLVKLERLYLSKNQLKELP 95
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN--NRLVGKI 140
L N IT L+ + ++L + G
Sbjct: 96 EKMPKTLQELRVH-------------ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 142
Query: 141 PPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNF 200
+ +KKL ++ ++ N + TIP L SL + LD N ++ L +
Sbjct: 143 NGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAK 199
Query: 201 TGNNLNCGKTLPHSC 215
G + N + +
Sbjct: 200 LGLSFNSISAVDNGS 214
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 37.3 bits (85), Expect = 0.004
Identities = 22/167 (13%), Positives = 54/167 (32%), Gaps = 24/167 (14%)
Query: 1 MLLIDLLLYCLKCFRFFDNFDPDLHNGWLTFLCSLS----GDALFALRTSLRVPNNQLRD 56
M++++L LK + + + + L T L + N++
Sbjct: 126 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITK 185
Query: 57 WNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTL-------------SPRIGVLRTLS 103
+ + + + N++++V S+ + L + + +
Sbjct: 186 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQ 245
Query: 104 TLTLKGNGITG------EIPEELGNLSSLTSLDLDNNRL-VGKIPPS 143
+ L N I+ P +S + + L +N + +I PS
Sbjct: 246 VVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 292
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.6 bits (142), Expect = 5e-10
Identities = 15/111 (13%), Positives = 29/111 (26%), Gaps = 5/111 (4%)
Query: 102 LSTLTLKGNGITGE-IPEELGNLSSLTSLDLDNNRL----VGKIPPSLGNLKKLQFLTLS 156
+ +L ++ ++ E L L + LD+ L I +L L L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNC 207
N + S ++ +L +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTL 114
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.6 bits (142), Expect = 5e-10
Identities = 20/80 (25%), Positives = 26/80 (32%), Gaps = 9/80 (11%)
Query: 101 TLSTLTLKGNGITGE----IPEELGNLSSLTSLDLDNNRLVGKIPPSLG-----NLKKLQ 151
L L L ++ + L SL LDL NN L L L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 152 FLTLSQNNFSGTIPDSLTTL 171
L L +S + D L L
Sbjct: 430 QLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.6 bits (129), Expect = 2e-08
Identities = 18/96 (18%), Positives = 34/96 (35%), Gaps = 10/96 (10%)
Query: 75 SNNVASVTLSSMNFSGT-LSPRIGVLRTLSTLTLKGNGITGE----IPEELGNLSSLTSL 129
S ++ S+ + S + + +L+ + L G+T I L +L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 130 DLDNNRLVGKIPPSLG-----NLKKLQFLTLSQNNF 160
+L +N L + K+Q L+L
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 4e-07
Identities = 15/109 (13%), Positives = 33/109 (30%), Gaps = 9/109 (8%)
Query: 50 PNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGT----LSPRIGVLRTLSTL 105
Q+ + + + + + L+ + S + L+ + +L L
Sbjct: 343 LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 402
Query: 106 TLKGNGITGEIPEELG-----NLSSLTSLDLDNNRLVGKIPPSLGNLKK 149
L N + +L L L L + ++ L L+K
Sbjct: 403 DLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 7e-04
Identities = 11/60 (18%), Positives = 22/60 (36%), Gaps = 4/60 (6%)
Query: 146 NLKKLQFLTLSQNNFSGT----IPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFT 201
L+ L L+ + S + + +L SL + L +N L + L + +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.5 bits (124), Expect = 1e-08
Identities = 25/121 (20%), Positives = 44/121 (36%), Gaps = 4/121 (3%)
Query: 94 PRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQF 152
P S L +G + L +LT L ++N + + + L L +L+
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 153 LTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV--HLFQIPKYNFTGNNLNCGKT 210
LT+ ++ PD+ L + L N L + + +GN L+C
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCA 120
Query: 211 L 211
L
Sbjct: 121 L 121
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.5 bits (124), Expect = 5e-08
Identities = 37/184 (20%), Positives = 58/184 (31%), Gaps = 3/184 (1%)
Query: 25 HNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLS 84
G L L L L L L L+ + + N+ + L
Sbjct: 103 GLGRLHTL-HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLH 161
Query: 85 SMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSL 144
S L +L L L N + P +L L +L L N L +L
Sbjct: 162 GNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEAL 221
Query: 145 GNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNN 204
L+ LQ+L L+ N + + + L + S+ + +P L N+
Sbjct: 222 APLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAAND 280
Query: 205 L-NC 207
L C
Sbjct: 281 LQGC 284
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.6 bits (119), Expect = 2e-07
Identities = 37/202 (18%), Positives = 60/202 (29%), Gaps = 17/202 (8%)
Query: 23 DLHNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVT 82
LH ++ + + S A L N R + ++ + SV
Sbjct: 38 FLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVD 97
Query: 83 --------------LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTS 128
L L L L L+ N + + +L +LT
Sbjct: 98 PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTH 157
Query: 129 LDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSN---NLS 185
L L NR+ + L L L L QN + P + L L+++ L +N L
Sbjct: 158 LFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALP 217
Query: 186 GQIPVHLFQIPKYNFTGNNLNC 207
+ L + N C
Sbjct: 218 TEALAPLRALQYLRLNDNPWVC 239
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.5 bits (111), Expect = 2e-06
Identities = 36/184 (19%), Positives = 58/184 (31%), Gaps = 9/184 (4%)
Query: 8 LYCLKCFRFFDNFDPDLHNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQN--QVNPC 65
L L +L G L +L L + N ++
Sbjct: 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163
Query: 66 TWSNVICDNSNNVASVTLSSM--NFSGTLSPR-IGVLRTLSTLTLKGNGITGEIPEELGN 122
S+V + S+ + N + P L L TL L N ++ E L
Sbjct: 164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAP 223
Query: 123 LSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSN 182
L +L L L++N V + LQ S + ++P L +L +N
Sbjct: 224 LRALQYLRLNDNPWVC-DCRARPLWAWLQKFRGSSSEVPCSLPQRLAGRDLK---RLAAN 279
Query: 183 NLSG 186
+L G
Sbjct: 280 DLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.5 bits (98), Expect = 7e-05
Identities = 33/223 (14%), Positives = 58/223 (26%), Gaps = 38/223 (17%)
Query: 25 HNGWLTFLCSLSG-----DALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVA 79
+ +T C G + A + + N++ C ++ +SN +A
Sbjct: 10 NEPKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA 69
Query: 80 SVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN------ 133
+ ++ L + P L L +L LD
Sbjct: 70 RIDAAAFTGLALLEQLDLSDNAQ---------LRSVDPATFHGLGRLHTLHLDRCGLQEL 120
Query: 134 ------------------NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLI 175
N L + +L L L L N S + L SL
Sbjct: 121 GPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLD 180
Query: 176 SIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHSCESS 218
+ L N ++ P + + N LP +
Sbjct: 181 RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAP 223
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.9 bits (120), Expect = 2e-07
Identities = 26/137 (18%), Positives = 34/137 (24%), Gaps = 2/137 (1%)
Query: 25 HNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLS 84
+G L L +L L N T +
Sbjct: 72 VDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL 131
Query: 85 SMNFSGTLSPRIGVLRTLSTLTLKG-NGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPS 143
N TL P + N +T L L +L +L L N L IP
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKG 190
Query: 144 LGNLKKLQFLTLSQNNF 160
L F L N +
Sbjct: 191 FFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 3e-06
Identities = 12/59 (20%), Positives = 19/59 (32%), Gaps = 3/59 (5%)
Query: 102 LSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNF 160
+ +T +P +L T L L N L +L +L L L +
Sbjct: 12 HLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (100), Expect = 4e-05
Identities = 13/64 (20%), Positives = 21/64 (32%), Gaps = 3/64 (4%)
Query: 72 CDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDL 131
+ V N + L P + + + L L N + L + LT L+L
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 132 DNNR 135
D
Sbjct: 63 DRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 2e-04
Identities = 21/75 (28%), Positives = 25/75 (33%), Gaps = 1/75 (1%)
Query: 110 NGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLT 169
N + P L L L L NN L L L+ L L L +N+ TIP
Sbjct: 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF 192
Query: 170 TLSSLISIQLDSNNL 184
L L N
Sbjct: 193 GSHLLPFAFLHGNPW 207
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 50.6 bits (119), Expect = 2e-07
Identities = 18/123 (14%), Positives = 34/123 (27%), Gaps = 8/123 (6%)
Query: 101 TLSTLTLKGNGITGE----IPEELGNLSSLTSLDLDNNRL----VGKIPPSLGNLKKLQF 152
++ +LK + IT E + L S+ + L N + + ++ + K L+
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 153 LTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLP 212
S + L L+ L L P + T
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123
Query: 213 HSC 215
Sbjct: 124 EHL 126
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 47.2 bits (110), Expect = 3e-06
Identities = 15/81 (18%), Positives = 27/81 (33%), Gaps = 12/81 (14%)
Query: 107 LKGNGITGEIPEELGN------LSSLTSLDLDNNRLVGKIPPSL-----GNLKKLQFLTL 155
L ++ + + L +L L N + +L + L FL L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 156 SQNNFSGTIPDSLTTLSSLIS 176
+ N FS D + + + S
Sbjct: 310 NGNRFSE-EDDVVDEIREVFS 329
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.1 bits (102), Expect = 3e-05
Identities = 18/148 (12%), Positives = 41/148 (27%), Gaps = 10/148 (6%)
Query: 8 LYCLKCFRFFDNFDPDLHNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTW 67
L + N L L L + +
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244
Query: 68 SNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEEL-----GN 122
+ N +++ +++ + + L TL L+ N I + L
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLE----NIGLQTLRLQYNEIELDAVRTLKTVIDEK 300
Query: 123 LSSLTSLDLDNNRLVGKIPPSLGNLKKL 150
+ L L+L+ NR + + ++++
Sbjct: 301 MPDLLFLELNGNRF-SEEDDVVDEIREV 327
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 46.5 bits (109), Expect = 2e-06
Identities = 12/70 (17%), Positives = 26/70 (37%), Gaps = 4/70 (5%)
Query: 98 VLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQ 157
LK +T + + L+S+ + +N+ + K + L + L L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDI--KSVQGIQYLPNVTKLFLNG 77
Query: 158 NNFSGTIPDS 167
N + P +
Sbjct: 78 NKLTDIKPLA 87
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 6e-05
Identities = 12/40 (30%), Positives = 16/40 (40%), Gaps = 2/40 (5%)
Query: 117 PEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 156
L L+ L +L L N + +L LK L L L
Sbjct: 171 IVPLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELF 208
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 45.6 bits (106), Expect = 4e-06
Identities = 16/100 (16%), Positives = 30/100 (30%), Gaps = 1/100 (1%)
Query: 116 IPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLI 175
+ L L +L+L +N++ +P S +L L L +N L
Sbjct: 94 SNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN-LASNPFNCNCHLAWFAEWLR 152
Query: 176 SIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHSC 215
L+ P + + + + C C
Sbjct: 153 KKSLNGGAARCGAPSKVRDVQIKDLPHSEFKCSSENSEGC 192
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 6e-06
Identities = 23/151 (15%), Positives = 44/151 (29%), Gaps = 10/151 (6%)
Query: 7 LLYCLKCFRFFDNFDPDLHNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCT 66
L + + L L SL + ++ P
Sbjct: 206 LTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPN 265
Query: 67 WSNVICDNSNNVASV----TLSSMNFSGT-LSPRIGVLRTLSTLTLKGNGITGEIPEELG 121
+ ++ + +L +N S L + L L N + E+PE
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLERLIASFNHLA-EVPELPQ 324
Query: 122 NLSSLTSLDLDNNRLVGKIPPSLGNLKKLQF 152
NL L ++ N L + P +++ L+
Sbjct: 325 NL---KQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.0 bits (107), Expect = 8e-06
Identities = 22/108 (20%), Positives = 37/108 (34%), Gaps = 29/108 (26%)
Query: 110 NGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLT 169
N + EI SL L++ NN+L+ ++P L++L S N+ + +P+
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPELPQ 324
Query: 170 TLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHSCES 217
L L + N L +P S E
Sbjct: 325 NLKQL------------------------HVEYNPLREFPDIPESVED 348
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.8 bits (104), Expect = 2e-05
Identities = 17/66 (25%), Positives = 25/66 (37%), Gaps = 5/66 (7%)
Query: 100 RTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNN 159
R L L G++ +PE +L SL N L ++P +LK L +
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 160 FSGTIP 165
S P
Sbjct: 93 LSDLPP 98
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.9 bits (104), Expect = 1e-05
Identities = 10/43 (23%), Positives = 15/43 (34%)
Query: 116 IPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
+ S LD+ R+ L NLKKL+ +
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 2e-04
Identities = 8/50 (16%), Positives = 14/50 (28%), Gaps = 3/50 (6%)
Query: 140 IPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 189
L +S+ L L L + + NL ++P
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA--RSTYNLK-KLP 239
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 4e-04
Identities = 12/64 (18%), Positives = 24/64 (37%), Gaps = 3/64 (4%)
Query: 101 TLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNF 160
+ + + +T EIP +L + L +L + L+ + +SQN+
Sbjct: 9 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 161 SGTI 164
I
Sbjct: 66 LEVI 69
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 7e-04
Identities = 9/44 (20%), Positives = 13/44 (29%), Gaps = 3/44 (6%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 142
L + I L NL L + N + K+P
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (105), Expect = 1e-05
Identities = 17/95 (17%), Positives = 36/95 (37%), Gaps = 3/95 (3%)
Query: 104 TLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSG- 162
TL L G + ++ L + + + + + + + +Q + LS +
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVS 61
Query: 163 TIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK 197
T+ L+ S L ++ L+ LS I L +
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSN 96
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 20/119 (16%), Positives = 38/119 (31%), Gaps = 5/119 (4%)
Query: 51 NNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKG- 109
L + +N + V + S+ L L L+L
Sbjct: 152 QLNLSGYRKNLQKSDLSTLVRRCPNLVH-LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC 210
Query: 110 NGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSL 168
I E ELG + +L +L + G + L LQ ++ ++F+ ++
Sbjct: 211 YDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ---INCSHFTTIARPTI 266
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.5 bits (88), Expect = 0.001
Identities = 21/167 (12%), Positives = 50/167 (29%), Gaps = 4/167 (2%)
Query: 24 LHNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTL 83
L+ + + L + + L N + ++V + S
Sbjct: 100 LNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR 159
Query: 84 SSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN-NRLVGKIPP 142
++ S + + + + +E L+ L L L ++ +
Sbjct: 160 KNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLL 219
Query: 143 SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 189
LG + L+ L + GT+ L L Q++ ++ +
Sbjct: 220 ELGEIPTLKTLQVFGIVPDGTLQLLKEALPHL---QINCSHFTTIAR 263
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.0 bits (98), Expect = 2e-05
Identities = 21/108 (19%), Positives = 32/108 (29%), Gaps = 25/108 (23%)
Query: 91 TLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSL----------------------TS 128
T+ + L ++ L L N + P L L L
Sbjct: 11 TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDGVANLPRLQE 69
Query: 129 LDLDNNRLVG-KIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLI 175
L L NNRL L + +L L L N+ L+ ++
Sbjct: 70 LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.7 bits (92), Expect = 1e-04
Identities = 24/129 (18%), Positives = 41/129 (31%), Gaps = 18/129 (13%)
Query: 23 DLHNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVT 82
L + LT LC L L + T L + +N+LR + +++ A
Sbjct: 4 HLAHKDLTVLCHLEQ--LLLV-THLDLSHNRLRALPPA---LAALRCLEVLQASDNALEN 57
Query: 83 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITG-EIPEELGNLSSLTSLDLDNNRLVGKIP 141
+ + L L L N + + L + L L+L N L
Sbjct: 58 VDGVANL----------PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EE 106
Query: 142 PSLGNLKKL 150
L ++
Sbjct: 107 GIQERLAEM 115
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (99), Expect = 3e-05
Identities = 18/105 (17%), Positives = 32/105 (30%), Gaps = 6/105 (5%)
Query: 112 ITGEIPEELG---NLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSL 168
+T E+ E+ N LDL ++ I L + + S N D
Sbjct: 3 LTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGF 59
Query: 169 TTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPH 213
L L ++ +++N + +P N L
Sbjct: 60 PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGD 104
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (99), Expect = 3e-05
Identities = 19/109 (17%), Positives = 34/109 (31%), Gaps = 3/109 (2%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
L L+G I I L ++D +N + + L++L+ L ++ N
Sbjct: 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNNN 73
Query: 159 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNC 207
L L + L +N+L + K L
Sbjct: 74 RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 122
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 3e-05
Identities = 22/66 (33%), Positives = 31/66 (46%), Gaps = 5/66 (7%)
Query: 117 PEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLIS 176
L NLS LT+L D+N++ P L +L L + L N S P L S+L
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221
Query: 177 IQLDSN 182
+ L +N
Sbjct: 222 VTL-TN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 1e-04
Identities = 11/62 (17%), Positives = 21/62 (33%), Gaps = 4/62 (6%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
L + + +T + + +L +T+L + I + L L L L N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDN 73
Query: 159 NF 160
Sbjct: 74 QI 75
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.0 bits (97), Expect = 6e-05
Identities = 12/64 (18%), Positives = 22/64 (34%), Gaps = 4/64 (6%)
Query: 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158
L L +T + + +L +T+L D + K + L L + S N
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNN 72
Query: 159 NFSG 162
+
Sbjct: 73 QLTD 76
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 3e-04
Identities = 11/37 (29%), Positives = 19/37 (51%), Gaps = 2/37 (5%)
Query: 117 PEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFL 153
+ L NL++L LD+ +N++ L L L+ L
Sbjct: 165 LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 38.9 bits (89), Expect = 7e-04
Identities = 19/68 (27%), Positives = 30/68 (44%), Gaps = 11/68 (16%)
Query: 116 IPEELGNLS---SLTSLDLDNNRLVGKIPP------SLGNLKKLQFLTLSQNNFSGTIPD 166
I + + S+ + + + L G IPP +L LK + L LS NN I
Sbjct: 7 IKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KIS- 64
Query: 167 SLTTLSSL 174
SL+ + +L
Sbjct: 65 SLSGMENL 72
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 619 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.92 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.76 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.72 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.69 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.68 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.62 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.58 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.52 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.47 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.46 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.45 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.43 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.41 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.4 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.4 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.37 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.3 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.22 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.21 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.19 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.19 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.17 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.15 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.01 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.99 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.95 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.88 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.86 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.8 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.64 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.5 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.37 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.32 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.3 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.29 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.09 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.09 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.99 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.97 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.85 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.62 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.56 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.9 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.84 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.84 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.52 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.44 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 94.95 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=416.35 Aligned_cols=256 Identities=26% Similarity=0.402 Sum_probs=200.5
Q ss_pred hcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
.++|++.+.||+|+||+||+|.+.+++.||||+++.. ....++|.+|++++++++|||||+++|+|..++..++||||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC--cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 3578889999999999999999988999999999753 33467899999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++|+|.+++... ...+++..+.+++.|+|+||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp CTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred cCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 9999999988753 34588999999999999999999999 99999999999999999999999999998776554
Q ss_pred cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
........||+.|+|||++.+..++.++|||||||++|||+|+..|+.... ... +.........+.
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~----~~~---~~~~~i~~~~~~------- 221 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR----SNS---EVVEDISTGFRL------- 221 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC----CHH---HHHHHHHHTCCC-------
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC----CHH---HHHHHHHhcCCC-------
Confidence 444455679999999999999999999999999999999999655543211 111 111222111111
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
..+...+.++.+++.+||+.||++||||+||++.|+++
T Consensus 222 ---~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 222 ---YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11222346789999999999999999999999999874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.8e-53 Score=422.85 Aligned_cols=264 Identities=27% Similarity=0.366 Sum_probs=218.7
Q ss_pred HHHHHHhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCc
Q 007073 287 RELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE 365 (619)
Q Consensus 287 ~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 365 (619)
++++...++|++.+.||+|+||+||+|.+. +|+.||||+++.. ....++|.+|++++++++|||||+++|++.+++.
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT--CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc--cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 345566788999999999999999999976 5889999998643 3346789999999999999999999999999999
Q ss_pred ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 445 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 445 (619)
.++||||+++|+|.+++.... ...+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+|
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a 162 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS 162 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred eEEEeecccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccce
Confidence 999999999999999987632 34589999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 446 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 446 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
+..............|++.|+|||++.+..++.++|||||||++|||+||+.|+..... .. ........
T Consensus 163 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~----~~---~~~~~i~~---- 231 (287)
T d1opja_ 163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LS---QVYELLEK---- 231 (287)
T ss_dssp TTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC----HH---HHHHHHHT----
T ss_pred eecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch----HH---HHHHHHhc----
Confidence 97765555555556689999999999999999999999999999999998777643211 11 11111111
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 574 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 574 (619)
......+...+.++.+++.+||+.||++|||+.||++.|+...
T Consensus 232 ------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 232 ------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1111223334567899999999999999999999999998753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=418.51 Aligned_cols=259 Identities=28% Similarity=0.418 Sum_probs=211.8
Q ss_pred HHHHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 289 LQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 289 l~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
+++..++|++.+.||+|+||+||+|.+++++.||||+++.. ....+.|.+|++++++++|||||+++|++.. +..++
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG--SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC--cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence 34456789999999999999999999988899999999743 2346789999999999999999999998754 56789
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||+++|+|.+++.... ...+++..+.+++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+..
T Consensus 85 v~Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp EEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEc
Confidence 999999999998876532 23489999999999999999999999 9999999999999999999999999999987
Q ss_pred ccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
............||+.|||||++.++.++.++|||||||++|||+||+.|+..... .. +....+....+
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~----~~---~~~~~i~~~~~---- 228 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT----NP---EVIQNLERGYR---- 228 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC----HH---HHHHHHHTTCC----
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC----HH---HHHHHHHhcCC----
Confidence 65554445556789999999999999999999999999999999997666532211 11 11112211111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
...+...+.++.+++.+||+.||++||||++|++.|+.
T Consensus 229 ------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 229 ------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 11122334578999999999999999999999999976
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-52 Score=415.55 Aligned_cols=262 Identities=27% Similarity=0.450 Sum_probs=204.7
Q ss_pred HHHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
++..++|++.+.||+|+||+||+|+++ ..||||+++... .....+.|.+|++++++++|||||+++|++.. +..++
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 345678999999999999999999975 369999986433 45567889999999999999999999998754 56899
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||+++|+|.+++.... ..+++..+..++.|+|+||+|||++ +||||||||+|||++.++.+||+|||+|+..
T Consensus 81 v~Ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp EEECCCEEEHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred EEecCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeec
Confidence 999999999999997532 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCc-ceeeeccccccccccccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 449 DVRKT-NVTTQVRGTMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 449 ~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
..... .......||+.|||||++.+ ..++.++|||||||++|||+||+.||...... ..+...+.. +.
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~----~~~~~~~~~----~~ 226 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR----DQIIFMVGR----GY 226 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH----HHHHHHHHH----TS
T ss_pred cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH----HHHHHHHhc----CC
Confidence 54322 23445679999999999864 45899999999999999999999999643211 111111111 11
Q ss_pred cchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 525 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 525 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
. .+.+ .......+..+.+++.+||+.||++||||+||++.|+.+
T Consensus 227 ~----~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 227 L----SPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp C----CCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----CCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 0 0000 111223346789999999999999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=404.85 Aligned_cols=254 Identities=20% Similarity=0.347 Sum_probs=214.0
Q ss_pred hcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
.++|+..+.||+|+||+||+|++++++.||||+++... ...++|.+|++++++++|||||+++|++.+++..++||||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~--~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc--CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 36889999999999999999999988999999997533 3467899999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++|++..++.... ..+++..+.+++.|+++||+|||++ +|+||||||+||++++++.+||+|||+++......
T Consensus 81 ~~~g~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 81 MANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CTTEEHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred cCCCcHHHhhhccc---cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 99999999876532 3488999999999999999999999 99999999999999999999999999998776554
Q ss_pred cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhccc
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 531 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (619)
........||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... +....+....+
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--------~~~~~i~~~~~------- 219 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------ETAEHIAQGLR------- 219 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--------HHHHHHHTTCC-------
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--------HHHHHHHhCCC-------
Confidence 444555679999999999999999999999999999999998 79898643321 11122211111
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 532 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 532 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
...+...+..+.+++.+||+.||++|||+++|++.|.+
T Consensus 220 ---~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 220 ---LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ---CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 11122334678999999999999999999999999865
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=409.47 Aligned_cols=252 Identities=21% Similarity=0.288 Sum_probs=203.1
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
++|++.+.||+|+||+||+|++. +|+.||||++.........+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57999999999999999999975 68999999997554444556789999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 85 ~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 9999999998753 3489999999999999999999999 99999999999999999999999999999775433
Q ss_pred c-ceeeeccccccccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 453 T-NVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 453 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
. ......+||+.|||||++.+..+ +.++||||+||++|||+||+.||....... ... .........
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~----~~~~~~~~~----- 225 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEY----SDWKEKKTY----- 225 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS---HHH----HHHHTTCTT-----
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH---HHH----HHHhcCCCC-----
Confidence 2 22345679999999999988876 678999999999999999999997533211 111 111111000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.......+.++.+++.+||+.||++|||++|+++
T Consensus 226 ----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 226 ----LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ----STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111122357789999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-51 Score=415.48 Aligned_cols=257 Identities=26% Similarity=0.400 Sum_probs=201.1
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CC---cEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DG---TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g---~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
.++|++.++||+|+||+||+|.++ +| ..||||++.........+.|.+|++++++++|||||+++|++..++..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 356777899999999999999975 23 36899998766666667889999999999999999999999999999999
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||+++|+|.+++... ...+++..+.+++.|||+||+|||++ +|+||||||+|||++.++++||+|||+|+..
T Consensus 105 v~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence 99999999999988753 23489999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCcce----eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhc
Q 007073 449 DVRKTNV----TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREK 523 (619)
Q Consensus 449 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (619)
....... .....||+.|||||.+.++.++.++|||||||++|||+| |+.||..... . +.........
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-----~---~~~~~i~~~~ 250 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-----Q---DVINAIEQDY 250 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----H---HHHHHHHTTC
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-----H---HHHHHHHcCC
Confidence 5432221 223457899999999999999999999999999999998 8999864321 1 1122222111
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 524 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 524 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
+ ...+...+..+.+++.+||+.||++||||.||++.|+.+
T Consensus 251 ~----------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 251 R----------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp C----------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred C----------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 112333456789999999999999999999999999763
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-51 Score=408.86 Aligned_cols=255 Identities=25% Similarity=0.361 Sum_probs=209.3
Q ss_pred hcCCcccCc-cccCCCceEEEEEeC---CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 293 TDNFSEKNV-LGQGGFGKVYRGVLA---DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 293 ~~~~~~~~~-lg~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
.++|.+.+. ||+|+||+||+|.++ ++..||||+++........+.|.+|++++++++|||||+++|++.. +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 355666674 999999999999864 3557999999876666667889999999999999999999999865 46889
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
||||+++|+|.+++... ...+++..+.+++.|+|+||+|||++ +|+||||||+|||++.++.+||+|||+|+.+
T Consensus 86 vmE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcc
Confidence 99999999999987653 23489999999999999999999999 9999999999999999999999999999987
Q ss_pred ccCCcce--eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 449 DVRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 449 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
....... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||...... +....+....+
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--------~~~~~i~~~~~- 230 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQGKR- 230 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------HHHHHHHTTCC-
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCC-
Confidence 6543322 234468999999999999999999999999999999998 89999643211 11112211111
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
...+...+.++.+|+.+||+.||++||||.+|++.|+.
T Consensus 231 ---------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 231 ---------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp ---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11223344678999999999999999999999999976
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=410.32 Aligned_cols=258 Identities=24% Similarity=0.398 Sum_probs=203.9
Q ss_pred hcCCcccCccccCCCceEEEEEeCCC-----cEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcce
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLADG-----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~~g-----~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 367 (619)
.+.|+..++||+|+||+||+|.++++ ..||||+++..........|.+|++++++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35688889999999999999997532 3799999976655556678999999999999999999999999999999
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
+||||+.+|++.+.+.... ..+++..+.+++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEecccCcchhhhhccc---ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence 9999999999998876532 3489999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCcc--eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 448 VDVRKTN--VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 448 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
....... ......||+.|||||++.++.++.++|||||||++|||+||+.|+...... . +........
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~----~---~~~~~i~~~--- 229 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----H---EVMKAINDG--- 229 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----H---HHHHHHHTT---
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH----H---HHHHHHhcc---
Confidence 6543222 233456899999999999999999999999999999999977665432211 1 111111111
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.....+...+..+.+|+.+||+.||++||||.||++.|+.+
T Consensus 230 -------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 230 -------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp -------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 11122333456789999999999999999999999999863
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=408.12 Aligned_cols=256 Identities=20% Similarity=0.290 Sum_probs=196.4
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeC--CCcceeE
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT--PTERLLV 369 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv 369 (619)
++|++.+.||+|+||+||+|+.. +|+.||||.+.... .....+.+.+|++++++++|||||++++++.+ ....++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999975 68999999987543 33445678999999999999999999999865 4557899
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC--NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
|||+++|+|.+++.........+++..++.++.|++.||+|||++. ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999765444556999999999999999999999972 12499999999999999999999999999987
Q ss_pred eccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccch
Q 007073 448 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527 (619)
Q Consensus 448 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (619)
..... .......||+.|||||.+.+..++.++|||||||++|||+||+.||...... +....... ....
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--------~~~~~i~~-~~~~- 232 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--------ELAGKIRE-GKFR- 232 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHH-TCCC-
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--------HHHHHHHc-CCCC-
Confidence 65432 2234567999999999999999999999999999999999999999643211 11111111 1111
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 528 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..+...+.++.+++.+||+.||++|||+.|+++
T Consensus 233 --------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 --------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 112233457899999999999999999999874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-51 Score=416.12 Aligned_cols=262 Identities=25% Similarity=0.390 Sum_probs=209.2
Q ss_pred HHHhcCCcccCccccCCCceEEEEEeCC------CcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeC
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTT 362 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 362 (619)
++..++|++.+.||+|+||+||+|++.. ...||||++...........+.+|+.++.++ +|||||++++++..
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 3455789999999999999999999642 2369999987655555567899999999988 89999999999999
Q ss_pred CCcceeEecccccchhhhhhcccCC-------------------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 007073 363 PTERLLVYPFMQNLSVAYRLREIKP-------------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRD 423 (619)
Q Consensus 363 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D 423 (619)
++..++||||+++|+|.++++.... ....+++..++.++.|+++||+|||++ +|+|||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence 9999999999999999999976432 123589999999999999999999999 999999
Q ss_pred CCCCcEEeCCCCcEEEcccccceeeccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCC
Q 007073 424 VKAANVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDF 501 (619)
Q Consensus 424 lkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~ 501 (619)
|||+|||++.++.+||+|||+|+........ ......||+.|||||.+.++.++.++|||||||++|||+| |+.||..
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876544332 2334568999999999999999999999999999999998 8999864
Q ss_pred CccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007073 502 SRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 571 (619)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 571 (619)
.... ..+...+. .. .....+...+.++.+|+.+||+.||++|||++||++.|.
T Consensus 270 ~~~~----~~~~~~~~---~~----------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 270 IPVD----ANFYKLIQ---NG----------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCCS----HHHHHHHH---TT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHH----HHHHHHHh---cC----------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 3221 11111111 11 111222334467899999999999999999999999985
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-51 Score=406.60 Aligned_cols=258 Identities=26% Similarity=0.384 Sum_probs=204.6
Q ss_pred HHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
+..++|++.+.||+|+||.||+|.+++++.||||+++.. ....+.|.+|+.++++++|||||+++|++. .++.++||
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~ 90 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT 90 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc--cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEE
Confidence 345789999999999999999999988889999999643 334578999999999999999999999985 45689999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++|+|...+.... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+....
T Consensus 91 Ey~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 91 EYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EecCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccC
Confidence 9999999998887632 23489999999999999999999999 999999999999999999999999999987755
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
..........||+.|+|||++.++.++.++|||||||++|||+||+.|+..... .. +.........
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~----~~---~~~~~i~~~~------- 231 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----NR---EVLDQVERGY------- 231 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----HH---HHHHHHHTTC-------
T ss_pred CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC----HH---HHHHHHHhcC-------
Confidence 444444556799999999999999999999999999999999997776643221 11 1111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
....+...++++.+++.+||+.||++||||++|+++|+..
T Consensus 232 ---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 232 ---RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred ---CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 1112233446789999999999999999999999999873
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=398.74 Aligned_cols=246 Identities=25% Similarity=0.401 Sum_probs=206.2
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++|++.+.||+|+||+||+|+.+ +|+.||+|++.+.. .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999975 68999999986321 2334677899999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++|+|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999997643 389999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
. ......||+.|||||++.+..++.++|||||||++|||+||+.||...... +.........
T Consensus 159 ~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~~------- 220 (263)
T d2j4za1 159 S---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--------ETYKRISRVE------- 220 (263)
T ss_dssp C---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTTC-------
T ss_pred C---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCC-------
Confidence 2 234567999999999999999999999999999999999999999643211 1111111110
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..++...+.++.+++.+||+.||++|||++|+++
T Consensus 221 ----~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 ----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 0112223467889999999999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-50 Score=401.12 Aligned_cols=247 Identities=25% Similarity=0.366 Sum_probs=199.4
Q ss_pred CccccCCCceEEEEEeC---CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEeccccc
Q 007073 300 NVLGQGGFGKVYRGVLA---DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 375 (619)
Q Consensus 300 ~~lg~G~fg~Vy~~~~~---~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 375 (619)
+.||+|+||+||+|.++ .++.||||+++... .+...+.|.+|++++++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999864 35689999997533 34446789999999999999999999999965 457899999999
Q ss_pred chhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCcce
Q 007073 376 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 455 (619)
Q Consensus 376 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 455 (619)
|+|.++++... .+++..+.+++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999987633 389999999999999999999999 99999999999999999999999999999875443332
Q ss_pred --eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 456 --TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 456 --~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
.....||+.|||||.+.+..++.++|||||||++|||+| |+.||...... +....+....+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--------~~~~~i~~~~~-------- 228 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAMLEKGER-------- 228 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTCC--------
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--------HHHHHHHcCCC--------
Confidence 234568999999999999999999999999999999998 89999643211 11111211111
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
...+...+.++.+|+.+||+.||++|||+++|+++|+.
T Consensus 229 --~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 229 --MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred --CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 11223344678999999999999999999999998876
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=397.45 Aligned_cols=249 Identities=20% Similarity=0.305 Sum_probs=206.3
Q ss_pred cCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
++|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc-ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 4799999999999999999996 479999999986433 33457799999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++|+|.+++... .++...+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+|+.+....
T Consensus 99 ~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 9999999887652 388999999999999999999999 99999999999999999999999999999775433
Q ss_pred cceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcccc
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 532 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (619)
. ......||+.|+|||++.+..++.++||||+||++|||+||+.||...... +............
T Consensus 171 ~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~~~~~~~~~~------ 235 (293)
T d1yhwa1 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--------RALYLIATNGTPE------ 235 (293)
T ss_dssp C-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHHCSCC------
T ss_pred c-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH--------HHHHHHHhCCCCC------
Confidence 2 234557999999999999999999999999999999999999999643211 1111111111100
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 533 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 533 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
...+...+..+.+++.+||+.||++|||+.|+++
T Consensus 236 --~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 236 --LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp --CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0112223467899999999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-51 Score=415.32 Aligned_cols=267 Identities=22% Similarity=0.282 Sum_probs=207.8
Q ss_pred HhcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
..++|++.+.||+|+||+||+|.+. +|+.||+|+++..........+.+|+.++++++|||||++++++.+++..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4678999999999999999999975 789999999976555666778999999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
||+++|+|.+++.... .+++..+..++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||+|+...
T Consensus 84 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp ECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 9999999999997643 38999999999999999999997 5 89999999999999999999999999998664
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHH-------h--
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL-------E-- 520 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~-- 520 (619)
.. .....+||+.|+|||++.+..|+.++||||+||++|||+||+.||.................... .
T Consensus 157 ~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 157 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp HH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred CC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 32 22346799999999999999999999999999999999999999975432111000000000000 0
Q ss_pred ------------hhcc----cchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 521 ------------REKR----LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 521 ------------~~~~----~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.... ...+.............+.++.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0000 00000000000001112357889999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.2e-50 Score=405.80 Aligned_cols=267 Identities=24% Similarity=0.391 Sum_probs=216.0
Q ss_pred HHHHHHHhcCCcccCccccCCCceEEEEEeC------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeee
Q 007073 286 WRELQLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 359 (619)
Q Consensus 286 ~~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 359 (619)
+.+++...++|++.+.||+|+||+||+|+++ +++.||||+++........+.|.+|++++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3456667789999999999999999999963 4578999999766555567889999999999999999999999
Q ss_pred eeCCCcceeEecccccchhhhhhcccC--------------------CCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 007073 360 CTTPTERLLVYPFMQNLSVAYRLREIK--------------------PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 419 (619)
Q Consensus 360 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 419 (619)
+......++||||+++|+|.+++.... .....+++..+..++.|++.||+|||++ +|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 999999999999999999999986432 1223588999999999999999999999 99
Q ss_pred EecCCCCCcEEeCCCCcEEEcccccceeeccCCc-ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCC-C
Q 007073 420 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ-R 497 (619)
Q Consensus 420 vH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~-~ 497 (619)
|||||||+|||+|.++.+||+|||+|+....... ...+...||+.|+|||.+.+..++.++|||||||++|||+||. .
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 9999999999999999999999999986643322 2334556899999999999999999999999999999999996 4
Q ss_pred CCCCCccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 498 AIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 498 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
||..... . +....+.... . ...+...+.++.+|+.+||+.||++||||.||+++|+++
T Consensus 242 p~~~~~~-----~---e~~~~v~~~~-~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 242 PYYGMAH-----E---EVIYYVRDGN-I---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTTSCH-----H---HHHHHHHTTC-C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCCH-----H---HHHHHHHcCC-C---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 5543221 1 1112221111 1 111223345789999999999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-50 Score=400.30 Aligned_cols=257 Identities=21% Similarity=0.340 Sum_probs=199.8
Q ss_pred HHhcCCcccCccccCCCceEEEEEeCC----CcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcc
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 366 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 366 (619)
+..++|++.+.||+|+||.||+|.+.. +..||||+++........+.|.+|++++++++|||||+++|++. .+..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 345789999999999999999999742 45799999876655666778999999999999999999999985 4678
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
++||||+++|++.+++... ...+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+|+
T Consensus 83 ~iv~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp EEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhe
Confidence 9999999999999987653 23489999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007073 447 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 525 (619)
Q Consensus 447 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (619)
..............||+.|+|||.+.+..++.++|||||||++|||+| |..||...... .+.. ........
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~-----~~~~---~i~~~~~~ 228 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DVIG---RIENGERL 228 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GHHH---HHHTTCCC
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH-----HHHH---HHHcCCCC
Confidence 776555545556678999999999999999999999999999999998 88888653321 1111 11111111
Q ss_pred chhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 526 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 526 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
..+...+..+.+++.+||+.||++|||+.||++.|+.
T Consensus 229 ----------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 229 ----------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1223344678999999999999999999999999876
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=396.26 Aligned_cols=251 Identities=22% Similarity=0.282 Sum_probs=204.4
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
+.|++.+.||+|+||+||+|.+. +|+.||||++... .....+.|.+|++++++++|||||++++++.+++..++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 46888999999999999999975 6899999998653 344567899999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 91 ~~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 91 CAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp CTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred CCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 99999999876532 3489999999999999999999999 99999999999999999999999999998654321
Q ss_pred cceeeecccccccccccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccch
Q 007073 453 TNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (619)
.......||+.|+|||++. +..|+.++|||||||++|||+||+.||...... ... ........ ..
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~-----~~~---~~i~~~~~-~~ 234 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM-----RVL---LKIAKSEP-PT 234 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG-----GHH---HHHHHSCC-CC
T ss_pred -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH-----HHH---HHHHcCCC-CC
Confidence 1233457999999999984 456899999999999999999999999643221 111 11111110 00
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 528 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
...+...+.++.+++.+||+.||++|||+.|+++
T Consensus 235 -------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 -------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0112233467899999999999999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=392.96 Aligned_cols=245 Identities=23% Similarity=0.395 Sum_probs=195.1
Q ss_pred cccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeC----CCcceeEe
Q 007073 297 SEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT----PTERLLVY 370 (619)
Q Consensus 297 ~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~ 370 (619)
+..+.||+|+||+||+|.+. +++.||+|++.... .....+.|.+|++++++++|||||++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45668999999999999975 68899999986533 34456779999999999999999999999864 34478999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEeC-CCCcEEEccccccee
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK--IIHRDVKAANVLLD-EDFEAVVGDFGLAKL 447 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DfGla~~ 447 (619)
||+++|+|.+++.... .+++..+..++.|+++||+|||++ + |+||||||+|||++ +++.+||+|||+|+.
T Consensus 92 E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 9999999999997643 388999999999999999999998 6 99999999999997 578999999999985
Q ss_pred eccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccch
Q 007073 448 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527 (619)
Q Consensus 448 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (619)
... .......||+.|||||.+.+ .++.++|||||||++|||+||+.||...... . ........... ..
T Consensus 165 ~~~---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~----~---~~~~~i~~~~~-~~ 232 (270)
T d1t4ha_ 165 KRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----A---QIYRRVTSGVK-PA 232 (270)
T ss_dssp CCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----H---HHHHHHTTTCC-CG
T ss_pred ccC---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH----H---HHHHHHHcCCC-Cc
Confidence 432 22345679999999999865 6999999999999999999999999632211 1 11111111111 00
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 528 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. ++...++++.+++.+||+.||++|||++|+++
T Consensus 233 ----~----~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 ----S----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ----G----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----c----cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 0 11112346889999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-49 Score=403.39 Aligned_cols=252 Identities=21% Similarity=0.320 Sum_probs=190.9
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.+.|++.+.||+|+||+||+|... +|+.||||++.........+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999975 6899999999755444455678899999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC---CCCcEEEcccccceee
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGDFGLAKLV 448 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGla~~~ 448 (619)
|+++|+|.+++... ..+++.....++.|++.||+|||++ +|+||||||+||+++ +++.+||+|||+|+..
T Consensus 88 ~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhcc----cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999753 3489999999999999999999999 999999999999994 5789999999999866
Q ss_pred ccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchh
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 528 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (619)
.... ......||+.|||||++.+..++.++|||||||++|||+||+.||...... +..........
T Consensus 161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i~~~~~---- 226 (307)
T d1a06a_ 161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--------KLFEQILKAEY---- 226 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHTTCC----
T ss_pred cCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHhccCC----
Confidence 4332 233457999999999999999999999999999999999999999643211 11111111100
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..........+.++.+++.+||+.||++|||++|+++
T Consensus 227 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 227 ---EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp ---CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0111112234467899999999999999999999987
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-49 Score=399.50 Aligned_cols=246 Identities=26% Similarity=0.350 Sum_probs=200.7
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCC--cchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
+.|+..+.||+|+||+||+|... +|+.||||++..... ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45888999999999999999964 789999999865432 233467899999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++|++..++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 999999997766542 3489999999999999999999999 999999999999999999999999999986533
Q ss_pred CCcceeeeccccccccccccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccch
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 527 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (619)
.....||+.|||||++.+ +.|+.++|||||||++|||+||+.||...... +.......... ..
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~--------~~~~~i~~~~~-~~ 233 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNES-PA 233 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSCC-CC
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhCCC-CC
Confidence 234569999999999864 46899999999999999999999999643211 11111111110 00
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 528 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 528 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
......++.+.+++.+||+.||++|||++|+++
T Consensus 234 --------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 234 --------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 111223467899999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=396.43 Aligned_cols=249 Identities=21% Similarity=0.284 Sum_probs=203.8
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++|++.+.||+|+||+||+|... +|+.||||++.... .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 67999999999999999999974 78999999986321 2334577999999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 88 Ey~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999887643 389999999999999999999999 999999999999999999999999999998754
Q ss_pred CCc-ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 451 RKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 451 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
... .......||+.|||||++.+..++.++||||+||++|||+||+.||...... ......... ..
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i~~~-~~---- 227 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY--------LIFQKIIKL-EY---- 227 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHTT-CC----
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH--------HHHHHHHcC-CC----
Confidence 332 2334567999999999999999999999999999999999999999743211 111111111 00
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.++...+.++.+++.+||+.||++|||++|+++
T Consensus 228 ------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 ------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 112223457899999999999999999999753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-49 Score=400.08 Aligned_cols=255 Identities=24% Similarity=0.392 Sum_probs=202.8
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCc----EEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCccee
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGT----KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 368 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 368 (619)
++|++.++||+|+||+||+|.+. +|+ +||||+++...+....+.|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46899999999999999999974 443 69999997666666788999999999999999999999999865 5678
Q ss_pred EecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007073 369 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 448 (619)
Q Consensus 369 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 448 (619)
++||+.+|+|.+.+... ...+++..+.+++.|||+||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 88 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 88999999999888763 34589999999999999999999999 9999999999999999999999999999877
Q ss_pred ccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 449 DVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 449 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
...... ......||+.|+|||.+.++.++.++|||||||++|||+| |+.||+..... .+...+. ...+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-----~~~~~i~---~~~~-- 231 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----EISSILE---KGER-- 231 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-----GHHHHHH---HTCC--
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-----HHHHHHH---cCCC--
Confidence 543333 2334568999999999999999999999999999999999 78888643321 1111111 1111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
...+...+..+.+++.+||+.||++|||+.||++.|+..
T Consensus 232 --------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 232 --------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp --------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 112233446789999999999999999999999988764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=392.17 Aligned_cols=251 Identities=27% Similarity=0.367 Sum_probs=198.3
Q ss_pred HhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeC-CCcceeEe
Q 007073 292 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT-PTERLLVY 370 (619)
Q Consensus 292 ~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lv~ 370 (619)
..++|++.+.||+|+||.||+|.++ |+.||||++++. ...+.|.+|++++++++|||||+++|++.. .+..++||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 3467888899999999999999995 789999999643 345789999999999999999999999865 45689999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++|+|.+++.... ...+++..+++++.||+.||+|||++ +|+||||||+||+++.++.+|++|||+++....
T Consensus 81 ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC
Confidence 9999999999997532 23489999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
. .....+|..|+|||++.++.+++++|||||||++|||+| |+.||...... .+... +...
T Consensus 156 ~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~-----~~~~~---i~~~------- 216 (262)
T d1byga_ 156 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPR---VEKG------- 216 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----GHHHH---HTTT-------
T ss_pred C----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH-----HHHHH---HHcC-------
Confidence 2 223457899999999999999999999999999999999 67777543221 11111 1111
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.....+...+..+.+++.+||+.||++||||.+++++|+.+
T Consensus 217 ---~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 217 ---YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 11122333346789999999999999999999999999874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-49 Score=398.61 Aligned_cols=270 Identities=25% Similarity=0.357 Sum_probs=205.0
Q ss_pred cCHHHHHHHhcCCcccCccccCCCceEEEEEeC------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccce
Q 007073 284 YSWRELQLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRL 356 (619)
Q Consensus 284 ~~~~el~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l 356 (619)
+...++++..++|++.+.||+|+||.||+|.+. +++.||||+++........+.+.+|..++.++ +|+||+.+
T Consensus 3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 344566666788999999999999999999963 35689999997666556677888898888776 68999999
Q ss_pred eeeeeCCC-cceeEecccccchhhhhhcccCC------------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 007073 357 IGFCTTPT-ERLLVYPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRD 423 (619)
Q Consensus 357 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D 423 (619)
++++..++ ..++||||+++|+|.++++.... ....+++..+..++.||++||+|||++ +|+|||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCc
Confidence 99987654 57899999999999999975321 134589999999999999999999999 999999
Q ss_pred CCCCcEEeCCCCcEEEcccccceeeccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCC-CCCCC
Q 007073 424 VKAANVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ-RAIDF 501 (619)
Q Consensus 424 lkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~-~p~~~ 501 (619)
|||+|||+++++++||+|||+|+........ ......||+.|+|||.+.+..++.++|||||||++|||+||. .||..
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876443332 334567999999999999999999999999999999999975 56653
Q ss_pred CccccccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 502 SRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.... ..+.. ....... ...+...+.++.+++.+||+.||++|||+.||++.|+.+
T Consensus 240 ~~~~----~~~~~---~~~~~~~----------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 240 VKID----EEFCR---RLKEGTR----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp CCCS----HHHHH---HHHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHH----HHHHH---HHhcCCC----------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 3221 11111 1111111 111222345789999999999999999999999999863
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=388.56 Aligned_cols=256 Identities=29% Similarity=0.377 Sum_probs=197.4
Q ss_pred hcCCcccCccccCCCceEEEEEeC--CC--cEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA--DG--TKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 366 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~--~g--~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 366 (619)
.++|++.+.||+|+||+||+|++. ++ ..||||++.... .....+.|.+|++++++++|||||+++|++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 367889999999999999999863 22 378999886432 33445789999999999999999999999976 467
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
++||||+++|++.+.+.... ..+++..+..++.|+|+||.|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred heeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhh
Confidence 89999999999998877532 3489999999999999999999999 99999999999999999999999999999
Q ss_pred eeccCCcce--eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhc
Q 007073 447 LVDVRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREK 523 (619)
Q Consensus 447 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (619)
......... .....|+..|+|||.+.+..++.++|||||||++|||+| |+.||...... +........+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--------~~~~~i~~~~ 231 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--------QILHKIDKEG 231 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTSC
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--------HHHHHHHhCC
Confidence 875443322 234567889999999999999999999999999999998 89998643211 1112221111
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 524 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 524 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
.....+...+..+.+++.+||+.||++||||.+|.+.|+.
T Consensus 232 ---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 232 ---------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1111222334678999999999999999999999999976
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=395.44 Aligned_cols=263 Identities=25% Similarity=0.358 Sum_probs=214.2
Q ss_pred HHHhcCCcccCccccCCCceEEEEEe------CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeC
Q 007073 290 QLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTT 362 (619)
Q Consensus 290 ~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 362 (619)
+...++|++.+.||+|+||.||+|++ .+++.||||+++..........|.+|+.+++++ +|||||+++|++.+
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 44567899999999999999999985 246789999998666556677899999999998 69999999999999
Q ss_pred CCcceeEecccccchhhhhhcccCC--------------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 007073 363 PTERLLVYPFMQNLSVAYRLREIKP--------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN 428 (619)
Q Consensus 363 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 428 (619)
+...++||||+++|+|.++++.... ....+++..+.+++.||++||+|||++ +|+||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence 9999999999999999999976432 234588999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEcccccceeeccCCc-ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCC-CCCCcccc
Q 007073 429 VLLDEDFEAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRA-IDFSRLEE 506 (619)
Q Consensus 429 Ill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p-~~~~~~~~ 506 (619)
|+++.++.+|++|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||+|++.| +......
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~- 254 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD- 254 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999997754433 333456789999999999999999999999999999999995555 4332211
Q ss_pred ccchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 507 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
..+...+. .......+...+..+.+|+.+||+.||++||||.+|+++|++
T Consensus 255 ---~~~~~~i~-------------~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 255 ---SKFYKMIK-------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp ---HHHHHHHH-------------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---HHHHHHHh-------------cCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11111111 111112222334678999999999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=383.48 Aligned_cols=251 Identities=19% Similarity=0.250 Sum_probs=205.6
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-----CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-----SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 366 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 366 (619)
.++|++.+.||+|+||+||+|... +|+.||||++.... .....+.+.+|++++++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999974 79999999986432 223467899999999999999999999999999999
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC----cEEEccc
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF----EAVVGDF 442 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df 442 (619)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+|++||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence 99999999999999997643 489999999999999999999999 999999999999998776 5999999
Q ss_pred ccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh
Q 007073 443 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 522 (619)
Q Consensus 443 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 522 (619)
|+|+...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...... +........
T Consensus 162 G~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i~~~ 231 (293)
T d1jksa_ 162 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANVSAV 231 (293)
T ss_dssp TTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHTT
T ss_pred hhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH--------HHHHHHHhc
Confidence 9998765332 233456899999999999999999999999999999999999999743211 111111111
Q ss_pred c-ccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 523 K-RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 523 ~-~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. .... .. ....+..+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~----~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 232 NYEFED----EY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CCCCCH----HH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCc----hh----cCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000 00 1122357889999999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.5e-47 Score=390.67 Aligned_cols=253 Identities=20% Similarity=0.276 Sum_probs=206.9
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.++|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 368999999999999999999974 79999999996432 3445778999999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC--CCCcEEEcccccceeec
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD--EDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfGla~~~~ 449 (619)
|+++|+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|+.+.
T Consensus 104 ~~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 104 FMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp CCCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred cCCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 99999999988642 23489999999999999999999999 999999999999996 46789999999999775
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
... ......||+.|||||++.+..++.++||||+||++|||+||+.||...... +.......... . .
T Consensus 178 ~~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~~~-~--~ 244 (350)
T d1koaa2 178 PKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--------ETLRNVKSCDW-N--M 244 (350)
T ss_dssp TTS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCC-C--S
T ss_pred ccc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCC-C--C
Confidence 433 234567999999999999999999999999999999999999999643211 11111111110 0 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
.. ......+.++.+++.+||+.||++|||++|+++.
T Consensus 245 ~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 DD----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CC----GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred Cc----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0111223578899999999999999999999873
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=393.29 Aligned_cols=265 Identities=24% Similarity=0.376 Sum_probs=215.8
Q ss_pred HHHHHhcCCcccCccccCCCceEEEEEeC------CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeee
Q 007073 288 ELQLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 361 (619)
Q Consensus 288 el~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 361 (619)
++++..++|.+.+.||+|+||+||+|.+. +++.||||+++..........|.+|+.++++++|||||+++|++.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 44556688999999999999999999863 357899999986655556678999999999999999999999999
Q ss_pred CCCcceeEecccccchhhhhhcccC------CCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC
Q 007073 362 TPTERLLVYPFMQNLSVAYRLREIK------PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 435 (619)
Q Consensus 362 ~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 435 (619)
.++..++||||+++|+|.+++.... .....+++..+.+++.|+|+||.|||++ +|+||||||+|||+++++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCc
Confidence 9999999999999999999986432 2224478899999999999999999999 999999999999999999
Q ss_pred cEEEcccccceeeccCCcce-eeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCC-CCCCCCccccccchhHH
Q 007073 436 EAVVGDFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ-RAIDFSRLEEEDDVLLL 513 (619)
Q Consensus 436 ~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~-~p~~~~~~~~~~~~~~~ 513 (619)
++||+|||+|+......... .....||+.|+|||.+.+..++.++||||||+++|||+||+ .||.... ..
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~--------~~ 242 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--------NE 242 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--------HH
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC--------HH
Confidence 99999999998765433322 23346899999999999999999999999999999999985 5554321 11
Q ss_pred HHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 514 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
+....+...... ..+...+..+.+++.+||+.+|++||||++|+++|++.
T Consensus 243 ~~~~~i~~~~~~----------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 243 QVLRFVMEGGLL----------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHHHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHHHhCCCC----------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 222222221111 11223346799999999999999999999999999884
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=389.50 Aligned_cols=252 Identities=29% Similarity=0.420 Sum_probs=203.0
Q ss_pred cCccccCCCceEEEEEeCCC----cEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeC-CCcceeEeccc
Q 007073 299 KNVLGQGGFGKVYRGVLADG----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT-PTERLLVYPFM 373 (619)
Q Consensus 299 ~~~lg~G~fg~Vy~~~~~~g----~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~~ 373 (619)
.++||+|+||+||+|.+.++ ..||||+++........++|.+|++++++++|||||+++|++.. +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999997532 36899999766666667889999999999999999999999865 45789999999
Q ss_pred ccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCc
Q 007073 374 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 453 (619)
Q Consensus 374 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 453 (619)
++|+|.+++.... ...++..+.+++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcccc---ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999887633 3477888999999999999999999 999999999999999999999999999987654322
Q ss_pred c---eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 454 N---VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 454 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
. ......||+.|+|||.+.++.++.++||||||+++|||+||+.||...... . +....+....+.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~----~---~~~~~i~~g~~~----- 253 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----F---DITVYLLQGRRL----- 253 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHTTCCC-----
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH----H---HHHHHHHcCCCC-----
Confidence 2 223456899999999999999999999999999999999988887532211 1 111111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
..+...+..+.+++.+||+.||++||+|.||++.|+++
T Consensus 254 -----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 254 -----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11222345789999999999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-48 Score=388.98 Aligned_cols=262 Identities=29% Similarity=0.396 Sum_probs=209.0
Q ss_pred HHhcCCcccCccccCCCceEEEEEeCC--------CcEEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeee
Q 007073 291 LATDNFSEKNVLGQGGFGKVYRGVLAD--------GTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCT 361 (619)
Q Consensus 291 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~ 361 (619)
+..++|++.+.||+|+||.||+|+... +..||||+++.........++.+|...+.++ +|||||+++++|.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 456789999999999999999998532 3479999998766556678899999999888 7999999999999
Q ss_pred CCCcceeEecccccchhhhhhcccCC------------CCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 007073 362 TPTERLLVYPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANV 429 (619)
Q Consensus 362 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 429 (619)
++...++||||+++|+|.+++..... ....+++.++++++.|++.||+|||++ +||||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence 99999999999999999999976432 234589999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEcccccceeeccCCcc-eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccc
Q 007073 430 LLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEE 507 (619)
Q Consensus 430 ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ellt-g~~p~~~~~~~~~ 507 (619)
|++.++.+||+|||+++........ ......||+.|+|||.+.++.++.++|||||||++|||+| |..||......
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~-- 244 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-- 244 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--
Confidence 9999999999999999877543332 2344568999999999999999999999999999999998 67777533221
Q ss_pred cchhHHHHHHHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 508 DDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.+ ...+..... ...+...+.++.+++.+||+.||++|||+.||++.|+++
T Consensus 245 ---~~---~~~i~~~~~----------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 245 ---EL---FKLLKEGHR----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp ---HH---HHHHHTTCC----------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HH---HHHHHcCCC----------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11 111111111 111222345789999999999999999999999999764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-48 Score=391.98 Aligned_cols=257 Identities=25% Similarity=0.410 Sum_probs=204.4
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCc--EEEEEEeccCCCcchHHHHHHHHHHHHHc-cCCCccceeeeeeCCCcceeE
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGT--KVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~--~vAvK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 369 (619)
++|++.++||+|+||+||+|.++ +|. .||||++.........+.|.+|+++++++ +|||||+++|++...+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 67888899999999999999975 344 57889887655555677899999999998 799999999999999999999
Q ss_pred ecccccchhhhhhcccC------------CCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcE
Q 007073 370 YPFMQNLSVAYRLREIK------------PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA 437 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 437 (619)
|||+++|+|.++++... .....+++..+.+++.|||+||.|+|++ +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 99999999999997531 2345689999999999999999999999 99999999999999999999
Q ss_pred EEcccccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCC-CCCCCccccccchhHHHHH
Q 007073 438 VVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR-AIDFSRLEEEDDVLLLDHV 516 (619)
Q Consensus 438 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~-p~~~~~~~~~~~~~~~~~~ 516 (619)
||+|||+++...... ......||..|+|||.+.++.++.++|||||||++|||+||.. ||..... .+..
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~--------~~~~ 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELY 236 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHH
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH--------HHHH
Confidence 999999998653322 1234468999999999999999999999999999999999765 5543211 1112
Q ss_pred HHHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 517 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 517 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
..+.... ....+...+.++.+|+.+||+.||++||||+||++.|+++
T Consensus 237 ~~i~~~~----------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 237 EKLPQGY----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp HHGGGTC----------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcC----------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 2221111 1122233446899999999999999999999999998874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.9e-47 Score=392.38 Aligned_cols=252 Identities=19% Similarity=0.254 Sum_probs=206.9
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.++|++.+.||+|+||+||+|... +|+.||||++.... ......+.+|++++++++|||||++++++.+++..++|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 357999999999999999999974 79999999986432 3345678899999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC--CCCcEEEcccccceeec
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD--EDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfGla~~~~ 449 (619)
|+++|+|.+.+... ...+++.....++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|+.+.
T Consensus 107 ~~~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 107 FLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp CCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecC
Confidence 99999998877642 33489999999999999999999999 999999999999998 67899999999999876
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
... ......||+.|+|||++.+..++.++||||+||++|||+||+.||...... .. ........ .
T Consensus 181 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~---~~~i~~~~-~---- 245 (352)
T d1koba_ 181 PDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-----ET---LQNVKRCD-W---- 245 (352)
T ss_dssp TTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HH---HHHHHHCC-C----
T ss_pred CCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-----HH---HHHHHhCC-C----
Confidence 433 234457999999999999999999999999999999999999999643211 11 11111110 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..........+.++.+|+.+||+.||++|||+.|+++
T Consensus 246 --~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 246 --EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp --CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred --CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111112233467899999999999999999999986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-47 Score=387.42 Aligned_cols=249 Identities=22% Similarity=0.260 Sum_probs=206.0
Q ss_pred hcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeE
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 369 (619)
.++|++.+.||+|+||+||+|+. .+|+.||||++.+.. .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 36799999999999999999997 479999999986421 233467789999999999999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||+++|+|..++.... .++....+.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 84 ~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence 99999999999988643 388889999999999999999999 99999999999999999999999999998654
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
... ......+||+.|+|||++.+..|+.++||||+||++|||+||+.||...... ........ ...
T Consensus 157 ~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~--------~~~~~i~~-~~~---- 222 (337)
T d1o6la_ 157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLFELILM-EEI---- 222 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHH-CCC----
T ss_pred cCC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH--------HHHHHHhc-CCC----
Confidence 322 2334567999999999999999999999999999999999999999753321 11111111 110
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVR 568 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 568 (619)
.++...+.++.+++.+||+.||++||+ ++|+++
T Consensus 223 ------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 ------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 112233457889999999999999995 677664
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6e-47 Score=384.70 Aligned_cols=245 Identities=24% Similarity=0.292 Sum_probs=203.8
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++|++.+.||+|+||+||+|+.+ +|+.||||++++.. .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999974 69999999986421 2334678899999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+++|++...+.... .++......++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccccc----cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999999887643 378888889999999999999999 999999999999999999999999999987643
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
. .....||+.|||||++.+..++.++||||+||++|||+||+.||...... +.........
T Consensus 157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~~i~~~~------- 217 (316)
T d1fota_ 157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--------KTYEKILNAE------- 217 (316)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHCC-------
T ss_pred c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH--------HHHHHHHcCC-------
Confidence 2 23467999999999999999999999999999999999999999743211 1111111110
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 568 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 568 (619)
..++...+.++.+++.+|++.||.+|| |++++++
T Consensus 218 ----~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 218 ----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 011222345788999999999999996 8888874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2e-46 Score=374.91 Aligned_cols=259 Identities=23% Similarity=0.276 Sum_probs=201.3
Q ss_pred hcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCC--cchHHHHHHHHHHHHHccCCCccceeeeeeCCCc----
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE---- 365 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---- 365 (619)
.++|++.+.||+|+||+||+|.. .+|+.||||+++.... ....+.|.+|+++++.++|||||++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999996 4799999999975432 3345679999999999999999999999876543
Q ss_pred ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 445 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 445 (619)
.++||||+++|+|..++.... .+++.++..++.|++.||+|||++ +|+||||||+|||++.++..+++|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 689999999999999887643 389999999999999999999999 9999999999999999999999999998
Q ss_pred eeeccCCc--ceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007073 446 KLVDVRKT--NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 523 (619)
Q Consensus 446 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (619)
........ .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... +.........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~~~~~~ 230 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--------SVAYQHVRED 230 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH--------HHHHHHHhcC
Confidence 76543222 2334567999999999999999999999999999999999999999643211 1111111111
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHhcC
Q 007073 524 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-AMSEVVRMLEGE 573 (619)
Q Consensus 524 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~ 573 (619)
... . .......+.++.+++.+|++.||++|| |++++.+.|.+.
T Consensus 231 ~~~---~----~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 231 PIP---P----SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp CCC---G----GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCC---C----chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 110 0 011122335789999999999999999 899999888763
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-47 Score=382.58 Aligned_cols=266 Identities=24% Similarity=0.346 Sum_probs=199.3
Q ss_pred cCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHH--HHHccCCCccceeeeeeCCC----cce
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEM--ISVAVHRNLLRLIGFCTTPT----ERL 367 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~~~----~~~ 367 (619)
++|.+.+.||+|+||+||+|++ +|+.||||++.. .....+.+|.++ +.+++|||||+++|++...+ ..+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~----~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECG----GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECc----cchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 4677888999999999999997 589999999863 233445555554 55789999999999997654 468
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCcEEeCCCCcEEEccc
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC-----NPKIIHRDVKAANVLLDEDFEAVVGDF 442 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~Df 442 (619)
+||||+++|+|.++++.. .++|..+.+++.|+|.||+|+|+.+ .++|+||||||+|||++.++.+||+||
T Consensus 78 lv~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 999999999999999863 3899999999999999999999731 248999999999999999999999999
Q ss_pred ccceeeccCCcc---eeeeccccccccccccccCCC------CCcchhhHHHHHHHHHHHhCCCCCCCCccccccc----
Q 007073 443 GLAKLVDVRKTN---VTTQVRGTMGHIAPEYLSTGK------SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD---- 509 (619)
Q Consensus 443 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~---- 509 (619)
|+++........ ......||+.|+|||++.+.. ++.++|||||||++|||+||..|+..........
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 999987544322 223467999999999987542 5789999999999999999998875432211100
Q ss_pred --hhHHHHHHHHhhhcccchhccccccCCC-CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007073 510 --VLLLDHVKKLEREKRLDAIVDRNLNKNY-NIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 573 (619)
Q Consensus 510 --~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 573 (619)
.............+.. ++.+.... .......+.+++.+||+.||++||||.||++.|+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CSSCCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccchHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 0011111111111111 11111111 234556799999999999999999999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.7e-46 Score=368.92 Aligned_cols=251 Identities=22% Similarity=0.298 Sum_probs=203.8
Q ss_pred cCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCc--------chHHHHHHHHHHHHHcc-CCCccceeeeeeCC
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESP--------GGDAAFQREVEMISVAV-HRNLLRLIGFCTTP 363 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~--------~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~ 363 (619)
++|++.+.||+|+||+||+|+. .+|+.||||++...... ...+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6799999999999999999997 47899999998643211 12346889999999997 99999999999999
Q ss_pred CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007073 364 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 443 (619)
Q Consensus 364 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 443 (619)
+..++||||+++|+|.+++.... .+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999997643 389999999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcceeeeccccccccccccccC------CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHH
Q 007073 444 LAKLVDVRKTNVTTQVRGTMGHIAPEYLST------GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 517 (619)
Q Consensus 444 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 517 (619)
+++...... ......||+.|+|||.+.+ ..++.++||||+||++|||+||+.||...... .. ..
T Consensus 156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-----~~---~~ 225 (277)
T d1phka_ 156 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-----LM---LR 225 (277)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HH---HH
T ss_pred heeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH-----HH---HH
Confidence 999775432 2344679999999999853 45789999999999999999999999753211 11 11
Q ss_pred HHhhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 518 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 518 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.... +... .........++++.+++.+||+.||++|||++||++
T Consensus 226 ~i~~-~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 226 MIMS-GNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHH-TCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHh-CCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1111 1110 001112234468899999999999999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.9e-46 Score=384.64 Aligned_cols=249 Identities=24% Similarity=0.310 Sum_probs=197.2
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHH---HHHHHHccCCCccceeeeeeCCCcce
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQRE---VEMISVAVHRNLLRLIGFCTTPTERL 367 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E---~~~l~~l~H~niv~l~~~~~~~~~~~ 367 (619)
++|++.++||+|+||.||+|+.. +|+.||||++.... .......+.+| +++++.++|||||++++++..++..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999975 69999999985321 11223344444 55666778999999999999999999
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999997643 378899999999999999999999 999999999999999999999999999997
Q ss_pred eccCCcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccc
Q 007073 448 VDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 526 (619)
Q Consensus 448 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (619)
..... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||........ ...... .
T Consensus 157 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~~~~~~-~------ 221 (364)
T d1omwa3 157 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRM-T------ 221 (364)
T ss_dssp CSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-----HHHHHH-S------
T ss_pred cCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHh-c------
Confidence 65432 334579999999999975 4689999999999999999999999975432211 111111 0
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007073 527 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVR 568 (619)
Q Consensus 527 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 568 (619)
.... ...+...+.++.+++.+||+.||++||| ++|+++
T Consensus 222 --~~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 222 --LTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --SSCC--CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --ccCC--CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0000 0112223457899999999999999999 577763
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-46 Score=384.51 Aligned_cols=245 Identities=21% Similarity=0.258 Sum_probs=204.2
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccC--CCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEe
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 370 (619)
++|++.+.||+|+||+||+|.++ +|+.||||++... ......+.+.+|+++++.++|||||++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999975 7999999998532 12334567899999999999999999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 450 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 450 (619)
||+.+|+|..++.... .++...+..++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+.+..
T Consensus 121 e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999997643 389999999999999999999999 999999999999999999999999999997653
Q ss_pred CCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhcc
Q 007073 451 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 530 (619)
Q Consensus 451 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (619)
. .....||+.|||||++.+..++.++|||||||++|||+||+.||..... . ......... ..
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~---~~~~~i~~~-~~----- 255 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----I---QIYEKIVSG-KV----- 255 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H---HHHHHHHHC-CC-----
T ss_pred c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-----H---HHHHHHhcC-CC-----
Confidence 2 2345799999999999999999999999999999999999999964321 1 111111111 00
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007073 531 RNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 568 (619)
Q Consensus 531 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 568 (619)
..+...+.++.+++.+||+.||++|+ |++++++
T Consensus 256 -----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11222345789999999999999994 7888764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=378.31 Aligned_cols=250 Identities=22% Similarity=0.251 Sum_probs=197.7
Q ss_pred hcCCccc-CccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHH-ccCCCccceeeeeeC----CCc
Q 007073 293 TDNFSEK-NVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISV-AVHRNLLRLIGFCTT----PTE 365 (619)
Q Consensus 293 ~~~~~~~-~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~----~~~ 365 (619)
.++|.+. ++||+|+||+||+|.+ .+|+.||||++++ ...+.+|++++.+ .+|||||++++++.+ ...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 3578776 4699999999999997 4789999999863 2457789998655 589999999999865 355
Q ss_pred ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEEccc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVVGDF 442 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Df 442 (619)
.++||||+++|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+||
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccc
Confidence 799999999999999997532 34599999999999999999999999 9999999999999985 567999999
Q ss_pred ccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh
Q 007073 443 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 522 (619)
Q Consensus 443 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 522 (619)
|+|+....... .....||+.|||||++.+..|+.++|||||||++|||+||+.||......... ....
T Consensus 159 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~-----~~~~----- 226 (335)
T d2ozaa1 159 GFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----PGMK----- 226 (335)
T ss_dssp TTCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------
T ss_pred ceeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH-----HHHH-----
Confidence 99987654332 34457999999999999999999999999999999999999999643221110 0000
Q ss_pred cccchhccccc--cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 523 KRLDAIVDRNL--NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 523 ~~~~~~~~~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
..+..... ........+.++.+++.+|++.||++|||+.|+++
T Consensus 227 ---~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 227 ---TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ----CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00111111 01111244568999999999999999999999987
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=372.76 Aligned_cols=250 Identities=18% Similarity=0.237 Sum_probs=204.3
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
.++|++.+.||+|+||+||+|.+. +|+.||||.++.. ......+.+|++++++++|||||++++++.+++..++|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 367999999999999999999975 6889999999643 2334568899999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC--CcEEEcccccceeec
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED--FEAVVGDFGLAKLVD 449 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfGla~~~~ 449 (619)
|+++|+|.+++... ...+++.+...++.||+.||+|||++ +|+||||||+|||++.+ ..+||+|||+++...
T Consensus 82 ~~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 82 FISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 99999999999753 23489999999999999999999999 99999999999999854 589999999998764
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc-ccchh
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK-RLDAI 528 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 528 (619)
... ......||+.|+|||.+.+..++.++||||+||++|||+||+.||...... +......... ....
T Consensus 156 ~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--------~~~~~i~~~~~~~~~- 224 (321)
T d1tkia_ 156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--------QIIENIMNAEYTFDE- 224 (321)
T ss_dssp TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCCCCCH-
T ss_pred cCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCh-
Confidence 432 234456899999999999999999999999999999999999999753211 1111111110 0000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 529 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 529 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
... ...+.++.+++.+|++.||++|||+.|+++
T Consensus 225 ---~~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 225 ---EAF----KEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ---HHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---hhc----cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 112356889999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=380.93 Aligned_cols=247 Identities=23% Similarity=0.319 Sum_probs=201.8
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC--CcchHHHHHHHHHHHH-HccCCCccceeeeeeCCCcceeE
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMIS-VAVHRNLLRLIGFCTTPTERLLV 369 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lv 369 (619)
++|++.+.||+|+||+||+|+.. +|+.||||++++.. .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999975 68999999996421 2234556677777665 68999999999999999999999
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 449 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 449 (619)
|||+++|+|.+++.... .++...+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999999998643 378899999999999999999999 99999999999999999999999999998664
Q ss_pred cCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcccchhc
Q 007073 450 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 529 (619)
Q Consensus 450 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (619)
... ...+...||+.|+|||++.+..++.++||||+||++|||+||+.||...... .+ ...... ..
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-----~~---~~~i~~-~~----- 219 (320)
T d1xjda_ 155 LGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-----EL---FHSIRM-DN----- 219 (320)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HH---HHHHHH-CC-----
T ss_pred ccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-----HH---HHHHHc-CC-----
Confidence 332 2334457999999999999999999999999999999999999999743321 11 111111 11
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 007073 530 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS-EVV 567 (619)
Q Consensus 530 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl 567 (619)
..++...+.++.+|+.+||+.||++|||+. +++
T Consensus 220 -----~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 220 -----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -----CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 011222345789999999999999999985 664
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=371.79 Aligned_cols=258 Identities=24% Similarity=0.252 Sum_probs=193.9
Q ss_pred cCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcc----hHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEeccc
Q 007073 299 KNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPG----GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 373 (619)
Q Consensus 299 ~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 373 (619)
.++||+|+||+||+|... +|+.||||+++...... ..+.+.+|+.++++++|||||++++++..++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999974 69999999986432211 1346889999999999999999999999999999999999
Q ss_pred ccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCc
Q 007073 374 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 453 (619)
Q Consensus 374 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 453 (619)
.++++...... ...++...+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 83 ~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 99888766653 33488889999999999999999999 999999999999999999999999999986644322
Q ss_pred ceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh--cccchhc-
Q 007073 454 NVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE--KRLDAIV- 529 (619)
Q Consensus 454 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~- 529 (619)
......||+.|+|||.+... .++.++|||||||++|||+||+.||...... ..+.........+ .......
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~----~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL----DQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHCCCCTTTSSSTTS
T ss_pred -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH----HHHHHHHHhcCCCChhhccchhc
Confidence 23345699999999998654 5799999999999999999999999643211 0111111111000 0000000
Q ss_pred --ccc-c--cCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 530 --DRN-L--NKNYN-----IQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 530 --~~~-l--~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
... . ....+ .....++.+++.+|++.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000 0 00001 122467899999999999999999999985
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-45 Score=369.04 Aligned_cols=264 Identities=21% Similarity=0.282 Sum_probs=199.4
Q ss_pred cCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
++|++.+.||+|+||+||+|.+ .+|+.||||+++... .....+.+.+|++++++++|||||++++++.++...++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999997 479999999996432 22335788999999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
|+.++.+....... ...+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~~~~~~~~~~---~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQDLKKFMDASA---LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEEHHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCchhhhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 99876555443332 23489999999999999999999999 9999999999999999999999999999876433
Q ss_pred CcceeeeccccccccccccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc--cchh
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR--LDAI 528 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 528 (619)
. .......||+.|+|||.+.... ++.++||||+||++|+|+||+.||...... ..+............ ....
T Consensus 156 ~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 156 V-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI----DQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp S-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHHHCCCCTTTSTTG
T ss_pred c-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH----HHHHHHHHhcCCCchhhcccc
Confidence 2 2233456999999999887665 589999999999999999999999743211 111111111110000 0000
Q ss_pred c-cccccCC-----------CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 529 V-DRNLNKN-----------YNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 529 ~-~~~l~~~-----------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. ....... .....+.++.+++.+|++.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0 0000000 01122357889999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.1e-45 Score=369.50 Aligned_cols=263 Identities=21% Similarity=0.287 Sum_probs=201.1
Q ss_pred cCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEecc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 372 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 372 (619)
++|++.+.||+|+||+||+|++++|+.||||++.... .....+.+.+|+.++++++|||||++++++..++..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5899999999999999999999999999999996433 233457899999999999999999999999999999999999
Q ss_pred cccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007073 373 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 452 (619)
Q Consensus 373 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 452 (619)
+.++.+....... ..++......++.|++.||+|||+. +|+||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9988877776542 3499999999999999999999999 99999999999999999999999999998764332
Q ss_pred cceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh--cccc---
Q 007073 453 TNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE--KRLD--- 526 (619)
Q Consensus 453 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~--- 526 (619)
. ......|++.|+|||.+.+. .++.++||||+||++|||+||+.||...... ..+.......... ....
T Consensus 155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA----DQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHHHCCCCTTTSTTGG
T ss_pred c-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH----HHHHHHHHhhCCCChhhccchh
Confidence 2 23344689999999998754 5699999999999999999999999743211 1111111111000 0000
Q ss_pred hh------c---cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 527 AI------V---DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 527 ~~------~---~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.. . .+..........+..+.+++.+|++.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0 000000111223457889999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-46 Score=369.20 Aligned_cols=241 Identities=22% Similarity=0.357 Sum_probs=195.3
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCc-----chHHHHHHHHHHHHHcc--CCCccceeeeeeCCC
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP-----GGDAAFQREVEMISVAV--HRNLLRLIGFCTTPT 364 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-----~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~ 364 (619)
.++|++.+.||+|+||+||+|+.. +|+.||||++...... .....+.+|+.++++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357999999999999999999974 7899999998642211 11234678999999987 899999999999999
Q ss_pred cceeEeccccc-chhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-CCcEEEccc
Q 007073 365 ERLLVYPFMQN-LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-DFEAVVGDF 442 (619)
Q Consensus 365 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Df 442 (619)
..++||||+.+ +++.+++... ..+++..+..++.|+++||+|||++ +|+||||||+|||++. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcc
Confidence 99999999976 5777777653 2389999999999999999999999 9999999999999985 479999999
Q ss_pred ccceeeccCCcceeeeccccccccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007073 443 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 521 (619)
Q Consensus 443 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 521 (619)
|+|+..... ..+...||+.|+|||++.+..+ +.++||||+||++|||+||+.||..... ...
T Consensus 156 G~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------------i~~ 218 (273)
T d1xwsa_ 156 GSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------IIR 218 (273)
T ss_dssp TTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------HHH
T ss_pred ccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH--------------Hhh
Confidence 999875432 2345679999999999987765 5779999999999999999999963210 000
Q ss_pred hcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 522 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 522 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. . . . ++...+.++.+++.+||+.||++|||++|+++
T Consensus 219 ~-~--~----~----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 219 G-Q--V----F----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp C-C--C----C----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c-c--c----C----CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0 0 0 0 11122357899999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-45 Score=369.13 Aligned_cols=264 Identities=23% Similarity=0.319 Sum_probs=196.5
Q ss_pred hcCCcccCccccCCCceEEEEEeC-C-CcEEEEEEeccCC-CcchHHHHHHHHHHHHHc---cCCCccceeeeeeC----
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-D-GTKVAVKRLTDFE-SPGGDAAFQREVEMISVA---VHRNLLRLIGFCTT---- 362 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~-g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~---- 362 (619)
.++|++.+.||+|+||+||+|.+. + ++.||||+++... .......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999973 4 5679999986432 222234566777776655 79999999999853
Q ss_pred -CCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcc
Q 007073 363 -PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD 441 (619)
Q Consensus 363 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 441 (619)
....+++|||+.++++....... ...+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 24578999999998876554432 23488999999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007073 442 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 521 (619)
Q Consensus 442 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 521 (619)
||+++..... .......||+.|+|||++.+..++.++||||+||++|||+||+.||...... ..+.........
T Consensus 160 fg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~ 233 (305)
T d1blxa_ 160 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV----DQLGKILDVIGL 233 (305)
T ss_dssp CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHHHCC
T ss_pred hhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH----HHHHHHHHhhCC
Confidence 9999865432 2334567999999999999999999999999999999999999999753321 111111111110
Q ss_pred hcc--cc-------hhccc---cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 522 EKR--LD-------AIVDR---NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 522 ~~~--~~-------~~~~~---~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
+.. .. ..... ..........++.+.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 00 00000 0000112233457889999999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-43 Score=355.50 Aligned_cols=258 Identities=19% Similarity=0.212 Sum_probs=194.7
Q ss_pred cCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceee-eeeCCCcceeEec
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG-FCTTPTERLLVYP 371 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~-~~~~~~~~~lv~e 371 (619)
++|++.+.||+|+||+||+|.+ .+|+.||||++..... .+++..|+++++.++|+|++..++ +....+..++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 5799999999999999999997 4689999998864332 245788999999998877665554 4566777889999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEEcccccceee
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVVGDFGLAKLV 448 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGla~~~ 448 (619)
|+.+ ++...+... ...+++..+..++.|++.||+|||++ +|+||||||+|||++. +..+||+|||+|+..
T Consensus 84 ~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LLGP-SLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CCCC-BHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EcCC-chhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 9855 555554432 23489999999999999999999999 9999999999999864 557999999999987
Q ss_pred ccCCcc------eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh
Q 007073 449 DVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 522 (619)
Q Consensus 449 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 522 (619)
...... ......||+.|||||.+.+..++.++|||||||++|||+||+.||........... ....... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~-~~~~~~~-~~~ 234 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-YERISEK-KMS 234 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHH-HHH
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH-HHHhhcc-cCC
Confidence 543322 23345799999999999999999999999999999999999999975433221111 1011000 000
Q ss_pred cccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 523 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 523 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
..... +. ...+.++.+++..||+.+|++||+++++.+.|+.
T Consensus 235 ~~~~~-----~~----~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 235 TPIEV-----LC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp SCHHH-----HT----TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred CChhH-----hc----cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 00000 11 1123578999999999999999999999988876
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.4e-43 Score=351.88 Aligned_cols=259 Identities=15% Similarity=0.192 Sum_probs=203.6
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccC-CCccceeeeeeCCCcceeEe
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH-RNLLRLIGFCTTPTERLLVY 370 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lv~ 370 (619)
.++|++.+.||+|+||+||+|++. +|+.||||++..... ...+.+|++.++.+.| +|++.+++++......++||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 467999999999999999999965 689999998864332 2356788999999976 89999999999999999999
Q ss_pred cccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-----CCcEEEcccccc
Q 007073 371 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-----DFEAVVGDFGLA 445 (619)
Q Consensus 371 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfGla 445 (619)
||+ +++|.+.+.... ..++..+...++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+|
T Consensus 81 e~~-~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp ECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEccccee
Confidence 998 678888886532 3488999999999999999999999 9999999999999974 578999999999
Q ss_pred eeeccCCcc------eeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHH
Q 007073 446 KLVDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL 519 (619)
Q Consensus 446 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 519 (619)
+........ ......||+.|||||.+.+..++.++|||||||++|||+||+.||.......... ....+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~--~~~~i~~~ 231 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ--KYERIGEK 231 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH--HHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH--HHHHHHhc
Confidence 987543221 2334579999999999999999999999999999999999999997543322111 11111111
Q ss_pred hhhcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007073 520 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 572 (619)
Q Consensus 520 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 572 (619)
.......+ +... .++++.+++..|++.+|++||+++.+.+.|++
T Consensus 232 ~~~~~~~~-----l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 232 KQSTPLRE-----LCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp HHHSCHHH-----HTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred cCCCChHH-----hcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 11111111 1111 23578899999999999999999999888766
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-43 Score=360.25 Aligned_cols=265 Identities=18% Similarity=0.276 Sum_probs=198.3
Q ss_pred hcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCCC----cce
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT----ERL 367 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~ 367 (619)
+++|++.+.||+|+||+||+|.. .+|+.||||++.........+.+.+|++++++++||||+++++++..+. ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999996 4799999999976555555678999999999999999999999986653 345
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
++++|+.+|+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 87 ~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 666778899999999652 389999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCcc--eeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 448 VDVRKTN--VTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 448 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
....... ......||+.|+|||.+.. ..++.++||||+||++|||+||+.||........ .............
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~----~~~~~~~~~~~~~ 234 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ----LNHILGILGSPSQ 234 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCSCCH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH----HHHHhhhccCCCh
Confidence 6443222 2344569999999999854 5678999999999999999999999975432110 0000000000000
Q ss_pred c----------ch-hccccccCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 525 L----------DA-IVDRNLNKNY-----NIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 525 ~----------~~-~~~~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
. .. .......... .+....++.+++.+|++.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00 0000000000 01122468899999999999999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=354.35 Aligned_cols=264 Identities=23% Similarity=0.300 Sum_probs=195.3
Q ss_pred hcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCC-------
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------- 363 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------- 363 (619)
.++|++.+.||+|+||+||+|++ .+|+.||||++.... .......+.+|++++++++||||+++++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36899999999999999999997 479999999986432 334457789999999999999999999988553
Q ss_pred -CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007073 364 -TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 442 (619)
Q Consensus 364 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 442 (619)
...++||||++++.+...... ...++....+.++.|++.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence 457899999998877655543 23478888999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcc---eeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH
Q 007073 443 GLAKLVDVRKTN---VTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 518 (619)
Q Consensus 443 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 518 (619)
|+++........ ......||+.|+|||.+.+. .++.++||||+||++|||+||+.||..... .........
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~-----~~~~~~i~~ 236 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-----QHQLALISQ 236 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHH
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH-----HHHHHHHHH
Confidence 999876533222 22335699999999998765 689999999999999999999999964321 111111111
Q ss_pred Hhhhcc---cchhcccc--------ccCCCC-------HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 519 LEREKR---LDAIVDRN--------LNKNYN-------IQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 519 ~~~~~~---~~~~~~~~--------l~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
...... ........ ...... ......+.+|+.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 110000 00000000 000000 111346778999999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-43 Score=361.18 Aligned_cols=259 Identities=24% Similarity=0.301 Sum_probs=192.7
Q ss_pred CCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCccceeeeeeCC------Ccce
Q 007073 295 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------TERL 367 (619)
Q Consensus 295 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~ 367 (619)
+|+..++||+|+||+||+|++. +|+.||||++..... .+.+|++++++++||||+++++++... ...+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 5788899999999999999975 699999999965332 224799999999999999999998543 2367
Q ss_pred eEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-cEEEcccccce
Q 007073 368 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-EAVVGDFGLAK 446 (619)
Q Consensus 368 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~ 446 (619)
+||||++++.+....+ .......+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++
T Consensus 96 lv~Ey~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEECCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEeccCCccHHHHHh-hhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchh
Confidence 9999998765544433 222344589999999999999999999999 999999999999999775 89999999998
Q ss_pred eeccCCcceeeeccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh----
Q 007073 447 LVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER---- 521 (619)
Q Consensus 447 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 521 (619)
....... .....||+.|+|||.+.+ ..++.++||||+||++|||+||+.||....... .+.........
T Consensus 172 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~----~l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 172 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD----QLVEIIKVLGTPTRE 245 (350)
T ss_dssp ECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH----HHHHHHHHHCCCCHH
T ss_pred hccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH----HHHHHHHHhCCChHH
Confidence 7654332 334579999999998765 568999999999999999999999996533211 11111111000
Q ss_pred ----------hcccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 522 ----------EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 522 ----------~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
....................+.++.+|+.+|++.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000011112234467899999999999999999999985
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-43 Score=351.36 Aligned_cols=263 Identities=21% Similarity=0.242 Sum_probs=204.3
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCCcceeEec
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 371 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 371 (619)
++|++.+.||+|+||+||+|++. +|+.||||+++... .......+.+|+.+++.++||||+++++++..+...++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999974 78999999986443 33456789999999999999999999999999999999999
Q ss_pred ccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007073 372 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 451 (619)
Q Consensus 372 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 451 (619)
++.++++...+... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccccc----cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 99999998877653 3478889999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeeeccccccccccccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc---c--
Q 007073 452 KTNVTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR---L-- 525 (619)
Q Consensus 452 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~-- 525 (619)
.. ......++..|+|||.+.... ++.++||||+||++|||+||+.||..... .......+........ .
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND----VDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS----HHHHHHHHHHHHCCCCTTTCTT
T ss_pred Cc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC----HHHHHHHHHhhcCCCChhhhhh
Confidence 32 233345788999999987665 69999999999999999999999753221 1111111111111000 0
Q ss_pred -chhcc---------ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 526 -DAIVD---------RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 526 -~~~~~---------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
....+ ..............+.+|+.+|++.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 00001112334467889999999999999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=357.68 Aligned_cols=259 Identities=24% Similarity=0.314 Sum_probs=192.7
Q ss_pred hcCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCCC------
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT------ 364 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 364 (619)
.++|++.+.||+|+||+||+|... +|+.||||+++... .....+.+.+|++++++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 467999999999999999999974 69999999997533 3334567889999999999999999999997654
Q ss_pred cceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007073 365 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 444 (619)
Q Consensus 365 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 444 (619)
+.++||||+ +.+|....+. ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 468999999 5567766653 2389999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCcceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh-
Q 007073 445 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE- 522 (619)
Q Consensus 445 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 522 (619)
|+..... .+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||....... .+..........
T Consensus 168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~----~~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD----QLKEIMKVTGTPP 239 (346)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCCCC
T ss_pred eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH----HHHHHHhccCCCc
Confidence 9876432 2345799999999998764 56899999999999999999999997542111 111111000000
Q ss_pred ----------------cccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007073 523 ----------------KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 569 (619)
Q Consensus 523 ----------------~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 569 (619)
..........+ ..........+.+|+.+|++.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000000 00112233577899999999999999999999863
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-43 Score=357.77 Aligned_cols=253 Identities=22% Similarity=0.283 Sum_probs=202.7
Q ss_pred cCCcccCccccCCCceEEEEEeC----CCcEEEEEEeccCC---CcchHHHHHHHHHHHHHccC-CCccceeeeeeCCCc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFE---SPGGDAAFQREVEMISVAVH-RNLLRLIGFCTTPTE 365 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~----~g~~vAvK~l~~~~---~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~ 365 (619)
++|++.+.||+|+||+||+|... +|+.||||.++... .....+.+.+|++++++++| |||+++++++.....
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999852 58899999986422 12234567899999999987 899999999999999
Q ss_pred ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 445 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 445 (619)
.+++|||+.+|+|.+++..... +.......++.|++.||+|+|++ +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~----~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhccc----ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999986543 66788889999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcceeeeccccccccccccccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007073 446 KLVDVRKTNVTTQVRGTMGHIAPEYLSTG--KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 523 (619)
Q Consensus 446 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (619)
+.+............|++.|+|||.+.+. .++.++||||+||++|||+||+.||......... ......... .
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~----~~i~~~~~~-~ 251 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ----AEISRRILK-S 251 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH----HHHHHHHHH-C
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHhccc-C
Confidence 88765555545566799999999999765 4688999999999999999999999754432211 111111110 0
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007073 524 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVR 568 (619)
Q Consensus 524 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 568 (619)
. ...+...+.++.+++.+||+.||++||| ++|+++
T Consensus 252 ~----------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 E----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp C----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred C----------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0 1112234568899999999999999995 677763
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.1e-42 Score=353.21 Aligned_cols=259 Identities=19% Similarity=0.264 Sum_probs=196.4
Q ss_pred cCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc-CCCccceeeeeeCC--CcceeE
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTP--TERLLV 369 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lv 369 (619)
++|++.+.||+|+||+||+|+. .+|+.||||+++. ...+.+.+|+++++++. ||||+++++++... ...++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~----~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH----HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 6799999999999999999997 4789999999864 23567899999999995 99999999998754 458899
Q ss_pred ecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-CcEEEcccccceee
Q 007073 370 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLV 448 (619)
Q Consensus 370 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~~~ 448 (619)
|||+.+++|....+ .++...+..++.||+.||+|||++ +|+||||||+|||++.+ ..+||+|||+|+..
T Consensus 111 ~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 111 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EeecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceec
Confidence 99999999977643 288999999999999999999999 99999999999999865 46999999999876
Q ss_pred ccCCcceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHH---------HHH
Q 007073 449 DVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH---------VKK 518 (619)
Q Consensus 449 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~---------~~~ 518 (619)
.... ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||................ ...
T Consensus 181 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 181 HPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp CTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred cCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 5432 23445689999999998765 47999999999999999999999996543221111111000 000
Q ss_pred Hhhh--cccchhccc--------cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 519 LERE--KRLDAIVDR--------NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 519 ~~~~--~~~~~~~~~--------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
.... ......... ..........+.++.+|+.+|++.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 000000000 0001111223457889999999999999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-41 Score=349.09 Aligned_cols=259 Identities=20% Similarity=0.235 Sum_probs=189.8
Q ss_pred cCCcccCccccCCCceEEEEEeC-CCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCC------Cc
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------TE 365 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~ 365 (619)
++|++.++||+|+||+||+|.+. +|+.||||++.... .......+.+|+.++++++|||||++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999975 69999999997543 233456788999999999999999999998643 56
Q ss_pred ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 445 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 445 (619)
.++||||+.++.+..... .+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~l~~~~~~-------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEEHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchHHHHhhhc-------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 799999998776654422 278899999999999999999999 9999999999999999999999999998
Q ss_pred eeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHH------
Q 007073 446 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL------ 519 (619)
Q Consensus 446 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 519 (619)
+..... .......||+.|+|||.+.+..+++++||||+||++|||++|+.||........ ........
T Consensus 167 ~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~----~~~i~~~~~~~~~~ 240 (355)
T d2b1pa1 167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ----WNKVIEQLGTPCPE 240 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHHHCCCCHH
T ss_pred hccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHH----HHHHHHhccCCCHH
Confidence 865432 233455789999999999999999999999999999999999999964321110 00000000
Q ss_pred -------------hhhccc-----chhccccccCC---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 520 -------------EREKRL-----DAIVDRNLNKN---YNIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 520 -------------~~~~~~-----~~~~~~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
...... ........... .....+.++.+|+.+|++.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 00000000000 12345678899999999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=343.30 Aligned_cols=259 Identities=21% Similarity=0.253 Sum_probs=194.1
Q ss_pred hcCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCC-CcchHHHHHHHHHHHHHccCCCccceeeeeeCC-----Cc
Q 007073 293 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-----TE 365 (619)
Q Consensus 293 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 365 (619)
.++|++.+.||+|+||+||+|.. .+|+.||||++.... .....+.+.+|++++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56899999999999999999996 479999999997543 233456788999999999999999999998643 34
Q ss_pred ceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007073 366 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 445 (619)
Q Consensus 366 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 445 (619)
.+++++|+.+|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 5777888999999998864 2389999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcceeeeccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007073 446 KLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 524 (619)
Q Consensus 446 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (619)
...... .....||+.|+|||...+. .++.++||||+||++|+|+||+.||...... .....+........
T Consensus 169 ~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~-----~~~~~i~~~~~~~~ 239 (348)
T d2gfsa1 169 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-----DQLKLILRLVGTPG 239 (348)
T ss_dssp -CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCCCC
T ss_pred cccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhcCCCC
Confidence 755322 2345689999999987665 4689999999999999999999999743221 11111111000000
Q ss_pred c--c---------hhccccc-cCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007073 525 L--D---------AIVDRNL-NKNY-----NIQEVETMIQVALLCTQASPEDRPAMSEVVR 568 (619)
Q Consensus 525 ~--~---------~~~~~~l-~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 568 (619)
. . ....... .... ......++.+|+.+|++.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0 0 0000000 0000 0122356889999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-36 Score=315.77 Aligned_cols=265 Identities=19% Similarity=0.206 Sum_probs=188.6
Q ss_pred cCCcccCccccCCCceEEEEEe-CCCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc-----------CCCccceeeeee
Q 007073 294 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-----------HRNLLRLIGFCT 361 (619)
Q Consensus 294 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~ 361 (619)
++|++.++||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 3589999999999999999997 47999999999642 233567788999888775 578999998875
Q ss_pred CC--CcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCC---
Q 007073 362 TP--TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDF--- 435 (619)
Q Consensus 362 ~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~--- 435 (619)
.. ....++++++..+......... .....++...+..++.|++.||+|||+ . +|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTT
T ss_pred eccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccc
Confidence 43 4455666665544333332222 223457888999999999999999998 6 899999999999998654
Q ss_pred ---cEEEcccccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccc--ch
Q 007073 436 ---EAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED--DV 510 (619)
Q Consensus 436 ---~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~elltg~~p~~~~~~~~~~--~~ 510 (619)
.++++|||.+...... .....||+.|+|||.+.+..++.++||||+||+++||++|+.||......... ..
T Consensus 167 ~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 4999999999865322 23456999999999999999999999999999999999999999753321111 11
Q ss_pred hHHHHHHHHhh--------hcccchhccc-------------------cccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 007073 511 LLLDHVKKLER--------EKRLDAIVDR-------------------NLNKNYNIQEVETMIQVALLCTQASPEDRPAM 563 (619)
Q Consensus 511 ~~~~~~~~~~~--------~~~~~~~~~~-------------------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 563 (619)
.+...+..+.. ........+. ............++.+|+.+|++.||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 11111111100 0000000000 00122346778899999999999999999999
Q ss_pred HHHHH
Q 007073 564 SEVVR 568 (619)
Q Consensus 564 ~evl~ 568 (619)
+|+++
T Consensus 323 ~e~L~ 327 (362)
T d1q8ya_ 323 GGLVN 327 (362)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99975
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.92 E-value=5.6e-26 Score=229.99 Aligned_cols=171 Identities=32% Similarity=0.595 Sum_probs=154.1
Q ss_pred c-chhHHHHHHHHHhcCCCCCCCCCCCCCCCCCC--CcceeEEcCCC---CeEEEEeCCCCccc--cCCccccCCCCCCE
Q 007073 33 C-SLSGDALFALRTSLRVPNNQLRDWNQNQVNPC--TWSNVICDNSN---NVASVTLSSMNFSG--TLSPRIGVLRTLST 104 (619)
Q Consensus 33 ~-~~~~~al~~~k~~l~~~~~~l~~w~~~~~~~c--~w~gv~c~~~~---~l~~L~L~~n~l~~--~~~~~~~~l~~L~~ 104 (619)
| .+|.+||++||+++.+|. .+++|.. +.||| .|.||+|+..+ +|+.|+|++|++.| .+|+.+++|++|++
T Consensus 3 c~~~e~~aLl~~k~~~~~~~-~l~sW~~-~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~ 80 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPT-TLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCG-GGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCHHHHHHHHHHHHHCCCCC-cCCCCCC-CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccc
Confidence 5 569999999999999875 6999985 45999 59999998743 79999999999998 58899999999999
Q ss_pred EEccC-CCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCCCc
Q 007073 105 LTLKG-NGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNN 183 (619)
Q Consensus 105 L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 183 (619)
|+|++ |+++|.+|..|++|++|++|+|++|+|++..|..+..+.+|+.+++++|++.+.+|..+..+++|+.+++++|.
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccc
Confidence 99986 89999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCccccccCc----cccCCCCC
Q 007073 184 LSGQIPVHLFQIPK----YNFTGNNL 205 (619)
Q Consensus 184 l~~~~p~~l~~l~~----l~~~~n~~ 205 (619)
++|.+|..+.++.. +.+.+|..
T Consensus 161 l~~~ip~~~~~l~~l~~~l~~~~n~l 186 (313)
T d1ogqa_ 161 ISGAIPDSYGSFSKLFTSMTISRNRL 186 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEE
T ss_pred cccccccccccccccccccccccccc
Confidence 99999988876654 34555544
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=2.2e-23 Score=194.75 Aligned_cols=171 Identities=12% Similarity=0.062 Sum_probs=121.2
Q ss_pred cccCccccCCCceEEEEEeCCCcEEEEEEeccCCCc-----------------chHHHHHHHHHHHHHccCCCccceeee
Q 007073 297 SEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESP-----------------GGDAAFQREVEMISVAVHRNLLRLIGF 359 (619)
Q Consensus 297 ~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~-----------------~~~~~~~~E~~~l~~l~H~niv~l~~~ 359 (619)
.+.+.||+|+||+||+|...+|+.||||+++..... ........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 457899999999999999889999999987531100 012344568888999999999988765
Q ss_pred eeCCCcceeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEE
Q 007073 360 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV 439 (619)
Q Consensus 360 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 439 (619)
. ..+++|||+++..+.. ++......++.|+++|++|||++ +|+||||||+|||++++ .++|
T Consensus 83 ~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred c----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence 3 3479999998865533 23334567899999999999999 99999999999999865 5899
Q ss_pred cccccceeeccCCcceeeeccccccccccccccCCCCCcchhhHHHHHHHH
Q 007073 440 GDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLL 490 (619)
Q Consensus 440 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv~l~ 490 (619)
+|||+|............. .+...+ .+. ..+.|+.++|+||..--+.
T Consensus 144 iDFG~a~~~~~~~~~~~l~--rd~~~~-~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 144 IDFPQSVEVGEEGWREILE--RDVRNI-ITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCCTTCEETTSTTHHHHHH--HHHHHH-HHH-HHHHHCCCCCHHHHHHHHH
T ss_pred EECCCcccCCCCCcHHHHH--HHHHHH-HHH-HcCCCCCcccHHHHHHHHh
Confidence 9999998654322111000 000000 111 1356788999999865443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.76 E-value=9.8e-19 Score=162.86 Aligned_cols=123 Identities=27% Similarity=0.369 Sum_probs=97.8
Q ss_pred CCcceeEEcCC----------CCeEEEEeCCCCccccC-CccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecC
Q 007073 65 CTWSNVICDNS----------NNVASVTLSSMNFSGTL-SPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 133 (619)
Q Consensus 65 c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 133 (619)
|.|..|.|++. .+++.|+|++|.|++.+ +..|..+++|+.|+|++|++.+..+..+..+++|++|+|++
T Consensus 8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 56777777642 36888888888887644 55677888888888888888877788888888888888888
Q ss_pred CCccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCCCccccc
Q 007073 134 NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQ 187 (619)
Q Consensus 134 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 187 (619)
|+|++..|..|.++++|++|+|++|+|++..|+.|..+++|++|+|++|.+...
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence 888876677788888888888888888866677788888888888888888743
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=1.7e-18 Score=170.09 Aligned_cols=176 Identities=23% Similarity=0.235 Sum_probs=138.3
Q ss_pred CccccccchhcccchhHHHHHHHHHhcCCCCCCCCCCCCCCCCCCCcceeEEcCCCCeEEEEeCCCCccccCCccccCCC
Q 007073 21 DPDLHNGWLTFLCSLSGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLR 100 (619)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~al~~~k~~l~~~~~~l~~w~~~~~~~c~w~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~ 100 (619)
..++++|.++.+....+..+-+++. |...+|.+++.... ....+|+.|+|++|+++ ..+..+..++
T Consensus 35 ~L~Ls~N~i~~l~~~~f~~l~~L~~-L~L~~N~l~~l~~~------------~~l~~L~~L~Ls~N~l~-~~~~~~~~l~ 100 (266)
T d1p9ag_ 35 ILHLSENLLYTFSLATLMPYTRLTQ-LNLDRAELTKLQVD------------GTLPVLGTLDLSHNQLQ-SLPLLGQTLP 100 (266)
T ss_dssp EEECTTSCCSEEEGGGGTTCTTCCE-EECTTSCCCEEECC------------SCCTTCCEEECCSSCCS-SCCCCTTTCT
T ss_pred EEECcCCcCCCcCHHHhhccccccc-cccccccccccccc------------ccccccccccccccccc-cccccccccc
Confidence 4566777777766555544444433 44455555433211 12457899999999988 4566788899
Q ss_pred CCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCC
Q 007073 101 TLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLD 180 (619)
Q Consensus 101 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 180 (619)
+|+.|++++|.+.+..+..+..+.+|++|++++|.+++..+..+..+++|+.|++++|+|++..+..|..+++|+.|+|+
T Consensus 101 ~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls 180 (266)
T d1p9ag_ 101 ALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180 (266)
T ss_dssp TCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECC
T ss_pred ccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecc
Confidence 99999999999987777788889999999999999997767778889999999999999997778889999999999999
Q ss_pred CCcccccCCcccc---ccCccccCCCCCCCCCCC
Q 007073 181 SNNLSGQIPVHLF---QIPKYNFTGNNLNCGKTL 211 (619)
Q Consensus 181 ~N~l~~~~p~~l~---~l~~l~~~~n~~~c~~~~ 211 (619)
+|+|+ .+|..+. +++.|+++||||.|+|.+
T Consensus 181 ~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~~ 213 (266)
T d1p9ag_ 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEI 213 (266)
T ss_dssp SSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred cCCCc-ccChhHCCCCCCCEEEecCCCCCCCcch
Confidence 99999 8997665 456688999999999863
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.69 E-value=1.8e-17 Score=154.14 Aligned_cols=136 Identities=21% Similarity=0.328 Sum_probs=116.9
Q ss_pred ceeEEcCCCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCC-cccccccccCcEeeecCCCccccCCCcccc
Q 007073 68 SNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEI-PEELGNLSSLTSLDLDNNRLVGKIPPSLGN 146 (619)
Q Consensus 68 ~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 146 (619)
.|-+|+. +.++.++++++ .+|..+ .+++++|+|++|+|++.+ +..|.++++|+.|+|++|++++..+..|..
T Consensus 4 ~~C~C~~----~~v~Cs~~~L~-~iP~~l--p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~ 76 (192)
T d1w8aa_ 4 AMCHCEG----TTVDCTGRGLK-EIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEG 76 (192)
T ss_dssp TTSEEET----TEEECTTSCCS-SCCSCC--CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTT
T ss_pred CCCEEcC----CEEEEeCCCcC-ccCCCC--CCCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccccc
Confidence 3556653 47999999999 677665 378999999999998645 567899999999999999999889999999
Q ss_pred cccchhhhccCCcCCCCCCCccccccccccccCCCCcccccCCcccc---ccCccccCCCCCCCCCC
Q 007073 147 LKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLNCGKT 210 (619)
Q Consensus 147 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~---~l~~l~~~~n~~~c~~~ 210 (619)
+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|. ++..+++++|++.|++.
T Consensus 77 ~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 77 ASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred ccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence 99999999999999977778899999999999999999965555554 56778899999999885
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.68 E-value=7.4e-18 Score=169.52 Aligned_cols=68 Identities=38% Similarity=0.628 Sum_probs=59.6
Q ss_pred cccchhhhccCCcCCCCCCCccccccccccccCCCCcccccCCc--cccccCccccCCCCCCCCCCCCCCC
Q 007073 147 LKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV--HLFQIPKYNFTGNNLNCGKTLPHSC 215 (619)
Q Consensus 147 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~l~~l~~l~~~~n~~~c~~~~~~~c 215 (619)
+++|+.|+|++|+|+|.+|..|.++++|++|+|++|+|+|.+|. .+.++..+++.||+..|+.|+| +|
T Consensus 243 ~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp-~c 312 (313)
T d1ogqa_ 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp CTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred ccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCC-CC
Confidence 45678899999999999999999999999999999999999996 3567778889999999998876 55
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=2.3e-16 Score=156.14 Aligned_cols=136 Identities=22% Similarity=0.255 Sum_probs=124.0
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
..+|++|+|++|.+....+..+..+++|+.+++++|+|++..+..|..+++|+.|+|++|+|++..+..|.++++|+.|+
T Consensus 104 l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~ 183 (284)
T d1ozna_ 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183 (284)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred cccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhh
Confidence 35899999999999988888899999999999999999977778899999999999999999988889999999999999
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCCcccc---ccCccccCCCCCCCCCC
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLNCGKT 210 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~---~l~~l~~~~n~~~c~~~ 210 (619)
+++|++++..|..|..+++|++|++++|++++..|..+. ++..+++++|++.|+|+
T Consensus 184 l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred hhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 999999988899999999999999999999966665554 57778999999999986
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.58 E-value=1.5e-15 Score=129.95 Aligned_cols=102 Identities=25% Similarity=0.395 Sum_probs=90.6
Q ss_pred EEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhccCC
Q 007073 79 ASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 158 (619)
Q Consensus 79 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 158 (619)
+.|+|++|+++ .++ .+..+++|++|+|++|+|+ .+|..++.+++|+.|++++|+|+ .+| .+.++++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 46999999998 555 4899999999999999999 78888999999999999999999 455 5999999999999999
Q ss_pred cCCCCCC--CccccccccccccCCCCcccc
Q 007073 159 NFSGTIP--DSLTTLSSLISIQLDSNNLSG 186 (619)
Q Consensus 159 ~l~~~~p--~~~~~l~~L~~L~l~~N~l~~ 186 (619)
+|+ .+| ..+..+++|+.|++++|+++.
T Consensus 76 ~i~-~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQ-QSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCC-SSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccC-CCCCchhhcCCCCCCEEECCCCcCCc
Confidence 998 444 468899999999999999983
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=4e-15 Score=133.66 Aligned_cols=121 Identities=19% Similarity=0.248 Sum_probs=100.9
Q ss_pred CCCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhh
Q 007073 74 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFL 153 (619)
Q Consensus 74 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 153 (619)
+..++++|+|++|+|+. ++..+..+++|+.|+|++|+|+ .++ .|..+++|++|+|++|+|+...+..+..+++|+.|
T Consensus 16 n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 92 (162)
T ss_dssp CTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred CcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccc
Confidence 34579999999999994 5667788999999999999999 665 48999999999999999995545556789999999
Q ss_pred hccCCcCCCCCC--CccccccccccccCCCCcccccCCc----cccccCccc
Q 007073 154 TLSQNNFSGTIP--DSLTTLSSLISIQLDSNNLSGQIPV----HLFQIPKYN 199 (619)
Q Consensus 154 ~l~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~p~----~l~~l~~l~ 199 (619)
+|++|+|+ .++ ..+..+++|+.|++++|+++ ..|. .+..++.|.
T Consensus 93 ~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~ 142 (162)
T d1a9na_ 93 ILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVR 142 (162)
T ss_dssp ECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCS
T ss_pred eecccccc-ccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcC
Confidence 99999998 555 36788999999999999998 5664 355566655
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=5.2e-14 Score=137.46 Aligned_cols=128 Identities=24% Similarity=0.270 Sum_probs=92.2
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
.+++.|+|++|+|++..+..|.++++|++|+|++|+|+ .+|. ++.+++|++|+|++|+++ .++..+.++++|+.|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-cccccccccccccccccc-ccccccccccccccccc
Confidence 36888888888888777778888888888888888887 5554 577888888888888888 56777888888888888
Q ss_pred cCCcCCCCCCCccccccccccccCCCCcccccCCcc---ccccCccccCCCCCC
Q 007073 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH---LFQIPKYNFTGNNLN 206 (619)
Q Consensus 156 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~---l~~l~~l~~~~n~~~ 206 (619)
++|.+.+..+..+..+.+|+.|++++|.+++..+.. +.++..+++++|...
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~ 161 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence 888877555566666667777777777666322222 234445566666543
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.46 E-value=3.6e-14 Score=121.16 Aligned_cols=102 Identities=30% Similarity=0.427 Sum_probs=87.3
Q ss_pred CEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhccCCcCCCCCCCccccccccccccCCCC
Q 007073 103 STLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSN 182 (619)
Q Consensus 103 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 182 (619)
+.|+|++|+|+ .+|. ++.+++|++|+|++|+|+ .+|..|+.+++|+.|++++|+|+ .+| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCcc-cccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 58999999999 6664 899999999999999999 78889999999999999999999 565 5899999999999999
Q ss_pred cccccCC--cccc---ccCccccCCCCCCCCCC
Q 007073 183 NLSGQIP--VHLF---QIPKYNFTGNNLNCGKT 210 (619)
Q Consensus 183 ~l~~~~p--~~l~---~l~~l~~~~n~~~c~~~ 210 (619)
+++ .+| ..+. ++..+++.+|+......
T Consensus 76 ~i~-~~~~~~~l~~~~~L~~L~l~~N~i~~~~~ 107 (124)
T d1dcea3 76 RLQ-QSAAIQPLVSCPRLVLLNLQGNSLCQEEG 107 (124)
T ss_dssp CCC-SSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred ccC-CCCCchhhcCCCCCCEEECCCCcCCcCcc
Confidence 998 455 3444 56668899999755443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.45 E-value=7e-14 Score=139.36 Aligned_cols=141 Identities=26% Similarity=0.335 Sum_probs=102.0
Q ss_pred CCcceeEEcCC----------CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCC
Q 007073 65 CTWSNVICDNS----------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNN 134 (619)
Q Consensus 65 c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 134 (619)
|.|.++.|++. .+++.|+|++|+|+...+..|.++++|++|++++|.++...|..|.++++|++|+|++|
T Consensus 10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n 89 (305)
T d1xkua_ 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89 (305)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCC
Confidence 68999999752 47999999999999776678999999999999999999777888999999999999999
Q ss_pred CccccCCCc------------------------------------------------cccccc-----------------
Q 007073 135 RLVGKIPPS------------------------------------------------LGNLKK----------------- 149 (619)
Q Consensus 135 ~l~~~~p~~------------------------------------------------~~~l~~----------------- 149 (619)
+|+ .+|.. +..+++
T Consensus 90 ~l~-~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~ 168 (305)
T d1xkua_ 90 QLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQG 168 (305)
T ss_dssp CCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSS
T ss_pred ccC-cCccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCcc
Confidence 886 23322 111223
Q ss_pred ----chhhhccCCcCCCCCCCccccccccccccCCCCcccccCCcccc---ccCccccCCCCCC
Q 007073 150 ----LQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLN 206 (619)
Q Consensus 150 ----L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~---~l~~l~~~~n~~~ 206 (619)
|+.|++++|.+++..+..+..++.++.|++++|++++..|..+. ++..|++++|.+.
T Consensus 169 ~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~ 232 (305)
T d1xkua_ 169 LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 232 (305)
T ss_dssp CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS
T ss_pred cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc
Confidence 34444444444444455566667777778888888755554443 4555677777654
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=5.8e-14 Score=125.07 Aligned_cols=103 Identities=17% Similarity=0.122 Sum_probs=82.4
Q ss_pred EEeCCCCccccCCccccCCCCCCEEEccCC-CCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhccCCc
Q 007073 81 VTLSSMNFSGTLSPRIGVLRTLSTLTLKGN-GITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNN 159 (619)
Q Consensus 81 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 159 (619)
++.+++++. ..|..+..+++|++|+|++| .|+...+..|.++++|+.|+|++|+|+...|..|..+++|++|+|++|+
T Consensus 13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 344556666 55677888999999999766 5886666779999999999999999997778889999999999999999
Q ss_pred CCCCCCCccccccccccccCCCCccc
Q 007073 160 FSGTIPDSLTTLSSLISIQLDSNNLS 185 (619)
Q Consensus 160 l~~~~p~~~~~l~~L~~L~l~~N~l~ 185 (619)
|+ .+|.......+|+.|+|++|++.
T Consensus 92 l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 92 LE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred Cc-ccChhhhccccccccccCCCccc
Confidence 99 66665555557888888888775
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=2.3e-13 Score=121.11 Aligned_cols=110 Identities=22% Similarity=0.280 Sum_probs=82.3
Q ss_pred CCCCCEEEccCCCCCCCCcccccccccCcEeeecCC-CccccCCCcccccccchhhhccCCcCCCCCCCccccccccccc
Q 007073 99 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNN-RLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISI 177 (619)
Q Consensus 99 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 177 (619)
......++.+++++. ..|..+..+++|++|+|++| .|+...+..|.++++|+.|+|++|+|+...|.+|..+++|+.|
T Consensus 7 c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (156)
T ss_dssp CSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred cCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence 344556788888887 66777888888888888665 4775555678888888888888888885557778888888888
Q ss_pred cCCCCcccccCCcccc---ccCccccCCCCCCCCCC
Q 007073 178 QLDSNNLSGQIPVHLF---QIPKYNFTGNNLNCGKT 210 (619)
Q Consensus 178 ~l~~N~l~~~~p~~l~---~l~~l~~~~n~~~c~~~ 210 (619)
+|++|+|+ .+|.... ++..|++++|++.|+|.
T Consensus 86 ~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~C~C~ 120 (156)
T d2ifga3 86 NLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCA 120 (156)
T ss_dssp ECCSSCCS-CCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred eccCCCCc-ccChhhhccccccccccCCCcccCCch
Confidence 88888888 5664332 45677888888888775
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=3.6e-14 Score=140.00 Aligned_cols=134 Identities=23% Similarity=0.290 Sum_probs=116.2
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
..+|+.+++++|+|+++.+..|..+++|+.|+|++|+|++..|..|.++++|+.|++++|++++..|..|.++++|+.|+
T Consensus 128 ~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~ 207 (284)
T d1ozna_ 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207 (284)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred hcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccc
Confidence 35799999999999988888899999999999999999988888999999999999999999999999999999999999
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCCcc-c-cccCccccCCCCCCCC
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH-L-FQIPKYNFTGNNLNCG 208 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-l-~~l~~l~~~~n~~~c~ 208 (619)
+++|++.+..|..|..+++|+.|++++|++...-+.. + ..+.++....+...|.
T Consensus 208 l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~ 263 (284)
T d1ozna_ 208 LFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS 263 (284)
T ss_dssp CCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEE
T ss_pred ccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeC
Confidence 9999999877888999999999999999999655421 1 2344555555666554
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.40 E-value=2.6e-13 Score=135.14 Aligned_cols=129 Identities=23% Similarity=0.305 Sum_probs=112.6
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
.+++.+++++|++. .+|..+ +++|+.|++++|.+++..+..|.+++.++.|++++|.+++..+..+.++++|++|+|
T Consensus 150 ~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L 226 (305)
T d1xkua_ 150 KKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 226 (305)
T ss_dssp TTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEEC
T ss_pred cccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeec
Confidence 47899999999998 455443 689999999999999889999999999999999999999888899999999999999
Q ss_pred cCCcCCCCCCCccccccccccccCCCCcccccCCcc----------ccccCccccCCCCCCCCC
Q 007073 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH----------LFQIPKYNFTGNNLNCGK 209 (619)
Q Consensus 156 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~----------l~~l~~l~~~~n~~~c~~ 209 (619)
++|+|+ .+|+++..+++|+.|+|++|+|+ .++.. ..++..|++.||++.+..
T Consensus 227 ~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~ 288 (305)
T d1xkua_ 227 NNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 288 (305)
T ss_dssp CSSCCS-SCCTTTTTCSSCCEEECCSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGG
T ss_pred cccccc-ccccccccccCCCEEECCCCccC-ccChhhccCcchhcccCCCCEEECCCCcCccCc
Confidence 999999 78999999999999999999999 56532 235667889999997643
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=1.3e-13 Score=123.49 Aligned_cols=109 Identities=18% Similarity=0.216 Sum_probs=91.1
Q ss_pred ccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhccCCcCCCCCCCccccccc
Q 007073 94 PRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSS 173 (619)
Q Consensus 94 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 173 (619)
+.+.++.+|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .++ .|..+++|++|++++|+++...+..+..+++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~ 88 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPD 88 (162)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred HhccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccc
Confidence 35678889999999999999 67877788999999999999999 564 5899999999999999999444444568999
Q ss_pred cccccCCCCcccccCCc--cc---cccCccccCCCCCC
Q 007073 174 LISIQLDSNNLSGQIPV--HL---FQIPKYNFTGNNLN 206 (619)
Q Consensus 174 L~~L~l~~N~l~~~~p~--~l---~~l~~l~~~~n~~~ 206 (619)
|+.|++++|+++ .+++ .+ .++..+++.+|+..
T Consensus 89 L~~L~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 89 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred cccceecccccc-ccccccccccccccchhhcCCCccc
Confidence 999999999998 4553 34 45667789999874
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.30 E-value=2.8e-12 Score=119.03 Aligned_cols=122 Identities=30% Similarity=0.472 Sum_probs=91.1
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
.++|++|+|++|++++..| ++.+++|++|++++|.+. .+|. +.++++|+.|++++|.+.. + ..+..+++|+.|+
T Consensus 61 l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~l~~~~~~~-~-~~~~~l~~L~~L~ 134 (199)
T d2omxa2 61 LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTLFNNQITD-I-DPLKNLTNLNRLE 134 (199)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCGG-GTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEE
T ss_pred CCCcCcCccccccccCccc--ccCCcccccccccccccc-cccc-ccccccccccccccccccc-c-cccchhhhhHHhh
Confidence 4578888888888875433 778888888888888887 4553 7788888888888888773 2 3477788888888
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCC--ccccccCccccCCCCC
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP--VHLFQIPKYNFTGNNL 205 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p--~~l~~l~~l~~~~n~~ 205 (619)
+++|++. .+| .+..+++|+.|++++|++++ ++ ..+.++..|++++|+.
T Consensus 135 l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~-l~~l~~l~~L~~L~ls~N~i 184 (199)
T d2omxa2 135 LSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTD-LKPLANLTTLERLDISSNKV 184 (199)
T ss_dssp CCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-CGGGTTCTTCCEEECCSSCC
T ss_pred hhhhhhc-ccc-cccccccccccccccccccC-CccccCCCCCCEEECCCCCC
Confidence 8888887 443 57778888888888888884 44 3455667777888765
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.22 E-value=9e-12 Score=115.56 Aligned_cols=123 Identities=28% Similarity=0.469 Sum_probs=102.6
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
..+++.|++++|+++. + +.+..+++|++|+|++|+|++ ++. ++++++|++|++++|.+. .++ .+.++++|+.|+
T Consensus 39 l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~ 112 (199)
T d2omxa2 39 LDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLT 112 (199)
T ss_dssp HTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEE
T ss_pred hcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccC-ccc-ccCCcccccccccccccc-ccc-cccccccccccc
Confidence 3589999999999984 4 358899999999999999995 443 999999999999999998 455 489999999999
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCC--ccccccCccccCCCCCC
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP--VHLFQIPKYNFTGNNLN 206 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p--~~l~~l~~l~~~~n~~~ 206 (619)
+++|.+... +.+..+++|+.|++++|++. .+| ..+.++..|++.+|...
T Consensus 113 l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~~l~~~~~L~~L~l~~n~l~ 163 (199)
T d2omxa2 113 LFNNQITDI--DPLKNLTNLNRLELSSNTIS-DISALSGLTSLQQLNFSSNQVT 163 (199)
T ss_dssp CCSSCCCCC--GGGTTCTTCSEEECCSSCCC-CCGGGTTCTTCSEEECCSSCCC
T ss_pred ccccccccc--cccchhhhhHHhhhhhhhhc-cccccccccccccccccccccc
Confidence 999999843 34788999999999999998 555 23456677888888653
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.21 E-value=1.2e-11 Score=115.67 Aligned_cols=123 Identities=25% Similarity=0.386 Sum_probs=93.7
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
..+|++|+|++|.|++.. .++.+++|+.|++++|+|+ .+| .+..+++|+.|++++|.+. .+ ..+..+++|+.++
T Consensus 67 l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~ 140 (210)
T d1h6ta2 67 LPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLY 140 (210)
T ss_dssp CTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEE
T ss_pred CCCCCEEeCCCccccCcc--ccccCcccccccccccccc-ccc-ccccccccccccccccccc-cc-ccccccccccccc
Confidence 457888888888888643 3678888888888888888 455 4788888888888888877 33 3577888888888
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCC--ccccccCccccCCCCCC
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP--VHLFQIPKYNFTGNNLN 206 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p--~~l~~l~~l~~~~n~~~ 206 (619)
+++|.+++ +..+..+++|+.+++++|++++ ++ ..+.++..|++++|...
T Consensus 141 ~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~~l~~l~~L~~L~Ls~N~i~ 191 (210)
T d1h6ta2 141 LGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHIS 191 (210)
T ss_dssp CCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CGGGTTCTTCCEEECCSSCCC
T ss_pred cccccccc--cccccccccccccccccccccc-cccccCCCCCCEEECCCCCCC
Confidence 88888873 3356778888999999998884 44 34556777888888764
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.19 E-value=6.4e-14 Score=130.11 Aligned_cols=109 Identities=23% Similarity=0.299 Sum_probs=85.8
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
..+|+.|+|++|+|+. ++ .+..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|+|+. ++ .+.++++|+.|+
T Consensus 47 L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~ 121 (198)
T d1m9la_ 47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLY 121 (198)
T ss_dssp TTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSEEE
T ss_pred ccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-cccccccccccc
Confidence 4578899999988884 44 5888889999999999888 677666667788999999998883 43 478888899999
Q ss_pred ccCCcCCCCCC--CccccccccccccCCCCcccccCC
Q 007073 155 LSQNNFSGTIP--DSLTTLSSLISIQLDSNNLSGQIP 189 (619)
Q Consensus 155 l~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~p 189 (619)
|++|+|+ .++ ..+..+++|+.|++++|+++...+
T Consensus 122 L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 122 MSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp ESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred cccchhc-cccccccccCCCccceeecCCCccccCcc
Confidence 9999888 444 357788889999999998874444
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.19 E-value=9.7e-12 Score=127.34 Aligned_cols=60 Identities=28% Similarity=0.411 Sum_probs=30.4
Q ss_pred ccccccchhhhccCCcCCCCCCCccccccccccccCCCCcccccCCc--cccccCccccCCCCCC
Q 007073 144 LGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV--HLFQIPKYNFTGNNLN 206 (619)
Q Consensus 144 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~l~~l~~l~~~~n~~~ 206 (619)
+..+++|+.|++++|++++.. .+..+++|+.|++++|+++ .+|. .+.++..|++++|+..
T Consensus 303 ~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~-~l~~l~~l~~L~~L~l~~N~l~ 364 (384)
T d2omza2 303 ISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVS-DVSSLANLTNINWLSAGHNQIS 364 (384)
T ss_dssp GGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCC-CCGGGGGCTTCCEEECCSSCCC
T ss_pred cchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCC-CChhHcCCCCCCEEECCCCcCC
Confidence 444555566666666665332 2555566666666666665 2331 1223444555555543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.17 E-value=2.2e-11 Score=113.90 Aligned_cols=123 Identities=29% Similarity=0.435 Sum_probs=103.1
Q ss_pred CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 76 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
.+++.|++++|.++... .+..+++|++|+|++|+|++ ++. ++.+++|++|++++|+|+ .+| .+.++++|+.|++
T Consensus 46 ~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~-l~~-~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l 119 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSL 119 (210)
T ss_dssp HTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEEC
T ss_pred cCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccC-ccc-cccCcccccccccccccc-ccc-ccccccccccccc
Confidence 47999999999998543 48899999999999999995 543 789999999999999999 466 5899999999999
Q ss_pred cCCcCCCCCCCccccccccccccCCCCcccccCC-ccccccCccccCCCCCC
Q 007073 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP-VHLFQIPKYNFTGNNLN 206 (619)
Q Consensus 156 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~l~~~~n~~~ 206 (619)
++|.+. .+ ..+..+++|+.+++++|.+++..+ ..+.++..+++.+|...
T Consensus 120 ~~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l~ 169 (210)
T d1h6ta2 120 EHNGIS-DI-NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS 169 (210)
T ss_dssp TTSCCC-CC-GGGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCC
T ss_pred cccccc-cc-cccccccccccccccccccccccccccccccccccccccccc
Confidence 999997 44 368889999999999999984322 34567777888888764
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.15 E-value=1.3e-13 Score=127.93 Aligned_cols=123 Identities=22% Similarity=0.305 Sum_probs=98.5
Q ss_pred eEEEEeCCC--CccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhc
Q 007073 78 VASVTLSSM--NFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 155 (619)
Q Consensus 78 l~~L~L~~n--~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 155 (619)
++.+++.++ .+. .++..+..|++|++|+|++|+|+ .++ .+.++++|+.|+|++|+|+ .+|..+..+++|+.|++
T Consensus 25 ~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l 100 (198)
T d1m9la_ 25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWI 100 (198)
T ss_dssp CSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEEC
T ss_pred cceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccc
Confidence 344445443 233 45677899999999999999999 565 4999999999999999999 67877777889999999
Q ss_pred cCCcCCCCCCCccccccccccccCCCCcccccCC--c---cccccCccccCCCCCCC
Q 007073 156 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP--V---HLFQIPKYNFTGNNLNC 207 (619)
Q Consensus 156 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p--~---~l~~l~~l~~~~n~~~c 207 (619)
++|+|+ .++ .+..+++|+.|++++|+++ .++ . .+.++..|++++|+..+
T Consensus 101 ~~N~i~-~l~-~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 101 SYNQIA-SLS-GIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp SEEECC-CHH-HHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred cccccc-ccc-cccccccccccccccchhc-cccccccccCCCccceeecCCCcccc
Confidence 999999 453 4788999999999999998 444 2 34566778899998643
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.01 E-value=2.7e-10 Score=108.61 Aligned_cols=121 Identities=18% Similarity=0.298 Sum_probs=80.9
Q ss_pred CCcceeEEcCC----------CCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCC-cccccccccCcEeeecC
Q 007073 65 CTWSNVICDNS----------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEI-PEELGNLSSLTSLDLDN 133 (619)
Q Consensus 65 c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~ 133 (619)
|....|.|.+. .++++|+|++|+|+...+..|.++++|++|+|++|.+...+ +..|.+++++++|++..
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 45556667531 26778888888887655566777888888888888776544 34577777888777653
Q ss_pred -CCccccCCCcccccccchhhhccCCcCCCCCCC-ccccccccccccCCCCccc
Q 007073 134 -NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPD-SLTTLSSLISIQLDSNNLS 185 (619)
Q Consensus 134 -N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~ 185 (619)
|++....+..|.++++|+.|++++|++....+. .+..++.|..+..+++++.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~ 141 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH 141 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCC
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccc
Confidence 567666667777788888888888877632221 2344555666666666666
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.99 E-value=5.1e-10 Score=105.71 Aligned_cols=125 Identities=24% Similarity=0.441 Sum_probs=88.3
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCC-------------
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIP------------- 141 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p------------- 141 (619)
.++|+.|+|++|.+++..| +..+++|+.|++++|.++ .++ .+.++++|+.|++++|.+.+..+
T Consensus 62 l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~ 137 (227)
T d1h6ua2 62 LNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLD 137 (227)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECC
T ss_pred CCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-cccccccccccccccccccccchhccccchhhhhch
Confidence 4678888888888875543 777888888888888877 454 37778888888887777653211
Q ss_pred -------CcccccccchhhhccCCcCCCCCCCccccccccccccCCCCcccccCCc--cccccCccccCCCCCC
Q 007073 142 -------PSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV--HLFQIPKYNFTGNNLN 206 (619)
Q Consensus 142 -------~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~l~~l~~l~~~~n~~~ 206 (619)
..+.++++|+.|++++|.+++.. .+..+++|+.|+|++|++++ +|. .+.++..|++++|+..
T Consensus 138 ~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N~lt 208 (227)
T d1h6ua2 138 LNQITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQIS 208 (227)
T ss_dssp SSCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECTTSCCC
T ss_pred hhhhchhhhhccccccccccccccccccch--hhcccccceecccCCCccCC-ChhhcCCCCCCEEECcCCcCC
Confidence 12455677888888888877332 37788888888888888884 553 4556677788888654
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.95 E-value=3.1e-10 Score=115.79 Aligned_cols=121 Identities=25% Similarity=0.359 Sum_probs=102.8
Q ss_pred CCCeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhh
Q 007073 75 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 154 (619)
Q Consensus 75 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 154 (619)
..+|+.|++++|.+++.. .+..++.++.++++.|++++ ++ .+..+++++.|+|++|+|++. + .+..+++|+.|+
T Consensus 262 ~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~-~~-~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~ 335 (384)
T d2omza2 262 LTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED-IS-PISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLF 335 (384)
T ss_dssp CTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC-CG-GGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEE
T ss_pred cccCCEeeccCcccCCCC--cccccccccccccccccccc-cc-ccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEE
Confidence 458999999999998654 37889999999999999995 44 488999999999999999964 3 389999999999
Q ss_pred ccCCcCCCCCCCccccccccccccCCCCcccccCC-ccccccCccccCCC
Q 007073 155 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP-VHLFQIPKYNFTGN 203 (619)
Q Consensus 155 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~l~~~~n 203 (619)
|++|+|+ .+| .+.++++|++|++++|++++..| ..+.++..|++++|
T Consensus 336 L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 336 FANNKVS-DVS-SLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp CCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCCE
T ss_pred CCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChhhccCCCCCEeeCCCC
Confidence 9999998 455 68999999999999999996555 34556777888887
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.88 E-value=9.7e-10 Score=103.71 Aligned_cols=115 Identities=26% Similarity=0.372 Sum_probs=78.2
Q ss_pred CeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhcc
Q 007073 77 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 156 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 156 (619)
+|+.++++++...+. ..+...+.+..+.++++.+.... .+.++++|+.|++++|.+++. ..++++++|+.|+|+
T Consensus 108 ~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls 181 (227)
T d1h6ua2 108 SIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKAD 181 (227)
T ss_dssp TCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECC
T ss_pred ccccccccccccccc--chhccccchhhhhchhhhhchhh--hhccccccccccccccccccc--hhhcccccceecccC
Confidence 444445544444322 12334455555555555554222 367888999999999999843 348999999999999
Q ss_pred CCcCCCCCCCccccccccccccCCCCcccccCCc--cccccCcccc
Q 007073 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV--HLFQIPKYNF 200 (619)
Q Consensus 157 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~l~~l~~l~~ 200 (619)
+|++++ +|. +..+++|++|+|++|+++ .+|. .+.+|..|++
T Consensus 182 ~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt-~i~~l~~l~~L~~L~l 224 (227)
T d1h6ua2 182 DNKISD-ISP-LASLPNLIEVHLKNNQIS-DVSPLANTSNLFIVTL 224 (227)
T ss_dssp SSCCCC-CGG-GGGCTTCCEEECTTSCCC-BCGGGTTCTTCCEEEE
T ss_pred CCccCC-Chh-hcCCCCCCEEECcCCcCC-CCcccccCCCCCEEEe
Confidence 999994 543 889999999999999999 4552 3444444444
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.86 E-value=3e-09 Score=106.70 Aligned_cols=114 Identities=29% Similarity=0.392 Sum_probs=91.8
Q ss_pred CeEEEEeCCCCccccCCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCccccCCCcccccccchhhhcc
Q 007073 77 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 156 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 156 (619)
+++.|||++|+++ .+|+ .+++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++... ++|++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~---~~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~lp---~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDLP---PLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCS---CCTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSCC---TTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCC---CCCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhhc---ccccccccc
Confidence 6889999999998 5675 3678999999999999 888754 58899999999998 565422 469999999
Q ss_pred CCcCCCCCCCccccccccccccCCCCcccccCCccccccCccccCCCCC
Q 007073 157 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNL 205 (619)
Q Consensus 157 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~l~~~~n~~ 205 (619)
+|.++ .+|. +..+++|+.|++++|.++ ..|.....+..+.+..+..
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~-~~~~~~~~l~~l~~~~~~~ 152 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIAAGNNQL 152 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCS-CCCCCCTTCCEEECCSSCC
T ss_pred ccccc-cccc-hhhhccceeecccccccc-ccccccccccchhhccccc
Confidence 99999 7775 578999999999999998 5666666666666554443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.80 E-value=8.2e-09 Score=103.39 Aligned_cols=33 Identities=21% Similarity=0.289 Sum_probs=18.4
Q ss_pred cccccccCCCCcccccCCccccccCccccCCCCC
Q 007073 172 SSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNL 205 (619)
Q Consensus 172 ~~L~~L~l~~N~l~~~~p~~l~~l~~l~~~~n~~ 205 (619)
++|++|++++|+|+ .+|..+.++..|++++|..
T Consensus 284 ~~L~~L~Ls~N~l~-~lp~~~~~L~~L~L~~N~L 316 (353)
T d1jl5a_ 284 PSLEELNVSNNKLI-ELPALPPRLERLIASFNHL 316 (353)
T ss_dssp TTCCEEECCSSCCS-CCCCCCTTCCEEECCSSCC
T ss_pred CCCCEEECCCCccC-ccccccCCCCEEECCCCcC
Confidence 34555566666555 4555555555555555544
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.64 E-value=2.3e-08 Score=94.80 Aligned_cols=123 Identities=17% Similarity=0.146 Sum_probs=63.4
Q ss_pred CeEEEEeC-CCCccccCCccccCCCCCCEEEccCCCCC-------------------------CCCcccccccc-cCcEe
Q 007073 77 NVASVTLS-SMNFSGTLSPRIGVLRTLSTLTLKGNGIT-------------------------GEIPEELGNLS-SLTSL 129 (619)
Q Consensus 77 ~l~~L~L~-~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-------------------------~~~p~~~~~l~-~L~~L 129 (619)
+++.|.+. .|++....+..|..+++|+.|++++|++. ...+..|.+++ .++.|
T Consensus 79 ~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L 158 (242)
T d1xwdc1 79 KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVIL 158 (242)
T ss_dssp TCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEE
T ss_pred ccccccccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceee
Confidence 44444433 24454444455555555555555555554 22223333333 45566
Q ss_pred eecCCCccccCCCcccccccchh-hhccCCcCCCCCCCccccccccccccCCCCcccccCCc-cccccCccccC
Q 007073 130 DLDNNRLVGKIPPSLGNLKKLQF-LTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV-HLFQIPKYNFT 201 (619)
Q Consensus 130 ~L~~N~l~~~~p~~~~~l~~L~~-L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~l~~l~~l~~~ 201 (619)
++++|+++ .++....+.++++. +++++|+|+...+..|..+++|+.|+|++|+|+ .+|. .|.+++.|...
T Consensus 159 ~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~l~~L~~l 230 (242)
T d1xwdc1 159 WLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRAR 230 (242)
T ss_dssp ECCSSCCC-EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC-CCCSSSCTTCCEEESS
T ss_pred eccccccc-ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCC-ccCHHHHcCCcccccC
Confidence 66666666 33333334444433 345666666322334666777777777777776 4543 45555555443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.50 E-value=1.6e-09 Score=96.37 Aligned_cols=90 Identities=23% Similarity=0.224 Sum_probs=48.3
Q ss_pred cCCCCCCEEEccCCCCCCCCcccccccccCcEeeecCCCcccc--CCCcccccccchhhhccCCcCCCCCCC-ccccccc
Q 007073 97 GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGK--IPPSLGNLKKLQFLTLSQNNFSGTIPD-SLTTLSS 173 (619)
Q Consensus 97 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~ 173 (619)
..+..+..|++.+|... .++..+.++++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+ .+++ ......+
T Consensus 39 ~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~ 116 (162)
T d1koha1 39 VAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLK 116 (162)
T ss_dssp TTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCC
T ss_pred hhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccc
Confidence 33444444444444433 4444445566666666666666632 1234555666666666666666 3332 2223345
Q ss_pred cccccCCCCcccccC
Q 007073 174 LISIQLDSNNLSGQI 188 (619)
Q Consensus 174 L~~L~l~~N~l~~~~ 188 (619)
|+.|++++|+++...
T Consensus 117 L~~L~L~~Npl~~~~ 131 (162)
T d1koha1 117 LEELWLDGNSLSDTF 131 (162)
T ss_dssp CSSCCCTTSTTSSSS
T ss_pred cceeecCCCCcCcCc
Confidence 666667777666443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.37 E-value=9.9e-07 Score=84.22 Aligned_cols=149 Identities=13% Similarity=0.095 Sum_probs=98.2
Q ss_pred HHHHHhcCCcccCccccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHcc-CCCccceeeeeeCCCcc
Q 007073 288 ELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTER 366 (619)
Q Consensus 288 el~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~ 366 (619)
++....+.|+..+..+.++.+.||+... ++..+++|+..... ......+.+|..++..+. +--+.+++.+...++..
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~-~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRY-KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGG-TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCc-ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 4555556676666555455578999875 46677888875322 122335678888887764 33355677777778888
Q ss_pred eeEecccccchhhhhhcccCCCCCCcCHHHHHHHHHHHHHHHHHHHhcC-------------------------------
Q 007073 367 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC------------------------------- 415 (619)
Q Consensus 367 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------- 415 (619)
++||+++++.++....... .....++.++++.++.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEeccccccccccccc---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 9999999998775543211 012234445555555555321
Q ss_pred -------------------------CCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007073 416 -------------------------NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 447 (619)
Q Consensus 416 -------------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 447 (619)
.+.++|+|+.|.||+++++..+-|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12378999999999999877778999998863
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.32 E-value=5e-08 Score=86.40 Aligned_cols=91 Identities=23% Similarity=0.193 Sum_probs=68.7
Q ss_pred cCCccccCCCCCCEEEccCCCCCCCC--cccccccccCcEeeecCCCccccCCC-cccccccchhhhccCCcCCCCCCCc
Q 007073 91 TLSPRIGVLRTLSTLTLKGNGITGEI--PEELGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPDS 167 (619)
Q Consensus 91 ~~~~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~ 167 (619)
.++..+..+++|++|+|++|+|+..- +..+..+++|+.|+|++|+|+. +++ .+....+|+.|++++|.++....+.
T Consensus 56 ~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~~~~~~ 134 (162)
T d1koha1 56 TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSDTFRDQ 134 (162)
T ss_dssp HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSSSSSSH
T ss_pred hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCcCcccc
Confidence 44444567999999999999999542 4557789999999999999994 443 3445567999999999998655432
Q ss_pred -------cccccccccccCCCCcc
Q 007073 168 -------LTTLSSLISIQLDSNNL 184 (619)
Q Consensus 168 -------~~~l~~L~~L~l~~N~l 184 (619)
+..+|+|+.|| ++++
T Consensus 135 ~~y~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 135 STYISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp HHHHHHHHTTSTTCCEET--TEEC
T ss_pred hhHHHHHHHHCCCCCEEC--cCCC
Confidence 55678888776 5544
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.30 E-value=1.2e-08 Score=106.03 Aligned_cols=110 Identities=24% Similarity=0.351 Sum_probs=86.2
Q ss_pred CeEEEEeCCCCccccC-CccccCCCCCCEEEccCCCCCC----CCcccccccccCcEeeecCCCcccc----CCCccc-c
Q 007073 77 NVASVTLSSMNFSGTL-SPRIGVLRTLSTLTLKGNGITG----EIPEELGNLSSLTSLDLDNNRLVGK----IPPSLG-N 146 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~-~ 146 (619)
+|++||+++|++++.. ..-+..+++|+.|+|++|.|+. .++..+..+++|++|||++|.|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 6999999999998632 3445678999999999999983 3455678899999999999998621 222232 2
Q ss_pred cccchhhhccCCcCCCC----CCCccccccccccccCCCCcccc
Q 007073 147 LKKLQFLTLSQNNFSGT----IPDSLTTLSSLISIQLDSNNLSG 186 (619)
Q Consensus 147 l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~ 186 (619)
..+|+.|+|++|+++.. ++..+..+++|+.|++++|+++.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 35799999999999743 45567788999999999999874
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.29 E-value=4e-08 Score=95.68 Aligned_cols=57 Identities=25% Similarity=0.311 Sum_probs=26.4
Q ss_pred CeEEEEeCCCCcccc-CCccccCCCCCCEEEccCCCCCCCCcccccccccCcEeeecC
Q 007073 77 NVASVTLSSMNFSGT-LSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 133 (619)
Q Consensus 77 ~l~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 133 (619)
+|++|||+++.+++. +...+.++++|++|+|+++.+++..+..++.+++|++|+|++
T Consensus 47 ~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 47 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred CCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence 455555555444322 222334445555555555554444444444444555555544
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.09 E-value=7.5e-08 Score=96.46 Aligned_cols=130 Identities=19% Similarity=0.252 Sum_probs=79.5
Q ss_pred CeEEEEeCCCCccc----cCCccccCCCCCCEEEccCCCCCCC-----CcccccccccCcEeeecCCCcccc----CCCc
Q 007073 77 NVASVTLSSMNFSG----TLSPRIGVLRTLSTLTLKGNGITGE-----IPEELGNLSSLTSLDLDNNRLVGK----IPPS 143 (619)
Q Consensus 77 ~l~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~ 143 (619)
.++.|++++|.+.. .+...+...+.|+.|+|++|+|+.. +...+..+++|+.|+|++|.|+.. +...
T Consensus 159 ~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~ 238 (344)
T d2ca6a1 159 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 238 (344)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred ccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccccc
Confidence 55666666665542 1223344567788888888887631 234466777888888888877522 3345
Q ss_pred ccccccchhhhccCCcCCCCCCC----ccc--cccccccccCCCCccccc----CCc----cccccCccccCCCCCC
Q 007073 144 LGNLKKLQFLTLSQNNFSGTIPD----SLT--TLSSLISIQLDSNNLSGQ----IPV----HLFQIPKYNFTGNNLN 206 (619)
Q Consensus 144 ~~~l~~L~~L~l~~N~l~~~~p~----~~~--~l~~L~~L~l~~N~l~~~----~p~----~l~~l~~l~~~~n~~~ 206 (619)
+..+++|++|+|++|.|++.-.. .+. ..+.|+.|++++|+++.. +.. ...++..|+++||.+.
T Consensus 239 l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 239 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp GGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred ccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 66777888888888887632111 121 124678888888887632 111 2335677778887764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.09 E-value=7e-06 Score=77.66 Aligned_cols=142 Identities=14% Similarity=0.065 Sum_probs=84.9
Q ss_pred ccccCCC-ceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCC--ccceeeeeeCCCcceeEecccccch
Q 007073 301 VLGQGGF-GKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN--LLRLIGFCTTPTERLLVYPFMQNLS 377 (619)
Q Consensus 301 ~lg~G~f-g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~gs 377 (619)
.+..|.. +.||+....+|..+++|.-.... ...+..|.+.++.+.... +.+++++...++..++||++++|-+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 3445554 68999998888889999765322 234677888887765433 4567777788888899999998866
Q ss_pred hhhhh-----------------cccCCCCCCc--CHHHHHHH--------------------HHHHHHHHHHHHhcC---
Q 007073 378 VAYRL-----------------REIKPGEPVL--DWVTRKRV--------------------ALGAARGLEYLHEHC--- 415 (619)
Q Consensus 378 L~~~l-----------------~~~~~~~~~l--~~~~~~~i--------------------~~~ia~~L~~LH~~~--- 415 (619)
+.... +......... .......- .......+..+.+..
T Consensus 93 ~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 172 (255)
T d1nd4a_ 93 LLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDG 172 (255)
T ss_dssp TTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSS
T ss_pred cccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCcc
Confidence 54311 1100000000 00000000 000111223332221
Q ss_pred -CCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 416 -NPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 416 -~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
.+.++|+|+.|.||+++++..+-|+||+.+.
T Consensus 173 ~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 173 EDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 2248999999999999988777899999875
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.99 E-value=2.1e-07 Score=93.05 Aligned_cols=110 Identities=19% Similarity=0.250 Sum_probs=84.4
Q ss_pred CCeEEEEeCCCCcccc-----CCccccCCCCCCEEEccCCCCCCC----CcccccccccCcEeeecCCCccccCCC----
Q 007073 76 NNVASVTLSSMNFSGT-----LSPRIGVLRTLSTLTLKGNGITGE----IPEELGNLSSLTSLDLDNNRLVGKIPP---- 142 (619)
Q Consensus 76 ~~l~~L~L~~n~l~~~-----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~---- 142 (619)
..++.|+|++|++... +...+..+++|+.|+|++|.++.. +...+..+++|++|+|++|.|++.-..
T Consensus 186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~ 265 (344)
T d2ca6a1 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 265 (344)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHH
Confidence 4799999999998742 345677899999999999998732 455678899999999999999853222
Q ss_pred cccc--cccchhhhccCCcCCCC----CCCccc-cccccccccCCCCccc
Q 007073 143 SLGN--LKKLQFLTLSQNNFSGT----IPDSLT-TLSSLISIQLDSNNLS 185 (619)
Q Consensus 143 ~~~~--l~~L~~L~l~~N~l~~~----~p~~~~-~l~~L~~L~l~~N~l~ 185 (619)
.+.. .++|+.|++++|+|+.. +...+. ++++|+.|+|++|++.
T Consensus 266 ~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 266 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred HhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 2322 36799999999998732 223332 5678999999999997
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.97 E-value=5.3e-07 Score=87.46 Aligned_cols=118 Identities=19% Similarity=0.228 Sum_probs=60.4
Q ss_pred CCeEEEEeCCC-Ccccc-CCccccCCCCCCEEEccCC-CCCCC-Ccccccc-cccCcEeeecCC--Cccc-cCCCccccc
Q 007073 76 NNVASVTLSSM-NFSGT-LSPRIGVLRTLSTLTLKGN-GITGE-IPEELGN-LSSLTSLDLDNN--RLVG-KIPPSLGNL 147 (619)
Q Consensus 76 ~~l~~L~L~~n-~l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~-l~~L~~L~L~~N--~l~~-~~p~~~~~l 147 (619)
++|+.|+|+++ +++.. +..-+..+++|++|+|+++ .++.. ++..+.. .++|+.|++++. .++. .+...+.++
T Consensus 95 ~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~ 174 (284)
T d2astb2 95 SNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRC 174 (284)
T ss_dssp TTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHC
T ss_pred CCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccccccccccccccccc
Confidence 46788888774 45421 1222345677777777764 34311 1122222 345666666643 2321 122223455
Q ss_pred ccchhhhccCC-cCCCCCCCccccccccccccCCC-CcccccCCcccc
Q 007073 148 KKLQFLTLSQN-NFSGTIPDSLTTLSSLISIQLDS-NNLSGQIPVHLF 193 (619)
Q Consensus 148 ~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~l~ 193 (619)
++|+.|+|++| .+++.....+..+++|++|++++ +.+++.....+.
T Consensus 175 ~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~ 222 (284)
T d2astb2 175 PNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELG 222 (284)
T ss_dssp TTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGG
T ss_pred ccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHh
Confidence 66666666654 35544455566666666666666 345544333333
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.85 E-value=2.6e-07 Score=95.51 Aligned_cols=107 Identities=22% Similarity=0.219 Sum_probs=55.9
Q ss_pred CCCCEEEccCCCCCCCCcc----cccccccCcEeeecCCCcccc----CCCccc-ccccchhhhccCCcCCC----CCCC
Q 007073 100 RTLSTLTLKGNGITGEIPE----ELGNLSSLTSLDLDNNRLVGK----IPPSLG-NLKKLQFLTLSQNNFSG----TIPD 166 (619)
Q Consensus 100 ~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~~~----~p~~~~-~l~~L~~L~l~~N~l~~----~~p~ 166 (619)
..|+.+++++|.++..... .+...++|++|+|++|+|++. ++..+. ..+.|++|+|++|+|+. .+++
T Consensus 312 ~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~ 391 (460)
T d1z7xw1 312 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA 391 (460)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred cccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHH
Confidence 4566666666666533222 223344677777777766531 222222 34556677777777652 1333
Q ss_pred ccccccccccccCCCCcccccCCccc--------cccCccccCCCCCC
Q 007073 167 SLTTLSSLISIQLDSNNLSGQIPVHL--------FQIPKYNFTGNNLN 206 (619)
Q Consensus 167 ~~~~l~~L~~L~l~~N~l~~~~p~~l--------~~l~~l~~~~n~~~ 206 (619)
.+..+++|++|+|++|+|+......+ ..+..|++.+|.+.
T Consensus 392 ~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~ 439 (460)
T d1z7xw1 392 TLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 439 (460)
T ss_dssp HHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred HHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCC
Confidence 44555667777777777653222111 23555666666553
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.62 E-value=3.5e-06 Score=74.48 Aligned_cols=109 Identities=15% Similarity=0.174 Sum_probs=73.2
Q ss_pred CCeEEEEeCCC-Ccccc----CCccccCCCCCCEEEccCCCCCC----CCcccccccccCcEeeecCCCcccc----CCC
Q 007073 76 NNVASVTLSSM-NFSGT----LSPRIGVLRTLSTLTLKGNGITG----EIPEELGNLSSLTSLDLDNNRLVGK----IPP 142 (619)
Q Consensus 76 ~~l~~L~L~~n-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~ 142 (619)
++|++|+|+++ .++.. +-..+...++|++|+|++|.+.. .+...+...+.|+.|+|++|.|+.. +-.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 47999999874 46532 33456667889999999998873 2334455678899999999988732 223
Q ss_pred cccccccchhhhccCCcCCCC-------CCCccccccccccccCCCCcc
Q 007073 143 SLGNLKKLQFLTLSQNNFSGT-------IPDSLTTLSSLISIQLDSNNL 184 (619)
Q Consensus 143 ~~~~l~~L~~L~l~~N~l~~~-------~p~~~~~l~~L~~L~l~~N~l 184 (619)
.+...++|+.|+|++|.+... +...+...++|+.|+++.+..
T Consensus 95 aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 456667888888888876621 122334456777777766644
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.56 E-value=0.00014 Score=73.20 Aligned_cols=77 Identities=13% Similarity=0.118 Sum_probs=47.7
Q ss_pred cCccccCCCceEEEEEeCC-CcEEEEEEeccC------CCcchHHHHHHHHHHHHHcc-C-CC-ccceeeeeeCCCccee
Q 007073 299 KNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDF------ESPGGDAAFQREVEMISVAV-H-RN-LLRLIGFCTTPTERLL 368 (619)
Q Consensus 299 ~~~lg~G~fg~Vy~~~~~~-g~~vAvK~l~~~------~~~~~~~~~~~E~~~l~~l~-H-~n-iv~l~~~~~~~~~~~l 368 (619)
.+.||.|....||+....+ |+.|+||.-... ..+........|.+.++.+. + |. +.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4568999999999998654 678999964321 11122233456888887663 2 33 4445443 4456789
Q ss_pred Eecccccch
Q 007073 369 VYPFMQNLS 377 (619)
Q Consensus 369 v~e~~~~gs 377 (619)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997643
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.90 E-value=3e-05 Score=68.06 Aligned_cols=110 Identities=15% Similarity=0.227 Sum_probs=73.9
Q ss_pred CCeEEEEeCC-CCcccc----CCccccCCCCCCEEEccCCCCCCC----CcccccccccCcEeeecCCCcccc----CCC
Q 007073 76 NNVASVTLSS-MNFSGT----LSPRIGVLRTLSTLTLKGNGITGE----IPEELGNLSSLTSLDLDNNRLVGK----IPP 142 (619)
Q Consensus 76 ~~l~~L~L~~-n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~ 142 (619)
+.|++|+|++ +.++.. +-..+...++|++|+|++|.++.. +-..+...++|+.|++++|.+... +-.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 5789999987 456532 334556788899999999988743 223456678899999999988632 224
Q ss_pred cccccccchh--hhccCCcCCC----CCCCccccccccccccCCCCccc
Q 007073 143 SLGNLKKLQF--LTLSQNNFSG----TIPDSLTTLSSLISIQLDSNNLS 185 (619)
Q Consensus 143 ~~~~l~~L~~--L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~ 185 (619)
.+...++|+. |++++|.+.. .+...+...++|+.|+++.|+..
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 5666777876 4445667652 13334556778888888776553
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.84 E-value=5.2e-05 Score=66.57 Aligned_cols=89 Identities=15% Similarity=0.183 Sum_probs=64.4
Q ss_pred cCCCCCCEEEccCC-CCCCC----CcccccccccCcEeeecCCCccccCC----CcccccccchhhhccCCcCCCC----
Q 007073 97 GVLRTLSTLTLKGN-GITGE----IPEELGNLSSLTSLDLDNNRLVGKIP----PSLGNLKKLQFLTLSQNNFSGT---- 163 (619)
Q Consensus 97 ~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~l~~N~l~~~---- 163 (619)
.+.++|++|+|+++ .++.. +-..+...+.|+.|+|++|.+...-. ..+...+.|+.|+|++|.|+..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 35688999999974 56532 23346677889999999999973222 3445668899999999998732
Q ss_pred CCCccccccccccccCCCCccc
Q 007073 164 IPDSLTTLSSLISIQLDSNNLS 185 (619)
Q Consensus 164 ~p~~~~~l~~L~~L~l~~N~l~ 185 (619)
+-..+...++|+.|++++|.+.
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHHhCCcCCEEECCCCcCC
Confidence 1224556678999999988766
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.84 E-value=0.0032 Score=61.15 Aligned_cols=138 Identities=13% Similarity=0.107 Sum_probs=78.3
Q ss_pred CCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCc--cceee-----eeeCCCcceeEecccccch
Q 007073 305 GGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL--LRLIG-----FCTTPTERLLVYPFMQNLS 377 (619)
Q Consensus 305 G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~~-----~~~~~~~~~lv~e~~~~gs 377 (619)
+.--.||++..++|++|++|..+... ...+++..|.+.+..+...++ +..+. ........+.++++++|..
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~--~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cccceeEEEEcCCCCEEEEEEeCCCC--CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 33468999999999999999875432 235678889988887753332 11111 1223445677888887643
Q ss_pred hhh--------------hhcc----cC-CCCCCcCHHH-------------------HHHHHHHHHHHHHHHHh----cC
Q 007073 378 VAY--------------RLRE----IK-PGEPVLDWVT-------------------RKRVALGAARGLEYLHE----HC 415 (619)
Q Consensus 378 L~~--------------~l~~----~~-~~~~~l~~~~-------------------~~~i~~~ia~~L~~LH~----~~ 415 (619)
+.. .++. .. ......++.. +..+...+.+.++.+.. ..
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~ 190 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF 190 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence 221 1111 00 0111112111 11122222333333332 22
Q ss_pred CCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 416 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 416 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
..++||+|+.+.|||++++ ..++||+-+.
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhcc
Confidence 4478999999999999754 4589999876
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.52 E-value=0.0068 Score=60.42 Aligned_cols=74 Identities=12% Similarity=0.173 Sum_probs=49.3
Q ss_pred cCccccCCCceEEEEEeCCC--------cEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCcc-ceeeeeeCCCcceeE
Q 007073 299 KNVLGQGGFGKVYRGVLADG--------TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL-RLIGFCTTPTERLLV 369 (619)
Q Consensus 299 ~~~lg~G~fg~Vy~~~~~~g--------~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lv 369 (619)
.+.|+.|-.-.+|+....++ +.|.+++.-. .. ......+|..+++.+.-.+++ ++++++. -..|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I 119 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PE-TESHLVAESVIFTLLSERHLGPKLYGIFS----GGRL 119 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceE
Confidence 35788899999999987543 4566665432 22 234556899998887644554 6677663 3689
Q ss_pred ecccccchhh
Q 007073 370 YPFMQNLSVA 379 (619)
Q Consensus 370 ~e~~~~gsL~ 379 (619)
+||+++.++.
T Consensus 120 ~efi~g~~l~ 129 (395)
T d1nw1a_ 120 EEYIPSRPLS 129 (395)
T ss_dssp ECCCCEEECC
T ss_pred EEEeccccCC
Confidence 9999875543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.44 E-value=0.014 Score=56.01 Aligned_cols=158 Identities=11% Similarity=0.038 Sum_probs=79.0
Q ss_pred CHHHHHHHhcCCcccCc-----cccCCCceEEEEEeCCCcEEEEEEeccCCCcchHHHHHHHHHHHHHccCCCc-----c
Q 007073 285 SWRELQLATDNFSEKNV-----LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL-----L 354 (619)
Q Consensus 285 ~~~el~~~~~~~~~~~~-----lg~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~E~~~l~~l~H~ni-----v 354 (619)
+.+|++....+|.+.++ |..|---+.|+....+| .+++|+.....+. ++...|++++..+...++ +
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~~---~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCCH---HHHHHHHHHHHhhhhccccccccc
Confidence 44677777778877544 44666688999988655 5899987543222 334456666666543222 2
Q ss_pred cee-e--eeeCCCcceeEecccccchhhh--------------hhccc----CCC---CCCcCHH---------------
Q 007073 355 RLI-G--FCTTPTERLLVYPFMQNLSVAY--------------RLREI----KPG---EPVLDWV--------------- 395 (619)
Q Consensus 355 ~l~-~--~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~----~~~---~~~l~~~--------------- 395 (619)
... | +.........++.+..+..... .++.. ... .....+.
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 110 0 1111233444455544321110 11100 000 0000000
Q ss_pred -HHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007073 396 -TRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 446 (619)
Q Consensus 396 -~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 446 (619)
.....+..+...+...+. ....++||+|+.++||+++++...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 011112222222222221 124479999999999999998877899999886
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=94.95 E-value=0.00053 Score=59.71 Aligned_cols=92 Identities=21% Similarity=0.204 Sum_probs=64.1
Q ss_pred ccccCCCCCCEEEccC-CCCCCC----CcccccccccCcEeeecCCCcccc----CCCcccccccchhhhccCCcCCCC-
Q 007073 94 PRIGVLRTLSTLTLKG-NGITGE----IPEELGNLSSLTSLDLDNNRLVGK----IPPSLGNLKKLQFLTLSQNNFSGT- 163 (619)
Q Consensus 94 ~~~~~l~~L~~L~L~~-N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~- 163 (619)
....+.++|++|+|++ |.++.. +-..+...++|+.|+|++|.++.. +-..+...++|+.|++++|.+...
T Consensus 11 ~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g 90 (166)
T d1io0a_ 11 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG 90 (166)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchh
Confidence 3345678999999997 567632 233456789999999999998733 223456678899999999988632
Q ss_pred ---CCCcccccccccc--ccCCCCccc
Q 007073 164 ---IPDSLTTLSSLIS--IQLDSNNLS 185 (619)
Q Consensus 164 ---~p~~~~~l~~L~~--L~l~~N~l~ 185 (619)
+-..+...++|+. |++++|++.
T Consensus 91 ~~~l~~~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 91 ILALVEALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred HHHHHHHHHhCccccEEeeccCCCcCc
Confidence 2235566778876 455677775
|